PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Harholt, J; Sorensen, I; Fangel, J; Roberts, A; Willats, WGT; Scheller, HV; Petersen, BL; Banks, A; Ulvskov, P				Harholt, Jesper; Sorensen, Iben; Fangel, Jonatan; Roberts, Alison; Willats, William G. T.; Scheller, Henrik Vibe; Petersen, Bent Larsen; Banks, Ann; Ulvskov, Peter			The Glycosyltransferase Repertoire of the Spikemoss Selaginella moellendorffii and a Comparative Study of Its Cell Wall	PLOS ONE			English	Article							CELLULOSE-SYNTHASE-LIKE; SUSPENSION-CULTURED CELLS; ARABIDOPSIS-THALIANA; MONOCLONAL-ANTIBODY; GLUCURONOXYLAN BIOSYNTHESIS; FUNCTIONAL IDENTIFICATION; BIOINFORMATICS APPROACH; RHAMNOGALACTURONAN-II; VASCULAR PLANTS; GENE FAMILIES	Spike mosses are among the most basal vascular plants, and one species, Selaginella moellendorffii, was recently selected for full genome sequencing by the Joint Genome Institute (JGI). Glycosyltransferases (GTs) are involved in many aspects of a plant life, including cell wall biosynthesis, protein glycosylation, primary and secondary metabolism. Here, we present a comparative study of the S. moellendorffii genome across 92 GT families and an additional family (DUF266) likely to include GTs. The study encompasses the moss Physcomitrella patens, a non-vascular land plant, while rice and Arabidopsis represent commelinid and non-commelinid seed plants. Analysis of the subset of GT-families particularly relevant to cell wall polysaccharide biosynthesis was complemented by a detailed analysis of S. moellendorffii cell walls. The S. moellendorffii cell wall contains many of the same components as seed plant cell walls, but appears to differ somewhat in its detailed architecture. The S. moellendorffii genome encodes fewer GTs (287 GTs including DUF266s) than the reference genomes. In a few families, notably GT51 and GT78, S. moellendorffii GTs have no higher plant orthologs, but in most families S. moellendorffii GTs have clear orthologies with Arabidopsis and rice. A gene naming convention of GTs is proposed which takes orthologies and GT-family membership into account. The evolutionary significance of apparently modern and ancient traits in S. moellendorffii is discussed, as is its use as a reference organism for functional annotation of GTs.	[Harholt, Jesper; Sorensen, Iben; Fangel, Jonatan; Willats, William G. T.; Petersen, Bent Larsen; Ulvskov, Peter] Univ Copenhagen, Dept Plant Biol & Biotechnol, VKR Res Ctr Pro Active Plants, Frederiksberg, Denmark; [Sorensen, Iben] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Roberts, Alison] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Scheller, Henrik Vibe] Joint Bioenergy Inst, Feedstocks Div, Emeryville, CA USA; [Scheller, Henrik Vibe] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Scheller, Henrik Vibe] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Banks, Ann] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	University of Copenhagen; Cornell University; University of Rhode Island; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Harholt, J (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, VKR Res Ctr Pro Active Plants, Frederiksberg, Denmark.	ulvskov@life.ku.dk	Scheller, Henrik/AAH-4770-2020; Scheller, Henrik V/A-8106-2008; Petersen, Bent/H-9437-2014; Harholt, Jesper/F-6865-2014; Ulvskov, Peter/I-1228-2014	Scheller, Henrik/0000-0002-6702-3560; Scheller, Henrik V/0000-0002-6702-3560; Petersen, Bent/0000-0002-2004-9077; Harholt, Jesper/0000-0002-7984-0066; Ulvskov, Peter/0000-0003-3776-818X; Willats, William/0000-0003-2064-4025; Sorensen, Iben/0000-0002-9768-620X	Villum-Kann Rasmussen grant; Danish Research Council [FTP-09-066624]; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DEAC02-05CH11231]; Agriculture and Food Research Initiative Competitive grant from the USDA National Institute of Food and Agriculture [2007-35318-18389]; Villum Fonden [00007173] Funding Source: researchfish	Villum-Kann Rasmussen grant; Danish Research Council(Det Frie Forskningsrad (DFF)); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Agriculture and Food Research Initiative Competitive grant from the USDA National Institute of Food and Agriculture; Villum Fonden(Villum Fonden)	This work was supported by a Villum-Kann Rasmussen grant to the Pro-Active Plant Centre (www.proactiveplants.life.ku.dk), by the Danish Research Council (FTP-09-066624 to PU), by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DEAC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy and by Agriculture and Food Research Initiative Competitive grant no. 2007-35318-18389 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anders N, 2012, P NATL ACAD SCI USA, V109, P989, DOI 10.1073/pnas.1115858109; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Banks JA, 2009, ANNU REV PLANT BIOL, V60, P223, DOI 10.1146/annurev.arplant.59.032607.092851; Bernal AJ, 2007, PLANT J, V52, P791, DOI 10.1111/j.1365-313X.2007.03281.x; Bollig K, 2007, CARBOHYD RES, V342, P2557, DOI 10.1016/j.carres.2007.08.008; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Bown L, 2007, J EXP BOT, V58, P1813, DOI 10.1093/jxb/erm040; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; BURKE D, 1974, PLANT PHYSIOL, V54, P109, DOI 10.1104/pp.54.1.109; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Chatterjee M, 2005, PLANT SCI, V168, P501, DOI 10.1016/j.plantsci.2004.09.015; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Cocuron JC, 2007, P NATL ACAD SCI USA, V104, P8550, DOI 10.1073/pnas.0703133104; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Dhugga KS, 2001, CURR OPIN PLANT BIOL, V4, P488, DOI 10.1016/S1369-5266(00)00205-3; Doblin MS, 2009, P NATL ACAD SCI USA, V106, P5996, DOI 10.1073/pnas.0902019106; Egelund J, 2004, PLANT PHYSIOL, V136, P2609, DOI 10.1104/pp.104.042978; Egelund J, 2008, FEBS LETT, V582, P3217, DOI 10.1016/j.febslet.2008.08.015; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Egelund J, 2006, PLANT CELL, V18, P2593, DOI 10.1105/tpc.105.036566; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Friedman WE, 2000, PHILOS T R SOC B, V355, P857, DOI 10.1098/rstb.2000.0620; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Gunl M, 2011, PLANTA, V233, P707, DOI 10.1007/s00425-010-1330-7; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hansen SF, 2009, J PROTEOME RES, V8, P743, DOI 10.1021/pr800808m; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; Izumi Y, 2003, PLANT CELL PHYSIOL, V44, P183, DOI 10.1093/pcp/pcg028; Jensen JK, 2008, PLANT CELL, V20, P1289, DOI 10.1105/tpc.107.050906; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; KATO Y, 1982, PLANT CELL PHYSIOL, V23, P351, DOI 10.1093/oxfordjournals.pcp.a076357; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumar M, 2009, TRENDS PLANT SCI, V14, P248, DOI 10.1016/j.tplants.2009.02.004; LABAVITCH JM, 1978, PHYTOCHEMISTRY, V17, P933, DOI 10.1016/S0031-9422(00)88649-5; Lao NT, 2003, PLANT MOL BIOL, V53, P687, DOI 10.1023/B:PLAN.0000019074.60542.6c; Li XM, 2004, PLANT PHYSIOL, V134, P940, DOI 10.1104/pp.103.036285; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Liepman AH, 2010, PLANT J, V61, P1107, DOI 10.1111/j.1365-313X.2010.04161.x; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; Manfield IW, 2004, PLANT J, V40, P260, DOI 10.1111/j.1365-313X.2004.02208.x; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Matsunaga T, 2004, PLANT PHYSIOL, V134, P339, DOI 10.1104/pp.103.030072; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MCDOUGALL GJ, 1994, J PLANT PHYSIOL, V143, P591, DOI 10.1016/S0176-1617(11)81143-0; Mitchell RAC, 2007, PLANT PHYSIOL, V144, P43, DOI 10.1104/pp.106.094995; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Nairn CJ, 2005, NEW PHYTOL, V166, P907, DOI 10.1111/j.1469-8137.2005.01372.x; Narimatsu H, 2006, CURR OPIN STRUC BIOL, V16, P567, DOI 10.1016/j.sbi.2006.09.001; Nobles DR, 2001, PLANT PHYSIOL, V127, P529, DOI 10.1104/pp.010557; Obro J, 2004, PHYTOCHEMISTRY, V65, P1429, DOI 10.1016/j.phytochem.2004.05.002; Oikawa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015481; Ordaz-Ortiz JJ, 2009, MOL PLANT, V2, P910, DOI 10.1093/mp/ssp049; Orfila C, 2005, PLANTA, V222, P613, DOI 10.1007/s00425-005-0008-z; Park S, 2011, NAT CELL BIOL, V13, P973, DOI 10.1038/ncb2294; Pena MJ, 2008, GLYCOBIOLOGY, V18, P891, DOI 10.1093/glycob/cwn078; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pettolino FA, 2001, PLANTA, V214, P235, DOI 10.1007/s004250100606; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; RAVEN JA, 1993, BIOL REV, V68, P337, DOI 10.1111/j.1469-185X.1993.tb00735.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Roberts AW, 2007, PLANT MOL BIOL, V63, P207, DOI 10.1007/s11103-006-9083-1; Roberts A, 2007, CHEM IND-LONDON, P17, DOI 10.1007/978-1-4020-5380-1_2; Roberts E, 2009, J PHYCOL, V45, P203, DOI 10.1111/j.1529-8817.2008.00626.x; Sadowski PG, 2008, PROTEOMICS, V8, P3991, DOI 10.1002/pmic.200800217; Sarria R, 2001, PLANT PHYSIOL, V127, P1595, DOI 10.1104/pp.010596; Saxena IM, 2000, CURR OPIN PLANT BIOL, V3, P523, DOI 10.1016/S1369-5266(00)00125-4; Scheller HV, 2007, PHYSIOL PLANTARUM, V129, P283, DOI 10.1111/j.1399-3054.2006.00834.x; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Singh SK, 2005, PLANT J, V43, P384, DOI 10.1111/j.1365-313X.2005.02455.x; Sorensen I, 2008, PLANT J, V54, P510, DOI 10.1111/j.1365-313X.2008.03453.x; Sorensen I, 2010, PLANT PHYSIOL, V153, P366, DOI 10.1104/pp.110.154427; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Stone BA, 2010, PLANT POLYSACCHARIDE, P09; Strasser R, 2000, FEBS LETT, V472, P105, DOI 10.1016/S0014-5793(00)01443-5; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Tounou Eiichirou, 2002, Cytologia (Tokyo), V67, P429, DOI 10.1508/cytologia.67.429; TSEKOS I, 1994, J PHYCOL, V30, P300, DOI 10.1111/j.0022-3646.1994.00300.x; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Wang WM, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-10; Wende G, 1997, PHYTOCHEMISTRY, V44, P1019, DOI 10.1016/S0031-9422(96)00649-8; Weng JK, 2008, P NATL ACAD SCI USA, V105, P7887, DOI 10.1073/pnas.0801696105; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Xu JF, 2008, PHYTOCHEMISTRY, V69, P1631, DOI 10.1016/j.phytochem.2008.02.006; Xu ZY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S3; Yin L, 2011, MOL PLANT, V4, P1024, DOI 10.1093/mp/ssr026; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Yokoyama R, 2004, PLANT CELL PHYSIOL, V45, P1111, DOI 10.1093/pcp/pch151; York WS, 2008, CURR OPIN PLANT BIOL, V11, P258, DOI 10.1016/j.pbi.2008.02.007; Zabotina OA, 2008, PLANT J, V56, P101, DOI 10.1111/j.1365-313X.2008.03580.x; Zhou YH, 2009, PLANT J, V57, P446, DOI 10.1111/j.1365-313X.2008.03703.x	111	53	53	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35846	10.1371/journal.pone.0035846	http://dx.doi.org/10.1371/journal.pone.0035846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567114	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500032
J	Mishra, P; Das, S; Panicker, L; Hosur, MV; Sharma, S; Hosur, RV				Mishra, Pushpa; Das, Sudipta; Panicker, Lata; Hosur, Madhusoodan V.; Sharma, Shobhona; Hosur, Ramakrishna V.			NMR Insights into Folding and Self-Association of Plasmodium falciparum P2	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SECONDARY STRUCTURE PREDICTION; DENATURED STATE ENSEMBLE; GTPASE-ASSOCIATED CENTER; ESCHERICHIA-COLI; PROTEIN-STRUCTURE; INITIATION-SITES; SACCHAROMYCES-CEREVISIAE; STRUCTURAL GENOMICS; NONNATIVE PROTEIN	The eukaryotic 60S-ribosomal stalk is composed of acidic ribosomal proteins (P1 and P2) and neutral protein P0, which are thought to be associated as a pentameric structure, [2P1, 2P2, P0]. Plasmodium falciparum P2 (PfP2) appears to play additional non-ribosomal functions associated with its tendency for homo-oligomerization. Recombinant bacterially expressed PfP2 protein also undergoes self-association, as shown by SDS-PAGE analysis and light scattering studies. Secondary structure prediction algorithms predict the native PfP2 protein to be largely helical and this is corroborated by circular dichroism investigation. The H-1-N-15 HSQC spectrum of native P2 showed only 43 cross peaks compared to the expected 138. The observed peaks were found to belong to the C-terminal region, suggesting that this segment is flexible and solvent exposed. In 9 M urea denaturing conditions the chain exhibited mostly non-native beta structural propensity. N-15 Relaxation data for the denatured state indicated substantial variation in ms-mu s time scale motion along the chain. Average area buried upon folding (AABUF) calculations on the monomer enabled identification of hydrophobic patches along the sequence. Interestingly, the segments of slower motion in the denatured state coincided with these hydrophobic patches, suggesting that in the denatured state the monomeric chain undergoes transient hydrophobic collapse. The implications of these results for the folding mechanism and self-association of PfP2 are discussed.	[Mishra, Pushpa; Hosur, Ramakrishna V.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Das, Sudipta; Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Panicker, Lata; Hosur, Madhusoodan V.] Bhabha Atom Res Ctr, Dept Solid State Phys Div, Bombay 400085, Maharashtra, India; [Hosur, Ramakrishna V.] UM DAE Ctr Excellence Basic Sci, Bombay, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR); Bhabha Atomic Research Center (BARC); UM-DAE Centre for Excellence in Basic Sciences	Mishra, P (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	hosur@tifr.res.in		Hosur, Madhusoodan/0000-0003-1012-0906; DAS, SUDIPTA/0000-0002-8644-7342	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	The work was supported by the Department of Atomic Energy, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BALDWIN RL, 1989, TRENDS BIOCHEM SCI, V14, P291, DOI 10.1016/0968-0004(89)90067-4; Beaucage G, 2008, BIOPHYS J, V95, P503, DOI 10.1529/biophysj.107.121855; Bhavesh NS, 2001, BIOCHEMISTRY-US, V40, P14727, DOI 10.1021/bi015683p; BUSHUEV VN, 1989, J BIOL CHEM, V264, P4498; Chakraborty S, 2011, J MOL BIOL, V405, P1202, DOI 10.1016/j.jmb.2010.11.050; Chatterjee A, 2002, BIOCHEM BIOPH RES CO, V293, P427, DOI 10.1016/S0006-291X(02)00240-1; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chugh J, 2007, BIOCHEMISTRY-US, V46, P11819, DOI 10.1021/bi701280p; Chugh J, 2009, ARCH BIOCHEM BIOPHYS, V481, P169, DOI 10.1016/j.abb.2008.11.002; Chugha P, 2007, BIOCHEMISTRY-US, V46, P1141, DOI 10.1021/bi061371g; Claes P. D. M., 1992, LASER LIGHT SCATTERI, P66; Dadlez M, 1999, ACTA BIOCHIM POL, V46, P487, DOI 10.18388/abp.1999_4126; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; Ecroyd H, 2008, IUBMB LIFE, V60, P769, DOI 10.1002/iub.117; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; Freund SMV, 1996, P NATL ACAD SCI USA, V93, P10600, DOI 10.1073/pnas.93.20.10600; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; Goswami A, 1997, J BIOL CHEM, V272, P12138, DOI 10.1074/jbc.272.18.12138; Grela P, 2008, J BIOCHEM, V143, P169, DOI 10.1093/jb/mvm207; GUDKOV AT, 1978, EUR J BIOCHEM, V90, P313, DOI 10.1111/j.1432-1033.1978.tb12606.x; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Hass MAS, 2006, MAGN RESON CHEM, V44, P761, DOI 10.1002/mrc.1845; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Justice MC, 1999, J BIOL CHEM, V274, P4869, DOI 10.1074/jbc.274.8.4869; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Kiefhaber T, 1997, BIOCHEMISTRY-US, V36, P5108, DOI 10.1021/bi9702391; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kumar A, 2006, BIOPHYS J, V90, P2498, DOI 10.1529/biophysj.105.071746; Le Duff CS, 2006, J MOL BIOL, V364, P824, DOI 10.1016/j.jmb.2006.09.037; Lee JP, 2002, BIOPHYS J, V82, p304A; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P5206, DOI 10.1093/nar/gkq231; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; LEIJONMARCK M, 1987, J MOL BIOL, V195, P555, DOI 10.1016/0022-2836(87)90183-5; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; McCarney ER, 2005, CRIT REV BIOCHEM MOL, V40, P181, DOI 10.1080/10409230591008143; MEILER J, JUFO SECONDARY STRUC; Naganuma T, 2007, GENES CELLS, V12, P501, DOI 10.1111/j.1365-2443.2007.01067.x; OTZEN DE, 1994, P NATL ACAD SCI USA, V91, P10422, DOI 10.1073/pnas.91.22.10422; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Penkett CJ, 1997, J MOL BIOL, V274, P152, DOI 10.1006/jmbi.1997.1369; Permi P, 2004, PROG NUCL MAG RES SP, V44, P97, DOI 10.1016/j.pnmrs.2003.12.001; PTITSYN OB, 1975, BIOPHYS CHEM, V3, P1, DOI 10.1016/0301-4622(75)80033-0; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryabov Y, 2011, J AM CHEM SOC, V133, P6154, DOI 10.1021/ja201020c; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; Sagle LB, 2009, J AM CHEM SOC, V131, P9304, DOI 10.1021/ja9016057; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Stumpe MC, 2009, BIOPHYS J, V96, P3744, DOI 10.1016/j.bpj.2009.01.051; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; Tchorzewski M, 2000, INT J BIOCHEM CELL B, V32, P737, DOI 10.1016/S1357-2725(00)00017-0; Tchorzewski M, 2003, BIOCHEMISTRY-US, V42, P3399, DOI 10.1021/bi0206006; Tchorzewski M, 2000, BBA-MOL CELL RES, V1499, P63, DOI 10.1016/S0167-4889(00)00108-7; Tozawa K, 2005, BIOCHEMISTRY-US, V44, P11496, DOI 10.1021/bi0503596; Tugarinov V, 2004, ANNU REV BIOCHEM, V73, P107, DOI 10.1146/annurev.biochem.73.011303.074004; UCHIUMI T, 1987, P NATL ACAD SCI USA, V84, P5580, DOI 10.1073/pnas.84.16.5580; Uchiumi T, 1997, J BIOL CHEM, V272, P3302, DOI 10.1074/jbc.272.6.3302; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wishart DS, 1994, NUCL MAGNETIC RESO C, P363; Zurdo J, 2000, BIOCHEMISTRY-US, V39, P8929, DOI 10.1021/bi000362j	80	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36279	10.1371/journal.pone.0036279	http://dx.doi.org/10.1371/journal.pone.0036279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567147	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500066
J	Raymond, JA; Kim, HJ				Raymond, James A.; Kim, Hak Jun			Possible Role of Horizontal Gene Transfer in the Colonization of Sea Ice by Algae	PLOS ONE			English	Article							DIATOM FRAGILARIOPSIS-CYLINDRUS; ANTIFREEZE PROTEINS; BINDING PROTEINS; MICROBIAL COMMUNITIES; MCMURDO-SOUND; BACTERIA; ANTARCTICA; EVOLUTION; GENOME; MICROORGANISMS	Diatoms and other algae not only survive, but thrive in sea ice. Among sea ice diatoms, all species examined so far produce ice-binding proteins (IBPs), whereas no such proteins are found in non-ice-associated diatoms, which strongly suggests that IBPs are essential for survival in ice. The restricted occurrence also raises the question of how the IBP genes were acquired. Proteins with similar sequences and ice-binding activities are produced by ice-associated bacteria, and so it has previously been speculated that the genes were acquired by horizontal transfer (HGT) from bacteria. Here we report several new IBP sequences from three types of ice algae, which together with previously determined sequences reveal a phylogeny that is completely incongruent with algal phylogeny, and that can be most easily explained by HGT. HGT is also supported by the finding that the closest matches to the algal IBP genes are all bacterial genes and that the algal IBP genes lack introns. We also describe a highly freeze-tolerant bacterium from the bottom layer of Antarctic sea ice that produces an IBP with 47% amino acid identity to a diatom IBP from the same layer, demonstrating at least an opportunity for gene transfer. Together, these results suggest that the success of diatoms and other algae in sea ice can be at least partly attributed to their acquisition of prokaryotic IBP genes.	[Raymond, James A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Kim, Hak Jun] Korea Polar Res Inst, Div Polar Life Sci, Inchon, South Korea; [Kim, Hak Jun] Univ Sci & Technol, Dept Polar Sci, Inchon, South Korea	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Raymond, JA (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	raymond@unlv.nevada.edu			NSF [0088000]; National Agenda Project from The Korea Research Council of Fundamental Science & Technology (KRCF); Korea Polar Research Institute (KOPRI) [PG11010, PE11100]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Agenda Project from The Korea Research Council of Fundamental Science & Technology (KRCF); Korea Polar Research Institute (KOPRI); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Collections of sea ice and diatom samples in McMurdo Sound, Antarctica, were supported by NSF grant 0088000 to JR. The Pyramimonas studies and part of the F. frigoris studies were supported by the National Agenda Project from The Korea Research Council of Fundamental Science & Technology (KRCF) and the Korea Polar Research Institute (KOPRI) (Grant nos. PG11010 and PE11100 to HJK). Additional material support was provided by the University of Nevada Las Vegas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2011, J MOL MICROB BIOTECH, V20, P83, DOI 10.1159/000324505; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001138; Bayer-Giraldi M, 2011, CRYOBIOLOGY, V63, P210, DOI 10.1016/j.cryobiol.2011.08.006; Bayer-Giraldi M, 2010, ENVIRON MICROBIOL, V12, P1041, DOI 10.1111/j.1462-2920.2009.02149.x; Belbahri L, 2008, GENE, V408, P1, DOI 10.1016/j.gene.2007.10.019; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Collins RE, 2011, POLAR BIOL, V34, P1831, DOI 10.1007/s00300-011-1008-z; Collins RE, 2011, POLAR BIOL, V34, P1819, DOI 10.1007/s00300-011-1041-y; Derelle E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002250; Finneran KT, 2003, INT J SYST EVOL MICR, V53, P669, DOI 10.1099/ijs.0.02298-0; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Goldenfeld N, 2007, NATURE, V445, P369, DOI 10.1038/445369a; Gosink JJ, 1998, INT J SYST BACTERIOL, V48, P223, DOI 10.1099/00207713-48-1-223; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; GROSSI SM, 1984, MICROBIAL ECOL, V10, P231; Gwak IG, 2010, MAR BIOTECHNOL, V12, P630, DOI 10.1007/s10126-009-9250-x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Horner R., 1985, P147; Hoshino T, 2003, CAN J BOT, V81, P1175, DOI [10.1139/b03-116, 10.1139/B03-116]; Hwang YS, 2008, BIOCHEM BIOPH RES CO, V367, P635, DOI 10.1016/j.bbrc.2007.12.176; Janech MG, 2006, J PHYCOL, V42, P410, DOI 10.1111/j.1529-8817.2006.00208.x; Johnson DB, 2001, ENVIRON MICROBIOL, V3, P630, DOI 10.1046/j.1462-2920.2001.00234.x; Kiko R, 2010, POLAR BIOL, V33, P543, DOI 10.1007/s00300-009-0732-0; Krell A, 2007, J PHYCOL, V43, P753, DOI 10.1111/j.1529-8817.2007.00366.x; Krembs C, 2011, P NATL ACAD SCI USA, V108, P3653, DOI 10.1073/pnas.1100701108; Kropuenske LR, 2010, J PHYCOL, V46, P1138, DOI 10.1111/j.1529-8817.2010.00922.x; Lee JK, 2010, CRYOBIOLOGY, V60, P222, DOI 10.1016/j.cryobiol.2010.01.002; MCFADDEN GI, 1982, PHYCOLOGIA, V21, P103, DOI 10.2216/i0031-8884-21-2-103.1; Mock T, 2004, J PHYCOL, V40, P732, DOI 10.1111/j.1529-8817.2004.03224.x; Monier A, 2009, GENOME RES, V19, P1441, DOI 10.1101/gr.091686.109; Morgan-Kiss RM, 2006, MICROBIOL MOL BIOL R, V70, P222, DOI 10.1128/MMBR.70.1.222-252.2006; Park S, 2010, PLANTA, V231, P349, DOI 10.1007/s00425-009-1044-x; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; Price PB, 2000, P NATL ACAD SCI USA, V97, P1247, DOI 10.1073/pnas.97.3.1247; Rampen SW, 2009, J PHYCOL, V45, P444, DOI 10.1111/j.1529-8817.2009.00657.x; RAYMOND JA, 1994, POLAR BIOL, V14, P71; Raymond JA, 2003, CRYOBIOLOGY, V46, P203, DOI 10.1016/S0011-2240(03)00026-9; Raymond JA, 2001, CRYOBIOLOGY, V43, P63, DOI 10.1006/cryo.2001.2341; Raymond JA, 2008, EXTREMOPHILES, V12, P713, DOI 10.1007/s00792-008-0178-2; Raymond JA, 2007, FEMS MICROBIOL ECOL, V61, P214, DOI 10.1111/j.1574-6941.2007.00345.x; Raymond JA, 2009, J PHYCOL, V45, P130, DOI 10.1111/j.1529-8817.2008.00623.x; Raymond JA, 2009, CRYOBIOLOGY, V58, P151, DOI 10.1016/j.cryobiol.2008.11.009; SULLIVAN CW, 1984, APPL ENVIRON MICROB, V47, P788, DOI 10.1128/AEM.47.4.788-795.1984; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Wenzl P, 2005, MOL BIOL EVOL, V22, P308, DOI 10.1093/molbev/msi018; Yu Y, 2009, POLAR BIOL, V32, P1539, DOI 10.1007/s00300-009-0654-x	50	68	69	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35968	10.1371/journal.pone.0035968	http://dx.doi.org/10.1371/journal.pone.0035968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567121	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500039
J	Laichoubi, KB; Espinosa, J; Castells, MA; Contreras, A				Boumediene Laichoubi, Karim; Espinosa, Javier; Angel Castells, Miguel; Contreras, Asuncion			Mutational Analysis of the Cyanobacterial Nitrogen Regulator PipX	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PROTEIN; SP STRAIN PCC-7942; SYNECHOCOCCUS-SP PCC-7942; ACETYL GLUTAMATE KINASE; YEAST 2-HYBRID SYSTEM; GLNB GENE-PRODUCT; P-II PROTEIN; ACETYLGLUTAMATE KINASE; TRANSCRIPTION FACTOR; DOMAIN INTERACTIONS	PipX provides a functional link between the cyanobacterial global transcriptional regulator NtcA and the signal transduction protein PII, a protein found in all three domains of life as integrators of signals of the nitrogen and carbon balance. PipX, which is toxic in the absence of PII, can form alternative complexes with NtcA and PII and these interactions are respectively stimulated and inhibited by 2-oxoglutarate, providing a mechanism by which PII can modulate expression at the NtcA regulon. Structural information on PipX-NtcA complexes suggests that PipX coactivates NtcA controlled genes by stabilizing the active conformation of NtcA bound to 2-oxoglutarate and by possibly helping recruit RNA polymerase. To get insights into PipX functions, we perform here a mutational analysis of pipX informed by the structures of PipX-PII and PipX-NtcA complexes and evaluate the impact of point mutations on toxicity and gene expression. Two amino acid substitutions (Y32A and E4A) were of particular interest, since they increased PipX toxicity and activated NtcA dependent genes in vivo at lower 2-oxoglutarate levels than wild type PipX. While both mutations impaired complex formation with PII, only Y32A had a negative impact on PipX-NtcA interactions.	[Boumediene Laichoubi, Karim; Espinosa, Javier; Angel Castells, Miguel; Contreras, Asuncion] Univ Alicante, Div Genet, E-03080 Alicante, Spain	Universitat d'Alacant	Laichoubi, KB (corresponding author), Univ Alicante, Div Genet, E-03080 Alicante, Spain.	contrera@ua.es	Espinosa, Javier/B-2595-2012; Contreras, Asunción/K-2159-2012	Espinosa, Javier/0000-0003-0669-4974; Contreras, Asunción/0000-0001-6591-9294	Ministerio de Ciencia e Innovacion [BFU2009-07371]; Generalitat Valenciana [ACOMP2011/211]; Universidad de Alicante	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universidad de Alicante	This work was supported by the Ministerio de Ciencia e Innovacion (grant BFU2009-07371), the Generalitat Valenciana (ACOMP2011/211), and the Universidad de Alicante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldehni MF, 2006, ARCH MICROBIOL, V184, P378, DOI 10.1007/s00203-005-0056-6; Aldehni MF, 2003, J BACTERIOL, V185, P2582, DOI 10.1128/JB.185.8.2582-2591.2003; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Burillo S, 2004, J BACTERIOL, V186, P3346, DOI 10.1128/JB.186.11.3346-3354.2004; Chen YM, 2006, J BIOL CHEM, V281, P5726, DOI 10.1074/jbc.M510945200; Espinosa J, 2007, MICROBIOL-SGM, V153, P711, DOI 10.1099/mic.0.2006/003574-0; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Espinosa J, 2010, MICROBIOL-SGM, V156, P1517, DOI 10.1099/mic.0.037309-0; Espinosa J, 2009, J BACTERIOL, V191, P4863, DOI 10.1128/JB.00557-09; Fokina O, 2011, BIOCH J; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; FORCHHAMMER K, 1995, J BACTERIOL, V177, P5812, DOI 10.1128/jb.177.20.5812-5817.1995; FORCHHAMMER K, 1995, J BACTERIOL, V177, P2033, DOI 10.1128/jb.177.8.2033-2040.1995; FORCHHAMMER K, 1994, J BACTERIOL, V176, P84, DOI 10.1128/JB.176.1.84-91.1994; Forchhammer K, 2010, ADV EXP MED BIOL, V675, P71, DOI 10.1007/978-1-4419-1528-3_5; GOLDEN SS, 1984, J BACTERIOL, V158, P36, DOI 10.1128/JB.158.1.36-42.1984; Hanahan D., 1985, DNA CLONING PRACTICA, P109; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Laurent S, 2005, P NATL ACAD SCI USA, V102, P9907, DOI 10.1073/pnas.0502337102; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Llacer JL, 2010, P NATL ACAD SCI USA, V107, P15397, DOI 10.1073/pnas.1007015107; Luque I, 2001, MOL MICROBIOL, V41, P937, DOI 10.1046/j.1365-2958.2001.02566.x; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; Martinez-Argudo I, 2002, J BACTERIOL, V184, P3746, DOI 10.1128/JB.184.13.3746-3748.2002; Martinez-Argudo I, 2002, J BACTERIOL, V184, P200, DOI 10.1128/JB.184.1.200-206.2002; Martinez-Argudo I, 2001, MOL MICROBIOL, V40, P169, DOI 10.1046/j.1365-2958.2001.02369.x; Muro-Pastor MI, 2001, J BIOL CHEM, V276, P38320; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; Ohashi Y, 2011, J EXP BOT, V62, P1411, DOI 10.1093/jxb/erq427; Radchenko M, 2011, BIOCHEM SOC T, V39, P189, DOI 10.1042/BST0390189; Salinas P, 2003, MOL GENET GENOMICS, V269, P574, DOI 10.1007/s00438-003-0866-7; Sambrook J., 2002, MOL CLONING LAB MANU; Sauer J, 2000, J BACTERIOL, V182, P5615, DOI 10.1128/JB.182.19.5615-5619.2000; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Sugiyama K, 2004, PLANT CELL PHYSIOL, V45, P1768, DOI 10.1093/pcp/pch199; Tanigawa R, 2002, P NATL ACAD SCI USA, V99, P4251, DOI 10.1073/pnas.072587199; Valladares A, 2011, J BACTERIOL, V193, P1172, DOI 10.1128/JB.01202-10; Vazquez-Bermudez MF, 2002, FEBS LETT, V512, P71, DOI 10.1016/S0014-5793(02)02219-6; Zhao MX, 2010, J MOL BIOL, V402, P552, DOI 10.1016/j.jmb.2010.08.006; Zhao MX, 2010, P NATL ACAD SCI USA, V107, P12487, DOI 10.1073/pnas.1001556107	41	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35845	10.1371/journal.pone.0035845	http://dx.doi.org/10.1371/journal.pone.0035845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558239	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200025
J	Cao, L; Lim, T; Jun, SM; Thornburg, T; Avci, R; Yang, XH				Cao, Ling; Lim, Timothy; Jun, SangMu; Thornburg, Theresa; Avci, Recep; Yang, Xinghong			Vulnerabilities in Yersinia pestis caf Operon Are Unveiled by a Salmonella Vector	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; PNEUMONIC PLAGUE; POLYMYXIN-B; ANTIGEN; VACCINE; MACROPHAGES; PROTECTION; IDENTIFICATION; PHAGOCYTOSIS	During infection, Yersinia pestis uses its F1 capsule to enhance survival and cause virulence to mammalian host. Since F1 is produced in large quantities and secreted into the host tissues, it also serves as a major immune target. To hold this detrimental effect under proper control, Y. pestis expresses the caf operon (encoding the F1 capsule) in a temperature-dependent manner. However, additional properties of the caf operon limit its expression. By overexpressing the caf operon in wild-type Salmonella enterica serovar Typhimurium under a potent promoter, virulence of Salmonella was greatly attenuated both in vitro and in vivo. In contrast, expression of the caf operon under the regulation of its native promoter exhibited negligible impairment of Salmonellae virulence. In-depth investigation revealed all individual genes in the caf operon attenuated Salmonella when overexpressed. The deleterious effects of caf operon and the caf individual genes were further confirmed when they were overexpressed in Y. pestis KIM6+. This study suggests that by using a weak inducible promoter, the detrimental effects of the caf operon are minimally manifested in Y. pestis. Thus, through tight regulation of the caf operon, Y. pestis precisely balances its capsular anti-phagocytic properties with the detrimental effects of caf during interaction with mammalian host.	[Cao, Ling; Avci, Recep] Montana State Univ, Dept Phys, Imaging & Chem Anal Lab, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Cao, L (corresponding author), Montana State Univ, Dept Phys, Imaging & Chem Anal Lab, Bozeman, MT 59717 USA.	yangxh@montana.edu	Yang, Xinghong/A-5473-2012		National Institute of Allergy and Infectious Diseases [R21 AI-080960]; National Center for Research Resources [RR020185-09]; National Institute of General Medical Sciences from the National Institutes of Health [GM103500-09]; M.J. Murdock Charitable Trust, Montana Agricultural Station; U.S. Department of Agriculture Formula Funds; Office of Navy Research Award [N00014-10-1-0946]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103500] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); M.J. Murdock Charitable Trust, Montana Agricultural Station; U.S. Department of Agriculture Formula Funds(United States Department of Agriculture (USDA)); Office of Navy Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants from National Institute of Allergy and Infectious Diseases (R21 AI-080960), National Center for Research Resources (RR020185-09), and the National Institute of General Medical Sciences (GM103500-09) from the National Institutes of Health. It is supported in part by an equipment grant from the M.J. Murdock Charitable Trust, Montana Agricultural Station, and U.S. Department of Agriculture Formula Funds. It is also supported in part by Office of Navy Research Award (N00014-10-1-0946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Alvarez ML, 2010, BIOTECHNOL ADV, V28, P184, DOI 10.1016/j.biotechadv.2009.11.006; Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; Andrews GP, 1996, INFECT IMMUN, V64, P2180, DOI 10.1128/IAI.64.6.2180-2187.1996; Anisimov AP, 2005, INFECT IMMUN, V73, P7324, DOI 10.1128/IAI.73.11.7324-7331.2005; Bearden SW, 2008, CURR PROC MICROBIOL; CHARNETZKY WT, 1985, INFECT IMMUN, V47, P234, DOI 10.1128/IAI.47.1.234-241.1985; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; Douglass II W. C., 2003, HYDROGEN PEROXIDE ME; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; Goto S, 1995, J INFECT CHEMOTHER, V1, P133, DOI [10.1007/BF02348758, DOI 10.1007/BF02348758]; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Meka-Mechenko TV, 2003, ADV EXP MED BIOL, V529, P379; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Pascual DW, 2002, INFECT IMMUN, V70, P4273, DOI 10.1128/IAI.70.8.4273-4281.2002; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PERRY RD, 1990, J BACTERIOL, V172, P5929, DOI 10.1128/jb.172.10.5929-5937.1990; Perry RD, 2011, MICROBES INFECT, V13, P808, DOI 10.1016/j.micinf.2011.04.008; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Prouty AM, 2002, J BACTERIOL, V184, P1270, DOI 10.1128/JB.184.5.1270-1276.2002; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Quenee LE, 2008, INFECT IMMUN, V76, P2025, DOI 10.1128/IAI.00105-08; Ramos-Morales F, 2003, J BACTERIOL, V185, P5328, DOI 10.1128/JB.185.17.5328-5332.2003; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Runco LM, 2008, J BACTERIOL, V190, P3381, DOI 10.1128/JB.01840-07; RUSSELL P, 1995, VACCINE, V13, P1551, DOI 10.1016/0264-410X(95)00090-N; SCHMIDT G, 1987, J CLIN MICROBIOL, V25, P1993, DOI 10.1128/JCM.25.10.1993-1998.1987; Sebbane F, 2009, INFECT IMMUN, V77, P1222, DOI 10.1128/IAI.00950-08; Sikora AE, 2007, J BACTERIOL, V189, P8484, DOI 10.1128/JB.00583-07; Soliakov A, 2010, VACCINE, V28, P5746, DOI 10.1016/j.vaccine.2010.05.074; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Suo ZY, 2009, LANGMUIR, V25, P4588, DOI 10.1021/la8033319; Urakawa H, 2010, BIOORG MED CHEM LETT, V20, P1771, DOI 10.1016/j.bmcl.2010.01.040; Vaara M, 2010, CURR OPIN MICROBIOL, V13, P574, DOI 10.1016/j.mib.2010.09.002; Walters N, 2005, INFECT IMMUN, V73, P317, DOI 10.1128/IAI.73.1.317-324.2005; Weening EH, 2011, INFECT IMMUN, V79, P644, DOI 10.1128/IAI.00981-10; Williamson ED, 2009, VACCINE, V27, pD56, DOI 10.1016/j.vaccine.2009.07.068; WU SG, 1995, INFECT IMMUN, V63, P4933, DOI 10.1128/IAI.63.12.4933-4938.1995; Yang XH, 2007, J IMMUNOL, V178, P1059, DOI 10.4049/jimmunol.178.2.1059; Yang XH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/632396; Yang XH, 2012, VIRULENCE, V3, P29, DOI 10.4161/viru.3.1.18447; Zhang SS, 2008, J BIOL CHEM, V283, P31511, DOI 10.1074/jbc.M804646200	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36283	10.1371/journal.pone.0036283	http://dx.doi.org/10.1371/journal.pone.0036283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558420	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200061
J	Wong, KA; Wilson, J; Russo, A; Wang, L; Okur, MN; Wang, XR; Martin, NP; Scappini, E; Carnegie, GK; O'Bryan, JP				Wong, Katy A.; Wilson, Jessica; Russo, Angela; Wang, Li; Okur, Mustafa Nazir; Wang, Xuerong; Martin, Negin P.; Scappini, Erica; Carnegie, Graeme K.; O'Bryan, John P.			Intersectin (ITSN) Family of Scaffolds Function as Molecular Hubs in Protein Interaction Networks	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ADAPTER PROTEIN; EPS15 HOMOLOGY; BINDING; ENDOCYTOSIS; MEMBRANE; RAS; UBIQUITYLATION; VISUALIZATION; PARALLEL	Members of the intersectin (ITSN) family of scaffold proteins consist of multiple modular domains, each with distinct ligand preferences. Although ITSNs were initially implicated in the regulation of endocytosis, subsequent studies have revealed a more complex role for these scaffold proteins in regulation of additional biochemical pathways. In this study, we performed a high throughput yeast two-hybrid screen to identify additional pathways regulated by these scaffolds. Although several known ITSN binding partners were identified, we isolated more than 100 new targets for the two mammalian ITSN proteins, ITSN1 and ITSN2. We present the characterization of several of these new targets which implicate ITSNs in the regulation of the Rab and Arf GTPase pathways as well as regulation of the disrupted in schizophrenia 1 (DISC1) interactome. In addition, we demonstrate that ITSN proteins form homomeric and heteromeric complexes with each other revealing an added level of complexity in the function of these evolutionarily conserved scaffolds.	[Wong, Katy A.; Wilson, Jessica; Russo, Angela; Wang, Li; Okur, Mustafa Nazir; Wang, Xuerong; Carnegie, Graeme K.; O'Bryan, John P.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA; [Wong, Katy A.; Wilson, Jessica; Russo, Angela; Okur, Mustafa Nazir; Wang, Xuerong; O'Bryan, John P.] Univ Illinois, Coll Med, Cardiovasc Res Ctr, Chicago, IL USA; [Wong, Katy A.; Wilson, Jessica; Russo, Angela; Okur, Mustafa Nazir; Wang, Xuerong; O'Bryan, John P.] Univ Illinois, Coll Med, UIC Canc Ctr, Chicago, IL USA; [Okur, Mustafa Nazir] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL USA; [Martin, Negin P.; Scappini, Erica] NIEHS, Neurobiol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wong, KA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA.	obryanj@uic.edu	Scappini, Erica/C-7684-2019	Scappini, Erica/0000-0002-9100-0027; Martin, Negin/0000-0003-3166-8989; O'Bryan, John/0000-0001-5386-1080	Foundation Jerome Lejeune; American Heart Association [11SDG5230003]; National Institutes of Health; National Institutes of Health [HL090651]; Department of Defense [PR080428]; St. Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090651] Funding Source: NIH RePORTER	Foundation Jerome Lejeune; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); St. Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	KAW was supported by a grant from the Foundation Jerome Lejeune, and LW and GKC were supported by an American Heart Association grant (11SDG5230003). These studies were supported by funds from the intramural research program of the National Institutes of Health (JPO) and by grants to JPO from the National Institutes of Health (HL090651), Department of Defense (PR080428), the Foundation Jerome Lejeune, and the St. Baldrick's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 2000, J BIOL CHEM, V275, P27414; Boxall R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016263; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Cupers P, 1997, J BIOL CHEM, V272, P33430, DOI 10.1074/jbc.272.52.33430; Das M, 2007, MOL CELL BIOL, V27, P7906, DOI 10.1128/MCB.01369-07; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Martin NP, 2006, MOL PHARMACOL, V70, P1643, DOI 10.1124/mol.106.028274; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mohney RP, 2003, J BIOL CHEM, V278, P47038, DOI 10.1074/jbc.M303895200; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nakatsu F, 2010, J CELL BIOL, V190, P307, DOI 10.1083/jcb.201005018; Nikolaienko O, 2009, CELL SIGNAL, V21, P753, DOI 10.1016/j.cellsig.2009.01.013; O'Bryan JP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3152re10; O'Bryan JP, 1998, J BIOL CHEM, V273, P20431, DOI 10.1074/jbc.273.32.20431; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Okur MN, 2012, MOL CELL BIOL, V32, P817, DOI 10.1128/MCB.05647-11; Pechstein A, 2010, BIOCHEM SOC T, V38, P181, DOI 10.1042/BST0380181; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Pucharcos C, 1999, EUR J HUM GENET, V7, P704, DOI 10.1038/sj.ejhg.5200356; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Rose S, 2007, MOL BIOL CELL, V18, P5091, DOI 10.1091/mbc.E07-05-0460; Scappini E, 2007, HUM MOL GENET, V16, P1862, DOI 10.1093/hmg/ddm134; Schubert KO, 2011, MOL PSYCHIAT; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tebar F, 1997, J BIOL CHEM, V272, P15413, DOI 10.1074/jbc.272.24.15413; Tong XK, 2000, J BIOL CHEM, V275, P29894, DOI 10.1074/jbc.M004096200; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Tsyba L, 2004, GENOMICS, V84, P106, DOI 10.1016/j.ygeno.2004.02.005; Tsyba L, 2010, GENE; Tsyba L, 2011, GENE, V473, P67, DOI 10.1016/j.gene.2010.11.016; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang JB, 2005, J BIOL CHEM, V280, P22883, DOI 10.1074/jbc.M414375200; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Wong KA, 2011, JOVE-J VIS EXP, DOI 10.3791/2643; Xie JW, 2008, FEBS LETT, V582, P3011, DOI 10.1016/j.febslet.2008.07.048; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yamabhai M, 2001, METHOD ENZYMOL, V332, P88; Yu Y, 2008, HUM MOL GENET, V17, P3281, DOI 10.1093/hmg/ddn224; Zwang Yaara, 2009, Traffic, V10, P349, DOI 10.1111/j.1600-0854.2008.00870.x	58	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36023	10.1371/journal.pone.0036023	http://dx.doi.org/10.1371/journal.pone.0036023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558309	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336000102
J	Schrouff, J; Kusse, C; Wehenkel, L; Maquet, P; Phillips, C				Schrouff, Jessica; Kusse, Caroline; Wehenkel, Louis; Maquet, Pierre; Phillips, Christophe			Decoding Semi-Constrained Brain Activity from fMRI Using Support Vector Machines and Gaussian Processes	PLOS ONE			English	Article							COGNITIVE STATES; CLASSIFICATION; SELECTION; INVENTORY	Predicting a particular cognitive state from a specific pattern of fMRI voxel values is still a methodological challenge. Decoding brain activity is usually performed in highly controlled experimental paradigms characterized by a series of distinct states induced by a temporally constrained experimental design. In more realistic conditions, the number, sequence and duration of mental states are unpredictably generated by the individual, resulting in complex and imbalanced fMRI data sets. This study tests the classification of brain activity, acquired on 16 volunteers using fMRI, during mental imagery, a condition in which the number and duration of mental events were not externally imposed but self-generated. To deal with these issues, two classification techniques were considered (Support Vector Machines, SVM, and Gaussian Processes, GP), as well as different feature extraction methods (General Linear Model, GLM and SVM). These techniques were combined in order to identify the procedures leading to the highest accuracy measures. Our results showed that 12 data sets out of 16 could be significantly modeled by either SVM or GP. Model accuracies tended to be related to the degree of imbalance between classes and to task performance of the volunteers. We also conclude that the GP technique tends to be more robust than SVM to model unbalanced data sets.	[Schrouff, Jessica; Kusse, Caroline; Maquet, Pierre; Phillips, Christophe] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Schrouff, Jessica; Wehenkel, Louis; Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Wehenkel, Louis] Univ Liege, Giga R, Liege, Belgium; [Maquet, Pierre] Liege Univ Hosp, Dept Neurol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Schrouff, J (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	jschrouff@doct.ulg.ac.be	Phillips, Christophe/M-3025-2017	Phillips, Christophe/0000-0002-4990-425X; , Pierre/0000-0003-3106-3357; Schrouff, Jessica/0000-0003-4992-3183	F.R.S.; Fondation Medicale Reine Elisabeth; Research Fund of ULg; PAI/IAP Interuniversity Pole of Attraction; BIAL foundation; F.N.R.S. (Belgium) [FC86538, FC86292]	F.R.S.(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth; Research Fund of ULg; PAI/IAP Interuniversity Pole of Attraction; BIAL foundation(Bial Foundation); F.N.R.S. (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This study was supported by the Belgian Fonds National de la Recherche Scientifique (F.R.S.-F.N.R.S.), the Fondation Medicale Reine Elisabeth, the Research Fund of ULg, the PAI/IAP Interuniversity Pole of Attraction and the BIAL foundation. JS and CK are funded by F.N.R.S. (Belgium) - Fonds pour la Recherche Industrielle et Agronomique (FRIA) grants FC86538 and FC86292, PM and CP are supported by F.N.R.S. (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, APPL SOFT COMPUT, V6, P119, DOI 10.1016/j.asoc.2004.12.002; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bishop C.M., 2006, PATTERN RECOGNITION; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chadwick M.J., 2010, CURR BIOL, P1; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Dietterich TG, 1994, J ARTIF INTELL RES, V2, P263; Formisano E, 2008, MAGN RESON IMAGING, V26, P921, DOI 10.1016/j.mri.2008.01.052; Frackowiak R, 2004, HUMAIN BRAIN FUNCTIO; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mourao-Miranda J, 2006, NEUROIMAGE, V33, P1055, DOI 10.1016/j.neuroimage.2006.08.016; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Shinkareva SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001394; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443	33	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35860	10.1371/journal.pone.0035860	http://dx.doi.org/10.1371/journal.pone.0035860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563410	Green Published, gold			2022-12-25	WOS:000305349100036
J	Takahara, T; Minamoto, T; Yamanaka, H; Doi, H; Kawabata, Z				Takahara, Teruhiko; Minamoto, Toshifumi; Yamanaka, Hiroki; Doi, Hideyuki; Kawabata, Zen'ichiro			Estimation of Fish Biomass Using Environmental DNA	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; COMMON CARP; BENTHIVOROUS FISH; LAKE; WATER; TEMPERATURE; COMMUNITIES; STRESS; PONDS	Environmental DNA (eDNA) from aquatic vertebrates has recently been used to estimate the presence of a species. We hypothesized that fish release DNA into the water at a rate commensurate with their biomass. Thus, the concentration of eDNA of a target species may be used to estimate the species biomass. We developed an eDNA method to estimate the biomass of common carp (Cyprinus carpio L.) using laboratory and field experiments. In the aquarium, the concentration of eDNA changed initially, but reached an equilibrium after 6 days. Temperature had no effect on eDNA concentrations in aquaria. The concentration of eDNA was positively correlated with carp biomass in both aquaria and experimental ponds. We used this method to estimate the biomass and distribution of carp in a natural freshwater lagoon. We demonstrated that the distribution of carp eDNA concentration was explained by water temperature. Our results suggest that biomass data estimated from eDNA concentration reflects the potential distribution of common carp in the natural environment. Measuring eDNA concentration offers a non-invasive, simple, and rapid method for estimating biomass. This method could inform management plans for the conservation of ecosystems.	[Takahara, Teruhiko; Minamoto, Toshifumi; Kawabata, Zen'ichiro] Res Inst Human & Nat, Kyoto, Japan; [Yamanaka, Hiroki] Ryukoku Univ, Fac Sci & Technol, Dept Environm Solut Technol, Otsu, Shiga 52021, Japan; [Takahara, Teruhiko; Doi, Hideyuki] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan	Research Institute for Humanity & Nature (RIHN); Ryukoku University; Hiroshima University	Takahara, T (corresponding author), Res Inst Human & Nat, Kyoto, Japan.	takahara@hiroshima-u.ac.jp	Doi, Hideyuki/D-2012-2010; Minamoto, Toshifumi/C-6453-2009	Doi, Hideyuki/0000-0002-2701-3982; Minamoto, Toshifumi/0000-0002-5379-1622	RIHN [C-06]	RIHN	This research project has been funded by RIHN C-06. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy. Dr. Y. Iseri is working for a private company (the West Japan Engineering Consultants, Inc.). The RIHN possessed all the data and materials, because the RIHN and his company were making a contract of research support. Thus, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Barus V., 2002, FRESHWATER FISHES EU, P85; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; BEITINGER TL, 1990, J GREAT LAKES RES, V16, P495, DOI 10.1016/S0380-1330(90)71443-8; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Engelsma MY, 2003, FISH SHELLFISH IMMUN, V15, P397, DOI 10.1016/S1050-4648(03)00006-8; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Mabuchi Kohji, 2010, Japanese Journal of Ichthyology, V57, P1; Matsui K, 2001, AQUAT MICROB ECOL, V26, P95, DOI 10.3354/ame026095; Miller SA, 2006, FRESHWATER BIOL, V51, P85, DOI 10.1111/j.1365-2427.2005.01477.x; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Minamoto T, 2012, RES VET SCI, V93, P508, DOI 10.1016/j.rvsc.2011.06.004; Minamoto T, 2009, APPL ENVIRON MICROB, V75, P6900, DOI 10.1128/AEM.01411-09; Mittelbach G.G., 1987, P315; Person-Le Ruyet J, 2004, AQUACULTURE, V237, P269, DOI 10.1016/j.aquaculture.2004.04.021; PITT T. K., 1956, CANADIAN JOUR ZOOL, V34, P555, DOI 10.1139/z56-055; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roberts J, 1995, MAR FRESHWATER RES, V46, P1171, DOI 10.1071/MF9951171; Takahara T, 2011, HYDROBIOLOGIA, V675, P65, DOI 10.1007/s10750-011-0796-z; Titus JE, 2004, AQUAT BOT, V79, P33, DOI 10.1016/j.aquabot.2003.11.006; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Venables W. N., 2002, STAT COMPLEMENTS MOD; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Zambrano L, 2001, OIKOS, V94, P344, DOI 10.1034/j.1600-0706.2001.940215.x; Zambrano L, 1999, HYDROBIOLOGIA, V408, P131, DOI 10.1023/A:1017085129620	29	410	459	34	370	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35868	10.1371/journal.pone.0035868	http://dx.doi.org/10.1371/journal.pone.0035868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563411	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100037
J	Hsu, CC; Lee, YC; Yeh, SH; Chen, CH; Wu, CC; Wang, TY; Chen, YN; Hung, LY; Liu, YW; Chen, HK; Hsiao, YT; Wang, WS; Tsou, JH; Tsou, YH; Wu, MH; Chang, WC; Lin, DY				Hsu, Che-Chia; Lee, Yi-Chao; Yeh, Shiu-Hwa; Chen, Chang-Han; Wu, Chih-Ching; Wang, Tsui-Ying; Chen, Yu-Nong; Hung, Liang-Yi; Liu, Yao-Wen; Chen, Han-Ku; Hsiao, Yi-Ting; Wang, Wei-Sheng; Tsou, Jen-Hui; Tsou, Yi-Huan; Wu, Mei-Hsiang; Chang, Wen-Chang; Lin, Ding-Yen			58-kDa Microspherule Protein (MSP58) Is Novel Brahma-related Gene 1 (BRG1)-associated Protein That Modulates p53/p21 Senescence Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; CHROMATIN REMODELING COMPLEXES; DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; CELLULAR SENESCENCE; TRANSCRIPTIONAL ACTIVITY; RETINOBLASTOMA PROTEIN; HUMAN TUMORIGENESIS; TUMOR SUPPRESSION; DOWN-REGULATION	The nucleolar 58-kDa microspherule protein (MSP58) protein is a candidate oncogene implicated in modulating cellular proliferation and malignant transformation. In this study, we show that knocking down MSP58 expression caused aneuploidy and led to apoptosis, whereas ectopic expression of MSP58 regulated cell proliferation in a context-dependent manner. Specifically, ectopic expression of MSP58 in normal human IMR90 and Hs68 diploid fibroblasts, the H184B5F5/M10 mammary epithelial cell line, HT1080 fibrosarcoma cells, primary mouse embryonic fibroblasts, and immortalized NIH3T3 fibroblasts resulted in induction of premature senescence, an enlarged and flattened cellular morphology, and increased senescence-associated beta-galactosidase activity. MSP58-driven senescence was strictly dependent on the presence of functional p53 as revealed by the fact that normal cells with p53 knockdown by specific shRNA or cells with a mutated or functionally impaired p53 pathway were effective in bypassing MSP58-induced senescence. At least two senescence mechanisms are induced by MSP58. First, MSP58 activates the DNA damage response and p53/p21 signaling pathways. Second, MSP58, p53, and the SWI/SNF chromatinremodeling subunit Brahma-related gene 1 (BRG1) form a ternary complex on the p21 promoter and collaborate to activate p21. Additionally, MSP58 protein levels increased in cells undergoing replicative senescence and stress-induced senescence. Notably, the results of analyzing expression levels of MSP58 between tumors and matched normal tissues showed significant changes (both up-and down-regulation) in its expression in various types of tumors. Our findings highlight new aspects of MSP58 in modulating cellular senescence and suggest that MSP58 has both oncogenic and tumor-suppressive properties.	[Chang, Wen-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 11031, Taiwan; [Hsu, Che-Chia; Hung, Liang-Yi; Tsou, Jen-Hui; Wu, Mei-Hsiang; Lin, Ding-Yen] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Wang, Tsui-Ying; Chen, Yu-Nong; Tsou, Yi-Huan; Chang, Wen-Chang; Lin, Ding-Yen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Chang, Wen-Chang; Lin, Ding-Yen] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan; [Chang, Wen-Chang; Lin, Ding-Yen] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan; [Lee, Yi-Chao] Taipei Med Univ, Coll Med Sci & Technol, Program Neural Regenerat Med, Taipei 11031, Taiwan; [Yeh, Shiu-Hwa; Hsiao, Yi-Ting] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli 35053, Taiwan; [Chen, Chang-Han] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung 833, Taiwan; [Wang, Wei-Sheng] Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung 833, Taiwan; [Wu, Chih-Ching] Chang Gung Univ, Albany Med Coll, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan; [Liu, Yao-Wen] Kuo Gen Hosp, Dept Pathol, Tainan 700, Taiwan; [Chen, Han-Ku] Fooyin Univ Hosp, Dept Pathol, Pingtung 928, Taiwan	Taipei Medical University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chang, WC (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 11031, Taiwan.	wcchang@mail.ncku.edu.tw; lindy@mail.ncku.edu.tw	Yeh, Shiu-Hwa/D-2088-2010; Hung, Liang-Yi/AAG-4174-2019	Wu, Chih-Ching/0000-0002-7264-9672; Lee, Yi-Chao/0000-0003-3451-183X; , Liang-Yi/0000-0002-7284-2608	National Science Council of Taiwan [NSC96-2320-B-006-011, NSC96-2320-B-006-049-MY2, NSC98-2320-B-006-035-MY3]; National Cheng Kung University Landmark [C015]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Landmark	This work was supported by National Science Council of Taiwan Grants NSC96-2320-B-006-011, NSC96-2320-B-006-049-MY2, and NSC98-2320-B-006-035-MY3) and National Cheng Kung University Landmark Grant C015 (to D.-Y. L.).	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Andersen DS, 2010, MOL CELL BIOL, V30, P4744, DOI 10.1128/MCB.01586-09; Bader AG, 2001, ONCOGENE, V20, P7524, DOI 10.1038/sj.onc.1204938; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Campisi J, 2000, IN VIVO, V14, P183; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Chen QM, 2000, ANN NY ACAD SCI, V908, P111; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Du XL, 2006, EXP MOL PATHOL, V81, P184, DOI 10.1016/j.yexmp.2006.07.008; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HARPER JW, 1993, CELL, V75, P805; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hirohashi Y, 2006, ONCOGENE, V25, P4937, DOI 10.1038/sj.onc.1209500; HUNTER T, 1993, CELL, V75, P839, DOI 10.1016/0092-8674(93)90528-X; Ivanova AV, 2005, CELL MOL LIFE SCI, V62, P471, DOI 10.1007/s00018-004-4423-2; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kim S, 2002, ONCOGENE, V21, P503, DOI 10.1038/sj.onc.1205077; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lin DY, 2002, J BIOL CHEM, V277, P25446, DOI 10.1074/jbc.M200633200; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Lin W, 2009, J CELL MOL MED, V13, P4608, DOI 10.1111/j.1582-4934.2008.00499.x; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Okumura K, 2005, P NATL ACAD SCI USA, V102, P2703, DOI 10.1073/pnas.0409370102; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Ren Y, 1998, EUR J BIOCHEM, V253, P734, DOI 10.1046/j.1432-1327.1998.2530734.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Sharma SV, 2010, BIOCHEM PHARMACOL, V80, P666, DOI 10.1016/j.bcp.2010.03.001; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shi H, 2009, CANCER SCI, V100, P1585, DOI 10.1111/j.1349-7006.2009.01223.x; Shimono K, 2005, J BIOL CHEM, V280, P39436, DOI 10.1074/jbc.M507356200; Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com; Song H, 2004, BIOCHEM BIOPH RES CO, V316, P1116, DOI 10.1016/j.bbrc.2004.02.166; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Wu JL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-9; Wu RC, 1997, J BIOL CHEM, V272, P29091, DOI 10.1074/jbc.272.46.29091; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06	58	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22533	22548		10.1074/jbc.M111.335331	http://dx.doi.org/10.1074/jbc.M111.335331			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22563078	Green Published, hybrid			2022-12-25	WOS:000306495000011
J	Chu, H; Wang, JJ; Qi, ML; Yoon, JJ; Wen, XY; Chen, XM; Ding, LM; Spearman, P				Chu, Hin; Wang, Jaang-Jiun; Qi, Mingli; Yoon, Jeong-Joong; Wen, Xiaoyun; Chen, Xuemin; Ding, Lingmei; Spearman, Paul			The Intracellular Virus-Containing Compartments in Primary Human Macrophages Are Largely Inaccessible to Antibodies and Small Molecules	PLOS ONE			English	Article							PLASMA-MEMBRANE; HIV-1 ASSEMBLES; SURFACE-CHARGE; TYPE-1; TRAFFICKING; CELLS; REPLICATION; ENDOSOMES; INFECTION; VIRIONS	HIV-1 assembly and release occurs at the plasma membrane of human T lymphocytes and model epithelial cell lines, whereas in macrophages intracellular sites of virus assembly or accumulation predominate. The origin of the intracellular virus-containing compartment (VCC) has been controversial. This compartment is enriched in markers of the multivesicular body, and has been described as a modified endosomal compartment. Several studies of this compartment have revealed the presence of small channels connecting to the plasma membrane, suggesting that instead of an endosomal origin the compartment is a modified plasma membrane compartment. If the compartment is accessible to the external environment, this would have important implications for antiviral immune responses and antiviral therapy. We performed a series of experiments designed to determine if the VCC in macrophages was open to the external environment and accessible to antibodies and small molecules. The majority of VCCs were found to be inaccessible to exogenously-applied antibodies to tetraspanins in the absence of membrane permeabilization, while tetraspanin staining was readily observed following membrane permeabilization. Cationized ferritin was utilized to stain the plasma membrane, and revealed that the majority of virus-containing compartments were inaccessible to ferritin. Low molecular weight dextrans could access only a very small percentage of VCCs, and these tended to be more peripheral compartments. We conclude that the VCCs in monocyte-derived human macrophages are heterogeneous, but the majority of VCCs are closed to the external environment.	[Chu, Hin] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; Childrens Healthcare Atlanta, Atlanta, GA USA	Emory University; Children's Healthcare of Atlanta (CHOA)	Chu, H (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.	paul.spearman@emory.edu	CHU, HIN/ABU-1193-2022	CHU, HIN/0000-0003-2855-9837	National Institutes of Health (NIH) [AI058828, AI40338]; Children's Healthcare of Atlanta; flow cytometry/cell sorting core of Children's Healthcare of Atlanta; Emory Center for AIDS Research [P30 AI050409]; Robert P. Apkarian Integrated Electron Microscopy Core Laboratory of Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI040338, R29AI040338, R01AI058828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Healthcare of Atlanta; flow cytometry/cell sorting core of Children's Healthcare of Atlanta; Emory Center for AIDS Research; Robert P. Apkarian Integrated Electron Microscopy Core Laboratory of Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) AI058828 and NIH AI40338 and by funds from Children's Healthcare of Atlanta. The work was partly supported by the flow cytometry/cell sorting core of Children's Healthcare of Atlanta, by the Emory Center for AIDS Research (P30 AI050409), and by the Robert P. Apkarian Integrated Electron Microscopy Core Laboratory of Emory University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaroch P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-29; Bennett AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000591; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; BURRY RW, 1979, J CELL BIOL, V82, P726, DOI 10.1083/jcb.82.3.726; Chu H, 2009, CURR TOP MICROBIOL, V339, P67, DOI 10.1007/978-3-642-02175-6_4; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; Crowe SM, 2006, CURR OPIN HIV AIDS, V1, P129, DOI 10.1097/01.COH.0000209583.89952.9d; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; GELDERBLOM HR, 1991, AIDS, V5, P617, DOI 10.1097/00002030-199106000-00001; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Koppensteiner H, 2011, J VIROLOGY; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488; MUTSAERS SE, 1988, J LEUKOCYTE BIOL, V44, P17, DOI 10.1002/jlb.44.1.17; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; ORENSTEIN JM, 1988, J VIROL, V62, P2578, DOI 10.1128/JVI.62.8.2578-2586.1988; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pelchen-Matthews A, 2012, TRAFFIC, V13, P273, DOI 10.1111/j.1600-0854.2011.01306.x; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Thole AA, 1999, J SUBMICR CYTOL PATH, V31, P131; Varthakavi V, 1999, J VIROL, V73, P10329, DOI 10.1128/JVI.73.12.10329-10338.1999; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Welsch S, 2011, J VIROL, V85, P7922, DOI 10.1128/JVI.00834-11; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134	34	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35297	10.1371/journal.pone.0035297	http://dx.doi.org/10.1371/journal.pone.0035297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567100	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500018
J	Ehlers, K; Oster, G				Ehlers, Kurt; Oster, George			On the Mysterious Propulsion of Synechococcus	PLOS ONE			English	Article							BACTERIAL GLIDING MOTILITY; LOW REYNOLDS-NUMBER; CILIARY PROPULSION; SWIMMING MOTILITY; ELECTROPHORESIS; CYANOBACTERIA; LOCOMOTION; MECHANICS; ROTATION; MOTOR	We propose a model for the self-propulsion of the marine bacterium Synechococcus utilizing a continuous looped helical track analogous to that found in Myxobacteria [1]. In our model cargo-carrying protein motors, driven by proton-motive force, move along a continuous looped helical track. The movement of the cargo creates surface distortions in the form of small amplitude traveling ridges along the S-layer above the helical track. The resulting fluid motion adjacent to the helical ribbon provides the propulsive thrust. A variation on the helical rotor model of [1] allows the motors to be anchored to the peptidoglycan layer, where they drive rotation of the track creating traveling helical waves along the S-layer. We derive expressions relating the swimming speed to the amplitude, wavelength, and velocity of the surface waves induced by the helical rotor, and show that they fall in reasonable ranges to explain the velocity and rotation rate of swimming Synechococcus.	[Ehlers, Kurt] Truckee Meadows Community Coll, Dept Math, Reno, NV USA; [Ehlers, Kurt] Nevada Syst Higher Educ, Desert Res Inst, Dept Atmospher Sci, Reno, NV USA; [Oster, George] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Oster, George] Univ Calif Berkeley, ESPM, Berkeley, CA 94720 USA	Nevada System of Higher Education (NSHE); Truckee Meadows Community College; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ehlers, K (corresponding author), Truckee Meadows Community Coll, Dept Math, Reno, NV USA.	goster@berkeley.edu			NSF [DMS 0414039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104979] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GO was supported by NSF Grant DMS 0414039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE JR, 1971, J FLUID MECH, V46, P199, DOI 10.1017/S002211207100048X; BLAKE JR, 1971, J FLUID MECH, V49, P209, DOI 10.1017/S0022112071002027; BLAKE JR, 1974, BIOL REV, V49, P85, DOI 10.1111/j.1469-185X.1974.tb01299.x; Brahamsha B, 1996, P NATL ACAD SCI USA, V93, P6504, DOI 10.1073/pnas.93.13.6504; Brahamsha B., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P59; Chan B, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2102927; Chen XB, 2000, BIOPHYS J, V78, P1036, DOI 10.1016/S0006-3495(00)76662-8; Childress S, 1978, MECH SWIMMING FLYING; Cortez R, 2004, COMPUT SCI ENG, V6, P38, DOI 10.1109/MCISE.2004.1289307; Ehlers KM, 1996, P NATL ACAD SCI USA, V93, P8340, DOI 10.1073/pnas.93.16.8340; Ehlers KM, 2011, REGUL CHAOTIC DYN, V16, P623, DOI 10.1134/S1560354711060050; FAIR MC, 1989, J COLLOID INTERF SCI, V127, P388, DOI 10.1016/0021-9797(89)90045-3; Happel, 2012, LOW REYNOLDS NUMBER; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Koiller J, 1996, J NONLINEAR SCI, V6, P1432; Leshansky AM, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/5/145; LIGHTHILL MJ, 1952, COMMUN PUR APPL MATH, V5, P109, DOI 10.1002/cpa.3160050201; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; McCarren J, 2007, J BACTERIOL, V189, P1158, DOI 10.1128/JB.01500-06; McCarren J, 2005, J BACTERIOL, V187, P224, DOI 10.1128/JB.187.1.224-230.2005; Nan BY, 2011, P NATL ACAD SCI USA, V108, P2498, DOI 10.1073/pnas.1018556108; PITTA TP, 1995, J BACTERIOL, V177, P5701, DOI 10.1128/jb.177.19.5701-5703.1995; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Samuel A D, 2001, BMC Microbiol, V1, P4, DOI 10.1186/1471-2180-1-4; SHAPERE A, 1989, J FLUID MECH, V198, P557, DOI 10.1017/S002211208900025X; Spagnolie SE, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3469786; Stone HA, 1996, PHYS REV LETT, V77, P4102, DOI 10.1103/PhysRevLett.77.4102; Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108; Swan JW, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3594790; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; WATERBURY JB, 1985, SCIENCE, V230, P74, DOI 10.1126/science.230.4721.74	32	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36081	10.1371/journal.pone.0036081	http://dx.doi.org/10.1371/journal.pone.0036081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567124	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500042
J	Ishitani, Y; Ujiie, Y; de Vargas, C; Not, F; Takahashi, K				Ishitani, Yoshiyuki; Ujiie, Yurika; de Vargas, Colomban; Not, Fabrice; Takahashi, Kozo			Phylogenetic Relationships and Evolutionary Patterns of the Order Collodaria (Radiolaria)	PLOS ONE			English	Article							COLONIAL RADIOLARIAN; FINE-STRUCTURE; ANTARCTIC GLACIATION; MAXIMUM-LIKELIHOOD; GLOBAL CLIMATE; DNA-SEQUENCES; OCEAN; SEA; EOCENE; ZOOXANTHELLAE	Collodaria are the only group of Radiolaria that has a colonial lifestyle. This group is potentially the most important plankton in the oligotrophic ocean because of its large biomass and the high primary productivity associated with the numerous symbionts inside a cell or colony. The evolution of Collodaria could thus be related to the changes in paleo-productivity that have affected organic carbon fixation in the oligotrophic ocean. However, the fossil record of Collodaria is insufficient to trace their abundance through geological time, because most collodarians do not have silicified shells. Recently, molecular phylogeny based on nuclear small sub-unit ribosomal DNA (SSU rDNA) confirmed Collodaria to be one of five orders of Radiolaria, though the relationship among collodarians is still unresolved because of inadequate taxonomic sampling. Our phylogenetic analysis has revealed four novel collodarian sequences, on the basis of which collodarians can be divided into four clades that correspond to taxonomic grouping at the family level: Thalassicollidae, Collozoidae, Collosphaeridae, and Collophidae. Comparison of the results of our phylogenetic analyses with the morphological characteristics of each collodarian family suggests that the first ancestral collodarians had a solitary lifestyle and left no silica deposits. The timing of events estimated from molecular divergence calculations indicates that naked collodarian lineages first appeared around 45.6 million years (Ma) ago, coincident with the diversification of diatoms in the pelagic oceans. Colonial collodarians appeared after the formation of the present ocean circulation system and the development of oligotrophic conditions in the equatorial Pacific (ca. 33.4 Ma ago). The divergence of colonial collodarians probably caused a shift in the efficiency of primary production during this period.	[Ishitani, Yoshiyuki] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa, Japan; [Ujiie, Yurika] Kochi Univ, Ctr Adv Marine Core Res, Nankoku, Kochi, Japan; [de Vargas, Colomban; Not, Fabrice] Stn Biolog, UMR CNRS Evolut Plancton & PaleOceans 7144, Roscoff, France; [Takahashi, Kozo] Kyushu Univ, Dept Sci, Higashi Ku, Fukuoka 812, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kochi University; UDICE-French Research Universities; Sorbonne Universite; Kyushu University	Ishitani, Y (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa, Japan.	Ishitani@jamstec.go.jp		Takahashi, Kozo/0000-0001-8660-4371; Ishitani, Yoshiyuki/0000-0001-8941-6990; Ujiie, Yurika/0000-0001-7627-7979; Not, Fabrice/0000-0002-9342-195X	JSPS [17310009]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was entirely supported by a JSPS Grant-in-Aid for Scientific Research (B) Project No. 17310009 (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson O.R., 2002, 2 ILLUSTRATED GUIDE, P994; ANDERSON OR, 1983, MAR BIOL, V77, P265, DOI 10.1007/BF00395815; Anderson OR, 1999, MAR MICROPALEONTOL, V36, P81, DOI 10.1016/S0377-8398(98)00029-2; ANDERSON OR, 1976, MAR MICROPALEONTOL, V1, P81, DOI 10.1016/0377-8398(76)90006-2; ANDERSON OR, 1978, J ULTRA MOL STRUCT R, V62, P181, DOI 10.1016/S0022-5320(78)90031-X; ANDERSON OR, 1976, TISSUE CELL, V8, P195, DOI 10.1016/0040-8166(76)90046-X; Anderson OR, 1980, BIOCH PHYSL PROTOZOA; BARRON JA, 1989, LIFE SCI R, V44, P341; BJORKLUND KR, 1979, J PALEONTOL, V53, P1293; Carter L, 2004, MAR GEOL, V205, P9, DOI 10.1016/S0025-3227(04)00016-7; Cault JP, 1991, P OCEAN DRILLING PRO, V19, P513; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; De Wever P., 2001, RADIOLARIANS SEDIMEN; Diekmann B, 2004, GLOBAL PLANET CHANGE, V40, P295, DOI 10.1016/j.gloplacha.2003.09.001; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x; Fenner J, PLANKTON STRATIGRAPH, P713; Funakawa S, 2006, PALAEOGEOGR PALAEOCL, V230, P183, DOI 10.1016/j.palaeo.2005.07.014; Griffith E, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001932; Haeckel E., 1862, RADIOLARIEN RHIZOPOD, V2; Haeckel E, 1887, REPORTS SCI RESULTS; Harwood DM, SILICEOUS MICROFOSSI, P81; Huber M, 2003, SCIENCE, V299, P877, DOI 10.1126/science.1078766; Hugall AF, 2007, EVOLUTION, V61, P2293, DOI 10.1111/j.1558-5646.2007.00188.x; Ishitani Y, 2012, DEEP-SEA RES PT II, V61-64, P172, DOI 10.1016/j.dsr2.2011.12.005; Jobb G, 2008, TREEFINDER VERSION O; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; KHMELEVA NN, 1967, DOKL AKAD NAUK SSSR+, V172, P1430; Kunitomo Y, 2006, EUR J PROTISTOL, V42, P143, DOI 10.1016/j.ejop.2006.04.001; Lazarus DB, 2009, P NATL ACAD SCI USA, V106, P9333, DOI 10.1073/pnas.0812979106; MALIVA R G, 1989, Palaios, V4, P519, DOI 10.2307/3514743; Merico A, 2008, NATURE, V452, P979, DOI 10.1038/nature06853; Miller KG, 2008, GEOL SOC AM BULL, V120, P34, DOI 10.1130/B26105.1; MOORE TC, 1969, GEOL SOC AM BULL, V80, P2103, DOI 10.1130/0016-7606(1969)80[2103:RCISWA]2.0.CO;2; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Nikolaev VA, P 16 INT DIAT S, P127; Nylander J, 2004, MR MODELTEST V2 PROG; Polet S, 2004, PROTIST, V155, P53, DOI 10.1078/1434461000164; Rabosky DL, 2009, NATURE, V457, P183, DOI 10.1038/nature07435; Riedel W.R., 1967, FOSSIL RECORD S DOCU, P291; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shevenell AE, 2007, DEEP-SEA RES PT II, V54, P2308, DOI 10.1016/j.dsr2.2007.07.018; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Strelkov AA, 1971, EXPLORATIONS FAUNA S, V9, P295; SWANBERG NR, 1980, DEEP-SEA RES, V27, P715, DOI 10.1016/0198-0149(80)90024-2; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Taylor F.J.R., 1990, P323; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	51	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35775	10.1371/journal.pone.0035775	http://dx.doi.org/10.1371/journal.pone.0035775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567112	Green Published, gold			2022-12-25	WOS:000305341500030
J	Nishiyama, A; Dey, A; Tamura, T; Ko, M; Ozato, K				Nishiyama, Akira; Dey, Anup; Tamura, Tomohiko; Ko, Minoru; Ozato, Keiko			Activation of JNK Triggers Release of Brd4 from Mitotic Chromosomes and Mediates Protection from Drug-Induced Mitotic Stress	PLOS ONE			English	Article							N-TERMINAL KINASE; BROMODOMAIN PROTEIN BRD4; CELL-DEATH; TRANSCRIPTION FACTOR; HISTONE H3; S-PHASE; P-TEFB; MITOSIS; PHOSPHORYLATION; PROGRESSION	Some anti-cancer drugs, including those that alter microtubule dynamics target mitotic cells and induce apoptosis in some cell types. However, such drugs elicit protective responses in other cell types allowing cells to escape from drug-induced mitotic inhibition. Cells with a faulty protective mechanism undergo defective mitosis, leading to genome instability. Brd4 is a double bromodomain protein that remains on chromosomes during mitosis. However, Brd4 is released from mitotic chromosomes when cells are exposed to anti-mitotic drugs including nocodazole. Neither the mechanisms, nor the biological significance of drug-induced Brd4 release has been fully understood. We found that deletion of the internal C-terminal region abolished nocodazole induced Brd4 release from mouse P19 cells. Furthermore, cells expressing truncated Brd4, unable to dissociate from chromosomes were blocked from mitotic progression and failed to complete cell division. We also found that pharmacological and peptide inhibitors of the c-jun-N-terminal kinases (JNK) pathway, but not inhibitors of other MAP kinases, prevented release of Brd4 from chromosomes. The JNK inhibitor that blocked Brd4 release also blocked mitotic progression. Further supporting the role of JNK in Brd4 release, JNK2-/- embryonic fibroblasts were defective in Brd4 release and sustained greater inhibition of cell growth after nocodazole treatment. In sum, activation of JNK pathway triggers release of Brd4 from chromosomes upon nocodazole treatment, which mediates a protective response designed to minimize drug-induced mitotic stress.	[Nishiyama, Akira; Dey, Anup; Ozato, Keiko] NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Nishiyama, Akira; Tamura, Tomohiko] Yokohama City Univ, Dept Immunol, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Nishiyama, Akira; Ko, Minoru] NIA, Sect Dev Genom & Aging, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Yokohama City University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Nishiyama, A (corresponding author), NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	ozatok@nih.gov	Ko, Minoru S. H./B-7969-2009	Ko, Minoru S. H./0000-0002-3530-3015	National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008815, ZIAHD001310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000662] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23659492] Funding Source: KAKEN	National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Intramural Program of National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Delcuve GP, 2008, J CELL BIOCH; Dey A, 2000, BROMODOMAIN PROTEIN, P6537; Dey A, 2003, DOUBLE BROMODOMAIN P, P8758; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Fan MY, 2000, CANCER RES, V60, P6403; Gaillard P, 2005, J MED CHEM, V48, P4596, DOI 10.1021/jm0310986; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kim JA, 2010, ONCOGENE, V29, P1702, DOI 10.1038/onc.2009.464; Kolomeichuk SN, 2008, FEBS J, V275, P1889, DOI 10.1111/j.1742-4658.2008.06349.x; Lee K, 2008, CELL CYCLE, V7, P216, DOI 10.4161/cc.7.2.5155; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mikhailov A, 2002, CURR BIOL, V12, pR331, DOI 10.1016/S0960-9822(02)00833-3; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Oktay K, 2008, CELL CYCLE, V7, P533, DOI 10.4161/cc.7.4.5660; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sorger PK, 1997, CURR OPIN CELL BIOL, V9, P807, DOI 10.1016/S0955-0674(97)80081-6; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Toyama R, 2008, DEV DYNAM, V237, P1636, DOI 10.1002/dvdy.21576; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wolf F, 2007, CELL CYCLE, V6, P1408; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605	59	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34719	10.1371/journal.pone.0034719	http://dx.doi.org/10.1371/journal.pone.0034719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567088	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500006
J	Kariya, Y; Sato, H; Katou, N; Kariya, Y; Miyazaki, K				Kariya, Yoshinobu; Sato, Hiroki; Katou, Naoko; Kariya, Yukiko; Miyazaki, Kaoru			Polymerized Laminin-332 Matrix Supports Rapid and Tight Adhesion of Keratinocytes, Suppressing Cell Migration	PLOS ONE			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; CHAIN SHORT ARM; EXTRACELLULAR-MATRIX; BIOLOGICAL-ACTIVITY; RECOMBINANT LAMININ-5; PLASMINOGEN-ACTIVATOR; BASEMENT-MEMBRANES; ALPHA-3B CHAIN; SCATTER FACTOR; HUMAN TISSUES	Laminin-332 (alpha 3 beta 3c2) (Lm332) supports the stable anchoring of basal keratinocytes to the epidermal basement membrane, while it functions as a motility factor for wound healing and cancer invasion. To understand these contrasting activities of Lm332, we investigated Lm332 matrices deposited by normal human keratinocytes and other Lm332-expressing cell lines. All types of the cells efficiently deposited Lm332 on the culture plates in specific patterns. On the contrary, laminins containing laminin beta 1 and/or gamma 1 chains, such as Lm511 and Lm311, were not deposited on the culture plates even if secreted into culture medium. The Lm332 deposition was not inhibited by function-blocking antibodies to the alpha 3 and alpha 6 integrins but was inhibited by sodium selenate, suggesting that sulfated glycosaminoglycans on cell surface, e. g. heparan sulfate proteoglycans, might be involved in the process. HEK293 cells overexpressing exogenous Lm332 (Lm332-HEK) almost exclusively deposited Lm332 on the plates. The deposited Lm332 matrix showed a mesh-like network structure as analyzed by electron microscopy, suggesting that Lm332 was highly polymerized. When biological activity was analyzed, the Lm332 matrix rather suppressed the migration of keratinocytes as compared with purified Lm332, which highly promoted the cell migration. The Lm332 matrix supported adhesion of keratinocytes much more strongly and stably than purified Lm332. Integrin alpha 3 beta 1 bound to the Lm332 matrix at a three times higher level than purified Lm332. Normal keratinocytes prominently showed integrin alpha 6 beta 4-containing, hemidesmosome-like structures on the Lm332 matrix but not on the purified one. These results indicate that the polymerized Lm332 matrix supports stable cell adhesion by interacting with both integrin alpha 6 beta 4 and alpha 3 beta 1, whereas unassembled soluble Lm332 supports cell migration.	[Kariya, Yoshinobu; Kariya, Yukiko; Miyazaki, Kaoru] Yokohama City Univ, Div Cell Biol, Kihara Inst Biol Res, Yokohama, Kanagawa 232, Japan; [Kariya, Yoshinobu] Kihara Mem Yokohama Fdn Adv Life Sci, Yokohama, Kanagawa, Japan; [Sato, Hiroki; Katou, Naoko; Kariya, Yukiko; Miyazaki, Kaoru] Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University	Kariya, Y (corresponding author), Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima, Japan.	miyazaki@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [17014077, 23300351, 23112517]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding came from the Ministry of Education, Culture, Sports, Science and Technology of Japan: 17014077, 23300351, and 23112517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Arimura A, 1991, Hum Cell, V4, P67; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Baker SE, 1996, J CELL SCI, V109, P2509; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DeHart GW, 2003, EXP CELL RES, V283, P67, DOI 10.1016/S0014-4827(02)00028-9; DIETRICH CP, 1988, FASEB J, V2, P56, DOI 10.1096/fasebj.2.1.2961646; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Gagnoux-Palacios L, 2001, J CELL BIOL, V153, P835, DOI 10.1083/jcb.153.4.835; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Hirosaki T, 2000, J BIOL CHEM, V275, P22495, DOI 10.1074/jbc.M001326200; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kariya Y, 2003, J CELL BIOCHEM, V88, P506, DOI 10.1002/jcb.10350; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Kariya Y, 2004, J BIOL CHEM, V279, P24774, DOI 10.1074/jbc.M400670200; Kariya Y, 2009, MINI-REV MED CHEM, V9, P1284, DOI 10.2174/138955709789878114; Kariya Y, 2008, J MOL HISTOL, V39, P435, DOI 10.1007/s10735-008-9183-0; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; KIKKAWA Y, 1994, J BIOCHEM-TOKYO, V116, P862, DOI 10.1093/oxfordjournals.jbchem.a124608; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Lohi J, 2001, INT J CANCER, V94, P763, DOI 10.1002/ijc.1539; MIYAZAKI K, 1993, P NATL ACAD SCI USA, V90, P11767, DOI 10.1073/pnas.90.24.11767; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Mizushima H, 1996, J BIOCHEM-TOKYO, V120, P1196; Mori T, 2010, J BIOL CHEM, V285, P35068, DOI 10.1074/jbc.M110.146126; Nakashima Y, 2005, J BIOCHEM, V138, P539, DOI 10.1093/jb/mvi153; Nakashima Y, 2007, J CELL BIOCHEM, V100, P545, DOI 10.1002/jcb.21032; Nguyen BP, 2000, CURR OPIN CELL BIOL, V12, P554, DOI 10.1016/S0955-0674(00)00131-9; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; Ogawa T, 2004, J CELL BIOCHEM, V92, P701, DOI 10.1002/jcb.20112; OToole EA, 1997, EXP CELL RES, V233, P330, DOI 10.1006/excr.1997.3586; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; PYKE C, 1995, CANCER RES, V55, P4132; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; Tsubota Y, 2005, J BIOL CHEM, V280, P14370, DOI 10.1074/jbc.M413051200	49	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35546	10.1371/journal.pone.0035546	http://dx.doi.org/10.1371/journal.pone.0035546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563463	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340700012
J	Sluder, A; Shah, S; Cassayre, J; Clover, R; Maienfisch, P; Molleyres, LP; Hirst, EA; Flemming, AJ; Shi, M; Cutler, P; Stanger, C; Roberts, RS; Hughes, DJ; Flury, T; Robinson, MP; Hillesheim, E; Pitterna, T; Cederbaum, F; Worthington, PA; Crossthwaite, AJ; Windass, JD; Currie, RA; Earley, FGP				Sluder, Ann; Shah, Sheetal; Cassayre, Jerome; Clover, Ralph; Maienfisch, Peter; Molleyres, Louis-Pierre; Hirst, Elizabeth A.; Flemming, Anthony J.; Shi, Min; Cutler, Penny; Stanger, Carole; Roberts, Richard S.; Hughes, David J.; Flury, Thomas; Robinson, Michael P.; Hillesheim, Elke; Pitterna, Thomas; Cederbaum, Fredrik; Worthington, Paul A.; Crossthwaite, Andrew J.; Windass, John D.; Currie, Richard A.; Earley, Fergus G. P.			Spiroindolines Identify the Vesicular Acetylcholine Transporter as a Novel Target for Insecticide Action	PLOS ONE			English	Article							GROWTH-HORMONE SECRETAGOGUE; CAENORHABDITIS-ELEGANS; GENETIC-ANALYSIS; RESISTANCE; RECEPTORS; MUTANTS; MONOAMINE; DISCOVERY; RESIDUES; VESICLES	The efficacy of all major insecticide classes continues to be eroded by the development of resistance mediated, in part, by selection of alleles encoding insecticide insensitive target proteins. The discovery of new insecticide classes acting at novel protein binding sites is therefore important for the continued protection of the food supply from insect predators, and of human and animal health from insect borne disease. Here we describe a novel class of insecticides (Spiroindolines) encompassing molecules that combine excellent activity against major agricultural pest species with low mammalian toxicity. We confidently assign the vesicular acetylcholine transporter as the molecular target of Spiroindolines through the combination of molecular genetics in model organisms with a pharmacological approach in insect tissues. The vesicular acetylcholine transporter can now be added to the list of validated insecticide targets in the acetylcholine signalling pathway and we anticipate that this will lead to the discovery of novel molecules useful in sustaining agriculture. In addition to their potential as insecticides and nematocides, Spiroindolines represent the only other class of chemical ligands for the vesicular acetylcholine transporter since those based on the discovery of vesamicol over 40 years ago, and as such, have potential to provide more selective tools for PET imaging in the diagnosis of neurodegenerative disease. They also provide novel biochemical tools for studies of the function of this protein family.	[Sluder, Ann; Clover, Ralph] Cambria Biosci, Woburn, MA USA; [Shah, Sheetal; Hirst, Elizabeth A.; Flemming, Anthony J.; Shi, Min; Cutler, Penny; Stanger, Carole; Roberts, Richard S.; Hughes, David J.; Robinson, Michael P.; Worthington, Paul A.; Crossthwaite, Andrew J.; Windass, John D.; Currie, Richard A.; Earley, Fergus G. P.] Syngenta Crop Protect Res, Bracknell, Berks, England; [Cassayre, Jerome; Maienfisch, Peter; Molleyres, Louis-Pierre; Flury, Thomas; Hillesheim, Elke; Pitterna, Thomas; Cederbaum, Fredrik] Syngenta Crop Protect AG, Stein, Switzerland	Syngenta; Syngenta	Sluder, A (corresponding author), Scynexis Inc, Res Triangle Pk, NC USA.	fergus.earley@syngenta.com	Sluder, Ann/AAS-3102-2020; Currie, Richard/N-6074-2017	Roberts, Richard/0000-0003-2343-6301; Currie, Richard/0000-0002-6528-3326				ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Anderson P, 1995, METHOD CELL BIOL, V48, P31; Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Bondensgaard K, 2004, J MED CHEM, V47, P888, DOI 10.1021/jm0309452; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bravo DT, 2005, BIOCHEMISTRY-US, V44, P7955, DOI 10.1021/bi047442y; Brittain RT, 1969, BRIT J PHARMACOL, V36, P173; Cheng Y, 1997, TETRAHEDRON LETT, V38, P1497, DOI 10.1016/S0040-4039(97)00139-1; CLARKSON ED, 1992, J NEUROCHEM, V59, P695, DOI 10.1111/j.1471-4159.1992.tb09424.x; Eiden LE, 1998, J NEUROCHEM, V70, P2227; Elbert A., 2008, IRAC INSECTICIDE RES, P753; EVANS BE, 1988, J MED CHEM, V31, P2235, DOI 10.1021/jm00120a002; Fliri AF, 2005, P NATL ACAD SCI USA, V102, P261, DOI 10.1073/pnas.0407790101; Griswold CM, 2002, DROSOPHILA INF SERV, V85, P129; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; Horti AG, 2010, LIFE SCI, V86, P575, DOI 10.1016/j.lfs.2009.02.029; HUGHES DJ, 2003, Patent No. 2003106457; Jerome C., 2005, [No title captured], Patent No. [WO 2005058897, 2005058897, 058897]; Jeschke P, 2010, PEST MANAG SCI, V66, P10, DOI 10.1002/ps.1829; Kaufman PE, 2010, PEST MANAG SCI, V66, P290, DOI 10.1002/ps.1872; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khare P, 2009, BIOCHEMISTRY-US, V48, P8965, DOI 10.1021/bi900759v; Kim MH, 1999, J BIOL CHEM, V274, P673, DOI 10.1074/jbc.274.2.673; Lind RJ, 2001, INSECT BIOCHEM MOLEC, V31, P533, DOI 10.1016/S0965-1748(00)00153-3; Maligres PE, 1997, TETRAHEDRON, V53, P10983, DOI 10.1016/S0040-4020(97)00359-1; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; NGUYEN M, 1995, GENETICS, V140, P527; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Ojeda AM, 2004, BIOCHEMISTRY-US, V43, P11163, DOI 10.1021/bi049562b; Oyarzun MP, 2008, MED VET ENTOMOL, V22, P188, DOI 10.1111/j.1365-2915.2008.00733.x; PATCHETT AA, 1995, P NATL ACAD SCI USA, V92, P7001, DOI 10.1073/pnas.92.15.7001; RAND JB, 1984, GENETICS, V106, P227; RAND JB, 1989, GENETICS, V122, P73; Acevedo GR, 2009, PARASITOL RES, V105, P489, DOI 10.1007/s00436-009-1425-x; Schafer WR, 2002, J NEUROBIOL, V53, P535, DOI 10.1002/neu.10154; Thompson GD, 2000, PEST MANAG SCI, V56, P696, DOI 10.1002/1526-4998(200008)56:8<696::AID-PS182>3.0.CO;2-5; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Varoqui H, 1998, METHOD ENZYMOL, V296, P84; Zhu HM, 2001, J BIOL CHEM, V276, P41580, DOI 10.1074/jbc.M103550200	40	24	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e34712	10.1371/journal.pone.0034712	http://dx.doi.org/10.1371/journal.pone.0034712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563457	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700006
J	Frenette, JJ; Massicotte, P; Lapierre, JF				Frenette, Jean-Jacques; Massicotte, Philippe; Lapierre, Jean-Francois			Colorful Niches of Phytoplankton Shaped by the Spatial Connectivity in a Large River Ecosystem: A Riverscape Perspective	PLOS ONE			English	Article							ST-LAWRENCE-RIVER; FRESH-WATER PICOCYANOBACTERIA; DISSOLVED ORGANIC-CARBON; LANDSCAPE ECOLOGY; SPECTRAL REFLECTANCE; COMMUNITY STRUCTURE; LIGHT QUALITY; LAKES; TERRESTRIAL; PICOPHYTOPLANKTON	Large rivers represent a significant component of inland waters and are considered sentinels and integrators of terrestrial and atmospheric processes. They represent hotspots for the transport and processing of organic and inorganic material from the surrounding landscape, which ultimately impacts the bio-optical properties and food webs of the rivers. In large rivers, hydraulic connectivity operates as a major forcing variable to structure the functioning of the riverscape, and-despite increasing interest in large-river studies-riverscape structural properties, such as the underwater spectral regime, and their impact on autotrophic ecological processes remain poorly studied. Here we used the St. Lawrence River to identify the mechanisms structuring the underwater spectral environment and their consequences on pico- and nanophytoplankton communities, which are good biological tracers of environmental changes. Our results, obtained from a 450 km sampling transect, demonstrate that tributaries exert a profound impact on the receiving river's photosynthetic potential. This occurs mainly through injection of chromophoric dissolved organic matter (CDOM) and non-algal material (tripton). CDOM and tripton in the water column selectively absorbed wavelengths in a gradient from blue to red, and the resulting underwater light climate was in turn a strong driver of the phytoplankton community structure (prokaryote/eukaryote relative and absolute abundances) at scales of many kilometers from the tributary confluence. Our results conclusively demonstrate the proximal impact of watershed properties on underwater spectral composition in a highly dynamic river environment characterized by unique structuring properties such as high directional connectivity, numerous sources and forms of carbon, and a rapidly varying hydrodynamic regime. We surmise that the underwater spectral composition represents a key integrating and structural property of large, heterogeneous river ecosystems and a promising tool to study autotrophic functional properties. It confirms the usefulness of using the riverscape approach to study large-river ecosystems and initiate comparison along latitudinal gradients.	[Frenette, Jean-Jacques; Massicotte, Philippe] Univ Quebec Trois Rivieres, Dept Chim Biol, Trois Rivieres, PQ GA9 5H7, Canada; [Lapierre, Jean-Francois] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Montreal	Frenette, JJ (corresponding author), Univ Quebec Trois Rivieres, Dept Chim Biol, CP 500, Trois Rivieres, PQ GA9 5H7, Canada.	Jean-Jacques.Frenette@uqtr.ca	Lapierre, Jean-Francois/F-1838-2010	Massicotte, Philippe/0000-0002-5919-4116; Lapierre, Jean-Francois/0000-0001-5862-7955	Natural Sciences Research Council of Canada (NSERC ship time and discovery programs); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)	Natural Sciences Research Council of Canada (NSERC ship time and discovery programs)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT)	This research was funded by the Natural Sciences Research Council of Canada (NSERC ship time and discovery programs) and the Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) to Dr. Frenette, a graduate NSERC to Dr. Lapierre, and a postgraduate NSERC to Dr. Massicotte. Quebec-Ocean's logistical support during sampling is greatly acknowledged. This is a contribution of the Groupe de Recherche Interuniversitaire en Limnologie (GRIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2007, STREAM ECOLOGY STRUC, VXIV, P436, DOI DOI 10.1007/978-1-4020-5583-6; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1957, COLD SPRING HARB SYM; APHA A, 1998, STANDARD METHODS EXA; Assani AA, 2010, J HYDROL, V385, P292, DOI 10.1016/j.jhydrol.2010.02.031; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Basu BK, 2000, FRESHWATER BIOL, V45, P373, DOI 10.1046/j.1365-2427.2000.00635.x; Bell T, 2001, LIMNOL OCEANOGR, V46, P1243, DOI 10.4319/lo.2001.46.5.1243; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blough NVDV R, 2002, BIOGEOCHEMISTRY MARI, Vxxii, P774; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Bukata R.P., 1995, OPTICAL PROPERTIES R; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Callieri C, 1996, INT REV GES HYDROBIO, V81, P13, DOI 10.1002/iroh.19960810103; Callieri C, 2007, AQUAT ECOL, V41, P511, DOI 10.1007/s10452-007-9125-z; Callieri Cristiana, 2008, Freshwater Reviews, V1, P1, DOI 10.1608/FRJ-1.1.1; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Constant H, 1978, CONTRIBUTION ETUDE Q; Davies-Colley RJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000722; DESCY JP, 1993, HYDROBIOLOGIA, V249, P111, DOI 10.1007/BF00008847; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; Frenette JJ, 2006, LIMNOL OCEANOGR, V51, P2632, DOI 10.4319/lo.2006.51.6.2632; Frenette JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035891; Frenette JJ, 2003, AQUAT ECOL, V37, P77, DOI 10.1023/A:1022133530244; GLOVER HE, 1987, J EXP MAR BIOL ECOL, V105, P137, DOI 10.1016/0022-0981(87)90168-7; Hoeinghaus DJ, 2007, ECOSYSTEMS, V10, P1019, DOI 10.1007/s10021-007-9075-2; Hudon C, 1996, HYDROBIOLOGIA, V337, P11, DOI 10.1007/BF00028503; Humborg C, 2010, GLOBAL CHANGE BIOL, V16, P1966, DOI 10.1111/j.1365-2486.2009.02092.x; Hunter PD, 2008, REMOTE SENS ENVIRON, V112, P1527, DOI 10.1016/j.rse.2007.08.003; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kahru M, 1998, J GEOPHYS RES-OCEANS, V103, P21601, DOI 10.1029/98JC01945; Katano T, 2007, AQUAT MICROB ECOL, V46, P191, DOI 10.3354/ame046191; KIRK JTO, 1988, J WATER POLLUT CON F, V60, P194; Kirk JTO, 1994, LIGHT PHOTOSYNTHESIS, Vxvi; Kutser T, 2006, ESTUAR COAST SHELF S, V67, P303, DOI 10.1016/j.ecss.2005.11.024; Lapierre JF, 2009, AQUAT SCI, V71, P15, DOI 10.1007/s00027-009-9133-2; Lapierre JF, 2008, MAR ECOL PROG SER, V372, P19, DOI 10.3354/meps07685; Liu HB, 2004, ESTUARIES, V27, P147, DOI 10.1007/BF02803568; Marie D, 2004, ALGAL CULTURING TECH, V17, P253; Massicotte P, 2011, ECOL APPL, V21, P2600, DOI 10.1890/10-1475.1; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Miller AJ, 2002, SUBSET SELECTION REG, Vxvii, P238; Miller CB, 2004, BIOL OCEANOGRAPHY, Vix; MILLS EL, 1981, HYDROBIOLOGIA, V79, P65, DOI 10.1007/BF00005820; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Pace ML, 2004, NATURE, V427, P240, DOI 10.1038/nature02227; Parsons TR, 1984, MANUAL CHEM BIOL MET, Vxiv; PICK FR, 1991, INT REV GES HYDROBIO, V76, P565, DOI 10.1002/iroh.19910760409; PICK FR, 1991, LIMNOL OCEANOGR, V36, P1457, DOI 10.4319/lo.1991.36.7.1457; Platt T, 2010, ESTUAR COAST, V33, P428, DOI 10.1007/s12237-009-9161-0; Pommier J, 2012, AQUATIC SCI; Pommier J, 2010, MAR ECOL PROG SER, V400, P143, DOI 10.3354/meps08413; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; Rice SP, 2006, CAN J FISH AQUAT SCI, V63, P2553, DOI 10.1139/F06-145; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Schallenberg M, 2001, FRESHWATER BIOL, V46, P27, DOI 10.1046/j.1365-2427.2001.00647.x; Siegel DA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000965; Simons RD, 2010, ATMOS OCEAN, V48, P132, DOI 10.3137/OC316.2010; Somogyi B, 2009, AQUAT ECOL, V43, P735, DOI 10.1007/s10452-009-9269-0; Stomp M, 2007, ISME J, V1, P271, DOI 10.1038/ismej.2007.59; Stomp M, 2007, ECOL LETT, V10, P290, DOI 10.1111/j.1461-0248.2007.01026.x; Svab E, 2005, INT J REMOTE SENS, V26, P919, DOI 10.1080/0143116042000274087; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Tremblay G, 2009, AQUAT MICROB ECOL, V54, P55, DOI 10.3354/ame01257; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Victoriano V, 2004, OCEANOGRAPHY MARINE, Vxxiv, P616; Vis C, 2007, ECOSYSTEMS, V10, P293, DOI 10.1007/s10021-007-9021-3; Voros L, 1998, HYDROBIOLOGIA, V370, P117; Wang BL, 2009, J LIMNOL, V68, P53, DOI 10.4081/jlimnol.2009.53; Wetzel RG, 2001, LAKE RIVER ECOSYSTEM; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; Williamson CE, 1999, LIMNOL OCEANOGR, V44, P795, DOI 10.4319/lo.1999.44.3_part_2.0795; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273; Winder M, 2009, J PLANKTON RES, V31, P1307, DOI 10.1093/plankt/fbp074; Xie HX, 2012, MAR CHEM, V128, P44, DOI 10.1016/j.marchem.2011.10.001; YENTSCH CS, 1960, DEEP-SEA RES, V7, P1, DOI 10.1016/0146-6313(60)90002-2; [No title captured]	83	23	23	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35891	10.1371/journal.pone.0035891	http://dx.doi.org/10.1371/journal.pone.0035891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558259	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200029
J	Gebhard, LG; Kaufman, SB; Gamarnik, AV				Gebhard, Leopoldo G.; Kaufman, Sergio B.; Gamarnik, Andrea V.			Novel ATP-Independent RNA Annealing Activity of the Dengue Virus NS3 Helicase	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; DEAD-BOX PROTEIN; WEST-NILE-VIRUS; STIMULATED NUCLEOSIDE TRIPHOSPHATASE; TYPE-2 NONSTRUCTURAL PROTEIN-3; VIRAL REPLICATION; IN-VITRO; CRYSTAL-STRUCTURE; HELICASE/NUCLEOSIDE TRIPHOSPHATASE; CATALYTIC DOMAIN	The flavivirus nonstructural protein 3 (NS3) bears multiple enzymatic activities and represents an attractive target for antiviral intervention. NS3 contains the viral serine protease at the N-terminus and ATPase, RTPase, and helicase activities at the C-terminus. These activities are essential for viral replication; however, the biological role of RNA remodeling by NS3 helicase during the viral life cycle is still unclear. Secondary and tertiary RNA structures present in the viral genome are crucial for viral replication. Here, we used the NS3 protein from dengue virus to investigate functions of NS3 associated to changes in RNA structures. Using different NS3 variants, we characterized a domain spanning residues 171 to 618 that displays ATPase and RNA unwinding activities similar to those observed for the full-length protein. Interestingly, we found that, besides the RNA unwinding activity, dengue virus NS3 greatly accelerates annealing of complementary RNA strands with viral or non-viral sequences. This new activity was found to be ATP-independent. It was determined that a mutated NS3 lacking ATPase activity retained full-RNA annealing activity. Using an ATP regeneration system and different ATP concentrations, we observed that NS3 establishes an ATP-dependent steady state between RNA unwinding and annealing, allowing modulation of the two opposing activities of this enzyme through ATP concentration. In addition, we observed that NS3 enhanced RNA-RNA interactions between molecules representing the ends of the viral genome that are known to be necessary for viral RNA synthesis. We propose that, according to the ATP availability, NS3 could function regulating the folding or unfolding of viral RNA structures.	[Gebhard, Leopoldo G.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Kaufman, Sergio B.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Kaufman, Sergio B.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires; University of Buenos Aires	Gebhard, LG (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina.	agamarnik@leloir.org.ar		Kaufman, Sergio Benjamin/0000-0002-8763-4086	NIH [1R01AI095175-01]; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICT-2010-2092]; CONICET; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to AVG from NIH (1R01AI095175-01) and Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) PICT-2010-2092. AVG is a member of the Argentinean Council of Investigation (CONICET). LG was funded by a CONICET fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J; [Anonymous], VECT BORN VIR INF; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Belon CA, 2009, J MOL BIOL, V388, P851, DOI 10.1016/j.jmb.2009.03.059; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; CHAMBERS TJ, 1993, J VIROL, V67, P6797, DOI 10.1128/JVI.67.11.6797-6807.1993; CHAMBERS TJ, 1995, J VIROL, V69, P1600, DOI 10.1128/JVI.69.3.1600-1605.1995; Chamot D, 2005, J BIOL CHEM, V280, P2036, DOI 10.1074/jbc.M409700200; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Ding SC, 2011, J VIROL, V85, P4343, DOI 10.1128/JVI.02130-10; Dreher TW, 1999, ANNU REV PHYTOPATHOL, V37, P151, DOI 10.1146/annurev.phyto.37.1.151; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; EAGLES RM, 1994, EUR J BIOCHEM, V224, P677, DOI 10.1111/j.1432-1033.1994.t01-1-00677.x; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Frick DN, 2006, HCV HELICASE STRUCTU; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Heck JA, 2008, ANTIMICROB AGENTS CH, V52, P1901, DOI 10.1128/AAC.01496-07; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Huang ZS, 2010, FEBS LETT, V584, P2356, DOI 10.1016/j.febslet.2010.04.020; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kadare G, 1997, J VIROL, V71, P2583; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Liu WJ, 2002, J VIROL, V76, P10766, DOI 10.1128/JVI.76.21.10766-10775.2002; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; McKnight KL, 1998, RNA, V4, P1569, DOI 10.1017/S1355838298981006; Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07; Paul AV, 2000, J VIROL, V74, P10359, DOI 10.1128/JVI.74.22.10359-10370.2000; Pogany J, 2003, EMBO J, V22, P5602, DOI 10.1093/emboj/cdg523; Rajagopal V, 2010, J BIOL CHEM, V285, P17821, DOI 10.1074/jbc.M110.114785; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; SHUMAN S, 1992, P NATL ACAD SCI USA, V89, P10935, DOI 10.1073/pnas.89.22.10935; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; SONG CZ, 1995, J MOL BIOL, V254, P6, DOI 10.1006/jmbi.1995.0594; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Uhlmann-Schiffler H, 2006, NUCLEIC ACIDS RES, V34, P10, DOI 10.1093/nar/gkj403; Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410; Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008; WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993; WARRENER P, 1995, J VIROL, V69, P1720, DOI 10.1128/JVI.69.3.1720-1726.1995; WENGLER G, 1991, J GEN VIROL, V72, P851, DOI 10.1099/0022-1317-72-4-851; WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M; Wu BD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000323; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yamashita T, 2008, VIROLOGY, V373, P426, DOI 10.1016/j.virol.2007.12.018; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Yu E, 2000, NUCLEIC ACIDS RES, V28, P3926, DOI 10.1093/nar/28.20.3926	77	55	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36244	10.1371/journal.pone.0036244	http://dx.doi.org/10.1371/journal.pone.0036244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558403	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340200054
J	Koper, A; Schenck, A; Prokop, A				Koper, Andre; Schenck, Annette; Prokop, Andreas			Analysis of Adhesion Molecules and Basement Membrane Contributions to Synaptic Adhesion at the Drosophila Embryonic NMJ	PLOS ONE			English	Article							SULFATE PROTEOGLYCAN SYNDECAN; ATYPICAL CADHERIN FLAMINGO; CELL-ADHESION; NEUROMUSCULAR-JUNCTIONS; EXTRACELLULAR-MATRIX; GLUTAMATE RECEPTORS; POSTSYNAPTIC SPECIALIZATIONS; IMMUNOGLOBULIN SUPERFAMILY; PRESYNAPTIC DEVELOPMENT; CAENORHABDITIS-ELEGANS	Synapse formation and maintenance crucially underlie brain function in health and disease. Both processes are believed to depend on cell adhesion molecules (CAMs). Many different classes of CAMs localise to synapses, including cadherins, protocadherins, neuroligins, neurexins, integrins, and immunoglobulin adhesion proteins, and further contributions come from the extracellular matrix and its receptors. Most of these factors have been scrutinised by loss-of-function analyses in animal models. However, which adhesion factors establish the essential physical links across synaptic clefts and allow the assembly of synaptic machineries at the contact site in vivo is still unclear. To investigate these key questions, we have used the neuromuscular junction (NMJ) of Drosophila embryos as a genetically amenable model synapse. Our ultrastructural analyses of NMJs lacking different classes of CAMs revealed that loss of all neurexins, all classical cadherins or all glutamate receptors, as well as combinations between these or with a Laminin deficiency, failed to reveal structural phenotypes. These results are compatible with a view that these CAMs might have no structural role at this model synapse. However, we consider it far more likely that they operate in a redundant or well buffered context. We propose a model based on a multi-adaptor principle to explain this phenomenon. Furthermore, we report a new CAM-independent adhesion mechanism that involves the basement membranes (BM) covering neuromuscular terminals. Thus, motorneuronal terminals show strong partial detachment of the junction when BM-to-cell surface attachment is impaired by removing Laminin A, or when BMs lose their structural integrity upon loss of type IV collagens. We conclude that BMs are essential to tie embryonic motorneuronal terminals to the muscle surface, lending CAM-independent structural support to their adhesion. Therefore, future developmental studies of these synaptic junctions in Drosophila need to consider the important contribution made by BM-dependent mechanisms, in addition to CAM-dependent adhesion.	[Koper, Andre; Prokop, Andreas] Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England; [Schenck, Annette] Radboud Univ Nijmegen, Dept Human Genet, Nijmegen Ctr Mol Life Sci, Donders Inst Brain Cognit & Behav,Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Manchester; Radboud University Nijmegen	Koper, A (corresponding author), Sch Translat Med, Manchester, Lancs, England.	Prokop@manchester.ac.uk	Schenck, Annette/E-4514-2012	Schenck, Annette/0000-0002-6918-3314; Prokop, Andreas/0000-0001-8482-3298	BBSRC [BB/E009085/1]; Wellcome Trust VIP funding [092403/Z/10/Z]; FP7 Gencodys [Health-241995]; NWO VIDI grants; University of Manchester Strategic Fund; Wellcome Trust [087742/Z/08/Z]; Biotechnology and Biological Sciences Research Council [BB/E009085/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust VIP funding(Wellcome Trust); FP7 Gencodys; NWO VIDI grants; University of Manchester Strategic Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded through a grant by the BBSRC (www.bbsrc.ac.uk)(BB/E009085/1) and Wellcome Trust (www.wellcome.ac.uk) VIP funding (092403/Z/10/Z) to AP, and FP7 Gencodys (Health-241995)(http://cordis.europa.eu/fetch?CALLER=FP7_PROJ_EN&ACTION=D&DOC=1&CAT=PROJ&RCN=94690) and NWO VIDI grants (http://www.nwo.nl/nwohome.nsf/pages/nwop_5vtgqw_eng) to AS. The EM Facilities used for this project are supported by grants from the BBSRC, The Wellcome Trust and the University of Manchester Strategic Fund. The Drosophila core facility is supported by the Wellcome Trust (www.wellcome.ac.uk)(087742/Z/08/Z). The publication costs were paid for by The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Al-Anzi B, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-31; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Astigarraga S, 2010, CURR OPIN GENET DEV, V20, P400, DOI 10.1016/j.gde.2010.04.001; Ataman B, 2006, INT REV NEUROBIOL, V75, P181, DOI 10.1016/S0074-7742(06)75009-7; Aumailley Monique, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000123; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Bao H, 2007, MOL CELL NEUROSCI, V34, P662, DOI 10.1016/j.mcn.2007.01.007; Bate Michael, 1993, P1013; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bodily KD, 2001, J NEUROSCI, V21, P3113, DOI 10.1523/JNEUROSCI.21-09-03113.2001; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; Broadie K, 2011, DEV NEUROBIOL, V71, P1102, DOI 10.1002/dneu.20935; Budnik V, 2006, INT REV NEUROBIOL, V75, P323, DOI 10.1016/S0074-7742(06)75015-2; BUNCH TA, 1992, GENETICS, V132, P519; Bunt S, 2010, DEV CELL, V19, P296, DOI 10.1016/j.devcel.2010.07.019; Butler SJ, 1997, DEVELOPMENT, V124, P781; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Carlson SS, 2010, J NEUROCHEM; Chen K, 2005, J NEUROSCI, V25, P6667, DOI 10.1523/JNEUROSCI.1527-05.2005; Chen KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011115; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Christoforou CP, 2008, DEV BIOL, V313, P519, DOI 10.1016/j.ydbio.2007.09.044; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Egles C, 2007, MOL CELL NEUROSCI, V34, P288, DOI 10.1016/j.mcn.2006.11.004; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Ferguson K, 2009, J NEUROSCI, V29, P14151, DOI 10.1523/JNEUROSCI.2497-09.2009; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Friedrich MVK, 2000, EUR J BIOCHEM, V267, P3149, DOI 10.1046/j.1432-1327.2000.01337.x; Fung S, 2009, DEV BIOL, V332, P371, DOI 10.1016/j.ydbio.2009.06.005; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; GUTZEIT HO, 1991, J CELL SCI, V100, P781; HENCHCLIFFE C, 1993, DEVELOPMENT, V118, P325; Hill E, 2001, J MOL BIOL, V305, P1011, DOI 10.1006/jmbi.2000.4361; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Jonkman MF, 1999, J DERMATOL SCI, V20, P103, DOI 10.1016/S0923-1811(99)00017-1; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Kuppers-Munther B, 2004, DEV BIOL, V269, P459, DOI 10.1016/j.ydbio.2004.01.038; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Lardi-Studler B, 2007, NEUROSCIENTIST, V13, P115, DOI 10.1177/1073858406296803; Latefi NS, 2007, NEUROCHEM RES, V32, P303, DOI 10.1007/s11064-006-9181-0; Latvanlehto A, 2010, J NEUROSCI, V30, P12230, DOI 10.1523/JNEUROSCI.5518-09.2010; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Matsuno M, 2009, P NATL ACAD SCI USA, V106, P310, DOI 10.1073/pnas.0807665106; McMahon SA, 2011, CURR OPIN NEUROBIOL, V21, P221, DOI 10.1016/j.conb.2010.12.005; Melom JE, 2011, CURR OPIN GENET DEV, V21, P256, DOI 10.1016/j.gde.2011.01.002; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Owald D, 2009, CURR OPIN NEUROBIOL, V19, P311, DOI 10.1016/j.conb.2009.03.003; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Piechotta K, 2006, CELL TISSUE RES, V326, P617, DOI 10.1007/s00441-006-0267-4; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Prokop A, 1999, CELL TISSUE RES, V297, P169, DOI 10.1007/s004410051345; Prokop A, 2006, INT REV NEUROBIOL, V75, P71, DOI 10.1016/S0074-7742(06)75004-8; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; RAKIC P, 1975, COLD SPRING HARB SYM, V40, P333, DOI 10.1101/SQB.1976.040.01.033; Rawls AS, 2003, DEVELOPMENT, V130, P1877, DOI 10.1242/dev.00411; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Rohrbough J, 2007, GENE DEV, V21, P2607, DOI 10.1101/gad.1574107; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmid A, 2006, J NEUROSCI, V26, P11267, DOI 10.1523/JNEUROSCI.2722-06.2006; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Singhal N, 2011, DEV NEUROBIOL, V71, P982, DOI 10.1002/dneu.20953; Slovakova J, 2011, DEVELOPMENT, V138, P1563, DOI 10.1242/dev.056192; Sone M, 2000, DEVELOPMENT, V127, P4157; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Steinel MC, 2009, DEV BIOL, V327, P447, DOI 10.1016/j.ydbio.2008.12.026; Sudhof TC, 2001, SYNAPSES, P275; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Sun MK, 2012, SCI CHINA LIFE SCI, V55, P20, DOI 10.1007/s11427-012-4273-3; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Thomas U, 2010, J NEUROGENET, V24, P109, DOI 10.3109/01677063.2010.493589; Tsai PI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-26; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Urbano JM, 2009, DEVELOPMENT, V136, P4165, DOI 10.1242/dev.044263; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vogel C, 2003, DEVELOPMENT, V130, P6317, DOI 10.1242/dev.00848; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wheeler SR, 2009, DEVELOPMENT, V136, P1147, DOI 10.1242/dev.030254; Wolfstetter G, 2012, CELL MOL LIFE SCI, V69, P267, DOI 10.1007/s00018-011-0652-3; YEE GH, 1993, DEVELOPMENT, V118, P845; Yonekura S, 2007, DEV BIOL, V304, P759, DOI 10.1016/j.ydbio.2007.01.030; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	114	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36339	10.1371/journal.pone.0036339	http://dx.doi.org/10.1371/journal.pone.0036339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558441	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200068
J	Girard, C; Renaud, S				Girard, Catherine; Renaud, Sabrina			Disparity Changes in 370 Ma Devonian Fossils: The Signature of Ecological Dynamics?	PLOS ONE			English	Article							MORPHOLOGICAL DISPARITY; BRACHIOPOD FAUNAS; CONODONT; EXTINCTION; EVOLUTION; PALMATOLEPIS; INDICATE; RECOVERY; EVENTS; STRATEGIES	Early periods in Earth's history have seen a progressive increase in complexity of the ecosystems, but also dramatic crises decimating the biosphere. Such patterns are usually considered as large-scale changes among supra-specific groups, including morphological novelties, radiation, and extinctions. Nevertheless, in the same time, each species evolved by the way of micro-evolutionary processes, extended over millions of years into the evolution of lineages. How these two evolutionary scales interacted is a challenging issue because this requires bridging a gap between scales of observation and processes. The present study aims at transferring a typical macro-evolutionary approach, namely disparity analysis, to the study of fine-scale evolutionary variations in order to decipher what processes actually drove the dynamics of diversity at a micro-evolutionary level. The Late Frasnian to Late Famennian period was selected because it is punctuated by two major macro-evolutionary crises, as well as a progressive diversification of marine ecosystem. Disparity was estimated through this period on conodonts, tooth-like fossil remains of small eel-like predators that were part of the nektonic fauna. The study was focused on the emblematic genus of the period, Palmatolepis. Strikingly, both crises affected an already impoverished Palmatolepis disparity, increasing risks of random extinction. The major disparity signal rather emerged as a cycle of increase and decrease in disparity during the inter-crises period. The diversification shortly followed the first crisis and might correspond to an opportunistic occupation of empty ecological niche. The subsequent oriented shrinking in the morphospace occupation suggests that the ecological space available to Palmatolepis decreased through time, due to a combination of factors: deteriorating climate, expansion of competitors and predators. Disparity changes of Palmatolepis thus reflect changes in the structure of the ecological space itself, which was prone to evolve during this ancient period where modern ecosystems were progressively shaped.	[Girard, Catherine] Univ Montpellier 2, Inst Sci Evolut, CNRS, Montpellier, France; [Renaud, Sabrina] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Girard, C (corresponding author), Univ Montpellier 2, Inst Sci Evolut, CNRS, Montpellier, France.	Catherine.Girard@univ-montp2.fr	Renaud, Sabrina/AAV-3141-2020; Girard, Catherine/ABB-3841-2021; Renaud, Sabrina/D-4247-2009	Renaud, Sabrina/0000-0002-8730-3113; Renaud, Sabrina/0000-0002-8730-3113	CNRS "Morphologie et Evolution des Formes'' [GDR 2474]	CNRS "Morphologie et Evolution des Formes''	This study has been supported by the GDR 2474 CNRS "Morphologie et Evolution des Formes''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeo T.J., 1995, GEOL SURV AM TODAY, V5, P65; Balter V, 2008, GEOLOGY, V36, P907, DOI 10.1130/G24989A.1; Bambach Richard K., 2002, Paleontological Society Papers, V8, P319; BECKER RT, 1989, CR ACAD SCI II, V309, P259; Borsa P, 2002, BIOL J LINN SOC, V75, P261, DOI 10.1111/j.1095-8312.2002.tb01426.x; Bottjer D.J., 2008, GSA TODAY, V18, P4, DOI DOI 10.1130/GSATG8A.1; Buggisch W, 2008, PALAEOGEOGR PALAEOCL, V268, P273, DOI 10.1016/j.palaeo.2008.03.043; Cardini A, 2007, ZOOMORPHOLOGY, V126, P121, DOI 10.1007/s00435-007-0036-2; Chen ZQ, 2005, PALAEOGEOGR PALAEOCL, V224, P232, DOI 10.1016/j.palaeo.2005.04.014; Chen ZQ, 2005, PALAEOGEOGR PALAEOCL, V224, P270, DOI 10.1016/j.palaeo.2005.03.037; Corradini C., 2003, PALAEONTOGRAPH ITAL, V89, P65; Dzik J, 2002, ACTA PALAEONTOL POL, V47, P565; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Gerber S, 2007, EVOL DEV, V9, P472, DOI 10.1111/j.1525-142X.2007.00185.x; Ginter Michal, 2002, Acta Geologica Polonica, V52, P169; Girard C, 2004, GEOBIOS-LYON, V37, P404, DOI 10.1016/j.geobios.2003.07.002; Girard C, 2004, CR PALEVOL, V3, P1, DOI 10.1016/j.crpv.2003.09.008; GIRARD C., 1994, WILLI ZIEGLER FESTSC, V168, P299; Girard C, 2005, DEV PALAEONTOL STRAT, V20, P181; Girard C, 2007, PALAEOGEOGR PALAEOCL, V250, P114, DOI 10.1016/j.palaeo.2007.03.007; Girard C, 2007, J MICROPALAEONTOL, V26, P61, DOI 10.1144/jm.26.1.61; Girard Catherine, 1996, Revue de Micropaleontologie, V39, P261, DOI 10.1016/S0035-1598(96)90110-5; Girard C, 2011, CR PALEVOL, V10, P107, DOI 10.1016/j.crpv.2010.10.009; Girard C, 2010, ACTA PALAEONTOL POL, V55, P675, DOI 10.4202/app.2009.0098; Girard C, 2008, LETHAIA, V41, P383, DOI 10.1111/j.1502-3931.2008.00095.x; Godderis Y, 2004, PALAEOGEOGR PALAEOCL, V202, P309, DOI 10.1016/S0031-0182(03)00641-2; Hallam A., 1997, MASS EXTINCTIONS THE; Helms J., 1963, Geologie, V12, P449; Helms JJ, 1981, CONODONTA TREATISE W, P202; Jacobsen ND, 2011, PALAEOGEOGR PALAEOCL, V308, P200, DOI 10.1016/j.palaeo.2010.04.024; Janevski GA, 2009, PALEOBIOLOGY, V35, P553, DOI 10.1666/0094-8373-35.4.553; Joachimski MM, 2009, EARTH PLANET SC LETT, V284, P599, DOI 10.1016/j.epsl.2009.05.028; Joachimski MM, 2002, GEOLOGY, V30, P711, DOI 10.1130/0091-7613(2002)030<0711:CAOSIC>2.0.CO;2; Johansson F, 2006, ICHTHYOL RES, V53, P63, DOI 10.1007/s10228-005-0316-0; Kaiser SI, 2008, GEOL J, V43, P241, DOI 10.1002/gj.1111; Kassahn KS, 2003, MAR BIOL, V143, P947, DOI 10.1007/s00227-003-1141-5; Kaufmann B, 2006, EARTH-SCI REV, V76, P175, DOI 10.1016/j.earscirev.2006.01.001; KLAPPER G, 1993, J PALEONTOL, V67, P1; KLAPPER G, 1986, CAN J EARTH SCI, V23, P1214, DOI 10.1139/e86-117; Klug C, 2010, LETHAIA, V43, P465, DOI 10.1111/j.1502-3931.2009.00206.x; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Linde M, 2004, J EVOLUTION BIOL, V17, P941, DOI 10.1111/j.1420-9101.2004.00763.x; Long JA, 2010, ANNU REV EARTH PL SC, V38, P255, DOI 10.1146/annurev-earth-040809-152416; McGhee G.R., 1996, LATE DEVONIAN MASS E; Morrow Jared R., 2000, Courier Forschungsinstitut Senckenberg, V219, P1; Muller KJ, 1956, GESELLSCHAFT, V494, P1; Nicoll RS, 1977, J AUSTR GEOLOGY GEOP, V2, P217; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; PURNELL MA, 1995, NATURE, V374, P798, DOI 10.1038/374798a0; Purnell MA, 2000, J PALEONTOL, V74, P113, DOI 10.1666/0022-3360(2000)074<0113:OAANIC>2.0.CO;2; Racki G, 2005, DEV PALAEONTOL STRAT, V20, P5; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Renaud S, 1999, PALAEOGEOGR PALAEOCL, V146, P19, DOI 10.1016/S0031-0182(98)00138-2; Renaud S, 1996, PALEOBIOLOGY, V22, P255, DOI 10.1017/S0094837300016201; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; Saltzman MR, 2005, GEOLOGY, V33, P573, DOI 10.1130/G21535.1; Sandberg CA, 2002, GEOL SOC AM SPEC PAP, V356, P473; Sandberg CA., 1976, GEOLOGICAL ASS CANAD, V15, P171; Scheckler S.E., 1986, ANN SOC GEOL BELG, V109, P209; Schulke I., 1995, EVOLUTIVE PROZESSE B; SCOTESE CR, 1990, GEO SOC MEM, V12, P1, DOI 10.1144/GSL.MEM.1990.012.01.01; Sepkoski J.J. Jr, 1982, Geological Society of America Special Paper, P283; Sepkoski J.J. Jr, 1986, Life Sciences Research Report, P277; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Sepkoski Jr J.J., 1996, GLOBAL EVENTS EVENT, P35, DOI DOI 10.1007/978-3-642-79634-0_4; Stigall AL, 2012, GEOLOGICAL SOC AM TO, V22, P4, DOI DOI 10.1130/G128A.1; Svanback R, 2004, FUNCT ECOL, V18, P503, DOI 10.1111/j.0269-8463.2004.00858.x; Sweet W.C, 1971, J PALEONTOL, V45, P869; van den Boogaard, 1979, SCRIPTA GEOLOGICA, V49, P1; Viguier B, 2000, CR ACAD SCI III-VIE, V323, P573, DOI 10.1016/S0764-4469(00)00148-7; Villier L, 2004, SCIENCE, V306, P264, DOI 10.1126/science.1102127; Ziegler W., 1990, Courier Forschungsinstitut Senckenberg, V121, P1; Ziegler W., 1984, Geological Society of America Special Paper, P179; Ziegler W, 2000, COUR FORSCH I SENCKE, V225, P335	77	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36230	10.1371/journal.pone.0036230	http://dx.doi.org/10.1371/journal.pone.0036230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558396	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000163
J	Jacobs, SA; Tsien, JZ				Jacobs, Stephanie A.; Tsien, Joe Z.			Genetic Overexpression of NR2B Subunit Enhances Social Recognition Memory for Different Strains and Species	PLOS ONE			English	Article							LONG-TERM-MEMORY; NMDA RECEPTOR; SYNAPTIC PLASTICITY; CYTOTOXIC LESIONS; SPATIAL MEMORY; ENVIRONMENTAL ENRICHMENT; OLFACTORY MEMORY; RAT HIPPOCAMPUS; TRANSGENIC MICE; MEDIAL AMYGDALA	The ability to learn and remember conspecifics is essential for the establishment and maintenance of social groups. Many animals, including humans, primates and rodents, depend on stable social relationships for survival. Social learning and social recognition have become emerging areas of interest for neuroscientists but are still not well understood. It has been established that several hormones play a role in the modulation of social recognition including estrogen, oxytocin and arginine vasopression. Relatively few studies have investigated how social recognition might be improved or enhanced. In this study, we investigate the role of the NMDA receptor in social recognition memory, specifically the consequences of altering the ratio of the NR2B:NR2A subunits in the forebrain regions in social behavior. We produced transgenic mice in which the NR2B subunit of the NMDA receptor was overexpressed postnatally in the excitatory neurons of the forebrain areas including the cortex, amygdala and hippocampus. We investigated the ability of both our transgenic animals and their wild-type littermate to learn and remember juvenile conspecifics using both 1-hr and 24-hr memory tests. Our experiments show that the wild-type animals and NR2B transgenic mice preformed similarly in the 1-hr test. However, transgenic mice showed better performances in 24-hr tests of recognizing animals of a different strain or animals of a different species. We conclude that NR2B overexpression in the forebrain enhances social recognition memory for different strains and animal species.	[Jacobs, Stephanie A.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Med Coll Georgia, Augusta, GA USA; Georgia Hlth Sci Univ, Dept Neurol, Med Coll Georgia, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Jacobs, SA (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Med Coll Georgia, Augusta, GA USA.	jtsien@georgiahealth.edu			National Institute of Mental Health [MH060236]; National Institute on Aging [AG024022, AG034663, AG025918]; Georgia Research Alliance; USAMRA00002; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024022, R01AG025918, R01AG034663] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Georgia Research Alliance; USAMRA00002; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the National Institute of Mental Health (MH060236), National Institute on Aging (AG024022, AG034663 & AG025918), USAMRA00002, and Georgia Research Alliance (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman DM, 2002, EXP BRAIN RES, V142, P395, DOI 10.1007/s00221-001-0938-z; Bannerman DM, 2001, EXP BRAIN RES, V138, P100, DOI 10.1007/s002210100687; BERTAINA V, 1995, COGNITIVE BRAIN RES, V2, P269, DOI 10.1016/0926-6410(95)90018-7; Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; BLUTHE RM, 1993, BRAIN RES, V604, P205, DOI 10.1016/0006-8993(93)90370-3; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Celerier A, 2011, BIOL LETTERS, V7, P807, DOI 10.1098/rsbl.2011.0340; Choleris E, 2009, FRONT NEUROENDOCRIN, V30, P442, DOI 10.1016/j.yfrne.2009.05.003; CORKIN S, 1984, ARCH NEUROL-CHICAGO, V41, P975, DOI 10.1001/archneur.1984.04050200081022; Coudereau JP, 1996, PROG NEURO-PSYCHOPH, V20, P827, DOI 10.1016/0278-5846(96)00062-0; Cui YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020312; Cui ZZ, 2005, EUR J NEUROSCI, V22, P755, DOI 10.1111/j.1460-9568.2005.04257.x; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DANTZER R, 1987, PSYCHOPHARMACOLOGY, V91, P363, DOI 10.1007/BF00518192; Duffy SN, 2001, LEARN MEMORY, V8, P26, DOI 10.1101/lm.36301; ENGELMANN M, 1994, PHYSIOL BEHAV, V55, P145, DOI 10.1016/0031-9384(94)90022-1; Engelmann M, 2009, NEUROBIOL LEARN MEM, V91, P58, DOI 10.1016/j.nlm.2008.08.009; ESSMAN WB, 1966, ANIM BEHAV, V14, P406, DOI 10.1016/S0003-3472(66)80037-4; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Feinberg LM, 2012, NEUROBIOL LEARN MEM, V97, P7, DOI 10.1016/j.nlm.2011.08.008; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gao XM, 2009, PHARMACOL BIOCHEM BE, V92, P236, DOI 10.1016/j.pbb.2008.11.016; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hlinak Z, 2002, NEUROSCI LETT, V330, P227, DOI 10.1016/S0304-3940(02)00802-9; HLINAK Z, 1991, PHYSIOL RES, V40, P59; Holmes A, 2002, GENES BRAIN BEHAV, V1, P55, DOI 10.1046/j.1601-1848.2001.00005.x; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Kasahara M, 2011, BEHAV BRAIN RES, V218, P357, DOI 10.1016/j.bbr.2010.12.029; Kempermann G, 1999, HIPPOCAMPUS, V9, P321, DOI 10.1002/(SICI)1098-1063(1999)9:3<321::AID-HIPO11>3.0.CO;2-C; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; KONISHI M, 1989, NEURON, V3, P541, DOI 10.1016/0896-6273(89)90264-X; KUHL PK, 1994, CURR OPIN NEUROBIOL, V4, P812, DOI 10.1016/0959-4388(94)90128-7; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Letty S, 1997, NEUROPHARMACOLOGY, V36, P681, DOI 10.1016/S0028-3908(96)00169-4; Li SJ, 2010, BRAIN RES, V1351, P165, DOI 10.1016/j.brainres.2010.06.004; Maaswinkel H, 1996, PHYSIOL BEHAV, V60, P55, DOI 10.1016/0031-9384(95)02233-3; Macbeth AH, 2009, GENES BRAIN BEHAV, V8, P558, DOI 10.1111/j.1601-183X.2009.00506.x; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Noack J, 2010, NEUROBIOL LEARN MEM, V94, P568, DOI 10.1016/j.nlm.2010.09.013; Penka LL, 2004, STRESS, V7, P63, DOI 10.1080/10253890410001677231; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Popik Piotr, 1991, Journal of Basic and Clinical Physiology and Pharmacology, V2, P315; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Richter K, 2005, LEARN MEMORY, V12, P407, DOI 10.1101/lm.97505; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Rudy JW, 1996, BEHAV NEUROSCI, V110, P238, DOI 10.1037/0735-7044.110.2.238; Samuelsen CL, 2011, NEUROSCIENCE, V180, P96, DOI 10.1016/j.neuroscience.2011.02.030; Sanchez-Andrade G, 2005, J REPROD DEVELOP, V51, P547, DOI 10.1262/jrd.17031; SCHELLINCK HM, 1995, PHYSIOL BEHAV, V57, P1005, DOI 10.1016/0031-9384(94)00353-7; SEKIGUCHI R, 1991, PHYSIOL BEHAV, V50, P1253, DOI 10.1016/0031-9384(91)90591-B; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; Spiteri T, 2010, BEHAV BRAIN RES, V210, P211, DOI 10.1016/j.bbr.2010.02.033; Spiteri T, 2010, NEUROENDOCRINOLOGY, V91, P142, DOI 10.1159/000255766; Squires AS, 2006, NEUROBIOL LEARN MEM, V85, P95, DOI 10.1016/j.nlm.2005.08.012; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; THOR DH, 1982, J COMP PHYSIOL PSYCH, V96, P1000, DOI 10.1037/0735-7036.96.6.1000; THOR DH, 1981, ANIM LEARN BEHAV, V9, P561, DOI 10.3758/BF03209791; Tonegawa S, 1996, COLD SPRING HARB SYM, V61, P225; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; van der Staay FJ, 2011, BEHAV BRAIN RES, V220, P215, DOI 10.1016/j.bbr.2011.01.052; Vann SD, 2000, J NEUROSCI, V20, P8144; Vann SD, 2000, J NEUROSCI, V20, P2711; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; White TL, 2004, BRAIN RES, V1021, P1, DOI 10.1016/j.brainres.2004.05.114; Winslow James T, 2003, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0816s22; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817	79	34	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36387	10.1371/journal.pone.0036387	http://dx.doi.org/10.1371/journal.pone.0036387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558458	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000203
J	Liang, JA; Sun, LM; Su, KP; Chang, SN; Sung, FC; Muo, CH; Kao, CH				Liang, Ji-An; Sun, Li-Min; Su, Kuan-Pin; Chang, Shih-Ni; Sung, Fung-Chang; Muo, Chih-Hsin; Kao, Chia-Hung			A Nationwide Population-Based Cohort Study: Will Anxiety Disorders Increase Subsequent Cancer Risk?	PLOS ONE			English	Article							BREAST-CANCER; PSYCHOSOCIAL FACTORS; LIFE EVENTS; STRESS; DEPRESSION; METAANALYSIS; OUTPATIENTS; PREVALENCE; NONSMOKERS; SMOKERS	Background: The aim of this study was to evaluate a possible association between malignancy and anxiety disorders (AD) in Taiwan. Methods: We employed data from the National Health Insurance system of Taiwan. The AD cohort contained 24,066 patients with each patient randomly frequency matched according to age and sex with 4 individuals from the general population without AD. Cox's proportional hazard regression analysis was conducted to estimate the influence of AD on the risk of cancer. Results: Among patients with AD, the overall risk of developing cancer was only 1% higher than among subjects without AD, and the difference was not significant (hazard ratio [HR] = 1.01, 95% confidence interval [ 95% CI] = 0.95-1.07). With regard to individual types of cancer, the risk of developing prostate cancer among male patients with AD was significantly higher (HR = 1.32, 95% CI = 1.02-1.71). On the other hand, the risk of cervical cancer among female patients with AD was marginally significantly lower than among female subjects without AD (HR = 0.72, 95% CI = 0.51-1.03). Limitations: One major limitation is the lack of information regarding the life style or behavior of patients in the NHI database, such as smoking and alcohol consumption. Conclusions: Despite the failure to identify a relationship between AD and the overall risk of cancer, we found that Taiwanese patients with AD had a higher risk of developing prostate cancer and a lower risk of developing cervical cancer.	[Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Liang, Ji-An; Su, Kuan-Pin; Kao, Chia-Hung] China Med Univ, Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Liang, Ji-An; Su, Kuan-Pin; Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Sun, Li-Min] Zuoying Armed Forces Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Su, Kuan-Pin] China Med Univ Hosp, Dept Gen Psychiat, Taichung, Taiwan; [Su, Kuan-Pin] China Med Univ Hosp, Mind Body Interface Lab, Taichung, Taiwan; [Chang, Shih-Ni; Sung, Fung-Chang; Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chang, Shih-Ni; Sung, Fung-Chang; Muo, Chih-Hsin] China Med Univ, Inst Environm Hlth, Coll Publ Hlth, Taichung, Taiwan; [Chang, Shih-Ni] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Chang, Shih-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liang, JA (corresponding author), China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan.	A17776@mail.cmuh.org; d10040@mail.cmuh.org.tw	Su, Kuan-Pin/P-5284-2015	Su, Kuan-Pin/0000-0002-4501-2502	Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH101-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH101-TD-C-111-005];  [DMR-99-105];  [DMR-98-050]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Department of Health Cancer Research Center for Excellence; ; 	This work was supported by the study projects (DMR-99-105 and DMR-98-050) in our hospital and Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH101-TD-B-111-004), and Taiwan Department of Health Cancer Research Center for Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown LF, 2009, PSYCHOSOMATICS, V50, P440, DOI 10.1176/appi.psy.50.5.440; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; CHEN CN, 1993, ARCH GEN PSYCHIAT, V50, P125; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; COX T, 1982, SOC SCI MED, V16, P381, DOI 10.1016/0277-9536(82)90048-X; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; EYSENCK HJ, 1994, ADV BEHAV RES THER, V16, P167, DOI 10.1016/0146-6402(94)00001-8; FARAVELLI C, 1989, ACTA PSYCHIAT SCAND, V79, P308, DOI 10.1111/j.1600-0447.1989.tb10263.x; FORSEN A, 1991, PSYCHOTHER PSYCHOSOM, V55, P176, DOI 10.1159/000288427; Geyer S, 2000, WIEN KLIN WOCHENSCHR, V112, P986; Ginsberg A, 1996, EUR J CANCER, V32A, P2049, DOI 10.1016/S0959-8049(96)00275-4; GROSS J, 1989, SOC SCI MED, V28, P1239, DOI 10.1016/0277-9536(89)90342-0; Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002; HWU HG, 1989, ACTA PSYCHIAT SCAND, V79, P136, DOI 10.1111/j.1600-0447.1989.tb08581.x; Jadoon NA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-594; Khuwaja AK, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-72; Liang JA, 2012, RHEUMATOL INT, V32, P773, DOI 10.1007/s00296-010-1684-y; Lillberg K, 2001, INT J CANCER, V91, P888, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1138>3.0.CO;2-D; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Masmoudi Jawaher, 2010, Tunis Med, V88, P223; McKenna MC, 1999, HEALTH PSYCHOL, V18, P520, DOI 10.1037/0278-6133.18.5.520; Morissette SB, 2008, ADDICT BEHAV, V33, P1425, DOI 10.1016/j.addbeh.2008.06.012; Morissette SB, 2006, J ANXIETY DISORD, V20, P597, DOI 10.1016/j.janxdis.2005.08.003; Papadimitriou GN, 2005, INT REV PSYCHIATR, V17, P229, DOI 10.1080/09540260500104524; Protheroe D, 1999, BRIT MED J, V319, P1027, DOI 10.1136/bmj.319.7216.1027; Reynaert C, 2000, B CANCER, V87, P655; Ritz T, 2000, PSYCHOSOM MED, V62, P401, DOI 10.1097/00006842-200005000-00014; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Schwarz S, 2007, MED KLIN, V102, P967, DOI 10.1007/s00063-007-1128-y; Taiwan Cancer Registry, CABC STAT; WITTCHEN HU, 1994, ARCH GEN PSYCHIAT, V51, P355	31	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36370	10.1371/journal.pone.0036370	http://dx.doi.org/10.1371/journal.pone.0036370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558450	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000198
J	van Dooremalen, C; Gerritsen, L; Cornelissen, B; van der Steen, JJM; van Langevelde, F; Blacquiere, T				van Dooremalen, Coby; Gerritsen, Lonne; Cornelissen, Bram; van der Steen, Jozef J. M.; van Langevelde, Frank; Blacquiere, Tjeerd			Winter Survival of Individual Honey Bees and Honey Bee Colonies Depends on Level of Varroa destructor Infestation	PLOS ONE			English	Article							JACOBSONI OUD; OXALIC-ACID; POPULATION; ACARI; HYMENOPTERA; LONGEVITY; LIFE; PHYSIOLOGY; DECLINES; SEASON	Background: Recent elevated winter loss of honey bee colonies is a major concern. The presence of the mite Varroa destructor in colonies places an important pressure on bee health. V. destructor shortens the lifespan of individual bees, while long lifespan during winter is a primary requirement to survive until the next spring. We investigated in two subsequent years the effects of different levels of V. destructor infestation during the transition from short-lived summer bees to long-lived winter bees on the lifespan of individual bees and the survival of bee colonies during winter. Colonies treated earlier in the season to reduce V. destructor infestation during the development of winter bees were expected to have longer bee lifespan and higher colony survival after winter. Methodology/Principal Findings: Mite infestation was reduced using acaricide treatments during different months (July, August, September, or not treated). We found that the number of capped brood cells decreased drastically between August and November, while at the same time, the lifespan of the bees (marked cohorts) increased indicating the transition to winter bees. Low V. destructor infestation levels before and during the transition to winter bees resulted in an increase in lifespan of bees and higher colony survival compared to colonies that were not treated and that had higher infestation levels. A variety of stress-related factors could have contributed to the variation in longevity and winter survival that we found between years. Conclusions/Significance: This study contributes to theory about the multiple causes for the recent elevated colony losses in honey bees. Our study shows the correlation between long lifespan of winter bees and colony loss in spring. Moreover, we show that colonies treated earlier in the season had reduced V. destructor infestation during the development of winter bees resulting in longer bee lifespan and higher colony survival after winter.	[van Dooremalen, Coby; Gerritsen, Lonne; Cornelissen, Bram; van der Steen, Jozef J. M.; Blacquiere, Tjeerd] Bees Wur, Plant Res Int, Wageningen, Netherlands; [van Langevelde, Frank] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands	Wageningen University & Research	van Dooremalen, C (corresponding author), Bees Wur, Plant Res Int, Wageningen, Netherlands.	coby.vandooremalen@wur.nl	Cornelissen, Bram ACM/B-3440-2013	van Dooremalen, Coby/0000-0002-1525-0171; Van Langevelde, Frank/0000-0001-8870-0797	Ministry of Agriculture, Nature Conservation and Food Quality (LNV) of the Netherlands; European Union [NP11/2.1, NL08/2.1, BO-06-012-001, BO-12.03-007-001]; Food Quality (LNV) of the Netherlands	Ministry of Agriculture, Nature Conservation and Food Quality (LNV) of the Netherlands; European Union(European Commission); Food Quality (LNV) of the Netherlands(Netherlands Government)	The project was funded by Ministry of Agriculture, Nature Conservation and Food Quality (LNV) of the Netherlands and by the European Union (project numbers NP11/2.1, NL08/2.1, BO-06-012-001, and BO-12.03-007-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol E, 2008, ITAL J ANIM SCI, V7, P237; Aliano NP, 2009, EXP APPL ACAROL, V48, P303, DOI 10.1007/s10493-009-9240-8; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; BOOT WJ, 1995, APIDOLOGIE, V26, P109, DOI 10.1051/apido:19950204; Branco MR, 2006, APIDOLOGIE, V37, P452, DOI 10.1051/apido:2006010; Currie RW, 2006, CAN ENTOMOL, V138, P238; DEJONG D, 1983, J ECON ENTOMOL, V76, P766, DOI 10.1093/jee/76.4.766; Delaplane KS, 1997, J APICULT RES, V36, P125, DOI 10.1080/00218839.1997.11100938; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; FRIES I, 1991, EXP APPL ACAROL, V10, P279, DOI 10.1007/BF01198656; FUKUDA HIROMI, 1966, JAP J ECOL, V16, P206; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; KOVAC H, 1988, J APICULT RES, V27, P230, DOI 10.1080/00218839.1988.11100808; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Martin S, 1998, ECOL MODEL, V109, P267, DOI 10.1016/S0304-3800(98)00059-3; Martin SJ, 1997, J APICULT RES, V36, P113, DOI 10.1080/00218839.1997.11100937; Mattila HR, 2001, INSECT SOC, V48, P88, DOI 10.1007/PL00001764; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rademacher E, 2006, APIDOLOGIE, V37, P98, DOI 10.1051/apido:2005063; Rademacher E, 2001, APIDOLOGIE, V32, P488; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; SCHNEIDER P, 1987, APIDOLOGIE, V18, P101, DOI 10.1051/apido:19870108; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; WOYKE J, 1984, J APICULT RES, V23, P148, DOI 10.1080/00218839.1984.11100624; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720	27	95	99	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36285	10.1371/journal.pone.0036285	http://dx.doi.org/10.1371/journal.pone.0036285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558421	Green Published, gold			2022-12-25	WOS:000305336000179
J	He, WM; Montesinos, D; Thelen, GC; Callaway, RM				He, Wei-Ming; Montesinos, Daniel; Thelen, Giles C.; Callaway, Ragan M.			Growth and Competitive Effects of Centaurea stoebe Populations in Response to Simulated Nitrogen Deposition	PLOS ONE			English	Article							INVASION BIOGEOGRAPHIC DIFFERENCES; EXOTIC PERENNIAL GRASSES; BROMUS-TECTORUM; NUTRIENT LIMITATION; PLANT-COMMUNITIES; SOIL-NITROGEN; IMPACTS; MECHANISMS; FEEDBACKS; MACULOSA	Increased resource availability can promote invasion by exotic plants, raising concerns over the potential effects of global increases in the deposition of nitrogen (N). It is poorly understood why increased N favors exotics over natives. Fast growth may be a general trait of good invaders and these species may have exceptional abilities to increase growth rates in response to N deposition. Additionally, invaders commonly displace locals, and thus may have inherently greater competitive abilities. The mean growth response of Centaurea stoebe to two N levels was significantly greater than that of North American (NA) species. Growth responses to N did not vary among C. stoebe populations or NA species. Without supplemental N, NA species were better competitors than C. stoebe, and C. stoebe populations varied in competitive effects. The competitive effects of C. stoebe populations increased with N whereas the competitive effects of NA species decreased, eliminating the overall competitive advantage demonstrated by NA species in soil without N added. These results suggest that simulated N deposition may enhance C. stoebe invasion through increasing its growth and relative competitive advantage, and also indicate the possibility of local adaptation in competitive effects across the introduced range of an invader.	[He, Wei-Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Montesinos, Daniel] Ctr Invest Desertificac CIDE CSIC UV GV, Albal, Spain; [Thelen, Giles C.; Callaway, Ragan M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE); University of Montana System; University of Montana	He, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weiminghe@ibcas.ac.cn	Montesinos, Daniel/A-9070-2012	Montesinos, Daniel/0000-0003-2893-0878	National Natural Science Foundation of China [31170507]; State Key Laboratory of Vegetation and Environmental Change [2011zyts02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Vegetation and Environmental Change	Two grants supported this work: No. 1. The National Natural Science Foundation of China (31170507, www.nsfc.gov.cn). No. 2. The State Key Laboratory of Vegetation and Environmental Change (2011zyts02, www.ibcas.ac.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JK, 2009, PLANT ECOL, V201, P445, DOI 10.1007/s11258-008-9467-1; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 2005, J ECOL, V93, P576, DOI 10.1111/j.1365-2745.2005.00994.x; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Grime J. P., 2001, PLANT STRATEGIES VEG; He WM, 2011, ECOGRAPHY, V34, P1059, DOI 10.1111/j.1600-0587.2011.06835.x; He WM, 2010, BIOL INVASIONS, V12, P3591, DOI 10.1007/s10530-010-9753-4; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Hebel CL, 2009, APPL SOIL ECOL, V42, P150, DOI 10.1016/j.apsoil.2009.03.004; Knochel DG, 2010, BIOL INVASIONS, V12, P3771, DOI 10.1007/s10530-010-9769-9; Knochel DG, 2010, ECOL APPL, V20, P1903, DOI 10.1890/09-1944.1; Kolb A, 2002, J ECOL, V90, P871, DOI 10.1046/j.1365-2745.2002.00719.x; Kourtev P.S., 1999, Biological Invasions, V1, P237, DOI 10.1023/A:1010048909563; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lowe PN, 2003, PLANT ECOL, V167, P247, DOI 10.1023/A:1023934515420; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Maron JL, 2008, J ECOL, V96, P1187, DOI 10.1111/j.1365-2745.2008.01440.x; MILCHUNAS DG, 1995, ECOL APPL, V5, P452, DOI 10.2307/1942035; Nybakken L, 2009, GLOBAL CHANGE BIOL, V15, P2247, DOI 10.1111/j.1365-2486.2009.01853.x; Ortega YK, 2005, ECOL APPL, V15, P651, DOI 10.1890/04-0119; Peltzer DA, 2010, GLOBAL CHANGE BIOL, V16, P732, DOI 10.1111/j.1365-2486.2009.02038.x; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Reinhart KO, 2011, PLANT ECOL, V212, P821, DOI 10.1007/s11258-010-9867-x; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; ROCHE CT, 1988, NORTHWEST SCI, V62, P242; Siguenza C, 2006, PLANT SOIL, V286, P153, DOI 10.1007/s11104-006-9034-2; Thomsen MA, 2006, PLANT ECOL, V186, P23, DOI 10.1007/s11258-006-9109-4; Thorpe AS, 2011, J ECOL, V99, P729, DOI 10.1111/j.1365-2745.2011.01802.x; Tilman D., 1982, Monographs in Population Biology, pi; Tomassen HBM, 2004, J APPL ECOL, V41, P139, DOI 10.1111/j.1365-2664.2004.00870.x; van der Wal R, 2003, ECOL LETT, V6, P141, DOI 10.1046/j.1461-0248.2003.00407.x; Vasquez E, 2008, INVAS PLANT SCI MANA, V1, P287, DOI 10.1614/IPSM-08-062.1; Vellend M, 2006, ECOLOGY, V87, P304, DOI 10.1890/05-0173; Vitousek P. M., 1997, ISSUES ECOL, V1, P1; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180; WEIR TL, 2010, ANN REV PLANT BIOL	46	15	17	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36257	10.1371/journal.pone.0036257	http://dx.doi.org/10.1371/journal.pone.0036257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563451	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349100076
J	Todd, JD; Curson, ARJ; Sullivan, MJ; Kirkwood, M; Johnston, AWB				Todd, Jonathan D.; Curson, Andrew R. J.; Sullivan, Matthew J.; Kirkwood, Mark; Johnston, Andrew W. B.			The Ruegeria pomeroyi acuI Gene Has a Role in DMSP Catabolism and Resembles yhdH of E. coli and Other Bacteria in Conferring Resistance to Acrylate	PLOS ONE			English	Article							PROPIONYL-COENZYME-A; DIMETHYL SULFIDE; RHIZOBIUM-LEGUMINOSARUM; ESCHERICHIA-COLI; DIMETHYLSULFONIOPROPIONATE LYASE; MARINE-BACTERIA; COA DEHYDROGENASE; SULFUR-COMPOUNDS; GENOME SEQUENCE; ENZYME	The Escherichia coli YhdH polypeptide is in the MDR012 sub-group of medium chain reductase/dehydrogenases, but its biological function was unknown and no phenotypes of YhdH(-) mutants had been described. We found that an E. coli strain with an insertional mutation in yhdH was hyper-sensitive to inhibitory effects of acrylate, and, to a lesser extent, to those of 3-hydroxypropionate. Close homologues of YhdH occur in many Bacterial taxa and at least two animals. The acrylate sensitivity of YhdH(-) mutants was corrected by the corresponding, cloned homologues from several bacteria. One such homologue is acuI, which has a role in acrylate degradation in marine bacteria that catabolise dimethylsulfoniopropionate (DMSP) an abundant anti-stress compound made by marine phytoplankton. The acuI genes of such bacteria are often linked to ddd genes that encode enzymes that cleave DMSP into acrylate plus dimethyl sulfide (DMS), even though these are in different polypeptide families, in unrelated bacteria. Furthermore, most strains of Roseobacters, a clade of abundant marine bacteria, cleave DMSP into acrylate plus DMS, and can also demethylate it, using DMSP demethylase. In most Roseobacters, the corresponding gene, dmdA, lies immediately upstream of acuI and in the model Roseobacter strain Ruegeria pomeroyi DSS-3, dmdA-acuI were co-regulated in response to the co-inducer, acrylate. These observations, together with findings by others that AcuI has acryloyl-CoA reductase activity, lead us to suggest that YdhH/AcuI enzymes protect cells against damaging effects of intracellular acryloyl-CoA, formed endogenously, and/or via catabolising exogenous acrylate. To provide "added protection" for bacteria that form acrylate from DMSP, acuI was recruited into clusters of genes involved in this conversion and, in the case of acuI and dmdA in the Roseobacters, their co-expression may underpin an interaction between the two routes of DMSP catabolism, whereby the acrylate product of DMSP lyases is a co-inducer for the demethylation pathway.	[Todd, Jonathan D.; Curson, Andrew R. J.; Sullivan, Matthew J.; Kirkwood, Mark; Johnston, Andrew W. B.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Todd, JD (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	a.johnston@uea.ac.uk	Sullivan, Matthew J/C-3857-2009; Todd, Jonathan/B-8967-2009; Johnston, Andrew W B/D-1859-2009; Curson, Andrew RJ/B-8964-2009	Sullivan, Matthew J/0000-0003-2276-3132; Todd, Jonathan/0000-0003-0777-9312; 	BBSRC; Natural Environment Research Council (NERC) of the United Kingdom; Biotechnology and Biological Sciences Research Council [BB/H002642/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC) of the United Kingdom(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC and the Natural Environment Research Council (NERC) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber BE, 2002, J BIOL CHEM, V277, P12137, DOI 10.1074/jbc.M110802200; ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Burgmann H, 2007, ENVIRON MICROBIOL, V9, P2742, DOI 10.1111/j.1462-2920.2007.01386.x; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Curson ARJ, 2011, ISME J, V5, P1191, DOI 10.1038/ismej.2010.203; Curson ARJ, BIOGEOCHEMI IN PRESS; DESOUZA MP, 1995, APPL ENVIRON MICROB, V61, P21, DOI 10.1128/AEM.61.1.21-26.1995; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gonzalez JM, 2003, INT J SYST EVOL MICR, V53, P1261, DOI 10.1099/ijs.0.02491-0; Gonzalez JM, 1997, INT J SYST BACTERIOL, V47, P773, DOI 10.1099/00207713-47-3-773; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; Hedlund J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-534; Herrmann G, 2005, FEBS J, V272, P813, DOI 10.1111/j.1742-4658.2004.04518.x; Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jornvall H, 2010, BIOCHEM BIOPH RES CO, V396, P125, DOI 10.1016/j.bbrc.2010.03.094; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1996, MAR CHEM, V54, P69, DOI 10.1016/0304-4203(96)00006-0; LOVELOCK JE, 1972, NATURE, V237, P452, DOI 10.1038/237452a0; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; PATEL SS, 1987, J BIOL CHEM, V262, P7132; Pati A, 2010, STAND GENOMIC SCI, V2, P300, DOI 10.4056/sigs.912121; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Reisch CR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00172; Reisch CR, 2011, NATURE, V473, P208, DOI 10.1038/nature10078; ROSSEN L, 1985, EMBO J, V4, P3369, DOI 10.1002/j.1460-2075.1985.tb04092.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schneider K, 2012, J BACTERIOL, V194, P225, DOI 10.1128/JB.05959-11; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; SHAW L, 1985, BIOCHEM J, V230, P723, DOI 10.1042/bj2300723; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Sullivan MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015972; Sulzenbacher G, 2004, ACTA CRYSTALLOGR D, V60, P1855, DOI 10.1107/S0907444904020220; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapiolas DM, 2010, CORAL REEFS, V29, P621, DOI 10.1007/s00338-010-0608-3; TAYLOR BF, 1991, APPL ENVIRON MICROB, V57, P3581, DOI 10.1128/AEM.57.12.3581-3584.1991; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2012, ISME J, V6, P223, DOI 10.1038/ismej.2011.79; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Todd JD, 2010, ENVIRON MICROBIOL, V12, P327, DOI 10.1111/j.1462-2920.2009.02071.x; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; van Niel CB, 1944, BACTERIOL REV, V8, P1; Wexler M, 2001, MOL MICROBIOL, V41, P801, DOI 10.1046/j.1365-2958.2001.02556.x; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	59	35	43	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35947	10.1371/journal.pone.0035947	http://dx.doi.org/10.1371/journal.pone.0035947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563425	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349100051
J	Walker, MB; King, BL; Paigen, K				Walker, Michael B.; King, Benjamin L.; Paigen, Kenneth			Clusters of Ancestrally Related Genes That Show Paralogy in Whole or in Part Are a Major Feature of the Genomes of Humans and Other Species	PLOS ONE			English	Article							PROTOCADHERIN-ALPHA; SCOP DATABASE; PROTEINS; FAMILY; EVOLUTION; COMPLEX; IDENTIFICATION; IMMUNOGLOBULIN; PROMOTER	Arrangements of genes along chromosomes are a product of evolutionary processes, and we can expect that preferable arrangements will prevail over the span of evolutionary time, often being reflected in the non-random clustering of structurally and/or functionally related genes. Such non-random arrangements can arise by two distinct evolutionary processes: duplications of DNA sequences that give rise to clusters of genes sharing both sequence similarity and common sequence features and the migration together of genes related by function, but not by common descent [ 1,2,3]. To provide a background for distinguishing between the two, which is important for future efforts to unravel the evolutionary processes involved, we here provide a description of the extent to which ancestrally related genes are found in proximity. Towards this purpose, we combined information from five genomic datasets, InterPro, SCOP, PANTHER, Ensembl protein families, and Ensembl gene paralogs. The results are provided in publicly available datasets (http://cgd.jax.org/datasets/clustering/paraclustering.shtml) describing the extent to which ancestrally related genes are in proximity beyond what is expected by chance (i.e. form paraclusters) in the human and nine other vertebrate genomes, as well as the D. melanogaster, C. elegans, A. thaliana, and S. cerevisiae genomes. With the exception of Saccharomyces, paraclusters are a common feature of the genomes we examined. In the human genome they are estimated to include at least 22% of all protein coding genes. Paraclusters are far more prevalent among some gene families than others, are highly species or clade specific and can evolve rapidly, sometimes in response to environmental cues. Altogether, they account for a large portion of the functional clustering previously reported in several genomes.	[Walker, Michael B.; King, Benjamin L.; Paigen, Kenneth] Jackson Lab, Bar Harbor, ME 04609 USA; [King, Benjamin L.] Mt Desert Isl Biol Lab, Salsbury Cove, ME USA	Jackson Laboratory; Mount Desert Island Biological Laboratory	Walker, MB (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	kenneth.paigen@jax.org	King, Benjamin/AAI-1492-2019	King, Benjamin/0000-0001-6463-1336	United States National Institutes of Health [GM 076468]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health grant GM 076468. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000953; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Bretaudeau A, 2010, DGD DUPLICATED GENE; Cao H, 2009, IMMUNOGENETICS, V61, P401, DOI 10.1007/s00251-009-0372-0; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Despons L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-56; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Fisher R.A, 1930, GENETIC THEORY NATUR; Force A, 1999, GENETICS, V151, P1531; Franzin CM, 2007, J BIOENERG BIOMEMBR, V39, P379, DOI 10.1007/s10863-007-9105-y; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Lanave C, 2004, GENE, V333, P71, DOI 10.1016/j.gene.2004.02.017; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Makino T, 2008, MOL BIOL EVOL, V25, P1855, DOI 10.1093/molbev/msn137; Marenholz I, 2001, GENOME RES, V11, P341, DOI 10.1101/gr.114801; Mayor LR, 2004, J MOL BIOL, V340, P991, DOI 10.1016/j.jmb.2004.05.036; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Minguillon C, 2005, INT J BIOL SCI, V1, P19; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEI M, 1967, GENETICS, V57, P625; Nei M, 2003, HEREDITY, V90, P411, DOI 10.1038/sj.hdy.6800287; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pan D, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/545269; Patel S, 2003, MAMM GENOME, V14, P140, DOI 10.1007/s00335-002-2205-4; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Shiina T, 2001, GENOME RES, V11, P789, DOI 10.1101/gr.175801; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; Song G, 2010, J COMPUT BIOL, V17, P1227, DOI 10.1089/cmb.2010.0094; Suzuki ST, 2000, EXP CELL RES, V261, P13, DOI 10.1006/excr.2000.5039; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trowsdale J, 2002, GENOME BIOL, V3; Tzifi F, 2012, ADV HEMATOL, P524308; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Yi G, 2007, BIOINFORMATICS, V23, P1053, DOI 10.1093/bioinformatics/btl673; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204	54	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35274	10.1371/journal.pone.0035274	http://dx.doi.org/10.1371/journal.pone.0035274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563380	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349100009
J	Gollamudi, S; Johri, A; Calingasan, NY; Yang, LC; Elemento, O; Beal, MF				Gollamudi, Seema; Johri, Ashu; Calingasan, Noel Y.; Yang, Lichuan; Elemento, Olivier; Beal, M. Flint			Concordant Signaling Pathways Produced by Pesticide Exposure in Mice Correspond to Pathways Identified in Human Parkinson's Disease	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; TRANSCRIPTIONAL ANALYSIS; HEME OXYGENASE-1; GENE-EXPRESSION; ALPHA-SYNUCLEIN; PROTEIN SACSIN; RODENT MODELS; NEURODEGENERATION; PARAQUAT; ROLES	Parkinson's disease (PD) is a neurodegenerative disease in which the etiology of 90 percent of the patients is unknown. Pesticide exposure is a major risk factor for PD, and paraquat (PQ), pyridaben (PY) and maneb (MN) are amongst the most widely used pesticides. We studied mRNA expression using transcriptome sequencing (RNA-Seq) in the ventral midbrain (VMB) and striatum (STR) of PQ, PY and paraquat+maneb (MNPQ) treated mice, followed by pathway analysis. We found concordance of signaling pathways between the three pesticide models in both the VMB and STR as well as concordance in these two brain areas. The concordant signaling pathways with relevance to PD pathogenesis were e. g. axonal guidance signaling, Wnt/beta-catenin signaling, as well as pathways not previously linked to PD, e. g. basal cell carcinoma, human embryonic stem cell pluripotency and role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis. Human PD pathways previously identified by expression analysis, concordant with VMB pathways identified in our study were axonal guidance signaling, Wnt/beta-catenin signaling, IL-6 signaling, ephrin receptor signaling, TGF-beta signaling, PPAR signaling and G-protein coupled receptor signaling. Human PD pathways concordant with the STR pathways in our study were Wnt/beta-catenin signaling, axonal guidance signaling and G-protein coupled receptor signaling. Peroxisome proliferator activated receptor delta (Ppard) and G-Protein Coupled Receptors (GPCRs) were common genes in VMB and STR identified by network analysis. In conclusion, the pesticides PQ, PY and MNPQ elicit common signaling pathways in the VMB and STR in mice, which are concordant with known signaling pathways identified in human PD, suggesting that these pathways contribute to the pathogenesis of idiopathic PD. The analysis of these networks and pathways may therefore lead to improved understanding of disease pathogenesis, and potential novel therapeutic targets.	[Gollamudi, Seema; Johri, Ashu; Calingasan, Noel Y.; Yang, Lichuan; Beal, M. Flint] Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA; [Elemento, Olivier] Cornell Univ, Inst Computat Biomed, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Gollamudi, S (corresponding author), Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA.	fbeal@med.cornell.edu			National Institute of Health NIH [R01 ES017295-01]; National Institute of Environmental Health Sciences (NIEHS) [ES017295]; Parkinson's Disease Foundation; NSF [1054964]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017295] Funding Source: NIH RePORTER	National Institute of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Parkinson's Disease Foundation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the National Institute of Health NIH grant R01 ES017295-01. MFB would like to acknowledge funding from the National Institute of Environmental Health Sciences (NIEHS) grant ES017295 and the Parkinson's Disease Foundation. OE would like to acknowledge receipt of NSF Career grant 1054964. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuirmeileh A, 2007, EUR J NEUROSCI, V26, P417, DOI 10.1111/j.1460-9568.2007.05653.x; Ali F, 2010, CARDIOVASC RES, V85, P701, DOI 10.1093/cvr/cvp365; Anderrson JF, 2011, J MOL BIOL, V411, P870, DOI 10.1016/j.jmb.2011.06.016; Austin PJ, 2010, BRIT J PHARMACOL, V160, P1741, DOI 10.1111/j.1476-5381.2010.00820.x; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Bartus RT, 2011, NEUROBIOL DIS, V44, P38, DOI 10.1016/j.nbd.2011.05.026; Beal MF, 2010, NATURE, V466, pS8, DOI 10.1038/466S8a; Bezard E, 2011, MOVEMENT DISORD, V26, P993, DOI 10.1002/mds.23696; Bjorklund A, 2010, PROG BRAIN RES, V184, P17, DOI 10.1016/S0079-6123(10)84002-6; Blakely BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018373; Braak H, 2000, J NEUROL, V247, P3; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chang SC, 2009, MOL MEMBR BIOL, V26, P104, DOI 10.1080/09687680802706432; Chien WL, 2011, J NEUROCHEM, V117, P643, DOI 10.1111/j.1471-4159.2011.07229.x; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; Cocco E, 2010, CANCER-AM CANCER SOC, V116, P843, DOI 10.1002/cncr.24838; Cory-Slechta DA, 2005, ENVIRON HEALTH PERSP, V113, P1263, DOI 10.1289/ehp.7570; Cotter D, 1998, NEUROREPORT, V9, P1379, DOI 10.1097/00001756-199805110-00024; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Deng QL, 2011, DEVELOPMENT, V138, P3399, DOI 10.1242/dev.065482; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Goetz CG, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a008862; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Guerreiro S, 2008, MOL PHARMACOL, V74, P980, DOI 10.1124/mol.108.048207; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hurley MJ, 2012, PHARM THER; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Inzelberg R, 2007, NEUROLOGY, V69, P1542, DOI 10.1212/01.wnl.0000277638.63767.b8; Lenzken SC, 2011, HUM MUTAT, V32, P168, DOI 10.1002/humu.21394; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Morgan AR, 2007, AM J MED GENET B, V144B, P762, DOI 10.1002/ajmg.b.30509; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navarro A, 2010, J BIOENERG BIOMEMBR, V42, P405, DOI 10.1007/s10863-010-9309-4; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Patel S, 2008, MOL BIOTECHNOL, V40, P59, DOI 10.1007/s12033-008-9060-9; Rawal N, 2009, BIOCHEM BIOPH RES CO, V388, P473, DOI 10.1016/j.bbrc.2009.07.014; RIESS O, 1994, GENOMICS, V19, P298, DOI 10.1006/geno.1994.1061; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Si W, 2010, J NEUROCHEM, V115, P475, DOI 10.1111/j.1471-4159.2010.06947.x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Thiruchelvam M, 2000, BRAIN RES, V873, P225, DOI 10.1016/S0006-8993(00)02496-3; Thrash Bessy, 2007, Proc West Pharmacol Soc, V50, P31; Tremblay L, 2010, B ACAD NAT MED PARIS, V194, P1321, DOI 10.1016/S0001-4079(19)32211-3; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Vogt IR, 2006, EXP NEUROL, V199, P465, DOI 10.1016/j.expneurol.2006.01.008; Wexler EM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002282; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Yin LN, 2011, NEUROTOXICOL TERATOL, V33, P415, DOI 10.1016/j.ntt.2011.02.012; Zhang J, 2003, J NEUROCHEM, V84, P336, DOI 10.1046/j.1471-4159.2003.01525.x; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	67	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36191	10.1371/journal.pone.0036191	http://dx.doi.org/10.1371/journal.pone.0036191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563483	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340700032
J	Mancuso, G; Barth, E; Crivello, P; Rugarli, EI				Mancuso, Giuseppe; Barth, Esther; Crivello, Pietro; Rugarli, Elena I.			Alternative Splicing of Spg7, a Gene Involved in Hereditary Spastic Paraplegia, Encodes a Variant of Paraplegin Targeted to the Endoplasmic Reticulum	PLOS ONE			English	Article							M-AAA PROTEASE; MITOCHONDRIAL METALLOPROTEASE; UBIQUITIN-LIGASE; MUTATIONS; PROTEINS; MEMBRANE; DEGENERATION; IMPAIRMENT; PROTECTION; MECHANISM	Background: Hereditary spastic paraplegia defines a group of genetically heterogeneous diseases characterized by weakness and spasticity of the lower limbs owing to retrograde degeneration of corticospinal axons. One autosomal recessive form of the disease is caused by mutation in the SPG7 gene. Paraplegin, the product of SPG7, is a component of the m-AAA protease, a high molecular weight complex that resides in the mitochondrial inner membrane, and performs crucial quality control and biogenesis functions in mitochondria. Principal Findings: Here we show the existence in the mouse of a novel isoform of paraplegin, which we name paraplegin-2, encoded by alternative splicing of Spg7 through usage of an alternative first exon. Paraplegin-2 lacks the mitochondrial targeting sequence, and is identical to the mature mitochondrial protein. Remarkably, paraplegin-2 is targeted to the endoplasmic reticulum. We find that paraplegin-2 exposes the catalytic domains to the lumen of the endoplasmic reticulum. Moreover, endogenous paraplegin-2 accumulates in microsomal fractions prepared from mouse brain and retina. Finally, we show that the previously generated mouse model of Spg7-linked hereditary spastic paraplegia is an isoform-specific knockout, in which mitochondrial paraplegin is specifically ablated, while expression of paraplegin-2 is retained. Conclusions/Significance: These data suggest a possible additional role of AAA proteases outside mitochondria and open the question of their implication in neurodegeneration.	[Mancuso, Giuseppe; Barth, Esther; Rugarli, Elena I.] Univ Cologne, Inst Zool, Cologne, Germany; [Crivello, Pietro] Natl Neurol Inst Carlo Besta, Milan, Italy; [Rugarli, Elena I.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Rugarli, Elena I.] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany	University of Cologne; IRCCS Istituto Neurologico Besta; University of Cologne; University of Cologne	Mancuso, G (corresponding author), Univ Cologne, Inst Zool, Weyertal 119, Cologne, Germany.	Elena.Rugarli@uni-koeln.de	Crivello, Pietro/AFO-1225-2022	Rugarli, Elena/0000-0002-5782-1067	Spastic Paraplegia Foundation	Spastic Paraplegia Foundation	This study was supported by a grant from the Spastic Paraplegia Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoldi A, 2008, HUM MUTAT, V29, P522, DOI 10.1002/humu.20682; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Brugman F, 2008, NEUROLOGY, V71, P1500, DOI 10.1212/01.wnl.0000319700.11606.21; Bulbarelli A, 2002, J CELL SCI, V115, P1689; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Ito D, 2008, NEUROBIOL DIS, V31, P266, DOI 10.1016/j.nbd.2008.05.004; Koppen M, 2009, MOL BIOL CELL; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Kremmidiotis G, 2001, GENOMICS, V76, P58, DOI 10.1006/geno.2001.6560; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; Pierson TM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002325; Pirozzi M, 2006, J CLIN INVEST, V116, P202, DOI 10.1172/JCI26210; Reid E, SCRIVERS ONLINE META; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125; Zhao JL, 2008, J NEUROSCI, V28, P13938, DOI 10.1523/JNEUROSCI.4668-08.2008	36	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36337	10.1371/journal.pone.0036337	http://dx.doi.org/10.1371/journal.pone.0036337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563492	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340700041
J	Moran, EV; Clark, JS				Moran, Emily V.; Clark, James S.			Between-Site Differences in the Scale of Dispersal and Gene Flow in Red Oak	PLOS ONE			English	Article							SEED DISPERSAL; MICROSATELLITE MARKERS; QUERCUS-SALICINA; POLLEN DISPERSAL; MATING PATTERNS; ACORN DISPERSAL; BUR OAK; POPULATION; FOREST; PLANT	Background: Nut-bearing trees, including oaks (Quercus spp.), are considered to be highly dispersal limited, leading to concerns about their ability to colonize new sites or migrate in response to climate change. However, estimating seed dispersal is challenging in species that are secondarily dispersed by animals, and differences in disperser abundance or behavior could lead to large spatio-temporal variation in dispersal ability. Parentage and dispersal analyses combining genetic and ecological data provide accurate estimates of current dispersal, while spatial genetic structure (SGS) can shed light on past patterns of dispersal and establishment. Methodology and Principal Findings: In this study, we estimate seed and pollen dispersal and parentage for two mixed-species red oak populations using a hierarchical Bayesian approach. We compare these results to those of a genetic ML parentage model. We also test whether observed patterns of SGS in three size cohorts are consistent with known site history and current dispersal patterns. We find that, while pollen dispersal is extensive at both sites, the scale of seed dispersal differs substantially. Parentage results differ between models due to additional data included in Bayesian model and differing genotyping error assumptions, but both indicate between-site dispersal differences. Patterns of SGS in large adults, small adults, and seedlings are consistent with known site history (farmed vs. selectively harvested), and with long-term differences in seed dispersal. This difference is consistent with predator/disperser satiation due to higher acorn production at the low-dispersal site. While this site-to-site variation results in substantial differences in asymptotic spread rates, dispersal for both sites is substantially lower than required to track latitudinal temperature shifts. Conclusions: Animal-dispersed trees can exhibit considerable spatial variation in seed dispersal, although patterns may be surprisingly constant over time. However, even under favorable conditions, migration in heavy-seeded species is likely to lag contemporary climate change.	[Moran, Emily V.] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA; [Clark, James S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	University of Tennessee System; University of Tennessee Knoxville; Duke University	Moran, EV (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA.	moranev@nimbios.org		Moran, Emily/0000-0003-4624-1910	Duke Biology Department; Duke Center for Theoretical and Mathematical Sciences; Association for Women in Science; National Science Foundation; US Department of Homeland Security; USDA, NSF [EF 0832858]; University of Tennessee; Division Of Environmental Biology [0823293] Funding Source: National Science Foundation	Duke Biology Department; Duke Center for Theoretical and Mathematical Sciences; Association for Women in Science; National Science Foundation(National Science Foundation (NSF)); US Department of Homeland Security(United States Department of Homeland Security (DHS)); USDA, NSF; University of Tennessee; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding sources include the Duke Biology Department (http://www.biology.duke.edu), the Duke Center for Theoretical and Mathematical Sciences (http://ctms.phy.duke.edu/wp), and the Association for Women in Science (http://www.awis.org). Part of this work was conducted while Moran was a postdoctoral fellow at the National Institute for Mathematical and Biological Synthesis; NIMBioS is an institute sponsored by the National Science Foundation, US Department of Homeland Security, and the USDA, NSF Award # EF 0832858, with additional support from the University of Tennessee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich PR, 2005, J HERED, V96, P627, DOI 10.1093/jhered/esi115; Aldrich PR, 2003, SILVAE GENET, V52, P176; Aldrich PR, 2003, CAN J FOREST RES, V33, P2228, DOI 10.1139/X03-160; Aldrich PR, 2002, MOL ECOL NOTES, V2, P472, DOI 10.1046/j.1471-8286.2002.00282.x; Ashley MV, 2010, CRIT REV PLANT SCI, V29, P148, DOI 10.1080/07352689.2010.481167; Asuka Y, 2005, MOL ECOL, V14, P2565, DOI 10.1111/j.1365-294X.2005.02585.x; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Burczyk J, 2006, GENETICS, V173, P363, DOI 10.1534/genetics.105.046805; Burczyk J., 2004, FOR GENET, V11, P179, DOI DOI 10.1080/10623320490432434; Burger W. C., 1975, Taxon, V24, P45, DOI 10.2307/1218998; Chybicki IJ, 2010, MOL ECOL, V19, P2137, DOI 10.1111/j.1365-294X.2010.04632.x; Clark J. S., 2010, OXFORD HDB APPL BAYE, P431; Clark JS, 2010, ECOL MONOGR, V80, P569, DOI 10.1890/09-1541.1; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Clark JS, 2004, ECOL MONOGR, V74, P415, DOI 10.1890/02-4093; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Clark JS, HIERARCHICAL MODELLI; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Craft KJ, 2007, FOREST ECOL MANAG, V239, P13, DOI 10.1016/j.foreco.2006.11.005; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; DARLEYHILL S, 1981, OECOLOGIA, V50, P231, DOI 10.1007/BF00348043; Dodd RS, 2004, EVOLUTION, V58, P261, DOI 10.1111/j.0014-3820.2004.tb01643.x; Dow BD, 1996, MOL ECOL, V5, P615, DOI 10.1111/j.1365-294X.1996.tb00357.x; Ducousso A., 1993, ANN SCIENC FOR VOL, V50, p91s, DOI 10.1051/forest:19930708; DYER JM, 1995, ECOL MODEL, V79, P199, DOI 10.1016/0304-3800(94)00038-J; Epperson BK, 1997, EVOLUTION, V51, P275, DOI 10.1111/j.1558-5646.1997.tb02409.x; Fernandez-Manjarres JF, 2006, J HERED, V97, P451, DOI 10.1093/jhered/esl022; Gaino APSC, 2010, CONSERV GENET, V11, P1631, DOI 10.1007/s10592-010-0046-3; Geng QF, 2008, MOL ECOL, V17, P4724, DOI 10.1111/j.1365-294X.2008.03948.x; Gerwein JB, 2006, RHODORA, V108, P1, DOI 10.3119/05-9.1; Gomez JM, 2003, ECOGRAPHY, V26, P573, DOI 10.1034/j.1600-0587.2003.03586.x; Gonzalez-Martinez SC, 2002, THEOR APPL GENET, V104, P1290, DOI 10.1007/s00122-002-0894-4; Goto S, 2006, MOL ECOL, V15, P2985, DOI 10.1111/j.1365-294X.2006.02976.x; Grace SL, 2004, CASTANEA, V69, P207, DOI 10.2179/0008-7475(2004)069&lt;0207:EOSDIA&gt;2.0.CO;2; GUTTMAN SI, 1989, CAN J BOT, V67, P339, DOI 10.1139/b89-050; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Hampe A, 2010, MOL ECOL, V19, P459, DOI 10.1111/j.1365-294X.2009.04492.x; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Hardesty BD, 2006, ECOL LETT, V9, P516, DOI 10.1111/j.1461-0248.2006.00897.x; Hein EW, 1997, ENVIRON MANAGE, V21, P943, DOI 10.1007/s002679900078; Herrera CM, 2010, ECOLOGY, V91, P422, DOI 10.1890/09-0849.1; HEYWOOD JS, 1986, AM NAT, V127, P851, DOI 10.1086/284529; Ibanez I, 2007, ECOL MONOGR, V77, P163, DOI 10.1890/06-1097; Iverson LR, 2004, LANDSCAPE ECOL, V19, P787, DOI 10.1007/s10980-005-3990-5; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JENSEN RJ, 1977, TAXON, V26, P399, DOI 10.2307/1220040; JOHNSON WC, 1989, J BIOGEOGR, V16, P561, DOI 10.2307/2845211; Johnson WC, 1997, AM MIDL NAT, V138, P357, DOI 10.2307/2426828; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones FA, 2008, J ECOL, V96, P642, DOI 10.1111/j.1365-2745.2008.01400.x; Jones FA, 2006, MOL ECOL, V15, P851, DOI 10.1111/j.1365-294X.2005.02830.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; LEVIN DA, 1981, ANN MO BOT GARD, V68, P233, DOI 10.2307/2398797; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Li HJ, 2003, FOREST ECOL MANAG, V176, P387, DOI 10.1016/S0378-1127(02)00286-4; Little Jr EL, 1980, NATL AUDUBON SOC FIE; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matlack GR, 2005, J ECOL, V93, P50, DOI 10.1111/j.1365-2745.2004.00947.x; McShea WJ, 2007, J WILDLIFE MANAGE, V71, P1717, DOI 10.2193/2006-169; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; Moran EV, 2012, AM J BOT, V99, P92, DOI 10.3732/ajb.1100023; Moran EV, 2011, MOL ECOL, V20, P1248, DOI 10.1111/j.1365-294X.2011.05019.x; Nakanishi A, 2004, SILVAE GENET, V53, P258, DOI 10.1515/sg-2004-0048; Nakanishi A, 2009, HEREDITY, V102, P182, DOI 10.1038/hdy.2008.101; Oddou-Muratorio S, 2008, MOL ECOL, V17, P2743, DOI 10.1111/j.1365-294X.2008.03783.x; Oddou-Muratorio S, 2010, FOREST ECOL MANAG, V259, P2151, DOI 10.1016/j.foreco.2010.03.001; Oosting H. J., 1942, American Midland Naturalist, V28, P1, DOI 10.2307/2420696; Purves DW, 2007, ECOL MONOGR, V77, P77, DOI 10.1890/05-1923; Rushton B., 1993, ANN FOREST SCI, V50, P73, DOI DOI 10.1051/FOREST:19930707; Sato T, 2006, HEREDITY, V96, P79, DOI 10.1038/sj.hdy.6800748; Schnabel A, 1998, MOL ECOL, V7, P819, DOI 10.1046/j.1365-294x.1998.00397.x; SCHWARZMANN JF, 1991, FOREST SCI, V37, P1376; Sezen UU, 2005, SCIENCE, V307, P891, DOI 10.1126/science.1105034; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; SORK VL, 1984, ECOLOGY, V65, P1020, DOI 10.2307/1938075; STAPANIAN MA, 1986, J MAMMAL, V67, P326, DOI 10.2307/1380886; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Thomas L, 2010, J APPL ECOLOGY; Tomlinson PT, 2000, AM MIDL NAT, V143, P154, DOI 10.1674/0003-0031(2000)143[0154:DWTSCI]2.0.CO;2; Tramer EJ, BREEDING BIRD CENSUS; Troupin D, 2006, MOL ECOL, V15, P3617, DOI 10.1111/j.1365-294X.2006.03047.x; Vander Wall SB, 2001, BOT REV, V67, P74, DOI 10.1007/BF02857850; Yang S, 2008, MOL ECOL, V17, P731, DOI [10.1111/j.1365-294X.2007.03625.x, 10.1111/j.1365-294X.2008.03976.x]	92	30	32	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36492	10.1371/journal.pone.0036492	http://dx.doi.org/10.1371/journal.pone.0036492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563504	Green Published, gold			2022-12-25	WOS:000305340700053
J	Muller-Redetzky, HC; Kummer, W; Pfeil, U; Hellwig, K; Will, D; Paddenberg, R; Tabeling, C; Hippenstiel, S; Suttorp, N; Witzenrath, M				Mueller-Redetzky, Holger Christian; Kummer, Wolfgang; Pfeil, Uwe; Hellwig, Katharina; Will, Daniel; Paddenberg, Renate; Tabeling, Christoph; Hippenstiel, Stefan; Suttorp, Norbert; Witzenrath, Martin			Intermedin Stabilized Endothelial Barrier Function and Attenuated Ventilator-induced Lung Injury in Mice	PLOS ONE			English	Article							MECHANICAL VENTILATION; ADRENOMEDULLIN; PEPTIDE; INFLAMMATION; ENDOTOXEMIA; ADULT; CELLS	Background: Even protective ventilation may aggravate or induce lung failure, particularly in preinjured lungs. Thus, new adjuvant pharmacologic strategies are needed to minimize ventilator-induced lung injury (VILI). Intermedin/Adrenomedullin-2 (IMD) stabilized pulmonary endothelial barrier function in vitro. We hypothesized that IMD may attenuate VILI-associated lung permeability in vivo. Methodology/Principal Findings: Human pulmonary microvascular endothelial cell (HPMVEC) monolayers were incubated with IMD, and transcellular electrical resistance was measured to quantify endothelial barrier function. Expression and localization of endogenous pulmonary IMD, and its receptor complexes composed of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMPs) 1-3 were analyzed by qRT-PCR and immunofluorescence in non ventilated mouse lungs and in lungs ventilated for 6 h. In untreated and IMD treated mice, lung permeability, pulmonary leukocyte recruitment and cytokine levels were assessed after mechanical ventilation. Further, the impact of IMD on pulmonary vasoconstriction was investigated in precision cut lung slices (PCLS) and in isolated perfused and ventilated mouse lungs. IMD stabilized endothelial barrier function in HPMVECs. Mechanical ventilation reduced the expression of RAMP3, but not of IMD, CRLR, and RAMP1 and 2. Mechanical ventilation induced lung hyperpermeability, which was ameliorated by IMD treatment. Oxygenation was not improved by IMD, which may be attributed to impaired hypoxic vasoconstriction due to IMD treatment. IMD had minor impact on pulmonary leukocyte recruitment and did not reduce cytokine levels in VILI. Conclusions/Significance: IMD may possibly provide a new approach to attenuate VILI.	[Mueller-Redetzky, Holger Christian; Hellwig, Katharina; Will, Daniel; Tabeling, Christoph; Hippenstiel, Stefan; Suttorp, Norbert; Witzenrath, Martin] Charite, Dept Infect Dis & Pulm Med, D-13353 Berlin, Germany; [Kummer, Wolfgang; Pfeil, Uwe; Paddenberg, Renate] Univ Giessen, Inst Anat & Cell Biol, D-35390 Giessen, Germany; [Kummer, Wolfgang; Pfeil, Uwe; Paddenberg, Renate] Univ Giessen, Marburg Lung Ctr, D-35390 Giessen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Justus Liebig University Giessen; Justus Liebig University Giessen	Muller-Redetzky, HC (corresponding author), Charite, Dept Infect Dis & Pulm Med, D-13353 Berlin, Germany.	martin.witzenrath@charite.de		Suttorp, Norbert/0000-0002-3958-1151; Hippenstiel, Stefan/0000-0002-5146-1064; Tabeling, Christoph/0000-0001-9189-4318; Kummer, Wolfgang/0000-0002-3946-0683	German Research Foundation [SFB/TR84, HI-789/6-1, OP-87/1]; Excellence Cluster Cardio-Pulmonary System; German Federal Ministry of Education and Research	German Research Foundation(German Research Foundation (DFG)); Excellence Cluster Cardio-Pulmonary System(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study is supported in part by grants from the German Research Foundation (http://www.dfg.de/index.jsp) to ACH, SH, NS, MW (SFB/TR84) and SH (HI-789/6-1) and MW (OP-87/1), the Excellence Cluster Cardio-Pulmonary System to UP and WK, and the German Federal Ministry of Education and Research (http://www.bmbf.de/) to SH, NS (Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Sepsis PROGRESS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam M, 2011, BR J PHARM; BANKSTON PW, 1991, EUR J CELL BIOL, V54, P187; Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; Brell B, 2005, CRIT CARE MED, V33, P819, DOI 10.1097/01.CCM.0000159194.53695.7A; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Dhanireddy S, 2006, LAB INVEST, V86, P790, DOI 10.1038/labinvest.3700440; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Fujisawa Y, 2007, EUR J PHARMACOL, V558, P128, DOI 10.1016/j.ejphar.2006.11.043; Gonzalez-Rey E, 2006, AM J PATHOL, V168, P1921, DOI 10.2353/ajpath.2006.051104; Hagner S, 2001, NEUROPEPTIDES, V35, P58, DOI 10.1054/npep.2000.0844; Hippenstiel S, 2002, CIRC RES, V91, P618, DOI 10.1161/01.RES.0000036603.61868.F9; Itoh T, 2007, AM J PHYSIOL-LUNG C, V293, pL446, DOI 10.1152/ajplung.00412.2005; Korner C, 2011, PNEUMOLOGIE, V65, P114, DOI DOI 10.1055/s-0030-1270376; Muller HC, 2010, CRIT CARE, V14, DOI 10.1186/cc9209; Muller HC, 2011, PULM PHARMACOL THER, V24, P377, DOI 10.1016/j.pupt.2011.01.017; Muller HC, 2010, THORAX, V65, P1077, DOI 10.1136/thx.2010.135996; O'Mahony DS, 2006, CRIT CARE, V10, DOI 10.1186/cc5050; Paddenberg R, 2009, ADV EXP MED BIOL, V648, P361, DOI 10.1007/978-90-481-2259-2_41; Paddenberg R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-93; Pfeil U, 2009, AM J PHYSIOL-LUNG C, V297, pL837, DOI 10.1152/ajplung.90608.2008; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Takei Y, 2004, PEPTIDES, V25, P1643, DOI 10.1016/j.peptides.2004.06.026; Temmesfeld-Wollbruck B, 2007, THROMB HAEMOSTASIS, V98, P944, DOI 10.1160/TH07-02-0128; Temmesfeld-Wollbruck B, 2007, INTENS CARE MED, V33, P703, DOI 10.1007/s00134-007-0561-y; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Verbrugge SJC, 2007, CLIN PHYSIOL FUNCT I, V27, P67, DOI 10.1111/j.1475-097X.2007.00722.x; Witzenrath M, 2006, EUR RESPIR J, V28, P370, DOI 10.1183/09031936.06.00080105; Witzenrath M, 2006, CRIT CARE MED, V34, P1947, DOI 10.1097/01.CCM.0000220496.48295.A9; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Yang JH, 2005, BIOCHEM BIOPH RES CO, V327, P713, DOI 10.1016/j.bbrc.2004.12.071	30	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35832	10.1371/journal.pone.0035832	http://dx.doi.org/10.1371/journal.pone.0035832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563471	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700020
J	Spiegel, DP; Hansen, BC; Byblow, WD; Thompson, B				Spiegel, Daniel P.; Hansen, Bruce C.; Byblow, Winston D.; Thompson, Benjamin			Anodal Transcranial Direct Current Stimulation Reduces Psychophysically Measured Surround Suppression in the Human Visual Cortex	PLOS ONE			English	Article							CROSS-ORIENTATION SUPPRESSION; CAT STRIATE CORTEX; HUMAN MOTOR CORTEX; RECEPTIVE-FIELD; PHOSPHENE THRESHOLDS; SPATIAL-DISTRIBUTION; MOTION PERCEPTION; BRAIN PLASTICITY; INHIBITION; MODULATION	Transcranial direct current stimulation (tDCS) is a safe, non-invasive technique for transiently modulating the balance of excitation and inhibition within the human brain. It has been reported that anodal tDCS can reduce both GABA mediated inhibition and GABA concentration within the human motor cortex. As GABA mediated inhibition is thought to be a key modulator of plasticity within the adult brain, these findings have broad implications for the future use of tDCS. It is important, therefore, to establish whether tDCS can exert similar effects within non-motor brain areas. The aim of this study was to assess whether anodal tDCS could reduce inhibitory interactions within the human visual cortex. Psychophysical measures of surround suppression were used as an index of inhibition within V1. Overlay suppression, which is thought to originate within the lateral geniculate nucleus (LGN), was also measured as a control. Anodal stimulation of the occipital poles significantly reduced psychophysical surround suppression, but had no effect on overlay suppression. This effect was specific to anodal stimulation as cathodal stimulation had no effect on either measure. These psychophysical results provide the first evidence for tDCS-induced reductions of intracortical inhibition within the human visual cortex.	[Spiegel, Daniel P.; Thompson, Benjamin] Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand; [Hansen, Bruce C.] Colgate Univ, Dept Psychol, Hamilton, NY 13346 USA; [Hansen, Bruce C.] Colgate Univ, Neurosci Program, Hamilton, NY 13346 USA; [Byblow, Winston D.] Univ Auckland, Dept Sport & Exercise Sci, Auckland 1, New Zealand	University of Auckland; Colgate University; Colgate University; University of Auckland	Spiegel, DP (corresponding author), Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand.	b.thompson@auckland.ac.nz	Byblow, Winston/D-3579-2009; Hansen, Bruce/E-8516-2010	Byblow, Winston/0000-0001-8347-6730; Hansen, Bruce/0000-0002-8898-1688; Thompson, Benjamin/0000-0002-3902-2712	Health Research Council of New Zealand Emerging Researcher Grant [09/150]; University of Auckland Faculty Development Research Fund Grant [3622919]	Health Research Council of New Zealand Emerging Researcher Grant; University of Auckland Faculty Development Research Fund Grant	This study was supported by a Health Research Council of New Zealand Emerging Researcher Grant (09/150) to BT and WDB and a University of Auckland Faculty Development Research Fund Grant (3622919) to BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero N, 2007, EXP BRAIN RES, V178, P261, DOI 10.1007/s00221-006-0733-y; Akasaki T, 2002, NEUROSCI RES, V43, P207, DOI 10.1016/S0168-0102(02)00038-X; Angelakis E., 2011, THE J, V15, P337, DOI [10.1080/10874208.2011.623092, DOI 10.1080/10874208.2011.623092]; Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2006, BRAIN RES BULL, V68, P459, DOI 10.1016/j.brainresbull.2005.10.006; Antal A, 2004, INVEST OPHTH VIS SCI, V45, P702, DOI 10.1167/iovs.03-0688; Antal A, 2003, NEUROPSYCHOLOGIA, V41, P1802, DOI 10.1016/S0028-3932(03)00181-7; Antal A, 2001, NEUROREPORT, V12, P3553, DOI 10.1097/00001756-200111160-00036; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Antal A, 2008, PERCEPTION, V37, P367, DOI 10.1068/p5872; Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Bex PJ, 2007, J VISION, V7, DOI 10.1167/7.11.12; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Boros K, 2008, EUR J NEUROSCI, V27, P1292, DOI 10.1111/j.1460-9568.2008.06090.x; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Darrien JH, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-13; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DUFFY FH, 1985, BRAIN RES, V339, P257, DOI 10.1016/0006-8993(85)90090-3; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; Fu Y, 2010, NEUROSCIENCE, V169, P874, DOI 10.1016/j.neuroscience.2010.05.015; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Halko MA, 2011, NEUROIMAGE, V57, P885, DOI 10.1016/j.neuroimage.2011.05.026; HEGGELUND P, 1983, EXP BRAIN RES, V52, P235; Huang SY, 2010, J NEUROSCI, V30, P16636, DOI 10.1523/JNEUROSCI.4384-10.2010; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kraft A, 2010, EXP BRAIN RES, V207, P283, DOI 10.1007/s00221-010-2453-6; Lang N, 2007, INVEST OPHTH VIS SCI, V48, P5782, DOI 10.1167/iovs.07-0706; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Li BW, 2006, J NEUROPHYSIOL, V96, P1755, DOI 10.1152/jn.00425.2006; Li G, 2008, NEUROSCIENCE, V155, P914, DOI 10.1016/j.neuroscience.2008.06.032; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Ohtani Y, 2002, VISION RES, V42, P1825, DOI 10.1016/S0042-6989(02)00103-7; Osaki H, 2011, EUR J NEUROSCI, V33, P923, DOI 10.1111/j.1460-9568.2010.07572.x; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Petrov Y, 2006, J VISION, V6, P224, DOI 10.1167/6.3.4; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Rokem A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00127; Saint-Amour D, 2005, EUR J NEUROSCI, V21, P1107, DOI 10.1111/j.1460-9568.2005.03914.x; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sale A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00010; Sengpiel F, 2006, CEREB CORTEX, V16, P1750, DOI 10.1093/cercor/bhj110; Smith MA, 2006, J NEUROSCI, V26, P4826, DOI 10.1523/JNEUROSCI.5542-06.2006; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Thompson B, 2008, CURR BIOL, V18, P1067, DOI 10.1016/j.cub.2008.06.052; Thompson B, 2012, DEV PSYCHOBIOL, V54, P263, DOI 10.1002/dev.20509; Tyler CW, 1997, SPATIAL VISION, V10, P369, DOI 10.1163/156856897X00294; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; Yoon JH, 2009, SCHIZOPHRENIA BULL, V35, P1078, DOI 10.1093/schbul/sbp064; Yu C, 2002, J VISION, V2, DOI 10.1167/2.3.4	68	41	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36220	10.1371/journal.pone.0036220	http://dx.doi.org/10.1371/journal.pone.0036220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563485	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340700034
J	Brissette, MJ; Lepage, S; Lamonde, AS; Sirois, I; Groleau, J; Laurin, LP; Cailhier, JF				Brissette, Marie-Joelle; Lepage, Stephanie; Lamonde, Anne-Sophie; Sirois, Isabelle; Groleau, Jessika; Laurin, Louis-Philippe; Cailhier, Jean-Francois			MFG-E8 Released by Apoptotic Endothelial Cells Triggers Anti-Inflammatory Macrophage Reprogramming	PLOS ONE			English	Article							CHRONIC TRANSPLANT VASCULOPATHY; FIND-ME; SELECTIVE DEPLETION; GROWTH-FACTOR; TGF-BETA; CLEARANCE; PHAGOCYTOSIS; INFLAMMATION; NUCLEOTIDES; ACTIVATION	Apoptotic endothelial cells are an important component of the "response to injury" process. Several atherosclerosis risk factors such as hyperglycemia and oxidized low-density lipoproteins, and immune injuries, such as antibodies and complement, induce endothelial cell apoptosis. While endothelial cell apoptosis is known to affect neighboring vascular wall cell biology, its consequences on macrophage reprogramming are ill defined. In this study, we report that apoptosis of human and mouse endothelial cells triggers the release of milk fat globule-epidermal growth factor 8 (MFG-E8) and reprograms macrophages into an anti-inflammatory cells. We demonstrated that MFG-E8 is released by apoptotic endothelial cells in a caspase-3-dependent manner. When macrophages were exposed to conditioned media from serum-starved apoptotic endothelial cells, they adopt a high anti-inflammatory, low pro-inflammatory cytokine/chemokine secreting phenotype that is lost if MFG-E8 is absent from the media. Macrophage treatment with recombinant MFG-E8 recapitulates the effect of conditioned media. Finally, we showed that MFG-E8-mediated reprogramming of macrophages occurs through increased phosphorylation of signal transducer and activator of transcription-3 (STAT-3). Taken together, our study suggests a key role of MFG-E8 release from apoptotic endothelial cells in macrophage reprogramming and demonstrates the importance of the apoptotic microenvironment in anti-inflammatory macrophage responses.	[Brissette, Marie-Joelle; Lepage, Stephanie; Lamonde, Anne-Sophie; Sirois, Isabelle; Groleau, Jessika; Laurin, Louis-Philippe; Cailhier, Jean-Francois] Univ Montreal, CRCHUM, Montreal, PQ, Canada; [Brissette, Marie-Joelle; Lepage, Stephanie; Lamonde, Anne-Sophie; Cailhier, Jean-Francois] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Laurin, Louis-Philippe; Cailhier, Jean-Francois] Univ Montreal, Dept Med, CHUM, Div Nephrol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Brissette, MJ (corresponding author), Univ Montreal, CRCHUM, Montreal, PQ, Canada.	jf.cailhier@umontreal.ca			Kidney Foundation of Canada; Fonds de la recherche en sante du Quebec (FRSQ); Foundation from the Centre hospitalier de l'Universite de Montreal (CHUM); l'Institut du Cancer de Montreal; J.-L. Levesque Foundation; CHUM Renal Division	Kidney Foundation of Canada; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Foundation from the Centre hospitalier de l'Universite de Montreal (CHUM); l'Institut du Cancer de Montreal; J.-L. Levesque Foundation; CHUM Renal Division	This work was funded in part by research grants from the Kidney Foundation of Canada, the Fonds de la recherche en sante du Quebec (FRSQ), the Foundation from the Centre hospitalier de l'Universite de Montreal (CHUM), and from l'Institut du Cancer de Montreal. JFC was the recipient of a Kidney Foundation of Canada scholarship and is now a FRSQ clinician-scientist scholar. The authors thank the J.-L. Levesque Foundation and the CHUM Renal Division for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cailhier JFO, 2006, AM J RESP CRIT CARE, V173, P540, DOI 10.1164/rccm.200504-538OC; Chekeni FB, 2011, J MOL MED, V89, P13, DOI 10.1007/s00109-010-0673-7; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; Cui TP, 2010, AM J RESP CRIT CARE, V181, P238, DOI 10.1164/rccm.200804-625OC; De Meyer I, 2012, BRIT J CLIN PHARMACO, V74, P246, DOI 10.1111/j.1365-2125.2012.04211.x; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Hamet P, 2001, CAN J CARDIOL, V17, p26A; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Kitchens WH, 2007, AM J TRANSPLANT, V7, P2675, DOI 10.1111/j.1600-6143.2007.01997.x; Kluth DC, 2004, KIDNEY INT, V66, P542, DOI 10.1111/j.1523-1755.2004.00773.x; Laplante P, 2005, J IMMUNOL, V174, P5740, DOI 10.4049/jimmunol.174.9.5740; Laplante P, 2010, CELL DEATH DIFFER, V17, P291, DOI 10.1038/cdd.2009.124; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lepage S, 2009, TRANSPL P, V41, P3311, DOI 10.1016/j.transproceed.2009.08.035; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Martinet W, 2007, TRENDS CARDIOVAS MED, V17, P69, DOI 10.1016/j.tcm.2006.12.004; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Raymond MA, 2004, FASEB J, V18, P705, DOI 10.1096/fj.03-0573fje; Rovere P, 1998, J IMMUNOL, V161, P4467; Sata M, 1998, J CLIN INVEST, V102, P1682, DOI 10.1172/JCI3531; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Schaub FJ, 2000, NAT MED, V6, P790, DOI 10.1038/77521; Sean Eardley K, 2005, KIDNEY INT, V68, P437, DOI 10.1111/j.1523-1755.2005.00422.x; Sirois I, 2011, CELL DEATH DIFFER, V18, P549, DOI 10.1038/cdd.2010.126; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weigert A, 2006, BLOOD, V108, P1635, DOI 10.1182/blood-2006-04-014852	47	47	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36368	10.1371/journal.pone.0036368	http://dx.doi.org/10.1371/journal.pone.0036368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558449	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200071
J	Jansen, C; Parchi, P; Capellari, S; Ibrahim-Verbaas, CA; Schuur, M; Strammiello, R; Corrado, P; Bishop, MT; van Gool, WA; Verbeek, MM; Baas, F; van Saane, W; Spliet, WGM; Jansen, GH; van Duijn, CM; Rozemuller, AJM				Jansen, Casper; Parchi, Piero; Capellari, Sabina; Ibrahim-Verbaas, Carla A.; Schuur, Maaike; Strammiello, Rosaria; Corrado, Patrizia; Bishop, Matthew T.; van Gool, Willem A.; Verbeek, Marcel M.; Baas, Frank; van Saane, Wesley; Spliet, Wim G. M.; Jansen, Gerard H.; van Duijn, Cornelia M.; Rozemuller, Annemieke J. M.			Human Prion Diseases in The Netherlands (1998-2009): Clinical, Genetic and Molecular Aspects	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PROTEASE-SENSITIVE PRIONOPATHY; FATAL FAMILIAL INSOMNIA; VARIANT; PRPSC; CLASSIFICATION; COOCCURRENCE; PHENOTYPE; STRAINS; PATIENT	Prion diseases are rare and fatal neurodegenerative disorders that can be sporadic, inherited or acquired by infection. Based on a national surveillance program in the Netherlands we describe here the clinical, neuropathological, genetic and molecular characteristics of 162 patients with neuropathologically confirmed prion disease over a 12-year period (1998-2009). Since 1998, there has been a relatively stable mortality of Creutzfeldt-Jakob disease (CJD) in the Netherlands, ranging from 0.63 to 1.53 per million inhabitants per annum. Genetic analysis of the codon 129 methionine/valine (M/V) polymorphism in all patients with sporadic CJD (sCJD) showed a trend for under-representation of VV cases (7.0%), compared with sCJD cohorts in other Western countries, whereas the MV genotype was relatively over-represented (22,4%). Combined PrP Sc and histopathological typing identified all sCJD subtypes known to date, except for the VV1 subtype. In particular, a "pure" phenotype was demonstrated in 60.1% of patients, whereas a mixed phenotype was detected in 39.9% of all sCJD cases. The relative excess of MV cases was largely accounted for by a relatively high incidence of the MV 2K subtype. Genetic analysis of the prion protein gene (PRNP) was performed in 161 patients and showed a mutation in 9 of them (5.6%), including one FFI and four GSS cases. Iatrogenic CJD was a rare phenomenon (3.1%), mainly associated with dura mater grafts. Three patients were diagnosed with new variant CJD (1.9%) and one with variably protease-sensitive prionopathy (VPSPr). Post-mortem examination revealed an alternative diagnosis in 156 patients, most commonly Alzheimer's disease (21.2%) or vascular causes of dementia (19.9%). The mortality rates of sCJD in the Netherlands are similar to those in other European countries, whereas iatrogenic and genetic cases are relatively rare. The unusual incidence of the VV2 sCJD subtype compared to that reported to date in other Western countries deserves further investigation.	[Jansen, Casper; van Saane, Wesley; Spliet, Wim G. M.; Rozemuller, Annemieke J. M.] Univ Med Ctr Utrecht, Dutch Surveillance Ctr Prion Dis, Utrecht, Netherlands; [Parchi, Piero; Capellari, Sabina; Strammiello, Rosaria; Corrado, Patrizia] Univ Bologna, Ist Sci Neurol, Bologna, Italy; [Parchi, Piero; Capellari, Sabina; Strammiello, Rosaria; Corrado, Patrizia] Univ Bologna, Dipartimento Sci Neurol, Bologna, Italy; [Ibrahim-Verbaas, Carla A.; Schuur, Maaike] Erasmus Univ, Dept Neurol, Med Ctr, Rotterdam, Netherlands; [Ibrahim-Verbaas, Carla A.; van Duijn, Cornelia M.] Erasmus Univ, Dept Epidemiol, Med Ctr, Dutch Natl Prion Dis Registry, Rotterdam, Netherlands; [Bishop, Matthew T.] Univ Edinburgh, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh, Midlothian, Scotland; [van Gool, Willem A.; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav,Alzheimer Ctr N, NL-6525 ED Nijmegen, Netherlands; [Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Donders Inst Brain Cognit & Behav,Alzheimer Ctr N, NL-6525 ED Nijmegen, Netherlands; [Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Jansen, Gerard H.] Publ Hlth Agcy Canada, Prion Dis Program, Creutzfeldt Jakob Dis Surveillance Syst, Ottawa, ON, Canada; [Rozemuller, Annemieke J. M.] Netherlands Brain Bank, Amsterdam, Netherlands; [Rozemuller, Annemieke J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Agency of Canada; Vrije Universiteit Amsterdam	Jansen, C (corresponding author), Univ Med Ctr Utrecht, Dutch Surveillance Ctr Prion Dis, Utrecht, Netherlands.	c.jansen@umcutrecht.nl	Rozemuller, Annemieke/ABA-7093-2021; Van Gool, Willem A/G-5985-2012; Rozemuller, Annemieke/C-2084-2008; Verbeek, Marcel M/D-1971-2010; Parchi, Piero/L-9833-2015; Baas, Frank/F-9574-2010; capellari, sabina/F-5545-2012	Verbeek, Marcel M/0000-0003-4635-7876; Parchi, Piero/0000-0002-9444-9524; Baas, Frank/0000-0003-3912-5428; capellari, sabina/0000-0003-1631-1439; Ibrahim-verbaas, Carla/0000-0002-4325-0857; Van Gool, Willem/0000-0003-3174-8233; Van Duijn, Cornelia/0000-0002-2374-9204				Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Alperovitch A, 1999, LANCET, V353, P1673, DOI 10.1016/S0140-6736(99)01342-2; Bishop MT, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-146; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Cali I, 2006, BRAIN, V129, P2266, DOI 10.1093/brain/awl224; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Croes EA, 2003, ANN NEUROL, V54, P275, DOI 10.1002/ana.10658; Croes EA, 2002, J NEUROL NEUROSUR PS, V72, P792, DOI 10.1136/jnnp.72.6.792; Dyrbye H, 2008, EUR J EPIDEMIOL, V23, P23, DOI 10.1007/s10654-007-9197-z; Ferrer I, 2007, BRAIN PATHOL, V17, P297, DOI 10.1111/j.1750-3639.2007.00073.x; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Ghetti B, 2003, CLIN LAB MED, V23, P65, DOI 10.1016/S0272-2712(02)00064-1; Ghetti B, 2003, CLIN LAB MED, V23, pviii; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Head MW, 2004, ANN NEUROL, V55, P851, DOI 10.1002/ana.20127; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Jansen C, 2011, NEUROPATH APPL NEURO, V37, P549, DOI 10.1111/j.1365-2990.2010.01126.x; Jansen C, 2010, J NEUROL NEUROSUR PS, V81, P1052, DOI 10.1136/jnnp.2009.175646; Jansen C, 2009, J NEUROL NEUROSUR PS, V80, P1386, DOI 10.1136/jnnp.2008.169359; Jansen C, 2011, J NEUROPATH EXP NEUR, V70, P698, DOI 10.1097/NEN.0b013e3182270c54; Jansen C, 2011, ACTA NEUROPATHOL, V121, P59, DOI 10.1007/s00401-010-0656-3; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; Kobayashi A, 2011, AM J PATHOL, V178, P1309, DOI 10.1016/j.ajpath.2010.11.069; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Kovacs GG, 2002, BRAIN PATHOL, V12, P1; Ladogana A, 2005, NEUROLOGY, V64, P1586, DOI 10.1212/01.WNL.0000160117.56690.B2; Lewis V, 2005, NEUROLOGY, V65, P113, DOI 10.1212/01.wnl.0000167188.65787.a0; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Nozaki I, 2010, BRAIN, V133, P3043, DOI 10.1093/brain/awq216; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; Parchi P, 2011, ACTA NEUROPATHOL, V121, P91, DOI 10.1007/s00401-010-0779-6; Parchi P, 2010, BRAIN, V133, P3030, DOI 10.1093/brain/awq234; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Parchi P, 2009, BRAIN PATHOL, V19, P384, DOI 10.1111/j.1750-3639.2008.00187.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Sanchez-Juan P, 2007, J NEUROL, V254, P958, DOI 10.1007/s00415-006-0360-3; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; Uro-Coste E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000029; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Will RG, 1998, ANN NEUROL, V43, P763, DOI 10.1002/ana.410430611; Yull HM, 2009, BIOLOGICALS, V37, P210, DOI 10.1016/j.biologicals.2009.01.009; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Zimmermann K, 1999, ACTA NEUROPATHOL, V97, P355, DOI 10.1007/s004010050998; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094	52	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36333	10.1371/journal.pone.0036333	http://dx.doi.org/10.1371/journal.pone.0036333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558438	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200067
J	Schreur, PJW; van Weeghel, C; Rebel, JMJ; Smits, MA; van Putten, JPM; Smith, HE				Schreur, Paul J. Wichgers; van Weeghel, Christian; Rebel, Johanna M. J.; Smits, Mari A.; van Putten, Jos P. M.; Smith, Hilde E.			Lysozyme Resistance in Streptococcus suis Is Highly Variable and Multifactorial	PLOS ONE			English	Article							PENICILLIN RESISTANCE; ANTIBIOTIC TOLERANCE; MURMN OPERON; PGDA GENE; VIRULENCE; DEACETYLASE	Background: Streptococcus suis is an important infectious agent for pigs and occasionally for humans. The host innate immune system plays a key role in preventing and eliminating S. suis infections. One important constituent of the innate immune system is the protein lysozyme, which is present in a variety of body fluids and immune cells. Lysozyme acts as a peptidoglycan degrading enzyme causing bacterial lysis. Several pathogens have developed mechanisms to evade lysozyme-mediated killing. In the present study we compared the lysozyme sensitivity of various S. suis isolates and investigated the molecular basis of lysozyme resistance for this pathogen. Results: The lysozyme minimal inhibitory concentrations of a wide panel of S. suis isolates varied between 0.3 to 10 mg/ml. By inactivating the oatA gene in a serotype 2 and a serotype 9 strain, we showed that OatA-mediated peptidoglycan modification partly contributes to lysozyme resistance. Furthermore, inactivation of the murMN operon provided evidence that additional peptidoglycan crosslinking is not involved in lysozyme resistance in S. suis. Besides a targeted approach, we also used an unbiased approach for identifying factors involved in lysozyme resistance. Based on whole genome comparisons of a lysozyme sensitive strain and selected lysozyme resistant derivatives, we detected several single nucleotide polymorphisms (SNPs) that were correlated with the lysozyme resistance trait. Two SNPs caused defects in protein expression of an autolysin and a capsule sugar transferase. Analysis of specific isogenic mutants, confirmed the involvement of autolysin activity and capsule structures in lysozyme resistance of S. suis. Conclusions: This study shows that lysozyme resistance levels are highly variable among S. suis isolates and serotypes. Furthermore, the results show that lysozyme resistance in S. suis can involve different mechanisms including OatA-mediated peptidolycan modification, autolysin activity and capsule production.	[Schreur, Paul J. Wichgers; van Weeghel, Christian; Rebel, Johanna M. J.; Smits, Mari A.; Smith, Hilde E.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Schreur, Paul J. Wichgers; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Smits, Mari A.] Wageningen UR, Wageningen Livestock Res, Lelystad, Netherlands	Wageningen University & Research; Utrecht University; Wageningen University & Research	Schreur, PJW (corresponding author), Wageningen UR, Cent Vet Inst, Lelystad, Netherlands.	hilde.smith@wur.nl	smits, mari/J-4892-2013	smits, mari/0000-0002-3493-291X; van Putten, Jos/0000-0002-4126-8172; Rebel, Annemarie/0000-0003-4765-4215	Dutch Ministry of Economic Affairs, Agriculture and Innovation	Dutch Ministry of Economic Affairs, Agriculture and Innovation	This project was financially supported by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINE E, 1984, ACTA OPHTHALMOL, V62, P932; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; BUNGENER W, 1989, EUR J CLIN MICROBIOL, V8, P306, DOI 10.1007/BF01963457; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Cole AM, 2002, J IMMUNOL, V169, P6985, DOI 10.4049/jimmunol.169.12.6985; COTTAGNOUD P, 1993, J INFECT DIS, V167, P684, DOI 10.1093/infdis/167.3.684; CRAMER EM, 1987, J LEUKOCYTE BIOL, V41, P242, DOI 10.1002/jlb.41.3.242; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; Filipe SR, 2001, MICROB DRUG RESIST, V7, P303, DOI 10.1089/10766290152773310; Filipe SR, 2002, P NATL ACAD SCI USA, V99, P1550, DOI 10.1073/pnas.032671699; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Hirst RA, 2008, J INFECT DIS, V197, P744, DOI 10.1086/527322; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; JACQUES M, 1990, J BACTERIOL, V172, P2833, DOI 10.1128/jb.172.6.2833-2838.1990; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Laaberki MH, 2011, J BIOL CHEM, V286, P5278, DOI 10.1074/jbc.M110.183236; Markart P, 2004, AM J RESP CRIT CARE, V169, P454, DOI 10.1164/rccm.200305-669OC; PEETERMANS WEC, 1989, J INFECT DIS, V159, P595, DOI 10.1093/infdis/159.3.595; PEREZMARTINEZ G, 1992, MOL GEN GENET, V234, P401, DOI 10.1007/BF00538699; Rae CS, 2011, INFECT IMMUN, V79, P3596, DOI 10.1128/IAI.00077-11; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schreur PJW, 2011, J BACTERIOL, V193, P5073, DOI 10.1128/JB.05305-11; Schreur PJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022299; Shimada J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-134; Smith HE, 1999, INFECT IMMUN, V67, P1750; SMITH HE, 1995, MICROBIOL-UK, V141, P181, DOI 10.1099/00221287-141-1-181; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; VECHT U, 1992, INFECT IMMUN, V60, P550, DOI 10.1128/IAI.60.2.550-556.1992; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; WELSH IRH, 1971, INFECT IMMUN, V4, P97, DOI 10.1128/IAI.4.2.97-102.1971; Wichgers Schreur PJ, 2009, VET MICROBIOL; Wichgers Schreur PJ, 2011, PLOS ONE IN PRESS; Zhang AD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-523; Zhu HD, 2011, MICROB PATHOGENESIS, V51, P442, DOI 10.1016/j.micpath.2011.08.002	39	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36281	10.1371/journal.pone.0036281	http://dx.doi.org/10.1371/journal.pone.0036281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558419	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200060
J	Bonar, SL; Brydges, SD; Mueller, JL; McGeough, MD; Pena, C; Chen, D; Grimston, SK; Hickman-Brecks, CL; Ravindran, S; McAlinden, A; Novack, DV; Kastner, DL; Civitelli, R; Hoffman, HM; Mbalaviele, G				Bonar, Sheri L.; Brydges, Susannah D.; Mueller, James L.; McGeough, Matthew D.; Pena, Carla; Chen, Debbie; Grimston, Susan K.; Hickman-Brecks, Cynthia L.; Ravindran, Soumya; McAlinden, Audrey; Novack, Deborah V.; Kastner, Daniel L.; Civitelli, Roberto; Hoffman, Hal M.; Mbalaviele, Gabriel			Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice	PLOS ONE			English	Article							CIAS1 MUTATIONS; TNF-ALPHA; BONE; OSTEOCLAST; DISEASE; GROWTH; DIFFERENTIATION; INCREASE; COLLAGEN; BLOOD	The NLRP3 inflammasome complex is responsible for maturation of the pro-inflammatory cytokine, IL-1 beta. Mutations in NLRP3 are responsible for the cryopyrinopathies, a spectrum of conditions including neonatal-onset multisystem inflammatory disease (NOMID). While excessive production of IL-1 beta and systemic inflammation are common to all cryopyrinopathy disorders, skeletal abnormalities, prominently in the knees, and low bone mass are unique features of patients with NOMID. To gain insights into the mechanisms underlying skeletal abnormalities in NOMID, we generated knock-in mice globally expressing the D301N NLRP3 mutation (ortholog of D303N in human NLRP3). NOMID mice exhibit neutrophilia in blood and many tissues, including knee joints, and high levels of serum inflammatory mediators. They also exhibit growth retardation and severe postnatal osteopenia stemming at least in part from abnormally accelerated bone resorption, attended by increased osteoclastogenesis. Histologic analysis of knee joints revealed abnormal growth plates, with loss of chondrocytes and growth arrest in the central region of the epiphyses. Most strikingly, a tissue "spike" was observed in the mid-region of the growth plate in the long bones of all NOMID mice that may be the precursor to more severe deformations analogous to those observed in NOMID patients. These findings provide direct evidence linking a NOMID-associated NLRP3-activating mutation to abnormalities of postnatal skeletal growth and bone remodeling.	[Bonar, Sheri L.; Grimston, Susan K.; Hickman-Brecks, Cynthia L.; Novack, Deborah V.; Civitelli, Roberto; Mbalaviele, Gabriel] Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO 63130 USA; [Brydges, Susannah D.; Mueller, James L.; McGeough, Matthew D.; Pena, Carla; Chen, Debbie; Hoffman, Hal M.] Univ Calif San Diego, Div Allergy Immunol & Rheumatol, La Jolla, CA 92093 USA; [Brydges, Susannah D.; Mueller, James L.; McGeough, Matthew D.; Pena, Carla; Chen, Debbie; Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Brydges, Susannah D.; Mueller, James L.; McGeough, Matthew D.; Pena, Carla; Chen, Debbie; Hoffman, Hal M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ravindran, Soumya; McAlinden, Audrey] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO USA; [Kastner, Daniel L.] NHGRI, Med Genet Branch, US Dept HHS, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Bonar, SL (corresponding author), Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO 63130 USA.	gmbalavi@DOM.wustl.edu	Civitelli, Roberto/AAA-8260-2019	Civitelli, Roberto/0000-0003-4076-4315; Novack, Deborah/0000-0001-7101-5582; McAlinden, Audrey/0000-0001-8433-4224	National Institute of Arthritis and Musculoskeletal and Skin Diseases; NIH [RO1-AI52430]; National Institutes of Health/Core Center for Musculoskeletal Biology and Medicine [5 P30 AR057235]; Arthritis National Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052705, P30AR057235] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/Core Center for Musculoskeletal Biology and Medicine; Arthritis National Research Foundation(National Research Foundation of Korea); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, extramural grants NIH RO1-AI52430, the 5 P30 AR057235 National Institutes of Health/Core Center for Musculoskeletal Biology and Medicine and the Arthritis National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Cremer M A, 1988, Int Rev Immunol, V4, P65, DOI 10.3109/08830188809044771; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013; Doherty TA, 2011, J LEUKOCYTE BIOL, V90, P37, DOI 10.1189/jlb.1110616; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Ford-Hutchinson AF, 2007, J BONE MINER RES, V22, P1245, DOI 10.1359/JBMR.070420; Hill SC, 2007, PEDIATR RADIOL, V37, P145, DOI 10.1007/s00247-006-0358-0; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mbalaviele G, 2006, J PHARMACOL EXP THER, V317, P1044, DOI 10.1124/jpet.105.100362; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Muto A, 2011, J BONE MINER RES, V26, P2978, DOI 10.1002/jbmr.490; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; PACIFICI R, 1989, P NATL ACAD SCI USA, V86, P2398, DOI 10.1073/pnas.86.7.2398; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sibley CH, 2012, ARTHRITIS RHEUM; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Walsh NC, 2010, IMMUNOL REV, V233, P301, DOI 10.1111/j.0105-2896.2009.00857.x; Watkins M, 2011, MOL BIOL CELL, V22, P1240, DOI 10.1091/mbc.E10-07-0571; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	32	81	82	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35979	10.1371/journal.pone.0035979	http://dx.doi.org/10.1371/journal.pone.0035979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558291	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000095
J	Bouchard, S; Bernier, F; Boivin, E; Morin, B; Robillard, G				Bouchard, Stephane; Bernier, Francois; Boivin, Eric; Morin, Brian; Robillard, Genevieve			Using Biofeedback while Immersed in a Stressful Videogame Increases the Effectiveness of Stress Management Skills in Soldiers	PLOS ONE			English	Article							MENTAL-HEALTH; RESILIENCE; FITNESS; RESPONSES; MILITARY; NEUROENDOCRINE; CORTISOL; SCIENCE; GENDER; IRAQ	This study assessed the efficacy of using visual and auditory biofeedback while immersed in a tridimensional videogame to practice a stress management skill (tactical breathing). All 41 participants were soldiers who had previously received basic stress management training and first aid training in combat. On the first day, they received a 15-minute refresher briefing and were randomly assigned to either: (a) no additional stress management training (SMT) for three days, or (b) 30-minute sessions (one per day for three days) of biofeedback-assisted SMT while immersed in a horror/first-person shooter game. The training was performed in a dark and enclosed environment using a 50-inch television with active stereoscopic display and loudspeakers. On the last day, all participants underwent a live simulated ambush with an improvised explosive device, where they had to provide first aid to a wounded soldier. Stress levels were measured with salivary cortisol collected when waking-up, before and after the live simulation. Stress was also measured with heart rate at baseline, during an apprehension phase, and during the live simulation. Repeated-measure ANOVAs and ANCOVAs confirmed that practicing SMT was effective in reducing stress. Results are discussed in terms of the advantages of the proposed program for military personnel and the need to practice SMT.	[Bouchard, Stephane; Robillard, Genevieve] Univ Quebec Outaouais, Lab Cyberpsychol, Gatineau, PQ, Canada; [Bernier, Francois; Boivin, Eric] Def Res & Dev Canada ValCartier, Quebec City, PQ, Canada; [Morin, Brian] Clin Psychol Cognit, Quebec City, PQ, Canada	University of Quebec; University Quebec Outaouais	Bouchard, S (corresponding author), Univ Quebec Outaouais, Lab Cyberpsychol, Gatineau, PQ, Canada.	stephane.bouchard@uqo.ca	Bernier, Francois/AAP-2174-2020; Bernier, Francois/V-7150-2018		Public Works and Government Services Canada; Canada Research Chairs program; Natural Science and Engineering Research Council of Canada	Public Works and Government Services Canada; Canada Research Chairs program(Canada Research Chairs); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was financially supported by a contract from Public Works and Government Services Canada and the financial support of research awards from the Canada Research Chairs program and the Natural Science and Engineering Research Council of Canada awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Algoe SB, 2011, AM PSYCHOL, V66, P35, DOI 10.1037/a0021720; [Anonymous], 1987, EUR J PERSONALITY, V1, P141, DOI DOI 10.1002/PER.2410010304; Bandura A., 1986, SOCIAL FDN THOUGHT A, DOI DOI 10.4135/9781446221129.N6; Benoit A, 2005, ENTERFACE 2005 SUMM; Bouchard S, J DEFENSE M IN PRESS; Bouchard S., 2011, J COMPUTER INFORM TE, V1, P20; Bouchard S, 2012, POSTTRAUMATIC STRESS, P271; Bouchard S, 2011, STUD COMPUT INTELL, V337, P109; Bouchard S, 2010, CYBERPSYCH BEH SOC N, V13, P83, DOI 10.1089/cyber.2009.0336; Casey GW, 2011, AM PSYCHOL, V66, P1, DOI 10.1037/a0021930; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cornum R, 2011, AM PSYCHOL, V66, P4, DOI 10.1037/a0021420; Davis SN, 2000, J CLIN ENDOCR METAB, V85, P224, DOI 10.1210/jc.85.1.224; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Dekker A, P DIGRA TOK JAP; Driskell JE, 2008, PERFORMANCE STRESS, P271; Ferguson K., 2009, GEN PRINCIPLES EMPIR, P532; Good GE, 2005, J CLIN PSYCHOL, V61, P699, DOI 10.1002/jclp.20104; Green G, 2010, SOC SCI MED, V71, P1480, DOI 10.1016/j.socscimed.2010.07.015; Grossman D., 2008, COMBAT PSYCHOL PHYSL; Guest L, 2011, PREDEPLOYEMENT TRAIN; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Homeland Security, 2004, SURV SCOR RES PROJ F; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Katertsidis NS, 2009, P 9 INT C INF TECHN; Kennedy RS., 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; Kirk Roger, 1982, EXPT DESIGN PROCEDUR, V2nd; Leal-Cerro A, 2003, J ENDOCRINOL INVEST, V26, P879, DOI 10.1007/BF03345239; Lester PB, 2011, AM PSYCHOL, V66, P77, DOI 10.1037/a0022083; Levant R. F., 1995, NEW PSYCHOL MEN; Masten AS, 2007, DEV PSYCHOPATHOL, V19, P921, DOI 10.1017/S0954579407000442; Mental Health Advisory Team (MHAT) 6, 2009, OP END FREED 2009 AF; Murphy P, 2008, J OCCUP HEALTH, V24, P541; Nakasone A, 2005, 5 INT WORKSH BIOS IN; O'Donohue W.T., 2009, GEN PRINCIPLES EMPIR; OCONNOR PJ, 1987, MED SCI SPORT EXER, V19, P224; Oman D, 2008, INT J PSYCHOL RELIG, V18, P79, DOI 10.1080/10508610701879316; Orvis KA, 2010, MIL PSYCHOL, V22, P143, DOI 10.1080/08995600903417225; Ravaj N, 2005, P DIGRA 2005 C CHANG, P1; Reivich KJ, 2011, AM PSYCHOL, V66, P25, DOI 10.1037/a0021897; Rimmele U, 2007, PSYCHONEUROENDOCRINO, V32, P627, DOI 10.1016/j.psyneuen.2007.04.005; Rosen LN, 2000, MIL MED, V165, P54, DOI 10.1093/milmed/165.1.54; Routhier C, 2007, PROGRAMME ENTR UNPUB; Routhier C, 2009, IND OP READ PERS PER; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Schwartz M. S., 2003, BIOFEEDBACK PRACTITI, V3rd; Shi Y., 2010, INT S QUAL LIFE TECH, P28; Stetz MC, 2007, AVIAT SPACE ENVIR MD, V78, pB252; Stuempfle KJ, 2010, WILD ENVIRON MED, V21, P22, DOI 10.1016/j.wem.2009.12.020; Taylor MK, 2011, MIL MED, V12, P1362; Thompson MM, 2006, PSYCHOL SERVING PEAC, P54; Timmerman IGH, 1998, BEHAV RES THER, V36, P863, DOI 10.1016/S0005-7967(98)00053-9; Wexler DB, 2009, MEN THERAPY NEW APPR; Wolpe J., 1990, PRACTICE BEHAV THERA; Yun C, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2195	57	62	64	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36169	10.1371/journal.pone.0036169	http://dx.doi.org/10.1371/journal.pone.0036169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558370	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000145
J	Fan, Q; Yan, X; Wang, JJ; Chen, Y; Wang, XM; Li, CB; Tan, L; You, C; Zhang, TH; Zuo, S; Xu, DR; Chen, KM; Finlayson-Burden, JM; Xiao, ZP				Fan, Qing; Yan, Xu; Wang, Jijun; Chen, Ying; Wang, Xuemei; Li, Chunbo; Tan, Ling; You, Chao; Zhang, Tianhong; Zuo, Sai; Xu, Dongrong; Chen, Kemin; Finlayson-Burden, Jodie Marie; Xiao, Zeping			Abnormalities of White Matter Microstructure in Unmedicated Obsessive-Compulsive Disorder and Changes after Medication	PLOS ONE			English	Article							DRUG-NAIVE PATIENTS; DIFFUSION-TENSOR; CORPUS-CALLOSUM; FRACTIONAL ANISOTROPY; CITALOPRAM TREATMENT; SEROTONIN; SCHIZOPHRENIA; AVAILABILITY; METAANALYSIS; ADOLESCENTS	Background: Abnormalities of myelin integrity have been reported in obsessive-compulsive disorder (OCD) using multi-parameter maps of diffusion tensor imaging (DTI). However, it was still unknown to what degree these abnormalities might be affected by pharmacological treatment. Objective: To investigate whether the abnormalities of white matter microstructure including myelin integrity exist in OCD and whether they are affected by medication. Methodology and Principal Findings: Parameter maps of DTI, including fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD) and mean diffusivity (MD), were acquired from 27 unmedicated OCD patients (including 13 drug-naive individuals) and 23 healthy controls. Voxel-based analysis was then performed to detect regions with significant group difference. We compared the DTI-derived parameters of 15 patients before and after 12-week Selective Serotonin Reuptake Inhibitor (SSRI) therapies. Significant differences of DTI-derived parameters were observed between OCD and healthy groups in multiple structures, mainly within the fronto-striato-thalamo-cortical loop. An increased RD in combination with no change in AD among OCD patients was found in the left medial superior frontal gyrus, temporo-parietal lobe, occipital lobe, striatum, insula and right midbrain. There was no statistical difference in DTI-derived parameters between drug-naive and previously medicated OCD patients. After being medicated, OCD patients showed a reduction in RD of the left striatum and right midbrain, and in MD of the right midbrain. Conclusion: Our preliminary findings suggest that abnormalities of white matter microstructure, particularly in terms of myelin integrity, are primari ly located within the fronto-striato-thalamo-cortical circuit of individuals with OCD. Some abnormalities may be partly reversed by SSRI treatment.	[Fan, Qing; Wang, Jijun; Wang, Xuemei; Li, Chunbo; Zhang, Tianhong; Zuo, Sai; Xiao, Zeping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Yan, Xu; Xu, Dongrong] E China Normal Univ, Shanghai Key Lab Brain Funct Gen, Shanghai Key Lab Magnet Resonance, Key Lab Brain Funct Gen,Minist Educ, Shanghai 200062, Peoples R China; [Chen, Ying; Chen, Kemin] Shanghai TCM Intergrated Hosp, Shanghai, Peoples R China; [Tan, Ling; You, Chao] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Radiol, Sch Med, Shanghai 200030, Peoples R China; [Finlayson-Burden, Jodie Marie] Univ Nottingham, Nottingham Inst Mental Hlth, Nottingham NG7 2RD, England	Shanghai Jiao Tong University; East China Normal University; Shanghai Jiao Tong University; University of Nottingham	Fan, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	dx2103@columbia.edu; xiaozeping@gmail.com	Wang, Xuemei/GXF-3702-2022		Joint Key Project of National High Technology Research and Development Program of China (863 Program) [2007AA02Z420]; Natural Science Foundation of Shanghai Jiao Tong University School of Medicine, China [09XJ21023]; Shanghai Municipal Health Bureau Foundation, China [2010Y028]; Shanghai Commission of Science and Technology [10440710200]; East China Normal University School Psychology and Cognitive Science	Joint Key Project of National High Technology Research and Development Program of China (863 Program); Natural Science Foundation of Shanghai Jiao Tong University School of Medicine, China; Shanghai Municipal Health Bureau Foundation, China; Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); East China Normal University School Psychology and Cognitive Science	The study was supported by the Joint Key Project of National High Technology Research and Development Program of China (863 Program) (No: 2007AA02Z420), Natural Science Foundation of Shanghai Jiao Tong University School of Medicine, China (No.09XJ21023), Shanghai Municipal Health Bureau Foundation, China (2010Y028), a grant from Shanghai Commission of Science and Technology (No. 10440710200), and two grants from the East China Normal University School Psychology and Cognitive Science. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Ashtari M, 2007, ARCH GEN PSYCHIAT, V64, P1270, DOI 10.1001/archpsyc.64.11.1270; Atmaca M, 2010, J AFFECT DISORDERS, V124, P309, DOI 10.1016/j.jad.2010.03.027; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BENKELFAT C, 1990, ARCH GEN PSYCHIAT, V47, P840; Bora E, 2011, J PSYCHIATR NEUROSCI, V36, P42, DOI 10.1503/jpn.100082; Cannistraro PA, 2007, DEPRESS ANXIETY, V24, P440, DOI 10.1002/da.20246; Fan Q, 2010, PSYCHIAT CLIN NEUROS, V64, P483, DOI 10.1111/j.1440-1819.2010.02128.x; Garibotto V, 2010, NEUROBIOL DIS, V37, P468, DOI 10.1016/j.nbd.2009.11.003; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Ha TH, 2009, NEUROREPORT, V20, P735, DOI 10.1097/WNR.0b013e32832ad3da; Hasan KM, 2006, RADIOLOGY, V239, P611, DOI 10.1148/radiol.2392051172; Hesse S, 2005, PSYCHIAT RES-NEUROIM, V140, P63, DOI 10.1016/j.pscychresns.2005.07.002; Hunsberger Joshua, 2009, Dialogues Clin Neurosci, V11, P333; Jang JH, 2006, AM J PSYCHIAT, V163, P1202, DOI 10.1176/appi.ajp.163.7.1202; Koprivova J, 2009, NEUROSCI LETT, V464, P62, DOI 10.1016/j.neulet.2009.08.012; Koran LM, 1996, AM J PSYCHIAT, V153, P783; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Kwon JS, 2009, EXPERT REV NEUROTHER, V9, P255, DOI 10.1586/14737175.9.2.255; Lazaro L, 2008, J PSYCHIATR RES, V42, P1051, DOI 10.1016/j.jpsychires.2007.12.007; Lazaro L, 2009, PSYCHIAT RES-NEUROIM, V172, P140, DOI 10.1016/j.pscychresns.2008.12.007; Lee JE, 2007, NEUROSCI LETT, V424, P127, DOI 10.1016/j.neulet.2007.07.042; Levitt JJ, 2010, PSYCHIAT RES-NEUROIM, V184, P143, DOI 10.1016/j.pscychresns.2010.08.004; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Matsumoto R, 2010, NEUROIMAGE, V49, P121, DOI 10.1016/j.neuroimage.2009.07.069; Menzies L, 2008, AM J PSYCHIAT, V165, P1308, DOI 10.1176/appi.ajp.2008.07101677; Michael AM, 2008, IEEE ENG MED BIO, P5494, DOI 10.1109/IEMBS.2008.4650458; Nabeyama M, 2008, PSYCHIAT RES-NEUROIM, V163, P236, DOI 10.1016/j.pscychresns.2007.11.001; Nakamae T, 2008, PROG NEURO-PSYCHOPH, V32, P1221, DOI 10.1016/j.pnpbp.2008.03.010; Nakamae T, 2011, J PSYCHIATR RES, V45, P687, DOI 10.1016/j.jpsychires.2010.09.016; Nakao T, 2009, J PSYCHIATR RES, V43, P784, DOI 10.1016/j.jpsychires.2008.10.013; Pujol J, 2004, ARCH GEN PSYCHIAT, V61, P720, DOI 10.1001/archpsyc.61.7.720; Reimold M, 2007, J NEURAL TRANSM, V114, P1603, DOI 10.1007/s00702-007-0785-6; Rosenberg DR, 1997, ARCH GEN PSYCHIAT, V54, P824; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Saito Y, 2008, RADIOLOGY, V246, P536, DOI 10.1148/radiol.2462061469; Saxena S, 2002, ARCH GEN PSYCHIAT, V59, P250, DOI 10.1001/archpsyc.59.3.250; Seal ML, 2008, SCHIZOPHR RES, V101, P106, DOI 10.1016/j.schres.2007.12.489; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stengler-Wenzke K, 2006, NEUROPSYCHOBIOLOGY, V53, P40, DOI 10.1159/000090702; Stengler-Wenzke K, 2004, EUR ARCH PSY CLIN N, V254, P252, DOI 10.1007/s00406-004-0489-y; Stewart SE, 2007, ARCH GEN PSYCHIAT, V64, P209, DOI 10.1001/archpsyc.64.2.209; Szeszko PR, 2005, ARCH GEN PSYCHIAT, V62, P782, DOI 10.1001/archpsyc.62.7.782; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; WEISSMAN MM, 1994, J CLIN PSYCHIAT, V55, P5; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001; Whitford TJ, 2010, BIOL PSYCHIAT, V68, P70, DOI 10.1016/j.biopsych.2010.03.025; Xiao JH, 2010, NEUROSIGNALS, V18, P186, DOI 10.1159/000323170; Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x; Zai G, 2004, AM J MED GENET B, V129B, P64, DOI 10.1002/ajmg.b.30077	53	62	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35889	10.1371/journal.pone.0035889	http://dx.doi.org/10.1371/journal.pone.0035889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558258	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000077
J	Lin, RH; Xie, ZY; Zhang, JF; Xu, HW; Su, H; Tan, XR; Tian, DP; Su, M				Lin, Runhua; Xie, Zeyu; Zhang, Jianfa; Xu, Hongwu; Su, Hang; Tan, Xuerui; Tian, Dongping; Su, Min			Clinical and Immunopathological Features of Moyamoya Disease	PLOS ONE			English	Article							EPIDEMIOLOGIC FEATURES; UNITED-STATES; AUTOPSY; S100A4; BRAIN; JAPAN; CELLS	Background: Moyamoya disease (MMD) is a cerebrovascular disease characterized by progressive stenosis or occlusion of the terminal portion of internal carotid arteries and the formation of a vascular network at the base of the brain. The pathogenesis of MMD is still unclear. Methodology/Principal Findings: We retrospectively analyzed clinical data for 65 consecutive patients with MMD in our institutions and evaluated the histopathological and immunohistochemical findings of intracranial vessels from 3 patients. The onset age distribution was found to have 1 peak at 40-49 year-old age group, no significant difference was observed in the female-to-male ratio (F/M=1.2). Intracranial hemorrhage was the predominant disease type (75%). Positive family history was observed in 4.6% of patients. Histopathological findings were a narrowed lumen due to intimal fibrous thickening without significant inflammatory cell infiltration, and the internal elastic lamina was markedly tortuous and stratified. All 3 autopsy cases showed vacuolar degeneration in the cerebrovascular smooth muscle cells. Immunohistochemical study showed the migration of smooth muscle cells in the thickened intima, and aberrant expression of IgG and S100A4 protein in vascular smooth muscle cells. The Complement C3 immunoreactivity was negative. Conclusion/Significance: This study indicated that aberrant expression of IgG and S100A4 protein in intracranial vascular wall of MMD patients, which suggested that immune-related factors may be involved in the functional and morphological changes of smooth muscle cells, and finally caused the thickened intima. A possible mechanism is that deposits of IgG in the damaged internal elastic lamina may underlie the disruption of internal elastic lamina, which facilitated S100A4 positive SMCs migrated into intima through broken portions of the internal elastic lamina, resulting in lumen stenosis or occlusion, leading to compensatory small vessels proliferation.	[Lin, Runhua; Su, Hang; Tian, Dongping; Su, Min] Shantou Univ, Coll Med, Inst Clin Pathol, Shantou, Guangdong, Peoples R China; [Lin, Runhua; Su, Hang; Tian, Dongping; Su, Min] Shantou Univ, Coll Med, Dept Pathol, Shantou, Guangdong, Peoples R China; [Xie, Zeyu; Xu, Hongwu] Shantou Univ, Coll Med, Affiliated Hosp 2, Shantou, Guangdong, Peoples R China; [Zhang, Jianfa; Tan, Xuerui] Shantou Univ, Coll Med, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China; [Tian, Dongping; Su, Min] Shantou Univ, Coll Med, Judicial Crit Ctr, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University	Lin, RH (corresponding author), Shantou Univ, Coll Med, Inst Clin Pathol, Shantou, Guangdong, Peoples R China.	dp_tian@163.com; minsu@stu.edu.cn			National Natural Science Foundation of China [31171226]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant from National Natural Science Foundation of China (31171226, www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Battistella PA, 1997, CLIN NEUROL NEUROSUR, V99, pS54, DOI 10.1016/S0303-8467(97)00041-3; Borota L, 1997, CLIN NEUROL NEUROSUR, V99, pS49, DOI 10.1016/S0303-8467(97)00040-1; Brisset AC, 2007, CIRC RES, V100, P1055, DOI 10.1161/01.RES.0000262654.84810.6c; Burke GM, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.1.FOCUS08310; Chen D, 2012, WORLD J GASTROENTERO, V18, P915, DOI 10.3748/wjg.v18.i9.915; Chiu D, 1998, STROKE, V29, P1347, DOI 10.1161/01.STR.29.7.1347; Duan L, 2012, STROKE, V43, P56, DOI 10.1161/STROKEAHA.111.621300; Graham JF, 1997, CLIN NEUROL NEUROSUR, V99, pS31, DOI 10.1016/S0303-8467(97)00037-1; Grigorian M, 2008, CURR MOL MED, V8, P492, DOI 10.2174/156652408785747942; Han DH, 2000, ACTA NEUROCHIR, V142, P1263, DOI 10.1007/s007010070024; He YT, 2010, AM J FOREN MED PATH, V31, P77, DOI 10.1097/PAF.0b013e3181c215e2; Hosoda Y, 1997, CLIN NEUROL NEUROSUR, V99, pS203, DOI 10.1016/s0303-8467(97)00044-9; Kraemer M, 2008, STROKE, V39, P3193, DOI 10.1161/STROKEAHA.107.513408; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; Kuroda S, 2005, STROKE, V36, P2148, DOI 10.1161/01.STR.0000182256.32489.99; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Miao W, 2010, CLIN NEUROL NEUROSUR, V112, P199, DOI 10.1016/j.clineuro.2009.11.009; Mishra S.K., 2011, CANC METASTASIS REV; Numaguchi Y, 1997, CLIN NEUROL NEUROSUR, V99, pS26, DOI 10.1016/S0303-8467(97)00060-7; OKA K, 1981, VIRCHOWS ARCH A, V392, P247, DOI 10.1007/BF02155663; Reid AJ, 2010, J NEUROSURG-PEDIATR, V6, P244, DOI 10.3171/2010.5.PEDS09505; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Takekawa Y, 2004, NEUROPATHOLOGY, V24, P236, DOI 10.1111/j.1440-1789.2004.00550.x; Takeuchi K., 1957, BRAIN NERVE, V9, P37; Wakai K, 1997, CLIN NEUROL NEUROSUR, V99, pS1, DOI 10.1016/S0303-8467(97)00031-0; YAMASHITA M, 1983, STROKE, V14, P50, DOI 10.1161/01.STR.14.1.50	27	40	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36386	10.1371/journal.pone.0036386	http://dx.doi.org/10.1371/journal.pone.0036386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558457	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000202
J	Liu, MQ; Zhou, DJ; Wang, X; Zhou, W; Ye, L; Li, JL; Wang, YZ; Ho, WZ				Liu, Man-Qing; Zhou, Dun-Jin; Wang, Xu; Zhou, Wang; Ye, Li; Li, Jie-Liang; Wang, Yi-Zhong; Ho, Wen-Zhe			IFN-lambda 3 Inhibits HIV Infection of Macrophages through the JAK-STAT Pathway	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INTERFERON-LAMBDA; GENETIC-VARIATION; IFN-LAMBDA; INDUCTION; IL28B; ACTIVATION; ALPHA; RECOGNITION; RECRUITMENT	Background: Interferon lambda 3 (IFN-lambda 3) is a newly identified cytokine with antiviral activity, and its single nucleotide polymorphisms are strongly associated with the treatment effectiveness and development of chronic hepatitis C virus infection. We thus examined the potential of IFN-lambda 3 to inhibit HIV replication and the possible mechanisms of the anti-HIV action by IFN-lambda 3 in human macrophages. Principal Findings: Under different conditions (before, during, and after HIV infection), IFN-lambda 3 significantly inhibited viral replication in macrophages, which was associated with the induction of multiple antiviral cellular factors (ISG56, MxA, OAS1, A3G/F and tetherin) and IFN regulatory factors (IRF-1, 3, 5, 7 and 9). This anti-HIV action of IFN-lambda 3 could be compromised by the JAK-STAT inhibitor. In addition, IFN-lambda 3 treatment of macrophages induced the expression of toll-like receptor 3 (TLR3) and two key adaptors (MyD88 and TRIF) in type I IFN pathway activation. However, HIV infection compromised IFN-lambda 3-mediated induction of the key elements in JAK-STAT signaling pathway. Conclusions: These data indicate that IFN-lambda 3 exerts its anti-HIV function by activating JAK-STAT pathway-mediated innate immunity in macrophages. Future in vivo studies are necessary in order to explore the potential for developing IFN-lambda 3-based therapy for HIV disease.	[Liu, Man-Qing; Zhou, Dun-Jin; Zhou, Wang] Wuhan Ctr Dis Prevent & Control, Div Virol, Wuhan, Hubei, Peoples R China; [Wang, Xu; Ho, Wen-Zhe] Wuhan Univ, State Key Lab Virol, Ctr Anim Expt Anim, Wuhan 430072, Hubei, Peoples R China; [Wang, Xu; Ho, Wen-Zhe] Wuhan Univ, State Key Lab Virol, Biosafety Level Lab 3, Wuhan 430072, Hubei, Peoples R China; [Wang, Xu; Ye, Li; Li, Jie-Liang; Wang, Yi-Zhong; Ho, Wen-Zhe] Temple Univ, Sch Med, Dept Med Pathol, Philadelphia, PA 19122 USA; [Wang, Xu; Ye, Li; Li, Jie-Liang; Wang, Yi-Zhong; Ho, Wen-Zhe] Temple Univ, Sch Med, Lab Med, Philadelphia, PA 19122 USA	Wuhan University; Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Liu, MQ (corresponding author), Wuhan Ctr Dis Prevent & Control, Div Virol, Wuhan, Hubei, Peoples R China.	wenzheho@temple.edu	Liu, Man-Qing/M-9598-2014	Liu, Man-Qing/0000-0002-9754-3102	National Institutes of Health/National Institute on Drug Abuse [DA12815, DA22177, DA27550]; National Natural Sciences Foundation of China [81001303]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027550, R01DA012815, R01DA022177] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health/National Institute on Drug Abuse (No: DA12815, DA22177, and DA27550) and the National Natural Sciences Foundation of China (No: 81001303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; Au WC, 2001, J BIOL CHEM, V276, P41629, DOI 10.1074/jbc.M105121200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; HO WZ, 1992, J VIROL, V66, P573, DOI 10.1128/JVI.66.1.573-579.1992; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Iversen MB, 2010, J VIROL, V84, P4579, DOI 10.1128/JVI.02591-09; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Megjugorac NJ, 2010, BLOOD, V115, P4185, DOI 10.1182/blood-2009-09-246157; Miller DM, 2009, ANN NY ACAD SCI, V1182, P80, DOI 10.1111/j.1749-6632.2009.05241.x; Pagliaccetti NE, 2010, VIRUSES-BASEL, V2, P1589, DOI 10.3390/v2081589; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019; Zhou Y, 2010, IMMUNOLOGY, V131, P40, DOI 10.1111/j.1365-2567.2010.03270.x	28	60	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35902	10.1371/journal.pone.0035902	http://dx.doi.org/10.1371/journal.pone.0035902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558263	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000079
J	Marzi, A; Yoshida, R; Miyamoto, H; Ishijima, M; Suzuki, Y; Higuchi, M; Matsuyama, Y; Igarashi, M; Nakayama, E; Kuroda, M; Saijo, M; Feldmann, F; Brining, D; Feldmann, H; Takada, A				Marzi, Andrea; Yoshida, Reiko; Miyamoto, Hiroko; Ishijima, Mari; Suzuki, Yasuhiko; Higuchi, Megumi; Matsuyama, Yukie; Igarashi, Manabu; Nakayama, Eri; Kuroda, Makoto; Saijo, Masayuki; Feldmann, Friederike; Brining, Douglas; Feldmann, Heinz; Takada, Ayato			Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever	PLOS ONE			English	Article							DEPENDENT ENHANCEMENT; VIRUS GLYCOPROTEIN; INFECTION; EPITOPES; IDENTIFICATION; TROPISM; RNA; GP	Ebola virus (EBOV) is the causative agent of severe hemorrhagic fever in primates, with human case fatality rates up to 90%. Today, there is neither a licensed vaccine nor a treatment available for Ebola hemorrhagic fever (EHF). Single monoclonal antibodies (MAbs) specific for Zaire ebolavirus (ZEBOV) have been successfully used in passive immunization experiments in rodent models, but have failed to protect nonhuman primates from lethal disease. In this study, we used two clones of human-mouse chimeric MAbs (ch133 and ch226) with strong neutralizing activity against ZEBOV and evaluated their protective potential in a rhesus macaque model of EHF. Reduced viral loads and partial protection were observed in animals given MAbs ch133 and ch226 combined intravenously at 24 hours before and 24 and 72 hours after challenge. MAbs circulated in the blood of a surviving animal until virus-induced IgG responses were detected. In contrast, serum MAb concentrations decreased to undetectable levels at terminal stages of disease in animals that succumbed to infection, indicating substantial consumption of these antibodies due to virus replication. Accordingly, the rapid decrease of serum MAbs was clearly associated with increased viremia in non-survivors. Our results indicate that EBOV neutralizing antibodies, particularly in combination with other therapeutic strategies, might be beneficial in reducing viral loads and prolonging disease progression during EHF.	[Marzi, Andrea; Feldmann, Heinz] NIAID, Virol Lab, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA; [Yoshida, Reiko; Miyamoto, Hiroko; Ishijima, Mari; Suzuki, Yasuhiko; Higuchi, Megumi; Matsuyama, Yukie; Nakayama, Eri; Kuroda, Makoto; Takada, Ayato] Hokkaido Univ, Div Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Igarashi, Manabu] Hokkaido Univ, Res Ctr Zoonosis Control, Div Bioinformat, Sapporo, Hokkaido, Japan; [Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Feldmann, Friederike] NIAID, Off Operat Management, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA; [Brining, Douglas] NIAID, Rocky Mt Vet Branch, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hokkaido University; Hokkaido University; National Institute of Infectious Diseases (NIID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Marzi, A (corresponding author), NIAID, Virol Lab, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA.	atakada@czc.hokudai.ac.jp	Igarashi, Manabu/F-6871-2012; Takada, Ayato/A-6679-2012; YOSHIDA, Reiko/F-6883-2012; Suzuki, Yasuhiko/F-6890-2012; Saijo, Masayuki/L-2697-2019; Marzi, Andrea/AAF-4617-2020	Marzi, Andrea/0000-0003-0186-9587; Saijo, Masayuki/0000-0001-5458-7298	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency Basic Research Programs; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIGAI001048, ZIAAI001089] Funding Source: NIH RePORTER	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency Basic Research Programs; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and the Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a Grant-in-Aid for JSPS Fellows Japan. The work was further supported by Japan Science and Technology Agency Basic Research Programs. Funding was also provided by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471; Brining DL, 2010, COMPARATIVE MED, V60, P389; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219; Ebihara H, 2000, J VIROL, V74, P9245, DOI 10.1128/JVI.74.19.9245-9255.2000; Feldmann H, 2007, FIELDS VIROLOGY, P1409; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert Thomas W., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008300; Ito H, 2001, J VIROL, V75, P1576, DOI 10.1128/JVI.75.3.1576-1580.2001; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Matsuno K, 2007, FUTURE VIROL, V2, P607, DOI 10.2217/17460794.2.6.607; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Nakayama E, 2011, J INFECT DIS, V204, pS978, DOI 10.1093/infdis/jir334; Nakayama E, 2010, CLIN VACCINE IMMUNOL, V17, P1723, DOI 10.1128/CVI.00170-10; Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saijo M, 2001, J CLIN MICROBIOL, V39, P1, DOI 10.1128/JCM.39.1.1-7.2001; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Shedlock DJ, 2010, VIROLOGY, V401, P228, DOI 10.1016/j.virol.2010.02.029; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405; Takada A, 2003, J VIROL, V77, P7539, DOI 10.1128/JVI.77.13.7539-7544.2003; Takada A, 2003, J VIROL, V77, P1069, DOI 10.1128/JVI.77.2.1069-1074.2003; Takada A, 2001, TRENDS MICROBIOL, V9, P506, DOI 10.1016/S0966-842X(01)02201-6; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takada A, 2007, J INFECT DIS, V196, pS347, DOI 10.1086/520581; Takada A, 2007, VACCINE, V25, P993, DOI 10.1016/j.vaccine.2006.09.076; Takada A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00034; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Zhang M, 2010, BIOTECHNOL BIOENG, V105, P1094, DOI 10.1002/bit.22633	36	102	114	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36192	10.1371/journal.pone.0036192	http://dx.doi.org/10.1371/journal.pone.0036192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558378	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000150
J	Meijerink, M; Ferrando, ML; Lammers, G; Taverne, N; Smith, HE; Wells, JM				Meijerink, Marjolein; Ferrando, Maria Laura; Lammers, Geraldine; Taverne, Nico; Smith, Hilde E.; Wells, Jerry M.			Immunomodulatory Effects of Streptococcus suis Capsule Type on Human Dendritic Cell Responses, Phagocytosis and Intracellular Survival	PLOS ONE			English	Article							GENETIC DIVERSITY; DC-SIGN; VIRULENCE; SEROTYPE-2; STRAINS; PIGS; POLYSACCHARIDE; RECOGNITION; PREVALENCE; MECHANISM	Streptococcus suis is a major porcine pathogen of significant commercial importance worldwide and an emerging zoonotic pathogen of humans. Given the important sentinel role of mucosal dendritic cells and their importance in induction of T cell responses we investigated the effect of different S. suis serotype strains and an isogenic capsule mutant of serotype 2 on the maturation, activation and expression of IL-10, IL-12p70 and TNF-alpha in human monocyte-derived dendritic cells. Additionally, we compared phagocytosis levels and bacterial survival after internalization. The capsule of serotype 2, the most common serotype associated with infection in humans and pigs, was highly anti-phagocytic and modulated the IL-10/IL-12 and IL-10/TNF-alpha cytokine production in favor of a more anti-inflammatory profile compared to other serotypes. This may have consequences for the induction of effective immunity to S. suis serotype 2 in humans. A shielding effect of the capsule on innate Toll-like receptor signaling was also demonstrated. Furthermore, we showed that 24 h after phagocytosis, significant numbers of viable intracellular S. suis were still present intracellularly. This may contribute to the dissemination of S. suis in the body.	[Meijerink, Marjolein; Ferrando, Maria Laura; Lammers, Geraldine; Taverne, Nico; Wells, Jerry M.] Wageningen Univ, Wageningen, Netherlands; [Smith, Hilde E.] Wageningen Univ, Anim Sci Grp, Lelystad, Netherlands	Wageningen University & Research; Animal Sciences Group of Wageningen UR; Wageningen University & Research	Meijerink, M (corresponding author), Wageningen Univ, Wageningen, Netherlands.	jerry.wells@wur.nl	Ferrando, Maria Laura/M-3026-2018; Meijerink, Marjolein/B-9258-2014	Ferrando, Maria Laura/0000-0002-1398-8244; Meijerink, Marjolein/0000-0003-3994-9785				Amass S. F., 1996, Swine Health and Production, V4, P196; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Celli J, 2002, TRENDS MICROBIOL, V10, P232, DOI 10.1016/S0966-842X(02)02343-0; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; Galina L, 1996, CAN J VET RES, V60, P72; Geijtenbeek TBH, 2009, FUTURE MICROBIOL, V4, P879, DOI 10.2217/FMB.09.51; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Higgins R, 1996, CAN VET J, V37, P242; Inaba K, 1997, IMMUNOL CELL BIOL, V75, P206, DOI 10.1038/icb.1997.31; Ip M, 2007, DIAGN MICR INFEC DIS, V57, P15, DOI 10.1016/j.diagmicrobio.2006.05.011; JACOBS AAC, 1995, VET REC, V137, P295, DOI 10.1136/vr.137.12.295; Jim K, 2004, GENOME RES, V14, P109; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerdsin A, 2011, LANCET, V378, P960, DOI 10.1016/S0140-6736(11)60923-9; King SJ, 2001, INFECT IMMUN, V69, P7572, DOI 10.1128/IAI.69.12.7572-7582.2001; Kopic J, 2002, SCAND J INFECT DIS, V34, P683, DOI 10.1080/00365540210147769; Lecours MP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-72; LEVIN D, 1993, J IMMUNOL, V151, P6742; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; Meijerink M, 2010, BENEF MICROBES, V1, P317, DOI 10.3920/BM2010.0029; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; ROBERTSON ID, 1989, VET REC, V124, P391, DOI 10.1136/vr.124.15.391; Schreur PJW, 2010, VET MICROBIOL, V143, P363, DOI 10.1016/j.vetmic.2009.12.010; Sing A, 2005, P NATL ACAD SCI USA, V102, P16049, DOI 10.1073/pnas.0504728102; Smith HE, 1999, J CLIN MICROBIOL, V37, P3146, DOI 10.1128/JCM.37.10.3146-3152.1999; Smith HE, 1999, INFECT IMMUN, V67, P1750; Smith HE, 1999, FEMS MICROBIOL LETT, V178, P265, DOI 10.1111/j.1574-6968.1999.tb08686.x; Smith HE, 1997, J CLIN MICROBIOL, V35, P1049, DOI 10.1128/JCM.35.5.1049-1053.1997; Smith HE, 1997, ADV EXP MED BIOL, V418, P651; Sriskandan S, 2006, PLOS MED, V3, P595, DOI 10.1371/journal.pmed.0030187; STOCKHOFEZURWIE.N, 1996, 14 IPVS 1996 1996 BO, P299; Tizard, 2004, VET IMMUNOLOGY INTRO; Van Calsteren MR, 2010, BIOCHEM CELL BIOL, V88, P513, DOI [10.1139/O09-170, 10.1139/o09-170]; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; VECHT U, 1992, INFECT IMMUN, V60, P550, DOI 10.1128/IAI.60.2.550-556.1992; Wang KC, 2011, FEMS MICROBIOL LETT, V324, P117, DOI 10.1111/j.1574-6968.2011.02394.x; Watkins EJ, 2001, LANCET, V357, P38, DOI 10.1016/S0140-6736(00)03570-4; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; WIBAWAN IWT, 1991, J GEN MICROBIOL, V137, P2721, DOI 10.1099/00221287-137-12-2721; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	50	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35849	10.1371/journal.pone.0035849	http://dx.doi.org/10.1371/journal.pone.0035849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558240	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000066
J	Petkova, VI; Zetterberg, H; Ehrsson, HH				Petkova, Valeria I.; Zetterberg, Hedvig; Ehrsson, H. Henrik			Rubber Hands Feel Touch, but Not in Blind Individuals	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; TACTILE PERCEPTION; VISUAL-CORTEX; MULTISENSORY REPRESENTATION; NEURONAL REPRESENTATION; PERIPERSONAL SPACE; REFERENCE FRAME; NEURAL BASIS; BODY; ILLUSION	Psychology and neuroscience have a long-standing tradition of studying blind individuals to investigate how visual experience shapes perception of the external world. Here, we study how blind people experience their own body by exposing them to a multisensory body illusion: the somatic rubber hand illusion. In this illusion, healthy blindfolded participants experience that they are touching their own right hand with their left index finger, when in fact they are touching a rubber hand with their left index finger while the experimenter touches their right hand in a synchronized manner (Ehrsson et al. 2005). We compared the strength of this illusion in a group of blind individuals (n = 10), all of whom had experienced severe visual impairment or complete blindness from birth, and a group of age-matched blindfolded sighted participants (n = 12). The illusion was quantified subjectively using questionnaires and behaviorally by asking participants to point to the felt location of the right hand. The results showed that the sighted participants experienced a strong illusion, whereas the blind participants experienced no illusion at all, a difference that was evident in both tests employed. A further experiment testing the participants' basic ability to localize the right hand in space without vision (proprioception) revealed no difference between the two groups. Taken together, these results suggest that blind individuals with impaired visual development have a more veridical percept of self-touch and a less flexible and dynamic representation of their own body in space compared to sighted individuals. We speculate that the multisensory brain systems that re-map somatosensory signals onto external reference frames are less developed in blind individuals and therefore do not allow efficient fusion of tactile and proprioceptive signals from the two upper limbs into a single illusory experience of self-touch as in sighted individuals.	[Petkova, Valeria I.; Zetterberg, Hedvig; Ehrsson, H. Henrik] Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden	Karolinska Institutet	Petkova, VI (corresponding author), Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden.	henrik.ehrsson@ki.se			European Research Council; Swedish Foundation for Strategic Research; Soderbergska Stiftelsen; James S. McDonnell Foundation; Human Frontier Science Program; graduate school of the Stockholm Brain Institute	European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Soderbergska Stiftelsen; James S. McDonnell Foundation; Human Frontier Science Program(Human Frontier Science Program); graduate school of the Stockholm Brain Institute	This study was funded by the European Research Council, the Swedish Foundation for Strategic Research, Soderbergska Stiftelsen, James S. McDonnell Foundation, and the Human Frontier Science Program. VIP is supported by the graduate school of the Stockholm Brain Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; Brozzoli C, 2010, NEUROPSYCHOLOGIA, V48, P796, DOI 10.1016/j.neuropsychologia.2009.10.009; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Carriere BN, 2007, J NEUROPHYSIOL, V98, P2858, DOI 10.1152/jn.00587.2007; Cattaneo Z, 2008, NEUROSCI BIOBEHAV R, V32, P1346, DOI 10.1016/j.neubiorev.2008.05.002; Chen AH, 2011, J NEUROSCI, V31, P12036, DOI 10.1523/JNEUROSCI.0395-11.2011; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2005, PLOS BIOL, V3, P2200, DOI 10.1371/journal.pbio.0030412; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fiehler K, 2009, NEUROPSYCHOLOGIA, V47, P897, DOI 10.1016/j.neuropsychologia.2008.12.023; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Goldreich D, 2003, J NEUROSCI, V23, P3439; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P2621, DOI 10.1016/j.neuropsychologia.2005.09.011; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Hagura N, 2009, CEREB CORTEX, V19, P176, DOI 10.1093/cercor/bhn068; Held R, 2011, NAT NEUROSCI, V14, P551, DOI 10.1038/nn.2795; Heller M., 1991, PSYCHOL TOUCH, P239; Hotting K, 2009, HEARING RES, V258, P165, DOI 10.1016/j.heares.2009.07.012; KELLOGG WN, 1962, SCIENCE, V137, P399, DOI 10.1126/science.137.3528.399; Kupers R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00019; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; Ladavas E., 2006, HUMAN BODY PERCEPTIO, P89; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Locke J., 2011, ESSAY HUMAN UNDERSTA; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; Naito E, 2001, NEUROREPORT, V12, P3805, DOI 10.1097/00001756-200112040-00041; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Rauschecker JP, 2004, HDB MULTISENSORY PRO, P695; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roder B., 2004, HDB MULTISENSORY PRO, P719; Roder B, 2007, P NATL ACAD SCI USA, V104, P4753, DOI 10.1073/pnas.0607158104; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Roll JP, 2009, J NEUROPHYSIOL, V101, P816, DOI 10.1152/jn.91075.2008; Sathian K, 2002, BEHAV BRAIN RES, V135, P127, DOI 10.1016/S0166-4328(02)00141-9; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Sathian K, 2010, RESTOR NEUROL NEUROS, V28, P271, DOI 10.3233/RNN-2010-0534; Schicke T, 2006, P NATL ACAD SCI USA, V103, P11808, DOI 10.1073/pnas.0601486103; Schutz-Bosbach S, 2009, BRAIN COGNITION, V70, P136, DOI 10.1016/j.bandc.2009.01.006; Serino A, 2007, PSYCHOL SCI, V18, P642, DOI 10.1111/j.1467-9280.2007.01952.x; Serino A, 2011, J COGNITIVE NEUROSCI, V23, P2956, DOI 10.1162/jocn_a_00006; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006185; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; STRELOW ER, 1985, PSYCHOL REV, V92, P226, DOI 10.1037/0033-295X.92.2.226; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; Van Boven RW, 2000, NEUROLOGY, V54, P2230; Von Senden M., 1960, SPACE SIGHT; Wallace MT, 1997, J NEUROSCI, V17, P2429; Wallace MT, 2004, J NEUROSCI, V24, P9580, DOI 10.1523/JNEUROSCI.2535-04.2004; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P3009, DOI 10.1113/jphysiol.2011.204941; WELCH RB, 1986, HDB PERCEPTION HUMAN; White RC, 2011, CONSCIOUS COGN, V20, P956, DOI 10.1016/j.concog.2011.03.021; White RC, 2010, CONSCIOUS COGN, V19, P505, DOI 10.1016/j.concog.2009.08.003; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wong M, 2011, J NEUROSCI, V31, P7028, DOI 10.1523/JNEUROSCI.6461-10.2011; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	90	37	38	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35912	10.1371/journal.pone.0035912	http://dx.doi.org/10.1371/journal.pone.0035912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558268	Green Published, gold			2022-12-25	WOS:000305336000083
J	Sardi, ML; Rozzi, FVR				Sardi, Marina L.; Rozzi, Fernando V. Ramirez			Different Cranial Ontogeny in Europeans and Southern Africans	PLOS ONE			English	Article							HETEROCHRONY; GROWTH; APPORTIONMENT; EVOLUTION; SHAPE	Modern human populations differ in developmental processes and in several phenotypic traits. However, the link between ontogenetic variation and human diversification has not been frequently addressed. Here, we analysed craniofacial ontogenies by means of geometric-morphometrics of Europeans and Southern Africans, according to dental and chronological ages. Results suggest that different adult cranial morphologies between Southern Africans and Europeans arise by a combination of processes that involve traits modified during the prenatal life and others that diverge during early postnatal ontogeny. Main craniofacial changes indicate that Europeans differ from Southern Africans by increasing facial developmental rates and extending the attainment of adult size and shape. Since other studies have suggested that native subsaharan populations attain adulthood earlier than Europeans, it is probable that facial ontogeny is linked with other developmental mechanisms that control the timing of maturation in other variables. Southern Africans appear as retaining young features in adulthood. Facial ontogeny in Europeans produces taller and narrower noses, which seems as an adaptation to colder environments. The lack of these morphological traits in Neanderthals, who lived in cold environments, seems a paradox, but it is probably the consequence of a warm-adapted faces together with precocious maturation. When modern Homo sapiens migrated into Asia and Europe, colder environments might establish pressures that constrained facial growth and development in order to depart from the warm-adapted morphology. Our results provide some answers about how cranial growth and development occur in two human populations and when developmental shifts take place providing a better adaptation to environmental constraints.	[Sardi, Marina L.] Univ Nacl La Plata, CONICET, Fac Ciencias Nat & Museo, Div Antropol, La Plata, Buenos Aires, Argentina; [Rozzi, Fernando V. Ramirez] CNRS, UPR 2147, Paris, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Sardi, ML (corresponding author), Univ Nacl La Plata, CONICET, Fac Ciencias Nat & Museo, Div Antropol, La Plata, Buenos Aires, Argentina.	msardi@fcnym.unlp.edu.ar		Sardi, Marina L./0000-0003-3614-8341	Agencia Nacional de Promocion Cientifica y Tecnica, Argentina [PICT 1822]; Universidad Nacional de La Plata, Argentina [PI N531]	Agencia Nacional de Promocion Cientifica y Tecnica, Argentina(ANPCyT); Universidad Nacional de La Plata, Argentina(National University of La Plata)	Financial support was provided by: PICT 1822 Agencia Nacional de Promocion Cientifica y Tecnica, Argentina [http://www.agencia.gov.ar/] and PI N531 Universidad Nacional de La Plata, Argentina [www.unlp.edu.ar]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba DM, 2002, HUMAN EVOLUTION THROUGH DEVELOPMENTAL CHANGE, P28; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Arthur W, 2002, NATURE, V415, P757, DOI 10.1038/415757a; Cobb SN, 2007, J HUM EVOL, V53, P176, DOI 10.1016/j.jhevol.2007.03.006; Cobb SN, 2004, J EXP ZOOL PART B, V302B, P302, DOI 10.1002/jez.b.21005; Dayal MR, 2009, AM J PHYS ANTHROPOL, V140, P324, DOI 10.1002/ajpa.21072; de Leon MSP, 2001, NATURE, V412, P534, DOI 10.1038/35087573; Enlow DH, 1996, CRECIMIENTO FACIAL; EVELETH PB, 1986, HUMAN GROWTH, V3, P221; FRANCISCUS RG, 1991, AM J PHYS ANTHROPOL, V85, P419, DOI 10.1002/ajpa.1330850406; Frelat MA, 2011, AM J HUM BIOL, V23, P796, DOI 10.1002/ajhb.21217; Gerber S, 2007, EVOL DEV, V9, P472, DOI 10.1111/j.1525-142X.2007.00185.x; GODFREY LR, 1995, J HUM EVOL, V29, P405, DOI 10.1006/jhev.1995.1066; Gould S. J., 1977, ONTOGENY PHYLOGENY; Hanihara T, 2000, AM J PHYS ANTHROPOL, V111, P105, DOI 10.1002/(SICI)1096-8644(200001)111:1<105::AID-AJPA7>3.0.CO;2-O; Hennessy RJ, 2002, AM J PHYS ANTHROPOL, V117, P37, DOI 10.1002/ajpa.10005; Holton NE, 2008, J HUM EVOL, V55, P942, DOI 10.1016/j.jhevol.2008.07.001; Howells WW, 1989, SKULL SHAPES MAP; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Krovitz G.E., 2003, PATTERNS GROWTH DEV, P320; Lahr M. M, 1996, EVOLUTION MODERN HUM; Lieberman DE, 2007, J HUM EVOL, V52, P647, DOI 10.1016/j.jhevol.2006.12.005; Lieberman DE, 2004, J EXP ZOOL PART B, V302B, P284, DOI 10.1002/jez.b.21004; Liversidge H, 2008, TECHNIQUE APPL DENT, P234; McKinney ML, 1991, HETEROCHORONY EVOLUT; Mitteroecker P, 2004, ANN ANAT, V186, P463, DOI 10.1016/S0940-9602(04)80085-2; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; MOSS ML, 1960, AM J PHYS ANTHROPOL, V18, P281, DOI 10.1002/ajpa.1330180406; Noback ML, 2011, AM J PHYS ANTHROPOL, V145, P599, DOI 10.1002/ajpa.21523; Olze A, 2007, INT J LEGAL MED, V121, P445, DOI 10.1007/s00414-007-0171-9; PASQUET P, 1996, CAHIERS ANTHR BIOM H, V14, P223; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rae TC, 2006, P R SOC B, V273, P2606; Rae TC, 2011, J HUM EVOL, V60, P234, DOI 10.1016/j.jhevol.2010.10.003; Raff R.A., 1996, SHAPE LIFE; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Relethford JH, 2004, AM J HUM BIOL, V16, P379, DOI 10.1002/ajhb.20045; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; Rozzi FVR, 2005, J HUM EVOL, V49, P515, DOI 10.1016/j.jhevol.2005.06.002; Rozzi FVR, 2004, NATURE, V428, P936, DOI 10.1038/nature02428; Sgouros S, 1999, J NEUROSURG, V91, P610, DOI 10.3171/jns.1999.91.4.0610; Smith KK, 1996, AM ZOOL, V36, P70; Sperber G.H., 2001, CRANIOFACIAL DEV; Vioarsdottir US, 2002, J ANAT, V201, P211; Zollikofer CPE, 2010, SEMIN CELL DEV BIOL, V21, P441, DOI 10.1016/j.semcdb.2009.10.012	48	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35917	10.1371/journal.pone.0035917	http://dx.doi.org/10.1371/journal.pone.0035917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558270	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000084
J	Ambarus, CA; Santegoets, KCM; van Bon, L; Wenink, MH; Tak, PP; Radstake, TRDJ; Baeten, DLP				Ambarus, Carmen A.; Santegoets, Kim C. M.; van Bon, Lenny; Wenink, Mark H.; Tak, Paul P.; Radstake, Timothy R. D. J.; Baeten, Dominique L. P.			Soluble Immune Complexes Shift the TLR-Induced Cytokine Production of Distinct Polarized Human Macrophage Subsets towards IL-10	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FC-GAMMA-RECEPTORS; COLONY-STIMULATING FACTOR; BLOOD MONONUCLEAR-CELLS; FACTOR-ALPHA PRODUCTION; RHEUMATOID-ARTHRITIS; HUMAN MONOCYTES; CROSS-LINKING; ALTERNATIVE ACTIVATION; CITRULLINATED PROTEINS	Background: Costimulation of murine macrophages with immune complexes (ICs) and TLR ligands leads to alternative activation. Studies on human myeloid cells, however, indicate that ICs induce an increased pro-inflammatory cytokine production. This study aimed to clarify the effect of ICs on the pro-versus anti-inflammatory profile of human polarized macrophages. Materials and Methods: Monocytes isolated from peripheral blood of healthy donors were polarized for four days with IFN-gamma, IL-4, IL-10, GM-CSF, M-CSF, or LPS, in the presence or absence of heat aggregated gamma-globulins (HAGGs). Phenotypic polarization markers were measured by flow cytometry. Polarized macrophages were stimulated with HAGGs or immobilized IgG alone or in combination with TLR ligands. TNF, IL-6, IL-10, IL-12, and IL-23 were measured by Luminex and/or RT-qPCR. Results: HAGGs did not modulate the phenotypic polarization and the cytokine production of macrophages. However, HAGGs significantly altered the TLR-induced cytokine production of all polarized macrophage subsets, with the exception of M Phi(IL-4). In particular, HAGGs consistently enhanced the TLR-induced IL-10 production in both classically and alternatively polarized macrophages (M1 and M2). The effect of HAGGs on TNF and IL-6 production was less pronounced and depended on the polarization status, while IL-23p19 and IL-12p35 expression was not affected. In contrast with HAGGs, immobilized IgG induced a strong upregulation of not only IL-10, but also TNF and IL-6. Conclusion: HAGGs alone do not alter the phenotype and cytokine production of in vitro polarized human macrophages. In combination with TLR-ligands, however, HAGGs but not immobilized IgG shift the cytokine production of distinct macrophage subsets toward IL-10.	[Ambarus, Carmen A.; Tak, Paul P.; Baeten, Dominique L. P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Santegoets, Kim C. M.; van Bon, Lenny; Wenink, Mark H.; Radstake, Timothy R. D. J.] Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Ambarus, CA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.a.ambarus@amc.nl	Santegoets, Kim/S-4267-2017		The Netherlands Organization for Scientific Research (NWO); Dutch Arthritis Foundation	The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Arthritis Foundation	This research is supported by a VIDI grant from The Netherlands Organization for Scientific Research (NWO) and by a grant from the Dutch Arthritis Foundation (Reumafonds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2000, ARTHRITIS RHEUM-US, V43, P608, DOI 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Anderson CF, 2002, J IMMUNOL, V168, P3697, DOI 10.4049/jimmunol.168.8.3697; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Berger S, 1996, EUR J IMMUNOL, V26, P1297, DOI 10.1002/eji.1830260618; Berger S, 1997, EUR J IMMUNOL, V27, P2994, DOI 10.1002/eji.1830271136; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; BONNEY RJ, 1979, PROSTAGLANDINS, V18, P605, DOI 10.1016/0090-6980(79)90027-3; Boross P, 2006, SPRINGER SEMIN IMMUN, V28, P339, DOI 10.1007/s00281-006-0049-9; Chroneos Z, 1995, AM J PHYSIOL-LUNG C, V269, pL721, DOI 10.1152/ajplung.1995.269.6.L721; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; DEBETS JMH, 1990, J IMMUNOL, V144, P1304; DiMartino SJ, 2008, CLIN IMMUNOL, V127, P56, DOI 10.1016/j.clim.2007.11.014; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ephrem A, 2005, CLIN EXP MED, V5, P135, DOI 10.1007/s10238-005-0079-y; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017; Gupta S, 2010, BIOCHEM BIOPH RES CO, V402, P301, DOI 10.1016/j.bbrc.2010.10.020; HERRMANN F, 1992, EUR J IMMUNOL, V22, P1681, DOI 10.1002/eji.1830220703; Hogger P, 1998, J IMMUNOL, V161, P1883; Ji JD, 2003, J EXP MED, V197, P1573, DOI 10.1084/jem.20021820; KIM JW, 1991, AM J RESP CELL MOL, V5, P249, DOI 10.1165/ajrcmb/5.3.249; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; KRUTMANN J, 1990, J IMMUNOL, V145, P1337; Landmann R, 1996, INFECT IMMUN, V64, P1762, DOI 10.1128/IAI.64.5.1762-1769.1996; Laurent L, 2011, ANN RHEUM DIS, V70, P1052, DOI 10.1136/ard.2010.142091; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mathsson L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1926; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Mullazehi M, 2006, ARTHRITIS RHEUM-US, V54, P1759, DOI 10.1002/art.21892; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; POLAT GL, 1993, IMMUNOLOGY, V80, P287; Radstake TRDJ, 2004, ANN RHEUM DIS, V63, P1556, DOI 10.1136/ard.2003.016550; Radstake TRDJ, 2004, ANN RHEUM DIS, V63, P696, DOI 10.1136/ard.2003.010033; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ronnelid J, 2003, ANN RHEUM DIS, V62, P37, DOI 10.1136/ard.62.1.37; SHANLEY TP, 1995, J IMMUNOL, V154, P3454; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; TRIPP CS, 1995, J CLIN INVEST, V95, P1628, DOI 10.1172/JCI117837; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; VIRGIN HW, 1984, ANN NY ACAD SCI, V437, P16, DOI 10.1111/j.1749-6632.1984.tb37118.x; Vos ACW, 2012, INFLAMM BOWEL DIS, V18, P401, DOI 10.1002/ibd.21818; Vos ACW, 2011, GASTROENTEROLOGY, V140, P221, DOI 10.1053/j.gastro.2010.10.008; Wenink MH, 2009, J IMMUNOL, V183, P4509, DOI 10.4049/jimmunol.0900153; Wernersson S, 1999, J IMMUNOL, V163, P618; Wijngaarden S, 2004, ARTHRITIS RHEUM-US, V50, P3878, DOI 10.1002/art.20672; Yuan WJ, 2011, ARTHRITIS RHEUM-US, V63, P212, DOI 10.1002/art.30083	57	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35994	10.1371/journal.pone.0035994	http://dx.doi.org/10.1371/journal.pone.0035994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563430	Green Published, gold			2022-12-25	WOS:000305349100056
J	He, ZY; Gao, Y; Deng, YX; Li, W; Chen, YM; Xing, SP; Zhao, XY; Ding, J; Wang, XR				He, Zhengyu; Gao, Yuan; Deng, Yuxiao; Li, Wen; Chen, Yongming; Xing, Shunpeng; Zhao, Xianyuan; Ding, Jia; Wang, Xiangrui			Lipopolysaccharide Induces Lung Fibroblast Proliferation through Toll-Like Receptor 4 Signaling and the Phosphoinositide3-Kinase-Akt Pathway	PLOS ONE			English	Article							LAMINA PROPRIA FIBROBLASTS; HUMAN GINGIVAL FIBROBLASTS; IN-VITRO; NEGATIVE REGULATION; PULMONARY-FIBROSIS; INJURY; PTEN; PHOSPHATASE; ACTIVATION; HYPOXIA	Pulmonary fibrosis is characterized by lung fibroblast proliferation and collagen secretion. In lipopolysaccharide (LPS)-induced acute lung injury (ALI), aberrant proliferation of lung fibroblasts is initiated in early disease stages, but the underlying mechanism remains unknown. In this study, we knocked down Toll-like receptor 4 (TLR4) expression in cultured mouse lung fibroblasts using TLR4-siRNA-lentivirus in order to investigate the effects of LPS challenge on lung fibroblast proliferation, phosphoinositide3-kinase (PI3K)-Akt pathway activation, and phosphatase and tensin homolog (PTEN) expression. Lung fibroblast proliferation, detected by BrdU assay, was unaffected by 1 mug/mL LPS challenge up to 24 hours, but at 72 hours, cell proliferation increased significantly. This proliferation was inhibited by siRNA-mediated TLR4 knockdown or treatment with the PI3K inhibitor, Ly294002. In addition, siRNA-mediated knockdown of TLR4 inhibited the LPS-induced up-regulation of TLR4, down-regulation of PTEN, and activation of the PI3K-Akt pathway (overexpression of phospho-Akt) at 72 hours, as detected by real-time PCR and Western blot analysis. Treatment with the PTEN inhibitor, bpV(phen), led to activation of the PI3K-Akt pathway. Neither the baseline expression nor LPS-induced down-regulation of PTEN in lung fibroblasts was influenced by PI3K activation state. PTEN inhibition was sufficient to exert the LPS effect on lung fibroblast proliferation, and PI3K-Akt pathway inhibition could reverse this process. Collectively, these results indicate that LPS can promote lung fibroblast proliferation via a TLR4 signaling mechanism that involves PTEN expression down-regulation and PI3K-Akt pathway activation. Moreover, PI3K-Akt pathway activation is a downstream effect of PTEN inhibition and plays a critical role in lung fibroblast proliferation. This mechanism could contribute to, and possibly accelerate, pulmonary fibrosis in the early stages of ALI/ARDS.	[He, Zhengyu; Gao, Yuan; Deng, Yuxiao; Li, Wen; Chen, Yongming; Xing, Shunpeng; Zhao, Xianyuan; Ding, Jia; Wang, Xiangrui] Shanghai Jiao Tong Univ, Dept Anesthesiol, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	He, ZY (corresponding author), Shanghai Jiao Tong Univ, Dept Anesthesiol, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China.	xiangruiwang@gmail.com	GAO, YUAN/AFF-0781-2022; gao, yuan/GWM-8846-2022	He, Zhengyu/0000-0001-7354-850X	National Natural Science Foundation of China (NSFC) [81000025]; Science and Technology Commission of Shanghai Municipality Foundation [10411951600]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Foundation(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by a grant from the National Natural Science Foundation of China (NSFC) (No. 81000025) and the Science and Technology Commission of Shanghai Municipality Foundation (No. 10411951600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKEY P, 1989, J TRAUMA, V29, P972, DOI 10.1097/00005373-198907000-00011; Brass DM, 2007, J ALLERGY CLIN IMMUN, V120, P121, DOI 10.1016/j.jaci.2007.03.051; Cai XJ, 2010, CELL BIOL INT, V34, P163, DOI 10.1042/CBI20090013; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Chakravortty D, 1999, BBA-MOL BASIS DIS, V1453, P261, DOI 10.1016/S0925-4439(98)00106-9; Chakravortty D, 1997, BIOCHEM BIOPH RES CO, V240, P458, DOI 10.1006/bbrc.1997.7680; CHEN B, 1992, J CLIN INVEST, V90, P1778, DOI 10.1172/JCI116052; Chen XH, 2008, BASIC CLIN PHARMACOL, V103, P278, DOI 10.1111/j.1742-7843.2008.00287.x; Churg A, 2007, AM J SURG PATHOL, V31, P277, DOI 10.1097/01.pas.0000213341.70852.9d; Dzierzewicz Z, 2010, ARCH ORAL BIOL; Fagone E, 2011, EXP LUNG RES, V37, P162, DOI 10.3109/01902148.2010.524722; Gerasimovskaya EV, 2005, J APPL PHYSIOL, V98, P722, DOI 10.1152/japplphysiol.00715.2004; Gutierrez-Venegas G, 2006, EUR J PHARMACOL, V541, P95, DOI 10.1016/j.ejphar.2006.03.069; He WG, 2007, MOL IMMUNOL, V44, P2850, DOI 10.1016/j.molimm.2007.01.022; He ZY, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-126; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Howell DCJ, 2006, THORAX, V61, pII51; Kim CS, 2007, MOL CELLS, V24, P424; Krick S, 2005, FASEB J, V19, P857, DOI 10.1096/fj.04-2890fje; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; Lai JP, 2007, BRIT J PHARMACOL, V152, P1172, DOI 10.1038/sj.bjp.0707501; LAYMAN DL, 1987, J PERIODONTOL, V58, P387, DOI 10.1902/jop.1987.58.6.387; Marshall RP, 2000, AM J RESP CRIT CARE, V162, P1783, DOI 10.1164/ajrccm.162.5.2001061; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; SUBRAMONIAM A, 1985, P SOC EXP BIOL MED, V178, P50; Susilowati Heni, 2002, Journal of Microbiology Immunology and Infection, V35, P203; Suzuki S, 2003, ARTHRITIS RHEUM, V48, pS355; Takemura A, 1998, J PERIODONTAL RES, V33, P400; Takeuchi R, 2011, ARCH ORAL BIOL; Tasaka Sadamoto, 2005, Nihon Naika Gakkai Zasshi, V94, P1106; Tian J, 2011, ANESTH ANALG, V113, P112, DOI 10.1213/ANE.0b013e3182159c15; Tsugawa K, 2002, FRONT BIOSCI-LANDMRK, V7, pE245, DOI 10.2741/tsugawa; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Wu WKK, 2007, WOUND REPAIR REGEN, V15, P221, DOI 10.1111/j.1524-475X.2007.00208.x; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Yang H, 2002, PHYTOTHER RES, V16, P43, DOI 10.1002/ptr.912; Zhang J, 2011, CYTOKINE, V54, P289, DOI 10.1016/j.cyto.2011.02.018	40	67	76	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35926	10.1371/journal.pone.0035926	http://dx.doi.org/10.1371/journal.pone.0035926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563417	gold, Green Submitted, Green Published			2022-12-25	WOS:000305349100043
J	Rutti, S; Sauter, NS; Bouzakri, K; Prazak, R; Halban, PA; Donath, MY				Rutti, Sabine; Sauter, Nadine S.; Bouzakri, Karim; Prazak, Richard; Halban, Philippe A.; Donath, Marc Y.			In Vitro Proliferation of Adult Human Beta-Cells	PLOS ONE			English	Article							MASS; REPLICATION; APOPTOSIS	A decrease in functional beta-cell mass is a key feature of type 2 diabetes. Glucagon-like peptide 1 (GLP-1) analogues induce proliferation of rodent beta-cells. However, the proliferative capacity of human beta-cells and its modulation by GLP-1 analogues remain to be fully investigated. We therefore sought to quantify adult human beta-cell proliferation in vitro and whether this is affected by the GLP-1 analogue liraglutide. Human islets from 7 adult cadaveric organ donors were dispersed into single cells. Beta-cells were purified by FACS. Non-sorted cells and the beta-cell enriched ("beta-cells'') population were plated on extracellular matrix from rat (804G) and human bladder carcinoma cells (HTB9) or bovine corneal endothelial ECM (BCEC). Cells were maintained in culture+/-liraglutide for 4 days in the presence of BrdU. Rare human beta-cell proliferation could be observed either in the purified beta-cell population (0.051 +/- 0.020%; 22 beta-cells proliferating out of 84'283 beta-cells counted) or in the non-sorted cell population (0.055 +/- 0.011%; 104 proliferating beta-cells out of 232'826 beta-cells counted), independently of the matrix or the culture conditions. Liraglutide increased human beta-cell proliferation on BCEC in the non-sorted cell population (0.082 +/- 0.034% proliferating beta-cells vs. 0.017 +/- 0.008% in control, p<0.05). These results indicate that adult human beta-cell proliferation can occur in vitro but remains an extremely rare event with these donors and particular culture conditions. Liraglutide increases beta-cell proliferation only in the non-sorted cell population and only on BCEC. However, it cannot be excluded that human beta-cells may proliferate to a greater extent in situ in response to natural stimuli.	[Rutti, Sabine; Bouzakri, Karim; Halban, Philippe A.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Sauter, Nadine S.; Prazak, Richard; Donath, Marc Y.] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Sauter, Nadine S.; Prazak, Richard; Donath, Marc Y.] Univ Basel Hosp, Div Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland	University of Geneva; University of Basel; University of Basel	Rutti, S (corresponding author), Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland.	sabine.rutti@unige.ch			Novo Nordisk	Novo Nordisk(Novo Nordisk)	The study was supported by Novo Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The study was supported by Novo Nordisk who provided Liraglutide for this study. There are no other patents, products in development or other marketed products to declare. This does not alter the authors' adherence to all the PLos ONE policies on sharing data and materials, as detailed online in the guide for authors.	Banerjee M, 2012, MOL CELL ENDOCRINOL; Beattie GM, 2002, DIABETES, V51, P3435, DOI 10.2337/diabetes.51.12.3435; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; In't Veld P, 2010, DIABETES, V59, P1702, DOI 10.2337/db09-1698; Lee YC, 2009, MOL CELL ENDOCRINOL, V297, P18, DOI 10.1016/j.mce.2008.08.033; Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Reers C, 2009, EUR J ENDOCRINOL, V160, P185, DOI 10.1530/EJE-08-0596; Rolin B, 2002, AM J PHYSIOL-ENDOC M, V283, pE745, DOI 10.1152/ajpendo.00030.2002; Virtanen I, 2008, DIABETOLOGIA, V51, P1181, DOI 10.1007/s00125-008-0997-9	14	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35801	10.1371/journal.pone.0035801	http://dx.doi.org/10.1371/journal.pone.0035801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563404	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100031
J	Beilke, JN; Meagher, CT; Hosiawa, K; Champsaur, M; Bluestone, JA; Lanier, LL				Beilke, Joshua N.; Meagher, Craig T.; Hosiawa, Karoline; Champsaur, Marine; Bluestone, Jeffrey A.; Lanier, Lewis L.			NK Cells Are Not Required for Spontaneous Autoimmune Diabetes in NOD Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CENTRAL-NERVOUS-SYSTEM; AUTOREACTIVE T-CELLS; IFN-GAMMA; IMMUNITY; ACTIVATION; INDUCTION; MECHANISM; ARTHRITIS; SUBSETS	NK cells have been shown to either promote or protect from autoimmune diseases. Several studies have examined the role of receptors preferentially expressed by NK cells in the spontaneous disease of NOD mice or the direct role of NK cells in acute induced disease models of diabetes. Yet, the role of NK cells in spontaneous diabetes has not been directly addressed. Here, we used the NOD.NK1.1 congenic mouse model to examine the role of NK cells in spontaneous diabetes. Significant numbers of NK cells were only seen in the pancreas of mice with disease. Pancreatic NK cells displayed an activated surface phenotype and proliferated more than NK cells from other tissues in the diseased mice. Nonetheless, depletion of NK cells had no effect on dendritic cell maturation or T cell proliferation. In spontaneous disease, the deletion of NK cells had no significant impact on disease onset. NK cells were also not required to promote disease induced by adoptively transferred pathogenic CD4(+) T cells. Thus, NK cells are not required for spontaneous autoimmune diabetes in NOD mice.	[Beilke, Joshua N.; Champsaur, Marine; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Beilke, Joshua N.; Champsaur, Marine; Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Meagher, Craig T.] Univ Calif San Francisco, Proctor Fdn, San Francisco, CA 94143 USA; [Hosiawa, Karoline] Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA USA; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Beilke, JN (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	NIH [AI066897]; JDRF postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF postdoctoral fellowship(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH grant AI066897. L.L.L. is an American Cancer Society Professor and a JDRF postdoctoral fellowship supported J.N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Brauner H, 2010, J IMMUNOL, V184, P2272, DOI 10.4049/jimmunol.0804358; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Dilts SM, 1999, J AUTOIMMUN, V13, P285, DOI 10.1006/jaut.1999.0323; Ferlazzo G, 2009, J CLIN IMMUNOL, V29, P265, DOI 10.1007/s10875-009-9283-y; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Leavenworth JW, 2010, P NATL ACAD SCI USA, V107, P2562, DOI 10.1073/pnas.0914732107; Lee IF, 2008, EUR J IMMUNOL, V38, P82, DOI 10.1002/eji.200737189; Liao YP, 2007, FRONT BIOSCI-LANDMRK, V12, P3576, DOI 10.2741/2336; Lo CKC, 2008, ARTHRITIS RHEUM, V58, P2700, DOI 10.1002/art.23760; Melli K, 2009, J IMMUNOL, V182, P2590, DOI 10.4049/jimmunol.0803543; Miyake T, 2009, J IMMUNOL, V183, P2522, DOI 10.4049/jimmunol.0901500; Naumov YN, 2001, P NATL ACAD SCI USA, V98, P13838, DOI 10.1073/pnas.251531798; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Schleinitz N, 2010, IMMUNOLOGY, V131, P451, DOI 10.1111/j.1365-2567.2010.03360.x; Shi FD, 2000, J IMMUNOL, V165, P3099, DOI 10.4049/jimmunol.165.6.3099; Shi FD, 2006, NAT REV IMMUNOL, V6, P751, DOI 10.1038/nri1935; Soderstrom K, 2010, P NATL ACAD SCI USA, V107, P13028, DOI 10.1073/pnas.1000546107; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Suwanai H, 2010, P NATL ACAD SCI USA, V107, P9305, DOI 10.1073/pnas.1004492107; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Xu W, 2005, J NEUROIMMUNOL, V163, P24, DOI 10.1016/j.jneuroim.2005.02.011	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36011	10.1371/journal.pone.0036011	http://dx.doi.org/10.1371/journal.pone.0036011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558306	gold, Green Published			2022-12-25	WOS:000305345200109
J	Yin, ZJ; Li, Y; Han, XL; Shen, FF				Yin, Zujun; Li, Yan; Han, Xiulan; Shen, Fafu			Genome-Wide Profiling of miRNAs and Other Small Non-Coding RNAs in the Verticillium dahliae-Inoculated Cotton Roots	PLOS ONE			English	Article							STRESS-RESPONSIVE MICRORNAS; CONSERVED MICRORNAS; REGULATED MICRORNAS; PLANT MICRORNAS; TARGET GENES; ARABIDOPSIS; IDENTIFICATION; GOSSYPIUM; IMMUNITY; SIRNA	MicroRNAs (miRNAs) and small interfering RNAs (siRNAs) are short (19-25 nucleotides) non-coding RNA molecules that have large-scale regulatory effects on development and stress responses in plants. Verticillium wilt is a vascular disease in plants caused by the fungal pathogen Verticillium dahliae. The objective of this study is to investigate the transcriptional profile of miRNAs and other small non-coding RNAs in Verticillium-inoculated cotton roots. Four small RNA libraries were constructed from mocked and infected roots of two cotton cultured species which are with different Verticillium wilt tolerance ('Hai-7124', Gossypium barbadense L., a Verticillium-tolerant cultivar, and 'Yi-11', Gossypium hirsutum L. a Verticillium-sensitive cultivar). The length distribution of obtained small RNAs was significantly different between libraries. There were a total of 215 miRNA families identified in the two cotton species. Of them 14 were novel miRNAs. There were >65 families with different expression between libraries. We also identified two trans-acting siRNAs and thousands of endogenous siRNA candidates, and hundred of them exhibited altered expression after inoculation of Verticillium. Interesting, many siRNAs were found with a perfect match with retrotransposon sequences, suggested that retrotransposons maybe one of sources for the generation of plant endogenous siRNAs. The profiling of these miRNAs and other small non-coding RNAs lay the foundation for further understanding of small RNAs function in the regulation of Verticillium defence responses in cotton roots.	[Yin, Zujun; Han, Xiulan; Shen, Fafu] Shandong Agr Univ, Coll Agron, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Yin, Zujun; Li, Yan] Chinese Acad Agr Sci, Cotton Res Inst, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yin, ZJ (corresponding author), Shandong Agr Univ, Coll Agron, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	ffshen@sdau.edu.cn			China Key Development Project for Basic Research [2007CB116208]; China Major Projects for Transgenic Breeding [2011ZX005-004, 2011ZX08005-002, 2009ZX08005-020]	China Key Development Project for Basic Research; China Major Projects for Transgenic Breeding	This work was supported by the China Key Development Project for Basic Research (Grant No. 2007CB116208), and the China Major Projects for Transgenic Breeding (Grant No. 2011ZX005-004, 2011ZX08005-002, 2009ZX08005-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; [Anonymous], COTTON EST DATABASE; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Cai YF, 2009, AFR J BIOTECHNOL, V8, P7363; Carra A, 2007, ANAL BIOCHEM, V360, P318, DOI 10.1016/j.ab.2006.09.022; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen XM, 2002, DEVELOPMENT, V129, P1085; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ellendorff U, 2009, RNA SILENCING IS REQ, P591; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hawkins JS, 2009, RAPID DNA LOSS COUNT; Hewezi T, 2008, ARABIDOPSIS SMALL RN, P1622; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jia Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000737; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Katiyar-Agarwal S, 2007, GENE DEV, V21, P3123, DOI 10.1101/gad.1595107; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Krasnikova MS, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/952304; Kuang H, 2009, IDENTIFICATION MINIA, P42; Le Trionnaire G, 2011, J EXP BOT, V62, P1601, DOI 10.1093/jxb/erq399; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li H, 2010, PLANT PHYSIOL, V153, P1759, DOI 10.1104/pp.110.156950; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Seelanan T, 1999, SYST BOT, V24, P183, DOI 10.2307/2419548; Shen D, 2009, PLANT SYST EVOL, V283, P125, DOI 10.1007/s00606-009-0221-5; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yan YS, 2011, PLANT J, V65, P820, DOI 10.1111/j.1365-313X.2010.04467.x; Yang C, 2008, PLANT SCI, V174, P290, DOI 10.1016/j.plantsci.2007.11.016; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zaki EA, 2005, DNA SEQUENCE, V16, P288, DOI 10.1080/10425170500097966; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhou XF, 2009, GENOME RES, V19, P70, DOI 10.1101/gr.084806.108; Zuo K, 2005, Mol Biol (Mosk), V39, P214	57	83	96	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35765	10.1371/journal.pone.0035765	http://dx.doi.org/10.1371/journal.pone.0035765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558219	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200075
J	Elamin, E; Jonkers, D; Juuti-Uusitalo, K; van IJzendoorn, S; Troost, F; Duimel, H; Broers, J; Verheyen, F; Dekker, J; Masclee, A				Elamin, Elhaseen; Jonkers, Daisy; Juuti-Uusitalo, Kati; van IJzendoorn, Sven; Troost, Freddy; Duimel, Hans; Broers, Jos; Verheyen, Fons; Dekker, Jan; Masclee, Ad			Effects of Ethanol and Acetaldehyde on Tight Junction Integrity: In Vitro Study in a Three Dimensional Intestinal Epithelial Cell Culture Model	PLOS ONE			English	Article							PARACELLULAR PERMEABILITY; LIVER-DISEASE; ALCOHOL-CONSUMPTION; INDUCED INCREASE; MOLECULAR-BASIS; LEAKY GUT; BARRIER; TISSUE; MONOLAYER; COMPLEX	Background: Intestinal barrier dysfunction and translocation of endotoxins are involved in the pathogenesis of alcoholic liver disease. Exposure to ethanol and its metabolite, acetaldehyde at relatively high concentrations have been shown to disrupt intestinal epithelial tight junctions in the conventional two dimensional cell culture models. The present study investigated quantitatively and qualitatively the effects of ethanol at concentrations detected in the blood after moderate ethanol consumption, of its metabolite acetaldehyde and of the combination of both compounds on intestinal barrier function in a three-dimensional cell culture model. Methods and Findings: Caco-2 cells were grown in a basement membrane matrix (Matrigel (TM)) to induce spheroid formation and were then exposed to the compounds at the basolateral side. Morphological differentiation of the spheroids was assessed by immunocytochemistry and transmission electron microscopy. The barrier function was assessed by the flux of FITC-labeled dextran from the basal side into the spheroids' luminal compartment using confocal microscopy. Caco-2 cells grown on Matrigel assembled into fully differentiated and polarized spheroids with a central lumen, closely resembling enterocytes in vivo and provide an excellent model to study epithelial barrier functionality. Exposure to ethanol (10-40 mM) or acetaldehyde (25-200 mu M) for 3 h, dose-dependently and additively increased the paracellular permeability and induced redistribution of ZO-1 and occludin without affecting cell viability or tight junction-encoding gene expression. Furthermore, ethanol and acetaldehyde induced lysine residue and microtubules hyperacetylation. Conclusions: These results indicate that ethanol at concentrations found in the blood after moderate drinking and acetaldehyde, alone and in combination, can increase the intestinal epithelial permeability. The data also point to the involvement of protein hyperacetylation in ethanol- and acetaldehyde-induced loss of tight junctions integrity.	[Elamin, Elhaseen; Jonkers, Daisy; Juuti-Uusitalo, Kati; van IJzendoorn, Sven; Troost, Freddy; Dekker, Jan; Masclee, Ad] Top Inst Food & Nutr, Wageningen, Netherlands; [Elamin, Elhaseen; Jonkers, Daisy; Troost, Freddy; Masclee, Ad] Maastricht Univ, Med Ctr, Div Gastroenterol Hepatol, Maastricht, Netherlands; [Elamin, Elhaseen; Jonkers, Daisy; Troost, Freddy; Masclee, Ad] Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Juuti-Uusitalo, Kati; van IJzendoorn, Sven] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Duimel, Hans; Broers, Jos; Verheyen, Fons] Maastricht Univ, Med Ctr, Dept Mol Cell Biol, Maastricht, Netherlands; [Duimel, Hans; Verheyen, Fons] Maastricht Univ, Med Ctr, Electron Microscopy Unit, Maastricht, Netherlands; [Dekker, Jan] Wageningen Univ, Dept Anim Sci, Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; Maastricht University; University of Groningen; Maastricht University; Maastricht University; Wageningen University & Research	Elamin, E (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	d.jonkers@maastrichtuniversity.nl	Troost, Freddy/B-2782-2015	Juuti-Uusitalo, Kati/0000-0003-2275-5562	Top Institute Food and Nutrition	Top Institute Food and Nutrition	This study was funded by Top Institute Food and Nutrition. Both funders and providers had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; ARTURSSON P, 1993, PHARMACEUT RES, V10, P1123, DOI 10.1023/A:1018903931777; Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280, DOI 10.1152/ajpgi.2001.280.6.G1280; Banan A, 1999, J PHARMACOL EXP THER, V291, P1075; Banan A, 1998, AM J PHYSIOL-GASTR L, V274, pG111, DOI 10.1152/ajpgi.1998.274.1.G111; Bentrup KHZ, 2006, MICROBES INFECT, V8, P1813, DOI 10.1016/j.micinf.2006.02.020; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; BJARNASON I, 1984, LANCET, V1, P179; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Collett A, 1996, PHARMACEUT RES, V13, P216, DOI 10.1023/A:1016082829111; Dufour MC, 1999, ALCOHOL RES HEALTH, V23, P5; Eckardt MJ, 1998, ALCOHOL CLIN EXP RES, V22, P998, DOI 10.1111/j.1530-0277.1998.tb03695.x; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Forsyth CB, 2011, ALCOHOL CLIN EXP RES; Forsyth CB, 2011, ALCOHOL CLIN EXP RES, V35, P1635, DOI 10.1111/j.1530-0277.2011.01510.x; Forsyth CB, 2010, ALCOHOL CLIN EXP RES, V34, P19, DOI 10.1111/j.1530-0277.2009.01061.x; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Geetha S, 2009, GASTROENTEROLOGY S1, V136, pA; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2008, J CELL SCI, V121, P1803, DOI 10.1242/jcs.015842; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Juuti-Uusitalo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022967; Kannarkat GT, 2006, J HEPATOL, V44, P963, DOI 10.1016/j.jhep.2005.07.007; KESHAVARZIAN A, 1994, AM J GASTROENTEROL, V89, P2205; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Laukoetter MG, 2006, CURR OPIN GASTROEN, V22, P85, DOI 10.1097/01.mog.0000203864.48255.4f; Lindfors K, 2000, BIOCHEM BIOPH RES CO, V276, P660, DOI 10.1006/bbrc.2000.3480; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; MILLAN MS, 1980, DIGEST DIS SCI, V25, P513, DOI 10.1007/BF01315213; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Ohata A, 2005, NUTRITION, V21, P838, DOI 10.1016/j.nut.2004.12.004; Ohmori T, 1998, EXP CELL RES, V245, P350, DOI 10.1006/excr.1998.4261; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Rao R. K., 2008, V447, P171, DOI 10.1007/978-1-59745-242-7_13; Rao RK, 1998, ALCOHOL CLIN EXP RES, V22, P1724, DOI 10.1097/00000374-199811000-00015; ROBINSON GM, 1981, DIGEST DIS SCI, V26, P971, DOI 10.1007/BF01314757; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P1, DOI 10.1111/j.1749-6632.2009.04925.x; Services USDoAUSDoHaH, 1990, SERV USDOAUSDOHAH B; Seth A, 2004, AM J PHYSIOL-GASTR L, V287, pG510, DOI 10.1152/ajpgi.00058.2004; Shepard BD, 2010, ALCOHOL CLIN EXP RES, V34, P280, DOI 10.1111/j.1530-0277.2009.01091.x; Sheth P, 2004, ALCOHOL CLIN EXP RES, V28, P797, DOI 10.1097/01.ALC.0000125358.92335.90; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Swanson G, 2011, ALCOHOL CLIN EXP RES, V35, P1305, DOI 10.1111/j.1530-0277.2011.01466.x; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; TUMA DJ, 1991, ANN NY ACAD SCI, V625, P786, DOI 10.1111/j.1749-6632.1991.tb33920.x; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; WERCH CE, 1987, J DRUG EDUC, V17, P261, DOI 10.2190/KQDE-YYW2-7H4N-QQGJ; Willner IR, 2005, CURR OPIN GASTROEN, V21, P323; WORTHINGTON BS, 1978, AM J DIG DIS, V23, P23, DOI 10.1007/BF01072571; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; Zhong W, 2010, AM J PHYSIOL-GASTR L, V299, pG643, DOI 10.1152/ajpgi.00515.2009	67	82	88	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35008	10.1371/journal.pone.0035008	http://dx.doi.org/10.1371/journal.pone.0035008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22563376	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200020
J	Pereira, CA; Silber, AM				Alejandro Pereira, Claudio; Silber, Ariel Mariano			On the Evolution of Hexose Transporters in Kinetoplastid Potozoans	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER; FUNCTIONAL EXPRESSION; SEQUENCE; FAMILY; FACILITATORS; GENES; GLUT1	Glucose, an almost universally used energy and carbon source, is processed through several well-known metabolic pathways, primarily glycolysis. Glucose uptake is considered to be the first step in glycolysis. In kinetoplastids, a protozoan group that includes relevant human pathogens, the importance of glucose uptake in different phases of the life cycles is well established, and hexose transporters have been proposed as targets for therapeutic drugs. However, little is known about the evolutionary history of these hexose transporters. Hexose transporters contain an intracellular N- and C-termini, and 12 transmembrane spans connected by alternate intracellular and extracellular loops. In the present work we tested the hypothesis that the evolutionary rate of the transmembrane span is different from that of the whole sequence and that it is possible to define evolutionary units inside the sequence. The phylogeny of whole molecules was compared to that of their transmembrane spans and the loops connecting the transmembrane spans. We show that the evolutionary units in these proteins primarily consist of clustered rather than individual transmembrane spans. These analyses demonstrate that there are evolutionary constraints on the organization of these proteins; more specifically, the order of the transmembrane spans along the protein is highly conserved. Finally, we defined a signature sequence for the identification of kinetoplastid hexose transporters.	[Alejandro Pereira, Claudio] Inst Invest Med Alfredo Lanari, Buenos Aires, DF, Argentina; [Silber, Ariel Mariano] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Pereira, CA (corresponding author), Inst Invest Med Alfredo Lanari, Buenos Aires, DF, Argentina.	cpereira@retina.ar; asilber@usp.br	Pereira, Claudio A/F-5382-2012; 4, INCT/H-4499-2013; Inbeqmedi, Inct/I-1929-2013; Silber, Ariel/O-6951-2015	Pereira, Claudio A/0000-0001-7874-1894; Silber, Ariel/0000-0003-4528-4732	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [0685]; Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT) [2008-1209]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/50631-1]; Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI)	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP Grant # 0685 to CAP), and Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT Grant #2008-1209 to CAP), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants #11/50631-1 to AMS) and Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI). CAP is a member of the career of scientific investigator of CONICET (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Barrett MP, 1995, BIOCHEM J, V312, P687, DOI 10.1042/bj3120687; Barrett MP, 1998, MOL BIOCHEM PARASIT, V91, P195, DOI 10.1016/S0166-6851(97)00192-8; Bouvier LA, 2004, BIOCHEM BIOPH RES CO, V321, P547, DOI 10.1016/j.bbrc.2004.07.002; BRINGAUD F, 1994, MOL BIOL EVOL, V11, P220; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Burchmore RJS, 1998, J BIOL CHEM, V273, P29118, DOI 10.1074/jbc.273.44.29118; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; CAZZULO JJ, 1994, J BIOENERG BIOMEMBR, V26, P157, DOI 10.1007/BF00763064; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Krishna S, 2000, PARASITOL TODAY, V16, P516, DOI 10.1016/S0169-4758(00)01762-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Landfear SM, 2008, ADV EXP MED BIOL, V625, P22; Landfear SM, 2011, EUKARYOT CELL, V10, P483, DOI 10.1128/EC.00287-10; LANGFORD CK, 1995, BIOCHEMISTRY-US, V34, P11814, DOI 10.1021/bi00037a020; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Rodriguez-Contreras D, 2007, MOL BIOCHEM PARASIT, V153, P9, DOI 10.1016/j.molbiopara.2007.01.010; Silber AM, 2009, MOL BIOCHEM PARASIT, V168, P102, DOI 10.1016/j.molbiopara.2009.07.006; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tetaud E, 1996, BIOCHEM J, V317, P353, DOI 10.1042/bj3170353; Tetaud E, 1997, BIOCHEM J, V325, P569, DOI 10.1042/bj3250569; TETAUD E, 1994, P NATL ACAD SCI USA, V91, P8278, DOI 10.1073/pnas.91.17.8278; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; Vedrenne C, 2000, EUR J BIOCHEM, V267, P4850, DOI 10.1046/j.1432-1327.2000.01543.x; Waitumbi JN, 1996, EUR J BIOCHEM, V237, P234, DOI 10.1111/j.1432-1033.1996.0234n.x	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36303	10.1371/journal.pone.0036303	http://dx.doi.org/10.1371/journal.pone.0036303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567148	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341500067
J	Goncalves, JP; Aires, RS; Francisco, AP; Madeira, SC				Goncalves, Joana P.; Aires, Ricardo S.; Francisco, Alexandre P.; Madeira, Sara C.			Regulatory Snapshots: Integrative Mining of Regulatory Modules from Expression Time Series and Regulatory Networks	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; TGF-BETA; TOOL; IDENTIFICATION; ASSOCIATIONS; VERSATILITY; METASTASIS; ALGORITHMS; ACTIVATION	Explaining regulatory mechanisms is crucial to understand complex cellular responses leading to system perturbations. Some strategies reverse engineer regulatory interactions from experimental data, while others identify functional regulatory units (modules) under the assumption that biological systems yield a modular organization. Most modular studies focus on network structure and static properties, ignoring that gene regulation is largely driven by stimulus-response behavior. Expression time series are key to gain insight into dynamics, but have been insufficiently explored by current methods, which often (1) apply generic algorithms unsuited for expression analysis over time, due to inability to maintain the chronology of events or incorporate time dependency; (2) ignore local patterns, abundant in most interesting cases of transcriptional activity; (3) neglect physical binding or lack automatic association of regulators, focusing mainly on expression patterns; or (4) limit the discovery to a predefined number of modules. We propose Regulatory Snapshots, an integrative mining approach to identify regulatory modules over time by combining transcriptional control with response, while overcoming the above challenges. Temporal biclustering is first used to reveal transcriptional modules composed of genes showing coherent expression profiles over time. Personalized ranking is then applied to prioritize prominent regulators targeting the modules at each time point using a network of documented regulatory associations and the expression data. Custom graphics are finally depicted to expose the regulatory activity in a module at consecutive time points (snapshots). Regulatory Snapshots successfully unraveled modules underlying yeast response to heat shock and human epithelial-to-mesenchymal transition, based on regulations documented in the YEASTRACT and JASPAR databases, respectively, and available expression data. Regulatory players involved in functionally enriched processes related to these biological events were identified. Ranking scores further suggested ability to discern the primary role of a gene (target or regulator). Prototype is available at: http://kdbio.inesc-id.pt/software/regulatorysnapshots.	[Goncalves, Joana P.; Aires, Ricardo S.; Francisco, Alexandre P.; Madeira, Sara C.] INESC ID, Knowledge Discovery & Bioinformat Grp KDBIO, Lisbon, Portugal; [Goncalves, Joana P.; Aires, Ricardo S.; Francisco, Alexandre P.; Madeira, Sara C.] Univ Tecn Lisboa, Inst Super Tecn, P-1096 Lisbon, Portugal	INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Goncalves, JP (corresponding author), INESC ID, Knowledge Discovery & Bioinformat Grp KDBIO, Lisbon, Portugal.	jpg@kdbio.inesc-id.pt; smadeira@kdbio.inesc-id.pt	Gonçalves, Joana/GSI-9858-2022; Francisco, Alexandre/B-9429-2009; Gonçalves, Joana/B-2330-2009; Madeira, Sara/AAR-3658-2020; Madeira, Sara/C-5494-2008	Francisco, Alexandre/0000-0003-4852-1641; Gonçalves, Joana/0000-0001-6072-9627; Madeira, Sara/0000-0002-1459-8096; Madeira, Sara/0000-0002-1459-8096	Fundacao para a Ciencia e a Tecnologia (FCT) via: INESC-ID multiannual funding through the PIDDAC program funds [SFRH/BD/36586/2007, PTDC/SAU-MII/100964/2008, PTDC/EIA-EIA/111239/2009]	Fundacao para a Ciencia e a Tecnologia (FCT) via: INESC-ID multiannual funding through the PIDDAC program funds	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) via: INESC-ID multiannual funding through the PIDDAC program funds; doctoral grant SFRH/BD/36586/2007 to J.P.G.; project grants PTDC/SAU-MII/100964/2008 to PneumoSys and PTDC/EIA-EIA/111239/2009 to NEUROCLINOMICS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires RS, 2011, ADV INTEL SOFT COMPU, V93, P49; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Andersen R, 2006, P 15 INT C WORLD WID, P223, DOI DOI 10.1145/1135777.1135814; Androulakis IP, 2007, ANNU REV BIOMED ENG, V9, P205, DOI 10.1146/annurev.bioeng.9.060906.151904; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beckstette M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-389; Bozdag S, 2010, BIOINFORMATICS, V26, P1792, DOI 10.1093/bioinformatics/btq275; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brynildsen MP, 2006, BIOPHYS J, V91, P2749, DOI 10.1529/biophysj.106.082560; Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chung F., 1999, ELECTRON J COMB, V6, pR12; Chung F, 2007, P NATL ACAD SCI USA, V104, P19735, DOI 10.1073/pnas.0708838104; Coleman CB, 2008, BIOTECHNOL BIOENG, V100, P334, DOI 10.1002/bit.21748; Costa IG, 2005, BIOINFORMATICS, V21, P2544, DOI 10.1093/bioinformatics/bti311; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Garber K, 2008, J NATL CANCER I, V100, P232, DOI 10.1093/jnci/djn032; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Goncalves JP, 2011, BIOINFORMATICS, V27, P3149, DOI 10.1093/bioinformatics/btr546; Goncalves Joana P, 2009, BMC Res Notes, V2, P124, DOI 10.1186/1756-0500-2-124; Goncalves JP, 2010, WORKSH DYN NETW KNOW; Gusfield D., 1997, COMPUTER SCI COMPUTA; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hiyama Keiko, 2009, TELOMERES TELOMERASE; Ji LP, 2005, BIOINFORMATICS, V21, P509, DOI 10.1093/bioinformatics/bti026; Kasabov NK, 2004, LECT NOTES COMPUT SC, V3316, P1344; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Kreizenbeck GM, 2008, CANCER EPIDEM BIOMAR, V17, P949, DOI 10.1158/1055-9965.EPI-07-2729; Ksienzyk A, 2011, CANC RES; Kundaje A, 2005, IEEE ACM T COMPUT BI, V2, P194, DOI 10.1109/TCBB.2005.34; Kundaje A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000224; Lemmens K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r37; Li S, 2006, BIOINFORMATICS, V22, P2143, DOI 10.1093/bioinformatics/btl363; Madeira SC, 2010, IEEE ACM T COMPUT BI, V7, P153, DOI 10.1109/TCBB.2008.34; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meng J, 2009, BIOINFORMATICS, V25, P1521, DOI 10.1093/bioinformatics/btp235; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Nam H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S3-S6; Novershtern N, 2011, BIOINFORMATICS, V27, pI177, DOI 10.1093/bioinformatics/btr222; Ramakrishnan N, 2010, P NATL ACAD SCI USA, V107, P12511, DOI 10.1073/pnas.1006283107; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Segal E, 2005, J MACH LEARN RES, V6, P557; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Van Dyck F, 2007, INT J ONCOL, V30, P765; Wu WS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-439; Wu Z, 2011, ONCOGENE, V30, P3979, DOI 10.1038/onc.2011.129; Xue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027748; Yang H., 2007, P 30 ANN INT ACM SIG, P431; Yeang C, 2003, 3 IEEE S BIOINFORMAT, V14, P755; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang YJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-203; Zhang YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S15	61	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35977	10.1371/journal.pone.0035977	http://dx.doi.org/10.1371/journal.pone.0035977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563474	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340700023
J	Skoog, EC; Sjoling, A; Navabi, N; Holgersson, J; Lundin, SB; Linden, SK				Skoog, Emma C.; Sjoling, Asa; Navabi, Nazanin; Holgersson, Jan; Lundin, Samuel B.; Linden, Sara K.			Human Gastric Mucins Differently Regulate Helicobacter pylori Proliferation, Gene Expression and Interactions with Host Cells	PLOS ONE			English	Article							LEWIS-B; ADHESION; INFECTION; BINDING; MUC5AC; GROWTH; GLAND; IDENTIFICATION; GLYCOSYLATION; EPITHELIUM	Helicobacter pylori colonizes the mucus niche of the gastric mucosa and is a risk factor for gastritis, ulcers and cancer. The main components of the mucus layer are heavily glycosylated mucins, to which H. pylori can adhere. Mucin glycosylation differs between individuals and changes during disease. Here we have examined the H. pylori response to purified mucins from a range of tumor and normal human gastric tissue samples. Our results demonstrate that mucins from different individuals differ in how they modulate both proliferation and gene expression of H. pylori. The mucin effect on proliferation varied significantly between samples, and ranged from stimulatory to inhibitory, depending on the type of mucins and the ability of the mucins to bind to H. pylori. Tumor-derived mucins and mucins from the surface mucosa had potential to stimulate proliferation, while gland-derived mucins tended to inhibit proliferation and mucins from healthy uninfected individuals showed little effect. Artificial glycoconjugates containing H. pylori ligands also modulated H. pylori proliferation, albeit to a lesser degree than human mucins. Expression of genes important for the pathogenicity of H. pylori (babA, sabA, cagA, flaA and ureA) appeared co-regulated in response to mucins. The addition of mucins to co-cultures of H. pylori and gastric epithelial cells protected the viability of the cells and modulated the cytokine production in a manner that differed between individuals, was partially dependent of adhesion of H. pylori to the gastric cells, but also revealed that other mucin factors in addition to adhesion are important for H. pylori-induced host signaling. The combined data reveal host-specific effects on proliferation, gene expression and virulence of H. pylori due to the gastric mucin environment, demonstrating a dynamic interplay between the bacterium and its host.	[Skoog, Emma C.; Sjoling, Asa; Navabi, Nazanin; Lundin, Samuel B.; Linden, Sara K.] Univ Gothenburg, Mucosal Immunobiol & Vaccine Ctr, Sahlgrenska Acad, Gothenburg, Sweden; [Skoog, Emma C.; Navabi, Nazanin; Linden, Sara K.] Univ Gothenburg, Dept Biomed Chem & Cell Biol, Sahlgrenska Acad, Gothenburg, Sweden; [Sjoling, Asa; Lundin, Samuel B.] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden; [Holgersson, Jan] Univ Gothenburg, Dept Clin Chem & Transfus Med, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg	Skoog, EC (corresponding author), Univ Gothenburg, Mucosal Immunobiol & Vaccine Ctr, Sahlgrenska Acad, Gothenburg, Sweden.	sara.linden@gu.se	Lindén, Sara K/A-3271-2011	Lindén, Sara K/0000-0002-7751-9586; Skoog, Emma/0000-0002-2543-6412; Sjoling, Asa/0000-0003-1529-1720	Swedish Research Council [K2008-58X-20693-01-4]; Swedish Cancer Foundation; Royal Swedish Academy of Sciences; Mucosal Immunobiology and Vaccine Center; Jeansson Foundation; Ake Wibergs Foundation; Magnus Bergvall Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Royal Swedish Academy of Sciences; Mucosal Immunobiology and Vaccine Center; Jeansson Foundation; Ake Wibergs Foundation; Magnus Bergvall Foundation	The work was supported by the Swedish Research Council (grant number: K2008-58X-20693-01-4, http://www.vr.se), the Swedish Cancer Foundation (http://www.cancerfonden.se), The Royal Swedish Academy of Sciences (http://kva.se), Mucosal Immunobiology and Vaccine Center (www.mivac.se), the Jeansson Foundation (www.jeanssonsstiftelser.se), Ake Wibergs Foundation (http://www.ake-wiberg.com) and the Magnus Bergvall Foundation (http://www.magnbergvallsstiftelse.nu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado M, 1998, GASTROENTEROLOGY, V114, P462, DOI 10.1016/S0016-5085(98)70529-3; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Backstrom M, 2003, BIOCHEM J, V376, P677, DOI 10.1042/BJ20031130; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Byrd JC, 1997, GASTROENTEROLOGY, V113, P455, DOI 10.1053/gast.1997.v113.pm9247464; Cole SP, 2004, J BACTERIOL, V186, P3124, DOI 10.1128/JB.186.10.3124-3132.2004; Cooke CL, 2009, GASTROENTEROLOGY, V137, P1061, DOI 10.1053/j.gastro.2009.04.014; Fox JT, 2009, J ANIM SCI, V87, P1304, DOI 10.2527/jas.2008-1166; Fujimoto S, 2007, CLIN GASTROENTEROL H, V5, P49, DOI 10.1016/j.cgh.2006.09.015; Gustafsson A, 2011, GLYCOBIOLOGY; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; HESSEY SJ, 1990, GUT, V31, P134, DOI 10.1136/gut.31.2.134; HO SB, 1995, CANCER RES, V55, P2681; Holgersson J, 2006, GLYCOBIOLOGY, V16, P584, DOI 10.1093/glycob/cwj090; Ishijima N, 2011, J BIOL CHEM; Janzon A, 2009, HELICOBACTER, V14, P237, DOI 10.1111/j.1523-5378.2009.00692.x; Jiang XP, 2000, J CLIN MICROBIOL, V38, P1984, DOI 10.1128/JCM.38.5.1984-1987.2000; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; KLEIN A, 1993, EUR J BIOCHEM, V211, P491, DOI 10.1111/j.1432-1033.1993.tb17575.x; Linden S, 2002, GASTROENTEROLOGY, V123, P1923, DOI 10.1053/gast.2002.37076; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Linden SK, 2008, HELICOBACTER, V13, P81, DOI 10.1111/j.1523-5378.2008.00587.x; Linden SK, 2007, HELICOBACTER, V12, P341, DOI 10.1111/j.1523-5378.2007.00509.x; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Liu JN, 2003, XENOTRANSPLANTATION, V10, P149, DOI 10.1034/j.1399-3089.2003.01144.x; Lofling J, 2008, GLYCOBIOLOGY, V18, P494, DOI 10.1093/glycob/cwn030; LOHMANDER LS, 1980, J BIOL CHEM, V255, P6084; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Nakajima K, 2003, J HISTOCHEM CYTOCHEM, V51, P1689, DOI 10.1177/002215540305101213; Nakamura N, 1998, J HISTOCHEM CYTOCHEM, V46, P793, DOI 10.1177/002215549804600702; Nordman H, 2002, BIOCHEM J, V364, P191, DOI 10.1042/bj3640191; Odenbreit S, 2009, INFECT IMMUN, V77, P3782, DOI 10.1128/IAI.00364-09; Park SA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-96; SAKAMOTO J, 1989, CANCER RES, V49, P745; Skoog EC, 2011, HELICOBACTER, V16, P9, DOI 10.1111/j.1523-5378.2010.00810.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tsai CJ, 2006, CANCER EPIDEM BIOMAR, V15, P272, DOI 10.1158/1055-9965.EPI-05-0632; Tu QV, 2008, J MED MICROBIOL, V57, P795, DOI 10.1099/jmm.0.47752-0; Van den Brink GR, 2000, GUT, V46, P601, DOI 10.1136/gut.46.5.601; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Zambon CF, 2003, J CLIN PATHOL, V56, P287, DOI 10.1136/jcp.56.4.287	42	66	69	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36378	10.1371/journal.pone.0036378	http://dx.doi.org/10.1371/journal.pone.0036378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563496	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340700045
J	Xie, GQ; Zhang, HT; Du, GP; Huang, QL; Liang, XH; Ma, J; Jiao, RJ				Xie, Gengqiang; Zhang, Hongtao; Du, Guiping; Huang, Qinglei; Liang, Xuehong; Ma, Jun; Jiao, Renjie			Uif, a Large Transmembrane Protein with EGF-Like Repeats, Can Antagonize Notch Signaling in Drosophila	PLOS ONE			English	Article							CELL FATE DECISIONS; WING FORMATION; SERRATE; DELTA; BOUNDARY; MELANOGASTER; ACTIVATION; SUPPRESSOR; EXPRESSION; HAIRLESS	Background: Notch signaling is a highly conserved pathway in multi-cellular organisms ranging from flies to humans. It controls a variety of developmental processes by stimulating the expression of its target genes in a highly specific manner both spatially and temporally. The diversity, specificity and sensitivity of the Notch signaling output are regulated at distinct levels, particularly at the level of ligand-receptor interactions. Methodology/Principal Findings: Here, we report that the Drosophila gene uninflatable (uif), which encodes a large transmembrane protein with eighteen EGF-like repeats in its extracellular domain, can antagonize the canonical Notch signaling pathway. Overexpression of Uif or ectopic expression of a neomorphic form of Uif, Uif*, causes Notch signaling defects in both the wing and the sensory organ precursors. Further experiments suggest that ectopic expression of Uif* inhibits Notch signaling in cis and acts at a step that is dependent on the extracellular domain of Notch. Our results suggest that Uif can alter the accessibility of the Notch extracellular domain to its ligands during Notch activation. Conclusions/Significance: Our study shows that Uif can modulate Notch activity, illustrating the importance of a delicate regulation of this signaling pathway for normal patterning.	[Xie, Gengqiang; Zhang, Hongtao; Du, Guiping; Huang, Qinglei; Liang, Xuehong; Jiao, Renjie] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Xie, Gengqiang; Zhang, Hongtao; Du, Guiping] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Xie, Gengqiang; Ma, Jun] Cincinnati Childrens Res Fdn, Div Biomed Informat, Cincinnati, OH USA; [Ma, Jun] Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Xie, GQ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	jun.ma@cchmc.org; rjiao@sun5.ibp.ac.cn	Jiao, Renjie/AAE-8902-2019; XIE, Gengqiang/R-9285-2016; Ma, Jun/GLT-4809-2022	XIE, Gengqiang/0000-0002-2064-4757; Ma, Jun/0000-0002-1609-3294	973 program [2009CB918702]; NSFC [31071087]; NIH; NSF	973 program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was supported in part by grants from the 973 program (2009CB918702) and the NSFC (31071087) (to RJ) and from NIH and NSF (to JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Ahmed A, 2003, DEVELOPMENT, V130, P6295, DOI 10.1242/dev.00796; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Callebaut I, 2000, PROTEIN SCI, V9, P1382, DOI 10.1110/ps.9.7.1382; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Couso JP, 1995, CURR BIOL, V5, P1437, DOI 10.1016/S0960-9822(95)00281-8; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; deCelis JF, 1997, DEVELOPMENT, V124, P3241; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Escudero LM, 2003, DEVELOPMENT, V130, P6305, DOI 10.1242/dev.00869; Fiuza UM, 2010, DEV DYNAM, V239, P798, DOI 10.1002/dvdy.22207; Gho M, 1996, DEVELOPMENT, V122, P1673; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Huang H, 2011, DEVELOPMENT, V138, P2477, DOI 10.1242/dev.061770; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; KANE WH, 1988, BLOOD, V71, P539; Kim IM, 2010, CIRC RES, V106, P1233, DOI 10.1161/CIRCRESAHA.109.213785; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Koles K, 2007, GLYCOBIOLOGY, V17, P1388, DOI 10.1093/glycob/cwm097; Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418; Lee EC, 1996, MOL CELL BIOL, V16, P1179; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Li Yanxia, 2004, BMC Dev Biol, V4, P5, DOI 10.1186/1471-213X-4-5; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Ligoxygakis P, 1999, DEVELOPMENT, V126, P2205; Liu JY, 2011, J GENET GENOMICS, V38, P225, DOI 10.1016/j.jgg.2011.05.002; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Pi HW, 2001, DEVELOPMENT, V128, P2699; Powell PA, 2001, NATURE, V409, P626, DOI 10.1038/35054566; Prout M, 1997, GENETICS, V146, P275; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Sun X, 1996, DEVELOPMENT, V122, P2465; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Wang SW, 1997, DEVELOPMENT, V124, P4435; Xu YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006107; Zhang L, 2009, DEV BIOL, V336, P201, DOI 10.1016/j.ydbio.2009.09.040	53	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36362	10.1371/journal.pone.0036362	http://dx.doi.org/10.1371/journal.pone.0036362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558447	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200070
J	Ioannoni, R; Beaudoin, J; Lopez-Maury, L; Codlin, S; Bahler, J; Labbe, S				Ioannoni, Raphael; Beaudoin, Jude; Lopez-Maury, Luis; Codlin, Sandra; Bahler, Jurg; Labbe, Simon			Cuf2 Is a Novel Meiosis-Specific Regulatory Factor of Meiosis Maturation	PLOS ONE			English	Article							MEMBRANE COPPER TRANSPORTER; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; SEXUAL-DIFFERENTIATION; GENOME SEQUENCE; DNA-BINDING; RECOMBINATION; SPORULATION; IDENTIFICATION	Background: Meiosis is the specialized form of the cell cycle by which diploid cells produce the haploid gametes required for sexual reproduction. Initiation and progression through meiosis requires that the expression of the meiotic genes is precisely controlled so as to provide the correct gene products at the correct times. During meiosis, four temporal gene clusters are either induced or repressed by a cascade of transcription factors. Principal Findings: In this report a novel copper-fist-type regulator, Cuf2, is shown to be expressed exclusively during meiosis. The expression profile of the cuf2(+) mRNA revealed that it was induced during middle-phase meiosis. Both cuf2(+) mRNA and protein levels are unregulated by copper addition or starvation. The transcription of cuf2(+) required the presence of a functional mei4(+) gene encoding a key transcription factor that activates the expression of numerous middle meiotic genes. Microscopic analyses of cells expressing a functional Cuf2-GFP protein revealed that Cuf2 co-localized with both homologous chromosomes and sister chromatids during the meiotic divisions. Cells lacking Cuf2 showed an elevated and sustained expression of several of the middle meiotic genes that persisted even during late meiosis. Moreover, cells carrying disrupted cuf2 Delta/cuf2 Delta alleles displayed an abnormal morphology of the forespore membranes and a dramatic reduction of spore viability. Significance: Collectively, the results revealed that Cuf2 functions in the timely repression of the middle-phase genes during meiotic differentiation.	[Ioannoni, Raphael; Beaudoin, Jude; Labbe, Simon] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada; [Lopez-Maury, Luis; Codlin, Sandra; Bahler, Jurg] UCL, Dept Genet Evolut & Environm, London, England	University of Sherbrooke; University of London; University College London	Ioannoni, R (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Simon.Labbe@USherbrooke.ca	Bahler, Jurg/B-4572-2009; Lopez-Maury, Luis/B-3715-2015	Bahler, Jurg/0000-0003-4036-1532; Lopez-Maury, Luis/0000-0002-3510-0621; Labbe, Simon/0000-0002-4947-523X	Canadian Institutes of Health Research (CIHR) [MOP-3645, MOP-114986]; Foundation of Stars for Children's Health Research; Cancer Research UK grant (CUK) [C9546/A6517]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Foundation of Stars for Children's Health Research; Cancer Research UK grant (CUK)	This work was supported in part by grants MOP-3645 and MOP-114986 from the Canadian Institutes of Health Research (CIHR), and by a grant from the Foundation of Stars for Children's Health Research awarded to SL. This study was also supported by a Cancer Research UK grant (CUK C9546/A6517) to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, GENETICS, V154, P1497; Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Beaudoin J, 2006, EUKARYOT CELL, V5, P277, DOI 10.1128/EC.5.2.277-292.2006; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Beaudoin J, 2003, J BIOL CHEM, V278, P14565, DOI 10.1074/jbc.M300861200; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Beaudoin J, 2007, EUKARYOT CELL, V6, P764, DOI 10.1128/EC.00002-07; Beaudoin J, 2011, J BIOL CHEM, V286, P34356, DOI 10.1074/jbc.M111.280396; Beaudoin J, 2011, MICROBIOL-SGM, V157, P1021, DOI 10.1099/mic.0.046854-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Davis L, 2001, P NATL ACAD SCI USA, V98, P8395, DOI 10.1073/pnas.121005598; Doll E, 2008, GENETICS, V180, P727, DOI 10.1534/genetics.108.092619; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Jensen LT, 1998, EMBO J, V17, P5400, DOI 10.1093/emboj/17.18.5400; KEENEY JB, 1994, GENETICS, V136, P849; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Klutstein M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-478; Koch KA, 1996, MOL CELL BIOL, V16, P724; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Li YF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-125; Lindgren A, 2000, EMBO J, V19, P6489, DOI 10.1093/emboj/19.23.6489; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; Nevitt T, 2012, BIOCH BIOPH IN PRESS; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Shigehisa A, 2010, MOL BIOL CELL, V21, P1955, DOI 10.1091/mbc.E09-12-0997; Shimoda C, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P311; Staub C, 2001, J ANDROL, V22, P911; Turner RB, 1998, NAT STRUCT BIOL, V5, P551, DOI 10.1038/805; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Yamamoto M, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P297; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200; Zhu ZW, 1998, J BIOL CHEM, V273, P1277, DOI 10.1074/jbc.273.3.1277	54	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36338	10.1371/journal.pone.0036338	http://dx.doi.org/10.1371/journal.pone.0036338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558440	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000192
J	Kabakyenga, JK; Ostergren, PO; Turyakira, E; Pettersson, KO				Kabakyenga, Jerome K.; Ostergren, Per-Olof; Turyakira, Eleanor; Pettersson, Karen Odberg			Influence of Birth Preparedness, Decision-Making on Location of Birth and Assistance by Skilled Birth Attendants among Women in South-Western Uganda	PLOS ONE			English	Article							MATERNAL HEALTH; COMPLICATION READINESS; MALE INVOLVEMENT; CARE; DELIVERY; SERVICES; DISTRICT; ACCESS; PREGNANCY; MORTALITY	Introduction: Assistance by skilled birth attendants (SBAs) during childbirth is one of the strategies aimed at reducing maternal morbidity and mortality in low-income countries. However, the relationship between birth preparedness and decision-making on location of birth and assistance by skilled birth attendants in this context is not well studied. The aim of this study was to assess the influence of birth preparedness practices and decision-making and assistance by SBAs among women in south-western Uganda. Methods: Community survey methods were used to identify 759 recently delivered women from 120 villages in rural Mbarara district. Interviewer-administered questionnaires were used to collect data. Logistic regression analyses were conducted to assess the relationship between birth preparedness, decision-making on location of birth and assistance by SBAs. Results: 35% of the women had been prepared for childbirth and the prevalence of assistance by SBAs in the sample was 68%. The final decision regarding location of birth was made by the woman herself (36%), the woman with spouse (56%) and the woman with relative/friend (8%). The relationships between birth preparedness and women decision-making on location of birth in consultation with spouse/friends/relatives and choosing assistance by SBAs showed statistical significance which persisted after adjusting for possible confounders (OR 1.5, 95% CI: 1.0-2.4) and (OR 4.4, 95% CI: 3.0-6.7) respectively. Education, household assets and birth preparedness showed clear synergistic effect on the relationship between decision-maker on location of birth and assistance by SBAs. Other factors which showed statistical significant relationships with assistance by SBAs were ANC attendance, parity and residence. Conclusion: Women's decision-making on location of birth in consultation with spouse/friends/relatives and birth preparedness showed significant effect on choosing assistance by SBAs at birth. Education and household assets ownership showed a synergistic effect on the relationship between the decision-maker and assistance by SBAs.	[Kabakyenga, Jerome K.; Ostergren, Per-Olof; Pettersson, Karen Odberg] Lund Univ, Dept Clin Sci Social Med & Global Hlth, Malmo, Sweden; [Kabakyenga, Jerome K.; Turyakira, Eleanor] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda	Lund University; Mbarara University of Science & Technology	Kabakyenga, JK (corresponding author), Lund Univ, Dept Clin Sci Social Med & Global Hlth, Malmo, Sweden.	Jerome.Kabakyenga@med.lu.se			Swedish International Development Cooperation Agency/SAREC [SWE-2009-084]; Global Health Research Initiative [103460-069]; Mbarara District Health Office	Swedish International Development Cooperation Agency/SAREC; Global Health Research Initiative; Mbarara District Health Office	External funding for this study was made possible by Grants from Swedish International Development Cooperation Agency/SAREC (SWE-2009-084 http://www.sida.se/English/Partners/Universities-and-research/From-funding-research-to-fighting-poverty)and Global Health Research Initiative (Centre File: 103460-069ttp://www.idrc.ca/EN/Programs/Global_Health_Policy/Global_Health_Research_Initiative/Pages/ProjectsList.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the contributions of all study participants and the following research assistants; Phionah Kyomuhendo, Bruce Natukunda, John Baptist Mwebesa, Angella Natukunda, Bob Harold Ashabahebwa, Innocent Tukashaba, Joanita Tumwikirize, Bridget Atuhairwe, Angel Kyompaire, Elizabeth Ayebazibwe, Peace Nagyemba, Eleanor Byaruhanga and Edmund Akatuhamya. The support provided by Mbarara District Health Office is also acknowledged.	Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Amooti-Kaguna B, 2000, SOC SCI MED, V50, P203, DOI 10.1016/S0277-9536(99)00275-0; Aschengrau A, 2008, ESSENTIALS EPIDEMIOL, P343; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; de Bernis L, 2003, BRIT MED BULL, V67, P39, DOI 10.1093/bmb/ldg017; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Essendi H, 2011, J URBAN HEALTH, V88, P356, DOI 10.1007/s11524-010-9481-1; Fotso Jean-Christophe, 2009, Reprod Health, V6, P9, DOI 10.1186/1742-4755-6-9; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Hindin MJ, 2011, J SEX RES, V48, P511, DOI 10.1080/00224499.2011.554918; Iliyasu Zubairu, 2010, Afr J Reprod Health, V14, P21; JHPIEGO, 2004, MON BIRTH PREP COMPL; Kabakyenga JK, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8529; Kakaire O, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-12; Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403; Koblinsky MA, 1999, B WORLD HEALTH ORGAN, V77, P399; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; Mbarara, 2011, MBAR DISTR HLTH SUMM; Merchant N, 2010, DECISION MAKING RELA; Ministry of Finance and Economic Development Uganda, 2010, MILL DEV GOALS REP U; Ministry of Health Uganda, 2008, ROAD MAP ACC RED MAT; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Mullany BC, 2005, SOC SCI MED, V61, P1993, DOI 10.1016/j.socscimed.2005.04.006; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Mulogo E M, 2006, East Afr Med J, V83, P74; Orji EO, 2007, J TURK-GER GYNECOL A, V8, P240; Osubor KM, 2006, MATERN CHILD HLTH J, V10, P159, DOI 10.1007/s10995-005-0037-z; Parkhurst JO, 2006, J HEALTH POPUL NUTR, V24, P438; Pathmanathan I., 2003, INT BANK RECONSTRUCT; Perreira Krista M, 2002, Matern Child Health J, V6, P19, DOI 10.1023/A:1014360015605; Post M, 1997, PREVENTING MATERNAL; Sharma SK, 2007, J BIOSOC SCI, V39, P671, DOI 10.1017/S0021932007001952; Starrs AM, 2007, LANCET, V370, P1285, DOI 10.1016/S0140-6736(07)61549-9; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; Uganda Bureau of Statistics Macro International Inc, 2007, UG DEM HLTH SURV 200, P119; United Nations General Assembly, 2000, UN MILL DECL; United Nations Population Fund, 1994, INT C POP DEV PROGR; World Health Organization department of reproductive health and research, 2004, MAK PREGN SAF CRIT R, P1; Zere E, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-34	44	84	84	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35747	10.1371/journal.pone.0035747	http://dx.doi.org/10.1371/journal.pone.0035747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558214	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000055
J	LoMauro, A; Pochintesta, S; Romei, M; D'Angelo, MG; Pedotti, A; Turconi, AC; Aliverti, A				LoMauro, Antonella; Pochintesta, Simona; Romei, Marianna; D'Angelo, Maria Grazia; Pedotti, Antonio; Turconi, Anna Carla; Aliverti, Andrea			Rib Cage Deformities Alter Respiratory Muscle Action and Chest Wall Function in Patients with Severe Osteogenesis Imperfecta	PLOS ONE			English	Article							MECHANICS; MOTION; VOLUME; LIFE	Background: Osteogenesis imperfecta (OI) is an inherited connective tissue disorder characterized by bone fragility, multiple fractures and significant chest wall deformities. Cardiopulmonary insufficiency is the leading cause of death in these patients. Methods: Seven patients with severe OI type III, 15 with moderate OI type IV and 26 healthy subjects were studied. In addition to standard spirometry, rib cage geometry, breathing pattern and regional chest wall volume changes at rest in seated and supine position were assessed by opto-electronic plethysmography to investigate if structural modifications of the rib cage in OI have consequences on ventilatory pattern. One-way or two-way analysis of variance was performed to compare the results between the three groups and the two postures. Results: Both OI type III and IV patients showed reduced FVC and FEV1 compared to predicted values, on condition that updated reference equations are considered. In both positions, ventilation was lower in OI patients than control because of lower tidal volume (p<0.01). In contrast to OI type IV patients, whose chest wall geometry and function was normal, OI type III patients were characterized by reduced (p<0.01) angle at the sternum (pectus carinatum), paradoxical inspiratory inward motion of the pulmonary rib cage, significant thoraco-abdominal asynchronies and rib cage distortions in supine position (p<0.001). Conclusions: In conclusion, the restrictive respiratory pattern of Osteogenesis Imperfecta is closely related to the severity of the disease and to the sternal deformities. Pectus carinatum characterizes OI type III patients and alters respiratory muscles coordination, leading to chest wall and rib cage distortions and an inefficient ventilator pattern. OI type IV is characterized by lower alterations in the respiratory function. These findings suggest that functional assessment and treatment of OI should be differentiated in these two forms of the disease.	[LoMauro, Antonella; Pedotti, Antonio; Aliverti, Andrea] Politecn Milan, TBMLab, Dipartimento Bioingn, I-20133 Milan, Italy; [Pochintesta, Simona; Romei, Marianna; D'Angelo, Maria Grazia; Turconi, Anna Carla] IRCCS E Medea, Bosisio Parini, Lc, Italy	Polytechnic University of Milan; IRCCS Eugenio Medea	LoMauro, A (corresponding author), Politecn Milan, TBMLab, Dipartimento Bioingn, I-20133 Milan, Italy.	andrea.aliverti@polimi.it	D'Angelo, Maria Grazia/K-4685-2016; Andrea, Aliverti/A-3901-2015; Turconi, Anna Carla/ABE-6747-2020; Turconi, Anna Carla/AAX-6521-2020	D'Angelo, Maria Grazia/0000-0003-1241-4350; Andrea, Aliverti/0000-0002-2950-0231; Turconi, Anna Carla/0000-0002-5482-924X; LoMauro, Antonella/0000-0002-1408-6971	Fondazione Cariplo: Health Innovation Network Technology @ Lecco (HINT@Lecco)	Fondazione Cariplo: Health Innovation Network Technology @ Lecco (HINT@Lecco)	This work was supported by a grant of Fondazione Cariplo: Health Innovation Network Technology @ Lecco (HINT@Lecco). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTONI E, 1966, J APPL PHYSIOL, V21, P1827, DOI 10.1152/jappl.1966.21.6.1827; Aliverti A, 1997, J APPL PHYSIOL, V83, P1256, DOI 10.1152/jappl.1997.83.4.1256; Aliverti A, 2001, ANN BIOMED ENG, V29, P60, DOI 10.1114/1.1332084; Antoniazzi F, 2000, Paediatr Drugs, V2, P465, DOI 10.2165/00128072-200002060-00005; BENSON DR, 1978, J BONE JOINT SURG AM, V60, P925, DOI 10.2106/00004623-197860070-00009; Cala SJ, 1996, J APPL PHYSIOL, V81, P2680, DOI 10.1152/jappl.1996.81.6.2680; Chihara K, 1996, J APPL PHYSIOL, V81, P437, DOI 10.1152/jappl.1996.81.1.437; DETROYER A, 1985, J CLIN INVEST, V75, P850, DOI 10.1172/JCI111782; DRUZ WS, 1981, J APPL PHYSIOL, V51, P1552, DOI 10.1152/jappl.1981.51.6.1552; FALVO KA, 1973, AM REV RESPIR DIS, V108, P1258; Kenyon CM, 1997, J APPL PHYSIOL, V83, P1242, DOI 10.1152/jappl.1997.83.4.1242; KONNO K, 1967, J APPL PHYSIOL, V22, P407, DOI 10.1152/jappl.1967.22.3.407; Kuster SP, 2008, EUR RESPIR J, V31, P860, DOI 10.1183/09031936.00091407; Lo Mauro A, 2010, EUR RESPIR J, V35, P1118, DOI 10.1183/09031936.00037209; McAllion SJ, 1996, J CLIN PATHOL, V49, P627, DOI 10.1136/jcp.49.8.627; PATERSON CR, 1987, ACTA PAEDIATR SCAND, V76, P548, DOI 10.1111/j.1651-2227.1987.tb10519.x; Paterson CR, 1996, BRIT MED J, V312, P351; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Romei M, 2010, RESP PHYSIOL NEUROBI, V172, P184, DOI 10.1016/j.resp.2010.05.018; SACKNER MA, 1984, AM REV RESPIR DIS, V130, P588; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SILLENCE DO, 1986, AM J MED GENET, V23, P821, DOI 10.1002/ajmg.1320230309; Singer R B, 2001, J Insur Med, V33, P216; Stanojevic S, 2010, EUR RESPIR J, V36, P12, DOI 10.1183/09031936.00143209; Takken T, 2004, J PEDIATR-US, V145, P813, DOI 10.1016/j.jpeds.2004.08.003; Van Dijk FS, 2010, EUR J MED GENET, V53, P1, DOI 10.1016/j.ejmg.2009.10.007; Widmann RF, 1999, SPINE, V24, P1673, DOI 10.1097/00007632-199908150-00008	28	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35965	10.1371/journal.pone.0035965	http://dx.doi.org/10.1371/journal.pone.0035965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558284	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000092
J	Sami, N; Ali, TS; Wasim, S; Saleem, S				Sami, Neelofar; Ali, Tazeen Saeed; Wasim, Saba; Saleem, Sarah			Risk Factors for Secondary Infertility among Women in Karachi, Pakistan	PLOS ONE			English	Article							MORBIDITY; SERVICE; HEALTH	Background: Secondary infertility in developing countries is mostly attributable to blockage of the fallopian tubes due to adhesions caused by reproductive tract infections. There is a dearth of information on the prevalence and causes of secondary infertility from Pakistan. This paper presents results on factors associated with secondary infertility among married women in Karachi, Pakistan. Methods: A matched case-control study was conducted. Cases were women aged 15-35 years with history of at least one previous conception and currently seeking treatment for secondary infertility. Controls were women residing in the neighborhood of cases with at least one live birth and not taking treatment for secondary infertility. The age of controls was matched by +/- 5 years to that of cases. Data was collected from June to August 2003. Conditional logistic regression was used to determine crude and adjusted odds ratios (OR) with corresponding 95% confidence intervals (CI) for factors associated with secondary infertility. Results: The final multivariate logistic regression model revealed that after adjusting for age, cases were more likely to be the housewives (AOR = 2.6, 95% CI: 1.5-4.4), had used inappropriate material to absorb blood during menstruation (AOR = 9.0, 95% CI: 5.0-16.4), and at their last delivery, had a birth attendant who did not wash hands with soap and water (AOR = 3.0, 95% CI: 1.4-5.7). Moreover, women with secondary infertility were more likely to report current or past history of having STI symptoms (AOR = 3.6, 95% CI: 2.4-5.6) and use of intra-vaginal indigenous medicines during their last postpartum period (AOR = 3.1, 95% CI: 1.6-5.7). Conclusion: We recommend health education and awareness messages for safe practices during menstruation, delivery, and the postpartum period for women in general. Additionally, sanitary napkins should be made available at an affordable cost, and safe delivery kits should contain educational/pictorial brochures for appropriate hand washing skills.	[Sami, Neelofar; Ali, Tazeen Saeed; Wasim, Saba; Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Ali, Tazeen Saeed] Aga Khan Univ, Sch Nursing, Karachi, Pakistan	Aga Khan University; Aga Khan University	Sami, N (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan.	neelofar.sami@aku.edu	S Ali, Tazeen/AAC-8790-2022; Ali, Tazeen Saeed/AAW-5284-2020	S Ali, Tazeen/0000-0002-8896-8766; 	Seed Money Grant [SM 020405]	Seed Money Grant	This work was supported by a Seed Money Grant (ID # SM 020405). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzahr C, 2003, CONTEMP OBSTET GYNEC, P128; Ali Tazeen Saeed, 2006, J Pak Med Assoc, V56, P99; Ali TS, 2007, J HEALTH POPUL NUTR, V25, P189; Alsaawi M, 2000, GENUS, VLVI, P99; Bhurt Abdul Wahid, 1999, JPMA (Journal of the Pakistan Medical Association), V49, P188; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; CATES W, 1990, EPIDEMIOL REV, V12, P199, DOI 10.1093/oxfordjournals.epirev.a036054; CHATURVEDI SK, 1993, J PSYCHOSOM RES, V37, P575, DOI 10.1016/0022-3999(93)90051-G; De Silva WI, 1998, SOC BIOL, V45, P223; Durr-e-Nayab, 2005, Pakistan Development Review, V44, P131; Farley TMM, 1988, P AFR POP C DAK; Farr G, 1998, ADV CONTRACEPT, V14, P45, DOI 10.1023/A:1006575610716; Fikree F, 2001, TRADITIONAL PRACTICE; Fikree FF, 2004, SOC SCI MED, V59, P681, DOI 10.1016/j.socscimed.2003.11.034; Ghani Nasreen, 2007, J Pak Med Assoc, V57, P363; Goodburn EA, 1994, INVESTIGATION NATURE; HERNADI Z, 1986, ACTA MED HUNG, V43, P155; Hossain MA, 1989, ROLE TRADITIONAL BIR; Inhorn MC, 1994, ANTHR INFECT DIS INT, P173; KHATAMEE MA, 1988, INT J FERTIL, V33, P246; KOCHAR M, 1980, AM J OBSTET GYNECOL, V138, P872, DOI 10.1016/0002-9378(80)91074-1; Larsen U., 2003, J HLTH POPULATION DE, P1; LARSON E, 1988, INFECT CONT HOSP EP, V9, P28, DOI 10.1086/645729; Lunenfeld B, 2004, HUM REPROD UPDATE, V10, P317, DOI 10.1093/humupd/dmh028; Mathews A, 1995, FOOTSTEPS, V24, P2; Mayaud P., 2001, WOMEN INFERTILITY SU, p71 ; Population Council, 1999, REPR TRACT INF SET F; Qureshi MS, 1991, INFERTILITY PAKISTAN, P222; Saleem S, 2007, OBSTET GYNECOL, V110, P977, DOI 10.1097/01.AOG.0000285653.17869.26; SATHAR Z, 1988, POPUL DEV REV, V14, P415, DOI 10.2307/1972196; Shahid NS, 1996, J DIARRHOEAL DIS RES, V14, P85; Siemer J, 2008, AM J TROP MED HYG, V78, P323, DOI 10.4269/ajtmh.2008.78.323; SPIRA A, 1986, HUM REPROD, V1, P111, DOI 10.1093/oxfordjournals.humrep.a136353; TZONOU A, 1993, J EPIDEMIOL COMMUN H, V47, P36, DOI 10.1136/jech.47.1.36; United Nations, 1993, WOM STAT FERT PAK RE; *WHO, 1991, INF TAB AV DAT PREV; World Health Organization, 1994, CHALL REPR HLTH RES; World Health Organization, 2009, WHO GUID HAND HYG HL; World Health Organization (WHO), 2008, PROP BIRTHS ATT SKIL	39	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35828	10.1371/journal.pone.0035828	http://dx.doi.org/10.1371/journal.pone.0035828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558233	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000064
J	Shen, C; Zhang, GL; Meng, Q				Shen, Chong; Zhang, Guoliang; Meng, Qin			Regulation of Epithelial Cell Morphology and Functions Approaching To More In Vivo-Like by Modifying Polyethylene Glycol on Polysulfone Membranes	PLOS ONE			English	Article							3-DIMENSIONAL CULTURE; HUMAN HEPATOCYTES; TISSUE; CYTOCOMPATIBILITY; PROLIFERATION; MORPHOGENESIS; BIOMATERIALS; HYDROGELS; ADHESION; INSIGHTS	Cytocompatibility is critically important in design of biomaterials for application in tissue engineering. However, the currently well-accepted "cytocompatible" biomaterials are those which promote cells to sustain good attachment/spreading. The cells on such materials usually lack the self-assembled cell morphology and high cell functions as in vivo. In our view, biomaterials that can promote the ability of cells to self-assemble and demonstrate cell-specific functions would be cytocompatible. This paper examined the interaction of polyethylene glycol (PEG) modified polysulfone (PSf) membranes with four epithelial cell types (primary liver cells, a liver tumor cell line, and two renal tubular cell lines). Our results show that PSf membranes modified with proper PEG promoted the aggregation of both liver and renal cells, but the liver cells more easily formed aggregates than the renal tubular cells. The culture on PEG-modified PSf membranes also enhanced cell-specific functions. In particular, the cells cultured on F127 membranes with the proper PEG content mimicked the in vivo ultrastructure of liver cells or renal tubules cells and displayed the highest cell functions. Gene expression data for adhesion proteins suggest that the PEG modification impaired cell-membrane interactions and increased cell-cell interactions, thus facilitating cell self-assembly. In conclusion, PEG-modified membrane could be a cytocompatible material which regulates the morphology and functions of epithelial cells in mimicking cell performance in vivo.	[Shen, Chong; Meng, Qin] Zhejiang Univ, Dept Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Guoliang] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University of Technology	Shen, C (corresponding author), Zhejiang Univ, Dept Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China.	mengq@zju.edu.cn	chong, shen/AAG-5560-2019		National Natural Science Foundation of China [21076186, 21006089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (No 21076186 and 21006089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia M, 2011, BIOMATERIALS, V32, P450, DOI 10.1016/j.biomaterials.2010.09.010; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Cho CS, 2006, BIOMATERIALS, V27, P576, DOI 10.1016/j.biomaterials.2005.06.008; Dahe GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025236; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Domhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021283; Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8; Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103; ISHIKURA H, 1993, VIRCHOWS ARCH B, V63, P115, DOI 10.1007/BF02899250; Jameson JL, 2010, HARRISONS NEPHROLOGY; Kafi MA, 2012, BIOMATERIALS, V33, P731, DOI 10.1016/j.biomaterials.2011.10.003; Lahiri D, 2010, ACTA BIOMATER, V6, P3524, DOI 10.1016/j.actbio.2010.02.044; Lan SF, 2010, TOXICOL IN VITRO, V24, P1314, DOI 10.1016/j.tiv.2010.02.015; Lang R, 2011, BIOMATERIALS, V32, P7042, DOI 10.1016/j.biomaterials.2011.06.005; Legallais C, 2001, J MEMBRANE SCI, V181, P81, DOI 10.1016/S0376-7388(00)00539-1; Liver Cancer: The New Epidemic, LIVER CANC NEW EPIDE; Lu HF, 2003, BIOMATERIALS, V24, P4893, DOI 10.1016/S0142-9612(03)00404-6; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Payen L, 2001, BRIT J PHARMACOL, V132, P778, DOI 10.1038/sj.bjp.0703863; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; Saito A, 2011, HEMODIAL INT, V15, P183, DOI 10.1111/j.1542-4758.2011.00530.x; Salerno S, 2011, BIOMATERIALS, V32, P8848, DOI 10.1016/j.biomaterials.2011.08.004; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shen C, 2011, J MEMBRANE SCI, V369, P474, DOI 10.1016/j.memsci.2010.12.016; SZASZ G, 1969, CLIN CHEM, V15, P124; Takahashi H, 2011, BIOMATERIALS, V32, P8830, DOI 10.1016/j.biomaterials.2011.08.006; Teo JCM, 2011, ACTA BIOMATER, V7, P2060, DOI 10.1016/j.actbio.2011.01.009; Vermonden T, 2008, BIOMACROMOLECULES, V9, P919, DOI 10.1021/bm7013075; von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059; Watanabe J, 2005, BIOMACROMOLECULES, V6, P1797, DOI 10.1021/bm050138f; Wilkening S, 2003, J BIOCHEM MOL TOXIC, V17, P207, DOI 10.1002/jbt.10085; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Zhao LZ, 2010, BIOMATERIALS, V31, P2055, DOI 10.1016/j.biomaterials.2009.11.103; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044	41	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36110	10.1371/journal.pone.0036110	http://dx.doi.org/10.1371/journal.pone.0036110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558349	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000130
J	Kuo, HC; Wang, TY; Hsu, HH; Chen, PP; Lee, SH; Chen, YM; Tsai, TJ; Wang, CK; Ku, HT; Lee, GB; Chen, TY				Kuo, Hsiao-Che; Wang, Ting-Yu; Hsu, Hao-Hsuan; Chen, Peng-Peng; Lee, Szu-Hsien; Chen, Young-Mao; Tsai, Tieh-Jung; Wang, Chien-Kai; Ku, Hsiao-Tung; Lee, Gwo-Bin; Chen, Tzong-Yueh			Nervous Necrosis Virus Replicates Following the Embryo Development and Dual Infection with Iridovirus at Juvenile Stage in Grouper	PLOS ONE			English	Article							LARVAL STRIPED JACK; SALMON SALMO-SALAR; VERTICAL TRANSMISSION; PSEUDOCARANX-DENTEX; VIBRIO-ANGUILLARUM; MARINE FISH; HBV DNA; NODAVIRUS; PROTEINS; SEQUENCE	Infection of virus (such as nodavirus and iridovirus) and bacteria (such as Vibrio anguillarum) in farmed grouper has been widely reported and caused large economic losses to Taiwanese fish aquaculture industry since 1979. The multiplex assay was used to detect dual viral infection and showed that only nervous necrosis virus (NNV) can be detected till the end of experiments (100% mortality) once it appeared. In addition, iridovirus can be detected in a certain period of rearing. The results of real-time PCR and in situ PCR indicated that NNV, in fact, was not on the surface of the eggs but present in the embryo, which can continue to replicate during the embryo development. The virus may be vertically transmitted by packing into eggs during egg development (formation) or delivering into eggs by sperm during fertilization. The ozone treatment of eggs may fail to remove the virus, so a new strategy to prevent NNV is needed.	[Kuo, Hsiao-Che; Wang, Ting-Yu; Hsu, Hao-Hsuan; Chen, Peng-Peng; Chen, Young-Mao; Tsai, Tieh-Jung; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Mol Genet Lab, Inst Biotechnol, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Res Ctr Ocean Environm & Technol, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Hsu, Hao-Hsuan; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Agr Biotechnol Res Ctr, Tainan 70101, Taiwan; [Lee, Szu-Hsien; Lee, Gwo-Bin] Natl Cheng Kung Univ, Inst Nanotechnol & Microsyst Engn, Tainan 70101, Taiwan; [Lee, Szu-Hsien; Lee, Gwo-Bin] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 70101, Taiwan; [Wang, Chien-Kai] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Miaoli, Taiwan; [Ku, Hsiao-Tung] Taiwan Inst Econ Res, Res Div 1, Taipei, Taiwan; [Ku, Hsiao-Tung] Natl Sci Council, Off Energy Strategy Dev, Taipei, Taiwan; [Lee, Gwo-Bin] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan; National Tsing Hua University	Kuo, HC (corresponding author), Natl Cheng Kung Univ, Mol Genet Lab, Inst Biotechnol, Tainan 70101, Taiwan.	gwobin@pme.nthu.edu.tw; ibcty@mail.ncku.edu.tw	Lee, Gwo-Bin Vincent/D-3032-2012	Lee, Gwo-Bin Vincent/0000-0001-6910-9133; Wang, Chien-Kai/0000-0002-9162-6820	Sanfong Technology Co. Ltd.; Council of Agriculture, Taiwan [97AS-14.3.1-BQ-B6, 98AS-5.4.2-BQ-B1, 99AS-5.3.1-ST-aC]	Sanfong Technology Co. Ltd.; Council of Agriculture, Taiwan	This research was funded and supported by Sanfong Technology Co. Ltd. and the Council of Agriculture, Taiwan (97AS-14.3.1-BQ-B6, 98AS-5.4.2-BQ-B1, 99AS-5.3.1-ST-aC to TYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BA, 2005, MOL REPROD DEV, V70, P30, DOI 10.1002/mrd.20185; Arimoto M, 1996, AQUACULTURE, V143, P15, DOI 10.1016/0044-8486(96)01261-6; Breuil G, 2002, J FISH DIS, V25, P697, DOI 10.1046/j.1365-2761.2002.00406.x; Chen YM, 2006, FISH SHELLFISH IMMUN, V20, P58, DOI 10.1016/j.fsi.2005.04.001; Chou HY, 1998, FISH PATHOL, V33, P201, DOI 10.3147/jsfp.33.201; Emmy E, 1987, AQUACULTURE, V67, P15; Fenner BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006; Gomez DK, 2004, J FISH DIS, V27, P603, DOI 10.1111/j.1365-2761.2004.00577.x; Grotmol S, 2000, DIS AQUAT ORGAN, V39, P89, DOI 10.3354/dao039089; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Huang TH, 2005, WORLD J GASTROENTERO, V11, P2869, DOI 10.3748/wjg.v11.i19.2869; Huang YH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-224; Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963; Kai YH, 2010, VACCINE, V28, P996, DOI 10.1016/j.vaccine.2009.10.132; Kanthong N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-14; Kuo HC, 2011, J CLIN MICROBIOL, V49, P1090, DOI 10.1128/JCM.01016-10; Larochelle N, 2011, TRANSGENIC RES, V20, P123, DOI 10.1007/s11248-010-9401-x; Leong JAC, 1998, IMMUNOL REV, V166, P349, DOI 10.1111/j.1600-065X.1998.tb01275.x; Lien KY, 2009, MICROFLUID NANOFLUID, V7, P795, DOI 10.1007/s10404-009-0438-1; MEIER E, 1988, J VIROL, V62, P2386, DOI 10.1128/JVI.62.7.2386-2393.1988; Melville KJ, 1999, DIS AQUAT ORGAN, V38, P231, DOI 10.3354/dao038231; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; MULCAHY D, 1984, SCIENCE, V225, P333, DOI 10.1126/science.6740314; Munday BL, 1997, WORLD J MICROB BIOT, V13, P375, DOI 10.1023/A:1018516014782; MUNDAY BL, 1994, AUST VET J, V71, P384, DOI 10.1111/j.1751-0813.1994.tb00937.x; MYHR E, 1991, APPL ENVIRON MICROB, V57, P2750, DOI 10.1128/AEM.57.9.2750-2757.1991; NUOVO GJ, 1995, PCR METH APPL, V4, pS151; Nylund A, 2007, ARCH VIROL, V152, P151, DOI 10.1007/s00705-006-0825-9; Ohta T, 2011, FISH SHELLFISH IMMUN, V30, P1064, DOI 10.1016/j.fsi.2011.02.003; Pakingking R, 2005, FISH PATHOL, V40, P125, DOI 10.3147/jsfp.40.125; Samuelsen OB, 2006, DIS AQUAT ORGAN, V71, P239, DOI 10.3354/dao071239; Skliris GP, 2001, VIRUS RES, V75, P59, DOI 10.1016/S0168-1702(01)00225-8; SONG YL, 1988, FISH PATHOL, V23, P185, DOI 10.3147/jsfp.23.185; Tsai CT, 2005, J VIROL, V79, P2010, DOI 10.1128/JVI.79.4.2010-2023.2005; Verrier ER, 2011, DEV COMP IMMUNOL, V35, P1204, DOI 10.1016/j.dci.2011.03.012; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028586; Williams T, 2005, ADV VIRUS RES, V65, P173, DOI 10.1016/S0065-3527(05)65006-3	37	31	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36183	10.1371/journal.pone.0036183	http://dx.doi.org/10.1371/journal.pone.0036183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563447	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349100072
J	Swietach, P; Hulikova, A; Patiar, S; Vaughan-Jones, RD; Harris, AL				Swietach, Pawel; Hulikova, Alzbeta; Patiar, Shalini; Vaughan-Jones, Richard D.; Harris, Adrian L.			Importance of Intracellular pH in Determining the Uptake and Efficacy of the Weakly Basic Chemotherapeutic Drug, Doxorubicin	PLOS ONE			English	Article							TUMOR ACIDITY; CELL-LINES; TRANSPORTER SLC22A16; BREAST-CANCER; DNA-ADDUCTS; IN-VITRO; ADRIAMYCIN; DAUNORUBICIN; FLOW; ACCUMULATION	Low extracellular pH (pH(e)), that is characteristic of many tumours, tends to reduce the uptake of weakly basic drugs, such as doxorubicin, thereby conferring a degree of physiological resistance to chemotherapy. It has been assumed, from pH-partition theory, that the effect of intracellular pH (pH(i)) is symmetrically opposite, although this has not been tested experimentally. Doxorubicin uptake into colon HCT116 cells was measured using the drug's intrinsic fluorescence under conditions that alter pH(i) and pH(e) or pH(i) alone. Acutely, doxorubicin influx across the cell-membrane correlates with the trans-membrane pH-gradient (facilitated at alkaline pH(e) and acidic pH(i)). However, the protonated molecule is not completely membrane-impermeant and, therefore, overall drug uptake is less pH(e)-sensitive than expected from pH-partitioning. Once inside cells, doxorubicin associates with slowly-releasing nuclear binding sites. The occupancy of these sites increases with pH(i), such that steady-state drug uptake can be greater with alkaline cytoplasm, in contradiction to pH-partition theory. Measurements of cell proliferation demonstrate that doxorubicin efficacy is enhanced at alkaline pH(i) and that pH-partition theory is inadequate to account for this. The limitations in the predictive power of pH-partition theory arise because it only accounts for the pH(i)/pH(e)-sensitivity of drug entry into cells but not the drug's subsequent interactions that, independently, show pH(i)-dependence. In summary, doxorubicin uptake into cells is favoured by high pH(e) and high pH(i). This modified formalism should be taken into account when designing manoeuvres aimed at increasing doxorubicin efficacy.	[Swietach, Pawel; Hulikova, Alzbeta; Vaughan-Jones, Richard D.] Dept Physiol Anat & Genet, Oxford, England; [Patiar, Shalini; Harris, Adrian L.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford	Swietach, P (corresponding author), Dept Physiol Anat & Genet, Oxford, England.	pawel.swietach@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020; Harris, Adrian L/ABA-3343-2020	Swietach, Pawel/0000-0002-9945-9473; Harris, Adrian L/0000-0003-1376-8409	Royal Society; Medical Research Council; British Heart Foundation; Cancer Research UK; British Heart Foundation [RG/08/016/26423] Funding Source: researchfish; Cancer Research UK [11359] Funding Source: researchfish; Medical Research Council [G0700698] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; MRC [G0700698] Funding Source: UKRI	Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This works was supported by the Royal Society (PS), Medical Research Council (PS), British Heart Foundation (RDV-J) and Cancer Research UK (ALH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BYRN SR, 1978, J PHARM SCI, V67, P688, DOI 10.1002/jps.2600670532; CULLINANE C, 1994, NUCLEIC ACIDS RES, V22, P2296, DOI 10.1093/nar/22.12.2296; Cutts SM, 2005, IUBMB LIFE, V57, P73, DOI 10.1080/15216540500079093; DURAND RE, 1981, CANCER RES, V41, P3489; Gerweck LE, 2006, MOL CANCER THER, V5, P1275, DOI 10.1158/1535-7163.MCT-06-0024; Gerweck LE, 1999, BRIT J CANCER, V79, P838, DOI 10.1038/sj.bjc.6690134; Gerweck LE, 1996, CANCER RES, V56, P1194; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Huber V, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-57; Hulikova A, 2011, J BIOL CHEM, V286, P13815, DOI 10.1074/jbc.M111.219899; Karukstis KK, 1998, BIOPHYS CHEM, V73, P249, DOI 10.1016/S0301-4622(98)00150-1; Lee CM, 2006, BRIT J CANCER, V94, P863, DOI 10.1038/sj.bjc.6603010; LONG BH, 1991, CANCER RES, V51, P5275; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; LUK CK, 1989, JNCI-J NATL CANCER I, V81, P55, DOI 10.1093/jnci/81.1.55; Mahoney BP, 2003, BIOCHEM PHARMACOL, V66, P1207, DOI 10.1016/S0006-2952(03)00467-2; NOEL G, 1978, EUR J CANCER, V14, P363, DOI 10.1016/0014-2964(78)90206-2; Okabe M, 2005, BIOCHEM BIOPH RES CO, V333, P754, DOI 10.1016/j.bbrc.2005.05.174; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; Raghunand N, 2003, BIOCHEM PHARMACOL, V66, P1219, DOI 10.1016/S0006-2952(03)00468-4; Raghunand N, 2002, ACAD RADIOL, V9, pS481, DOI 10.1016/S1076-6332(03)80270-2; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Schindler M, 1996, BIOCHEMISTRY-US, V35, P2811, DOI 10.1021/bi952234e; SCHNEIDER YJ, 1979, CANCER CHEMOTH PHARM, V2, P7; SMALLEY RV, 1983, BREAST CANCER RES TR, V3, P209, DOI 10.1007/BF01803563; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; VAUPEL P, 1989, CANCER RES, V49, P6449; WU L, 1992, CANCER RES, V52, P3029	34	64	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35949	10.1371/journal.pone.0035949	http://dx.doi.org/10.1371/journal.pone.0035949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563426	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100052
J	Bentmann, E; Neumann, M; Tahirovic, S; Rodde, R; Dormann, D; Haass, C				Bentmann, Eva; Neumann, Manuela; Tahirovic, Sabina; Rodde, Ramona; Dormann, Dorothee; Haass, Christian			Requirements for Stress Granule Recruitment of Fused in Sarcoma (FUS) and TAR DNA-binding Protein of 43 kDa (TDP-43)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; HIPPOCAMPAL CORNU AMMONIS-1; C-TERMINAL FRAGMENTS; NEURONAL VULNERABILITY; BASOPHILIC INCLUSIONS; SPLICING REGULATION; MUTATIONS; ALS; NUCLEAR	Cytoplasmic inclusions containing TAR DNA-binding protein of 43 kDa (TDP-43) or Fused in sarcoma (FUS) are a hallmark of amyotrophic lateral sclerosis (ALS) and several subtypes of frontotemporal lobar degeneration (FTLD). FUS-positive inclusions in FTLD and ALS patients are consistently co-labeled with stress granule (SG) marker proteins. Whether TDP-43 inclusions contain SG markers is currently still debated. We determined the requirements for SG recruitment of FUS and TDP-43 and found that cytoplasmic mislocalization is a common prerequisite for SG recruitment of FUS and TDP-43. For FUS, the arginine-glycine-glycine zinc finger domain, which is the protein's main RNA binding domain, is most important for SG recruitment, whereas the glycine-rich domain and RNA recognition motif (RRM) domain have a minor contribution and the glutamine-rich domain is dispensable. For TDP-43, both the RRM1 and the C-terminal glycine-rich domain are required for SG localization. ALS-associated point mutations located in the glycine-rich domain of TDP-43 do not affect SG recruitment. Interestingly, a 25-kDa C-terminal fragment of TDP-43, which is enriched in FTLD/ALS cortical inclusions but not spinal cord inclusions, fails to be recruited into SG. Consistently, inclusions in the cortex of FTLD patients, which are enriched for C-terminal fragments, are not co-labeled with the SG marker poly(A)-binding protein 1 (PABP-1), whereas inclusions in spinal cord, which contain full-length TDP-43, are frequently positive for this marker protein.	[Bentmann, Eva; Rodde, Ramona; Dormann, Dorothee; Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Tahirovic, Sabina; Haass, Christian] DZNE German Ctr Neurodegenerat Dis, D-80336 Munich, Germany; [Neumann, Manuela] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Zurich; University Zurich Hospital	Haass, C (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	christian.haass@dzne.lmu.de	Neumann, Manuela/F-6558-2011	Neumann, Manuela/0000-0002-6232-4057; Dormann, Dorothee/0000-0002-9260-2775	Sonderforschungsbereich Molecular Mechanisms of Neurodegeneration [SFB 596]; Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF); EMBO post-doctoral fellowship; Robert Bosch Foundation; "Forschungsprofessur" of the Ludwig-Maximilians University	Sonderforschungsbereich Molecular Mechanisms of Neurodegeneration(German Research Foundation (DFG)); Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); EMBO post-doctoral fellowship(European Molecular Biology Organization (EMBO)); Robert Bosch Foundation; "Forschungsprofessur" of the Ludwig-Maximilians University	This work was supported by the Sonderforschungsbereich Molecular Mechanisms of Neurodegeneration (SFB 596), the Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF), and an EMBO post-doctoral fellowship (to D. D.).; Supported by the Robert Bosch Foundation. To whom correspondence may be addressed: Adolf-Butenandt-Institute, Biochemistry, Ludwig-Maximilians-University, Schillerstrasse 44, 80336 Munich, Germany. Tel.: 49-89-2180-75471; Fax: 49-89-2180-75415; E-mail: dorothee.dormann@dzne.lmu.de.; Supported by a "Forschungsprofessur" of the Ludwig-Maximilians University. To whom correspondence may be addressed: Adolf-Butenandt-Institute, Biochemistry, Ludwig-Maximilians-University and DZNE-German Center for Neurodegenerative Diseases, Munich, Schillerstrasse 44, 80336 Munich, Germany. Tel.: 49-89-2180-75471; Fax: 49-89-2180-75415; E-mail: christian.haass@dzne.lmu.de.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baumer D, 2010, NEUROLOGY, V75, P611, DOI 10.1212/WNL.0b013e3181ed9cde; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chio A, 2009, NEUROBIOL AGING, V30, P1272, DOI 10.1016/j.neurobiolaging.2009.05.001; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; DeGracia DJ, 2007, NEUROSCIENCE, V146, P562, DOI 10.1016/j.neuroscience.2007.01.050; Dewey C. M., 2012, BRAIN RES IN PRESS; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Fujita K, 2008, ACTA NEUROPATHOL, V116, P439, DOI 10.1007/s00401-008-0415-x; Furukawa Y, 2011, BBA-MOL BASIS DIS, V1812, P1577, DOI 10.1016/j.bbadis.2011.09.005; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Huang EJ, 2010, BRAIN PATHOL, V20, P1069, DOI 10.1111/j.1750-3639.2010.00413.x; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kayali F, 2005, NEUROSCIENCE, V134, P1223, DOI 10.1016/j.neuroscience.2005.05.047; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lashley T, 2011, BRAIN, V134, P2548, DOI 10.1093/brain/awr160; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V121, P207, DOI 10.1007/s00401-010-0764-0; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mackenzie IRA, 2008, CURR OPIN NEUROL, V21, P693, DOI 10.1097/WCO.0b013e3283168d1d; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; PRASAD DDK, 1994, ONCOGENE, V9, P3717; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	74	192	195	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23079	23094		10.1074/jbc.M111.328757	http://dx.doi.org/10.1074/jbc.M111.328757			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22563080	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000306495000064
J	Gupta, N; Hartmann, A; Lucius, R; Voelker, DR				Gupta, Nishith; Hartmann, Anne; Lucius, Richard; Voelker, Dennis R.			The Obligate Intracellular Parasite Toxoplasma gondii Secretes a Soluble Phosphatidylserine Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MAMMALIAN-CELLS; PARASITOPHOROUS VACUOLE; MEMBRANE; INVASION; SYNTHASE; GENE; BIOSYNTHESIS; PURIFICATION; APICOMPLEXA	Toxoplasma gondii is an obligate intracellular parasite capable of causing fatal infections in immunocompromised individuals and neonates. Examination of the phosphatidylserine (PtdSer) metabolism of T. gondii reveals that the parasite secretes a soluble form of PtdSer decarboxylase (TgPSD1), which preferentially decarboxylates liposomal PtdSer with an apparent K-m of 67 mu M. The specific enzyme activity increases by 3-fold during the replication of T. gondii, and soluble phosphatidylserine decarboxylase (PSD) accounts for similar to 20% of the total PSD, prior to the parasite egress from the host cells. Extracellular T. gondii secreted similar to 20% of its total PSD activity at 37 degrees C, and the intracellular Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis (acetoxymethyl ester) inhibited the process by 50%. Cycloheximide, brefeldin A, ionic composition of the medium, and exogenous PtdSer did not modulate the enzyme secretion, which suggests a constitutive discharge of a presynthesized pool of PSD in axenic T. gondii. TgPSD1 consists of 968 amino acids with a 26-amino acid hydrophobic peptide at the N terminus and no predicted membrane domains. Parasites overexpressing TgPSD1-HA secreted 10-fold more activity compared with the parental strain. Exposure of apoptotic Jurkat cells to transgenic parasites demonstrated interfacial catalysis by secreted TgPSD1 that reduced host cell surface exposure of PtdSer. Immunolocalization experiments revealed that TgPSD1 resides in the dense granules of T. gondii and is also found in the parasitophorous vacuole of replicating parasites. Together, these findings demonstrate novel features of the parasite enzyme because a secreted, soluble, and interfacially active form of PSD has not been previously described for any organism.	[Gupta, Nishith; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Gupta, Nishith; Hartmann, Anne; Lucius, Richard] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany	National Jewish Health; Humboldt University of Berlin	Gupta, N (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	Gupta.Nishith@staff.hu-berlin.de; voelkerd@njc.org		Gupta, Nishith/0000-0003-1452-5126	National Institutes of Health [AI030060, 2R37GM32453]; German Research Foundation [SFB618, GRK1121]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032453, R01GM032453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI030060 and 2R37GM32453 (to D. R. V.). This work was also supported by German Research Foundation Grants SFB618 and GRK1121 (to N. G. and R. L.).	Baunaure F, 2004, MOL MICROBIOL, V51, P33, DOI 10.1046/j.1365-2958.2003.03822.x; BECKERS CJM, 1995, J CLIN INVEST, V95, P367, DOI 10.1172/JCI117665; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Cesbron-Delauw MF, 2008, TRAFFIC, V9, P657, DOI 10.1111/j.1600-0854.2008.00728.x; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; DENNIS EA, 1970, J LIPID RES, V11, P394; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KENNEDY EP, 1959, J BIOL CHEM, V234, P1998; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kim K, 2008, MICROBES INFECT, V10, P978, DOI 10.1016/j.micinf.2008.07.015; Kuge O, 1997, BBA-LIPID LIPID MET, V1348, P151, DOI 10.1016/S0005-2760(97)00137-9; KUGE O, 1991, J BIOL CHEM, V266, P6370; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; OHTA A, 1981, J BIOL CHEM, V256, P2219; Schuiki I, 2009, IUBMB LIFE, V61, P151, DOI 10.1002/iub.159; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; TYHACH RJ, 1979, J BIOL CHEM, V254, P627; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voelker DR, 1997, BBA-LIPID LIPID MET, V1348, P236, DOI 10.1016/S0005-2760(97)00101-X; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200	33	23	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22938	22947		10.1074/jbc.M112.373639	http://dx.doi.org/10.1074/jbc.M112.373639			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22563079	Green Published, hybrid			2022-12-25	WOS:000306495000051
J	Mahajan, K; Coppola, D; Rawal, B; Chen, YA; Lawrence, HR; Engelman, RW; Lawrence, NJ; Mahajan, NP				Mahajan, Kiran; Coppola, Domenico; Rawal, Bhupendra; Chen, Y. Ann; Lawrence, Harshani R.; Engelman, Robert W.; Lawrence, Nicholas J.; Mahajan, Nupam P.			Ack1-mediated Androgen Receptor Phosphorylation Modulates Radiation Resistance in Castration-resistant Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE ACK1; DOUBLE-STRAND BREAKS; DNA-DAMAGE; ATM KINASE; ACTIVATION; AUTOPHOSPHORYLATION; PROGRESSION; INHIBITOR; RESPONSES; THERAPY	Androgen deprivation therapy has been the standard of care in prostate cancer due to its effectiveness in initial stages. However, the disease recurs, and this recurrent cancer is referred to as castration-resistant prostate cancer (CRPC). Radiotherapy is the treatment of choice; however, in addition to androgen independence, CRPC is often resistant to radiotherapy, making radioresistant CRPC an incurable disease. The molecular mechanisms by which CRPC cells acquire radioresistance are unclear. Androgen receptor (AR)-tyrosine 267 phosphorylation by Ack1 tyrosine kinase (also known as TNK2) has emerged as an important mechanism of CRPC growth. Here, we demonstrate that pTyr(267)-AR is recruited to the ATM (ataxia telangiectasia mutated) enhancer in an Ack1-dependent manner to up-regulate ATM expression. Mice engineered to express activated Ack1 exhibited a significant increase in pTyr(267)-AR and ATM levels. Furthermore, primary human CRPCs with up-regulated activated Ack1 and pTyr(267)-AR also exhibited significant increase in ATM expression. The Ack1 inhibitor AIM-100 not only inhibited Ack1 activity but also was able to suppress AR Tyr(267) phosphorylation and its recruitment to the ATM enhancer. Notably, AIM-100 suppressed Ack1 mediated ATM expression and mitigated the growth of radioresistant CRPC tumors. Thus, our study uncovers a previously unknown mechanism of radioresistance in CRPC, which can be therapeutically reversed by a new synergistic approach that includes radiotherapy along with the suppression of Ack1/AR/ATM signaling by the Ack1 inhibitor, AIM-100.	[Mahajan, Kiran; Lawrence, Harshani R.; Lawrence, Nicholas J.; Mahajan, Nupam P.] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Coppola, Domenico; Engelman, Robert W.] H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL 33612 USA; [Coppola, Domenico] H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut, Tampa, FL 33612 USA; [Rawal, Bhupendra; Chen, Y. Ann] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL 33612 USA; [Lawrence, Harshani R.; Lawrence, Nicholas J.] H Lee Moffitt Canc Ctr & Res Inst, High Throughput Screening Core Facil, Tampa, FL 33612 USA; [Mahajan, Nupam P.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33620 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Mahajan, NP (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, 12902 Magnolia Dr, Tampa, FL 33612 USA.	nupam.mahajan@moffitt.org	Mahajan, Kiran/ABA-3013-2020	Mahajan, Kiran/0000-0001-7192-396X; Chen, yian/0000-0003-1468-3490	National Institutes of Health Grant [1R01CA135328]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA135328] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA135328.	Attar RM, 2009, CLIN CANCER RES, V15, P3251, DOI 10.1158/1078-0432.CCR-08-1171; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Cesaretti JA, 2005, INT J RADIAT ONCOL, V61, P196, DOI 10.1016/j.ijrobp.2004.09.031; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Di Lorenzo G, 2010, DRUGS, V70, P983, DOI 10.2165/10898600-000000000-00000; DiMauro EF, 2007, BIOORG MED CHEM LETT, V17, P2305, DOI 10.1016/j.bmcl.2007.01.057; Fang Zhiming, 2010, Genome Integr, V1, P9, DOI 10.1186/2041-9414-1-9; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kastan MB, 2001, ACTA ONCOL, V40, P686; Kastan MB, 2008, MOL CANCER RES, V6, P517, DOI 10.1158/1541-7786.MCR-08-0020; Kawabe T, 2004, MOL CANCER THER, V3, P513; Krempler A, 2007, CELL CYCLE, V6, P1682, DOI 10.4161/cc.6.14.4480; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Mahajan K, 2012, AM J PATHOL, V180, P1386, DOI 10.1016/j.ajpath.2011.12.028; Mahajan K, 2010, PROSTATE, V70, P1274, DOI 10.1002/pros.21163; Mahajan K, 2010, J CELL PHYSIOL, V224, P327, DOI 10.1002/jcp.22162; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Prieto-Echague V, 2010, J BIOL CHEM, V285, P10605, DOI 10.1074/jbc.M109.060459; Pugh TJ, 2009, CLIN CANCER RES, V15, P5008, DOI 10.1158/1078-0432.CCR-08-3357; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200	41	57	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22112	22122		10.1074/jbc.M112.357384	http://dx.doi.org/10.1074/jbc.M112.357384			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22566699	hybrid, Green Published			2022-12-25	WOS:000306418600048
J	Cummings, JR; Muchlinski, MN; Kirk, EC; Rehorek, SJ; DeLeon, VB; Smith, TD				Cummings, Joshua R.; Muchlinski, Magdalena N.; Kirk, E. Christopher; Rehorek, Susan J.; DeLeon, Valerie B.; Smith, Timothy D.			Eye Size at Birth in Prosimian Primates: Life History Correlates and Growth Patterns	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; TARSIUS-BANCANUS; BRAIN GROWTH; LORISES; ENUCLEATION; EVOLUTION; ORBIT; SHAPE	Background: Primates have large eyes relative to head size, which profoundly influence the ontogenetic emergence of facial form. However, growth of the primate eye is only understood in a narrow taxonomic perspective, with information biased toward anthropoids. Methodology/Principal Findings: We measured eye and bony orbit size in perinatal prosimian primates (17 strepsirrhine taxa and Tarsius syrichta) to infer the extent of prenatal as compared to postnatal eye growth. In addition, multiple linear regression was used to detect relationships of relative eye and orbit diameter to life history variables. ANOVA was used to determine if eye size differed according to activity pattern. In most of the species, eye diameter at birth measures more than half of that for adults. Two exceptions include Nycticebus and Tarsius, in which more than half of eye diameter growth occurs postnatally. Ratios of neonate/adult eye and orbit diameters indicate prenatal growth of the eye is actually more rapid than that of the orbit. For example, mean neonatal transverse eye diameter is 57.5% of the adult value (excluding Nycticebus and Tarsius), compared to 50.8% for orbital diameter. If Nycticebus is excluded, relative gestation age has a significant positive correlation with relative eye diameter in strepsirrhines, explaining 59% of the variance in relative transverse eye diameter. No significant differences were found among species with different activity patterns. Conclusions/Significance: The primate developmental strategy of relatively long gestations is probably tied to an extended period of neural development, and this principle appears to apply to eye growth as well. Our findings indicate that growth rates of the eye and bony orbit are disassociated, with eyes growing faster prenatally, and the growth rate of the bony orbit exceeding that of the eyes after birth. Some well-documented patterns of orbital morphology in adult primates, such as the enlarged orbits of nocturnal species, mainly emerge during postnatal development.	[Cummings, Joshua R.; Rehorek, Susan J.] Slippery Rock Univ, Dept Biol, Slippery Rock, PA 16057 USA; [Muchlinski, Magdalena N.] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY USA; [Kirk, E. Christopher] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [DeLeon, Valerie B.] Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD USA; [Smith, Timothy D.] Slippery Rock Univ, Sch Phys Therapy, Slippery Rock, PA 16057 USA; [Smith, Timothy D.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA	Pennsylvania State System of Higher Education (PASSHE); Slippery Rock University - Pennsylvania; University of Kentucky; University of Texas System; University of Texas Austin; Johns Hopkins University; Pennsylvania State System of Higher Education (PASSHE); Slippery Rock University - Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cummings, JR (corresponding author), Slippery Rock Univ, Dept Biol, Slippery Rock, PA 16057 USA.	timothy.smith@sru.edu		Kirk, Chris/0000-0001-9439-3041; Rehorek, Susan/0000-0003-2550-905X	Pennsylvania State System of Higher Education and Slippery Rock University; NSF [BCS-0923791, BCS-0959438]; National Evolutionary Synthesis Center [EF-0905606]; Division Of Behavioral and Cognitive Sci [0959438] Funding Source: National Science Foundation	Pennsylvania State System of Higher Education and Slippery Rock University; NSF(National Science Foundation (NSF)); National Evolutionary Synthesis Center; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was supported by grants from the Pennsylvania State System of Higher Education and Slippery Rock University. For training in phylogenetic comparative methods, we thank the AnthroTree Workshop which is supported by the NSF (BCS-0923791) and the National Evolutionary Synthesis Center (NSF grant EF-0905606). The CT scan was made possible by NSF grant # BCS-0959438 (MRI-R2 Acquisition: Establishment of a Core Facility for the Hierarchical Analysis of Bone). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzeva M, 2007, J HUM EVOL, V52, P231, DOI 10.1016/j.jhevol.2006.08.009; Barathi A, 2002, CELLS TISSUES ORGANS, V171, P276, DOI 10.1159/000063123; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; Cartmill M., 1972, FUNCTIONAL EVOLUTION, P97, DOI DOI 10.4324/9781315132129; Castenholz A., 1984, P303; DEROUSSEAU CJ, 1981, EXP EYE RES, V32, P407, DOI 10.1016/S0014-4835(81)80020-6; Fitch-Snyder H, 2003, ZOO BIOL, V22, P15, DOI 10.1002/zoo.10072; Fledelius HC, 1996, BRIT J OPHTHALMOL, V80, P918, DOI 10.1136/bjo.80.10.918; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Godfrey Laurie R., 2003, P177; Harvey P.H., 1987, P181; Hintschich C, 2001, BRIT J OPHTHALMOL, V85, P205, DOI 10.1136/bjo.85.2.205; Hoyte DAN, 1997, FUNDAMENTALS CRANIOF, P225; Jeffery N, 2007, J ANAT, V210, P703, DOI 10.1111/j.1469-7580.2007.00725.x; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kappeler P M, 2003, PRIMATE LIFE HIST SO; Kirk EC, 2006, J HUM EVOL, V51, P159, DOI 10.1016/j.jhevol.2006.02.004; Kurta A., 1987, Symposia of the Zoological Society of London, P79; Leigh SR, 2004, AM J PRIMATOL, V62, P139, DOI 10.1002/ajp.20012; LEIGH SR, 2007, PRIMATES PERSPECTIVE, P396; Lindenfors P, 2002, J EVOLUTION BIOL, V15, P595, DOI 10.1046/j.1420-9101.2002.00422.x; Martin R.D., 1983, HUMAN BRAIN EVOLUTIO; Martin R.D., 1990, PRIMATE ORIGINS EVOL; MARTIN RD, 1985, NATURE, V313, P220, DOI 10.1038/313220a0; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Moore Persuad, 2008, DEV HUMAN; Nash Leanne T., 1993, P119; Norrby A., 1958, ACTA OPHTHALMOL, V49, P5; NORTON TT, 1992, VISION RES, V32, P833, DOI 10.1016/0042-6989(92)90026-F; O'Mara MT, 2012, AM J PHYS ANTHROPOL, V147, P11, DOI 10.1002/ajpa.21600; ORAHILLY R, 1975, EXP EYE RES, V21, P93, DOI 10.1016/0014-4835(75)90075-5; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PEREIRA M, 1993, JUVENILE PRIMATES; Pereira Michael E., 2003, P149; RASMUSSEN DT, 1988, AM J PHYS ANTHROPOL, V75, P357, DOI 10.1002/ajpa.1330750307; Riordan-Eva P, 2008, VAUGHAN ASBURYS GEN; ROBERTS M, 1994, INT J PRIMATOL, V15, P1, DOI 10.1007/BF02735232; Rosenberger AL, 2010, INT J PRIMATOL, V31, P1032, DOI 10.1007/s10764-010-9447-x; Ross C, 2001, INT J PRIMATOL, V22, P749, DOI 10.1023/A:1012065332758; Ross CF, 2007, J HUM EVOL, V52, P294, DOI 10.1016/j.jhevol.2006.09.006; ROSS CF, 1995, J HUM EVOL, V29, P201, DOI 10.1006/jhev.1995.1057; Ross CF, 2009, EVOLUTIONARY NEUROSC, P819; SARNAT BG, 1972, ACTA ANAT, V82, P497; Scammon RE, 1925, J COMP NEUROL, V38, P165, DOI 10.1002/cne.900380203; Schmechel DE, 1996, EXP NEUROL, V142, P111, DOI 10.1006/exnr.1996.0183; Schultz AH, 1940, AM J PHYS ANTHROPOL, V26, P389, DOI 10.1002/ajpa.1330260138; Smith RJ, 1998, J HUM EVOL, V34, P173, DOI 10.1006/jhev.1997.0190; Smith TD, 2011, AM J PHYS ANTHROPOL, V144, P392, DOI 10.1002/ajpa.21421; St Clair EM, 2007, INT J PRIMATOL, V28, P1109, DOI 10.1007/s10764-007-9198-5; Tecot SR, 2010, INT J PRIMATOL, V31, P715, DOI 10.1007/s10764-010-9423-5; TIGGES M, 1990, INVEST OPHTH VIS SCI, V31, P1035; TROILO D, 1993, VISION RES, V33, P1311, DOI 10.1016/0042-6989(93)90039-Y; Tuntivanich N, 2007, VET OPHTHALMOL, V10, P2, DOI 10.1111/j.1463-5224.2007.00481.x; van Limborgh J, 1982, Prog Clin Biol Res, V101, P1; Washburn SL, 1943, AM J PHYS ANTHROP-NE, V1, P171, DOI 10.1002/ajpa.1330010211; Weisenseel KA, 1998, FOLIA PRIMATOL, V69, P321, DOI 10.1159/000052720; WILKINSON F, 1986, BEHAV BRAIN RES, V19, P59, DOI 10.1016/0166-4328(86)90048-3	57	18	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36097	10.1371/journal.pone.0036097	http://dx.doi.org/10.1371/journal.pone.0036097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567127	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500045
J	Lunde, K; Egelandsdal, B; Skuterud, E; Mainland, JD; Lea, T; Hersleth, M; Matsunami, H				Lunde, Kathrine; Egelandsdal, Bjorg; Skuterud, Ellen; Mainland, Joel D.; Lea, Tor; Hersleth, Margrethe; Matsunami, Hiroaki			Genetic Variation of an Odorant Receptor OR7D4 and Sensory Perception of Cooked Meat Containing Androstenone	PLOS ONE			English	Article							SENSITIVITY; PLASTICITY; PHEROMONE; ABILITY; TAINT; FAT	Although odour perception impacts food preferences, the effect of genotypic variation of odorant receptors (ORs) on the sensory perception of food is unclear. Human OR7D4 responds to androstenone, and genotypic variation in OR7D4 predicts variation in the perception of androstenone. Since androstenone is naturally present in meat derived from male pigs, we asked whether OR7D4 genotype correlates with either the ability to detect androstenone or the evaluation of cooked pork tainted with varying levels of androstenone within the naturally-occurring range. Consistent with previous findings, subjects with two copies of the functional OR7D4 RT variant were more sensitive to androstenone than subjects carrying a nonfunctional OR7D4 WM variant. When pork containing varying levels of androstenone was cooked and tested by sniffing and tasting, subjects with two copies of the RT variant tended to rate the androstenone-containing meat as less favourable than subjects carrying the WM variant. Our data is consistent with the idea that OR7D4 genotype predicts the sensory perception of meat containing androstenone and that genetic variation in an odorant receptor can alter food preferences.	[Lunde, Kathrine; Skuterud, Ellen] Norwegian Meat Res Ctr, Oslo, Norway; [Lunde, Kathrine; Egelandsdal, Bjorg; Skuterud, Ellen; Lea, Tor; Hersleth, Margrethe] Univ Life Sci, Inst Chem Biotechnol & Food Sci, As, Norway; [Hersleth, Margrethe] Nofima Mat, As, Norway; [Mainland, Joel D.; Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol & Neurobiol, Durham, NC USA	Norwegian University of Life Sciences; Nofima; Duke University	Lunde, K (corresponding author), Norwegian Meat Res Ctr, Oslo, Norway.	kathrine.lunde@animalia.no	Mainland, Joel/C-5171-2009	Mainland, Joel/0000-0002-5056-4598	Norwegian Research Council [63164]; United States National Institutes of Health (NIH)-NRSA; NIH [DC005782, DC010857];  [DC011373]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008932, R01DC005782, R01DC010857, R03DC011373] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); United States National Institutes of Health (NIH)-NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Norwegian Research Council for its grant to this activity through project number 63164, "Boar meat-consumer aspects and exploitation of resources." JM is supported by a United States National Institutes of Health (NIH)-NRSA fellowship and DC011373 and HM is supported by the NIH (DC005782 and DC010857). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN O, 1974, ACTA ENDOCRINOL-COP, V76, P377; Banon S, 2003, MEAT SCI, V63, P381, DOI 10.1016/S0309-1740(02)00097-9; Beets M. G. J., 1970, TASTE SMELL VERTEBRA, P313; Dorries KM, 1997, BRAIN BEHAV EVOLUT, V49, P53, DOI 10.1159/000112981; Dotson CD, 2010, APPETITE, V54, P93, DOI 10.1016/j.appet.2009.09.011; Font I, 2000, J SENS STUD, V15, P393; GIBIS M, 1994, THESIS U HOHENHEIM G; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kline JP, 2007, BIOL PSYCHOL, V74, P405, DOI 10.1016/j.biopsycho.2006.10.003; Lunde K, 2010, MEAT SCI, V86, P706, DOI 10.1016/j.meatsci.2010.06.009; Lunde K, 2009, FOOD QUAL PREFER, V20, P304, DOI 10.1016/j.foodqual.2009.02.001; Mainland JD, 2002, NATURE, V419, P802, DOI 10.1038/419802a; Oliver MA, 2009, STUDY IMPROVED METHO; PATTERSON RL, 1968, J SCI FOOD AGR, V19, P31, DOI 10.1002/jsfa.2740190107; Pause BM, 1999, PHYSIOL BEHAV, V68, P129, DOI 10.1016/S0031-9384(99)00158-4; Shahidi F, 1998, FLAVOR MEAT MEAT PRO, V2nd; STEVENS DA, 1995, CHEM SENSES, V20, P413, DOI 10.1093/chemse/20.4.413; Tuomola M, 1997, J AGR FOOD CHEM, V45, P3529, DOI 10.1021/jf9702398; VOLD E, 1970, Meldinger fra Norges Landbrukshogskole, V49, P1; Wang LW, 2004, J PHYSIOL-LONDON, V554, P236, DOI 10.1113/jphysiol.2003.054726; Weiler U, 1997, EAAP PUBLICATION, V92, P147; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; WYSOCKI CJ, 1984, P NATL ACAD SCI-BIOL, V81, P4899, DOI 10.1073/pnas.81.15.4899	25	52	52	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35259	10.1371/journal.pone.0035259	http://dx.doi.org/10.1371/journal.pone.0035259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567099	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341500017
J	Morena, M; Jaussent, I; Halkovich, A; Dupuy, AM; Bargnoux, AS; Chenine, L; Leray-Moragues, H; Klouche, K; Vernhet, H; Canaud, B; Cristol, JP				Morena, Marion; Jaussent, Isabelle; Halkovich, Aurore; Dupuy, Anne-Marie; Bargnoux, Anne-Sophie; Chenine, Leila; Leray-Moragues, Helene; Klouche, Kada; Vernhet, Helene; Canaud, Bernard; Cristol, Jean-Paul			Bone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-23; PERIPHERAL VASCULAR CALCIFICATION; SERUM OSTEOPROTEGERIN LEVELS; ARTERY CALCIFICATION; COMPUTED-TOMOGRAPHY; RENAL-DISEASE; FGF23; RISK; HYPOPHOSPHATEMIA; ATHEROSCLEROSIS	Background: Osteoprotegerin (OPG) and fibroblast growth factor-23 (FGF23) are recognized as strong risk factors of vascular calcifications in non dialysis chronic kidney disease (ND-CKD) patients. The aim of this study was to investigate the relationships between FGF23, OPG, and coronary artery calcifications (CAC) in this population and to attempt identification of the most powerful biomarker of CAC: FGF23? OPG? Methodology/Principal Findings: 195 ND-CKD patients (112 males/83 females, 70.8 [27.4-94.6] years) were enrolled in this cross-sectional study. All underwent chest multidetector computed tomography for CAC scoring. Vascular risk markers including FGF23 and OPG were measured. Logistic regression analyses were used to study the potential relationships between CAC and these markers. The fully adjusted-univariate analysis clearly showed high OPG (>= 10.71 pmol/L) as the only variable significantly associated with moderate CAC ([100-400[) (OR = 2.73 [1.03; 7.26]; p = 0.04). Such association failed to persist for CAC scoring higher than 400. Indeed, severe CAC was only associated with high phosphate fractional excretion (FEPO4) (>= 38.71%) (OR = 5.47 [1.76; 17.0]; p = 0.003) and high FGF23 (>= 173.30 RU/mL) (OR = 5.40 [1.91; 15.3]; p = 0.002). In addition, the risk to present severe CAC when FGF23 level was high was not significantly different when OPG was normal or high. Conversely, the risk to present moderate CAC when OPG level was high was not significantly different when FGF23 was normal or high. Conclusions: Our results strongly suggest that OPG is associated to moderate CAC while FGF23 rather represents a biomarker of severe CAC in ND-CKD patients.	[Morena, Marion; Halkovich, Aurore; Dupuy, Anne-Marie; Bargnoux, Anne-Sophie; Cristol, Jean-Paul] CHRU Montpellier, Biochim Lab, Montpellier, France; [Morena, Marion; Canaud, Bernard] Inst Rech & Format Dialyse, Montpellier, France; [Morena, Marion; Bargnoux, Anne-Sophie; Klouche, Kada; Canaud, Bernard; Cristol, Jean-Paul] Univ Montpellier I, UMR 204, Montpellier, France; [Jaussent, Isabelle] INSERM, U1061, Montpellier, France; [Chenine, Leila; Leray-Moragues, Helene; Canaud, Bernard] CHRU Montpellier, Serv Nephrol Hemodialyse & Soins Intensifs, Montpellier, France; [Vernhet, Helene] CHRU Montpellier, Serv Radiol, Montpellier, France; [Klouche, Kada] CHRU Montpellier, Serv Reanimat Metabol, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Morena, M (corresponding author), CHRU Montpellier, Biochim Lab, Montpellier, France.	jp-cristol@chu-montpellier.fr		dupuy, anne marie/0000-0001-6538-3944; MORENA CARRERE, Marion/0000-0001-9563-5217; Jaussent, Isabelle/0000-0002-8205-7590	Ministere de la Sante [PHRC-UF 7853]	Ministere de la Sante	This work was partly supported by a grant from Ministere de la Sante (PHRC-UF 7853). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Anand DV, 2006, J AM COLL CARDIOL, V47, P1850, DOI 10.1016/j.jacc.2005.12.054; Avignon A, 2005, DIABETES CARE, V28, P2176, DOI 10.2337/diacare.28.9.2176; Brindis RG, 2005, J AM COLL CARDIOL, V46, P1587, DOI 10.1016/j.jacc.2005.08.029; Chiu YW, 2010, KIDNEY INT, V77, P1107, DOI 10.1038/ki.2010.70; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Desjardins L, 2012, OSTEOPOROSIS INT, V23, P2017, DOI 10.1007/s00198-011-1838-0; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Goolsby Mary Jo, 2002, J Am Acad Nurse Pract, V14, P238, DOI 10.1111/j.1745-7599.2002.tb00119.x; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Haas MH, 2010, KIDNEY INT, V77, P1057, DOI 10.1038/ki.2010.92; Inaba M, 2006, OSTEOPOROSIS INT, V17, P1506, DOI 10.1007/s00198-006-0154-6; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P948, DOI 10.1093/ndt/gfn571; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Maimoun L, 2005, CALCIFIED TISSUE INT, V76, P404, DOI 10.1007/s00223-004-0048-6; Mikami S, 2008, HYPERTENS RES, V31, P1163, DOI 10.1291/hypres.31.1163; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Moe SM, 2008, J AM SOC NEPHROL, V19, P213, DOI 10.1681/ASN.2007080854; Morena M, 2009, NEPHROL DIAL TRANSPL, V24, P3389, DOI 10.1093/ndt/gfp301; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Nasrallah MM, 2010, NEPHROL DIAL TRANSPL, V25, P2679, DOI 10.1093/ndt/gfq089; Nitta K, 2004, NEPHROL DIAL TRANSPL, V19, P1886, DOI 10.1093/ndt/gfh263; Nitta K, 2003, AM J KIDNEY DIS, V42, P303, DOI 10.1016/S0272-6386(03)00655-3; Olauson H, 2010, NEPHROL DIAL TRANSPL, V25, P3033, DOI 10.1093/ndt/gfq191; Russo D, 2004, AM J KIDNEY DIS, V44, P1024, DOI 10.1053/j.ajkd.2004.07.022; Russo D, 2010, KIDNEY INT, V78, P818, DOI 10.1038/ki.2010.307; Shioi A, 2002, CIRC RES, V91, P9, DOI 10.1161/01.RES.0000026421.61398.F2; Strewler GJ, 2001, P NATL ACAD SCI USA, V98, P5945, DOI 10.1073/pnas.11154898; Trouvin AP, 2010, CLIN INTERV AGING, V5, P345, DOI 10.2147/CIA.S10153; Weber TJ, 2003, J BONE MINER RES, V18, P1227, DOI 10.1359/jbmr.2003.18.7.1227	36	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36175	10.1371/journal.pone.0036175	http://dx.doi.org/10.1371/journal.pone.0036175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567137	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341500056
J	Nahirya-Ntege, P; Cook, A; Vhembo, T; Opilo, W; Namuddu, R; Katuramu, R; Tezikyabbiri, J; Naidoo-James, B; Gibb, D				Nahirya-Ntege, Patricia; Cook, Adrian; Vhembo, Tichaona; Opilo, Wilfred; Namuddu, Rachel; Katuramu, Richard; Tezikyabbiri, Jessica; Naidoo-James, Bethany; Gibb, Diana		ARROW Trial Team	Young HIV-Infected Children and Their Adult Caregivers Prefer Tablets to Syrup Antiretroviral Medications in Africa	PLOS ONE			English	Article							FIXED-DOSE COMBINATION; PEDIATRIC-PATIENTS; ADHERENCE; THERAPY; PHARMACOKINETICS; NEVIRAPINE; LAMIVUDINE; SURVIVAL	Background: Provision of anti-retroviral therapy (ART) for HIV-infected children is complicated using syrup formulations, which are costlier than tablets, harder to transport and store and difficult for health-workers to prescribe and caregivers to administer. Dispersible/crushable tablets may be more appropriate. We studied the acceptability of syrups and scored tablets among young children who used both in the AntiRetroviral Research fOr Watoto (ARROW) trial. Methods: ARROW is an ongoing randomized trial of paediatric ART monitoring and treatment strategies in 1206 children in Uganda and Zimbabwe. 405 children initially received syrups of combination ART including Nevirapine, Zidovudine, Abacavir and Lamivudine before changing, when reaching the 12-<15 kg weightband, to scored adult-dose tablets prescribed according to WHO weightband tables. Caregiver expectations and experiences were collected in questionnaires at their last visit on syrups and after 8 and 24 weeks on tablets. Results: Questionnaires were completed by caregivers of 267 children (median age 2.9 years (IQR 2.5, 3.4)). At last visit on syrups, 79% caregivers reported problems with syrups, mostly related to number, weight, transportation and conspicuousness of bottles. Difficulties taking tablets were expected by 127(48%) caregivers; however, after 8 and 24 weeks, only 26% and 18% reported their children had problems with tablets and no problems were reported with transportation/conspicuousness. Taste, swallowing or vomiting were reported as problems 'sometimes/often' for 14%, 9%, 22% children on syrups and 16%, 9%, 8% on tablets. At last visit on syrups, 74% caregivers expected to prefer tablets but only 27% thought their child would. After 8/24 weeks, 94%/97% caregivers preferred tablets and 57%/59% reported their child did. Conclusions: Most children at about 3 years can take tablets; caregivers and children themselves generally prefer tablets to liquid formulations of HIV medications above this age. Preferences of caregivers and children should be considered when designing and licensing paediatric drug formulations.	[Nahirya-Ntege, Patricia; Katuramu, Richard] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Cook, Adrian; Naidoo-James, Bethany; Gibb, Diana] MRC Clin Trials Unit, London, England; [Vhembo, Tichaona] Univ Zimbabwe, Sch Med, Harare, Zimbabwe; [Opilo, Wilfred; Tezikyabbiri, Jessica] Joint Clin Res Ctr, Kampala, Uganda; [Namuddu, Rachel] Mulago Hosp, Baylor Uganda Paediat Infect Dis Clin, Kampala, Uganda	Medical Research Council Clinical Trials Unit; University of Zimbabwe; Joint Clinic Research Center - United Arab Emirates; Baylor College of Medicine; Mulago National Referral Hospital	Nahirya-Ntege, P (corresponding author), MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda.	adc@ctu.mrc.ac.uk	; Bwakura-Dangarembizi, Mutsa/D-5686-2018	Gibb, Diana/0000-0002-9738-5490; Thomason, Margaret/0000-0003-3590-0140; Kasirye, Phillip/0000-0001-6620-483X; Bwakura-Dangarembizi, Mutsa/0000-0001-7751-6177	UK Medical Research Council; UK Department for International Development [G0300400]; MRC [MC_EX_G0300400] Funding Source: UKRI; Medical Research Council [MC_EX_G0300400] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The main trial was funded by the UK Medical Research Council, www.mrc.ac.uk and the UK Department for International Development, www.dfid.gov.uk. Grant number G0300400. First-line drugs were provided by GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagenda A, 2011, ANN TROP PAEDIATR, V31, P235, DOI 10.1179/1465328111Y.0000000025; Bagenda A, 2010, 18 INT AIDS C 2010 V; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Calmy A, 2004, LANCET, V364, P329, DOI 10.1016/S0140-6736(04)16716-0; Chokephaibulkit K, 2005, AIDS, V19, P1495, DOI 10.1097/01.aids.0000183625.97170.59; Eldridge K, 2000, Int J Paediatr Dent, V10, P19, DOI 10.1046/j.1365-263x.2000.00168.x; Fillekes Q, 2011, JAIDS-J ACQ IMM DEF, V58, P392, DOI 10.1097/QAI.0b013e318235e560; Garvie PA, 2007, PEDIATRICS, V119, pE893, DOI 10.1542/peds.2006-1488; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Kasirye P, 2012, CLIN PHARMACOL THER, V91, P272, DOI 10.1038/clpt.2011.225; King JR, 2004, HIV CLIN TRIALS, V5, P288, DOI 10.1310/GRQX-761M-DPB1-V9CG; Livshits Z, 2011, CLIN TOXICOL, V49, P747, DOI 10.3109/15563650.2011.602081; Mulenga V, 2010, CLIN INFECT DIS, V51, P1081, DOI 10.1086/656628; Musiime V, 2010, ANTIVIR THER, V15, P1115, DOI 10.3851/IMP1695; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Pujari SN, 2004, JAIDS-J ACQ IMM DEF, V37, P1566, DOI 10.1097/00126334-200412150-00005; Shingadia D, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e80; Sohn AH, 2007, CURR OPIN HIV AIDS, V2, P426, DOI 10.1097/COH.0b013e3282ced12c; Swan J, 2007, PEDIATRICS, V119, P838, DOI 10.1542/peds.2007-0273; Temple ME, 2001, ANN PHARMACOTHER, V35, P414; Thomson SA, 2009, PEDIATRICS, V123, pE235, DOI 10.1542/peds.2008-2059; UNICEF, 2004, IMPR ACC APPR PAED A; UNICEF WHO, 2010, SOURC PRIC SEL MED C; Walker AS, 2009, AIDS BEHAV, V13, P33, DOI 10.1007/s10461-008-9382-4; World Health Organization, 2010, ANT THER HIV INF INF; Yeung VW, 2005, PHARM WORLD SCI, V27, P399, DOI 10.1007/s11096-005-7911-z	27	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36186	10.1371/journal.pone.0036186	http://dx.doi.org/10.1371/journal.pone.0036186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567139	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341500058
J	O'Loghlen, AL; Rothstein, SI				O'Loghlen, Adrian L.; Rothstein, Stephen I.			When Less Is Best: Female Brown-Headed Cowbirds Prefer Less Intense Male Displays	PLOS ONE			English	Article							MOLOTHRUS-ATER; SEXUAL PREFERENCES; VOCAL DEVELOPMENT; WILD POPULATIONS; SONG PREFERENCES; COURTSHIP SONGS; ZEBRA FINCHES; OLDER MALES; MATE CHOICE; SIGNAL	Sexual selection theory predicts that females should prefer males with the most intense courtship displays. However, wingspread song displays that male brown-headed cowbirds (Molothrus ater) direct at females are generally less intense than versions of this display that are directed at other males. Because male-directed displays are used in aggressive signaling, we hypothesized that females should prefer lower intensity performances of this display. To test this hypothesis, we played audiovisual recordings showing the same males performing both high intensity male-directed and low intensity female-directed displays to females (N = 8) and recorded the females' copulation solicitation display (CSD) responses. All eight females responded strongly to both categories of playbacks but were more sexually stimulated by the low intensity female-directed displays. Because each pair of high and low intensity playback videos had the exact same audio track, the divergent responses of females must have been based on differences in the visual content of the displays shown in the videos. Preferences female cowbirds show in acoustic CSD studies are correlated with mate choice in field and captivity studies and this is also likely to be true for preferences elucidated by playback of audiovisual displays. Female preferences for low intensity female-directed displays may explain why male cowbirds rarely use high intensity displays when signaling to females. Repetitive high intensity displays may demonstrate a male's current condition and explain why these displays are used in male-male interactions which can escalate into physical fights in which males in poorer condition could be injured or killed. This is the first study in songbirds to use audiovisual playbacks to assess how female sexual behavior varies in response to variation in a male visual display.	[O'Loghlen, Adrian L.; Rothstein, Stephen I.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	O'Loghlen, AL (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	ologhlen@lifesci.ucsb.edu			National Science Foundation [IOS-0446371]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a National Science Foundation (www.nsf.gov) grant (IOS-0446371) to SIR and ALO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bird CD, 2008, ANIM BEHAV, V76, P679, DOI 10.1016/j.anbehav.2008.04.014; Bradbury Jack W., 1998, pi; Brazas ML, 2002, ANIM COGN, V5, P91, DOI 10.1007/s10071-002-0136-9; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 1999, ANIM BEHAV, V58, P1261, DOI 10.1006/anbe.1999.1259; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; DUFTY AM, 1992, J FIELD ORNITHOL, V63, P16; DUFTY AM, 1986, BEHAV ECOL SOCIOBIOL, V19, P49, DOI 10.1007/BF00303842; DUFTY AM, 1982, ANIM BEHAV, V30, P1043, DOI 10.1016/S0003-3472(82)80194-2; Fleishman L.J., 2000, Acta Ethologica, V3, P15, DOI 10.1007/s102110000025; Freeberg TM, 2001, J COMP PSYCHOL, V115, P201, DOI 10.1037/0735-7036.115.2.201; Freeberg TM, 2006, INT J COMP PSYCHOL, V19, P206; Friedmann H., 1929, COWBIRDS STUDY BIOL; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Galoch Zdzislaw, 2006, Ornithological Science, V5, P57, DOI 10.2326/osj.5.57; Galoch Z, 2007, BEHAV PROCESS, V74, P21, DOI 10.1016/j.beproc.2006.09.002; Gorney-Labinger E, 2002, CONDOR, V104, P866, DOI 10.1650/0010-5422(2002)104[0866:BHCIEA]2.0.CO;2; Gorney-Labinger E, THESIS U CALIFORNIA; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hill JA, 1999, BEHAV ECOL, V10, P91, DOI 10.1093/beheco/10.1.91; Hosken D, 2005, AM NAT, V165, pS1, DOI 10.1086/429355; Hosoi SA, 2005, AUK, V122, P82, DOI 10.1642/0004-8038(2005)122[0082:SPOFBC]2.0.CO;2; Hunt KE, 2004, GEN COMP ENDOCR, V137, P248, DOI 10.1016/j.ygcen.2004.03.015; Ikebuchi M, 1999, ZOOL SCI, V16, P63, DOI 10.2108/zsj.16.63; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P2109, DOI 10.1098/rspb.1999.0895; Maddocks SA, 2001, GEN COMP ENDOCR, V124, P315, DOI 10.1006/gcen.2001.7718; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Moller AP, 1998, AM NAT, V151, P236, DOI 10.1086/286114; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; O'Loghlen AL, 2010, CONDOR, V112, P615, DOI 10.1525/cond.2010.090216; O'Loghlen AL, 2010, ANIM BEHAV, V79, P1285, DOI 10.1016/j.anbehav.2010.03.001; O'Loghlen AL, 2004, AUK, V121, P824, DOI 10.1642/0004-8038(2004)121[0824:DSRTDC]2.0.CO;2; O'Loghlen AL, 2003, BEHAV ECOL SOCIOBIOL, V53, P102, DOI 10.1007/s00265-002-0551-6; O'Loghlen AL, 2002, ANIM BEHAV, V64, P609, DOI 10.1006/anbe.2002.3081; O'Loghlen AL, 2002, CONDOR, V104, P761, DOI 10.1650/0010-5422(2002)104[0761:VDICWA]2.0.CO;2; O'Loghlen AL, 2002, ANIM BEHAV, V63, P475, DOI 10.1006/anbe.2001.1951; OLOGHLEN AL, 1993, ANIM BEHAV, V46, P293, DOI 10.1006/anbe.1993.1190; OLOGHLEN AL, 1995, BEHAV ECOL SOCIOBIOL, V36, P251, DOI 10.1007/s002650050147; OLoghlen AL, 1997, ANIM BEHAV, V53, P835, DOI 10.1006/anbe.1996.0348; Ophir AG, 2005, J COMP PSYCHOL, V119, P3, DOI 10.1037/0735-7036.119.1.3; Ortega CP, 1996, J FIELD ORNITHOL, V67, P542; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Proulx SR, 2002, P ROY SOC B-BIOL SCI, V269, P2291, DOI 10.1098/rspb.2002.2129; RATCLIFFE L, 1987, ANIM BEHAV, V35, P1260, DOI 10.1016/S0003-3472(87)80188-4; Rothstein S.I., 1986, Current Ornithology, V3, P127; ROTHSTEIN SI, 1988, ANIM BEHAV, V36, P73, DOI 10.1016/S0003-3472(88)80251-3; Searcy WA, 1997, CONDOR, V99, P826, DOI 10.2307/1370497; SELANDER ROBERT K., 1960, CONDOR, V62, P202, DOI 10.2307/1365603; SULLIVAN MS, 1994, ANIM BEHAV, V47, P141, DOI 10.1006/anbe.1994.1016; West MJ, 2006, ETHOLOGY, V112, P1095, DOI 10.1111/j.1439-0310.2006.01264.x; West MJ, 1998, ETHOLOGY, V104, P250; WEST MJ, 1981, ANIM BEHAV, V29, P490, DOI 10.1016/S0003-3472(81)80110-8; Wilkie SE, 1998, BIOCHEM J, V330, P541; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Yokel D. A., 1986, NATURAL HIST WHITE I, V1, P164; YOKEL DA, 1991, BEHAV ECOL SOCIOBIOL, V29, P39, DOI 10.1007/BF00164293	65	17	17	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36130	10.1371/journal.pone.0036130	http://dx.doi.org/10.1371/journal.pone.0036130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567131	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500049
J	Vidwan, NK; Regi, A; Steinhoff, M; Huppert, JS; Staat, MA; Dodd, C; Nongrum, R; Anandan, S; Verghese, V				Vidwan, Navjyot K.; Regi, Annie; Steinhoff, Mark; Huppert, Jill S.; Staat, Mary Allen; Dodd, Caitlin; Nongrum, Rida; Anandan, Shalini; Verghese, Valsan			Low Prevalence of Chlamydia trachomatis Infection in Non-Urban Pregnant Women in Vellore, S. India	PLOS ONE			English	Article							PACE 2 ASSAY; CLEARVIEW; TESTS; CULTURE	Objective: To determine the prevalence and risk factors for Chlamydia trachomatis (CT) infection in pregnant women and the rate of transmission of CT to infants. Methods: Pregnant women (>= 28 weeks gestation) in Vellore, South India were approached for enrollment from April 2009 to January 2010. After informed consent was obtained, women completed a socio-demographic, prenatal, and sexual history questionnaire. Endocervical samples collected at delivery were examined for CT by a rapid enzyme test and nucleic acid amplification test (NAAT). Neonatal nasopharyngeal and conjunctival swabs were collected for NAAT testing. Results: Overall, 1198 women were enrolled and 799 (67%) endocervical samples were collected at birth. Analyses were completed on 784 participants with available rapid and NAAT results. The mean age of women was 25.8 years (range 18-39 yrs) and 22% (95% CI: 19.7-24.4%) were primigravida. All women enrolled were married; one reported. one sexual partner; and six reported prior STI. We found 71 positive rapid CT tests and 1/784 (0.1%; 95% CI: 0-0.38%) true positive CT infection using NAAT. Conclusions: To our knowledge, this is the largest study on CT prevalence amongst healthy pregnant mothers in southern India, and it documents a very low prevalence with NAAT. Many false positive results were noted using the rapid test. These data suggest that universal CT screening is not indicated in this population.	[Vidwan, Navjyot K.; Steinhoff, Mark; Huppert, Jill S.; Staat, Mary Allen; Dodd, Caitlin] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Regi, Annie; Nongrum, Rida; Anandan, Shalini; Verghese, Valsan] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India	Cincinnati Children's Hospital Medical Center; Christian Medical College & Hospital (CMCH) Vellore	Vidwan, NK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.	nkvidwan@gmail.com			Fogarty International Center, National Institutes of Health [R24TW007988]; Cincinnati Children's Hospital Medical Center Infectious Diseases Department; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Cincinnati Children's Hospital Medical Center Infectious Diseases Department; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Fogarty International Center, National Institutes of Health (R24TW007988, the Fogarty International Clinical Research Scholars Support Center), and Cincinnati Children's Hospital Medical Center Infectious Diseases Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER R, 1993, GENITOURIN MED, V69, P240; Becker M, 2010, SEX TRANSM DIS, V37, P159, DOI 10.1097/OLQ.0b013e3181bd1007; Berg AO, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(01)00254-9; BLANDING J, 1993, J CLIN MICROBIOL, V31, P1622, DOI 10.1128/JCM.31.6.1622-1625.1993; Brabin L, 1998, B WORLD HEALTH ORGAN, V76, P277; Centers for Disease Control and Prevention, 2009, SEX TRANSM DIS SURV; Chen Chun-Jen, 2007, Journal of Microbiology Immunology and Infection, V40, P255; El Qouqa IA, 2009, INT J INFECT DIS, V13, P334, DOI 10.1016/j.ijid.2008.07.013; HAMMERSCHLAG MR, 1989, J PEDIATR-US, V114, P727, DOI 10.1016/S0022-3476(89)80128-3; Hislop J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14290; Horner P, 2005, J CLIN MICROBIOL, V43, P2065, DOI 10.1128/JCM.43.5.2065-2069.2005; Joyee A G, 2005, Indian J Med Microbiol, V23, P37; Joyee AG, 2004, INT J STD AIDS, V15, P51, DOI 10.1258/095646204322637272; KLUYTMANS JAJW, 1993, J CLIN MICROBIOL, V31, P3204, DOI 10.1128/JCM.31.12.3204-3210.1993; Lauderdale TL, 1999, J CLIN MICROBIOL, V37, P2223, DOI 10.1128/JCM.37.7.2223-2229.1999; Livengood CH, 2001, J CLIN MICROBIOL, V39, P2928, DOI 10.1128/JCM.39.8.2928-2932.2001; Malik A, 2009, FERTIL STERIL, V91, P91, DOI 10.1016/j.fertnstert.2007.05.070; Mania-Pramanik J, 2001, SEX TRANSM INFECT, V77, P141, DOI 10.1136/sti.77.2.141; Paul VK, 1999, NATL MED J INDIA, V12, P11; Rastogi S, 2003, INT J GYNECOL OBSTET, V80, P129, DOI 10.1016/S0020-7292(02)00371-5; Rosenman MB, 2003, ARCH PEDIAT ADOL MED, V157, P565, DOI 10.1001/archpedi.157.6.565; Saison F, 2007, J CLIN MICROBIOL, V45, P4011, DOI 10.1128/JCM.01343-07; SINGH V, 1995, OBSTET GYNECOL, V85, P215, DOI 10.1016/0029-7844(94)00367-M; Singh V, 2003, J CLIN MICROBIOL, V41, P2700, DOI 10.1128/JCM.41.6.2700-2702.2003; Sturm AW, 1998, AM J PUBLIC HEALTH, V88, P1243, DOI 10.2105/AJPH.88.8.1243; Tang YJ, 2009, SE ASIAN J TROP MED, V40, P1038; The Inverness Medical Group of Companies, 2006, CLEARV CHAL MF; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172; Wessel H F, 1998, Afr J Reprod Health, V2, P32; World Health Organization, 2010, SEX TRANSM DIS CHAL; Yin YP, 2006, SEX TRANSM INFECT, V82, pV33, DOI 10.1136/sti.2006.022475	31	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34794	10.1371/journal.pone.0034794	http://dx.doi.org/10.1371/journal.pone.0034794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567090	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500008
J	Ho, D; Chen, L; Zhao, X; Durham, N; Pannirselvam, M; Vatner, DE; Morgans, DJ; Malik, FI; Vatner, SF; Shen, YT				Ho, David; Chen, Li; Zhao, Xin; Durham, Nicquanna; Pannirselvam, Malar; Vatner, Dorothy E.; Morgans, David J.; Malik, Fady I.; Vatner, Stephen F.; Shen, You-Tang			Smooth Muscle Myosin Inhibition: A Novel Therapeutic Approach for Pulmonary Hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; NITRIC-OXIDE; NITROPRUSSIDE; VASODILATION; GUIDELINES; DIAGNOSIS; PIGLETS	Objective: Pulmonary hypertension remains a major clinical problem despite current therapies. In this study, we examine for the first time a novel pharmacological target, smooth muscle myosin, and determine if the smooth muscle myosin inhibitor, CK-2019165 (CK-165) ameliorates pulmonary hypertension. Materials and Methods: Six domestic female pigs were surgically instrumented to measure pulmonary blood flow and systemic and pulmonary vascular dynamics. Pulmonary hypertension was induced by hypoxia, or infusion of the thromboxane analog (U-46619, 0.1 mu g/kg/min, i.v.). In rats, chronic pulmonary hypertension was induced by monocrotaline. Results: CK-165 (4 mg/kg, i.v.) reduced pulmonary vascular resistance by 22 +/- 3 and 28 +/- 6% from baseline in hypoxia and thromboxane pig models, respectively (p<0.01 and 0.01), while mean arterial pressure also fell and heart rate rose slightly. When CK-165 was delivered via inhalation in the hypoxia model, pulmonary vascular resistance fell by 17 +/- 6% (p<0.05) while mean arterial pressure and heart rate were unchanged. In the monocrotaline model of chronic pulmonary hypertension, inhaled CK-165 resulted in a similar (18.0 +/- 3.8%) reduction in right ventricular systolic pressure as compared with sildenafil (20.3 +/- 4.5%). Conclusion: Inhibition of smooth muscle myosin may be a novel therapeutic target for treatment of pulmonary hypertension.	[Ho, David; Chen, Li; Zhao, Xin; Vatner, Dorothy E.; Vatner, Stephen F.; Shen, You-Tang] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Vatner, Stephen F.; Shen, You-Tang] CV Dynam Inc, N Brunswick, NJ USA; [Durham, Nicquanna; Pannirselvam, Malar; Morgans, David J.; Malik, Fady I.] Cytokinetics Inc, San Francisco, CA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Ho, D (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, 185 S Orange Ave, Newark, NJ 07103 USA.	vatnersf@umdnj.edu			National Institutes of Health [HL033107-27, HL069020-10, HL101420-01, HL093481-02, HL102472-01, HL069752-08, AG027211-04]; Cytokinetics; CV Dynamics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL101420, T32HL069752, R01HL102472, R01HL093481, R01HL106511, P01HL069020, R01HL033107, R37HL033107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytokinetics; CV Dynamics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by National Institutes of Health (grants HL033107-27, HL069020-10, HL101420-01, HL093481-02, HL102472-01, HL069752-08, AG027211-04), and a grant from Cytokinetics and CV Dynamics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 1998, J APPL PHYSIOL, V84, P435, DOI 10.1152/jappl.1998.84.2.435; Babu GJ, 2001, NAT CELL BIOL, V3, P1025, DOI 10.1038/ncb1101-1025; Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gomberg-Maitland M, 2011, J AM COLL CARDIOL, V57, P1053, DOI 10.1016/j.jacc.2010.11.020; Humbert M, 2010, EUR RESPIR J, V36, P549, DOI 10.1183/09031936.00057010; Meadow W, 1998, PEDIATR RES, V44, P181, DOI 10.1203/00006450-199808000-00007; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Morano S, 2000, Minerva Med, V91, P117; ROSSAINT R, 1993, NEW ENGL J MED, V328, P399, DOI 10.1056/NEJM199302113280605; Safdar Z, 2011, RESP MED, V105, P818, DOI 10.1016/j.rmed.2010.12.018; Schutte H, 1997, J PHARMACOL EXP THER, V282, P985; Yu XQ, 1999, PEDIATR RES, V45, P255, DOI 10.1203/00006450-199902000-00017; Zhao X, 2011, J PHARMACOL EXP THER, V339, P307, DOI 10.1124/jpet.111.182402	15	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36302	10.1371/journal.pone.0036302	http://dx.doi.org/10.1371/journal.pone.0036302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563487	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700036
J	Dark, MJ; Lundgren, AM; Barbet, AF				Dark, Michael J.; Lundgren, Anna M.; Barbet, Anthony F.			Determining the Repertoire of Immunodominant Proteins via Whole-Genome Amplification of Intracellular Pathogens	PLOS ONE			English	Article							ANAPLASMA-MARGINALE; ANTIGENIC VARIATION; GENE CONVERSION; DIVERSITY; GENERATION; SURFACE; PHAGOCYTOPHILUM; SUPERINFECTION; TRANSMISSION; CONSERVATION	Culturing many obligate intracellular bacteria is difficult or impossible. However, these organisms have numerous adaptations allowing for infection persistence and immune system evasion, making them some of the most interesting to study. Recent advancements in genome sequencing, pyrosequencing and Phi29 amplification, have allowed for examination of whole-genome sequences of intracellular bacteria without culture. We have applied both techniques to the model obligate intracellular pathogen Anaplasma marginale and the human pathogen Anaplasma phagocytophilum, in order to examine the ability of phi29 amplification to determine the sequence of genes allowing for immune system evasion and long-term persistence in the host. When compared to traditional pyrosequencing, phi29-mediated genome amplification had similar genome coverage, with no additional gaps in coverage. Additionally, all msp2 functional pseudogenes from two strains of A. marginale were detected and extracted from the phi29-amplified genomes, highlighting its utility in determining the full complement of genes involved in immune evasion.	[Dark, Michael J.; Lundgren, Anna M.; Barbet, Anthony F.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA; [Dark, Michael J.; Barbet, Anthony F.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Dark, MJ (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA.	darkmich@ufl.edu	Dark, Michael/AAB-4603-2021	Dark, Michael/0000-0002-6547-1298	National Institutes of Health [RO1GM081714]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was received from University-provided startup funds to MJD and National Institutes of Health grant RO1GM081714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Barbet AF, 2000, INFECT IMMUN, V68, P6133, DOI 10.1128/IAI.68.11.6133-6138.2000; Barbet AF, 2001, INFECT IMMUN, V69, P3057, DOI 10.1128/IAI.69.5.3057-3066.2001; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brayton KA, 2002, MOL MICROBIOL, V43, P1151, DOI 10.1046/j.1365-2958.2002.02792.x; Dahlgren FS, 2011, AM J TROP MED HYG, V85, P124, DOI 10.4269/ajtmh.2011.10-0613; Dark MJ, 2011, VACCINE, V29, P4923, DOI 10.1016/j.vaccine.2011.04.131; Dark MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-16; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Felsheim RF, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-42; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Futse JE, 2005, MOL MICROBIOL, V57, P212, DOI 10.1111/j.1365-2958.2005.04670.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hongoh Y, 2011, METHODS MOL BIOL, V733, P25, DOI 10.1007/978-1-61779-089-8_2; Lew AE, 2003, VET MICROBIOL, V92, P145, DOI 10.1016/S0378-1135(02)00352-8; Meeus PFM, 2003, MOL MICROBIOL, V47, P633, DOI 10.1046/j.1365-2958.2003.03331.x; Palmer GH, 2011, FEMS IMMUNOL MED MIC; Rodriguez JL, 2005, GENE, V361, P127, DOI 10.1016/j.gene.2005.06.038; Rurangirwa FR, 2000, INFECT IMMUN, V68, P3023, DOI 10.1128/IAI.68.5.3023-3027.2000; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Sperling U, 2011, BOVINE ANAPLASMOSIS, p[59, 94]; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102	24	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36456	10.1371/journal.pone.0036456	http://dx.doi.org/10.1371/journal.pone.0036456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558468	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200081
J	Das, K; De la Garza, G; Maffi, S; Saikolappan, S; Dhandayuthapani, S				Das, Kishore; De la Garza, Georgina; Maffi, Shivani; Saikolappan, Sankaralingam; Dhandayuthapani, Subramanian			Methionine Sulfoxide Reductase A (MsrA) Deficient Mycoplasma genitalium Shows Decreased Interactions with Host Cells	PLOS ONE			English	Article							PATHOGEN ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; MYCOIDES SMALL COLONY; TOLL-LIKE RECEPTORS; NF-KAPPA-B; EPITHELIAL-CELLS; STREPTOCOCCUS-GORDONII; VIRULENCE DETERMINANT; EXTRACELLULAR-MATRIX; HELICOBACTER-PYLORI; CYTOKINE SECRETION	Mycoplasma genitalium is an important sexually transmitted pathogen that affects both men and women. In genital-mucosal tissues, it initiates colonization of epithelial cells by attaching itself to host cells via several identified bacterial ligands and host cell surface receptors. We have previously shown that a mutant form of M. genitalium lacking methionine sulfoxide reductase A (MsrA), an antioxidant enzyme which converts oxidized methionine (Met(O)) into methionine (Met), shows decreased viability in infected animals. To gain more insights into the mechanisms by which MsrA controls M. genitalium virulence, we compared the wild-type M. genitalium strain (G37) with an msrA mutant (MS5) strain for their ability to interact with target cervical epithelial cell lines (HeLa and C33A) and THP-1 monocytic cells. Infection of epithelial cell lines with both strains revealed that MS5 was less cytotoxic to HeLa and C33A cell lines than the G37 strain. Also, the MS5 strain was more susceptible to phagocytosis by THP-1 cells than wild type strain (G37). Further, MS5 was less able to induce aggregation and differentiation in THP-1 cells than the wild type strain, as determined by carboxyfluorescein diacetate succinimidyl ester (CFSE) labeling of the cells, followed by counting of cells attached to the culture dish using image analysis. Finally, MS5 was observed to induce less proinflammatory cytokine TNF-a by THP-1 cells than wild type G37 strain. These results indicate that MsrA affects the virulence properties of M. genitalium by modulating its interaction with host cells.	[Das, Kishore; De la Garza, Georgina; Maffi, Shivani; Saikolappan, Sankaralingam; Dhandayuthapani, Subramanian] Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Edinburg, TX 78541 USA; [Das, Kishore; De la Garza, Georgina; Saikolappan, Sankaralingam; Dhandayuthapani, Subramanian] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, Edinburg, TX USA; [Maffi, Shivani] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Edinburg, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Das, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Edinburg, TX 78541 USA.	dhandayutha@uthscsa.edu			NIH [AI08346]; ERAHC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI008346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERAHC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH AI08346 and ERAHC research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; AUSUBEL F, 1989, CURRENT PRTOCOLS MOL; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Balasubramanian S, 2009, INFECT IMMUN, V77, P3533, DOI 10.1128/IAI.00081-09; BASEMAN JB, 1995, MICROB PATHOGENESIS, V19, P105, DOI 10.1006/mpat.1995.0050; Baseman JB, 1996, AM J RESP CRIT CARE, V154, pS137, DOI 10.1164/ajrccm/154.4_Pt_2.S137; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bischof DF, 2008, INFECT IMMUN, V76, P263, DOI 10.1128/IAI.00938-07; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Campbell P, 1994, MEASUREMENT BACTERIA, P1451; Cao P, 1998, INFECT IMMUN, V66, P2984, DOI 10.1128/IAI.66.6.2984-2986.1998; Clanchy FIL, 2006, J LEUKOCYTE BIOL, V79, P757, DOI 10.1189/jlb.0905522; Cohen CR, 2002, LANCET, V359, P765, DOI 10.1016/S0140-6736(02)07848-0; Dallo SF, 2000, MICROB PATHOGENESIS, V29, P301, DOI 10.1006/mpat.2000.0395; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Dhandayuthapani S, 1999, P NATL ACAD SCI USA, V96, P5227, DOI 10.1073/pnas.96.9.5227; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Dumke R, 2011, MICROBIOL-SGM, V157, P2328, DOI 10.1099/mic.0.048298-0; El Hassouni M, 1999, P NATL ACAD SCI USA, V96, P887, DOI 10.1073/pnas.96.3.887; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Falk L, 2005, SEX TRANSM INFECT, V81, P73, DOI 10.1136/sti.2004.010439; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gaydos C, 2009, SEX TRANSM DIS, V36, P598, DOI 10.1097/OLQ.0b013e3181b01948; Giomarelli B, 2006, FEMS MICROBIOL LETT, V265, P172, DOI 10.1111/j.1574-6968.2006.00479.x; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; He J, 2009, CLIN VACCINE IMMUNOL, V16, P1750, DOI 10.1128/CVI.00281-09; Herzberg MC, 2005, J PERIODONTOL, V76, P2101, DOI 10.1902/jop.2005.76.11-S.2101; JENSEN JS, 1994, INT J EXP PATHOL, V75, P91; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Lahiri A, 2008, MICROBIOL-SGM, V154, P2837, DOI 10.1099/mic.0.2008/017574-0; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Mavedzenge SN, 2009, AIDS, V23, P611, DOI 10.1097/QAD.0b013e328323da3e; McGowin CL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-139; McGowin CL, 2009, INFECT IMMUN, V77, P1175, DOI 10.1128/IAI.00845-08; Medina E, 2011, CURRENT PROTOC IMMUN, V19, P1; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Mintz KP, 2002, MICROBIOL-SGM, V148, P3695, DOI 10.1099/00221287-148-11-3695; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C., 2004, TUBERCULOSIS, V84, P215; Pich OQ, 2008, MICROBIOL-SGM, V154, P3188, DOI 10.1099/mic.0.2008/020636-0; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Razin S, 1983, METHODS MYCOPLASMOLO, P22; REDDY SP, 1995, J BACTERIOL, V177, P5943, DOI 10.1128/jb.177.20.5943-5951.1995; Rey P, 2005, PLANT J, V41, P31, DOI 10.1111/j.1365-313X.2004.02271.x; Reyes L, 1999, INFECT IMMUN, V67, P3188, DOI 10.1128/IAI.67.7.3188-3192.1999; Rodrigo MJ, 2002, MOL GENET GENOMICS, V267, P613, DOI 10.1007/s00438-002-0692-3; Saikolappan S, 2009, J BACTERIOL, V191, P6675, DOI 10.1128/JB.01066-08; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; Short VL, 2010, SEX TRANSM INFECT, V86, P29, DOI 10.1136/sti.2009.037721; Short VL, 2009, CLIN INFECT DIS, V48, P41, DOI 10.1086/594123; Singh VK, 2001, FEMS MICROBIOL LETT, V199, P79, DOI 10.1016/S0378-1097(01)00163-X; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; SOMERSON NL, 1965, SCIENCE, V150, P226, DOI 10.1126/science.150.3693.226; Taylor-Robinson D, 2004, INT J STD AIDS, V15, P21, DOI 10.1258/095646204322637209; Vattanaviboon P, 2005, J BACTERIOL, V187, P5831, DOI 10.1128/JB.187.16.5831-5836.2005; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vilei EM, 2000, MICROBIOL-UK, V146, P477, DOI 10.1099/00221287-146-2-477; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Ward J, 2001, INFECT IMMUN, V69, P2748, DOI 10.1128/IAI.69.4.2748-2752.2001; Wayne KJ, 2010, J BACTERIOL, V192, P4388, DOI 10.1128/JB.00578-10; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985; Wu YM, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/195427; You Xiao-xing, 2006, J Zhejiang Univ Sci B, V7, P342, DOI 10.1631/jzus.2006.B0342; You XX, 2008, FEMS IMMUNOL MED MIC, V52, P228, DOI 10.1111/j.1574-695X.2007.00366.x; Zeng YH, 2008, CAN J MICROBIOL, V54, P150, DOI [10.1139/W07-125, 10.1139/w07-125]; Zuo LL, 2009, J ZHEJIANG UNIV-SC B, V10, P67, DOI 10.1631/jzus.B0820256	75	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36247	10.1371/journal.pone.0036247	http://dx.doi.org/10.1371/journal.pone.0036247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558404	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200055
J	Li, JY; Sun, XD; Wang, ZZ; Chen, L; Li, DW; Zhou, J; Liu, M				Li, Jingyu; Sun, Xiaodong; Wang, Zaizhu; Chen, Li; Li, Dengwen; Zhou, Jun; Liu, Min			Regulation of Vascular Endothelial Cell Polarization and Migration by Hsp70/Hsp90-Organizing Protein	PLOS ONE			English	Article							MICROTUBULE-BINDING PROTEIN; STRESS-INDUCIBLE PROTEIN-1; TUMOR-SUPPRESSOR CYLD; CANCER GENE-THERAPY; CO-CHAPERONE HOP; TARGETING ANGIOGENESIS; CYCLE KINASES; IN-VITRO; AURORA-B; HSP90	Hsp70/Hsp90-organizing protein (HOP) is a member of the co-chaperone family, which directly binds to chaperones to regulate their activities. The participation of HOP in cell motility and endothelial cell functions remains largely unknown. In this study, we demonstrate that HOP is critically involved in endothelial cell migration and angiogenesis. Tube formation and capillary sprouting experiments reveal that depletion of HOP expression significantly inhibits vessel formation from endothelial cells. Wound healing and transwell migration assays show that HOP is important for endothelial cell migration. By examination of centrosome reorientation and membrane ruffle dynamics, we find that HOP plays a crucial role in the establishment of cell polarity in response to migratory stimulus. Furthermore, our data show that HOP interacts with tubulin and colocalizes with microtubules in endothelial cells. These findings indicate HOP as a novel regulator of angiogenesis that functions through promoting vascular endothelial cell polarization and migration.	[Li, Jingyu; Sun, Xiaodong; Wang, Zaizhu; Chen, Li; Li, Dengwen; Zhou, Jun] Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Liu, Min] Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Minist Educ, Basic Med Coll, Tianjin, Peoples R China	Nankai University; Tianjin Medical University	Li, JY (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Tianjin 300071, Peoples R China.	minliu@tijmu.edu.cn	Li, Jingyu/GSD-1924-2022; Zhou, Jun/D-4654-2017	Zhou, Jun/0000-0001-7858-8260	National Basic Research Program of China [2012CB945002, 2010CB912204]; National Natural Science Foundation of China [30825022]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (2012CB945002 and 2010CB912204) and the National Natural Science Foundation of China (30825022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-20; AUERBACH R, 1979, J IMMUNOL, V123, P751; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Cavallaro U, 2000, J NEURO-ONCOL, V50, P63, DOI 10.1023/A:1006414621286; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Chen QR, 2001, MOL GENET METAB, V74, P120, DOI 10.1006/mgme.2001.3223; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Dong X, 2010, J PATHOL, V220, P361, DOI 10.1002/path.2662; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fonseca Ana-Violeta, 2011, Commun Integr Biol, V4, P201, DOI 10.4161/cib.4.2.14419; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Gao JM, 2010, BLOOD, V115, P4130, DOI 10.1182/blood-2009-10-248526; Gardlik R, 2011, BRATISL MED J, V112, P428; Huo LH, 2011, J BIOL CHEM, V286, P9280, DOI 10.1074/jbc.M110.208884; Huo LH, 2011, J PATHOL, V223, P28, DOI 10.1002/path.2768; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Li DW, 2011, PROTEIN CELL, V2, P150, DOI 10.1007/s13238-011-1015-4; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Liu CC, 2006, WORLD J GASTROENTERO, V12, P6941, DOI 10.3748/wjg.v12.i43.6941; Liu M, 2010, J PATHOL, V221, P221, DOI 10.1002/path.2706; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; Longshaw VM, 2000, BIOL CHEM, V381, P1133, DOI 10.1515/BC.2000.139; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; McKenna LB, 2007, CELL MOL LIFE SCI, V64, P2723, DOI 10.1007/s00018-007-7247-z; NICOLET CM, 1989, MOL CELL BIOL, V9, P3638, DOI 10.1128/MCB.9.9.3638; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shi XJ, 2011, J BIOL CHEM, V286, P33401, DOI 10.1074/jbc.M111.252262; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Skalnikova H, 2011, J PROTEOME RES, V10, P404, DOI 10.1021/pr100468w; Song XM, 2010, J BIOL CHEM, V285, P40039, DOI 10.1074/jbc.M110.181941; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; Sun L, 2010, J PATHOL, V221, P425, DOI 10.1002/path.2723; Sun XD, 2011, ACTA PHARMACOL SIN, V32, P1543, DOI 10.1038/aps.2011.130; Sun XD, 2012, J PATHOL, V226, P666, DOI 10.1002/path.3026; Sun XO, 2011, CELL CYCLE, V10, P3929, DOI 10.4161/cc.10.22.18106; Tandle Anita, 2004, J Transl Med, V2, P22, DOI 10.1186/1479-5876-2-22; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Walsh N, 2011, CANCER LETT, V306, P180, DOI 10.1016/j.canlet.2011.03.004; Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200; Whitfield C, 2010, STRUCTURE, V18, P151, DOI 10.1016/j.str.2010.01.006; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	51	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36389	10.1371/journal.pone.0036389	http://dx.doi.org/10.1371/journal.pone.0036389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558459	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340200075
J	Zlotkowska, D; Maddaloni, M; Riccardi, C; Walters, N; Holderness, K; Callis, G; Rynda-Apple, A; Pascual, DW				Zlotkowska, Dagmara; Maddaloni, Massimo; Riccardi, Carol; Walters, Nancy; Holderness, Kathryn; Callis, Gayle; Rynda-Apple, Agnieszka; Pascual, David W.			Loss of Sialic Acid Binding Domain Redirects Protein sigma 1 to Enhance M Cell-Directed Vaccination	PLOS ONE			English	Article							INTESTINAL M-CELLS; TOXIN B-SUBUNIT; CHOLERA-TOXIN; DENDRITIC CELLS; MUCOSAL IMMUNIZATION; REOVIRUS ATTACHMENT; IMMUNE-RESPONSES; ORAL TOLERANCE; ANTIGEN; RECEPTOR	Ovalbumin (OVA) genetically fused to protein sigma 1 (p sigma 1) results in tolerance to both OVA and p sigma 1. P sigma 1 binds in a multi-step fashion, involving both protein-and carbohydrate-based receptors. To assess the relative p sigma 1 components responsible for inducing tolerance and the importance of its sialic binding domain (SABD) for immunization, modified OVA-p sigma 1, termed OVA-p sigma 1(short), was deleted of its SABD, but with its M cell targeting moiety intact, and was found to be immunostimulatory and enhanced CD4(+) and CD8(+) T cell proliferation. When used to nasally immunize mice given with and without cholera toxin (CT) adjuvant, elevated SIgA and serum IgG responses were induced, and OVA-p sigma 1(s) was more efficient for immunization than native OVA+CT. The immune antibodies (Abs) were derived from elevated Ab-forming cells in the upper respiratory tissues and submaxillary glands and were supported by mixed Th cell responses. Thus, these studies show that p sigma 1(s) can be fused to vaccines to effectively elicit improved SIgA responses.	[Zlotkowska, Dagmara] Polish Acad Sci, Inst Food Res, Dept Food Chem, Olsztyn, Poland; [Maddaloni, Massimo; Riccardi, Carol; Walters, Nancy; Holderness, Kathryn; Callis, Gayle; Rynda-Apple, Agnieszka; Pascual, David W.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Polish Academy of Sciences; Montana State University System; Montana State University Bozeman	Zlotkowska, D (corresponding author), Polish Acad Sci, Inst Food Res, Dept Food Chem, Olsztyn, Poland.	dpascual@montana.edu	Pascual, David/AAC-2248-2022; Zlotkowska, Dagmara/H-7275-2017	Zlotkowska, Dagmara/0000-0002-5624-5707	Public Health Service [AI-078938]; Montana Agricultural Experiment Station; U.S. Department of Agriculture Formula Funds; National Institutes of Health/National Center for Research Resources; Centers of Biomedical Excellence [P20 RR-020185]; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI078938, R01AI078938] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Montana Agricultural Experiment Station; U.S. Department of Agriculture Formula Funds(United States Department of Agriculture (USDA)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Centers of Biomedical Excellence; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI-078938 and, in part, by Montana Agricultural Experiment Station and U.S. Department of Agriculture Formula Funds. The Immunology and Infectious Diseases' flow cytometry facility was, in part, supported by National Institutes of Health/National Center for Research Resources, Centers of Biomedical Excellence P20 RR-020185, and an equipment grant from the M.J. Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001147; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Birebent B, 2001, J CANCER RES CLIN, V127, pR27, DOI 10.1007/BF01470996; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Chabot S, 2006, J IMMUNOL, V176, P4275, DOI 10.4049/jimmunol.176.7.4275; Chappell JD, 2000, J VIROL, V74, P8472, DOI 10.1128/JVI.74.18.8472-8479.2000; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Cohen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025558; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Corthesy B, 2007, J IMMUNOL, V178, P27, DOI 10.4049/jimmunol.178.1.27; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; Gockel CM, 2005, IMMUNOLOGY, V116, P477, DOI 10.1111/j.1365-2567.2005.02246.x; Harakuni T, 2005, INFECT IMMUN, V73, P5654, DOI 10.1128/IAI.73.9.5654-5665.2005; Harokopakis E, 1998, INFECT IMMUN, V66, P4299; Hathaway LJ, 2000, CELL MOL LIFE SCI, V57, P323, DOI 10.1007/PL00000693; Huarte E, 2011, J AUTOIMMUN, V37, P328, DOI 10.1016/j.jaut.2011.09.005; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Kato H, 2001, J IMMUNOL, V166, P3114, DOI 10.4049/jimmunol.166.5.3114; Kiyone H., 2008, FUNDAMENTAL IMMUNOLO, P983; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; LEBENS M, 1994, DEV BIOL STAND, V82, P215; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Liu JL, 2011, FEMS IMMUNOL MED MIC, V61, P179, DOI 10.1111/j.1574-695X.2010.00764.x; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; NIBERT ML, 1995, J VIROL, V69, P5057, DOI 10.1128/JVI.69.8.5057-5067.1995; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Pascual D. W., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P203, DOI 10.2174/187153007781662549; Pascual DW, 2008, J IMMUNOL, V181, P1345, DOI 10.4049/jimmunol.181.2.1345; Rynda A, 2008, J IMMUNOL, V180, P5187, DOI 10.4049/jimmunol.180.8.5187; Rynda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008720; Rynda-Apple A, 2011, EUR J IMMUNOL, V41, P313, DOI 10.1002/eji.201041104; Snider DP, 1997, IMMUNOLOGY, V90, P323, DOI 10.1111/j.1365-2567.1997.00323.x; SPIT BJ, 1989, CELL TISSUE RES, V255, P193; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; Tacken PJ, 2005, BLOOD, V106, P1278, DOI 10.1182/blood-2005-01-0318; TURNER DL, 1992, VIROLOGY, V186, P219, DOI 10.1016/0042-6822(92)90076-2; Uto T, 2007, J IMMUNOL, V178, P2979, DOI 10.4049/jimmunol.178.5.2979; Wang XH, 2005, VACCINE, V23, P3836, DOI 10.1016/j.vaccine.2005.02.023; Wang XH, 2003, J IMMUNOL, V171, P4717, DOI 10.4049/jimmunol.171.9.4717; WOLF JL, 1983, GASTROENTEROLOGY, V85, P291; WOLF JL, 1981, SCIENCE, V212, P471, DOI 10.1126/science.6259737; Wu YP, 2001, P NATL ACAD SCI USA, V98, P9318, DOI 10.1073/pnas.161204098	45	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36182	10.1371/journal.pone.0036182	http://dx.doi.org/10.1371/journal.pone.0036182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558374	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200048
J	Cox, PG; Rayfield, EJ; Fagan, MJ; Herrel, A; Pataky, TC; Jeffery, N				Cox, Philip G.; Rayfield, Emily J.; Fagan, Michael J.; Herrel, Anthony; Pataky, Todd C.; Jeffery, Nathan			Functional Evolution of the Feeding System in Rodents	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; 2 MURID RODENTS; APODEMUS-SPECIOSUS; ONYCHOMYS-LEUCOGASTER; MASTICATORY MUSCLES; MANDIBULAR MOVEMENT; GUINEA-PIG; BITE-FORCE; MORPHOLOGY; MECHANICS	The masticatory musculature of rodents has evolved to enable both gnawing at the incisors and chewing at the molars. In particular, the masseter muscle is highly specialised, having extended anteriorly to originate from the rostrum. All living rodents have achieved this masseteric expansion in one of three ways, known as the sciuromorph, hystricomorph and myomorph conditions. Here, we used finite element analysis (FEA) to investigate the biomechanical implications of these three morphologies, in a squirrel, guinea pig and rat. In particular, we wished to determine whether each of the three morphologies is better adapted for either gnawing or chewing. Results show that squirrels are more efficient at muscle-bite force transmission during incisor gnawing than guinea pigs, and that guinea pigs are more efficient at molar chewing than squirrels. This matches the known diet of nuts and seeds that squirrels gnaw, and of grasses that guinea pigs grind down with their molars. Surprisingly, results also indicate that rats are more efficient as well as more versatile feeders than both the squirrel and guinea pig. There seems to be no compromise in biting efficiency to accommodate the wider range of foodstuffs and the more general feeding behaviour adopted by rats. Our results show that the morphology of the skull and masticatory muscles have allowed squirrels to specialise as gnawers and guinea pigs as chewers, but that rats are high-performance generalists, which helps explain their overwhelming success as a group.	[Cox, Philip G.] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Rayfield, Emily J.] Univ Bristol, Dept Earth Sci, Bristol, Avon, England; [Fagan, Michael J.] Univ Hull, Dept Engn, Kingston Upon Hull HU6 7RX, N Humberside, England; [Herrel, Anthony] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, F-75231 Paris, France; [Pataky, Todd C.] Shinshu Univ, Dept Bioengn, Ueda, Nagano, Japan; [Jeffery, Nathan] Univ Liverpool, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England	University of Hull; University of York - UK; University of Bristol; University of Hull; Museum National d'Histoire Naturelle (MNHN); Shinshu University; University of Liverpool	Cox, PG (corresponding author), Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England.	philip.cox@hyms.ac.uk	Rayfield, Emily/F-5038-2010; Herrel, Anthony/C-3712-2013	Rayfield, Emily/0000-0002-2618-750X; Herrel, Anthony/0000-0003-0991-4434; Jeffery, Nathan/0000-0001-5166-2029; Pataky, Todd/0000-0002-8292-7189; Cox, Philip Graham/0000-0001-9782-2358	Natural Environment Research Council (NERC) [NE/G001952/1]; NERC [NE/G002207/1, NE/G001979/1, NE/G001952/1] Funding Source: UKRI; Natural Environment Research Council [NE/G002207/1, NE/G001979/1, NE/G001952/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a grant from the Natural Environment Research Council (NERC grant NE/G001952/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2003, MOL PHYLOGENET EVOL, V26, P409, DOI 10.1016/S1055-7903(02)00304-4; [Anonymous], 1999, WALKERS MAMMALS WORL; Becht G., 1953, Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen, V56C, P508; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; BRANDT J.F., 1855, MEM ACAD IMP SCI S 6, V7, P1; Bright JA, 2011, J ANAT, V219, P456, DOI 10.1111/j.1469-7580.2011.01408.x; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; BYRD KE, 1981, J MORPHOL, V170, P147, DOI 10.1002/jmor.1051700203; Chamoli U, 2011, J THEOR BIOL, V283, P217, DOI 10.1016/j.jtbi.2011.05.020; Christiansen P, 2011, ZOOL J LINN SOC-LOND, V162, P220, DOI 10.1111/j.1096-3642.2010.00675.x; Cox PG, 2011, J ANAT, V219, P696, DOI 10.1111/j.1469-7580.2011.01436.x; Cox PG, 2011, ANAT REC, V294, P915, DOI 10.1002/ar.21381; Curtis N, 2011, ANAT REC, V294, P1178, DOI 10.1002/ar.21415; Druzinsky RE, 2011, INTEGR COMP BIOL, V51, P224, DOI 10.1093/icb/icr067; Druzinsky RE, 2010, CELLS TISSUES ORGANS, V192, P50, DOI 10.1159/000284930; Druzinsky RE, 2010, CELLS TISSUES ORGANS, V191, P510, DOI 10.1159/000284931; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2011, J ANAT, V218, P151, DOI 10.1111/j.1469-7580.2010.01247.x; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Eng CM, 2009, J EXP BIOL, V212, P4040, DOI 10.1242/jeb.029983; GORNIAK GC, 1977, J MORPHOL, V154, P427, DOI 10.1002/jmor.1051540305; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; HIIEMAE K, 1971, ZOOL J LINN SOC-LOND, V50, P111, DOI 10.1111/j.1096-3642.1971.tb00754.x; HIIEMAE KM, 1968, J ZOOL, V154, P139; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Macdonald D, 2001, NEW ENCY MAMMALS; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meng J, 2003, B AM MUS NAT HIST, P1; Meng Jin, 2005, P145; Miller G.S., 1918, J WASH ACAD SCI, V8, P431, DOI DOI 10.5962/BHL.PART.6490; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; ROBINS MW, 1977, ARCH ORAL BIOL, V22, P43, DOI 10.1016/0003-9969(77)90138-8; Satoh K, 1999, J MORPHOL, V240, P1; Satoh K, 1998, J MORPHOL, V236, P49, DOI 10.1002/(SICI)1097-4687(199804)236:1<49::AID-JMOR3>3.0.CO;2-J; Satoh K, 1997, J MORPHOL, V231, P131; Satoh K, 2006, J MORPHOL, V267, P987, DOI 10.1002/jmor.10443; Satoh K, 2009, ZOOMORPHOLOGY, V128, P339, DOI 10.1007/s00435-009-0094-8; Satoh Kazuhiko, 2008, Mammal Study, V33, P35, DOI 10.3106/1348-6160(2008)33[35:MMAIAM]2.0.CO;2; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Turnbull W. D., 1970, Fieldiana (Geol.), V18, P147; VANSPRONSEN PH, 1989, J DENT RES, V68, P1765, DOI 10.1177/00220345890680120901; WEIJS WA, 1975, J MORPHOL, V146, P1, DOI 10.1002/jmor.1051460102; WILLIAMS KR, 1984, BIOMATERIALS, V5, P347, DOI 10.1016/0142-9612(84)90033-4; Williams SH, 2009, J MORPHOL, V270, P1338, DOI 10.1002/jmor.10761; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WOOD AE, 1965, EVOLUTION, V19, P115, DOI 10.2307/2406300	51	121	130	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36299	10.1371/journal.pone.0036299	http://dx.doi.org/10.1371/journal.pone.0036299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558427	Green Published, gold, Green Accepted			2022-12-25	WOS:000305336000182
J	Delhaes, L; Monchy, S; Frealle, E; Hubans, C; Salleron, J; Leroy, S; Prevotat, A; Wallet, F; Wallaert, B; Dei-Cas, E; Sime-Ngando, T; Chabe, M; Viscogliosi, E				Delhaes, Laurence; Monchy, Sebastien; Frealle, Emilie; Hubans, Christine; Salleron, Julia; Leroy, Sylvie; Prevotat, Anne; Wallet, Frederick; Wallaert, Benoit; Dei-Cas, Eduardo; Sime-Ngando, Telesphore; Chabe, Magali; Viscogliosi, Eric			The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community-Implications for Therapeutic Management	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ASPERGILLUS-FUMIGATUS; RESPIRATORY-TRACT; CANDIDA-ALBICANS; BRONCHOALVEOLAR LAVAGE; SPUTUM SAMPLES; ADULT PATIENTS; DNA; INFECTIONS; DIVERSITY	Background: Given the polymicrobial nature of pulmonary infections in patients with cystic fibrosis (CF), it is essential to enhance our knowledge on the composition of the microbial community to improve patient management. In this study, we developed a pyrosequencing approach to extensively explore the diversity and dynamics of fungal and prokaryotic populations in CF lower airways. Methodology and Principal Findings: Fungi and bacteria diversity in eight sputum samples collected from four adult CF patients was investigated using conventional microbiological culturing and high-throughput pyrosequencing approach targeting the ITS2 locus and the 16S rDNA gene. The unveiled microbial community structure was compared to the clinical profile of the CF patients. Pyrosequencing confirmed recently reported bacterial diversity and observed complex fungal communities, in which more than 60% of the species or genera were not detected by cultures. Strikingly, the diversity and species richness of fungal and bacterial communities was significantly lower in patients with decreased lung function and poor clinical status. Values of Chao1 richness estimator were statistically correlated with values of the Shwachman-Kulczycki score, body mass index, forced vital capacity, and forced expiratory volume in 1 s (p = 0.046, 0.047, 0.004, and 0.001, respectively for fungal Chao1 indices, and p = 0.010, 0.047, 0.002, and 0.0003, respectively for bacterial Chao1 values). Phylogenetic analysis showed high molecular diversities at the sub-species level for the main fungal and bacterial taxa identified in the present study. Anaerobes were isolated with Pseudomonas aeruginosa, which was more likely to be observed in association with Candida albicans than with Aspergillus fumigatus. Conclusions: In light of the recent concept of CF lung microbiota, we viewed the microbial community as a unique pathogenic entity. We thus interpreted our results to highlight the potential interactions between microorganisms and the role of fungi in the context of improving survival in CF.	[Delhaes, Laurence; Frealle, Emilie; Dei-Cas, Eduardo; Chabe, Magali; Viscogliosi, Eric] Inst Pasteur, CIIL, Lille, France; [Delhaes, Laurence; Frealle, Emilie; Dei-Cas, Eduardo; Chabe, Magali; Viscogliosi, Eric] INSERM U1019, Lille, France; [Delhaes, Laurence; Frealle, Emilie; Dei-Cas, Eduardo; Chabe, Magali; Viscogliosi, Eric] UMR CNRS 8402, Lille, France; [Delhaes, Laurence; Frealle, Emilie; Dei-Cas, Eduardo; Chabe, Magali; Viscogliosi, Eric] Univ Lille Nord France, EA4547, Dept Parasitol Mycol, Fac Pharm, Lille, France; [Delhaes, Laurence; Frealle, Emilie; Dei-Cas, Eduardo] Lille Hosp, Fac Med, Dept Microbiol, Lille, France; [Monchy, Sebastien; Sime-Ngando, Telesphore] Clermont Univ, LMGE, UMR CNRS 6023, Aubiere, France; [Monchy, Sebastien] ULCO, Univ Lille Nord France, LOG, UMR CNRS 8187, Wimereux, France; [Salleron, Julia] Lille Hosp, Fac Med, Dept Biostat, Lille, France; [Leroy, Sylvie; Prevotat, Anne; Wallaert, Benoit] Calmette Hosp, CRCM Adulte, Dept Pneumol & Immunoallergol, Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Delhaes, L (corresponding author), Inst Pasteur, CIIL, BP 245, Lille, France.	Laurence.delhaes@pasteur-lille.fr	Leroy, Sylvie SL/A-6903-2017; Sime-Ngando, Télesphore/M-4134-2019; Fréalle, Emilie/AAF-5162-2020; Delhaes, Laurence/AAD-6930-2020; Chabe, Magali/H-6045-2017	Leroy, Sylvie SL/0000-0002-3465-8180; Sime-Ngando, Télesphore/0000-0002-7240-5803; Frealle, Emilie/0000-0003-3129-979X; Viscogliosi, Eric/0000-0002-5805-7179; MONCHY, Sebastien/0000-0001-5808-4700; Chabe, Magali/0000-0002-6732-6772	French Ministry of Health and Research (PHRC) [2006/1902]; Pfizer France Pharmaceutical Division [2006/158]; Lille-Nord-de-France University; Pasteur Institute of Lille	French Ministry of Health and Research (PHRC); Pfizer France Pharmaceutical Division; Lille-Nord-de-France University; Pasteur Institute of Lille	This work was part of a study supported by the French Ministry of Health and Research (PHRC No 2006/1902), and Pfizer France Pharmaceutical Division (No 2006/158). The authors also thank the Lille-Nord-de-France University, the Pasteur Institute of Lille for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from Pfizer France pharmaceutical Division (No 2006/158). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aguero-Chapin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026638; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Amin R, 2010, CHEST, V137, P171, DOI 10.1378/chest.09-1103; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Balajee SA, 2005, EUKARYOT CELL, V4, P625, DOI 10.1128/EC.4.3.625-632.2005; Bandara HMHN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-125; Bearchell SJ, 2005, P NATL ACAD SCI USA, V102, P5438, DOI 10.1073/pnas.0501596102; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Borman AM, 2010, MED MYCOL, V48, pS88, DOI 10.3109/13693786.2010.511287; Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08; Casagrande BF, 2006, J INVEST DERMATOL, V126, P2414, DOI 10.1038/sj.jid.5700431; Chabe M, 2011, FEMS YEAST RES, V11, P2, DOI 10.1111/j.1567-1364.2010.00698.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chotirmall SH, 2010, CHEST, V138, P1186, DOI 10.1378/chest.09-2996; Cimerman M, 1999, J CLIN MICROBIOL, V37, P1532, DOI 10.1128/JCM.37.5.1532-1535.1999; Cimon B, 2001, J MED MICROBIOL, V50, P367, DOI 10.1099/0022-1317-50-4-367; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Delhaes L, 2008, EMERG INFECT DIS, V14, P282, DOI 10.3201/eid1402.070920; Dumitru R, 2004, ANTIMICROB AGENTS CH, V48, P2350, DOI 10.1128/AAC.48.7.2350-2354.2004; Dumitru R, 2007, EUKARYOT CELL, V6, P465, DOI 10.1128/EC.00316-06; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; European Commission Health & Consumers Directorate-General Phlebiopsis gigantea, SANCO16308REV3 EUR C; Fava F, 2011, WORLD J GASTROENTERO, V17, P557, DOI 10.3748/wjg.v17.i5.557; FEGAN M, 1991, J CLIN MICROBIOL, V29, P2151, DOI 10.1128/JCM.29.10.2151-2157.1991; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Frealle E, 2009, EUR J CLIN MICROBIOL, V28, P223, DOI 10.1007/s10096-008-0616-1; Fredricks DN, 2005, J CLIN MICROBIOL, V43, P5122, DOI 10.1128/JCM.43.10.5122-5128.2005; Friaza V, 2010, J MICROBIOL METH, V82, P98, DOI 10.1016/j.mimet.2010.03.026; Gammelsrud KW, 2011, CLIN MICROBIOL INFEC, V17, P1875, DOI 10.1111/j.1469-0691.2011.03528.x; Gilgado F, 2008, J CLIN MICROBIOL, V46, P766, DOI 10.1128/JCM.01122-07; Gomez-Lopez A, 2010, DIAGN MICR INFEC DIS, V66, P116, DOI 10.1016/j.diagmicrobio.2009.06.007; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Grinwis ME, 2010, J CLIN MICROBIOL, V48, P395, DOI 10.1128/JCM.01807-09; Guarro J, 1999, CLIN MICROBIOL REV, V12, P454, DOI 10.1128/CMR.12.3.454; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; HARRIES MG, 1985, LANCET, V1, P1063; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hirooka Y, 2011, STUD MYCOL, P35, DOI [10.3114/sim.2011.68.02, 10.3114/sim.2011.68.03]; Hogan DA, 2006, EUKARYOT CELL, V5, P613, DOI 10.1128/EC.5.4.613-619.2006; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Horre R, 2010, MED MYCOL, V48, pS1, DOI 10.3109/13693786.2010.529304; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Inacio J, 2005, FEMS YEAST RES, V5, P1167, DOI 10.1016/j.femsyr.2005.05.007; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Lachance MA, 2003, FEMS YEAST RES, V4, P253, DOI 10.1016/S1567-1356(03)00113-2; Lattif AA, 2010, INT J MED MICROBIOL, V300, P265, DOI 10.1016/j.ijmm.2009.09.001; Leclair LW, 2010, MED MYCOL, V48, pS125, DOI 10.3109/13693786.2010.521522; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; McAlester G, 2008, J MED MICROBIOL, V57, P563, DOI 10.1099/jmm.0.47705-0; Merget R, 2008, RESPIRATION, V76, P109, DOI 10.1159/000097137; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Montes-Cano MA, 2007, CLIN MICROBIOL INFEC, V13, P1008, DOI 10.1111/j.1469-0691.2007.01789.x; Moore JE, 2002, MYCOPATHOLOGIA, V154, P25, DOI 10.1023/A:1015236422992; Mortensen KL, 2011, EUR J CLIN MICROBIOL, V30, P1355, DOI 10.1007/s10096-011-1229-7; Mowat E, 2010, FEMS MICROBIOL LETT, V313, P96, DOI 10.1111/j.1574-6968.2010.02130.x; Muthig M, 2010, MED MYCOL, V48, P56, DOI 10.3109/13693780802716532; Nagano Y, 2010, MED MYCOL, V48, P166, DOI 10.3109/13693780903127506; Nagano Y, 2008, J CYST FIBROS, V7, P566, DOI 10.1016/j.jcf.2008.06.007; Nahimana A, 2000, J EUKARYOT MICROBIOL, V47, P368, DOI 10.1111/j.1550-7408.2000.tb00062.x; Neuveglise C, 1997, EUR J CLIN MICROBIOL, V16, P747, DOI 10.1007/BF01709257; Perkins SD, 2010, INT J MED MICROBIOL, V300, P503, DOI 10.1016/j.ijmm.2010.02.005; Peterson SW, 2008, MYCOLOGIA, V100, P205, DOI 10.3852/mycologia.100.2.205; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reen FJ, 2011, FEMS MICROBIOL ECOL, V77, P413, DOI 10.1111/j.1574-6941.2011.01121.x; Reihill JA, 2011, J CYST FIBROS, V10, P401, DOI 10.1016/j.jcf.2011.06.006; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2010, GUT MICROBES, V1, P85, DOI 10.4161/gmic.1.2.11350; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rybtke Morten T., 2011, Inflammation & Allergy Drug Targets, V10, P141; SAMSON RA, 1978, MYCOPATHOLOGIA, V64, P13, DOI 10.1007/BF00443082; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Seidler MJ, 2008, ANTIMICROB AGENTS CH, V52, P4130, DOI 10.1128/AAC.00234-08; Semighini CP, 2006, MOL MICROBIOL, V59, P753, DOI 10.1111/j.1365-2958.2005.04976.x; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Sudfeld CR, 2010, J CYST FIBROS, V9, P110, DOI 10.1016/j.jcf.2009.11.010; Sundquist A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-108; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Tre-Hardy M, 2010, ANTIMICROB AGENTS CH, V54, P4409, DOI 10.1128/AAC.00372-10; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Vanhee LME, 2008, EUR J CLIN MICROBIOL, V27, P1005, DOI 10.1007/s10096-008-0527-1; Vilela DM, 2010, FOOD MICROBIOL, V27, P1128, DOI 10.1016/j.fm.2010.07.024; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wolcott RD, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-226; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zemanick ET, 2011, CURR OPIN PEDIATR, V23, P319, DOI 10.1097/MOP.0b013e32834604f2; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	104	247	251	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36313	10.1371/journal.pone.0036313	http://dx.doi.org/10.1371/journal.pone.0036313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558432	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000187
J	Huang, W; Deng, B; Wang, RW; Tan, QY; He, Y; Jiang, YG; Zhou, JH				Huang, Wei; Deng, Bo; Wang, Ru-Wen; Tan, Qun-You; He, Yong; Jiang, Yao-Guang; Zhou, Jing-Hai			BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; ANTIESTROGEN RESISTANCE; PULMONARY-DISEASE; SRC; P130CAS; TRANSFORMATION; SUBSTRATE; INVASION; CRK	Objective: Our previous study suggested the potential clinical implications of BCAR1 in non-small-cell lung cancer (NSCLC) (Mol Diagn Ther. 2011. 15(1): 31-40). Herein, we aim to evaluate the predictive power of BCAR1 as a marker for poor prognosis in NSCLC cases, verify the carcinogenic roles of BCAR1 in the A549 lung adenocarcinoma cell line, and testify to the BCAR1/phospho-p38 axis. Methods: Between January 2006 and June 2010, there were a total of 182 patients with NSCLC (151 cases with available follow up data, and 31 cases lost to follow-up due to the invalid contact information). We inspected BCAR1, phospho-BCAR1(Tyr410), phospho-p38(Thr180/Tyr182) and p38 expression in NSCLC tissues and matched adjacent normal tissues by immunoblotting and IHC. After BCAR1 -RNA interference in A549 cells, we inspected the protein expression (BCAR1, phospho-BCAR1, phospho-p38 and p38) and performed cell biology experiments (cell growth, migration and cycle). Results: BCAR1 was overexpressed in NSCLC tissues (177/182) and cell lines (A549 and Calu-3). However, it was not detected in the normal adjacent tissue in 161 of the 182 cases. Higher BCAR1 levels were strongly associated with more poorly differentiated NSCLC and predicted poorer prognosis. BCAR1 knockdown caused cell growth arrest, cell migration inhibition and cell cycle arrest of A549 cells. Overexpression of BCAR1 was associated with activation of p38 in NSCLC cases, and BCAR1 knockdown caused reduction of phospho-p38 levels in A549 cells. Conclusion: Overexpression of BCAR1 is a predictor of poor prognosis in NSCLC and plays important carcinogenic roles in carcinogenesis, probably via activation of p38 MAPK. However, further investigations are required immediately.	[Huang, Wei; Deng, Bo; Wang, Ru-Wen; Tan, Qun-You; He, Yong; Jiang, Yao-Guang; Zhou, Jing-Hai] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Thorac Surg, Chongqing, Peoples R China	Army Medical University	Deng, B (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Thorac Surg, Chongqing, Peoples R China.	superdb@163.com; wangrw53@126.com	Deng, Bo/AAH-8533-2021		National Natural Science Foundation of China (NSFC) [81101782, CSTC2011BB5020]; NSFC Third Military Medical University [2010XQN36]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Third Military Medical University	The work was supported by the National Natural Science Foundation of China (NSFC) (No. 81101782), NSFC project CQ CSTC (No. CSTC2011BB5020), and NSFC Third Military Medical University (No. 2010XQN36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Deng B, 2011, MOL DIAGN THER, V15, P31, DOI 10.2165/11588850-000000000-00000; Dorssers LCJ, 2004, CLIN CANCER RES, V10, P6194, DOI 10.1158/1078-0432.CCR-04-0444; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang C, 2005, BRIT J CANCER, V92, P1231, DOI 10.1038/sj.bjc.6602481; Ji C, 2010, BRAZ J MED BIOL RES, V43, P821, DOI 10.1590/S0100-879X2010000900003; KANNER SB, 1991, MOL CELL BIOL, V11, P713, DOI 10.1128/MCB.11.2.713; Kim W, 2004, J BIOL CHEM, V279, P8333, DOI 10.1074/jbc.M312026200; Kim W, 2008, MOL BIOL CELL, V19, P2135, DOI 10.1091/mbc.E07-10-0991; Matsuda K, 2002, CANCER RES, V62, P5611; Purnell PR, 2009, J THORAC ONCOL, V4, P448, DOI 10.1097/JTO.0b013e31819c78fb; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Rooney C, 2011, RESPIRATION, V81, P89, DOI 10.1159/000323946; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Takino T, 2003, J CELL SCI, V116, P3145, DOI 10.1242/jcs.00632; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Ulahannan SV, 2011, CANCER INVEST, V29, P325, DOI 10.3109/07357907.2011.554476; Wei L, 2002, J CELL BIOCHEM, V87, P439, DOI 10.1002/jcb.10322; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Yu JQ, 2004, J BIOL CHEM, V279, P50446, DOI 10.1074/jbc.M409221200	25	13	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36124	10.1371/journal.pone.0036124	http://dx.doi.org/10.1371/journal.pone.0036124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558353	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000132
J	Lee, HS; Daniels, BH; Salas, E; Bollen, AW; Debnath, J; Margeta, M				Lee, Han S.; Daniels, Brianne H.; Salas, Eduardo; Bollen, Andrew W.; Debnath, Jayanta; Margeta, Marta			Clinical Utility of LC3 and p62 Immunohistochemistry in Diagnosis of Drug-Induced Autophagic Vacuolar Myopathies: A Case-Control Study	PLOS ONE			English	Article							COLCHICINE MYOPATHY; SKELETAL-MUSCLE; CHLOROQUINE; DISEASE; MICE	Background: Some patients treated with chloroquine, hydroxychloroquine, or colchicine develop autophagic vacuolar myopathy, the diagnosis of which currently requires electron microscopy. The goal of the current study was to develop an immunohistochemical diagnostic marker for this pathologic entity. Methodology: Microtubule-associated protein light chain 3 (LC3) has emerged as a robust marker of autophagosomes. LC3 binds p62/SQSTM1, an adapter protein that is selectively degraded via autophagy. In this study, we evaluated the utility of immunohistochemical stains for LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar myopathy. The staining was performed on archival muscle biopsy material, with subject assignment to normal control, drug-treated control, and autophagic myopathy groups based on history of drug use and morphologic criteria. Principal Findings: In all drug-treated subjects, but not in normal controls, LC3 and p62 showed punctate staining characteristic of autophagosome buildup. In the autophagic myopathy subjects, puncta were coarser and tended to coalesce into linear structures aligned with the longitudinal axis of the fiber, often in the vicinity of vacuoles. The percentage of LC3- and p62-positive fibers was significantly higher in the autophagic myopathy group compared to either the normal control (p<0.001) or the drug-treated control group (p<0.05). With the diagnostic threshold set between 8% and 15% positive fibers (depending on the desired level of sensitivity and specificity), immunohistochemical staining for either LC3 or p62 could be used to identify subjects with autophagic vacuolar myopathy within the drug-treated subject group (p <= 0.001). Significance: Immunohistochemistry for LC3 and p62 can facilitate tissue-based diagnosis of drug-induced autophagic vacuolar myopathies. By limiting the need for electron microscopy (a time consuming and costly technique with high specificity, but low sensitivity), clinical use of these markers will improve the speed and accuracy of diagnosis, resulting in significantly improved clinical care.	[Lee, Han S.; Daniels, Brianne H.; Salas, Eduardo; Bollen, Andrew W.; Debnath, Jayanta; Margeta, Marta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Daniels, Brianne H.] Touro Univ Calif, Coll Osteopath Med, Vallejo, CA USA	University of California System; University of California San Francisco; Touro University California	Lee, HS (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	Marta.Margeta@ucsf.edu		Debnath, Jayanta/0000-0002-8745-4069; Margeta, Marta/0000-0001-6889-2488	NCI NIH HHS [R01 CA126792] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA126792] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdel-Hamid H, 2008, MUSCLE NERVE, V38, P1206, DOI 10.1002/mus.21091; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Casado E, 2006, ANN RHEUM DIS, V65, P385, DOI 10.1136/ard.2004.023200; Chen N, 2010, FEBS LETT, V584, P1427, DOI 10.1016/j.febslet.2009.12.034; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Estes M L, 1987, Am J Med, V82, P447, DOI 10.1016/0002-9343(87)90444-X; Fernandez C, 2002, ACTA NEUROPATHOL, V103, P100; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura N, 2007, PATHOBIOLOGY, V74, P169, DOI 10.1159/000103376; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; KUMAMOTO T, 1993, MUSCLE NERVE, V16, P819, DOI 10.1002/mus.880160803; Kuncl RW, 2003, EXP CELL RES, V285, P196, DOI 10.1016/S0014-4827(03)00034-X; KUNCL RW, 1987, NEW ENGL J MED, V316, P1562, DOI 10.1056/NEJM198706183162502; Kuusisto E, 2008, NEUROPATH APPL NEURO, V34, P169, DOI 10.1111/j.1365-2990.2007.00884.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; MARKAND ON, 1971, ARCH NEUROL-CHICAGO, V24, P72, DOI 10.1001/archneur.1971.00480310100010; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Nishino Ichizo, 2006, Semin Pediatr Neurol, V13, P90, DOI 10.1016/j.spen.2006.06.004; Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Siddiqui AK, 2007, CHEST, V131, P588, DOI 10.1378/chest.06-1146; STAUBER WT, 1981, EXP NEUROL, V71, P295, DOI 10.1016/0014-4886(81)90090-X; Stein M, 2000, J RHEUMATOL, V27, P2927; Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Wilbur K, 2004, PHARMACOTHERAPY, V24, P1784, DOI 10.1592/phco.24.17.1784.52334; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278	37	55	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36221	10.1371/journal.pone.0036221	http://dx.doi.org/10.1371/journal.pone.0036221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558391	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000160
J	Racca, A; Guo, K; Meints, K; Mills, DS				Racca, Anais; Guo, Kun; Meints, Kerstin; Mills, Daniel S.			Reading Faces: Differential Lateral Gaze Bias in Processing Canine and Human Facial Expressions in Dogs and 4-Year-Old Children	PLOS ONE			English	Article							ASYMMETRICAL BRAIN; FAMILIARIS; CUES; COMPREHENSION; RECOGNITION; EVOLUTION; RESPONSES	Sensitivity to the emotions of others provides clear biological advantages. However, in the case of heterospecific relationships, such as that existing between dogs and humans, there are additional challenges since some elements of the expression of emotions are species-specific. Given that faces provide important visual cues for communicating emotional state in both humans and dogs, and that processing of emotions is subject to brain lateralisation, we investigated lateral gaze bias in adult dogs when presented with pictures of expressive human and dog faces. Our analysis revealed clear differences in laterality of eye movements in dogs towards conspecific faces according to the emotional valence of the expressions. Differences were also found towards human faces, but to a lesser extent. For comparative purpose, a similar experiment was also run with 4-year-old children and it was observed that they showed differential processing of facial expressions compared to dogs, suggesting a species-dependent engagement of the right or left hemisphere in processing emotions.	[Racca, Anais; Guo, Kun; Meints, Kerstin] Lincoln Univ, Sch Psychol, Lincoln, England; [Racca, Anais; Mills, Daniel S.] Lincoln Univ, Sch Life Sci, Lincoln, England	University of Lincoln; University of Lincoln	Racca, A (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	kguo@lincoln.ac.uk		Meints, Kerstin/0000-0003-1048-5091; Mills, Daniel/0000-0002-4765-9625; Guo, Kun/0000-0001-6765-1957				Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; ANDREW RJ, 1963, SCIENCE, V142, P1034, DOI 10.1126/science.142.3595.1034; [Anonymous], 1983, COGN PROCESS, DOI [10.1016/B978-0-12-550680-9.50011-X, DOI 10.1016/B978-0-12-550680-9.50011-X]; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Bolwig N., 1964, Behaviour, V22, P167; BULLOCK M, 1985, INT J BEHAV DEV, V8, P15, DOI 10.1177/016502548500800103; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Chevalier-Skolnikoff S., 1973, DARWIN FACIAL EXPRES, P11; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Deputte BL., 2011, J VET BEHAV, V6, P78, DOI [10.1016/j.jveb.2010.09.013, DOI 10.1016/J.JVEB.2010.09.013]; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Dobson SD, 2009, AM J PHYS ANTHROPOL, V138, P70, DOI 10.1002/ajpa.20902; Ehrlichman H, 1986, DUALITY UNITY BRAIN, P194; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; Ekman P., 1975, PICTURES FACIAL AFFE; Ekman P, 1978, FACIAL ACTION CODING; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Feddersen-Petersen DU, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P105, DOI 10.1079/9781845931872.0105; FOX MW, 1970, BEHAVIOUR, V36, P49, DOI 10.1163/156853970X00042; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Green JR, 2010, J SPEECH LANG HEAR R, V53, P1529, DOI 10.1044/1092-4388(2010/09-0005); Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Hare B., 1998, EVOL COMMUN, V2, P137; Hinde RA, 1962, P ZOOL SOC LOND, V138, P121; Indersmitten T, 2003, J NEUROSCI, V23, P3820; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Lee E, 2008, PSYCHIAT RES, V157, P77, DOI 10.1016/j.psychres.2007.02.005; MCMANUS IC, 1988, BRIT J DEV PSYCHOL, V6, P257, DOI 10.1111/j.2044-835X.1988.tb01099.x; Meints K, 2009, J PEDIATR PSYCHOL, V34, P1084, DOI 10.1093/jpepsy/jsp053; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miles L, 2007, J NONVERBAL BEHAV, V31, P259, DOI 10.1007/s10919-007-0036-4; MILLOT JL, 1994, BEHAV PROCESS, V33, P177, DOI 10.1016/0376-6357(94)90065-5; Mills DS, 2005, Current Issues and Research in Veterinary Behavioral Medicine, P217; Mitchell RW, 2001, RES LANG SOC INTERAC, V34, P183, DOI 10.1207/S15327973RLSI34-2_2; Mongillo P, 2010, ANIM BEHAV, V80, P1057, DOI 10.1016/j.anbehav.2010.09.014; Nagasawa M, 2011, ANIM COGN, V14, P525, DOI 10.1007/s10071-011-0386-5; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Parr LA, 2008, EMOTION, V8, P216, DOI 10.1037/1528-3542.8.2.216; Parr LA, 2007, CURR DIR PSYCHOL SCI, V16, P117, DOI 10.1111/j.1467-8721.2007.00487.x; Phillips ML, 1997, BRAIN COGNITION, V35, P225, DOI 10.1006/brcg.1997.0939; Phillips ML, 2004, NEUROIMAGE, V21, P1484, DOI 10.1016/j.neuroimage.2003.12.013; Preuschoft S., 1997, NONVERBAL COMMUNICAT, P171; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Racca A, 2010, ANIM COGN, V13, P525, DOI 10.1007/s10071-009-0303-3; Ruffman T, 2011, J VET BEHAV, V6, P97, DOI DOI 10.1016/J.JVEB.2010.08.009; Siniscalchi M, 2011, ANIM BEHAV, V82, P399, DOI 10.1016/j.anbehav.2011.05.020; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Siniscalchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003349; Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122; Topal J, 2009, ADV STUD BEHAV, V39, P71, DOI 10.1016/S0065-3454(09)39003-8; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; VALLORTIGARA G, 1994, BEHAV PROCESS, V33, P41, DOI 10.1016/0376-6357(94)90059-0; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; van Hooff J. A. R. A. M., 1967, PRIMATE ETHOLOGY, P9; Vas J, 2005, APPL ANIM BEHAV SCI, V94, P99, DOI 10.1016/j.applanim.2005.02.001; Viranyi Z, 2006, ANIM COGN, V9, P13, DOI 10.1007/s10071-005-0257-z; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012; Widen SC, 2003, DEV PSYCHOL, V39, P114, DOI 10.1037//0012-1649.39.1.114	64	83	84	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36076	10.1371/journal.pone.0036076	http://dx.doi.org/10.1371/journal.pone.0036076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558335	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000305336000121
J	Seena, S; Duarte, S; Pascoal, C; Cassio, F				Seena, Sahadevan; Duarte, Sofia; Pascoal, Claudia; Cassio, Fernanda			Intraspecific Variation of the Aquatic Fungus Articulospora tetracladia: An Ubiquitous Perspective	PLOS ONE			English	Article							LEAF-LITTER DECOMPOSITION; HYPHOMYCETE DIVERSITY; SPECIES RECOGNITION; BASE SUBSTITUTIONS; GENETIC DIVERSITY; BIOGEOGRAPHY; POPULATIONS; DISPERSAL; RIVERS; STREAM	The worldwide-distributed aquatic fungus Articulospora tetracladia Ingold is a dominant sporulating species in streams of the Northwest Iberian Peninsula. To elucidate the genetic diversity of A. tetracladia, we analyzed isolates collected from various types of plant litter or foam in streams from North and Central Portugal and North Spain, between 2000 and 2010. Genetic diversity of these fungal populations was assessed by denaturing gradient gel electrophoresis (DGGE) fingerprints and by using ITS1-5.8S-ITS2 barcodes. Moreover, ITS1-5.8S-ITS2 barcodes of A. tetracladia reported in other parts of the world (Central Europe, United Kingdom, Canada, Japan and Malaysia) were retrieved from the National Center for Biotechnology (NCBI) and the National Institute of Technology and Evaluation Biological Resource Center (NBRC) to probe into genetic diversity of A. tetracladia. PCR-DGGE of ITS2 region of 50 Iberian fungal isolates distinguished eight operational taxonomic units (OTUs), which were similar to those obtained from neighboring trees based on ITS2 gene sequences. On the other hand, ITS1-5.8S-ITS2 barcodes of 68 fungal isolates yielded nine OTUs, but five fungal isolates were not assigned to any of these OTUs. Molecular diversity was highest for OTU-8, which included only European isolates. Two haplotypes were observed within OTU-8 and OTU-9, while only one haplotype was found within each of the remaining OTUs. Malaysia did not share haplotypes with other countries. Overall results indicate that, apart from the Malaysian genotypes, A. tetracladia genotypes were geographically widespread irrespective of sampling time, sites or substrates. Furthermore, PCR-DGGE appeared to be a rapid tool for assessing intraspecific diversity of aquatic hyphomycetes.	[Seena, Sahadevan; Duarte, Sofia; Pascoal, Claudia; Cassio, Fernanda] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal	Universidade do Minho	Seena, S (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	ssahadevan@bio.uminho.pt	Duarte, Sofia/H-3323-2013; Pascoal, Claudia/C-4072-2009; Duarte, Sofia/ABD-8278-2021; Cassio, Fernanda/A-6653-2011	Duarte, Sofia/0000-0002-0181-0676; Pascoal, Claudia/0000-0002-2018-4201; Duarte, Sofia/0000-0002-0181-0676; Cassio, Fernanda/0000-0003-3924-3280; sahadevan, seena/0000-0002-5598-4794	European Regional Development Fund - Operational Competitiveness Programme (FEDER-POFC-COMPETE); Portuguese Foundation for Science and Technology [PEst-C/BIA/UI4050/2011, PTDC/AAC-AMB/113746/2009];  [SFRH/BPD/47574/2008]; Fundação para a Ciência e a Tecnologia [PTDC/AAC-AMB/113746/2009] Funding Source: FCT	European Regional Development Fund - Operational Competitiveness Programme (FEDER-POFC-COMPETE); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); ; Fundação para a Ciência e a Tecnologia	The European Regional Development Fund - Operational Competitiveness Programme (FEDER-POFC-COMPETE) and the Portuguese Foundation for Science and Technology supported this study (PEst-C/BIA/UI4050/2011 and PTDC/AAC-AMB/113746/2009) and S. Duarte (SFRH/BPD/47574/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMER RD, 1985, NEW ZEAL J BOT, V23, P273, DOI 10.1080/0028825X.1985.10425331; Anderson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015908; Barlocher F, 2009, MYCOSCIENCE, V50, P3, DOI 10.1007/s10267-008-0449-x; Barlocher F, 2003, OIKOS, V101, P247, DOI 10.1034/j.1600-0706.2003.12372.x; BARLOCHER F, 2005, FUNGAL COMMUNITY ITS, P39, DOI DOI 10.1201/9781420027891.CH3; Baudoin JM, 2008, MICROB ECOL, V56, P260, DOI 10.1007/s00248-007-9344-9; Chan S. Y., 2000, Fungal Diversity, V5, P109; Charcosset JY, 1999, MYCOL RES, V103, P736, DOI 10.1017/S0953756298007606; DELFRATE G, 1983, HYDROBIOLOGIA, V102, P69, DOI 10.1007/BF00006051; Duarte S, 2006, OECOLOGIA, V147, P658, DOI 10.1007/s00442-005-0300-4; Duarte S, 2008, MICROB ECOL, V56, P688, DOI 10.1007/s00248-008-9388-5; Duarte S, 2010, MICROBIOL RES, V165, P351, DOI 10.1016/j.micres.2009.06.002; Duarte S, 2009, APPL ENVIRON MICROB, V75, P6211, DOI 10.1128/AEM.00971-09; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabre E, 1998, CAN J BOT, V76, P107, DOI 10.1139/b97-156; Fernandes I, 2011, OECOLOGIA, V166, P1019, DOI 10.1007/s00442-011-1930-3; GONCZOL J, 1976, Acta Botanica Academiae Scientiarum Hungaricae, V22, P51; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Halling RE, 2008, MYCOL RES, V112, P437, DOI 10.1016/j.mycres.2007.11.021; Harrington TJ, 1997, BIOL ENVIRON, V97B, P139; Hartl Daniel L., 1997; Hosaka K, 2008, MYCOL RES, V112, P448, DOI 10.1016/j.mycres.2007.06.004; HUDSON RR, 1992, GENETICS, V132, P583; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; INGOLD C. T., 1949, TRANS BRIT MYCOL SOC, V32, P341; Ingold C. T., 1942, TRANS BRIT MYCOL SOC, V25, P339; Iqbal Syed Hussain, 1994, Mycoscience, V35, P331, DOI 10.1007/BF02268503; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Laitung B, 2004, MOL ECOL, V13, P1679, DOI 10.1111/j.1365-294X.2004.02135.x; Lumbsch HT, 2008, MYCOL RES, V112, P423, DOI 10.1016/j.mycres.2008.02.002; Moncalvo JM, 2008, MYCOL RES, V112, P425, DOI 10.1016/j.mycres.2007.12.001; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Muyzer G., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P743; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nikolcheva LG, 2003, APPL ENVIRON MICROB, V69, P2548, DOI 10.1128/AEM.69.5.2548-2554.2003; Nikolcheva LG, 2005, MYCOL RES, V109, P246, DOI 10.1017/S0953756204001698; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Pascoal C, 2005, ARCH HYDROBIOL, V162, P481, DOI 10.1127/0003-9136/2005/0162-0481; Pascoal C, 2004, APPL ENVIRON MICROB, V70, P5266, DOI 10.1128/AEM.70.9.5266-5273.2004; Pascoal C, 2010, MICROB ECOL, V59, P84, DOI 10.1007/s00248-009-9567-z; Pelaez F, 1996, MYCOL RES, V100, P831, DOI 10.1016/S0953-7562(96)80030-X; Rajashekhar M, 2003, HYDROBIOLOGIA, V501, P167, DOI 10.1023/A:1026239917232; Ramirez-Flandes S, 2008, BIOINFORMATICS, V24, P2539, DOI 10.1093/bioinformatics/btn466; Schoenlein-Crusius IH, 2003, BRAZ J MICROBIOL, V34, P183, DOI 10.1590/S1517-83822003000300001; Seena S, 2010, FUNGAL DIVERS, V44, P77, DOI 10.1007/s13225-010-0056-y; Seymour FA, 2004, FUNGAL GENET BIOL, V41, P721, DOI 10.1016/j.fgb.2004.02.007; SMITS Gunta, 2007, Acta Bot. Venez., V30, P345; Sridhar KR, 2009, INT REV HYDROBIOL, V94, P399, DOI 10.1002/iroh.200811154; Suberkropp K, 2001, APPL ENVIRON MICROB, V67, P5063, DOI 10.1128/AEM.67.11.5063-5068.2001; Tacao M, 2005, FEMS MICROBIOL LETT, V246, P11, DOI 10.1016/j.femsle.2005.03.033; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wilkinson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012604; Wirtz N, 2008, MYCOL RES, V112, P472, DOI 10.1016/j.mycres.2007.05.006	61	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35884	10.1371/journal.pone.0035884	http://dx.doi.org/10.1371/journal.pone.0035884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558256	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000075
J	Swarts, DC; Mosterd, C; van Passel, MWJ; Brouns, SJJ				Swarts, Daan C.; Mosterd, Cas; van Passel, Mark W. J.; Brouns, Stan J. J.			CRISPR Interference Directs Strand Specific Spacer Acquisition	PLOS ONE			English	Article							ANTIVIRAL DEFENSE; CRYSTAL-STRUCTURE; IMMUNE-SYSTEM; RNA; DNA; TRANSCRIPTION; RESISTANCE; DIVERSITY; EVOLUTION; HELICASE	Background: CRISPR/Cas is a widespread adaptive immune system in prokaryotes. This system integrates short stretches of DNA derived from invading nucleic acids into genomic CRISPR loci, which function as memory of previously encountered invaders. In Escherichia coli, transcripts of these loci are cleaved into small RNAs and utilized by the Cascade complex to bind invader DNA, which is then likely degraded by Cas3 during CRISPR interference. Results: We describe how a CRISPR-activated E. coli K12 is cured from a high copy number plasmid under non-selective conditions in a CRISPR-mediated way. Cured clones integrated at least one up to five anti-plasmid spacers in genomic CRISPR loci. New spacers are integrated directly downstream of the leader sequence. The spacers are non-randomly selected to target protospacers with an AAG protospacer adjacent motif, which is located directly upstream of the protospacer. A co-occurrence of PAM deviations and CRISPR repeat mutations was observed, indicating that one nucleotide from the PAM is incorporated as the last nucleotide of the repeat during integration of a new spacer. When multiple spacers were integrated in a single clone, all spacer targeted the same strand of the plasmid, implying that CRISPR interference caused by the first integrated spacer directs subsequent spacer acquisition events in a strand specific manner. Conclusions: The E. coli Type I-E CRISPR/Cas system provides resistance against bacteriophage infection, but also enables removal of residing plasmids. We established that there is a positive feedback loop between active spacers in a cluster - in our case the first acquired spacer -and spacers acquired thereafter, possibly through the use of specific DNA degradation products of the CRISPR interference machinery by the CRISPR adaptation machinery. This loop enables a rapid expansion of the spacer repertoire against an actively present DNA element that is already targeted, amplifying the CRISPR interference effect.	[Swarts, Daan C.; Mosterd, Cas; Brouns, Stan J. J.] Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, Wageningen, Netherlands	Wageningen University & Research	Swarts, DC (corresponding author), Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, Wageningen, Netherlands.	stan.brouns@wur.nl	van Passel, Mark WJ/K-5698-2012; Swarts, Daan/Z-6262-2019	Swarts, Daan/0000-0003-4412-9191; Brouns, Stan/0000-0002-9573-1724	Netherlands Organization for Scientific Research (NWO) [863.08.014, 863.08.016]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by a Veni grant from the Netherlands Organization for Scientific Research (NWO, www.nwo.nl) to SJJB (863.08.014), MWJvP (863.08.016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Baba Tomoya, 2008, V416, P183, DOI 10.1007/978-1-59745-321-9_12; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; CONRAD SE, 1979, P NATL ACAD SCI USA, V76, P736, DOI 10.1073/pnas.76.2.736; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; DYKHUIZEN DE, 1983, MICROBIOL REV, V47, P150, DOI 10.1128/MMBR.47.2.150-168.1983; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; HALL KB, 1991, BIOCHEMISTRY-US, V30, P10606, DOI 10.1021/bi00108a002; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Howard JAL, 2011, BIOCHEM J, V439, P85, DOI 10.1042/BJ20110901; Jore MM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003657; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Nam KH, 2011, J BIOL CHEM, V286, P30759, DOI 10.1074/jbc.M111.256263; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; MARTIN P, 1988, MOL MICROBIOL, V2, P615, DOI 10.1111/j.1365-2958.1988.tb00070.x; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; ROBERTS RW, 1992, SCIENCE, V258, P1463, DOI 10.1126/science.1279808; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Westra ER, 2012, MOL CELL IN PRESS	37	258	285	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35888	10.1371/journal.pone.0035888	http://dx.doi.org/10.1371/journal.pone.0035888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558257	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000076
J	Zhu, M; Li, WW; Lu, CZ				Zhu, Min; Li, Wenwei; Lu, Chuanzhen			Role of Alpha-Synuclein Protein Levels in Mitochondrial Morphology and Cell Survival in Cell Lines	PLOS ONE			English	Article							PARKINSON-DISEASE; TRANSGENIC MICE; COMPLEX-I; NEURONS; EXPRESSION; DYNAMICS; FISSION; FUSION; MUTANT; FRAGMENTATION	alpha-Synuclein is highly associated with some neurodegeneration and malignancies. Overexpressing wild-type or mutant alpha-synuclein promotes neuronal death by mitochondrial dysfunction, the underlying mechanisms of which remain poorly defined. It was recently reported that alpha-synuclein synuclein expression could directly lead to mitochondrial fragmentation in vitro and in vivo, which may be due to alpha-synuclein localization on mitochondria. Here, we applied a double staining method to demonstrate mitochondrial morphogenetic changes in cells overexpressed with alpha-synuclein. We show that mitochondrial localization of alpha-synuclein was increased following its overexpression in three distinct cell lines, including HeLa, SH-SY5Y, and PC12 cells, but no alteration in mitochondrial morphology was detected. However, alpha-synuclein knockdown prevents MPP+-induced mitochondrial fragmentation in SH-SY5Y and PC12 cells. These data suggest that alpha-synuclein protein levels hardly affect mitochondrial morphology in normal cell lines, but may have some influence on that under certain environmental conditions.	[Zhu, Min; Li, Wenwei] Fudan Univ, Lab Neurol Inst Integrat Med, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Min; Li, Wenwei; Lu, Chuanzhen] Fudan Univ, Inst Neurol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Min; Li, Wenwei; Lu, Chuanzhen] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Min; Li, Wenwei] Fudan Univ, State Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Zhu, M (corresponding author), Fudan Univ, Lab Neurol Inst Integrat Med, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	wenweili2000@yahoo.com.cn; czlu@shmu.edu.cn			China Postdoctoral Foundation [20080430076, 200902205]; Ph.D. Programs Foundation from the China Ministry of Education [200802461038]; Shanghai Natural Science Foundation [10ZR1406100]; Opening Foundation from Institutes of Brain Science of Fudan University	China Postdoctoral Foundation(China Postdoctoral Science Foundation); Ph.D. Programs Foundation from the China Ministry of Education; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Opening Foundation from Institutes of Brain Science of Fudan University	This work was supported by the China Postdoctoral Foundation (20080430076 & 200902205), Ph.D. Programs Foundation from the China Ministry of Education (200802461038), and the Shanghai Natural Science Foundation (10ZR1406100). The imaging was performed at the Institutes of Brain Science of Fudan University, in part, supported by Opening Foundation from Institutes of Brain Science of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Andringa G, 2003, J NEUROPATH EXP NEUR, V62, P1060, DOI 10.1093/jnen/62.10.1060; Baltic S, 2004, J MOL NEUROSCI, V22, P199, DOI 10.1385/JMN:22:3:199; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chang DTW, 2006, NEUROSCIENCE, V141, P727, DOI 10.1016/j.neuroscience.2006.01.034; Chen HC, 2004, CURR TOP DEV BIOL, V59, P119, DOI 10.1016/S0070-2153(04)59005-1; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261; Fung KM, 2003, ACTA NEUROPATHOL, V106, P167, DOI 10.1007/s00401-003-0718-x; HEIKKILA RE, 1984, NATURE, V311, P467, DOI 10.1038/311467a0; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Iwai A, 2000, BBA-MOL BASIS DIS, V1502, P95, DOI 10.1016/S0925-4439(00)00036-3; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kingsbury AE, 2004, MOVEMENT DISORD, V19, P162, DOI 10.1002/mds.10683; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1; Piccini P, 1999, ANN NEUROL, V45, P577, DOI 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O; Raghavan R, 2004, PEDIATR DEVEL PATHOL, V7, P506, DOI 10.1007/s10024-003-7080-9; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steidl JV, 2003, NEUROREPORT, V14, P219, DOI 10.1097/00001756-200302100-00012; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; von Bohlen und Halbach O, 2004, PROG NEUROBIOL, V73, P151, DOI 10.1016/j.pneurobio.2004.05.002; Wang XL, 2011, AGING CELL, V10, P807, DOI 10.1111/j.1474-9726.2011.00721.x; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wirdefeldt K, 2004, NEUROLOGY, V63, P305, DOI 10.1212/01.WNL.0000129841.30587.9D; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105	48	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36377	10.1371/journal.pone.0036377	http://dx.doi.org/10.1371/journal.pone.0036377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558453	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000200
J	Dorokhov, YL; Komarova, TV; Petrunia, IV; Kosorukov, VS; Zinovkin, RA; Shindyapina, AV; Frolova, OY; Gleba, YY				Dorokhov, Yuri L.; Komarova, Tatiana V.; Petrunia, Igor V.; Kosorukov, Vyacheslav S.; Zinovkin, Roman A.; Shindyapina, Anastasia V.; Frolova, Olga Y.; Gleba, Yuri Y.			Methanol May Function as a Cross-Kingdom Signal	PLOS ONE			English	Article							ENZYME PECTIN METHYLESTERASE; TUBE MASS-SPECTROMETRY; MODIFIED CITRUS PECTIN; TRANSDUCED HELA-CELLS; MOSAIC-VIRUS MOVEMENT; ADENOSYL-L-METHIONINE; U-SHAPED CURVE; PROTEIN CARBOXYMETHYLASE; S-ADENOSYLMETHIONINE; ALZHEIMERS-DISEASE	Recently, we demonstrated that leaf wounding results in the synthesis of pectin methylesterase (PME), which causes the plant to release methanol into the air. Methanol emitted by a wounded plant increases the accumulation of methanol-inducible gene mRNA and enhances antibacterial resistance as well as cell-to-cell communication, which facilitates virus spreading in neighboring plants. We concluded that methanol is a signaling molecule involved in within-plant and plant-to-plant communication. Methanol is considered to be a poison in humans because of the alcohol dehydrogenase (ADH)-mediated conversion of methanol into toxic formaldehyde. However, recent data showed that methanol is a natural compound in normal, healthy humans. These data call into question whether human methanol is a metabolic waste product or whether methanol has specific function in humans. Here, to reveal human methanol-responsive genes (MRGs), we used suppression subtractive hybridization cDNA libraries of HeLa cells lacking ADH and exposed to methanol. This design allowed us to exclude genes involved in formaldehyde and formic acid detoxification from our analysis. We identified MRGs and revealed a correlation between increases in methanol content in the plasma and changes in human leukocyte MRG mRNA levels after fresh salad consumption by volunteers. Subsequently, we showed that the methanol generated by the pectin/PME complex in the gastrointestinal tract of mice induces the up- and downregulation of brain MRG mRNA. We used an adapted Y-maze to measure the locomotor behavior of the mice while breathing wounded plant vapors in two-choice assays. We showed that mice prefer the odor of methanol to other plant volatiles and that methanol changed MRG mRNA accumulation in the mouse brain. We hypothesize that the methanol emitted by wounded plants may have a role in plant-animal signaling. The known positive effect of plant food intake on human health suggests a role for physiological methanol in human gene regulation.	[Dorokhov, Yuri L.; Komarova, Tatiana V.; Zinovkin, Roman A.; Shindyapina, Anastasia V.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Dorokhov, Yuri L.; Komarova, Tatiana V.; Petrunia, Igor V.; Frolova, Olga Y.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia; [Kosorukov, Vyacheslav S.] Russian Acad Med Sci, NN Blokhin Natl Canc Res Ctr, Moscow, Russia; [Gleba, Yuri Y.] Nomad Biosci GmbH, Biozentrum Halle, Halle, Saale, Germany	Lomonosov Moscow State University; Russian Academy of Sciences; Vavilov Institute of General Genetics; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences	Dorokhov, YL (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	dorokhov@genebee.msu.su	Komarova, Tatiana V./D-5824-2012; Dorokhov, Yuri L/D-3565-2012; Zinovkin, Roman/J-2500-2013; Kosorukov, Viacheslav S/A-3901-2014	Komarova, Tatiana V./0000-0001-6558-8755; Dorokhov, Yuri L/0000-0002-4066-8940; Zinovkin, Roman/0000-0001-5337-4346; Kosorukov, Viacheslav S/0000-0002-8462-2178; Gleba, Yuri/0000-0003-4675-7474; Shindyapina, Anastasia/0000-0002-7336-3086	Russian Fund of Basic Research [11-04-01152-a]	Russian Fund of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grant (11-04-01152-a) from Russian Fund of Basic Research (http://grant.rfbr.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altorf-van Der Kuil W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012102; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2002, PLANT J, V29, P87, DOI 10.1046/j.1365-313x.2002.01198.x; Attar N, 2010, ADV ENZYME REGUL, V50, P216, DOI 10.1016/j.advenzreg.2009.10.002; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Bergman M, 2010, BIOMED PHARMACOTHER, V64, P44, DOI 10.1016/j.biopha.2009.03.004; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Boyle R, SCEPTICAL CHYMIST CH; Brent J, 2010, CLIN TOXICOL, V48, P401, DOI 10.3109/15563650.2010.495347; Brent J, 2009, NEW ENGL J MED, V360, P2216, DOI 10.1056/NEJMct0806112; Brown L, 1999, AM J CLIN NUTR, V69, P30; BYERS JA, 1992, J CHEM ECOL, V18, P2385, DOI 10.1007/BF00984957; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Chen MH, 2003, PLANT J, V35, P386, DOI 10.1046/j.1365-313X.2003.01818.x; Coppede F, 2010, CURR GENOMICS, V11, P246, DOI 10.2174/138920210791233090; Craig WJ, 1997, J AM DIET ASSOC, V97, pS199, DOI 10.1016/S0002-8223(97)00765-7; Datta NJ, 2003, DRUG ALCOHOL DEPEN, V71, P87, DOI 10.1016/S0376-8716(03)00066-8; De Gouw JA, 2000, ENVIRON SCI TECHNOL, V34, P2640, DOI 10.1021/es991219k; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Diachenko L., 1996, P NATL ACAD SCI USA, V93, P6025; DICKSON D, 1981, NATURE, V292, P283, DOI 10.1038/292283b0; DILIBERT.EJ, 1974, P NATL ACAD SCI USA, V71, P1701, DOI 10.1073/pnas.71.5.1701; DILIBERTO EJ, 1976, P NATL ACAD SCI USA, V73, P4050, DOI 10.1073/pnas.73.11.4050; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; Divol F, 2005, PLANT MOL BIOL, V57, P517, DOI 10.1007/s11103-005-0338-z; Dorokhov YL, 1999, FEBS LETT, V461, P223, DOI 10.1016/S0014-5793(99)01447-7; Dorokhov YL, 2006, FEBS LETT, V580, P3872, DOI 10.1016/j.febslet.2006.06.013; Dorokhov YL, 2006, FEBS LETT, V580, P3329, DOI 10.1016/j.febslet.2006.04.090; Dorokhov YL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002640; Downie B, 1998, ANAL BIOCHEM, V264, P149, DOI 10.1006/abio.1998.2847; DWYER JT, 1988, AM J CLIN NUTR, V48, P712, DOI 10.1093/ajcn/48.3.712; Ehlting J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-154; Enderby B, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/3/036001; ERIKSEN SP, 1963, SCIENCE, V141, P639, DOI 10.1126/science.141.3581.639; Ewen R, 2005, RAPID DIAGNOSIS GAST; Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0; Fedorova E, 2009, CURR OPIN GENET DEV, V19, P166, DOI 10.1016/j.gde.2009.02.003; Fisher JW, 2000, TOXICOL SCI, V53, P185, DOI 10.1093/toxsci/53.2.185; Fosu-Nyarko J, 2009, MOL PLANT PATHOL, V10, P237, DOI 10.1111/j.1364-3703.2008.00526.x; Francies KE, 2007, PLANT PHYSIOL, V142, P1004; Frenkel C, 1998, J BIOL CHEM, V273, P4293, DOI 10.1074/jbc.273.8.4293; Fuso A, 2012, NEUROBIOL A IN PRESS, DOI [10.1016/j.bbr.2011.03.031, DOI 10.1016/J.BBR.2011.03.031]; GAGNON C, 1978, LIFE SCI, V22, P2155, DOI 10.1016/0024-3205(78)90566-0; Gallaher CM, 2009, BRIT J NUTR, V101, P233, DOI 10.1017/S0007114508995684; Galli A, 1999, HEPATOLOGY, V29, P1164, DOI 10.1002/hep.510290420; Gasanova TV, 2008, MOL BIOL+, V42, P421, DOI 10.1134/S0026893308030102; Glinsky VV, 2009, CARBOHYD RES, V344, P1788, DOI 10.1016/j.carres.2008.08.038; Goren JL, 2004, PHARMACOTHERAPY, V24, P1501, DOI 10.1592/phco.24.16.1501.50943; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Haffner HT, 1997, FORENSIC SCI INT, V86, P69, DOI 10.1016/S0379-0738(97)02119-1; Hansen JM, 2005, BIRTH DEFECTS RES A, V73, P72, DOI 10.1002/bdra.20094; Hasunuma T, 2004, J BIOTECHNOL, V111, P241, DOI 10.1016/j.jbiotec.2004.04.015; Hasunuma T, 2003, J BIOTECHNOL, V106, P45, DOI 10.1016/j.jbiotec.2003.07.008; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006; Hoog JO, 2011, CHEM-BIOL INTERACT, V191, P2, DOI 10.1016/j.cbi.2011.01.028; Hovda KE, 2008, HUM EXP TOXICOL, V27, P539, DOI 10.1177/0960327108095992; Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038; Martin-Subero JI, 2011, ADV EXP MED BIOL, V711, P162; Jacobsen D, 1997, J TOXICOL-CLIN TOXIC, V35, P127, DOI 10.3109/15563659709001182; JACOBSEN D, 1986, MED TOXICOL ADV DRUG, V1, P309, DOI 10.1007/BF03259846; Jenkins J, 2001, J MOL BIOL, V305, P951, DOI 10.1006/jmbi.2000.4324; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; JONES AW, 1987, PHARMACOL TOXICOL, V60, P217, DOI 10.1111/j.1600-0773.1987.tb01737.x; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Kimura M, 2011, PSYCHIAT CLIN NEUROS, V65, P213, DOI 10.1111/j.1440-1819.2011.02190.x; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Korner E, 2009, J EXP BOT, V60, P2631, DOI 10.1093/jxb/erp106; Kostic MA, 2003, J TOXICOL-CLIN TOXIC, V41, P793, DOI 10.1081/CLT-120025344; Krautt JA, 2008, CLIN J AM SOC NEPHRO, V3, P208, DOI 10.2215/CJN.03220807; Lagaert S, 2009, SEMIN CELL DEV BIOL, V20, P1064, DOI 10.1016/j.semcdb.2009.05.008; Ledochowski M, 2005, BREATH ANALYSIS: FOR CLINICAL DIAGNOSIS AND ATHERAPEUTIC MONITORING, P375, DOI 10.1142/9789812701954_0026; Lee ES, 2008, LIFE SCI, V83, P821, DOI 10.1016/j.lfs.2008.09.020; LESTER D, 1962, Q J STUD ALCOHOL, V23, P17; Lindinger W, 1997, ALCOHOL CLIN EXP RES, V21, P939; Linnebank M, 2010, NEURODEGENER DIS, V7, P373, DOI 10.1159/000309657; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Liu HY, 2008, WORLD J GASTROENTERO, V14, P7386, DOI 10.3748/wjg.14.7386; Liu JR, 2009, J AGR FOOD CHEM, V57, P297, DOI 10.1021/jf801826w; Liu L, 2010, CARCINOGENESIS, V31, P1822, DOI 10.1093/carcin/bgq070; Louvet R, 2006, PLANTA, V224, P782, DOI 10.1007/s00425-006-0261-9; LUKYANOV SA, 1994, BIOORG KHIM+, V20, P701; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Magnuson BA, 2007, CRIT REV TOXICOL, V37, P629, DOI 10.1080/10408440701516184; Markovic O, 2004, CARBOHYD RES, V339, P2281, DOI 10.1016/j.carres.2004.06.023; Markovic O, 2002, CELL MOL LIFE SCI, V59, P513, DOI 10.1007/s00018-002-8442-6; MARMOT M, 1991, BMJ-BRIT MED J, V303, P565, DOI 10.1136/bmj.303.6802.565; Matsumoto M, 2011, ALCOHOL CLIN EXP RES, V35, P28, DOI 10.1111/j.1530-0277.2010.01319.x; Megarbane B, 2005, INTENS CARE MED, V31, P189, DOI 10.1007/s00134-004-2521-0; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Miura K, 2004, AM J EPIDEMIOL, V159, P572, DOI 10.1093/aje/kwh085; Monte W. C., 1984, Journal of Applied Nutrition, V36, P42; Monte WC, 2010, MED HYPOTHESES, V74, P493, DOI 10.1016/j.mehy.2009.09.059; Nakao H, 2003, J PHARMACOL SCI, V91, P83, DOI 10.1254/jphs.91.83; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nassirpour R, 2007, CHANNELS, V1, P331, DOI 10.4161/chan.5191; NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359; Neuthouser ML, 2006, CANCER EPIDEM BIOMAR, V15, P1755, DOI 10.1158/1055-9965.EPI-06-0728; Oyama Y, 2002, CELL BIOL TOXICOL, V18, P43, DOI 10.1023/A:1014419229301; Panza F, 2009, THESCIENTIFICWORLDJO, V9, P373, DOI 10.1100/tsw.2009.48; Pelletier S, 2010, NEW PHYTOL, V188, P726, DOI 10.1111/j.1469-8137.2010.03409.x; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Penuelas J, 2005, NEW PHYTOL, V167, P851, DOI 10.1111/j.1469-8137.2005.01459.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potter JD, 1996, IARC SCI PUBL, P61; Preston CA, 1999, PLANTA, V209, P87, DOI 10.1007/s004250050609; Raiola A, 2011, MOL PLANT MICROBE IN, V24, P432, DOI 10.1094/MPMI-07-10-0157; Rebrikov DV, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e90; San Jose B, 1999, J STUD ALCOHOL, V60, P725, DOI 10.15288/jsa.1999.60.725; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; SMITH RJ, 1981, SCIENCE, V213, P986, DOI 10.1126/science.7268411; SNYDER SH, 1967, NATURE, V215, P773, DOI 10.1038/215773b0; STASSEWOLTHUIS M, 1980, AM J CLIN NUTR, V33, P1745, DOI 10.1093/ajcn/33.8.1745; Steffen LM, 2005, AM J CLIN NUTR, V82, P1169, DOI 10.1093/ajcn/82.6.1169; TAUCHER J, 1995, ALCOHOL CLIN EXP RES, V19, P1147, DOI 10.1111/j.1530-0277.1995.tb01593.x; TEPHLY TR, 1991, LIFE SCI, V48, P1031, DOI 10.1016/0024-3205(91)90504-5; Tian GW, 2006, DEV BIOL, V294, P83, DOI 10.1016/j.ydbio.2006.02.026; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Trocho C, 1998, LIFE SCI, V63, P337, DOI 10.1016/S0024-3205(98)00282-3; Turner C, 2008, RAPID COMMUN MASS SP, V22, P526, DOI 10.1002/rcm.3402; Turner C, 2006, PHYSIOL MEAS, V27, P637, DOI 10.1088/0967-3334/27/7/007; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; Velikova V, 2008, PLANT CELL ENVIRON, V31, P1882, DOI 10.1111/j.1365-3040.2008.01893.x; Voglesonger KM, 2001, CHEM GEOL, V180, P129, DOI 10.1016/S0009-2541(01)00310-2; von Dahl CC, 2006, PLANT J, V46, P948, DOI 10.1111/j.1365-313X.2006.02760.x; Walley JW, 2010, J INTEGR PLANT BIOL, V52, P354, DOI 10.1111/j.1744-7909.2010.00940.x; Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; WESTERN O C, 1949, U S Nav Med Bull, V49, P574; Williams LB, 2005, GEOLOGY, V33, P913, DOI 10.1130/G21751.1; Williams LB, 2011, EARLIEST LIFE ON EARTH: HABITATS, ENVIORNMENTS AND METHODS OF DETECTION, P79, DOI 10.1007/978-90-481-8794-2_4; WOLF ME, 1985, J NEUROCHEM, V44, P291, DOI 10.1111/j.1471-4159.1985.tb07143.x; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Wolgemuth DJ, 2008, CELL CYCLE, V7, P3509, DOI 10.4161/cc.7.22.6978; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x; XIAO Q, 1995, J CLIN INVEST, V96, P2180, DOI 10.1172/JCI118272; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; ZATMAN LJ, 1946, BIOCHEM J, V40, P67	144	23	24	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36122	10.1371/journal.pone.0036122	http://dx.doi.org/10.1371/journal.pone.0036122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563443	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100068
J	Lee, ST; Chu, K; Jung, KH; Kim, JM; Moon, HJ; Bahn, JJ; Im, WS; Sunwoo, J; Moon, J; Kim, M; Lee, SK; Roh, JK				Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Jeong-Min; Moon, Hye-Jin; Bahn, Jae-Jun; Im, Woo-Seok; Sunwoo, Junsang; Moon, Jangsup; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu			Circulating CD62E(+) Microparticles and Cardiovascular Outcomes	PLOS ONE			English	Article							ENDOTHELIAL MICROPARTICLES; IN-VITRO; PLATELET MICROPARTICLES; MYOCARDIAL-INFARCTION; HEART-DISEASE; CELLS; DYSFUNCTION; ATHEROSCLEROSIS; ACTIVATION; PREDICTION	Background: Activated endothelial cells release plasma membrane submicron vesicles expressing CD62E (E-selectin) into blood, known as endothelial microparticles (EMPs). We studied whether the levels of endothelial microparticles expressing CD62E(+), CD31(+)/Annexin-V+, or CD31(+)/CD42(-) predict cardiovascular outcomes in patients with stroke history. Methods/Principal Findings: Patients with stroke history at least 3 months prior to enrolment were recruited. Peripheral blood EMP levels were measured by flow cytometry. Major cardiovascular events and death were monitored for 36 months. Three hundred patients were enrolled, of which 298 completed the study according to protocol. Major cardiovascular events occurred in 29 patients (9.7%). Nine patients died, five from cardiovascular causes. Cumulative event-free survival rates were lower in patients with high levels of CD62E(+) microparticles. Multivariate Cox regression analysis adjusted for cardiovascular risk factors, medications and stroke etiologic groups showed an association between a high CD62E(+) microparticle level and a risk of major cardiovascular events and hospitalization. Levels of other kinds of EMPs expressing CD31(+)/Annexin-V+ or CD31(+)/CD42(-) markers were not predictive of cardiovascular outcomes. Conclusion: A high level of CD62E(+) microparticles is associated with cardiovascular events in patients with stroke history, suggesting that the systemic endothelial activation increases the risk for cardiovascular morbidities.	[Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Jeong-Min; Moon, Hye-Jin; Bahn, Jae-Jun; Im, Woo-Seok; Sunwoo, Junsang; Moon, Jangsup; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Biomed Res Inst, Dept Neurol, Seoul 110744, South Korea; [Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ, Coll Med, Program Neurosci, Neurosci Res Inst,Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, ST (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Dept Neurol, Seoul 110744, South Korea.	rohjk@snu.ac.kr	Kim, Manho/J-2738-2012; Roh, Jae Kyu/J-5459-2012; Lee, Soon-Tae/C-4663-2013; Lee, Sang Kun/J-5578-2012	Kim, Jeong-Min/0000-0001-7213-5527; Moon, Jangsup/0000-0003-1282-4528; Sunwoo, Jun-Sang/0000-0001-8834-0568; Lee, Soon-Tae/0000-0003-4767-7564; Chu, Kon/0000-0001-5863-0302	Stem Cell Research Center [SC4120]; National Research Foundation of Korea [2009-0080355]; Ministry of Education, Science and Technology, South Korea	Stem Cell Research Center; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant (SC4120) from Stem Cell Research Center of the 21st Century Frontier Research Program, and the Original Technology Research Program for Brain Science (2009-0080355) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Amabile N, 2010, SEMIN THROMB HEMOST, V36, P907, DOI 10.1055/s-0030-1267044; Amabile N, 2009, J HEART LUNG TRANSPL, V28, P1081, DOI 10.1016/j.healun.2009.06.005; Arteaga RB, 2006, AM J CARDIOL, V98, P70, DOI 10.1016/j.amjcard.2006.01.054; Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Brogan PA, 2004, ARTHRITIS RHEUM, V50, P927, DOI 10.1002/art.20199; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; De Caterina R, 2010, ANN NY ACAD SCI, V1207, P23, DOI 10.1111/j.1749-6632.2010.05784.x; Ferreira AC, 2004, CIRCULATION, V110, P3599, DOI 10.1161/01.CIR.0000148820.55611.6B; Horstman LL, 2004, FRONT BIOSCI-LANDMRK, V9, P1118, DOI 10.2741/1270; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Jung KH, 2009, ANN NEUROL, V66, P191, DOI 10.1002/ana.21681; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; Kushak RI, 2005, THROMB RES, V116, P409, DOI 10.1016/j.thromres.2005.01.013; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Pirro M, 2006, ARTERIOSCL THROM VAS, V26, P2530, DOI 10.1161/01.ATV.0000243941.72375.15; Rand ML, 2006, J THROMB HAEMOST, V4, P1621, DOI 10.1111/j.1538-7836.2006.02011.x; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rossig L, 2000, J AM COLL CARDIOL, V36, P2081, DOI 10.1016/S0735-1097(00)01002-0; Sabatier F, 2002, DIABETES, V51, P2840, DOI 10.2337/diabetes.51.9.2840; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yun CH, 2010, J CLIN NEUROL, V6, P89, DOI 10.3988/jcn.2010.6.2.89; ZEIHER AM, 1991, CIRCULATION, V84, P1984, DOI 10.1161/01.CIR.84.5.1984	33	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35713	10.1371/journal.pone.0035713	http://dx.doi.org/10.1371/journal.pone.0035713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563392	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100020
J	Murray, TS; Okegbe, C; Gao, Y; Kazmierczak, BI; Motterlini, R; Dietrich, LEP; Bruscia, EM				Murray, Thomas S.; Okegbe, Chinweike; Gao, Yuan; Kazmierczak, Barbara I.; Motterlini, Roberto; Dietrich, Lars E. P.; Bruscia, Emanuela M.			The Carbon Monoxide Releasing Molecule CORM-2 Attenuates Pseudomonas aeruginosa Biofilm Formation	PLOS ONE			English	Article							ANTIMICROBIAL ACTION; LIPOPOLYSACCHARIDE; RESPIRATION; INFECTIONS; TARGETS; OXYGEN	Chronic infections resulting from biofilm formation are difficult to eradicate with current antimicrobial agents and consequently new therapies are needed. This work demonstrates that the carbon monoxide-releasing molecule CORM-2, previously shown to kill planktonic bacteria, also attenuates surface-associated growth of the Gram-negative pathogen Pseudomonas aeruginosa by both preventing biofilm maturation and killing bacteria within the established biofilm. CORM-2 treatment has an additive effect when combined with tobramycin, a drug commonly used to treat P. aeruginosa lung infections. CORM-2 inhibited biofilm formation and planktonic growth of the majority of clinical P. aeruginosa isolates tested, for both mucoid and non-mucoid strains. While CORM-2 treatment increased the production of reactive oxygen species by P. aeruginosa biofilms, this increase did not correlate with bacterial death. These data demonstrate that CO-RMs possess potential novel therapeutic properties against a subset of P. aeruginosa biofilm related infections.	[Murray, Thomas S.; Bruscia, Emanuela M.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Okegbe, Chinweike; Dietrich, Lars E. P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Motterlini, Roberto] Univ Paris Est, INSERM, U955, Creteil, France	Yale University; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Murray, TS (corresponding author), Quinnipiac Univ Frank H Netter MD, Sch Med, Dept Basic Sci, Hamden, CT 06518 USA.	emanuela.bruscia@yale.edu	Motterlini, Roberto/Q-1890-2019	Motterlini, Roberto/0000-0003-2684-2612; Kazmierczak, Barbara/0000-0002-8162-803X; Dietrich, Lars/0000-0003-2049-1137	United States National Institutes of Health [R01 HL093004, P30 DK072442, K08 AI071074]; Charles Hood Foundation; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075051, K08AI071074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072442] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles Hood Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the United States National Institutes of Health (R01 HL093004 to E. M. B.; P30 DK072442 to the Yale Center of Excellence in Molecular Hematology; and K08 AI071074 to T.S.M.). T.S.M. is also supported by a Charles Hood Foundation Award. C.O. has a Gilliam Fellowship from the Howard Hughes Medical Institute. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathoorn E, 2007, EUR RESPIR J, V30, P1131, DOI 10.1183/09031936.00163206; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Chhikara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008139; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Desmard M, 2011, ANTIOXID REDOX SIGNA; Desmard M, 2007, ANTIOXID REDOX SIGN, V9, P2139, DOI 10.1089/ars.2007.1803; Desmard M, 2009, FASEB J, V23, P1023, DOI 10.1096/fj.08-122804; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Megias J, 2007, BRIT J PHARMACOL, V150, P977, DOI 10.1038/sj.bjp.0707184; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Mizuguchi S, 2009, AM J PHYSIOL-HEART C, V297, pH920, DOI 10.1152/ajpheart.00305.2009; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Moreau-Marquis S, 2009, AM J RESP CELL MOL, V41, P305, DOI 10.1165/rcmb.2008-0299OC; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Murray TS, 2010, J MED MICROBIOL, V59, P511, DOI 10.1099/jmm.0.017715-0; Nobre LS, 2007, ANTIMICROB AGENTS CH, V51, P4303, DOI 10.1128/AAC.00802-07; Nobre LS, 2009, MICROBIOL-SGM, V155, P813, DOI 10.1099/mic.0.023911-0; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Smith H, 2011, IUBMB LIFE, V63, P363, DOI 10.1002/iub.476; Tavares AF, 2011, J BIOL CHEM; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Wood LF, 2006, J BACTERIOL, V188, P3134, DOI 10.1128/JB.188.8.3134-3137.2006	33	39	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35499	10.1371/journal.pone.0035499	http://dx.doi.org/10.1371/journal.pone.0035499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563385	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100014
J	Barua, H; Biswas, PK; Olsen, KEP; Christensen, JP				Barua, Himel; Biswas, Paritosh K.; Olsen, Katharina E. P.; Christensen, Jens P.			Prevalence and Characterization of Motile Salmonella in Commercial Layer Poultry Farms in Bangladesh	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; INTERNATIONAL SPREAD; RISK-FACTORS; KENTUCKY; STRAIN; CIPROFLOXACIN; EPIDEMIOLOGY; POPULATION; SEROTYPES	Salmonella is a globally widespread food-borne pathogen having major impact on public health. All motile serovars of Salmonella enterica of poultry origin are zoonotic, and contaminated meat and raw eggs are an important source to human infections. Information on the prevalence of Salmonella at farm/holding level, and the zoonotic serovars circulating in layer poultry in the South and South-East Asian countries including Bangladesh, where small-scale commercial farms are predominant, is limited. To investigate the prevalence of Salmonella at layer farm level, and to identify the prevalent serovars we conducted a cross-sectional survey by randomly selecting 500 commercial layer poultry farms in Bangladesh. Faecal samples from the selected farms were collected following standard procedure, and examined for the presence of Salmonella using conventional bacteriological procedures. Thirty isolates were randomly selected, from the ninety obtained from the survey, for serotyping and characterized further by plasmid profiling and pulsed-field gel electrophoresis (PFGE). Results of the survey showed that the prevalence of motile Salmonella at layer farm level was 18% (95% confidence interval 15-21%), and Salmonella Kentucky was identified to be the only serovar circulating in the study population. Plasmid analysis of the S. Kentucky and non-serotyped isolates revealed two distinct profiles with a variation of two different sizes (2.7 and 4.8 kb). PFGE of the 30 S. Kentucky and 30 non-serotyped isolates showed that all of them were clonally related because only one genotype and three subtypes were determined based on the variation in two or three bands. This is also the first report on the presence of any specific serovar of Salmonella enterica in poultry in Bangladesh.	[Barua, Himel; Christensen, Jens P.] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Copenhagen, Denmark; [Barua, Himel; Biswas, Paritosh K.] Chittagong Vet & Anim Sci Univ, Fac Vet Med, Dept Microbiol, Chittagong, Bangladesh; [Olsen, Katharina E. P.] Statens Serum Inst, Natl Reference Lab Enteropathogen Bacteria, Dept Microbiol Diagnost, DK-2300 Copenhagen, Denmark	University of Copenhagen; Statens Serum Institut	Barua, H (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Copenhagen, Denmark.	hiba@life.ku.dk	Lahti, Elina Tast/R-8664-2016	Christensen, Jens Peter/0000-0002-6430-9010				Aarestrup FM, 2007, EMERG INFECT DIS, V13, P726, DOI 10.3201/eid1305.061489; [Anonymous], 2007, EFSA J, V5, DOI 10.2903/j.efsa.2007.130r; BARBOUR EK, 1983, AVIAN DIS, V27, P616, DOI 10.2307/1590303; Bouzidi N, 2011, FOOD RES INT, DOI [10.1016/j.fooders.2011.05.027, DOI 10.1016/J.FOODERS.2011.05.027]; Carrique-Mas JJ, 2008, REV SCI TECH OIE, V27, P665, DOI 10.20506/rst.27.3.1829; Centers for Disease Control and Prevention, 2009, ON DAY 24 28 H STAND; Centers for Disease Control and Prevention, 2008, SALM SURV ANN SUMM 2; Collard JM, 2007, J ANTIMICROB CHEMOTH, V60, P190, DOI 10.1093/jac/dkm114; Cozens M, 2008, SALMONELLA ENTERITID; Edwards PR, 1938, J HYG-CAMBRIDGE, V38, P306, DOI 10.1017/S0022172400011177; *EUR COMM, 2004, SANCO342004 EUR COMM; FAO, 2008, POULTRY SECTOR COUNT; FAO and OIE in collaboration with WHO, 2005, GLOB STRAT PROGR CON; Foley SL, 2011, APPL ENVIRON MICROB, V77, P4273, DOI 10.1128/AEM.00598-11; Gast RK, 2007, AVIAN DIS, V51, P817, DOI 10.1637/8090-081807.1; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Heir E, 2002, EPIDEMIOL INFECT, V128, P373, DOI 10.1017/S0950268802007045; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Johnson TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015524; Kabir SML, 2010, INT J ENV RES PUB HE, V7, P89, DOI 10.3390/ijerph7010089; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Keery I., 2010, SALMONELLA ENTERITID; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Li X, 2007, POULTRY SCI, V86, P591, DOI 10.1093/ps/86.3.591; MACRINA FL, 1978, PLASMID, V1, P417, DOI 10.1016/0147-619X(78)90056-2; Mahmud MS, 2011, FOODBORNE PATHOG DIS, V8, P1111, DOI 10.1089/fpd.2011.0917; Majtan V, 2006, JPN J INFECT DIS, V59, P358; MAYER L W, 1988, Clinical Microbiology Reviews, V1, P228; Mollenhorst H, 2005, POULTRY SCI, V84, P1308, DOI 10.1093/ps/84.8.1308; Namata H, 2008, PREV VET MED, V83, P323, DOI 10.1016/j.prevetmed.2007.09.002; Nogrady N, 2007, J ANTIMICROB CHEMOTH, V60, P645, DOI 10.1093/jac/dkm249; Olsen J. E., 2000, Salmonella in domestic animals., P429, DOI 10.1079/9780851992617.0429; OLSEN JE, 1994, J APPL BACTERIOL, V77, P155, DOI 10.1111/j.1365-2672.1994.tb03059.x; Papadopoulou C, 2009, VET REC, V165, P681; Pointon A, 2008, J FOOD PROTECT, V71, P1123, DOI 10.4315/0362-028X-71.6.1123; Poppe C., 2000, Salmonella in domestic animals., P107, DOI 10.1079/9780851992617.0107; Raufu I, 2009, FOODBORNE PATHOG DIS, V6, P425, DOI 10.1089/fpd.2008.0150; ROCHELLE PA, 1986, J GEN MICROBIOL, V132, P53; Rose N, 1999, PREV VET MED, V39, P265, DOI 10.1016/S0167-5877(99)00002-1; Sanchez S, 2002, J AM VET MED ASSOC, V221, P492, DOI 10.2460/javma.2002.221.492; SHIVAPRASAD HL, 2003, DIS POULTRY, P568; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; THRELFALL EJ, 1986, J HYG-CAMBRIDGE, V97, P419, DOI 10.1017/S0022172400063609; Turki Y, 2012, FOOD RES INT, V45, P925, DOI 10.1016/j.foodres.2011.03.044; USDA, 2008, NAT ANT RES MON SYST; van Pelt W, 2003, Euro Surveill, V8, P31; Wegener HC, 2003, EMERG INFECT DIS, V9, P774; Weill FX, 2006, EMERG INFECT DIS, V12, P1611, DOI 10.3201/eid1210.060589; Xi ML, 2008, J FOOD PROTECT, V71, P2067, DOI 10.4315/0362-028X-71.10.2067	49	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35914	10.1371/journal.pone.0035914	http://dx.doi.org/10.1371/journal.pone.0035914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558269	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200093
J	Iaffaldano, P; Viterbo, RG; Paolicelli, D; Lucchese, G; Portaccio, E; Goretti, B; Direnzo, V; D'Onghia, M; Zoccolella, S; Amato, MP; Trojano, M				Iaffaldano, Pietro; Viterbo, Rosa Gemma; Paolicelli, Damiano; Lucchese, Guglielmo; Portaccio, Emilio; Goretti, Benedetta; Direnzo, Vita; D'Onghia, Mariangela; Zoccolella, Stefano; Amato, Maria Pia; Trojano, Maria			Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MILDLY DISABLED PATIENTS; INTERFERON BETA-1A; IMMUNOMODULATORY TREATMENT; INTELLECTUAL ENRICHMENT; BRAIN ATROPHY; IMPAIRMENT; DYSFUNCTION; DISABILITY; EFFICIENCY	Background and Objectives: Natalizumab reduces the relapse rate and magnetic resonance imaging activity in patients with Relapsing-Remitting Multiple Sclerosis (RRMS). So far the influence of natalizumab on cognitive functions and fatigue in MS remains uncertain. The aim of this prospective, open-label, observational study was to evaluate the possible effects of natalizumab on cognition and fatigue measures in RRMS patients treated for up to two years. Methods: Cognitive performances were examined by the Rao's Brief Repeatable Battery (BRB), the Stroop test (ST) and the Cognitive Impairment Index (CII), every 12 months. Patients who failed in at least 3 tests of the BRB and the ST were classified as cognitively impaired (CI). Fatigue Severity Scale (FSS) was administered every 12 months to assess patient's self-reported fatigue. One hundred and 53 patients completed 1 and 2 year-natalizumab treatment, respectively. Results: After 1 year of treatment the percentage of CI patients decreased from 29% (29/100) at baseline to 19% (19/100) (p = 0.031) and the mean baseline values of CII (13.52 +/- 6.85) and FSS (4.01 +/- 1.63) scores were significantly reduced (10.48 +/- 7.12, p < 0.0001 and 3.61 +/- 1.56, p = 0.008). These significant effects were confirmed in the subgroup of patients treated up to two years. Conclusions: These results demonstrate that a short-term NTZ treatment may significantly improve cognitive performances and fatigue in RRMS patients.	[Iaffaldano, Pietro; Viterbo, Rosa Gemma; Paolicelli, Damiano; Lucchese, Guglielmo; Direnzo, Vita; D'Onghia, Mariangela; Zoccolella, Stefano; Trojano, Maria] Univ Bari Aldo Moro, Dept Neurosci & Sense Organs, Bari, Italy; [Portaccio, Emilio; Goretti, Benedetta; Amato, Maria Pia] Univ Florence, Dept Neurol, Florence, Italy	Universita degli Studi di Bari Aldo Moro; University of Florence	Iaffaldano, P (corresponding author), Univ Bari Aldo Moro, Dept Neurosci & Sense Organs, Bari, Italy.	mtrojano@neurol.uniba.it	Amato, Maria Pia/AAC-5940-2022; Iaffaldano, Pietro/AFE-8061-2022; Lucchese, Guglielmo/AAL-9860-2020; amato, Maria Pia/AAL-5998-2020; zoccolella, stefano/AAA-2515-2020	Iaffaldano, Pietro/0000-0003-2308-1731; Lucchese, Guglielmo/0000-0002-1809-6376; amato, Maria Pia/0000-0003-3325-3760; Portaccio, Emilio/0000-0002-9662-1762; Trojano, Maria/0000-0002-6329-8946	Merck Serono; Biogen; Novartis; Biogen-Idec; Bayer Schering; Sanofi Aventis; Serono Foundation	Merck Serono(Merck & Company); Biogen(Biogen); Novartis(Novartis); Biogen-Idec(Biogen); Bayer Schering(Bayer AG); Sanofi Aventis(Sanofi-Aventis); Serono Foundation	The authors have read the journal's policy and have the following conflicts: Maria Trojano received honoraria for consultancy or speaking from Biogen, Sanofi-Aventis, Merck Serono and Bayer-Schering and research grants from Merck Serono, Biogen and Novartis; Maria Pia Amato serves on scientific advisory boards for Biogen-Idec, Merck Serono, Bayer Schering and Sanofi Aventis and receives research support and honoraria for speaking from Biogen-Idec, Merck Serono, Bayer Schering and Sanofi Aventis; Rosa Gemma Viterbo serves on scientific advisory boards for Biogen-Idec and received honoraria for speaking from Novartis and Biogen; Damiano Paolicelli received honoraria for consultancy and/or speaking from Biogen Idec, Novartis and Bayer-Schering and research grant from Serono Foundation; Emilio Portaccio serves on a scientific advisory board for Biogen Idec and receives research support and honoraria from Merck Serono, Biogen Idec, Bayer Schering, Sanofi Aventis and Novartis; Benedetta Goretti serves on scientific advisory boards for Biogen Idec and honoraria from Merck Serono, Biogen Idec and Novartis; all other authors declare that there is no conflict of interest. Natalizumab is marketed by Biogen Idec. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato M P, 2003, Int MS J, V10, P72; Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Arnon R, 2009, J NEURAL TRANSM, V116, P1443, DOI 10.1007/s00702-009-0272-3; Bakshi R, 2003, MULT SCLER J, V9, P219, DOI 10.1191/1352458503ms904oa; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; Fischer JS, 2000, ANN NEUROL, V48, P885, DOI 10.1002/1531-8249(200012)48:6<885::AID-ANA9>3.3.CO;2-T; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; JOHNSON BF, 1991, PROG NEURO-PSYCHOPH, V15, P625, DOI 10.1016/0278-5846(91)90052-3; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Mattioli F, 2011, NEUROL SCI, V31, pS321, DOI 10.1007/s10072-010-0351-0; Mattioli F, 2011, NEUROL SCI, V32, P83, DOI 10.1007/s10072-010-0412-4; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Metz LM, 2004, J NEUROL NEUROSUR PS, V75, P1045, DOI 10.1136/jnnp.2002.007724; Patrick E, 2009, MULT SCLER J, V15, P258, DOI 10.1177/1352458508097466; Patti F, 2011, MULT SCLER J, V17, P991, DOI 10.1177/1352458511401943; Patti F, 2010, MULT SCLER, V16, P68, DOI 10.1177/1352458509350309; Piehl F, 2011, NEUROL SCI, V31, pS289, DOI 10.1007/s10072-010-0345-y; Pliskin NH, 1996, NEUROLOGY, V47, P1463, DOI 10.1212/WNL.47.6.1463; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Portaccio E, 2010, MULT SCLER J, V16, P611, DOI 10.1177/1352458510362818; Putzki N, 2009, J NEUROL SCI, V285, P109, DOI 10.1016/j.jns.2009.06.004; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P471, DOI 10.1080/01688638908400907; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P699, DOI 10.1080/01688638908400926; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rinaldi F, 2011, NEUROL SCI, V31, pS317, DOI 10.1007/s10072-010-0346-x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rudick RA, 1999, ARCH NEUROL-CHICAGO, V56, P1079, DOI 10.1001/archneur.56.9.1079; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Rudick RA, 2007, ANN NEUROL, V62, P335, DOI 10.1002/ana.21163; Schneeweiss S, 1997, PHARMACOEPIDEM DR S, V6, pS51, DOI 10.1002/(SICI)1099-1557(199710)6:3+<S51::AID-PDS301>3.3.CO;2-J; Schwid SR, 2007, J NEUROL SCI, V255, P57, DOI 10.1016/j.jns.2007.01.070; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be; Sumowski JF, 2010, BRAIN, V133, P362, DOI 10.1093/brain/awp307; Sumowski JF, 2009, J INT NEUROPSYCH SOC, V15, P606, DOI 10.1017/S1355617709090912; Trojano M, 2009, ANN NEUROL, V66, P513, DOI 10.1002/ana.21757; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; Weinstein A, 1999, ARCH NEUROL-CHICAGO, V56, P319, DOI 10.1001/archneur.56.3.319; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Yildiz M, 2011, EUR NEUROL, V65, P231, DOI 10.1159/000324028; Ziemssen T, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-67	52	61	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35843	10.1371/journal.pone.0035843	http://dx.doi.org/10.1371/journal.pone.0035843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558238	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345200086
J	Ma, XX; Hamadeh, MJ; Christie, BR; Foster, JA; Tarnopolsky, MA				Ma, Xiaoxing; Hamadeh, Mazen J.; Christie, Brain R.; Foster, Jane A.; Tarnopolsky, Mark A.			Impact of Treadmill Running and Sex on Hippocampal Neurogenesis in the Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGENITOR-CELL PROLIFERATION; CU/ZN SUPEROXIDE-DISMUTASE; GONADAL HORMONE MODULATION; INCREASED OXIDATIVE DAMAGE; MOTOR-NEURON DEGENERATION; HUMAN SPINAL-CORD; NEUROTROPHIC FACTOR; DENTATE GYRUS; TRANSGENIC MICE	Hippocampal neurogenesis in the subgranular zone (SGZ) of dentate gyrus (DG) occurs throughout life and is regulated by pathological and physiological processes. The role of oxidative stress in hippocampal neurogenesis and its response to exercise or neurodegenerative diseases remains controversial. The present study was designed to investigate the impact of oxidative stress, treadmill exercise and sex on hippocampal neurogenesis in a murine model of heightened oxidative stress (G93A mice). G93A and wild type (WT) mice were randomized to a treadmill running (EX) or a sedentary (SED) group for 1 or 4 wk. Immunohistochemistry was used to detect bromodeoxyuridine (BrdU) labeled proliferating cells, surviving cells, and their phenotype, as well as for determination of oxidative stress (3-NT; 8-OHdG). BDNF and IGF1 mRNA expression was assessed by in situ hybridization. Results showed that: (1) G93A-SED mice had greater hippocampal neurogenesis, BDNF mRNA, and 3-NT, as compared to WT-SED mice. (2) Treadmill running promoted hippocampal neurogenesis and BDNF mRNA content and lowered DNA oxidative damage (8-OHdG) in WT mice. (3) Male G93A mice showed significantly higher cell proliferation but a lower level of survival vs. female G93A mice. We conclude that G93A mice show higher hippocampal neurogenesis, in association with higher BDNF expression, yet running did not further enhance these phenomena in G93A mice, probably due to a 'ceiling effect' of an already heightened basal levels of hippocampal neurogenesis and BDNF expression.	[Ma, Xiaoxing; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Hamadeh, Mazen J.; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Hamadeh, Mazen J.] York Univ, Toronto, ON M3J 2R7, Canada; [Christie, Brain R.] Univ Victoria, Victoria, BC, Canada; [Foster, Jane A.] McMaster Univ, Brain Body Inst, Dept Psychiat & Behav Neurosci, St Josephs Healthcare, Hamilton, ON, Canada	McMaster University; McMaster University; York University - Canada; University of Victoria; McMaster University	Ma, XX (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Foster, Jane/AAW-7163-2021; Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160; Hamadeh, Mazen/0000-0002-3511-4345	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1997, NEUROL RES, V19, P124; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ADEM A, 1994, J NEURAL TRANSM-GEN, V97, P73, DOI 10.1007/BF01277964; Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Aguirre N, 2005, FREE RADICAL RES, V39, P383, DOI 10.1080/10715760400027979; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Andrus PK, 1998, J NEUROCHEM, V71, P2041; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Berchtold NC, 2001, EUR J NEUROSCI, V14, P1992, DOI 10.1046/j.0953-816x.2001.01825.x; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Bjornebekk A, 2005, INT J NEUROPSYCHOPH, V8, P357, DOI 10.1017/S1461145705005122; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carro E, 2000, J NEUROSCI, V20, P2926; Cechetti F, 2008, BRAIN RES, V1188, P182, DOI 10.1016/j.brainres.2007.10.012; Cha CI, 2000, BRAIN RES, V853, P156, DOI 10.1016/S0006-8993(99)02302-1; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076; CHIO A, 1991, NEUROEPIDEMIOLOGY, V10, P174, DOI 10.1159/000110267; Chung YH, 2005, BRAIN RES, V1050, P203, DOI 10.1016/j.brainres.2005.05.060; Chung YH, 2004, BRAIN RES, V1016, P272, DOI 10.1016/j.brainres.2004.05.040; Chung YH, 2004, BRAIN RES, V1003, P199, DOI 10.1016/j.brainres.2004.01.010; Chung YH, 2003, BRAIN RES, V990, P215, DOI 10.1016/S0006-8993(03)03457-7; Chung YH, 2003, BRAIN RES, V994, P253, DOI 10.1016/j.brainres.2003.09.047; Chung YH, 2003, BRAIN RES, V967, P226, DOI 10.1016/S0006-8993(03)02238-8; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Crews FT, 2004, ALCOHOL, V33, P63, DOI 10.1016/j.alcohol.2004.04.005; Czlonkowska A, 2006, ENDOCRINE, V29, P243, DOI 10.1385/ENDO:29:2:243; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Foster JA, 2004, J COMP NEUROL, V476, P91, DOI 10.1002/cne.20197; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Garza AA, 2004, PHARMACOL BIOCHEM BE, V77, P209, DOI 10.1016/j.pbb.2003.10.020; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Guan YJ, 2007, J NEUROCHEM, V102, P1125, DOI 10.1111/j.1471-4159.2007.04610.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Hauser T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-43; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; INCE PG, 1994, NEUROSCI LETT, V182, P87, DOI 10.1016/0304-3940(94)90213-5; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Johnson RA, 2003, BRAIN RES, V983, P108, DOI 10.1016/S0006-8993(03)03039-7; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Kim H, 2007, INT J DEV NEUROSCI, V25, P243, DOI 10.1016/j.ijdevneu.2007.03.003; Kim SH, 2004, NEUROLOGY, V62, P319, DOI 10.1212/01.WNL.0000103291.04985.DC; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kohl Z, 2007, BRAIN RES, V1155, P24, DOI 10.1016/j.brainres.2007.04.039; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kust BM, 2002, EXP NEUROL, V177, P419, DOI 10.1006/exnr.2002.8011; Lagace DC, 2007, HIPPOCAMPUS, V17, P175, DOI 10.1002/hipo.20265; Leasure JL, 2009, HIPPOCAMPUS; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Linnarsson S, 2000, MOL BRAIN RES, V75, P61, DOI 10.1016/S0169-328X(99)00295-8; Liu RG, 1998, ANN NEUROL, V44, P763, DOI 10.1002/ana.410440510; Liu ZP, 2006, J COMP NEUROL, V497, P468, DOI 10.1002/cne.21012; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; Mahoney DJ, 2004, MUSCLE NERVE, V29, P656, DOI 10.1002/mus.20004; Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Offen D, 2009, J MOL NEUROSCI, V38, P85, DOI 10.1007/s12031-007-9004-z; Oliff HS, 1998, MOL BRAIN RES, V61, P147, DOI 10.1016/S0169-328X(98)00222-8; Ormerod BK, 2001, NEUROSCIENCE, V102, P369, DOI 10.1016/S0306-4522(00)00474-7; Ozkaya YG, 2002, DIABETES METAB, V28, P377; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perluigi M, 2005, FREE RADICAL BIO MED, V38, P960, DOI 10.1016/j.freeradbiomed.2004.12.021; Popken GJ, 1997, J COMP NEUROL, V386, P8; POWERS SK, 1994, AM J PHYSIOL, V266, pR375, DOI 10.1152/ajpregu.1994.266.2.R375; Przedborski S, 1996, ANN NEUROL, V39, P158, DOI 10.1002/ana.410390204; Radak Z, 2001, NEUROCHEM INT, V38, P17, DOI 10.1016/S0197-0186(00)00063-2; Radak Z, 2001, EXERC IMMUNOL REV, V7, P90; Radak Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6; Radak Z, 2006, NEUROCHEM INT, V49, P387, DOI 10.1016/j.neuint.2006.02.004; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; Russo-Neustadt A, 1999, NEUROPSYCHOPHARMACOL, V21, P679, DOI 10.1016/S0893-133X(99)00059-7; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Shaw PJ, 1997, J NEUROL SCI, V147, P115, DOI 10.1016/S0022-510X(96)05316-6; Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008; SOMANI SM, 1995, PHARMACOL BIOCHEM BE, V50, P635, DOI 10.1016/0091-3057(94)00357-2; Spalloni A, 2006, EXP NEUROL, V197, P505, DOI 10.1016/j.expneurol.2005.10.014; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Suh H, 2009, ANN REV CELL DEV BIO; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Toldy A, 2005, BRAIN RES BULL, V65, P487, DOI 10.1016/j.brainresbull.2005.02.028; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Uda M, 2006, BRAIN RES, V1104, P64, DOI 10.1016/j.brainres.2006.05.066; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2009, EXERCISE BRAIN SOMET; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Veldink JH, 2003, NEUROMUSCULAR DISORD, V13, P737, DOI 10.1016/S0960-8966(03)00104-4; Wang H, 2006, J NEUROCHEM, V96, P694, DOI 10.1111/j.1471-4159.2005.03572.x; Warita H, 2001, MOL BRAIN RES, V89, P147, DOI 10.1016/S0169-328X(01)00029-8; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261	115	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36048	10.1371/journal.pone.0036048	http://dx.doi.org/10.1371/journal.pone.0036048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558322	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200113
J	Rentoukas, E; Tsarouhas, K; Kaplanis, I; Korou, E; Nikolaou, M; Marathonitis, G; Kokkinou, S; Haliassos, A; Mamalaki, A; Kouretas, D; Tsitsimpikou, C				Rentoukas, Elias; Tsarouhas, Konstantinos; Kaplanis, Ioannis; Korou, Eleni; Nikolaou, Maria; Marathonitis, George; Kokkinou, Stavroula; Haliassos, Alexander; Mamalaki, Avgi; Kouretas, Demetrios; Tsitsimpikou, Christina			Connection between Telomerase Activity in PBMC and Markers of Inflammation and Endothelial Dysfunction in Patients with Metabolic Syndrome	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE ADMA; BLOOD MONONUCLEAR-CELLS; OXIDATIVE STRESS; NITRIC-OXIDE; ASSOCIATION; ATHEROSCLEROSIS; MECHANISMS; EXPRESSION; DISEASE; BIOLOGY	Metabolic syndrome (MS) is a constellation of metabolic derangements associated with vascular endothelial dysfunction and oxidative stress and is widely regarded as an inflammatory condition, accompanied by an increased risk for cardiovascular disease. The present study tried to investigate the implications of telomerase activity with inflammation and impaired endothelial function in patients with metabolic syndrome. Telomerase activity in circulating peripheral blood mononuclear cells (PBMC), TNF-alpha, IL-6 and ADMA were monitored in 39 patients with MS and 20 age and sex-matched healthy volunteers. Telomerase activity in PBMC, TNF-alpha, IL-6 and ADMA were all significantly elevated in patients with MS compared to healthy volunteers. PBMC telomerase was negatively correlated with HDL and positively correlated with ADMA, while no association between TNF-alpha and IL-6 was observed. IL-6 was increasing with increasing systolic pressure both in the patients with MS and in the healthy volunteers, while smoking and diabetes were positively correlated with IL-6 only in the patients' group. In conclusion, in patients with MS characterised by a strong dyslipidemic profile and low diabetes prevalence, significant telomerase activity was detected in circulating PBMC, along with elevated markers of inflammation and endothelial dysfunction. These findings suggest a prolonged activity of inflammatory cells in the studied state of this metabolic disorder that could represent a contributory pathway in the pathogenesis of atherosclerosis.	[Rentoukas, Elias; Kaplanis, Ioannis; Korou, Eleni; Nikolaou, Maria] Amalia Fleming Gen Hosp, Cardiol Dept 2, Athens, Greece; [Tsarouhas, Konstantinos] Gen Hosp Karditsa, Div Cardiol, Terma Tavropou, Karditsa, Greece; [Marathonitis, George] Amalia Fleming Gen Hosp, Pathol Dept A, Athens, Greece; [Kokkinou, Stavroula] Sismanoglio Gen Hosp, Cytogenet Unit, Athens, Greece; [Haliassos, Alexander] Diamed Labs Dept SA, ESEAP Greek Proficiency Testing Scheme Lab Med, Athens, Greece; [Mamalaki, Avgi] Hellenic Pasteur Inst, Dept Biochem, Athens, Greece; [Kouretas, Demetrios] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Tsitsimpikou, Christina] Gen Chem State Lab Greece, Athens, Greece	University of Thessaly	Rentoukas, E (corresponding author), Amalia Fleming Gen Hosp, Cardiol Dept 2, Athens, Greece.	chtsitsi@yahoo.com	Haliassos, Alexander/GYJ-3828-2022; KOURETAS, DEMETRIOS/ABE-8519-2020; Tsarouhas, Konstantinos/H-5793-2019	KOURETAS, DEMETRIOS/0000-0002-7469-6640; Tsarouhas, Konstantinos/0000-0003-2651-3579				Al-Azzawi F, 2009, MATURITAS, V63, P135, DOI 10.1016/j.maturitas.2009.03.009; Antoniades C, 2006, AM J CLIN NUTR, V84, P781, DOI 10.1093/ajcn/84.4.781; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; COLLINS T, 1993, LAB INVEST, V68, P499; Cozma Angela, 2009, Rom J Intern Med, V47, P133; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Garcia RG, 2007, INT J CARDIOL, V122, P176, DOI 10.1016/j.ijcard.2006.11.058; Garlichs CD, 2004, J LEUKOCYTE BIOL, V75, P828, DOI 10.1189/jlb.0703358; Gizard F, 2011, ARTERIOSCL THROM VAS, V31, P245, DOI 10.1161/ATVBAHA.110.219808; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; McGrowder D, 2011, CHOLESTEROL, DOI 10.1155/2011/496925; Narducci ML, 2007, J AM COLL CARDIOL, V50, P2369, DOI 10.1016/j.jacc.2007.08.048; Palomo I, 2011, NITRIC OXIDE-BIOL CH, V24, P224, DOI 10.1016/j.niox.2011.03.002; Rahmati-Yamchi M, 2011, BREAST CANCER-BASIC, V5, P27, DOI 10.4137/BCBCR.S6734; Ramirez R, 2005, AM J KIDNEY DIS, V45, P353, DOI 10.1053/j.ajkd.2004.10.022; Rayssiguier Y, 2010, MAGNESIUM RES, V23, P73, DOI 10.1684/mrh.2010.0208; Rizvi AA, 2010, METAB SYNDR RELAT D, V8, P287, DOI 10.1089/met.2009.0116; Roth A, 2003, BLOOD, V102, P849, DOI 10.1182/blood-2002-07-2015; Satoh M, 2008, ATHEROSCLEROSIS, V198, P347, DOI 10.1016/j.atherosclerosis.2007.09.040; Thewissen M, 2005, IMMUNOL LETT, V100, P205, DOI 10.1016/j.imlet.2005.03.007; Tsiotra PC, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/892864; Tsirpanlis G, 2006, AM J NEPHROL, V26, P91, DOI 10.1159/000092031; Tsirpanlis G, 2006, NEPHROLOGY, V11, P506, DOI 10.1111/j.1440-1797.2006.00697.x; Vaidya D, 2011, EUR J CLIN NUTR, V65, P818, DOI 10.1038/ejcn.2011.47; Vilahur G, 2009, J THROMB HAEMOST, V7, P485, DOI 10.1111/j.1538-7836.2008.03244.x; von Leitner EC, 2011, CIRCULATION, V124, P2735, DOI 10.1161/CIRCULATIONAHA.111.060541; Vykoukal D, 2011, J VASC SURG, V54, P819, DOI 10.1016/j.jvs.2011.01.003; Wascher TC, 2011, MOL MED, V17, P189, DOI 10.2119/molmed.2010.00221; Watanabe T, 1998, INT J CARDIOL, V66, pS45, DOI 10.1016/S0167-5273(98)00147-8; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Zanni MV, 2011, CLIN ENDOCRINOL; Zhu H, 2011, INT J OBES	37	50	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35739	10.1371/journal.pone.0035739	http://dx.doi.org/10.1371/journal.pone.0035739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558213	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345200073
J	Yang, Y; Li, XW; Zhang, ZH; Qian, HZ; Ruan, YH; Zhou, F; Gao, C; Li, MF; Jin, Q; Gao, L				Yang, Yu; Li, Xiangwei; Zhang, Zhihui; Qian, Han-Zhu; Ruan, Yuhua; Zhou, Feng; Gao, Cong; Li, Mufei; Jin, Qi; Gao, Lei			Association of Human Papillomavirus Infection and Abnormal Anal Cytology among HIV-Infected MSM in Beijing, China	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; ACTIVE ANTIRETROVIRAL THERAPY; POSITIVE MEN; RISK-FACTORS; CANCER; SEX; PREVALENCE; NEOPLASIA; COHORT; AIDS	Background: In the recent years, dramatic increases in HIV transmission among men who have sex with men (MSM) have been observed in China. Human papillomavirus (HPV) infection related anal cancer is more common among HIV-infected MSM as compared to the general population. However, HPV infection and anal cytology has been rarely studied in HIV-infected MSM in China. Methods: HIV-infected MSM in Beijing, China were invited to participate in this study between January and April 2011. Anal swabs were collected for examining cytology and HPV genotypes. Results: Ninety-five eligible participants with complete questionnaire and laboratory data were included in the analyses. Thirty six of them (37.9%) showed abnormal anal cytology as follows: atypical squamous cells of undetermined significance (ASC-US) in 19 (20.0%), atypical squamous cells but cannot exclude HSIL (ASC-H) in 1 (1.1%), low-grade squamous intraepithelial lesion (LSIL) in 15 (15.8%), and high-grade squamous intraepithelial lesion (HSIL) in 1 (1.1%). HPV6 (20.0%), HPV16 (10.9%), HPV56 (10.9%), HPV52 (9.1%) and HPV39 (9.1%) were observed most frequently among those with normal anal cytology, while different distribution was found in the ones with abnormal anal cytology as HPV6 (19.4%), HPV16 (19.4%), HPV45 (16.7%), HPV52 (16.7%) and HPV18 (11.1%). In addition, HPV16, HPV45, HPV52 and HPV18 were the most frequent high-risk types in patients with abnormal anal cytology. HPV multiplicity was found to be significantly related to the prevalence of abnormal anal cytology (p for trend = 0.04). Conclusions: High prevalence of HPV infection and abnormal anal cytology was observed among HIV-infected MSM in China. Infection of multiple HPV types or high-risk types was found to be associated with an increased risk of abnormal anal cytology.	[Yang, Yu; Li, Xiangwei; Zhou, Feng; Gao, Cong; Li, Mufei; Jin, Qi; Gao, Lei] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Yang, Yu; Li, Xiangwei; Zhang, Zhihui; Zhou, Feng; Gao, Cong; Li, Mufei; Jin, Qi; Gao, Lei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Zhihui] Chinese Acad Med Sci, Hosp Canc, Beijing 100730, Peoples R China; [Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Div Epidemiol, Nashville, TN 37212 USA; [Ruan, Yuhua] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Vanderbilt University; Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Yang, Y (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China.	jinqi@ipbcams.ac.cn; gaolei@ipbcams.ac.cn	zhang, zh/GWV-4677-2022	Yang, Yu/0000-0002-5611-8951	National Natural Sciences Foundation of China [81001272]; Vanderbilt University Clinical & Translational Research Scholar (VCTRS) Program	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Vanderbilt University Clinical & Translational Research Scholar (VCTRS) Program	The work was partly supported by National Natural Sciences Foundation of China (Grant No: 81001272) and Vanderbilt University Clinical & Translational Research Scholar (VCTRS) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2010, ONCOLOGY-NY, V24, P364; Chaturvedi AK, 2009, JNCI-J NATL CANCER I, V101, P1120, DOI 10.1093/jnci/djp205; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Cress RD, 2003, PREV MED, V36, P555, DOI 10.1016/S0091-7435(03)00013-6; de Pokomandy A, 2011, CLIN INFECT DIS, V52, P1174, DOI 10.1093/cid/cir064; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Diamond C, 2005, SEX TRANSM DIS, V32, P314, DOI 10.1097/01.olq.0000162366.60245.02; Fox P, 2009, CURR OPIN HIV AIDS, V4, P64, DOI 10.1097/COH.0b013e32831a6fe0; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Ho KS, 2010, CURR OPIN INFECT DIS, V23, P21, DOI 10.1097/QCO.0b013e328334fe5a; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Jay N, 1997, DIS COLON RECTUM, V40, P919, DOI 10.1007/BF02051199; Kreuter A, 2009, CURR OPIN INFECT DIS, V22, P109, DOI 10.1097/QCO.0b013e3283229fc8; Lam JMC, 2011, AIDS, V25, P635, DOI 10.1097/QAD.0b013e3283434594; Li AH, 2009, SEX TRANSM INFECT, V85, P503, DOI 10.1136/sti.2009.036707; Palefsky JM, 2005, AIDS, V19, P1407, DOI 10.1097/01.aids.0000181012.62385.4a; PALEFSKY JM, 1994, J ACQ IMMUN DEF SYND, V7, P599; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; Palefsky JM, 2001, J ACQ IMMUN DEF SYND, V28, P422, DOI 10.1097/00042560-200112150-00003; PALEFSKY JM, 1991, CANCER RES, V51, P1014; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Panther LA, 2004, CLIN INFECT DIS, V38, P1495; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Park Ina U, 2010, Curr Infect Dis Rep, V12, P126, DOI 10.1007/s11908-010-0090-7; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Salit IE, 2010, AIDS, V24, P1307, DOI 10.1097/QAD.0b013e328339e592; Shah KV, 1997, NEW ENGL J MED, V337, P1386, DOI 10.1056/NEJM199711063371911; Silling S, 2012, J CLIN VIROL; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Vajdic CM, 2009, SEX TRANSM INFECT, V85, P330, DOI 10.1136/sti.2008.034744; van der Snoek EM, 2003, SEX TRANSM DIS, V30, P639, DOI 10.1097/01.OLQ.0000079520.04451.59; Wang N, 2010, INT J EPIDEMIOL, V39, pII21, DOI 10.1093/ije/dyq209	36	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35983	10.1371/journal.pone.0035983	http://dx.doi.org/10.1371/journal.pone.0035983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558293	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200102
J	Letnic, M; Fillios, M; Crowther, MS				Letnic, Mike; Fillios, Melanie; Crowther, Mathew S.			Could Direct Killing by Larger Dingoes Have Caused the Extinction of the Thylacine from Mainland Australia?	PLOS ONE			English	Article							INVASIVE MESOPREDATOR; MAMMALIAN CARNIVORES; PREDATORY BEHAVIOR; FEEDING-BEHAVIOR; ABUNDANCE; ECOLOGY; BIODIVERSITY; CONVERGENCE; POPULATIONS; VERTEBRATES	Invasive predators can impose strong selection pressure on species that evolved in their absence and drive species to extinction. Interactions between coexisting predators may be particularly strong, as larger predators frequently kill smaller predators and suppress their abundances. Until 3500 years ago the marsupial thylacine was Australia's largest predator. It became extinct from the mainland soon after the arrival of a morphologically convergent placental predator, the dingo, but persisted in the absence of dingoes on the island of Tasmania until the 20th century. As Tasmanian thylacines were larger than dingoes, it has been argued that dingoes were unlikely to have caused the extinction of mainland thylacines because larger predators are rarely killed by smaller predators. By comparing Holocene specimens from the same regions of mainland Australia, we show that dingoes were similarly sized to male thylacines but considerably larger than female thylacines. Female thylacines would have been vulnerable to killing by dingoes. Such killing could have depressed the reproductive output of thylacine populations. Our results support the hypothesis that direct killing by larger dingoes drove thylacines to extinction on mainland Australia. However, attributing the extinction of the thylacine to just one cause is problematic because the arrival of dingoes coincided with another the potential extinction driver, the intensification of the human economy.	[Letnic, Mike] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Fillios, Melanie] Univ Sydney, Dept Archaeol, Sydney, NSW 2006, Australia; [Crowther, Mathew S.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Letnic, M (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	m.letnic@unsw.edu.au	Crowther, Mathew/M-7406-2013; Fillios, Melanie/D-7473-2018	Crowther, Mathew/0000-0001-8968-1161; Fillios, Melanie/0000-0002-7889-0061; Letnic, Michael/0000-0003-4191-8427	Asia Pacific Science Foundation [APSF 10/6]	Asia Pacific Science Foundation	Funding was provided by a grant APSF 10/6 from the Asia Pacific Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; ARCHER M, 1974, Journal of the Royal Society of Western Australia, V57, P43; Attard MRG, 2011, J ZOOL, V285, P292, DOI 10.1111/j.1469-7998.2011.00844.x; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Corbett L. K., 1995, DINGO AUSTR ASIA; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; Dawson L., 1982, CARNIVOROUS MARSUPIA, P517; Donadio E, 2006, AM NAT, V167, P524, DOI 10.1086/501033; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Gale SJ, 2009, QUAT GEOCHRONOL, V4, P391, DOI 10.1016/j.quageo.2008.12.003; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Goswami A, 2011, P ROY SOC B-BIOL SCI, V278, P1831, DOI 10.1098/rspb.2010.2031; Johnson, 2006, AUSTRALIAS MAMMAL EX; Johnson CN, 2009, J APPL ECOL, V46, P641, DOI 10.1111/j.1365-2664.2009.01650.x; Johnson CN, 2011, P ROY SOC B-BIOL SCI, V278, P3748, DOI 10.1098/rspb.2011.0343; Johnson CN, 2003, HOLOCENE, V13, P941, DOI 10.1191/0959683603hl682fa; Jones M, 1997, ECOLOGY, V78, P2569; Jones ME, 1998, J ZOOL, V246, P239, DOI 10.1111/j.1469-7998.1998.tb00152.x; KENDRICK G W, 1973, Journal of the Royal Society of Western Australia, V56, P116; Kovacs EK, OECOLOGIA IN PRESS; Letnic M, 2009, ANIM CONSERV, V12, P302, DOI 10.1111/j.1469-1795.2009.00250.x; Letnic M, 2011, GLOBAL ECOL BIOGEOGR, V20, P343, DOI 10.1111/j.1466-8238.2010.00600.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOWRY J W J, 1972, Journal of the Royal Society of Western Australia, V55, P19; Luckett PW, 1993, MAMMAL PHYLOGENY MES, P182; Macintosh N.W.G., 1975, P87; Macintosh N. W. G., 1964, Proceedings of the Royal Society of Victoria, V77, P507; Mcnab BK, 2005, REV CHIL HIST NAT, V78, P183, DOI 10.4067/S0716-078X2005000200002; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Paddle R., 2000, LAST TASMANIAN TIGER; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Ride W. D. L., 1964, Journal of the Royal Society of Western Australia, V47, P97; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROSS A, 1985, Archaeology in Oceania, V20, P81; Ryan Lyndall., 1996, ABORIGINAL TASMANIAN; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Savidge J, 1997, ECOLOGY, V68, P660; Switalski TA, 2003, CAN J ZOOL, V81, P985, DOI 10.1139/Z03-080; Thompson CM, 2007, ECOLOGY, V88, P334, DOI 10.1890/0012-9658(2007)88[334:FWAIPC]2.0.CO;2; THOMSON PC, 1992, WILDLIFE RES, V19, P531, DOI 10.1071/WR9920531; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wroe S, 2002, AUST J ZOOL, V50, P1, DOI 10.1071/ZO01053; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Yom-Tov Y, 2011, BIOL REV, V86, P531, DOI 10.1111/j.1469-185X.2010.00168.x	47	34	36	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34877	10.1371/journal.pone.0034877	http://dx.doi.org/10.1371/journal.pone.0034877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567093	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500011
J	Montiel, R; Solorzano, E; Diaz, N; Alvarez-Sandoval, BA; Gonzalez-Ruiz, M; Canadas, MP; Simoes, N; Isidro, A; Malgosa, A				Montiel, Rafael; Solorzano, Eduvigis; Diaz, Nancy; Alvarez-Sandoval, Brenda A.; Gonzalez-Ruiz, Mercedes; Pau Canadas, Mari; Simoes, Nelson; Isidro, Albert; Malgosa, Assumpcio			Neonate Human Remains: A Window of Opportunity to the Molecular Study of Ancient Syphilis	PLOS ONE			English	Article							TREPONEMA-PALLIDUM; CONGENITAL-SYPHILIS; TUBERCULOSIS; SEQUENCES; LESIONS; LIMITS	Ancient DNA (aDNA) analysis can be a useful tool in bacterial disease diagnosis in human remains. However, while the recovery of Mycobacterium spp. has been widely successful, several authors report unsuccessful results regarding ancient treponemal DNA, casting doubts on the usefulness of this technique for the diagnosis of ancient syphilis. Here, we present results from an analysis of four newborn specimens recovered from the crypt of "La Ermita de la Soledad'' (XVI-XVII centuries), located in the province of Huelva in the southwest of Spain. We extracted and analyzed aDNA in three independent laboratories, following specific procedures generally practiced in the aDNA field, including cloning of the amplified DNA fragments and sequencing of several clones. This is the most ancient case, reported to date, from which detection of DNA from T. pallidum subspecies pallidum has been successful in more than one individual, and we put forward a hypothesis to explain this result, taking into account the course of the disease in neonate individuals.	[Montiel, Rafael; Alvarez-Sandoval, Brenda A.] Inst Politecn Nacl CINVESTAV IPN, Lab Nacl Genom Biodiversidad, Ctr Invest & Estudios Avanzados, Guanajuato, Mexico; [Solorzano, Eduvigis; Diaz, Nancy; Gonzalez-Ruiz, Mercedes; Isidro, Albert; Malgosa, Assumpcio] Univ Autonoma Barcelona, Unitat Antropol, Dept Biol Anim Biol Vegetal & Ecol, Bellaterra, Spain; [Pau Canadas, Mari] Gen Lab, Dept Biol Mol, Barcelona, Spain; [Simoes, Nelson] Univ Azores, Res Ctr Nat Resources CIRN, Dept Biol, Ponta Delgada, Azores, Portugal; [Isidro, Albert] Hosp Univ Sagrat Cor, Serv Cirurgia Ortoped & Traumatol COT, Barcelona, Spain	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Autonomous University of Barcelona; Universidade dos Acores	Montiel, R (corresponding author), Inst Politecn Nacl CINVESTAV IPN, Lab Nacl Genom Biodiversidad, Ctr Invest & Estudios Avanzados, Guanajuato, Mexico.	Assumpcio.Malgosa@uab.cat	Montiel, Rafael/A-6774-2008; Simões, Nelson/K-3843-2013; Malgosa, Assumpció/K-2406-2014; Isidro, Albert/L-6218-2014	Montiel, Rafael/0000-0001-8052-0679; Simões, Nelson/0000-0003-3612-6759; Malgosa, Assumpció/0000-0003-1723-3671; Isidro, Albert/0000-0001-8784-2945	Ministerio de Educacion y Ciencia, Spain (MEC) [CGL2008-00800]; Generalitat de Catalunya [PR2009-0128]; Consejo de Ciencia y Tecnologia del Estado de Guanajuato, Mexico (CONCYTEG) [08-03-K662-076 A04]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB-2008-01-105481]; Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) [SFRH/BPD/32473/2006]; CONACYT	Ministerio de Educacion y Ciencia, Spain (MEC)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Consejo de Ciencia y Tecnologia del Estado de Guanajuato, Mexico (CONCYTEG); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacao para a Ciencia e a Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors acknowledge the following grants: Ministerio de Educacion y Ciencia, Spain (MEC; www.educacion.gob.es) grant No. CGL2008-00800 to Dr. Malgosa; Generalitat de Catalunya (www.gencat.cat), grant No. PR2009-0128 to the Grup de Recerca en Antropologia Biologica (GREAB); Consejo de Ciencia y Tecnologia del Estado de Guanajuato, Mexico (CONCYTEG; www.concyteg.gob.mx) grant No. 08-03-K662-076 A04 to Dr. Montiel; Consejo Nacional de Ciencia y Tecnologia (CONACYT; www.conacyt.gob.mx) grant No. CB-2008-01-105481) to Dr. Montiel. Dr. Montiel received a postdoc grant (SFRH/BPD/32473/2006) from the Fundacao para a Ciencia e a Tecnologia, Portugal (FCT; www.fct.pt). Dr. Alvarez-Sandoval is supported by CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alduc-Le Bagousse A, 1988, NOTES MONOGRAPHIES T, V24, P81; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Armangil D, 2009, TURKISH J PEDIATR, V51, P169; Barnes I, 2006, P ROY SOC B-BIOL SCI, V273, P645, DOI 10.1098/rspb.2005.3339; BAUER MF, 1967, BRIT J VENER DIS, V43, P175; Bauer WH, 1944, AM J PATHOL, V20, P297; Blondiaux J, 1994, ORIGIN SYPHILIS EURO; Bouwman AS, 2005, J ARCHAEOL SCI, V32, P703, DOI 10.1016/j.jas.2004.11.014; Centurion-Lara A, 1998, J INFECT DIS, V177, P1036, DOI 10.1086/515247; Centurion-Lara A, 2006, J CLIN MICROBIOL, V44, P3377, DOI 10.1128/JCM.00784-06; DISMUKES WE, 1976, JAMA-J AM MED ASSOC, V236, P2646, DOI 10.1001/jama.236.23.2646; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Garcia C, 1999, ERMITA SOLEDAD TRAVE, P57; HANSEN K, 1984, BRIT J VENER DIS, V60, P265; Henneberg M, 1994, ORIGIN SYPHILIS EURO; Hershkovitz I, 1995, ORIGIN SYPHILIS EURO, P81; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173; Hudson MM, 1996, LANCET, V348, P1495, DOI 10.1016/S0140-6736(96)08170-6; Jaffe H., 1972, METABOLIC DEGENERATI; Je GC, 1979, SEOUL J MED, V20, P297; Kolman CJ, 1999, J INFECT DIS, V180, P2060, DOI 10.1086/315151; Liu H, 2007, J MED MICROBIOL, V56, P715, DOI 10.1099/jmm.0.46943-0; LUGER A, 1993, SEX TRANSM DIS, V20, P110, DOI 10.1097/00007435-199303000-00010; Malgosa A., 2005, Recent Research Developments in Microbiology, Vol. 9, Part II, P213; Malgosa A, 1996, INT J OSTEOARCHAEOL, V6, P388, DOI 10.1002/(SICI)1099-1212(199609)6:4<388::AID-OA286>3.3.CO;2-1; Marangoni A, 2008, CLIN MICROBIOL INFEC, V14, P1065, DOI 10.1111/j.1469-0691.2008.02066.x; Montiel R, 2003, FEMS MICROBIOL LETT, V226, P413, DOI 10.1016/S0378-1097(03)00617-7; Montiel R, 2001, HUM BIOL, V73, P689, DOI 10.1353/hub.2001.0069; Montiel R, 2001, THESIS U AUTONOMA BA; Montiel R., 1997, J ANCIENT BIOMOL, V1, P221; OHTSUKI F, 1977, AM J PHYS ANTHROPOL, V46, P141, DOI 10.1002/ajpa.1330460118; Palfi G, 1992, INT J OSTEOARCHAEOL, V2, P245; Peng RR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001273; Roberts C, 1994, ORIGIN SYPHILIS EURO; Safont S, 1996, SALUD ENFERMEDAD MUE, P41; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Shen Hui-jun, 2009, Zhonghua Er Ke Za Zhi, V47, P871; Stirland A, 1991, ORIGIN SYPHILIS EURO; SUNDICK RI, 1978, HOMO, V29, P228; von Hunnius TE, 2007, J ARCHAEOL SCI, V34, P2091, DOI 10.1016/j.jas.2007.02.007	44	20	21	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36371	10.1371/journal.pone.0036371	http://dx.doi.org/10.1371/journal.pone.0036371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567153	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500072
J	Norberg, AL; Poder, U; Ljungman, G; von Essen, L				Norberg, Annika Lindahl; Poder, Ulrika; Ljungman, Gustaf; von Essen, Louise			Objective and Subjective Factors as Predictors of Post-Traumatic Stress Symptoms in Parents of Children with Cancer - A Longitudinal Study	PLOS ONE			English	Article							CHILDHOOD-CANCER; DISORDER; MOTHERS; SATISFACTION; SURVIVORS; DISTRESS	Background: Parents of children with cancer report post-traumatic stress symptoms (PTSS) years after the child's successful treatment is completed. The aim of the present study was to analyze a number of objective and subjective childhood cancer-related factors as predictors of parental PTSS. Methods: Data were collected from 224 parents during and after their child's cancer treatment. Data sources include self-report questionnaires and medical records. Results: In a multivariate hierarchical model death of the child, parent's perception of child psychological distress and total symptom burden predicted higher levels of PTSS. In addition, immigrants and unemployed parents reported higher levels of PTSS. The following factors did not predict PTSS: parent gender, family income, previous trauma, child's prognosis, treatment intensity, non-fatal relapse, and parent's satisfaction with the child's care. Conclusions: Although medical complications can be temporarily stressful, a parent's perception of the child's distress is a more powerful predictor of parental PTSS. The vulnerability of unemployed parents and immigrants should be acknowledged. In addition, findings highlight that the death of a child is as traumatic as could be expected.	[Norberg, Annika Lindahl; Poder, Ulrika; von Essen, Louise] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Norberg, Annika Lindahl] Karolinska Inst, Dept Woman & Child Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Ljungman, Gustaf] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Uppsala University	Norberg, AL (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	Annika.Lindahl.Norberg@pubcare.uu.se		Ljungman, Gustaf/0000-0002-4949-2494	Swedish Cancer Society [02 0274, 03 0228]; Swedish Research Council [K2008-70X-20836-01-3]; Swedish Children's Cancer Foundation [02/004, 05/030, 08/006]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children's Cancer Foundation	This work was supported by The Swedish Cancer Society, grants numbers 02 0274 and 03 0228. http://www.cancerfonden.se/sv/Information-inEnglish/. The Swedish Research Council, grant number K2008-70X-20836-01-3. http://vetenskapsradet.wordpress.com/in-english/. The Swedish Children's Cancer Foundation, grant numbers 02/004, 05/030, and 08/006. http://www.barncancerfonden.se/Om-oss/In-English/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barakat LP, 1997, J PEDIATR PSYCHOL, V22, P843, DOI 10.1093/jpepsy/22.6.843; Bredart A, 1998, SUPPORT CARE CANCER, V6, P518, DOI 10.1007/s005200050207; Brewin Chris R., 2000, J CONSULTING CLIN PS, V68; Brown RT, 2003, J TRAUMA STRESS, V16, P309, DOI 10.1023/A:1024465415620; Butow PN, 2011, SUPPORT CARE CANCER, V19, P281, DOI 10.1007/s00520-010-0817-x; Collins JJ, 2000, J PAIN SYMPTOM MANAG, V19, P363, DOI 10.1016/S0885-3924(00)00127-5; Cull A., 1998, EORTC QUALITY LIFE S; Duffey-Lind Eileen C, 2006, J Pediatr Oncol Nurs, V23, P335, DOI 10.1177/1043454206293267; Elklit A, 2010, J PSYCHOSOC ONCOL, V28, P399, DOI 10.1080/07347332.2010.488142; Horowitz MJ, 1997, AM J PSYCHIAT, V154, P904; Jurbergs N, 2009, J PEDIATR PSYCHOL, V34, P4, DOI 10.1093/jpepsy/jsm119; Kazak AE, 2005, J CLIN ONCOL, V23, P7405, DOI 10.1200/JCO.2005.09.110; Kazak AE, 1998, J AM ACAD CHILD PSY, V37, P823, DOI 10.1097/00004583-199808000-00012; Lazarus R.S., 1991, EMOTION ADAPTATION; Libova BG, 2002, PSYCHOL HEALTH, V17, P501, DOI 10.1080/0887044022000004975; Magal-Vardi O, 2004, J NERV MENT DIS, V192, P872, DOI 10.1097/01.nmd.0000146881.00129.ec; Nandi A, 2004, J OCCUP ENVIRON MED, V46, P1057, DOI 10.1097/01.jom.0000141663.22902.0a; NOPHO, 1999, CHILDH CANC NORD COU; Norberg AL, 2009, EUR J CANCER CARE, V18, P371, DOI 10.1111/j.1365-2354.2008.00976.x; Norberg AL, 2005, ACTA ONCOL, V44, P382, DOI 10.1080/02841860510029789; Norberg AL, 2008, ACTA ONCOL, V47, P267, DOI 10.1080/02841860701558773; Pelcovitz D, 1996, PSYCHOSOMATICS, V37, P116, DOI 10.1016/S0033-3182(96)71577-3; Poder U, 2008, PSYCHO-ONCOLOGY, V17, P430, DOI 10.1002/pon.1263; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Schwartz SJ, 2010, AM PSYCHOL, V65, P237, DOI 10.1037/a0019330; Steele RG, 2004, J PEDIATR PSYCHOL, V29, P507, DOI 10.1093/jpepsy/jsh053; Weathers F. W., 1993, ANN M INT SOC TRAUM, DOI [10.1037/t02622-000, DOI 10.1037/T02622-000]; Yeh CH, 2003, APPL NURS RES, V16, P245, DOI 10.1016/S0897-1897(03)00054-5	31	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36218	10.1371/journal.pone.0036218	http://dx.doi.org/10.1371/journal.pone.0036218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959US	22567141	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500060
J	Szwedowski, TD; Taylor, WR; Heller, MO; Perka, C; Muller, M; Duda, GN				Szwedowski, Tomasz D.; Taylor, William R.; Heller, Markus O.; Perka, Carsten; Mueller, Michael; Duda, Georg N.			Generic Rules of Mechano-Regulation Combined with Subject Specific Loading Conditions Can Explain Bone Adaptation after THA	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; X-RAY ABSORPTIOMETRY; MINERAL DENSITY; REMODELING SIGNAL; PROXIMAL FEMUR; DESIGN; STEMS; PROSTHESIS; SIMULATION; RESORPTION	Bone adaptation after total hip arthroplasty is associated with the change in internal load environment, and can result in compromised bone stock, which presents a considerable challenge should a revision procedure be required. Under the assumption of a generic mechano-regulatory algorithm for governing bone adaptation, the aim of this study was to understand the contribution of subject specific loading conditions towards explaining the local periprosthetic remodelling variations in patients. CT scans of 3 consecutive THA patients were obtained and used for the construction of subject specific finite element models using verified musculoskeletal loading and physiological boundary conditions. Using either strain energy density or equivalent strain as mechano-transduction signals, predictions of bone adaptation were compared to DEXA derived BMD changes from 7 days to 12 months post-implantation. Individual changes in BMD of up to 33.6% were observed within the 12 month follow-up period, together with considerable inter-patient variability of up to 26%. Estimates of bone adaptation using equivalent strain and balanced loading conditions led to the best agreement with in vivo measured BMD, with RMS errors of only 3.9%, 7.3% and 7.3% for the individual subjects, compared to errors of over 10% when the loading conditions were simplified. This study provides evidence that subject specific loading conditions and physiological boundary constraints are essential for explaining inter-patient variations in bone adaptation patterns. This improved knowledge of the rules governing the adaptation of bone following THA helps towards understanding the interplay between mechanics and biology for better identifying patients at risk of excessive or problematic periprosthetic bone atrophy.	[Szwedowski, Tomasz D.; Taylor, William R.; Heller, Markus O.; Perka, Carsten; Mueller, Michael; Duda, Georg N.] Charite, Julius Wolff Inst JWI, Ctr Musculoskeletal Surg CMSC, Ctr Sports Sci & Sports Med Berlin CSSB, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Szwedowski, TD (corresponding author), Charite, Julius Wolff Inst JWI, Ctr Musculoskeletal Surg CMSC, Ctr Sports Sci & Sports Med Berlin CSSB, D-13353 Berlin, Germany.	bill.taylor@charite.de	Perka, Carsten/ABG-6505-2021; Müller, Michael/L-2732-2019; Duda, Georg N/H-2085-2016; Taylor, William R./F-8692-2010; Heller, Markus O/F-8437-2010	Müller, Michael/0000-0002-8934-9676; Duda, Georg N/0000-0001-7605-3908; Taylor, William R./0000-0003-4060-4098; Heller, Markus O/0000-0002-7879-1135; Perka, Carsten/0000-0002-0993-581X	Zimmer Orthopaedics Inc. (Warsaw, Indiana, United States of America); Deutsche Forschungsgemeinschaft DFG [SFB 760]	Zimmer Orthopaedics Inc. (Warsaw, Indiana, United States of America); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was financially supported by Zimmer Orthopaedics Inc. (Warsaw, Indiana, United States of America) and the Deutsche Forschungsgemeinschaft DFG SFB 760. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bitsakos C, 2005, J BIOMECH, V38, P133, DOI 10.1016/j.jbiomech.2004.03.005; Bryan JM, 1996, J ORTHOP RES, V14, P762, DOI 10.1002/jor.1100140513; Duda GN, 1998, J BIOMECH, V31, P841, DOI 10.1016/S0021-9290(98)00080-3; Dunbar M J, 2001, Instr Course Lect, V50, P197; ENGH CA, 1993, CLIN ORTHOP RELAT R, P177; Epari DR, 2006, CLIN BIOMECH, V21, P646, DOI 10.1016/j.clinbiomech.2006.01.003; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Heller MO, 2005, J BIOMECH, V38, P1155, DOI 10.1016/j.jbiomech.2004.05.022; Heller MO, 2003, LANGENBECK ARCH SURG, V388, P291, DOI 10.1007/s00423-003-0406-2; Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2; HUISKES R, 1995, CLIN ORTHOP RELAT R, P64; Huiskes R, 1993, Acta Orthop Belg, V59 Suppl 1, P118; HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3; HUISKES R, 1992, CLIN ORTHOP RELAT R, P124; HUISKES R, 1987, ACTA ORTHOP SCAND, V58, P620; HUISKES R, 1989, ORTHOPEDICS, V12, P1255; Kainmueller D, 2009, C P IEEE ENG MED BIO, V2009, P6345; Kerner J, 1999, J BIOMECH, V32, P695, DOI 10.1016/S0021-9290(99)00041-X; KILGUS DJ, 1993, J BONE JOINT SURG BR, V75, P279, DOI 10.1302/0301-620X.75B2.8444950; Kiratli BJ, 1996, J ARTHROPLASTY, V11, P184; KIRATLI BJ, 1992, J ORTHOP RES, V10, P836, DOI 10.1002/jor.1100100613; Kleemann RU, 2003, J ORTHOP RES, V21, P767, DOI 10.1016/S0736-0266(03)00040-8; LES CM, 1994, J ORTHOP RES, V12, P822, DOI 10.1002/jor.1100120610; MIKIC B, 1995, J BIOMECH, V28, P465, DOI 10.1016/0021-9290(94)00085-I; Perka C, 2005, CLIN ORTHOP RELAT R, P153; Rosenbaum TG, 2006, CLIN ORTHOP RELAT R, P129, DOI 10.1097/01.blo.0000223981.21584.35; RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217; Scannell PT, 2009, MED ENG PHYS, V31, P477, DOI 10.1016/j.medengphy.2008.11.007; Schmitz MJ, 2004, P I MECH ENG H, V218, P417, DOI 10.1243/0954411042632162; Smart RC, 1996, J ARTHROPLASTY, V11, P445, DOI 10.1016/S0883-5403(96)80035-0; Speirs AD, 2007, J BIOMECH, V40, P2318, DOI 10.1016/j.jbiomech.2006.10.038; Speirs AD, 2007, CLIN BIOMECH, V22, P431, DOI 10.1016/j.clinbiomech.2006.12.003; Stulpner MA, 1997, J BIOMECH, V30, P1063, DOI 10.1016/S0021-9290(97)00074-2; SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202; Taylor W. R., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P131, DOI 10.1080/10255840410001712108; Taylor WR, 2004, J ORTHOP RES, V22, P625, DOI 10.1016/j.orthres.2003.09.003; Taylor WR, 2003, P I MECH ENG H, V217, P349, DOI 10.1243/095441103770802513; Turner AWL, 2005, J ORTHOP RES, V23, P705, DOI 10.1016/j.orthres.2005.02.002; VANRIETBERGEN B, 1993, J BIOMECH, V26, P369, DOI 10.1016/0021-9290(93)90001-U; WEINANS H, 1993, J ORTHOPAED RES, V11, P500, DOI 10.1002/jor.1100110405; Wilkinson JM, 2003, J ORTHOP RES, V21, P691, DOI 10.1016/S0736-0266(02)00237-1; Wolff J, 2010, CLIN ORTHOP RELAT R, V468, P1056, DOI 10.1007/s11999-010-1239-2; Wolff J, 2010, CLIN ORTHOP RELAT R, V468, P1052, DOI 10.1007/s11999-010-1240-9	45	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36231	10.1371/journal.pone.0036231	http://dx.doi.org/10.1371/journal.pone.0036231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567143	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000305341500062
J	Wan, XW; Liu, YH; Zhang, B				Wan, Xuanwu; Liu, Yinghong; Zhang, Bin			Invasion History of the Oriental Fruit Fly, Bactrocera dorsalis, in the Pacific-Asia Region: Two Main Invasion Routes	PLOS ONE			English	Article							MULTIPLE INTRODUCTIONS; POPULATION-GENETICS; DIPTERA; POLYMORPHISM; INHERITANCE; DIVERSITY; PATTERNS	The oriental fruit fly, Bactrocera dorsalis, was initially recorded in Taiwan Island in 1912, and has dispersed to many areas in the Pacific-Asia region over the last century. The area of origin of the species may be confidently placed in South-East China. However, routes of range expansion to new areas and underlying population processes remain partially unclear, despite having been the subject of several studies. To explore the invasion history of this species, a partition of the cox1 gene of mitochondrial DNA was used to investigate genetic diversity, haplotype phylogeny and demographic history of 35 populations, covering China and South-East Asia and including marginal populations from Pakistan and Hawaii. Based on neighbor-joining tree analysis and the distribution of haplotypes, two main invasion routes are inferred: one from South-East China to Central China, another from South-East China to South-East Asia, with both routes probably coinciding in Central China. Populations in Taiwan Island and Hainan Island might have originated in South-East China. The marginal populations in Pakistan and Hawaii might have undergone founding events or genetic bottlenecks. Possible strategies for the control of this species are proposed based on the invasion history and reconstructed expansion routes.	[Wan, Xuanwu; Liu, Yinghong; Zhang, Bin] Southwest Univ, Coll Plant Protect, Chongqing Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Southwest University - China	Wan, XW (corresponding author), Southwest Univ, Coll Plant Protect, Chongqing Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	yhliu@swu.edu.cn	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022		National Basic Research Program of China [2009CB125903]; Innovation Fund for graduate student in Southwest University of China	National Basic Research Program of China(National Basic Research Program of China); Innovation Fund for graduate student in Southwest University of China	This study was supported by the National Basic Research Program of China (2009CB125903) and by the Innovation Fund for graduate student in Southwest University of China: Invasion History of the Fruit Flies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aketarawong N, 2007, MOL ECOL, V16, P3522, DOI 10.1111/j.1365-294X.2007.03409.x; Avise John C., 1994, pi; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; [陈鹏 CHEN Peng], 2007, [生态学报, Acta Ecologica Sinica], V27, P2468; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; di Castri F., 1989, SCOPE, V37, P1; Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Duyck PF, 2004, ECOL ENTOMOL, V29, P511, DOI 10.1111/j.0307-6946.2004.00638.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Facon B, 2003, MOL ECOL, V12, P3027, DOI 10.1046/j.1365-294X.2003.01972.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fonseca DM, 2000, MOL ECOL, V9, P1803, DOI 10.1046/j.1365-294x.2000.01070.x; FULLAWAY DT, 1953, P ENTOMOLOGY SOC WAS, V51, P181; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Li Wei-Feng, 2007, Acta Entomologica Sinica, V50, P1255; Li Y, 2012, J APPL ENTOMOL, V136, P241, DOI 10.1111/j.1439-0418.2011.01636.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; MacAlpine DM, 2001, EMBO J, V20, P1807, DOI 10.1093/emboj/20.7.1807; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; Nakahara S, 2008, APPL ENTOMOL ZOOL, V43, P457, DOI 10.1303/aez.2008.457; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Pinero JC, 2009, J ECON ENTOMOL, V102, P1123, DOI 10.1603/029.102.0334; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rollins LA, 2011, MOL ECOL, V20, P2307, DOI 10.1111/j.1365-294X.2011.05101.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Shi W, 2005, ENVIRON ENTOMOL, V34, P977, DOI 10.1603/0046-225X-34.4.977; Shi W, 2010, GENETICA, V138, P377, DOI 10.1007/s10709-009-9429-0; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wan X, 2011, PLOS ONE, V10	51	53	67	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36176	10.1371/journal.pone.0036176	http://dx.doi.org/10.1371/journal.pone.0036176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567138	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500057
J	Chen, YZ; Wang, Y; Zhuang, YL; Zhou, FL; Huang, LL				Chen, Yuezhou; Wang, Yan; Zhuang, Yaling; Zhou, Feng; Huang, Lili			Mifepristone Increases the Cytotoxicity of Uterine Natural Killer Cells by Acting as a Glucocorticoid Antagonist via ERK Activation	PLOS ONE			English	Article							NK CELLS; PROGESTERONE-RECEPTOR; GRANZYME-B; PERFORIN EXPRESSION; CONTRACEPTIVE DRUG; SIGNALING PATHWAYS; CUSHINGS-SYNDROME; IN-VITRO; T-CELLS; RU-486	Background: Mifepristone (RU486), a potent antagonist of progesterone and glucocorticoids, is involved in immune regulation. Our previous studies demonstrated that mifepristone directly augments the cytotoxicity of human uterine natural killer (uNK) cells. However, the mechanism responsible for this increase in cytotoxicity is not known. Here, we explored whether the increased cytotoxicity in uNK cells produced by mifepristone is due to either anti-progesterone or anti-glucocorticoid activity, and also investigated relevant changes in the mitogen-activated protein kinase (MAPK) pathway. Methodology/Principal Findings: Uterine NK cells were isolated from decidual samples and incubated with different concentrations of progesterone, cortisol, or mifepristone. The cytotoxicity and perforin expression of uNK cells were detected by mitochondrial lactate dehydrogenase-based MTS staining and flow cytometry assays, respectively. Phosphorylation of components of the MAPK signaling pathway was detected by Western blot. Cortisol attenuated uNK cell-mediated cytotoxicity in a concentration-dependent manner whereas progesterone had no effect. Mifepristone alone increased the cytotoxicity and perforin expression of uNK cells; these effects were blocked by cortisol. Furthermore, mifepristone increased the phosphorylation of ERK1/2 in a cortisol-reversible manner. Specific ERK1/2 inhibitor PD98059 or U0126 blocked cortisol-and mifepristone-induced responses in uNK cells. Conclusions/Significance: These results suggest that mifepristone acts as a glucocorticoid antagonist to augment uNK cell-mediated cytotoxicity via ERK activation, which may be caused by increased perforin expression. These observations may reveal an important mechanism by which mifepristone upregulates the cytotoxicity of uNK cells.	[Chen, Yuezhou; Zhuang, Yaling; Zhou, Feng; Huang, Lili] Zhejiang Univ, Womens Reprod Hlth Lab Zhejiang Prov, Womens Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yan] Hubei Med Univ, Taihe Hosp, Dept Gastroenterol, Shiyan, Hubei, Peoples R China	Zhejiang University	Chen, YZ (corresponding author), Zhejiang Univ, Womens Reprod Hlth Lab Zhejiang Prov, Womens Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	fbhuanglili@163.com	Chen, Yuezhou/E-5206-2011	Chen, Yuezhou/0000-0002-9138-7081	National Natural Science Foundation of China [81070525]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81070525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruvito L, 2008, J IMMUNOL, V180, P5746, DOI 10.4049/jimmunol.180.8.5746; BAGCHI MK, 1990, NATURE, V345, P547, DOI 10.1038/345547a0; Boomsma CM, 2007, COCHRANE DATABASE SY; Check JH, 2010, ANTICANCER RES, V30, P119; Chen XY, 2010, FERTIL STERIL, V93, P2615, DOI 10.1016/j.fertnstert.2009.09.015; Chen YZ, 2011, AM J REPROD IMMUNOL, V65, P589, DOI 10.1111/j.1600-0897.2010.00955.x; Chien CH, 2009, HUM REPROD, V24, P1968, DOI 10.1093/humrep/dep099; Chiossone L, 2007, BLOOD, V109, P3767, DOI 10.1182/blood-2006-07-037846; Clark AR, 2003, CURR OPIN PHARMACOL, V3, P404, DOI 10.1016/S1471-4892(03)00073-0; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Davis DM, 2002, TRENDS IMMUNOL, V23, P356, DOI 10.1016/S1471-4906(02)02243-3; Dosiou C, 2005, ENDOCR REV, V26, P44, DOI 10.1210/er.2003-0021; ELASHRY D, 1989, MOL ENDOCRINOL, V3, P1545, DOI 10.1210/mend-3-10-1545; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fukui A, 1999, AM J REPROD IMMUNOL, V41, P413; Ge NL, 2003, WORLD J GASTROENTERO, V9, P2182; Gonzalez R, 2010, REPROD TOXICOL, V29, P198, DOI 10.1016/j.reprotox.2009.10.009; Grossman WJ, 2003, CURR OPIN IMMUNOL, V15, P544, DOI 10.1016/S0952-7915(03)00099-2; HANSEN KA, 1992, AM J OBSTET GYNECOL, V166, P87, DOI 10.1016/0002-9378(92)91835-X; Henderson TA, 2003, J CLIN ENDOCR METAB, V88, P440, DOI 10.1210/jc.2002-021174; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Johanssen S, 2007, EUR J ENDOCRINOL, V157, P561, DOI 10.1530/EJE-07-0458; Kitaya K, 2003, FERTIL STERIL, V79, P730, DOI 10.1016/S0015-0282(02)04818-5; Lachapelle MH, 1996, J IMMUNOL, V156, P4027; Lash GE, 2011, J REPROD IMMUNOL, V88, P156, DOI 10.1016/j.jri.2011.01.003; LAUE L, 1988, J CLIN ENDOCR METAB, V66, P290, DOI 10.1210/jcem-66-2-290; Li AM, 2005, FERTIL STERIL, V84, P202, DOI 10.1016/j.fertnstert.2005.01.126; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; LIN MF, 1995, PROSTATE, V26, P194, DOI 10.1002/pros.2990260405; Lu CC, 2010, J CELL PHYSIOL, V223, P343, DOI 10.1002/jcp.22043; Lu S, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P625; Mattarollo SR, 2007, CANCER IMMUNOL IMMUN, V56, P1285, DOI 10.1007/s00262-007-0279-2; Miyaura H, 2002, J IMMUNOL, V168, P1087, DOI 10.4049/jimmunol.168.3.1087; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Quenby S, 2005, FERTIL STERIL, V84, P980, DOI 10.1016/j.fertnstert.2005.05.012; Rambal AA, 2009, LEUKEMIA, V23, P1744, DOI 10.1038/leu.2009.80; Ribeiro-Dias F, 2000, J IMMUNOL METHODS, V241, P121, DOI 10.1016/S0022-1759(00)00206-4; Sarkar NN, 2002, INT J CLIN PRACT, V56, P140; Sartor O, 1996, CLIN OBSTET GYNECOL, V39, P506, DOI 10.1097/00003081-199606000-00024; SPITZ IM, 1993, NEW ENGL J MED, V329, P404; Spitz IM, 1998, HUM REPROD UPDATE, V4, P584, DOI 10.1093/humupd/4.5.584; Spitz IM, 2006, CURR OPIN INVEST DR, V7, P882; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Tuckerman E, 2010, J REPROD IMMUNOL, V87, P60, DOI 10.1016/j.jri.2010.07.001; VANVOORHIS BJ, 1989, J CLIN ENDOCR METAB, V69, P1195; Verma S, 2000, BIOL REPROD, V62, P959, DOI 10.1095/biolreprod62.4.959; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zhang T, 2009, BLOOD; Zhou F, 2011, FERTIL STERIL, V96, P649, DOI 10.1016/j.fertnstert.2011.06.074; Zhu HX, 2009, AM J REPROD IMMUNOL, V61, P68, DOI 10.1111/j.1600-0897.2008.00664.x	55	27	30	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36413	10.1371/journal.pone.0036413	http://dx.doi.org/10.1371/journal.pone.0036413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563497	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340700046
J	Mansouri, S; Kutky, M; Hudak, KA				Mansouri, Sheila; Kutky, Meherzad; Hudak, Katalin A.			Pokeweed Antiviral Protein Increases HIV-1 Particle Infectivity by Activating the Cellular Mitogen Activated Protein Kinase Pathway	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEINS; SARCIN/RICIN LOOP; P38 MAPK; CELLS; RNA; TRICHOSANTHIN; APOPTOSIS; INHIBITION; MUTATIONS; RICIN	Pokeweed antiviral protein (PAP) is a plant-derived N-glycosidase that exhibits antiviral activity against several viruses. The enzyme removes purine bases from the messenger RNAs of the retroviruses Human immunodeficiency virus-1 and Human T-cell leukemia virus-1. This depurination reduces viral protein synthesis by stalling elongating ribosomes at nucleotides with a missing base. Here, we transiently expressed PAP in cells with a proviral clone of HIV-1 to examine the effect of the protein on virus production and quality. PAP reduced virus production by approximately 450-fold, as measured by p24 ELISA of media containing virions, which correlated with a substantial decline in virus protein synthesis in cells. However, particles released from PAP-expressing cells were approximately 7-fold more infectious, as determined by single-cycle infection of 1G5 cells and productive infection of MT2 cells. This increase in infectivity was not likely due to changes in the processing of HIV-1 polyproteins, RNA packaging efficiency or maturation of virus. Rather, expression of PAP activated the ERK1/2 MAPK pathway to a limited extent, resulting in increased phosphorylation of viral p17 matrix protein. The increase in infectivity of HIV-1 particles produced from PAP-expressing cells was compensated by the reduction in virus number; that is, virus production decreased upon de novo infection of cells over time. However, our findings emphasize the importance of investigating the influence of heterologous protein expression upon host cells when assessing their potential for antiviral applications.	[Mansouri, Sheila; Kutky, Meherzad; Hudak, Katalin A.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	Mansouri, S (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	hudak@yorku.ca			Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship in Science and Technology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship in Science and Technology	This work was supported by a Discovery Grant to KAH from the Natural Sciences and Engineering Research Council of Canada. MK is the recipient of an Ontario Graduate Scholarship in Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Blay WM, 2007, J VIROL, V81, P13037, DOI 10.1128/JVI.01215-07; Bukrinskaya AG, 1996, P NATL ACAD SCI USA, V93, P367, DOI 10.1073/pnas.93.1.367; Cartier C, 1999, J BIOL CHEM, V274, P19434, DOI 10.1074/jbc.274.27.19434; Cartier C, 2003, J BIOL CHEM, V278, P35211, DOI 10.1074/jbc.M301257200; Cartier C, 1997, J VIROL, V71, P4832, DOI 10.1128/JVI.71.6.4832-4837.1997; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ENDO Y, 1988, BIOCHEM BIOPH RES CO, V150, P1032, DOI 10.1016/0006-291X(88)90733-4; FOATOMASI L, 1982, ARCH VIROL, V71, P323, DOI 10.1007/BF01315062; GESSNER SL, 1980, J BIOL CHEM, V255, P3251; Giroud C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-71; Huang H, 2006, LIFE SCI, V79, P1287, DOI 10.1016/j.lfs.2006.03.047; Hui EKW, 2002, CELL MOL LIFE SCI, V59, P920, DOI 10.1007/s00018-002-8479-6; HUR Y, 1995, P NATL ACAD SCI USA, V92, P8448, DOI 10.1073/pnas.92.18.8448; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; IRVIN JD, 1975, ARCH BIOCHEM BIOPHYS, V169, P522, DOI 10.1016/0003-9861(75)90195-2; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Korcheva V, 2005, AM J PATHOL, V166, P323, DOI 10.1016/S0002-9440(10)62256-0; Li M, 2010, ANAT REC, V293, P986, DOI 10.1002/ar.21142; Mansouri S, 2006, RNA, V12, P1683, DOI 10.1261/rna.70306; Mansouri S, 2009, J BIOL CHEM, V284, P31453, DOI 10.1074/jbc.M109.046235; Miyake T, 2010, MOL CELL BIOL, V30, P722, DOI 10.1128/MCB.01005-09; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Narayanan S, 2004, BIOCHEM J, V377, P233, DOI 10.1042/BJ20030797; NILSSON L, 1986, EUR J BIOCHEM, V161, P111, DOI 10.1111/j.1432-1033.1986.tb10130.x; Poon DTK, 1996, J VIROL, V70, P6607, DOI 10.1128/JVI.70.10.6607-6616.1996; Rajamohan F, 1999, BIOCHEM BIOPH RES CO, V260, P453, DOI 10.1006/bbrc.1999.0922; SADAIE MR, 1992, VIROLOGY, V187, P604; Tung KWC, 2008, INT J BIOCHEM CELL B, V40, P2452, DOI 10.1016/j.biocel.2008.04.021; Wang P, 2010, MOL BIOL REP, V37, P1891, DOI 10.1007/s11033-009-9629-9; Wang YY, 2005, BIOCHEM BIOPH RES CO, V331, P1075, DOI 10.1016/j.bbrc.2005.03.230; ZARLING JM, 1990, NATURE, V347, P92, DOI 10.1038/347092a0	34	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36369	10.1371/journal.pone.0036369	http://dx.doi.org/10.1371/journal.pone.0036369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563495	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340700044
J	Merino, S; Bouamama, L; Knirel, YA; Senchenkova, SN; Regue, M; Tomas, JM				Merino, Susana; Bouamama, Lamiaa; Knirel, Yuriy A.; Senchenkova, Sofya N.; Regue, Miguel; Tomas, Juan M.			Aeromonas Surface Glucan Attached through the O-Antigen Ligase Represents a New Way to Obtain UDP-Glucose	PLOS ONE			English	Article							ESCHERICHIA-COLI; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; POLYSACCHARIDE; ADHESIN	We previously reported that A. hydrophila GalU mutants were still able to produce UDP-glucose introduced as a glucose residue in their lipopolysaccharide core. In this study, we found the unique origin of this UDP-glucose from a branched alpha-glucan surface polysaccharide. This glucan, surface attached through the O-antigen ligase (WaaL), is common to the mesophilic Aeromonas strains tested. The Aeromonas glucan is produced by the action of the glycogen synthase (GlgA) and the UDP-Glc pyrophosphorylase (GlgC), the latter wrongly indicated as an ADP-Glc pyrophosphorylase in the Aeromonas genomes available. The Aeromonas glycogen synthase is able to react with UDP or ADP-glucose, which is not the case of E. coli glycogen synthase only reacting with ADP-glucose. The Aeromonas surface glucan has a role enhancing biofilm formation. Finally, for the first time to our knowledge, a clear preference on behalf of bacterial survival and pathogenesis is observed when choosing to produce one or other surface saccharide molecules to produce (lipopolysaccharide core or glucan).	[Merino, Susana; Bouamama, Lamiaa; Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain; [Knirel, Yuriy A.; Senchenkova, Sofya N.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow, Russia; [Regue, Miguel] Univ Barcelona, Fac Farm, Dept Microbiol & Parasitol Sanitarias, E-08028 Barcelona, Spain	University of Barcelona; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; University of Barcelona	Merino, S (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain.	jtomas@ub.edu	Tomas, Juan M/L-1398-2015; Knirel, Yuriy A/E-2058-2014; Merino, Susana/D-4342-2014	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte, Spain); Generalitat de Catalunya (Centre de ReferAncia en Biotecnologia) grants; Spanish government	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte, Spain); Generalitat de Catalunya (Centre de ReferAncia en Biotecnologia) grants; Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte, Spain) and from Generalitat de Catalunya (Centre de ReferAncia en Biotecnologia) grants. These are competitve grants from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atlas R. M., 2004, Handbook of microbiological media; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GRANT WD, 1969, J BACTERIOL, V100, P1187, DOI 10.1128/JB.100.3.1187-1193.1969; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Jimenez N, 2008, J BACTERIOL, V190, P4198, DOI 10.1128/JB.00153-08; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Knirel YA, 2004, CARBOHYD RES, V339, P787, DOI 10.1016/j.carres.2003.12.008; Knirel YA, 2002, CARBOHYD RES, V337, P1381, DOI 10.1016/S0008-6215(02)00136-2; KUHN HM, 1988, FEMS MICROBIOL LETT, V54, P195, DOI 10.1111/j.1574-6968.1988.tb02743.x; Kumari J, 2006, J FISH DIS, V29, P95, DOI 10.1111/j.1365-2761.2006.00691.x; Leontein K., 1993, METHODS CARBOHYDR CH, V9, P87; Lou J, 1997, APPL ENVIRON MICROB, V63, P4355, DOI 10.1128/AEM.63.11.4355-4359.1997; Merino S, 1996, FEMS MICROBIOL LETT, V139, P97, DOI 10.1016/0378-1097(96)00068-7; Merino S, 2011, J BACTERIOL, V193, P1943, DOI 10.1128/JB.01441-10; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; PREISS J, 1984, ANNU REV MICROBIOL, V38, P419, DOI 10.1146/annurev.mi.38.100184.002223; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Rodriguez I, 2009, FISH SHELLFISH IMMUN, V27, P369, DOI 10.1016/j.fsi.2009.02.007; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; SOWOKINOS JR, 1976, PLANT PHYSIOL, V57, P63, DOI 10.1104/pp.57.1.63; STROBEL HJ, 1993, APPL ENVIRON MICROB, V59, P40, DOI 10.1128/AEM.59.1.40-46.1993; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vilches S, 2007, MICROBIOL-SGM, V153, P2393, DOI 10.1099/mic.0.2007/006437-0; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Westphal O, 1965, METHODS CARBOHYDR CH, V5, P83; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	37	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35707	10.1371/journal.pone.0035707	http://dx.doi.org/10.1371/journal.pone.0035707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563467	Green Published, gold			2022-12-25	WOS:000305340700016
J	Matsuse, M; Sasaki, K; Nishihara, E; Minami, S; Hayashida, C; Kondo, H; Suzuki, K; Saenko, V; Yoshiura, K; Mitsutake, N; Yamashita, S				Matsuse, Michiko; Sasaki, Kensaku; Nishihara, Eijun; Minami, Shigeki; Hayashida, Chisa; Kondo, Hisayoshi; Suzuki, Keiji; Saenko, Vladimir; Yoshiura, Koh-ichiro; Mitsutake, Norisato; Yamashita, Shunichi			Copy Number Alteration and Uniparental Disomy Analysis Categorizes Japanese Papillary Thyroid Carcinomas into Distinct Groups	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BRAF V600E MUTATION; GENE-EXPRESSION; SIGNALING PATHWAY; WIDE APPRAISAL; CANCER; ACTIVATION; INSTABILITY; HETEROZYGOSITY; BRAF(V600E)	The aim of the present study was to investigate chromosomal aberrations in sporadic Japanese papillary thyroid carcinomas (PTCs), concomitant with the analysis of oncogene mutational status. Twenty-five PTCs (11 with BRAF(V600E), 4 with RET/PTC1, and 10 without mutation in HRAS, KRAS, NRAS, BRAF, RET/PTC1, or RET/PTC3) were analyzed using Genome-Wide Human SNP Array 6.0 which allows us to detect copy number alteration (CNA) and uniparental disomy (UPD), also referred to as copy neutral loss of heterozygosity, in a single experiment. The Japanese PTCs showed relatively stable karyotypes. Seven cases (28%) showed CNA(s), and 6 (24%) showed UPD(s). Interestingly, CNA and UPD were rarely overlapped in the same tumor; the only one advanced case showed both CNA and UPD with a highly complex karyotype. Thirteen (52%) showed neither CNA nor UPD. Regarding CNA, deletions tended to be more frequent than amplifications. The most frequent and recurrent region was the deletion in chromosome 22; however, it was found in only 4 cases (16%). The degree of genomic instability did not depend on the oncogene status. However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors. These data suggest that Japanese PTCs may be classified into three distinct groups: CNA(+), UPD+, and no chromosomal aberrations. BRAF(V600E) mutational status did not correlate with any parameters of chromosomal defects.	[Matsuse, Michiko; Suzuki, Keiji; Mitsutake, Norisato; Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Med Sci, Nagasaki 852, Japan; [Sasaki, Kensaku; Hayashida, Chisa; Yoshiura, Koh-ichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan; [Nishihara, Eijun] Kuma Hosp, Dept Internal Med, Kobe, Hyogo, Japan; [Minami, Shigeki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 852, Japan; [Kondo, Hisayoshi] Nagasaki Univ, Grad Sch Biomed Sci, Div Sci Data Registry, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Saenko, Vladimir; Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hlth Risk Control, Nagasaki 852, Japan; [Mitsutake, Norisato] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis NRGIC, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Kuma Hospital; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University	Matsuse, M (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Med Sci, Nagasaki 852, Japan.	mitsu@nagasaki-u.ac.jp	Nishihara, Eijun/AAU-9152-2021; Yamashita, Shunichi/GVS-9508-2022; Mitsutake, Norisato/U-9626-2018	Nishihara, Eijun/0000-0003-1786-0077; Mitsutake, Norisato/0000-0002-2744-8046; matsuse, michiko/0000-0001-6178-3342; Yamashita, Shunichi/0000-0001-6399-6261	Global Centers of Excellence (GCOE) Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [22256004];  [22390189];  [23591357];  [22791204]; Grants-in-Aid for Scientific Research [22390189] Funding Source: KAKEN	Global Centers of Excellence (GCOE) Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (#22256004, #22390189, and #23591357), Grant-in-Aid for Young Scientists (#22791204), and the Global Centers of Excellence (GCOE) Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anania MC, 2011, ONCOGENE, V30, P3011, DOI 10.1038/onc.2011.18; Astolfi A, 2010, LAB INVEST, V90, P1285, DOI 10.1038/labinvest.2010.110; Bauer AJ, 2002, CANCER GENET CYTOGEN, V135, P182, DOI 10.1016/S0165-4608(01)00656-2; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Feldt-Rasmussen U, 2001, THYROID, V11, P483, DOI 10.1089/105072501300176435; Finn S, 2007, ARCH PATHOL LAB MED, V131, P65; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; Guan HX, 2009, J CLIN ENDOCR METAB, V94, P1612, DOI 10.1210/jc.2008-2390; Hemmer S, 1999, AM J PATHOL, V154, P1539, DOI 10.1016/S0002-9440(10)65407-7; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hsu FF, 2010, ONCOGENE, V29, P2864, DOI 10.1038/onc.2010.40; Hung CJ, 2003, J CLIN ENDOCR METAB, V88, P3694, DOI 10.1210/jc.2003-030080; Ito Y, 2009, ENDOCR J, V56, P89, DOI 10.1507/endocrj.K08E-208; Kimura ET, 2003, CANCER RES, V63, P1454; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kumagai A, 2007, ENDOCR J, V54, P399, DOI 10.1507/endocrj.K06-194; Makishima H, 2011, CLIN CANCER RES, V17, P3913, DOI 10.1158/1078-0432.CCR-10-2900; Mesa C, 2006, CANCER RES, V66, P6521, DOI 10.1158/0008-5472.CAN-06-0739; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Nakayama H, 2007, ANTICANCER RES, V27, P3645; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Richter H, 2004, THYROID, V14, P1061, DOI 10.1089/thy.2004.14.1061; Rodrigues R, 2007, ONCOL REP, V18, P917; Siironen P, 2006, ENDOCR-RELAT CANCER, V13, P465, DOI 10.1677/erc.1.01114; Singh B, 2000, SURGERY, V128, P888, DOI 10.1067/msy.2000.110847; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Tiu RV, 2009, J CLIN ONCOL, V27, P5219, DOI 10.1200/JCO.2009.21.9840; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Unger K, 2008, ONCOGENE, V27, P4592, DOI 10.1038/onc.2008.99; Viglietto G, 2011, FRONT BIOSCI-LANDMRK, V16, P1461, DOI 10.2741/3799; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Watanabe R, 2009, ENDOCR J, V56, P407, DOI 10.1507/endocrj.K08E-329; Williams ED, 2008, THYROID, V18, P847, DOI 10.1089/thy.2008.0039; Wreesmann VB, 2002, AM J PATHOL, V161, P1549, DOI 10.1016/S0002-9440(10)64433-1; Wreesmann VB, 2004, GENE CHROMOSOME CANC, V40, P355, DOI 10.1002/gcc.20049; Wreesmann VB, 2004, CANCER RES, V64, P3780, DOI 10.1158/0008-5472.CAN-03-1460; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Zuo H, 2007, PATHOL INT, V57, P12, DOI 10.1111/j.1440-1827.2007.02050.x; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	47	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36063	10.1371/journal.pone.0036063	http://dx.doi.org/10.1371/journal.pone.0036063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558328	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200036
J	Vegh, A; Farkas, A; Kovesdi, D; Papp, K; Cervenak, J; Schneider, Z; Bender, B; Hiripi, L; Laszlo, G; Prechl, J; Matko, J; Kacskovics, I				Vegh, Attila; Farkas, Anita; Koevesdi, Dorottya; Papp, Krisztian; Cervenak, Judit; Schneider, Zita; Bender, Balazs; Hiripi, Laszlo; Laszlo, Gloria; Prechl, Jozsef; Matko, Janos; Kacskovics, Imre			FcRn Overexpression in Transgenic Mice Results in Augmented APC Activity and Robust Immune Response with Increased Diversity of Induced Antibodies	PLOS ONE			English	Article							I-RELATED RECEPTOR; DENDRITIC CELLS; THERAPEUTIC ANTIBODIES; MEDIATED PRESENTATION; IGG; ANTIGEN; EXPRESSION; COMPLEXES; EPITOPE; SERUM	Our previous studies have shown that overexpression of bovine FcRn (bFcRn) in transgenic (Tg) mice leads to an increase in the humoral immune response, characterized by larger numbers of Ag-specific B cells and other immune cells in secondary lymphoid organs and higher levels of circulating Ag-specific antibodies (Abs). To gain additional insights into the mechanisms underlying this increase in humoral immune response, we further characterized the bFcRn Tg mice. Our Western blot analysis showed strong expression of the bFcRn transgene in peritoneal macrophages and bone marrow derived dendritic cells; and a quantitative PCR analysis demonstrated that the expression ratios of the bFcRn to mFcRn were 2.6- and 10-fold in these cells, respectively. We also found that overexpression of bFcRn enhances the phagocytosis of Ag-IgG immune complexes (ICs) by both macrophages and dendritic cells and significantly improves Ag presentation by dendritic cells. Finally, we determined that immunized bFcRn mice produce a much greater diversity of Ag-specific IgM, whereas only the levels, but not the diversity, of IgG is increased by overexpression of bFcRn. We suggest that the increase in diversity of IgG in Tg mice is prevented by a selective bias towards immunodominant epitopes of ovalbumin, which was used in this study as a model antigen. These results are also in line with our previous reports describing a substantial increase in the levels of Ag-specific IgG in FcRn Tg mice immunized with Ags that are weakly immunogenic and, therefore, not affected by immunodominance.	[Vegh, Attila; Cervenak, Judit; Bender, Balazs; Kacskovics, Imre] ImmunoGenes Kft, Budakeszi, Hungary; [Farkas, Anita; Koevesdi, Dorottya; Schneider, Zita; Laszlo, Gloria; Matko, Janos; Kacskovics, Imre] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Papp, Krisztian; Prechl, Jozsef] Eotvos Lorand Univ, Hungarian Acad Sci, Immunol Res Grp, Budapest, Hungary; [Hiripi, Laszlo] Agr Biotechnol Ctr, H-2101 Godollo, Hungary	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences	Vegh, A (corresponding author), ImmunoGenes Kft, Budakeszi, Hungary.	ikacsko@elte.hu	Prechl, József/B-2094-2009; Kacskovics, Imre/J-8449-2013; Matko, Janos/C-9008-2013; Papp, Krisztián/B-2251-2009; Hiripi, Laszlo/AAL-8243-2021	Prechl, József/0000-0003-3859-4353; Kacskovics, Imre/0000-0002-0402-3862; Matko, Janos/0000-0001-9434-934X; Papp, Krisztián/0000-0003-0619-8233; Hiripi, Laszlo/0000-0002-1023-0112; Schneider, Zita/0000-0001-8188-5952	National Office for Research, Hungary [OM-00117-119/2008]; National Development Agency, Hungary [TAMOP 4.2.1./B-09/1/KMR-2010-0003]; Technology and National Development Agency, Hungary [KMOP-1.1.1-08]; Hungarian Scientific Research Fund [K101364]; EEA Grant; Norway Grant; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	National Office for Research, Hungary; National Development Agency, Hungary; Technology and National Development Agency, Hungary; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EEA Grant; Norway Grant; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the grants OM-00117-119/2008 from the National Office for Research, Hungary, TAMOP 4.2.1./B-09/1/KMR-2010-0003 from National Development Agency, Hungary, KMOP-1.1.1-08 from the Technology and National Development Agency, Hungary and K101364 from Hungarian Scientific Research Fund. Dr. Kovesdi is a Magyary Zoltan Postdoctoral Fellow supported by the EEA and Norway Grants, and Dr. Papp is supported by Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 1996, J IMMUNOL, V157, P2779; Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Bender B, 2007, TRANSGENIC RES, V16, P613, DOI 10.1007/s11248-007-9108-9; Borvak J, 1998, INT IMMUNOL, V10, P1289, DOI 10.1093/intimm/10.9.1289; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Cervenak J, 2011, J IMMUNOL, V186, P959, DOI 10.4049/jimmunol.1000353; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chappell CP, 2006, J IMMUNOL, V176, P4706, DOI 10.4049/jimmunol.176.8.4706; COULIE PG, 1985, EUR J IMMUNOL, V15, P793, DOI 10.1002/eji.1830150810; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Garrity RR, 1997, J IMMUNOL, V159, P279; Getahun A, 2006, IMMUNOL LETT, V104, P38, DOI 10.1016/j.imlet.2005.11.005; Goins CL, 2010, J IMMUNOL, V184, P6293, DOI 10.4049/jimmunol.0902530; Golestani R, 2007, HYBRIDOMA, V26, P296, DOI 10.1089/hyb.2007.0510; Henry Kevin A, 2011, Bioeng Bugs, V2, P275, DOI 10.4161/bbug.2.5.16559; Hesselgesser J, 1998, J IMMUNOL, V160, P877; HIBBS ML, 1985, IMMUNOGENETICS, V22, P335, DOI 10.1007/BF00430917; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Kacskovics I, 2006, INT IMMUNOL, V18, P525, DOI 10.1093/intimm/dxh393; Kacskovics I, 2011, MABS-AUSTIN, V3, P431, DOI 10.4161/mabs.3.5.17023; KUNKL A, 1981, IMMUNOLOGY, V43, P371; LAISSUE J, 1971, J IMMUNOL, V107, P822; Lemos APC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028869; Liu XD, 2011, J IMMUNOL, V186, P4674, DOI 10.4049/jimmunol.1003584; Lu W, 2007, IMMUNOLOGY, V122, P401, DOI 10.1111/j.1365-2567.2007.02654.x; Maletto BA, 2006, BLOOD, V108, P3094, DOI 10.1182/blood-2006-04-016659; Mi WT, 2008, J IMMUNOL, V181, P7550, DOI 10.4049/jimmunol.181.11.7550; Mine Y, 2007, BBA-PROTEINS PROTEOM, V1774, P200, DOI 10.1016/j.bbapap.2006.12.003; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Onisk D, 2011, MABS UNPUB; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; RAZIWOLF Z, 1992, P NATL ACAD SCI USA, V89, P4210, DOI 10.1073/pnas.89.9.4210; Schneider Z, 2011, IMMUNOL LETT, V137, P62, DOI 10.1016/j.imlet.2011.02.018; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P511, DOI 10.1016/j.it.2009.07.002; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; Vegh A, 2011, MABS-AUSTIN, V3, P173, DOI 10.4161/mabs.3.2.14462; Vidarsson G, 2006, BLOOD, V108, P3573, DOI 10.1182/blood-2006-05-024539; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; WESTERWOUDT RJ, 1986, METHOD ENZYMOL, V121, P3; Zhu XP, 2001, J IMMUNOL, V166, P3266, DOI 10.4049/jimmunol.166.5.3266	46	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36286	10.1371/journal.pone.0036286	http://dx.doi.org/10.1371/journal.pone.0036286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558422	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200062
J	Porter, TM; Golding, GB				Porter, Teresita M.; Golding, G. Brian			Factors That Affect Large Subunit Ribosomal DNA Amplicon Sequencing Studies of Fungal Communities: Classification Method, Primer Choice, and Error	PLOS ONE			English	Article							GROUP-I INTRONS; SECONDARY STRUCTURE; RARE BIOSPHERE; RNA GENE; PHYLOGENETIC-RELATIONSHIPS; STRUCTURAL CHARACTERISTICS; ECTOMYCORRHIZAL FUNGI; DIVERSITY; RDNA; IDENTIFICATION	Nuclear large subunit ribosomal DNA is widely used in fungal phylogenetics and to an increasing extent also amplicon-based environmental sequencing. The relatively short reads produced by next-generation sequencing, however, makes primer choice and sequence error important variables for obtaining accurate taxonomic classifications. In this simulation study we tested the performance of three classification methods: 1) a similarity-based method (BLAST + Metagenomic Analyzer, MEGAN); 2) a composition-based method (Ribosomal Database Project naive Bayesian classifier, NBC); and, 3) a phylogeny-based method (Statistical Assignment Package, SAP). We also tested the effects of sequence length, primer choice, and sequence error on classification accuracy and perceived community composition. Using a leave-one-out cross validation approach, results for classifications to the genus rank were as follows: BLAST + MEGAN had the lowest error rate and was particularly robust to sequence error; SAP accuracy was highest when long LSU query sequences were classified; and, NBC runs significantly faster than the other tested methods. All methods performed poorly with the shortest 50-100 bp sequences. Increasing simulated sequence error reduced classification accuracy. Community shifts were detected due to sequence error and primer selection even though there was no change in the underlying community composition. Short read datasets from individual primers, as well as pooled datasets, appear to only approximate the true community composition. We hope this work informs investigators of some of the factors that affect the quality and interpretation of their environmental gene surveys.	[Porter, Teresita M.; Golding, G. Brian] McMaster Univ, Hamilton, ON, Canada	McMaster University	Porter, TM (corresponding author), McMaster Univ, Hamilton, ON, Canada.	terri@evol.mcmaster.ca	Porter, Teresita M/H-4072-2011		National Sciences and Engineering Research Council of Canada (NSERC); Genome Canada	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada)	Funded by an National Sciences and Engineering Research Council of Canada (NSERC) discovery grant and by a Genome Canada grant to GBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brock PM, 2009, NEW PHYTOL, V181, P719, DOI 10.1111/j.1469-8137.2008.02703.x; BRUNS TD, 1991, ANNU REV ECOL SYST, V22, P525, DOI 10.1146/annurev.es.22.110191.002521; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Faith DP, 2009, INT J MOL SCI, V10, P4723, DOI 10.3390/ijms10114723; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett D, 2011, NEW PHYTOL, V191, P592, DOI 10.1111/j.1469-8137.2011.03819.x; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hibbett DS, 1996, MOL BIOL EVOL, V13, P903, DOI 10.1093/oxfordjournals.molbev.a025658; Holst-Jensen A, 1999, MOL BIOL EVOL, V16, P114, DOI 10.1093/oxfordjournals.molbev.a026031; Hopple JS, 1999, MOL PHYLOGENET EVOL, V13, P1, DOI 10.1006/mpev.1999.0634; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Karen O, 1997, NEW PHYTOL, V136, P313, DOI 10.1046/j.1469-8137.1997.00742.x; Kjoller R, 2000, PLANT SOIL, V226, P189, DOI 10.1023/A:1026499923717; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lara E, 2011, PROTIST, V162, P14, DOI 10.1016/j.protis.2010.05.003; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; MICHOT B, 1982, NUCLEIC ACIDS RES, V10, P5273, DOI 10.1093/nar/10.17.5273; MICHOT B, 1990, EUR J BIOCHEM, V188, P219, DOI 10.1111/j.1432-1033.1990.tb15393.x; MICHOT B, 1984, NUCLEIC ACIDS RES, V12, P4259, DOI 10.1093/nar/12.10.4259; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; Moncalvo JM, 2000, SYST BIOL, V49, P278, DOI 10.1093/sysbio/49.2.278; MONCALVO JM, 1993, MYCOLOGIA, V85, P788, DOI 10.2307/3760610; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nagahama T, 2011, ENVIRON MICROBIOL, V13, P2359, DOI 10.1111/j.1462-2920.2011.02507.x; Nagy LG, 2011, NEW PHYTOL, V191, P789, DOI 10.1111/j.1469-8137.2011.03707.x; ODONNELL K, 1992, CURR GENET, V22, P213, DOI 10.1007/BF00351728; Ovaskainen O, 2010, FUNGAL ECOL, V3, P274, DOI 10.1016/j.funeco.2010.01.001; Porter TM, 2008, MOL PHYLOGENET EVOL, V46, P635, DOI 10.1016/j.ympev.2007.10.002; Porter TM, 2008, MOL ECOL, V17, P3037, DOI 10.1111/j.1365-294X.2008.03813.x; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Rosen GL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/495849; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Simon DM, 2005, CURR GENET, V47, P389, DOI 10.1007/s00294-005-0581-5; Smith ME, 2007, MYCORRHIZA, V18, P15, DOI 10.1007/s00572-007-0148-z; Spatafora J., 2005, MYCOL RES, V109, P755, DOI DOI 10.1017/S0953756205243551; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stubben C, 2010, GENOMES GENOME SEQUE; Taylor DL, 2007, ENVIRON MICROBIOL, V9, P1329, DOI 10.1111/j.1462-2920.2007.01253.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Van Tuinen D, 1998, MOL ECOL, V7, P879, DOI 10.1046/j.1365-294x.1998.00410.x; VELDMAN GM, 1981, NUCLEIC ACIDS RES, V9, P6935, DOI 10.1093/nar/9.24.6935; VILGALYS R, 1990, Journal of Bacteriology, V172, P4238; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	93	54	54	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35749	10.1371/journal.pone.0035749	http://dx.doi.org/10.1371/journal.pone.0035749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558215	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000056
J	Sarris, PF; Trantas, EA; Mpalantinaki, E; Ververidis, F; Goumas, DE				Sarris, Panagiotis F.; Trantas, Emmanouil A.; Mpalantinaki, Evaggelia; Ververidis, Filippos; Goumas, Dimitrios E.			Pseudomonas viridiflava, a Multi Host Plant Pathogen with Significant Genetic Variation at the Molecular Level	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; NEIGHBOR-JOINING METHOD; FLUORESCENT PSEUDOMONADS; NUCLEOTIDE-SEQUENCES; GENUS PSEUDOMONAS; SYRINGAE; DIVERSITY; STRAINS; TOMATO; DNA	The pectinolytic species Pseudomonas viridiflava has a wide host range among plants, causing foliar and stem necrotic lesions and basal stem and root rots. However, little is known about the molecular evolution of this species. In this study we investigated the intraspecies genetic variation of P. viridiflava amongst local (Cretan), as well as international isolates of the pathogen. The genetic and phenotypic variability were investigated by molecular fingerprinting (rep-PCR) and partial sequencing of three housekeeping genes (gyrB, rpoD and rpoB), and by biochemical and pathogenicity profiling. The biochemical tests and pathogenicity profiling did not reveal any variability among the isolates studied. However, the molecular fingerprinting patterns and housekeeping gene sequences clearly differentiated them. In a broader phylogenetic comparison of housekeeping gene sequences deposited in GenBank, significant genetic variability at the molecular level was found between isolates of P. viridiflava originated from different host species as well as among isolates from the same host. Our results provide a basis for more comprehensive understanding of the biology, sources and shifts in genetic diversity and evolution of P. viridiflava populations and should support the development of molecular identification tools and epidemiological studies in diseases caused by this species.	[Sarris, Panagiotis F.; Trantas, Emmanouil A.; Mpalantinaki, Evaggelia; Ververidis, Filippos; Goumas, Dimitrios E.] Technol Educ Inst Crete, Sch Agr Technol, Dept Plant Sci, Iraklion, Greece	Hellenic Mediterranean University	Sarris, PF (corresponding author), Technol Educ Inst Crete, Sch Agr Technol, Dept Plant Sci, Iraklion, Greece.	sarrispanos@science.agrool.gr; dgoumas@staff.teicrete.gr	Ververidis, Filippos/AAH-9553-2019; Trantas, Emmanouil/AAM-2974-2021; Sarris, Panagiotis F./N-9978-2015	Sarris, Panagiotis/0000-0001-7000-8997; Ververidis, Filippos/0000-0002-3104-6103; Trantas, Emmanouil/0000-0001-7536-101X				ALIVIZATOS A S, 1986, Annales de l'Institut Phytopathologique Benaki, V15, P41; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Aysan Y, 2003, NEW DIS REPORTS, V7; Aysan Y, DISPERSION BACTERIAL, P51; BILLING E, 1970, J APPL BACTERIOL, V33, P492, DOI 10.1111/j.1365-2672.1970.tb02225.x; Bull CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318; BURKHOLDER WH, 1930, MEMOIRS CORNELL U AG, V127, P1; Chen Qing, 2011, Journal of Plant Sciences, V6, P52, DOI 10.3923/jps.2011.52.65; Clerc A, 1998, APPL ENVIRON MICROB, V64, P1180; Cottyn B, 2009, SYST APPL MICROBIOL, V32, P211, DOI 10.1016/j.syapm.2008.11.006; CROSSE JE, 1963, J APPL BACTERIOL, V26, P159, DOI 10.1111/j.1365-2672.1963.tb04764.x; Dawson SL, 2002, J MICROBIOL METH, V50, P9, DOI 10.1016/S0167-7012(02)00003-9; DENNY TP, 1988, J GEN MICROBIOL, V134, P1949; DOWSON W. J., 1939, ZENTRALBL BAKT II ABT, V100, P177; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gonzalez AJ, 2003, APPL ENVIRON MICROB, V69, P2936, DOI 10.1128/AEM.69.5.2936-2941.2003; Goss EM, 2005, GENETICS, V169, P21, DOI 10.1534/genetics.104.031351; Goumans DE, 1998, EUR J PLANT PATHOL, V104, P181, DOI 10.1023/A:1008675704834; Goumas DE, 1999, EUR J PLANT PATHOL, V105, P927, DOI 10.1023/A:1008725818334; HUGH R, 1953, J BACTERIOL, V66, P24, DOI 10.1128/JB.66.1.24-26.1953; JONES JB, 1986, PLANT DIS, V70, P151, DOI 10.1094/PD-70-151; KING EO, 1954, J LAB CLIN MED, V44, P301; LELLIOTT RA, 1966, J APPL BACTERIOL, V29, P470, DOI 10.1111/j.1365-2672.1966.tb03499.x; Little EL, 1998, APPL ENVIRON MICROB, V64, P3818; Louws FJ, 1999, ANNU REV PHYTOPATHOL, V37, P81, DOI 10.1146/annurev.phyto.37.1.81; MALATHRAKIS NE, 1987, ANN APPL BIOL, V111, P115, DOI 10.1111/j.1744-7348.1987.tb01438.x; MANTEL N, 1967, CANCER RES, V27, P209; MISAGHI I, 1969, PHYTOPATHOLOGY, V59, P1436; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Palencia ER, 2009, J MICROBIOL METH, V79, P1, DOI 10.1016/j.mimet.2009.07.012; Palleroni N., 1984, BERGEYS MANUAL SYSTE, VVolume 1, P141; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Rademaker JLW, 1997, DNA MARKERS, P151; Ramette A, 2006, FEMS MICROBIOL ECOL, V55, P369, DOI 10.1111/j.1574-6941.2005.00052.x; Rumbou A, 2006, PHYTOPATHOLOGY, V96, P501, DOI 10.1094/PHYTO-96-0501; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDS DC, 1970, J BACTERIOL, V101, P9, DOI 10.1128/JB.101.1.9-23.1970; Sarris P, 2009, PLANT PATHOL, V58, P933, DOI 10.1111/j.1365-3059.2009.02093.x; Sarris PF, 2011, INFECT GENET EVOL, V11, P1352, DOI 10.1016/j.meegid.2011.04.029; Sarris PF, 2010, MOL PLANT PATHOL, V11, P795, DOI 10.1111/j.1364-3703.2010.00644.x; Sarris PF, 2010, NEW DIS REPORTS, V22; Schaad NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/annurev.phyto.41.052002.095435; Scortichini M, 2005, PHYTOPATHOLOGY, V95, P1316, DOI 10.1094/PHYTO-95-1316; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL; Tayeb LA, 2005, RES MICROBIOL, V156, P763, DOI 10.1016/j.resmic.2005.02.009; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ustun N, PITH NECROSIS GREENH, P70; Vinuesa P, 1998, APPL ENVIRON MICROB, V64, P2096; Wilson MK, 2009, MICROB ECOL, V58, P843, DOI 10.1007/s00248-009-9571-3; Woo PCY, 2011, DIAGN MICR INFEC DIS, V70, P316, DOI 10.1016/j.diagmicrobio.2011.03.006; Xie M, 2008, T NONFERR METAL SOC, V18, P1392, DOI 10.1016/S1003-6326(09)60014-5; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Yamamoto S, 1998, INT J SYST BACTERIOL, V48, P813, DOI 10.1099/00207713-48-3-813; Yamamoto S, 1999, INT J SYST BACTERIOL, V49, P87, DOI 10.1099/00207713-49-1-87	58	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36090	10.1371/journal.pone.0036090	http://dx.doi.org/10.1371/journal.pone.0036090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558343	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000127
J	Zalcman, SS; Patel, A; Mohla, R; Zhu, YH; Siegel, A				Zalcman, Steven S.; Patel, Ankur; Mohla, Ruchika; Zhu, Youhua; Siegel, Allan			Soluble Cytokine Receptors (sIL-2R alpha, sIL-2R beta) Induce Subunit-Specific Behavioral Responses and Accumulate in the Cerebral Cortex and Basal Forebrain	PLOS ONE			English	Article							INTERLEUKIN-2 RECEPTOR; IL-2; SCHIZOPHRENIA	Soluble cytokine receptors are normal constituents of body fluids that regulate peripheral cytokine and lymphoid activity. Levels of soluble IL-2 receptors (sIL-2R) are elevated in psychiatric disorders linked with autoimmune processes, including ones in which repetitive stereotypic behaviors and motor disturbances are present. However, there is no evidence that sIL-2Rs (or any peripheral soluble receptor) induce such behavioral changes, or that they localize in relevant brain regions. Here, we determined in male Balb/c mice the effects of single peripheral injections of sIL-2R alpha or sIL-2R beta (0-2 mu g/male Balb/c mouse; s.c.) on novelty-induced ambulatory activity and stereotypic motor behaviors. We discovered that sIL-2R alpha increased the incidence of in-place stereotypic motor behaviors, including head up head bobbing, rearing/sniffing, turning, and grooming behavior. A wider spectrum of behavioral changes was evident in sIL-2R beta-treated mice, including increases in vertical and horizontal ambulatory activity and stereotypic motor movements. To our knowledge, this is the first demonstration that soluble receptors induce such behavioral disturbances. In contrast, soluble IL-1 Type-1 receptors (0-4 mu g, s.c.) didn't appreciably affect these behaviors. We further demonstrated that sIL-2R alpha and sIL-2R beta induced marked increases in c-Fos in caudate-putamen, nucleus accumbens and prefrontal cortex. Anatomical specificity was supported by the presence of increased activity in lateral caudate in sIL-2R alpha treated mice, while sIL-2R beta treated mice induced greater c-Fos activity in prepyriform cortex. Moreover, injected sIL-2Rs were widely distributed in regions that showed increased c-Fos expression. Thus, sIL-2R alpha and sIL-2R beta induce marked subunit- and soluble cytokine receptor-specific behavioral disturbances, which included increases in the expression of ambulatory activity and stereotypic motor behaviors, while inducing increased neuronal activity localized to cortex and striatum. These findings suggest that sIL-2Rs act as novel immune-to- brain messengers and raise the possibility that they contribute to the disease process in psychiatric disorders in which marked increases in these receptors have been reported.	[Zalcman, Steven S.; Patel, Ankur; Mohla, Ruchika; Zhu, Youhua; Siegel, Allan] UMDNJ New Jersey Med Sch, Dept Psychiat, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zalcman, SS (corresponding author), UMDNJ New Jersey Med Sch, Dept Psychiat, Newark, NJ USA.	dr.ankur@yahoo.com			National Institutes of Health (NIH) [R01 MH74689]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074689] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by National Institutes of Health (NIH) grant R01 MH74689 (to SSZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bien E, 2008, BIOMARKERS, V13, P1, DOI 10.1080/13547500701674063; Bresee C, 2009, INT J NEUROPSYCHOPH, V12, P861, DOI 10.1017/S1461145709000315; CARUSO C, 1993, MEDIAT INFLAMM, V2, P3, DOI 10.1155/S0962935193000018; Ebrinc S, 2002, J INT MED RES, V30, P314, DOI 10.1177/147323000203000313; Ellery JM, 2002, IMMUNOL CELL BIOL, V80, P351, DOI 10.1046/j.1440-1711.2002.01097.x; Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025; Hanisch UK, 1995, BRAIN RES REV, V21, P246, DOI 10.1016/0165-0173(95)00015-1; HONDA M, 1990, J IMMUNOL, V145, P4131; Kowalski J, 2000, World J Biol Psychiatry, V1, P190, DOI 10.3109/15622970009150591; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; LICINIO J, 1993, AM J PSYCHIAT, V150, P1408; MAES M, 1995, J PSYCHIAT RES, V29, P141, DOI 10.1016/0022-3956(94)00049-W; Novick D, 2007, CYTOKINE GROWTH F R, V18, P525, DOI 10.1016/j.cytogfr.2007.06.024; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Rapaport MH, 1997, SCHIZOPHR RES, V25, P123, DOI 10.1016/S0920-9964(97)00008-X; Rapaport MH, 1997, PROG NEURO-PSYCHOPH, V21, P817, DOI 10.1016/S0278-5846(97)00082-1; RAPAPORT MH, 1994, ACTA PSYCHIAT SCAND, V90, P311, DOI 10.1111/j.1600-0447.1994.tb01599.x; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Suh CH, 2008, EXPERT REV MOL DIAGN, V8, P189, DOI 10.1586/14737159.8.2.189; Taylor JM, 2007, J NEUROIMMUNOL, V183, P118, DOI 10.1016/j.jneuroim.2006.11.027; Tsai SYM, 2001, J AFFECT DISORDERS, V64, P185, DOI 10.1016/S0165-0327(00)00252-4; Zalcman SS, 2002, BRAIN RES, V944, P157, DOI 10.1016/S0006-8993(02)02740-3; Zalcman SS, 2001, BRAIN RES, V899, P1, DOI 10.1016/S0006-8993(01)02090-X	23	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36316	10.1371/journal.pone.0036316	http://dx.doi.org/10.1371/journal.pone.0036316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558434	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000189
J	Zhao, JQ; Li, S; Jiang, TF; Liu, Z; Zhang, WW; Jian, GL; Qi, FJ				Zhao, Jingqing; Li, Sha; Jiang, Tengfei; Liu, Zhi; Zhang, Wenwei; Jian, Guiliang; Qi, Fangjun			Chilling Stress-The Key Predisposing Factor for Causing Alternaria alternata Infection and Leading to Cotton (Gossypium hirsutum L.) Leaf Senescence	PLOS ONE			English	Article							LIPID-PEROXIDATION; ABSCISIC-ACID; B RADIATION; CELL-DEATH; XYLEM SAP; LEAVES; ARABIDOPSIS; REFLECTANCE; TEMPERATURE; EXPRESSION	Leaf senescence plays a vital role in nutrient recycling and overall capacity to assimilate carbon dioxide. Cotton premature leaf senescence, often accompanied with unexpected short-term low temperature, has been occurring with an increasing frequency in many cotton-growing areas and causes serious reduction in yield and quality of cotton. The key factors for causing and promoting cotton premature leaf senescence are still unclear. In this case, the relationship between the pre-chilling stress and Alternaria alternata infection for causing cotton leaf senescence was investigated under precisely controlled laboratory conditions with four to five leaves stage cotton plants. The results showed short-term chilling stress could cause a certain degree of physiological impairment to cotton leaves, which could be recovered to normal levels in 2-4 days when the chilling stresses were removed. When these chilling stress injured leaves were further inoculated with A. alternata, the pronounced appearance and development of leaf spot disease, and eventually the pronounced symptoms of leaf senescence, occurred on these cotton leaves. The onset of cotton leaf senescence at this condition was also reflected in various physiological indexes such as irreversible increase in malondialdehyde (MDA) content and electrolyte leakage, irreversible decrease in soluble protein content and chlorophyll content, and irreversible damage in leaves' photosynthesis ability. The presented results demonstrated that chilling stress acted as the key predisposing factor for causing A. alternata infection and leading to cotton leaf senescence. It could be expected that the understanding of the key factors causing and promoting cotton leaf senescence would be helpful for taking appropriate management steps to prevent cotton premature leaf senescence.	[Zhao, Jingqing; Li, Sha; Jiang, Tengfei; Liu, Zhi; Zhang, Wenwei; Jian, Guiliang; Qi, Fangjun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhao, JQ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	fjqi@ippcaas.cn			Xinjiang Production and Construction Corps [2009JC004]; State Key Laboratory of BPDIP, China [SKL2010SR01]; National Genetically Modified Organisms Breeding Major Project [2011ZX08005-004]	Xinjiang Production and Construction Corps; State Key Laboratory of BPDIP, China; National Genetically Modified Organisms Breeding Major Project	This work was supported by the Xinjiang Production and Construction Corps Fund Project (2009JC004), the Special Funding of State Key Laboratory of BPDIP, China (SKL2010SR01), and the National Genetically Modified Organisms Breeding Major Project (2011ZX08005-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASHAN Y, 1984, PHYTOPATHOL Z, V110, P110; BASHAN Y, 1991, CAN J BOT, V69, P2603, DOI 10.1139/b91-324; Bashan Y., 1992, ALTERNARIA BIOL PLAN, P233; BASHI E, 1983, PHYTOPARASITICA, V11, P89, DOI 10.1007/BF02980716; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; CASSMAN KG, 1989, AGRON J, V81, P870, DOI 10.2134/agronj1989.00021962008100060006x; COTTY PJ, 1987, PLANT DIS, V71, P1082, DOI 10.1094/PD-71-1082; DAVIS ND, 1977, APPL ENVIRON MICROB, V34, P155, DOI 10.1128/AEM.34.2.155-157.1977; Dong HH, 2008, J EXP BOT, V59, P1295, DOI 10.1093/jxb/ern035; [董合忠 Dong Hezhong], 2005, [棉花学报, Cotton Science], V17, P56; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; Dong HZ, 2009, PLANT GROWTH REGUL, V59, P93, DOI 10.1007/s10725-009-9392-x; Fourie PH, 2009, AUSTRALAS PLANT PATH, V38, P173, DOI 10.1071/AP08095; Ganieva Rena A., 1998, Turkish Journal of Botany, V22, P217; Gergoff G, 2010, PLANT SCI, V178, P207, DOI 10.1016/j.plantsci.2009.12.003; Gomez F, 2008, POSTHARVEST BIOL TEC, V49, P229, DOI 10.1016/j.postharvbio.2008.02.012; Hillocks R. J., 1992, P191; HORTENSTEINER S, 2004, PLANT CELL DEATH PRO, P189; Humbeck K, 1996, PLANT CELL ENVIRON, V19, P337, DOI 10.1111/j.1365-3040.1996.tb00256.x; Humbeck K, 2003, J EXP BOT, V54, P375, DOI [10.1093/jxb/54.381.375, 10.1093/jxb/erg012]; ISHIDA Y, 1988, PLANT DIS, V72, P892, DOI 10.1094/PD-72-0892; Jia YJ, 2010, PHYSIOL PLANTARUM, V138, P164, DOI 10.1111/j.1399-3054.2009.01300.x; Kakani VG, 2004, PHYSIOL PLANTARUM, V121, P250, DOI 10.1111/j.0031-9317.2004.00314.x; Kargiotidou A, 2010, J EXP BOT, V61, P2991, DOI 10.1093/jxb/erq124; Kim JI, 2011, J EXP BOT, V62, P3981, DOI 10.1093/jxb/err094; KRAMER GF, 1991, PHYTOCHEMISTRY, V30, P2101, DOI 10.1016/0031-9422(91)83595-C; Li Sha, 2011, Cotton Science, V23, P472; Lichtenthaler HK, 1998, ANN NY ACAD SCI, V851, P271, DOI 10.1111/j.1749-6632.1998.tb09002.x; Lim PO, 2005, CURR TOP DEV BIOL, V67, P49, DOI 10.1016/S0070-2153(05)67002-0; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu L, 2010, PLANT PROT, V37, P107; Lv SL, 2009, PLANTA, V229, P899, DOI 10.1007/s00425-008-0880-4; MARANI A, 1985, CROP SCI, V25, P798, DOI 10.2135/cropsci1985.0011183X0025000500018x; Markham JE, 2001, MOL PLANT PATHOL, V2, P229, DOI 10.1046/j.1464-6722.2001.00066.x; Mehta YR, 1998, PLANT DIS, V82, P333, DOI 10.1094/PDIS.1998.82.3.333; MILLER JW, 1969, PHYTOPATHOLOGY, V59, P767; NEWTON MARGARET, 1936, CANADIAN JOUR RES SEC C BOT SCI, V14, P89; NISHIMURA S, 1983, ANNU REV PHYTOPATHOL, V21, P87, DOI 10.1146/annurev.py.21.090183.000511; Padaganur G. M., 1989, Journal of the Indian Society for Cotton Improvement, V14, P144; PEEVER TL, 1989, PLANT PHYSIOL, V90, P867, DOI 10.1104/pp.90.3.867; Pettigrew WT, 2003, AGRON J, V95, P1323, DOI 10.2134/agronj2003.1323; RADIN JW, 1981, PLANT PHYSIOL, V67, P115, DOI 10.1104/pp.67.1.115; SCIUMBATO GL, 1974, PLANT DIS REP, V58, P201; Thomas H, 2003, J EXP BOT, V54, P1127, DOI 10.1093/jxb/erg133; Thomma BPHJ, 2003, MOL PLANT PATHOL, V4, P225, DOI 10.1046/J.1364-3703.2003.00173.X; van Doorn WG, 2004, J EXP BOT, V55, P2147, DOI 10.1093/jxb/erh264; Watkins, 1981, COMPENDIUM COTTON DI; WHITE JL, 1977, PHYTOPATHOLOGY, V67, P60, DOI 10.1094/Phyto-67-60; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Woo HR, 2004, PLANT CELL PHYSIOL, V45, P923, DOI 10.1093/pcp/pch110; Wright P., 1998, Better Crops International, V12, P14; Wright PR, 1999, PLANT SOIL, V211, P231, DOI 10.1023/A:1004652728420; Yong JWH, 2000, PLANT PHYSIOL, V124, P767, DOI 10.1104/pp.124.2.767; Yu H. X, 2007, CHINA COTTON, V34, P41; [董志强 Zhong Zhiqiang], 2005, [核农学报, Acta Agriculturae Nucleatae Sinica], V19, P62; Zhu JianFen, 2010, Cotton Science, V22, P354	58	26	41	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36126	10.1371/journal.pone.0036126	http://dx.doi.org/10.1371/journal.pone.0036126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558354	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336000133
J	Tallent, J; Goodall, S; Hortobagyi, T; Gibson, AS; French, DN; Howatson, G				Tallent, Jamie; Goodall, Stuart; Hortobagyi, Tibor; Gibson, Alan St Clair; French, Duncan N.; Howatson, Glyn			Repeatability of Corticospinal and Spinal Measures during Lengthening and Shortening Contractions in the Human Tibialis Anterior Muscle	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR-EVOKED-POTENTIALS; SOLEUS H-REFLEX; POST-ACTIVATION DEPRESSION; TEST-RETEST RELIABILITY; INPUT-OUTPUT PROPERTIES; SILENT PERIOD; SKELETAL-MUSCLE; V-WAVE; EXCITABILITY	Elements of the human central nervous system (CNS) constantly oscillate. In addition, there are also methodological factors and changes in muscle mechanics during dynamic muscle contractions that threaten the stability and consistency of transcranial magnetic stimulation (TMS) and perpherial nerve stimulation (PNS) measures. Purpose: To determine the repeatability of TMS and PNS measures during lengthening and shortening muscle actions in the intact human tibialis anterior. Methods: On three consecutive days, 20 males performed lengthening and shortening muscle actions at 15, 25, 50 and 80% of maximal voluntary contraction (MVC). The amplitude of the Motor Evoked Potentials (MEPs) produced by TMS was measured at rest and during muscle contraction at 90 degrees of ankle joint position. MEPs were normalised to Mmax determined with PNS. The corticospinal silent period was recorded at 80% MVC. Hoffman reflex (H-reflex) at 10% isometric and 25% shortening and lengthening MVCs, and V-waves during MVCs were also evoked on each of the three days. Results: With the exception of MEPs evoked at 80% shortening MVC, all TMS-derived measures showed good reliability (ICC = 0.81-0.94) from days 2 to 3. Confidence intervals (CI, 95%) were lower between days 2 and 3 when compared to days 1 and 2. MEPs significantly increased at rest from days 1 to 2 (P = 0.016) and days 1 to 3 (P = 0.046). The H-reflex during dynamic muscle contraction was reliable across the three days (ICC = 0.76-0.84). V-waves (shortening, ICC = 0.77, lengthening ICC = 0.54) and the H-reflex at 10% isometric MVC (ICC = 0.66) was generally less reliable over the three days. Conclusion: Although it is well known that measures of the intact human CNS exhibit moment-to-moment fluctuations, careful experimental arrangements make it possible to obtain consistent and repeatable measurements of corticospinal and spinal excitability in the actively lengthening and shortening human TA muscle.	[Tallent, Jamie; Goodall, Stuart; Gibson, Alan St Clair; French, Duncan N.; Howatson, Glyn] Northumbria Univ, Sch Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Hortobagyi, Tibor] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Howatson, Glyn] Univ Johannesburg, Ctr Aquat Res, Gauteng, South Africa	Northumbria University; University of Groningen; University of Johannesburg	Tallent, J (corresponding author), Northumbria Univ, Sch Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	glyn.howatson@northumbria.ac.uk	Howatson, Glyn/AAE-9508-2021	Howatson, Glyn/0000-0001-8494-2043; Goodall, Stuart/0000-0001-9029-2171				Aagaard P, 2002, J APPL PHYSIOL, V92, P2309, DOI 10.1152/japplphysiol.01185.2001; BARKER AT, 1985, LANCET, V1, P1106; Cacchio A, 2011, J NEUROL SCI, V303, P90, DOI 10.1016/j.jns.2011.01.004; Cacchio A, 2009, CLIN NEUROPHYSIOL, V120, P414, DOI 10.1016/j.clinph.2008.11.019; Carroll TJ, 2011, ACTA PHYSIOL, V202, P119, DOI 10.1111/j.1748-1716.2011.02271.x; Carroll TJ, 2001, J NEUROSCI METH, V112, P193, DOI 10.1016/S0165-0270(01)00468-X; Chen YS, 2010, J ELECTROMYOGR KINES, V20, P980, DOI 10.1016/j.jelekin.2009.11.003; Christie A, 2004, CLIN NEUROPHYSIOL, V115, P116, DOI 10.1016/S1388-2457(03)00306-7; Christie AD, 2005, J CLIN NEUROPHYSIOL, V22, P204; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; CRONE C, 1989, EXP BRAIN RES, V78, P28, DOI 10.1007/bf00230683; Damron LA, 2008, J NEUROSCI METH, V173, P121, DOI 10.1016/j.jneumeth.2008.06.001; Darling WG, 2006, EXP BRAIN RES, V174, P376, DOI 10.1007/s00221-006-0468-9; Daskalakis ZJ, 2003, CLIN NEUROPHYSIOL, V114, P938, DOI 10.1016/S1388-2457(03)00038-5; Del Balso C, 2007, J APPL PHYSIOL, V103, P402, DOI 10.1152/japplphysiol.00477.2006; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Dragert K, 2011, EXP BRAIN RES, V208, P217, DOI 10.1007/s00221-010-2472-3; Duchateau J, 2008, J PHYSIOL-LONDON, V586, P5853, DOI 10.1113/jphysiol.2008.160747; Duclay J, 2011, J PHYSIOL-LONDON, V589, P2901, DOI 10.1113/jphysiol.2011.207472; Duclay J, 2009, J ELECTROMYOGR KINES, V19, P948, DOI 10.1016/j.jelekin.2008.04.011; Ellaway PH, 1998, ELECTROMYOGR MOTOR C, V109, P104, DOI 10.1016/S0924-980X(98)00007-1; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Field-Fote EC, 2006, NEUROSCI LETT, V410, P37, DOI 10.1016/j.neulet.2006.09.058; Fimland MS, 2009, EUR J APPL PHYSIOL, V107, P21, DOI 10.1007/s00421-009-1096-4; Fritz C, 1997, ELECTROMYOGR MOTOR C, V105, P235, DOI 10.1016/S0924-980X(97)96675-3; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hebbal GV, 2006, PERCEPT MOTOR SKILL, V102, P163, DOI 10.2466/PMS.102.1.163-164; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Herwig U, 2001, BIOL PSYCHIAT, V50, P58, DOI 10.1016/S0006-3223(01)01153-2; Hoffman P., 1910, ARCH F PHYSL, V1, P223; Hwang IS, 2002, J ELECTROMYOGR KINES, V12, P361, DOI 10.1016/S1050-6411(02)00034-2; Kamen G, 2004, MED SCI SPORT EXER, V36, P1574, DOI 10.1249/01.MSS.0000139804.02576.6A; Kasai T, 1997, BRAIN RES, V744, P147, DOI 10.1016/S0006-8993(96)01101-8; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; Lee M, 2005, J NEUROSCI METH, V149, P95, DOI 10.1016/j.jneumeth.2005.03.016; Magistris MR, 1999, BRAIN, V122, P265, DOI 10.1093/brain/122.2.265; Malcolm MP, 2006, CLIN NEUROPHYSIOL, V117, P1037, DOI 10.1016/j.clinph.2006.02.005; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Mynark RG, 2005, CLIN NEUROPHYSIOL, V116, P1400, DOI 10.1016/j.clinph.2005.02.001; Palmieri RM, 2004, J ATHL TRAINING, V39, P268; Palmieri TM, 2002, INT J NEUROSCI, V112, P841, DOI 10.1080/00207450290025851; PROSKE U, 1993, PROG NEUROBIOL, V41, P705, DOI 10.1016/0301-0082(93)90032-N; Robertson CT, 2004, MED SCI SPORT EXER, V36, pS164, DOI 10.1097/00005768-200405001-00784; Rosler KM, 2001, NEWS PHYSIOL SCI, V16, P297; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell JC, 2007, J PHYSIOL-LONDON, V584, P363, DOI 10.1113/jphysiol.2007.143677; Saisanen L, 2008, J NEUROSCI METH, V169, P231, DOI 10.1016/j.jneumeth.2007.12.005; Sekiguchi H, 2003, BRAIN RES, V977, P169, DOI 10.1016/S0006-8993(03)02621-0; Sekiguchi H, 2007, EXP BRAIN RES, V178, P374, DOI 10.1007/s00221-006-0743-9; Selvanayagam VS, 2011, J APPL PHYSL; Semmler JG, 2002, J PHYSIOL-LONDON, V545, P681, DOI 10.1113/jphysiol.2002.026948; Simonsen EB, 2011, HUM MOVEMENT SCI, V30, P333, DOI 10.1016/j.humov.2010.02.009; Solstad GM, 2011, J CLIN NEUROPHYSIOL, V28, P217, DOI 10.1097/WNP.0b013e31821215cf; Tallent J, 2012, J CLIN NEUROSCI, DOI [10.1016/j.jocn.2012.1001.1022, DOI 10.1016/J.JOCN.2012.1001.1022]; Troni W, 1996, MUSCLE NERVE, V19, P595, DOI 10.1002/(SICI)1097-4598(199605)19:5<595::AID-MUS7>3.3.CO;2-4; van Hedel HJA, 2007, J NEUROL, V254, P1089, DOI 10.1007/s00415-006-0493-4; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; Yahagi S, 1998, ELECTROMYOGR MOTOR C, V109, P409, DOI 10.1016/S0924-980X(98)00041-1; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	63	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35930	10.1371/journal.pone.0035930	http://dx.doi.org/10.1371/journal.pone.0035930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563418	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000305349100044
J	Eadsforth, TC; Gardiner, M; Maluf, FV; McElroy, S; James, D; Frearson, J; Gray, D; Hunter, WN				Eadsforth, Thomas C.; Gardiner, Mary; Maluf, Fernando V.; McElroy, Stuart; James, Daniel; Frearson, Julie; Gray, David; Hunter, William N.			Assessment of Pseudomonas aeruginosa N-5,N-10-Methylenetetrahydrofolate Dehydrogenase - Cyclohydrolase as a Potential Antibacterial Drug Target	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE INHIBITORS; TRANSPOSON MUTANT LIBRARY; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; ANTIMICROBIAL RESISTANCE; PTERIDINE REDUCTASE; MECHANISM; DEHYDROGENASE/CYCLOHYDROLASE; ANTIFOLATE; PROTEIN; ACID	The bifunctional enzyme methylenetetrahydrofolate dehydrogenase - cyclohydrolase (FolD) is identified as a potential drug target in Gram-negative bacteria, in particular the troublesome Pseudomonas aeruginosa. In order to provide a comprehensive and realistic assessment of the potential of this target for drug discovery we generated a highly efficient recombinant protein production system and purification protocol, characterized the enzyme, carried out screening of two commercial compound libraries by differential scanning fluorimetry, developed a high-throughput enzyme assay and prosecuted a screening campaign against almost 80,000 compounds. The crystal structure of P. aeruginosa FolD was determined at 2.2 angstrom resolution and provided a template for an assessment of druggability and for modelling of ligand complexes as well as for comparisons with the human enzyme. New FolD inhibitors were identified and characterized but the weak levels of enzyme inhibition suggest that these compounds are not optimal starting points for future development. Furthermore, the close similarity of the bacterial and human enzyme structures suggest that selective inhibition might be difficult to attain. In conclusion, although the preliminary biological data indicates that FolD represents a valuable target for the development of new antibacterial drugs, indeed spurred us to investigate it, our screening results and structural data suggest that this would be a difficult enzyme to target with respect to developing the appropriate lead molecules required to underpin a serious drug discovery effort.	[Eadsforth, Thomas C.; Gardiner, Mary; Maluf, Fernando V.; McElroy, Stuart; James, Daniel; Frearson, Julie; Gray, David; Hunter, William N.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee, Scotland	University of Dundee	Eadsforth, TC (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee, Scotland.	w.n.hunter@dundee.ac.uk	Hunter, William/AAE-3947-2019; Gray, David W/F-6674-2011	Gray, David W/0000-0001-9512-3828	Wellcome Trust [082596, 083481]; European Commission Seventh Framework Programme (FP7)	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission Seventh Framework Programme (FP7)	Funded by The Wellcome Trust (grants 082596 and 083481) and the European Commission Seventh Framework Programme (FP7/2007-2013; Aeropath). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire M, 1998, STRUCTURE, V6, P173, DOI 10.1016/S0969-2126(98)00019-7; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corey GR, 2009, CLIN INFECT DIS, V48, pS254, DOI 10.1086/598186; Dawson A, 2006, MOL MICROBIOL, V61, P1457, DOI 10.1111/j.1365-2958.2006.05332.x; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; DeLano DL, PYMOL MOL GRAPHICS S; Eadsforth TC, 2011, MOL BIOCHEM PARASIT; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fauman EB, 2011, CURR OPIN CHEM BIOL, V15, P463, DOI 10.1016/j.cbpa.2011.05.020; Frearson JA, 2007, TRENDS PARASITOL, V23, P589, DOI 10.1016/j.pt.2007.08.019; Gales AC, 2001, CLIN INFECT DIS, V32, pS146, DOI 10.1086/320186; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gourley DG, 2001, NAT STRUCT BIOL, V8, P521, DOI 10.1038/88584; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Hunter WN, 2009, J BIOL CHEM, V284, P11749, DOI 10.1074/jbc.R800072200; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murta SMF, 2009, MOL MICROBIOL, V71, P1386, DOI 10.1111/j.1365-2958.2009.06610.x; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Shea R, 2008, J MED CHEM, V51, P2871, DOI 10.1021/jm700967e; Obritsch MD, 2004, ANTIMICROB AGENTS CH, V48, P4606, DOI 10.1128/AAC.48.12.4606-4610.2004; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2233, DOI 10.1128/AAC.44.9.2233-2241.2000; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Sainsbury S, 2011, J MOL BIOL, V405, P173, DOI 10.1016/j.jmb.2010.10.024; Schmidt A, 2000, BIOCHEMISTRY-US, V39, P6325, DOI 10.1021/bi992734y; Shen BW, 1999, PROTEIN SCI, V8, P1342, DOI 10.1110/ps.8.6.1342; Shih C, 1997, CANCER RES, V57, P1116; Shlaes DM, 2003, CURR OPIN PHARMACOL, V3, P470, DOI 10.1016/j.coph.2003.04.003; Sundararajan S, 2002, J BIOL CHEM, V277, P18703, DOI 10.1074/jbc.M200127200; TAN LUL, 1977, J BIOL CHEM, V252, P1117; Then RL, 2004, J CHEMOTHERAPY, V16, P3, DOI 10.1179/joc.2004.16.1.3; Tonkinson JL, 1998, J PHARMACOL EXP THER, V287, P315; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	47	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35973	10.1371/journal.pone.0035973	http://dx.doi.org/10.1371/journal.pone.0035973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558288	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200100
J	O'Dwyer, L; Lamberton, F; Matura, S; Scheibe, M; Miller, J; Rujescu, D; Prvulovic, D; Hampel, H				O'Dwyer, Laurence; Lamberton, Franck; Matura, Silke; Scheibe, Monika; Miller, Julia; Rujescu, Dan; Prvulovic, David; Hampel, Harald			White Matter Differences between Healthy Young ApoE4 Carriers and Non-Carriers Identified with Tractography and Support Vector Machines	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E GENOTYPES; E EPSILON-4 CARRIERS; ALZHEIMERS-DISEASE; GENETIC RISK; WORKING-MEMORY; OLDER-ADULTS; LEARNING ALGORITHMS; ENTORHINAL CORTEX; ONSET ALZHEIMERS	The apolipoprotein E4 (ApoE4) is an established risk factor for Alzheimer's disease (AD). Previous work has shown that this allele is associated with functional (fMRI) changes as well structural grey matter (GM) changes in healthy young, middle-aged and older subjects. Here, we assess the diffusion characteristics and the white matter (WM) tracts of healthy young (20-38 years) ApoE4 carriers and non-carriers. No significant differences in diffusion indices were found between young carriers (ApoE4+) and non-carriers (ApoE4-). There were also no significant differences between the groups in terms of normalised GM or WM volume. A feature selection algorithm (ReliefF) was used to select the most salient voxels from the diffusion data for subsequent classification with support vector machines (SVMs). SVMs were capable of classifying ApoE4 carrier and non-carrier groups with an extremely high level of accuracy. The top 500 voxels selected by ReliefF were then used as seeds for tractography which identified a WM network that included regions of the parietal lobe, the cingulum bundle and the dorsolateral frontal lobe. There was a non-significant decrease in volume of this WM network in the ApoE4 carrier group. Our results indicate that there are subtle WM differences between healthy young ApoE4 carriers and non-carriers and that the WM network identified may be particularly vulnerable to further degeneration in ApoE4 carriers as they enter middle and old age.	[O'Dwyer, Laurence; Matura, Silke; Scheibe, Monika; Miller, Julia; Prvulovic, David; Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Lamberton, Franck] Univ Caen & Paris Descartes, Ctr Imaging Neurosci & Applicat Pathol, CEA, CNRS,UMR 6232, Caen, France; [Rujescu, Dan] Univ Munich, Dept Psychiat, D-8000 Munich, Germany; [Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, Halle, Germany	Goethe University Frankfurt; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; University of Munich; Martin Luther University Halle Wittenberg	O'Dwyer, L (corresponding author), Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany.	larodwyer@gmail.com	Lamberton, Franck/GRO-7517-2022; Rujescu, Dan/GRS-3875-2022; O'Dwyer, Laurence/J-1699-2012	Hampel, Harald/0000-0003-0894-8982; Lamberton, Franck/0000-0002-4655-4397	School of Medicine, Goethe University, Frankfurt, Germany; Neurodegeneration & Alzheimer's disease research grant of the LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz) program "Neuronal Coordination Research Focus Frankfurt'' (NeFF)	School of Medicine, Goethe University, Frankfurt, Germany; Neurodegeneration & Alzheimer's disease research grant of the LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz) program "Neuronal Coordination Research Focus Frankfurt'' (NeFF)	This work was supported by institutional research funds of the School of Medicine, Goethe University, Frankfurt, Germany, to HH. This work was also supported by the Neurodegeneration & Alzheimer's disease research grant of the LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz) program "Neuronal Coordination Research Focus Frankfurt'' (NeFF) to HH and DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Barboriak DP, 2000, NEUROLOGY, V54, P2150, DOI 10.1212/WNL.54.11.2150; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Becher JC, 2006, J MED GENET, V43, P414, DOI 10.1136/jmg.2005.033936; Beck AT, 1996, PSYCHOL ASSESS; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benedict R, 1997, BRIEFVISUOSPATIAL ME; Bishop C, 1991, NEURAL COMPUT, V3, P579, DOI 10.1162/neco.1991.3.4.579; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bondi MW, 2006, ALZHEIMERS DEMENT, V2, pS308, DOI [DOI 10.1016/J.JALZ.2006.05.1085, 10.1016/j.jalz.2006.05.1085]; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Bosch B, 2010, NEUROBIOL AGING; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cherbuin N, 2008, J GERONTOL A-BIOL, V63, P501, DOI 10.1093/gerona/63.5.501; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Cui Y, 2011, NEUROIMAGE; Davis SW, 2012, CEREB CORTEX, V22, P232, DOI 10.1093/cercor/bhr123; Delis DC., 2000, CALIFORNIA VERBAL LE; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Dennis NA, 2007, NEUROPSYCHOLOGIA, V45, P3157, DOI 10.1016/j.neuropsychologia.2007.07.003; Dennis NA, 2010, ALZHEIMERS DEMENT, V6, P303, DOI 10.1016/j.jalz.2009.07.003; Du AT, 2006, NEUROBIOL AGING, V27, P733, DOI 10.1016/j.neurobiolaging.2005.03.021; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; ENGLUND E, 1990, HISTOPATHOLOGY, V16, P433; Englund E, 1998, DEMENT GERIATR COGN, V9, P6, DOI 10.1159/000051183; Fan Y, 2007, NEUROIMAGE, V36, P1189, DOI 10.1016/j.neuroimage.2007.04.009; Ferrarini L, 2008, NEUROIMAGE, V39, P1832, DOI 10.1016/j.neuroimage.2007.11.003; Filippini N, 2010, NEUROIMAGE; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Filippini N, 2009, NEUROIMAGE, V44, P724, DOI 10.1016/j.neuroimage.2008.10.003; Finch CE, 1999, NEUROBIOL AGING, V20, P407, DOI 10.1016/S0197-4580(99)00053-6; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Frisoni GB, 1999, NEUROLOGY, V52, P91, DOI 10.1212/WNL.52.1.91; Gold JM, 1997, ARCH GEN PSYCHIAT, V54, P159; Grana M, 2011, NEUROSCI LETT, V502, P225, DOI 10.1016/j.neulet.2011.07.049; Haller S, 2010, J ALZHEIMERS DIS, V22, P315, DOI 10.3233/JAD-2010-100840; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, NEUROBIOL AGING, V28, P238, DOI 10.1016/j.neurobiolaging.2005.12.013; Han XL, 2007, J NEUROCHEM, V103, P171, DOI 10.1111/j.1471-4159.2007.04708.x; Hautzinger M., 2006, BECK DEPRESSIONS INV; Heise V., 2010, MOL PSYCHIAT; Hubacek JA, 2001, NEUROPSYCHOBIOLOGY, V43, P200, DOI 10.1159/000054890; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kitamura HW, 2004, NEUROSCI LETT, V369, P173, DOI 10.1016/j.neulet.2004.07.084; Kononenko I, 1997, APPL INTELL, V7, P39, DOI 10.1023/A:1008280620621; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; LEHTOVIRTA M, 1995, NEUROSCIENCE, V67, P65, DOI 10.1016/0306-4522(95)00014-A; Lind J, 2006, BRAIN, V129, P1240, DOI 10.1093/brain/awl054; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Morcom AM, 2003, BRAIN, V126, P213, DOI 10.1093/brain/awg020; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niemann H., 2008, CALIFORNIA VERBAL LE; Nierenberg J, 2005, NEUROREPORT, V16, P1369, DOI 10.1097/01.wnr.0000174058.49521.16; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032441; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; OKUIZUMI K, 1994, NAT GENET, V7, P10, DOI 10.1038/ng0594-10b; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Persson J, 2006, NEUROLOGY, V66, P1029, DOI 10.1212/01.wnl.0000204180.25361.48; PLATT J, 1999, ADV KERNEL METHODS S, V208, P98; Ravaja N, 1997, J BEHAV MED, V20, P571, DOI 10.1023/A:1025518524884; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1998, ANN NEUROL, V44, P288, DOI 10.1002/ana.410440226; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Schmidt H, 1996, CLIN GENET, V50, P293; Scholkopf B, 1997, IEEE T SIGNAL PROCES, V45, P2758, DOI 10.1109/78.650102; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Supek F, 2008, PROTEOMICS, V8, P28, DOI 10.1002/pmic.200700555; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wechsler D, 1997, WMS 3 ADM SCORING MA; Wee CY, 2011, NEUROIMAGE, V54, P1812, DOI 10.1016/j.neuroimage.2010.10.026; Wierenga CE, 2010, NEUROIMAGE, V51, P1222, DOI 10.1016/j.neuroimage.2010.03.021; Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a; Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603; Witten IH, 2011, MOR KAUF D, P1; Yu VWY, 2000, NEUROSCI LETT, V294, P179, DOI 10.1016/S0304-3940(00)01569-X; ZANNIS VI, 1982, J LIPID RES, V23, P911; Zetterberg H, 2002, NEUROSCI LETT, V324, P189, DOI 10.1016/S0304-3940(02)00198-2; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	100	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36024	10.1371/journal.pone.0036024	http://dx.doi.org/10.1371/journal.pone.0036024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558310	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200111
J	Rao, SS; Bentil, S; DeJesus, J; Larison, J; Hissong, A; Dupaix, R; Sarkar, A; Winter, JO				Rao, Shreyas S.; Bentil, Sarah; DeJesus, Jessica; Larison, John; Hissong, Alex; Dupaix, Rebecca; Sarkar, Atom; Winter, Jessica O.			Inherent Interfacial Mechanical Gradients in 3D Hydrogels Influence Tumor Cell Behaviors	PLOS ONE			English	Article							SUBSTRATE STIFFNESS; MICROSCALE CONTROL; FORCE MICROSCOPY; MIGRATION; MATRIX; FEEL; ELASTICITY; MOVEMENT; RIGIDITY; ADHESION	Cells sense and respond to the rigidity of their microenvironment by altering their morphology and migration behavior. To examine this response, hydrogels with a range of moduli or mechanical gradients have been developed. Here, we show that edge effects inherent in hydrogels supported on rigid substrates also influence cell behavior. A Matrigel hydrogel was supported on a rigid glass substrate, an interface which computational techniques revealed to yield relative stiffening close to the rigid substrate support. To explore the influence of these gradients in 3D, hydrogels of varying Matrigel content were synthesized and the morphology, spreading, actin organization, and migration of glioblastoma multiforme (GBM) tumor cells were examined at the lowest (< 50 mu m) and highest (> 500 mu m) gel positions. GBMs adopted bipolar morphologies, displayed actin stress fiber formation, and evidenced fast, mesenchymal migration close to the substrate, whereas away from the interface, they adopted more rounded or ellipsoid morphologies, displayed poor actin architecture, and evidenced slow migration with some amoeboid characteristics. Mechanical gradients produced via edge effects could be observed with other hydrogels and substrates and permit observation of responses to multiple mechanical environments in a single hydrogel. Thus, hydrogel-support edge effects could be used to explore mechanosensitivity in a single 3D hydrogel system and should be considered in 3D hydrogel cell culture systems.	[Rao, Shreyas S.; Larison, John; Winter, Jessica O.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Bentil, Sarah; Dupaix, Rebecca] Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA; [DeJesus, Jessica] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Hissong, Alex; Winter, Jessica O.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Sarkar, Atom] Geisinger Hlth Syst, Dept Neurosurg & Lab Nanomed, Danville, PA USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Geisinger Health System	Rao, SS (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA.	winter.63@osu.edu	Winter, Jessica O./AAO-5773-2020	Winter, Jessica O./0000-0002-5370-0137; Rao, Shreyas/0000-0001-7649-0171; Bentil, Sarah/0000-0003-3983-0987	National Science Foundation, Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET), Biomedical Engineering (BME) [0854015]; Women in Philanthropy, OSU; H.C. "Slip" Slider Professorship; Pelotonia Graduate Fellowship	National Science Foundation, Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET), Biomedical Engineering (BME); Women in Philanthropy, OSU; H.C. "Slip" Slider Professorship; Pelotonia Graduate Fellowship	The authors would like to acknowledge financial support from the National Science Foundation, Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET), Biomedical Engineering (BME) Award Number 0854015, (to JOW and AS), Women in Philanthropy, OSU (to JOW), the H.C. "Slip" Slider Professorship (to JOW), and a Pelotonia Graduate Fellowship (to SSR). Any opinions, findings, and conclusions expressed in this material are those of the author(s) and do not necessarily reflect those of the Pelotonia Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNSTEIN JJ, 1994, J NEURO-ONCOL, V18, P151, DOI 10.1007/BF01050421; BERNSTEIN JJ, 1991, NEUROSURGERY, V28, P652, DOI 10.1227/00006123-199105000-00003; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Cheung YK, 2009, ANGEW CHEM INT EDIT, V48, P7188, DOI 10.1002/anie.200900807; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015; Kotlarchyk MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020201; Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052; Lin YC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041918; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Maloney JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041923; Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d; Merkel R, 2007, BIOPHYS J, V93, P3314, DOI 10.1529/biophysj.107.111328; Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Sant S, 2010, CAN J CHEM ENG, V88, P899, DOI 10.1002/cjce.20411; Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z; Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005; Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698; Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382; Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	36	38	38	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35852	10.1371/journal.pone.0035852	http://dx.doi.org/10.1371/journal.pone.0035852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558241	Green Published, gold			2022-12-25	WOS:000305345200087
J	Forrester, TE; Badaloo, AV; Boyne, MS; Osmond, C; Thompson, D; Green, C; Taylor-Bryan, C; Barnett, A; Soares-Wynter, S; Hanson, MA; Beedle, AS; Gluckman, PD				Forrester, Terrence E.; Badaloo, Asha V.; Boyne, Michael S.; Osmond, Clive; Thompson, Debbie; Green, Curtis; Taylor-Bryan, Carolyn; Barnett, Alan; Soares-Wynter, Suzanne; Hanson, Mark A.; Beedle, Alan S.; Gluckman, Peter D.			Prenatal Factors Contribute to the Emergence of Kwashiorkor or Marasmus in Severe Undernutrition: Evidence for the Predictive Adaptation Model	PLOS ONE			English	Article							ERYTHROCYTE GLUTATHIONE SYNTHESIS; PROTEIN-ENERGY MALNUTRITION; CHILD UNDERNUTRITION; KINETIC DIFFERENCES; HEALTH; CONSEQUENCES; DISEASE; PLASTICITY; EVOLUTION; OBESITY	Background: Severe acute malnutrition in childhood manifests as oedematous (kwashiorkor, marasmic kwashiorkor) and non-oedematous (marasmus) syndromes with very different prognoses. Kwashiorkor differs from marasmus in the patterns of protein, amino acid and lipid metabolism when patients are acutely ill as well as after rehabilitation to ideal weight for height. Metabolic patterns among marasmic patients define them as metabolically thrifty, while kwashiorkor patients function as metabolically profligate. Such differences might underlie syndromic presentation and prognosis. However, no fundamental explanation exists for these differences in metabolism, nor clinical pictures, given similar exposures to undernutrition. We hypothesized that different developmental trajectories underlie these clinical-metabolic phenotypes: if so this would be strong evidence in support of predictive adaptation model of developmental plasticity. Methodology/Principal Findings: We reviewed the records of all children admitted with severe acute malnutrition to the Tropical Metabolism Research Unit Ward of the University Hospital of the West Indies, Kingston, Jamaica during 1962-1992. We used Wellcome criteria to establish the diagnoses of kwashiorkor (n = 391), marasmus (n = 383), and marasmic-kwashiorkor (n = 375). We recorded participants' birth weights, as determined from maternal recall at the time of admission. Those who developed kwashiorkor had 333 g (95% confidence interval 217 to 449, p<0.001) higher mean birthweight than those who developed marasmus. Conclusions/Significance: These data are consistent with a model suggesting that plastic mechanisms operative in utero induce potential marasmics to develop with a metabolic physiology more able to adapt to postnatal undernutrition than those of higher birthweight. Given the different mortality risks of these different syndromes, this observation is supportive of the predictive adaptive response hypothesis and is the first empirical demonstration of the advantageous effects of such a response in humans. The study has implications for understanding pathways to obesity and its cardio-metabolic co-morbidities in poor countries and for famine intervention programs.	[Forrester, Terrence E.; Badaloo, Asha V.; Boyne, Michael S.; Thompson, Debbie; Green, Curtis; Taylor-Bryan, Carolyn; Barnett, Alan; Soares-Wynter, Suzanne] Univ W Indies, Res Inst Trop Med, Trop Metab Res Unit, Kingston 7, Jamaica; [Osmond, Clive] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Hanson, Mark A.] Univ Southampton, Inst Dev Sci, Southampton, Hants, England; [Forrester, Terrence E.; Beedle, Alan S.; Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Forrester, Terrence E.; Beedle, Alan S.; Gluckman, Peter D.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand	University West Indies Mona Jamaica; University of Southampton; University of Southampton; University of Auckland; University of Auckland	Forrester, TE (corresponding author), Univ W Indies, Res Inst Trop Med, Trop Metab Res Unit, Kingston 7, Jamaica.	terrence.forrester@uwimona.edu.jm	Thompson, Debbie S/AAE-8408-2022; Boyne, Michael/AAC-3675-2020; Boyne, Michael S/I-2242-2013; Hanson, Mark/AAE-8236-2019	Thompson, Debbie S/0000-0001-6781-7646; Boyne, Michael/0000-0002-5227-2492; Boyne, Michael S/0000-0002-5227-2492; Hanson, Mark/0000-0002-6907-613X; Osmond, Clive/0000-0002-9054-4655; badaloo, asha/0000-0001-9555-3967	National Institutes of Health [5RO1 DK06689-08-12]; Health Research Council of New Zealand; National Research Centre for Growth and Development (New Zealand); Medical Research Council [MC_UP_A620_1017, MC_UP_A620_1016] Funding Source: researchfish; MRC [MC_UP_A620_1016, MC_UP_A620_1017] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Council of New Zealand(Health Research Council of New Zealand); National Research Centre for Growth and Development (New Zealand); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Institutes of Health (5RO1 DK06689-08-12), the Health Research Council of New Zealand, and the National Research Centre for Growth and Development (New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaloo A, 2002, AM J CLIN NUTR, V76, P646, DOI 10.1093/ajcn/76.3.646; Badaloo AV, 2006, AM J CLIN NUTR, V83, P1283, DOI 10.1093/ajcn/83.6.1283; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Gaskin P, 1997, AM J PUBLIC HEALTH, V87, P114, DOI 10.2105/AJPH.87.1.114; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Golden MH, 2010, INDIAN PEDIATR, V47, P667, DOI 10.1007/s13312-010-0103-5; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Jahoor F, 2005, AM J CLIN NUTR, V82, P792, DOI 10.1093/ajcn/82.4.792; Jahoor F, 2006, TROPICAL METABOLISM, P25; Jahoor F, 2008, ANN TROP PAEDIATR, V28, P87, DOI 10.1179/146532808X302107; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Reid M, 2000, AM J PHYSIOL-ENDOC M, V278, pE405, DOI 10.1152/ajpendo.2000.278.3.E405; Reid M, 2002, AM J CLIN NUTR, V76, P1409, DOI 10.1093/ajcn/76.6.1409; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; World Health Organization, 2009, FACT SHEET 178	21	50	52	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35907	10.1371/journal.pone.0035907	http://dx.doi.org/10.1371/journal.pone.0035907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558267	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305340200030
J	Leong, NL; Hurng, JM; Djomehri, SI; Gansky, SA; Ryder, MI; Ho, SP				Leong, Narita L.; Hurng, Jonathan M.; Djomehri, Sabra I.; Gansky, Stuart A.; Ryder, Mark I.; Ho, Sunita P.			Age-Related Adaptation of Bone-PDL-Tooth Complex: Rattus-Norvegicus as a Model System	PLOS ONE			English	Article							EXPERIMENTAL PERIODONTAL-DISEASE; ALVEOLAR BONE; TEMPOROMANDIBULAR-JOINT; MECHANICAL-PROPERTIES; ALKALINE-PHOSPHATASE; CHEMICAL-COMPOSITION; MOLECULAR REGULATION; CONNECTIVE TISSUES; GNOTOBIOTIC RATS; ADULT-RATS	Functional loads on an organ induce tissue adaptations by converting mechanical energy into chemical energy at a cell-level. The transducing capacity of cells alters physico-chemical properties of tissues, developing a positive feedback commonly recognized as the form-function relationship. In this study, organ and tissue adaptations were mapped in the bone-tooth complex by identifying and correlating biomolecular expressions to physico-chemical properties in rats from 1.5 to 15 months. However, future research using hard and soft chow over relevant age groups would decouple the function related effects from aging affects. Progressive curvature in the distal root with increased root resorption was observed using micro X-ray computed tomography. Resorption was correlated to the increased activity of multinucleated osteoclasts on the distal side of the molars until 6 months using tartrate resistant acid phosphatase (TRAP). Interestingly, mononucleated TRAP positive cells within PDL vasculature were observed in older rats. Higher levels of glycosaminoglycans were identified at PDL-bone and PDL-cementum entheses using alcian blue stain. Decreasing biochemical gradients from coronal to apical zones, specifically biomolecules that can induce osteogenic (biglycan) and fibrogenic (fibromodulin, decorin) phenotypes, and PDL-specific negative regulator of mineralization (asporin) were observed using immunohistochemistry. Heterogeneous distribution of Ca and P in alveolar bone, and relatively lower contents at the entheses, were observed using energy dispersive X-ray analysis. No correlation between age and microhardness of alveolar bone (0.7 +/- 0.1 to 0.9 +/- 0.2 GPa) and cementum (0.6 +/- 0.1 to 0.8 +/- 0.3 GPa) was observed using a microindenter. However, hardness of cementum and alveolar bone at any given age were significantly different (P<0.05). These observations should be taken into account as baseline parameters, during development (1.5 to 4 months), growth (4 to 10 months), followed by a senescent phase (10 to 15 months), from which deviations due to experimentally induced perturbations can be effectively investigated.	[Leong, Narita L.; Hurng, Jonathan M.; Djomehri, Sabra I.; Ho, Sunita P.] Univ Calif San Francisco, Div Biomat & Bioengn, San Francisco, CA 94143 USA; [Gansky, Stuart A.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, Div Oral Epidemiol & Dent Publ Hlth, San Francisco, CA 94143 USA; [Ryder, Mark I.] Univ Calif San Francisco, Dept Orofacial Sci, Div Periodontol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Leong, NL (corresponding author), Univ Calif San Francisco, Div Biomat & Bioengn, San Francisco, CA 94143 USA.	sunita.ho@ucsf.edu	Ho, Sunita P/B-1084-2008	Ho, Sunita/0000-0001-9999-8226	NIH/NIDCR [R01DE022032, R00 DE018212]; NIH/NCRR [1S10RR026645]; Division of Bioengineering and Biomaterials, Department of Preventive and Restorative Dental Sciences, UCSF; Praxis Fund; Benjamin Dienstein Fund, Division of Periodontology, Department of Orofacial Sciences, UCSF; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R00DE018212] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Division of Bioengineering and Biomaterials, Department of Preventive and Restorative Dental Sciences, UCSF; Praxis Fund; Benjamin Dienstein Fund, Division of Periodontology, Department of Orofacial Sciences, UCSF; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by: NIH/NIDCR R01DE022032 (SPH), NIH/NIDCR R00 DE018212 (SPH) and NIH/NCRR 1S10RR026645 (SPH), Division of Bioengineering and Biomaterials, Department of Preventive and Restorative Dental Sciences, UCSF; The Praxis Fund and the Benjamin Dienstein Fund, Division of Periodontology, Department of Orofacial Sciences, UCSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achong R, 2003, J PERIODONTOL, V74, P494, DOI 10.1902/jop.2003.74.4.494; Afonso L, 2011, J CLIN HYPERTENS, V13, P551, DOI 10.1111/j.1751-7176.2011.00476.x; [Anonymous], E384 ASTM, P399; APPLEBAUM E, 1947, J DENT RES, V26, P73, DOI 10.1177/00220345470260011001; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Arai K, 2005, ARCH GERONTOL GERIAT, V40, P225, DOI 10.1016/j.archger.2004.08.005; Baer MJ, 1983, POSTNATAL DEV RAT SK, Vxv; Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Bani D, 1999, J DENT RES, V78, P1735, DOI 10.1177/00220345990780111101; Barros Erika M K P, 2002, Spine J, V2, P57, DOI 10.1016/S1529-9430(01)00167-X; BAUMHAMM.A, 1965, J PERIODONTOL, V36, P439, DOI 10.1902/jop.1965.36.6.439; Boissy P, 1998, J CELL SCI, V111, P2563; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BRIDGES T, 1988, AM J ORTHOD DENTOFAC, V93, P245, DOI 10.1016/S0889-5406(88)80010-6; Brinckmann P, 2002, MUSCULOSKELETAL BIOM, Vx; Buffenstein R, 2008, ANIMAL MODELS AGING, P499; Cao JJ, 2007, J BONE MINER RES, V22, P1271, DOI 10.1359/JBMR.070506; Carter DR, 2001, SKELETAL FUNCTION FO, Vxii; CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0; Chattah NLT, 2009, ADV MATER, V21, P413, DOI 10.1002/adma.200801187; CRAWFORD JM, 1978, J PERIODONTAL RES, V13, P316, DOI 10.1111/j.1600-0765.1978.tb00186.x; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Edwards A. L., 1979, MULTIPLE REGRESSION; ENLOW DH, 1967, J DENT RES, V46, P1209, DOI 10.1177/00220345670460061501; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Foster BL, 2011, CELLS TISSUES ORGANS; Foster BL, 2007, CURR TOP DEV BIOL, V78, P47, DOI 10.1016/S0070-2153(06)78003-6; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; FROST HM, 1992, BONE MINER, V18, P227, DOI 10.1016/0169-6009(92)90809-R; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; Frost HM, 1964, BONE BIODYNAMICS, Vxvi; Fujita T, 2009, ARCH ORAL BIOL, V54, P40, DOI 10.1016/j.archoralbio.2008.07.010; GHANADIAN R, 1975, STEROIDS, V25, P753, DOI 10.1016/0039-128X(75)90039-2; GOLDBERG M, 1995, INT J DEV BIOL, V39, P93; Goto KT, 2011, J DENT RES, V90, P793, DOI 10.1177/0022034511400742; GROENEVELD MC, 1995, J DENT RES, V74, P1374, DOI 10.1177/00220345950740070901; Grzesik WJ, 2002, J BIOL CHEM, V277, P43638, DOI 10.1074/jbc.M202124200; GUGGENHEIM B, 1974, INFECT IMMUN, V10, P565, DOI 10.1128/IAI.10.3.565-577.1974; Hakkinen L, 2000, LAB INVEST, V80, P1869, DOI 10.1038/labinvest.3780197; Hall R C, 1997, Adv Dent Res, V11, P478; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HAYFLICK L, 1970, EXP GERONTOL, V5, P291, DOI 10.1016/0531-5565(70)90012-4; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; Ho SP, 2010, BIOMATERIALS, V31, P6635, DOI 10.1016/j.biomaterials.2010.05.024; Ho SP, 2009, DENT MATER, V25, P1195, DOI 10.1016/j.dental.2009.04.005; Ho SP, 2009, ACTA BIOMATER, V5, P707, DOI 10.1016/j.actbio.2008.08.013; Hoffman MMaS I, 1940, AM ASS ORTH, P854; Holliday Sean, 2005, World J Orthod, V6, P61; Ijuhin N, 1988, Adv Dent Res, V2, P209; Ingber D E, 2004, Mech Chem Biosyst, V1, P53; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Ito Y, 2001, EXP ANIM TOKYO, V50, P159, DOI 10.1538/expanim.50.159; JENKINS HG, 1988, J NEUROCHEM, V51, P1634, DOI 10.1111/j.1471-4159.1988.tb01134.x; Keles GC, 2005, INDIAN J MED RES, V121, P176; KING GJ, 1991, AM J ORTHOD DENTOFAC, V99, P456, DOI 10.1016/S0889-5406(05)81579-3; Kingsmill VJ, 2010, J DENT RES, V89, P510, DOI 10.1177/0022034510362970; KLAUSEN B, 1991, J PERIODONTOL, V62, P59, DOI 10.1902/jop.1991.62.1.59; KLAUSEN B, 1989, SCAND J DENT RES, V97, P494; KLAUSEN B, 1991, ARCH ORAL BIOL, V36, P685, DOI 10.1016/0003-9969(91)90022-M; KLINGSBERG J, 1960, J Dent Res, V39, P158, DOI 10.1177/00220345600390011101; Komatsu K, 2004, ARCH ORAL BIOL, V49, P817, DOI 10.1016/j.archoralbio.2004.04.002; Krishnan V, 2006, AM J ORTHOD DENTOFAC, V129, P1, DOI DOI 10.1016/J.AJ0D0.2005.10.007; Krishnan V., 2006, AM J ORTHOD DENTOFAC, V129, pe461; Kuhr A, 2004, J PERIODONTAL RES, V39, P101, DOI 10.1111/j.1600-0765.2004.00710.x; LOURIDIS O, 1972, J PERIODONTOL, V43, P533, DOI 10.1902/jop.1972.43.9.533; Luan XH, 2007, BIOESSAYS, V29, P819, DOI 10.1002/bies.20608; LUKINMAA PL, 1991, J DENT RES, V70, P19, DOI 10.1177/00220345910700010201; Mann S, 2001, BIOMINERALIZATION PR, Vxii; Mariotti A, 1993, Periodontol 2000, V3, P39; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Meikle MC, 2006, EUR J ORTHODONT, V28, P221, DOI 10.1093/ejo/cj1001; Melrose J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2453; Misawa-Kageyama Y, 2007, EUR J ORAL SCI, V115, P124, DOI 10.1111/j.1600-0722.2007.00428.x; Nakamura Y, 2003, J PERIODONTAL RES, V38, P343, DOI 10.1034/j.1600-0765.2003.00671.x; Nakamura Y, 2008, EUR J ORTHODONT, V30, P320, DOI 10.1093/ejo/cjm133; Nanci A, 2007, T CATES ORAL HISTOLO; Nishijima K, 2009, ARCH GERONTOL GERIAT, V48, P178, DOI 10.1016/j.archger.2008.01.006; Niver EL, 2011, J PERIODONTAL RES; Oehmke MJ, 2004, MICROSC RES TECHNIQ, V63, P198, DOI 10.1002/jemt.20027; Okazaki J, 1996, J ORAL REHABIL, V23, P536, DOI 10.1111/j.1365-2842.1996.tb00892.x; Paul RG, 1999, INT J BIOCHEM CELL B, V31, P653, DOI 10.1016/S1357-2725(99)00023-0; PEDLAR J, 1979, ARCH ORAL BIOL, V24, P777, DOI 10.1016/0003-9969(79)90038-4; Pereira FJ, 1996, J ORAL MAXIL SURG, V54, P55, DOI 10.1016/S0278-2391(96)90305-5; Pereira Junior FJ, 1996, J ORAL MAXILLOFAC SU, V54, P61; POSNER AS, 1965, ANN NY ACAD SCI, V131, P737, DOI 10.1111/j.1749-6632.1965.tb34837.x; Qian LH, 2009, DENT MATER, V25, P1285, DOI 10.1016/j.dental.2009.03.014; Ramamurthy NS, 2002, J PERIODONTAL RES, V37, P1, DOI 10.1034/j.1600-0765.2002.00342.x; Ren YJ, 2008, ACTA ODONTOL SCAND, V66, P93, DOI 10.1080/00016350801982522; Ren YJ, 2004, EUR J ORTHODONT, V26, P483, DOI 10.1093/ejo/26.5.483; Robert L, 2000, BIOGERONTOLOGY, V1, P123, DOI 10.1023/A:1010048014925; Roberts W.E., 2006, SEMIN ORTHOD, V12, P216, DOI [10.1053/j.sodo.2006.08.002, DOI 10.1053/J.SODO.2006.08.002]; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.50; ROHOLL PJM, 1994, J BONE MINER RES, V9, P355; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; Royce PM, 2002, CONNECTIVE TISSUE IT, Vxvii; Saffar JL, 1997, PERIODONTOL 2000, V13, P76, DOI 10.1111/j.1600-0757.1997.tb00096.x; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Sawyer A, 2003, BIOTECH HISTOCHEM, V78, P271, DOI 10.1080/10520290310001646668; SCHNEIDER B J, 1965, Angle Orthod, V35, P187; Shimizu N, 2000, J GERONTOL A-BIOL, V55, pB489, DOI 10.1093/gerona/55.10.B489; Shimono M, 2003, MICROSC RES TECHNIQ, V60, P491, DOI 10.1002/jemt.10290; Sicher H, 1944, AM J ORTHOD ORAL SUR, V30, pC109; Sievanen H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P255; Spence JM, 1940, ANGLE ORTHOD, V10, P127; Struillou X, 2010, OPEN DENT J, V4, P37, DOI 10.2174/1874210601004010037; TAKAGI M, 1991, J HISTOCHEM CYTOCHEM, V39, P41, DOI 10.1177/39.1.1898498; Thompson A., 2009, CTR XRAY OPTICS ADV; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Wang L, 2001, BONE, V29, P141, DOI 10.1016/S8756-3282(01)00483-5; Weiner J P, 1998, J Ambul Care Manage, V21, P29; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200	118	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35980	10.1371/journal.pone.0035980	http://dx.doi.org/10.1371/journal.pone.0035980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558292	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340200033
J	Matsui, K; Sugimoto, K; Mano, J; Ozawa, R; Takabayashi, J				Matsui, Kenji; Sugimoto, Kohichi; Mano, Jun'ichi; Ozawa, Rika; Takabayashi, Junji			Differential Metabolisms of Green Leaf Volatiles in Injured and Intact Parts of a Wounded Leaf Meet Distinct Ecophysiological Requirements	PLOS ONE			English	Article							HYDROPEROXIDE LYASE PATHWAY; ARABIDOPSIS-THALIANA; DEFENSE GENES; PLANTS; ALDEHYDES; PRODUCT; INSECTICIDES; PEROXIDATION; ACETATE; LEAVES	Almost all terrestrial plants produce green leaf volatiles (GLVs), consisting of six-carbon (C6) aldehydes, alcohols and their esters, after mechanical wounding. C6 aldehydes deter enemies, but C6 alcohols and esters are rather inert. In this study, we address why the ability to produce various GLVs in wounded plant tissues has been conserved in the plant kingdom. The major product in completely disrupted Arabidopsis leaf tissues was (Z)-3-hexenal, while (Z)-3-hexenol and (Z)-3-hexenyl acetate were the main products formed in the intact parts of partially wounded leaves. 13 C-labeled C6 aldehydes placed on the disrupted part of a wounded leaf diffused into neighboring intact tissues and were reduced to C6 alcohols. The reduction of the aldehydes to alcohols was catalyzed by an NADPH-dependent reductase. When NADPH was supplemented to disrupted tissues, C6 aldehydes were reduced to C6 alcohols, indicating that C6 aldehydes accumulated because of insufficient NADPH. When the leaves were exposed to higher doses of C6 aldehydes, however, a substantial fraction of C6 aldehydes persisted in the leaves and damaged them, indicating potential toxicity of C6 aldehydes to the leaf cells. Thus, the production of C6 aldehydes and their differential metabolisms in wounded leaves has dual benefits. In disrupted tissues, C6 aldehydes and their alpha,beta-unsaturated aldehyde derivatives accumulate to deter invaders. In intact cells, the aldehydes are reduced to minimize self-toxicity and allow healthy cells to survive. The metabolism of GLVs is thus efficiently designed to meet ecophysiological requirements of the microenvironments within a wounded leaf.	[Matsui, Kenji; Sugimoto, Kohichi] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 753, Japan; [Sugimoto, Kohichi; Ozawa, Rika; Takabayashi, Junji] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Mano, Jun'ichi] Yamaguchi Univ, Ctr Sci Res, Yamaguchi, Japan; [Matsui, Kenji; Sugimoto, Kohichi] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Yamaguchi, Japan	Yamaguchi University; Kyoto University; Yamaguchi University; Yamaguchi University	Matsui, K (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 753, Japan.	matsui@yamaguchi-u.ac.jp	Sugimoto, Koichi/N-2302-2014; Mano, Jun'ichi/K-7437-2019; Takabayashi, Junji/G-2212-2010	Sugimoto, Koichi/0000-0002-8335-1396; Takabayashi, Junji/0000-0002-3575-9952; Mano, Jun'ichi/0000-0001-5030-8845	Japan Society for the Promotion of Science [18580105, 23580151, 19101009]; Core-to-Core Program from Japan Society for the Promotion of Science; Research Support Program of Sekisui Chemical Company, Tokyo, Japan; Yamaguchi University; Grants-in-Aid for Scientific Research [19101009] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core-to-Core Program from Japan Society for the Promotion of Science; Research Support Program of Sekisui Chemical Company, Tokyo, Japan; Yamaguchi University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Grants-in-Aid for Scientific Research (18580105, 23580151 to KM and 19101009 to JT) and by the Core-to-Core Program (20004) from Japan Society for the Promotion of Science; the Research Support Program of Sekisui Chemical Company, Tokyo, Japan; and Yamaguchi University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Barakat A, 2011, PLANT SCI, V181, P249, DOI 10.1016/j.plantsci.2011.05.012; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; Davoine C, 2006, PLANT PHYSIOL, V140, P1484, DOI 10.1104/pp.105.074690; Duan H, 2005, PLANT PHYSIOL, V139, P1529, DOI 10.1104/pp.105.067249; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Farag MA, 2005, PLANTA, V220, P900, DOI 10.1007/s00425-004-1404-5; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Hammond DG, 2000, J AGR FOOD CHEM, V48, P4410, DOI 10.1021/jf000233+; Heil M, 2008, J CHEM ECOL, V34, P601, DOI 10.1007/s10886-008-9464-9; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Hubert J, 2008, PEST MANAG SCI, V64, P57, DOI 10.1002/ps.1471; Kallenbach M, 2011, NEW PHYTOL, V191, P1054, DOI 10.1111/j.1469-8137.2011.03767.x; Kasai H, 2008, MUTAT RES-REV MUTAT, V659, P56, DOI 10.1016/j.mrrev.2008.02.003; Kawai K, 2006, MUTAT RES-GEN TOX EN, V603, P186, DOI 10.1016/j.mrgentox.2005.11.012; Kishimoto K, 2008, PHYTOCHEMISTRY, V69, P2127, DOI 10.1016/j.phytochem.2008.04.023; Liu ZQ, 2004, PEST MANAG SCI, V60, P434, DOI 10.1002/ps.816; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; Matsui K, 1996, FEBS LETT, V394, P21, DOI 10.1016/0014-5793(96)00924-6; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Nakamura S, 2002, J AGR FOOD CHEM, V50, P7639, DOI 10.1021/jf025808c; Noordermeer MA, 1999, FEBS LETT, V443, P201, DOI 10.1016/S0014-5793(98)01706-2; Nyambura MC, 2011, J PLANT INTERACT, V6, P185, DOI 10.1080/17429145.2010.544777; Queval G, 2007, ANAL BIOCHEM, V363, P58, DOI 10.1016/j.ab.2007.01.005; Reinecke A, 2002, NATURWISSENSCHAFTEN, V89, P265, DOI 10.1007/s00114-002-0314-2; Riahi Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE879, DOI 10.1152/ajpendo.00508.2010; Shimoda T, 2010, EXP APPL ACAROL, V50, P9, DOI 10.1007/s10493-009-9275-x; Shiojiri K, 2006, P NATL ACAD SCI USA, V103, P16672, DOI 10.1073/pnas.0607780103; Shiojiri K, 2006, J CHEM ECOL, V32, P969, DOI 10.1007/s10886-006-9047-6; Snoeren TAL, 2010, J EXP BOT, V61, P3041, DOI 10.1093/jxb/erq127; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Wei JN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000852; Yamauchi Y, 2011, J BIOL CHEM, V286, P6999, DOI 10.1074/jbc.M110.202226	38	108	112	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36433	10.1371/journal.pone.0036433	http://dx.doi.org/10.1371/journal.pone.0036433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558466	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340200080
J	Pho, MT; Swaminathan, S; Kumarasamy, N; Losina, E; Ponnuraja, C; Uhler, LM; Scott, CA; Mayer, KH; Freedberg, KA; Walensky, RP				Pho, Mai T.; Swaminathan, Soumya; Kumarasamy, Nagalingeswaran; Losina, Elena; Ponnuraja, C.; Uhler, Lauren M.; Scott, Callie A.; Mayer, Kenneth H.; Freedberg, Kenneth A.; Walensky, Rochelle P.			The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; OBSERVATIONAL DATABASE; COTE-DIVOIRE; ADULTS; RISK; DISEASE; COHORT; COUNTRIES; CRITERIA	Background: Regimens for isoniazid-based preventive therapy (IPT) for tuberculosis (TB) in HIV-infected individuals have not been widely adopted given concerns regarding efficacy, adherence and drug resistance. Further, the cost-effectiveness of IPT has not been studied in India. Methods: We used an HIV/TB model to project TB incidence, life expectancy, cost and incremental cost-effectiveness of six months of isoniazid plus ethambutol (6EH), thirty-six months of isoniazid (36H) and no IPT for HIV-infected patients in India. Model input parameters included a median CD4 count of 324 cells/mm(3), and a rate ratio of developing TB of 0.35 for 6EH and 0.22 for 36H at three years as compared to no IPT. Results of 6EH and 36H were also compared to six months of isoniazid (6H), three months of isoniazid plus rifampin (3RH) and three months of isoniazid plus rifapentine (3RPTH). Results: Projected TB incidence decreased in the 6EH and 36H regimens by 51% and 62% respectively at three-year follow-up compared to no IPT. Without IPT, projected life expectancy was 136.1 months at a lifetime per person cost of $5,630. 6EH increased life expectancy by 0.8 months at an additional per person cost of $100 (incremental cost-effectiveness ratio (ICER) of $1,490/year of life saved (YLS)). 36H further increased life expectancy by 0.2 months with an additional per person cost of $55 (ICER of $3,120/YLS). The projected clinical impact of 6EH was comparable to 6H and 3RH; however when compared to these other options, 6EH was no longer cost-effective given the high cost of ethambutol. Results were sensitive to baseline CD4 count and adherence. Conclusions: Three, six and thirty-six-month regimens of isoniazid-based therapy are effective in preventing TB. Three months of isoniazid plus rifampin and six-months of isoniazid are similarly cost-effective in India, and should be considered part of HIV care.	[Pho, Mai T.] Univ Chicago, Med Ctr, Dept Med, Sect Hosp Med, Chicago, IL 60637 USA; [Swaminathan, Soumya; Ponnuraja, C.] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Kumarasamy, Nagalingeswaran] VHS, YR Gaitonde Ctr AIDS Res & Educ, Chennai, Tamil Nadu, India; [Uhler, Lauren M.; Scott, Callie A.; Freedberg, Kenneth A.; Walensky, Rochelle P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Med, Boston, MA USA; [Freedberg, Kenneth A.; Walensky, Rochelle P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Losina, Elena; Freedberg, Kenneth A.; Walensky, Rochelle P.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Mayer, Kenneth H.] Brown Univ, Miriam Hosp, Providence, RI USA	University of Chicago; University of Chicago Medical Center; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Pho, MT (corresponding author), Univ Chicago, Med Ctr, Dept Med, Sect Hosp Med, Chicago, IL 60637 USA.	mpho@medicine.bsd.uchicago.edu; rwalensky@partners.org	Kumarasasmy, Nagalingeswaran/AAB-7348-2021	Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892	National Institute of Allergy And Infectious Diseases [T32 AI07433, R01-AI058736, K24-AI062476, K24-AR057827]; National Institute of Health - Fogarty International Center [D43-TW000237]; Indian Council of Medical Research; WHO/USAID (Model DOTS Project); FOGARTY INTERNATIONAL CENTER [D43TW000237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093269, R01AI058736, T32AI007433, R37AI042006, K24AI062476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR057827] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); WHO/USAID (Model DOTS Project)(United States Agency for International Development (USAID)World Health Organization); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Allergy And Infectious Diseases award numbers [T32 AI07433, R01-AI058736, K24-AI062476, and K24-AR057827]; the National Institute of Health - Fogarty International Center [D43-TW000237]; the Indian Council of Medical Research; and the WHO/USAID (Model DOTS Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], MONTHLY INDEX MED SP; [Anonymous], 2011, GUID INT TUB CAS FIN; [Anonymous], 2009, UN COSTS COMP HIV RE; Bachani D, 2009, J Indian Med Assoc, V107, P310; Bachani D, 2009, J INDIAN MED ASSOC, V107, P310; Bachani D, 2009, J INDIAN MED ASSOC, V107; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bell JC, 1999, AIDS, V13, P1549, DOI 10.1097/00002030-199908200-00016; Cecelia AJ, 2006, NATL MED J INDIA, V19, P14; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; Gold R, 1996, COST EFFECTIVENESS H; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Hausler HP, 2006, B WORLD HEALTH ORGAN, V84, P528, DOI 10.2471/BLT.04.018606; Holland DP, 2009, PHARMACOTHERAPY, V29, P503, DOI 10.1592/phco.29.5.503; Homan RK, 2000, EC AN YRG CARE SERV; Hovell M, 2003, SOC SCI MED, V56, P1789, DOI 10.1016/S0277-9536(02)00176-4; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; International Monetary Fund, 2009, WORLD EC OUTL DAT; John KR, 2009, INT J TUBERC LUNG D, V13, P1281; Kumarasamy N, 2005, CLIN INFECT DIS, V41, P1525, DOI 10.1086/497267; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Losina E, 2007, ANTIVIR THER, V12, P543; Machado A, 2009, INT J TUBERC LUNG D, V13, P719; Martinson NA, N ENGL J MED, V365, P11; MASOBE P, 1995, S AFR MED J, V85, P75; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Menzies D, 2008, ANN INTERN MED, V149, P689, DOI 10.7326/0003-4819-149-10-200811180-00003; Menzies D, 2011, INDIAN J MED RES, V133, P257; Minga A, 2007, B WORLD HEALTH ORGAN, V85, P116, DOI 10.2471/BLT.06.032292; Muniyandi M., 2006, Indian Journal of Tuberculosis, V53, P12; NACO, 2010, CAR SUPP TREATM NAT; NACO, 2007, GUID PREV MAN COMM O; Pardeshi Geeta, 2009, Indian J Med Sci, V63, P180, DOI 10.4103/0019-5359.53163; Seyler C, 2007, AIDS RES HUM RETROV, V23, P1338, DOI 10.1089/aid.2006.0308; Shrestha RK, 2007, INT J TUBERC LUNG D, V11, P747; Steinbrook R, 2007, NEW ENGL J MED, V356, P1197, DOI 10.1056/NEJMp078011; Sterling TR, N ENGL J MED, V365, P2155; Sutton BS, 2009, INT J TUBERC LUNG D, V13, P713; Swaminathan S, 2008, INT J TUBERC LUNG D, V12, P168; Swaminathan S, 2000, INT J TUBERC LUNG D, V4, P839; Swaminathan S, 2005, INT J TUBERC LUNG D, V9, P896; SWAMINATHAN S, 2010, 17 C RETR OPP INF SA; Swaminathan S, 2008, J BIOSCIENCES, V33, P527, DOI 10.1007/s12038-008-0071-2; TB India, 2011, RNTCP STAT REP; Tedla Z, 2010, AM J RESP CRIT CARE, V182, P278, DOI 10.1164/rccm.200911-1783OC; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; Uhler LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012747; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Wang B, 2006, 16 INT AIDS C TOR CA; WHO, 2010, ANT THER HIV INF AD; WHO, 2009, 3 IS M INT FIND ICF; WHO, 2010, MULT EXT DRUG REST T; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2001, MACR HLTH INV HLTH E; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	58	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36001	10.1371/journal.pone.0036001	http://dx.doi.org/10.1371/journal.pone.0036001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558301	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305340200034
J	Fischer, A; Shapiro, B; Muriuki, C; Heller, M; Schnee, C; Bongcam-Rudloff, E; Vilei, EM; Frey, J; Jores, J				Fischer, Anne; Shapiro, Beth; Muriuki, Cecilia; Heller, Martin; Schnee, Christiane; Bongcam-Rudloff, Erik; Vilei, Edy M.; Frey, Joachim; Jores, Joerg			The Origin of the 'Mycoplasma mycoides Cluster' Coincides with Domestication of Ruminants	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; BOVINE PLEURO-PNEUMONIA; SMALL COLONY; MOLECULAR EPIDEMIOLOGY; INFERENCE; GOATS; CAPRIPNEUMONIAE; EVOLUTIONARY; PHYLOGENY; SOFTWARE	The 'Mycoplasma mycoides cluster' comprises the ruminant pathogens Mycoplasma mycoides subsp. mycoides the causative agent of contagious bovine pleuropneumonia (CBPP), Mycoplasma capricolum subsp. capripneumoniae the agent of contagious caprine pleuropneumonia (CCPP), Mycoplasma capricolum subsp. capricolum, Mycoplasma leachii and Mycoplasma mycoides subsp. capri. CBPP and CCPP are major livestock diseases and impact the agricultural sector especially in developing countries through reduced food-supply and international trade restrictions. In addition, these diseases are a threat to disease-free countries. We used a multilocus sequence typing (MLST) approach to gain insights into the demographic history of and phylogenetic relationships among the members of the 'M. mycoides cluster'. We collected partial sequences from seven housekeeping genes representing a total of 3,816 base pairs from 118 strains within this cluster, and five strains isolated from wild Caprinae. Strikingly, the origin of the 'M. mycoides cluster' dates to about 10,000 years ago, suggesting that the establishment and spread of the cluster coincided with livestock domestication. In addition, we show that hybridization and recombination may be important factors in the evolutionary history of the cluster.	[Fischer, Anne] Int Ctr Insect Physiol & Ecol, Dept Mol Biol & Biotechnol, Nairobi, Kenya; [Fischer, Anne; Muriuki, Cecilia; Jores, Joerg] Int Livestock Res Inst, Dept Biotechnol, Nairobi, Kenya; [Shapiro, Beth] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Heller, Martin; Schnee, Christiane] Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany; [Bongcam-Rudloff, Erik] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden; [Vilei, Edy M.; Frey, Joachim] Univ Bern, Inst Vet Bacteriol, Bern, Switzerland	International Centre of Insect Physiology & Ecology (ICIPE); CGIAR; International Livestock Research Institute (ILRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Swedish University of Agricultural Sciences; University of Bern	Fischer, A (corresponding author), Int Ctr Insect Physiol & Ecol, Dept Mol Biol & Biotechnol, POB 30772, Nairobi, Kenya.	jores@web.de	Vilei, Edy/A-6138-2009	Shapiro, Beth/0000-0002-2733-7776; Schnee, Christiane/0000-0001-7643-9114; Bongcam-Rudloff, Erik/0000-0002-1947-8288; Jores, Joerg/0000-0003-3790-5746	German Federal Ministry for Economic Cooperation and Development [09.7860.1-001.00, 81121408]; Swedish International Development Cooperation (SIDA) [2007-2510, 75000506]	German Federal Ministry for Economic Cooperation and Development; Swedish International Development Cooperation (SIDA)	The work was funded by the German Federal Ministry for Economic Cooperation and Development (Project No: 09.7860.1-001.00, Contract No: 81121408, http://www.bmz.de), and by the Swedish International Development Cooperation (SIDA reference: 2007-2510, Contribution No. 75000506, http://www.sida.se). JJ and AF were supported by the German Federal Ministry for Economic Cooperation and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; COTTEW GS, 1987, ISRAEL J MED SCI, V23, P632; DAMASSA AJ, 1983, AM J VET RES, V44, P322; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fisher J, 2003, MED HIST, V47, P314, DOI 10.1017/S0025727300057033; Fisher J, 2006, AUST VET J, V84, P439, DOI 10.1111/j.1751-0813.2006.00079.x; Fu YX, 1997, GENETICS, V147, P915; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hudson RR, 2001, GENETICS, V159, P1805; Hutyra F, 1938, CONTAGIOUS BOVINE PL; Kim KS, 2003, FEMS MICROBIOL LETT, V226, P299, DOI 10.1016/S0378-1097(03)00618-9; Kusiluka LJM, 2001, VET MICROBIOL, V82, P27, DOI 10.1016/S0378-1135(01)00352-2; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Manso-Silvan L, 2009, INT J SYST EVOL MICR, V59, P1353, DOI 10.1099/ijs.0.005546-0; Manso-Silvan L, 2007, INT J SYST EVOL MICR, V57, P2247, DOI 10.1099/ijs.0.64918-0; Manso-Silvan L, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-86; Mayor D, 2008, VET MICROBIOL, V127, P63, DOI 10.1016/j.vetmic.2007.08.010; McVean G, 2002, GENETICS, V160, P1231; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Nicolas MM, 2005, J CLIN MICROBIOL, V43, P1330, DOI 10.1128/JCM.43.3.1330-1340.2005; Nwankpa ND, 2010, VET MICROBIOL, V146, P354, DOI 10.1016/j.vetmic.2010.05.020; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043; STIPKOVITS L, 1977, ZBL VET MED B, V24, P218; TAJIMA F, 1989, GENETICS, V123, P585; Thiaucourt F, 2000, VET MICROBIOL, V72, P251, DOI 10.1016/S0378-1135(99)00204-7; Thiaucourt F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-114; Thomas A, 2005, FEMS MICROBIOL LETT, V245, P249, DOI 10.1016/j.femsle.2005.03.013; Thomas P, 1873, RAPPORT MED BOU FRID; Vilei EM, 2006, VET RES, V37, P779, DOI 10.1051/vetres:2006037; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yaya A, 2008, VET RES, V39, DOI 10.1051/vetres:2007052; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254	45	51	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36150	10.1371/journal.pone.0036150	http://dx.doi.org/10.1371/journal.pone.0036150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558362	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336000139
J	Ganel, T; Freud, E; Chajut, E; Algom, D				Ganel, Tzvi; Freud, Erez; Chajut, Eran; Algom, Daniel			Accurate Visuomotor Control below the Perceptual Threshold of Size Discrimination	PLOS ONE			English	Article							VISUAL ILLUSIONS; DISSOCIATION; REAL; HANDEDNESS	Background: Human resolution for object size is typically determined by psychophysical methods that are based on conscious perception. In contrast, grasping of the same objects might be less conscious. It is suggested that grasping is mediated by mechanisms other than those mediating conscious perception. In this study, we compared the visual resolution for object size of the visuomotor and the perceptual system. Methodology/Principal Findings: In Experiment 1, participants discriminated the size of pairs of objects once through perceptual judgments and once by grasping movements toward the objects. Notably, the actual size differences were set below the Just Noticeable Difference (JND). We found that grasping trajectories reflected the actual size differences between the objects regardless of the JND. This pattern was observed even in trials in which the perceptual judgments were erroneous. The results of an additional control experiment showed that these findings were not confounded by task demands. Participants were not aware, therefore, that their size discrimination via grasp was veridical. Conclusions/Significance: We conclude that human resolution is not fully tapped by perceptually determined thresholds. Grasping likely exhibits greater resolving power than people usually realize.	[Ganel, Tzvi; Freud, Erez] Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel; [Ganel, Tzvi; Freud, Erez] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Chajut, Eran] Open Univ Israel, Dept Educ & Psychol, Raanana, Israel; [Algom, Daniel] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; Open University Israel; Tel Aviv University	Ganel, T (corresponding author), Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel.	tganel@bgu.ac.il	Ganel, Tzvi/B-9344-2011	Ganel, Tzvi/0000-0003-0658-0598; Freud, Erez/0000-0003-3758-3855	Israel National Science Foundation [830/07]	Israel National Science Foundation(Israel Science Foundation)	This study was supported by an Israel National Science Foundation grant 830/07 to T.G. http://www.isf.org.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JC, 1978, FUNDAMENTALS SCALING; Bruno N, 2001, TRENDS COGN SCI, V5, P379, DOI 10.1016/S1364-6613(00)01725-3; Bruno N, 2009, NEUROPSYCHOLOGIA, V47, P1421, DOI 10.1016/j.neuropsychologia.2008.10.031; Carey DP, 2001, TRENDS COGN SCI, V5, P109, DOI 10.1016/S1364-6613(00)01592-8; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Cohen NR, 2009, NEUROPSYCHOLOGIA, V47, P1553, DOI 10.1016/j.neuropsychologia.2008.12.034; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Falmagne JC, 2001, ELEMENTS PSYCHOPHYSI; Franz VH, 2001, J EXP PSYCHOL HUMAN, V27, P1124, DOI 10.1037//0096-1523.27.5.1124; Ganel T, 2003, NATURE, V426, P664, DOI 10.1038/nature02156; Ganel T, 2008, CURR BIOL, V18; Ganel T, 2008, CURR BIOL, V18, pR599, DOI 10.1016/j.cub.2008.04.052; Ganel T, 2008, PSYCHOL SCI, V19, P221, DOI 10.1111/j.1467-9280.2008.02071.x; Gescheider G. A., 1976, PSYCHOPHYSICS METHOD; Glover SR, 2001, J EXP PSYCHOL HUMAN, V27, P560, DOI 10.1037/0096-1523.27.3.560; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Goodale MA, 2003, PROG BRAIN RES, V144, P131, DOI 10.1016/S0079-6123(03)14400-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Goodale MA, 2010, VISION RES; Haffenden AM, 2000, VISION RES, V40, P1597, DOI 10.1016/S0042-6989(00)00056-0; Hollands JG, 2010, PSYCHON B REV, V17, P135, DOI 10.3758/PBR.17.1.135; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; Marks LE, 1998, MEASUREMENT JUDGMENT, Vxviii, P81; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Stevens SS, 1975, PSYCHOPHYSICS INTRO; TEGHTSOONIAN R, 1971, PSYCHOL REV, V78, P71, DOI 10.1037/h0030300; Westwood DA, 2003, SPATIAL VISION, V16, P243, DOI 10.1163/156856803322467518	29	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36253	10.1371/journal.pone.0036253	http://dx.doi.org/10.1371/journal.pone.0036253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558407	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000171
J	Tao, X; Gu, YH; Wang, HY; Zheng, W; Li, X; Zhao, CW; Zhang, YZ				Tao, Xiang; Gu, Ying-Hong; Wang, Hai-Yan; Zheng, Wen; Li, Xiao; Zhao, Chuan-Wu; Zhang, Yi-Zheng			Digital Gene Expression Analysis Based on Integrated De Novo Transcriptome Assembly of Sweet Potato [Ipomoea batatas (L.) Lam.]	PLOS ONE			English	Article							RNA-SEQ DATA; SEQUENCING ANALYSIS; GENOME SEQUENCE; CODON USAGE; SHORT READS; GENERATION; PROTEIN; TOOL; DISCOVERY; ALIGNMENT	Background: Sweet potato (Ipomoea batatas L. [Lam.]) ranks among the top six most important food crops in the world. It is widely grown throughout the world with high and stable yield, strong adaptability, rich nutrient content, and multiple uses. However, little is known about the molecular biology of this important non-model organism due to lack of genomic resources. Hence, studies based on high-throughput sequencing technologies are needed to get a comprehensive and integrated genomic resource and better understanding of gene expression patterns in different tissues and at various developmental stages. Methodology/Principal Findings: Illumina paired-end (PE) RNA-Sequencing was performed, and generated 48.7 million of 75 bp PE reads. These reads were de novo assembled into 128,052 transcripts (>= 100 bp), which correspond to 41.1 million base pairs, by using a combined assembly strategy. Transcripts were annotated by Blast2GO and 51,763 transcripts got BLASTX hits, in which 39,677 transcripts have GO terms and 14,117 have ECs that are associated with 147 KEGG pathways. Furthermore, transcriptome differences of seven tissues were analyzed by using Illumina digital gene expression (DGE) tag profiling and numerous differentially and specifically expressed transcripts were identified. Moreover, the expression characteristics of genes involved in viral genomes, starch metabolism and potential stress tolerance and insect resistance were also identified. Conclusions/Significance: The combined de novo transcriptome assembly strategy can be applied to other organisms whose reference genomes are not available. The data provided here represent the most comprehensive and integrated genomic resources for cloning and identifying genes of interest in sweet potato. Characterization of sweet potato transcriptome provides an effective tool for better understanding the molecular mechanisms of cellular processes including development of leaves and storage roots, tissue-specific gene expression, potential biotic and abiotic stress response in sweet potato.	[Tao, Xiang; Gu, Ying-Hong; Wang, Hai-Yan; Zheng, Wen; Li, Xiao; Zhao, Chuan-Wu; Zhang, Yi-Zheng] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ,Coll Life Sci, Sichuan Key Lab Mol Biol & Biotechnol,Ctr Funct G, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Tao, X (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ,Coll Life Sci, Sichuan Key Lab Mol Biol & Biotechnol,Ctr Funct G, Chengdu 610064, Sichuan, Peoples R China.	yizzhang@scu.edu.cn	GU, Yinghong/D-2433-2010	GU, Yinghong/0000-0002-9364-1389	National Science & Technology Pillar Program of China [2007BAD78B03]; "Eleventh-Five'' Key Project of Sichuan Province, China [07SG111-003-1]	National Science & Technology Pillar Program of China; "Eleventh-Five'' Key Project of Sichuan Province, China	This work was supported by funds from the National Science & Technology Pillar Program of China (No. 2007BAD78B03, http://kjzc.jhgl.org/) and the "Eleventh-Five'' Key Project of Sichuan Province, China (No. 07SG111-003-1, http://www.scst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blankenberg D, 2010, GALAXY WEB BASED GEN; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; CAMPBELL WH, 1990, PLANT PHYSIOL, V92, P1, DOI 10.1104/pp.92.1.1; Carpena A. L., 2009, P27, DOI 10.1007/978-1-4020-9475-0_4; Chen Jen-Chih, 1997, Taiwania, V42, P34; CIP, 2010, FACTS FIG SWEETP; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Ekblom R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-219; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Fernie AR, 2002, TRENDS PLANT SCI, V7, P35, DOI 10.1016/S1360-1385(01)02183-5; Firon N., 2009, P13, DOI 10.1007/978-1-4020-9475-0_3; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; HABIB, 2007, BIOTECH MOL BIOL REV, V2, P68; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Loebenstein G., 2009, P105, DOI 10.1007/978-1-4020-9475-0_8; Loebenstein G., 2009, P9, DOI 10.1007/978-1-4020-9475-0_2; Low J., 2009, P359, DOI 10.1007/978-1-4020-9475-0_16; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Mbanzibwa DR, 2011, PLANT DIS, V95, P224, DOI 10.1094/PDIS-10-10-0707; McGregor CE, DIFFERENTIAL EXPRESS; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Padmaja G., 2009, P189, DOI 10.1007/978-1-4020-9475-0_11; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson MD, 2010, GENOME BIOL, V11, P9; Robischon M, 2011, PLANT PHYSIOL, V155, P1214, DOI 10.1104/pp.110.167007; Rodriguez MCS, 2010, PLANT J, V63, P212, DOI 10.1111/j.1365-313X.2010.04243.x; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Srinivas T., 2009, P235, DOI 10.1007/978-1-4020-9475-0_12; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thottappilly G., 2009, P503, DOI 10.1007/978-1-4020-9475-0_23; Varshney RK, 2010, TRENDS BIOTECHNOL, V28, P452, DOI 10.1016/j.tibtech.2010.06.007; Wang HC, 2004, MOL BIOL EVOL, V21, P90, DOI [10.1093/molbev/msh003, 10.1093/molbev/msg003]; Wang HC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S6; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang QM, 2010, CROP PROT, V29, P110, DOI 10.1016/j.cropro.2009.11.002; Wang RL, 2008, ARCH VIROL, V153, P1765, DOI 10.1007/s00705-008-0180-0; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh KW, 1997, PLANT MOL BIOL, V33, P565, DOI 10.1023/A:1005764702510; You MK, 2003, FEBS LETT, V536, P101, DOI 10.1016/S0014-5793(03)00035-8; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang L., 2009, P325, DOI 10.1007/978-1-4020-9475-0_15; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	82	150	166	5	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36234	10.1371/journal.pone.0036234	http://dx.doi.org/10.1371/journal.pone.0036234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558397	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000164
J	Ge, Y; Wu, JY; Xia, YJ; Yang, M; Xiao, JF; Yu, J				Ge, Yan; Wu, Jiayan; Xia, Yingjie; Yang, Ming; Xiao, Jingfa; Yu, Jun			Molecular Dynamics Simulation of the Complex PBP-2x with Drug Cefuroxime to Explore the Drug Resistance Mechanism of Streptococcus suis R61	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; ACID SUBSTITUTION MATRICES; ANTIBIOTIC-RESISTANCE; SUBSTRATE-BINDING; FREE-ENERGIES; PNEUMONIAE; SUSCEPTIBILITY; IDENTIFICATION; PBP2X	Drug resistance of Streptococcus suis strains is a worldwide problem for both humans and pigs. Previous studies have noted that penicillin-binding protein (PBPs) mutation is one important cause of beta-lactam antibiotic resistance. In this study, we used the molecular dynamics (MD) method to study the interaction differences between cefuroxime (CES) and PBP2x within two newly sequenced Streptococcus suis: drug-sensitive strain A7, and drug-resistant strain R61. The MM-PBSA results proved that the drug bound much more tightly to PBP2x in A7 (PBP2x-A7) than to PBP2x in R61 (PBP2x-R61). This is consistent with the evidently different resistances of the two strains to cefuroxime. Hydrogen bond analysis indicated that PBP2x-A7 preferred to bind to cefuroxime rather than to PBP2x-R61. Three stable hydrogen bonds were formed by the drug and PBP2x-A7, while only one unstable bond existed between the drug and PBP2x-R61. Further, we found that the Gln569, Tyr594, and Gly596 residues were the key mutant residues contributing directly to the different binding by pair wise energy decomposition comparison. By investigating the binding mode of the drug, we found that mutant residues Ala320, Gln553, and Thr595 indirectly affected the final phenomenon by topological conformation alteration. Above all, our results revealed some details about the specific interaction between the two PBP2x proteins and the drug cefuroxime. To some degree, this explained the drug resistance mechanism of Streptococcus suis and as a result could be helpful for further drug design or improvement.	[Ge, Yan] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Wu, Jiayan; Yang, Ming; Xiao, Jingfa; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Xia, Yingjie] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Revolut, Kunming, Peoples R China; [Xia, Yingjie; Yang, Ming] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ge, Y (corresponding author), China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China.	xiaojingfa@big.ac.cn; junyu@big.ac.cn		wu, jia yan/0000-0001-6048-405X	National Basic Research Program (973 Program) [2010CB126604]; Special Foundation Work Program [2009FY120100]; Ministry of Science and Technology of the People's Republic of China; National Science Foundation of China [31071163]; Scientific Research Foundation, State Education Ministry	National Basic Research Program (973 Program)(National Basic Research Program of China); Special Foundation Work Program; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation, State Education Ministry	This study was supported by a grant from the National Basic Research Program (973 Program) (No. 2010CB126604), the Special Foundation Work Program (No. 2009FY120100), the Ministry of Science and Technology of the People's Republic of China and grant from the National Science Foundation of China (No. 31071163). The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376; ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Escudero JA, 2007, ANTIMICROB AGENTS CH, V51, P777, DOI 10.1128/AAC.00972-06; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; CANTIN M, 1992, J VET DIAGN INVEST, V4, P170, DOI 10.1177/104063879200400209; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang YT, 1999, PROTEINS, V34, P403, DOI 10.1002/(SICI)1097-0134(19990215)34:3<403::AID-PROT12>3.0.CO;2-D; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Donadio S, 2010, J ANTIBIOT, V63, P423, DOI 10.1038/ja.2010.62; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Hakenbeck R, 1998, J BACTERIOL, V180, P1831, DOI 10.1128/JB.180.7.1831-1840.1998; HAKENBECK R, 1995, BIOCHEM PHARMACOL, V50, P1121, DOI 10.1016/0006-2952(95)00158-V; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024988; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; KELL CM, 1993, FEMS MICROBIOL LETT, V106, P171; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeszczynskiJerzy, 2005, COMPUTATIONAL CHEM R, V9, P54; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Martel A, 2001, VET MICROBIOL, V83, P287, DOI 10.1016/S0378-1135(01)00426-6; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mouz N, 1998, P NATL ACAD SCI USA, V95, P13403, DOI 10.1073/pnas.95.23.13403; Nienhaus Gerd Ulrich, 2005, PROTEIN LIGAND INTER, P54; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Payne VA, 1999, PROTEINS, V37, P176, DOI 10.1002/(SICI)1097-0134(19991101)37:2<176::AID-PROT4>3.0.CO;2-8; Pernot L, 2004, J BIOL CHEM, V279, P16463, DOI 10.1074/jbc.M313492200; Princivalli MS, 2009, EUROSURVEILLANCE, V14, P15; Pucci MJ, 1997, J BACTERIOL, V179, P5632, DOI 10.1128/jb.179.17.5632-5635.1997; RAHMAN A, 1964, PHYS REV, V136, pA405, DOI 10.1103/PhysRev.136.A405; Sakata Hiroshi, 2011, Kansenshogaku Zasshi, V85, P26; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; SPRATT BG, 1988, REV INFECT DIS, V10, P699; SPRATT BG, 1994, SCIENCE, V264, P388, DOI 10.1126/science.8153626; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Takamatsu D, 2003, PLASMID, V49, P143, DOI 10.1016/S0147-619X(02)00149-X; Walker Ross, 2010, AMBER TUTORIALS TUTO; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wangkaew S, 2006, J INFECTION, V52, P455, DOI 10.1016/j.jinf.2005.02.012; WASTESON Y, 1994, VET MICROBIOL, V41, P41, DOI 10.1016/0378-1135(94)90134-1; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Willenburg KS, 2006, NEW ENGL J MED, V354, P1325, DOI 10.1056/NEJMc053089; Zhang CP, 2008, VET MICROBIOL, V131, P386, DOI 10.1016/j.vetmic.2008.04.005	53	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35941	10.1371/journal.pone.0035941	http://dx.doi.org/10.1371/journal.pone.0035941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563422	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100048
J	Midha, M; Prasad, NK; Vindal, V				Midha, Mohit; Prasad, Nirmal K.; Vindal, Vaibhav			MycoRRdb: A Database of Computationally Identified Regulatory Regions within Intergenic Sequences in Mycobacterial Genomes	PLOS ONE			English	Article							BINDING-SITES; CONTROLS TRANSCRIPTION; ESCHERICHIA-COLI; TUBERCULOSIS; PREDICTION; DNA; FAMILY; GENES; EXPRESSION; PROTEIN	The identification of regulatory regions for a gene is an important step towards deciphering the gene regulation. Regulatory regions tend to be conserved under evolution that facilitates the application of comparative genomics to identify such regions. The present study is an attempt to make use of this attribute to identify regulatory regions in the Mycobacterium species followed by the development of a database, MycoRRdb. It consist the regulatory regions identified within the intergenic distances of 25 mycobacterial species. MycoRRdb allows to retrieve the identified intergenic regulatory elements in the mycobacterial genomes. In addition to the predicted motifs, it also allows user to retrieve the Reciprocal Best BLAST Hits across the mycobacterial genomes. It is a useful resource to understand the transcriptional regulatory mechanism of mycobacterial species. This database is first of its kind which specifically addresses cis-regulatory regions and also comprehensive to the mycobacterial species. Database URL: http://mycorrdb.uohbif.in.	[Midha, Mohit; Prasad, Nirmal K.; Vindal, Vaibhav] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Midha, M (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India.	vvls@uohyd.ernet.in	Midha, Mohit/AAD-9858-2019; midha, mohit/F-4848-2015	Midha, Mohit/0000-0001-7554-4086; midha, mohit/0000-0001-7554-4086	RGYI scheme from Department of Biotechnology, Government of India	RGYI scheme from Department of Biotechnology, Government of India	Research in VV's laboratory is supported under RGYI scheme from Department of Biotechnology, Government of India. VV acknowledges the Bioinformatics Infrastructure Facility, University of Hyderabad, to host the database.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BERGH S, 1994, MOL MICROBIOL, V12, P517, DOI 10.1111/j.1365-2958.1994.tb01039.x; Brooks PC, 2001, J BACTERIOL, V183, P4459, DOI 10.1128/JB.183.15.4459-4467.2001; Bulyk ML, 2004, GENOME RES, V14, P201, DOI 10.1101/gr.1448004; Catanho M, 2006, GENET MOL RES, V5, P115; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Davis EO, 2002, J BACTERIOL, V184, P3287, DOI 10.1128/JB.184.12.3287-3295.2002; Dullaghan EM, 2002, MICROBIOL-SGM, V148, P3609, DOI 10.1099/00221287-148-11-3609; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Fulton DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-270; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Haydel SE, 2002, J BACTERIOL, V184, P2192, DOI 10.1128/JB.184.8.2192-2203.2002; He HJ, 2005, J BACTERIOL, V187, P202, DOI 10.1128/JB.187.1.202-212.2005; Jacques PE, 2005, BIOINFORMATICS, V21, P2563, DOI 10.1093/bioinformatics/bti321; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Lee SA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S11; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Movahedzadeh F, 1997, J BACTERIOL, V179, P3509, DOI 10.1128/jb.179.11.3509-3518.1997; Prakash P, 2005, BIOINFORMATICS, V21, P2161, DOI 10.1093/bioinformatics/bti375; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Ranjan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S9; Ranjan S, 2006, NUCLEIC ACIDS RES, V34, pW584, DOI 10.1093/nar/gkl202; Recchi C, 2003, J BIOL CHEM, V278, P33763, DOI 10.1074/jbc.M305963200; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rodriguez G. Marcela, 1999, Tubercle and Lung Disease, V79, P287; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Thieffry D, 1998, BIOINFORMATICS, V14, P391, DOI 10.1093/bioinformatics/14.5.391; Vindal V, 2008, FEBS LETT, V582, P1117, DOI 10.1016/j.febslet.2008.02.074; Vindal V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-289; Vishnoi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-373; Young DB, 2001, NAT MED, V7, P11, DOI 10.1038/83250; Zhu XX, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-40	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36094	10.1371/journal.pone.0036094	http://dx.doi.org/10.1371/journal.pone.0036094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563442	gold, Green Published			2022-12-25	WOS:000305349100067
J	Shi, HY; Lee, KT; Lee, HH; Ho, WH; Sun, DP; Wang, JJ; Chiu, CC				Shi, Hon-Yi; Lee, King-Teh; Lee, Hao-Hsien; Ho, Wen-Hsien; Sun, Ding-Ping; Wang, Jhi-Joung; Chiu, Chong-Chi			Comparison of Artificial Neural Network and Logistic Regression Models for Predicting In-Hospital Mortality after Primary Liver Cancer Surgery	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TRANSPLANTATION; RISK	Background: Since most published articles comparing the performance of artificial neural network (ANN) models and logistic regression (LR) models for predicting hepatocellular carcinoma (HCC) outcomes used only a single dataset, the essential issue of internal validity (reproducibility) of the models has not been addressed. The study purposes to validate the use of ANN model for predicting in-hospital mortality in HCC surgery patients in Taiwan and to compare the predictive accuracy of ANN with that of LR model. Methodology/Principal Findings: Patients who underwent a HCC surgery during the period from 1998 to 2009 were included in the study. This study retrospectively compared 1,000 pairs of LR and ANN models based on initial clinical data for 22,926 HCC surgery patients. For each pair of ANN and LR models, the area under the receiver operating characteristic (AUROC) curves, Hosmer-Lemeshow (H-L) statistics and accuracy rate were calculated and compared using paired T-tests. A global sensitivity analysis was also performed to assess the relative significance of input parameters in the system model and the relative importance of variables. Compared to the LR models, the ANN models had a better accuracy rate in 97.28% of cases, a better H-L statistic in 41.18% of cases, and a better AUROC curve in 84.67% of cases. Surgeon volume was the most influential (sensitive) parameter affecting in-hospital mortality followed by age and lengths of stay. Conclusions/Significance: In comparison with the conventional LR model, the ANN model in the study was more accurate in predicting in-hospital mortality and had higher overall performance indices. Further studies of this model may consider the effect of a more detailed database that includes complications and clinical examination findings as well as more detailed outcome data.	[Shi, Hon-Yi; Lee, King-Teh; Ho, Wen-Hsien] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Lee, Hao-Hsien; Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Surg, Liouying, Taiwan; [Sun, Ding-Ping; Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Chiu, Chong-Chi] Taipei Med Univ, Dept Surg, Taipei, Taiwan; [Chiu, Chong-Chi] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, Tainan, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Taipei Medical University; Chia Nan University of Pharmacy & Science	Shi, HY (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	chiuchongchi@yahoo.com.tw			National Science Council, Taiwan, Republic of China [NSC 99-2320-B-037-026-MY2, NSC 99-2314-B-037-069-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by the National Science Council, Taiwan, Republic of China, under grant numbers NSC 99-2320-B-037-026-MY2 and NSC 99-2314-B-037-069-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Cazzaniga M, 2009, EUR J GASTROEN HEPAT, V21, P681, DOI 10.1097/MEG.0b013e328317f4da; Chen HY, 1999, THER DRUG MONIT, V21, P50, DOI 10.1097/00007691-199902000-00008; Chen MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027186; Cucchetti A, 2010, J HEPATOL, V52, P880, DOI 10.1016/j.jhep.2009.12.037; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Dvorchik I, 2007, CURR PHARM DESIGN, V13, P1527, DOI 10.2174/138161207780765846; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fan ST, 2011, ANN SURG, V253, P745, DOI 10.1097/SLA.0b013e3182111195; Guo X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028404; Han YF, 2011, WORLD J GASTROENTERO, V17, P4258, DOI 10.3748/wjg.v17.i38.4258; Haykin S, 1999, P842; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; Ho WH, 2011, EXPERT SYST APPL, V38, P13050, DOI 10.1016/j.eswa.2011.04.109; Ho WH, 2011, EXPERT SYST APPL, V38, P6319, DOI 10.1016/j.eswa.2010.11.110; Huang Y, 2010, STAT MED, V29, P1391, DOI 10.1002/sim.3876; Jarnagin WR, 2010, ANN SURG ONCOL, V17, P1226, DOI 10.1245/s10434-010-0978-3; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018776; Livingston EH, 2010, JAMA-J AM MED ASSOC, V304, P95, DOI 10.1001/jama.2010.905; Marsh JW, 1997, HEPATOLOGY, V26, P444, DOI 10.1002/hep.510260227; Sighoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018415; Tsai JT, 2006, IEEE T NEURAL NETWOR, V17, P69, DOI 10.1109/TNN.2005.860885; Wang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025295; Zou Jinming, 2008, V458, P15	23	51	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35781	10.1371/journal.pone.0035781	http://dx.doi.org/10.1371/journal.pone.0035781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563399	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100027
J	Walsh, RK; Bradley, C; Apperson, CS; Gould, F				Walsh, Rachael K.; Bradley, Caitlin; Apperson, Charles S.; Gould, Fred			An Experimental Field Study of Delayed Density Dependence in Natural Populations of Aedes albopictus	PLOS ONE			English	Article							FEEDING-BEHAVIOR; INTERSPECIFIC COMPETITION; DYNAMICS; DIPTERA; MOSQUITO; AEGYPTI; CULICIDAE; DETRITUS; SURVIVAL; CYCLES	Aedes albopictus, a species known to transmit dengue and chikungunya viruses, is primarily a container-inhabiting mosquito. The potential for pathogen transmission by Ae. albopictus has increased our need to understand its ecology and population dynamics. Two parameters that we know little about are the impact of direct density-dependence and delayed density-dependence in the larval stage. The present study uses a manipulative experimental design, under field conditions, to understand the impact of delayed density dependence in a natural population of Ae. albopictus in Raleigh, North Carolina. Twenty liter buckets, divided in half prior to experimentation, placed in the field accumulated rainwater and detritus, providing oviposition and larval production sites for natural populations of Ae. albopictus. Two treatments, a larvae present and larvae absent treatment, were produced in each bucket. After five weeks all larvae were removed from both treatments and the buckets were covered with fine mesh cloth. Equal numbers of first instars were added to both treatments in every bucket. Pupae were collected daily and adults were frozen as they emerged. We found a significant impact of delayed density-dependence on larval survival, development time and adult body size in containers with high larval densities. Our results indicate that delayed density-dependence will have negative impacts on the mosquito population when larval densities are high enough to deplete accessible nutrients faster than the rate of natural food accumulation.	[Walsh, Rachael K.; Apperson, Charles S.; Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Bradley, Caitlin] Univ N Carolina, Chapel Hill, NC USA; [Gould, Fred] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Walsh, RK (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	rskatz@ncsu.edu			National Institutes of Health (US) (NIH) [R01-AI54954-0IA2]; Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054954, R01AI091980] Funding Source: NIH RePORTER	National Institutes of Health (US) (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (US) (NIH) grant R01-AI54954-0IA2 and a grant to the Regents of the University of California from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyokhin A, 2005, POPUL ECOL, V47, P257, DOI 10.1007/s10144-005-0232-1; Arrivillaga J, 2004, J VECTOR ECOL, V29, P11; Aspbury AS, 1998, OECOLOGIA, V115, P137, DOI 10.1007/s004420050500; Bowman J, 2006, J MAMMAL, V87, P480, DOI 10.1644/05-MAMM-A-202R2.1; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Cooke BJ, 2006, FOREST ECOL MANAG, V226, P110, DOI 10.1016/j.foreco.2006.01.034; FISH D, 1982, ECOLOGY, V63, P283, DOI 10.2307/1938943; Friedenberg NA, 2008, ENVIRON ENTOMOL, V37, P650, DOI 10.1603/0046-225X(2008)37[650:TEDDAS]2.0.CO;2; GILPIN ME, 1979, FORTS ZOOL, V25, P355; Gotelli NJ, 2001, PRIMER ECOLOGY; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; HARRISON S, 1986, OECOLOGIA, V69, P354, DOI 10.1007/BF00377056; HAUKIOJA E, 1980, OIKOS, V35, P202, DOI 10.2307/3544428; HAWLEY W A, 1988, Journal of the American Mosquito Control Association, V4, P2; HAWLEY WA, 1985, J ANIM ECOL, V54, P955, DOI 10.2307/4389; HO BC, 1989, J MED ENTOMOL, V26, P615, DOI 10.1093/jmedent/26.6.615; Hunter MD, 1998, ECOL ENTOMOL, V23, P216, DOI 10.1046/j.1365-2311.1998.00123.x; Kesavaraju B, 2007, J MED ENTOMOL, V44, P215, DOI 10.1603/0022-2585(2007)44[215:IAIDIF]2.0.CO;2; LEATHER SR, 1987, ECOL ENTOMOL, V12, P275, DOI 10.1111/j.1365-2311.1987.tb01006.x; Little RC, 2006, SAS MIXED MODELS; Lord CC, 1998, J MED ENTOMOL, V35, P825, DOI 10.1093/jmedent/35.5.825; MAY RM, 1974, J ANIM ECOL, V43, P747, DOI 10.2307/3535; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; MORI A, 1979, Tropical Medicine, V21, P85; O'GOWER A. K., 1957, PROC LINN SOC N S WALES, V82, P285; Ott R., 2008, INTRO STAT METHODS D; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Pedraza-Garcia M, 2008, ENVIRON BIOL FISH, V82, P111, DOI 10.1007/s10641-007-9260-3; Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2; Solow AR, 2001, ECOLOGY, V82, P3263, DOI 10.1890/0012-9658(2001)082[3263:OEATDO]2.0.CO;2; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; TURCHIN P, 1990, NATURE, V344, P660, DOI 10.1038/344660a0; Turchin P, 2000, ECOL ENTOMOL, V25, P119, DOI 10.1046/j.1365-2311.2000.00228.x; TURCHIN P, 1992, ECOLOGY, V73, P289, DOI 10.2307/1938740; Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015; Yee DA, 2006, FRESHWATER BIOL, V51, P448, DOI 10.1111/j.1365-2427.2005.01504.x; Yee DA, 2004, J VECTOR ECOL, V29, P315; Yee DA, 2004, ANN ENTOMOL SOC AM, V97, P720, DOI 10.1603/0013-8746(2004)097[0720:IDIFBA]2.0.CO;2; Yee DA, 2007, J MED ENTOMOL, V44, P580, DOI 10.1603/0022-2585(2007)44[580:DAIEOA]2.0.CO;2	42	21	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35959	10.1371/journal.pone.0035959	http://dx.doi.org/10.1371/journal.pone.0035959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563428	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100054
J	Huusgaard, RS; Vismann, B; Kuhl, M; Macnaugton, M; Colmander, V; Rouse, GW; Glover, AG; Dahlgren, T; Worsaae, K				Huusgaard, Randi S.; Vismann, Bent; Kuehl, Michael; Macnaugton, Martin; Colmander, Veronica; Rouse, Greg W.; Glover, Adrian G.; Dahlgren, Thomas; Worsaae, Katrine			The Potent Respiratory System of Osedax mucofloris (Siboglinidae, Annelida) - A Prerequisite for the Origin of Bone-Eating Osedax?	PLOS ONE			English	Article							TUBEWORM RIFTIA-PACHYPTILA; WHALE-FALL; MICROBIAL COMMUNITIES; BRANCHIAL PLUME; NORTH-ATLANTIC; MARINE WORMS; DWARF MALES; SULFIDE; ROOTS; ACQUISITION	Members of the conspicuous bone-eating genus, Osedax, are widely distributed on whale falls in the Pacific and Atlantic Oceans. These gutless annelids contain endosymbiotic heterotrophic bacteria in a branching root system embedded in the bones of vertebrates, whereas a trunk and anterior palps extend into the surrounding water. The unique life style within a bone environment is challenged by the high bacterial activity on, and within, the bone matrix possibly causing O-2 depletion, and build-up of potentially toxic sulphide. We measured the O-2 distribution around embedded Osedax and showed that the bone microenvironment is anoxic. Morphological studies showed that ventilation mechanisms in Osedax are restricted to the anterior palps, which are optimized for high O-2 uptake by possessing a large surface area, large surface to volume ratio, and short diffusion distances. The blood vascular system comprises large vessels in the trunk, which facilitate an ample supply of oxygenated blood from the anterior crown to a highly vascularised root structure. Respirometry studies of O. mucofloris showed a high O-2 consumption that exceeded the average O-2 consumption of a broad line of resting annelids without endosymbionts. We regard this combination of features of the respiratory system of O. mucofloris as an adaptation to their unique nutrition strategy with roots embedded in anoxic bones and elevated O-2 demand due to aerobic heterotrophic endosymbionts.	[Huusgaard, Randi S.; Vismann, Bent; Kuehl, Michael; Macnaugton, Martin; Colmander, Veronica; Worsaae, Katrine] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark; [Kuehl, Michael] Univ Technol Sydney, Dept Environm Sci, Sydney, NSW 2007, Australia; [Rouse, Greg W.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Glover, Adrian G.] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Dahlgren, Thomas] Uni Environm Uni Res, Bergen, Norway	University of Copenhagen; University of Technology Sydney; University of California System; University of California San Diego; Scripps Institution of Oceanography; Natural History Museum London	Huusgaard, RS (corresponding author), Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark.	kworsaae@bio.ku.dk	Vismann, Bent/L-2731-2014; Worsaae, Katrine/L-8739-2014; Worsaae, Katrine/AEX-9585-2022; Rouse, Greg W/F-2611-2010; Rouse, Gregory/AAW-1494-2021; Kühl, Michael/A-1977-2009; Dahlgren, Thomas/X-6610-2019	Vismann, Bent/0000-0002-3613-6511; Worsaae, Katrine/0000-0003-0443-4298; Rouse, Greg W/0000-0001-9036-9263; Rouse, Gregory/0000-0001-9036-9263; Kühl, Michael/0000-0002-1792-4790; Dahlgren, Thomas/0000-0001-6854-2031	Danish Research Council [272-06-0260]; Swedish Research Council [2006-2768]; Natural Environment Research Council [NE/D000483/1] Funding Source: researchfish	Danish Research Council(Det Frie Forskningsrad (DFF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by the Danish Research Council (www.fi.dk/raad-og-udvalg/det-frie-forskningsraad; grant # 272-06-0260 to K. Worsaae) and the Swedish Research Council (www.vr.se; grant # 2006-2768 to T. Dahlgren). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AC, 2006, CAN J ZOOL, V84, P1810, DOI 10.1139/Z06-168; Andersen AC, 2002, CAN J ZOOL, V80, P320, DOI 10.1139/Z02-005; ARP AJ, 1987, J EXP BIOL, V128, P139; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; Cammen LM, 1987, ANIMAL ENERGETICS, V1; CHILDRESS JJ, 1984, MAR BIOL, V83, P109, DOI 10.1007/BF00394718; Dahlgren TG, 2006, CAH BIOL MAR, V47, P385; Dattagupta S, 2006, J EXP BIOL, V209, P3795, DOI 10.1242/jeb.02413; Freytag JK, 2001, P NATL ACAD SCI USA, V98, P13408, DOI 10.1073/pnas.231589498; Fujikura K, 2006, ZOOL SCI, V23, P733, DOI 10.2108/zsj.23.733; Gardiner SL., 1993, MICROSCOPIC ANATOMY; Girguis PR, 2006, J EXP BIOL, V209, P3516, DOI 10.1242/jeb.02404; Glover AG, 2005, P ROY SOC B-BIOL SCI, V272, P2587, DOI 10.1098/rspb.2005.3275; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Goffredi SK, 2005, ENVIRON MICROBIOL, V7, P1369, DOI 10.1111/j.1462-2920.2005.00824.x; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; HENRY EC, 1977, STAIN TECHNOL, V52, P59, DOI 10.3109/10520297709116748; Higgs ND, 2012, HIST BIOL, V24, P269, DOI 10.1080/08912963.2011.621167; Higgs ND, 2011, P ROY SOC B-BIOL SCI, V278, P9, DOI 10.1098/rspb.2010.1267; Hilario A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016309; Hourdez S, 2005, J INORG BIOCHEM, V99, P130, DOI 10.1016/j.jinorgbio.2004.09.017; Jones WJ, 2008, P ROY SOC B-BIOL SCI, V275, P387, DOI 10.1098/rspb.2007.1437; JORGENSEN BB, 1983, APPL ENVIRON MICROB, V45, P1261; JOUIN C, 1989, ACTA ZOOL-STOCKHOLM, V70, P121, DOI 10.1111/j.1463-6395.1989.tb01061.x; Julian D, 1999, J EXP BIOL, V202, P2245; Katz S, 2010, J MORPHOL, V271, P1272, DOI 10.1002/jmor.10873; Kiel S, 2010, P NATL ACAD SCI USA, V107, P8656, DOI 10.1073/pnas.1002014107; Kitazato H, 1996, VIE MILIEU, V46, P1; KNOX GA, 1954, STAIN TECHNOL, V29, P139, DOI 10.3109/10520295409115458; Kuhl M, 2005, METHOD ENZYMOL, V397, P166, DOI 10.1016/S0076-6879(05)97010-9; Kuhl M., 2001, BENTHIC BOUNDARY LAY, P180; Kuhl M, 2008, AQUAT MICROB ECOL, V53, P99, DOI 10.3354/ame01224; NORREVANG ARNE, 1965, SARSIA, V21, P37; Purschke G, 2006, INTEGR COMP BIOL, V46, P497, DOI 10.1093/icb/icj053; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rouse GW, 2008, BIOL BULL-US, V214, P67, DOI 10.2307/25066661; Rouse G. W., 2001, POLYCHAETES; Rouse GW, 2011, BIOL LETTERS, V7, P736, DOI 10.1098/rsbl.2011.0202; Rouse GW, 2009, MAR BIOL, V156, P395, DOI 10.1007/s00227-008-1091-z; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Ruthensteiner B, 2008, ZOOSYMPOSIA, V1, P63, DOI 10.11646/zoosymposia.1.1.8; Schander Christoffer, 2010, Fauna Norvegica, V30, P5, DOI 10.5324/fn.v30i0.632; SHUMWAY SE, 1979, COMP BIOCHEM PHYS A, V64, P273, DOI 10.1016/0300-9629(79)90660-1; Southward AC, 1993, MICROSCOPIC ANATOMY; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; Tzetlin AB, 2005, HYDROBIOLOGIA, V535, P113, DOI 10.1007/s10750-004-1409-x; Vismann B, 1996, MAR ECOL PROG SER, V143, P131, DOI 10.3354/meps143131; Vrijenhoek RC, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-74; Weber RE, 1978, PHYSL ANNELIDS; WELLS GP, 1952, PROC R SOC SER B-BIO, V140, P70, DOI 10.1098/rspb.1952.0045; Worsaae K, 2010, J MORPHOL, V271, P127, DOI 10.1002/jmor.10786; Zoond A, 1931, J EXP BIOL, V8, P258	52	18	18	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35975	10.1371/journal.pone.0035975	http://dx.doi.org/10.1371/journal.pone.0035975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558289	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200101
J	Rachubinski, AL; Crowley, SK; Sladek, JR; Maclean, KN; Bjugstad, KB				Rachubinski, Angela L.; Crowley, Shannon K.; Sladek, John R., Jr.; Maclean, Kenneth N.; Bjugstad, Kimberly B.			Effects of Neonatal Neural Progenitor Cell Implantation on Adult Neuroanatomy and Cognition in the Ts65Dn Model of Down Syndrome	PLOS ONE			English	Article							AGE-RELATED IMPAIRMENTS; TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; STEM-CELLS; MOUSE MODEL; ALZHEIMERS-DISEASE; DENTATE GYRUS; MICE; TRANSPLANTATION; MEMORY	As much of the aberrant neural development in Down syndrome (DS) occurs postnatally, an early opportunity exists to intervene and influence life-long cognitive development. Recent success using neural progenitor cells (NPC) in models of adult neurodegeneration indicate such therapy may be a viable option in diseases such as DS. Murine NPC (mNPC, C17.2 cell line) or saline were implanted bilaterally into the dorsal hippocampus of postnatal day 2 (PND 2) Ts65Dn pups to explore the feasibility of early postnatal treatment in this mouse model of DS. Disomic littermates provided karyotype controls for trisomic pups. Pups were monitored for developmental milestone achievement, and then underwent adult behavior testing at 14 weeks of age. We found that implanted mNPC survived into adulthood and migrated beyond the implant site in both karyotypes. The implantation of mNPC resulted in a significant increase in the density of dentate granule cells. However, mNPC implantation did not elicit cognitive changes in trisomic mice either neonatally or in adulthood. To the best of our knowledge, these results constitute the first assessment of mNPC as an early intervention on cognitive ability in a DS model.	[Rachubinski, Angela L.; Maclean, Kenneth N.; Bjugstad, Kimberly B.] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Crowley, Shannon K.] Univ S Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Crowley, Shannon K.] Univ S Carolina, Dept Neuropsychiat & Behav Sci, Columbia, SC 29208 USA; [Sladek, John R., Jr.] Univ Colorado Denver, Sch Med, Dept Neurol, Aurora, CO USA; [Sladek, John R., Jr.] Univ Colorado Denver, Sch Med, Ctr Neurosci, Aurora, CO USA; [Maclean, Kenneth N.; Bjugstad, Kimberly B.] Univ Colorado Denver, Colorado Intellectual & Dev Disabil Res Ctr IDDRC, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Rachubinski, AL (corresponding author), Univ Colorado Denver, Sch Med, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.	kimberly.bjugstad@ucdenver.edu	Rachubinski, Angela/HGB-4304-2022	Bjugstad, Kimberly/0000-0002-0473-5413	Ruth L. Kirschstein National Research Service Award (NRSA) [F31NS060517]; Anna and John J. Sie Foundation; National Institutes of Health/NCRR Colorado CTSI [TL1 RR025778]; NICHD [R01HD045224-03]; Linda Crnic Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045224] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001081] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS060517] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna and John J. Sie Foundation; National Institutes of Health/NCRR Colorado CTSI; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Linda Crnic Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) (F31NS060517), The Anna and John J. Sie Foundation, The Linda Crnic Institute, and was supported by National Institutes of Health/NCRR Colorado CTSI Grant Number TL1 RR025778. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. KNM gratefully acknowledges support from the NICHD (R01HD045224-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson EC, 2001, CYTOGENET CELL GENET, V93, P270, DOI 10.1159/000056997; Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Bautista A, 2010, DEV PSYCHOBIOL, V52, P35, DOI 10.1002/dev.20409; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Bimonte-Nelson HA, 2003, BEHAV BRAIN RES, V139, P47, DOI 10.1016/S0166-4328(02)00082-7; Bjugstad KB, 2006, EXP NEUROL, V198, P561, DOI 10.1016/j.expneurol.2006.02.023; Bjugstad KB, 2004, EXP NEUROL, V187, P204; Bjugstad KB, 2005, CELL TRANSPLANT, V14, P183, DOI 10.3727/000000005783983098; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; Chang Q, 2008, NEUROBIOL LEARN MEM, V89, P167, DOI 10.1016/j.nlm.2007.05.007; Contestabile A, 2009, CELL PROLIFERAT, V42, P171, DOI 10.1111/j.1365-2184.2009.00587.x; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Down JL, 1866, CLIN LECT REPORTS LO, V3, P259; Feng ZQ, 2009, NEUROSCI LETT, V462, P213, DOI 10.1016/j.neulet.2009.07.008; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fong SP, 2007, J NEUROSCI RES, V85, P1851, DOI 10.1002/jnr.21319; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Frotscher M, 2007, HIPPOCAMPUS BOOK, P115; Gordon RJ, 2009, MOL CELL NEUROSCI, V41, P219, DOI 10.1016/j.mcn.2009.03.001; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; Hattiangady B, 2007, STEM CELLS, V25, P2104, DOI 10.1634/stemcells.2006-0726; Heyser CJ, 2001, ASSESSMENT DEV MILES; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004; Hunter CL, 2003, BEHAV BRAIN RES, V138, P121, DOI 10.1016/S0166-4328(02)00275-9; Iivonen H, 2003, BEHAV BRAIN RES, V141, P207, DOI 10.1016/S0166-4328(02)00369-8; Insausti AM, 1998, NEUROSCI LETT, V253, P175, DOI 10.1016/S0304-3940(98)00641-7; Jucker Mathias, 1994, V719, P238; Kern DS, 2011, CELL TRANSPLANT, V20, P371, DOI 10.3727/096368910X528085; Lanfranchi S, 2010, J INTELL DISABIL RES, V54, P308, DOI 10.1111/j.1365-2788.2010.01262.x; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Lockrow J, 2011, BEHAV BRAIN RES, V221, P610, DOI 10.1016/j.bbr.2010.03.036; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Lott IT, 2005, NEUROBIOL AGING, V26, P383, DOI 10.1016/j.neurobiolaging.2004.08.005; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; Miranda MI, 2003, NEUROBIOL LEARN MEM, V80, P211, DOI 10.1016/S1074-7427(03)00061-3; Moon J, 2010, BEHAV NEUROSCI, V124, P346, DOI 10.1037/a0019590; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; Park KI, 2000, YONSEI MED J, V41, P825, DOI 10.3349/ymj.2000.41.6.825; Pennington BF, 2003, CHILD DEV, V74, P75, DOI 10.1111/1467-8624.00522; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Rueda N, 2005, NEUROSCI LETT, V380, P197, DOI 10.1016/j.neulet.2005.01.039; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Schmitz C, 1998, ANAT EMBRYOL, V198, P371, DOI 10.1007/s004290050191; Snyder EY, 1996, CURR OPIN NEUROL, V9, P126, DOI 10.1097/00019052-199604000-00013; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Stasko MR, 2004, BEHAV BRAIN RES, V154, P1, DOI 10.1016/j.bbr.2004.01.012; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Toso L, 2008, OBSTET GYNECOL, V112, P1242, DOI 10.1097/AOG.0b013e31818c91dc; UECKER A, 1993, J CLIN CHILD PSYCHOL, V22, P266, DOI 10.1207/s15374424jccp2202_12; Wainwright PE, 1998, J NUTR, V128, P661, DOI 10.1093/jn/128.3.661; Watson DJ, 2006, HUM GENE THER, V17, P693, DOI 10.1089/hum.2006.17.693; Zigman WB, 2007, MENT RETARD DEV D R, V13, P237, DOI 10.1002/mrdd.20163; Zorrilla EP, 1997, DEV PSYCHOBIOL, V30, P141, DOI 10.1002/(SICI)1098-2302(199703)30:2<141::AID-DEV5>3.0.CO;2-Q	64	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36082	10.1371/journal.pone.0036082	http://dx.doi.org/10.1371/journal.pone.0036082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558337	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200114
J	Sher, YP; Chang, CM; Juo, CG; Chen, CT; Hsu, JL; Lin, CY; Han, Z; Shiah, SG; Hung, MC				Sher, Y-P; Chang, C-M; Juo, C-G; Chen, C-T; Hsu, J. L.; Lin, C-Y; Han, Z.; Shiah, S-G; Hung, M-C			Targeted endostatin-cytosine deaminase fusion gene therapy plus 5-fluorocytosine suppresses ovarian tumor growth	ONCOGENE			English	Article						ovarian cancer; anti-angiogenesis; VISA; gene therapy	EXPRESSION; CANCER; SURVIVIN; DELIVERY; CELLS; YEAST; 5-FLUOROURACIL; ANGIOGENESIS; CHEMOTHERAPY; CISPLATIN	There are currently no effective therapies for cancer patients with advanced ovarian cancer, therefore developing an efficient and safe strategy is urgent. To ensure cancer-specific targeting, efficient delivery, and efficacy, we developed an ovarian cancer-specific construct (Survivin-VISA-hEndoyCD) composed of the cancer specific promoter survivin in a transgene amplification vector (VISA; VP16-GAL4-WPRE integrated systemic amplifier) to express a secreted human endostatin-yeast cytosine deaminase fusion protein (hEndoyCD) for advanced ovarian cancer treatment. hEndoyCD contains an endostatin domain that has tumor-targeting ability for anti-angiogenesis and a cytosine deaminase domain that converts the prodrug 5-fluorocytosine (5-FC) into the chemotherapeutic drug, 5-fluorouracil. Survivin-VISA-hEndoyCD was found to be highly specific, selectively express secreted hEndoyCD from ovarian cancer cells, and induce cancer-cell killing in vitro and in vivo in the presence of 5-FC without affecting normal cells. In addition, Survivin-VISA-hEndoyCD plus 5-FC showed strong synergistic effects in combination with cisplatin in ovarian cancer cell lines. Intraperitoneal (i.p.) treatment with Survivin-VISA-hEndoyCD coupled with liposome attenuated tumor growth and prolonged survival in mice bearing advanced ovarian tumors. Importantly, there was virtually no severe toxicity when hEndoyCD is expressed by Survivin-VISA plus 5-FC compared with CMV plus 5-FC. Thus, the current study demonstrates an effective cancer-targeted gene therapy that is worthy of development in clinical trials for treating advanced ovarian cancer. Oncogene (2013) 32, 1082-1090; doi:10.1038/onc.2012.134; published online 7 May 2012	[Sher, Y-P; Chang, C-M; Hung, M-C] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Lin, C-Y] China Med Univ Hosp, Div Hematol & Oncol, Taichung, Taiwan; [Sher, Y-P; Lin, C-Y] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hung, M-C] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Juo, C-G] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Shiah, S-G] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Chen, C-T; Hsu, J. L.; Han, Z.; Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hsu, J. L.; Hung, M-C] Asia Univ, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Chang Gung University; National Health Research Institutes - Taiwan; University of Texas System; UTMD Anderson Cancer Center; Asia University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Shiah, Shine-Gwo/D-2087-2010	Hung, Mien-Chie/0000-0003-4317-4740; 	National Science Council [NSC100-3112-B-039-003]; Private University [N5C99-2314-B-039-029-MY3, NSC99-2632-B]; Department of Health Cancer Research Center of Excellence [DOH99-TD-C-111-005]; Sister Institution Fund of China Medical University and Hospital; University of Texas MD Anderson Cancer Center	National Science Council(Ministry of Science and Technology, Taiwan); Private University; Department of Health Cancer Research Center of Excellence; Sister Institution Fund of China Medical University and Hospital; University of Texas MD Anderson Cancer Center	This work was supported by grants from National Science Council (NSC100-3112-B-039-003), Private University (N5C99-2314-B-039-029-MY3 to Y-PS and NSC99-2632-B to M-CH), Department of Health Cancer Research Center of Excellence (DOH99-TD-C-111-005), and The Sister Institution Fund of China Medical University and Hospital and The University of Texas MD Anderson Cancer Center.	Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chen CT, 2011, MOL CANCER THER, V10, P1327, DOI 10.1158/1535-7163.MCT-10-1117; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dixelius J, 2000, BLOOD, V95, P3403, DOI 10.1182/blood.V95.11.3403.011k07_3403_3411; Dixelius J, 2002, CANCER RES, V62, P1944; Erbs P, 2000, CANCER RES, V60, P3813; Glover CPJ, 2002, MOL THER, V5, P509, DOI 10.1006/mthe.2002.0588; Gunther Michael, 2005, Curr Med Chem Anticancer Agents, V5, P157, DOI 10.2174/1568011053174855; Hydzik Catherine, 2009, Oncology (Williston Park), V23, P15; Iyer M, 2001, P NATL ACAD SCI USA, V98, P14595, DOI 10.1073/pnas.251551098; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kievit E, 1999, CANCER RES, V59, P1417; Kim YM, 2000, CANCER RES, V60, P5410; KISH JA, 1988, AM J CLIN ONCOL-CANC, V11, P553, DOI 10.1097/00000421-198810000-00009; Lang JY, 2011, CANCER CELL, V20, P341, DOI 10.1016/j.ccr.2011.07.017; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Markman M, 2009, CANCER J, V15, P105, DOI 10.1097/PPO.0b013e31819e31f2; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; OLSON TA, 1994, CANCER RES, V54, P276; Ou-Yang F, 2006, CANCER RES, V66, P378, DOI 10.1158/0008-5472.CAN-05-1578; Parsons SL, 1996, EUR J SURG ONCOL, V22, P237, DOI 10.1016/S0748-7983(96)80009-6; Pisano R, 2005, J PHARMACEUT BIOMED, V38, P738, DOI 10.1016/j.jpba.2005.01.039; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Sher YP, 2009, ONCOGENE, V28, P3286, DOI 10.1038/onc.2009.187; Sim BKL, 2000, CANCER METAST REV, V19, P181, DOI 10.1023/A:1026551202548; Subramanian IV, 2006, CANCER RES, V66, P4319, DOI 10.1158/0008-5472.CAN-05-3297; Sui L, 2002, INT J ONCOL, V21, P315; Tanaka T, 2001, ANTICANCER RES, V21, P2463; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Xie XM, 2007, CANCER CELL, V12, P52, DOI 10.1016/j.ccr.2007.05.009; Xie XM, 2009, MOL CANCER THER, V8, P2375, DOI 10.1158/1535-7163.MCT-09-0056; Yoneda J, 1998, JNCI-J NATL CANCER I, V90, P447, DOI 10.1093/jnci/90.6.447; YU DH, 1993, CANCER RES, V53, P891; Zaffaroni N, 2005, J CELL MOL MED, V9, P360, DOI 10.1111/j.1582-4934.2005.tb00361.x; Zhang LQ, 2003, CANCER RES, V63, P4552; Zhang M, 2003, CANCER RES, V63, P658; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	40	19	20	0	27	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2013	32	9					1082	1090		10.1038/onc.2012.134	http://dx.doi.org/10.1038/onc.2012.134			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110FU	22562248				2022-12-25	WOS:000316428800002
J	Rana, MK; Worthylake, RA				Rana, Manish K.; Worthylake, Rebecca A.			Novel Mechanism for Negatively Regulating Rho-Kinase (ROCK) Signaling through Coronin1B Protein in Neuregulin 1 (NRG-1)-induced Tumor Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATASE TARGET SUBUNIT; MYOSIN PHOSPHATASE; LIM-KINASE; ACTIN REORGANIZATION; CRUCIAL ROLE; PHOSPHORYLATION; BINDING; DYNAMICS; COFILIN; SLINGSHOT	Although many mechanisms that activate ROCK are known, corresponding negative regulatory mechanisms required for cytoskeletal plasticity are poorly understood. We have discovered that Coronin1B is a novel attenuator of ROCK signaling. We initially identified Coronin1A in a proteomics screen for ROCK2-binding proteins, and here we demonstrate that Coronin1A/B bind directly to ROCK2 through its PH (Pleckstrin Homology) domain. The consequence of the ROCK2-Coronin1B interaction was tested and revealed that increased expression of Coronin1B inhibited, whereas knockdown of Coronin1B stimulated, phosphorylation of the ROCK substrate myosin light chain phosphatase and subsequently, myosin light chain. Thus, Coronin1B is a previously unrecognized inhibitor of ROCK signaling to myosin. Furthermore, we found that the phosphatase Slingshot IL (SSH1L) was required for Coronin1B to inhibit ROCK signaling. To test the significance of this novel mechanism in tumor cell motility, we investigated its role in neuregulin 1 (NRG-1)-induced cell scattering. Importantly, we found that attenuation of the ROCK signaling by Coronin1B was required for NRG-1 stimulated scattering. Our data support a model in which Coronin1B fine-tunes ROCK signaling to modulate myosin activity, which is important for tumor cell motility.	[Rana, Manish K.; Worthylake, Rebecca A.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70119 USA; [Worthylake, Rebecca A.] Louisiana State Univ, Hlth Sci Ctr, Dept Oral & Craniofacial Biol, New Orleans, LA 70119 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Worthylake, RA (corresponding author), 1100 Florida Ave, New Orleans, LA 70119 USA.	bworth@lsuhsc.edu			National Institutes of Health from NIDCR [R03DE19166]; National Center for Research Resources [P20RR020160]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019166] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R03DE19166 from the NIDCR. This work was also supported by National Center for Research Resources Grant P20RR020160.	Amano M, 2000, METHOD ENZYMOL, V325, P149; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Fukata Y, 1999, BIOPHYS CHEM, V82, P139, DOI 10.1016/S0301-4622(99)00113-1; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Gray SG, 2003, HORM METAB RES, V35, P857; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Inada H, 1999, J BIOL CHEM, V274, P34932, DOI 10.1074/jbc.274.49.34932; Izawa T, 2000, BIOCHEM BIOPH RES CO, V278, P72, DOI 10.1006/bbrc.2000.3772; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita Michiru, 2006, Tanpakushitsu Kakusan Koso, V51, P516; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Shaw G, 1996, BIOESSAYS, V18, P35, DOI 10.1002/bies.950180109; Shum WWC, 2003, BRIT J PHARMACOL, V139, P1449, DOI 10.1038/sj.bjp.0705393; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Struckhoff AP, 2010, J CELL SCI, V123, P401, DOI 10.1242/jcs.052167; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; Tumusiime S, 2009, BIOCHEM BIOPH RES CO, V381, P393, DOI 10.1016/j.bbrc.2009.02.056; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; WANG DS, 1995, BIOCHEM BIOPH RES CO, V209, P622, DOI 10.1006/bbrc.1995.1545; Wang DS, 1995, BIOCHEM BIOPH RES CO, V217, P608, DOI 10.1006/bbrc.1995.2818; Wen WY, 2008, J BIOL CHEM, V283, P26263, DOI 10.1074/jbc.M803417200; Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043	58	16	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21836	21845		10.1074/jbc.M112.346114	http://dx.doi.org/10.1074/jbc.M112.346114			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22563075	Green Published, hybrid			2022-12-25	WOS:000306418600025
J	Hassan, I; Chibber, S; Khan, AA; Naseem, I				Hassan, Iftekhar; Chibber, Sandesh; Khan, Aijaz A.; Naseem, Imrana			Riboflavin Ameliorates Cisplatin Induced Toxicities under Photoillumination	PLOS ONE			English	Article							INDUCED NEPHROTOXICITY; OXIDATIVE STRESS; NITRIC-OXIDE; APOPTOSIS; CANCER; INHIBITION; CYTOTOXICITY; MODULATION; KINASE; REPAIR	Background: Cisplatin is an effective anticancer drug that elicits many side effects mainly due to induction of oxidative and nitrosative stresses during prolonged chemotherapy. The severity of these side effects consequently restricts its clinical use under long term treatment. Riboflavin is an essential vitamin used in various metabolic redox reactions in the form of flavin adenine dinucleotide and flavin mononucleotide. Besides, it has excellent photosensitizing property that can be used to ameliorate these toxicities in mice under photodynamic therapy. Methods and Findings: Riboflavin, cisplatin and their combinations were given to the separate groups of mice under photoilluminated condition under specific treatment regime. Their kidney and liver were excised for comet assay and histopathological studies. Furthermore, Fourier Transform Infrared Spectroscopy of riboflavin-cisplatin combination in vitro was also conducted to investigate any possible interaction between the two compounds. Their comet assay and histopathological examination revealed that riboflavin in combination with cisplatin was able to protect the tissues from cisplatin induced toxicities and damages. Moreover, Fourier Transform Infrared Spectroscopy analysis of the combination indicated a strong molecular interaction among their constituent groups that may be assigned for the protective effect of the combination in the treated animals. Conclusion: Inclusion of riboflavin diminishes cisplatin induced toxicities which may possibly make the cisplatin-riboflavin combination, an effective treatment strategy under chemoradiotherapy in pronouncing its antineoplastic activity and sensitivity towards the cancer cells as compared to cisplatin alone.	[Hassan, Iftekhar; Chibber, Sandesh; Naseem, Imrana] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India; [Khan, Aijaz A.] Aligarh Muslim Univ, Dept Anat, Jawaharlal Nehru Med Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Hassan, I (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India.	imrananaseem2009@gmail.com	Hassan, Iftekhar/AAX-5261-2021	Hassan, Iftekhar/0000-0001-6993-9954	University Grant Commission (UGC), New Delhi under SAP-DRS II Program; UGC-BSR fellowship; department of Biochemistry; Aligarh Muslim University	University Grant Commission (UGC), New Delhi under SAP-DRS II Program(University Grants Commission, India); UGC-BSR fellowship; department of Biochemistry; Aligarh Muslim University	This work was financially supported by the University Grant Commission (UGC), New Delhi under SAP-DRS II Program, UGC-BSR fellowship and the facilities provided by the department of Biochemistry, Aligarh Muslim University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2006, J PHOTOCH PHOTOBIO B, V82, P21, DOI 10.1016/j.jphotobiol.2005.08.004; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Barabas K, 2008, VET COMP ONCOL, V6, P1, DOI 10.1111/j.1476-5829.2007.00142.x; Bareford LM, 2008, MOL PHARMACEUT, V5, P839, DOI 10.1021/mp800046m; Boulikas T, 2003, ONCOL REP, V10, P1663; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chirino YI, 2008, TOXICOL LETT, V176, P48, DOI 10.1016/j.toxlet.2007.10.006; Chirino YI, 2009, EXP TOXICOL PATHOL, V61, P223, DOI 10.1016/j.etp.2008.09.003; De Souza AC, 2006, APOPTOSIS, V11, P1761, DOI 10.1007/s10495-006-9549-2; Queiroz KCD, 2007, CANCER LETT, V258, P126, DOI 10.1016/j.canlet.2007.08.024; Dobrosz-Teperek K, 1998, J MOL STRUCT, V471, P115, DOI 10.1016/S0022-2860(98)00395-0; Edwards AM, 2001, J PHOTOCH PHOTOBIO B, V63, P126, DOI 10.1016/S1011-1344(01)00209-3; Furuta T, 2002, CANCER RES, V62, P4899; Hassan I, 2010, FOOD CHEM TOXICOL, V48, P2052, DOI 10.1016/j.fct.2010.05.004; Ho JW, 2006, RECENT PAT ANTI-CANC, V1, P129, DOI 10.2174/157489206775246485; Hodeify R, 2010, AM J PHYSIOL-RENAL, V299, pF112, DOI 10.1152/ajprenal.00151.2010; Husain E, 2008, PHOTODERMATOL PHOTO, V24, P301, DOI 10.1111/j.1600-0781.2008.00380.x; Jazzar MM, 1996, FREE RADICAL BIO MED, V21, P7, DOI 10.1016/0891-5849(95)02156-6; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Kart A, 2010, EXP TOXICOL PATHOL, V62, P45, DOI 10.1016/j.etp.2009.02.066; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V270, pF700, DOI 10.1152/ajprenal.1996.270.4.F700; Mohamed Yousif Ibrahim, 2009, Research Journal of Biological Sciences, V4, P777; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; Munoz MA, 2011, J PHOTOCH PHOTOBIO B, V103, P57, DOI 10.1016/j.jphotobiol.2011.01.012; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pathmamanoharan C, 1996, LANGMUIR, V12, P4372, DOI 10.1021/la960350s; PRABHU AL, 1989, CANCER LETT, V48, P89, DOI 10.1016/0304-3835(89)90042-6; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Shacter E, 2000, BLOOD, V96, P307, DOI 10.1182/blood.V96.1.307.013k47_307_313; Shin JS, 2010, INT J ONCOL, V36, P1445, DOI 10.3892/ijo_00000630; Tang CH, 2004, J BIOL CHEM, V279, P288, DOI 10.1074/jbc.M310821200; Webster RP, 1996, CANCER LETT, V98, P129; Wu W, 2010, MUTAT RES-FUND MOL M, V691, P1, DOI 10.1016/j.mrfmmm.2010.06.002; Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791; Zhang JG, 1996, TOXICOL LETT, V89, P11, DOI 10.1016/S0378-4274(96)03776-9; Zhang YZ, 2009, PHOTOCHEM PHOTOBIOL, V85, P943, DOI 10.1111/j.1751-1097.2009.00547.x; Zhu XY, 2006, P NATL ACAD SCI USA, V103, P3581, DOI 10.1073/pnas.0600251103	39	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36273	10.1371/journal.pone.0036273	http://dx.doi.org/10.1371/journal.pone.0036273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567145	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500064
J	Lutz, JA; Larson, AJ; Swanson, ME; Freund, JA				Lutz, James A.; Larson, Andrew J.; Swanson, Mark E.; Freund, James A.			Ecological Importance of Large-Diameter Trees in a Temperate Mixed-Conifer Forest	PLOS ONE			English	Article							YOSEMITE-NATIONAL-PARK; GENERAL QUANTITATIVE THEORY; NORTHERN FLYING SQUIRRELS; OLD-GROWTH; SPATIAL-PATTERNS; PRESCRIBED FIRE; CLIMATE-CHANGE; SIERRA-NEVADA; NEST TREES; MORTALITY	Large-diameter trees dominate the structure, dynamics and function of many temperate and tropical forests. Although both scaling theory and competition theory make predictions about the relative composition and spatial patterns of large-diameter trees compared to smaller diameter trees, these predictions are rarely tested. We established a 25.6 ha permanent plot within which we tagged and mapped all trees >= 1 cm dbh, all snags >= 10 cm dbh, and all shrub patches >= 2 m(2). We sampled downed woody debris, litter, and duff with line intercept transects. Aboveground live biomass of the 23 woody species was 507.9 Mg/ha, of which 503.8 Mg/ha was trees (SD = 114.3 Mg/ha) and 4.1 Mg/ha was shrubs. Aboveground live and dead biomass was 652.0 Mg/ha. Large-diameter trees comprised 1.4% of individuals but 49.4% of biomass, with biomass dominated by Abies concolor and Pinus lambertiana (93.0% of tree biomass). The large-diameter component dominated the biomass of snags (59.5%) and contributed significantly to that of woody debris (36.6%). Traditional scaling theory was not a good model for either the relationship between tree radii and tree abundance or tree biomass. Spatial patterning of large-diameter trees of the three most abundant species differed from that of small-diameter conspecifics. For A. concolor and P. lambertiana, as well as all trees pooled, large-diameter and small-diameter trees were spatially segregated through inter-tree distances,10 m. Competition alone was insufficient to explain the spatial patterns of large-diameter trees and spatial relationships between large-diameter and small-diameter trees. Long-term observations may reveal regulation of forest biomass and spatial structure by fire, wind, pathogens, and insects in Sierra Nevada mixed-conifer forests. Sustaining ecosystem functions such as carbon storage or provision of specialist species habitat will likely require different management strategies when the functions are performed primarily by a few large trees as opposed to many smaller trees.	[Lutz, James A.] Univ Washington, Coll Environm, Seattle, WA 98195 USA; [Larson, Andrew J.] Univ Montana, Dept Forest Management, Missoula, MT 59812 USA; [Swanson, Mark E.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Freund, James A.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Montana System; University of Montana; Washington State University; University of Washington; University of Washington Seattle	Lutz, JA (corresponding author), Univ Washington, Coll Environm, Seattle, WA 98195 USA.	jlutz@uw.edu	Lutz, James/AAA-9574-2019; Lutz, James/B-3785-2012	Lutz, James/0000-0002-2560-0710	Smithsonian Institution Center for Tropical Forest Science; University of Washington College of the Environment; Direct For Biological Sciences [1046113] Funding Source: National Science Foundation	Smithsonian Institution Center for Tropical Forest Science; University of Washington College of the Environment; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was received from the Smithsonian Institution Center for Tropical Forest Science (http://www.ctfs.si.edu/) and the University of Washington College of the Environment (http://coenv.washington.edu/). In-kind support was received from the University of Washington, the University of Montana, Washington State University, the US Geological Survey, and Yosemite National Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baishya R, 2009, TROP ECOL, V50, P295; Baumgartner K, 2001, MYCOLOGIA, V93, P821, DOI 10.2307/3761748; BONNICKSEN TM, 1981, FOREST ECOL MANAG, V3, P307; BROWN IF, 1995, FOREST ECOL MANAG, V75, P175, DOI 10.1016/0378-1127(94)03512-U; Brown J. K., 1974, USDA Forest Service General Technical Report, Intermountain Forest and Range Experiment Station; Bunnel LH, 1880, DISCOVERY YOSEMITE I; Busing RT, 2005, ECOLOGY, V86, P73, DOI 10.1890/04-0410; Busing RT, 2002, J VEG SCI, V13, P785, DOI 10.1111/j.1654-1103.2002.tb02108.x; Chao KJ, 2009, J VEG SCI, V20, P260, DOI 10.1111/j.1654-1103.2009.05755.x; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; CLARK DB, 1991, J ECOL, V79, P447, DOI 10.2307/2260725; Clark DB, 1996, FOREST ECOL MANAG, V80, P235, DOI 10.1016/0378-1127(95)03607-5; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Das A, 2011, FOREST ECOL MANAG, V261, P1203, DOI 10.1016/j.foreco.2010.12.035; Diggle P., 2003, STAT ANAL SPATIAL PO; Edmonds RL, 2000, FOREST HLTH PROTECTI; Elsasser AB, 1978, HDB N AM INDIANS, V8, P37; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Furniss RL, 1977, MISCELLANEOUS PUBLIC, V1339, P1, DOI [10.5962/bhl.title.131875, DOI 10.5962/BHL.TITLE.131875]; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Gholz, 1979, EQUATIONS ESTIMATING; Gilbert GS, 2010, J VEG SCI, V21, P388, DOI 10.1111/j.1654-1103.2009.01151.x; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Hall CM, 2011, J HERIT TOUR, V6, P309, DOI 10.1080/1743873X.2011.620116; Hammer TE, 1995, ECOLOGY CONSERVATION; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harmon M. E, 2008, NRS29 USDA FOR SERV, DOI DOI 10.2737/NRS-GTR-29; Harmon M.E., 1996, GUIDELINES MEASUREME; HARMON ME, 1987, CAN J FOREST RES, V17, P1265, DOI 10.1139/x87-196; Hawksworth, 1996, AGR HDB, P410; Hickman JC, JEPSON MANUAL HIGHER; Hiskes G, 2009, DISCOVERY YOSEMITE 1; Jenkins J. C., 2004, NE319 USDA FOR SERV, DOI [10.2737/NE-GTR-319, DOI 10.2737/NE-GTR-319]; Jenkins JC, 2003, FOREST SCI, V49, P12; Jennings MD, 2009, ECOL MONOGR, V79, P173, DOI 10.1890/07-1804.1; Keeler-Wolf T, YOSEMITE NA IN PRESS; Keeton WS, 2011, FOREST SCI, V57, P489; Keeton WS, 2005, ECOL MONOGR, V75, P103, DOI 10.1890/03-0626; Knight FR, 2003, STEM MAPPING METHODO; Larson AJ, 2012, FOREST ECOL MANAG, V267, P74, DOI 10.1016/j.foreco.2011.11.038; Larson AJ, 2010, CAN J FOREST RES, V40, P2091, DOI 10.1139/X10-149; Larson AJ, 2008, CAN J FOREST RES, V38, P2814, DOI 10.1139/X08-123; Larson JA, 2006, J VEG SCI, V17, P489, DOI 10.1111/j.1654-1103.2006.tb02470.x; Levy R., 1978, HDB N AM INDIANS, V8, P398; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Lutz JA, 2009, FOREST ECOL MANAG, V257, P2296, DOI 10.1016/j.foreco.2009.03.009; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Lutz JA, 2011, FIRE ECOL, V7, P51, DOI 10.4996/fireecology.0702051; Lutz JA, 2010, J BIOGEOGR, V37, P936, DOI 10.1111/j.1365-2699.2009.02268.x; Makana JR, 2011, J TROP ECOL, V27, P447, DOI 10.1017/S0266467411000265; Martin TA, 2001, FOREST ECOL MANAG, V152, P211, DOI 10.1016/S0378-1127(00)00604-6; Meador AJS, 2009, J VEG SCI, V20, P79, DOI 10.1111/j.1654-1103.2009.05464.x; Means J. E., 1994, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Meyer MD, 2007, SOUTHWEST NAT, V52, P157, DOI 10.1894/0038-4909(2007)52[157:NTONFS]2.0.CO;2; Meyer MD, 2005, J MAMMAL, V86, P275, DOI 10.1644/BEH-110.1; MORRISON ML, 1993, ECOL APPL, V3, P322, DOI 10.2307/1941835; Muir J., 1911, MY 1 SUMMER SIERRA; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; NADKARNI NM, 1989, CONDOR, V91, P891, DOI 10.2307/1368074; Nesmith JCB, 2010, FIRE ECOL, V6, P97, DOI 10.4996/fireecology.0603097; North M, 2004, FOREST SCI, V50, P299; North M, 2007, CAN J FOREST RES, V37, P331, DOI 10.1139/X06-236; NRCS (Natural Resource Conservation Services), 2007, SOIL SURV GEOGR SSUR; Omura H, 2004, MT RES DEV, V24, P179, DOI 10.1659/0276-4741(2004)024[0179:TFARIJ]2.0.CO;2; Parker A.J., 2002, FIRE NATIVE PEOPLES, P233; PIELOU EC, 1962, J ECOL, V50, P357, DOI 10.2307/2257448; Pierson ED, 2006, BAT USE GIANT SEQUOI; PRISM, 2004, 800 M CLIM NORM 1971; R Core Team, 2016, R FDN STAT COMP; Rambo TR, 2009, FOREST ECOL MANAG, V257, P435, DOI 10.1016/j.foreco.2008.09.029; Rizzo DM, 2001, FOREST ECOL MANAG, V146, P159, DOI 10.1016/S0378-1127(00)00455-2; Roberts S. L., 2008, Fire Ecology, V4, P83; Roberts SL, 2011, BIOL CONSERV, V144, P610, DOI 10.1016/j.biocon.2010.11.002; Scholl AE, 2010, ECOL APPL, V20, P362, DOI 10.1890/08-2324.1; Sillett SC, 2007, ECOL MONOGR, V77, P335, DOI 10.1890/06-0994.1; Stephens SL, 2004, NORTHWEST SCI, V78, P93; Stephenson NL, 2011, ECOL MONOGR, V81, P527, DOI 10.1890/10-1077.1; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; Sugihara NG, 2006, FIRE IN CALIFORNIA'S ECOSYSTEMS, P1; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Tarnay LW, 2011, PARK SCI, V28, P48; Taylor AH, 2004, ECOL APPL, V14, P1903, DOI 10.1890/02-5257; Thode AE, 2011, INT J WILDLAND FIRE, V20, P223, DOI 10.1071/WF09060; USDI National Park Service, 2003, FIR MON HDB; van Mantgem PJ, 2004, ECOL APPL, V14, P1590, DOI 10.1890/03-5109; Van Pelt R, 2000, CAN J FOREST RES, V30, P1231, DOI 10.1139/cjfr-30-8-1231; Van Pelt R., 2001, FOREST GIANTS PACIFI; Van Pelt R, 2008, ECOL MONOGR, V78, P283, DOI 10.1890/07-0158.1; van Wagtendonk JW, 2010, FOREST ECOL MANAG, V259, P2122, DOI 10.1016/j.foreco.2010.02.024; van Wagtendonk JW, 2007, FIRE ECOL, V3, P34; Wang XG, 2011, J ECOL, V99, P1382, DOI 10.1111/j.1365-2745.2011.01857.x; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; Westman WE, 1998, J FOREST RES, V17, P311, DOI DOI 10.1139/X87-052; Winter LE, 2002, CAN J FOREST RES, V32, P1057, DOI 10.1139/X02-030	101	144	150	9	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36131	10.1371/journal.pone.0036131	http://dx.doi.org/10.1371/journal.pone.0036131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567132	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500050
J	Ray, S; Pyne, S				Ray, Surajit; Pyne, Saumyadipta			A Computational Framework to Emulate the Human Perspective in Flow Cytometric Data Analysis	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; TRANSFORMATIONS; DISPLAY	Background: In recent years, intense research efforts have focused on developing methods for automated flow cytometric data analysis. However, while designing such applications, little or no attention has been paid to the human perspective that is absolutely central to the manual gating process of identifying and characterizing cell populations. In particular, the assumption of many common techniques that cell populations could be modeled reliably with pre-specified distributions may not hold true in real-life samples, which can have populations of arbitrary shapes and considerable inter-sample variation. Results: To address this, we developed a new framework flowScape for emulating certain key aspects of the human perspective in analyzing flow data, which we implemented in multiple steps. First, flowScape begins with creating a mathematically rigorous map of the high-dimensional flow data landscape based on dense and sparse regions defined by relative concentrations of events around modes. In the second step, these modal clusters are connected with a global hierarchical structure. This representation allows flowScape to perform ridgeline analysis for both traversing the landscape and isolating cell populations at different levels of resolution. Finally, we extended manual gating with a new capacity for constructing templates that can identify target populations in terms of their relative parameters, as opposed to the more commonly used absolute or physical parameters. This allows flowScape to apply such templates in batch mode for detecting the corresponding populations in a flexible, sample-specific manner. We also demonstrated different applications of our framework to flow data analysis and show its superiority over other analytical methods. Conclusions: The human perspective, built on top of intuition and experience, is a very important component of flow cytometric data analysis. By emulating some of its approaches and extending these with automation and rigor, flowScape provides a flexible and robust framework for computational cytomics.	[Ray, Surajit] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Pyne, Saumyadipta] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Pyne, Saumyadipta] MIT, Broad Inst, Cambridge, MA 02139 USA; [Pyne, Saumyadipta] Harvard Univ, Cambridge, MA 02138 USA	Boston University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Ray, S (corresponding author), Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.	sray@math.bu.edu; spyne@broad.mit.edu	Ray, Surajit/H-4633-2019	Ray, Surajit/0000-0003-3965-8136				Aghaeepour N, 2010, RAPID CELL POPULATIO; Baudry JP, 2010, J COMPUT GRAPH STAT, V19, P332, DOI 10.1198/jcgs.2010.08111; Brinkman RR, 2007, BIOL BLOOD MARROW TR, V13, P691, DOI 10.1016/j.bbmt.2007.02.002; Cheng MY, 1998, J R STAT SOC B, V60, P579, DOI 10.1111/1467-9868.00141; Cheng MY, 1999, ANN STAT, V27, P1294; Cheng MY, 2004, IMS LECT NOTES MONOG, V45, P237; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ellis B, 2011, FLOWCORE FLOWCORE BA; Finak G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-546; Finak Greg, 2009, Advances in Bioinformatics, V2009, P247646, DOI 10.1155/2009/247646; Hahne F, 2010, FLOWSTATS STAT METHO; HAHNE F, 2009, BMC BIOINFORMATICS, V10; Hahne F, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r77; Hartigan J. A., 1988, Classification and Related Methods of Data Analysis. Proceedings of the First Conference of the International Federation of Classification Societies (IFCS), P229; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HARTIGAN PM, 1985, J R STAT SOC C-APPL, V34, P320; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Li J, 2007, J MACH LEARN RES, V8, P1687; Lin TI, 2009, J MULTIVARIATE ANAL, V100, P257, DOI 10.1016/j.jmva.2008.04.010; Lin TI, 2010, STAT COMPUT, V20, P343, DOI 10.1007/s11222-009-9128-9; Lindsay B, 2011, DEGREES FREEDOM QUAD; Lindsay BG, 2008, ANN STAT, V36, P983, DOI 10.1214/009053607000000956; Lo K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-145; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; Luta G, 2011, CYTOM PART A, V79A, P3, DOI 10.1002/cyto.a.20988; Maier LM, 2007, P NATL ACAD SCI USA, V104, P18607, DOI 10.1073/pnas.0706409104; Marchette DJ, 1997, J COMPUT GRAPH STAT, V6, P143; McLachlan G, 2000, WILEY SERIES PROBABI, DOI [10.1002/0471721182, DOI 10.1002/0471721182]; Minnotte MC, 1998, J COMPUT GRAPH STAT, V7, P239, DOI 10.2307/1390816; Novo D, 2008, CYTOM PART A, V73A, P685, DOI 10.1002/cyto.a.20592; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Ray S, 2005, ANN STAT, V33, P2042, DOI 10.1214/009053605000000417; Ray S, THESIS PENNSYLVANIA; Sarkar D, 2008, BIOINFORMATICS, V24, P878, DOI 10.1093/bioinformatics/btn021; Scheuermann R, 2009, J IMMUNOL, V42, P182; SILVERMAN BW, 1981, J ROY STAT SOC B MET, V43, P97; Silverman BW, 1983, PROBABILITY STAT ANA, V79, P248; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Trotter J, ALTERNATIVES LOG SCA, DOI [10.1002/0471142956.cy1016s42, DOI 10.1002/0471142956.CY1016S42]; Zare H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-403	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35693	10.1371/journal.pone.0035693	http://dx.doi.org/10.1371/journal.pone.0035693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563466	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000305340700015
J	Thompson, DA; Khan, NW; Othman, MI; Chang, B; Jia, L; Grahek, G; Wu, ZJ; Hiriyanna, S; Nellissery, J; Li, TS; Khanna, H; Colosi, P; Swaroop, A; Heckenlively, JR				Thompson, Debra A.; Khan, Naheed W.; Othman, Mohammad I.; Chang, Bo; Jia, Lin; Grahek, Garrett; Wu, Zhijian; Hiriyanna, Suja; Nellissery, Jacob; Li, Tiansen; Khanna, Hemant; Colosi, Peter; Swaroop, Anand; Heckenlively, John R.			Rd9 Is a Naturally Occurring Mouse Model of a Common Form of Retinitis Pigmentosa Caused by Mutations in RPGR-ORF15	PLOS ONE			English	Article							RPGR EXON ORF15; ONSET RETINAL DEGENERATION; CONE OPSIN MISLOCALIZATION; GTPASE REGULATOR RPGR; PHOTORECEPTOR DEGENERATION; DISEASE EXPRESSION; NEGATIVE RESPONSE; B-WAVE; A-WAVE; GENE	Animal models of human disease are an invaluable component of studies aimed at understanding disease pathogenesis and therapeutic possibilities. Mutations in the gene encoding retinitis pigmentosa GTPase regulator (RPGR) are the most common cause of X-linked retinitis pigmentosa (XLRP) and are estimated to cause 20% of all retinal dystrophy cases. A majority of RPGR mutations are present in ORF15, the purine-rich terminal exon of the predominant splice-variant expressed in retina. Here we describe the genetic and phenotypic characterization of the retinal degeneration 9 (Rd9) strain of mice, a naturally occurring animal model of XLRP. Rd9 mice were found to carry a 32-base-pair duplication within ORF15 that causes a shift in the reading frame that introduces a premature-stop codon. Rpgr ORF15 transcripts, but not protein, were detected in retinas from Rd9/Y male mice that exhibited retinal pathology, including pigment loss and slowly progressing decrease in outer nuclear layer thickness. The levels of rhodopsin and transducin in rod outer segments were also decreased, and M-cone opsin appeared mislocalized within cone photoreceptors. In addition, electroretinogram (ERG) a-and b-wave amplitudes of both Rd9/Y male and Rd9/Rd9 female mice showed moderate gradual reduction that continued to 24 months of age. The presence of multiple retinal features that correlate with findings in individuals with XLRP identifies Rd9 as a valuable model for use in gaining insight into ORF15-associated disease progression and pathogenesis, as well as accelerating the development and testing of therapeutic strategies for this common form of retinal dystrophy.	[Thompson, Debra A.; Khan, Naheed W.; Othman, Mohammad I.; Jia, Lin; Grahek, Garrett; Heckenlively, John R.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Thompson, Debra A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Chang, Bo] Jackson Lab, Bar Harbor, ME 04609 USA; [Wu, Zhijian; Hiriyanna, Suja; Nellissery, Jacob; Li, Tiansen; Colosi, Peter; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Khanna, Hemant] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Jackson Laboratory; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Massachusetts System; University of Massachusetts Worcester	Thompson, DA (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	swaroopa@nei.nih.gov; jrheck@umich.edu	wu, zhi/GXH-3041-2022	Thompson, Debra/0000-0003-3485-0794; Chang, Bo/0000-0001-8259-7290; Swaroop, Anand/0000-0002-1975-1141; NELLISSERY, JACOB/0000-0002-1209-664X	National Institutes of Health [RO1-EY007758, RO1-EY007961, RO1-EY019943, P30-EY07003, P60-DK-20572, UL1RR024986]; Foundation Fighting Blindness; Research to Prevent Blindness; intramural program of the National Eye Institute; Senior Scientific Investigator Awards; Clinician-Scientist Award from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000443, ZIAEY000490, R01EY007961, R01EY019943, P30EY007003, ZIAEY000473, R01EY007758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); intramural program of the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Senior Scientific Investigator Awards; Clinician-Scientist Award from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from National Institutes of Health (RO1-EY007758, RO1-EY007961, RO1-EY019943, P30-EY07003, P60-DK-20572, UL1RR024986), The Foundation Fighting Blindness, Research to Prevent Blindness, and the intramural program of the National Eye Institute. DAT, JRH, and AS are recipients of Senior Scientific Investigator Awards, and JRH received the Clinician-Scientist Award from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamian M, 2006, AM J OPHTHALMOL, V142, P515, DOI 10.1016/j.ajo.2006.03.061; Aguirre GD, 2002, EXP EYE RES, V75, P431, DOI 10.1006/exer.2002.2037; Aleman TS, 2007, INVEST OPHTH VIS SCI, V48, P4759, DOI 10.1167/iovs.07-0453; Aleman TS, 2001, VISION RES, V41, P2779, DOI 10.1016/S0042-6989(01)00157-2; Andreasson S, 1997, AM J OPHTHALMOL, V124, P95; Ayyagari R, 2002, GENOMICS, V80, P166, DOI 10.1006/geno.2002.6815; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Beltran WA, 2009, INVEST OPHTH VIS SCI, V50, P3985, DOI 10.1167/iovs.08-3364; Ben-Arie-Weintrob Yael, 2005, Ophthalmic Genet, V26, P91; Boylan JP, 2000, HUM MOL GENET, V9, P2085, DOI 10.1093/hmg/9.14.2085; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Brunner S, 2010, INVEST OPHTH VIS SCI, V51, P1106, DOI 10.1167/iovs.08-2742; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Chavali VRM, 2011, HUM MOL GENET, V20, P2000, DOI 10.1093/hmg/ddr080; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Fahim AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023021; Fishman GA, 1998, OPHTHALMOLOGY, V105, P2286, DOI 10.1016/S0161-6420(98)91231-3; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; Ghosh AK, 2010, HUM MOL GENET, V19, P90, DOI 10.1093/hmg/ddp469; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; He S, 2008, VISION RES, V48, P366, DOI 10.1016/j.visres.2007.08.005; Hemati N, 2005, MOL VIS, V11, P1151; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; HOOD DC, 1992, VISUAL NEUROSCI, V8, P107, DOI 10.1017/S0952523800009275; Iannaccone A, 2004, AM J OPHTHALMOL, V137, P785, DOI 10.1016/S0002-9394(03)01459-4; Jacobson SG, 1997, INVEST OPHTH VIS SCI, V38, P1983; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; LaVail MM, 1997, HISTOLOGICAL METHOD; Lorenz Birgit, 2003, Ophthalmic Genet, V24, P89, DOI 10.1076/opge.24.2.89.14001; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P442, DOI 10.1167/iovs.07-0291; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Murga-Zamalloa CA, 2010, HUM MOL GENET, V19, P3591, DOI 10.1093/hmg/ddq275; Neidhardt J, 2008, MOL VIS, V14, P1081; NUSINOWITZ S, 2002, SYSTEMATIC EVALUATIO, P320; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Sandberg MA, 2007, INVEST OPHTH VIS SCI, V48, P1298, DOI 10.1167/iovs.06-0971; Sharon D, 2003, AM J HUM GENET, V73, P1131, DOI 10.1086/379379; Shu X, 2005, HUM MOL GENET, V14, P1183, DOI 10.1093/hmg/ddi129; Shu XH, 2007, HUM MUTAT, V28, P322, DOI 10.1002/humu.20461; Shu XH, 2010, HUM MOL GENET, V19, P657, DOI 10.1093/hmg/ddp533; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; WALI N, 1991, DOC OPHTHALMOL, V76, P367, DOI 10.1007/BF00142675; Weleber RG, 1997, ARCH OPHTHALMOL-CHIC, V115, P1429, DOI 10.1001/archopht.1997.01100160599013; Yan D, 1998, J BIOL CHEM, V273, P19656, DOI 10.1074/jbc.273.31.19656; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993	61	48	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35865	10.1371/journal.pone.0035865	http://dx.doi.org/10.1371/journal.pone.0035865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563472	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340700021
J	Hroudova, M; Vojta, P; Strnad, H; Krejcik, Z; Ridl, J; Paces, J; Vlcek, C; Paces, V				Hroudova, Miluse; Vojta, Petr; Strnad, Hynek; Krejcik, Zdenek; Ridl, Jakub; Paces, Jan; Vlcek, Cestmir; Paces, Vaclav			Diversity, Phylogeny and Expression Patterns of Pou and Six Homeodomain Transcription Factors in Hydrozoan Jellyfish Craspedacusta sowerbyi	PLOS ONE			English	Article							LIM HOMEOBOX GENE; SENSORY ORGAN DEVELOPMENT; CENTRAL-NERVOUS-SYSTEM; RETINAL GANGLION; EYE DEVELOPMENT; SINE-OCULIS; C-ELEGANS; DEVELOPMENTAL EXPRESSION; CAENORHABDITIS-ELEGANS; SEA-ANEMONE	Formation of all metazoan bodies is controlled by a group of selector genes including homeobox genes, highly conserved across the entire animal kingdom. The homeobox genes from Pou and Six classes are key members of the regulation cascades determining development of sensory organs, nervous system, gonads and muscles. Besides using common bilaterian models, more attention has recently been targeted at the identification and characterization of these genes within the basal metazoan phyla. Cnidaria as a diploblastic sister group to bilateria with simple and yet specialized organs are suitable models for studies on the sensory organ origin and the associated role of homeobox genes. In this work, Pou and Six homeobox genes, together with a broad range of other sensory-specific transcription factors, were identified in the transcriptome of hydrozoan jellyfish Craspedacusta sowerbyi. Phylogenetic analyses of Pou and Six proteins revealed cnidarian-specific sequence motifs and contributed to the classification of individual factors. The majority of the Craspedacusta sowerbyi Pou and Six homeobox genes are predominantly expressed in statocysts, manubrium and nerve ring, the tissues with sensory and nervous activities. The described diversity and expression patterns of Pou and Six factors in hydrozoan jellyfish highlight their evolutionarily conserved functions. This study extends the knowledge of the cnidarian genome complexity and shows that the transcriptome of hydrozoan jellyfish is generally rich in homeodomain transcription factors employed in the regulation of sensory and nervous functions.	[Hroudova, Miluse; Vojta, Petr; Strnad, Hynek; Krejcik, Zdenek; Ridl, Jakub; Paces, Jan; Vlcek, Cestmir; Paces, Vaclav] Acad Sci Czech Republ, Inst Mol Genet, Dept Genom & Bioinformat, Prague, Czech Republic; [Hroudova, Miluse; Paces, Vaclav] Prague Inst Chem Technol, Dept Biochem & Microbiol, Fac Food & Biochem Technol, CR-16628 Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Chemistry & Technology, Prague	Hroudova, M (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Dept Genom & Bioinformat, Prague, Czech Republic.	hroudova@img.cas.cz	Krejcik, Zdenek/A-3505-2013; Pačes, Jan/C-8851-2009; Hradilova, Miluse/G-3829-2014	Pačes, Jan/0000-0003-3059-6127; Hradilova, Miluse/0000-0001-6615-0149; Vojta, Petr/0000-0003-0036-1853; Krejcik, Zdenek/0000-0002-8321-2644	Ministry of Education, Youth and Sports of the Czech Republic [1M6837805002, AV0Z50520514, MSM6046137305]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by grants of the Ministry of Education, Youth and Sports of the Czech Republic 1M6837805002, AV0Z50520514 and MSM6046137305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Ann KJ, 2009, GENESIS, V47, P137, DOI 10.1002/dvg.20454; Appolloni I, 2008, CEREB CORTEX, V18, P553, DOI 10.1093/cercor/bhm092; Arendt D, 2003, INT J DEV BIOL, V47, P563; Ball EE, 2004, NAT REV GENET, V5, P567, DOI 10.1038/nrg1402; Ball EE, 2002, INT J DEV BIOL, V46, P671; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Bebenek IG, 2004, DEV GENES EVOL, V214, P342, DOI 10.1007/s00427-004-0407-3; Bessarab DA, 2004, DEV DYNAM, V230, P781, DOI 10.1002/dvdy.20093; Bharathan G, 1997, P NATL ACAD SCI USA, V94, P13749, DOI 10.1073/pnas.94.25.13749; Boero F, 2007, INTEGR COMP BIOL, V47, P693, DOI 10.1093/icb/icm041; Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; Cillo C, 1999, EXP CELL RES, V248, P1, DOI 10.1006/excr.1999.4451; Collin RWJ, 2008, HUM MUTAT, V29, P545, DOI 10.1002/humu.20693; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; Cupit PM, 2006, GENE, V383, P1, DOI 10.1016/j.gene.2006.05.009; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; DECORDOBA SR, 2001, CURR GENOMICS, V2, P231; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Fritzsch B, 2007, INT J DEV BIOL, V51, P663, DOI 10.1387/ijdb.072367bf; Galliot B, 1999, DEV GENES EVOL, V209, P186, DOI 10.1007/s004270050243; Galliot B, 2011, EUR J NEUROSCI, V34, P847, DOI 10.1111/j.1460-9568.2011.07829.x; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Guder C, 2006, ONCOGENE, V25, P7450, DOI 10.1038/sj.onc.1210052; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanson IM, 2001, SEMIN CELL DEV BIOL, V12, P475, DOI 10.1006/scdb.2001.0271; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hobert O, 1998, J NEUROSCI, V18, P2084; Hobert O, 1998, BIOL BULL, V195, P377, DOI 10.2307/1543153; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Huang EJ, 1999, DEVELOPMENT, V126, P2869; Kappen C, 2000, P NATL ACAD SCI USA, V97, P4481, DOI 10.1073/pnas.97.9.4481; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kenyon KL, 2005, DEV DYNAM, V234, P497, DOI 10.1002/dvdy.20442; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; Kumar J, 1997, GENE DEV, V11, P2023, DOI 10.1101/gad.11.16.2023; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lanier J, 2007, DEV BIOL, V302, P703, DOI 10.1016/j.ydbio.2006.10.050; Larroux C, 2008, MOL BIOL EVOL; Lee MH, 2002, J NEUROSCI, V22, P5291; Lee SE, 2003, J MOL EVOL, V56, P509, DOI 10.1007/s00239-002-2421-2; Lesh-Laurie GE, 1991, PLACOZOA PORIFERA CN, VII, P185; Mackie GO, 2000, J EXP BIOL, V203, P1797; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; Mazet F, 2005, DEV BIOL, V282, P494, DOI 10.1016/j.ydbio.2005.02.021; Milani R, 1941, D I S, V14, P52; Millane RC, 2011, DEVELOPMENT, V138, P2429, DOI 10.1242/dev.064931; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Nakanishi N, 2010, EVOL DEV, V12, P404, DOI 10.1111/j.1525-142X.2010.00427.x; Nakanishi N, 2009, DEV GENES EVOL, V219, P301, DOI 10.1007/s00427-009-0291-y; Nam J, 2005, MOL BIOL EVOL, V22, P2386, DOI 10.1093/molbev/msi229; O'Brien EK, 2002, DEV GENES EVOL, V212, P394, DOI 10.1007/s00427-002-0256-x; Ozaki H, 2001, MOL CELL BIOL, V21, P3343, DOI 10.1128/MCB.21.10.3343-3350.2001; Pan L, 2005, DEVELOPMENT, V132, P703, DOI 10.1242/dev.01646; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Pang K, 2008, DEV GENES EVOL, V218, P307, DOI 10.1007/s00427-008-0222-3; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Piatigorsky J, 2004, INT J DEV BIOL, V48, P719, DOI 10.1387/ijdb.041851jp; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Plachetzki DC, 2005, TRENDS ECOL EVOL, V20, P465, DOI 10.1016/j.tree.2005.07.001; Porter FD, 1997, DEVELOPMENT, V124, P2935; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramachandra NB, 2002, DEV GENES EVOL, V212, P55, DOI 10.1007/s00427-001-0207-y; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Ryan JF, 2010, EVODEVO, V1, DOI [10.1186/2041-9139-1181-1189, DOI 10.1186/2041-9139-1181-1189]; Ryan JF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r64; Sampath K, 1996, BIOCHEM BIOPH RES CO, V219, P565, DOI 10.1006/bbrc.1996.0274; Sarafi-Reinach TR, 2001, DEVELOPMENT, V128, P3269; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Satterlie RA, 2011, J EXP BIOL, V214, P1215, DOI 10.1242/jeb.043687; Schierwater B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002457; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Seimiya M, 1997, EUR J BIOCHEM, V243, P27, DOI 10.1111/j.1432-1033.1997.0027a.x; Seimiya M, 2000, DEVELOPMENT, V127, P1879; Seo HC, 1999, MECH DEVELOP, V83, P127, DOI 10.1016/S0925-4773(99)00045-3; Shah D, 2000, DNA SEQUENCE, V11, P457, DOI 10.3109/10425170009033997; Spaniol P, 1996, NUCLEIC ACIDS RES, V24, P4874, DOI 10.1093/nar/24.24.4874; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Stierwald M, 2004, DEV BIOL, V274, P70, DOI 10.1016/j.ydbio.2004.06.018; Sze JY, 2003, P NATL ACAD SCI USA, V100, P9560, DOI 10.1073/pnas.1530752100; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Tichy AL, 2008, J NEUROSCI, V28, P7121, DOI 10.1523/JNEUROSCI.2063-08.2008; Veenstra GJC, 1997, MOL BIOL REP, V24, P139, DOI 10.1023/A:1006855632268; Wada S, 2003, DEV GENES EVOL, V213, P222, DOI 10.1007/s00427-003-0321-0; Wang LB, 2008, DEVELOPMENT, V135, P3425, DOI 10.1242/dev.012237; Weasner B, 2007, DEV BIOL, V303, P756, DOI 10.1016/j.ydbio.2006.10.040; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Zhang JM, 1999, DEV BIOL, V208, P465, DOI 10.1006/dbio.1999.9218; Zhao Yangu, 2002, Current Molecular Medicine (Hilversum), V2, P13, DOI 10.2174/1566524023363077; Zhou H, 1996, J NEUROSCI, V16, P2261, DOI 10.1523/jneurosci.16-07-02261.1996	106	17	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36420	10.1371/journal.pone.0036420	http://dx.doi.org/10.1371/journal.pone.0036420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558464	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200078
J	Dewhirst, FE; Klein, EA; Thompson, EC; Blanton, JM; Chen, T; Milella, L; Buckley, CMF; Davis, IJ; Bennett, ML; Marshall-Jones, ZV				Dewhirst, Floyd E.; Klein, Erin A.; Thompson, Emily C.; Blanton, Jessica M.; Chen, Tsute; Milella, Lisa; Buckley, Catherine M. F.; Davis, Ian J.; Bennett, Marie-Lousie; Marshall-Jones, Zoe V.			The Canine Oral Microbiome	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; SP-NOV.; GEN. NOV.; EMENDED DESCRIPTION; DOMAIN BACTERIA; PURE-CULTURE; FAM. NOV; PORPHYROMONAS; PHYLOGENY; DIVERSITY	Determining the bacterial composition of the canine oral microbiome is of interest for two primary reasons. First, while the human oral microbiome has been well studied using molecular techniques, the oral microbiomes of other mammals have not been studied in equal depth using culture independent methods. This study allows a comparison of the number of bacterial taxa, based on 16S rRNA-gene sequence comparison, shared between humans and dogs, two divergent mammalian species. Second, canine oral bacteria are of interest to veterinary and human medical communities for understanding their roles in health and infectious diseases. The bacteria involved are mostly unnamed and not linked by 16S rRNA-gene sequence identity to a taxonomic scheme. This manuscript describes the analysis of 5,958 16S rRNA-gene sequences from 65 clone libraries. Full length 16S rRNA reference sequences have been obtained for 353 canine bacterial taxa, which were placed in 14 bacterial phyla, 23 classes, 37 orders, 66 families, and 148 genera. Eighty percent of the taxa are currently unnamed. The bacterial taxa identified in dogs are markedly different from those of humans with only 16.4% of oral taxa are shared between dogs and humans based on a 98.5% 16S rRNA sequence similarity cutoff. This indicates that there is a large divergence in the bacteria comprising the oral microbiomes of divergent mammalian species. The historic practice of identifying animal associated bacteria based on phenotypic similarities to human bacteria is generally invalid. This report describes the diversity of the canine oral microbiome and provides a provisional 16S rRNA based taxonomic scheme for naming and identifying unnamed canine bacterial taxa.	[Dewhirst, Floyd E.; Klein, Erin A.; Thompson, Emily C.; Blanton, Jessica M.; Chen, Tsute] Forsyth Inst, Dept Mol Genet, Cambridge, MA 02142 USA; [Dewhirst, Floyd E.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Milella, Lisa] Vet Dent Surg, Byfleet, Surrey, England; [Buckley, Catherine M. F.; Davis, Ian J.; Marshall-Jones, Zoe V.] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England; [Bennett, Marie-Lousie] Mars Pet Care Europe, Birstall, W Yorkshire, England	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Mars; WALTHAM Petcare Science Institute; Mars	Dewhirst, FE (corresponding author), Forsyth Inst, Dept Mol Genet, Cambridge, MA 02142 USA.	fdewhirst@forsyth.org	Chen, Tsute/ABC-2676-2020	Dewhirst, Floyd E./0000-0003-4427-7928	WALTHAM Centre for Pet Nutrition	WALTHAM Centre for Pet Nutrition	This work was supported by the WALTHAM Centre for Pet Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Allaker RP, 1997, VET REC, V140, P147, DOI 10.1136/vr.140.6.147; ALLISON MJ, 1992, SYST APPL MICROBIOL, V15, P522, DOI 10.1016/S0723-2020(11)80111-6; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P674, DOI 10.1099/00207713-44-4-674; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; de Lillo A, 2006, ORAL MICROBIOL IMMUN, V21, P61, DOI 10.1111/j.1399-302X.2005.00255.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Downes J, 2009, INT J SYST EVOL MICR, V59, P972, DOI 10.1099/ijs.0.000364-0; Elliott DR, 2005, J CLIN MICROBIOL, V43, P5470, DOI 10.1128/JCM.43.11.5470-5476.2005; Fournier D, 2001, INT J SYST EVOL MICR, V51, P1179, DOI 10.1099/00207713-51-3-1179; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Garrity G.M., 2001, BERGEYS MANUAL SYSTE, P601; Garrity GM., 2001, BERGEYS MANUAL SYSTE, P427, DOI DOI 10.1007/978-0-387-21609-6_23; Hardham J, 2005, VET MICROBIOL, V106, P119, DOI 10.1016/j.vetmic.2004.12.018; Hardham JM, 2008, INT J SYST EVOL MICR, V58, P103, DOI 10.1099/ijs.0.63458-0; Harris JK, 2004, APPL ENVIRON MICROB, V70, P845, DOI 10.1128/AEM.70.2.845-849.2004; HIRASAWA M, 1994, INT J SYST BACTERIOL, V44, P637, DOI 10.1099/00207713-44-4-637; Hoyles L, 2002, INT J SYST EVOL MICR, V52, P1201, DOI [10.1099/ijs.0.01934-0, 10.1099/00207713-52-4-1201]; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Iino T, 2010, INT J SYST EVOL MICR, V60, P1376, DOI 10.1099/ijs.0.012484-0; Janssen PH, 2003, ARCH MICROBIOL, V179, P321, DOI 10.1007/s00203-003-0528-5; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; JUKES T H, 1969, P21; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Ludwig W., 2009, BERGEYS MANUAL SYSTE; Marchandin H, 2010, INT J SYST EVOL MICR, V60, P1271, DOI 10.1099/ijs.0.013102-0; Nogales B, 2001, APPL ENVIRON MICROB, V67, P1874, DOI 10.1128/AEM.67.4.1874-1884.2001; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; PASTER BJ, 1988, INT J SYST BACTERIOL, V38, P56, DOI 10.1099/00207713-38-1-56; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Pikuta EV, 2009, INT J SYST EVOL MICR, V59, P2302, DOI 10.1099/ijs.0.002816-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Leeuwenhoek A, 1683, COMMUNICATION   0917; Wouters EGH, 2008, VET MICROBIOL, V128, P419, DOI 10.1016/j.vetmic.2007.10.019; Yabe S, 2010, INT J SYST EVOL MICR, V60, P1794, DOI 10.1099/ijs.0.018069-0; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0	43	138	143	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36067	10.1371/journal.pone.0036067	http://dx.doi.org/10.1371/journal.pone.0036067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000117
J	Jonsson, F; Gurniak, CB; Fleischer, B; Kirfel, G; Witke, W				Joensson, Friederike; Gurniak, Christine B.; Fleischer, Bernhard; Kirfel, Gregor; Witke, Walter			Immunological Responses and Actin Dynamics in Macrophages Are Controlled by N-Cofilin but Are Independent from ADF	PLOS ONE			English	Article							T-CELL-ACTIVATION; WISKOTT-ALDRICH-SYNDROME; DEPOLYMERIZING FACTOR; SYNAPSE FORMATION; CYTOSKELETAL DYNAMICS; IMMUNE SYNAPSE; F-ACTIN; PROTEIN; BINDING; ADF/COFILIN	Dynamic changes in the actin cytoskeleton are essential for immune cell function and a number of immune deficiencies have been linked to mutations, which disturb the actin cytoskeleton. In macrophages and dendritic cells, actin remodelling is critical for motility, phagocytosis and antigen presentation, however the actin binding proteins, which control antigen presentation have been poorly characterized. Here we dissect the specific roles of the family of ADF/cofilin F-actin depolymerizing factors in macrophages and in local immune responses. Macrophage migration, cell polarization and antigen presentation to T-cells require n-cofilin mediated F-actin remodelling. Using a conditional mouse model, we show that n-cofilin also controls MHC class II-dependent antigen presentation. Other cellular processes such as phagocytosis and antigen processing were found to be independent of n-cofilin. Our data identify n-cofilin as a novel regulator of antigen presentation, while ADF on the other hand is dispensable for macrophage motility and antigen presentation.	[Joensson, Friederike; Fleischer, Bernhard] Bernhard Nocht Inst Trop Med, Dept Immunol, Hamburg, Germany; [Gurniak, Christine B.; Witke, Walter] Univ Bonn, Inst Genet, Cell Motil Unit, Bonn, Germany; [Joensson, Friederike] Inst Pasteur, INSERM, U760, Dept Immunol,Unite Allergol Mol & Cellulaire, F-75724 Paris, France; [Kirfel, Gregor] Univ Bonn, Inst Cell Biol, Bonn, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Bonn; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Bonn	Jonsson, F (corresponding author), Bernhard Nocht Inst Trop Med, Dept Immunol, Hamburg, Germany.	w.witke@uni-bonn.de	Jönsson, Friederike/H-7525-2014	Jönsson, Friederike/0000-0002-1667-8065	Gottlieb Daimler- and Karl Benz-Foundation; Olympus-Europe-Foundation; Deutsche Forschungsgemeinschaft [SFB704]	Gottlieb Daimler- and Karl Benz-Foundation; Olympus-Europe-Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	FJ was supported by Gottlieb Daimler- and Karl Benz-Foundation and by Olympus-Europe-Foundation fellowships. Running cost for the project were provided by the Project Grant SFB704 of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Adachi R, 2002, J BIOL CHEM, V277, P45566, DOI 10.1074/jbc.M207419200; Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Bamburg JR, 2008, CURR BIOL, V18, pR273, DOI 10.1016/j.cub.2008.02.002; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Billadeau DD, 2006, TRAFFIC, V7, P1451, DOI 10.1111/j.1600-0854.2006.00491.x; Binks M, 1998, EUR J IMMUNOL, V28, P3259; Bouma G, 2011, BLOOD, V118, P2492, DOI 10.1182/blood-2011-03-340265; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gombos I, 2004, IMMUNOL LETT, V92, P117, DOI 10.1016/j.imlet.2003.11.022; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Hiltbold EM, 2003, J IMMUNOL, V170, P1329, DOI 10.4049/jimmunol.170.3.1329; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; IIDA K, 1993, GENE, V124, P115; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Matsui S, 2002, J BIOL CHEM, V277, P544, DOI 10.1074/jbc.M110153200; May RC, 2001, J CELL SCI, V114, P1061; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Muller N, 2006, TRAFFIC, V7, P849, DOI 10.1111/j.1600-0854.2006.00426.x; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; PERRIN D, 1992, J CELL BIOL, V116, P127, DOI 10.1083/jcb.116.1.127; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Samstag Y, 1996, J IMMUNOL, V156, P4167; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Stradal Theresia E. B., 2006, V43, P219, DOI 10.1007/022; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; WEEDS AG, 1991, BIOCHEM SOC T, V19, P1016, DOI 10.1042/bst0191016; White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280	56	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36034	10.1371/journal.pone.0036034	http://dx.doi.org/10.1371/journal.pone.0036034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558315	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000106
J	Liu, YH; Vaghjiani, V; Tee, JY; To, K; Cui, P; Oh, DY; Manuelpillai, U; Toh, BH; Chan, J				Liu, Yu Han; Vaghjiani, Vijesh; Tee, Jing Yang; To, Kelly; Cui, Peng; Oh, Ding Yuan; Manuelpillai, Ursula; Toh, Ban-Hock; Chan, James			Amniotic Epithelial Cells from the Human Placenta Potently Suppress a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MESENCHYMAL STEM-CELLS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; LYMPHOCYTE-T; TRANSPLANTATION; TOLERANCE; DISEASE	Human amniotic epithelial cells (hAEC) have stem cell-like features and immunomodulatory properties. Here we show that hAEC significantly suppressed splenocyte proliferation in vitro and potently attenuated a mouse model of multiple sclerosis (MS). Central nervous system (CNS) CD3(+) T cell and F4/80(+) monocyte/macrophage infiltration and demyelination were significantly reduced with hAEC treatment. Besides the known secretion of prostaglandin E2 (PGE2), we report the novel finding that hAEC utilize transforming growth factor-beta (TGF-beta) for immunosuppression. Neutralization of TGF-beta or PGE2 in splenocyte proliferation assays significantly reduced hAEC-induced suppression. Splenocytes from hAEC-treated mice showed a Th2 cytokine shift with significantly elevated IL-5 production. While transferred CFSE-labeled hAEC could be detected in the lung, none were identified in the CNS or in lymphoid organs. This is the first report documenting the therapeutic effect of hAEC in a MS-like model and suggest that hAEC may have potential for use as therapy for MS.	[Liu, Yu Han; To, Kelly; Cui, Peng; Oh, Ding Yuan; Toh, Ban-Hock; Chan, James] Monash Univ, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia; [Vaghjiani, Vijesh; Tee, Jing Yang; Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia	Monash University; Monash University	Liu, YH (corresponding author), Monash Univ, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia.	james.chan@monash.edu	Tee, Jing Yang/F-2821-2013	Tee, Jing Yang/0000-0003-1605-4938; Vaghjiani, Vijesh/0000-0001-8004-3876; Oh, Ding Yuan/0000-0003-0695-8490	Australian National Health & Medical Research Council (NHMRC) [606473]; National Health and Medical Research Council (NHMRC) [436634]; Victorian Government	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	W, JYT, UM supported by Australian National Health & Medical Research Council (NHMRC) grant #606473, YHL, KT, DYO, BHT and JC by National Health and Medical Research Council (NHMRC) program grant #436634 and Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Chan J, 2008, AUTOIMMUNITY, V41, P405, DOI 10.1080/08916930802011258; Chan J, 2008, J IMMUNOL, V181, P7571, DOI 10.4049/jimmunol.181.11.7571; Chen XT, 2011, AUTOIMMUNITY, V44, P384, DOI 10.3109/08916934.2010.541173; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kong XY, 2008, BRAIN RES, V1205, P108, DOI 10.1016/j.brainres.2008.02.040; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495; Li HM, 2011, J IMMUNOL, V187, P274, DOI 10.4049/jimmunol.1003603; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496; McKarns SC, 2000, IMMUNOPHARMACOLOGY, V48, P101, DOI 10.1016/S0162-3109(00)00183-1; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pratama G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026136; Prockop DJ, 2011, MOL THER; RACKE MK, 1991, J IMMUNOL, V146, P3012; RACKE MK, 1992, INT IMMUNOL, V4, P615, DOI 10.1093/intimm/4.5.615; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; SHALABY MR, 1988, CELL IMMUNOL, V112, P343, DOI 10.1016/0008-8749(88)90303-6; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; Stinissen P, 1997, CRIT REV IMMUNOL, V17, P33, DOI 10.1615/CritRevImmunol.v17.i1.20; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; Uccelli A, 2011, LANCET NEUROL, V10, P649, DOI 10.1016/S1474-4422(11)70121-1; Uchida S, 2000, J NEUROSCI RES, V62, P585, DOI 10.1002/1097-4547(20001115)62:4<585::AID-JNR13>3.0.CO;2-U; Uchida S, 2003, NEUROSCI LETT, V341, P1, DOI 10.1016/S0304-3940(02)01454-4; Von Budingen HC, 2001, J CLIN IMMUNOL, V21, P155; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202	46	64	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35758	10.1371/journal.pone.0035758	http://dx.doi.org/10.1371/journal.pone.0035758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563398	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349100026
J	Arendash, GW; Mori, T; Dorsey, M; Gonzalez, R; Tajiri, N; Borlongan, C				Arendash, Gary W.; Mori, Takashi; Dorsey, Maggie; Gonzalez, Rich; Tajiri, Naoki; Borlongan, Cesar			Electromagnetic Treatment to Old Alzheimer's Mice Reverses beta-Amyloid Deposition, Modifies Cerebral Blood Flow, and Provides Selected Cognitive Benefit	PLOS ONE			English	Article							HEAD-ONLY EXPOSURE; MOBILE PHONE USE; BRAIN TEMPERATURE; A-BETA; FIELDS; TERM; PERFORMANCE; IMPAIRMENT; DISEASE; MEMORY	Few studies have investigated physiologic and cognitive effects of "long-term" electromagnetic field (EMF) exposure in humans or animals. Our recent studies have provided initial insight into the long-term impact of adulthood EMF exposure (GSM, pulsed/modulated, 918 MHz, 0.25-1.05 W/kg) by showing 6+ months of daily EMF treatment protects against or reverses cognitive impairment in Alzheimer's transgenic (Tg) mice, while even having cognitive benefit to normal mice. Mechanistically, EMF-induced cognitive benefits involve suppression of brain beta-amyloid (A beta) aggregation/deposition in Tg mice and brain mitochondrial enhancement in both Tg and normal mice. The present study extends this work by showing that daily EMF treatment given to very old (21-27 month) Tg mice over a 2-month period reverses their very advanced brain A beta aggregation/deposition. These very old Tg mice and their normal littermates together showed an increase in general memory function in the Y-maze task, although not in more complex tasks. Measurement of both body and brain temperature at intervals during the 2-month EMF treatment, as well as in a separate group of Tg mice during a 12-day treatment period, revealed no appreciable increases in brain temperature (and no/slight increases in body temperature) during EMF "ON" periods. Thus, the neuropathologic/cognitive benefits of EMF treatment occur without brain hyperthermia. Finally, regional cerebral blood flow in cerebral cortex was determined to be reduced in both Tg and normal mice after 2 months of EMF treatment, most probably through cerebrovascular constriction induced by freed/disaggregated A beta (Tg mice) and slight body hyperthermia during "ON" periods. These results demonstrate that long-term EMF treatment can provide general cognitive benefit to very old Alzheimer's Tg mice and normal mice, as well as reversal of advanced A beta neuropathology in Tg mice without brain heating. Results further underscore the potential for EMF treatment against AD.	[Arendash, Gary W.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Arendash, Gary W.] Florida Alzheimers Dis Res Ctr, Tampa, FL USA; [Mori, Takashi] Saitama Med Ctr, Dept Biomed Sci, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Univ, Kawagoe, Saitama, Japan; [Dorsey, Maggie] Univ S Florida, Hlth Byrd Alzheimers Inst, Tampa, FL USA; [Gonzalez, Rich] SAI Florida, Redington Beach, FL USA; [Tajiri, Naoki; Borlongan, Cesar] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL USA	State University System of Florida; University of South Florida; Saitama Medical University; Saitama Medical University; Saitama Medical University; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Arendash, GW (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	arendash@cas.usf.edu	Tajiri, Naoki/K-1230-2012; Borlongan, Cesar/I-5696-2012	Tajiri, Naoki/0000-0003-2189-662X; Borlongan, Cesar/0000-0002-2966-9782	NIA-designated Florida Alzheimer's Disease Research Center [AG025711]; USF/Byrd Alzheimer's Institute; USF Interdisciplinary Research Development Grant; Alzheimer's Drug Discovery Foundation Young Investigator Scholarship; NATIONAL INSTITUTE ON AGING [P50AG025711] Funding Source: NIH RePORTER	NIA-designated Florida Alzheimer's Disease Research Center; USF/Byrd Alzheimer's Institute; USF Interdisciplinary Research Development Grant; Alzheimer's Drug Discovery Foundation Young Investigator Scholarship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the NIA-designated Florida Alzheimer's Disease Research Center (AG025711) to G. A., the USF/Byrd Alzheimer's Institute to G. A., and a USF Interdisciplinary Research Development Grant to G. A. and C. V. B. N.T. is a recipient of the 2011 Alzheimer's Drug Discovery Foundation Young Investigator Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto S, 2006, J CEREBR BLOOD F MET, V26, P885, DOI 10.1038/sj.jcbfm.9600279; Ammari M, 2008, BRAIN INJURY, V22, P1021, DOI 10.1080/02699050802530599; Arendash GW, 2007, NEUROSCIENCE, V149, P286, DOI 10.1016/j.neuroscience.2007.08.018; Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Arendash GW, 2010, J ALZHEIMERS DIS, V19, P191, DOI 10.3233/JAD-2010-1228; Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087; Arendash GW, 1999, NEUROSCI LETT, V268, P17, DOI 10.1016/S0304-3940(99)00239-6; Arns M, 2007, INT J NEUROSCI, V117, P1341, DOI 10.1080/00207450600936882; Aydin D, 2011, JNCI-J NATL CANCER I, V103, P1264, DOI 10.1093/jnci/djr244; Barth A, 2012, BIOELECTROMAGNETICS, V33, P159, DOI 10.1002/bem.20697; Besset A, 2005, BIOELECTROMAGNETICS, V26, P102, DOI 10.1002/bem.20053; Borlongan CV, 2004, BRAIN RES, V1009, P26, DOI 10.1016/j.brainres.2004.02.050; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; Brambrink AM, 1999, J NEUROSCI METH, V92, P111, DOI 10.1016/S0165-0270(99)00100-4; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cook CM, 2009, BIOELECTROMAGNETICS, V30, P9, DOI 10.1002/bem.20434; DeBow S, 2003, METHODS, V30, P167, DOI 10.1016/S1046-2023(03)00080-X; Dragicevic N, 2011, NEUROSCIENCE, V185, P135, DOI 10.1016/j.neuroscience.2011.04.012; Dubreuil D, 2003, BEHAV BRAIN RES, V145, P51, DOI 10.1016/S0166-4328(03)00100-1; Dubreuil D, 2002, BEHAV BRAIN RES, V129, P203, DOI 10.1016/S0166-4328(01)00344-8; Echeverria V, 2011, J ALZHEIMERS DIS, V24, P817, DOI 10.3233/JAD-2011-102136; Fritzer G, 2007, BIOELECTROMAGNETICS, V28, P316, DOI 10.1002/bem.20301; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Haarala C, 2003, NEUROREPORT, V14, P2019, DOI 10.1097/00001756-200311140-00003; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hardell L, 2008, INT J ONCOL, V32, P1097; Huber R, 2005, EUR J NEUROSCI, V21, P1000, DOI 10.1111/j.1460-9568.2005.03929.x; Ito S, 2007, J NEUROCHEM, V103, P2482, DOI 10.1111/j.1471-4159.2007.04938.x; Juutilainen J, 2011, BIOELECTROMAGNETICS, V32, P511, DOI 10.1002/bem.20652; Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019; Krewski D, 2007, J TOXICOL ENV HEAL B, V10, P287, DOI 10.1080/15287390600974973; Kubacki R, 2007, 2 INT C EL FIELDS HL; Kumlin T, 2007, RADIAT RES, V168, P471, DOI 10.1667/RR1002.1; Kwon MS, 2011, BIOELECTROMAGNETICS, V32, P253, DOI 10.1002/bem.20635; Leighty RE, 2004, BEHAV BRAIN RES, V153, P107, DOI 10.1016/j.bbr.2003.11.004; Masuda H, 2011, J APPL PHYSIOL, V110, P142, DOI 10.1152/japplphysiol.01035.2010; Mori T, 2011, J ALZHEIMERS DIS PAR, V1, P2; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Nelson MD, 2011, J PHYSIOL-LONDON, V589, P4053, DOI 10.1113/jphysiol.2011.212118; NIGHTINGALE NRV, 1983, PHYS MED BIOL, V28, P897, DOI 10.1088/0031-9155/28/8/002; Nybo L, 2002, J APPL PHYSIOL, V93, P58, DOI 10.1152/japplphysiol.00049.2002; Olcese JM, 2009, J PINEAL RES, V47, P82, DOI 10.1111/j.1600-079X.2009.00692.x; Paris D, 2003, NEUROL RES, V25, P642, DOI 10.1179/016164103101201940; Schuz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004389; Shimizu H, 1997, MAGNET RESON MED, V37, P833, DOI 10.1002/mrm.1910370606; Sienkiewicz ZJ, 2000, BIOELECTROMAGNETICS, V21, P151, DOI 10.1002/(SICI)1521-186X(200004)21:3<151::AID-BEM1>3.0.CO;2-Q; Swerdlow AJ, 2011, MOBILE PHONES BRAIN, DOI DOI 10.1289/EHP.1103693; Tattersall JEH, 2001, BRAIN RES, V904, P43, DOI 10.1016/S0006-8993(01)02434-9; Valberg PA, 2007, ENVIRON HEALTH PERSP, V115, P416, DOI 10.1289/ehp.9633; Van Leeuwen GMJ, 1999, PHYS MED BIOL, V44, P2367, DOI 10.1088/0031-9155/44/10/301; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P808, DOI 10.1001/jama.2011.186	52	70	74	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35751	10.1371/journal.pone.0035751	http://dx.doi.org/10.1371/journal.pone.0035751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558216	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345200074
J	Nelson, SA; Sanson, AM; Park, HO; Cooper, JA				Nelson, Scott A.; Sanson, Anthony M.; Park, Hay-Oak; Cooper, John A.			A Novel Role for the GTPase-Activating Protein Bud2 in the Spindle Position Checkpoint	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SITE-SELECTION; MITOTIC EXIT; BUDDING YEAST; EXCHANGE FACTOR; CELL POLARITY; KINASE KIN4; RAS; LTE1; PATHWAY	The spindle position checkpoint (SPC) ensures correct mitotic spindle position before allowing mitotic exit in the budding yeast Saccharomyces cerevisiae. In a candidate screen for checkpoint genes, we identified bud2 Delta as deficient for the SPC. Bud2 is a GTPase activating protein (GAP), and the only known substrate of Bud2 was Rsr1/Bud1, a Ras-like GTPase and a central component of the bud-site-selection pathway. Mutants lacking Rsr1/Bud1 had no checkpoint defect, as did strains lacking and overexpressing Bud5, a guanine-nucleotide exchange factor (GEF) for Rsr1/Bud1. Thus, the checkpoint function of Bud2 is distinct from its role in bud site selection. The catalytic activity of the Bud2 GAP domain was required for the checkpoint, based on the failure of the known catalytic point mutant Bud2(R682A) to function in the checkpoint. Based on assays of heterozygous diploids, bud2(R682A), was dominant for loss of checkpoint but recessive for bud-site-selection failure, further indicating a separation of function. Tem1 is a Ras-like protein and is the critical regulator of mitotic exit, sitting atop the mitotic exit network (MEN). Tem1 is a likely target for Bud2, supported by genetic analyses that exclude other Ras-like proteins.	[Nelson, Scott A.; Cooper, John A.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63130 USA; [Sanson, Anthony M.; Park, Hay-Oak] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	Washington University (WUSTL); University System of Ohio; Ohio State University	Nelson, SA (corresponding author), Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63130 USA.	jcooper@wustl.edu	Cooper, John/E-9389-2012; Cooper, John/D-4448-2014	Park, Hay-Oak/0000-0001-5782-2257; Cooper, John/0000-0002-0933-4571	National Institutes of Health (NIH) [GM 76375, GM 69895, 47337]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069895, R01GM047337, R01GM076375] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM 76375 to Dr. Park and GM 69895 and 47337 to Dr. Cooper, www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; Bardin AJ, 2003, MOL CELL BIOL, V23, P5018, DOI 10.1128/MCB.23.14.5018-5030.2003; BENDER A, 1993, P NATL ACAD SCI USA, V90, P9926, DOI 10.1073/pnas.90.21.9926; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bertazzi DT, 2011, J CELL BIOL, V193, P1033, DOI 10.1083/jcb.201101056; Castillon GA, 2003, CURR BIOL, V13, P654, DOI 10.1016/S0960-9822(03)00247-1; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; D'Aquino KE, 2005, MOL CELL, V19, P223, DOI 10.1016/j.molcel.2005.06.005; Geymonat M, 2009, J CELL BIOL, V187, P497, DOI 10.1083/jcb.200905114; Ho J, 2001, MOL BIOL CELL, V12, P1541, DOI 10.1091/mbc.12.6.1541; Huisman SM, 2005, J CELL SCI, V118, P463, DOI 10.1242/jcs.01650; Kang PJ, 2001, SCIENCE, V292, P1376, DOI 10.1126/science.1060360; Marston AL, 2001, CURR BIOL, V11, P803, DOI 10.1016/S0960-9822(01)00230-5; MORISHITA T, 1995, SCIENCE, V270, P1213, DOI 10.1126/science.270.5239.1213; Nelson SA, 2007, MOL BIOL CELL, V18, P3440, DOI 10.1091/mbc.E07-03-0242; Park HO, 1999, GENE DEV, V13, P1912, DOI 10.1101/gad.13.15.1912; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; Pereira G, 2005, MOL CELL, V19, P209, DOI 10.1016/j.molcel.2005.05.030; Piatti S, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-2; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Seshan A, 2005, CELL CYCLE, V4, P940, DOI 10.4161/cc.4.7.1785; Wittinghofer A, 1997, FEBS LETT, V410, P63, DOI 10.1016/S0014-5793(97)00321-9; Yoshida S, 2003, J CELL BIOL, V161, P889, DOI 10.1083/jcb.200301128; Zahner JE, 1996, MOL CELL BIOL, V16, P1857	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36127	10.1371/journal.pone.0036127	http://dx.doi.org/10.1371/journal.pone.0036127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558355	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200118
J	Mythreye, K; Knelson, EH; Gatza, CE; Gatza, ML; Blobe, GC				Mythreye, K.; Knelson, E. H.; Gatza, C. E.; Gatza, M. L.; Blobe, G. C.			T beta RIII/beta-arrestin2 regulates integrin alpha 5 beta 1 trafficking, function, and localization in epithelial cells	ONCOGENE			English	Article						integrin alpha 5 beta 1; beta-arrestin2; TGF-beta; betaglycan	TGF-BETA RECEPTOR; FOCAL ADHESION KINASE; CANCER; BETAGLYCAN; PROTEIN; ALPHA-V-BETA-3; EXPRESSION; MEMBRANE; BINDING; INVASIVENESS	The type III TGF-beta receptor (T beta RIII) is a ubiquitous co-receptor for TGF-beta superfamily ligands with roles in suppressing cancer progression, in part through suppressing cell motility. Here we demonstrate that T beta RIII promotes epithelial cell adhesion to fibronectin in a beta-arrestin2 dependent and TGF-beta/BMP independent manner by complexing with active integrin alpha 5 beta 1, and mediating beta-arrestin2-dependent alpha 5 beta 1 internalization and trafficking to nascent focal adhesions. T beta RIII-mediated integrin alpha 5 beta 1 trafficking regulates cell adhesion and fibronectin fibrillogenesis in epithelial cells, as well as alpha 5 localization in breast cancer patients. We further demonstrate that increased T beta RIII expression correlates with increased alpha 5 localization at sites of cell-cell adhesion in breast cancer patients, while higher T beta RIII expression is a strong predictor of overall survival in breast cancer patients. These data support a novel, clinically relevant role for T beta RIII in regulating integrin alpha 5 localization, reveal a novel crosstalk mechanism between the integrin and TGF-beta superfamily signaling pathways and identify beta-arrestin2 as a regulator of alpha 5 beta 1 trafficking. Oncogene (2013) 32, 1416-1427; doi:10.1038/onc.2012.157; published online 7 May 2012	[Mythreye, K.; Gatza, C. E.; Blobe, G. C.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27708 USA; [Knelson, E. H.; Blobe, G. C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Gatza, M. L.] Duke Univ, Med Ctr, Duke IGSP, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Blobe, GC (corresponding author), Duke Univ, Med Ctr, Dept Med, B354 LSRC,Box 91004 DUMC, Durham, NC 27708 USA.	blobe001@mc.duke.edu	Blobe, Gerard/AAJ-5945-2020; Karthikeyan, Mythreye/ABC-7345-2020	Blobe, Gerard/0000-0002-4274-8901; Karthikeyan, Mythreye/0000-0001-5478-0098; Knelson, Erik/0000-0003-4087-2017; Gatza, Michael/0000-0001-6796-7791	NIH Grants [R01-CA135006, R01-CA136786]; Komen for the Cure Grants [KG090154, SAC100002]; Department of Defense grant [W81 XWH-09-1-0265]; NATIONAL CANCER INSTITUTE [R01CA136786, R01CA135006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	NIH Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen for the Cure Grants; Department of Defense grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We sincerely thank Sue Craig and Martin Humphries for generously providing us with SNAKA51, L. Attisano for BMPRII construct, Tam How and Alisha Holtzhausen for technical help in generation of the ratT beta RIII-T841A plasmid and plasmid purifications respectively, Duke University Light Microscopy facility for help in training individuals with the use of the TIRFM and confocal microscopes. This work was supported in part by NIH Grants R01-CA135006 and R01-CA136786 (GCB), Komen for the Cure Grants KG090154 and SAC100002 (GCB) and Department of Defense grant W81 XWH-09-1-0265 (KM).	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Bilandzic M, 2011, MOL CELL ENDOCRINOL, V28; Bilandzic M, 2009, MOL ENDOCRINOL, V23, P539, DOI 10.1210/me.2008-0300; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; BRETSCHER MS, 1992, EMBO J, V11, P383, DOI 10.1002/j.1460-2075.1992.tb05066.x; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Clark K, 2005, J CELL SCI, V118, P291, DOI 10.1242/jcs.01623; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hempel N, 2007, CANCER RES, V67, P5231, DOI 10.1158/0008-5472.CAN-07-0035; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kuwada SK, 2000, MOL BIOL CELL, V11, P2485, DOI 10.1091/mbc.11.7.2485; Lee NY, 2009, MOL BIOL CELL, V20, P4362, DOI 10.1091/mbc.E09-07-0539; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; LIU F, 1995, MOL CELL BIOL, V15, P3479; LOFTUS JC, 1994, J BIOL CHEM, V269, P25235; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Molteni R, 2009, BLOOD, V114, P1073, DOI 10.1182/blood-2008-10-183699; Morgan MR, 2009, IUBMB LIFE, V61, P731, DOI 10.1002/iub.200; Mythreye K, 2009, CELL SIGNAL, V8; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; PARSONS JT, 1994, J CELL SCI, P109; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; You HJ, 2007, CARCINOGENESIS, V28, P2491, DOI 10.1093/carcin/bgm195; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	53	19	19	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2013	32	11					1416	1427		10.1038/onc.2012.157	http://dx.doi.org/10.1038/onc.2012.157			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22562249	Green Accepted			2022-12-25	WOS:000316455600008
J	Danilenko, N; Merkulava, E; Siniauskaya, M; Olejnik, O; Levaya-Smaliak, A; Kushniarevich, A; Shymkevich, A; Davydenko, O				Danilenko, Nina; Merkulava, Elena; Siniauskaya, Marina; Olejnik, Olga; Levaya-Smaliak, Anastasia; Kushniarevich, Alena; Shymkevich, Andrey; Davydenko, Oleg			Spectrum of Genetic Changes in Patients with Non-Syndromic Hearing Impairment and Extremely High Carrier Frequency of 35delG GJB2 Mutation in Belarus	PLOS ONE			English	Article							12S RIBOSOMAL-RNA; GJB2 MUTATIONS; HIGH PREVALENCE; DEAFNESS; EXPRESSION	The genetic nature of sensorineural hearing loss (SNHL) has so far been studied for many ethnic groups in various parts of the world. The single-nucleotide guanine deletion (35delG) of the GJB2 gene coding for connexin 26 was shown to be the main genetic cause of autosomal recessive deafness among Europeans. Here we present the results of the first study of GJB2 and three mitochondrial mutations among two groups of Belarusian inhabitants: native people with normal hearing (757 persons) and 391 young patients with non-syndromic SNHL. We have found an extremely high carrier frequency of 35delG GJB2 mutation in Belarus 25.7%. This point deletion has also been detected in 53% of the patients with SNHL. The 312del14 GJB2 was the second most common mutation in the Belarus patient cohort. Mitochondrial A1555G mt-RNR1 substitution was found in two SNHL patients (0.55%) but none were found in the population cohort. No individuals carried the A7445G mutation of mitochondrial mt-TS1. G7444A as well as T961G substitutions were detected in mitochondrial mt-RNR1 at a rate of about 1% both in the patient and population cohorts. A possible reason for Belarusians having the highest mutation carrier frequency in Europe 35delG is discussed.	[Danilenko, Nina; Siniauskaya, Marina; Olejnik, Olga; Shymkevich, Andrey; Davydenko, Oleg] Natl Acad Sci, Inst Cytol & Genet, Minsk, BELARUS; [Merkulava, Elena; Levaya-Smaliak, Anastasia] Belarusian State Med Univ, Minsk, BELARUS; [Kushniarevich, Alena] Estonian Bioctr, Tartu, Estonia	National Academy of Sciences of Belarus (NASB); Institute of Genetics & Cytology of the National Academy of Sciences of Belarus; Belarusian State Medical University; Estonian Biocentre	Danilenko, N (corresponding author), Natl Acad Sci, Inst Cytol & Genet, Minsk, BELARUS.	n.danilenko@tut.by			Belarus government program Health of mother and child - well-being of family [03.03.10]	Belarus government program Health of mother and child - well-being of family	The study was supported by Belarus government program Health of mother and child - well-being of family and state (2010-2012) assignment No. 03.03.10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Antoniadi T, 1999, CLIN GENET, V55, P381; Bitner-Glindzicz M, 2002, BRIT MED BULL, V63, P73, DOI 10.1093/bmb/63.1.73; Cryns K, 2004, J MED GENET, V41, P147, DOI 10.1136/jmg.2003.013896; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Dzhemileva LU, 2010, J HUM GENET, V55, P749, DOI 10.1038/jhg.2010.101; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; FischelGhodsian N, 1997, AM J OTOLARYNG, V18, P173, DOI 10.1016/S0196-0709(97)90078-8; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Guastalla P, 2009, RADIOLOGY, V251, P280, DOI 10.1148/radiol.2511080912; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Kokotas H, 2008, AM J MED GENET A, V146A, P2879, DOI 10.1002/ajmg.a.32546; Kokotas H, 2011, DIS MARKERS, V30, P283, DOI [10.1155/2011/350987, 10.3233/DMA-2011-0786]; Kokotas H, 2010, J HUM GENET, V55, P265, DOI 10.1038/jhg.2010.23; Li R, 2004, J MED GENET, V41, P615, DOI 10.1136/jmg.2004.020230; Lucotte G, 2005, GENET TEST, V9, P20, DOI 10.1089/gte.2005.9.20; Man YKS, 2007, J MEMBRANE BIOL, V218, P29, DOI 10.1007/s00232-007-9025-0; Mathew C.G., 1985, METHOD MOL BIOL, V2, P31, DOI DOI 10.1385/0-89603-064-4:31; Meyer CG, 2002, NAT MED, V8, P1332, DOI 10.1038/nm1202-1332; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Palmada M, 2006, NEUROBIOL DIS, V22, P112, DOI 10.1016/j.nbd.2005.10.005; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Rabionet R, 2000, HUM MUTAT, V16, P190, DOI 10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.3.CO;2-9; Rothrock CR, 2003, HUM GENET, V113, P18, DOI 10.1007/s00439-003-0944-2; Rydzanicz M, 2010, BIOCHEM BIOPH RES CO, V395, P116, DOI 10.1016/j.bbrc.2010.03.149; Schon Eric A, 2002, Methods Mol Biol, V197, P55, DOI 10.1385/1-59259-284-8:055; Shanske AL, 2001, ARCH PEDIAT ADOL MED, V155, P1210; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Toth T, 2007, INT J MOL MED, V20, P315; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VanCamp G, 1997, AM J HUM GENET, V60, P758; Wilch E, 2010, CLIN GENET, V78, P267, DOI 10.1111/j.1399-0004.2010.01387.x; Wilcox SA, 2000, HUM GENET, V106, P399, DOI 10.1007/s004390000273; Yang Ai-Fen, 2008, Yichuan, V30, P728, DOI 10.3724/SP.J.1005.2008.00728	40	18	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36354	10.1371/journal.pone.0036354	http://dx.doi.org/10.1371/journal.pone.0036354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567152	gold, Green Published			2022-12-25	WOS:000305341500071
J	Liu, HY; Li, Y; Li, YW; Liu, BX; Wu, H; Wang, J; Wang, YL; Wang, M; Tang, SC; Zhou, QH; Chen, J				Liu, Hongyu; Li, Ying; Li, Yongwen; Liu, Baoxin; Wu, Heng; Wang, Jing; Wang, Yuli; Wang, Min; Tang, Shou-Ching; Zhou, Qinghua; Chen, Jun			Cloning and Functional Analysis of FLJ20420: A Novel Transcription Factor for the BAG-1 Promoter	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; INDUCED APOPTOSIS; CANCER-CELLS; PROTEIN; HSP70/HSC70; ISOFORMS; MODELS; BCL-2; P53	BAG-1 is an anti-apoptotic protein that interacts with a variety of cellular molecules to inhibit apoptosis. The mechanisms by which BAG-1 interacts with other proteins to inhibit apoptosis have been extensively explored. However, it is currently unknown how BAG-1 expression is regulated at the molecular level, especially in cancer cells. Here we reported to clone a novel down-regulated BAG-1 expression gene named FLJ20420 using hBAG-1 promoter as a probe to screen Human Hela 59 cDNA library by Southernwestern blot. The FLJ20420 gene encodes a similar to 26-kDa protein that is localized in both the cytoplasm and nucleus. We proved that FLJ20420 protein can specially bind hBAG-1 promoter region by EMSA in vivo and ChIP assay in vivo. Northern blot analysis revealed a low level of FLJ20420 transcriptional expression in normal human tissues (i.e., brain, placenta, lung, liver, kidney, pancreas and cervix), except for heart and skeletal muscles, which showed higher levels. Furthermore, enhanced FLJ20420 expression was observed in tumor cell lines (i.e., MDA468, BT-20, MCF-7, C33A, HeLa and Caski). Knockdown of endogenous FLJ20420 expression significantly increased BAG-1 expression in A549 and L9981 cells, and also significantly enhanced their sensitivity to cisplatin-induced apoptosis. A microarray assay of the FLJ20420 siRNA -transfectants showed altered expression of 505 known genes, including 272 upregulated and 233 downregulated genes. Finally, our gene array studies in lung cancer tissue samples revealed a significant increase in FLJ20420 expression in primary lung cancer relative to the paired normal lung tissue controls (p = 0.0006). The increased expression of FLJ20420 corresponded to a significant decrease in BAG-1 protein expression in the primary lung cancers, relative to the paired normal lung tissue controls (p = 0.0001). Taken together, our experiments suggest that FLJ20420 functions as a down-regulator of BAG-1 expression. Its abnormal expression may be involved in the oncogenesis of human malignancies such as lung cancer.	[Liu, Hongyu; Li, Ying; Li, Yongwen; Wu, Heng; Wang, Jing; Wang, Yuli; Wang, Min; Zhou, Qinghua; Chen, Jun] Tianjin Med Univ Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China; [Liu, Baoxin] Henan Tumor Hosp, Dept Thorac Surg, Zhengzhou, Henan, Peoples R China; [Tang, Shou-Ching] Univ Minnesota, Fac Med, Div Hematol Oncol, Minneapolis, MN USA; [Tang, Shou-Ching] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China	Tianjin Medical University; Zhengzhou University; University of Minnesota System; University of Minnesota Twin Cities; Tianjin Medical University	Liu, HY (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China.	sctang2000@yahoo.com; zhouqh1016@yahoo.com.cn; huntercj2004@yahoo.com	, leeywen/ABA-5704-2020	, leeywen/0000-0001-6102-2949	National Natural Science Foundation of China [30500221, 30500496]; Science and Technology Support Key Program of Tianjin [09ZCZDSF04000, 09ZCZDSF04100, 09ZCZDSF03800]; Ministry of Education for New Century Excellent Talents [NCET-10-0956]; Sylvester Comprehensive Cancer Center at the University of Miami	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Key Program of Tianjin; Ministry of Education for New Century Excellent Talents; Sylvester Comprehensive Cancer Center at the University of Miami	This research was supported by grants from the National Natural Science Foundation of China (30500221 and 30500496), Science and Technology Support Key Program of Tianjin (09ZCZDSF04000, 09ZCZDSF04100 and 09ZCZDSF03800) and the project of Ministry of Education for New Century Excellent Talents (NCET-10-0956). The original cloning of FLJ20420 was carried out in the laboratory of Dr. Shou-Ching Tang in Miami, FL, with grant support from the Sylvester Comprehensive Cancer Center at the University of Miami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1998, LEUKEMIA LYMPHOMA, V30, P483, DOI 10.3109/10428199809057561; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Brochier C, 2008, PHYSIOL GENOMICS, V33, P170, DOI 10.1152/physiolgenomics.00125.2007; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; Chen J, 2005, GENESIS, V43, P196, DOI 10.1002/gene.20171; Coldwell MJ, 2001, ONCOGENE, V20, P4095, DOI 10.1038/sj.onc.1204547; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Dreger M, 2005, J PROTEOME RES, V4, P238, DOI 10.1021/pr049870w; Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Li RCX, 2000, AM J PHYSIOL-HEART C, V279, pH1679, DOI 10.1152/ajpheart.2000.279.4.H1679; Liu HY, 2009, ACTA PHARMACOL SIN, V30, P235, DOI 10.1038/aps.2008.21; Lu XQ, 2007, BLOOD, V110, P4268, DOI 10.1182/blood-2007-04-087775; Ma W, 2008, BIOCHEM BIOPH RES CO, V371, P425, DOI 10.1016/j.bbrc.2008.04.083; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; Quentmeier H, 2003, LEUKEMIA RES, V27, P539, DOI 10.1016/S0145-2126(02)00269-2; Rorke S, 2001, INT J CANCER, V95, P317, DOI 10.1002/1097-0215(20010920)95:5<317::AID-IJC1055>3.0.CO;2-J; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Sekiya M, 1997, BIOCHEM BIOPH RES CO, V239, P401, DOI 10.1006/bbrc.1997.7478; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Tang SC, 2004, BREAST CANCER RES TR, V84, P203, DOI 10.1023/B:BREA.0000019951.32001.93; Tang SC, 1999, J CLIN ONCOL, V17, P1710, DOI 10.1200/JCO.1999.17.6.1710; Tang SC, 2002, IUBMB LIFE, V53, P99, DOI 10.1080/15216540211473; Uriguen L, 2008, GENES BRAIN BEHAV, V7, P649, DOI 10.1111/j.1601-183X.2008.00402.x; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yang XL, 1999, ONCOGENE, V18, P4546, DOI 10.1038/sj.onc.1202843; Yang XL, 1999, CLIN CANCER RES, V5, P1816; Yang XL, 1999, EXP CELL RES, V247, P200, DOI 10.1006/excr.1998.4349; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Zhang F, 2010, ACTA PHARMACOL SIN, V31, P111, DOI 10.1038/aps.2009.178	35	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34832	10.1371/journal.pone.0034832	http://dx.doi.org/10.1371/journal.pone.0034832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567091	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500009
J	Galvez-Peralta, M; He, L; Jorge-Nebert, LF; Wang, B; Miller, ML; Eppert, BL; Afton, S; Nebert, DW				Galvez-Peralta, Marina; He, Lei; Jorge-Nebert, Lucia F.; Wang, Bin; Miller, Marian L.; Eppert, Bryan L.; Afton, Scott; Nebert, Daniel W.			ZIP8 Zinc Transporter: Indispensable Role for Both Multiple-Organ Organogenesis and Hematopoiesis In Utero	PLOS ONE			English	Article							DYNAMIC TRANSCRIPTOMIC PROFILES; ZEBRAFISH GILLS; IMMUNE-SYSTEM; MOUSE; GENE; MUTATIONS; FAMILY; MEMBER; IDENTIFICATION; ASSOCIATION	Previously this laboratory characterized Slc39a8-encoded ZIP8 as a Zn2+/(HCO3-)(2) symporter; yet, the overall physiological importance of ZIP8 at the whole-organism level remains unclear. Herein we describe the phenotype of the hypomorphic Slc39a8(neo/neo) mouse which has retained the neomycin-resistance gene in intron 3, hence causing significantly decreased ZIP8 mRNA and protein levels in embryo, fetus, placenta, yolk sac, and several tissues of neonates. The Slc39a8(neo) allele is associated with diminished zinc and iron uptake in mouse fetal fibroblast and liver-derived cultures; consequently, Slc39a8(neo/neo) newborns exhibit diminished zinc and iron levels in several tissues. Slc39a8(neo/neo) homozygotes from gestational day(GD)-11.5 onward are pale, growth-stunted, and die between GD18.5 and 48 h postnatally. Defects include: severely hypoplastic spleen; hypoplasia of liver, kidney, lung, and lower limbs. Histologically, Slc39a8(neo/neo) neonates show decreased numbers of hematopoietic islands in yolk sac and liver. Low hemoglobin, hematocrit, red cell count, serum iron, and total iron-binding capacity confirmed severe anemia. Flow cytometry of fetal liver cells revealed the erythroid series strikingly affected in the hypomorph. Zinc-dependent 5-aminolevulinic acid dehydratase, required for heme synthesis, was not different between Slc39a8(+/+) and Slc39a8(neo/neo) offspring. To demonstrate further that the mouse phenotype is due to ZIP8 deficiency, we bred Slc39a8(+/neo) with BAC-transgenic BTZIP8-3 line (carrying three extra copies of the Slc39a8 allele); this cross generated viable Slc39a8(neo/neo)_BTZIP8-3(+/+) pups showing none of the above-mentioned congenital defects-proving Slc39a8(neo/neo) causes the described phenotype. Our study demonstrates that ZIP8-mediated zinc transport plays an unappreciated critical role during in utero and neonatal growth, organ morphogenesis, and hematopoiesis.	[Galvez-Peralta, Marina; He, Lei; Jorge-Nebert, Lucia F.; Wang, Bin; Miller, Marian L.; Eppert, Bryan L.; Nebert, Daniel W.] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Galvez-Peralta, Marina; He, Lei; Jorge-Nebert, Lucia F.; Wang, Bin; Miller, Marian L.; Eppert, Bryan L.; Nebert, Daniel W.] Univ Cincinnati, Med Ctr, CEG, Cincinnati, OH 45267 USA; [Afton, Scott] Univ Cincinnati, Dept Chem, Sch Arts & Sci, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Galvez-Peralta, M (corresponding author), Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA.	dan.nebert@uc.edu			NIH [R01 ES010416, T32 ES016646, P30 ES06096]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016646, R01ES010416, P30ES006096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH Grants R01 ES010416 (D.W.N.), T32 ES016646 (M. G.-P.), and P30 ES06096 (D.W.N., M. L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; BINGHAM PM, 1985, CELL, V40, P819, DOI 10.1016/0092-8674(85)90341-1; Cao YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020634; Carrera N, 2012, BIOL PSYCHIAT, V71, P169, DOI 10.1016/j.biopsych.2011.09.032; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Dalton TP, 2000, PHARMACOGENETICS, V10, P141, DOI 10.1097/00008571-200003000-00006; Dietz RM, 2009, J NEUROCHEM, V109, P145, DOI 10.1111/j.1471-4159.2009.05853.x; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Dworkin I, 2005, GENETICS, V169, P2115, DOI 10.1534/genetics.104.035766; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Food Nutrition Board, 2001, ZINC DIET REF INT VI, V1, P442; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Gibson JB, 1999, BIOCHEM GENET, V37, P301, DOI 10.1023/A:1018707226595; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Goldsborough AS, 1996, NATURE, V381, P807, DOI 10.1038/381807a0; HARRISON SM, 1995, DEVELOPMENT, V121, P2479; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; He L, 2009, TOXICOL APPL PHARM, V238, P250, DOI 10.1016/j.taap.2009.02.017; He Lei, 2009, Human Genomics, V3, P195; Hirano T, 2000, ADV IMMUNOL, V97, P149; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P395, DOI 10.3324/haematol.13619; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kawamura T, 1997, HEPATOLOGY, V26, P1567; Koolen DA, 2009, HUM MUTAT, V30, P283, DOI 10.1002/humu.20883; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Liu Z, 2008, BIOCHEM BIOPH RES CO, V365, P814, DOI 10.1016/j.bbrc.2007.11.067; MANSUKHANI A, 1988, MOL GEN GENET, V211, P121, DOI 10.1007/BF00338402; Mocchegiani E, 2010, P NUTR SOC, V69, P290, DOI 10.1017/S0029665110001862; Moore-Scott BA, 2007, DEV DYNAM, V236, P1997, DOI 10.1002/dvdy.21204; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Permyakov EA, 2009, J INORG BIOCHEM, V103, P77, DOI 10.1016/j.jinorgbio.2008.09.006; Prasad AS, 2003, BMJ-BRIT MED J, V326, P409, DOI 10.1136/bmj.326.7386.409; Robin C, 2004, METH MOLEC MED, V105, P257; Schmitt S, 2009, HUM MUTAT, V30, P926, DOI 10.1002/humu.20988; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Strolin Benedetti M, 2005, Expert Opin Drug Metab Toxicol, V1, P447; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Wang B, 2007, AM J PHYSIOL-CELL PH, V292, pC1523, DOI 10.1152/ajpcell.00409.2006; Wang B, 2011, BIOCHEM BIOPH RES CO, V410, P289, DOI 10.1016/j.bbrc.2011.05.134; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Zheng DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-553; Zheng D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-548; Zhu Hao, 2007, Syst Synth Biol, V1, P171, DOI 10.1007/s11693-008-9015-2	49	75	76	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36055	10.1371/journal.pone.0036055	http://dx.doi.org/10.1371/journal.pone.0036055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563477	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340700026
J	Haag, LM; Fischer, A; Otto, B; Plickert, R; Kuhl, AA; Gobel, UB; Bereswill, S; Heimesaat, MM				Haag, Lea-Maxie; Fischer, Andre; Otto, Bettina; Plickert, Rita; Kuehl, Anja A.; Goebel, Ulf B.; Bereswill, Stefan; Heimesaat, Markus M.			Intestinal Microbiota Shifts towards Elevated Commensal Escherichia coli Loads Abrogate Colonization Resistance against Campylobacter jejuni in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GERM-FREE-MICE; INFANT MICE; MURINE COLITIS; CROHNS-DISEASE; MUCOSAL FLORA; INFECTION; PATHOGENESIS; ENTERITIS; BACTERIA	Background: The zoonotic pathogen Campylobacter jejuni is a leading cause of bacterial foodborne enterocolitis in humans worldwide. The understanding of immunopathology underlying human campylobacteriosis is hampered by the fact that mice display strong colonization resistance against the pathogen due to their host specific gut microbiota composition. Methodology/Principal Findings: Since the microbiota composition changes significantly during intestinal inflammation we dissected factors contributing to colonization resistance against C. jejuni in murine ileitis, colitis and in infant mice. In contrast to healthy animals C. jejuni could stably colonize mice suffering from intestinal inflammation. Strikingly, in mice with Toxoplasma gondii-induced acute ileitis, C. jejuni disseminated to mesenteric lymphnodes, spleen, liver, kidney, and blood. In infant mice C. jejuni infection induced enterocolitis. Mice suffering from intestinal inflammation and C. jejuni susceptible infant mice displayed characteristical microbiota shifts dominated by increased numbers of commensal Escherichia coli. To further dissect the pivotal role of those distinct microbiota shifts in abrogating colonization resistance, we investigated C. jejuni infection in healthy adult mice in which the microbiota was artificially modified by feeding live commensal E. coli. Strikingly, in animals harboring supra-physiological intestinal E. coli loads, colonization resistance was significantly diminished and C. jejuni infection induced enterocolitis mimicking key features of human campylobacteriosis. Conclusion/Significance: Murine colonization resistance against C. jejuni is abrogated by changes in the microbiota composition towards elevated E. coli loads during intestinal inflammation as well as in infant mice. Intestinal inflammation and microbiota shifts thus represent potential risk factors for C. jejuni infection. Corresponding interplays between C. jejuni and microbiota might occur in human campylobacteriosis. Murine models introduced here mimick key features of human campylobacteriosis and allow for further analysis of immunological and molecular mechanisms of C. jejuni - host interactions.	[Haag, Lea-Maxie; Fischer, Andre; Otto, Bettina; Plickert, Rita; Goebel, Ulf B.; Bereswill, Stefan; Heimesaat, Markus M.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Kuehl, Anja A.] Charite, Res Ctr ImmunoSci RCIS, Dept Internal Med Rheumatol & Clin Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Haag, LM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de	Haag, Lea Maxie/AAP-9001-2020	Haag, Lea-Maxie/0000-0002-3754-5317; Heimesaat, Markus/0000-0001-6399-651X; Kuhl, Anja/0000-0003-2293-5387	15 German Research Foundation (DFG) [GO363/12-1, CampyGerm, SFB633, TP A7, TP Z1, TP B6, Immuco]; German Federal Ministery of Education and Research (BMBF) [TP1.1, TP 8.2]	15 German Research Foundation (DFG); German Federal Ministery of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the 15 German Research Foundation (DFG) to UBG (GO363/12-1, CampyGerm; SFB633, TP A7), SB (SFB633, TP A7), AK (SFB633, TP Z1), MMH (SFB633, TP B6), LMH and BO (SFB633, Immuco), and from the German Federal Ministery of Education and Research (BMBF) to SB ("Lab in a hanky'' projects TP1.1 and TP 8.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIMIKU AG, 1987, J MED MICROBIOL, V23, P339, DOI 10.1099/00222615-23-4-339; Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Allos BM, 1997, J INFECT DIS, V176, pS125, DOI 10.1086/513783; Bereswill S, 2011, EUR J MICROBIOL IMMU, V1, P237, DOI 10.1556/EuJMI.1.2011.3.8; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; DIKER KS, 1992, ACTA MICROBIOL HUNG, V39, P133; Dorrell N, 2007, CURR OPIN INFECT DIS, V20, P514, DOI 10.1097/QCO.0b013e3282a56b15; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; FIELD LH, 1986, INFECT IMMUN, V54, P126, DOI 10.1128/IAI.54.1.126-132.1986; FIELD LH, 1981, INFECT IMMUN, V33, P884, DOI 10.1128/IAI.33.3.884-892.1981; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Haag LM, 2012, EUR J MICROBIOL IMMU, V2, P2, DOI 10.1556/EuJMI.2.2012.1.2; HANNINEN ML, 1989, J MED MICROBIOL, V30, P199, DOI 10.1099/00222615-30-3-199; HANNINEN ML, 1990, EPIDEMIOL INFECT, V104, P397, DOI 10.1017/S0950268800047415; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Helms M, 2006, CLIN INFECT DIS, V42, P498, DOI 10.1086/499813; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Jess T, 2011, GUT, V60, P318, DOI 10.1136/gut.2010.223396; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; Kist M, 2001, Contrib Microbiol, V8, P150; Lane JA, 2010, INT J FOOD MICROBIOL, V142, P1, DOI 10.1016/j.ijfoodmicro.2010.05.027; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; WALKER RI, 1986, MICROBIOL REV, V50, P81, DOI 10.1128/MMBR.50.1.81-94.1986; Wohlgemuth S, 2011, GUT MICROBES, V2, P159, DOI 10.4161/gmic.2.3.16104; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; YRIOS JW, 1986, INFECT IMMUN, V53, P378, DOI 10.1128/IAI.53.2.378-383.1986; YRIOS JW, 1986, INFECT IMMUN, V53, P384, DOI 10.1128/IAI.53.2.384-392.1986; YRIOS JW, 1986, INFECT IMMUN, V54, P339, DOI 10.1128/IAI.54.2.339-346.1986	50	130	130	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35988	10.1371/journal.pone.0035988	http://dx.doi.org/10.1371/journal.pone.0035988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563475	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340700024
J	Jessen, S; Obleser, J; Kotz, SA				Jessen, Sarah; Obleser, Jonas; Kotz, Sonja A.			How Bodies and Voices Interact in Early Emotion Perception	PLOS ONE			English	Article							LIGHT BIOLOGICAL MOTION; AUDIOVISUAL INTEGRATION; MULTISENSORY INTEGRATION; POINT-LIGHT; BODY EXPRESSIONS; INFLUENCE RECOGNITION; OSCILLATORY ACTIVITY; LOOMING SIGNALS; VISUAL SPEECH; MU-RHYTHMS	Successful social communication draws strongly on the correct interpretation of others' body and vocal expressions. Both can provide emotional information and often occur simultaneously. Yet their interplay has hardly been studied. Using electroencephalography, we investigated the temporal development underlying their neural interaction in auditory and visual perception. In particular, we tested whether this interaction qualifies as true integration following multisensory integration principles such as inverse effectiveness. Emotional vocalizations were embedded in either low or high levels of noise and presented with or without video clips of matching emotional body expressions. In both, high and low noise conditions, a reduction in auditory N100 amplitude was observed for audiovisual stimuli. However, only under high noise, the N100 peaked earlier in the audiovisual than the auditory condition, suggesting facilitatory effects as predicted by the inverse effectiveness principle. Similarly, we observed earlier N100 peaks in response to emotional compared to neutral audiovisual stimuli. This was not the case in the unimodal auditory condition. Furthermore, suppression of beta-band oscillations (15-25 Hz) primarily reflecting biological motion perception was modulated 200-400 ms after the vocalization. While larger differences in suppression between audiovisual and audio stimuli in high compared to low noise levels were found for emotional stimuli, no such difference was observed for neutral stimuli. This observation is in accordance with the inverse effectiveness principle and suggests a modulation of integration by emotional content. Overall, results show that ecologically valid, complex stimuli such as joined body and vocal expressions are effectively integrated very early in processing.	[Jessen, Sarah; Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Minerva Res Grp Neurocognit Rhythm Commun, Leipzig, Germany; [Jessen, Sarah] Free Univ Berlin, Berlin, Germany; [Obleser, Jonas] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Auditory Cognit, Leipzig, Germany	Max Planck Society; Free University of Berlin; Max Planck Society	Jessen, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Minerva Res Grp Neurocognit Rhythm Commun, Leipzig, Germany.	jessen@cbs.mpg.de	Obleser, Jonas/C-9891-2011; Jessen, Sarah/T-8421-2018	Obleser, Jonas/0000-0002-7619-0459; Jessen, Sarah/0000-0003-4067-271X	Max Planck Society; Cluster of Excellence "Languages of Emotion" at the Free University of Berlin	Max Planck Society(Max Planck SocietyFoundation CELLEX); Cluster of Excellence "Languages of Emotion" at the Free University of Berlin	The research was supported by the Max Planck Society and the Cluster of Excellence "Languages of Emotion" at the Free University of Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Beauchamp MS, 2005, NEUROINFORMATICS, V3, P93, DOI 10.1385/NI:3:2:093; Callan DE, 2003, NEUROREPORT, V14, P2213, DOI 10.1097/00001756-200312020-00016; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; Dietrich S, 2008, NEUROREPORT, V19, P1751, DOI 10.1097/WNR.0b013e3283193e9e; Ethofer T, 2006, PROG BRAIN RES, V156, P345, DOI 10.1016/S0079-6123(06)56019-4; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Holle H, 2010, NEUROIMAGE, V49, P875, DOI 10.1016/j.neuroimage.2009.08.058; HOLM S, 1979, SCAND J STAT, V6, P65; Jessen S, 2011, NEUROIMAGE, V58, P665, DOI 10.1016/j.neuroimage.2011.06.035; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Laurienti PJ, 2005, EXP BRAIN RES, V166, P289, DOI 10.1007/s00221-005-2370-2; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Macmillan N. A., 2005, DETECTION THEORY USE; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Medendorp WP, 2007, CEREB CORTEX, V17, P2364, DOI 10.1093/cercor/bhl145; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Muthukumaraswamy SD, 2006, BRAIN RES, V1071, P105, DOI 10.1016/j.brainres.2005.11.053; Muthukumaraswamy SD, 2008, PSYCHOPHYSIOLOGY, V45, P896, DOI 10.1111/j.1469-8986.2008.00711.x; Oberman LM, 2007, NEUROCOMPUTING, V70, P2194, DOI 10.1016/j.neucom.2006.02.024; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2009, J PSYCHOPHYSIOL, V23, P63, DOI 10.1027/0269-8803.23.2.63; Perry A, 2010, SOC NEUROSCI-UK, V5, P272, DOI 10.1080/17470910903395767; Petrini K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019165; Petrini K, 2010, BRAIN RES, V1323, P139, DOI 10.1016/j.brainres.2010.02.012; Pichon S, 2008, SOC NEUROSCI-UK, V3, P199, DOI 10.1080/17470910701394368; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pollick FE, 2005, J EXP PSYCHOL HUMAN, V31, P1247, DOI 10.1037/0096-1523.31.6.1247; Pourtois G, 2002, COGNITIVE BRAIN RES, V14, P99, DOI 10.1016/S0926-6410(02)00064-2; Romei V, 2009, CURR BIOL, V19, P1799, DOI 10.1016/j.cub.2009.09.027; Rosenthal R, 1991, METAANALYTIC  PROCED; Sauter DA, 2010, J COGNITIVE NEUROSCI, V22, P474, DOI 10.1162/jocn.2009.21215; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Senkowski D, 2007, EXP BRAIN RES, V177, P184, DOI 10.1007/s00221-006-0664-7; Senkowski D, 2011, NEUROIMAGE, V56, P2200, DOI 10.1016/j.neuroimage.2011.03.075; Shahin AJ, 2009, BRAIN COGNITION, V70, P259, DOI 10.1016/j.bandc.2009.02.008; SHARBROUGH F, 1991, CLIN NEUROPHYSIOL, V8, P200, DOI DOI 10.1097/00004691-199104000-00007; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Stein BE., 1993, MERGING SENSES; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Stevenson RA, 2009, NEUROIMAGE, V44, P1210, DOI 10.1016/j.neuroimage.2008.09.034; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Thomas JP, 2010, J VISION, V10, DOI 10.1167/10.12.14; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; Van den Stock J, 2008, BRAIN RES, V1242, P185, DOI 10.1016/j.brainres.2008.05.040; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Werner S, 2010, CEREB CORTEX, V20, P1829, DOI 10.1093/cercor/bhp248; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043	66	33	34	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36070	10.1371/journal.pone.0036070	http://dx.doi.org/10.1371/journal.pone.0036070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UL	22558332	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200038
J	Valenzuela, NT; Perera, E; Naranjo, T				Valenzuela, Nohelia T.; Perera, Esther; Naranjo, Tomas			Dynamics of Rye Chromosome 1R Regions with High or Low Crossover Frequency in Homology Search and Synapsis Development	PLOS ONE			English	Article							PHYSICAL DISTRIBUTION; CHIASMA FORMATION; TELOMERIC HETEROCHROMATIN; ALLOHEXAPLOID WHEAT; BOUQUET FORMATION; RECOMBINATION; GENOME; ORGANIZATION; MEIOSIS; BEHAVIOR	In many organisms, homologous pairing and synapsis depend on the meiotic recombination machinery that repairs double-strand DNA breaks (DSBs) produced at the onset of meiosis. The culmination of recombination via crossover gives rise to chiasmata, which locate distally in many plant species such as rye, Secale cereale. Although, synapsis initiates close to the chromosome ends, a direct effect of regions with high crossover frequency on partner identification and synapsis initiation has not been demonstrated. Here, we analyze the dynamics of distal and proximal regions of a rye chromosome introgressed into wheat to define their role on meiotic homology search and synapsis. We have used lines with a pair of two-armed chromosome 1R of rye, or a pair of telocentrics of its long arm (1RL), which were homozygous for the standard 1RL structure, homozygous for an inversion of 1RL that changes chiasma location from distal to proximal, or heterozygous for the inversion. Physical mapping of recombination produced in the ditelocentric heterozygote (1RL/1RL(inv)) showed that 70% of crossovers in the arm were confined to a terminal segment representing 10% of the 1RL length. The dynamics of the arms 1RL and 1RL(inv) during zygotene demonstrates that crossover-rich regions are more active in recognizing the homologous partner and developing synapsis than crossover-poor regions. When the crossover-rich regions are positioned in the vicinity of chromosome ends, their association is facilitated by telomere clustering; when they are positioned centrally in one of the two-armed chromosomes and distally in the homolog, their association is probably derived from chromosome elongation. On the other hand, chromosome movements that disassemble the bouquet may facilitate chromosome pairing correction by dissolution of improper chromosome associations. Taken together, these data support that repair of DSBs via crossover is essential in both the search of the homologous partner and consolidation of homologous synapsis.	[Valenzuela, Nohelia T.; Naranjo, Tomas] Univ Complutense, Fac Biol, Dept Genet, E-28040 Madrid, Spain; [Perera, Esther] Univ Complutense, Fac Biol, Dept Biol Vegetal, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Valenzuela, NT (corresponding author), Univ Complutense, Fac Biol, Dept Genet, E-28040 Madrid, Spain.	toranjo@bio.ucm.es	Naranjo, Tomas/R-3238-2018	Naranjo, Tomas/0000-0003-4057-0473; Valenzuela-Martinez, Nohelia T./0000-0002-7091-6992	Direccion General de Investigacion, Ministerio de Educacion y Ciencia of Spain [BFU2007-66544]; CONICYT from the Chile Government	Direccion General de Investigacion, Ministerio de Educacion y Ciencia of Spain(Spanish Government); CONICYT from the Chile Government	This work has been supported by grants: BFU2007-66544 from Direccion General de Investigacion, Ministerio de Educacion y Ciencia of Spain, and CONICYT for PhD study from the Chile Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, GENOME RES, V13, P753, DOI 10.1101/gr.808603; Anderson LK, 2004, GENETICS, V166, P1923, DOI 10.1534/genetics.166.4.1923; Bass HW, 2000, J CELL SCI, V113, P1033; Bass HW, 1997, J CELL BIOL, V137, P5, DOI 10.1083/jcb.137.1.5; BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Corredor E, 2007, GENETICS, V177, P699, DOI 10.1534/genetics.107.078121; Corredor E, 2007, CHROMOSOME RES, V15, P231, DOI 10.1007/s10577-006-1117-7; Cowan CR, 2001, PLANT PHYSIOL, V125, P532, DOI 10.1104/pp.125.2.532; Cuadrado A, 1998, CHROMOSOMA, V107, P587, DOI 10.1007/s004120050345; CURTIS CA, 1991, GENOME, V34, P553, DOI 10.1139/g91-085; DEJONG JH, 1991, GENOME, V34, P109, DOI 10.1139/g91-018; Driscoll CJ, 1971, AGR ABSTR; ENDO TR, 1991, JPN J GENET, V66, P291, DOI 10.1266/jjg.66.291; Francki MG, 2001, GENOME, V44, P266, DOI 10.1139/gen-44-2-266; GILLIES CB, 1975, CR TRAV LAB CARLSB, V40, P135; GILLIES CB, 1985, CHROMOSOMA, V92, P165, DOI 10.1007/BF00348690; Gonzalez-Garcia M, 2011, GENOME, V54, P555, DOI [10.1139/G11-003, 10.1139/g11-003]; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; HOBOLTH P, 1981, CARLSBERG RES COMMUN, V46, P129, DOI 10.1007/BF02910465; HOLM PB, 1988, CARLSBERG RES COMMUN, V53, P191, DOI 10.1007/BF02907179; HOLM PB, 1986, CARLSBERG RES COMMUN, V51, P239, DOI 10.1007/BF02906837; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Jones LE, 2002, THEOR APPL GENET, V104, P1204, DOI 10.1007/s00122-002-0876-6; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kunzel G, 2000, GENETICS, V154, P397; Lacadena JR, 1981, GENETICA; Lukaszewski AJ, 1992, THEOR APPL GENET, V83, P1048, DOI 10.1007/BF00232971; Lukaszewski AJ, 2008, CHROMOSOMA, V117, P569, DOI 10.1007/s00412-008-0174-4; Lukaszewski AJ, 2012, CHROMOSOMA, V121, P201, DOI 10.1007/s00412-011-0354-5; LUKASZEWSKI AJ, 1993, THEOR APPL GENET, V86, P121, DOI 10.1007/BF00223816; LUKASZEWSKI AJ, 1995, THEOR APPL GENET, V90, P714, DOI 10.1007/BF00222138; Luo MC, 1996, GENETICS, V144, P1195; Maestra B, 2002, CHROMOSOME RES, V10, P655, DOI 10.1023/A:1021564327226; Martinez M, 2001, THEOR APPL GENET, V102, P751, DOI 10.1007/s001220051706; Mezard C, 2007, TRENDS GENET, V23, P91, DOI 10.1016/j.tig.2006.12.007; Naranjo T, 2008, CYTOGENET GENOME RES, V120, P320, DOI 10.1159/000121081; Naranjo T, 2010, CYTOGENET GENOME RES, V129, P133, DOI 10.1159/000314029; NARANJO T, 1980, CHROMOSOMA, V81, P249, DOI 10.1007/BF00285951; Niwa O, 2000, EMBO J, V19, P3831, DOI 10.1093/emboj/19.14.3831; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Pawlowski WP, 2005, TRENDS CELL BIOL, V15, P674, DOI 10.1016/j.tcb.2005.10.005; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Qi LL, 2002, CHROMOSOME RES, V10, P645, DOI 10.1023/A:1021512309480; RICHARDS EJ, 1988, CELL, V53, P127, DOI 10.1016/0092-8674(88)90494-1; SCHERTHAN H, 2001, NAT REV MOL CELL BIO, V6, P975; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95	49	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36385	10.1371/journal.pone.0036385	http://dx.doi.org/10.1371/journal.pone.0036385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558456	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340200074
J	Moldavski, O; Levin-Kravets, O; Ziv, T; Adam, Z; Prag, G				Moldavski, Ofer; Levin-Kravets, Olga; Ziv, Tamar; Adam, Zach; Prag, Gali			The Hetero-Hexameric Nature of a Chloroplast AAA plus FtsH Protease Contributes to Its Thermodynamic Stability	PLOS ONE			English	Article							ATP-DEPENDENT PROTEASE; PHOTOSYSTEM-II REPAIR; SYNECHOCYSTIS SP PCC-6803; LEAF VARIEGATION; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; D1 DEGRADATION; MEMBRANE; COMPLEX; MITOCHONDRIA	FtsH is an evolutionary conserved membrane-bound metalloprotease complex. While in most prokaryotes FtsH is encoded by a single gene, multiple FtsH genes are found in eukaryotes. Genetic and biochemical data suggest that the Arabidopsis chloroplast FtsH is a hetero-hexamer. This raises the question why photosynthetic organisms require a heteromeric complex, whereas in most bacteria a homomeric one is sufficient. To gain structural information of the possible complexes, the Arabidopsis FtsH2 (type B) and FtsH5 (type A) were modeled. An in silico study with mixed models of FtsH2/5 suggests that heteromeric hexamer structure with ratio of 4: 2 is more likely to exists. Specifically, calculation of the buried surface area at the interfaces between neighboring subunits revealed that a hetero-complex should be thermodynamically more stable than a homo-hexamer, due to the presence of additional hydrophobic and hydrophilic interactions. To biochemically assess this model, we generated Arabidopsis transgenic plants, expressing epitope-tagged FtsH2 and immuno-purified the protein. Mass-spectrometry analysis showed that FtsH2 is associated with FtsH1, FtsH5 and FtsH8. Interestingly, we found that 'type B' subunits (FtsH2 and FtsH8) were 2-3 fold more abundant than 'type A' (FtsH1 and FtsH5). The biochemical data corroborate the in silico model and suggest that the thylakoid FtsH hexamer is composed of two 'type A' and four 'type B' subunits.	[Moldavski, Ofer; Adam, Zach] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; [Levin-Kravets, Olga; Prag, Gali] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Levin-Kravets, Olga; Prag, Gali] Tel Aviv Univ, George S Wise Fac Life Sci, Inst Biol Struct, IL-69978 Tel Aviv, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Dept Biol, Smoler Prote Ctr, IL-32000 Haifa, Israel	Hebrew University of Jerusalem; Tel Aviv University; Tel Aviv University; Technion Israel Institute of Technology	Moldavski, O (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel.	prag@post.tau.ac.il		Ziv, Tamar/0000-0003-4299-7454	US - Israel Binational Science Foundation (BSF) [2003302]; US - Israel Binational Agricultural Research and Development Fund (BARD) [4228-09]	US - Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); US - Israel Binational Agricultural Research and Development Fund (BARD)	This research was supported by grants from the US - Israel Binational Science Foundation (BSF; www.bsf.org.il; Grant # 2003302) and the US - Israel Binational Agricultural Research and Development Fund (BARD; http://www.bard-isus.com; Grant # 4228-09) to ZA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2005, PHYSIOL PLANTARUM, V123, P386, DOI 10.1111/j.1399-3054.2004.00436.x; Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; Bar-Nun S, 2011, BIOCH BIOPHYS ACTA; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; Chen JP, 2006, PLANT J, V48, P73, DOI 10.1111/j.1365-313X.2006.02855.x; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolan Michael A, 2012, Methods Mol Biol, V857, P399, DOI 10.1007/978-1-61779-588-6_18; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Kato Y, 2009, PLANT PHYSIOL, V151, P1790, DOI 10.1104/pp.109.146589; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Lindahl M, 2000, PLANT CELL, V12, P419, DOI 10.1105/tpc.12.3.419; Miura E, 2007, PLANT CELL, V19, P1313, DOI 10.1105/tpc.106.049270; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Sakamoto W, 2002, GENES CELLS, V7, P769, DOI 10.1046/j.1365-2443.2002.00558.x; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Schroda M, 2008, NEW CHLAMYDOMONAS SO, V2, P671; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Sinvany-Villalobo G, 2004, PLANT PHYSIOL, V135, P1336, DOI 10.1104/pp.104.043299; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Takechi K, 2000, PLANT CELL PHYSIOL, V41, P1334, DOI 10.1093/pcp/pcd067; Tatsuta T, 2009, RES MICROBIOL, V160, P711, DOI 10.1016/j.resmic.2009.09.005; Urantowka A, 2005, PLANT MOL BIOL, V59, P239, DOI 10.1007/s11103-005-8766-3; Vallone B, 1998, P NATL ACAD SCI USA, V95, P6103, DOI 10.1073/pnas.95.11.6103; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200; Yu F, 2005, PLANT PHYSIOL, V138, P1957, DOI 10.1104/pp.105.061234; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Yu F, 2008, PLANT CELL, V20, P1786, DOI 10.1105/tpc.107.054965; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071; Zaltsman A, 2005, PLANT J, V42, P609, DOI 10.1111/j.1365-313X.2005.02401.x	52	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36008	10.1371/journal.pone.0036008	http://dx.doi.org/10.1371/journal.pone.0036008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558304	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000099
J	Muraoka, Y; Ikeda, HO; Nakano, N; Hangai, M; Toda, Y; Okamoto-Furuta, K; Kohda, H; Kondo, M; Terasaki, H; Kakizuka, A; Yoshimura, N				Muraoka, Yuki; Ikeda, Hanako Ohashi; Nakano, Noriko; Hangai, Masanori; Toda, Yoshinobu; Okamoto-Furuta, Keiko; Kohda, Haruyasu; Kondo, Mineo; Terasaki, Hiroko; Kakizuka, Akira; Yoshimura, Nagahisa			Real-Time Imaging of Rabbit Retina with Retinal Degeneration by Using Spectral-Domain Optical Coherence Tomography	PLOS ONE			English	Article							ANIMAL-MODELS; ULTRAHIGH-RESOLUTION; RHODOPSIN MUTATION; GANGLION-CELLS; RODENT RETINA; VISUAL-ACUITY; HIGH-SPEED; DELIVERY; HISTOPATHOLOGY; PIGMENTOSA	Background: Recently, a transgenic rabbit with rhodopsin Pro 347 Leu mutation was generated as a model of retinitis pigmentosa (RP), which is characterized by a gradual loss of vision due to photoreceptor degeneration. The purpose of the current study is to noninvasively visualize and assess time-dependent changes in the retinal structures of a rabbit model of retinal degeneration by using speckle noise-reduced spectral-domain optical coherence tomography (SD-OCT). Methodology/Principal Findings: Wild type (WT) and RP rabbits (aged 4-20 weeks) were investigated using SD-OCT. The total retinal thickness in RP rabbits decreased with age. The thickness of the outer nuclear layer (ONL) and between the external limiting membrane and Bruch's membrane (ELM-BM) were reduced in RP rabbits around the visual streak, compared to WT rabbits even at 4 weeks of age, and the differences increased with age. However, inner nuclear layer (INL) thickness in RP rabbits did not differ from that of WT during the observation period. The ganglion cell complex (GCC) thickness in RP rabbits increased near the optic nerve head but not around the visual streak in the later stages of the observation period. Hyper-reflective change was widely observed in the inner segments (IS) and outer segments (OS) of the photoreceptors in the OCT images of RP rabbits. Ultrastructural findings in RP retinas included the appearance of small rhodopsin-containing vesicles scattered in the extracellular space around the photoreceptors. Conclusions/Significance: In the current study, SD-OCT provided the pattern of photoreceptor degeneration in RP rabbits and the longitudinal changes in each retinal layer through the evaluation of identical areas over time. The time-dependent changes in the retinal structure of RP rabbits showed regional and time-stage variations. In vivo imaging of RP rabbit retinas by using SD-OCT is a powerful method for characterizing disease dynamics and for assessing the therapeutic effects of experimental interventions.	[Muraoka, Yuki; Ikeda, Hanako Ohashi; Nakano, Noriko; Hangai, Masanori; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Toda, Yoshinobu; Okamoto-Furuta, Keiko; Kohda, Haruyasu] Kyoto Univ, Grad Sch Med, Ctr Anat Studies, Kyoto, Japan; [Kondo, Mineo] Mie Univ, Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan; [Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Kakizuka, Akira] Kyoto Univ, Lab Funct Biol, Grad Sch Biostudies & Solut Oriented Res Sci & Te, Kyoto, Japan	Kyoto University; Kyoto University; Mie University; Nagoya University; Kyoto University	Muraoka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	hanakoi@kuhp.kyoto-u.ac.jp	Terasaki, Hiroko/M-5054-2014	Ikeda, Hanako/0000-0001-9572-8659	Astellas Foundation for Research on Metabolic Disorders; Japan Foundation for Applied Enzymology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22791656]; Grants-in-Aid for Scientific Research [23592603] Funding Source: KAKEN	Astellas Foundation for Research on Metabolic Disorders; Japan Foundation for Applied Enzymology; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Research grants from the Astellas Foundation for Research on Metabolic Disorders and the Japan Foundation for Applied Enzymology, and a Grant-in-Aid for Young Scientists (22791656) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aleman TS, 2008, INVEST OPHTH VIS SCI, V49, P1580, DOI 10.1167/iovs.07-1110; BARNETT KC, 1985, J HERED, V76, P168, DOI 10.1093/oxfordjournals.jhered.a110058; Bush RA, 2004, INVEST OPHTH VIS SCI, V45, P2420, DOI 10.1167/iovs.03-1342; Byeon SH, 2009, OPHTHALMOLOGY, V116, P1949, DOI 10.1016/j.ophtha.2009.06.066; Chader GJ, 2002, VISION RES, V42, P393, DOI 10.1016/S0042-6989(01)00212-7; Chen TC, 2006, AM J OPHTHALMOL, V141, P1165, DOI 10.1016/j.ajo.2006.01.086; Chen TC, 2005, ARCH OPHTHALMOL-CHIC, V123, P1715, DOI 10.1001/archopht.123.12.1715; Costa RA, 2004, INVEST OPHTH VIS SCI, V45, P2399, DOI 10.1167/iovs.04-0155; FAMIGLIETTI EV, 1995, VISUAL NEUROSCI, V12, P1151, DOI 10.1017/S0952523800006799; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Hangai M, 2009, OPT EXPRESS, V17, P4221, DOI 10.1364/OE.17.004221; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Kim KH, 2008, J VISION, V8, DOI 10.1167/8.1.17; Kondo M, 2009, INVEST OPHTH VIS SCI, V50, P1371, DOI 10.1167/iovs.08-2863; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; MARC RE, 1986, VISION RES, V26, P223, DOI 10.1016/0042-6989(86)90017-9; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Menotti-Raymond M, 2007, J HERED, V98, P211, DOI 10.1093/jhered/esm019; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Murakami T, 2011, AM J OPHTHALMOL, V151, P310, DOI 10.1016/j.ajo.2010.08.022; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Nakano N, 2011, INVEST OPHTH VIS SCI, V52, P8754, DOI 10.1167/iovs.10-6654; NARFSTROM K, 1983, J HERED, V74, P273, DOI 10.1093/oxfordjournals.jhered.a109782; Ng Y, 2008, INVEST OPHTH VIS SCI, V49, P2208, DOI 10.1167/iovs.07-1159; Oishi A, 2010, AM J OPHTHALMOL, V150, P27, DOI 10.1016/j.ajo.2010.02.012; Osakada F, 2010, BIOTECHNOL GENET ENG, V26, P297; Petersen-Jones SM, 1998, EYE, V12, P566, DOI 10.1038/eye.1998.146; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Sandberg MA, 2005, INVEST OPHTH VIS SCI, V46, P3349, DOI 10.1167/iovs.04-1383; Srinivasan VJ, 2006, INVEST OPHTH VIS SCI, V47, P5522, DOI 10.1167/iovs.06-0195; Stanzel BV, 2012, INVEST OPHTH VIS SCI, V53, P490, DOI 10.1167/iovs.11-8260; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; VANEY DI, 1991, VISUAL NEUROSCI, V7, P141, DOI 10.1017/S0952523800011019; Wojtkowski M, 2004, AM J OPHTHALMOL, V138, P412, DOI 10.1016/j.ajo.2004.04.049; Yamauchi Y, 2011, BRIT J OPHTHALMOL, V95, P1161, DOI 10.1136/bjo.2010.198317	42	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36135	10.1371/journal.pone.0036135	http://dx.doi.org/10.1371/journal.pone.0036135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558356	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000134
J	Tang, J; Huang, ZM; Chen, YY; Zhang, ZH; Liu, GL; Zhang, J				Tang, Jing; Huang, Zhi-Min; Chen, Ying-Yi; Zhang, Zhao-Hui; Liu, Gao-Lin; Zhang, Jian			A Novel Inhibitor of Human La Protein with Anti-HBV Activity Discovered by Structure-Based Virtual Screening and In Vitro Evaluation	PLOS ONE			English	Article							NASCENT RNA; RECOGNITION; AUTOANTIGEN; BINDING; CELLS	Background: Over 350 million people worldwide are infected with hepatitis B virus (HBV), a major cause of liver failure and hepatocellular carcinoma. Current therapeutic agents are highly effective, but are also associated with development of viral resistance. Therefore, strategies for identifying other anti-HBV agents with specific, but distinctive mechanisms of action are needed. The human La (hLa) protein, which forms a stabilizing complex with HBV RNA ribonucleoprotein to promote HBV replication, is a promising target of molecular therapy. Aims: This study aimed to discover novel inhibitors of hLa that could inhibit HBV replication and expression. Methods: A multistage molecular docking approach was used to screen a Specs database and an in-house library against hLa binding sites. Sequential in vitro evaluations were performed to detect potential compounds with high scores in HepG2.2.15 cells. Results: Of the 26 potential compounds with high scores chosen for experimental verification, 12 had HBV DNA inhibition ratios of less than 50% with P<0.05. Six had significant inhibition of HBV e antigen (HBeAg) levels, and 13 had significant inhibition of HBV surface antigen (HBsAg) levels by in vitro assays. Compounds HBSC-11, HBSC-15 and HBSC-34 (HBSC is system prefix for active compounds screened by the library) were selected for evaluation. HBSC-11 was found to have an obvious inhibitory effect on hLa transcription and expression. Conclusions: Our findings suggest that anti-HBV activity of HBSC-11 may be mediated by a reduction in hLa levels. In addition, our data suggest the potential clinical use of hLa inhibitors, such as HBSC-11, for treating HBV infection.	[Tang, Jing; Liu, Gao-Lin] Shanghai Jiao Tong Univ, Dept Pharm, Peoples Hosp 1, Shanghai 200030, Peoples R China; [Huang, Zhi-Min; Chen, Ying-Yi; Zhang, Jian] Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Zhao-Hui] Shanghai Jiao Tong Univ, Dept Urol, Ruijin Hosp, Luwan Branch, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tang, J (corresponding author), Shanghai Jiao Tong Univ, Dept Pharm, Peoples Hosp 1, Shanghai 200030, Peoples R China.	gaolinliu2009@gmail.com; jzhang.dr@gmail.com	Zhang, Jian/GXA-1303-2022; huang, zhimin/H-7878-2013; huang, zhimin o/R-4712-2018; zhang, zh/GWV-4677-2022	Zhang, Jian/0000-0002-6558-791X; huang, zhimin o/0000-0001-9230-6039; tang, jing/0000-0003-3100-1842	Natural Science Foundation of China [30873105, 21002062, 81100289]; Natural Science Foundation of Shanghai Province [08ZR1411900]; Research Foundation of First People's Hospital; Shanghai JiaoTong University [10B08]; Shanghai PuJiang Program [10PJ406800]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Province; Research Foundation of First People's Hospital; Shanghai JiaoTong University; Shanghai PuJiang Program(Shanghai Pujiang Program)	This study was supported by grants from the Natural Science Foundation of China (30873105, 21002062 and 81100289), the Natural Science Foundation of Shanghai Province (08ZR1411900), the Research Foundation of First People's Hospital Affiliated with Shanghai JiaoTong University (10B08), in part by grants from Shanghai PuJiang Program (10PJ406800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CS, 2009, J MED CHEM, V52, P2716, DOI 10.1021/jm8011905; Donello JE, 1996, J VIROL, V70, P4345, DOI 10.1128/JVI.70.7.4345-4351.1996; Ehlers I, 2004, J BIOL CHEM, V279, P43437, DOI 10.1074/jbc.M402227200; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Heise T, 2001, J VIROL, V75, P6874, DOI 10.1128/JVI.75.15.6874-6883.2001; Heise T, 1999, J VIROL, V73, P5767, DOI 10.1128/JVI.73.7.5767-5776.1999; Heise TD, 2000, CHRONIC HEPATITIS NE, P23; Hoke Stephen Mt, 2007, BMC Biochemistry, V8, P16, DOI 10.1186/1471-2091-8-16; Horke S, 2002, J BIOL CHEM, V277, P34949, DOI 10.1074/jbc.M201911200; Kim ND, 2011, BIOORG MED CHEM LETT, V21, P3329, DOI 10.1016/j.bmcl.2011.04.010; Kotik-Kogan O, 2008, STRUCTURE, V16, P852, DOI 10.1016/j.str.2008.02.021; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Maraia RJ, 2001, MOL CELL BIOL, V21, P367, DOI 10.1128/MCB.21.2.367-379.2001; Melagraki G, 2011, CURR MED CHEM, V18, P2612, DOI 10.2174/092986711795933759; Ni Q, 2004, WORLD J GASTROENTERO, V10, P2050, DOI 10.3748/wjg.v10.i14.2050; Schaffler K, 2010, RNA, V16, P1488, DOI 10.1261/rna.2146910; Schrodinger LLC, 2009, GLID VERS 5 5; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Spangberg K, 2001, J GEN VIROL, V82, P113, DOI 10.1099/0022-1317-82-1-113; Stein Lance L., 2009, Infectious Disorders - Drug Targets, V9, P105; Talele TT, 2010, BIOORGAN MED CHEM, V18, P4630, DOI 10.1016/j.bmc.2010.05.030; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Zhang Hui, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P735	24	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36363	10.1371/journal.pone.0036363	http://dx.doi.org/10.1371/journal.pone.0036363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558448	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336000197
J	VanderLaan, DP; Forrester, DL; Petterson, LJ; Vasey, PL				VanderLaan, Doug P.; Forrester, Deanna L.; Petterson, Lanna J.; Vasey, Paul L.			Offspring Production among the Extended Relatives of Samoan Men and Fa'afafine	PLOS ONE			English	Article							MALE SEXUAL ORIENTATION; MALE HOMOSEXUALITY; BIRTH-ORDER; MALE ANDROPHILIA; X-CHROMOSOME; BEHAVIOR; LINKAGE; CHILDHOOD; MARKERS; FECUNDITY	Androphilia refers to sexual attraction to adult males, whereas gynephilia refers to sexual attraction to adult females. Male androphilia is an evolutionary paradox. Its development is at least partially influenced by genetic factors, yet male androphiles exhibit lower reproductive output, thus raising the question of how genetic factors underlying its development persist. The sexual antagonism hypothesis posits that the fitness costs associated with genetic factors underlying male androphilia are offset because these same factors lead to elevated reproduction on the part of the female relatives of androphilic males. Western samples drawn from low fertility populations have yielded inconsistent results when testing this hypothesis. Some studies documented elevated reproduction among the matrilineal female kin of androphilic males, whereas others found such effects in the paternal line. Samoa is a high-fertility population in which individuals reproduce closer to their maximum capacities. This study compared the reproductive output of the paternal and maternal line grandmothers, aunts, and uncles of 86 Samoan androphilic males, known locally as fa'afafine, and 86 Samoan gynephilic males. Reproductive output was elevated in the paternal and maternal line grandmothers, but not aunts or uncles, of fa'afafine. These findings are consistent with the sexual antagonism hypothesis and suggest that male androphilia is associated with elevated reproduction among extended relatives in both the maternal and paternal line. Discussion focuses on how this study, in conjunction with the broader literature, informs various models for the evolution of male androphilia via elevated reproduction on the part of female kin.	[VanderLaan, Doug P.; Forrester, Deanna L.; Petterson, Lanna J.; Vasey, Paul L.] Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	VanderLaan, DP (corresponding author), Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada.	doug.vanderlaan@uleth.ca			Government of Alberta; Natural Sciences and Engineering Research Council of Canada; Sigma Xi Grant in Aid of Research; University of Lethbridge; American Psychological Foundation	Government of Alberta; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Sigma Xi Grant in Aid of Research; University of Lethbridge; American Psychological Foundation	The students involved in this research were funded by the Government of Alberta Awards and Federal Scholarships. Government of Alberta Awards include a Ralph Steinhauer Award of Distinction and a Chinook Summer Research Award. Federal scholarships include scholarships from the Social Sciences and Engineering Research Council of Canada (http://www.sshrc-crsh.gc.ca/), and the Natural Sciences and Engineering Research Council of Canada (URL below). The research was funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp), Sigma Xi Grant in Aid of Research (http://www.sigmaxi.org/), the University of Lethbridge (http://www.uleth.ca/), and a Henry David Travel Grant from the American Psychological Foundation (http://www.apa.org/apf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanko K, 2010, ARCH SEX BEHAV, V39, P81, DOI 10.1007/s10508-008-9457-3; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; BAILEY JM, 1995, DEV PSYCHOL, V31, P43, DOI 10.1037/0012-1649.31.1.43; Bailey JM, 1999, BEHAV GENET, V29, P79, DOI 10.1023/A:1021652204405; Bartlett NH, 2006, ARCH SEX BEHAV, V35, P659, DOI 10.1007/s10508-006-9055-1; Blanchard R, 2004, J THEOR BIOL, V230, P173, DOI 10.1016/j.jtbi.2004.04.021; Blanchard R, 2007, ARCH SEX BEHAV, V36, P163, DOI 10.1007/s10508-006-9159-7; Bocklandt S, 2006, HUM GENET, V118, P691, DOI 10.1007/s00439-005-0119-4; Bogaert AF, 2011, FRONT NEUROENDOCRIN, V32, P247, DOI 10.1016/j.yfrne.2011.02.004; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; Central Intelligence Agency, 2011, WORLD FACTB; CROALL H, 1999, PARADISE BENT GENDER; Dixson A.F., 2010, ANIMAL HOMOSEXUALITY, P381; Gavrilets S, 2006, P ROY SOC B-BIOL SCI, V273, P3031, DOI 10.1098/rspb.2006.3684; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Iemmola F, 2009, ARCH SEX BEHAV, V38, P393, DOI 10.1007/s10508-008-9381-6; Kendler KS, 2000, AM J PSYCHIAT, V157, P1843, DOI 10.1176/appi.ajp.157.11.1843; King M, 2005, ARCH SEX BEHAV, V34, P117, DOI 10.1007/s10508-005-1006-8; Langstrom N, 2010, ARCH SEX BEHAV, V39, P75, DOI 10.1007/s10508-008-9386-1; Larco Hoyle R, 1998, ARTE EROTICO ANTIGUO; LeVay Simon, 1996, QUEER SCI USE ABUSE; Murray S. O., 2000, HOMOSEXUALITIES; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Nash G., 2001, INDECENT EXPOSURE SE, P43; Poasa K. H., 1992, J PSYCHOL HUMAN SEXU, V5, P39, DOI DOI 10.1300/J056V05N03_04; Rahman Q, 2008, ARCH SEX BEHAV, V37, P962, DOI 10.1007/s10508-007-9191-2; Rice G, 1999, SCIENCE, V284, P665, DOI 10.1126/science.284.5414.665; Ringrose Kathryn M., 1996, 3 SEX 3 GENDER SEXUA, P85; Rosenthal AM, 2012, ARCH SEX BEHAV, V41, P135, DOI 10.1007/s10508-011-9881-7; Schmidt J.M., 2003, CURR SOCIOL, V51, P417, DOI DOI 10.1177/0011392103051003014; Schwartz G, 2010, ARCH SEX BEHAV, V39, P93, DOI 10.1007/s10508-009-9499-1; SHORE B, 1981, CULTURAL CONSTRUCTIO, P192; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vanderlaan DP, 2012, PERS RELATIONSHIP, V19, P326, DOI 10.1111/j.1475-6811.2011.01364.x; VanderLaan DP, 2011, ARCH SEX BEHAV, V40, P1233, DOI 10.1007/s10508-010-9695-z; VanderLaan DP, 2011, ARCH SEX BEHAV, V40, P495, DOI 10.1007/s10508-009-9576-5; Vasey PL, 2007, PERSPECT BIOL MED, V50, P481, DOI 10.1353/pbm.2007.0056; Vasey PL, 2007, P ROY SOC B-BIOL SCI, V274, P1437, DOI 10.1098/rspb.2007.0120; Vasey PL, 2007, EVOL HUM BEHAV, V28, P159, DOI 10.1016/j.evolhumbehav.2006.08.004; Vasey PL, 2010, EVOL HUM BEHAV, V31, P373, DOI 10.1016/j.evolhumbehav.2010.04.001; Vasey PL, 2011, ARCH SEX BEHAV, V40, P511, DOI 10.1007/s10508-009-9589-0; Vasey PL, 2010, PSYCHOL SCI, V21, P292, DOI 10.1177/0956797609359623; Vasey PL, 2009, HUM NATURE-INT BIOS, V20, P269, DOI 10.1007/s12110-009-9066-4; Vasey PL, 2010, ARCH SEX BEHAV, V39, P821, DOI 10.1007/s10508-008-9404-3; VASEY PL, 1995, INT J PRIMATOL, V16, P173, DOI 10.1007/BF02735477; Weeks DE, 2002, GENOME RES, V12, P430, DOI 10.1101/gr.211502; WHITAM FL, 1983, ARCH SEX BEHAV, V12, P207, DOI 10.1007/BF01542072; Yates T., 1993, INTERPRETATIVE ARCHA, P31; Zucker KJ, 2007, PSYCHIAT CLIN NEUROS, V61, P529, DOI 10.1111/j.1440-1819.2007.01703.x	51	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36088	10.1371/journal.pone.0036088	http://dx.doi.org/10.1371/journal.pone.0036088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558342	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000126
J	Wang, C; Chin-Sang, I; Bendena, WG				Wang, Christine; Chin-Sang, Ian; Bendena, William G.			The FGLamide-Allatostatins Influence Foraging Behavior in Drosophila melanogaster	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; JUVENILE-HORMONE SYNTHESIS; COCKROACH DIPLOPTERA-PUNCTATA; GENOMIC ORGANIZATION; MOLECULAR-CLONING; GENE; EXPRESSION; IDENTIFICATION; RECEPTOR; FAMILY	Allatostatins (ASTs) are multifunctional neuropeptides that generally act in an inhibitory fashion. ASTs were identified as inhibitors of juvenile hormone biosynthesis. Juvenile hormone regulates insect metamorphosis, reproduction, food intake, growth, and development. Drosophila melanogaster RNAi lines of PheGlyLeu-amide-ASTs (FGLa/ASTs) and their cognate receptor, Dar-1, were used to characterize roles these neuropeptides and their respective receptor may play in behavior and physiology. Dar-1 and FGLa/AST RNAi lines showed a significant reduction in larval foraging in the presence of food. The larval foraging defect is not observed in the absence of food. These RNAi lines have decreased for transcript levels which encodes cGMP-dependent protein kinase. A reduction in the for transcript is known to be associated with a naturally occuring allelic variation that creates a sitter phenotype in contrast to the rover phenotype which is caused by a for allele associated with increased for activity. The sitting phenotype of FGLa/AST and Dar-1 RNAi lines is similar to the phenotype of a deletion mutant of an AST/galanin-like receptor (NPR-9) in Caenorhabditis elegans. Associated with the foraging defect in C. elegans npr-9 mutants is accumulation of intestinal lipid. Lipid accumulation was not a phenotype associated with the FGLa/AST and Dar-1 RNAi lines.	[Wang, Christine; Chin-Sang, Ian; Bendena, William G.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Wang, C (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	william.bendena@queensu.ca	Bendena, William/N-6080-2019	Chin-Sang, Ian/0000-0001-7480-9775	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 36481-08]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant RGPIN 36481-08 to WGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2003, REGUL PEPTIDES, V115, P171, DOI 10.1016/S0167-0115(03)00165-4; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bendena WG, 1999, ANN NY ACAD SCI, V897, P311, DOI 10.1111/j.1749-6632.1999.tb07902.x; Bendena WG, 1997, ANN NY ACAD SCI, V814, P53, DOI 10.1111/j.1749-6632.1997.tb46144.x; Bendena WG, 2008, P NATL ACAD SCI USA, V105, P1339, DOI 10.1073/pnas.0709492105; Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; DEBELLE JS, 1987, HEREDITY, V59, P73, DOI 10.1038/hdy.1987.98; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DUVE H, 1993, P NATL ACAD SCI USA, V90, P2456, DOI 10.1073/pnas.90.6.2456; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Fuse M, 1999, PEPTIDES, V20, P1285, DOI 10.1016/S0196-9781(99)00133-3; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Ingram KK, 2005, MOL ECOL, V14, P813, DOI 10.1111/j.1365-294X.2005.02450.x; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Kaun KR, 2009, GENOME, V52, P1, DOI 10.1139/G08-090; LANGE AB, 1995, J INSECT PHYSIOL, V41, P581, DOI 10.1016/0022-1910(95)00008-I; Lenz C, 2000, BIOCHEM BIOPH RES CO, V273, P1126, DOI 10.1006/bbrc.2000.3062; Lenz C, 2000, BIOCHEM BIOPH RES CO, V273, P571, DOI 10.1006/bbrc.2000.2964; Lenz C, 2000, BIOCHEM BIOPH RES CO, V269, P91, DOI 10.1006/bbrc.2000.2251; LORENZ MW, 1995, REGUL PEPTIDES, V57, P227, DOI 10.1016/0167-0115(95)00036-B; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEREIRA HS, 1995, GENETICS, V141, P263; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; PRATT GE, 1989, BIOCHEM BIOPH RES CO, V163, P1243, DOI 10.1016/0006-291X(89)91111-X; REICHWALD K, 1994, P NATL ACAD SCI USA, V91, P11894, DOI 10.1073/pnas.91.25.11894; SOKOLOWSKI MB, 1980, BEHAV GENET, V10, P291, DOI 10.1007/BF01067774; SOKOLOWSKI MB, 1992, GENETICA, V85, P205, DOI 10.1007/BF00132272; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Stay B, 2007, ANNU REV ENTOMOL, V52, P277, DOI 10.1146/annurev.ento.51.110104.151050; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Wang C, 2012, GEN COMP ENDOCRINOL; Williamson M, 2001, BIOCHEM BIOPH RES CO, V282, P124, DOI 10.1006/bbrc.2001.4565; Williamson M, 2001, BIOCHEM BIOPH RES CO, V281, P544, DOI 10.1006/bbrc.2001.4402; WOODHEAD AP, 1989, P NATL ACAD SCI USA, V86, P5997, DOI 10.1073/pnas.86.15.5997; Yagi KJ, 2005, J INSECT PHYSIOL, V51, P357, DOI 10.1016/j.jinsphys.2004.12.006; Yoon JG, 1995, J COMP NEUROL, V363, P475, DOI 10.1002/cne.903630310; YU CG, 1995, J INSECT PHYSIOL, V41, P1035, DOI 10.1016/0022-1910(95)00075-6	39	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36059	10.1371/journal.pone.0036059	http://dx.doi.org/10.1371/journal.pone.0036059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558326	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000116
J	Xi, D; Gandhi, N; Lai, MZ; Kublaoui, BM				Xi, Dong; Gandhi, Nilay; Lai, Meizan; Kublaoui, Bassil M.			Ablation of Sim1 Neurons Causes Obesity through Hyperphagia and Reduced Energy Expenditure	PLOS ONE			English	Article							THYROTROPIN-RELEASING-HORMONE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; AGOUTI-RELATED PROTEIN; BROWN ADIPOSE-TISSUE; INDUCED THERMOGENESIS; SYNTHESIZING NEURONS; NEUROPEPTIDE-Y; DEFICIENT MICE; PATHWAYS; LESIONS	Single-minded 1 (Sim1) is a transcription factor necessary for development of the paraventricular nucleus of the hypothalamus (PVH). This nucleus is a critical regulator of appetite, energy expenditure and body weight. Previously we showed that Sim1(+/-) mice and conditional postnatal Sim1(-/-) mice exhibit hyperphagia, obesity, increased linear growth and susceptibility to diet-induced obesity, but no decrease in energy expenditure. Bilateral ablation of the PVH causes obesity due to hyperphagia and reduced energy expenditure. It remains unknown whether Sim1 neurons regulate energy expenditure. In this study, Sim1cre mice were bred to homozygous inducible diphtheria toxin receptor (iDTR) mice to generate mice expressing the simian DTR in Sim1 cells. In these mice, Sim1 neuron ablation was performed by intracerebroventricular (ICV) injection of diphtheria toxin. Compared to controls, mice with Sim1 neuron ablation became obese (with increased fat mass) on a chow diet due to increased food intake and reduced energy expenditure. In post-injection mice, we observed a strong inverse correlation between the degree of obesity and hypothalamic Sim1 expression. The reduction in baseline energy expenditure observed in these mice was accompanied by a reduction in activity. This reduction in activity did not fully account for the reduced energy expenditure as these mice exhibited decreased resting energy expenditure, decreased body temperature, decreased brown adipose tissue temperature, and decreased UCP1 expression suggesting an impairment of thermogenesis. In injected mice, hypothalamic gene expression of Sim1, oxytocin (OXT) and thyrotropin releasing hormone (TRH) was reduced by about 50%. These results demonstrate that Sim1 neurons in adult mice regulate both food intake and energy expenditure. Based on the body of work in the field, feeding regulation by Sim1 neurons likely occurs in both the PVH and medial amygdala, in contrast to energy expenditure regulation by Sim1 neurons, which likely is localized to the PVH.	[Xi, Dong; Gandhi, Nilay; Lai, Meizan; Kublaoui, Bassil M.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Endocrinol & Diabet,Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Xi, D (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Endocrinol & Diabet,Dept Pediat, Philadelphia, PA 19104 USA.	kublaouib@email.chop.edu			National Institutes of Health [R03 DK091500-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK091500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant from the National Institutes of Health (R03 DK091500-01 as well as institutional funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER RA, 1995, J COMP NEUROL, V358, P518, DOI 10.1002/cne.903580405; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Brown LM, 2010, BRAIN RES, V1350, P77, DOI 10.1016/j.brainres.2010.04.056; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Camerino C, 2009, OBESITY, V17, P980, DOI 10.1038/oby.2009.12; Cano G, 2003, J COMP NEUROL, V460, P303, DOI 10.1002/cne.10643; CHI ML, 1983, J NEURAL TRANSM, V58, P213, DOI 10.1007/BF01252807; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; DELUCA B, 1989, PHYSIOL BEHAV, V46, P685, DOI 10.1016/0031-9384(89)90352-1; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; EGAWA M, 1991, AM J PHYSIOL, V260, pR328, DOI 10.1152/ajpregu.1991.260.2.R328; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Elmquist JK, 2001, INT J OBESITY, V25, pS78, DOI 10.1038/sj.ijo.0801918; Fekete C, 2000, J NEUROSCI, V20, P1550; Foster MT, 2009, OBESITY SILVER SPRIN, V18, P682; Grill HJ, 2010, FRONT NEUROENDOCRIN, V31, P61, DOI 10.1016/j.yfrne.2009.10.005; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Holder JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE105, DOI 10.1152/ajpendo.00446.2003; Kasahara Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3122, DOI 10.1271/bbb.70498; King BM, 1996, PHYSIOL BEHAV, V60, P1569, DOI 10.1016/S0031-9384(96)00318-6; King BM, 2003, AM J PHYSIOL-REG I, V284, pR965, DOI 10.1152/ajpregu.00249.2002; KIRCHGESSNER AL, 1988, PHYSIOL BEHAV, V42, P517, DOI 10.1016/0031-9384(88)90153-9; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Kublaoui BM, 2006, ENDOCRINOLOGY, V147, P4542, DOI 10.1210/en.2006-0453; Lee EB, 2011, J NEUROSCI, V31, P14361, DOI 10.1523/JNEUROSCI.3171-11.2011; Legradi G, 1999, ENDOCRINOLOGY, V140, P3643, DOI 10.1210/en.140.8.3643; LEIBOWITZ SF, 1981, PHYSIOL BEHAV, V27, P1031, DOI 10.1016/0031-9384(81)90366-8; Li XS, 2010, OBESITY, V18, P456, DOI 10.1038/oby.2009.312; LUITEN PGM, 1985, BRAIN RES, V329, P374, DOI 10.1016/0006-8993(85)90554-2; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Michaud JL, 2000, MECH DEVELOP, V90, P253, DOI 10.1016/S0925-4773(99)00328-7; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Rezende EL, 2009, PHYSIOL BIOCHEM ZOOL, V82, P662, DOI 10.1086/605917; Rollins BL, 2000, AM J PHYSIOL-REG I, V279, pR1348, DOI 10.1152/ajpregu.2000.279.4.R1348; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Rosa CB, 2011, ANAT REC, V294, P1226, DOI 10.1002/ar.21419; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; Shintani M, 2005, BRAIN RES, V1039, P22, DOI 10.1016/j.brainres.2005.01.040; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Takayanagi Y, 2008, NEUROREPORT, V19, P951, DOI 10.1097/WNR.0b013e3283021ca9; TERHORST GJ, 1987, BRAIN RES BULL, V18, P191, DOI 10.1016/0361-9230(87)90190-0; Tolson KP, 2010, J NEUROSCI, V30, P3803, DOI 10.1523/JNEUROSCI.5444-09.2010; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wittmann G, 2009, J COMP NEUROL, V515, P313, DOI 10.1002/cne.22017; Wu Q, 2008, P NATL ACAD SCI USA, V105, P2687, DOI 10.1073/pnas.0712062105; Xu C, 2007, MOL ENDOCRINOL, V21, P1234, DOI 10.1210/me.2007-0034; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Yang C, 2006, J NEUROSCI, V26, P7116, DOI 10.1523/JNEUROSCI.0672-06.2006; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437	58	66	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36453	10.1371/journal.pone.0036453	http://dx.doi.org/10.1371/journal.pone.0036453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558467	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000206
J	You, XY; Zhang, ZP; Fan, JY; Cui, ZQ; Zhang, XE				You, Xiangyu; Zhang, Zhiping; Fan, Jinyu; Cui, Zongqiang; Zhang, Xian-En			Functionally Orthologous Viral and Cellular MicroRNAs Studied by a Novel Dual-Fluorescent Reporter System	PLOS ONE			English	Article							GENE-EXPRESSION; RNAS; INHIBIT; PROTEIN	Recent research raised the possibility that some viral microRNAs (miRNAs) may function as orthologs of cellular miRNAs. In the present work, to study the functional orthologous relationships of viral and cellular miRNAs, we first constructed a dual-fluorescent protein reporter vector system for the easy determination of miRNA function. By expressing the miRNAs and the indicator and internal control fluorescent proteins individually from a single vector, this simple reporter system can be used for miRNA functional assays that include visualizing miRNA activity in live cells. Sequence alignments indicated that the simian virus 40 (SV40) encoded miRNA sv40-mir-S1-5p contains a seed region identical to that of the human miRNA hsa-miR423-5p. Using the new reporter system, it was found that sv40-mir-S1-5p and hsa-miR423-5p downregulate the expression of common artificial target mRNAs and some predicted biological targets of hsa-miR423-5p, demonstrating that they are functional orthologs. The human immunodeficiency virus 1 (HIV-1) encoded hiv1-miR-N367 also contains a seed sequence identical to that of the human miRNA hsa-miR192. Functional assays showed that hiv1-miR-N367 and hsa-miR192 could downregulate common artificial and predicted biological targets, suggesting that these miRNAs may also act as functional orthologs. Thus, this study presents a simple and universal system for testing miRNA function and identifies two new pairs of functional orthologs, sv40-mir-S1-5p and hsa-miR423-5p as well as hiv-1-miR-N367 and hsa-miR192. These findings also expand upon our current knowledge of functional homology and imply that a more general phenomenon of orthologous relationships exists between viral and cellular miRNAs.	[You, Xiangyu; Zhang, Zhiping; Fan, Jinyu; Cui, Zongqiang; Zhang, Xian-En] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [You, Xiangyu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	You, XY (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	czq@wh.iov.cn; x.zhang@wh.iov.cn	ZHANG, Xian-En/AAJ-5579-2021		National Nano Project [2011CB933600]; National Natural Science Foundation of China [31070774]; Chinese Academy of Sciences [XDA01020403, KJCX2-YW-M15]	National Nano Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	Z.-Q. Cui is supported by the National Nano Project (no. 2011CB933600 http://program.most.gov.cn/#) and the National Natural Science Foundation of China (no. 31070774 http://www.nsfc.gov.cn/Portal0/default152.htm). The authors also thank the support from the Chinese Academy of Sciences (no. XDA01020403 and KJCX2-YW-M15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Cochrane A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-22; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Houzet L, 2011, BBA-GENE REGUL MECH, V1809, P686, DOI 10.1016/j.bbagrm.2011.05.009; Kato Y, 2010, J BIOCHEM, V147, P63, DOI 10.1093/jb/mvp144; Kato Y, 2009, INT J BIOCHEM CELL B, V41, P2225, DOI 10.1016/j.biocel.2009.04.018; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Marsh K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-97; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tran N, 2009, BIOCHEM INSIGHTS, V2, P1; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Westerlaken JHAM, 2003, BRAIN RES, V971, P116, DOI 10.1016/S0006-8993(03)02430-2; YANG HD, 1995, MOL CELL BIOL, V15, P6770; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08	26	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36157	10.1371/journal.pone.0036157	http://dx.doi.org/10.1371/journal.pone.0036157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558366	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000141
J	Kang, JA; Lee, K; Lee, KM; Cho, S; Seo, J; Hur, EM; Park, CS; Baik, JH; Choi, SY				Kang, Ji-Ah; Lee, Keimin; Lee, Kwang Min; Cho, Sukhee; Seo, Jinsoo; Hur, Eun-Mi; Park, Chul-Seung; Baik, Ja-Hyun; Choi, Se-Young			Desipramine Inhibits Histamine H1 Receptor-Induced Ca2+ Signaling in Rat Hypothalamic Cells	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; REGULATES FOOD-INTAKE; NEURONAL HISTAMINE; WEIGHT-GAIN; PHARMACOLOGICAL-TREATMENT; OVERWEIGHT PATIENT; DIABETES-MELLITUS; FEEDING-BEHAVIOR; H-1 RECEPTOR; AMP-KINASE	The hypothalamus in the brain is the main center for appetite control and integrates signals from adipose tissue and the gastrointestinal tract. Antidepressants are known to modulate the activities of hypothalamic neurons and affect food intake, but the cellular and molecular mechanisms by which antidepressants modulate hypothalamic function remain unclear. Here we have investigated how hypothalamic neurons respond to treatment with antidepressants, including desipramine and sibutramine. In primary cultured rat hypothalamic cells, desipramine markedly suppressed the elevation of intracellular Ca2+ evoked by histamine H1 receptor activation. Desipramine also inhibited the histamine-induced Ca2+ increase and the expression of corticotrophin-releasing hormone in hypothalamic GT1-1 cells. The effect of desipramine was not affected by pretreatment with prazosin or propranolol, excluding catecholamine reuptake activity of desipramine as an underlying mechanism. Sibutramine which is also an antidepressant but decreases food intake, had little effect on the histamine-induced Ca2+ increase or AMP-activated protein kinase activity. Our results reveal that desipramine and sibutramine have different effects on histamine H1 receptor signaling in hypothalamic cells and suggest that distinct regulation of hypothalamic histamine signaling might underlie the differential regulation of food intake between antidepressants.	[Kang, Ji-Ah; Lee, Keimin; Cho, Sukhee; Seo, Jinsoo; Choi, Se-Young] Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Physiol, Seoul, South Korea; [Lee, Kwang Min; Park, Chul-Seung] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Hur, Eun-Mi] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD USA; [Baik, Ja-Hyun] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea	Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Johns Hopkins University; Korea University	Kang, JA (corresponding author), Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Physiol, Seoul, South Korea.	sychoi@snu.ac.kr	Hur, Eun Mi/AAU-4906-2021; Seo, Jinsoo/AAD-4950-2019	Seo, Jinsoo/0000-0001-6432-6964; Park, Chul-Seung/0000-0003-0209-1412; Choi, Se-Young/0000-0001-7534-5167	National Research Foundation of Korea from Korean Ministry of Education, Science and Technology [R01-2007-000-20850, 2011-0028233]	National Research Foundation of Korea from Korean Ministry of Education, Science and Technology	This work was supported by National Research Foundation of Korea (R01-2007-000-20850 and 2011-0028233) from Korean Ministry of Education, Science and Technology (http://www.nrf.re.kr/html/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTELMAN SM, 1977, LIFE SCI, V21, P1747, DOI 10.1016/0024-3205(77)90154-0; Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2; Bray GA, 2007, GASTROENTEROLOGY, V132, P2239, DOI 10.1053/j.gastro.2007.03.053; Chai BX, 2009, PEPTIDES, V30, P1098, DOI 10.1016/j.peptides.2009.03.006; Choi SY, 2001, J NEUROCHEM, V79, P303; Davoodi N, 2008, BEHAV PHARMACOL, V19, P121, DOI 10.1097/FBP.0b013e3282f62c66; DELAESCALERA GM, 1992, ENDOCRINOLOGY, V131, P1397; Galanter CA, 2002, J CHILD ADOL PSYCHOP, V12, P137, DOI 10.1089/104454602760219171; Gobshtis N, 2007, EUR J PHARMACOL, V554, P155, DOI 10.1016/j.ejphar.2006.10.028; Gotoh K, 2005, FASEB J, V19, P1131, DOI 10.1096/fj.04-2384fje; Gotoh K, 2007, J NEUROCHEM, V103, P1102, DOI 10.1111/j.1471-4159.2007.04802.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Heinrichs SC, 1999, NEUROPEPTIDES, V33, P350, DOI 10.1054/npep.1999.0047; Jorgensen EA, 2007, NEUROENDOCRINOLOGY, V86, P210, DOI 10.1159/000108341; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; Masaki T, 2003, ENDOCRINOLOGY, V144, P2741, DOI 10.1210/en.2003-0031; Masaki T, 2006, TRENDS PHARMACOL SCI, V27, P279, DOI 10.1016/j.tips.2006.03.008; McIntyre RS, 2001, CAN J PSYCHIAT, V46, P273, DOI 10.1177/070674370104600308; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; NELSON JC, 1984, ARCH GEN PSYCHIAT, V41, P55; NORIS G, 1995, ENDOCRINOLOGY, V136, P2967, DOI 10.1210/en.136.7.2967; OOKUMA K, 1993, BRAIN RES, V628, P235, DOI 10.1016/0006-8993(93)90960-U; OOKUMA K, 1990, PSYCHOPHARMACOLOGY, V101, P481, DOI 10.1007/BF02244225; POTTER WZ, 1991, NEW ENGL J MED, V325, P633; Richelson E, 2000, LIFE SCI, V68, P29, DOI 10.1016/S0024-3205(00)00911-5; SAKATA T, 1988, BRAIN RES, V441, P403, DOI 10.1016/0006-8993(88)91423-0; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Vitalis EA, 2000, P NATL ACAD SCI USA, V97, P1861, DOI 10.1073/pnas.040545197; Yamamoto R, 2011, J BIOL CHEM, V286, P21458, DOI 10.1074/jbc.M110.192260; YAMASHITA N, 1992, BRAIN RES, V594, P215, DOI 10.1016/0006-8993(92)91128-2; Yoshimoto R, 2008, EUR J PHARMACOL, V579, P229, DOI 10.1016/j.ejphar.2007.11.001; Yoshimoto R, 2006, P NATL ACAD SCI USA, V103, P13866, DOI 10.1073/pnas.0506104103; Yoshizawa M, 2009, BIOL PSYCHIAT, V65, P329, DOI 10.1016/j.biopsych.2008.08.012	35	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36185	10.1371/journal.pone.0036185	http://dx.doi.org/10.1371/journal.pone.0036185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563449	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100074
J	Kim, HJ; Lim, SJ; Kwag, HL; Kim, HJ				Kim, Hyoung Jin; Lim, Su Jeung; Kwag, Hye-Lim; Kim, Hong-Jin			The Choice of Resin-Bound Ligand Affects the Structure and Immunogenicity of Column-Purified Human Papillomavirus Type 16 Virus-Like Particles	PLOS ONE			English	Article							MAJOR NEUTRALIZING EPITOPE; HELPER T-CELL; L1 PROTEIN; MONOCLONAL-ANTIBODIES; PURIFICATION; HPV16; BINDING; SPECIFICITY; REACTIVITY; RESPONSES	Cell growth conditions and purification methods are important in determining biopharmaceutical activity. However, in studies aimed at manufacturing virus-like particles (VLPs) for the purpose of creating a prophylactic vaccine and antigen for human papillomavirus (HPV), the effects of the presence of a resin-bound ligand during purification have never been investigated. In this study, we compared the structural integrity and immunogenicity of two kinds of VLPs derived from HPV type 16 (HPV16 VLPs): one VLP was purified by heparin chromatography (hHPV16 VLP) and the other by cation-exchange chromatography (cHPV16 VLP). The reactivity of anti-HPV16 neutralizing monoclonal antibodies (H16.V5 and H16.E70) towards hHPV16 VLP were significantly higher than the observed cHPV16 VLP reactivities, implying that hHPV16 VLP possesses a greater number of neutralizing epitopes and has a greater potential to elicit anti-HPV16 neutralizing antibodies. After the application of heparin chromatography, HPV16 VLP has a higher affinity for H16.V5 and H16.E70. This result indicates that heparin chromatography is valuable in selecting functional HPV16 VLPs. In regard to VLP immunogenicity, the anti-HPV16 L1 IgG and neutralizing antibody levels elicited by immunizations of mice with hHPV16 VLPs were higher than those elicited by cHPV16 VLP with and without adjuvant. Therefore, the ability of hHPV16 VLP to elicit humoral immune responses was superior to that of cHPV16 VLP. We conclude that the specific chromatographic technique employed for the purification of HPV16 VLPs is an important factor in determining the structural characteristics and immunogenicity of column-purified VLPs.	[Kim, Hyoung Jin; Lim, Su Jeung; Kwag, Hye-Lim; Kim, Hong-Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Chung Ang University	Kim, HJ (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	hongjink@cau.ac.kr			Ministry of Health & Welfare of the Republic of Korea [A085139]	Ministry of Health & Welfare of the Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a Grant (A085139) of the Research & Development Project in Health 363 and Medical Technology of the Ministry of Health & Welfare of the Republic of Korea. http://www.hpeb.re.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires KA, 2006, APPL ENVIRON MICROB, V72, P745, DOI 10.1128/AEM.72.1.745-752.2006; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buonamassa DT, 2002, VIROLOGY, V293, P335, DOI 10.1006/viro.2001.1289; Carter JJ, 2003, J VIROL, V77, P11625, DOI 10.1128/JVI.77.21.11625-11632.2003; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Christensen ND, 2001, VIROLOGY, V291, P324, DOI 10.1006/viro.2001.1220; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Conway MJ, 2009, J DENT RES, V88, P307, DOI 10.1177/0022034509333446; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; Cook JC, 1999, PROTEIN EXPRES PURIF, V17, P477, DOI 10.1006/prep.1999.1155; Culp TD, 2007, VIROLOGY, V361, P435, DOI 10.1016/j.virol.2006.12.002; Dai GX, 2001, J BIOL CHEM, V276, P41913, DOI 10.1074/jbc.M106018200; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; De Witte L, 2007, IMMUNOBIOLOGY, V212, P679, DOI 10.1016/j.imbio.2007.09.006; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; Kim HJ, 2010, J BIOTECHNOL, V150, P31, DOI 10.1016/j.jbiotec.2010.07.032; Kim HJ, 2010, PROTEIN EXPRES PURIF, V70, P68, DOI 10.1016/j.pep.2009.08.005; Kim SN, 2007, J VIROL METHODS, V139, P24, DOI 10.1016/j.jviromet.2006.09.004; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mach H, 2006, J PHARM SCI-US, V95, P2195, DOI 10.1002/jps.20696; Madrid-Marina V, 2009, ARCH MED RES, V40, P471, DOI 10.1016/j.arcmed.2009.08.005; Mirano-Bascos D, 2010, J VIROL, V84, P3303, DOI 10.1128/JVI.02242-09; Montefiori DC, 2009, CURR OPIN HIV AIDS, V4, P347, DOI 10.1097/COH.0b013e32832f4a4d; Moyer AL, 2010, 26 INT PAP C; Opalka D, 2010, CLIN VACCINE IMMUNOL, V17, P818, DOI 10.1128/CVI.00348-09; Park JY, 2002, J MICROBIOL, V40, P313; Park MA, 2008, PROTEIN EXPRES PURIF, V59, P175, DOI 10.1016/j.pep.2008.01.021; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pattenden LK, 2005, TRENDS BIOTECHNOL, V23, P523, DOI 10.1016/j.tibtech.2005.07.011; Rizk RZ, 2008, J GEN VIROL, V89, P117, DOI 10.1099/vir.0.83145-0; Ros C, 2006, J VIROL, V80, P12017, DOI 10.1128/JVI.01435-06; Ryding J, 2007, J GEN VIROL, V88, P792, DOI 10.1099/vir.0.82449-0; Schadlicha L, 2009, VACCINE, V27, P1511, DOI 10.1016/j.vaccine.2009.01.014; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Schwarz TF, 2009, ADV THER, V26, P983, DOI 10.1007/s12325-009-0079-5; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Shi L, 2005, J PHARM SCI-US, V94, P1538, DOI 10.1002/jps.20377; Sun JH, 2008, CLIN VACCINE IMMUNOL, V15, P303, DOI 10.1128/CVI.00448-07; Thones N, 2008, J VIROL, V82, P5472, DOI 10.1128/JVI.02482-07; Vicente T, 2011, J INVERTEBR PATHOL, V107, pS42, DOI 10.1016/j.jip.2011.05.004; White WI, 1999, J VIROL, V73, P4882, DOI 10.1128/JVI.73.6.4882-4889.1999; Woo MK, 2007, J MICROBIOL BIOTECHN, V17, P1738; Zhang YZ, 2006, HUM IMMUNOL, V67, P215, DOI 10.1016/j.humimm.2006.02.014; Zhao QJ, 2005, J VIROL METHODS, V127, P133, DOI 10.1016/j.jviromet.2005.03.015	49	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35893	10.1371/journal.pone.0035893	http://dx.doi.org/10.1371/journal.pone.0035893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563414	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100040
J	Koren, J; Miyata, Y; Kiray, J; O'Leary, JC; Nguyen, L; Guo, JP; Blair, LJ; Li, XK; Jinwal, UK; Cheng, JQ; Gestwicki, JE; Dickey, CA				Koren, John, III; Miyata, Yoshinari; Kiray, Janine; O'Leary, John C., III; Nguyen, Lana; Guo, Jianping; Blair, Laura J.; Li, Xiokai; Jinwal, Umesh K.; Cheng, Jin Q.; Gestwicki, Jason E.; Dickey, Chad A.			Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; PHASE-I; MKT 077; HSP70; CHEMOTHERAPY; BINDING; MKT-077; MOT-2; DYE; AKT	MKT-077, a rhodacyanine dye, was shown to produce cancer specific cell death. However, complications prevented the use of this compound beyond clinical trials. Here we describe YM-1, a derivative of MKT-077. We found that YM-1 was more cytotoxic and localized differently than MKT-077. YM-1 demonstrated this cytotoxicity across multiple cancer cell lines. This toxicity was limited to cancer cell lines; immortalized cell models were unaffected. Brief applications of YM-1 were found to be non-toxic. Brief treatment with YM-1 restored tamoxifen sensitivity to a refractory tamoxifen-resistant MCF7 cell model. This effect is potentially due to altered estrogen receptor alpha phosphorylation, an outcome precipitated by selective reductions in Akt levels (Akt/PKB). Thus, modifications to the rhodocyanine scaffold could potentially be made to improve efficacy and pharmacokinetic properties. Moreover, the impact on tamoxifen sensitivity could be a new utility for this compound family.	[Koren, John, III; Kiray, Janine; O'Leary, John C., III; Nguyen, Lana; Blair, Laura J.; Dickey, Chad A.] Univ S Florida, Coll Med, Dept Mol Med, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33620 USA; [Miyata, Yoshinari; Li, Xiokai; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Inst Life Sci, Ann Arbor, MI 48109 USA; [Miyata, Yoshinari; Li, Xiokai; Gestwicki, Jason E.] Univ Michigan, Dept Biol Chem, Inst Life Sci, Ann Arbor, MI 48109 USA; [Guo, Jianping; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Jinwal, Umesh K.] Univ S Florida, Coll Pharm, Tampa, FL USA	State University System of Florida; University of South Florida; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Koren, J (corresponding author), Univ S Florida, Coll Med, Dept Mol Med, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33620 USA.	cdickey@health.usf.edu	Li, Xiaokai/D-2680-2014; Li, Xiaokai/A-7162-2012	Koren, John/0000-0002-6017-1763; Blair, Laura/0000-0002-4981-5564	Alzheimer's Association; CurePSP (Progressive supranuclear palsy); National Institutes of Health/National Institute on Aging (NIH/NIA) [R00AG031291]; NINDS (National Institute of Neurological Disorders and Stroke) [R01NS073899]; NIH [R01NS059690]; James & Esther King Grant [1KG02-33967]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899, R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); CurePSP (Progressive supranuclear palsy); National Institutes of Health/National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James & Esther King Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Dickey was supported by the Alzheimer's Association, CurePSP (Progressive supranuclear palsy), National Institutes of Health/National Institute on Aging (NIH/NIA) R00AG031291 and NINDS (National Institute of Neurological Disorders and Stroke) R01NS073899. Dr. Gestwicki was supported by the NIH R01NS059690. Dr. Cheng was supported by James & Esther King Grant 1KG02-33967. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badia E, 2007, CURR MED CHEM, V14, P3035, DOI 10.2174/092986707782794023; Britten CD, 2000, CLIN CANCER RES, V6, P42; Brognard J, 2001, CANCER RES, V61, P3986; Campbell RA, 2001, J BIOL CHEM; Clark AS, 2002, MOL CANCER THER, V1, P707; Cobleigh MA, 2011, SEMIN ONCOL, V38, pS11, DOI 10.1053/j.seminoncol.2011.04.005; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Gabrielli D, 2004, PHOTOCHEM PHOTOBIOL, V79, P227, DOI 10.1562/BE-03-27.1; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Guo JP, 2010, J BIOL CHEM, V285, P3676, DOI 10.1074/jbc.M109.078212; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kawakami M, 1998, J MED CHEM, V41, P130, DOI 10.1021/jm970590k; Koren J, 2010, J BIOL CHEM; Koya K, 1996, CANCER RES, V56, P538; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Nahta R, 2012, CURR MED CHEM; Oliveira Andre M, 2005, Am J Clin Pathol, V124 Suppl, pS16; Propper DJ, 1999, ANN ONCOL, V10, P923, DOI 10.1023/A:1008336904585; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rousaki A, 2011, J MOL BIOL; Sun M, 2001, CANCER RES, V61, P5985; Uray IP, 2011, RECENT RESULTS CANC, V188, P147, DOI 10.1007/978-3-642-10858-7_13; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2000, CANCER RES, V60, P6818	27	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35566	10.1371/journal.pone.0035566	http://dx.doi.org/10.1371/journal.pone.0035566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563386	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100015
J	Pitzalis, S; Strappini, F; De Gasperis, M; Bultrini, A; Di Russo, F				Pitzalis, Sabrina; Strappini, Francesca; De Gasperis, Marco; Bultrini, Alessandro; Di Russo, Francesco			Spatio-Temporal Brain Mapping of Motion-Onset VEPs Combined with fMRI and Retinotopic Maps	PLOS ONE			English	Article							FUNCTIONAL MAGNETIC-RESONANCE; HUMAN VISUAL-CORTEX; SURFACE-BASED ANALYSIS; CORTICAL AREA; SPEED DISCRIMINATION; SUPERIOR COLLICULUS; EVOKED-POTENTIALS; RESPONSES; IDENTIFICATION; REPRESENTATION	Neuroimaging studies have identified several motion-sensitive visual areas in the human brain, but the time course of their activation cannot be measured with these techniques. In the present study, we combined electrophysiological and neuroimaging methods (including retinotopic brain mapping) to determine the spatio-temporal profile of motion-onset visual evoked potentials for slow and fast motion stimuli and to localize its neural generators. We found that cortical activity initiates in the primary visual area (V1) for slow stimuli, peaking 100 ms after the onset of motion. Subsequently, activity in the mid-temporal motion-sensitive areas, MT+, peaked at 120 ms, followed by peaks in activity in the more dorsal area, V3A, at 160 ms and the lateral occipital complex at 180 ms. Approximately 250 ms after stimulus onset, activity fast motion stimuli was predominant in area V6 along the parieto-occipital sulcus. Finally, at 350 ms (100 ms after the motion offset) brain activity was visible again in area V1. For fast motion stimuli, the spatio-temporal brain pattern was similar, except that the first activity was detected at 70 ms in area MT+. Comparing functional magnetic resonance data for slow vs. fast motion, we found signs of slow-fast motion stimulus topography along the posterior brain in at least three cortical regions (MT+, V3A and LOR).	[Pitzalis, Sabrina; De Gasperis, Marco; Bultrini, Alessandro; Di Russo, Francesco] Univ Rome Foro Italico, Dept Educ Sci Motor Act & Sport, Rome, Italy; [Pitzalis, Sabrina; Strappini, Francesca; Di Russo, Francesco] IRCCS, Santa Lucia Fdn, Neuropsychol Ctr, Rome, Italy	Foro Italico University of Rome; IRCCS Santa Lucia	Pitzalis, S (corresponding author), Univ Rome Foro Italico, Dept Educ Sci Motor Act & Sport, Rome, Italy.	francesco.dirusso@uniroma4.it	Di Russo, Francesco/N-6686-2015; Pitzalis, Sabrina/AAA-9406-2019	Di Russo, Francesco/0000-0002-3127-9433; Strappini, Francesca/0000-0002-4371-6995; pitzalis, sabrina/0000-0002-4445-0391	University of Rome "Foro Italico" grant [RIC992009]; IRCCS Santa Lucia Foundation	University of Rome "Foro Italico" grant; IRCCS Santa Lucia Foundation	This research was supported by the University of Rome "Foro Italico" grant RIC992009 and the IRCCS Santa Lucia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 1999, J NEUROPHYSIOL, V82, P2545, DOI 10.1152/jn.1999.82.5.2545; Aine CJ, 1996, CEREB CORTEX, V6, P354, DOI 10.1093/cercor/6.3.354; Berman RA, 2010, J NEUROSCI, V30, P6342, DOI 10.1523/JNEUROSCI.6176-09.2010; Bocker Koen B. E., 1994, Brain Topography, V7, P71, DOI 10.1007/BF01184839; Bonmassar G, 2001, NEUROIMAGE, V13, P1035, DOI 10.1006/nimg.2001.0754; Buchner H, 1997, NEUROREPORT, V8, P2419, DOI 10.1097/00001756-199707280-00002; Castriota-Scanderbeg A, 2005, NEUROIMAGE, V25, P570, DOI 10.1016/j.neuroimage.2004.11.045; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; DEVRIES M, 1989, ELECTROEN CLIN NEURO, V74, P81, DOI 10.1016/0168-5597(89)90012-9; Di Russo F, 2005, NEUROIMAGE, V24, P874, DOI 10.1016/j.neuroimage.2004.09.029; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; Di Russo F, 2012, HUM BRAIN MAPP, V33, P1334, DOI 10.1002/hbm.21285; DUCATI A, 1988, ELECTROEN CLIN NEURO, V71, P89, DOI 10.1016/0168-5597(88)90010-X; Fattori P, 2009, J PHYSIOL-PARIS, V103, P88, DOI 10.1016/j.jphysparis.2009.05.012; ffytche DH, 1995, BRAIN, V118, P1375, DOI 10.1093/brain/118.6.1375; Ffytche DH, 1996, BRAIN, V119, P1971, DOI 10.1093/brain/119.6.1971; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Galati G, 2011, EUR J NEUROSCI, V34, P1871, DOI 10.1111/j.1460-9568.2011.07885.x; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Gratton G, 2001, HUM BRAIN MAPP, V13, P13, DOI 10.1002/hbm.1021; Grefkes C, 2004, NEUROIMAGE, V23, P1494, DOI 10.1016/j.neuroimage.2004.08.031; GROSS CG, 1991, NEUROPSYCHOLOGIA, V29, P497, DOI 10.1016/0028-3932(91)90007-U; Hagler DJ, 2007, NEUROIMAGE, V35, P1562, DOI 10.1016/j.neuroimage.2007.01.033; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Huk AC, 2000, J NEUROPHYSIOL, V83, P3525, DOI 10.1152/jn.2000.83.6.3525; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; JEFFREYS DA, 1972, EXP BRAIN RES, V16, P1; Kuba M, 2007, VISION RES, V47, P189, DOI 10.1016/j.visres.2006.09.020; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Laycock R, 2007, J NEUROPHYSIOL, V98, P1253, DOI 10.1152/jn.00416.2007; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Liu JJ, 2005, J NEUROSCI, V25, P3459, DOI 10.1523/JNEUROSCI.4206-04.2005; Lorteije JAM, 2008, EUR J NEUROSCI, V27, P2341, DOI 10.1111/j.1460-9568.2008.06193.x; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; Mangun GR, 2001, VISION RES, V41, P1423, DOI 10.1016/S0042-6989(01)00046-3; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McKeefry DJ, 2008, J NEUROSCI, V28, P6848, DOI 10.1523/JNEUROSCI.1287-08.2008; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; ORBAN GA, 1995, EUR J NEUROSCI, V7, P2261, DOI 10.1111/j.1460-9568.1995.tb00647.x; Pitzalis S, 2010, CEREB CORTEX, V20, P411, DOI 10.1093/cercor/bhp112; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Priebe NJ, 2004, J NEUROSCI, V24, P1907, DOI 10.1523/JNEUROSCI.4233-03.2004; PROBST T, 1993, EXP BRAIN RES, V93, P345; Rosa MJ, 2010, J INTEGR NEUROSCI, V9, P453, DOI 10.1142/S0219635210002512; Schellart NAM, 2004, VISION RES, V44, P119, DOI 10.1016/j.visres.2003.09.016; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schoenfeld MA, 2002, NEUROIMAGE, V17, P769, DOI 10.1006/nimg.2002.1204; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Smith AT, 1998, J NEUROSCI, V18, P3816; SNYDER AZ, 1995, P NATL ACAD SCI USA, V92, P1689, DOI 10.1073/pnas.92.5.1689; Sunaert S, 2000, NEUROIMAGE, V11, P612, DOI 10.1006/nimg.2000.0587; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; van Boxtel JJA, 2006, VISION RES, V46, P4634, DOI 10.1016/j.visres.2006.06.015; van de Grind WA, 2001, P ROY SOC B-BIOL SCI, V268, P437, DOI 10.1098/rspb.2000.1380; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vanni S, 2004, NEUROIMAGE, V21, P801, DOI 10.1016/j.neuroimage.2003.10.047; VanOostende S, 1997, CEREB CORTEX, V7, P690, DOI 10.1093/cercor/7.7.690; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053	73	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35771	10.1371/journal.pone.0035771	http://dx.doi.org/10.1371/journal.pone.0035771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558222	Green Published, gold			2022-12-25	WOS:000305345200077
J	Bendtsen, KM; Juul, J; Trusina, A				Bendtsen, Kristian Moss; Juul, Jeppe; Trusina, Ala			Fragile DNA Repair Mechanism Reduces Ageing in Multicellular Model	PLOS ONE			English	Article							STEM-CELLS; CELLULAR SENESCENCE; DAMAGE; INSTABILITY; EXPRESSION; CANCER; BRAIN; VITRO; AGE	DNA damages, as well as mutations, increase with age. It is believed that these result from increased genotoxic stress and decreased capacity for DNA repair. The two causes are not independent, DNA damage can, for example, through mutations, compromise the capacity for DNA repair, which in turn increases the amount of unrepaired DNA damage. Despite this vicious circle, we ask, can cells maintain a high DNA repair capacity for some time or is repair capacity bound to continuously decline with age? We here present a simple mathematical model for ageing in multicellular systems where cells subjected to DNA damage can undergo full repair, go apoptotic, or accumulate mutations thus reducing DNA repair capacity. Our model predicts that at the tissue level repair rate does not continuously decline with age, but instead has a characteristic extended period of high and non-declining DNA repair capacity, followed by a rapid decline. Furthermore, the time of high functionality increases, and consequently slows down the ageing process, if the DNA repair mechanism itself is vulnerable to DNA damages. Although counterintuitive at first glance, a fragile repair mechanism allows for a faster removal of compromised cells, thus freeing the space for healthy peers. This finding might be a first step toward understanding why a mutation in single DNA repair protein (e.g. Wrn or Blm) is not buffered by other repair proteins and therefore, leads to severe ageing disorders.	[Bendtsen, Kristian Moss; Juul, Jeppe; Trusina, Ala] Univ Copenhagen, Niels Bohr Inst, CMOL, DK-2100 Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute	Bendtsen, KM (corresponding author), Univ Copenhagen, Niels Bohr Inst, CMOL, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	kmoss@nbi.dk	Trusina, Ala/L-6069-2013; Trusina, Ala/N-5030-2019; trusina, ala/H-7312-2012	Trusina, Ala/0000-0003-1945-454X; Trusina, Ala/0000-0003-1945-454X; 	Danish Research Council, Nordea-fonden, Steno Fellowship	Danish Research Council, Nordea-fonden, Steno Fellowship	This work was supported by the Danish Research Council, Nordea-fonden, Steno Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araia F, 2011, STEMBOOK; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Busuttil RA, 2004, ANN NY ACAD SCI, V1019, P245, DOI 10.1196/annals.1297.041; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Charville GW, 2011, PHILOS T R SOC B, V366, P85, DOI 10.1098/rstb.2010.0279; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Flindt R, 2006, AMAZING NUMBERS BIOL; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Karahalil B, 2002, FASEB J, V16, P1895, DOI 10.1096/fj.02-0463com; KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x; Richardson LL, 2000, BIOL REPROD, V62, P789, DOI 10.1095/biolreprod62.3.789; Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Sieburg HB, 2011, P NATL ACAD SCI USA, V108, P4370, DOI 10.1073/pnas.1011414108; Wilson DM, 2008, MECH AGEING DEV, V129, P349, DOI 10.1016/j.mad.2008.02.013; Wilson TM, 1996, MUTAT RES-DNA REPAIR, V362, P237, DOI 10.1016/0921-8777(95)00053-4; Wodarz D, 2007, J THEOR BIOL, V245, P449, DOI 10.1016/j.jtbi.2006.10.013	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36018	10.1371/journal.pone.0036018	http://dx.doi.org/10.1371/journal.pone.0036018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567122	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500040
J	Jaramillo, E; Dugan, JE; Hubbard, DM; Melnick, D; Manzano, M; Duarte, C; Campos, C; Sanchez, R				Jaramillo, Eduardo; Dugan, Jenifer E.; Hubbard, David M.; Melnick, Daniel; Manzano, Mario; Duarte, Cristian; Campos, Cesar; Sanchez, Roland			Ecological Implications of Extreme Events: Footprints of the 2010 Earthquake along the Chilean Coast	PLOS ONE			English	Article							MAULE EARTHQUAKE; BEACH ECOSYSTEMS; SEISMIC GAP; TSUNAMI; LESSONS; SLIP	Deciphering ecological effects of major catastrophic events such as earthquakes, tsunamis, volcanic eruptions, storms and fires, requires rapid interdisciplinary efforts often hampered by a lack of pre-event data. Using results of intertidal surveys conducted shortly before and immediately after Chile's 2010 M-w 8.8 earthquake along the entire rupture zone (ca. 34-38 degrees S), we provide the first quantification of earthquake and tsunami effects on sandy beach ecosystems. Our study incorporated anthropogenic coastal development as a key design factor. Ecological responses of beach ecosystems were strongly affected by the magnitude of land-level change. Subsidence along the northern rupture segment combined with tsunami-associated disturbance and drowned beaches. In contrast, along the co-seismically uplifted southern rupture, beaches widened and flattened increasing habitat availability. Post-event changes in abundance and distribution of mobile intertidal invertebrates were not uniform, varying with land-level change, tsunami height and coastal development. On beaches where subsidence occurred, intertidal zones and their associated species disappeared. On some beaches, uplift of rocky subtidal substrate eliminated low intertidal sand beach habitat for ecologically important species. On others, unexpected interactions of uplift with man-made coastal armouring included restoration of upper and mid-intertidal habitat seaward of armouring followed by rapid colonization of mobile crustaceans typical of these zones formerly excluded by constraints imposed by the armouring structures. Responses of coastal ecosystems to major earthquakes appear to vary strongly with land-level change, the mobility of the biota and shore type. Our results show that interactions of extreme events with human-altered shorelines can produce surprising ecological outcomes, and suggest these complex responses to landscape alteration can leave lasting footprints in coastal ecosystems.	[Jaramillo, Eduardo; Manzano, Mario; Campos, Cesar; Sanchez, Roland] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Dugan, Jenifer E.; Hubbard, David M.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Melnick, Daniel] Univ Potsdam, Inst Geowissensch, Potsdam, Germany; [Duarte, Cristian] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Austral de Chile; University of California System; University of California Santa Barbara; University of Potsdam; Universidad Austral de Chile	Jaramillo, E (corresponding author), Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	ejaramillo@uach.cl	Duarte, Cristian/I-4013-2016; Melnick, Daniel/G-8484-2011	Melnick, Daniel/0000-0001-8397-7391; Duarte, Cristian/0000-0002-7033-3551; Sanchez Munoz, Roland/0000-0003-1866-0237	CONICYT (National Commision for Science, Chile); Direccion de Investigacion y Desarrollo, Universidad Austral de Chile; National Science Foundation [OCE-0620276]; German Science Foundation [ME 3157/2-1]	CONICYT (National Commision for Science, Chile); Direccion de Investigacion y Desarrollo, Universidad Austral de Chile; National Science Foundation(National Science Foundation (NSF)); German Science Foundation(German Research Foundation (DFG))	This work was supported by grants from CONICYT (National Commision for Science, Chile; www.conicyt.cl) and Direccion de Investigacion y Desarrollo, Universidad Austral de Chile (http://investigacion.uach.cl/direccion/index.php) to EJ. Support was provided by Santa Barbara Coastal Long Term Ecological Research program (National Science Foundation Award # OCE-0620276) (www.nsf.gov) for JED's participation. DM was supported by grant ME 3157/2-1, German Science Foundation (www.dfg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWATER BF, 1992, SCIENCE, V258, P1614, DOI 10.1126/science.258.5088.1614; ATWATER BF, 1987, SCIENCE, V236, P942, DOI 10.1126/science.236.4804.942; Brown AC, 2001, ENCY OCEAN SCI, V5, P2496; Byrnes JE, 2011, GLOBAL CHANGE BIOL, V17, P2513, DOI 10.1111/j.1365-2486.2011.02409.x; Castilla JC, 2010, MAR ECOL PROG SER, V418, P17, DOI 10.3354/meps08830; Charlier RH, 2005, J COASTAL RES, V21, P79, DOI 10.2112/03561.1; Cisternas M, 2005, NATURE, V437, P404, DOI 10.1038/nature03943; Corti P, 2002, STUD NEOTROP FAUNA E, V37, P9, DOI 10.1076/snfe.37.1.9.2118; Darwin C, 1851, GEOLOGICAL OBSERVATI; Dugan JE, 2008, MAR ECOL-EVOL PERSP, V29, P160, DOI 10.1111/j.1439-0485.2008.00231.x; Dugan JE, 2010, SCIENCE, V329, P1146, DOI 10.1126/science.329.5996.1146-a; Dugan JE, 2010, ESTUAR COAST, V33, P67, DOI 10.1007/s12237-009-9239-8; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; EMERY KO, 1961, LIMNOL OCEANOGR, V6, P90, DOI 10.4319/lo.1961.6.1.0090; Farias M, 2010, SCIENCE, V329, P916, DOI 10.1126/science.1192094; Feagin RA, 2005, FRONT ECOL ENVIRON, V3, P359, DOI 10.2307/3868584; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; Franklin J.F., 2000, CONSERVATION BIOL PR, V1, P9, DOI DOI 10.1111/J.1526-4629.2000.TB00155.X; Franklin JF, 2000, SCIENCE, V288, P1183, DOI 10.1126/science.288.5469.1183; Fritz HM, 2011, PURE APPL GEOPHYS, V168, P1989, DOI 10.1007/s00024-011-0283-5; HALL MJ, 1991, J COASTAL RES, V7, P771; International Federation of Red Cross and Red Crescent Societies, 2009, WORLD DIS REP 2009 F; Jaramillo E, 2001, ECOL STU AN, V144, P219; Lagos NA, 2008, WETLANDS, V28, P938, DOI 10.1672/07-119.1; Liew SC, 2010, GEOMORPHOLOGY, V114, P520, DOI 10.1016/j.geomorph.2009.08.010; Lindenmayer DB, 2010, FRONT ECOL ENVIRON, V8, P527, DOI 10.1890/090184; Lindenmayer DB, 2009, SCIENCE, V324, P463, DOI 10.1126/science.324_463b; Lomnitz C, 2004, SEISMOL RES LETT, V75, P368, DOI 10.1785/gssrl.75.3.368; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; Lorito S, 2011, NAT GEOSCI, V4, P173, DOI [10.1038/ngeo1073, 10.1038/NGEO1073]; McLachlan A, 1995, OCEANOGR MAR BIOL, V33, P305; Moreno M, 2010, NATURE, V467, P198, DOI 10.1038/nature09349; Nelson A.R., 1992, QUATERN INT, V15, P61, DOI [10.1016/1040-6182(92)90036-2, DOI 10.1016/1040-6182(92)90036-2]; Nordstrom K.F, 2000, BEACHES DUNES DEV CO; PLAFKER G, 1970, GEOL SOC AM BULL, V81, P1001, DOI 10.1130/0016-7606(1970)81[1001:MOTCEO]2.0.CO;2; Reinhardt EG, 2010, MAR GEOL, V269, P18, DOI 10.1016/j.margeo.2009.12.003; Ruegg JC, 2009, PHYS EARTH PLANET IN, V175, P78, DOI 10.1016/j.pepi.2008.02.015; Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x; The Ramsar Convention on Wetlands, CARL ANW SANCT RAMS; Tong XP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045805; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; Turner MG, 2003, FRONT ECOL ENVIRON, V1, P351, DOI 10.2307/3868187; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Vargas G, 2011, ANDEAN GEOL, V38, P219, DOI 10.5027/andgeoV38n1-a12; Vigny C, 2011, SCIENCE, V332, P1417, DOI 10.1126/science.1204132; Wiegel R.L, 2002, SHORE BEACH, V70, P17; Wong PP, 2009, POL J ENVIRON STUD, V18, P5	50	94	97	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35348	10.1371/journal.pone.0035348	http://dx.doi.org/10.1371/journal.pone.0035348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567101	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500019
J	Abdelli, S; Bonny, C				Abdelli, Saida; Bonny, Christophe			JNK3 Maintains Expression of the Insulin Receptor Substrate 2 (IRS2) in Insulin-Secreting Cells: Functional Consequences for Insulin Signaling	PLOS ONE			English	Article							PROTEIN-KINASE-B; PANCREATIC BETA-CELLS; PHYSIOLOGICAL FUNCTIONS; TUMOR SUPPRESSION; MICE LACKING; TRANSCRIPTION; APOPTOSIS; AKT; RESISTANCE; GROWTH	We have recently shown that silencing of the brain/islet specific c-Jun N-terminal Kinase3 (JNK3) isoform enhances both basal and cytokine-induced beta-cell apoptosis, whereas silencing of JNK1 or JNK2 has opposite effects. While it is known that JNK1 or JNK2 may promote apoptosis by inhibiting the activity of the pro-survival Akt pathway, the effect of JNK3 on Akt has not been documented. This study aims to determine the involvement of individual JNKs and specifically JNK3 in the regulation of the Akt signaling pathway in insulin-secreting cells. JNK3 silencing strongly decreases Insulin Receptor Substrate 2 (IRS2) protein expression, and blocks Akt2 but not Akt1 activation by insulin, while the silencing of JNK1 or JNK2 activates both Akt1 and Akt2. Concomitantly, the silencing of JNK1 or JNK2, but not of JNK3, potently phosphorylates the glycogen synthase kinase3 (GSK3 beta). JNK3 silencing also decreases the activity of the transcription factor Forkhead BoxO3A (FoxO3A) that is known to control IRS2 expression, in addition to increasing c-Jun levels that are known to inhibit insulin gene expression. In conclusion, we propose that JNK1/2 on one hand and JNK3 on the other hand, have opposite effects on insulin-signaling in insulin-secreting cells; JNK3 protects beta-cells from apoptosis and dysfunction mainly through maintenance of a normal IRS2 to Akt2 signaling pathway. It seems that JNK3 mediates its effects mainly at the transcriptional level, while JNK1 or JNK2 appear to mediate their pro-apoptotic effect in the cytoplasm.	[Abdelli, Saida; Bonny, Christophe] CHU Vaudois, Serv Med Genet, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Abdelli, S (corresponding author), CHU Vaudois, Serv Med Genet, Lausanne, Switzerland.	christophe.bonny@chuv.ch	Bonny, Christophe/AAV-7214-2021		Swiss National Foundation [FNS 320000-118193]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by a grant from the Swiss National Foundation (FNS 320000-118193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2007, DIABETOLOGIA, V50, P1660, DOI 10.1007/s00125-007-0704-2; Abdelli S, 2004, DIABETES, V53, P2815, DOI 10.2337/diabetes.53.11.2815; Abdelli S, 2009, DIABETOLOGIA, V52, P1871, DOI 10.1007/s00125-009-1431-7; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Aikin R, 2004, ENDOCRINOLOGY, V145, P4522, DOI 10.1210/en.2004-0488; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; ALTOMARE DA, 1995, ONCOGENE, V11, P1055; Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burks DJ, 2001, DIABETES, V50, pS140, DOI 10.2337/diabetes.50.2007.S140; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Glauser DA, 2007, J ENDOCRINOL, V193, P195, DOI 10.1677/JOE-06-0191; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holst LS, 1998, BIOCHEM BIOPH RES CO, V250, P181, DOI 10.1006/bbrc.1998.9166; Jaeschke A, 2005, P NATL ACAD SCI USA, V102, P6931, DOI 10.1073/pnas.0502143102; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim JY, 2010, J KOREAN MED SCI, V25, P1626, DOI 10.3346/jkms.2010.25.11.1626; Kishimoto H, 2003, CELL STRUCT FUNCT, V28, P11; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Liu Y, 2010, DIABETOLOGIA, V53, P2600, DOI 10.1007/s00125-010-1882-x; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; ROBINSON GLWG, 1995, MOL CELL BIOL, V15, P1398; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Tanabe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018146; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Tsunekawa S, 2011, DIABETES, V60, P2883, DOI 10.2337/db11-0340; White MF, 1998, CURR TOP MICROBIOL, V228, P179; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350	61	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35997	10.1371/journal.pone.0035997	http://dx.doi.org/10.1371/journal.pone.0035997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563476	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340700025
J	Bokulich, NA; Joseph, CML; Allen, G; Benson, AK; Mills, DA				Bokulich, Nicholas A.; Joseph, C. M. Lucy; Allen, Greg; Benson, Andrew K.; Mills, David A.			Next-Generation Sequencing Reveals Significant Bacterial Diversity of Botrytized Wine	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; MICROBIAL COMMUNITIES; ACID BACTERIA; YEAST; 16S; FERMENTATION; EVOLUTION; HEALTHY; GRAPE	While wine fermentation has long been known to involve complex microbial communities, the composition and role of bacteria other than a select set of lactic acid bacteria (LAB) has often been assumed either negligible or detrimental. This study served as a pilot study for using barcoded amplicon next-generation sequencing to profile bacterial community structure in wines and grape musts, comparing the taxonomic depth achieved by sequencing two different domains of prokaryotic 16S rDNA (V4 and V5). This study was designed to serve two goals: 1) to empirically determine the most taxonomically informative 16S rDNA target region for barcoded amplicon sequencing of wine, comparing V4 and V5 domains of bacterial 16S rDNA to terminal restriction fragment length polymorphism (TRFLP) of LAB communities; and 2) to explore the bacterial communities of wine fermentation to better understand the biodiversity of wine at a depth previously unattainable using other techniques. Analysis of amplicons from the V4 and V5 provided similar views of the bacterial communities of botrytized wine fermentations, revealing a broad diversity of low-abundance taxa not traditionally associated with wine, as well as atypical LAB communities initially detected by TRFLP. The V4 domain was determined as the more suitable read for wine ecology studies, as it provided greater taxonomic depth for profiling LAB communities. In addition, targeted enrichment was used to isolate two species of Alphaproteobacteria from a finished fermentation. Significant differences in diversity between inoculated and uninoculated samples suggest that Saccharomyces inoculation exerts selective pressure on bacterial diversity in these fermentations, most notably suppressing abundance of acetic acid bacteria. These results determine the bacterial diversity of botrytized wines to be far higher than previously realized, providing further insight into the fermentation dynamics of these wines, and demonstrate the utility of next-generation sequencing for wine ecology studies.	[Bokulich, Nicholas A.; Joseph, C. M. Lucy; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Allen, Greg] Dolce Winery, Oakville, CA USA; [Benson, Andrew K.] Univ Nebraska, Dept Food Sci, Lincoln, NE USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Nebraska System; University of Nebraska Lincoln	Bokulich, NA (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	damills@ucdavis.edu	Mills, David/GXF-1821-2022; Mills, David Andrew/G-2282-2011	Mills, David Andrew/0000-0003-1913-9865; Benson, Andrew/0000-0001-6330-0252; Bokulich, Nicholas/0000-0002-1784-8935	Oregon Wine Board; California Competitive Grants Program for Research in Viticulture and Enology; Wine Spectator scholarship; Wine Spectator; University of California Davis, Department of Viticulture and Enology	Oregon Wine Board; California Competitive Grants Program for Research in Viticulture and Enology; Wine Spectator scholarship; Wine Spectator; University of California Davis, Department of Viticulture and Enology	This work was supported in part by funding from the Oregon Wine Board and the California Competitive Grants Program for Research in Viticulture and Enology. NAB was supported by a Wine Spectator scholarship during the completion of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NAB was supported by a scholarship from a commercial source (Wine Spectator). This scholarship was awarded by a third-party source (University of California Davis, Department of Viticulture and Enology). GA is employed by the Dolce Winery, Oakville. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Allen GR, 2004, THESIS U CALIFORNIA; Andorra I, 2008, FOOD MICROBIOL, V25, P849, DOI 10.1016/j.fm.2008.05.005; Andorra I, 2010, FOOD RES INT, V43, P773, DOI 10.1016/j.foodres.2009.11.014; Atlas R. M., 1993, HDB MICROBIOLOGICAL; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bokulich NA, 2012, AM J ENOL VITICULT, V63, P185, DOI 10.5344/ajev.2011.11077; Bokulich NA, 2012, FOOD MICROBIOL, V31, P126, DOI 10.1016/j.fm.2012.02.007; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cocolin L, 2001, AM J ENOL VITICULT, V52, P49; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; JOYEUX A, 1984, APPL ENVIRON MICROB, V48, P153, DOI 10.1128/AEM.48.1.153-156.1984; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Leveau JHJ, 2011, ACTA HORTIC, V905, P31; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Mills DA, 2002, APPL ENVIRON MICROB, V68, P4884, DOI 10.1128/AEM.68.10.4884-4893.2002; Mills DA, 2007, MOL METHODS MICROBIA; Nisiotou AA, 2007, APPL ENVIRON MICROB, V73, P6705, DOI 10.1128/AEM.01279-07; Nisiotou AA, 2007, APPL ENVIRON MICROB, V73, P2765, DOI 10.1128/AEM.01864-06; Nisiotou AA, 2011, INT J FOOD MICROBIOL, V145, P432, DOI 10.1016/j.ijfoodmicro.2011.01.017; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Renouf V, 2006, J APPL MICROBIOL, V100, P1208, DOI 10.1111/j.1365-2672.2006.02959.x; Renouf V, 2007, APPL MICROBIOL BIOT, V75, P149, DOI 10.1007/s00253-006-0798-3; Ribereau-Gayon P, 1985, AM J ENOL VITICULT, V36, P1985; Sato T, 1998, APPL ENV MICROBIOL, V64; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Sipiczki M, 2003, INT J SYST EVOL MICR, V53, P2079, DOI 10.1099/ijs.0.02649-0; Soergel DAW, 2012, ISME, V7, DOI [10.1038/ismej.2011.1208, DOI 10.1038/ISMEJ.2011.1208]; Wang Q, 2007, APPL ENV MICROBIOL, V73; Werner JJ, 2011, ISME, DOI [10.1038/ismej.2011.1186, DOI 10.1038/ISMEJ.2011.1186]	39	151	160	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36357	10.1371/journal.pone.0036357	http://dx.doi.org/10.1371/journal.pone.0036357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563494	Green Published, gold			2022-12-25	WOS:000305340700043
J	Hsu, TW; Wu, CWW; Cheng, YF; Chen, HL; Lu, CH; Cho, KH; Lin, WC; Lin, CP				Hsu, Tun-Wei; Wu, Changwei W.; Cheng, Yu-Fan; Chen, Hsiu-Ling; Lu, Cheng-Hsien; Cho, Kuan-Hung; Lin, Wei-Che; Lin, Ching-Po			Impaired Small-World Network Efficiency and Dynamic Functional Distribution in Patients with Cirrhosis	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SUBCLINICAL HEPATIC-ENCEPHALOPATHY; GRAPH-THEORETICAL ANALYSIS; RESTING-STATE; GLUCOSE-METABOLISM; CORTICAL THICKNESS; BRAIN; CONNECTIVITY; CORTEX; FREQUENCY	Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome and a major complication of liver cirrhosis. Dysmetabolism of the brain, related to elevated ammonia levels, interferes with intercortical connectivity and cognitive function. For evaluation of network efficiency, a 'small-world' network model can quantify the effectiveness of information transfer within brain networks. This study aimed to use small-world topology to investigate abnormalities of neuronal connectivity among widely distributed brain regions in patients with liver cirrhosis using resting-state functional magnetic resonance imaging (rs-fMRI). Seventeen cirrhotic patients without HE, 9 with minimal HE, 9 with overt HE, and 35 healthy controls were compared. The interregional correlation matrix was obtained by averaging the rs-fMRI time series over all voxels in each of the 90 regions using the automated anatomical labeling model. Cost and correlation threshold values were then applied to construct the functional brain network. The absolute and relative network efficiencies were calculated; quantifying distinct aspects of the local and global topological network organization. Correlations between network topology parameters, ammonia levels, and the severity of HE were determined using linear regression and ANOVA. The local and global topological efficiencies of the functional connectivity network were significantly disrupted in HE patients; showing abnormal small-world properties. Alterations in regional characteristics, including nodal efficiency and nodal strength, occurred predominantly in the association, primary, and limbic/paralimbic regions. The degree of network organization disruption depended on the severity of HE. Ammonia levels were also significantly associated with the alterations in local network properties. Results indicated that alterations in the rs-fMRI network topology of the brain were associated with HE grade; and that focal or diffuse lesions disturbed the functional network to further alter the global topology and efficiency of the whole brain network. These findings provide insights into the functional changes in the human brain in HE.	[Hsu, Tun-Wei; Chen, Hsiu-Ling; Lin, Wei-Che; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Hsu, Tun-Wei] Taipei Vet Gen Hosp, Dept Diagnost Radiol, Taipei, Taiwan; [Wu, Changwei W.] Natl Cent Univ, Inst Biomed Engn, Tao Yuan, Taiwan; [Cheng, Yu-Fan; Chen, Hsiu-Ling; Lin, Wei-Che] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Neurol, Kaohsiung, Taiwan; [Cho, Kuan-Hung; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Brain Connect Lab, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Central University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University	Hsu, TW (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	u64lin@yahoo.com.tw; cplin@ym.edu.tw		Wu, Changwei W./0000-0001-8968-9366; Hsu, Tun-Wei/0000-0002-4614-6449	National Science Council [NSC 97-2314-B-182A-104-MY3, NSC 100-2628-E-010-002-MY3]; National Health Research Institute [NHRI-EX100-9813EC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This study was supported by grants from the National Science Council (NSC 97-2314-B-182A-104-MY3 to Dr. W. Lin, NSC 100-2628-E-010-002-MY3 to Dr. C. Lin) and National Health Research Institute (NHRI-EX100-9813EC to Dr. C. Lin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ALMDAL T, 1989, SCAND J GASTROENTERO, V24, P299, DOI 10.3109/00365528909093050; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Cordoba J, 1996, SEMIN LIVER DIS, V16, P271, DOI 10.1055/s-2007-1007240; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fernandez R, 2007, NEUROLOGY, V68, P2066, DOI 10.1212/01.wnl.0000264873.62313.81; Gerber T, 2000, DRUGS, V60, P1353, DOI 10.2165/00003495-200060060-00008; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Hertz L, 2007, METAB BRAIN DIS, V22, P199, DOI 10.1007/s11011-007-9068-z; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Kale RA, 2006, HEPATOLOGY, V43, P698, DOI 10.1002/hep.21114; Kato A, 2000, HEPATOL RES, V17, P237, DOI 10.1016/S1386-6346(99)00080-7; KAWATOKO T, 1992, Fukuoka Acta Medica, V83, P33; LAI JCK, 1986, J NEUROCHEM, V47, P1376, DOI 10.1111/j.1471-4159.1986.tb00768.x; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; Lockwood AH, 2002, METAB BRAIN DIS, V17, P29, DOI 10.1023/A:1014000313824; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Norenberg MD, 2005, METAB BRAIN DIS, V20, P303, DOI 10.1007/s11011-005-7911-7; OCARROLL RE, 1991, LANCET, V337, P1250, DOI 10.1016/0140-6736(91)92920-W; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Schiff S, 2006, CLIN NEUROPHYSIOL, V117, P1728, DOI 10.1016/j.clinph.2006.04.020; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; TRZEPACZ PT, 1994, J NEUROPSYCH CLIN N, V6, P170; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; van Dellen E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008081; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019608; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zhao QB, 2008, PHYSICA A, V387, P5952, DOI 10.1016/j.physa.2008.07.002; Zwingmann C, 2003, HEPATOLOGY, V37, P420, DOI 10.1053/jhep.2003.50052	59	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35266	10.1371/journal.pone.0035266	http://dx.doi.org/10.1371/journal.pone.0035266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563460	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340700009
J	Lardizabal, MN; Nocito, AL; Daniele, SM; Ornella, LA; Palatnik, JF; Veggi, LM				Lardizabal, Maria N.; Nocito, Ana L.; Daniele, Stella M.; Ornella, Leonardo A.; Palatnik, Javier F.; Veggi, Luis M.			Reference Genes for Real-Time PCR Quantification of MicroRNAs and Messenger RNAs in Rat Models of Hepatotoxicity	PLOS ONE			English	Article							RT-PCR; HOUSEKEEPING GENES; RELATIVE QUANTIFICATION; QUANTITATIVE PCR; LIVER-DISEASES; EXPRESSION; NORMALIZATION; TARGET; INJURY; GUIDELINES	Hepatotoxicity is associated with major changes in liver gene expression induced by xenobiotic exposure. Understanding the underlying mechanisms is critical for its clinical diagnosis and treatment. MicroRNAs are key regulators of gene expression that control mRNA stability and translation, during normal development and pathology. The canonical technique to measure gene transcript levels is Real-Time qPCR, which has been successfully modified to determine the levels of microRNAs as well. However, in order to obtain accurate data in a multi-step method like RT-qPCR, the normalization with endogenous, stably expressed reference genes is mandatory. Since the expression stability of candidate reference genes varies greatly depending on experimental factors, the aim of our study was to identify a combination of genes for optimal normalization of microRNA and mRNA qPCR expression data in experimental models of acute hepatotoxicity. Rats were treated with four traditional hepatotoxins: acetaminophen, carbon tetrachloride, D-galactosamine and thioacetamide, and the liver expression levels of two groups of candidate reference genes, one for microRNA and the other for mRNA normalization, were determined by RT-qPCR in compliance with the MIQE guidelines. In the present study, we report that traditional reference genes such as U6 spliceosomal RNA, Beta Actin and Glyceraldehyde-3P-dehydrogenase altered their expression in response to classic hepatotoxins and therefore cannot be used as reference genes in hepatotoxicity studies. Stability rankings of candidate reference genes, considering only those that did not alter their expression, were determined using geNorm, NormFinder and BestKeeper software packages. The potential candidates whose measurements were stable were further tested in different combinations to find the optimal set of reference genes that accurately determine mRNA and miRNA levels. Finally, the combination of MicroRNA-16/5S Ribosomal RNA and Beta 2 Microglobulin/18S Ribosomal RNA were validated as optimal reference genes for microRNA and mRNA quantification, respectively, in rat models of acute hepatotoxicity.	[Lardizabal, Maria N.; Veggi, Luis M.] CONICET UNR, IFISE, Rosario, Santa Fe, Argentina; [Nocito, Ana L.] Univ Nacl Rosario, Fac Ciencias Med, RA-2000 Rosario, Santa Fe, Argentina; [Daniele, Stella M.; Veggi, Luis M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina; [Palatnik, Javier F.] CONICET UNR, IBR, Rosario, Santa Fe, Argentina; [Ornella, Leonardo A.] CONICET UNR UPCAM, CIFASIS, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Lardizabal, MN (corresponding author), CONICET UNR, IFISE, Rosario, Santa Fe, Argentina.	veggi@ifise-conicet.gov.ar	Ornella, Leonardo/ABA-6551-2021	Palatnik, Javier/0000-0001-7996-5224	Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Nacional de Rosario	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Rosario	This work was supported financially by Research Grants from Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.gov.ar/), Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar) and from Universidad Nacional de Rosario (http://www.unr.edu.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ARMENDARIZBORUNDA J, 1990, FASEB J, V4, P215, DOI 10.1096/fasebj.4.2.2298342; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bargaje R, 2010, RNA, V16, P16, DOI 10.1261/rna.1688110; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2009, WORLD J GASTROENTERO, V15, P1665, DOI 10.3748/wjg.15.1665; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Fox BC, 2010, TOXICOL IN VITRO, V24, P1962, DOI 10.1016/j.tiv.2010.08.007; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gant TW, 2005, MUTAT RES-FUND MOL M, V575, P4, DOI 10.1016/j.mrfmmm.2005.02.007; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Heinloth AN, 2004, TOXICOL SCI, V80, P193, DOI 10.1093/toxsci/kfh145; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jung M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-47; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Li JN, 2010, J VIROL METHODS, V169, P316, DOI 10.1016/j.jviromet.2010.07.036; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Mehendale HM, 2005, TOXICOL PATHOL, V33, P41, DOI 10.1080/01926230590881808; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Miyamoto M, 2008, TOXICOL SCI, V106, P538, DOI 10.1093/toxsci/kfn188; Nishimura M, 2006, BIOCHEM BIOPH RES CO, V346, P1033, DOI 10.1016/j.bbrc.2006.06.012; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Pohjanvirta R, 2006, CHEM-BIOL INTERACT, V160, P134, DOI 10.1016/j.cbi.2006.01.001; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smits Katrien, 2009, BMC Res Notes, V2, P246, DOI 10.1186/1756-0500-2-246; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GP, 2010, MOL BIOTECHNOL, V46, P49, DOI 10.1007/s12033-010-9274-5; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Xing Wei, 2009, J Biomol Tech, V20, P109; Yoshitsugu H, 2006, DRUG METAB PHARMACOK, V21, P465, DOI 10.2133/dmpk.21.465; Zimmerman H., 1999, HEPATOTOXICITY, V2; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	55	78	83	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36323	10.1371/journal.pone.0036323	http://dx.doi.org/10.1371/journal.pone.0036323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563491	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700040
J	Boulanger, J; Muresan, L; Tiemann-Boege, I				Boulanger, Jerome; Muresan, Leila; Tiemann-Boege, Irene			Massively Parallel Haplotyping on Microscopic Beads for the High-Throughput Phase Analysis of Single Molecules	PLOS ONE			English	Article							PCR-MEDIATED RECOMBINATION; DNA-POLYMERASE-I; SEQUENCE VARIANTS; EMULSION-PCR; HUMAN GENOME; LONG-RANGE; AMPLIFICATION; ARTIFACTS; COMPLEX; SPERM	In spite of the many advances in haplotyping methods, it is still very difficult to characterize rare haplotypes in tissues and different environmental samples or to accurately assess the haplotype diversity in large mixtures. This would require a haplotyping method capable of analyzing the phase of single molecules with an unprecedented throughput. Here we describe such a haplotyping method capable of analyzing in parallel hundreds of thousands single molecules in one experiment. In this method, multiple PCR reactions amplify different polymorphic regions of a single DNA molecule on a magnetic bead compartmentalized in an emulsion drop. The allelic states of the amplified polymorphisms are identified with fluorescently labeled probes that are then decoded from images taken of the arrayed beads by a microscope. This method can evaluate the phase of up to 3 polymorphisms separated by up to 5 kilobases in hundreds of thousands single molecules. We tested the sensitivity of the method by measuring the number of mutant haplotypes synthesized by four different commercially available enzymes: Phusion, Platinum Taq, Titanium Taq, and Phire. The digital nature of the method makes it highly sensitive to detecting haplotype ratios of less than 1:10,000. We also accurately quantified chimera formation during the exponential phase of PCR by different DNA polymerases.	[Boulanger, Jerome] Inst Curie, CNRS, Cell & Tissue Imaging Core, F-75231 Paris, France; [Boulanger, Jerome] Austrian Acad Sci, Radon Inst Computat & Appl Math, Linz, Austria; [Muresan, Leila] Johannes Kepler Univ Linz, Dept Knowledge Based Math Syst, A-4040 Linz, Austria; [Tiemann-Boege, Irene] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Austrian Academy of Sciences; Johannes Kepler University Linz; Johannes Kepler University Linz	Boulanger, J (corresponding author), Inst Curie, CNRS, Cell & Tissue Imaging Core, F-75231 Paris, France.	irene.tiemann@jku.at	Muresan, Leila/AGK-4203-2022; Tiemann-Boege, Irene/H-4437-2012	Muresan, Leila/0000-0002-7602-0249; Tiemann-Boege, Irene/0000-0002-3621-7020; Boulanger, Jerome/0000-0003-0237-3743	Austrian Science Fund (FWF) [M1097]; National Center for Research Resources [U54 RR020278]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Austrian Science Fund (FWF) [M1097]. The Broad Institute Center for Genotyping and Analysis was supported by grant U54 RR020278 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bansal V, 2008, GENOME RES, V18, P1336, DOI 10.1101/gr.077065.108; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; Dempster AP, 1977, J ROYAL STAT SOC B, V39, P138; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Ding CM, 2003, P NATL ACAD SCI USA, V100, P7449, DOI 10.1073/pnas.1232475100; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Dudoit S, 2002, STAT SINICA, V12, P111; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Fang GW, 1998, J VIROL METHODS, V76, P139, DOI 10.1016/S0166-0934(98)00133-5; FINDLAY I, 1995, HUM REPROD, V10, P1609, DOI 10.1093/HUMREP/10.6.1609; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Hayden MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-80; Huet S, 2006, ESAIM-PROBAB STAT, V10, P164; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jiang ZH, 2009, INT J BIOL SCI, V5, P298; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kurata S, 2004, APPL ENVIRON MICROB, V70, P7545, DOI 10.1128/AEM.70.12.7545-7549.2004; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Shammas FV, 2001, CLIN CHIM ACTA, V304, P19, DOI 10.1016/S0009-8981(00)00374-0; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Tiemann-Boege I, 2009, ANAL CHEM, V81, P5770, DOI 10.1021/ac900633y; Turner DJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn373; Wetmur JG, 2005, NUCLEIC ACIDS RES, V33, P2615, DOI 10.1093/nar/gki556; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Xiao M, 2009, NAT METHODS, V6, P199, DOI [10.1038/nmeth.1301, 10.1038/NMETH.1301]; Yu W, 2006, BIOTECHNIQUES, V40, P499, DOI 10.2144/000112124; Zaphiropoulos PG, 1998, NUCLEIC ACIDS RES, V26, P2843, DOI 10.1093/nar/26.12.2843; Zeng Y, 2010, ANAL CHEM, V82, P3183, DOI 10.1021/ac902683t; Zhu J, 2003, SCIENCE, V301, P836, DOI 10.1126/science.1085792; Zylstra P, 1998, IMMUNOL CELL BIOL, V76, P395, DOI 10.1046/j.1440-1711.1998.00772.x	48	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36064	10.1371/journal.pone.0036064	http://dx.doi.org/10.1371/journal.pone.0036064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558329	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200037
J	Hughes, GL; Pike, AD; Xue, P; Rasgon, JL				Hughes, Grant L.; Pike, Andrew D.; Xue, Ping; Rasgon, Jason L.			Invasion of Wolbachia into Anopheles and Other Insect Germlines in an Ex vivo Organ Culture System	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; AEDES-AEGYPTI; MOSQUITO; GAMBIAE; VITELLOGENIN; STRAIN; ENDOSYMBIONTS; PIPIENTIS; INFECTION	The common bacterial endosymbiont Wolbachia manipulates its host's reproduction to promote its own maternal transmission, and can interfere with pathogen development in many insects making it an attractive agent for the control of arthropod-borne disease. However, many important species, including Anopheles mosquitoes, are uninfected. Wolbachia can be artificially transferred between insects in the laboratory but this can be a laborious and sometimes fruitless process. We used a simple ex vivo culturing technique to assess the suitability of Wolbachia-host germline associations. Wolbachia infects the dissected germline tissue of multiple insect species when the host tissue and bacteria are cultured together. Ovary and testis infection occurs in a density-dependent manner. Wolbachia strains are more capable of invading the germline of their native or closely related rather than divergent hosts. The ability of Wolbachia to associate with the germline of novel hosts is crucial for the development of stably-transinfected insect lines. Rapid assessment of the suitability of a strain-host combination prior to transinfection may dictate use of a particular Wolbachia strain. Furthermore, the cultured germline tissues of two major Anopheline vectors of Plasmodium parasites are susceptible to Wolbachia infection. This finding further enhances the prospect of using Wolbachia for the biological control of malaria.	[Hughes, Grant L.; Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Hughes, Grant L.; Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Pike, Andrew D.; Xue, Ping] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hughes, GL (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	jlr54@psu.edu		Rasgon, Jason/0000-0002-4050-8429; Hughes, Grant/0000-0002-7567-7185; Pike, Andrew/0000-0003-3155-9969	United States National Institutes of Health [R21AI070178]; Johns Hopkins School of Public Health (JHSPH) Jane Welsh Russell Scholarship; Johns Hopkins Malaria Research Institute (JHMRI) postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070178] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins School of Public Health (JHSPH) Jane Welsh Russell Scholarship; Johns Hopkins Malaria Research Institute (JHMRI) postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by United States National Institutes of Health grant R21AI070178 to JLR. GLH was supported by the Johns Hopkins School of Public Health (JHSPH) Jane Welsh Russell Scholarship and a Johns Hopkins Malaria Research Institute (JHMRI) postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; DEITSCH KW, 1995, INSECT BIOCHEM MOLEC, V25, P449, DOI 10.1016/0965-1748(94)00082-A; FALLON AM, 1974, J INSECT PHYSIOL, V20, P1815, DOI 10.1016/0022-1910(74)90211-X; Fenollar F, 2003, ANTIMICROB AGENTS CH, V47, P1665, DOI 10.1128/AAC.47.5.1665-1671.2003; Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; GUBLER DJ, 1968, AM J EPIDEMIOL, V87, P502, DOI 10.1093/oxfordjournals.aje.a120840; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jin CY, 2009, APPL ENVIRON MICROB, V75, P3373, DOI 10.1128/AEM.00207-09; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; KAMBHAMPATI S, 1993, EVOLUTION, V47, P673, DOI [10.2307/2410079, 10.1111/j.1558-5646.1993.tb02121.x]; KITAMURA SIRO, 1964, KOBE J MED SCI, V10, P85; KOLLER CN, 1989, INSECT BIOCHEM, V19, P693; MARHOUL Z, 1972, T ROY SOC TROP MED H, V66, P183, DOI 10.1016/0035-9203(72)90068-5; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Provost-Javier KN, 2010, INSECT MOL BIOL, V19, P423, DOI 10.1111/j.1365-2583.2010.00999.x; Rasgon JL, 2006, APPL ENVIRON MICROB, V72, P7718, DOI 10.1128/AEM.01578-06; Ricci I, 2002, J MED ENTOMOL, V39, P562, DOI 10.1603/0022-2585-39.4.562; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Walker T, 2011, MEM I OSWALDO CRUZ, V106, P212, DOI 10.1590/S0074-02762011000900026; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098	34	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36277	10.1371/journal.pone.0036277	http://dx.doi.org/10.1371/journal.pone.0036277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558418	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340200059
J	Chiron, S; Tomczak, C; Duperray, A; Laine, J; Bonne, G; Eder, A; Hansen, A; Eschenhagen, T; Verdier, C; Coirault, C				Chiron, Stephane; Tomczak, Carole; Duperray, Alain; Laine, Jeanne; Bonne, Gisele; Eder, Alexandra; Hansen, Arne; Eschenhagen, Thomas; Verdier, Claude; Coirault, Catherine			Complex Interactions between Human Myoblasts and the Surrounding 3D Fibrin-Based Matrix	PLOS ONE			English	Article							ENGINEERED SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; 3-DIMENSIONAL CELL; MORPHOLOGY; CYTOSKELETON; FIBROBLASTS; ADHESIONS; STIFFNESS; PROTEINS; MYOTUBES	Anchorage of muscle cells to the extracellular matrix is crucial for a range of fundamental biological processes including migration, survival and differentiation. Three-dimensional (3D) culture has been proposed to provide a more physiological in vitro model of muscle growth and differentiation than routine 2D cultures. However, muscle cell adhesion and cell-matrix interplay of engineered muscle tissue remain to be determined. We have characterized cell-matrix interactions in 3D muscle culture and analyzed their consequences on cell differentiation. Human myoblasts were embedded in a fibrin matrix cast between two posts, cultured until confluence, and then induced to differentiate. Myoblasts in 3D aligned along the longitudinal axis of the gel. They displayed actin stress fibers evenly distributed around the nucleus and a cortical mesh of thin actin filaments. Adhesion sites in 3D were smaller in size than in rigid 2D culture but expression of adhesion site proteins, including alpha 5 integrin and vinculin, was higher in 3D compared with 2D (p<0.05). Myoblasts and myotubes in 3D exhibited thicker and ellipsoid nuclei instead of the thin disk-like shape of the nuclei in 2D (p<0.001). Differentiation kinetics were faster in 3D as demonstrated by higher mRNA concentrations of a-actinin and myosin. More important, the elastic modulus of engineered muscle tissues increased significantly from 3.5 +/- 0.8 to 7.4 +/- 4.7 kPa during proliferation (p<0.05) and reached 12.2 +/- 6.0 kPa during differentiation (p<0.05), thus attesting the increase of matrix stiffness during proliferation and differentiation of the myocytes. In conclusion, we reported modulations of the adhesion complexes, the actin cytoskeleton and nuclear shape in 3D compared with routine 2D muscle culture. These findings point to complex interactions between muscle cells and the surrounding matrix with dynamic regulation of the cell-matrix stiffness.	[Chiron, Stephane; Tomczak, Carole; Laine, Jeanne; Bonne, Gisele; Coirault, Catherine] INSERM, U974, Paris, France; [Chiron, Stephane; Tomczak, Carole; Bonne, Gisele; Coirault, Catherine] CNRS, UMR7215, Paris, France; [Chiron, Stephane; Tomczak, Carole; Bonne, Gisele; Coirault, Catherine] Univ Paris 06, UM76, IFR14, Paris, France; [Chiron, Stephane; Tomczak, Carole; Bonne, Gisele; Coirault, Catherine] Inst Myol, Paris, France; [Duperray, Alain] INSERM, Inst Albert Bonniot, U823, Grenoble, France; [Laine, Jeanne] Univ Paris 06, Dept Physiol, Paris, France; [Bonne, Gisele] Grp Hosp Pitie Salpetriere, AP HP, UF Cardiogenet & Myogenet, Serv Biochim & Metab, F-75634 Paris, France; [Eder, Alexandra; Hansen, Arne; Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Verdier, Claude] Univ Grenoble 1, CNRS, LIPhy UMR 5588, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Chiron, S (corresponding author), INSERM, U974, Paris, France.	c.coirault@institut-myologie.org	Bonne, Gisèle/G-3121-2013; Duperray, Alain/E-8428-2012; Coirault, Catherine/S-2454-2019; Coirault, Catherine/I-2979-2016; Verdier, Claude/C-1419-2008	Bonne, Gisèle/0000-0002-2516-3258; Duperray, Alain/0000-0002-2719-252X; Coirault, Catherine/0000-0002-5594-1057; Verdier, Claude/0000-0003-3706-7148	Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie Paris 06; Centre National de la Recherche Scientifique; Association Francaise contre les Myopathies; Grenoble Nanosciences Foundation; Association pour la Recherche sur le Cancer (Villejuif, France); Nanobio program	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie Paris 06; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Grenoble Nanosciences Foundation; Association pour la Recherche sur le Cancer (Villejuif, France)(Fondation ARC pour la Recherche sur le Cancer); Nanobio program	This work was financially supported by the Institut National de la Sante et de la Recherche Medicale; the Universite Pierre et Marie Curie Paris 06; the Centre National de la Recherche Scientifique; the Association Francaise contre les Myopathies and the "Grenoble Nanosciences Foundation." The equipment used at the microscopy facility of the Institut Albert Bonniot was partly funded by the Association pour la Recherche sur le Cancer (Villejuif, France) and the Nanobio program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Carmignac V, 2011, J PATHOL; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001; DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Engel A.G., 2004, MYOLOGY; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Formigli L, 2007, EUR J HISTOCHEM, V51, P21; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Gerard C, 2011, CELL TRANSPLANT; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; HAYWARD LJ, 1988, J CELL BIOL, V106, P2077, DOI 10.1083/jcb.106.6.2077; Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190; Kubow Kristopher E, 2011, Nat Cell Biol, V13, P3, DOI 10.1038/ncb0111-3; Levy-Mishali M, 2009, TISSUE ENG PT A, V15, P935, DOI 10.1089/ten.tea.2008.0111; Liao H, 2009, TISSUE ENG PART B-RE, V15, P319, DOI 10.1089/ten.teb.2009.0092; Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Okano T, 1998, CELL TRANSPLANT, V7, P71, DOI 10.1016/S0963-6897(97)00067-5; Orlando Giuseppe, 2011, Transpl Int, V24, P223, DOI 10.1111/j.1432-2277.2010.01182.x; Rhim C, 2007, MUSCLE NERVE, V36, P71, DOI 10.1002/mus.20788; Sander EA, 2011, ANN BIOMED ENG, V39, P714, DOI 10.1007/s10439-010-0192-2; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Shah R, 2005, BIOMATERIALS, V26, P1497, DOI 10.1016/j.biomaterials.2004.04.049; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931; Vandenburgh H, 2010, TISSUE ENG PART B-RE, V16, P55, DOI [10.1089/ten.teb.2009.0445, 10.1089/ten.TEB.2009.0445]; VANDENBURGH HH, 1988, IN VITRO CELL DEV B, V24, P166, DOI 10.1007/BF02623542; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Williamson MR, 2006, BIOMATERIALS, V27, P1019, DOI 10.1016/j.biomaterials.2005.06.018; Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382	40	70	70	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36173	10.1371/journal.pone.0036173	http://dx.doi.org/10.1371/journal.pone.0036173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558372	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000146
J	Liu, N; He, S; Tolbert, E; Gong, RJ; Bayliss, G; Zhuang, SG				Liu, Na; He, Song; Tolbert, Evelyn; Gong, Rujun; Bayliss, George; Zhuang, Shougang			Suramin Alleviates Glomerular Injury and Inflammation in the Remnant Kidney	PLOS ONE			English	Article							NF-KAPPA-B; ATTENUATES RENAL INJURY; GROWTH-FACTOR; INTERSTITIAL FIBROSIS; CHEMOATTRACTANT PROTEIN-1; FIBROBLAST ACTIVATION; CHEMOKINE RECEPTORS; RAT-KIDNEY; EXPRESSION; INHIBITION	Background: Recently, we demonstrated that suramin, a compound that inhibits the interaction of multiple cytokines/growth factors with their receptors, inhibits activation and proliferation of renal interstitial fibroblasts, and attenuates the development of renal interstitial fibrosis in the murine model of unilateral ureteral obstruction (UUO). However, it remains unclear whether suramin can alleviate glomerular and vascular lesions, which are not typical pathological changes in the UUO model. So we tested the efficacy of suramin in the remnant kidney after 5/6 nephrectomy, a model characterized by the slow development of glomerulosclerosis, vascular sclerosis, tubulointerstitial fibrosis and renal inflammation, mimicking human disease. Methods/Findings: 5/6 of normal renal mass was surgically ablated in male rats. On the second week after surgery, rats were randomly divided into suramin treatment and non-treatment groups. Suramin was given at 10 mg/kg once per week for two weeks. In the remnant kidney of mice receiving suramin, glomerulosclerosis and vascular sclerosis as well as inflammation were ameliorated. Suramin also attenuated tubular expression of two chemokines, monocyte chemoattractant protein-1 and regulated upon expression normal T cell expressed and secreted (RANTES). After renal mass ablation, several intracellular molecules associated with renal fibrosis, including NF-kappaB p65, Smad-3, signal transducer and activator of transcription-3 and extracellular regulated kinase 1/2, are phosphorylated; suramin treatment inhibited their phosphorylation. Futhermore, suramin abolished renal ablation-induced phosphorylation of epidermal growth factor receptor and platelet derived growth factor receptor, two receptors that mediate renal fibrosis. Conclusions and Significance: These findings suggest that suramin attenuates glomerular and vascular injury and reduces inflammatory responses by suppression of multiple growth factor receptor-mediated profibrotic signaling pathways. Therefore, suramin may be a useful drug in preventing the fibrosis and sclerosis that characterizes progression of chronic kidney disease.	[Liu, Na; He, Song; Zhuang, Shougang] Tongji Univ, Dept Nephrol, Shanghai E Hosp, Sch Med, Shanghai 200092, Peoples R China; [Liu, Na; Tolbert, Evelyn; Gong, Rujun; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Alpert Med Sch, Providence, RI 02903 USA; [He, Song] Shekou Peoples Hosp, Dept Lab Med, Shenzhen, Guangdong, Peoples R China	Tongji University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Liu, N (corresponding author), Tongji Univ, Dept Nephrol, Shanghai E Hosp, Sch Med, Shanghai 200092, Peoples R China.	szhuang@lifespan.org			National Institutes of Health [DK-071997, DK-085065]; Brown Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071997, R01DK085065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK-071997, and DK-085065) and the Brown Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiu A, 1999, CANCER LETT, V146, P189, DOI 10.1016/S0304-3835(99)00260-8; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; BEHRENS MT, 1989, AM J PHYSIOL, V257, pF1059, DOI 10.1152/ajprenal.1989.257.6.F1059; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Bidani AK, 2000, KIDNEY INT, V57, P1651, DOI 10.1046/j.1523-1755.2000.00009.x; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Chen SL, 2003, AM J PHYSIOL-ENDOC M, V284, pE1089, DOI 10.1152/ajpendo.00540.2002; Chen Y, 2011, MOL VIS, V17, P3072; Cho Min Hyun, 2010, Korean J Pediatr, V53, P735, DOI 10.3345/kjp.2010.53.7.735; COFFEY RJ, 1987, J CELL PHYSIOL, V132, P143, DOI 10.1002/jcp.1041320120; Daha MR, 2000, NEPHROL DIAL TRANSPL, V15, P41, DOI 10.1093/ndt/15.suppl_6.41; DIAMOND JR, 1991, AM J PHYSIOL, V260, pF779, DOI 10.1152/ajprenal.1991.260.6.F779; FLOEGE J, 1992, KIDNEY INT, V41, P297, DOI 10.1038/ki.1992.42; FOGO A, 1989, SEMIN NEPHROL, V9, P329; Fujihara CK, 1998, KIDNEY INT, V54, P1510, DOI 10.1046/j.1523-1755.1998.00138.x; Fujiuchi S, 1997, ONCOLOGY, V54, P134; Gong RJ, 2004, J AM SOC NEPHROL, V15, P2868, DOI 10.1097/01.ASN.0000141962.44300.3A; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; HARRIS KPG, 1993, CLIN SCI, V85, P27, DOI 10.1042/cs0850027; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Kakuta Y, 2011, TRANSPL INT, V24, P514, DOI 10.1111/j.1432-2277.2011.01224.x; KLOEN P, 1994, EUR J CANCER, V30A, P678, DOI 10.1016/0959-8049(94)90544-4; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Li J, 2009, J RECEPT SIG TRANSD, V29, P280, DOI 10.1080/10799890903078465; Liu N, 2011, J PHARMACOL EXP THER, V338, P758, DOI 10.1124/jpet.111.181727; Liu N, 2011, CURR CLIN PHARMACOL, V6, P137, DOI 10.2174/157488411796151174; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Ludewig D, 2000, CELL TISSUE RES, V299, P97, DOI 10.1007/s004419900118; Melenhorst WBWH, 2008, HYPERTENSION, V52, P987, DOI 10.1161/HYPERTENSIONAHA.108.113860; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Pawluczyk IZA, 1997, J AM SOC NEPHROL, V8, P1525; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Sabatel H, 2011, BIOCHEM PHARMACOL, V82, P1371, DOI 10.1016/j.bcp.2011.07.105; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Shimizu H, 2003, J AM SOC NEPHROL, V14, P1496, DOI 10.1097/01.ASN.0000069223.98703.8E; STEIN CA, 1989, J CLIN ONCOL, V7, P499, DOI 10.1200/JCO.1989.7.4.499; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Timoshanko JR, 2005, J AM SOC NEPHROL, V16, P2646, DOI 10.1681/ASN.2004121107; VANGOOR H, 1992, LAB INVEST, V66, P564; Wada Takashi, 2006, Nihon Rinsho, V64 Suppl 2, P288; Waldherr R, 1988, Contrib Nephrol, V60, P64; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	53	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36194	10.1371/journal.pone.0036194	http://dx.doi.org/10.1371/journal.pone.0036194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558380	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000152
J	Minch, K; Rustad, T; Sherman, DR				Minch, Kyle; Rustad, Tige; Sherman, David R.			Mycobacterium tuberculosis Growth following Aerobic Expression of the DosR Regulon	PLOS ONE			English	Article							HYPOXIC RESPONSE; DORMANCY; SYSTEM	The Mycobacterium tuberculosis regulator DosR is induced by multiple stimuli including hypoxia, nitric oxide and redox stress. Overlap of these stimuli with conditions thought to promote latency in infected patients fuels a model in which DosR regulon expression is correlated with bacteriostasis in vitro and a proxy for latency in vivo. Here, we find that inducing the DosR regulon to wildtype levels in aerobic, replicating M. tuberculosis does not alter bacterial growth kinetics. We conclude that DosR regulon expression alone is insufficient for bacterial latency, but rather is expressed during a range of growth states in a dynamic environment.	[Minch, Kyle; Rustad, Tige; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Minch, Kyle; Sherman, David R.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Minch, K (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	david.sherman@seattlebiomed.org			Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200800059C]; National Science Foundation Graduate Research Fellowship Program	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported by Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract No. HHSN272200800059C. KM was supported by the National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; DYE C, 2008, GLOBAL TUBERCULOSIS; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Fallow A, 2010, J BACTERIOL, V192, P2228, DOI 10.1128/JB.01597-09; Flores Valdez MA, 2010, TUBERCULOSIS EDINB, V90, P197, DOI DOI 10.1016/J.TUBE.2010.04.001; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205	18	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35935	10.1371/journal.pone.0035935	http://dx.doi.org/10.1371/journal.pone.0035935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558276	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000088
J	Perez-Martinez, J; Perez-Martinez, FC; Carrion, B; Masia, J; Ortega, A; Simarro, E; Nam-Cha, SH; Cena, V				Perez-Martinez, Juan; Perez-Martinez, Francisco C.; Carrion, Blanca; Masia, Jesus; Ortega, Agustin; Simarro, Esther; Nam-Cha, Syong H.; Cena, Valentin			Aliskiren Prevents the Toxic Effects of Peritoneal Dialysis Fluids during Chronic Dialysis in Rats	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; HIGH GLUCOSE; ULTRAFILTRATION CAPACITY; MESENCHYMAL TRANSITION; MESOTHELIAL CELLS; OXIDATIVE STRESS; SOLUTE TRANSPORT; P38 MAPK; MEMBRANE; DEATH	The benefits of long-term peritoneal dialysis (PD) in patients with end-stage renal failure are short-lived due to structural and functional changes in the peritoneal membrane. In this report, we provide evidence for the in vitro and in vivo participation of the renin-angiotensin-aldosterone system (RAAS) in the signaling pathway leading to peritoneal fibrosis during PD. Exposure to high-glucose PD fluids (PDFs) increases damage and fibrosis markers in both isolated rat peritoneal mesothelial cells and in the peritoneum of rats after chronic dialysis. In both cases, the addition of the RAAS inhibitor aliskiren markedly improved damage and fibrosis markers, and prevented functional modifications in the peritoneal transport, as measured by the peritoneal equilibrium test. These data suggest that inhibition of the RAAS may be a novel way to improve the efficacy of PD by preventing inflammation and fibrosis following peritoneal exposure to high-glucose PDFs.	[Cena, Valentin] Univ Castilla La Mancha, Unidad Asociada Neurodeath, Dept Ciencias Med, CSIC, Albacete, Spain; [Perez-Martinez, Juan; Masia, Jesus; Ortega, Agustin] Complejo Hosp Univ, Dept Nephrol, Albacete, Spain; [Cena, Valentin] Inst Salud Carlos III, CIBERNED, Madrid, Spain; [Perez-Martinez, Francisco C.; Carrion, Blanca] NanoDrugs SL, Dept Res & Dev, Albacete, Spain; [Simarro, Esther] Complejo Hosp Univ, Dept Clin Chem, Albacete, Spain; [Nam-Cha, Syong H.] Complejo Hosp Univ, Dept Pathol, Albacete, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; CIBERNED; Instituto de Salud Carlos III	Perez-Martinez, J (corresponding author), Complejo Hosp Univ, Dept Nephrol, Albacete, Spain.	valentin.cena@gmail.com	Cena, Valentin/L-1751-2017	Cena, Valentin/0000-0001-8928-3681	Fondo de Investigaciones Sanitarias [PI081434]; Ministerio de Ciencia e Innovacion [BFU2011-30161-C02-01, PI10/01420]; Consejeria de Educacion [PII1I09-0163-4002, POII10-0274-3182]; Consejeria de Salud y Bienestar Social [PI-2009/32]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Educacion; Consejeria de Salud y Bienestar Social	This work has been supported, in part, by grants PI081434 from Fondo de Investigaciones Sanitarias, BFU2011-30161-C02-01 from Ministerio de Ciencia e Innovacion and PII1I09-0163-4002 and POII10-0274-3182 from Consejeria de Educacion, JCCM to V.C.; and PI10/01420 from the Fondo de Investigaciones Sanitarias, Ministerio de Ciencia e Innovacion; and PI-2009/32 from Consejeria de Salud y Bienestar Social, JCCM, to J.P.-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Bailie GR, 2005, PHARMACOTHERAPY, V25, P491, DOI 10.1592/phco.25.4.491.61034; Bozkurt D, 2008, PERITON DIALYSIS INT, V28, pS38; Carrion B, 2011, PERITON DIALYSIS INT, V31, P325, DOI 10.3747/pdi.2010.00164; Chaudhary K, 2010, CLIN J AM SOC NEPHRO, V5, P723, DOI 10.2215/CJN.05720809; Chung SH, 2005, NEPHROL DIAL TRANSPL, V20, P1207, DOI 10.1093/ndt/gfh772; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; Davies SJ, 2004, KIDNEY INT, V66, P2437, DOI 10.1111/j.1523-1755.2004.66021.x; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Fusshoeller A, 2008, PEDIATR NEPHROL, V23, P19, DOI 10.1007/s00467-007-0541-z; Gotloib L, 2009, CONTRIB NEPHROL, V163, P35, DOI 10.1159/000223778; Ha H, 2000, PERITON DIALYSIS INT, V20, pS10; HEIMBURGER O, 1990, KIDNEY INT, V38, P495, DOI 10.1038/ki.1990.231; Holmes C, 2006, KIDNEY INT, V70, pS104, DOI 10.1038/sj.ki.5001924; Jensen C, 2008, NAT REV DRUG DISCOV, V7, P399, DOI 10.1038/nrd2550; Jiang N, 2008, BLOOD PURIFICAT, V26, P423, DOI 10.1159/000153248; Jordan J, 2000, BRIT J PHARMACOL, V130, P1496, DOI 10.1038/sj.bjp.0703451; Ke CY, 2010, EUR J CLIN INVEST, V40, P301, DOI 10.1111/j.1365-2362.2010.02264.x; Krediet RT, 1999, KIDNEY INT, V55, P341, DOI 10.1046/j.1523-1755.1999.00264.x; Lameire N, 2010, NAT REV NEPHROL, V6, P75, DOI 10.1038/nrneph.2009.210; Lavrentyev EN, 2009, AM J PHYSIOL-HEART C, V296, pH106, DOI 10.1152/ajpheart.00239.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Mortier S, 2003, BLOOD PURIFICAT, V21, P14, DOI 10.1159/000067867; Muller DN, 2006, CLIN J AM SOC NEPHRO, V1, P221, DOI 10.2215/CJN.01201005; Nagy JA, 1996, KIDNEY INT S, V56, pS2; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Nessim SJ, 2010, KIDNEY INT, V78, P23, DOI 10.1038/ki.2010.90; Noh H, 2005, PERITON DIALYSIS INT, V25, P38; Posadas I, 2007, BRIT J PHARMACOL, V150, P577, DOI 10.1038/sj.bjp.0706993; Simoncini S, 2005, INT IMMUNOL, V17, P489, DOI 10.1093/intimm/dxh229; Singh R, 2003, J AM SOC NEPHROL, V14, P873, DOI 10.1097/01.ASN.0000060804.40201.6E; Singh VP, 2008, AM J PHYSIOL-HEART C, V294, pH1675, DOI 10.1152/ajpheart.91493.2007; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Weber KT, 1999, INT J BIOCHEM CELL B, V31, P395, DOI 10.1016/S1357-2725(98)00125-3; Westermann D, 2008, HYPERTENSION, V52, P1068, DOI 10.1161/HYPERTENSIONAHA.108.116350; Xu ZG, 2003, KIDNEY INT, V63, P958, DOI 10.1046/j.1523-1755.2003.00836.x; Yung S, 2000, KIDNEY INT, V58, P1953, DOI 10.1111/j.1523-1755.2000.00367.x	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36268	10.1371/journal.pone.0036268	http://dx.doi.org/10.1371/journal.pone.0036268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558414	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000175
J	Roth, ED; Yu, XT; Rao, G; Knierim, JJ				Roth, Eric D.; Yu, Xintian; Rao, Geeta; Knierim, James J.			Functional Differences in the Backward Shifts of CA1 and CA3 Place Fields in Novel and Familiar Environments	PLOS ONE			English	Article							HIPPOCAMPAL SUBFIELDS; MEMORY SYSTEM; UNIT-ACTIVITY; SPATIAL MAP; CELLS; EXPERIENCE; RAT; SELECTIVITY; PLASTICITY; SUBREGION	Insight into the processing dynamics and other neurophysiological properties of different hippocampal subfields is critically important for understanding hippocampal function. In this study, we compared shifts in the center of mass (COM) of CA3 and CA1 place fields in a familiar and completely novel environment. Place fields in CA1 and CA3 were simultaneously recorded as rats ran along a closed loop track in a familiar room followed by a session in a completely novel room. This process was repeated each day over a 4-day period. CA3 place fields shifted backward (opposite to the direction of motion of the rat) only in novel environments. This backward shift gradually diminished across days, as the novel environment became more familiar with repeated exposures. Conversely, CA1 place fields shifted backward across all days in both familiar and novel environments. Prior studies demonstrated that CA1 place fields on average do not exhibit a backward shift during the first exposure to an environment in which the familiar cues are rearranged into a novel configuration, although CA3 place fields showed a strong backward shift. Under the completely novel conditions of the present study, no dissociation was observed between CA3 and CA1 during the first novel session (although a strong dissociation was observed in the familiar sessions and the later novel sessions). In summary, this is the first study to use simultaneous recordings in CA1 and CA3 to compare place field COM shift and other associated properties in truly novel and familiar environments. This study further demonstrates functional differentiation between CA1 and CA3 as the plasticity of CA1 place fields is affected differently by exposure to a completely novel environment in comparison to an altered, familiar environment, whereas the plasticity of CA3 place fields is affected similarly during both types of environmental novelty.	[Roth, Eric D.] Univ Delaware, Dept Psychol, Newark, DE 19716 USA; [Roth, Eric D.; Yu, Xintian; Rao, Geeta; Knierim, James J.] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX USA; [Knierim, James J.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Knierim, James J.] Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD USA	University of Delaware; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Johns Hopkins University	Roth, ED (corresponding author), Univ Delaware, Dept Psychol, Newark, DE 19716 USA.	jknierim@jhu.edu		Knierim, James/0000-0002-1796-2930	National Institutes of Health (NIH) [R01 NS039456, K02 MH063297]; National Science Foundation (NSF) [0344213]; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH063297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039456] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants R01 NS039456 and K02 MH063297 (www.nih.gov) and National Science Foundation (NSF) grant 0344213 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, NEURAL NETWORKS BRAI; August DA, 1999, J COMPUT NEUROSCI, V6, P71, DOI 10.1023/A:1008861001091; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Burke SN, 2008, BEHAV NEUROSCI, V122, P535, DOI 10.1037/0735-7044.122.3.535; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Frank LM, 2002, J NEUROSCI, V22, P3817; Gold AE, 2005, HIPPOCAMPUS, V15, P808, DOI 10.1002/hipo.20103; Guzowski JF, 2004, NEURON, V44, P581, DOI 10.1016/j.neuron.2004.11.003; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Knierim JJ, 2006, HIPPOCAMPUS, V16, P755, DOI 10.1002/hipo.20203; Knierim JJ, 2002, J NEUROSCI, V22, P6254; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Lee I, 2006, NEURON, V51, P639, DOI 10.1016/j.neuron.2006.06.033; Lee I, 2007, LEARN MEMORY, V14, P807, DOI 10.1101/lm.706207; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Levy W. B., 1989, COMPUTATIONAL MODELS, P243, DOI DOI 10.1016/S0079-7421(08)60113-9; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Mizumori SJY, 2004, NEUROBIOL LEARN MEM, V82, P278, DOI 10.1016/j.nlm.2004.07.007; Mizumori SJY, 1995, BEHAV NEUROSCI, V109, P1081; Myers CE, 2011, HIPPOCAMPUS, V21, P1190, DOI 10.1002/hipo.20828; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Navratilova Z, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00006; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Shen J, 1997, J NEUROSCI, V17, P6789; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wilson IA, 2005, J NEUROSCI, V25, P6877, DOI 10.1523/JNEUROSCI.1744-05.2005; Yu X, 2006, NEUROCOMPUTING, V69, P1253, DOI 10.1016/j.neucom.2005.12.087; Yu X, 2006, NEURON, V52, P717, DOI 10.1016/j.neuron.2006.10.003	46	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36035	10.1371/journal.pone.0036035	http://dx.doi.org/10.1371/journal.pone.0036035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558316	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000107
J	Starr, C; Nekaris, KAI; Leung, L				Starr, Carly; Nekaris, K. A. I.; Leung, Luke			Hiding from the Moonlight: Luminosity and Temperature Affect Activity of Asian Nocturnal Primates in a Highly Seasonal Forest	PLOS ONE			English	Article							LORIS NYCTICEBUS-COUCANG; CATHEMERAL ACTIVITY; DAILY TORPOR; SOCIAL-ORGANIZATION; MICROCEBUS-MURINUS; ACTIVITY PATTERNS; SLOW; LEMUR; BEHAVIOR; METABOLISM	The effect of moonlight and temperature on activity of slow lorises was previously little known and this knowledge might be useful for understanding many aspects of their behavioural ecology, and developing strategies to monitor and protect populations. In this study we aimed to determine if the activity of the pygmy loris (Nycticebus pygmaeus) is affected by ambient temperature and/or moonlight in a mixed deciduous forest. We radio-collared five females and five males in the Seima Protection Forest, Cambodia, in February to May, 2008 and January to March, 2009 and recorded their behaviour at 5 minutes intervals, totalling 2736 observations. We classified each observation as either inactive (sleeping or alert) or active behaviour (travel, feeding, grooming, or others). Moon luminosity (bright/dark) and ambient temperature were recorded for each observation. The response variable, activity, was binary (active or inactive), and a logit link function was used. Ambient temperature alone did not significantly affect mean activity. Although mean activity was significantly affected by moonlight, the interaction between moonlight and temperature was also significant: on bright nights, studied animals were increasingly more active with higher temperature; and on dark nights they were consistently active regardless of temperature. The most plausible explanation is that on bright cold nights the combined risk of being seen and attacked by predators and heat loss outweigh the benefit of active behaviours.	[Starr, Carly; Leung, Luke] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia; [Nekaris, K. A. I.] Oxford Brookes Univ, Nocturnal Primate Res Grp, Sch Social Sci & Law, Oxford OX3 0BP, England	University of Queensland; Oxford Brookes University	Starr, C (corresponding author), Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia.	c.starr@uq.edu.au		Leung, Luke/0000-0002-8829-4925	Wildlife Conservation Society; World Wide Fund for Nature; Fauna Cambodia programme; Flora International - Cambodia programme	Wildlife Conservation Society; World Wide Fund for Nature; Fauna Cambodia programme; Flora International - Cambodia programme	We are grateful to Mr Men Soriyun and staff from Cambodian Forestry Administration's Department of Wildlife and Biodiversity Forestry Administration, the Ministry of Environment for permission to work in the site. Staff from the Wildlife Conservation Society, World Wide Fund for Nature, and Fauna and Flora International - Cambodia programmes provided logistical assistance and support for this study. This would not have been possible without the help of many local people and field assistants; in particular, we wish to thank Hao, Sam At, Eam Sam Un, Som Piseth, Melissa Jenson, and Richard Moore. Allan Lisle assisted with the analysis.	Allman J., 1977, PROGR PSYCHOBIOLOGY, V7, P1; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bearder S.K., 1980, International Journal of Primatology, V1, P103, DOI 10.1007/BF02735592; Bearder SK, 2007, DEV PRIMATOL-PROG PR, P206, DOI 10.1007/978-0-387-34810-0_9; BEARDER SK, 1974, J HUM EVOL, V3, P37, DOI 10.1016/0047-2484(74)90105-5; Bearder SK, 2006, FOLIA PRIMATOL, V77, P50, DOI 10.1159/000089695; Bearder SK, 2002, EAT OR BE EATEN, P21, DOI 10.1017/CBO9780511610233.003; Bearder SK, 1967, THESIS U WITWATERSRA; Bernede L., 2009, THESIS OXFORD BROOKE; BOWERS MA, 1990, ECOLOGY, V71, P2334, DOI 10.2307/1938644; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Campbell Christina J., 2011, PRIMATES PERSPECTIVE; Charles-Dominique P., 1977, ECOLOGY BEHAV NOCTUR; Curtis DJ, 1999, AM J PRIMATOL, V47, P279, DOI 10.1002/(SICI)1098-2345(1999)47:4<279::AID-AJP2>3.0.CO;2-U; Dausmann K. H., 2008, HYPOMETABOLISM ANIMA, P327; Dausmann KH, 2005, J COMP PHYSIOL B, V175, P147, DOI 10.1007/s00360-004-0470-0; Donati G, 2006, FOLIA PRIMATOL, V77, P104, DOI 10.1159/000089698; Donati G, 2001, AM J PRIMATOL, V53, P69, DOI 10.1002/1098-2345(200102)53:2<69::AID-AJP2>3.0.CO;2-R; Donati G, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P119; Donati Giuseppe, 2006, Journal of Anthropological Sciences, V84, P7; Eberle M, 2008, AM J PRIMATOL, V70, P410, DOI 10.1002/ajp.20496; Evans, 2003, STUDY RESIN TAPPING; Evans TD, 2000, MAMMALIA, V64, P55, DOI 10.1515/mamm.2000.64.1.55; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; Fernandez-Duque E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012572; Fichtel C, 2007, AM J PRIMATOL, V69, P611, DOI 10.1002/ajp.20363; Fietz J, 1999, OECOLOGIA, V121, P157, DOI 10.1007/s004420050917; Fitch-Snyder H., 2001, MANAGEMENT LORISES C; Fooden J, 1996, INT J PRIMATOL, V17, P845, DOI 10.1007/BF02735268; Gursky S, 2006, AM J PHYS ANTHROPOL, V129, P601, DOI 10.1002/ajpa.20364; Gursky S, 2003, INT J PRIMATOL, V24, P351, DOI 10.1023/A:1023053301059; Hagey LR, 2007, DEV PRIMATOL-PROG PR, P253, DOI 10.1007/978-0-387-34810-0_12; Ishida Hidemi, 1992, P139; Javier E. L., 1997, RICE PRODUCTION CAMB, P39; JulienLaferriere D, 1997, J MAMMAL, V78, P251, DOI 10.2307/1382659; Kappeler PM, 2003, BEHAV ECOL SOCIOBIOL, V54, P359, DOI 10.1007/s00265-003-0652-x; Kawamura S, 2004, J MOL EVOL, V58, P314, DOI 10.1007/s00239-003-2553-z; Kays RW, 2001, J ZOOL, V253, P491, DOI 10.1017/S0952836901000450; Kramer KM, 2001, J MAMMAL, V82, P535, DOI 10.1644/1545-1542(2001)082<0535:EOLIOA>2.0.CO;2; LOCKARD RB, 1974, J MAMMAL, V55, P189, DOI 10.2307/1379266; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Martin P., 1993, MEASURING BEHAV, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McArdle JE, 1981, RECENT ADV PRIMATOL, P123; MULLER EF, 1985, FOLIA PRIMATOL, V44, P216, DOI 10.1159/000156215; MULLER EF, 1979, COMP BIOCHEM PHYS A, V64, P109, DOI 10.1016/0300-9629(79)90438-9; Mutschler T, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P221; Nash L.T., 1986, P357; Nash LT, 2007, DEV PRIMATOL-PROG PR, P173, DOI 10.1007/978-0-387-34810-0_8; Nekaris KAI, 2007, FOLIA PRIMATOL, V78, P211, DOI 10.1159/000102316; Nekaris KAI, 2010, DEV PRIMATOL-PROG PR, P155, DOI 10.1007/978-1-4419-6661-2_8; Nekaris KAI, 2007, DEV PRIMATOL-PROG PR, P222, DOI 10.1007/978-0-387-34810-0_10; Nekaris KAI, 2001, FOLIA PRIMATOL, V72, P228, DOI 10.1159/000049942; Newman C, 2005, OIKOS, V108, P623, DOI 10.1111/j.0030-1299.2005.13399.x; Nguyen KV, 2000, BIOCLIMATIC DIAGRAMS; NISBETT RA, 1993, INT J PRIMATOL, V14, P765, DOI 10.1007/BF02192190; Nowack J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010797; OFARRELL MJ, 1974, J MAMMAL, V55, P809, DOI 10.2307/1379409; Ortmann S, 1997, NATURWISSENSCHAFTEN, V84, P28, DOI 10.1007/s001140050344; Osman-Hill WC., 1953, PRIMATES COMP ANATOM; Overdorff DJ, 1995, CREATURES DARK NOCTU; Pullen SL, 2000, AM J PRIMATOL, V51, P79, DOI 10.1002/(SICI)1098-2345(200005)51:1<79::AID-AJP6>3.0.CO;2-B; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Radespiel U, 2003, AM J PRIMATOL, V59, P139, DOI 10.1002/ajp.10071; Rahlfs M, 2010, ETHOLOGY, V116, P429, DOI 10.1111/j.1439-0310.2010.01756.x; Ramussen DT, 1986, LIFE HIST BEHAV SLOW; Ratajszczak R, 1998, FOLIA PRIMATOL, V69, P171, DOI 10.1159/000052710; Regal P.J., 1978, P183; Schmid J, 2000, OECOLOGIA, V123, P175, DOI 10.1007/s004420051003; Schmid J, 2000, J COMP PHYSIOL B, V170, P59, DOI 10.1007/s003600050008; Schulke O, 2007, ACTA ETHOL, V10, P13, DOI 10.1007/s10211-006-0023-5; Starr C, 2011, ORYX, V45, P135, DOI 10.1017/S0030605310001316; Streicher U., 2004, THESIS LUDWIG MAXIMI; Streicher U, 2008, NYCTICEBUS PYGMAEUS; Streicher U., 2004, CONSERVATION PRIMATE; Tan Y, 2005, P NATL ACAD SCI USA, V102, P14712, DOI 10.1073/pnas.0507042102; TATTERSALL I, 1987, FOLIA PRIMATOL, V49, P200, DOI 10.1159/000156323; Walston J., 2001, WILDLIFE SURVEY SO M; Wang GD, 2010, GENOME BIOL EVOL, V2, P277, DOI 10.1093/gbe/evq020; Wiens F, 2003, J ZOOL, V261, P35, DOI 10.1017/S0952836903003947; Wiens F, 1999, FOLIA PRIMATOL, V70, P362, DOI 10.1159/000021719; WIENS F, 2002, THESIS BAYREUTH U BA; Wiens F, 2006, J MAMMAL, V87, P790, DOI 10.1644/06-MAMM-A-007R1.1	82	31	31	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36396	10.1371/journal.pone.0036396	http://dx.doi.org/10.1371/journal.pone.0036396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558461	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000205
J	Priore, SF; Moss, WN; Turner, DH				Priore, Salvatore F.; Moss, Walter N.; Turner, Douglas H.			Influenza A Virus Coding Regions Exhibit Host-Specific Global Ordered RNA Structure	PLOS ONE			English	Article							INTERSPECIES TRANSMISSION; SECONDARY STRUCTURE; PROTEIN; H1N1; EVOLUTION; NUCLEOPROTEIN; REPLICATION; TEMPERATURE; DEPENDENCE; VIRULENCE	Influenza A is a significant public health threat, partially because of its capacity to readily exchange gene segments between different host species to form novel pandemic strains. An understanding of the fundamental factors providing species barriers between different influenza hosts would facilitate identification of strains capable of leading to pandemic outbreaks and could also inform vaccine development. Here, we describe the difference in predicted RNA secondary structure stability that exists between avian, swine and human coding regions. The results predict that global ordered RNA structure exists in influenza A segments 1, 5, 7 and 8, and that ranges of free energies for secondary structure formation differ between host strains. The predicted free energy distributions for strains from avian, swine, and human species suggest criteria for segment reassortment and strains that might be ideal candidates for viral attenuation and vaccine development.	[Priore, Salvatore F.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; Univ Rochester, Ctr RNA Biol, Rochester, NY USA	University of Rochester; University of Rochester	Priore, SF (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	turner@chem.rochester.edu	Moss, Walter/H-8096-2019	Moss, Walter/0000-0001-6419-5570	NIH [T32 GM07356, R01 GM22939]; FOGARTY INTERNATIONAL CENTER [R03TW008739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939, T32GM007356] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.F.P. was a trainee in the Medical Scientist Training Program funded by NIH T32 GM07356. This work was also supported by NIH R01 GM22939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Greenberg H, 2011, BIRKHAUSER ADV INFEC, P273, DOI 10.1007/978-3-0346-0279-2_11; Gultyaev AP, 2007, BIOINFORMATICS, V23, P272, DOI 10.1093/bioinformatics/btl559; Gultyaev AP, 2010, INT REV IMMUNOL, V29, P533, DOI 10.3109/08830185.2010.507828; Gultyaev AP, 2010, RNA BIOL, V7, P125, DOI 10.4161/rna.7.2.11287; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hass J, 2011, INFECT GENET EVOL, V11, P437, DOI 10.1016/j.meegid.2010.12.001; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Ilyinskii PO, 2009, OMICS, V13, P421, DOI 10.1089/omi.2009.0036; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Massin P, 2010, VET MICROBIOL, V142, P232, DOI 10.1016/j.vetmic.2009.10.012; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MCCAULEY JW, 1990, VIRUS RES, V17, P191, DOI 10.1016/0168-1702(90)90064-I; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; MURPHY BR, 1982, INFECT IMMUN, V37, P1119, DOI 10.1128/IAI.37.3.1119-1126.1982; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Simmonds P, 1999, J VIROL, V73, P5787, DOI 10.1128/JVI.73.7.5787-5794.1999; Simmonds P, 2004, RNA, V10, P1337, DOI 10.1261/rna.7640104; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; SOMVANSHI P, 2008, J PROTEOM BIOINFORM, V1, P219, DOI DOI 10.4172/JPB.1000026; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; TIAN SF, 1985, J VIROL, V53, P771, DOI 10.1128/JVI.53.3.771-775.1985; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Wise HM, 2011, NUCLEIC ACIDS RES, V39, P7775, DOI 10.1093/nar/gkr487	32	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35989	10.1371/journal.pone.0035989	http://dx.doi.org/10.1371/journal.pone.0035989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558296	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200105
J	Murakami, J; Terao, Y; Morisaki, I; Hamada, S; Kawabata, S				Murakami, Jumpei; Terao, Yutaka; Morisaki, Ichijiro; Hamada, Shigeyuki; Kawabata, Shigetada			Group A Streptococcus Adheres to Pharyngeal Epithelial Cells with Salivary Proline-rich Proteins via GrpE Chaperone Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; PORPHYROMONAS-GINGIVALIS; PLAQUE ACCUMULATION; TOTAL LYSOZYME; PYOGENES; GENE; IDENTIFICATION; LACTOFERRIN	Group A Streptococcus pyogenes (GAS) is an important human pathogen that frequently causes pharyngitis. GAS organisms can adhere to and invade pharyngeal epithelial cells, which are overlaid by salivary components. However, the role of salivary components in GAS adhesion to pharyngeal cells has not been reported precisely. We collected human saliva and purified various salivary components, including proline-rich protein (PRP), statherin, and amylase, and performed invasion assays. The GAS-HEp-2 association ratio (invasion/adhesion ratio) and invasion ratio of GAS were increased significantly with whole human saliva and PRP, while the anti-PRP antibody inhibited the latter. GAS strain NY-5, which lacks M and F proteins on the cell surface, was promoted to cohere with HEp-2 cells by whole human saliva and PRP. The 28-kDa protein of GAS bound to PRP and was identified as GrpE, a chaperone protein, whereas the N-terminal of GrpE was found to bind to PRP. A GrpE-deficient mutant of GAS strain B514Sm, TR-45, exhibited a reduced ability to adhere to and invade HEp-2 cells. Microscopic observations showed the GrpE was mainly expressed on the surface of the cell division site of GAS. Furthermore, GrpE-deficient mutants of GAS and Streptococcus pneumoniae showed an elongated morphology as compared with the wild type. Taken together, this is the first study to show an interaction between salivary PRP and GAS GrpE, which plays an important role in GAS infection on the pharynx, whereas the expression of GrpE on the surface of GAS helps to maintain morphology.	[Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Murakami, Jumpei; Morisaki, Ichijiro] Osaka Univ, Div Special Care Dent, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Hamada, Shigeyuki] Minist Publ Hlth, Dept Med Sci, Res Collaborat Ctr Emerging & Reemerging Infect 6, Muang Nonthaburi 11000, Thailand	Osaka University; Osaka University; Ministry of Public Health - Thailand	Kawabata, S (corresponding author), Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp		Terao, Yutaka/0000-0002-4450-5583	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Challenging Exploratory Research; Japan Society for the Promotion of Science; Bill and Melinda Gates Foundation; Grants-in-Aid for Scientific Research [24659812, 23592700] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by grants-in-aid for Scientific Research (B), Young Scientists (A), and Challenging Exploratory Research, the Japan Society for the Promotion of Science, and a grant from the Bill and Melinda Gates Foundation.	Amano A, 1998, INFECT IMMUN, V66, P2072, DOI 10.1128/IAI.66.5.2072-2077.1998; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BUKAU B, 1989, J BACTERIOL, V171, P2337, DOI 10.1128/jb.171.5.2337-2346.1989; Chia JS, 2001, INFECT IMMUN, V69, P6987, DOI 10.1128/IAI.69.11.6987-6998.2001; Choglay AA, 2001, GENE, V267, P125, DOI 10.1016/S0378-1119(01)00396-1; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Cywes C, 2000, J CLIN INVEST, V106, P995, DOI 10.1172/JCI10195; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Du LD, 2000, INFECT IMMUN, V68, P4834, DOI 10.1128/IAI.68.8.4834-4837.2000; Frick IM, 2000, MOL MICROBIOL, V37, P1232, DOI 10.1046/j.1365-2958.2000.02084.x; GRECO R, 1995, RES MICROBIOL, V146, P551, DOI 10.1016/0923-2508(96)80561-4; HAMADA S, 1989, J GEN MICROBIOL, V135, P335; HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; JALIL RA, 1993, J PERIODONTAL RES, V28, P130, DOI 10.1111/j.1600-0765.1993.tb01060.x; JALIL RA, 1992, ARCH ORAL BIOL, V37, P23, DOI 10.1016/0003-9969(92)90148-2; Kataoka K, 1999, INFECT IMMUN, V67, P3780, DOI 10.1128/IAI.67.8.3780-3785.1999; LAMKIN MS, 1993, CRIT REV ORAL BIOL M, V4, P251, DOI 10.1177/10454411930040030101; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Liu B, 2000, BIOCHEM J, V345, P557, DOI 10.1042/0264-6021:3450557; Massidda O, 1998, MICROBIOL-SGM, V144, P3069, DOI 10.1099/00221287-144-11-3069; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; Pancholi V, 1997, J EXP MED, V186, P1633, DOI 10.1084/jem.186.10.1633; Reinscheid DJ, 2001, J BACTERIOL, V183, P1175, DOI 10.1128/JB.183.4.1175-1183.2001; Roger P, 2011, J APPL MICROBIOL, V111, P631, DOI 10.1111/j.1365-2672.2011.05077.x; Rudney JD, 1999, J DENT RES, V78, P759, DOI 10.1177/00220345990780030801; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; SUGAI M, 1991, ARCH MICROBIOL, V155, P199, DOI 10.1007/BF00248617; Sun SX, 2011, MICROBIOL MOL BIOL R, V75, P543, DOI 10.1128/MMBR.00006-11; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Uehara T, 2001, GENES CELLS, V6, P803, DOI 10.1046/j.1365-2443.2001.00463.x; van Wely KHM, 2001, FEMS MICROBIOL REV, V25, P437, DOI 10.1016/S0168-6445(01)00062-6; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Wu C, 2011, J BACTERIOL, V193, P3197, DOI 10.1128/JB.00173-11; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083	38	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22266	22275		10.1074/jbc.M112.350082	http://dx.doi.org/10.1074/jbc.M112.350082			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22566698	Green Published, hybrid			2022-12-25	WOS:000306418600064
J	Cheng, F; Wu, J; Fang, L; Sun, SL; Liu, B; Lin, K; Bonnema, G; Wang, XW				Cheng, Feng; Wu, Jian; Fang, Lu; Sun, Silong; Liu, Bo; Lin, Ke; Bonnema, Guusje; Wang, Xiaowu			Biased Gene Fractionation and Dominant Gene Expression among the Subgenomes of Brassica rapa	PLOS ONE			English	Article							SHORT READ ALIGNMENT; ARABIDOPSIS-THALIANA; DNA METHYLATION; GENOME SEQUENCE; DUPLICATION; EVOLUTION; POLYPLOIDS; PLANTS	Polyploidization, both ancient and recent, is frequent among plants. A "two-step theory'' was proposed to explain the meso-triplication of the Brassica "A'' genome: Brassica rapa. By accurately partitioning of this genome, we observed that genes in the less fractioned subgenome (LF) were dominantly expressed over the genes in more fractioned subgenomes (MFs: MF1 and MF2), while the genes in MF1 were slightly dominantly expressed over the genes in MF2. The results indicated that the dominantly expressed genes tended to be resistant against gene fractionation. By re-sequencing two B. rapa accessions: a vegetable turnip (VT117) and a Rapid Cycling line (L144), we found that genes in LF had less non-synonymous or frameshift mutations than genes in MFs; however mutation rates were not significantly different between MF1 and MF2. The differences in gene expression patterns and on-going gene death among the three subgenomes suggest that "two-step'' genome triplication and differential subgenome methylation played important roles in the genome evolution of B. rapa.	[Cheng, Feng; Wu, Jian; Fang, Lu; Sun, Silong; Liu, Bo; Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Lin, Ke; Bonnema, Guusje] Lab Plant Breeding, Wageningen, Netherlands	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Cheng, F (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	wangxw@mail.caas.net.cn	Cheng, Feng/P-3233-2015; Wang, Xiaowu/L-2579-2019; 刘博, 博/AAR-9824-2020	Cheng, Feng/0000-0003-2982-9675; Sun, Silong/0000-0002-4541-9126; Bonnema, Guusje/0000-0002-2298-6849	Chinese Ministry of Science and Technology; National Basic Research Program of China [2012CB113901, 2012CB113906]; National High Technology R&D Program of China [2012AA100201]; China International Science and Technology Cooperation [2010DFA31730]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); National High Technology R&D Program of China(National High Technology Research and Development Program of China); China International Science and Technology Cooperation	This work was funded by the Chinese Ministry of Science and Technology, the National Basic Research Program of China (2012CB113901, 2012CB113906), the National High Technology R&D Program of China (2012AA100201), and China International Science and Technology Cooperation (2010DFA31730) to Dr. Wang. The work was done in the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Buggs RJA, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04469.x; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Phillips T, 2008, NATURE ED, V1; Sankoff D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-313; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Spillane C, 2007, NATURE, V448, P349, DOI 10.1038/nature05984; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-239; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502	30	180	186	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36442	10.1371/journal.pone.0036442	http://dx.doi.org/10.1371/journal.pone.0036442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567157	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500076
J	Silver, HJ; Niswender, KD; Keil, CD; Jiang, L; Feng, QP; Chiu, S; Krauss, RM; Wilke, RA				Silver, Heidi J.; Niswender, Kevin D.; Keil, Charles D.; Jiang, Lan; Feng, Qiping; Chiu, Sally; Krauss, Ronald M.; Wilke, Russell A.			CNR1 Genotype Influences HDL-Cholesterol Response to Change in Dietary Fat Intake	PLOS ONE			English	Article							BODY-MASS INDEX; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; CB1 RECEPTOR; LOW-CARBOHYDRATE; ENDOTHELIAL LIPASE; METABOLIC SYNDROME; GENETIC-VARIATION; CONTROLLED-TRIALS; FASTING LIPIDS	Background: Success in further reducing the burden of cardiovascular disease (CVD) is threatened by the increasing prevalence of obesity-related atherogenic dyslipidemia. HDL-cholesterol (HDL-C) level is inversely correlated with CVD risk; each 1 mg/dl decrease in HDL-C is associated with a 6% reduction in risk. We previously showed that a common CNR1 haplotype, H3 (frequency 20%), is protective against the reduction in HDL-C that typically accompanies weight gain. In the present study, we extend that observation by reporting the effect of CNR1 haplotype on HDL-C response to modification of dietary fat intake in weight maintenance and weight loss. Methods: Six haplotype tagging SNPs that cover the CNR1 gene locus were genotyped in 590 adults of varying body mass index (cohort 1 is 411 males with BMI 18.5-30.0 kg/m(2); cohort 2 is 71 females with BMI18.5-30.0 kg/m(2); and cohort 3 is 108 females with BMI 30-39.9 kg/m(2)). Dietary intakes were modified so that fat intake in the "high fat'' condition was 15-20% greater than in the "low fat'' condition, and lipid profiles were compared between carriers versus noncarriers for each of the five commonly observed CNR1 haplotypes (H1-H5). Results: In normal to overweight subjects on eucaloric diets, the H3 haplotype was significantly associated with short-term high fat diet induced changes in HDL-C level in females (carriers 5.9 mg/dl. noncarriers, p = 0.007). The H3 haplotype was also significantly associated with HDL-C level after 16 weeks on high fat calorie restricted diet in obese females (carriers 6.8 mg/dl. noncarriers, p = 0.009). Conclusion: Variability within the CNR1 gene locus contributes to gender-related differences in the HDL-cholesterol response to change in dietary fat intake. Functional characterization of this relationship in vitro may offer insights that potentially yield therapeutic guidance targeting dietary macronutrient composition, a direction much needed in the current epidemic of obesity.	[Silver, Heidi J.; Keil, Charles D.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA; [Niswender, Kevin D.] Tennessee Valley Healthcare Syst, Nashville, TN USA; [Niswender, Kevin D.] Vanderbilt Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Nashville, TN 37212 USA; [Jiang, Lan] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37212 USA; [Feng, Qiping; Wilke, Russell A.] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Chiu, Sally; Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Silver, HJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA.	heidi.j.silver@vanderbilt.edu	Biguzzi, Felipe A/E-4724-2015; Feng, Qiping/F-7941-2013		Dr. Robert C. and Veronica Atkins Foundation; Vanderbilt CTSA from National Center for Research Resources, National Institutes of Health [1 UL1 RR024975]; Tennessee Valley Healthcare System, NIH [DK064857, DK069927]; Vanderbilt Diabetes Research and Training Center [DK020593]; NIH [U01HL069757, R01DK080007]; Department of Atherosclerosis Research; Children's Hospital Oakland Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, KL2RR024977, TL1RR024978] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, K08DK064857, R01DK069927, R01DK080007, P30DK020593] Funding Source: NIH RePORTER	Dr. Robert C. and Veronica Atkins Foundation; Vanderbilt CTSA from National Center for Research Resources, National Institutes of Health; Tennessee Valley Healthcare System, NIH; Vanderbilt Diabetes Research and Training Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Atherosclerosis Research; Children's Hospital Oakland Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The Dr. Robert C. and Veronica Atkins Foundation (HJS), the Vanderbilt CTSA grant 1 UL1 RR024975 from the National Center for Research Resources, National Institutes of Health (HJS), the Tennessee Valley Healthcare System, NIH grants DK064857 and DK069927, and the Vanderbilt Diabetes Research and Training Center grant DK020593 (KDN), NIH Grant U01HL069757 (RMK), the Department of Atherosclerosis Research, the Children's Hospital Oakland Research Institute (RMK), and NIH Grant R01DK080007 (RAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashen MD, 2005, NEW ENGL J MED, V353, P1252, DOI 10.1056/NEJMcp044370; Badellino KO, 2008, CIRCULATION, V117, P678, DOI 10.1161/CIRCULATIONAHA.107.707349; Baye TM, 2008, PHARMACOGENOMICS, V9, P1647, DOI 10.2217/14622416.9.11.1647; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bray GA, 2011, AM J CLIN NUTR, V93, P481, DOI 10.3945/ajcn.110.011114; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Denke MA, 2000, JAMA-J AM MED ASSOC, V284, P2740, DOI 10.1001/jama.284.21.2740; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dreon DM, 1997, ARTERIOSCL THROM VAS, V17, P707, DOI 10.1161/01.ATV.17.4.707; Dreon DM, 1998, AM J CLIN NUTR, V67, P828, DOI 10.1093/ajcn/67.5.828; Dreon DM, 1997, J AM COLL NUTR, V16, P313, DOI 10.1080/07315724.1997.10718692; Feng QP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015779; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Gary-Bobo M, 2006, MOL PHARMACOL, V69, P471, DOI 10.1124/mol.105.015040; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Ginsberg HN, 1998, ENDOCRIN METAB CLIN, V27, P503, DOI 10.1016/S0889-8529(05)70023-2; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Jansen S, 1998, J NUTR, V128, P1144, DOI 10.1093/jn/128.7.1144; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Kanders B, 1994, OBESITY PATHOPHYSIOL, P167; Kim JK, 2006, J WOMENS HEALTH, V15, P734, DOI 10.1089/jwh.2006.15.734; Knoblauch H, 2004, HUM MOL GENET, V13, P993, DOI 10.1093/hmg/ddh119; Krauss RM, 1997, WORLD REV NUTR DIET, V80, P22; KRAUSS RM, 1995, AM J CLIN NUTR, V62, p478S, DOI 10.1093/ajcn/62.2.478S; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Moshfegb A, 1999, FASEB J, V13, pA603; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Ordovas JM, 2006, J AM DIET ASSOC, V106, P1074, DOI 10.1016/j.jada.2006.04.016; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Ruilopea LM, 2008, J HYPERTENS, V26, P357, DOI 10.1097/HJH.0b013e3282f2d625; Russo P, 2007, J CLIN ENDOCR METAB, V92, P2382, DOI 10.1210/jc.2006-2523; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; Sharman MJ, 2004, J NUTR, V134, P880, DOI 10.1093/jn/134.4.880; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Stafford JM, 2008, DIABETES, V57, P1482, DOI 10.2337/db07-1702; Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586; Tyler K, 2000, EUR J PHARMACOL, V409, P207, DOI 10.1016/S0014-2999(00)00843-8; Volek JS, 2004, J AM COLL NUTR, V23, P177, DOI 10.1080/07315724.2004.10719359; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Weggemans RM, 1999, EUR J CLIN INVEST, V29, P827; Wilke RA, 2011, PHARMACOGENOMICS J, V11, P162, DOI 10.1038/tpj.2010.86; Wilke Russell A, 2010, Prev Cardiol, V13, P63, DOI 10.1111/j.1751-7141.2009.00055.x; Willett WC, 1998, AM J CLIN NUTR, V68, P1149, DOI 10.1093/ajcn/68.6.1149; Yasuda T, 2010, CIRC J, V74, P2263, DOI 10.1253/circj.CJ-10-0934	60	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36166	10.1371/journal.pone.0036166	http://dx.doi.org/10.1371/journal.pone.0036166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567136	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500055
J	Fischer, MD; Willmann, G; Schatz, A; Schommer, K; Zhour, A; Zrenner, E; Bartz-Schmidt, KU; Gekeler, F				Fischer, M. Dominik; Willmann, Gabriel; Schatz, Andreas; Schommer, Kai; Zhour, Ahmad; Zrenner, Eberhart; Bartz-Schmidt, Karl U.; Gekeler, Florian			Structural and Functional Changes of the Human Macula during Acute Exposure to High Altitude	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ENDOTHELIAL GROWTH-FACTOR; ACUTE MOUNTAIN-SICKNESS; VISUAL-ACUITY TEST; THICKNESS MEASUREMENTS; DIABETIC-RETINOPATHY; PHOTOCOAGULATION; VARIABILITY; INSIGHTS; EVEREST	Background: This study aimed to quantify structural and functional changes at the macula during acute exposure to high altitude and to assess their structure/function relationship. This work is related to the Tuebingen High Altitude Ophthalmology (THAO) study. Methodology/Principal Findings: Spectral domain optical coherence tomography and microperimetry were used to quantify changes of central retinal structure and function in 14 healthy subjects during acute exposure to high altitude (4559 m). High-resolution volume scans and fundus-controlled microperimetry of the posterior pole were performed in addition to best-corrected visual acuity (BCVA) measurements and assessment of acute mountain sickness. Analysis of measurements at altitude vs. baseline revealed increased total retinal thickness (TRT) in all four outer ETDRS grid subfields during acute altitude exposure (TRTouter = 2.80 +/- 1.00 mm; mean change +/- 95% CI). This change was inverted towards the inner four subfields (TRTinner = -1.89 +/- 0.97 mm) with significant reduction of TRT in the fovea (TRTfoveal = -6.62 +/- 0.90 mu m) at altitude. BCVA revealed no significant difference compared to baseline (0.06 +/- 0.08 logMAR). Microperimetry showed stable mean sensitivity in all but the foveal subfield (MSfoveal = -1.12 +/- 0.68 dB). At baseline recordings before and >2 weeks after high altitude exposure, all subjects showed equal levels with no sign of persisting structural or functional sequels. Conclusions/Significance: During acute exposure to high altitude central retinal thickness is subject to minor, yet statistically significant changes. These alterations describe a function of eccentricity with an increase in regions with relatively higher retinal nerve fiber content and vascular arcades. However, these changes did not correlate with measures of central retinal function or acute mountain sickness. For the first time a quantitative approach has been used to assess these changes during acute, non-acclimatized high altitude exposure.	[Fischer, M. Dominik; Willmann, Gabriel; Schatz, Andreas; Zhour, Ahmad; Zrenner, Eberhart; Bartz-Schmidt, Karl U.; Gekeler, Florian] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany; [Schommer, Kai] Univ Heidelberg Hosp, Med Clin, Dept Sports Med, Heidelberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Fischer, MD (corresponding author), Univ Oxford, Nuffield Lab Ophthalmol, Walton St, Oxford OX2 6AW, England.	Gabriel.Willmann@med.uni-tuebingen.de			Wilderness Medical Society (WMS); Charles Houston Award; Novartis; Bausch Lomb; Alcon; Allergan; Ursapharm; IMS Gear; OptimaPharma; Wilderness Medical Association; Heidelberg Engineering	Wilderness Medical Society (WMS); Charles Houston Award; Novartis(Novartis); Bausch Lomb; Alcon(Novartis); Allergan(AbbVieAllergan); Ursapharm; IMS Gear; OptimaPharma; Wilderness Medical Association; Heidelberg Engineering	This study was supported by the Wilderness Medical Society (WMS) with the Charles Houston Award. Additional unconditional grants were provided by Novartis, Bausch & Lomb, Alcon, Allergan, Ursapharm, IMS Gear and OptimaPharma. The Heidelberg Spectralis OCT was provided by Heidelberg Engineering. The study also received private donations by Martin Rohrbach, Till Schoeffel, Ulrich Gekeler, Christina Fasser, Eduard Schatz und Norbert Willmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: This study was supported by Wilderness Medical Association, Novartis, Bausch & Lomb, Alcon, Allergan, Ursapharm, OptimaPharma, IMS Gear and Heidelberg Engineering. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Arora R, 2011, SINGAP MED J, V52, P687; Ascaso FJ, 2012, EUR J OPHTHALMOL, V22, P580, DOI 10.5301/ejo.5000091; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Bailey DM, 2006, J CEREBR BLOOD F MET, V26, P99, DOI 10.1038/sj.jcbfm.9600169; Bandello F, 2011, CLIN OPHTHALMOL, V5, P1303, DOI 10.2147/OPTH.S17423; Binz N, 2006, FASEB J, V20, P383, DOI 10.1096/fj.05-3890fje; Bosch MM, 2008, ARCH OPHTHALMOL-CHIC, V126, P644, DOI 10.1001/archopht.126.5.644; Bosch MM, 2009, J APPL PHYSIOL, V106, P454, DOI 10.1152/japplphysiol.90904.2008; Bosch MM, 2010, ARCH OPHTHALMOL-CHIC, V128, P184, DOI 10.1001/archophthalmol.2009.385; Bosch MM, 2009, INVEST OPHTH VIS SCI, V51, P1609; Chen FK, 2009, INVEST OPHTH VIS SCI, V50, P3464, DOI 10.1167/iovs.08-2926; Cioffi GA., 2003, ADLERS PHYSL EYE, V10th ed., P747; Connolly DM, 2011, AVIAT SPACE ENVIR MD, V82, P2, DOI 10.3357/ASEM.2904.2011; FERRIS FL, 1987, OPHTHALMOLOGY, V94, P761; Fischer MD, 2011, MOVEMENT DISORD, V26, P914, DOI 10.1002/mds.23523; Grant MB, 2004, EXPERT OPIN INV DRUG, V13, P1275, DOI 10.1517/13543784.13.10.1275; Ho TY, 2011, RETINA-J RET VIT DIS, V31, P1650, DOI 10.1097/IAE.0b013e318207ceab; Issa PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012864; KELLER HR, 1995, BMJ-BRIT MED J, V310, P1232, DOI 10.1136/bmj.310.6989.1232; Kernstock C, 2012, GRAEF ARCH CLIN EXP, V250, P583, DOI 10.1007/s00417-011-1825-3; Kurtenbach A, 2006, VISUAL NEUROSCI, V23, P651, DOI 10.1017/S095252380623339X; Kurtenbach A, 2010, DOC OPHTHALMOL, V120, P229, DOI 10.1007/s10633-010-9217-2; LIEBERMAN HR, 1982, BEHAV RES METH INSTR, V14, P21, DOI 10.3758/BF03202110; Lutty GA, 1996, ARCH OPHTHALMOL-CHIC, V114, P971, DOI 10.1001/archopht.1996.01100140179011; Menke MN, 2009, AM J OPHTHALMOL, V147, P467, DOI 10.1016/j.ajo.2008.09.005; Modesti PA, 2011, MED SCI SPORT EXER, V43, P1811, DOI 10.1249/MSS.0b013e31821b55df; Nguyen QD, 2004, INVEST OPHTH VIS SCI, V45, P617, DOI 10.1167/iovs.03-0557; Pavlidis M, 2005, OPHTHALMOLOGICA, V219, P404, DOI 10.1159/000088387; Rotsos TG, 2008, CLIN OPHTHALMOL, V2, P919; Seth RK, 2010, SEMIN OPHTHALMOL, V25, P13, DOI 10.3109/08820538.2010.481560; Sutherland AI, 2008, BRIT J SPORT MED, V42, P183, DOI 10.1136/bjsm.2007.045286; Troeger E, 2010, IEEE ENG MED BIO, P6280, DOI 10.1109/IEMBS.2010.5628081; Vinores SA, 1998, J NEUROIMMUNOL, V89, P43, DOI 10.1016/S0165-5728(98)00075-7; Willmann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027022; Willmann G, 2010, BRIT J OPHTHALMOL, V94, P1393, DOI 10.1136/bjo.2009.178491; Wilson MH, 2008, HIGH ALT MED BIOL, V9, P319, DOI 10.1089/ham.2008.1026; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970	38	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36155	10.1371/journal.pone.0036155	http://dx.doi.org/10.1371/journal.pone.0036155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558365	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200045
J	Falcini, F; Jerolmack, DJ; Buongiorno Nardelli, B				Falcini, Frederico; Jerolmack, Douglas J.; Buongiorno Nardelli, Bruno			Mississippi River and Sea Surface Height Effects on Oil Slick Migration	PLOS ONE			English	Article							GULF-OF-MEXICO; SEDIMENT TRANSPORT; PLUME; SATELLITE; VARIABILITY; DISCHARGE; DYNAMICS; FATE	Millions of barrels of oil escaped into the Gulf of Mexico (GoM) after the 20 April, 2010 explosion of Deepwater Horizon (DH). Ocean circulation models were used to forecast oil slick migration in the GoM, however such models do not explicitly treat the effects of secondary eddy-slopes or Mississippi River (MR) hydrodynamics. Here we report oil front migration that appears to be driven by sea surface level (SSL) slopes, and identify a previously unreported effect of the MR plume: under conditions of relatively high river discharge and weak winds, a freshwater mound can form around the MR Delta. We performed temporal oil slick position and altimeter analysis, employing both interpolated altimetry data and along-track measurements for coastal applications. The observed freshwater mound appears to have pushed the DH oil slick seaward from the Delta coastline. We provide a physical mechanism for this novel effect of the MR, using a two-layer pressure-driven flow model. Results show how SSL variations can drive a cross-slope migration of surface oil slicks that may reach velocities of order km/day, and confirm a lag time of order 5-10 days between mound formation and slick migration, as observed form the satellite analysis. Incorporating these effects into more complex ocean models will improve forecasts of slick migration for future spills. More generally, large SSL variations at the MR mouth may also affect the dispersal of freshwater, nutrients and sediment associated with the MR plume.	[Falcini, Frederico] Univ Minnesota, St Anthony Falls Lab, Natl Ctr Earth Surface Dynam, Minneapolis, MN 55455 USA; [Jerolmack, Douglas J.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Buongiorno Nardelli, Bruno] CNR, Ist Sci Stmosfera & Clima, Rome, Italy; [Buongiorno Nardelli, Bruno] CNR, Ist Ambiente Marino Costiero, I-80125 Naples, Italy	University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Falcini, F (corresponding author), Univ Minnesota, St Anthony Falls Lab, Natl Ctr Earth Surface Dynam, Minneapolis, MN 55455 USA.	ffalcini@umn.edu	Nardelli, Bruno Buongiorno/AAY-4289-2020; Nardelli, Bruno Buongiorno/I-4810-2012	Nardelli, Bruno Buongiorno/0000-0002-3416-7189; Falcini, Federico/0000-0001-8105-2491	National Science Foundation [EAR-1049969]	National Science Foundation(National Science Foundation (NSF))	This work was supported by The National Science Foundation through contract EAR-1049969 to Douglas J. Jerolmack. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astraldi M, 2001, J PHYS OCEANOGR, V31, P3457, DOI 10.1175/1520-0485(2001)031<3457:DWDATS>2.0.CO;2; BARGER WR, 1970, J APPL METEOROL, V9, P396, DOI DOI 10.1175/1520-0450(1970)009; D'Sa EJ, 2008, SENSORS-BASEL, V8, P4249, DOI 10.3390/s8074249; Dumont J. P., 2009, OSTM JASON 2 PRODUCT; Falcini F, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2010JF001802; Horner-Devine AR, 2009, CONT SHELF RES, V29, P234, DOI 10.1016/j.csr.2007.12.012; Horner-Devine AR, 2006, J FLUID MECH, V555, P203, DOI 10.1017/S0022112006008937; HOULT DP, 1972, ANNU REV FLUID MECH, V4, P341, DOI 10.1146/annurev.fl.04.010172.002013; Jernelov A, 2010, NATURE, V466, P182, DOI 10.1038/466182a; Joye S, 2010, NATURE GEOSCI, V3, P44611; Karadogan E, OCEANS 2009 MTS IEEE, P1; Kourafalou VH, 1996, J GEOPHYS RES-OCEANS, V101, P3415, DOI 10.1029/95JC03024; Lamb MP, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002079; Lane-Serff GF, 2000, J FLUID MECH, V416, P269, DOI 10.1017/S0022112000008958; Leben RR., 2002, MAR GEOD, V25, P3, DOI [10.1080/014904102753516697, DOI 10.1080/014904102753516697]; Marsaleix P, 1998, J MARINE SYST, V14, P99, DOI 10.1016/S0924-7963(97)00011-0; McCabe RM, 2009, J PHYS OCEANOGR, V39, P2839, DOI 10.1175/2009JPO4061.1; Mercier F., COASTAL HYDROLOGY AL; Mezic I, 2010, SCIENCE, V330, P486, DOI 10.1126/science.1194607; Morehead MD, 1999, MAR GEOL, V154, P29, DOI 10.1016/S0025-3227(98)00101-7; Nof D, 2001, J PHYS OCEANOGR, V31, P3045, DOI 10.1175/1520-0485(2001)031<3045:TBOO>2.0.CO;2; Pozrikidis C., 2001, FLUID DYNAM+; Puckridge JT, 1998, MAR FRESHWATER RES, V49, P55, DOI 10.1071/MF94161; Reed M, 1999, SPILL SCI TECHNOL B, V5, P3, DOI 10.1016/S1353-2561(98)00029-2; Rego JL, 2010, J COASTAL RES, V26, P212, DOI 10.2112/08-1072.1; Schiller RV, 2010, OCEAN MODEL, V33, P101, DOI 10.1016/j.ocemod.2009.12.005; Walker N., 2009, OCEANS 2009 MTS IEEE, P1; Walker N, OCEANS 2009 MTS IEEE, P1; Walker ND, 2005, J COASTAL RES, V21, P1228, DOI 10.2112/04-0347.1; Walker ND, 1996, REMOTE SENS ENVIRON, V58, P21, DOI 10.1016/0034-4257(95)00259-6; WRIGHT LD, 1995, ESTUARIES, V18, P494, DOI 10.2307/1352367; WRIGHT LD, 1977, GEOL SOC AM BULL, V88, P857, DOI 10.1130/0016-7606(1977)88<857:STADAR>2.0.CO;2; Yuan JC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019335	33	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36037	10.1371/journal.pone.0036037	http://dx.doi.org/10.1371/journal.pone.0036037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558317	Green Published, gold			2022-12-25	WOS:000305336000108
J	Felcher, KJ; Coombs, JJ; Massa, AN; Hansey, CN; Hamilton, JP; Veilleux, RE; Buell, CR; Douches, DS				Felcher, Kimberly J.; Coombs, Joseph J.; Massa, Alicia N.; Hansey, Candice N.; Hamilton, John P.; Veilleux, Richard E.; Buell, C. Robin; Douches, David S.			Integration of Two Diploid Potato Linkage Maps with the Potato Genome Sequence	PLOS ONE			English	Article							SOLANUM-CHACOENSE; GENETIC-RECOMBINATION; RFLP MAPS; MAIZE; RICE; PHUREJA; TOMATO; HYBRID; MUTANT	To facilitate genome-guided breeding in potato, we developed an 8303 Single Nucleotide Polymorphism (SNP) marker array using potato genome and transcriptome resources. To validate the Infinium 8303 Potato Array, we developed linkage maps from two diploid populations (DRH and D84) and compared these maps with the assembled potato genome sequence. Both populations used the doubled monoploid reference genotype DM1-3 516 R44 as the female parent but had different heterozygous diploid male parents (RH89-039-16 and 84SD22). Over 4,400 markers were mapped (1,960 in DRH and 2,454 in D84, 787 in common) resulting in map sizes of 965 (DRH) and 792 (D84) cM, covering 87% (DRH) and 88% (D84) of genome sequence length. Of the mapped markers, 33.5% were in candidate genes selected for the array, 4.5% were markers from existing genetic maps, and 61% were selected based on distribution across the genome. Markers with distorted segregation ratios occurred in blocks in both linkage maps, accounting for 4% (DRH) and 9% (D84) of mapped markers. Markers with distorted segregation ratios were unique to each population with blocks on chromosomes 9 and 12 in DRH and 3, 4, 6 and 8 in D84. Chromosome assignment of markers based on linkage mapping differed from sequence alignment with the Potato Genome Sequencing Consortium (PGSC) pseudomolecules for 1% of the mapped markers with some disconcordant markers attributable to paralogs. In total, 126 (DRH) and 226 (D84) mapped markers were not anchored to the pseudomolecules and provide new scaffold anchoring data to improve the potato genome assembly. The high degree of concordance between the linkage maps and the pseudomolecules demonstrates both the quality of the potato genome sequence and the functionality of the Infinium 8303 Potato Array. The broad genome coverage of the Infinium 8303 Potato Array compared to other marker sets will enable numerous downstream applications.	[Felcher, Kimberly J.; Coombs, Joseph J.; Douches, David S.] Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA; [Massa, Alicia N.; Hansey, Candice N.; Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Veilleux, Richard E.] Virginia Tech, Dept Hort, Blacksburg, VA USA	Michigan State University; Michigan State University; Virginia Polytechnic Institute & State University	Felcher, KJ (corresponding author), Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA.	douchesd@msu.edu	Hamilton, John P/G-1379-2016	Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677	U.S. National Science Foundation [DBI-0834044]; USDA NIFA AFRI [2009-85606-05673]	U.S. National Science Foundation(National Science Foundation (NSF)); USDA NIFA AFRI(United States Department of Agriculture (USDA))	This work was supported by funds from the U.S. National Science Foundation Plant Genome Research Program (DBI-0834044) to CRB and funds from USDA NIFA AFRI Plant Breeding, Genetics and Genome grant 2009-85606-05673 to DSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anithakumari AM, 2010, MOL BREEDING, V26, P65, DOI 10.1007/s11032-009-9377-5; [Anonymous], 2006, JOINMAP4; BIRHMAN RK, 1994, J HERED, V85, P241, DOI 10.1093/oxfordjournals.jhered.a111445; BONIERBALE MW, 1988, GENETICS, V120, P1095; Caromel B, 2003, THEOR APPL GENET, V106, P1517, DOI 10.1007/s00122-003-1211-6; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; DOUCHES DS, 1988, HEREDITY, V60, P183, DOI 10.1038/hdy.1988.30; GEBHARDT C, 1991, THEOR APPL GENET, V83, P49, DOI 10.1007/BF00229225; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; JACOBS JME, 1995, THEOR APPL GENET, V91, P289, DOI 10.1007/BF00220891; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Milbourne D, 1998, MOL GEN GENET, V259, P233, DOI 10.1007/s004380050809; Paz MM, 1999, PLANT BREEDING, V118, P53, DOI 10.1046/j.1439-0523.1999.118001053.x; Potato Genome Sequencing Consortium, 2011, NATURE, V475, P186; Rezvoy C, 2007, BIOINFORMATICS, V23, P2188, DOI 10.1093/bioinformatics/btm315; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; van Zandvoort P, 1997, MOL GEN GENET, V255, P428; Veilleux RE, 1998, J AM SOC HORTIC SCI, V123, P854, DOI 10.21273/JASHS.123.5.854; Zhu YL, 2003, GENETICS, V163, P1123	26	147	152	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36347	10.1371/journal.pone.0036347	http://dx.doi.org/10.1371/journal.pone.0036347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558443	gold, Green Published			2022-12-25	WOS:000305336000193
J	Sadegh, MK; Ekman, M; Rippe, C; Uvelius, B; Sward, K; Albinsson, S				Sadegh, Mardjaneh Karbalaei; Ekman, Mari; Rippe, Catarina; Uvelius, Bengt; Sward, Karl; Albinsson, Sebastian			Deletion of Dicer in Smooth Muscle Affects Voiding Pattern and Reduces Detrusor Contractility and Neuroeffector Transmission	PLOS ONE			English	Article							URINARY-BLADDER; CALCIUM-CHANNEL; PURINERGIC NEUROTRANSMISSION; EXPRESSION; MICRORNA; CELLS; GENE; DIFFERENTIATION; CHOLESTEROL; CALPONIN	MicroRNAs have emerged as important regulators of smooth muscle phenotype and may play important roles in pathogenesis of various smooth muscle related disease states. The aim of this study was to investigate the role of miRNAs for urinary bladder function. We used an inducible and smooth muscle specific Dicer knockout (KO) mouse which resulted in significantly reduced levels of miRNAs, including miR-145, miR-143, miR-22, miR125b-5p and miR-27a, from detrusor preparations without mucosa. Deletion of Dicer resulted in a disturbed micturition pattern in vivo and reduced depolarization-induced pressure development in the isolated detrusor. Furthermore, electrical field stimulation revealed a decreased cholinergic but maintained purinergic component of neurogenic activation in Dicer KO bladder strips. The ultrastructure of detrusor smooth muscle cells was well maintained, and the density of nerve terminals was similar. Western blotting demonstrated reduced contents of calponin and desmin. Smooth muscle alpha-actin, SM22 alpha and myocardin were unchanged. Activation of strips with exogenous agonists showed that depolarization-induced contraction was preferentially reduced; ATP- and calyculin A-induced contractions were unchanged. Quantitative real time PCR and western blotting demonstrated reduced expression of Cav1.2 (Cacna1c). It is concluded that smooth muscle miRNAs play an important role for detrusor contractility and voiding pattern of unrestrained mice. This is mediated in part via effects on expression of smooth muscle differentiation markers and L-type Ca2+ channels in the detrusor.	[Sadegh, Mardjaneh Karbalaei; Ekman, Mari; Rippe, Catarina; Sward, Karl; Albinsson, Sebastian] Lund Univ, Dept Expt Med Sci, Biomed Ctr, Lund, Sweden; [Uvelius, Bengt] Lund Univ, Dept Urol, Lund, Sweden	Lund University; Lund University	Sadegh, MK (corresponding author), Lund Univ, Dept Expt Med Sci, Biomed Ctr, Lund, Sweden.	sebastian.albinsson@med.lu.se	sward, karl/J-5798-2012; Albinsson, Sebastian/B-4105-2010; Rippe, Catarina/B-4110-2010	Albinsson, Sebastian/0000-0001-6936-3967; Rippe, Catarina/0000-0001-8621-9836; Sward, Karl/0000-0002-7255-5510; Uvelius, Bengt/0000-0003-0201-8928	Swedish Research Council [K2009-65X-4955-01-3, K2011-67P-20608-02-4]; Swedish Heart and Lung Foundation; Crafoord Foundation; Royal Physiographic Society; Ake Wiberg Foundation; Tore Nilson Foundation; Greta and Johan Kock Foundation; Magnus Bergvall Foundation, regional health care grants (ALF); Medicine at Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Crafoord Foundation; Royal Physiographic Society; Ake Wiberg Foundation; Tore Nilson Foundation; Greta and Johan Kock Foundation; Magnus Bergvall Foundation, regional health care grants (ALF); Medicine at Lund University	This work was supported by the Swedish Research Council (K2009-65X-4955-01-3, K2011-67P-20608-02-4, and repatriation grant), the Swedish Heart and Lung Foundation, The Crafoord Foundation, The Royal Physiographic Society, The Ake Wiberg Foundation, The Tore Nilson Foundation, The Greta and Johan Kock Foundation, The Magnus Bergvall Foundation, regional health care grants (ALF), and the faculty of Medicine at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2011, PHYSIOL GENOMICS, V43, P529, DOI 10.1152/physiolgenomics.00146.2010; Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Andersson K-E, 2011, Handb Exp Pharmacol, P319, DOI 10.1007/978-3-642-16499-6_16; Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Ehlert FJ, 2005, J PHARMACOL EXP THER, V313, P368, DOI 10.1124/jpet.104.077909; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Ford APDW, 2006, BRIT J PHARMACOL, V147, pS132, DOI 10.1038/sj.bjp.0706637; Fry CH, 2010, AUTON NEUROSCI-BASIC, V154, P3, DOI 10.1016/j.autneu.2009.10.006; Fujishige A, 2002, ZOOL SCI, V19, P167, DOI 10.2108/zsj.19.167; GABELLA G, 1995, J NEUROCYTOL, V24, P159, DOI 10.1007/BF01181533; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Gollasch M, 1998, FASEB J, V12, P593, DOI 10.1096/fasebj.12.7.593; Gomez M, 1997, AM J PHYSIOL-CELL PH, V273, pC1714, DOI 10.1152/ajpcell.1997.273.5.C1714; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Narayanan D, 2010, CIRC RES, V107, P631, DOI 10.1161/CIRCRESAHA.110.224345; PALEA S, 1993, J UROLOGY, V150, P2007, DOI 10.1016/S0022-5347(17)35955-4; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Ronkainen JJ, 2011, J PHYSIOL-LONDON, V589, P2669, DOI 10.1113/jphysiol.2010.201400; Sadegh MK, 2011, BRIT J PHARMACOL, V162, P1156, DOI 10.1111/j.1476-5381.2010.01115.x; Schaefer A, 2010, UROL ONCOL-SEMIN ORI, V28, P4, DOI 10.1016/j.urolonc.2008.10.021; Schneider T, 2004, J PHARMACOL EXP THER, V309, P1148, DOI 10.1124/jpet.103.063735; Scott RS, 2008, AM J PHYSIOL-CELL PH, V295, pC324, DOI 10.1152/ajpcell.90622.2007; Shakirova Y, 2010, EUR J PHARMACOL, V634, P142, DOI 10.1016/j.ejphar.2010.02.017; Singer HA, 2011, J PHYSL; SJOGREN C, 1982, J UROLOGY, V128, P1368, DOI 10.1016/S0022-5347(17)53509-0; Takahashi K, 2000, BIOCHEM BIOPH RES CO, V279, P150, DOI 10.1006/bbrc.2000.3909; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Winder SJ, 1998, ACTA PHYSIOL SCAND, V164, P415, DOI 10.1111/j.1365-201X.1998.tb10697.x; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu L, 2010, CIRC RES, V107, P398, DOI 10.1161/CIRCRESAHA.110.222562; Yoshida M, 2001, EXP GERONTOL, V36, P99, DOI 10.1016/S0531-5565(00)00175-3	48	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35882	10.1371/journal.pone.0035882	http://dx.doi.org/10.1371/journal.pone.0035882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558254	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000073
J	Abderrahmani, R; Francois, A; Buard, V; Tarlet, G; Blirando, K; Hneino, M; Vaurijoux, A; Benderitter, M; Sabourin, JC; Milliat, F				Abderrahmani, Rym; Francois, Agnes; Buard, Valerie; Tarlet, Georges; Blirando, Karl; Hneino, Mohammad; Vaurijoux, Aurelie; Benderitter, Marc; Sabourin, Jean-Christophe; Milliat, Fabien			PAI-1-Dependent Endothelial Cell Death Determines Severity of Radiation-Induced Intestinal Injury	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; INDUCED GASTROINTESTINAL SYNDROME; INDUCED PULMONARY-FIBROSIS; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; IN-VIVO; IONIZING-RADIATION; INDUCED APOPTOSIS; TUMOR-GROWTH; AKT PATHWAY	Normal tissue toxicity still remains a dose-limiting factor in clinical radiation therapy. Recently, plasminogen activator inhibitor type 1 (SERPINE1/PAI-1) was reported as an essential mediator of late radiation-induced intestinal injury. However, it is not clear whether PAI-1 plays a role in acute radiation-induced intestinal damage and we hypothesized that PAI-1 may play a role in the endothelium radiosensitivity. In vivo, in a model of radiation enteropathy in PAI-1 -/- mice, apoptosis of radiosensitive compartments, epithelial and microvascular endothelium was quantified. In vitro, the role of PAI-1 in the radiation-induced endothelial cells (ECs) death was investigated. The level of apoptotic ECs is lower in PAI-1 -/- compared with Wt mice after irradiation. This is associated with a conserved microvascular density and consequently with a better mucosal integrity in PAI-1 -/- mice. In vitro, irradiation rapidly stimulates PAI-1 expression in ECs and radiation sensitivity is increased in ECs that stably overexpress PAI-1, whereas PAI-1 knockdown increases EC survival after irradiation. Moreover, ECs prepared from PAI-1 -/- mice are more resistant to radiation-induced cell death than Wt ECs and this is associated with activation of the Akt pathway. This study demonstrates that PAI-1 plays a key role in radiation-induced EC death in the intestine and suggests that this contributes strongly to the progression of radiation-induced intestinal injury.	[Abderrahmani, Rym; Francois, Agnes; Buard, Valerie; Tarlet, Georges; Blirando, Karl; Hneino, Mohammad; Benderitter, Marc; Milliat, Fabien] Inst Radiol Protect & Nucl Safety, Lab Radiopathol & Expt Therapeut, Fontenay Aux Roses, France; [Vaurijoux, Aurelie] Inst Radiol Protect & Nucl Safety, Lab Biol Dosimetry, Fontenay Aux Roses, France; [Sabourin, Jean-Christophe] Rouen Univ Hosp, Dept Pathol, Rouen, France	CHU de Rouen	Abderrahmani, R (corresponding author), Inst Radiol Protect & Nucl Safety, Lab Radiopathol & Expt Therapeut, Fontenay Aux Roses, France.	fabien.milliat@irsn.fr		Milliat, Fabien/0000-0001-8249-9498; TARLET, Georges/0000-0002-4756-5127; Vaurijoux, Aurelie/0000-0002-6418-4182	Electricite de France (EDF)	Electricite de France (EDF)(Electricite de France (EDF))	This work was supported by Electricite de France (EDF) and is included in the IRSN program ROSIRIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani R, 2009, INT J RADIAT ONCOL, V74, P942, DOI 10.1016/j.ijrobp.2009.01.077; Andreyev J, 2005, GUT, V54, P1051, DOI 10.1136/gut.2004.062596; Artman T, 2010, INT J RADIAT ONCOL, V76, P574, DOI 10.1016/j.ijrobp.2009.08.035; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Balsara RD, 2006, J BIOL CHEM, V281, P22527, DOI 10.1074/jbc.M512819200; Balsara RD, 2008, THROMB HAEMOSTASIS, V100, P1029, DOI 10.1160/TH08-07-0427; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Bonnaud S, 2007, CANCER RES, V67, P1803, DOI 10.1158/0008-5472.CAN-06-2802; Bonnaud S, 2010, CANCER RES, V70, P9905, DOI 10.1158/0008-5472.CAN-10-2043; Brown M, 2008, INT J RADIAT ONCOL, V70, P799, DOI 10.1016/j.ijrobp.2007.12.001; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Chen SC, 2008, MOL CANCER THER, V7, P1227, DOI 10.1158/1535-7163.MCT-08-0051; Chen YB, 2006, ARTERIOSCL THROM VAS, V26, P1777, DOI 10.1161/01.ATV.0000227514.50065.2a; Chen YB, 2004, J CELL BIOCHEM, V92, P178, DOI 10.1002/jcb.20058; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Collins-Underwood JR, 2008, FREE RADICAL BIO MED, V45, P929, DOI 10.1016/j.freeradbiomed.2008.06.024; Denham JW, 2002, RADIOTHER ONCOL, V63, P129, DOI 10.1016/S0167-8140(02)00060-9; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; Eitzman DT, 2000, BLOOD, V96, P4212; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Gudkov AV, 2008, INT J RADIAT ONCOL, V70, P800, DOI 10.1016/j.ijrobp.2007.07.2396; Hageman J, 2005, CLIN CANCER RES, V11, P5956, DOI 10.1158/1078-0432.CCR-05-0427; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Jin YP, 2004, HUM IMMUNOL, V65, P291, DOI 10.1016/j.humimm.2004.01.002; Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406; Lademann UA, 2008, THROMB HAEMOSTASIS, V100, P1041, DOI 10.1160/TH08-04-0266; Maxhimer JB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000139; Milliat F, 2008, AM J PATHOL, V172, P691, DOI 10.2353/ajpath.2008.070930; Oikawa T, 1997, KIDNEY INT, V51, P164, DOI 10.1038/ki.1997.20; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Ploplis VA, 2004, J BIOL CHEM, V279, P6143, DOI 10.1074/jbc.M307297200; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Rotolo JA, 2008, INT J RADIAT ONCOL, V70, P804, DOI 10.1016/j.ijrobp.2007.11.043; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Schneider DJ, 2008, THROMB HAEMOSTASIS, V100, P1037, DOI 10.1160/TH08-04-0234; Schuller BW, 2007, INT J RADIAT ONCOL, V68, P205, DOI 10.1016/j.ijrobp.2006.12.069; Schuller BW, 2006, P NATL ACAD SCI USA, V103, P3787, DOI 10.1073/pnas.0600133103; Soeda S, 2001, MOL BRAIN RES, V91, P96, DOI 10.1016/S0169-328X(01)00133-4; Soff GA, 1995, J CLIN INVEST, V96, P2593, DOI 10.1172/JCI118323; Stefansson S, 2001, J BIOL CHEM, V276, P8135, DOI 10.1074/jbc.M007609200; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Takeshita K, 2004, AM J PATHOL, V164, P449, DOI 10.1016/S0002-9440(10)63135-5; Vozenin-Brotons MC, 2004, RADIAT RES, V161, P299, DOI 10.1667/RR3128; Wang JR, 2007, WORLD J GASTROENTERO, V13, P3047, DOI 10.3748/wjg.v13.i22.3047; Zhao WL, 1999, RADIAT RES, V152, P160, DOI 10.2307/3580089; Zhao WL, 2001, CANCER RES, V61, P5537; Zheng H, 2000, GASTROENTEROLOGY, V119, P1286, DOI 10.1053/gast.2000.19282	52	40	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35740	10.1371/journal.pone.0035740	http://dx.doi.org/10.1371/journal.pone.0035740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563394	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100022
J	Glisic, S; Jailwala, P				Glisic, Sanja; Jailwala, Parthav			Interaction between Treg Apoptosis Pathways, Treg Function and HLA Risk Evolves during Type 1 Diabetes Pathogenesis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MHC CLASS-II; INDUCED CELL-DEATH; HUMAN T-CELLS; POLYMERASE CHAIN-REACTION; NF-KAPPA-B; OXIDATIVE STRESS; HUMAN NEUTROPHILS; HIGH-RESOLUTION; MESSENGER-RNA	We have previously reported increased apoptosis of regulatory T cells (Tregs) in recent-onset Type 1 Diabetes subjects (RO T1D) in the honeymoon phase and in multiple autoantibody-positive (Ab+) subjects, some of which are developing T1D. We have also reported that increased Treg apoptosis was associated with High HLA risk and that it subsided with cessation of honeymoon period. In this report, we present results generated using genetics, genomics, functional cell-based assays and flow cytometry to assess cellular changes at the T-cell level during T1D pathogenesis. We measured ex vivo Treg apoptosis and Treg function, surface markers expression, expression of HLA class II genes, the influence of HLA risk on Treg apoptosis and function, and evaluated contribution of genes reported to be involved in the apoptosis process. This integrated comprehensive approach uncovered important information that can serve as a basis for future studies aimed to modulate Treg cell responsiveness to apoptotic signals in autoimmunity. For example, T1D will progress in those subjects where increased Treg apoptosis is accompanied with decreased Treg function. Furthermore, Tregs from High HLA risk healthy controls had increased Treg apoptosis levels and overexpressed FADD but not Fas/FasL. Tregs from RO T1D subjects in the honeymoon phase were primarily dying through withdrawal of growth hormones with contribution of oxidative stress, mitochondrial apoptotic pathways, and employment of TNF-receptor family members. Ab+ subjects, however, expressed high inflammation level, which probably contributed to Treg apoptosis, although other apoptotic pathways were also activated: withdrawal of growth hormones, oxidative stress, mitochondrial apoptosis and Fas/FasL apoptotic pathways. The value of these results lie in potentially different preventive treatment subjects would receive depending on disease progression stage when treated.	[Glisic, Sanja] Med Coll Wisconsin, Childrens Hosp Wisconsin, Human & Mol Genet Ctr, Dept Pediat,Max McGee Natl Res Ctr Juvenile Diabe, Milwaukee, WI 53226 USA; [Jailwala, Parthav] NCI Frederick, SAIC Frederick, Adv Biomed Comp Ctr, Bethesda, MD USA	Children's Hospital of Wisconsin; Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Glisic, S (corresponding author), Med Coll Wisconsin, Childrens Hosp Wisconsin, Human & Mol Genet Ctr, Dept Pediat,Max McGee Natl Res Ctr Juvenile Diabe, Milwaukee, WI 53226 USA.	sglisic@mcw.edu			Research Affairs Committee [9304653]; Max McGee National Research Center for Juvenile Diabetes; Human Molecular Genetics Center at Medical College of Wisconsin; Children's Research Institute of Wisconsin	Research Affairs Committee; Max McGee National Research Center for Juvenile Diabetes; Human Molecular Genetics Center at Medical College of Wisconsin; Children's Research Institute of Wisconsin	This study was supported by Research Affairs Committee #9304653 and through Max McGee National Research Center for Juvenile Diabetes, Human Molecular Genetics Center at Medical College of Wisconsin and Children's Research Institute of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; BAISCH JM, 1990, NEW ENGL J MED, V322, P1836, DOI 10.1056/NEJM199006283222602; BARNABA V, 1994, EUR J IMMUNOL, V24, P71, DOI 10.1002/eji.1830240112; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Cowburn AS, 2011, AM J RESP CELL MOL, V44, P879, DOI 10.1165/rcmb.2010-0101OC; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Donner H, 2002, EUR J IMMUNOGENET, V29, P321, DOI 10.1046/j.1365-2370.2002.00321.x; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; ERLICH HA, 1991, DIABETES, V40, P478, DOI 10.2337/diabetes.40.4.478; Fang HY, 2011, ONCOL REP, V26, P359, DOI 10.3892/or.2011.1292; Ferstl B, 2004, GENES IMMUN, V5, P405, DOI 10.1038/sj.gene.6364108; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Glisic S, 2009, GENES IMMUN, V10, P334, DOI 10.1038/gene.2009.14; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Gorus F K, 1996, Verh K Acad Geneeskd Belg, V58, P539; Greenbaum CJ, 2002, J AUTOIMMUN, V18, P67, DOI 10.1006/jaut.2001.0562; HEWITT CRA, 1989, J IMMUNOL, V143, P762; Himer L, 2010, FASEB J, V24, P2631, DOI 10.1096/fj.10-155192; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; Ishola DA, 2006, KIDNEY INT, V70, P724, DOI 10.1038/sj.ki.5001629; Jailwala P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006527; KANSAS GS, 1991, J IMMUNOL, V147, P4094; Kato-Kogoe N, 2010, LAB INVEST, V90, P1747, DOI 10.1038/labinvest.2010.128; Klitz W, 2003, TISSUE ANTIGENS, V62, P296, DOI 10.1034/j.1399-0039.2003.00103.x; Kwok WW, 1996, J EXP MED, V183, P1253, DOI 10.1084/jem.183.3.1253; LASALLE JM, 1991, J IMMUNOL, V147, P774; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lie BA, 1999, AM J HUM GENET, V64, P793, DOI 10.1086/302283; MASCLE F, 1990, NOUV REV FR HEMATOL, V32, P333; Mauro C, 2006, J BIOL CHEM, V281, P2631, DOI 10.1074/jbc.M502181200; MOONEY NA, 1990, J IMMUNOL, V145, P2070; MorzyckaWroblewska E, 1997, IMMUNOGENETICS, V45, P163, DOI 10.1007/s002510050185; Nejentsev S, 2000, DIABETES, V49, P2217, DOI 10.2337/diabetes.49.12.2217; Nepom GT, 1998, DIABETES, V47, P1177, DOI 10.2337/diabetes.47.8.1177; NERUP J, 1974, LANCET, V2, P864; Noble JA, 1996, AM J HUM GENET, V59, P1134; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Redondo MJ, 2001, RECENT PROG HORM RES, V56, P69, DOI 10.1210/rp.56.1.69; Reinisch W, 2003, CLIN EXP IMMUNOL, V133, P476, DOI 10.1046/j.1365-2249.2003.02245.x; Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129; Robertson LA, 2006, CAN J PHYSIOL PHARM, V84, P39, DOI 10.1139/Y05-142; ROTTER JI, 1984, CLIN GENET, V26, P529; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; She JX, 1996, IMMUNOL TODAY, V17, P323, DOI 10.1016/0167-5699(96)10014-1; Shen HM, 2004, MOL CELL BIOL, V24, P5914, DOI 10.1128/MCB.24.13.5914-5922.2004; SHOOKSTER L, 1987, HUM IMMUNOL, V20, P59, DOI 10.1016/0198-8859(87)90006-1; Sohn D, 2011, CELL DEATH DIFFER, V18, P1664, DOI 10.1038/cdd.2011.34; Sood SK, 2011, WORLD J SURG, V35, P1984, DOI 10.1007/s00268-011-1185-5; Stehlik C, 2003, J BIOL CHEM, V278, P31941, DOI 10.1074/jbc.M300009200; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Taplin CE, 2008, AUTOIMMUNITY, V41, P11, DOI 10.1080/08916930701619169; Thibeault A, 1999, CELL IMMUNOL, V192, P79, DOI 10.1006/cimm.1998.1428; THORSBY E, 1993, DIABETOLOGIA, V36, P371, DOI 10.1007/BF00402270; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1990, CURR TOP MICROBIOL, V164, P17; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Valdes AM, 2005, TISSUE ANTIGENS, V65, P115, DOI 10.1111/j.1399-0039.2005.00348.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vincent R, 1996, J IMMUNOL, V156, P603; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; WYSSCORAY T, 1992, CELL IMMUNOL, V139, P268, DOI 10.1016/0008-8749(92)90119-A; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yamamoto T, 2002, J NEURAL TRANSM, V109, P1, DOI 10.1007/s702-002-8232-1; Yun TJ, 1998, J IMMUNOL, V161, P6113; Yun TJ, 2001, J IMMUNOL, V166, P1482, DOI 10.4049/jimmunol.166.3.1482; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	76	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36040	10.1371/journal.pone.0036040	http://dx.doi.org/10.1371/journal.pone.0036040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563437	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100063
J	Kroetz, SM; Srinivasan, J; Yaghoobian, J; Sternberg, PW; Hong, RL				Kroetz, Silvina M.; Srinivasan, Jagan; Yaghoobian, Jonathan; Sternberg, Paul W.; Hong, Ray L.			The cGMP Signaling Pathway Affects Feeding Behavior in the Necromenic Nematode Pristionchus pacificus	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; C-ELEGANS; BODY-SIZE; CAENORHABDITIS-ELEGANS; BEETLE; FOOD	Background: The genetic tractability and the species-specific association with beetles make the nematode Pristionchus pacificus an exciting emerging model organism for comparative studies in development and behavior. P. pacificus differs from Caenorhabditis elegans (a bacterial feeder) by its buccal teeth and the lack of pharyngeal grinders, but almost nothing is known about which genes coordinate P. pacificus feeding behaviors, such as pharyngeal pumping rate, locomotion, and fat storage. Methodology/Principal Findings: We analyzed P. pacificus pharyngeal pumping rate and locomotion behavior on and off food, as well as on different species of bacteria (Escherichia coli, Bacillus subtilis, and Caulobacter crescentus). We found that the cGMP-dependent protein kinase G (PKG) Ppa-EGL-4 in P. pacificus plays an important role in regulating the pumping rate, mouth form dimorphism, the duration of forward locomotion, and the amount of fat stored in intestine. In addition, Ppa-EGL-4 interacts with Ppa-OBI-1, a recently identified protein involved in chemosensation, to influence feeding and locomotion behavior. We also found that C. crescentus NA1000 increased pharyngeal pumping as well as fat storage in P. pacificus. Conclusions: The PKG EGL-4 has conserved functions in regulating feeding behavior in both C. elegans and P. pacificus nematodes. The Ppa-EGL-4 also has been co-opted during evolution to regulate P. pacificus mouth form dimorphism that indirectly affect pharyngeal pumping rate. Specifically, the lack of Ppa-EGL-4 function increases pharyngeal pumping, time spent in forward locomotion, and fat storage, in part as a result of higher food intake. Ppa-OBI-1 functions upstream or parallel to Ppa-EGL-4. The beetle-associated omnivorous P. pacificus respond differently to changes in food state and food quality compared to the exclusively bacteriovorous C. elegans.	[Kroetz, Silvina M.; Yaghoobian, Jonathan; Hong, Ray L.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Srinivasan, Jagan; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California State University System; California State University Northridge; California Institute of Technology	Kroetz, SM (corresponding author), Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA.	ray.hong@csun.edu	Srinivasan, Jagan/B-6215-2015	Sternberg, Paul/0000-0002-7699-0173; Srinivasan, Jagan/0000-0001-5449-7938	Minority Access to Research Careers (MARC); Caltech; National Institutes of Health [SC2GM089602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM105579, SC2GM089602] Funding Source: NIH RePORTER	Minority Access to Research Careers (MARC); Caltech; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Minority Access to Research Careers (MARC) and Caltech's MURF (Minority Undergraduate Research Fellowship) to SMK, HHMI to JS and PWS, and National Institutes of Health grant SC2GM089602 awarded to RLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY L, 1993, GENETICS, V134, P454; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avery L, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-69; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fitzpatrick MJ, 2004, INTEGR COMP BIOL, V44, P28, DOI 10.1093/icb/44.1.28; Foster Woodruff, 1946, J BACTERIOL, P51; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Hao Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002065; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann M, 2006, ZOOLOGY, V109, P96, DOI 10.1016/j.zool.2006.03.001; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; Hirschmann H., 1951, Zoologische Jahrbuecher (Systematik), V80, P132; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Hong RL, 2008, EVOL DEV, V10, P273, DOI 10.1111/j.1525-142X.2008.00236.x; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Li G, 2006, BIOPHYS J, V91, P2726, DOI 10.1529/biophysj.106.080697; Nakano Y, 2004, GENES CELLS, V9, P773, DOI 10.1111/j.1365-2443.2004.00771.x; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Poindexter, 1981, MICROBIOLOGICAL REV, V45, P123; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Rae R, 2008, J EXP BIOL, V211, P1927, DOI 10.1242/jeb.014944; Rae R, 2010, ENVIRON MICROBIOL, V12, P3007, DOI 10.1111/j.1462-2920.2010.02278.x; Raizen DM, 2006, GENETICS, V173, P177, DOI 10.1534/genetics.106.057380; RAIZEN DM, 1995, GENETICS, V141, P1365; Rivard L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-22; SARGENT MG, 1975, J BACTERIOL, V123, P7, DOI 10.1128/JB.123.1.7-19.1975; Schulte RD, 2011, BIOL LETT; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; TRENT C, 1983, GENETICS, V104, P619; von Lieven AF, 2000, J ZOOL SYST EVOL RES, V38, P37, DOI 10.1046/j.1439-0469.2000.381125.x; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005	40	22	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e34464	10.1371/journal.pone.0034464	http://dx.doi.org/10.1371/journal.pone.0034464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563372	Green Published, gold, Green Accepted			2022-12-25	WOS:000305349100002
J	Sheridan, MA; Sarsour, K; Jutte, D; D'Esposito, M; Boyce, WT				Sheridan, Margaret A.; Sarsour, Khaled; Jutte, Douglas; D'Esposito, Mark; Boyce, W. Thomas			The Impact of Social Disparity on Prefrontal Function in Childhood	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; LIFE-COURSE; SELECTIVE ATTENTION; COGNITIVE CONTROL; WORKING-MEMORY; RISK EXPOSURE; BRAIN; HEALTH; STRESS; PREDICTION	The prefrontal cortex (PFC) develops from birth through late adolescence. This extended developmental trajectory provides many opportunities for experience to shape the structure and function of the PFC. To date, a few studies have reported links between parental socioeconomic status (SES) and prefrontal function in childhood, raising the possibility that aspects of environment associated with SES impact prefrontal function. Considering that behavioral measures of prefrontal function are associated with learning across multiple domains, this is an important area of investigation. In this study, we used fMRI to replicate previous findings, demonstrating an association between parental SES and PFC function during childhood. In addition, we present two hypothetical mechanisms by which SES could come to affect PFC function of this association: language environment and stress reactivity. We measured language use in the home environment and change in salivary cortisol before and after fMRI scanning. Complexity of family language, but not the child's own language use, was associated with both parental SES and PFC activation. Change in salivary cortisol was also associated with both SES and PFC activation. These observed associations emphasize the importance of both enrichment and adversity-reduction interventions in creating good developmental environments for all children.	[Sheridan, Margaret A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sheridan, Margaret A.] Childrens Hosp, Boston, MA 02115 USA; [Sarsour, Khaled] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Jutte, Douglas] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [D'Esposito, Mark] Helen Wills Neurosci Inst, Berkeley, CA USA; [D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Boyce, W. Thomas] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Boyce, W. Thomas] Univ British Columbia, Coll Interdisciplinary Studies, Vancouver, BC V5Z 1M9, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Eli Lilly; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of British Columbia; University of British Columbia	Sheridan, MA (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	margaret.sheridan@childrens.harvard.edu		Sheridan, Margaret/0000-0002-8909-7501	National Institute of Mental Health [5R21MH70950]; Robert Wood Johnson Health and Society Scholars program (Harvard site); NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH092555, R21MH070950] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Robert Wood Johnson Health and Society Scholars program (Harvard site); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (5R21MH70950) and by the Robert Wood Johnson Health and Society Scholars program (Harvard site). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Balodis IM, 2010, PSYCHONEUROENDOCRINO, V35, P1363, DOI 10.1016/j.psyneuen.2010.03.011; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Boettiger CA, 2005, J NEUROSCI, V25, P2723, DOI 10.1523/JNEUROSCI.3697-04.2005; Botvin GJ, 2007, INT REV PSYCHIATR, V19, P607, DOI 10.1080/09540260701797753; Cao J, 2001, LECT NOTES STAT, V159, P169; Cohen S, 2004, PSYCHOSOM MED, V66, P553, DOI 10.1097/01.psy.0000126200.05189.d3; D'Angiulli A, 2008, NEUROPSYCHOLOGY, V22, P293, DOI 10.1037/0894-4105.22.3.293; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dowd JB, 2009, INT J EPIDEMIOL, V38, P1297, DOI 10.1093/ije/dyp277; Eiland L, 2010, HIPPOCAMPUS; Evans GW, 2010, ANN NY ACAD SCI, V1186, P174, DOI 10.1111/j.1749-6632.2009.05336.x; Evans GW, 2009, P NATL ACAD SCI USA, V106, P6545, DOI 10.1073/pnas.0811910106; Evans GW, 2006, ANNU REV PSYCHOL, V57, P423, DOI 10.1146/annurev.psych.57.102904.190057; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Fujiwara T, 2009, INT J EPIDEMIOL, V38, P1310, DOI 10.1093/ije/dyp226; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Gianaros PJ, 2010, PSYCHOSOM MED, V72, P450, DOI 10.1097/PSY.0b013e3181e1a23c; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldwater DS, 2009, NEUROSCIENCE, V164, P798, DOI 10.1016/j.neuroscience.2009.08.053; Gonzalez V, 2005, NABE REV RES PRACT, V3, P67; Gottlieb G, 2004, PREV SCI, V5, P245, DOI 10.1023/B:PREV.0000045358.12782.6b; Gunnar MR, 2007, PROG BRAIN RES, V167, P137, DOI 10.1016/S0079-6123(07)67010-1; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hart B., 1995, MEANINGFUL DIFFERENC; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hertzman C, 1999, DEVELOPMENTAL HEALTH AND THE WEALTH OF NATIONS, P21; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Kishiyama MM, 2009, J COGNITIVE NEUROSCI, V21, P1106, DOI 10.1162/jocn.2009.21101; Lupien SJ, 2000, BIOL PSYCHIAT, V48, P976, DOI 10.1016/S0006-3223(00)00965-3; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Melchior M, 2007, AM J EPIDEMIOL, V166, P966, DOI 10.1093/aje/kwm155; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller G, 2007, PSYCHOSOM MED, V69, P402, DOI 10.1097/PSY.0b013e318068fcf9; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Noble KG, 2006, DEVELOPMENTAL SCI, V9, P642; Nuru-Jeter AM, 2010, COMPR CHILD ADOLES N, V33, P59, DOI 10.3109/01460861003663953; Pollitt RA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-7; Raizada RDS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.003.2010; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Sarsour K, 2011, J INT NEUROPSYCH SOC, V17, P120, DOI 10.1017/S1355617710001335; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Stevens C, 2009, DEVELOPMENTAL SCI, V12, P634, DOI 10.1111/j.1467-7687.2009.00807.x; STEVENSON HW, 1986, CHILD DEV, V57, P646, DOI 10.2307/1130343; WALKER D, 1994, CHILD DEV, V65, P606, DOI 10.2307/1131404; Zelazo PD, 2006, PSYCHOL REP, V98, P858, DOI 10.2466/PR0.98.3.858-860	62	138	140	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35744	10.1371/journal.pone.0035744	http://dx.doi.org/10.1371/journal.pone.0035744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WQ	22563395	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100023
J	Tseng, HH; Chuah, QY; Yang, PM; Chen, CT; Chao, JC; Lin, MD; Chiu, SJ				Tseng, Ho-Hsing; Chuah, Qiu-Yu; Yang, Pei-Ming; Chen, Chiung-Tong; Chao, Jung-Chi; Lin, Ming-Der; Chiu, Shu-Jun			Securin Enhances the Anti-Cancer Effects of 6-Methoxy-3-(3 ',4 ',5 '-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in Human Colorectal Cancer Cells	PLOS ONE			English	Article							TUMOR-TRANSFORMING GENE; SPINDLE ASSEMBLY CHECKPOINT; SISTER-CHROMATID SEPARATION; MITOTIC CATASTROPHE; PROTEIN-KINASE; BREAST-CANCER; SIGNAL-TRANSDUCTION; RECENT PROGRESS; POOR-PROGNOSIS; EXPRESSION	BPR0L075 [6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole] is a novel anti-microtubule drug with anti-tumor and anti-angiogenic activities in vitro and in vivo. Securin is required for genome stability, and is expressed abundantly in most cancer cells, promoting cell proliferation and tumorigenesis. In this study, we found that BPR0L075 efficiently induced cell death of HCT116 human colorectal cancer cells that have higher expression levels of securin. The cytotoxicity of BPR0L075 was attenuated in isogenic securin-null HCT116 cells. BPR0L075 induced DNA damage response, G(2)/M arrest, and activation of the spindle assembly checkpoint in HCT116 cells. Interestingly, BPR0L075 induced phosphorylation of securin. BPR0L075 withdrawal resulted in degradation of securin, mitotic exit, and mitotic catastrophe, which were attenuated in securin-null cells. Inhibition of cdc2 decreased securin phosphorylation, G(2)/M arrest and cell death induced by BPR0L075. Moreover, BPR0L075 caused cell death through a caspase-independent mechanism and activation of JNK and p38 MAPK pathways. These findings provided evidence for the first time that BPR0L075 treatment is beneficial for the treatment of human colorectal tumors with higher levels of securin. Thus, we suggest that the expression levels of securin may be a predictive factor for application in anti-cancer therapy with BPR0L075 in human cancer cells.	[Tseng, Ho-Hsing; Chuah, Qiu-Yu; Chao, Jung-Chi; Chiu, Shu-Jun] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Yang, Pei-Ming] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan; [Chen, Chiung-Tong] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Taiwan; [Lin, Ming-Der] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan	Tzu Chi University; National Taiwan University; National Health Research Institutes - Taiwan; Tzu Chi University	Tseng, HH (corresponding author), Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan.	chiusj@mail.tcu.edu.tw	Chen, Chiung-Tong/D-2075-2010; Lin, Ming-Der/AAL-5302-2020; Yang, Pei-Ming/G-3763-2014	Yang, Pei-Ming/0000-0002-4004-2518; Lin, Ming-Der/0000-0003-3411-5685	National Science Council, Taiwan [NSC 99-2314-B-320-004-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan (NSC 99-2314-B-320-004-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Amos LA, 2000, CURR OPIN STRUC BIOL, V10, P236, DOI 10.1016/S0959-440X(00)00070-1; Bekier ME, 2009, MOL CANCER THER, V8, P1646, DOI 10.1158/1535-7163.MCT-08-1084; Chen CP, 2010, ANTICANCER RES, V30, P2813; Chen WS, 2010, INT J RADIAT ONCOL, V77, P566, DOI 10.1016/j.ijrobp.2009.12.013; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Chiu SJ, 2008, TOXICOL LETT, V179, P63, DOI 10.1016/j.toxlet.2008.04.004; Chiu SJ, 2006, TOXICOL LETT, V167, P122, DOI 10.1016/j.toxlet.2006.08.018; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Fujii T, 2006, HEPATOLOGY, V43, P1267, DOI 10.1002/hep.21181; Genkai N, 2006, ONCOL REP, V15, P1569; Gil-Bernabe AM, 2006, MOL CELL BIOL, V26, P4017, DOI 10.1128/MCB.01904-05; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hsu TS, 2008, CANCER CHEMOTH PHARM, V62, P799, DOI 10.1007/s00280-007-0667-5; Jiang RH, 2010, J CELL BIOCHEM, V111, P274, DOI 10.1002/jcb.22697; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Keyes BE, 2008, GENETICS, V178, P589, DOI 10.1534/genetics.107.083642; Kim DS, 2007, CARCINOGENESIS, V28, P749, DOI 10.1093/carcin/bgl202; Kiselyov A, 2007, ANTI-CANCER AGENT ME, V7, P189, DOI 10.2174/187152007780058650; Kroemer G, 2011, FRONTIERS ONCOLOGY, V1; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Moreno-Mateos MA, 2011, MOL BIOL CELL, V22, P4302, DOI 10.1091/mbc.E10-10-0838; Morse DL, 2005, MOL CANCER THER, V4, P1495, DOI 10.1158/1535-7163.MCT-05-0130; Nabha SM, 2002, CLIN CANCER RES, V8, P2735; Ogbagabriel S, 2005, MODERN PATHOL, V18, P985, DOI 10.1038/modpathol.3800382; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pei L, 2000, J BIOL CHEM, V275, P31191, DOI 10.1074/jbc.M002451200; Ramos-Morales F, 2000, ONCOGENE, V19, P403, DOI 10.1038/sj.onc.1203320; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romero F, 2004, MOL CELL BIOL, V24, P2720, DOI 10.1128/MCB.24.7.2720-2733.2004; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Shi Q, 1998, CURR PHARM DESIGN, V4, P219; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Tfelt-Hansen J, 2006, CLIN MED RES, V4, P130, DOI 10.3121/cmr.4.2.130; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Vogel C, 2004, ONCOGENE, V23, P6845, DOI 10.1038/sj.onc.1207860; Wang ZY, 2003, P NATL ACAD SCI USA, V100, P3428, DOI 10.1073/pnas.0638052100; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Xu R, 2009, ANTICANCER RES, V29, P261; Yu SH, 2011, CANCER LETT, V300, P96, DOI 10.1016/j.canlet.2010.09.015; Zhang WH, 2008, CELL CYCLE, V7, P1668, DOI 10.4161/cc.7.11.5982; Zhou YL, 2003, J BIOL CHEM, V278, P462, DOI 10.1074/jbc.M203793200; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	53	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36006	10.1371/journal.pone.0036006	http://dx.doi.org/10.1371/journal.pone.0036006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563433	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100059
J	Costa, FO; Landi, M; Martins, R; Costa, MH; Costa, ME; Carneiro, M; Alves, MJ; Steinke, D; Carvalho, GR				Costa, Filipe O.; Landi, Monica; Martins, Rogelia; Costa, Maria H.; Costa, Maria E.; Carneiro, Miguel; Alves, Maria J.; Steinke, Dirk; Carvalho, Gary R.			A Ranking System for Reference Libraries of DNA Barcodes: Application to Marine Fish Species from Portugal	PLOS ONE			English	Article							DIVERGENCE	Background: The increasing availability of reference libraries of DNA barcodes (RLDB) offers the opportunity to the screen the level of consistency in DNA barcode data among libraries, in order to detect possible disagreements generated from taxonomic uncertainty or operational shortcomings. We propose a ranking system to attribute a confidence level to species identifications associated with DNA barcode records from a RLDB. Here we apply the proposed ranking system to a newly generated RLDB for marine fish of Portugal. Methodology/Principal Findings: Specimens (n = 659) representing 102 marine fish species were collected along the continental shelf of Portugal, morphologically identified and archived in a museum collection. Samples were sequenced at the barcode region of the cytochrome oxidase subunit I gene (COI-5P). Resultant DNA barcodes had average intra-specific and inter-specific Kimura-2-parameter distances (0.32% and 8.84%, respectively) within the range usually observed for marine fishes. All specimens were ranked in five different levels (A-E), according to the reliability of the match between their species identification and the respective diagnostic DNA barcodes. Grades A to E were attributed upon submission of individual specimen sequences to BOLD-IDS and inspection of the clustering pattern in the NJ tree generated. Overall, our study resulted in 73.5% of unambiguous species IDs (grade A), 7.8% taxonomically congruent barcode clusters within our dataset, but awaiting external confirmation (grade B), and 18.7% of species identifications with lower levels of reliability (grades C/E). Conclusion/Significance: We highlight the importance of implementing a system to rank barcode records in RLDB, in order to flag taxa in need of taxonomic revision, or reduce ambiguities of discordant data. With increasing DNA barcode records publicly available, this cross-validation system would provide a metric of relative accuracy of barcodes, while enabling the continuous revision and annotation required in taxonomic work.	[Costa, Filipe O.; Landi, Monica] Univ Minho, CBMA Ctr Mol & Environm Biol, Dept Biol, Braga, Portugal; [Martins, Rogelia; Carneiro, Miguel] IP IPIMAR, INRB, Lisbon, Portugal; [Costa, Maria H.] Univ Nova Lisboa, Fac Ciencias & Tecnol, IMAR Inst Mar, Dept Ciencias & Engn Ambiente, Caparica, Portugal; [Costa, Maria E.] Univ Algarve, FCT, Ctr Ciencias Mar CCMAR, Faro, Portugal; [Alves, Maria J.] Univ Lisbon, Museu Nacl Hist Nat, P-1699 Lisbon, Portugal; [Alves, Maria J.] Univ Lisbon, Ctr Biol Ambiental, P-1699 Lisbon, Portugal; [Steinke, Dirk] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Carvalho, Gary R.] Bangor Univ, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales	Universidade do Minho; Portuguese Institute of Sea & Fisheries Research (IPIMAR); Universidade Nova de Lisboa; Universidade do Algarve; Universidade de Lisboa; Universidade de Lisboa; University of Guelph; Bangor University	Costa, FO (corresponding author), Univ Minho, CBMA Ctr Mol & Environm Biol, Dept Biol, Campus Gualtar, Braga, Portugal.	fcosta@bio.uminho.pt	Costa, Filipe/M-9623-2019; Costa, Filipe/GSD-2439-2022; Costa, Maria Helena/F-4957-2012; Landi, Monica/J-3611-2012; Steinke, Dirk/D-4700-2009; Costa, Filipe/B-5890-2009; Alves, Maria Judite/K-9315-2014	Costa, Filipe/0000-0001-5398-3942; Costa, Maria Helena/0000-0001-8479-4941; Landi, Monica/0000-0003-2180-5062; Costa, Filipe/0000-0001-5398-3942; Alves, Maria Judite/0000-0002-0550-4190; Martins, Rogelia/0000-0002-6273-8372; Steinke, Dirk/0000-0002-8992-575X	FEDER through POFC-COMPETE; national funds from "Fundacao para a Ciencia e a Tecnologia (FCT)" [FCOMP-01-0124-FEDER-007381, FCOMP-01-0124-FEDER-010596, PEst-C/BIA/UI4050/2011]; Marie Curie Fellowship [MEIF-CT-2005-024966]; European Reintegration Grant by European Commission [PERG02-GA-2007-224890]; FCT [SFRH/BPD/45246/2008]; Canadian Centre for DNA Barcoding from Ontario Genomics Institute [2008-OGI-ICI-03]; Genome Canada; Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Research Council of Canada; Alfred P. Sloan Foundation	FEDER through POFC-COMPETE; national funds from "Fundacao para a Ciencia e a Tecnologia (FCT)"(Portuguese Foundation for Science and Technology); Marie Curie Fellowship(European Commission); European Reintegration Grant by European Commission; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Canadian Centre for DNA Barcoding from Ontario Genomics Institute; Genome Canada(Genome Canada); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was supported by FEDER through POFC-COMPETE and by national funds from "Fundacao para a Ciencia e a Tecnologia (FCT)" in the scope of the grants FCOMP-01-0124-FEDER-007381, FCOMP-01-0124-FEDER-010596 and PEst-C/BIA/UI4050/2011. FOC benefitted from Marie Curie Fellowship MEIF-CT-2005-024966 and from an European Reintegration Grant PERG02-GA-2007-224890 provided by the European Commission. ML benefit from a fellowship (SFRH/BPD/45246/2008) granted by the FCT. Sequencing at the Biodiversity Institute of Ontario was supported by funding to the International Barcode of Life Project (iBOL) through the Canadian Centre for DNA Barcoding, from the Ontario Genomics Institute (2008-OGI-ICI-03), Genome Canada, the Ontario Ministry of Research and Innovation, and the Natural Sciences and Engineering Research Council of Canada. DS was supported by funding from the Alfred P. Sloan Foundation to MarBOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges TC, 2007, BIODIVERSITY FISHERI; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Castilho R, 2007, J FISH BIOL, V70, P346, DOI 10.1111/j.1095-8649.2007.01455.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cochrane G, 2011, NUCLEIC ACIDS RES, V39, pD15, DOI 10.1093/nar/gkq1150; COSTA FO, 2007, GENOMICS SOC POLICY, V3, P29, DOI DOI 10.1186/1746-5354-3-2-29; Frose R, 2010, FISHBASE; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kim S, 2010, MOL CELLS, V30, P507, DOI 10.1007/s10059-010-0148-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Lleonart J, 2006, MAR ECOL PROG SER, V316, P231, DOI 10.3354/meps316231; Page TJ, 2011, ZOOTAXA, P65; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Robalo JI, 2009, MAR BIOL, V156, P1733, DOI 10.1007/s00227-009-1197-y; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Sirovich L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007051; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WALTERS C, 2006, DNA BANKS PROVIDING, P25; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X	27	91	94	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35858	10.1371/journal.pone.0035858	http://dx.doi.org/10.1371/journal.pone.0035858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558244	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200088
J	Zhang, LH; Guo, DF; Niu, SL; Wang, CH; Shao, CL; Li, LH				Zhang, Lihua; Guo, Dufa; Niu, Shuli; Wang, Changhui; Shao, Changliang; Li, Linghao			Effects of Mowing on Methane Uptake in a Semiarid Grassland in Northern China	PLOS ONE			English	Article							SOIL MICROBIAL BIOMASS; LAND-USE CHANGE; CARBON-DIOXIDE; NITROGEN-FERTILIZATION; ATMOSPHERIC METHANE; BACTERIAL COMMUNITY; PINUS-RADIATA; PLANT BIOMASS; CH4 UPTAKE; FLUXES	Background: Mowing is a widely adopted management practice for the semiarid steppe in China and affects CH4 exchange. However, the magnitude and the underlying mechanisms for CH4 uptake in response to mowing remain uncertain. Methodology/Principal Findings: In two consecutive growing seasons, we measured the effect of mowing on CH4 uptake in a steppe community. Vegetation was mowed to 2 cm (M2), 5 cm (M5), 10 cm (M10), 15 cm (M15) above soil surface, respectively, and control was set as non-mowing (NM). Compared with control, CH4 uptake was substantially enhanced at almost all the mowing treatments except for M15 plots of 2009. CH4 uptake was significantly correlated with soil microbial biomass carbon, microbial biomass nitrogen, and soil moisture. Mowing affects CH4 uptake primarily through its effect on some biotic factors, such as net primary productivity, soil microbial C\N supply and soil microbial activities, while soil temperature and moisture were less important. Conclusions/Significance: This study found that mowing affects the fluxes of CH4 in the semiarid temperate steppe of north China.	[Zhang, Lihua; Niu, Shuli; Wang, Changhui; Shao, Changliang; Li, Linghao] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Guo, Dufa] Shandong Normal Univ, Jinan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Shandong Normal University	Zhang, LH (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	llinghao@ibcas.ac.cn	shao, changliang/ACG-3396-2022	Niu, Shuli/0000-0002-2394-2864	National Natural Science Foundation of China [40801037]; State Key Research Development Program of China [2010CB951301-2]; State Key Laboratory of Vegetation and Environmental Change Youth Funds; open funding of State Key Laboratory of Vegetation and Environmental Change, Institute of Botany	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Research Development Program of China(State Key Development Program for Basic Research of China); State Key Laboratory of Vegetation and Environmental Change Youth Funds; open funding of State Key Laboratory of Vegetation and Environmental Change, Institute of Botany	This work was funded by the National Natural Science Foundation of China (40801037), the State Key Research Development Program of China (2010CB951301-2) and State Key Laboratory of Vegetation and Environmental Change Youth Funds, and an open funding of the State Key Laboratory of Vegetation and Environmental Change, Institute of Botany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard V, 2007, AGR ECOSYST ENVIRON, V121, P47, DOI 10.1016/j.agee.2006.12.004; Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Borken W, 2006, SOIL BIOL BIOCHEM, V38, P1388, DOI 10.1016/j.soilbio.2005.10.011; Bubier J, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002351; Chen QS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003538; Chen WW, 2011, GLOBAL CHANGE BIOL, V17, P2803, DOI 10.1111/j.1365-2486.2011.02444.x; Chen WW, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013783; CHRISTENSEN TR, 1993, BIOGEOCHEMISTRY, V21, P117, DOI 10.1007/BF00000874; Dalal RC, 2008, PLANT SOIL, V309, P43, DOI 10.1007/s11104-007-9446-7; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Foster BL, 2009, ECOL APPL, V19, P1884, DOI 10.1890/08-0849.1; GARCIA FO, 1994, SOIL SCI SOC AM J, V58, P816, DOI 10.2136/sssaj1994.03615995005800030026x; Gavrichkova O, 2010, AGR ECOSYST ENVIRON, V136, P87, DOI 10.1016/j.agee.2009.11.015; Gulledge J, 2004, FEMS MICROBIOL ECOL, V49, P389, DOI 10.1016/j.femsec.2004.04.013; Hirota M, 2005, ATMOS ENVIRON, V39, P5255, DOI 10.1016/j.atmosenv.2005.05.036; Huang Y, 2010, GLOBAL CHANGE BIOL, V16, P680, DOI 10.1111/j.1365-2486.2009.01976.x; Ilmarinen K, 2009, RESTOR ECOL, V17, P78, DOI 10.1111/j.1526-100X.2007.00341.x; Ilmarinen K, 2009, ACTA OECOL, V35, P838, DOI 10.1016/j.actao.2009.08.008; IPCC, 2007, CLIM CHANG 2007 PHYS; Jin HM, 2010, J PLANT ECOL, V3, P209, DOI 10.1093/jpe/rtq001; Kaleita AL, 2005, APPL ENG AGRIC, V21, P865; Kaye JP, 2004, ECOL APPL, V14, P975, DOI 10.1890/03-5115; Li LH, 1998, ACTA BOT SIN, V40, P955; Li LH, 2002, ACTA BOT SIN, V44, P593; Lin XW, 2009, SOIL BIOL BIOCHEM, V41, P718, DOI 10.1016/j.soilbio.2009.01.007; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Liu CY, 2007, ATMOS ENVIRON, V41, P5948, DOI 10.1016/j.atmosenv.2007.03.017; Liu CY, 2009, ATMOS ENVIRON, V43, P3086, DOI 10.1016/j.atmosenv.2009.03.014; Liu WX, 2007, BIOL FERT SOILS, V44, P259, DOI 10.1007/s00374-007-0198-6; Livesley SJ, 2009, GLOBAL CHANGE BIOL, V15, P425, DOI 10.1111/j.1365-2486.2008.01759.x; Luo YQ, 2009, GCB BIOENERGY, V1, P62, DOI 10.1111/j.1757-1707.2008.01005.x; Menyailo OV, 2008, GLOBAL CHANGE BIOL, V14, P2405, DOI 10.1111/j.1365-2486.2008.01648.x; Merino A, 2004, SOIL BIOL BIOCHEM, V36, P917, DOI 10.1016/j.soilbio.2004.02.006; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Mosier AR, 1997, GLOBAL BIOGEOCHEM CY, V11, P29, DOI 10.1029/96GB03612; Nitschke N, 2010, J PLANT ECOL, V3, P109, DOI 10.1093/jpe/rtp036; PARR TW, 1988, J APPL ECOL, V25, P1073, DOI 10.2307/2403767; Peichl M, 2010, GLOBAL CHANGE BIOL, V16, P2198, DOI 10.1111/j.1365-2486.2009.02066.x; Pinares-Patino CS, 2007, AGR ECOSYST ENVIRON, V121, P30, DOI 10.1016/j.agee.2006.03.024; Potter CS, 1996, CHEMOSPHERE, V32, P2219, DOI 10.1016/0045-6535(96)00119-1; Prieme A, 1997, SOIL BIOL BIOCHEM, V29, P1269, DOI 10.1016/S0038-0717(97)00017-5; [齐玉春 Qi Yuchun], 2005, [资源科学, Resources science], V27, P103; Reay DS, 2004, SOIL BIOL BIOCHEM, V36, P2059, DOI 10.1016/j.soilbio.2004.06.002; Robson TM, 2007, SOIL BIOL BIOCHEM, V39, P930, DOI 10.1016/j.soilbio.2006.11.004; Sihgh BK, 2007, FEMS MICROBIO LETT, V275, P89; Smith KA, 2000, GLOBAL CHANGE BIOL, V6, P791, DOI 10.1046/j.1365-2486.2000.00356.x; Tate KR, 2007, SOIL BIOL BIOCHEM, V39, P1437, DOI 10.1016/j.soilbio.2007.01.005; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wang YS, 2005, CHEMOSPHERE, V58, P205, DOI 10.1016/j.chemosphere.2004.04.043; Wang YS, 2003, ADV ATMOS SCI, V20, P842, DOI 10.1007/BF02915410; Wang ZP, 2009, ATMOS ENVIRON, V43, P2148, DOI 10.1016/j.atmosenv.2009.01.021; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhao N, 2008, CHINESE J PLANT ECOL, V32, P591; Zhou XQ, 2008, SOIL BIOL BIOCHEM, V40, P258, DOI 10.1016/j.soilbio.2007.05.020; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x	57	8	9	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35952	10.1371/journal.pone.0035952	http://dx.doi.org/10.1371/journal.pone.0035952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558280	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200095
J	Hill, EJ; Jimenez-Gonzalez, C; Tarczyluk, M; Nagel, DA; Coleman, MD; Parri, HR				Hill, Eric J.; Jimenez-Gonzalez, Cristina; Tarczyluk, Marta; Nagel, David A.; Coleman, Michael D.; Parri, H. Rheinallt			NT2 Derived Neuronal and Astrocytic Network Signalling	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; IN-SITU; SYNAPTIC-TRANSMISSION; CALCIUM OSCILLATIONS; NTERA-2 CELLS; GLIAL-CELLS; GLUTAMATE; LINE; TERATOCARCINOMA; COMMUNICATION	A major focus of stem cell research is the generation of neurons that may then be implanted to treat neurodegenerative diseases. However, a picture is emerging where astrocytes are partners to neurons in sustaining and modulating brain function. We therefore investigated the functional properties of NT2 derived astrocytes and neurons using electrophysiological and calcium imaging approaches. NT2 neurons (NT2Ns) expressed sodium dependent action potentials, as well as responses to depolarisation and the neurotransmitter glutamate. NT2Ns exhibited spontaneous and coordinated calcium elevations in clusters and in extended processes, indicating local and long distance signalling. Tetrodotoxin sensitive network activity could also be evoked by electrical stimulation. Similarly, NT2 astrocytes (NT2As) exhibited morphology and functional properties consistent with this glial cell type. NT2As responded to neuronal activity and to exogenously applied neurotransmitters with calcium elevations, and in contrast to neurons, also exhibited spontaneous rhythmic calcium oscillations. NT2As also generated propagating calcium waves that were gap junction and purinergic signalling dependent. Our results show that NT2 derived astrocytes exhibit appropriate functionality and that NT2N networks interact with NT2A networks in co-culture. These findings underline the utility of such cultures to investigate human brain cell type signalling under controlled conditions. Furthermore, since stem cell derived neuron function and survival is of great importance therapeutically, our findings suggest that the presence of complementary astrocytes may be valuable in supporting stem cell derived neuronal networks. Indeed, this also supports the intriguing possibility of selective therapeutic replacement of astrocytes in diseases where these cells are either lost or lose functionality.	[Hill, Eric J.; Tarczyluk, Marta] Aston Univ, ARCHA, Birmingham B4 7ET, W Midlands, England; [Jimenez-Gonzalez, Cristina; Nagel, David A.; Coleman, Michael D.; Parri, H. Rheinallt] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University; Aston University	Hill, EJ (corresponding author), Aston Univ, ARCHA, Birmingham B4 7ET, W Midlands, England.	Parrihr@aston.ac.uk	Tarczyluk-Wells, Marta/H-9079-2019; Parri, Rheinallt/D-1748-2013; Coleman, Michael Damian/AAD-5503-2019	Tarczyluk-Wells, Marta/0000-0001-6381-8000; Parri, Rheinallt/0000-0002-1412-2688; Coleman, MIchael D/0000-0002-5510-6852; Hill, Eric/0000-0002-9419-1500	Biotechnology and Biological Sciences Research Council [BB/H008527/1]; Wellcome Trust [78068]; Humane Research Trust; Alzheimer's Research Trust [PPG2007B/6, PPG2009B-3]; BBSRC [BB/H008527/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Humane Research Trust; Alzheimer's Research Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Biotechnology and Biological Sciences Research Council (BB/H008527/1)(www.bbsrc.ac.uk), Wellcome Trust (78068)(www.wellcome.ac.uk), Humane Research Trust(www.humaneresearch.org.uk), Alzheimer's Research Trust (PPG2007B/6 and PPG2009B-3)(www.alzheimersresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Braet K, 2001, EUR J NEUROSCI, V13, P79, DOI 10.1046/j.1460-9568.2001.01372.x; Butt AM, 2011, SEMIN CELL DEV BIOL, V22, P205, DOI 10.1016/j.semcdb.2011.02.023; Chapman H, 2007, BRAIN RES, V1129, P15, DOI 10.1016/j.brainres.2006.10.060; Coyle DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016174; Fellin T, 2009, P NATL ACAD SCI USA, V106, P15037, DOI 10.1073/pnas.0906419106; Ferrari A, 2000, FEBS LETT, V486, P121, DOI 10.1016/S0014-5793(00)02251-1; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; de Arriba SG, 2006, NEUROCHEM INT, V49, P466, DOI 10.1016/j.neuint.2006.03.005; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; Gortz P, 2004, BRAIN RES, V1018, P18, DOI 10.1016/j.brainres.2004.05.076; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Guan XJ, 1997, J CELL BIOL, V139, P1785, DOI 10.1083/jcb.139.7.1785; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hara K, 2008, PROG NEUROBIOL, V85, P318, DOI 10.1016/j.pneurobio.2008.04.005; Hartley RS, 1999, J COMP NEUROL, V407, P1, DOI 10.1002/(SICI)1096-9861(19990428)407:1<1::AID-CNE1>3.0.CO;2-Z; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; LEE VMY, 1986, J NEUROSCI, V6, P514; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Neelands TR, 2000, J NEUROPHYSIOL, V84, P2933, DOI 10.1152/jn.2000.84.6.2933; Neelands TR, 1999, J NEUROSCI, V19, P7057, DOI 10.1523/JNEUROSCI.19-16-07057.1999; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Newman MB, 2002, DEV BRAIN RES, V139, P73, DOI 10.1016/S0165-3806(02)00513-8; Parri HR, 2010, EUR J NEUROSCI, V32, P29, DOI 10.1111/j.1460-9568.2010.07281.x; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Podrygajlo G, 2010, NEUROSCI LETT, V468, P207, DOI 10.1016/j.neulet.2009.10.092; Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0; Porter JT, 1996, J NEUROSCI, V16, P5073; Robertson SJ, 1998, J PHYSIOL-LONDON, V508, P691, DOI 10.1111/j.1469-7793.1998.691bp.x; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Sandhu JK, 2002, J NEUROSCI RES, V68, P604, DOI 10.1002/jnr.10236; Scheffler B, 2003, DEVELOPMENT, V130, P5533, DOI 10.1242/dev.00714; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Stewart R, 2003, STEM CELLS, V21, P248, DOI 10.1634/stemcells.21-3-248; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Woehrling EK, 2007, TOXICOL IN VITRO, V21, P1241, DOI 10.1016/j.tiv.2007.04.011; Woehrling EK, 2011, NEUROTOX RES, V19, P472, DOI 10.1007/s12640-010-9202-2; Woehrling EK, 2010, NEUROTOX RES, V17, P103, DOI 10.1007/s12640-009-9084-3; YOUNKIN DP, 1993, P NATL ACAD SCI USA, V90, P2174, DOI 10.1073/pnas.90.6.2174	47	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36098	10.1371/journal.pone.0036098	http://dx.doi.org/10.1371/journal.pone.0036098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567128	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500046
J	McCoy, ES; Taylor-Blake, B; Zylka, MJ				McCoy, Eric S.; Taylor-Blake, Bonnie; Zylka, Mark J.			CGRP alpha-Expressing Sensory Neurons Respond to Stimuli that Evoke Sensations of Pain and Itch	PLOS ONE			English	Article							GENE-RELATED-PEPTIDE; CENTRAL-NERVOUS-SYSTEM; PROSTATIC ACID-PHOSPHATASE; PRIMARY AFFERENT NEURONS; ROOT GANGLION NEURONS; DORSAL-HORN NEURONS; RAT SPINAL-CORD; NOCICEPTIVE NEURONS; BETA-CGRP; DIFFERENTIAL EXPRESSION	Calcitonin gene-related peptide (CGRP alpha, encoded by Calca) is a classic marker of nociceptive dorsal root ganglia (DRG) neurons. Despite years of research, it is unclear what stimuli these neurons detect in vitro or in vivo. To facilitate functional studies of these neurons, we genetically targeted an axonal tracer (farnesylated enhanced green fluorescent protein; GFP) and a LoxP-stopped cell ablation construct (human diphtheria toxin receptor; DTR) to the Calca locus. In culture, 10-50% (depending on ligand) of all CGRP alpha-GFP-positive (+) neurons responded to capsaicin, mustard oil, menthol, acidic pH, ATP, and pruritogens (histamine and chloroquine), suggesting a role for peptidergic neurons in detecting noxious stimuli and itch. In contrast, few (2.2 +/- 1.3%) CGRP alpha-GFP(+) neurons responded to the TRPM8-selective cooling agent icilin. In adult mice, CGRP alpha-GFP(+) cell bodies were located in the DRG, spinal cord (motor neurons and dorsal horn neurons), brain and thyroid-reproducibly marking all cell types known to express Calca. Half of all CGRP alpha-GFP(+) DRG neurons expressed TRPV1, similar to 25% expressed neurofilament-200, <10% contained nonpeptidergic markers (IB4 and Prostatic acid phosphatase) and almost none (<1%) expressed TRPM8. CGRP alpha-GFP(+) neurons innervated the dorsal spinal cord and innervated cutaneous and visceral tissues. This included nerve endings in the epidermis and on guard hairs. Our study provides direct evidence that CGRP alpha(+) DRG neurons respond to agonists that evoke pain and itch and constitute a sensory circuit that is largely distinct from nonpeptidergic circuits and TRPM8(+)/cool temperature circuits. In future studies, it should be possible to conditionally ablate CGRP alpha-expressing neurons to evaluate sensory and non-sensory functions for these neurons.	[McCoy, Eric S.; Taylor-Blake, Bonnie; Zylka, Mark J.] Univ N Carolina, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	McCoy, ES (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.	zylka@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022		Searle Scholars Program; Klingenstein Foundation; Rita Allen Foundation; NINDS [R01NS060725, R01NS067688, P30NS045892]; NICHD; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067688, P30NS045892, R01NS060725] Funding Source: NIH RePORTER	Searle Scholars Program; Klingenstein Foundation(Klingenstein Philanthropies); Rita Allen Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to MJZ from The Searle Scholars Program, The Klingenstein Foundation, The Rita Allen Foundation and NINDS (R01NS060725, R01NS067688). Confocal imaging was performed at the UNC Confocal and Multiphoton Imaging Core. The BAC Core and Imaging Core are funded by grants from NINDS (P30NS045892) and NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Baillie LD, 2011, J NEUROSCI METH, V198, P274, DOI 10.1016/j.jneumeth.2011.04.015; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Benemei Silvia, 2009, Handb Exp Pharmacol, P75, DOI 10.1007/978-3-540-79090-7_3; BIELLA G, 1991, BRAIN RES, V559, P352, DOI 10.1016/0006-8993(91)90024-P; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; Campagnola L, 2008, J NEUROSCI METH, V169, P27, DOI 10.1016/j.jneumeth.2007.11.012; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CONRATH M, 1989, J CHEM NEUROANAT, V2, P335; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; EMESON RB, 1989, NATURE, V341, P76, DOI 10.1038/341076a0; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; HOKFELT T, 1992, ANN NY ACAD SCI, V657, P119; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; ISHIDAYAMAMOTO A, 1989, BRAIN RES, V491, P93, DOI 10.1016/0006-8993(89)90090-5; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; KAWAI Y, 1985, NEUROSCIENCE, V15, P747, DOI 10.1016/0306-4522(85)90076-4; KRESSE A, 1995, BRAIN RES BULL, V36, P261, DOI 10.1016/0361-9230(94)00201-B; KRUGER L, 1988, BRAIN RES, V463, P223, DOI 10.1016/0006-8993(88)90395-2; KRUGER L, 1989, J COMP NEUROL, V280, P291, DOI 10.1002/cne.902800210; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; MCCARTHY PW, 1990, NEUROSCIENCE, V34, P623, DOI 10.1016/0306-4522(90)90169-5; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mishra SK, 2010, MOL CELL NEUROSCI, V43, P157, DOI 10.1016/j.mcn.2009.10.006; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; MULDERRY PK, 1988, NEUROSCIENCE, V25, P195; NAVARRO X, 1995, J NEUROSCI RES, V41, P111, DOI 10.1002/jnr.490410113; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; NOGUCHI K, 1990, MOL BRAIN RES, V7, P299, DOI 10.1016/0169-328X(90)90080-W; OHTANI R, 1989, CELL TISSUE RES, V258, P35; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; ROBINE S, 1985, P NATL ACAD SCI USA, V82, P8488, DOI 10.1073/pnas.82.24.8488; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Salmon AM, 1999, NEUROREPORT, V10, P849, DOI 10.1097/00001756-199903170-00033; Salmon AM, 2001, NAT NEUROSCI, V4, P357, DOI 10.1038/86001; SARIA A, 1986, NEUROSCI LETT, V63, P310, DOI 10.1016/0304-3940(86)90376-9; Schutz B, 2004, J COMP NEUROL, V476, P32, DOI 10.1002/cne.20211; SILVERMAN JD, 1989, J COMP NEUROL, V280, P303, DOI 10.1002/cne.902800211; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Suzuki SC, 2007, J NEUROSCI, V27, P3466, DOI 10.1523/JNEUROSCI.0243-07.2007; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Tan LL, 2008, NEUROSCIENCE, V156, P334, DOI 10.1016/j.neuroscience.2008.06.071; Taylor-Blake B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008674; Tie-Jun SS, 2001, NEUROREPORT, V12, P739, DOI 10.1097/00001756-200103260-00025; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; Wrigley PJ, 2009, BRIT J PHARMACOL, V157, P371, DOI 10.1111/j.1476-5381.2009.00167.x; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zhang LP, 2001, PAIN, V89, P265, DOI 10.1016/S0304-3959(00)00378-X; Zurborg S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-66; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	66	78	79	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36355	10.1371/journal.pone.0036355	http://dx.doi.org/10.1371/journal.pone.0036355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563493	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340700042
J	Lea, WA; Simeonov, A				Lea, Wendy A.; Simeonov, Anton			Differential Scanning Fluorometry Signatures as Indicators of Enzyme Inhibitor Mode of Action: Case Study of Glutathione S-Transferase	PLOS ONE			English	Article							PROMOTE PROTEIN STABILITY; ELECTROPHILE BINDING-SITE; THERMAL SHIFT ASSAYS; PI CLASS GLUTATHIONE; SCHISTOSOMA-JAPONICUM; ETHACRYNIC-ACID; CONFORMATIONAL STABILITY; 3-DIMENSIONAL STRUCTURE; SCREENING METHODS; DRUG DISCOVERY	Differential scanning fluorometry (DSF), also referred to as fluorescence thermal shift, is emerging as a convenient method to evaluate the stabilizing effect of small molecules on proteins of interest. However, its use in the mechanism of action studies has received far less attention. Herein, the ability of DSF to report on inhibitor mode of action was evaluated using glutathione S-transferase (GST) as a model enzyme that utilizes two distinct substrates and is known to be subject to a range of inhibition modes. Detailed investigation of the propensity of small molecule inhibitors to protect GST from thermal denaturation revealed that compounds with different inhibition modes displayed distinct thermal shift signatures when tested in the presence or absence of the enzyme's native co-substrate glutathione (GSH). Glutathione-competitive inhibitors produced dose-dependent thermal shift trendlines that converged at high compound concentrations. Inhibitors acting via the formation of glutathione conjugates induced a very pronounced stabilizing effect toward the protein only when GSH was present. Lastly, compounds known to act as noncompetitive inhibitors exhibited parallel concentration-dependent trends. Similar effects were observed with human GST isozymes A1-1 and M1-1. The results illustrate the potential of DSF as a tool to differentiate diverse classes of inhibitors based on simple analysis of co-substrate dependency of protein stabilization.	[Lea, Wendy A.; Simeonov, Anton] NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI)	Lea, WA (corresponding author), NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20892 USA.	asimeono@mail.nih.gov			Molecular Libraries of Initiative of the NIH Roadmap for Medical Research; Intramural Research Program of the NHGRI, NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	Molecular Libraries of Initiative of the NIH Roadmap for Medical Research; Intramural Research Program of the NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding by the Molecular Libraries of Initiative of the NIH Roadmap for Medical Research, and the Intramural Research Program of the NHGRI, NIH, is hereby gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andujar-Sanchez M, 2005, BIOCHEMISTRY-US, V44, P1174, DOI 10.1021/bi0483110; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; ASKELOF P, 1975, BIOCHEM J, V147, P513, DOI 10.1042/bj1470513; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; AWASTHI S, 1993, BIOCHIM BIOPHYS ACTA, V1164, P173, DOI 10.1016/0167-4838(93)90245-M; Bergsdorf C, 2010, EXPERT OPIN DRUG DIS, V5, P1095, DOI 10.1517/17460441.2010.524641; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Cardoso RMF, 2003, PROTEINS, V51, P137, DOI 10.1002/prot.10345; Carver TE, 2005, J BIOL CHEM, V280, P11704, DOI 10.1074/jbc.M413278200; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Erhardt J, 1996, FEBS LETT, V391, P313, DOI 10.1016/0014-5793(96)00768-5; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Filippakopoulos P, NATURE, V468, P1067; Kaplan W, 1997, PROTEIN SCI, V6, P399; Khan MA, 2010, CHINESE J CANCER RES, V22, P87, DOI 10.1007/s11670-010-0087-7; Kursula I, 2005, PROTEIN PEPTIDE LETT, V12, P709, DOI 10.2174/0929866054696154; Laborde E, CELL DEATH DIFFER, V17, P1373; Le Trong I, 2002, PROTEINS, V48, P618, DOI 10.1002/prot.10162; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lyon RP, 2003, BIOCHEMISTRY-US, V42, P10418, DOI 10.1021/bi0346188; Mahajan S, 2005, CELL MOL LIFE SCI, V62, P1221, DOI 10.1007/s00018-005-4524-6; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Mathew N, 2006, EXPERT OPIN THER PAT, V16, P431, DOI 10.1517/13543776.16.4.431; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Merlos M, 1990, EXPERIENTIA, V47, P616; MEYER DJ, 1993, XENOBIOTICA, V23, P823, DOI 10.3109/00498259309059411; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Niesen FH, PLOS ONE, V5; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nieslanik BS, 2000, J BIOL CHEM, V275, P17447, DOI 10.1074/jbc.M002083200; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; Oakley AJ, 1997, BIOCHEMISTRY-US, V36, P576, DOI 10.1021/bi962316i; Ortiz-Salmeron E, 2001, BBA-PROTEIN STRUCT M, V1548, P106, DOI 10.1016/S0167-4838(01)00224-2; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Poklar N, 1997, BIOCHEMISTRY-US, V36, P14345, DOI 10.1021/bi971719v; Quesada-Soriano I, 2006, BBA-PROTEINS PROTEOM, V1764, P979, DOI 10.1016/j.bbapap.2006.03.002; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; Ricci G, 2005, J BIOL CHEM, V280, P26397, DOI 10.1074/jbc.M503295200; Rufer AC, 2005, ACTA CRYSTALLOGR F, V61, P263, DOI 10.1107/S1744309105004823; Todd Matthew J, 2005, Drug Discov Today Technol, V2, P267, DOI 10.1016/j.ddtec.2005.08.015; van Zanden JJ, 2003, CHEM-BIOL INTERACT, V145, P139, DOI 10.1016/S0009-2797(02)00250-8; VANBLADEREN PJ, 1991, PHARMACOL THERAPEUT, V51, P35, DOI 10.1016/0163-7258(91)90040-S; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Xu XC, 1997, INFECT IMMUN, V65, P3867, DOI 10.1128/IAI.65.9.3867-3874.1997; Yasgar A, 2010, ASSAY DRUG DEV TECHN, V8, P200, DOI 10.1089/adt.2009.0248; Yassin Z, 2004, BBA-PROTEINS PROTEOM, V1698, P227, DOI 10.1016/j.bbapap.2003.12.004; Zubriene A, 2009, INT J MOL SCI, V10, P2662, DOI 10.3390/ijms10062662	52	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36219	10.1371/journal.pone.0036219	http://dx.doi.org/10.1371/journal.pone.0036219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558390	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200051
J	Chootong, P; Panichakul, T; Permmongkol, C; Barnes, SJ; Udomsangpetch, R; Adams, JH				Chootong, Patchanee; Panichakul, Tasanee; Permmongkol, Chongrak; Barnes, Samantha J.; Udomsangpetch, Rachanee; Adams, John H.			Characterization of Inhibitory Anti-Duffy Binding Protein II Immunity: Approach to Plasmodium vivax Vaccine Development in Thailand	PLOS ONE			English	Article							MALARIA; RESPONSES; RECEPTOR; IDENTIFICATION; FALCIPARUM; KNOWLESI; FAMILY; AREA	Plasmodium vivax Duffy binding protein region II (DBPII) is an important vaccine candidate for antibody-mediated immunity against vivax malaria. A significant challenge for vaccine development of DBPII is its highly polymorphic nature that alters sensitivity to neutralizing antibody responses. Here, we aim to characterize naturally-acquired neutralizing antibodies against DBPII in individual Thai residents to give insight into P. vivax vaccine development in Thailand. Anti-DBPII IgG significantly increased in acute vivax infections compared to uninfected residents and naive controls. Antibody titers and functional anti-DBPII inhibition varied widely and there was no association between titer and inhibition activity. Most high titer plasmas had only a moderate to no functional inhibitory effect on DBP binding to erythrocytes, indicating the protective immunity against DBPII binding is strain specific. Only 5 of 54 samples were highly inhibitory against DBP erythrocyte-binding function. Previously identified target epitopes of inhibitory anti-DBPPII IgG (H1, H2 and H3) were localized to the dimer interface that forms the DARC binding pocket. Amino acid polymorphisms (monomorphic or dimorphic) in H1 and H3 protective epitopes change sensitivity of immune inhibition by alteration of neutralizing antibody recognition. The present study indicates Thai variant H1.T1 (R308S), H3.T1 (D384G) and H3.T3 (K386N) are the most important variants for a DBPII candidate vaccine needed to protect P. vivax in Thai residents.	[Chootong, Patchanee; Permmongkol, Chongrak] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok 10700, Thailand; [Panichakul, Tasanee] Suan Dusit Rajabhat Univ, Dept Sci & Technol, Bangkok, Thailand; [Barnes, Samantha J.; Adams, John H.] Univ S Florida, Dept Global Hlth Infect Dis Res Program, Tampa, FL USA; [Udomsangpetch, Rachanee] Mahidol Univ, Fac Sci, Dept Pathobiol, Bangkok 10400, Thailand	Mahidol University; Suan Dusit University; State University System of Florida; University of South Florida; Mahidol University	Chootong, P (corresponding author), Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok 10700, Thailand.	pchooton@gmail.com	Adams, John/G-1800-2015; Adams, John H./ABB-8458-2020	Adams, John/0000-0003-3707-7979; Adams, John H./0000-0003-3707-7979	National Institutes of Health [R01AI064478]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health R01AI064478 (to J.H.A.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADAMS JH, 1992, MOL BIOCHEM PARASIT, V56, P181, DOI 10.1016/0166-6851(92)90166-H; ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; BARNWELL JW, 1995, ANN TROP MED PARASIT, V89, P113, DOI 10.1080/00034983.1995.11812941; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Ceravolo IP, 2008, SCAND J IMMUNOL, V67, P270, DOI 10.1111/j.1365-3083.2007.02059.x; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; de Sousa TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022944; Fraser T, 1997, INFECT IMMUN, V65, P2772, DOI 10.1128/IAI.65.7.2772-2777.1997; Gosi P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-112; Grimberg BT, 2007, PLOS MED, V4, P1940, DOI 10.1371/journal.pmed.0040337; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; HO M, 1986, J INFECT DIS, V153, P763, DOI 10.1093/infdis/153.4.763; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Jia XL, 2002, J IMMUNOL, V169, P3200, DOI 10.4049/jimmunol.169.6.3200; Kho Weon-Gyu, 2001, Korean Journal of Parasitology, V39, P143, DOI 10.3347/kjp.2001.39.2.143; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; McHenry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020192; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon PA, 1998, AM J TROP MED HYG, V59, P597, DOI 10.4269/ajtmh.1998.59.597; Ohas EA, 2004, INFECT IMMUN, V72, P735, DOI 10.1128/IAI.72.2.735-741.2004; RILEY EM, 1989, INFECT IMMUN, V57, P3181, DOI 10.1128/IAI.57.10.3181-3188.1989; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; TSUBOI T, 1994, INFECT IMMUN, V62, P5581, DOI 10.1128/IAI.62.12.5581-5586.1994; WHO, 2003, WORLD HLTH REP; WHO, 2001, WHOCDCRBM200133	30	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35769	10.1371/journal.pone.0035769	http://dx.doi.org/10.1371/journal.pone.0035769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558221	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000059
J	Kinoshita, Y; Kalir, T; Dottino, P; Kohtz, DS				Kinoshita, Yayoi; Kalir, Tamara; Dottino, Peter; Kohtz, D. Stave			Nuclear Distributions of NUP62 and NUP214 Suggest Architectural Diversity and Spatial Patterning among Nuclear Pore Complexes	PLOS ONE			English	Article							MESSENGER-RNA EXPORT; NUCLEOPORIN DOMAIN TOPOLOGY; FUNCTIONAL-CHARACTERIZATION; P62 COMPLEX; PROTEIN; PHOSPHORYLATION; LOCALIZES; TRANSPORT; INTERACTS; CHROMATIN	The shape of nuclei in many adherent cultured cells approximates an oblate ellipsoid, with contralateral flattened surfaces facing the culture plate or the medium. Observations of cultured cell nuclei from orthogonal perspectives revealed that nucleoporin p62 (NUP62) and nucleoporin 214 (NUP214) are differentially distributed between nuclear pore complexes on the flattened surfaces and peripheral rim of the nucleus. High resolution stimulated emission depletion (STED) immunofluorescence microscopy resolved individual NPCs, and suggested both heterogeneity and microheterogeneity in NUP62 and NUP214 immunolabeling among in NPC populations. Similar to nuclear domains and interphase chromosome territories, architectural diversity and spatial patterning of NPCs may be an intrinsic property of the nucleus that is linked to the functions and organization of underlying chromatin.	[Kinoshita, Yayoi; Kalir, Tamara; Kohtz, D. Stave] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [Kohtz, D. Stave] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kinoshita, Y (corresponding author), Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA.	stave.kohtz@mssm.edu			Ruttenberg family; National Institutes of Health/National Cancer Institute (NIH/NCI) [1R03CA141318, 5R24 CA095823-04]; NSF [DBI-9724504]; NIH [1 S10 RR0 9145-01]; NATIONAL CANCER INSTITUTE [R03CA141318, R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER	Ruttenberg family; National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by a generous grant from the Ruttenberg family, and by National Institutes of Health/National Cancer Institute (NIH/NCI) grant number 1R03CA141318 (to DSK). Widefield, confocal laser scanning, and STED microscopy were performed at the MSSM-Microscopy Shared Resource Facility, which is supported by NIH/NCI shared resources grant 5R24 CA095823-04, NSF Major Research Instrumentation grant DBI-9724504, and NIH shared instrumentation grant 1 S10 RR0 9145-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2007, TRENDS GENET, V23, P396, DOI 10.1016/j.tig.2007.05.009; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; BIEDLER JL, 1978, CANCER RES, V38, P3751; Braun IC, 2002, MOL CELL BIOL, V22, P5405, DOI 10.1128/MCB.22.15.5405-5418.2002; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Cole CN, 2006, CURR OPIN CELL BIOL, V18, P299, DOI 10.1016/j.ceb.2006.04.006; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Kalverda B, 2007, DEV CELL, V13, P164, DOI 10.1016/j.devcel.2007.07.008; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Kinoshita Y, 2012, AM J PATHOL, V180, P375, DOI 10.1016/j.ajpath.2011.09.024; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Lyman SK, 2001, J CELL BIOL, V154, P17, DOI 10.1083/jcb.200106071; Maeshima K, 2006, J CELL SCI, V119, P4442, DOI 10.1242/jcs.03207; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; Onischenko EA, 2004, TRAFFIC, V5, P152, DOI 10.1111/j.1600-0854.2004.0166.x; Pante N, 1996, CRIT REV BIOCHEM MOL, V31, P153, DOI 10.3109/10409239609106583; PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603; Paulillo SM, 2006, J MOL BIOL, V363, P39, DOI 10.1016/j.jmb.2006.08.021; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; Porter FW, 2010, J VIROL, V84, P12538, DOI 10.1128/JVI.01484-09; Porter FW, 2009, J VIROL, V83, P1941, DOI 10.1128/JVI.01752-08; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Stavru F, 2006, J CELL BIOL, V173, P477, DOI 10.1083/jcb.200601002; Steggerda SM, 2002, INT REV CYTOL, V217, P41; Stochaj U, 2006, EXP CELL RES, V312, P2490, DOI 10.1016/j.yexcr.2006.04.007; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Xylourgidis N, 2006, J CELL SCI, V119, P4409, DOI 10.1242/jcs.03201; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003	64	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36137	10.1371/journal.pone.0036137	http://dx.doi.org/10.1371/journal.pone.0036137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558357	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000135
J	Li, Y; Qin, W; Jiang, TZ; Zhang, YT; Yu, CS				Li, Ying; Qin, Wen; Jiang, Tianzi; Zhang, Yunting; Yu, Chunshui			Sex-Dependent Correlations between the Personality Dimension of Harm Avoidance and the Resting-State Functional Connectivity of Amygdala Subregions	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL GLUCOSE-METABOLISM; MAJOR DEPRESSION; SOCIAL COGNITION; CYTOARCHITECTONIC MAPS; INDIVIDUAL-DIFFERENCES; HIPPOCAMPAL VOLUME; ANTERIOR CINGULATE; GENDER-DIFFERENCES	Harm avoidance (HA) is a personality dimension involving the tendency to respond intensely to signals of aversive stimuli. Many previous neuroimaging studies have associated HA scores with the structural and functional organization of the amygdala, but none of these studies have evaluated the correlation between HA score and amygdala resting-state functional connectivity (rsFC). Moreover, the amygdala is not a homogeneous structure, and it has been divided into several structurally and functionally distinct subregions. Investigating the associations between HA score and properties of subregions of the amygdala could greatly improve our understanding of HA. In the present study, using a large sample of 291 healthy young adults, we aimed to uncover correlations between HA scores and the rsFCs of each amygdala subregion and to uncover possible sex-based differences in these correlations. We found that subregions of the amygdala showed different rsFC patterns, which contributed differently to individual HA scores. More specifically, HA scores were correlated with rsFCs between the laterobasal amygdala subregion and temporal and occipital cortices related to emotional information input, between the centromedial subregion and the frontal cortices associated with emotional output control, and between the superficial subregion and the frontal and temporal areas involved in both functions. Moreover, significant gender-based differences were uncovered in these correlations. Our findings provide a more detailed model of association between HA scores and amygdala rsFC, extend our understanding of the connectivity of subregions of the amygdala, and confirm sex-based differences in HA associations.	[Li, Ying; Qin, Wen; Zhang, Yunting; Yu, Chunshui] Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, LIAMA Ctr Computat Med, Beijing, Peoples R China	Tianjin Medical University; Chinese Academy of Sciences; Institute of Automation, CAS	Li, Y (corresponding author), Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	cjr.zhangyunting@vip.163.com; chunshuiyu@yahoo.cn	QIN, WEN/F-3783-2015; Jiang, Tianzi/I-4256-2012	QIN, WEN/0000-0002-9121-8296; Jiang, Tianzi/0000-0001-9531-291X; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of Tianjin [11JCZDJC19300]; Natural Science Foundation of China [30870694, 30730036]; National Basic Research Program of China (973 program) [2010CB732506]	Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by Natural Science Foundation of Tianjin (No. 11JCZDJC19300), Natural Science Foundation of China (Nos. 30870694 and 30730036) and National Basic Research Program of China (973 program, No. 2010CB732506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Baeken C, 2010, NEUROSCI LETT, V478, P97, DOI 10.1016/j.neulet.2010.04.073; Ball T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000307; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Beck AT., 1993, BDI BECK DEPRESSION; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Bowley MP, 2002, BIOL PSYCHIAT, V52, P404, DOI 10.1016/S0006-3223(02)01404-X; BOYCE P, 1991, BRIT J PSYCHIAT, V159, P106, DOI 10.1192/bjp.159.1.106; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; BROWN SL, 1992, J PSYCHIAT RES, V26, P197, DOI 10.1016/0022-3956(92)90023-H; Buckholtz JW, 2008, MOL PSYCHIATR, V13, P313, DOI 10.1038/sj.mp.4002020; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Celikel FC, 2009, COMPR PSYCHIAT, V50, P556, DOI 10.1016/j.comppsych.2008.11.012; Chen WJ, 2002, COMPR PSYCHIAT, V43, P158, DOI 10.1053/comp.2002.30797; Chouinard PA, 2010, NEUROPSYCHOLOGIA, V48, P409, DOI 10.1016/j.neuropsychologia.2009.09.032; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; Davey CG, 2011, BIOL PSYCHIAT, V69, P734, DOI 10.1016/j.biopsych.2010.12.004; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Fischer H, 2004, NEUROREPORT, V15, P235, DOI 10.1097/00001756-200402090-00004; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Goossens L, 2009, HUM BRAIN MAPP, V30, P3332, DOI 10.1002/hbm.20755; Gundel H, 2004, PSYCHOSOM MED, V66, P132, DOI 10.1097/01.PSY.0000097348.45087.96; GUR RC, 1995, SCIENCE, V267, P528, DOI 10.1126/science.7824953; Habel U, 2005, NEUROIMAGE, V26, P206, DOI 10.1016/j.neuroimage.2005.01.014; Hakamata Y, 2006, NEUROSCI LETT, V396, P33, DOI 10.1016/j.neulet.2005.11.017; Hakamata Y, 2009, PSYCHIAT RES-NEUROIM, V173, P206, DOI 10.1016/j.pscychresns.2008.10.002; Hamann S, 2005, NEUROSCIENTIST, V11, P288, DOI 10.1177/1073858404271981; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Heim S, 2009, HUM BRAIN MAPP, V30, P392, DOI 10.1002/hbm.20512; Hurlemann R, 2008, J NEUROSCI METH, V172, P13, DOI 10.1016/j.jneumeth.2008.04.004; Iidaka T, 2006, BRAIN RES, V1125, P85, DOI 10.1016/j.brainres.2006.09.015; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Jylha P, 2006, EUR PSYCHIAT, V21, P389, DOI 10.1016/j.eurpsy.2005.09.003; Kilpatrick LA, 2006, NEUROIMAGE, V30, P452, DOI 10.1016/j.neuroimage.2005.09.065; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kuo PH, 2004, COMPR PSYCHIAT, V45, P20, DOI 10.1016/j.comppsych.2003.09.011; Lange C, 2004, PSYCHOL MED, V34, P1059, DOI 10.1017/S0033291703001806; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Lochner C, 2007, EUR NEUROPSYCHOPHARM, V17, P321, DOI 10.1016/j.euroneuro.2006.06.010; Matthews SC, 2004, NEUROREPORT, V15, P2123, DOI 10.1097/00001756-200409150-00025; McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97; Miettunen J, 2004, ACTA PSYCHIAT SCAND, V110, P150, DOI 10.1111/j.1600-0047.2004.00344.x; Moreno N, 2007, J ANAT, V211, P151, DOI 10.1111/j.1469-7580.2007.00780.x; Most SB, 2006, NEUROIMAGE, V31, P934, DOI 10.1016/j.neuroimage.2005.12.031; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Nyman E, 2011, J AFFECT DISORDERS, V131, P393, DOI 10.1016/j.jad.2010.12.008; O'Gorman RL, 2006, NEUROIMAGE, V31, P489, DOI 10.1016/j.neuroimage.2005.12.048; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Scheff SW, 2011, J ALZHEIMERS DIS, V24, P547, DOI 10.3233/JAD-2011-101782; Schienle A, 2005, NEUROREPORT, V16, P277, DOI 10.1097/00001756-200502280-00015; Schneider S, 2011, NEUROIMAGE, V56, P1847, DOI 10.1016/j.neuroimage.2011.02.019; Schnell K, 2011, NEUROIMAGE, V54, P1743, DOI 10.1016/j.neuroimage.2010.08.024; Sheline YI, 1998, NEUROREPORT, V9, P2023, DOI 10.1097/00001756-199806220-00021; Starcevic V, 1996, J AFFECT DISORDERS, V37, P75, DOI 10.1016/0165-0327(95)00058-5; STEPHAN H, 1977, ACTA ANAT, V98, P130; Sugiura M, 2000, NEUROIMAGE, V11, P541, DOI 10.1006/nimg.2000.0564; Surguladze SA, 2010, J PSYCHIATR RES, V44, P894, DOI 10.1016/j.jpsychires.2010.02.010; Svrakic DM, 2002, ACTA PSYCHIAT SCAND, V106, P189, DOI 10.1034/j.1600-0447.2002.02196.x; Van Heeringen K, 2010, PSYCHIAT RES-NEUROIM, V181, P141, DOI 10.1016/j.pscychresns.2009.07.011; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Van Schuerbeek P, 2011, BRAIN RES, V1371, P32, DOI 10.1016/j.brainres.2010.11.073; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wrase J, 2003, NEUROSCI LETT, V348, P41, DOI 10.1016/S0304-3940(03)00565-2; Yamasue H, 2008, CEREB CORTEX, V18, P46, DOI 10.1093/cercor/bhm030; Zuckerman M, 1996, PERSONALITY INDIVIDU	92	41	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35925	10.1371/journal.pone.0035925	http://dx.doi.org/10.1371/journal.pone.0035925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558274	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000087
J	Macho, AP; Zumaquero, A; Gonzalez-Plaza, JJ; Ortiz-Martin, I; Rufian, JS; Beuzon, CR				Macho, Alberto P.; Zumaquero, Adela; Gonzalez-Plaza, Juan J.; Ortiz-Martin, Inmaculada; Rufian, Jose S.; Beuzon, Carmen R.			Genetic Analysis of the Individual Contribution to Virulence of the Type III Effector Inventory of Pseudomonas syringae pv. phaseolicola	PLOS ONE			English	Article							SECRETION SYSTEM CONTRIBUTE; ALTERNATE SIGMA-FACTOR; E3 UBIQUITIN LIGASE; PLANT IMMUNITY; PATHOGENICITY ISLAND; INNATE IMMUNITY; TOMATO DC3000; COMPETITIVE INDEX; DISEASE RESISTANCE; BACTERIAL DISEASE	Several reports have recently contributed to determine the effector inventory of the sequenced strain Pseudomonas syringae pv. phaseolicola (Pph) 1448a. However, the contribution to virulence of most of these effectors remains to be established. Genetic analysis of the contribution to virulence of individual P. syringae effectors has been traditionally hindered by the lack of phenotypes of the corresponding knockout mutants, largely attributed to a high degree of functional redundancy within their effector inventories. In support of this notion, effectors from Pseudomonas syringae pv. tomato (Pto) DC3000 have been classified into redundant effector groups (REGs), analysing virulence of polymutants in the model plant Nicotiana benthamiana. However, using competitive index (CI) as a virulence assay, we were able to establish the individual contribution of AvrPto1(PtoDC3000) to Pto DC3000 virulence in tomato, its natural host, even though typically, contribution to virulence of AvrPto1 is only shown in strains also lacking AvrPtoB (also called HopAB2), a member of its REG. This report raised the possibility that even effectors targeting the same defence signalling pathway may have an individual contribution to virulence, and pointed out to CI assays as the means to establish such a contribution for individual effectors. In this work, we have analysed the individual contribution to virulence of the majority of previously uncharacterised Pph 1448a effectors, by monitoring the development of disease symptoms and determining the CI of single knockout mutants at different stages of growth within bean, its natural host. Despite their potential functional redundancy, we have found individual contributions to virulence for six out of the fifteen effectors analysed. In addition, we have analysed the functional relationships between effectors displaying individual contribution to virulence, highlighting the diversity that these relationships may present, and the interest of analysing their functions within the context of the infection.	[Macho, Alberto P.; Zumaquero, Adela; Gonzalez-Plaza, Juan J.; Ortiz-Martin, Inmaculada; Rufian, Jose S.; Beuzon, Carmen R.] Univ Malaga Consejo Super Invest Cient IHSM UMA C, Inst Hortofruticultura Subtrop & Mediterranea, Dept Biol Celular Genet & Fisiol, Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Macho, AP (corresponding author), Sainsbury Lab, Norwich, Norfolk, England.	cbl@uma.es	Macho, Alberto/L-1393-2014; Plaza, Juan José González/C-7470-2015; Plaza, José Sebastián Rufián/AAR-2553-2021; Beuzon, Carmen/G-7302-2011	Plaza, Juan José González/0000-0001-9586-6197; Plaza, José Sebastián Rufián/0000-0002-3871-3706; Beuzon, Carmen/0000-0002-6888-3845; Macho, Alberto P/0000-0001-9935-8026	Ministerio de Ciencia e Innovacion, Gobiemo de Espana [BIO2009-11516]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia [P06-CVI-02088]; FEDER	Ministerio de Ciencia e Innovacion, Gobiemo de Espana; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia(Junta de Andalucia); FEDER(European Commission)	This work has been funded by Ministerio de Ciencia e Innovacion, Gobiemo de Espana (URL: http://www.micinn.es/)(Grant No:BIO2009-11516), and Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia (URL:http://www.juntadeandalucia.es/organismos/economiainnovacionyciencia.html)(Grant No: P06-CVI-02088) and co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; ASHFIELD T, 1995, GENETICS, V141, P1597; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Beuzon CR, 2001, INFECT IMMUN, V69, P7254, DOI 10.1128/IAI.69.12.7254-7261.2001; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Cunnac S, 2011, P NATL ACAD SCI USA, V108, P2975, DOI 10.1073/pnas.1013031108; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Eitas TK, 2008, P NATL ACAD SCI USA, V105, P6475, DOI 10.1073/pnas.0802157105; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; FRETER R, 1981, INFECT IMMUN, V34, P241, DOI 10.1128/IAI.34.1.241-249.1981; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Jackson RW, 2002, MOL PLANT PATHOL, V3, P205, DOI 10.1046/j.1364-3703.2002.00121.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Jelenska J, 2010, P NATL ACAD SCI USA, V107, P13177, DOI 10.1073/pnas.0910943107; Keith LW, 1997, MOL PLANT MICROBE IN, V10, P416, DOI 10.1094/MPMI.1997.10.3.416; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Lim MTS, 2005, MOL PLANT MICROBE IN, V18, P626, DOI 10.1094/MPMI-18-0626; Lindeberg M, 2005, MOL PLANT MICROBE IN, V18, P275, DOI 10.1094/MPMI-18-0275; Losada L, 2004, MOL PLANT MICROBE IN, V17, P254, DOI 10.1094/MPMI.2004.17.3.254; Macho AP, 2007, MOL PLANT PATHOL, V8, P437, DOI 10.1111/J.1364-3703.2007.00404.X; Macho AP, 2010, PLANT SIGNAL BEHAV, V5, P1590, DOI 10.4161/psb.5.12.13843; Macho AP, 2010, MOL PLANT MICROBE IN, V23, P1197, DOI 10.1094/MPMI-23-9-1197; Macho AP, 2010, NEW PHYTOL, V187, P1018, DOI 10.1111/j.1469-8137.2010.03381.x; Macho AP, 2009, MOL PLANT PATHOL, V10, P69, DOI 10.1111/j.1364-3703.2008.00511.x; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Oh HS, 2007, J BACTERIOL, V189, P8277, DOI 10.1128/JB.00998-07; Ortiz-Martin I, 2006, J MICROBIOL METH, V67, P395, DOI 10.1016/j.mimet.2006.04.011; Ortiz-Martin I, 2010, MOL PLANT MICROBE IN, V23, P682, DOI 10.1094/MPMI-23-5-0682; Ortiz-Martin I, 2010, MOL PLANT MICROBE IN, V23, P665, DOI 10.1094/MPMI-23-5-0665; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shang YL, 2006, P NATL ACAD SCI USA, V103, P19200, DOI 10.1073/pnas.0607279103; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Teverson DM, 1991, THESIS U BIRMINGHAM; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; XIAO YX, 1994, J BACTERIOL, V176, P3089, DOI 10.1128/JB.176.10.3089-3091.1994; XIAO YX, 1994, J BACTERIOL, V176, P1025, DOI 10.1128/JB.176.4.1025-1036.1994; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zumaquero A, 2010, J BACTERIOL, V192, P4474, DOI 10.1128/JB.00260-10	60	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35871	10.1371/journal.pone.0035871	http://dx.doi.org/10.1371/journal.pone.0035871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558247	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000069
J	Su, JM; Wang, YS; Li, RZ; Peng, H; Hua, S; Li, Q; Quan, FS; Guo, ZK; Zhang, Y				Su, Jianmin; Wang, Yongsheng; Li, Ruizhe; Peng, Hui; Hua, Song; Li, Qian; Quan, Fusheng; Guo, Zekun; Zhang, Yong			Oocytes Selected Using BCB Staining Enhance Nuclear Reprogramming and the In Vivo Development of SCNT Embryos in Cattle	PLOS ONE			English	Article							BRILLIANT CRESYL BLUE; BLASTOCYST DEVELOPMENT RATE; HISTONE DEACETYLASE; DNA METHYLATION; GENE-EXPRESSION; CLONING EFFICIENCY; VITRO DEVELOPMENT; IMPRINTED GENES; BOVINE OOCYTES; FOLLICLE SIZE	The selection of good quality oocytes is crucial for in vitro fertilization and somatic cloning. Brilliant cresyl blue (BCB) staining has been used for selection of oocytes from several mammalian species. However, the effects of differential oocyte selection by BCB staining on nuclear reprogramming and in vivo development of SCNT embryos are not well understood. Immature compact cumulus-oocyte complexes (COCs) were divided into control (not exposed to BCB), BCB+ (blue cytoplasm) and BCB- (colorless cytoplasm) groups. We found that BCB+ oocytes yielded a significantly higher somatic cell nuclear transfer (SCNT) blastocyst rate and full term development rate of bovine SCNT embryos than the BCB- and control oocytes. BCB+ embryos (embryos developed from BCB+ oocytes) showed increased acetylation levels of histone H3 at K9 and K18 (AcH3K9, AcH3K18), and methylation levels of histone H3 at K4 (H3K4me2) than BCB- embryos (embryos developed from BCB- oocytes) at the two-cell stage. Furthermore, BCB+ embryos generated more total cells, trophectoderm (TE) cells, and inner cell mass (ICM) cells, and fewer apoptotic cells than BCB- embryos. The expression of SOX2, CDX2, and anti-apoptotic microRNA-21 were up-regulated in the BCB+ blastocysts compared with BCB- blastocysts, whereas the expression of pro-apoptotic gene Bax was down-regulated in BCB+ blastocysts. These results strongly suggest that BCB+ oocytes have a higher nuclear reprogramming capacity, and that BCB staining can be used to select developmentally competent oocytes for nuclear transfer.	[Su, Jianmin; Wang, Yongsheng; Li, Ruizhe; Peng, Hui; Hua, Song; Li, Qian; Quan, Fusheng; Zhang, Yong] NW A&F Univ, Coll Vet Med, Key Lab Anim Reprod Physiol & Embryo Technol, Minist Agr, Yangling, Shaanxi, Peoples R China; [Guo, Zekun] NW A&F Univ, Dept Biochem & Mol Biol, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Zhang, Y (corresponding author), NW A&F Univ, Coll Vet Med, Key Lab Anim Reprod Physiol & Embryo Technol, Minist Agr, Yangling, Shaanxi, Peoples R China.	zhangylab@gmail.com	Zhang, Yong/K-7945-2016	Zhang, Yong/0000-0001-8642-4071; Su, Jianmin/0000-0001-7353-1265	National Key Project for Production of Transgenic Livestock, People's Republic of China [2008ZX08007-004]	National Key Project for Production of Transgenic Livestock, People's Republic of China	This work was supported by the National Key Project for Production of Transgenic Livestock, People's Republic of China (No. 2008ZX08007-004) [http://www.nmp.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Katanani YM, 2002, J DAIRY SCI, V85, P390, DOI 10.3168/jds.S0022-0302(02)74086-1; Alm H, 2005, THERIOGENOLOGY, V63, P2194, DOI 10.1016/j.theriogenology.2004.09.050; Bhojwani S, 2007, THERIOGENOLOGY, V67, P341, DOI 10.1016/j.theriogenology.2006.08.006; Blondin P, 2002, BIOL REPROD, V66, P38, DOI 10.1095/biolreprod66.1.38; Bui HT, 2010, BIOL REPROD, V83, P454, DOI 10.1095/biolreprod.109.083337; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cui XS, 2011, CELL REPROGRAM, V13, P179, DOI 10.1089/cell.2010.0060; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; Dai XP, 2010, J BIOL CHEM, V285, P31002, DOI 10.1074/jbc.M110.136085; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Ding X, 2008, THERIOGENOLOGY, V70, P622, DOI 10.1016/j.theriogenology.2008.04.042; Esteves TC, 2011, AGING CELL, V10, P80, DOI 10.1111/j.1474-9726.2010.00644.x; Fouladi-Nashta AA, 2007, BIOL REPROD, V77, P9, DOI 10.1095/biolreprod.106.058578; Catala MG, 2011, REPRODUCTION, V142, P517, DOI 10.1530/REP-10-0528; Grunder E, 2011, EUR J CANCER, V47, P2479, DOI 10.1016/j.ejca.2011.06.041; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Iager AE, 2008, CLONING STEM CELLS, V10, P371, DOI 10.1089/clo.2007.0002; Jeon K, 2008, ANIM REPROD SCI, V108, P319, DOI 10.1016/j.anireprosci.2007.09.003; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONERGAN P, 1994, MOL REPROD DEV, V37, P48, DOI 10.1002/mrd.1080370107; Machatkova M, 2004, THERIOGENOLOGY, V61, P329, DOI 10.1016/S0093-691X(03)00216-4; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Park SY, 2007, MOL REPROD DEV, V74, P582, DOI 10.1002/mrd.20641; Pujol M, 2004, THERIOGENOLOGY, V61, P735, DOI 10.1016/S0093-691X(03)00250-4; Rizos D, 2005, THERIOGENOLOGY, V63, P939, DOI 10.1016/j.theriogenology.2004.05.008; Roca J, 1998, REPROD FERT DEVELOP, V10, P479, DOI 10.1071/RD98060; Rodrigues BA, 2009, REPROD DOMEST ANIM, V44, P255, DOI 10.1111/j.1439-0531.2009.01408.x; Rodriguez-Gonzalez E, 2003, REPROD NUTR DEV, V43, P179, DOI 10.1051/rnd:2003012; Rodriguez-Gonzalez E, 2002, THERIOGENOLOGY, V57, P1397, DOI 10.1016/S0093-691X(02)00645-3; Sartori R, 2002, J DAIRY SCI, V85, P2803, DOI 10.3168/jds.S0022-0302(02)74367-1; Shao GB, 2008, J REPROD DEVELOP, V54, P233, DOI 10.1262/jrd.19173; Shao GB, 2008, IN VITRO CELL DEV-AN, V44, P115, DOI 10.1007/s11626-008-9082-4; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; STOCK AE, 1993, ENDOCRINOLOGY, V132, P1108, DOI 10.1210/en.132.3.1108; Su JM, 2011, THERIOGENOLOGY, V75, P1346, DOI 10.1016/j.theriogenology.2010.11.045; Su JM, 2011, LIVEST SCI, V141, P24, DOI 10.1016/j.livsci.2011.04.012; Su JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023805; Torner H, 2008, REPRODUCTION, V135, P197, DOI 10.1530/REP-07-0348; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; VanSoom A, 1996, MOL REPROD DEV, V45, P171, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;171::AID-MRD10&gt;3.0.CO;2-4; Vassena R, 2003, THERIOGENOLOGY, V60, P923, DOI 10.1016/S0093-691X(03)00101-8; Wang YS, 2011, REPROD DOMEST ANIM, V46, P404, DOI 10.1111/j.1439-0531.2010.01679.x; Wang YS, 2011, ANIM REPROD SCI, V124, P48, DOI 10.1016/j.anireprosci.2011.01.015; Wang YS, 2011, CELL REPROGRAM, V13, P297, DOI 10.1089/cell.2010.0098; Warzych E, 2007, ANIM REPROD SCI, V97, P334, DOI 10.1016/j.anireprosci.2006.01.011; Wee G, 2007, REPRODUCTION, V134, P781, DOI 10.1530/REP-07-0338; Wu YG, 2007, CELL RES, V17, P722, DOI 10.1038/cr.2007.66; Yamanaka K, 2009, J REPROD DEVELOP, V55, P638, DOI 10.1262/jrd.20245; Yang CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014242; Yu Y, 2007, REPRODUCTION, V133, P947, DOI 10.1530/REP-06-0358	57	57	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36181	10.1371/journal.pone.0036181	http://dx.doi.org/10.1371/journal.pone.0036181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558373	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000147
J	Chhatwal, P; Bankwitz, D; Gentzsch, J; Frentzen, A; Schult, P; Lohmann, V; Pietschmann, T				Chhatwal, Patrick; Bankwitz, Dorothea; Gentzsch, Juliane; Frentzen, Anne; Schult, Philipp; Lohmann, Volker; Pietschmann, Thomas			Bile Acids Specifically Increase Hepatitis C Virus RNA-Replication	PLOS ONE			English	Article							INFECTION; SYSTEM; CELLS; IDENTIFICATION; SECRETION; FXR	Background: Hepatitis C virus (HCV) patients with high serum levels of bile acids (BAs) respond poorly to IFN therapy. BAs have been shown to increase RNA-replication of genotype 1 but not genotype 2a replicons. Since BAs modulate lipid metabolism including lipoprotein secretion and as HCV depends on lipids and lipoproteins during RNA-replication, virus production and cell entry, BAs may affect multiple steps of the HCV life cycle. Therefore, we analyzed the influence of BAs on individual steps of virus replication. Methods: We measured replication of subgenomic genotype (GT) 1b and 2a RNAs as well as full-length GT2a genomes in the presence of BAs using quantitative RT-PCR and luciferase assays. Cell entry was determined using HCV pseudoparticles (HCVpp). Virus assembly and release were quantified using a core-specific ELISA. Replicon chimeras were employed to characterize genotype-specific modulation of HCV by BAs. Lunet CD81/GFP-NLS-MAVS cells were used to determine infection of Con1 particles. Results: BAs increased RNA-replication of GT1b replicons up to 10-fold but had no effect on subgenomic GT2a replicons both in Huh-7 and HuH6 cells. They did not increase viral RNA translation, virus assembly and release or cell entry. Lowering replication efficiency of GT2a replicons rendered them susceptible to stimulation by BAs. Moreover, replication of full length GT1b with or without replication enhancing mutations and GT2a genomes were also stimulated by BAs. Conclusions: Bile acids specifically enhance RNA-replication. This is not limited to GT1, but also holds true for GT2a full length genomes and subgenomic replicons with low replication capacity. The increase of HCV replication by BAs may influence the efficacy of antiviral treatment in vivo and may improve replication of primary HCV genomes in cell culture.	[Chhatwal, Patrick; Bankwitz, Dorothea; Gentzsch, Juliane; Frentzen, Anne; Pietschmann, Thomas] TWINCORE, Ctr Expt & Clin Infect Res, Dept Expt Virol, Hannover, Germany; [Schult, Philipp; Lohmann, Volker] Univ Heidelberg, Dept Infect Dis, Heidelberg, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Ruprecht Karls University Heidelberg	Chhatwal, P (corresponding author), TWINCORE, Ctr Expt & Clin Infect Res, Dept Expt Virol, Hannover, Germany.	thomas.pietschmann@twincore.de	Lohmann, Volker/H-4211-2019; Pietschmann, Thomas/E-9241-2015	Lohmann, Volker/0000-0001-8719-7608; Pietschmann, Thomas/0000-0001-5138-6239; Schult, Philipp/0000-0002-0533-7046	Deutsche Forschungsgemeinschaft [SFB 900, Teilprojekt A6]; Initiative and Networking Fund of the Helmholtz Association [SO-024]; Indo German Science Centre for Infectious Diseases [IG-SCIDTwin-Pro03]; international research training group 1273 (IRTG 1273) by DFG; Hannover Medical School STRUCMED program; DFG [LO1556/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Initiative and Networking Fund of the Helmholtz Association; Indo German Science Centre for Infectious Diseases; international research training group 1273 (IRTG 1273) by DFG; Hannover Medical School STRUCMED program; DFG(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 900, Teilprojekt A6), by grants from the Initiative and Networking Fund of the Helmholtz Association SO-024 and the Indo German Science Centre for Infectious Diseases IG-SCIDTwin-Pro03 to TP. DB and AF were funded by stipends from the international research training group 1273 (IRTG 1273) provided by the DFG. PC was supported by an intramural grant of the Hannover Medical School STRUCMED program. PS and VL were supported by DFG grant LO1556/1-2. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x; Backes P, 2010, J VIROL, V84, P5775, DOI 10.1128/JVI.02343-09; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Blasiole DA, 2007, MOL BIOSYST, V3, P608, DOI 10.1039/b700706j; Brohm C, 2009, J VIROL, V83, P11682, DOI 10.1128/JVI.00691-09; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Chang KO, 2007, J VIROL, V81, P9633, DOI 10.1128/JVI.00795-07; Drexler JF, 2009, PLOS MED, V6, P210, DOI 10.1371/journal.pmed.1000031; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gentzsch J, ANTIVIRAL RES, V89, P136; Haid S, J VIROL, V84, P964; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Ishizaki K, 2005, HEPATOL RES, V33, P174, DOI 10.1016/j.hepres.2005.09.029; Iwata R, 2010, J VIRAL HEPATITIS; Iwata R, 2011, CLIN SCI, V120, P287, DOI 10.1042/CS20100246; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Jorquera F, 2005, J GASTROEN HEPATOL, V20, P547, DOI 10.1111/j.1440-1746.2005.03725.x; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; PENNINGTON CR, 1978, SCAND J GASTROENTERO, V13, P77, DOI 10.3109/00365527809179809; Pietschmann T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000475; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Scholtes C, 2008, J HEPATOL, V48, P192, DOI 10.1016/j.jhep.2007.09.015; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; TRINCHET JC, 1994, J HEPATOL, V21, P235, DOI 10.1016/S0168-8278(05)80401-5; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Windisch MP, 2005, J VIROL, V79, P13778, DOI 10.1128/JVI.79.21.13778-13793.2005	33	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36029	10.1371/journal.pone.0036029	http://dx.doi.org/10.1371/journal.pone.0036029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558311	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200112
J	Cho, YG; Kim, JY; Cho, HH; Cha, PR; Suh, DW; Lee, JK; Han, HN				Cho, Yi-Gil; Kim, Jin-You; Cho, Hoon-Hwe; Cha, Pil-Ryung; Suh, Dong-Woo; Lee, Jae Kon; Han, Heung Nam			Analysis of Transformation Plasticity in Steel Using a Finite Element Method Coupled with a Phase Field Model	PLOS ONE			English	Article							EXTERNALLY APPLIED STRESS; LOW-CARBON STEEL; AUSTENITE; FERRITE; ALLOYS; SUPERPLASTICITY; TRIP; RECRYSTALLIZATION; SOLIDIFICATION; DEFORMATION	An implicit finite element model was developed to analyze the deformation behavior of low carbon steel during phase transformation. The finite element model was coupled hierarchically with a phase field model that could simulate the kinetics and micro-structural evolution during the austenite-to-ferrite transformation of low carbon steel. Thermo-elastic-plastic constitutive equations for each phase were adopted to confirm the transformation plasticity due to the weaker phase yielding that was proposed by Greenwood and Johnson. From the simulations under various possible plastic properties of each phase, a more quantitative understanding of the origin of transformation plasticity was attempted by a comparison with the experimental observation.	[Cho, Yi-Gil; Cho, Hoon-Hwe; Han, Heung Nam] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea; [Cho, Yi-Gil; Cho, Hoon-Hwe; Han, Heung Nam] Seoul Natl Univ, Ctr Iron & Steel Res, RIAM, Seoul, South Korea; [Kim, Jin-You; Lee, Jae Kon] POSCO, Sheet Prod & Proc Res Grp, Tech Res Labs, Pohang, South Korea; [Cha, Pil-Ryung] Kookmin Univ, Sch Adv Mat Engn, Seoul, South Korea; [Suh, Dong-Woo] Pohang Univ Sci & Technol, Grad Inst Ferrous Technol, Pohang, South Korea	Seoul National University (SNU); Seoul National University (SNU); POSCO; Kookmin University; Pohang University of Science & Technology (POSTECH)	Cho, YG (corresponding author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea.	hnhan@snu.ac.kr	Han, Heung Nam/I-7675-2016; Han, Heung Nam/D-6461-2013	Han, Heung Nam/0000-0001-5271-9023; Suh, Dong-Woo/0000-0002-3719-0202	National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0018936]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (Grant No. 2010-0018936). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ABAQUS US MAN VERS 6; Bhadeshia HKDH, 2002, ISIJ INT, V42, P1059, DOI 10.2355/isijinternational.42.1059; Cha PR, 2010, MATER MANUF PROCESS, V25, P106, DOI 10.1080/10426910903153166; Cha PR, 2001, ACTA MATER, V49, P3295, DOI 10.1016/S1359-6454(01)00184-7; Cho YG, 2011, METALL MATER TRANS A, V42A, P2094, DOI 10.1007/s11661-010-0598-3; Choi I, 2010, MET MATER INT, V16, P27, DOI 10.1007/s12540-010-0027-6; Choi JM, 2010, KOREAN J MET MATER, V48, P187, DOI 10.3365/KJMM.2010.48.03.187; Coret M, 2002, INT J PLASTICITY, V18, P1707, DOI 10.1016/S0749-6419(01)00067-5; Fischer FD, 2000, INT J PLASTICITY, V16, P723, DOI 10.1016/S0749-6419(99)00078-9; GREENWOOD GW, 1965, PROC R SOC LON SER-A, V283, P403, DOI 10.1098/rspa.1965.0029; Han HN, 2007, PHILOS MAG, V87, P159, DOI 10.1080/14786430600953731; Han HN, 2008, PHILOS MAG, V88, P1811, DOI 10.1080/14786430802320119; Han HN, 2005, MATER LETT, V59, P158, DOI 10.1016/j.matlet.2004.07.030; Han HN, 2004, ACTA MATER, V52, P5203, DOI 10.1016/j.actamat.2004.07.031; Han HN, 2003, ACTA MATER, V51, P4907, DOI 10.1016/S1359-6454(03)00333-1; Han HN, 2002, ISIJ INT, V42, P200, DOI 10.2355/isijinternational.42.200; Huang CJ, 2006, ACTA MATER, V54, P11, DOI 10.1016/j.actamat.2005.08.033; Kim SG, 2007, ACTA MATER, V55, P6513, DOI 10.1016/j.actamat.2007.07.058; Kim SG, 2004, J CRYST GROWTH, V263, P620, DOI 10.1016/j.jcrysgro.2003.12.003; Kim SG, 1999, PHYS REV E, V60, P7186, DOI 10.1103/PhysRevE.60.7186; Kundu S, 2004, SCRIPTA MATER, V50, P891, DOI 10.1016/j.scriptamat.2003.12.007; Lan YJ, 2004, ACTA MATER, V52, P1721, DOI 10.1016/j.actamat.2003.12.045; LEBLOND JB, 1989, INT J PLASTICITY, V5, P551, DOI 10.1016/0749-6419(89)90001-6; Loginova I, 2003, ACTA MATER, V51, P1327, DOI 10.1016/S1359-6454(02)00527-X; Magee CL, 1966, THESIS CARNEGIE I TE; Mecozzi MG, 2005, METALL MATER TRANS A, V36A, P2327, DOI 10.1007/s11661-005-0105-4; Miettinen J., 1995, TKKVB113 HELS U TECH; Nagayama K, 2000, KEY ENG MAT, V177-1, P443, DOI 10.4028/www.scientific.net/KEM.177-180.443; Steinbach I, 1996, PHYSICA D, V94, P135, DOI 10.1016/0167-2789(95)00298-7; Suzuki H, 1968, STUDIES STRESS METAL, V18; Taleb L, 2003, INT J PLASTICITY, V19, P1821, DOI 10.1016/S0749-6419(03)00020-2; Taleb L, 2001, INT J PLASTICITY, V17, P1, DOI 10.1016/S0749-6419(99)00090-X; Warren JA, 2003, ACTA MATER, V51, P6035, DOI 10.1016/S1359-6454(03)00388-4; Wits JJ, 2000, MAT SCI ENG A-STRUCT, V283, P234, DOI 10.1016/S0921-5093(00)00735-8; Wray PJ, 1980, MODELING CASTING WEL, P245; Yeon DH, 2001, SCRIPTA MATER, V45, P661, DOI 10.1016/S1359-6462(01)01077-6; Zwigl P, 1997, ACTA MATER, V45, P5285, DOI 10.1016/S1359-6454(97)00186-9; Zwigl P, 1999, MAT SCI ENG A-STRUCT, V262, P166, DOI 10.1016/S0921-5093(98)00991-5	38	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35987	10.1371/journal.pone.0035987	http://dx.doi.org/10.1371/journal.pone.0035987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558295	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200104
J	Gerber, YN; Sabourin, JC; Rabano, M; Vivanco, MD; Perrin, FE				Gerber, Yannick Nicolas; Sabourin, Jean-Charles; Rabano, Miriam; Vivanco, Maria dM.; Perrin, Florence Evelyne			Early Functional Deficit and Microglial Disturbances in a Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; TREADMILL GAIT ANALYSIS; SUPEROXIDE-DISMUTASE; FAMILIAL ALS; SPINAL-CORD; PARKINSONS-DISEASE; TRANSGENIC MICE; NERVOUS-SYSTEM; ANIMAL-MODELS; ASTROCYTES	Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by selective motoneurons degeneration. There is today no clear-cut pathogenesis sequence nor any treatment. However growing evidences are in favor of the involvement, besides neurons, of several partners such as glia and muscles. To better characterize the time course of pathological events in an animal model that recapitulates human ALS symptoms, we investigated functional and cellular characteristics of hSOD1(G93A) mice. Methods and Findings: We have evaluated locomotor function of hSOD1(G93A) mice through dynamic walking patterns and spontaneous motor activity analysis. We detected early functional deficits that redefine symptoms onset at 60 days of age, i.e. 20 days earlier than previously described. Moreover, sequential combination of these approaches allows monitoring of motor activity up to disease end stage. To tentatively correlate early functional deficit with cellular alterations we have used flow cytometry and immunohistochemistry approaches to characterize neuromuscular junctions, astrocytes and microglia. We show that (1) decrease in neuromuscular junction's number correlates with motor impairment, (2) astrocytes number is not altered at pre- and early-symptomatic ages but intraspinal repartition is modified at symptoms onset, and (3) microglia modifications precede disease onset. At pre-symptomatic age, we show a decrease in microglia number whereas at onset of the disease two distinct microglia sub-populations emerge. Conclusions: In conclusion, precise motor analysis updates the onset of the disease in hSOD1(G93A) mice and allows locomotor monitoring until the end stage of the disease. Early functional deficits coincide with alterations of neuromuscular junctions. Importantly, we identify different sets of changes in microglia before disease onset as well as at early-symptomatic stage. This finding not only brings a new sequence of cellular events in the natural history of the disease, but it may also provide clues in the search for biomarkers of the disease, and potential therapeutic targets.	[Gerber, Yannick Nicolas; Perrin, Florence Evelyne] St Elio Hosp, INSERM U1051, Inst Neurosci Montpellier, Montpellier, France; [Gerber, Yannick Nicolas; Perrin, Florence Evelyne] IKERBASQUE Basque Fdn Sci, Bilbao, Spain; [Sabourin, Jean-Charles; Perrin, Florence Evelyne] Univ Basque Country, Dept Neurosci, Leioa, Spain; [Rabano, Miriam; Vivanco, Maria dM.] CIC bioGUNE, Cell Biol & Stem Cells Unit, Derio, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Basque Foundation for Science; University of Basque Country; CIC bioGUNE	Gerber, YN (corresponding author), St Elio Hosp, INSERM U1051, Inst Neurosci Montpellier, Montpellier, France.	f.perrin@ikerbasque.org	cancer, biogune/H-7276-2012; Vivanco, Maria/G-2393-2011; PERRIN, Florence/AAY-6815-2021	Vivanco, Maria/0000-0002-9540-247X; PERRIN, Florence/0000-0002-7630-0515	Spanish Government, Plan Nacional de I+D+I2008-2011; Institudo de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la investigacion [PI10/00709]; Fondation pour la Recherche Medicale; patient organization "Demain Debout Aquitaine''; patient organization "Verticale"	Spanish Government, Plan Nacional de I+D+I2008-2011; Institudo de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la investigacion; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); patient organization "Demain Debout Aquitaine''; patient organization "Verticale"	This work was supported by the Spanish Government, Plan Nacional de I+D+I2008-2011 and the Institudo de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la investigacion [PI10/00709 to FEP], the "Fondation pour la Recherche Medicale" to FEP and the patient organizations "Demain Debout Aquitaine'' (to YNG) and "Verticale" (to FEP). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Appel S H, 2011, Acta Myol, V30, P4; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Barbeito AG, 2010, J NEURAL TRANSM, V117, P981, DOI 10.1007/s00702-010-0429-0; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Chiu IM, 2009, P NATL ACAD SCI USA, V106, P20960, DOI 10.1073/pnas.0911405106; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ferraiuolo L, 2011, BRAIN, V134, P2627, DOI 10.1093/brain/awr193; Ferrer-Alcon M, 2008, NEUROSCIENCE, V152, P291, DOI 10.1016/j.neuroscience.2007.11.058; Finkelstein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022374; Frey D, 2000, J NEUROSCI, V20, P2534; Guillot TS, 2008, J MOTOR BEHAV, V40, P568, DOI 10.3200/JMBR.40.6.568-577; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Hampton TG, 2010, J MOTOR BEHAV, V42, P1, DOI 10.1080/00222890903272025; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Julien JP, 2007, NAT NEUROSCI, V10, P535, DOI 10.1038/nn0507-535; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kaspar BK, 2005, ANN NEUROL, V57, P649, DOI 10.1002/ana.20451; Levine JB, 1999, GLIA, V28, P215; Mahoney DJ, 2004, MUSCLE NERVE, V29, P656, DOI 10.1002/mus.20004; Mancuso R, 2011, BRAIN RES, V1406, P65, DOI 10.1016/j.brainres.2011.06.033; Mead RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023244; Morrison BM, 1999, BRAIN RES REV, V29, P121, DOI 10.1016/S0165-0173(98)00049-6; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sanagi T, 2010, J NEUROSCI RES, V88, P2736, DOI 10.1002/jnr.22424; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Schiffer D, 2004, AMYOTROPH LATERAL SC, V5, P22, DOI 10.1080/14660820310016822; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; Van Damme P, 2009, CURR OPIN NEUROL, V22, P486, DOI 10.1097/WCO.0b013e32832ffbe3; Van Den Bosch L, 2008, EXP NEUROL, V211, P1, DOI 10.1016/j.expneurol.2008.01.008; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	41	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36000	10.1371/journal.pone.0036000	http://dx.doi.org/10.1371/journal.pone.0036000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558300	gold, Green Published			2022-12-25	WOS:000305345200107
J	Huang, GJ; Ben-David, E; Piella, AST; Edwards, A; Flint, J; Shifman, S				Huang, Guo-Jen; Ben-David, Eyal; Piella, Agne S. Tort; Edwards, Andrew; Flint, Jonathan; Shifman, Sagiv			Neurogenomic Evidence for a Shared Mechanism of the Antidepressant Effects of Exercise and Chronic Fluoxetine in Mice	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; LARGE GENE LISTS; ENVIRONMENTAL ENRICHMENT; BEHAVIOR; DEPRESSION; RESPONSES; NEURONS; ANXIETY; STRESS; MODEL	Several different interventions improve depressed mood, including medication and environmental factors such as regular physical exercise. The molecular pathways underlying these effects are still not fully understood. In this study, we sought to identify shared mechanisms underlying antidepressant interventions. We studied three groups of mice: mice treated with a widely used antidepressant drug - fluoxetine, mice engaged in voluntary exercise, and mice living in an enriched environment. The hippocampi of treated mice were investigated at the molecular and cellular levels. Mice treated with fluoxetine and mice who exercised daily showed, not only similar antidepressant behavior, but also similar changes in gene expression and hippocampal neurons. These changes were not observed in mice with environmental enrichment. An increase in neurogenesis and dendritic spine density was observed following four weeks of fluoxetine treatment and voluntary exercise. A weighted gene co-expression network analysis revealed four different modules of co-expressed genes that were correlated with the antidepressant effect. This network analysis enabled us to identify genes involved in the molecular pathways underlying the effects of fluoxetine and exercise. The existence of both neuronal and gene expression changes common to antidepressant drug and exercise suggests a shared mechanism underlying their effect. Further studies of these findings may be used to uncover the molecular mechanisms of depression, and to identify new avenues of therapy.	[Huang, Guo-Jen] Chang Gung Univ, Coll Med, Dept & Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Ben-David, Eyal; Shifman, Sagiv] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel; [Piella, Agne S. Tort; Edwards, Andrew; Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Chang Gung University; Hebrew University of Jerusalem; University of Oxford; Wellcome Centre for Human Genetics	Huang, GJ (corresponding author), Chang Gung Univ, Coll Med, Dept & Grad Inst Biomed Sci, Tao Yuan, Taiwan.	gjh30@mail.cgu.edu.tw; sagiv@vms.huji.ac.il	Shifman, Sagiv/D-8749-2017; Ben-David, Eyal/AAV-4126-2021	Shifman, Sagiv/0000-0003-4071-5361; Ben-David, Eyal/0000-0003-0514-0400; Huang, Guo-Jen/0000-0002-6392-2155; Flint, Jonathan/0000-0002-9427-4429	Chang Gung Memorial Hospital [CMRPD1A0211]; National Science Council of Taiwan [NSC100-2320-B-182-003]; Wellcome Trust; Legacy Heritage Fund program of Israel Science Foundation [1998/08]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Wellcome Trust(Wellcome Trust); Legacy Heritage Fund program of Israel Science Foundation	This study was supported by grants from the Chang Gung Memorial Hospital (CMRPD1A0211) and the National Science Council (NSC100-2320-B-182-003) of Taiwan (to GJH), by the Wellcome Trust (to JF), and by the Legacy Heritage Fund program of the Israel Science Foundation (grant no. 1998/08) (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Bjornebekk A, 2005, INT J NEUROPSYCHOPH, V8, P357, DOI 10.1017/S1461145705005122; BODNOFF SR, 1989, PSYCHOPHARMACOLOGY, V97, P277, DOI 10.1007/BF00442264; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang GJ, 2008, MOL PSYCHIATR, V13, P119, DOI 10.1038/sj.mp.4002104; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Miller BH, 2008, NEUROPSYCHOPHARMACOL, V33, P1312, DOI 10.1038/sj.npp.1301497; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	22	36	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35901	10.1371/journal.pone.0035901	http://dx.doi.org/10.1371/journal.pone.0035901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558262	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200092
J	Khanna, RC; Pallerla, SR; Eeda, SS; Gudapati, BK; Cassard, SD; Rani, PK; Shantha, GPS; Chakrabarti, S; Schein, OD				Khanna, Rohit C.; Pallerla, Srinivasa Reddy; Eeda, Shiva Shankar; Gudapati, Bala Krishna; Cassard, Sandra D.; Rani, Padmaja Kumari; Shantha, Ghanshyam Palamaner Subash; Chakrabarti, Subhabrata; Schein, Oliver D.			Population Based Outcomes of Cataract Surgery in Three Tribal Areas of Andhra Pradesh, India: Risk Factors for Poor Outcomes	PLOS ONE			English	Article							EYE SURVEY; VISUAL OUTCOMES; OLDER ADULTS; BLINDNESS; DISTRICT; PREVALENCE; ACUITY; NEPAL	Purpose: To report visual outcomes and risk factors for poor outcomes of cataract surgery in three Integrated Tribal Development Agency (ITDA) areas of Andhra Pradesh, India. Methods and Results: Using validated Rapid Assessment of Avoidable Blindness (RAAB) methodology, a population based cross-sectional study, was conducted in three ITDA areas. A two-stage sampling procedure was used to select 7281 participants aged 50 years and above. Vision assessment using a tumbling E chart and standard ocular examinations were completed. Visual outcomes and risk factors for poor outcomes were assessed among subjects undergoing cataract surgery (1548 eyes of 1124 subjects). Mean age at surgery was 67+/-68 years; Among the operated eyes, presenting visual acuity (PVA) and best corrected visual acuity (BCVA) worse than 6/18 was seen in 492 (31.8%; 95% CI, 29.5-34.2%) and 298 eyes (19.3%; 95% CI, 17.3-21.3%), respectively. Similarly, PVA and BCVA worse than 6/60 was seen in 219 (14.1%; 95% CI, 12.4-16%) and 147 eyes (9.5%; 95% CI, 8.1-11.1%), respectively. When either eye was taken into consideration, the PVA and BCVA worse than 6/18 was seen in 323 (20.1%; 95% CI, 18.9-23%) and 144 subjects (9.3%; 95% CI, 7.9-10.9%), respectively. PVA and BCVA worse than 6/60 was seen in 74 (4.8%; 95% CI, 3.8-6%) and 49 subjects (3.2%; 95% CI, 2.4-4.2%), respectively. Posterior capsular opacification was seen in 51 of 1316 pseudophakic eyes (3.9%; 95% CI, 2.9-5.1%). In multivariable analysis among pseudophakic subjects with PVA worse than 6/18, increasing age (p = 0.002) and undergoing free surgery (p = 0.05) were independent risk factors. Undergoing surgery before 2005 (p = 0.05) and being illiterate (p = 0.05) were independent risk factors for BCVA worse than 6/18. Conclusions: There are changing trends with improved outcomes in cataract surgery among these tribal populations of India. However, post-operative refractive error correction remains an issue, especially for those undergoing free surgeries.	[Khanna, Rohit C.; Rani, Padmaja Kumari; Chakrabarti, Subhabrata] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Hyderabad, Andhra Pradesh, India; [Khanna, Rohit C.; Rani, Padmaja Kumari] LV Prasad Eye Inst, Int Ctr Adv Rural Eyecare, Community Eye Hlth, Allen Foster Res Ctr, Hyderabad, Andhra Pradesh, India; [Pallerla, Srinivasa Reddy; Eeda, Shiva Shankar; Gudapati, Bala Krishna] Andhra Pradesh Right Sight Soc, Hyderabad, Andhra Pradesh, India; [Cassard, Sandra D.; Schein, Oliver D.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Shantha, Ghanshyam Palamaner Subash; Schein, Oliver D.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Khanna, RC (corresponding author), LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Banjara Hills, Hyderabad, Andhra Pradesh, India.	rohit@lvpei.org	pallerla, srinivasa r/F-4575-2014; Chakrabarti, Subhabrata/F-2468-2015	pallerla, srinivasa r/0000-0001-9126-1676; Chakrabarti, Subhabrata/0000-0003-3717-4963	Department for International Development (DFID) UK	Department for International Development (DFID) UK	Funding for conducting the study was received from Department for International Development (DFID) UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angra SK, 1997, INDIAN J MED RES, V106, P312; Baranano AE, 2008, OPHTHALMOLOGY, V115, P815, DOI 10.1016/j.ophtha.2007.05.052; Dandona L, 2003, CLIN EXP OPHTHALMOL, V31, P23, DOI 10.1046/j.1442-9071.2003.00595.x; Dandona L, 1999, AM J OPHTHALMOL, V127, P650, DOI 10.1016/S0002-9394(99)00044-6; Dua AS, 2005, NATL PROGRAMME CONTR, P299; GLYNN RJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P381, DOI 10.1001/archopht.1992.01080150079033; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Jose R, 1995, Indian J Ophthalmol, V43, P35; Kandel RP, 2010, OPHTHAL EPIDEMIOL, V17, P276, DOI 10.3109/09286586.2010.508355; Kuper Hannah, 2006, Community Eye Health, V19, P68; Lau J, 2002, BRIT J OPHTHALMOL, V86, P12, DOI 10.1136/bjo.86.1.12; Lavanya R, 2009, BRIT J OPHTHALMOL, V93, P299, DOI 10.1136/bjo.2008.148650; Murthy GVS, 2009, OPHTHAL EPIDEMIOL, V16, P400, DOI 10.3109/09286580903315809; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P686, DOI 10.1016/S0161-6420(00)00578-9; Nirmalan PK, 2002, BRIT J OPHTHALMOL, V86, P505, DOI 10.1136/bjo.86.5.505; Park K., 2007, TXB PREVENTIVE SOCIA; Sapkota YD, 2010, OPHTHAL EPIDEMIOL, V17, P82, DOI 10.3109/09286581003624947; StataCorp, 2009, STAT STAT SOFTW REL; Thulasiraj RD, 2002, OPHTHALMIC EPIDEMIOL, V9, P313, DOI 10.1076/opep.9.5.313.10339; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; Vijaya L, 2010, INDIAN J OPHTHALMOL, V58, P223, DOI 10.4103/0301-4738.62648; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	24	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35701	10.1371/journal.pone.0035701	http://dx.doi.org/10.1371/journal.pone.0035701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567108	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500026
J	Nzeduru, CV; Ronca, S; Wilkinson, MJ				Nzeduru, Chinyere V.; Ronca, Sandra; Wilkinson, Mike J.			DNA Barcoding Simplifies Environmental Risk Assessment of Genetically Modified Crops in Biodiverse Regions	PLOS ONE			English	Article							COWPEA VIGNA-UNGUICULATA; TRANSGENIC CROPS; NONTARGET; NIGERIA; WALP.; FOOD	Transgenes encoding for insecticidal crystal (Cry) proteins from the soil-dwelling bacterium Bacillus Thuringiensis have been widely introduced into Genetically Modified (GM) crops to confer protection against insect pests. Concern that these transgenes may also harm beneficial or otherwise valued insects (so-called Non Target Organisms, NTOs) represents a major element of the Environmental Risk Assessments (ERAs) used by all countries prior to commercial release. Compiling a comprehensive list of potentially susceptible NTOs is therefore a necessary part of an ERA for any Cry toxin-containing GM crop. In partly-characterised and biodiverse countries, NTO identification is slowed by the need for taxonomic expertise and time to enable morphological identifications. This limitation represents a potentially serious barrier to timely adoption of GM technology in some developing countries. We consider Bt Cry1A cowpea (Vigna unguiculata) in Nigeria as an exemplar to demonstrate how COI barcoding can provide a simple and cost-effective means of addressing this problem. Over a period of eight weeks, we collected 163 insects from cowpea flowers across the agroecological and geographic range of the crop in Nigeria. These individuals included 32 Operational Taxonomic Units (OTUs) spanning four Orders and that could mostly be assigned to genus or species level. They included 12 Lepidopterans and two Coleopterans (both potentially sensitive to different groups of Cry proteins). Thus, barcode-assisted diagnoses were highly harmonised across groups (typically to genus or species level) and so were insensitive to expertise or knowledge gaps. Decisively, the entire study was completed within four months at a cost of less than 10,000 US$. The broader implications of the findings for food security and the capacity for safe adoption of GM technology are briefly explored.	[Nzeduru, Chinyere V.] Fed Minist Environm, Dept Forestry, Biosafety Unit, Abuja, Nigeria; [Ronca, Sandra; Wilkinson, Mike J.] Aberystwyth Univ, Insitute Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales	Aberystwyth University	Nzeduru, CV (corresponding author), Fed Minist Environm, Dept Forestry, Biosafety Unit, Abuja, Nigeria.	Mike.Wilkinson@Adelaide.edu.au		Wilkinson, Michael/0000-0002-9881-6993	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The work was part of an M.Sc. dissertation. The scholarship to attend the course and consumables pent during its execution was funded by the Bill & Melinda Gates Foundation. The foundation requested to see the manuscript prior to submission via [Grantee.Comms@gatesfoundation.org] but did not change the manuscript in any way. They were not involved in its design or writing. Thus, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesoye A, 2008, AFR J BIOTECHNOL, V7, P3200; Agbonlahor M. U., 2009, Journal of Human Ecology, V25, P25; Aliyu B, 2007, EUPHYTICA, V155, P295, DOI 10.1007/s10681-006-9331-0; Anderson K, 2010, NEW BIOTECHNOL, V27, P558, DOI 10.1016/j.nbt.2010.05.012; Asiwe JAN, 2009, AFR J BIOTECHNOL, V8, P226; Ayanwale BA, 2002, ISSUES AFRICAN RURAL, V21; Bull SE, 2011, PLANT CELL REP, V30, P779, DOI 10.1007/s00299-010-0986-6; Delmer DP, 2005, P NATL ACAD SCI USA, V102, P15739, DOI 10.1073/pnas.0505895102; Dias FMS, 2010, NEOTROP ENTOMOL, V39, P1044, DOI 10.1590/S1519-566X2010000600030; Ellard S, 2009, PRACTICE GUIDELINES; Ferry N, 2006, TRANSGENIC RES, V15, P501, DOI 10.1007/s11248-006-0021-4; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Heinrichs E. A, 1994, BIOL MANAGEMENT RICE; Hordzi W. H. K., 2011, African Journal of Food, Agriculture, Nutrition and Development, V11, P4880; IUCN, 2019, IUCN RED LIST THREAT; Ivo NL, 2008, PLANT CELL REP, V27, P1475, DOI 10.1007/s00299-008-0573-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knecht S, 2010, BASIC APPL ECOL, V11, P346, DOI 10.1016/j.baae.2010.02.010; Langyintuo A. S., 2006, AgBioForum, V9, P111; Larsen TB, 2011, IUCN 2011 IUCN RED L; Machuka J, 1999, ENTOMOL EXP APPL, V93, P179, DOI 10.1023/A:1003801120192; Mahalakshmi V., 2007, Plant Genetic Resources Characterization and Utilization, V5, P113, DOI 10.1017/S1479262107837166; Manyong V., 2005, FARMERSPERCEPTIONS B; Nieto A, 2010, IUCN 2011 IUCN RED L; Odey J, 2010, CBD 4 NATL REPORT AB; Olaniyan S.A., 2007, ESTUD BIOL, V29; Olumukoro JO, 2007, AFR ZOOL, V42, P1; Popelka JC, 2004, PLANT SCI, V167, P195, DOI 10.1016/j.plantsci.2004.03.027; Ramirez-Romero R, 2008, ECOTOX ENVIRON SAFE, V70, P327, DOI 10.1016/j.ecoenv.2007.12.002; Raybould A, 2005, BIOL SCI SER, P169; Raybould A, 2010, FOOD SECUR, V2, P247, DOI 10.1007/s12571-010-0066-3; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2009, J APPL ENTOMOL, V133, P571, DOI 10.1111/j.1439-0418.2009.01423.x; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Roy DB, 2003, PHILOS T ROY SOC B, V358, P1879, DOI 10.1098/rstb.2003.1404; Sanchis V, 2011, AGRON SUSTAIN DEV, V31, P217, DOI 10.1051/agro/2010027; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Singh BB, 2003, FIELD CROP RES, V84, P169, DOI 10.1016/S0378-4290(03)00148-5; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Then C, 2010, ENVIRON SCI POLLUT R, V17, P791, DOI 10.1007/s11356-009-0208-3; Thomson JA, 2008, PHILOS T R SOC B, V363, P905, DOI 10.1098/rstb.2007.2191; VAILLANCOURT RE, 1992, AM J BOT, V79, P1194, DOI 10.2307/2445219; van Swaay C, 2010, IUCN 2011 IUCN RED L; Virgilio M, 2009, MOL PHYLOGENET EVOL, V51, P531, DOI 10.1016/j.ympev.2009.01.003; World Conservation Monitoring Centre, 1996, IUCN 2011 IUCN RED L; Yu HL, 2011, J INTEGR PLANT BIOL, V53, P520, DOI 10.1111/j.1744-7909.2011.01047.x	46	1	2	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35929	10.1371/journal.pone.0035929	http://dx.doi.org/10.1371/journal.pone.0035929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567120	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500038
J	Martino, L; Masini, M; Novelli, M; Beffy, P; Bugliani, M; Marselli, L; Masiello, P; Marchetti, P; De Tata, V				Martino, Luisa; Masini, Matilde; Novelli, Michela; Beffy, Pascale; Bugliani, Marco; Marselli, Lorella; Masiello, Pellegrino; Marchetti, Piero; De Tata, Vincenzo			Palmitate Activates Autophagy in INS-1E beta-Cells and in Isolated Rat and Human Pancreatic Islets	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FREE FATTY-ACIDS; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; LIPID-METABOLISM; MAMMALIAN-CELLS; SELF-DIGESTION; DEATH; APOPTOSIS; DISEASE	We have investigated the in vitro effects of increased levels of glucose and free fatty acids on autophagy activation in pancreatic beta cells. INS-1E cells and isolated rat and human pancreatic islets were incubated for various times (from 2 to 24 h) at different concentrations of glucose and/or palmitic acid. Then, cell survival was evaluated and autophagy activation was explored by using various biochemical and morphological techniques. In INS-1E cells as well as in rat and human islets, 0.5 and 1.0 mM palmitate markedly increased autophagic vacuole formation, whereas high glucose was ineffective alone and caused little additional change when combined with palmitate. Furthermore, LC3-II immunofluorescence co-localized with that of cathepsin D, a lysosomal marker, showing that the autophagic flux was not hampered in PA-treated cells. These effects were maintained up to 18-24 h incubation and were associated with a significant decline of cell survival correlated with both palmitate concentration and incubation time. Ultrastructural analysis showed that autophagy activation, as evidenced by the occurrence of many autophagic vacuoles in the cytoplasm of beta cells, was associated with a diffuse and remarkable swelling of the endoplasmic reticulum. Our results indicate that among the metabolic alterations typically associated with type 2 diabetes, high free fatty acids levels could play a role in the activation of autophagy in beta cells, through a mechanism that might involve the induction of endoplasmic reticulum stress.	[Martino, Luisa; Masini, Matilde; Novelli, Michela; Masiello, Pellegrino; De Tata, Vincenzo] Univ Pisa, Dept Expt Pathol, Pisa, Italy; [Beffy, Pascale] Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy; [Bugliani, Marco; Marselli, Lorella; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa; University of Pisa	Martino, L (corresponding author), Univ Pisa, Dept Expt Pathol, Pisa, Italy.	vincenzo.detata@med.unipi.it	Marchetti, Piero/J-7439-2013; Bugliani, Marco/I-3168-2019	Marchetti, Piero/0000-0003-4907-0635; Bugliani, Marco/0000-0002-1744-1561; Marselli, Lorella/0000-0002-6698-2962	Innovative Medicines Initiative Joint Undertaking [155005]; European Union; EFPIA companies	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA companies	The work leading to this publication has been supported in part by the Innovative Medicines Initiative Joint Undertaking under grant agreement no 155005 (IMIDIA), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaraviciene SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002182; Bergamini Ettore, 2006, Molecular Aspects of Medicine, V27, P403, DOI 10.1016/j.mam.2006.08.001; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Czaja MJ, 2011, GASTROENTEROLOGY, V140, P1895, DOI 10.1053/j.gastro.2011.04.038; Czaja MJ, 2009, AUTOPHAGY, V5, P866, DOI 10.4161/auto.9040; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; ELKS ML, 1993, ENDOCRINOLOGY, V133, P208, DOI 10.1210/en.133.1.208; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hwang SL, 2012, BIOCHEM BIOPH RES CO, V418, P402, DOI 10.1016/j.bbrc.2012.01.038; Ito S, 2007, INT J ONCOL, V31, P261; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kadowaki Motoni, 2006, Molecular Aspects of Medicine, V27, P426, DOI 10.1016/j.mam.2006.08.010; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kaushik S, 2010, DIABETES OBES METAB, V12, P4, DOI 10.1111/j.1463-1326.2010.01263.x; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Komiya K, 2010, BIOCHEM BIOPH RES CO, V401, P561, DOI 10.1016/j.bbrc.2010.09.101; Kovsan J, 2010, AM J PHYSIOL-ENDOC M, V298, pE1, DOI 10.1152/ajpendo.00562.2009; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Ladriere L, 2010, J CLIN ENDOCR METAB, V95, P1442, DOI 10.1210/jc.2009-2322; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li N, 2008, BIOCHEM SOC T, V36, P930, DOI 10.1042/BST0360930; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marchetti P, 2008, REGUL PEPTIDES, V146, P4, DOI 10.1016/j.regpep.2007.08.017; Marsh BJ, 2007, MOL ENDOCRINOL, V21, P2255, DOI 10.1210/me.2007-0077; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Meijer AJ, 2008, CELL METAB, V8, P275, DOI 10.1016/j.cmet.2008.09.001; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Misler S, 2010, ISLETS, V2, P210, DOI 10.4161/isl.2.4.12156; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2006, AUTOPHAGY, V2, P302, DOI 10.4161/auto.2945; Novelli M, 2001, MOL CELL ENDOCRINOL, V175, P57, DOI 10.1016/S0303-7207(01)00400-2; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Poitout V, 1996, DIABETES METAB, V22, P7; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	71	98	99	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36188	10.1371/journal.pone.0036188	http://dx.doi.org/10.1371/journal.pone.0036188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563482	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340700031
J	Nicklasson, M; Sjoling, A; von Mentzer, A; Qadri, F; Svennerholm, AM				Nicklasson, Matilda; Sjoling, Asa; von Mentzer, Astrid; Qadri, Firdausi; Svennerholm, Ann-Mari			Expression of Colonization Factor CS5 of Enterotoxigenic Escherichia coli (ETEC) Is Enhanced In Vivo and by the Bile Component Na Glycocholate Hydrate	PLOS ONE			English	Article							GM1-ENZYME-LINKED IMMUNOSORBENT-ASSAY; VIBRIO-CHOLERAE; VIRULENCE FACTORS; DIARRHEA; TOXIN; IDENTIFICATION; BANGLADESH; SECRETION; ANTIGENS; ADHESIN	Enterotoxigenic Escherichia coli (ETEC) is an important cause of acute watery diarrhoea in developing countries. Colonization factors (CFs) on the bacterial surface mediate adhesion to the small intestinal epithelium. Two of the most common CFs worldwide are coli surface antigens 5 and 6 (CS5, CS6). In this study we investigated the expression of CS5 and CS6 in vivo, and the effects of bile and sodium bicarbonate, present in the human gut, on the expression of CS5. Five CS5+ CS6 ETEC isolates from adult Bangladeshi patients with acute diarrhoea were studied. The level of transcription from the CS5 operon was approximately 100-fold higher than from the CS6 operon in ETEC bacteria recovered directly from diarrhoeal stool without sub-culturing (in vivo). The glyco-conjugated primary bile salt sodium glycocholate hydrate (NaGCH) induced phenotypic expression of CS5 in a dose-dependent manner and caused a 100-fold up-regulation of CS5 mRNA levels; this is the first description of NaGCH as an enteropathogenic virulence inducer. The relative transcription levels from the CS5 and CS6 operons in the presence of bile or NaGCH in vitro were similar to those in vivo. Another bile salt, sodium deoxycholate (NaDC), previously reported to induce enteropathogenic virulence, also induced expression of CS5, whereas sodium bicarbonate did not.	[Nicklasson, Matilda; Sjoling, Asa; von Mentzer, Astrid; Svennerholm, Ann-Mari] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Qadri, Firdausi] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	University of Gothenburg; International Centre for Diarrhoeal Disease Research (ICDDR)	Nicklasson, M (corresponding author), Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden.	matilda.nicklasson@microbio.gu.se	von Mentzer, Astrid/I-5449-2018; Qadri, Firdausi/AAF-4583-2019; Al, Mamun M./AAF-5850-2019	von Mentzer, Astrid/0000-0002-2167-1394; Sjoling, Asa/0000-0003-1529-1720	Swedish Agency for Research and Economic Cooperation (Sida-SAREC); Swedish International Development Agency [INT-ICDDR, B-HN-01-AV]; Swedish Research Council [16X-09084]; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b); Marianne and Marcus Wallenberg Foundation; Magnus Bergvall Foundation	Swedish Agency for Research and Economic Cooperation (Sida-SAREC); Swedish International Development Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission); International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b); Marianne and Marcus Wallenberg Foundation; Magnus Bergvall Foundation	This study was supported by the Swedish Agency for Research and Economic Cooperation (Sida-SAREC) and the Swedish International Development Agency (grants INT-ICDDR, B-HN-01-AV): www.sida.se; the Swedish Research Council (grant 16X-09084): www.vr.se; the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b): www.icddrb.org; the Marianne and Marcus Wallenberg Foundation: www.wallenberg.com; and the Magnus Bergvall Foundation: www.magnbergvallsstiftelse.nu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Barrett K, 2010, GASTROINTESTINAL PHY; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bolin I, 2006, J CLIN MICROBIOL, V44, P3872, DOI 10.1128/JCM.00790-06; DEHAAN LAM, 1991, FEMS MICROBIOL LETT, V83, P341, DOI 10.1016/0378-1097(91)90499-Z; Duthy TG, 2002, J BACTERIOL, V184, P1065, DOI 10.1128/jb.184.4.1065-1077.2002; EVANS DG, 1977, INFECT IMMUN, V18, P330, DOI 10.1128/IAI.18.2.330-337.1977; Favre D, 2006, VACCINE, V24, P4354, DOI 10.1016/j.vaccine.2006.02.052; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; GREWAL HMS, 1994, J CLIN MICROBIOL, V32, P1295, DOI 10.1128/JCM.32.5.1295-1301.1994; Grewal HMS, 1997, INFECT IMMUN, V65, P507, DOI 10.1128/IAI.65.2.507-513.1997; Gupta S, 1997, INFECT IMMUN, V65, P1131, DOI 10.1128/IAI.65.3.1131-1134.1997; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; Lothigius A, 2007, J APPL MICROBIOL; Lunelli M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002163; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nicklasson M, 2008, MICROB PATHOGENESIS, V44, P246, DOI 10.1016/j.micpath.2007.06.009; Pichel M, 2000, INFECT IMMUN, V68, P3280, DOI 10.1128/IAI.68.6.3280-3285.2000; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07; Qadri F, 2007, INFECT IMMUN, V75, P2269, DOI 10.1128/IAI.01856-06; Rivera-Amill V, 2001, J INFECT DIS, V183, P1607, DOI 10.1086/320704; Sanchez J, 2005, CURR OPIN IMMUNOL, V17, P388, DOI 10.1016/j.coi.2005.06.007; Shaheen HI, 2004, J CLIN MICROBIOL, V42, P5588, DOI 10.1128/JCM.42.12.5588-5595.2004; Sjoling A, 2007, J CLIN MICROBIOL; Sjoling A, 2006, MICROBES INFECT, V8, P2797, DOI 10.1016/j.micinf.2006.08.011; Stensrud KF, 2008, J BIOL CHEM, V283, P18646, DOI 10.1074/jbc.M802799200; Svennerholm AM, 2004, BEST PRACT RES CL GA, V18, P421, DOI 10.1016/j.bpg.2003.11.004; SVENNERHOLM AM, 1986, J CLIN MICROBIOL, V24, P585, DOI 10.1128/JCM.24.4.585-590.1986; SVENNERHOLM AM, 1983, J CLIN MICROBIOL, V17, P596, DOI 10.1128/JCM.17.4.596-600.1983; Torres AG, 2007, CELL MICROBIOL, V9, P1039, DOI 10.1111/j.1462-5822.2006.00850.x; von Sonnenburg F, 2000, LANCET, V356, P133, DOI 10.1016/S0140-6736(00)02451-X; WHO, 1987, PROGR CONTR DIARRH D, P9; Willson FE, 1933, J AM PHARM ASSOC, P788; Wolf MK, 1997, FEMS MICROBIOL LETT, V148, P35, DOI 10.1016/S0378-1097(97)00009-8; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; World health organization, 1999, WEEKLY EPIDEMIOL REC, V13, P98	42	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35827	10.1371/journal.pone.0035827	http://dx.doi.org/10.1371/journal.pone.0035827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22563407	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200023
J	Campbell, AL; Shih, HP; Xu, J; Gross, MK; Kioussi, C				Campbell, Adam L.; Shih, Hung-Ping; Xu, Jun; Gross, Michael K.; Kioussi, Chrissa			Regulation of Motility of Myogenic Cells in Filling Limb Muscle Anlagen by Pitx2	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ACTIN-BASED MOTILITY; PRECURSOR CELLS; MOUSE EMBRYO; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; ENA/VASP PROTEINS; BINDING PROTEIN; SKELETAL-MUSCLE; C-MET	Cells of the ventrolateral dermomyotome delaminate and migrate into the limb buds where they give rise to all muscles of the limbs. The migratory cells proliferate and form myoblasts, which withdraw from the cell cycle to become terminally differentiated myocytes. The myogenic lineage colonizes pre-patterned regions to form muscle anlagen as muscle fibers are assembled. The regulatory mechanisms that control the later steps of this myogenic program are not well understood. The homeodomain transcription factor Pitx2 is expressed specifically in the muscle lineage from the migration of precursors to adult muscle. Ablation of Pitx2 results in distortion, rather than loss, of limb muscle anlagen, suggesting that its function becomes critical during the colonization of, and/or fiber assembly in, the anlagen. Microarrays were used to identify changes in gene expression in flow-sorted migratory muscle precursors, labeled by Lbx1(EGFP/+), which resulted from the loss of Pitx2. Very few genes showed changes in expression. Many small-fold, yet significant, changes were observed in genes encoding cytoskeletal and adhesion proteins which play a role in cell motility. Myogenic cells from genetically-tagged mice were cultured and subjected to live cell-tracking analysis using time-lapse imaging. Myogenic cells lacking Pitx2 were smaller, more symmetrical, and had more actin bundling. They also migrated about half of the total distance and velocity. Decreased motility may prevent myogenic cells from filling pre-patterned regions of the limb bud in a timely manner. Altered shape may prevent proper assembly of higher-order fibers within anlagen. Pitx2 therefore appears to regulate muscle anlagen development by appropriately balancing expression of cytoskeletal and adhesion molecules.	[Campbell, Adam L.; Xu, Jun; Gross, Michael K.; Kioussi, Chrissa] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Shih, Hung-Ping] Univ Calif San Diego, Dept Pediat, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Oregon State University; University of California System; University of California San Diego	Campbell, AL (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	chrissa.kioussi@oregonstate.edu	Xu, Jun/K-1233-2016	Xu, Jun/0000-0003-4221-5563; Kioussi, Chrissa/0000-0001-8226-9908	National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS) [AR054406]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS) grant AR054406 to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; BANDMAN E, 1992, DEV BIOL, V154, P273, DOI 10.1016/0012-1606(92)90067-Q; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blaxall BC, 2003, PHYSIOL GENOMICS, V15, P105, DOI 10.1152/physiolgenomics.00087.2003; BOBER E, 1994, DEVELOPMENT, V120, P603; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; Carlier MF, 2003, BIOESSAYS, V25, P336, DOI 10.1002/bies.10257; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DAVID G, 1993, DEVELOPMENT, V119, P841; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Disatnik MH, 1999, J BIOL CHEM, V274, P32486, DOI 10.1074/jbc.274.45.32486; Dixson JD, 2003, J MOL EVOL, V56, P1, DOI 10.1007/s00239-002-2374-5; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Feoktistov I, 2000, MOL PHARMACOL, V58, P903, DOI 10.1124/mol.58.5.903; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gail M, 1973, Ciba Found Symp, V14, P287; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Gersdorff N, 2006, HISTOCHEM CELL BIOL, V126, P705, DOI 10.1007/s00418-006-0200-7; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GOULDING M, 1994, DEVELOPMENT, V120, P957; Gross MK, 2000, DEVELOPMENT, V127, P413; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Gunning PW, 2001, J CELL SCI, V114, P513; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; HAYASHI K, 1995, DEVELOPMENT, V121, P661; HAYWARD LJ, 1988, J CELL BIOL, V106, P2077, DOI 10.1083/jcb.106.6.2077; Hilton T, 2010, J BIOL CHEM, V285, P11129, DOI 10.1074/jbc.M109.087429; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jain MK, 1998, CIRC RES, V83, P980, DOI 10.1161/01.RES.83.10.980; Jin L, 2009, J BIOL CHEM, V284, P2121, DOI 10.1074/jbc.M806095200; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; KAMATH K, 2010, METHOD CELL BIOL, V97, P1; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; KIM E, 1989, MOL CELL BIOL, V9, P1875, DOI 10.1128/MCB.9.5.1875; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kioussi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002179; Kitamura K, 1999, DEVELOPMENT, V126, P5749; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; Lee C, 2007, DEVELOPMENT, V134, P1431, DOI 10.1242/dev.02828; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; LEWIS SA, 1985, J CELL BIOL, V101, P852, DOI 10.1083/jcb.101.3.852; Lilly B, 2010, ARTERIOSCL THROM VAS, V30, P694, DOI 10.1161/ATVBAHA.109.200741; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Mandicourt G, 2007, J BIOL CHEM, V282, P1830, DOI 10.1074/jbc.M605666200; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Mennerich D, 1998, MECH DEVELOP, V73, P147, DOI 10.1016/S0925-4773(98)00046-X; Mikhailov A, 1998, CELL MOTIL CYTOSKEL, V41, P325, DOI 10.1002/(SICI)1097-0169(1998)41:4<325::AID-CM5>3.0.CO;2-D; Miyasaka KY, 2007, P NATL ACAD SCI USA, V104, P11274, DOI 10.1073/pnas.0702000104; Nagae S, 2007, DEV DYNAM, V236, P534, DOI 10.1002/dvdy.21030; NELSON WJ, 1985, J CELL BIOL, V100, P1726, DOI 10.1083/jcb.100.5.1726; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; SASSOON DA, 1988, DEVELOPMENT, V104, P155; Schafer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843; Schevzov G, 2008, J BIOL CHEM, V283, P275, DOI 10.1074/jbc.M704392200; Schmetsdorf S, 2009, EUR J NEUROSCI, V29, P1096, DOI 10.1111/j.1460-9568.2009.06661.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shih HP, 2008, ACTA HISTOCHEM, V110, P97, DOI 10.1016/j.acthis.2007.08.004; Shih HP, 2007, P NATL ACAD SCI USA, V104, P5907, DOI 10.1073/pnas.0701122104; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; SINGH IS, 1991, BIOCHEM BIOPH RES CO, V178, P221, DOI 10.1016/0006-291X(91)91802-J; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; SUTHERLAND AE, 1991, DEVELOPMENT, V113, P339; Tachikawa K, 2008, NEUROSCI RES, V60, P135, DOI 10.1016/j.neures.2007.10.006; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041; Venters SJ, 2004, DEV DYNAM, V229, P591, DOI 10.1002/dvdy.20016; WANG D, 1986, J CELL BIOL, V103, P1903, DOI 10.1083/jcb.103.5.1903; Wang SY, 2009, J BIOL CHEM, V284, P913, DOI 10.1074/jbc.M804129200; Weernink PAO, 2004, EUR J PHARMACOL, V500, P87, DOI 10.1016/j.ejphar.2004.07.014; Wei Q, 2002, MOL BIOL CELL, V13, P683, DOI 10.1091/mbc.01-07-0358; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhang HY, 1996, DEV DYNAM, V205, P348, DOI 10.1002/(SICI)1097-0177(199603)205:3<348::AID-AJA13>3.0.CO;2-0; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	101	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35822	10.1371/journal.pone.0035822	http://dx.doi.org/10.1371/journal.pone.0035822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558231	Green Published, gold			2022-12-25	WOS:000305336000062
J	Jeong, HW; Kim, JH; Kim, JY; Ha, SJ; Kong, YY				Jeong, Hyun-Woo; Kim, Ji-Hoon; Kim, Joo-Yeon; Ha, Sang-Jun; Kong, Young-Yun			Mind Bomb-1 in Dendritic Cells Is Specifically Required for Notch-mediated T Helper Type 2 Differentiation	PLOS ONE			English	Article							IFN-GAMMA; UP-REGULATION; IN-VIVO; ACTIVATION; RESPONSES; EXPRESSION; LIGANDS; GENE; HOMOLOG; LIGASE	In dendritic cell (DC)-CD4(+) T cell interaction, Notch signaling has been implicated in the CD4(+) T cell activation, proliferation, and subset differentiation. However, there has been a lot of debate on the exact role of Notch signaling. Here, we observed that expression of Mind bomb-1 (Mib1), a critical regulator of Notch ligands for the activation of Notch signaling, increases gradually as precursor cells differentiate into DCs in mice. To clarify the role of Mib1 in DC-CD4(+) T cell interactions, we generated Mib1-null bone marrow-derived DCs. These cells readily expressed Notch ligands but failed to initiate Notch activation in the adjacent cells. Nevertheless, Mib1-null DCs were able to prime the activation and proliferation of CD4(+) T cells, suggesting that Notch activation in CD4(+) T cells is not required for these processes. Intriguingly, stimulation of CD4(+) T cells with Mib1-null DCs resulted in dramatically diminished Th2 cell populations, while preserving Th1 cell populations, both in vitro and in vivo. Our results demonstrate that Mib1 in DCs is critical for the activation of Notch signaling in CD4(+) T cells, and Notch signaling reinforces Th2 differentiation, but is not required for the activation or proliferation of the CD4(+) T cells.	[Jeong, Hyun-Woo; Kim, Ji-Hoon; Kim, Joo-Yeon; Kong, Young-Yun] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Ha, Sang-Jun] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea	Seoul National University (SNU); Yonsei University	Jeong, HW (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	ykong@snu.ac.kr		Jeong, Hyun-Woo/0000-0002-6976-6739; Ha, Sang-Jun/0000-0002-1192-6031	National Research Foundation of Korea [2011-0000309]; Korea Science and Engineering Foundation (KOSEF); Korea government (MOST) [2011-0019269]; Korean Government (MEST) [NRF-M1AXA002-2010-0029780, NRF-2011-355-C00079]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by grants from the Basic Science Research Program through the National Research Foundation of Korea (2011-0000309); the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MOST) (2011-0019269); and the National Research Foundation of Korea Grant funded by the Korean Government (MEST) (NRF-M1AXA002-2010-0029780 and NRF-2011-355-C00079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038/nri2488; De Renzis S, 2006, DEV CELL, V10, P257, DOI 10.1016/j.devcel.2006.01.011; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Ito T, 2009, J CLIN INVEST, V119, P33, DOI 10.1172/JCI35647; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Koo BK, 2009, GASTROENTEROLOGY, V137, P145, DOI 10.1053/j.gastro.2009.03.046; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kostianovsky AM, 2007, J IMMUNOL, V178, P6158, DOI 10.4049/jimmunol.178.10.6158; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; MAGGI E, 1992, J IMMUNOL, V148, P2142; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Ruan YL, 2001, P NATL ACAD SCI USA, V98, P9907, DOI 10.1073/pnas.171321098; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; SCOTT P, 1991, J IMMUNOL, V147, P3149; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Song R, 2006, J BIOL CHEM, V281, P36391, DOI 10.1074/jbc.M606601200; Sun J, 2008, J IMMUNOL, V180, P1655, DOI 10.4049/jimmunol.180.3.1655; Tacchini-Cottier F, 2004, EUR J IMMUNOL, V34, P1588, DOI 10.1002/eji.200324337; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Vollrath B, 2001, MOL CELL BIOL, V21, P7481, DOI 10.1128/MCB.21.21.7481-7494.2001; Weinmaster G, 2011, DEV CELL, V21, P134, DOI 10.1016/j.devcel.2011.06.006; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Yoon MJ, 2008, MOL CELL BIOL, V28, P4794, DOI 10.1128/MCB.00436-08; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36359	10.1371/journal.pone.0036359	http://dx.doi.org/10.1371/journal.pone.0036359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558446	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000196
J	Martincova, E; Voleman, L; Najdrova, V; De Napoli, M; Eshar, S; Gualdron, M; Hopp, CS; Sanin, DE; Tembo, DL; Van Tyne, D; Walker, D; Marcincikova, M; Tachezy, J; Dolezal, P				Martincova, Eva; Voleman, Lubos; Najdrova, Vladimira; De Napoli, Maximiliano; Eshar, Shiri; Gualdron, Melisa; Hopp, Christine S.; Sanin, David E.; Tembo, Dumizulu L.; Van Tyne, Daria; Walker, Dawn; Marcincikova, Michaela; Tachezy, Jan; Dolezal, Pavel			Live Imaging of Mitosomes and Hydrogenosomes by HaloTag Technology	PLOS ONE			English	Article							PROTOZOAN GIARDIA-LAMBLIA; TRICHOMONAS-VAGINALIS; FLUORESCENT PROTEINS; FUSION PROTEINS; LIVING CELLS; INTESTINALIS; COMPLEX; TRANSFORMATION; CYTOSKELETON; MATURATION	Hydrogenosomes and mitosomes represent remarkable mitochondrial adaptations in the anaerobic parasitic protists such as Trichomonas vaginalis and Giardia intestinalis, respectively. In order to provide a tool to study these organelles in the live cells, the HaloTag was fused to G. intestinalis IscU and T. vaginalis frataxin and expressed in the mitosomes and hydrogenosomes, respectively. The incubation of the parasites with the fluorescent Halo-ligand resulted in highly specific organellar labeling, allowing live imaging of the organelles. With the array of available ligands the HaloTag technology offers a new tool to study the dynamics of mitochondria-related compartments as well as other cellular components in these intriguing unicellular eukaryotes.	[Martincova, Eva; Voleman, Lubos; Najdrova, Vladimira; Marcincikova, Michaela; Tachezy, Jan; Dolezal, Pavel] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [De Napoli, Maximiliano] CONICET UNSAM, IIB INTECH, Lab Parasitol Mol, Chascomus, Buenos Aires, Argentina; [Eshar, Shiri] Hebrew Univ Jerusalem, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet, IMRIC,Hadassah Med Sch, Jerusalem, Israel; [Gualdron, Melisa] Christian De Duve Inst Cellular Pathol, Brussels, Belgium; [Hopp, Christine S.] London Sch Hyg & Trop Med, Malaria Ctr, London WC1, England; [Sanin, David E.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Tembo, Dumizulu L.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Van Tyne, Daria] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Walker, Dawn] Integrated Biomed Sci Ctr Microbial Interface Bio, Dept Internal Med, Columbus, OH USA	Charles University Prague; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hebrew University of Jerusalem; University of London; London School of Hygiene & Tropical Medicine; University of York - UK; University of Malawi; Harvard University; Harvard T.H. Chan School of Public Health	Martincova, E (corresponding author), Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic.	paveldolezal@yahoo.com	Gualdrón-López, Melisa/A-4438-2016; Najdrová, Vladimíra/R-4414-2017; Voleman, Luboš/M-8076-2017; Pyrihová, Eva/V-2088-2017; Tachezy, Jan/R-4945-2017; Sanin, David E/CAA-0391-2022; Sanin, David E/CAA-0373-2022; Dolezal, Pavel/V-1907-2017; Van Tyne, Daria/K-1251-2019	Gualdrón-López, Melisa/0000-0002-8202-6751; Najdrová, Vladimíra/0000-0002-1971-3882; Voleman, Luboš/0000-0003-0589-240X; Pyrihová, Eva/0000-0001-5611-1234; Tachezy, Jan/0000-0001-6976-8446; Sanin, David E/0000-0003-0188-7267; Sanin, David E/0000-0003-0188-7267; Dolezal, Pavel/0000-0003-1285-9026; Van Tyne, Daria/0000-0001-7284-0103; Hopp, Christine/0000-0002-0528-9531	Czech Science Agency [P305/10/0651, LC07032]; Ministry of Education of the Czech Republic MSM [0021620858]; Burroughs Wellcome Fund; Howard Hughes Medical Institute; Wellcome Trust	Czech Science Agency; Ministry of Education of the Czech Republic MSM(Ministry of Education, Youth & Sports - Czech Republic); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission)	Funding was provided by grants from the Czech Science Agency P305/10/0651 and LC07032 and from the Ministry of Education of the Czech Republic MSM 0021620858 and from the funders of the Biology of Parasitism course in Woods Hole (Burroughs Wellcome Fund, Howard Hughes Medical Institute and Wellcome Trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Carpenter ML, 2009, EUKARYOT CELL, V8, P916, DOI 10.1128/EC.00041-09; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Dagley MJ, 2009, MOL BIOL EVOL, V26, P1941, DOI 10.1093/molbev/msp117; Davis-Hayman SR, 2002, MOL BIOCHEM PARASIT, V122, P1, DOI 10.1016/S0166-6851(02)00063-4; Dawson SC, 2010, METHOD CELL BIOL, V97, P307, DOI 10.1016/S0091-679X(10)97017-9; Delgadillo MG, 1997, P NATL ACAD SCI USA, V94, P4716, DOI 10.1073/pnas.94.9.4716; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Dolezal P, 2007, EUKARYOT CELL, V6, P1431, DOI 10.1128/EC.00027-07; Dolezal P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000812; Drmota T, 1996, MOL BIOCHEM PARASIT, V83, P221, DOI 10.1016/S0166-6851(96)02777-6; Elias EV, 2008, J BIOL CHEM, V283, P35996, DOI 10.1074/jbc.M806545200; Elmendorf HG, 2003, INT J PARASITOL, V33, P3, DOI 10.1016/S0020-7519(02)00228-X; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gourguechon S, 2011, EUKARYOT CELL, V10, P142, DOI 10.1128/EC.00190-10; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hehl AB, 2004, MOL MICROBIOL, V53, P19, DOI 10.1111/j.1365-2958.2004.04115.x; House SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002167; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Konrad C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000835; Lauwaet T, 2007, MOL BIOCHEM PARASIT, V152, P80, DOI 10.1016/j.molbiopara.2006.12.001; Lloyd D, 2000, MICROBIOL-UK, V146, P3109, DOI 10.1099/00221287-146-12-3109; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Mukherjee M, 2006, EUKARYOT CELL, V5, P2062, DOI 10.1128/EC.00205-06; Paredez AR, 2011, P NATL ACAD SCI USA, V108, P6151, DOI 10.1073/pnas.1018593108; Poxleitner MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/science.1153752; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; Rada P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024428; Regoes A, 2005, BIOTECHNIQUES, V39, P809, DOI 10.2144/000112054; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Schneider RE, 2011, INT J PARASITOL, V41, P1421, DOI 10.1016/j.ijpara.2011.10.001; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shiflett AM, 2010, ANNU REV MICROBIOL, V64, P409, DOI 10.1146/annurev.micro.62.081307.162826; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Smith A, RES MICROBIOL, V162, P646; Smutna T, 2009, EUKARYOT CELL, V8, P47, DOI 10.1128/EC.00276-08; Stefanic S, 2009, J CELL SCI, V122, P2846, DOI 10.1242/jcs.049411; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Urh Marjeta, 2008, V421, P191; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wombacher R, 2011, J BIOPHOTONICS, V4, P391, DOI 10.1002/jbio.201100018; YU DC, 1995, MOL CELL BIOL, V15, P4867; Yu DC, 1996, MOL BIOCHEM PARASIT, V83, P81, DOI 10.1016/S0166-6851(96)02752-1	49	14	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36314	10.1371/journal.pone.0036314	http://dx.doi.org/10.1371/journal.pone.0036314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558433	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000188
J	McCabe, R; Bullenkamp, J; Hansson, L; Lauber, C; Martinez-Leal, R; Rossler, W; Salize, HJ; Svensson, B; Torres-Gonzalez, F; van den Brink, R; Wiersma, D; Priebe, S				McCabe, Rosemarie; Bullenkamp, Jens; Hansson, Lars; Lauber, Christoph; Martinez-Leal, Rafael; Roessler, Wulf; Salize, Hans Joachim; Svensson, Bengt; Torres-Gonzalez, Francisco; van den Brink, Rob; Wiersma, Durk; Priebe, Stefan			The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia	PLOS ONE			English	Article							2-WAY COMMUNICATION CHECKLIST; MENTAL-HEALTH-CARE; WORKING ALLIANCE; HELPING ALLIANCE; CASE-MANAGEMENT; PSYCHOTHERAPY; PHARMACOTHERAPY; PERSPECTIVES; VARIABLES; OUTCOMES	Objective: Previous research has shown that a better therapeutic relationship (TR) predicts more positive attitudes towards antipsychotic medication, but did not address whether it is also linked with actual adherence. This study investigated whether the TR is associated with adherence to antipsychotics in patients with schizophrenia. Methods: 134 clinicians and 507 of their patients with schizophrenia or a related psychotic disorder participated in a European multi-centre study. A logistic regression model examined how the TR as rated by patients and by clinicians is associated with medication adherence, adjusting for clinician clustering and symptom severity. Results: Patient and clinician ratings of the TR were weakly inter-correlated (r(s) = 0.13, p = 0.004), but each was independently linked with better adherence. After adjusting for patient rated TR and symptom severity, each unit increase in clinician rated TR was associated with an increase of the odds ratio of good compliance by 65.9% (95% CI: 34.6% to 104.5%). After adjusting for clinician rated TR and symptom severity, for each unit increase in patient rated TR the odds ratio of good compliance was increased by 20.8% (95% CI: 4.4% to 39.8%). Conclusions: A better TR is associated with better adherence to medication among patients with schizophrenia. Patients' and clinicians' perspectives of the TR are both important, but may reflect distinct aspects.	[McCabe, Rosemarie; Priebe, Stefan] Queen Mary Univ London, Unit Social & Community Psychiat, London, England; [Bullenkamp, Jens; Salize, Hans Joachim] Cent Inst Mental Hlth, D-6800 Mannheim, Germany; [Hansson, Lars; Svensson, Bengt] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Lauber, Christoph] Univ Liverpool, Dept Psychiat, Liverpool L69 3BX, Merseyside, England; [Martinez-Leal, Rafael] Fdn Villablanca, Intellectual Disabil Dual Diag Res Unit, Reus, Spain; [Roessler, Wulf] Psychiat Univ Hosp, Dept Gen & Social Psychiat, Zurich, Switzerland; [Torres-Gonzalez, Francisco] Univ Granada, Dept Psychiat, Granada, Spain; [van den Brink, Rob; Wiersma, Durk] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands	University of London; Queen Mary University London; Central Institute of Mental Health; Lund University; University of Liverpool; University of Granada; University of Groningen	McCabe, R (corresponding author), Queen Mary Univ London, Unit Social & Community Psychiat, London, England.	r.mccabe@qmul.ac.uk	Martínez-Leal, Rafael/B-4073-2009; McCabe, Rose/A-9802-2013	Martínez-Leal, Rafael/0000-0002-1333-7951; Priebe, Stefan/0000-0001-9864-3394; McCabe, Rose/0000-0003-2041-7383; Rossler, Wulf/0000-0003-0049-4533	Research Directorate of the European Commission [QLG5-CT-2002-01938]	Research Directorate of the European Commission	The study was funded by the Research Directorate of the European Commission within Framework Programme 5 (QLG5-CT-2002-01938). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnicot K, 2010, ACTA PSYCHIAT SCAND, P1; Bentall R, 2012, J CONSULT C IN PRESS; BRENNER MH, 1995, MED CARE, V33, pAS236; BUCHANAN A, 1992, PSYCHOL MED, V22, P787, DOI 10.1017/S0033291700038228; Calsyn Robert J, 2004, Care Manag J, V5, P199, DOI 10.1891/cmaj.2004.5.4.199; Catty J, 2007, ACTA PSYCHIAT SCAND, V116, P238, DOI 10.1111/j.1600-0447.2007.01070.x; CLARKIN JF, 1987, HOSP COMMUNITY PSYCH, V38, P871; Day JC, 2005, ARCH GEN PSYCHIAT, V62, P717, DOI 10.1001/archpsyc.62.7.717; Donohoe G, 2001, EUR PSYCHIAT, V16, P293, DOI 10.1016/S0924-9338(01)00581-8; FRANK AF, 1990, ARCH GEN PSYCHIAT, V47, P228; Gaudiano BA, 2006, J CONSULT CLIN PSYCH, V74, P671, DOI 10.1037/0022-006X.74.4.671; GEHRS M, 1994, PSYCHOSOC REHABIL J, V18, P43, DOI 10.1037/h0095517; Holzinger A, 2002, J NERV MENT DIS, V190, P597, DOI 10.1097/00005053-200209000-00004; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; Junghan UM, 2007, BRIT J PSYCHIAT, V191, P543, DOI 10.1192/bjp.bp.107.037978; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Klinkenberg WD, 1998, COMMUNITY MENT HLT J, V34, P569, DOI 10.1023/A:1018758917277; Krupnick JL, 1996, J CONSULT CLIN PSYCH, V64, P532, DOI 10.1037/0022-006X.64.3.532; Lacro JP, 2002, J CLIN PSYCHIAT, V63, P892, DOI 10.4088/JCP.v63n1007; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; McCabe R, 2003, EUR PSYCHIAT, V18, P220, DOI 10.1016/S0924-9338(03)00061-0; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; NEALE MS, 1995, PSYCHIATR SERV, V46, P719; PRIEBE S, 1993, J NERV MENT DIS, V181, P552, DOI 10.1097/00005053-199309000-00004; Priebe S, 2007, BRIT J PSYCHIAT, V191, P420, DOI 10.1192/bjp.bp.107.036939; SOLOMON P, 1995, J MENT HEALTH ADMIN, V22, P126, DOI 10.1007/BF02518753; Strachey J, STANDARD EDITION COM; Svensson B, 1999, J NERV MENT DIS, V187, P579, DOI 10.1097/00005053-199909000-00008; van Os J, 2008, ACTA PSYCHIAT SCAND, V118, P322, DOI 10.1111/j.1600-0447.2008.01228.x; Van Os J, 2004, BRIT J PSYCHIAT, V184, P79, DOI 10.1192/bjp.184.1.79; Velligan DI, 2006, SCHIZOPHRENIA BULL, V32, P724, DOI 10.1093/schbul/sbj075; Velligan DI, 2003, PSYCHIAT SERV, V54, P665, DOI 10.1176/appi.ps.54.5.665; Weiss M, 1997, J CLIN PSYCHIAT, V58, P196, DOI 10.4088/JCP.v58n0504; WOLFE BE, 1988, J CONSULT CLIN PSYCH, V56, P448, DOI 10.1037/0022-006X.56.3.448	34	70	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36080	10.1371/journal.pone.0036080	http://dx.doi.org/10.1371/journal.pone.0036080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558336	Green Accepted, Green Published, gold			2022-12-25	WOS:000305336000122
J	Qiu, M; Wang, Q; Chu, Y; Yuan, ZP; Song, HY; Chen, ZW; Wu, ZW				Qiu, Min; Wang, Qin; Chu, Ying; Yuan, Zhongping; Song, Hongyong; Chen, Zhiwei; Wu, Zhiwei			Lignosulfonic Acid Exhibits Broadly Anti-HIV-1 Activity - Potential as a Microbicide Candidate for the Prevention of HIV-1 Sexual Transmission	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEXTRAN SULFATE; ENVELOPE GLYCOPROTEINS; V3 REGION; BINDING; INFECTION; GP120; HEPARIN; INHIBITION; CELLS	Some secondary metabolites from plants show to have potent inhibitory activities against microbial pathogens, such as human immunodeficiency virus (HIV), herpes simplex virus (HSV), Treponema pallidum, Neisseria gonorrhoeae, etc. Here we report that lignosulfonic acid (LSA), a polymeric lignin derivative, exhibits potent and broad activity against HIV-1 isolates of diverse subtypes including two North America strains and a number of Chinese clinical isolates values ranging from 21.4 to 633 nM. Distinct from other polyanions, LSA functions as an entry inhibitor with multiple targets on viral gp120 as well as on host receptor CD4 and co-receptors CCR5/CXCR4. LSA blocks viral entry as determined by time-of-drug addiction and cell-cell fusion assays. Moreover, LSA inhibits CD4-gp120 interaction by blocking the binding of antibodies specific for CD4-binding sites (CD4bs) and for the V3 loop of gp120. Similarly, LSA interacts with CCR5 and CXCR4 via its inhibition of specific anti-CCR5 and anti-CXCR4 antibodies, respectively. Interestingly, the combination of LSA with AZT and Nevirapine exhibits synergism in viral inhibition. For the purpose of microbicide development, LSA displays low in vitro cytotoxicity to human genital tract epithelial cells, does not stimulate NF-kappa B activation and has no significant up-regulation of IL-1 alpha/beta and IL-8 as compared with N-9. Lastly, LSA shows no adverse effect on the epithelial integrity and the junctional protein expression. Taken together, our findings suggest that LSA can be a potential candidate for tropical microbicide.	[Qiu, Min; Wang, Qin; Chu, Ying; Yuan, Zhongping; Song, Hongyong; Wu, Zhiwei] Nanjing Univ, Sch Med, Ctr Publ Hlth Res, Nanjing 210008, Peoples R China; [Wu, Zhiwei] Nanjing Univ, State Key Lab Analyt Chem Life Sci, Nanjing 210008, Peoples R China; [Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Hong Kong, Peoples R China	Nanjing University; Nanjing University; University of Hong Kong	Qiu, M (corresponding author), Nanjing Univ, Sch Med, Ctr Publ Hlth Res, Nanjing 210008, Peoples R China.	zchenai@hku.hk; wzhw@nju.edu.cn	Chen, Zhiwei/B-7793-2019	Chen, Zhiwei/0000-0002-4511-2888	National Science and Technology Major Project Grant [2012ZX10001007-009-001]; National Science Foundation of China [30870124]; International Collaborative Research Grant from the Ministry of Sciences and Technology of China [2009DFA31260]	National Science and Technology Major Project Grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Collaborative Research Grant from the Ministry of Sciences and Technology of China	This study was supported by a National Science and Technology Major Project Grant (Grant No. 2012ZX10001007-009-001), and a grant from National Science Foundation of China (Grant No. 30870124) and an International Collaborative Research Grant from the Ministry of Sciences and Technology of China (Grant No. 2009DFA31260) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA M, 1988, ANTIVIR RES, V9, P335, DOI 10.1016/0166-3542(88)90035-6; BATINIC D, 1992, J BIOL CHEM, V267, P6664; CALLAHAN LN, 1991, J VIROL, V65, P1543, DOI 10.1128/JVI.65.3.1543-1550.1991; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chou T.C., 1991, CALCUSYN WINDOWS SOF; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; Daelemans D, 2005, MOL PHARMACOL, V67, P1574, DOI 10.1124/mol.104.010249; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Harrop HA, 1998, GLYCOBIOLOGY, V8, P131, DOI 10.1093/glycob/8.2.131; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; ITO M, 1987, ANTIVIR RES, V7, P361, DOI 10.1016/0166-3542(87)90018-0; JOHNSON VA, 1990, TECHNIQUES HIV RES, P71; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; LEDERMAN S, 1989, J IMMUNOL, V143, P1149; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Li L, 2010, ANTIMICROB AGENTS CH, V54, P1700, DOI 10.1128/AAC.01046-09; LORENTSEN KJ, 1989, ANN INTERN MED, V111, P561, DOI 10.7326/0003-4819-111-7-561; LYNCH G, 1994, J LEUKOCYTE BIOL, V56, P266, DOI 10.1002/jlb.56.3.266; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; NAHMIAS AJ, 1964, J BACTERIOL, V87, P1060, DOI 10.1128/JB.87.5.1060-1066.1964; NAKASHIMA H, 1995, ANTIVIR CHEM CHEMOTH, V6, P271, DOI 10.1177/095632029500600410; PARISH CR, 1990, J IMMUNOL, V145, P1188; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Raghuraman A, 2007, BIOMACROMOLECULES, V8, P1759, DOI 10.1021/bm0701651; RIDER CC, 1994, BIOCHEMISTRY-US, V33, P6974, DOI 10.1021/bi00188a029; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Roehr B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5538; Rusconi S, 1996, ANTIMICROB AGENTS CH, V40, P234, DOI 10.1128/AAC.40.1.234; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Tufaro F, 1997, TRENDS MICROBIOL, V5, P257, DOI 10.1016/S0966-842X(97)01057-3; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; WITVROUW M, 1994, ANTIVIR CHEM CHEMOTH, V5, P345, DOI 10.1177/095632029400500601; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	50	13	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35906	10.1371/journal.pone.0035906	http://dx.doi.org/10.1371/journal.pone.0035906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558266	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000082
J	Wilkinson, FL; Holley, RJ; Langford-Smith, KJ; Badrinath, S; Liao, AY; Langford-Smith, A; Cooper, JD; Jones, SA; Wraith, JE; Wynn, RF; Merry, CLR; Bigger, BW				Wilkinson, Fiona L.; Holley, Rebecca J.; Langford-Smith, Kia J.; Badrinath, Soumya; Liao, Aiyin; Langford-Smith, Alex; Cooper, Jonathan D.; Jones, Simon A.; Wraith, J. Ed; Wynn, Rob F.; Merry, Catherine L. R.; Bigger, Brian W.			Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; LYSOSOMAL STORAGE DISORDERS; ALPHA-L-IDURONIDASE; SYNDROME TYPE-B; SANFILIPPO-SYNDROME; MICROGLIAL ACTIVATION; TARGETED DISRUPTION; DISEASE; BRAIN; MICE	Mucopolysaccharide diseases (MPS) are caused by deficiency of glycosaminoglycan (GAG) degrading enzymes, leading to GAG accumulation. Neurodegenerative MPS diseases exhibit cognitive decline, behavioural problems and shortened lifespan. We have characterised neuropathological changes in mouse models of MPSI, IIIA and IIIB to provide a better understanding of these events. Wild-type (WT), MPSI, IIIA and IIIB mouse brains were analysed at 4 and 9 months of age. Quantitative immunohistochemistry showed significantly increased lysosomal compartment, GM2 ganglioside storage, neuroinflammation, decreased and mislocalised synaptic vesicle associated membrane protein, (VAMP2), and decreased post-synaptic protein, Homer-1, in layers II/III-VI of the primary motor, somatosensory and parietal cortex. Total heparan sulphate (HS), was significantly elevated, and abnormally N-, 6-O and 2-O sulphated compared to WT, potentially altering HS-dependent cellular functions. Neuroinflammation was confirmed by significantly increased MCP-1, MIP-1 alpha, IL-1 alpha, using cytometric bead arrays. An overall genotype effect was seen in all parameters tested except for synaptophysin staining, neuronal cell number and cortical thickness which were not significantly different from WT. MPSIIIA and IIIB showed significantly more pronounced pathology than MPSI in lysosomal storage, astrocytosis, microgliosis and the percentage of 2-O sulphation of HS. We also observed significant time progression of all genotypes from 4-9 months in lysosomal storage, astrocytosis, microgliosis and synaptic disorganisation but not GM2 gangliosidosis. Individual genotype*time differences were disparate, with significant progression from 4 to 9 months only seen for MPSIIIB with lysosomal storage, MPSI with astrocytocis and MPSIIIA with microgliosis as well as neuronal loss. Transmission electron microscopy of MPS brains revealed dystrophic axons, axonal storage, and extensive lipid and lysosomal storage. These data lend novel insight to MPS neuropathology, suggesting that MPSIIIA and IIIB have more pronounced neuropathology than MPSI, yet all are still progressive, at least in some aspects of neuropathology, from 4-9 months.	[Wilkinson, Fiona L.; Langford-Smith, Kia J.; Badrinath, Soumya; Liao, Aiyin; Langford-Smith, Alex; Bigger, Brian W.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Holley, Rebecca J.; Merry, Catherine L. R.] Univ Manchester, Sch Mat, Manchester, Lancs, England; [Cooper, Jonathan D.] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, Ctr Cellular Basis Behav, London, England; [Cooper, Jonathan D.] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, Pediat Storage Disorders Lab,Dept Neurosci, London, England; [Wynn, Rob F.] Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M27 1HA, Lancs, England; [Jones, Simon A.; Wraith, J. Ed] St Marys Hosp, Manchester M13 0JH, Lancs, England	University of Manchester; University of Manchester; University of London; King's College London; University of London; King's College London; Royal Manchester Children's Hospital; University of Manchester	Wilkinson, FL (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	Brian.Bigger@manchester.ac.uk	Langford-Smith, Alex/H-5249-2011; Langford-Smith, Alex/K-7624-2017; Badrinath, Soumya/AGK-8855-2022; Cooper, Jonathan/V-9962-2019; Cooper, Jonathan/C-8117-2009; Bigger, Brian/I-3553-2012	Langford-Smith, Alex/0000-0001-7006-0592; Langford-Smith, Alex/0000-0001-7006-0592; Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750; Bigger, Brian/0000-0002-9708-1112; merry, catherine/0000-0002-3490-2809; Wilkinson, Fiona/0000-0002-0358-3489	Mucopolysaccharidosis Society (United Kingdom); Lady Shauna Gosling Trust; National Institute of Health Research Manchester Biomedical Research Centre; Human Frontier Science Program; Medical Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Fund; University of Manchester	Mucopolysaccharidosis Society (United Kingdom); Lady Shauna Gosling Trust; National Institute of Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Fund(Burroughs Wellcome Fund); University of Manchester	This study was funded by grants awarded to BWB by the Mucopolysaccharidosis Society (United Kingdom), the Lady Shauna Gosling Trust and supported by the National Institute of Health Research Manchester Biomedical Research Centre. RJH and CLRM would like to acknowledge funding from The Human Frontier Science Program and The Medical Research Council. The Bioimaging Facility microscopes used in this study were purchased with grants from Biotechnology and Biological Sciences Research Council, Wellcome and the University of Manchester Strategic Fund. The funders had no role in the study design, data collection and analysis, decision to publish or in preparation of the manuscript.	Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bhaumik M, 1999, GLYCOBIOLOGY, V9, P1389, DOI 10.1093/glycob/9.12.1389; Blackhall FH, 2001, BRIT J CANCER, V85, P1094, DOI 10.1054/bjoc.2001.2054; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; Clarke Lorne A., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000550; CONSTANTOPOULOS G, 1978, J NEUROCHEM, V30, P965, DOI 10.1111/j.1471-4159.1978.tb12388.x; Crawley AC, 2006, BRAIN RES, V1104, P1, DOI 10.1016/j.brainres.2006.05.079; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Foa L, 2009, J NEUROCHEM, V108, P1, DOI 10.1111/j.1471-4159.2008.05726.x; Fraser J, 2002, CLIN GENET, V62, P418, DOI 10.1034/j.1399-0004.2002.620512.x; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Hemsley KM, 2009, EUR J NEUROSCI, V29, P1197, DOI 10.1111/j.1460-9568.2009.06666.x; Hemsley KM, 2008, GENES BRAIN BEHAV; Hochuli M, 2003, NMR BIOMED, V16, P224, DOI 10.1002/nbm.833; Holley RJ, 2011, J BIOL CHEM, V286, P37515, DOI 10.1074/jbc.M111.287474; Jaubert PJ, 2007, GENES BRAIN BEHAV, V6, P141, DOI 10.1111/j.1601-183X.2006.00240.x; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; King B, 2006, MOL GENET METAB, V87, P107, DOI 10.1016/j.ymgme.2005.09.026; Langford-Smith A, 2011, GENES BRAIN BEHAV, V10, P673, DOI 10.1111/j.1601-183X.2011.00706.x; Langford-Smith A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025717; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; Malinowska M, 2009, MOL GENET METAB, V98, P235, DOI 10.1016/j.ymgme.2009.06.013; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Neufeld EF, 2007, MUCOPOLYSACCHARIDOSE; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Paxinos F, 2004, MOUSE BRAIN STEREOTA; Perrimon N, 2001, SEMIN CELL DEV BIOL, V12, P65, DOI 10.1006/scdb.2000.0237; Prasad VK, 2008, BLOOD, V112, P2979, DOI 10.1182/blood-2008-03-140830; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Savas PS, 2004, MOL GENET METAB, V82, P273, DOI 10.1016/j.ymgme.2004.05.005; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Szumlinski KK, 2005, GENES BRAIN BEHAV, V4, P273, DOI 10.1111/j.1601-183X.2005.00120.x; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Tomatsu S, MOL GENET METAB, V99, P124; Tyynela J, 2004, BRAIN PATHOL, V14, P349; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5; Vitry S, 2009, MOL CELL NEUROSCI, V41, P8, DOI 10.1016/j.mcn.2009.01.001; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Wraith J E, 2002, Semin Neonatol, V7, P75, DOI 10.1053/siny.2001.0088; Yamaguchi Y, 2010, PROG MOL BIOL TRANSL, V93, P133, DOI 10.1016/S1877-1173(10)93007-X	55	126	130	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35787	10.1371/journal.pone.0035787	http://dx.doi.org/10.1371/journal.pone.0035787			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558223	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000060
J	Ekstrom, MP; Jogreus, C; Strom, KE				Ekstrom, Magnus P.; Jogreus, Claes; Strom, Kerstin E.			Comorbidity and Sex-Related Differences in Mortality in Oxygen-Dependent Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							PREDICT MORTALITY; CO-MORBIDITY; GENDER; SURVIVAL; THERAPY; DETERMINANTS; EMPHYSEMA; SEVERITY; OUTCOMES; MODELS	Background: It is not known why survival differs between men and women in oxygen-dependent chronic obstructive pulmonary disease (COPD). The present study evaluates differences in comorbidity between men and women, and tests the hypothesis that comorbidity contributes to sex-related differences in mortality in oxygen-dependent COPD. Methods: National prospective study of patients aged 50 years or older, starting long-term oxygen therapy (LTOT) for COPD in Sweden between 1992 and 2008. Comorbidities were obtained from the Swedish Hospital Discharge Register. Sex-related differences in comorbidity were estimated using logistic regression, adjusting for age, smoking status and year of inclusion. The effect of comorbidity on overall mortality and the interaction between comorbidity and sex were evaluated using Cox regression, adjusting for age, sex, Pa-O2 breathing air, FEV1, smoking history and year of inclusion. Results: In total, 8,712 patients (55% women) were included and 6,729 patients died during the study period. No patient was lost to follow-up. Compared with women, men had significantly more arrhythmia, cancer, ischemic heart disease and renal failure, and less hypertension, mental disorders, osteoporosis and rheumatoid arthritis (P<0.05 for all odds ratios). Comorbidity was an independent predictor of mortality, and the effect was similar for the sexes. Women had lower mortality, which remained unchanged even after adjusting for comorbidity; hazard ratio 0.73 (95% confidence interval, 0.68-0.77; P<0.001). Conclusions: Comorbidity is different in men and women, but does not explain the sex-related difference in mortality in oxygen-dependent COPD.	[Ekstrom, Magnus P.; Strom, Kerstin E.] Lund Univ, Dept Resp Med & Allergol, Inst Clin Sci, Lund, Sweden; [Jogreus, Claes] Blekinge Inst Technol, Dept Math & Sci, Sch Engn, Karlskrona, Sweden	Lund University; Blekinge Institute Technology	Ekstrom, MP (corresponding author), Lund Univ, Dept Resp Med & Allergol, Inst Clin Sci, Lund, Sweden.	pmekstrom@gmail.com		Ekstrom, Magnus/0000-0002-7227-5113	Swedish Heart and Lung Foundation; Swedish National Board of Health and Welfare; Research Council of Blekinge	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish National Board of Health and Welfare; Research Council of Blekinge	The study was supported by grants from the Swedish Heart and Lung Foundation (URL: http://www.hjart-lungfonden.se), the Swedish National Board of Health and Welfare (URL: http://www.socialstyrelsen.se), and the Research Council of Blekinge (http://www.ltblekinge.se/omlandstinget/blekingekompetenscentrum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2010, RESP MED, V104, P253, DOI 10.1016/j.rmed.2009.09.019; Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], 1980, ANN INTERN MED, V93, P391; [Anonymous], 1992, MAN INT STAT CLASS D; BERGLUND E, 1963, ACTA MED SCAND, V173, P185; Celli B, 2011, AM J RESP CRIT CARE, V183, P317, DOI 10.1164/rccm.201004-0665OC; Chailleux E, 1996, CHEST, V109, P741, DOI 10.1378/chest.109.3.741; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COX DR, 1972, J R STAT SOC B, V34, P187; Crockett AJ, 2001, INTERN MED J, V31, P448, DOI 10.1046/j.1445-5994.2001.00103.x; Curkendall SM, 2006, EUR J EPIDEMIOL, V21, P803, DOI 10.1007/s10654-006-9066-1; de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108; de Torres JP, 2005, CHEST, V128, P2012, DOI 10.1378/chest.128.4.2012; de Torres JP, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-72; Dransfield MT, 2007, CHEST, V132, P464, DOI 10.1378/chest.07-0863; Ekstrom M, 2010, CHEST, V137, P31, DOI 10.1378/chest.09-0636; Ekstrom MP, 2011, AM J RESP CRIT CARE, V183, P1032, DOI 10.1164/rccm.201010-1704OC; FLENLEY DC, 1981, LANCET, V1, P681; Franklin KA, 2007, RESP MED, V101, P1506, DOI 10.1016/j.rmed.2007.01.009; Hanania NA, 2011, AM J RESP CRIT CARE, V183, P604, DOI 10.1164/rccm.201003-0472OC; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Incalzi RA, 1997, EUR RESPIR J, V10, P2794, DOI 10.1183/09031936.97.10122794; Lash TL, 2011, LUNG, V189, P27, DOI 10.1007/s00408-010-9274-z; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Machado MCL, 2006, AM J RESP CRIT CARE, V174, P524, DOI 10.1164/rccm.200507-1057OC; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Marti S, 2006, EUR RESPIR J, V27, P689, DOI 10.1183/09031936.06.00076405; MIYAMOTO K, 1995, AM J RESP CRIT CARE, V152, P972, DOI 10.1164/ajrccm.152.3.7663812; Rothman K.J., 2008, MODERN EPIDEMIOLOGY, P128; Rutten FH, 2006, EUR J HEART FAIL, V8, P706, DOI 10.1016/j.ejheart.2006.01.010; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; STROM K, 1988, EUR RESPIR J, V1, P952; Swedish National Board of Health and Welfare, 2008, QUAL CONT SWED HOSP; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; World Health Organization (WHO), 1978, MAN INT CLASS DIS IN; XU X, 1994, EUR RESPIR J, V7, P1056	38	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35806	10.1371/journal.pone.0035806	http://dx.doi.org/10.1371/journal.pone.0035806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563405	gold, Green Published			2022-12-25	WOS:000305349100032
J	Luksha, L; Stenvinkel, P; Hammarqvist, F; Carrero, JJ; Davidge, ST; Kublickiene, K				Luksha, Leanid; Stenvinkel, Peter; Hammarqvist, Folke; Carrero, Juan Jesus; Davidge, Sandra T.; Kublickiene, Karolina			Mechanisms of Endothelial Dysfunction in Resistance Arteries from Patients with End-Stage Renal Disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CHRONIC KIDNEY-DISEASE; EXPERIMENTAL DIABETIC-NEPHROPATHY; HYPERPOLARIZING FACTOR; ASYMMETRIC DIMETHYLARGININE; DEPENDENT VASODILATION; CARDIOVASCULAR-DISEASE; SUPEROXIDE-PRODUCTION; MESENTERIC-ARTERIES; HYPERTENSIVE-RATS	The study focuses on the mechanisms of endothelial dysfunction in the uremic milieu. Subcutaneous resistance arteries from 35 end-stage renal disease (ESRD) patients and 28 matched controls were studied ex-vivo. Basal and receptor-dependent effects of endothelium-derived factors, expression of endothelial NO synthase (eNOS), prerequisites for myoendothelial gap junctions (MEGJ), and associations between endothelium-dependent responses and plasma levels of endothelial dysfunction markers were assessed. The contribution of endothelium-derived hyperpolarizing factor (EDHF) to endothelium-dependent relaxation was impaired in uremic arteries after stimulation with bradykinin, but not acetylcholine, reflecting the agonist-specific differences. Diminished vasodilator influences of the endothelium on basal tone and enhanced plasma levels of asymmetrical dimethyl L-arginine (ADMA) suggest impairment in NO-mediated regulation of uremic arteries. eNOS expression and contribution of MEGJs to EDHF type responses were unaltered. Plasma levels of ADMA were negatively associated with endothelium-dependent responses in uremic arteries. Preserved responses of smooth muscle to pinacidil and NO-donor indicate alterations within the endothelium and tolerance of vasodilator mechanisms to the uremic retention products at the level of smooth muscle. We conclude that both EDHF and NO pathways that control resistance artery tone are impaired in the uremic milieu. For the first time, we validate the alterations in EDHF type responses linked to kinin receptors in ESRD patients. The association between plasma ADMA concentrations and endothelial function in uremic resistance vasculature may have diagnostic and future therapeutic implications.	[Luksha, Leanid; Kublickiene, Karolina] Karolinska Inst, Karolinska Univ Hosp, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Stenvinkel, Peter; Carrero, Juan Jesus] Karolinska Inst, Karolinska Univ Hosp, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Hammarqvist, Folke] Karolinska Inst, Karolinska Univ Hosp, Div Surg, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Alberta	Luksha, L (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	karolina.kublickiene@ki.se		Kublickiene, Karolina/0000-0002-4841-6836; Carrero, Juan Jesus/0000-0003-4763-2024; Davidge, Sandra/0000-0002-5559-4905; Stenvinkel, Peter/0000-0002-8785-4820	Swedish Society of Medicine; Swedish Heart and Lung Foundation; Center for Gender Medicine at Karolinska Institutet; Loo and Hans Ostermans Foundation; Swedish Kidney Association; Karolinska Institute Research Funds; AFA insurance; Department of Clinical Science, Intervention & Technology (CLINTEC) at Karolinska Institutet, Sweden; Canadian Institute for Health Research	Swedish Society of Medicine; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Center for Gender Medicine at Karolinska Institutet(Karolinska Institutet); Loo and Hans Ostermans Foundation; Swedish Kidney Association; Karolinska Institute Research Funds(Karolinska Institutet); AFA insurance; Department of Clinical Science, Intervention & Technology (CLINTEC) at Karolinska Institutet, Sweden; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Financial support was provided by grants from the Swedish Society of Medicine, Swedish Heart and Lung Foundation, Center for Gender Medicine at Karolinska Institutet, Loo and Hans Ostermans Foundation, the Swedish Kidney Association and the Karolinska Institute Research Funds. L. Luksha is supported by PostDoc research grants from AFA insurance and Department of Clinical Science, Intervention & Technology (CLINTEC) at Karolinska Institutet, Sweden. S. Davidge is supported by Canadian Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Albrecht EWJA, 2003, NITRIC OXIDE-BIOL CH, V8, P53, DOI 10.1016/S1089-8603(02)00132-5; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Benchetrit S, 2003, EUR J CLIN INVEST, V33, P26, DOI 10.1046/j.1365-2362.2003.01102.x; Billecke SS, 2009, NEPHROL DIAL TRANSPL, V24, P489, DOI 10.1093/ndt/gfn500; Bonomini M, 2005, KIDNEY INT, V67, P1899, DOI 10.1111/j.1523-1755.2005.00288.x; Chhabra N, 2009, INTERNET J MED UPDAT, V4, P33; Deka DK, 1998, EUR J PHARMACOL, V348, P11, DOI 10.1016/S0014-2999(98)00066-1; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Gomez-Fernandez P, 2005, NEFROLOGIA, V25, P155; Gschwend S, 2009, LIFE SCI, V85, P431, DOI 10.1016/j.lfs.2009.07.006; Kalliovalkama J, 1999, AM J PHYSIOL-HEART C, V277, pH1622, DOI 10.1152/ajpheart.1999.277.4.H1622; Kao MPC, 2010, J HUM HYPERTENS, V24, P1, DOI 10.1038/jhh.2009.70; Kim SW, 2000, J KOREAN MED SCI, V15, P425, DOI 10.3346/jkms.2000.15.4.425; Kimura K, 1999, SCAND J CLIN LAB INV, V59, P199, DOI 10.1080/00365519950185724; Kohler R, 2005, KIDNEY INT, V67, P2280, DOI 10.1111/j.1523-1755.2005.00331.x; KUHBERGER E, 1993, J CARDIOVASC PHARM, V21, P947; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Linden E, 2008, CLIN J AM SOC NEPHRO, V3, P691, DOI 10.2215/CJN.04291007; Luksha L, 2008, AM J PHYSIOL-REG I, V294, pR510, DOI 10.1152/ajpregu.00458.2007; Luksha L, 2010, BIOL REPROD, V83, P728, DOI 10.1095/biolreprod.110.084426; Luksha L, 2009, ATHEROSCLEROSIS, V202, P330, DOI 10.1016/j.atherosclerosis.2008.06.008; Luksha R, 2011, CLIN SCI, V120, P525, DOI 10.1042/CS20100277; Malyszko JS, 2006, J NEPHROL, V19, P150; Mittermayer F, 2005, J AM SOC NEPHROL, V16, P1832, DOI 10.1681/ASN.2004121109; Morris STW, 2001, KIDNEY INT, V60, P1077, DOI 10.1046/j.1523-1755.2001.0600031077.x; Pascoal IF, 1998, J CLIN INVEST, V101, P464, DOI 10.1172/JCI557; Passauer J, 2005, KIDNEY INT, V67, P1907, DOI 10.1111/j.1523-1755.2005.00289.x; Passauer J, 2005, J AM SOC NEPHROL, V16, P959, DOI 10.1681/ASN.2004070582; Passauer J, 2000, J AM SOC NEPHROL, V11, P1726, DOI 10.1681/ASN.V1191726; Prasad A, 2000, J AM COLL CARDIOL, V36, P1467, DOI 10.1016/S0735-1097(00)00892-5; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; Satoh M, 2005, AM J PHYSIOL-RENAL, V288, pF1144, DOI 10.1152/ajprenal.00221.2004; Satoh M, 2008, NEPHROL DIAL TRANSPL, V23, P3806, DOI 10.1093/ndt/gfn357; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Sokoya EM, 2007, MICROVASC RES, V74, P39, DOI 10.1016/j.mvr.2007.03.003; Stenvinkel P, 2003, J AM SOC NEPHROL, V14, P1927, DOI 10.1097/01.ASN.0000069165.79509.42; Stojnic N, 2007, J PHARMACOL SCI, V104, P122, DOI 10.1254/jphs.FP0061434; Veresh Z, 2008, HYPERTENSION, V52, P960, DOI 10.1161/HYPERTENSIONAHA.108.116731; Vettoretti S, 2006, J HYPERTENS, V24, P2215, DOI 10.1097/01.hjh.0000249699.04113.36; Wadham C, 2009, EXPERT OPIN DRUG MET, V5, P303, DOI [10.1517/17425250902785172 , 10.1517/17425250902785172]; Wirth KJ, 1996, N-S ARCH PHARMACOL, V354, P38; Yilmaz MI, 2008, NEPHROL DIAL TRANSPL, V23, P959, DOI 10.1093/ndt/gfm727; Yilmaz MI, 2005, TRANSPLANTATION, V80, P1660, DOI 10.1097/01.tp.0000183750.22675.be	45	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36056	10.1371/journal.pone.0036056	http://dx.doi.org/10.1371/journal.pone.0036056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563439	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349100065
J	Nilsson, S; Moller, C; Jirstrom, K; Lee, A; Busch, S; Lamb, R; Landberg, G				Nilsson, Sofie; Moller, Christina; Jirstrom, Karin; Lee, Alexander; Busch, Susann; Lamb, Rebecca; Landberg, Goran			Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration	PLOS ONE			English	Article							EXPRESSION; MICRORNAS; DEREGULATION; PLASMA	Background: MicroRNAs are small non-coding RNAs involved in the regulation of gene expression on a posttranscriptional level. These regulatory RNAs have been implicated in numerous cellular processes and are further deregulated in different cancer types, including breast cancer. MiR-92a is part of the miR-17 similar to 92 cluster, which was first reported to be linked to tumourigenesis. However, little is known about the expression of miR-92a in breast cancer and potential associations to tumour properties. The expression of miR-92a was therefore characterized in 144 invasive breast cancer samples using in situ hybridization and related to clinico-pathological data as well as to selected key properties of the tumour stroma, including the presence of macrophages (CD68) and cancer activated fibroblasts (alpha-SMA). Methodology/Principal Findings: To measure miR-92a levels, an in situ hybridisation protocol was developed and validated using cell lines and miR-92a inhibitors. The expression in the tumour samples was objectively evaluated using digital image analysis program subtracting background activities. We found that the miR-92a expression varied between tumours and was inversely correlated to tumour grade (r = -0.276, p = 0.003) and recurrence-free survival (p = 0.008) and provided independent prognostic information in multivariate Cox analysis (HR: 0.375, CI: 0.145-0.972, p = 0.043). MiR-92a was moreover inversely correlated to the number of infiltrating macrophages in the tumour stroma (r = -0.357, p<0.001), and downregulation of miR-92a promoted cell migration (p<0.01). Conclusions/Significance: This study demonstrates that downregulation of miR-92a in breast cancer is linked to key epithelial and stromal properties as well as clinical outcome.	[Nilsson, Sofie; Moller, Christina; Landberg, Goran] Lund Univ, Ctr Mol Pathol, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden; [Jirstrom, Karin] Lund Univ, Dept Clin Sci, Skane Univ Hosp, Lund, Sweden; [Nilsson, Sofie; Lee, Alexander; Busch, Susann; Lamb, Rebecca; Landberg, Goran] Univ Manchester, Breakthrough Breast Canc Res Unit, Paterson Inst Canc Res,Manchester Acad Hlth Sci C, Sch Canc & Enabling Sci,Christie NHS Fdn Trust, Manchester, Lancs, England	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Christie NHS Foundation Trust; Paterson Institute for Cancer Research; University of Manchester	Nilsson, S (corresponding author), Lund Univ, Ctr Mol Pathol, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden.	goran.landberg@med.lu.se			Swedish Cancer Society; Breakthrough Breast Cancer	Swedish Cancer Society(Swedish Cancer Society); Breakthrough Breast Cancer	The study was supported by the Swedish Cancer Society, http://www.cancerfonden.se, and Breakthrough Breast Cancer, http://www.breakthrough.org.uk/. The funders provided financial support for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Fu SW, 2011, J CANCER, V2, P116, DOI 10.7150/jca.2.116; Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Mollerstrom E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-296; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	21	67	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36051	10.1371/journal.pone.0036051	http://dx.doi.org/10.1371/journal.pone.0036051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563438	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100064
J	Niwa, F; Bannai, H; Arizono, M; Fukatsu, K; Triller, A; Mikoshiba, K				Niwa, Fumihiro; Bannai, Hiroko; Arizono, Misa; Fukatsu, Kazumi; Triller, Antoine; Mikoshiba, Katsuhiko			Gephyrin-Independent GABA(A)R Mobility and Clustering during Plasticity	PLOS ONE			English	Article							INHIBITORY SYNAPSES; GABAERGIC SYNAPSES; STATUS EPILEPTICUS; LATERAL DIFFUSION; SYNAPTIC PLASTICITY; RECEPTOR SUBTYPES; GAMMA-2 SUBUNIT; DIRECT BINDING; TRAFFICKING; DYNAMICS	The activity-dependent modulation of GABA-A receptor (GABA(A)R) clustering at synapses controls inhibitory synaptic transmission. Several lines of evidence suggest that gephyrin, an inhibitory synaptic scaffold protein, is a critical factor in the regulation of GABA(A)R clustering during inhibitory synaptic plasticity induced by neuronal excitation. In this study, we tested this hypothesis by studying relative gephyrin dynamics and GABA(A)R declustering during excitatory activity. Surprisingly, we found that gephyrin dispersal is not essential for GABA(A)R declustering during excitatory activity. In cultured hippocampal neurons, quantitative immunocytochemistry showed that the dispersal of synaptic GABA(A)Rs accompanied with neuronal excitation evoked by 4-aminopyridine (4AP) or N-methyl-D-aspartic acid (NMDA) precedes that of gephyrin. Single-particle tracking of quantum dot labeled-GABA(A)Rs revealed that excitation-induced enhancement of GABA(A)R lateral mobility also occurred before the shrinkage of gephyrin clusters. Physical inhibition of GABA(A)R lateral diffusion on the cell surface and inhibition of a Ca2+ dependent phosphatase, calcineurin, completely eliminated the 4AP-induced decrease in gephyrin cluster size, but not the NMDA-induced decrease in cluster size, suggesting the existence of two different mechanisms of gephyrin declustering during activity-dependent plasticity, a GABA(A)R-dependent regulatory mechanism and a GABA(A)R-independent one. Our results also indicate that GABA(A)R mobility and clustering after sustained excitatory activity is independent of gephyrin.	[Niwa, Fumihiro; Bannai, Hiroko; Arizono, Misa; Fukatsu, Kazumi; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Saitama, Japan; [Niwa, Fumihiro] Univ Tokyo, Inst Med Sci, Grad Sch Frontier Sci, Lab Funct Genom,Dept Med Genome Sci,Minato Ku, Tokyo, Japan; [Arizono, Misa] Univ Tokyo, Inst Med Sci, Div Neuronal Network, Tokyo, Japan; [Triller, Antoine] Ecole Normale Super, Inst Natl Sante & Rech Med, U1024, Ctr Natl Rech Sci,UMR8197,Inst Biol, F-75231 Paris, France	RIKEN; University of Tokyo; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Niwa, F (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Saitama, Japan.	hbannai@brain.riken.jp	Bannai, Hiroko/I-7130-2014; Niwa, Fumihiro/GNP-0007-2022; Mikoshiba, Katsuhiko/N-7943-2015; Niwa, Fumihiro/U-4422-2019	Bannai, Hiroko/0000-0002-0951-488X; Niwa, Fumihiro/0000-0002-0206-1902; Niwa, Fumihiro/0000-0002-0206-1902; Arizono, Misa/0000-0002-7726-6531; TRILLER, Antoine/0000-0002-7530-1233	Kato Memorial Bioscience Foundation; Toray Science Foundation; RIKEN;  [20220007];  [20700300]	Kato Memorial Bioscience Foundation; Toray Science Foundation(Toray Industries, Inc.); RIKEN; ; 	This work is supported by Grant-in-Aid for Scientific Research (20220007 to KM, 20700300 to HB), grants from the Kato Memorial Bioscience Foundation, and Toray Science Foundation (to HB). FN and MA were supported by the Junior Research Associate program of RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; BENKE D, 1991, J BIOL CHEM, V266, P4478; BONNEAU S, 2004, P IEEE INT S BIOL IM; Bruneau EG, 2009, FASEB J, V23, P679, DOI 10.1096/fj.08-107946; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Das A, 2005, J NEUROSCI RES, V81, P551, DOI 10.1002/jnr.20581; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Dumoulin A, 2000, EUR J NEUROSCI, V12, P3883, DOI 10.1046/j.1460-9568.2000.00271.x; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; GOSLIN K, 1998, CULTURING NERVE CELL; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Kawasaki BT, 1997, J NEUROSCI RES, V49, P381, DOI 10.1002/(SICI)1097-4547(19970801)49:3<381::AID-JNR13>3.0.CO;2-2; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Muir J, 2010, P NATL ACAD SCI USA, V107, P16679, DOI 10.1073/pnas.1000589107; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Panzanelli P., 2011, J PHYSL; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Sekimoto K, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031905; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Terunuma M, 2008, J NEUROSCI, V28, P376, DOI 10.1523/JNEUROSCI.4346-07.2008; Tretter V, 2011, J BIOL CHEM; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Tyagarajan SK, 2010, J PHYSIOL-LONDON, V588, P101, DOI 10.1113/jphysiol.2009.178517; Wang J, 2003, J NEUROSCI, V23, P826	49	42	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36148	10.1371/journal.pone.0036148	http://dx.doi.org/10.1371/journal.pone.0036148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563445	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100070
J	Voytek, B; Soltani, M; Pickard, N; Kishiyama, MM; Knight, RT				Voytek, Bradley; Soltani, Maryam; Pickard, Natasha; Kishiyama, Mark M.; Knight, Robert T.			Prefrontal Cortex Lesions Impair Object-Spatial Integration	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; WORKING-MEMORY; HUMAN BRAIN; INFORMATION; LOCATION; NEURONS; HUMANS	How and where object and spatial information are perceptually integrated in the brain is a central question in visual cognition. Single-unit physiology, scalp EEG, and fMRI research suggests that the prefrontal cortex (PFC) is a critical locus for object-spatial integration. To test the causal participation of the PFC in an object-spatial integration network, we studied ten patients with unilateral PFC damage performing a lateralized object-spatial integration task. Consistent with single-unit and neuroimaging studies, we found that PFC lesions result in a significant behavioral impairment in object-spatial integration. Furthermore, by manipulating inter-hemispheric transfer of object-spatial information, we found that masking of visual transfer impairs performance in the contralesional visual field in the PFC patients. Our results provide the first evidence that the PFC plays a key, causal role in an object-spatial integration network. Patient performance is also discussed within the context of compensation by the non-lesioned PFC.	[Voytek, Bradley; Soltani, Maryam; Pickard, Natasha; Kishiyama, Mark M.; Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Soltani, Maryam; Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Voytek, Bradley] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Soltani, Maryam] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Diego	Voytek, B (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	bradley.voytek@gmail.com	Voytek, Bradley/K-3305-2016	Voytek, Bradley/0000-0003-1640-2525	American Psychological Association [5-T32-MH18882]; National Institute of Neurological Disorders and Stroke [NS21135-22S1, NS21135, PO40813]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021135, R56NS021135] Funding Source: NIH RePORTER	American Psychological Association; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	B.V. is funded by the American Psychological Association Diversity Program in Neuroscience (5-T32-MH18882) and B.V. and R.T.K. by the National Institute of Neurological Disorders and Stroke (NS21135-22S1, NS21135, and PO40813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Cichy RM, 2011, NEUROIMAGE, V54, P2297, DOI 10.1016/j.neuroimage.2010.09.044; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Green DM, 1966, SIGNAL DETECTION THE; Gronau N, 2008, J COGNITIVE NEUROSCI, V20, P371, DOI 10.1162/jocn.2008.20.3.371; Hasegawa I, 1998, SCIENCE, V281, P814, DOI 10.1126/science.281.5378.814; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lytton W W, 1999, Prog Brain Res, V121, P203; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; RUGG MD, 1984, NEUROPSYCHOLOGIA, V22, P215, DOI 10.1016/0028-3932(84)90064-2; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; Simon-Thomas ER, 2003, COGNITIVE BRAIN RES, V16, P457, DOI 10.1016/S0926-6410(03)00060-0; SMITH EE, 1995, J COGNITIVE NEUROSCI, V7, P337, DOI 10.1162/jocn.1995.7.3.337; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; SUZUKI H, 1983, EXP BRAIN RES, V53, P47; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; von Monakow C, 1969, MOOD STATES MIND; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; Voytek B, 2010, P NATL ACAD SCI USA, V107, P18167, DOI 10.1073/pnas.1007277107; Wang YP, 2000, NEUROSCI LETT, V293, P17, DOI 10.1016/S0304-3940(00)01480-4; WILSON FA, 1993, SCIENCE, V25, P1955; Wundt W., 1902, OUTLINES PSYCHOL; Yago Elena, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P609, DOI 10.3758/CABN.4.4.609	32	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e34937	10.1371/journal.pone.0034937	http://dx.doi.org/10.1371/journal.pone.0034937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563375	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100005
J	Domingues, CP; Nolasco, R; Dubert, J; Queiroga, H				Domingues, Carla P.; Nolasco, Rita; Dubert, Jesus; Queiroga, Henrique			Model-Derived Dispersal Pathways from Multiple Source Populations Explain Variability of Invertebrate Larval Supply	PLOS ONE			English	Article							CRAB CARCINUS-MAENAS; DIEL VERTICAL MIGRATION; TIDAL STREAM TRANSPORT; CORAL-REEF FISH; CALLINECTES-SAPIDUS; MARINE POPULATIONS; GENE FLOW; BENTHIC INVERTEBRATES; RETENTION MECHANISM; SEASCAPE GENETICS	Background: Predicting the spatial and temporal patterns of marine larval dispersal and supply is a challenging task due to the small size of the larvae and the variability of oceanographic processes. Addressing this problem requires the use of novel approaches capable of capturing the inherent variability in the mechanisms involved. Methodology/Principal Findings: In this study we test whether dispersal and connectivity patterns generated from a biophysical model of larval dispersal of the crab Carcinus maenas, along the west coast of the Iberian Peninsula, can predict the highly variable daily pattern of wind-driven larval supply to an estuary observed during the peak reproductive season (March-June) in 2006 and 2007. Cross-correlations between observed and predicted supply were significant (p < 0.05) and strong, ranging from 0.34 to 0.81 at time lags of -6 to + 5 d. Importantly, the model correctly predicted observed cross-shelf distributions (Pearson r = 0.82, p < 0.001, and r = 0.79, p < 0.01, in 2006 and 2007) and indicated that all supply events were comprised of larvae that had been retained within the inner shelf; larvae transported to the outer shelf and beyond never recruited. Estimated average dispersal distances ranged from 57 to 198 km and were only marginally affected by mortality. Conclusions/Significance: The high degree of predicted demographic connectivity over relatively large geographic scales is consistent with the lack of genetic structuring in C. maenas along the Iberian Peninsula. These findings indicate that the dynamic nature of larval dispersal can be captured by mechanistic biophysical models, which can be used to provide meaningful predictions of the patterns and causes of fine-scale variability in larval supply to marine populations.	[Domingues, Carla P.; Nolasco, Rita; Dubert, Jesus; Queiroga, Henrique] Univ Aveiro, Ctr Estudos Ambiente & Mar CESAM, P-3800 Aveiro, Portugal; [Domingues, Carla P.; Queiroga, Henrique] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Nolasco, Rita; Dubert, Jesus] Univ Aveiro, Dept Fis, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Domingues, CP (corresponding author), Univ Aveiro, Ctr Estudos Ambiente & Mar CESAM, Campus Univ Santiago, P-3800 Aveiro, Portugal.	cdomingues@ua.pt	Dubert, Jesus/B-7517-2008; Domingues, Carla/F-7503-2010; Nolasco, Rita TS/D-1809-2019; Queiroga, Henrique/C-5134-2008; Dubert, Jesus/B-2803-2009	Queiroga, Henrique/0000-0002-2338-0013; Dubert, Jesus/0000-0002-3338-6777; nolasco, maria rita/0000-0003-1942-8800	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/21593/2005]; FCT under European Regional Development Fund [PTDC/BIA-BDE/65425/2006, PTDC/MAR/65760/2006]; Fundação para a Ciência e a Tecnologia [PTDC/MAR/65760/2006, PTDC/BIA-BDE/65425/2006] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT under European Regional Development Fund; Fundação para a Ciência e a Tecnologia	Fundacao para a Ciencia e a Tecnologia (FCT) supported a PhD grant to CPD (SFRH/BD/21593/2005). This work is part of the "Connect - Connectivity of marine populations assessed with genetic and numerical modeling tools'' (No. PTDC/BIA-BDE/65425/2006) and "ISCAD - Inner shelf circulation and dispersion patterns: Interactions with estuarine systems" (No. PTDC/MAR/65760/2006) research projects, both funded by FCT under the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CM, 2007, MAR ECOL PROG SER, V339, P13, DOI 10.3354/meps339013; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Carr SD, 2008, FISH OCEANOGR, V17, P1, DOI 10.1111/j.1365-2419.2007.00447.x; Chatfield C, 1996, ANAL TIME SERIES DAT, V5; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; da Silva A M, 1994, ATLAS SURFACE MARINE; DEVRIES MC, 1994, MAR BIOL, V118, P403, DOI 10.1007/BF00350297; DOHERTY PJ, 1995, ECOLOGY, V76, P2373, DOI 10.2307/2265814; Domingues CP, 2011, HEREDITY, V106, P832, DOI 10.1038/hdy.2010.126; Domingues CP, 2011, MAR ECOL PROG SER, V425, P113, DOI 10.3354/meps08992; Domingues CP, 2010, MAR ECOL PROG SER, V410, P111, DOI 10.3354/meps08610; dos Santos A, 2008, MAR ECOL PROG SER, V359, P171, DOI 10.3354/meps07341; Ellien C, 2004, J PLANKTON RES, V26, P117, DOI 10.1093/plankt/fbh018; Erftemeijer PLA, 2009, MAR ECOL PROG SER, V390, P167, DOI 10.3354/meps08173; FORWARD RB, 1994, J EXP MAR BIOL ECOL, V182, P183, DOI 10.1016/0022-0981(94)90050-7; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Galindo HM, 2010, MOL ECOL, V19, P3692, DOI 10.1111/j.1365-294X.2010.04694.x; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; Incze LS, 2000, FISH OCEANOGR, V9, P99, DOI 10.1046/j.1365-2419.2000.00125.x; Jackson GA, 1981, AM NATURALIST, V118; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; KORDOS LM, 1993, MAR BIOL, V117, P227, DOI 10.1007/BF00345667; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Levitus S., 1994, WORLD OCEAN ATLAS 19, V3; Marchesiello P, 2001, OCEAN MODEL, V3, P1, DOI 10.1016/s1463-5003(00)00013-5; Marta-Almeida M, 2006, CONT SHELF RES, V26, P385, DOI 10.1016/j.csr.2005.11.011; Marta-Almeida M, 2006, MAR ECOL PROG SER, V307, P1, DOI 10.3354/meps307001; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Miller TJ, 2007, MAR ECOL PROG SER, V347, P127, DOI 10.3354/meps06973; Morgan Steven G., 1995, P279; Morgan SG, 2009, ECOLOGY, V90, P3489, DOI 10.1890/08-1550.1; Morgan SG, 2009, MAR ECOL PROG SER, V380, P173, DOI 10.3354/meps07913; Nagaraj M., 1993, Scientia Marina, V57, P1; OKUBO A, 1994, BIOPHYSICS MARINE LA, P5; Oliveira PB, 2009, CONT SHELF RES, V29, P759, DOI 10.1016/j.csr.2008.08.004; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Peliz A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004159; Peterson W, 1998, J MARINE SYST, V15, P313, DOI 10.1016/S0924-7963(97)00082-1; Pfeiffer-Herbert AS, 2007, LIMNOLOGY OCEANOGRAP, V52, P11; Pineda J, 2000, OCEANOGR E PAC, V1, P84; Queiroga H, 2006, MAR ECOL PROG SER, V307, P21, DOI 10.3354/meps307021; QUEIROGA H, 1994, MAR ECOL PROG SER, V111, P63, DOI 10.3354/meps111063; Queiroga H, 1996, J PLANKTON RES, V18, P1981, DOI 10.1093/plankt/18.11.1981; Queiroga H, 1998, HYDROBIOLOGIA, V375-76, P137, DOI 10.1023/A:1017004921555; Queiroga H, 1997, MAR ECOL PROG SER, V149, P121, DOI 10.3354/meps149121; Reyns NB, 2007, FISH OCEANOGR, V16, P257, DOI 10.1111/j.1365-2419.2007.00420.x; Rice A.L., 1975, Bulletin of the British Museum (Natural History) Zoology, V28, P103; ROUGHGARDEN J, 1985, ECOLOGY, V66, P54, DOI 10.2307/1941306; Sale Peter F., 2006, P3, DOI 10.1016/B978-012088781-1/50004-2; Santos AMP, 2004, CONT SHELF RES, V24, P149, DOI 10.1016/j.csr.2003.10.004; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 1998, MAR ECOL PROG SER, V168, P57, DOI 10.3354/meps168057; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; TANKERSLEY RA, 1995, MAR BIOL, V122, P391, DOI 10.1007/BF00350871; THORROLD SR, 1994, MAR ECOL PROG SER, V112, P75, DOI 10.3354/meps112075; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Welch JM, 2001, MAR BIOL, V139, P911; Werner FE, 2007, OCEANOGRAPHY, V20, P54, DOI 10.5670/oceanog.2007.29; Wing SR, 1995, MAR ECOL PROG SER, V128, P199, DOI 10.3354/meps128199; WOOSTER WS, 1976, J MAR RES, V34, P131	69	29	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35794	10.1371/journal.pone.0035794	http://dx.doi.org/10.1371/journal.pone.0035794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558225	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200079
J	Stock, RP; Brewer, J; Wagner, K; Ramos-Cerrillo, B; Duelund, L; Jernshoj, KD; Olsen, LF; Bagatolli, LA				Stock, Roberto P.; Brewer, Jonathan; Wagner, Kerstin; Ramos-Cerrillo, Blanca; Duelund, Lars; Jernshoj, Kit Drescher; Olsen, Lars Folke; Bagatolli, Luis A.			Sphingomyelinase D Activity in Model Membranes: Structural Effects of in situ Generation of Ceramide-1-Phosphate	PLOS ONE			English	Article							GIANT UNILAMELLAR VESICLES; 2-PHOTON FLUORESCENCE MICROSCOPY; PHOSPHOLIPASE A(2) ENZYMES; BROWN RECLUSE SPIDER; LOXOSCELES-RECLUSA; LAURDAN FLUORESCENCE; INFLAMMATORY RESPONSE; CERAMIDE 1-PHOSPHATE; LATERAL ORGANIZATION; DERMONECROTIC TOXIN	The toxicity of Loxosceles spider venom has been attributed to a rare enzyme, sphingomyelinase D, which transforms sphingomyelin to ceramide-1-phosphate. The bases of its inflammatory and dermonecrotic activity, however, remain unclear. In this work the effects of ceramide-1-phosphate on model membranes were studied both by in situ generation of this lipid using a recombinant sphingomyelinase D from the spider Loxosceles laeta and by pre-mixing it with sphingomyelin and cholesterol. The systems of choice were large unilamellar vesicles for bulk studies (enzyme kinetics, fluorescence spectroscopy and dynamic light scattering) and giant unilamellar vesicles for fluorescence microscopy examination using a variety of fluorescent probes. The influence of membrane lateral structure on the kinetics of enzyme activity and the consequences of enzyme activity on the structure of target membranes containing sphingomyelin were examined. The findings indicate that: 1) ceramide-1-phosphate (particularly lauroyl ceramide-1-phosphate) can be incorporated into sphingomyelin bilayers in a concentration-dependent manner and generates coexistence of liquid disordered/solid ordered domains, 2) the activity of sphingomyelinase D is clearly influenced by the supramolecular organization of its substrate in membranes and, 3) in situ ceramide-1-phosphate generation by enzymatic activity profoundly alters the lateral structure and morphology of the target membranes.	[Stock, Roberto P.; Ramos-Cerrillo, Blanca] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Stock, Roberto P.; Brewer, Jonathan; Wagner, Kerstin; Bagatolli, Luis A.] Univ So Denmark, Membrane Biophys & Biophoton Grp, Dept Biochem & Mol Biol, Ctr Biomembrane Phys,MEMPHYS, Odense, Denmark; [Duelund, Lars] Univ So Denmark, Ctr Biomembrane Phys, Dept Phys Chem & Pharm, MEMPHYS, Odense, Denmark; [Jernshoj, Kit Drescher; Olsen, Lars Folke] Univ So Denmark, Dept Biochem & Mol Biol, Cellular Complex Grp CelCom, Odense, Denmark	Universidad Nacional Autonoma de Mexico; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark	Stock, RP (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	bagatolli@memphys.sdu.dk	Duelund, Lars/AHB-2952-2022; Duelund, Lars/AAC-7110-2019; Brewer, Jonathan/C-7079-2012; Bagatolli, Luis/L-5159-2016	Duelund, Lars/0000-0002-3786-2822; Brewer, Jonathan/0000-0002-3444-1715; Bagatolli, Luis/0000-0002-4727-8611; Olsen, Lars Folke/0000-0001-7391-2340; Jernshoj, Kit Drescher/0000-0003-3697-2170	Forskningsradet for Natur og Univers (FNU) [272-08-0575]; Danish National Research Foundation; Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT) [146899]; Danish Research Council for Technology and Innovation (project NaKIM); European Community [236688]	Forskningsradet for Natur og Univers (FNU)(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Danish Research Council for Technology and Innovation (project NaKIM); European Community(European Commission)	This research was supported by Forskningsradet for Natur og Univers (FNU) research grant 272-08-0575 and the Danish National Research Foundation (which supports MEMPHYS - Center for Biomembrane Physics). Dr. Stock was supported by a sabbatical grant from the Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT, 146899). Dr. Jernshoj and Dr. Olsen acknowledges support from the Danish Research Council for Technology and Innovation (project NaKIM). Dr. Wagner was supported by the European Community's Seventh Framework Program FP7/2007-2013 under grant agreement no. 236688. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Bagatolli LA, 2000, BIOPHYS J, V79, P434, DOI 10.1016/S0006-3495(00)76305-3; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BELL JD, 1989, J BIOL CHEM, V264, P12194; Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274; Brewer J, 2010, BBA-BIOMEMBRANES, V1798, P1301, DOI 10.1016/j.bbamem.2010.02.024; Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005; Chaves-Moreira D, 2009, J CELL BIOCHEM, V107, P655, DOI 10.1002/jcb.22148; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Chioato L, 2003, TOXICON, V42, P869, DOI 10.1016/j.toxicon.2003.11.027; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dragulev B, 2007, J INVEST DERMATOL, V127, P1267, DOI 10.1038/sj.jid.5700812; Dragulev B, 2007, J INVEST DERMATOL, V127, P1264, DOI 10.1038/sj.jid.5700644; DRESSLER KA, 1990, J BIOL CHEM, V265, P14917; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; Epand RM, 2003, BIOPHYS J, V84, P3102, DOI 10.1016/S0006-3495(03)70035-6; Fidorra M, 2006, BIOPHYS J, V90, P4437, DOI 10.1529/biophysj.105.077107; FINSY R, 1992, PART PART SYST CHAR, V9, P125, DOI 10.1002/ppsc.19920090117; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gomes MTR, 2011, TOXICON, V57, P574, DOI 10.1016/j.toxicon.2011.01.001; Gomez-Munoz A, 2004, FEBS LETT, V562, P5, DOI 10.1016/S0014-5793(04)00211-X; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hinkovska-Galcheva VT, 1998, J BIOL CHEM, V273, P33203, DOI 10.1074/jbc.273.50.33203; Hogan CJ, 2004, ANN EMERG MED, V44, P608, DOI 10.1016/j.annemergmed.2004.08.028; Ibarguren M, 2010, BBA-BIOMEMBRANES, V1798, P1735, DOI 10.1016/j.bbamem.2010.06.004; Isbister GK, 2011, LANCET, V378, P2039, DOI 10.1016/S0140-6736(10)62230-1; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; Jensen LB, 2005, BIOPHYS J, V88, P2692, DOI 10.1529/biophysj.104.056457; Kini RM, 2005, TOXICON, V45, P1147, DOI 10.1016/j.toxicon.2005.02.018; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Kooijman EE, 2008, BIOPHYS J, V94, P4320, DOI 10.1529/biophysj.107.121046; Kubiak J, 2011, BIOPHYS J, V100, P978, DOI 10.1016/j.bpj.2011.01.012; KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Lohse B, 2008, J AM CHEM SOC, V130, P14372, DOI 10.1021/ja805030w; MAGGIO B, 1994, BBA-BIOMEMBRANES, V1190, P137, DOI 10.1016/0005-2736(94)90043-4; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Meseth U, 1999, BIOPHYS J, V76, P1619, DOI 10.1016/S0006-3495(99)77321-2; Montes LR, 2007, BIOPHYS J, V93, P3548, DOI 10.1529/biophysj.107.116228; Morrow MR, 2009, BIOPHYS J, V96, P2216, DOI 10.1016/j.bpj.2008.11.060; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Olvera A, 2006, TOXICON, V48, P64, DOI 10.1016/j.toxicon.2006.04.010; PARASASSI T, 1994, BIOPHYS J, V66, P763, DOI 10.1016/S0006-3495(94)80852-5; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1995, BIOPHYS J, V68, P1895, DOI 10.1016/S0006-3495(95)80367-X; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; PARASASSI T, 1994, BIOPHYS J, V66, P120, DOI 10.1016/S0006-3495(94)80763-5; Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638, DOI 10.1016/S0006-291X(02)02521-4; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Pott T, 2008, CHEM PHYS LIPIDS, V154, P115, DOI 10.1016/j.chemphyslip.2008.03.008; Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Subbaiah PV, 2003, J LIPID RES, V44, P1574, DOI 10.1194/jlr.M300103-JLR200; Tambourgi DV, 2007, MOL IMMUNOL, V44, P576, DOI 10.1016/j.molimm.2006.02.002; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; van Meeteren LA, 2007, J INVEST DERMATOL, V127, P1266, DOI 10.1038/sj.jid.5700745; VERNON LP, 1992, PHARMACOL THERAPEUT, V54, P269, DOI 10.1016/0163-7258(92)90003-I	66	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36003	10.1371/journal.pone.0036003	http://dx.doi.org/10.1371/journal.pone.0036003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558302	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200108
J	Delezie, J; Dumont, S; Dardente, H; Oudart, H; Grechez-Cassiau, A; Klosen, P; Teboul, M; Delaunay, F; Pevet, P; Challet, E				Delezie, Julien; Dumont, Stephanie; Dardente, Hugues; Oudart, Hugues; Grechez-Cassiau, Aline; Klosen, Paul; Teboul, Michele; Delaunay, Franck; Pevet, Paul; Challet, Etienne			The nuclear receptor REV-ERB alpha is required for the daily balance of carbohydrate and lipid metabolism	FASEB JOURNAL			English	Article						circadian; obesity; hyperglycemia; respiratory quotient; lipoprotein lipase	LIPOPROTEIN-LIPASE ACTIVITY; SKELETAL-MUSCLE; CIRCADIAN TRANSCRIPTION; INSULIN-RESISTANCE; GENE-EXPRESSION; PPAR-ALPHA; CLOCK; MICE; COMPONENTS; RHYTHMS	Mutations of clock genes can lead to diabetes and obesity. REV-ERB alpha, a nuclear receptor involved in the circadian clockwork, has been shown to control lipid metabolism. To gain insight into the role of REV-ERB alpha in energy homeostasis in vivo, we explored daily metabolism of carbohydrates and lipids in chow-fed, unfed, or high-fat-fed Rev-erb alpha(-/-) mice and their wild-type littermates. Chow-fed Rev-erb alpha(-/-) mice displayed increased adiposity (2.5-fold) and mild hyperglycemia (similar to 10%) without insulin resistance. Indirect calorimetry indicates that chow-fed Rev-erb alpha(-/-) mice utilize more fatty acids during daytime. A 24-h nonfeeding period in Rev-erb alpha(-/-) animals favors further fatty acid mobilization at the expense of glycogen utilization and gluconeogenesis, without triggering hypoglycemia and hypothermia. High-fat feeding in Rev-erb alpha(-/-) mice amplified metabolic disturbances, including expression of lipogenic factors. Lipoprotein lipase (Lpl) gene, critical in lipid utilization/storage, is triggered in liver at night and constitutively up-regulated (similar to 2-fold) in muscle and adipose tissue of Rev-erb alpha(-/-) mice. We show that CLOCK, up-regulated (2-fold) at night in Rev-erb alpha(-/-) mice, can transactivate Lpl. Thus, overexpression of Lpl facilitates muscle fatty acid utilization and contributes to fat overload. This study demonstrates the importance of clock-driven Lpl expression in energy balance and highlights circadian disruption as a potential cause for the metabolic syndrome.-Delezie, J., Dumont, S., Dardente, H., Oudart, H., Grechez-Cassiau, A., Klosen, P., Teboul, M., Delaunay, F., Pevet, P., Challet, E. The nuclear receptor REV-ERB alpha is required for the daily balance of carbohydrate and lipid metabolism. FASEBJ. 26, 3321-3335 (2012). www.fasebj.org	[Challet, Etienne] Univ Strasbourg, Dept Neurobiol Rhythms, Inst Cellular & Integrat Neurosci, CNRS,UPR3212, F-67084 Strasbourg, France; [Oudart, Hugues] Univ Strasbourg, Dept Ecol Physiol & Ethol, Hubert Curien Multidisciplinary Inst, F-67084 Strasbourg, France; [Dardente, Hugues] Univ Tours, French Inst Horse & Equitat, Nouzilly, France; [Grechez-Cassiau, Aline; Teboul, Michele; Delaunay, Franck] Univ Nice, Valrose Inst Biol, Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Tours; UDICE-French Research Universities; Universite Cote d'Azur	Challet, E (corresponding author), Univ Strasbourg, Dept Neurobiol Rhythms, Inst Cellular & Integrat Neurosci, CNRS,UPR3212, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.	challet@inci-cnrs.unistra.fr	Challet, Etienne/ABF-7553-2020; DARDENTE, Hugues/ABI-5590-2020	Challet, Etienne/0000-0001-9416-9496; DARDENTE, Hugues/0000-0001-7209-5940; Delaunay, Franck/0000-0003-4927-1701; Teboul, Michele/0000-0002-3418-4384; Klosen, Paul/0000-0001-9724-5044; Delezie, Julien/0000-0002-1350-8423	French Ministry of National Education and Research; Centre National de la Recherche Scientifique, CNRS; Agence Nationale pour la Recherche Jeunes Chercheurs/Jeunes Chercheuses [ANR-07-JCJC-0111]; University of Nice Sophia-Antipolis; CNRS; European Commission (integrated project CRESCENDO) [LSHM-CT-2005-018652]; University of Strasbourg	French Ministry of National Education and Research; Centre National de la Recherche Scientifique, CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche Jeunes Chercheurs/Jeunes Chercheuses(French National Research Agency (ANR)); University of Nice Sophia-Antipolis; CNRS(Centre National de la Recherche Scientifique (CNRS)); European Commission (integrated project CRESCENDO); University of Strasbourg	The authors thank Dr. Andre Malan for statistical advice. The authors are grateful to Laurence Huck and Dr. Sophie Reibel-Foisset for animal care and Sophie Brangolo, Marion Grandjean, and Sylviane Gourmelen for helpful technical assistance. The authors are indebted to the Mouse Clinical Institute (MCI; Strasbourg, France) for the clamp study. The authors also thank Prof. Ueli Schibler (University of Geneva, Geneva, Switzerland) for kindly providing the founder Reverb alpha<SUP>+/-</SUP> mice. J.D. is supported by a doctoral fellowship from the French Ministry of National Education and Research, and E.C. is supported by Centre National de la Recherche Scientifique, CNRS), University of Strasbourg, and Agence Nationale pour la Recherche Jeunes Chercheurs/Jeunes Chercheuses (ANR-07-JCJC-0111). A.G.C., M.T., and F.D. are supported by the University of Nice Sophia-Antipolis, CNRS, and the European Commission (integrated project CRESCENDO LSHM-CT-2005-018652).	Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bey L, 1998, GENE, V209, P31, DOI 10.1016/S0378-1119(98)00003-1; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Dardente H, 2009, COMP BIOCHEM PHYS A, V153, P391, DOI 10.1016/j.cbpa.2009.03.016; Delezie J, 2011, ANN NY ACAD SCI, V1243, P30, DOI 10.1111/j.1749-6632.2011.06246.x; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fergani A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-26; FERRARO RT, 1993, J CLIN INVEST, V92, P441, DOI 10.1172/JCI116586; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Gimble JM, 2009, J APPL PHYSIOL, V107, P1629, DOI 10.1152/japplphysiol.00090.2009; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Gonzales AM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-22; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Hensley LL, 2003, J BIOL CHEM, V278, P32702, DOI 10.1074/jbc.M304200200; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Jensen DR, 2008, J LIPID RES, V49, P870, DOI 10.1194/jlr.M700519-JLR200; Kalsbeek A, 2010, TRENDS ENDOCRIN MET, V21, P402, DOI 10.1016/j.tem.2010.02.005; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Manttari Satu, 2005, BMC Physiol, V5, P4, DOI 10.1186/1472-6793-5-4; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mendoza J, 2008, J PHYSIOL-LONDON, V586, P5901, DOI 10.1113/jphysiol.2008.159566; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; MURAT JC, 1974, CLIN CHEM, V20, P1576; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Ortega FJ, 2010, OBESITY, V18, P13, DOI 10.1038/oby.2009.202; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pircher P, 2005, AM J PHYSIOL-REG I, V288, pR482, DOI 10.1152/ajpregu.00690.2003; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Schutz Y, 2004, INT J OBESITY, V28, pS3, DOI 10.1038/sj.ijo.0802852; Shibata S, 2010, ADV DRUG DELIVER REV, V62, P918, DOI 10.1016/j.addr.2010.06.003; STAELS B, 1992, DEVELOPMENT, V115, P1035; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Tsutsumi K, 2002, BIOL PHARM BULL, V25, P1360, DOI 10.1248/bpb.25.1360; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vieira E, 2012, ENDOCRINOLOGY, V153, P592, DOI 10.1210/en.2011-1595; Voshol PJ, 2001, DIABETES, V50, P2585, DOI 10.2337/diabetes.50.11.2585; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	61	148	153	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3321	3335		10.1096/fj.12-208751	http://dx.doi.org/10.1096/fj.12-208751			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22562834				2022-12-25	WOS:000307162800022
J	Abdelwahab, MG; Fenton, KE; Preul, MC; Rho, JM; Lynch, A; Stafford, P; Scheck, AC				Abdelwahab, Mohammed G.; Fenton, Kathryn E.; Preul, Mark C.; Rho, Jong M.; Lynch, Andrew; Stafford, Phillip; Scheck, Adrienne C.			The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma	PLOS ONE			English	Article							KETONE-BODIES; GLIOBLASTOMA CELLS; CANCER-CELLS; BRAIN CANCER; 2-DEOXY-D-GLUCOSE; METABOLISM; GLUCOSE; GROWTH; AKT; RESTRICTION	Introduction: The ketogenic diet (KD) is a high-fat, low-carbohydrate diet that alters metabolism by increasing the level of ketone bodies in the blood. KetoCal (R) (KC) is a nutritionally complete, commercially available 4:1 (fat: carbohydrate+protein) ketogenic formula that is an effective non-pharmacologic treatment for the management of refractory pediatric epilepsy. Diet-induced ketosis causes changes to brain homeostasis that have potential for the treatment of other neurological diseases such as malignant gliomas. Methods: We used an intracranial bioluminescent mouse model of malignant glioma. Following implantation animals were maintained on standard diet (SD) or KC. The mice received 2x4 Gy of whole brain radiation and tumor growth was followed by in vivo imaging. Results: Animals fed KC had elevated levels of beta-hydroxybutyrate (p = 0.0173) and an increased median survival of approximately 5 days relative to animals maintained on SD. KC plus radiation treatment were more than additive, and in 9 of 11 irradiated animals maintained on KC the bioluminescent signal from the tumor cells diminished below the level of detection (p<0.0001). Animals were switched to SD 101 days after implantation and no signs of tumor recurrence were seen for over 200 days. Conclusions: KC significantly enhances the anti-tumor effect of radiation. This suggests that cellular metabolic alterations induced through KC may be useful as an adjuvant to the current standard of care for the treatment of human malignant gliomas.	[Abdelwahab, Mohammed G.; Fenton, Kathryn E.; Preul, Mark C.; Rho, Jong M.; Scheck, Adrienne C.] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Lynch, Andrew] Danone Res, Ctr Specialised Nutr, Nutricia Adv Med Nutr, Liverpool, Merseyside, England; [Stafford, Phillip] Arizona State Univ, AZ Biodesign, Ctr Innovat Med, Sch Life Sci, Tempe, AZ USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Danone Nutricia; Arizona State University; Arizona State University-Tempe	Abdelwahab, MG (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ USA.	adrienne.scheck@thebni.edu	Scheck, Adrienne/AAH-5040-2020	Scheck, Adrienne/0000-0003-3497-1895	Nutricia Advanced Medical Nutrition through Nutricia North America; Arizona Disease Research Commission [1010]	Nutricia Advanced Medical Nutrition through Nutricia North America(Danone Nutricia); Arizona Disease Research Commission	This work was supported in part by a grant from Nutricia Advanced Medical Nutrition through Nutricia North America, the company that distributes KetoCal (R) in the USA. The funders had no role in data collection and analysis, decision to publish or preparation of the manuscript, but did input to the study design. Web sites: Nutricia - http://nutrition.nutricia.com/ Students Supporting Brain Tumor Research - www.ssbtr.org Arizona Disease Research Commission - http://azdhs.gov/biomedical/ (contract 1010 to ACS) No additional external funding was received for this study.	Abdelwahab MG, 2011, JOVE-J VIS EXP, DOI 10.3791/3403; Baranano Kristin W, 2008, Curr Treat Options Neurol, V10, P410, DOI 10.1007/s11940-008-0043-8; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Chautard E, 2010, NEURO-ONCOLOGY, V12, P434, DOI 10.1093/neuonc/nop059; Dwarakanath BS, 2009, FUTURE ONCOL, V5, P581, DOI 10.2217/FON.09.44; Eloqayli H, 2011, NEUROCHEM RES, V36, P1566, DOI 10.1007/s11064-011-0485-3; Gupta S, 2009, J CANCER RES THER, V5, P16, DOI 10.4103/0973-1482.55135; Jouanneau E, 2006, CANCER IMMUNOL IMMUN, V55, P254, DOI 10.1007/s00262-005-0040-7; Li HF, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-43; Liang BC, 2011, INT J MOL MED, V27, P159, DOI 10.3892/ijmm.2010.579; Lund TM, 2009, J NEUROCHEM, V110, P80, DOI 10.1111/j.1471-4159.2009.06115.x; Marsh J, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-33; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Maurer GD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-315; Mukherjee P, 2004, CLIN CANCER RES, V10, P5622, DOI 10.1158/1078-0432.CCR-04-0308; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; Mulrooney TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018085; NEBELING LC, 1995, J AM DIET ASSOC, V95, P693, DOI 10.1016/S0002-8223(95)00189-1; NEBELING LC, 1995, J AM COLL NUTR, V14, P202; Newcomb EW, 2006, CLIN CANCER RES, V12, P4730, DOI 10.1158/1078-0432.CCR-06-0593; Nicholas MK, 2011, SEMIN ONCOL, V38, P243, DOI 10.1053/j.seminoncol.2011.01.009; Niyazi M, 2011, RADIOTHER ONCOL, V98, P1, DOI 10.1016/j.radonc.2010.11.006; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Roesler R, 2010, EXPERT REV ANTICANC, V10, P1735, DOI [10.1586/era.10.167, 10.1586/ERA.10.167]; Ruggiero A, 2006, J NEURO-ONCOL, V77, P89, DOI 10.1007/s11060-005-9011-2; Samala R, 2011, NEUROCHEM INT, V58, P5, DOI 10.1016/j.neuint.2010.10.011; Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x; Seyfried Thomas N, 2005, Nutr Metab (Lond), V2, P30, DOI 10.1186/1743-7075-2-30; Seyfried TN, 2010, LANCET ONCOL, V11, P811, DOI 10.1016/S1470-2045(10)70166-2; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Skinner R, 2009, J PEDIATR SURG, V44, P212, DOI 10.1016/j.jpedsurg.2008.10.042; Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yamada M, 1999, CANCER CHEMOTH PHARM, V44, P59, DOI 10.1007/s002800050945; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zuccoli G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-33	38	170	180	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36197	10.1371/journal.pone.0036197	http://dx.doi.org/10.1371/journal.pone.0036197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563484	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340700033
J	Richier, S; Macey, AI; Pratt, NJ; Honey, DJ; Moore, CM; Bibby, TS				Richier, Sophie; Macey, Anna I.; Pratt, Nicola J.; Honey, David J.; Moore, C. Mark; Bibby, Thomas S.			Abundances of Iron-Binding Photosynthetic and Nitrogen-Fixing Proteins of Trichodesmium Both in Culture and In Situ from the North Atlantic	PLOS ONE			English	Article							TRIMERIC PHOTOSYSTEM-I; N-2 FIXATION; PHOSPHORUS LIMITATION; MOLECULAR ASSESSMENT; STRUCTURAL BASIS; HIGH LIGHT; CYANOBACTERIUM; GROWTH; SPP.; PACIFIC	Marine cyanobacteria of the genus Trichodesmium occur throughout the oligotrophic tropical and subtropical oceans, where they can dominate the diazotrophic community in regions with high inputs of the trace metal iron (Fe). Iron is necessary for the functionality of enzymes involved in the processes of both photosynthesis and nitrogen fixation. We combined laboratory and field-based quantifications of the absolute concentrations of key enzymes involved in both photosynthesis and nitrogen fixation to determine how Trichodesmium allocates resources to these processes. We determined that protein level responses of Trichodesmium to iron-starvation involve down-regulation of the nitrogen fixation apparatus. In contrast, the photosynthetic apparatus is largely maintained, although re-arrangements do occur, including accumulation of the iron-stress-induced chlorophyll-binding protein IsiA. Data from natural populations of Trichodesmium spp. collected in the North Atlantic demonstrated a protein profile similar to iron-starved Trichodesmium in culture, suggestive of acclimation towards a minimal iron requirement even within an oceanic region receiving a high iron-flux. Estimates of cellular metabolic iron requirements are consistent with the availability of this trace metal playing a major role in restricting the biomass and activity of Trichodesmium throughout much of the subtropical ocean.	[Richier, Sophie; Macey, Anna I.; Pratt, Nicola J.; Honey, David J.; Moore, C. Mark; Bibby, Thomas S.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Richier, S (corresponding author), Univ Southampton, Natl Oceanog Ctr, European Way, Southampton, Hants, England.	s.richier@noc.soton.ac.uk	Bibby, Thomas/C-9159-2014	Bibby, Thomas/0000-0003-1743-473X; Moore, Mark/0000-0002-9541-6046	United Kingdom Natural Environment Research Council (NERC) [NE/F019254/1]; UK Natural Environment Research Council through the UK Marine Research Institutes strategic research programme Oceans [2025]; National Oceanography Centre, Southampton; AMT programme [206]; NERC [NE/F019254/1] Funding Source: UKRI; Natural Environment Research Council [NE/F019254/1] Funding Source: researchfish	United Kingdom Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Natural Environment Research Council through the UK Marine Research Institutes strategic research programme Oceans; National Oceanography Centre, Southampton; AMT programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was supported by the United Kingdom Natural Environment Research Council (NERC) through grant number NE/F019254/1 (TSB and CMM). This study was also supported by the UK Natural Environment Research Council through the UK Marine Research Institutes strategic research programme Oceans 2025 awarded to Plymouth Marine Laboratory and The National Oceanography Centre, Southampton. This contribution is number 206 of the AMT programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GL, 1984, BIOCHEMISTRY-US, V23, P2118, DOI 10.1021/bi00305a002; Baker AR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018518; Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Bergquist BA, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002505; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Berman-Frank I, 2007, LIMNOL OCEANOGR, V52, P2260, DOI 10.4319/lo.2007.52.5.2260; Bibby TS, 2008, DEEP-SEA RES PT II, V55, P1310, DOI 10.1016/j.dsr2.2008.01.014; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Bibby TS, 2009, PLOS ONE, DOI [10.1371/journal.pone.0004601, DOI 10.1371/JOURNAL.-PONE.0004601]; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 2001, CURR OPIN MICROBIOL, V4, P341, DOI 10.1016/S1369-5274(00)00215-0; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; Chappell PD, 2010, ENVIRON MICROBIOL, V12, P13, DOI 10.1111/j.1462-2920.2009.02026.x; Chappell PD, 2012, ISME J, V6, P1728, DOI 10.1038/ismej.2012.13; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Compaore J, 2010, ENVIRON MICROBIOL, V12, P54, DOI 10.1111/j.1462-2920.2009.02034.x; Dominic B, 1998, MICROBIOL-UK, V144, P3359, DOI 10.1099/00221287-144-12-3359; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Dutkiewicz S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003405; Eady R. R., 1979, A treatise on dinitrogen fixation. Inorganic and physical chemistry and biochemistry, P399; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Finzi-Hart JA, 2009, P NATL ACAD SCI USA, V106, P6345, DOI 10.1073/pnas.0810547106; Fu FX, 2003, BIOTECHNOL LETT, V25, P645, DOI 10.1023/A:1023068232375; GALLON JR, 1992, NEW PHYTOL, V122, P571; Gao Y, 2001, GEOPHYS RES LETT, V28, P29, DOI 10.1029/2000GL011926; Havaux M, 2005, FEBS LETT, V579, P2289, DOI 10.1016/j.febslet.2005.03.021; Hewson I, 2009, ISME J, V3, P1286, DOI 10.1038/ismej.2009.75; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; Hynes AM, 2009, LIMNOL OCEANOGR, V54, P1438, DOI 10.4319/lo.2009.54.5.1438; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Johnson JL, 2000, BBA-PROTEIN STRUCT M, V1543, P24, DOI 10.1016/S0167-4838(00)00195-3; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kouril R, 2005, FEBS LETT, V579, P3253, DOI 10.1016/j.febslet.2005.03.051; Kupper H, 2008, NEW PHYTOL, V179, P784, DOI 10.1111/j.1469-8137.2008.02497.x; Kustka A, 2003, J PHYCOL, V39, P12, DOI 10.1046/j.1529-8817.2003.01156.x; Kustka AB, 2003, LIMNOL OCEANOGR, V48, P1869, DOI 10.4319/lo.2003.48.5.1869; Levitan O, 2010, PLANT PHYSIOL, V154, P346, DOI 10.1104/pp.110.159285; Mahowald NM, 2009, ANNU REV MAR SCI, V1, P245, DOI 10.1146/annurev.marine.010908.163727; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; Milligan AJ, 2007, J PHYCOL, V43, P845, DOI 10.1111/j.1529-8817.2007.00395.x; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Monteiro FM, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003902; Monteiro FM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003731; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; MOREL FMM, 1991, LIMNOL OCEANOGR, V36, P1742, DOI 10.4319/lo.1991.36.8.1742; Murray JW, 2006, TRENDS PLANT SCI, V11, P152, DOI 10.1016/j.tplants.2006.01.007; PAERL HW, 1994, APPL ENVIRON MICROB, V60, P1044, DOI 10.1128/AEM.60.3.1044-1047.1994; PAERL HW, 1987, LIMNOL OCEANOGR, V32, P525, DOI 10.4319/lo.1987.32.3.0525; PAERL HW, 1989, J PHYCOL, V25, P773, DOI 10.1111/j.0022-3646.1989.00773.x; PRUFERTBEBOUT L, 1993, APPL ENVIRON MICROB, V59, P1367, DOI 10.1128/AEM.59.5.1367-1375.1993; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Rubin M, 2011, NAT GEOSCI, V4, P529, DOI 10.1038/NGEO1181; RUETER JG, 1990, J PHYCOL, V26, P30, DOI 10.1111/j.0022-3646.1990.00030.x; RUETER JG, 1988, J PHYCOL, V24, P249; Ryan-Keogh TJ, 2012, J PHYCOL, V48, P145, DOI 10.1111/j.1529-8817.2011.01092.x; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; SCHNEEGURT MA, 1994, J BACTERIOL, V176, P1586, DOI 10.1128/jb.176.6.1586-1597.1994; Sheridan CC, 2002, J PLANKTON RES, V24, P913, DOI 10.1093/plankt/24.9.913; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; Sohm JA, 2006, MAR ECOL PROG SER, V317, P21, DOI 10.3354/meps317021; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Sohm JA, 2008, LIMNOL OCEANOGR, V53, P2495, DOI 10.4319/lo.2008.53.6.2495; STEWART WDP, 1973, ANNU REV MICROBIOL, V27, P283, DOI 10.1146/annurev.mi.27.100173.001435; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Webb EA, 2001, APPL ENVIRON MICROB, V67, P5444, DOI 10.1128/AEM.67.12.5444-5452.2001; Webb EA, 2007, LIMNOL OCEANOGR, V52, P2221, DOI 10.4319/lo.2007.52.5.2221; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Westberry TK, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002673; Whittaker S, 2011, ENV MICROBIOL REP, V3, P54, DOI 10.1111/j.1758-2229.2010.00187.x; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	89	32	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35571	10.1371/journal.pone.0035571	http://dx.doi.org/10.1371/journal.pone.0035571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563465	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000305340700014
J	Schultsz, C; Jansen, E; Keijzers, W; Rothkamp, A; Duim, B; Wagenaar, JA; van der Ende, A				Schultsz, Constance; Jansen, Ewout; Keijzers, Wendy; Rothkamp, Anja; Duim, Birgitta; Wagenaar, Jaap A.; van der Ende, Arie			Differences in the Population Structure of Invasive Streptococcus suis Strains Isolated from Pigs and from Humans in the Netherlands	PLOS ONE			English	Article							MURAMIDASE-RELEASED PROTEIN; EXTRACELLULAR PROTEIN; DISEASED PIGS; SEROTYPE 14; CPS LOCUS; VIRULENCE; IDENTIFICATION; MENINGITIS; PHAGOCYTOSIS; DETERMINANT	Streptococcus suis serotype 2 is the main cause of zoonotic S. suis infection despite the fact that other serotypes are frequently isolated from diseased pigs. Studies comparing concurrent invasive human and pig isolates from a single geographical location are lacking. We compared the population structures of invasive S. suis strains isolated between 1986 and 2008 from human patients (N = 24) and from pigs with invasive disease (N = 124) in the Netherlands by serotyping and multi locus sequence typing (MLST). Fifty-six percent of pig isolates were of serotype 9 belonging to 15 clonal complexes (CCs) or singleton sequence types (ST). In contrast, all human isolates were of serotype 2 and belonged to two non-overlapping clonal complexes CC1 (58%) and CC20 (42%). The proportion of serotype 2 isolates among S. suis strains isolated from humans was significantly higher than among strains isolated from pigs (24/24 vs. 29/124; P<0.0001). This difference remained significant when only strains within CC1 and CC20 were considered (24/24 vs. 27/37, P = 0.004). The Simpson diversity index of the S. suis population isolated from humans (0.598) was smaller than of the population isolated from pigs (0.765, P = 0.05) indicating that the S. suis population isolated from infected pigs was more diverse than the S. suis population isolated from human patients. S. suis serotype 2 strains of CC20 were all negative in a PCR for detection of genes encoding extracellular protein factor (EF) variants. These data indicate that the polysaccharide capsule is an important correlate of human S. suis infection, irrespective of the ST and EF encoding gene type of S. suis strains.	[Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Schultsz, Constance] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Schultsz, Constance; Jansen, Ewout; van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Keijzers, Wendy; van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Ctr Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands; [Rothkamp, Anja] GD Anim Hlth Serv, Deventer, Netherlands; [Duim, Birgitta; Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University	Schultsz, C (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	schultsz@gmail.com		van der Ende, Arie/0000-0003-1298-3086	European Commission Seventh Framework Programme under ANTIGONE [278976]	European Commission Seventh Framework Programme under ANTIGONE	The work published in this article has received partial funding from the European Commission Seventh Framework Programme under ANTIGONE with project number 278976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AG, 2001, INFECT IMMUN, V69, P2732, DOI 10.1128/IAI.69.4.2732-2735.2001; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Beineke A, 2008, VET MICROBIOL, V128, P423, DOI 10.1016/j.vetmic.2007.10.028; Charland N, 1996, FEMS IMMUNOL MED MIC, V14, P195, DOI 10.1111/j.1574-695X.1996.tb00287.x; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2009, VET MICROBIOL, V139, P310, DOI 10.1016/j.vetmic.2009.06.024; Halaby T, 2000, EUR J CLIN MICROBIOL, V19, P943, DOI 10.1007/PL00011230; Haleis A, 2009, EMERG INFECT DIS, V15, P350, DOI 10.3201/eid1502.080842; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kerdsin A, 2011, EMERG INFECT DIS, V17, P835, DOI 10.3201/eid1705.100754; Kerdsin A, 2009, J MED MICROBIOL, V58, P1508, DOI 10.1099/jmm.0.013656-0; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Li P, 2010, MICROB PATHOGENESIS, V49, P305, DOI 10.1016/j.micpath.2010.07.001; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534; Hoa NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017943; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Segura M, 2002, INFECT IMMUN, V70, P4312, DOI 10.1128/IAI.70.8.4312-4322.2002; Smith HE, 2000, MICROB PATHOGENESIS, V29, P127, DOI 10.1006/mpat.2000.0372; Smith HE, 1996, INFECT IMMUN, V64, P4409, DOI 10.1128/IAI.64.10.4409-4412.1996; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; Smith HE, 1999, INFECT IMMUN, V67, P1750; Takamatsu D, 2008, EMERG INFECT DIS, V14, P181, DOI 10.3201/eid1401.070568; van de Beek D, 2008, J INFECTION, V57, P158, DOI 10.1016/j.jinf.2008.04.009; van der Peet-Schwering CMC, 2008, 119 AN SCI GROUP, P119; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Wei ZG, 2009, VET MICROBIOL, V137, P196, DOI 10.1016/j.vetmic.2008.12.015; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Wisselink HJ, 2002, J CLIN MICROBIOL, V40, P2922, DOI 10.1128/JCM.40.8.2922-2929.2002	35	76	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e33854	10.1371/journal.pone.0033854	http://dx.doi.org/10.1371/journal.pone.0033854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563452	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700001
J	Skorobogata, O; Rocheleau, CE				Skorobogata, Olga; Rocheleau, Christian E.			RAB-7 Antagonizes LET-23 EGFR Signaling during Vulva Development in Caenorhabditis elegans	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; C-ELEGANS; FACTOR RECEPTOR; ENDOCYTIC TRAFFICKING; CELL LINEAGES; PROTEIN; RAS; REGULATOR; NEMATODE; LOCALIZATION	The Rab7 GTPase regulates late endosome trafficking of the Epidermal Growth Factor Receptor (EGFR) to the lysosome for degradation. However, less is known about how Rab7 activity, functioning late in the endocytic pathway, affects EGFR signaling. Here we used Caenorhabditis elegans vulva cell fate induction, a paradigm for genetic analysis of EGFR/Receptor Tyrosine Kinase (RTK) signaling, to assess the genetic requirements for rab-7. Using a rab-7 deletion mutant, we demonstrate that rab-7 antagonizes LET-23 EGFR signaling to a similar extent, but in a distinct manner, as previously described negative regulators such as sli-1 c-Cbl. Epistasis analysis places rab-7 upstream of or in parallel to lin-3 EGF and let-23 EGFR. However, expression of gfp::rab-7 in the Vulva Presursor Cells (VPCs) is sufficient to rescue the rab-7(2) VPC induction phenotypes indicating that RAB-7 functions in the signal receiving cell. We show that components of the Endosomal Sorting Complex Required for Transport (ESCRT)-0, and -I, complexes, hgrs-1 Hrs, and vps-28, also antagonize signaling, suggesting that LET-23 EGFR likely transits through Multivesicular Bodies (MVBs) en route to the lysosome. Consistent with RAB-7 regulating LET-23 EGFR trafficking, rab-7 mutants have increased number of LET-23:: GFP-positive endosomes. Our data imply that Rab7, by mediating EGFR trafficking and degradation, plays an important role in downregulation of EGFR signaling. Failure to downregulate EGFR signaling contributes to oncogenesis, and thus Rab7 could possess tumor suppressor activity in humans.	[Skorobogata, Olga] McGill Univ, Dept Med, Div Endocrinol & Metab, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; McGill University	Skorobogata, O (corresponding author), McGill Univ, Dept Med, Div Endocrinol & Metab, Montreal, PQ, Canada.	christian.rocheleau@mcgill.ca		Rocheleau, Christian/0000-0001-6738-5636	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant [RGPIN 341579-07]; Canada Research Chair in Signaling and Development; Fonds de la recherche en sante du Quebec (FRSQ); Canadian Institutes for Health Research (CIHR) Frederick Banting and Charles Best Canada graduate scholarship; FRSQ Master's training award; National Institutes of Health (NIH) - National Center for Research Resources (NCRR)	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Signaling and Development; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes for Health Research (CIHR) Frederick Banting and Charles Best Canada graduate scholarship(Canadian Institutes of Health Research (CIHR)); FRSQ Master's training award; National Institutes of Health (NIH) - National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (RGPIN 341579-07) to CER. CER. was supported by a Canada Research Chair in Signaling and Development and is supported by the Fonds de la recherche en sante du Quebec (FRSQ). OS is supported by a Canadian Institutes for Health Research (CIHR) Frederick Banting and Charles Best Canada graduate scholarship and a FRSQ Master's training award. The Research Institute at the McGill University Health Centre is supported in part by the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Laetitia Chotard, Adam Saffer, and Meera Sundaram, for critical reading of the manuscript, Marc-Andre Sylvain for technical assistance, Aparna Bhat and Elaine Xie for help scoring LET-23::GFP foci, and Richard Roy, Stuart Kim, Barth Grant, Takao Inoue and Hiroyuki Arai for sharing reagents. C. E. R. thanks H. Robert Horvitz and lab members (M. I. T.) for their generosity and support. The rab-7(ok511) deletion mutant was generated by the C. elegans Reverse Genetics Core Facility at the University of British Columbia, which is part of the International C. elegans Gene Knockout Consortium. Most of the nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) - National Center for Research Resources (NCRR).	AROIAN RV, 1991, GENETICS, V128, P251; AROIAN RV, 1994, EMBO J, V13, P360, DOI 10.1002/j.1460-2075.1994.tb06269.x; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Berset TA, 2005, GENE DEV, V19, P1328, DOI 10.1101/gad.333505; BRENNER S, 1974, GENETICS, V77, P71; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Ceresa BP, 2006, HISTOL HISTOPATHOL, V21, P987, DOI 10.14670/HH-21.987; Ceresa BP, 2006, J BIOL CHEM, V281, P1099, DOI 10.1074/jbc.M504175200; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Duerr Janet S, 2006, WormBook, P1; Edgley ML, 2001, MOL GENET GENOMICS, V266, P385, DOI 10.1007/s004380100523; Eisenmann DM, 1997, GENETICS, V146, P553; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; FERGUSON EL, 1985, GENETICS, V110, P17; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Gu MY, 2008, J CELL BIOL, V183, P881, DOI 10.1083/jcb.200806088; Gupta BP, 2006, GENETICS, V174, P1315, DOI 10.1534/genetics.106.063990; Hajnal A, 1997, GENE DEV, V11, P2715, DOI 10.1101/gad.11.20.2715; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Hwang BJ, 2004, DEVELOPMENT, V131, P143, DOI 10.1242/dev.00924; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; JONGEWARD GD, 1995, GENETICS, V139, P1553; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kobuna H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001055; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kritikou EA, 2006, GENE DEV, V20, P2279, DOI 10.1101/gad.384506; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; LEE JH, 1994, GENE DEV, V8, P60, DOI 10.1101/gad.8.1.60; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MERESSE S, 1995, J CELL SCI, V108, P3349; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Myers TR, 2005, DEV CELL, V8, P117, DOI 10.1016/j.devcel.2004.11.015; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rocheleau CE, 2005, P NATL ACAD SCI USA, V102, P11757, DOI 10.1073/pnas.0500937102; Rocheleau CE, 2008, GENETICS, V178, P1431, DOI 10.1534/genetics.107.084608; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; SCHIMMOLLER F, 1993, J CELL SCI, V106, P823; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schubbert S, 2007, CURR OPIN GENET DEV, V17, P15, DOI 10.1016/j.gde.2006.12.004; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Shim J, 2000, MOL BIOL CELL, V11, P2743, DOI 10.1091/mbc.11.8.2743; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; SUNDARAM MV, 2006, RTK RAS MAPK SIGNALI, P1, DOI DOI 10.1895/WORMBOOK.1.80.1; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wang TL, 2012, J CELL PHYSIOL, V227, P2788, DOI 10.1002/jcp.23023; Whitfield CW, 1999, MOL BIOL CELL, V10, P2087, DOI 10.1091/mbc.10.6.2087; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061	73	16	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36489	10.1371/journal.pone.0036489	http://dx.doi.org/10.1371/journal.pone.0036489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558469	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200082
J	Chen, MQ; Zhang, AH; Zhang, Q; Zhang, BC; Nan, J; Li, X; Liu, N; Qu, H; Lu, CM; Sudmorgen; Zhou, YH; Xu, ZH; Bai, SN				Chen, Mei-Qin; Zhang, Ai-Hong; Zhang, Quan; Zhang, Bao-Cai; Nan, Jie; Li, Xia; Liu, Na; Qu, Hong; Lu, Cong-Ming; Sudmorgen; Zhou, Yi-Hua; Xu, Zhi-Hong; Bai, Shu-Nong			Arabidopsis NMD3 Is Required for Nuclear Export of 60S Ribosomal Subunits and Affects Secondary Cell Wall Thickening	PLOS ONE			English	Article							EXTRARIBOSOMAL FUNCTIONS; GENE-EXPRESSION; PROTEIN; BIOSYNTHESIS; TRANSLATION; COORDINATION; DEPOSITION; NUCLEOLUS; CELLULOSE; ADAPTER	NMD3 is required for nuclear export of the 60S ribosomal subunit in yeast and vertebrate cells, but no corresponding function of NMD3 has been reported in plants. Here we report that Arabidopsis thaliana NMD3 (AtNMD3) showed a similar function in the nuclear export of the 60S ribosomal subunit. Interference with AtNMD3 function by overexpressing a truncated dominant negative form of the protein lacking the nuclear export signal sequence caused retainment of the 60S ribosomal subunits in the nuclei. More interestingly, the transgenic Arabidopsis with dominant negative interference of AtNMD3 function showed a striking failure of secondary cell wall thickening, consistent with the altered expression of related genes and composition of cell wall components. Observation of a significant decrease of rough endoplasmic reticulum (RER) in the differentiating interfascicular fiber cells of the transgenic plant stems suggested a link between the defective nuclear export of 60S ribosomal subunits and the abnormal formation of the secondary cell wall. These findings not only clarified the evolutionary conservation of NMD3 functions in the nuclear export of 60S ribosomal subunits in yeast, animals and plants, but also revealed a new facet of the regulatory mechanism underlying secondary cell wall thickening in Arabidopsis. This new facet is that the nuclear export of 60S ribosomal subunits and the formation of RER may play regulatory roles in coordinating protein synthesis in cytoplasm and transcription in nuclei.	[Chen, Mei-Qin; Li, Xia; Liu, Na; Xu, Zhi-Hong; Bai, Shu-Nong] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, PKU Yale Joint Res Ctr Agr & Plant Mol Biol, Beijing 100871, Peoples R China; [Chen, Mei-Qin; Li, Xia; Liu, Na; Xu, Zhi-Hong; Bai, Shu-Nong] Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Zhang, Bao-Cai; Zhou, Yi-Hua] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Gen, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Chen, MQ (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, PKU Yale Joint Res Ctr Agr & Plant Mol Biol, Beijing 100871, Peoples R China.	shunongb@pku.edu.cn	Zhang, Baocai/AFS-9696-2022; Zhang, Baocai/AFW-3565-2022; Nan, Jie/I-5327-2013	Zhang, Baocai/0000-0002-3239-7263; Nan, Jie/0000-0003-1054-5082	Minstry of Sciences and Technology (MST) [J00-A-005, G19990116]; National Natural Science Fundation of China (NSFC) [30070361]	Minstry of Sciences and Technology (MST); National Natural Science Fundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants to SB from Minstry of Sciences and Technology (MST)(J00-A-005, G19990116) and National Natural Science Fundation of China (NSFC)(30070361), and to ZX from MST and NSFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; Blanvillain R, 2008, GENETICS, V180, P1493, DOI 10.1534/genetics.108.094896; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Conlon HE, 2010, METHODS MOL BIOL; Degenhardt RF, 2008, PLANT PHYSIOL, V147, P128, DOI 10.1104/pp.107.111799; Ferreyra MLF, 2010, PLANT PHYSIOL, V153, P1878, DOI 10.1104/pp.110.157057; Fujikura U, 2009, PLANT J, V59, P499, DOI 10.1111/j.1365-313X.2009.03886.x; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Haasen D, 1999, PLANT J, V20, P695, DOI 10.1046/j.1365-313X.1999.00644.x; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; HOEBLER C, 1989, J AGR FOOD CHEM, V37, P360, DOI 10.1021/jf00086a020; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Imai A, 2008, PLANT J, V56, P881, DOI 10.1111/j.1365-313X.2008.03647.x; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Karl T, 1999, CURR GENET, V34, P419, DOI 10.1007/s002940050416; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li M, 2009, PLANT J, V60, P1055, DOI 10.1111/j.1365-313X.2009.04022.x; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Obst J.R., 1988, METHOD ENZYMOL, V161, P87, DOI 10.1016/0076-6879(88)61014-7; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pinon V, 2008, DEVELOPMENT, V135, P1315, DOI 10.1242/dev.016469; R Core Team, 2022, R LANG ENV STAT COMP; Roberts K, 2001, PLANT PHYSIOL, V125, P127, DOI 10.1104/pp.125.1.127; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Rosado A, 2010, PLANT CELL, V22, P143, DOI 10.1105/tpc.109.068320; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Saxena IM, 2008, BIOCH MOL BIOL CELLU; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Szakonyi D, 2011, PLANT J, V65, P269, DOI 10.1111/j.1365-313X.2010.04422.x; Szymanski DB, 2009, CURR BIOL, V19, pR800, DOI 10.1016/j.cub.2009.07.056; Taylor NG, 2008, NEW PHYTOL, V178, P239, DOI 10.1111/j.1469-8137.2008.02385.x; Trotta CR, 2003, EMBO J, V22, P2841, DOI 10.1093/emboj/cdg249; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; VANLIJSEBETTENS M, 1994, EMBO J, V13, P3378, DOI 10.1002/j.1460-2075.1994.tb06640.x; Wang DH, 2010, PLANT J, V61, P862, DOI 10.1111/j.1365-313X.2009.04114.x; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; WESTAFER JM, 1976, CYTOBIOS, V15, P111; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Yang CY, 2007, PLANT CELL, V19, P534, DOI 10.1105/tpc.106.046391; Yao Y, 2008, DEVELOPMENT, V135, P1325, DOI 10.1242/dev.017913; Ye ZH, 2002, INT REV CYTOL, V220, P225; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zanetti ME, 2005, PLANT PHYSIOL, V138, P624, DOI 10.1104/pp.105.059477; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001	59	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35904	10.1371/journal.pone.0035904	http://dx.doi.org/10.1371/journal.pone.0035904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558264	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000080
J	Cheng, CC; Lian, WS; Hsiao, FSH; Liu, IH; Lin, SP; Lee, YH; Chang, CC; Xiao, GY; Huang, HY; Cheng, CF; Cheng, WTK; Wu, SC				Cheng, Chun-Chun; Lian, Wei-Shiung; Hsiao, Felix Shih-Hsiang; Liu, I-Hsuan; Lin, Shau-Ping; Lee, Yen-Hua; Chang, Chia-Chun; Xiao, Guan-Yu; Huang, Hsin-Yi; Cheng, Ching-Feng; Cheng, Winston Teng-Kuei; Wu, Shinn-Chih			Isolation and Characterization of Novel Murine Epiphysis Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; HUMAN UMBILICAL-CORD; BONE-MARROW; PROGENITOR CELLS; IN-VITRO; ADIPOSE-TISSUE; FRACTURE REPAIR; INBRED MICE; DIFFERENTIATION; CULTURE	Background: While bone marrow (BM) is a rich source of mesenchymal stem cells (MSCs), previous studies have shown that MSCs derived from mouse BM (BMMSCs) were difficult to manipulate as compared to MSCs derived from other species. The objective of this study was to find an alternative murine MSCs source that could provide sufficient MSCs. Methodology/Principal Findings: In this study, we described a novel type of MSCs that migrates directly from the mouse epiphysis in culture. Epiphysis-derived MSCs (EMSCs) could be extensively expanded in plastic adherent culture, and they had a greater ability for clonogenic formation and cell proliferation than BMMSCs. Under specific induction conditions, EMSCs demonstrated multipotency through their ability to differentiate into adipocytes, osteocytes and chondrocytes. Immunophenotypic analysis demonstrated that EMSCs were positive for CD29, CD44, CD73, CD105, CD166, Sca-1 and SSEA-4, while negative for CD11b, CD31, CD34 and CD45. Notably, EMSCs did not express major histocompatibility complex class I (MHC I) or MHC II under our culture system. EMSCs also successfully suppressed the proliferation of splenocytes triggered by concanavalin A (Con A) or allogeneic splenocytes, and decreased the expression of IL-1, IL-6 and TNF-alpha in Con A-stimulated splenocytes suggesting their anti-inflammatory properties. Moreover, EMSCs enhanced fracture repair, ameliorated necrosis in ischemic skin flap, and improved blood perfusion in hindlimb ischemia in the in vivo experiments. Conclusions/Significances: These results indicate that EMSCs, a new type of MSCs established by our simple isolation method, are a preferable alternative for mice MSCs due to their better growth and differentiation potentialities.	[Cheng, Chun-Chun; Hsiao, Felix Shih-Hsiang; Lin, Shau-Ping; Wu, Shinn-Chih] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Lian, Wei-Shiung; Cheng, Ching-Feng] Tzu Chi Univ, Dept Pediat, Hualien, Taiwan; [Lian, Wei-Shiung; Cheng, Ching-Feng] Tzu Chi Univ, Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Lian, Wei-Shiung; Cheng, Ching-Feng] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Liu, I-Hsuan; Lee, Yen-Hua; Chang, Chia-Chun; Xiao, Guan-Yu; Huang, Hsin-Yi; Cheng, Winston Teng-Kuei; Wu, Shinn-Chih] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan; [Liu, I-Hsuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Cheng, Winston Teng-Kuei] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan	National Taiwan University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Tunghai University	Cheng, CC (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan.	scw01@ntu.edu.tw	Liu, I-Hsuan/D-9043-2017; CHENG, Ching-Feng/AAB-8861-2019; Hsiao, Shih-Hsiang/AAB-7325-2022; Cheng, Ching-Feng/AAB-8523-2019	Liu, I-Hsuan/0000-0002-4524-3263; CHENG, Ching-Feng/0000-0003-0104-0146; Lee, Yen-Hua/0000-0001-8812-6094; Wu, Shinn-Chih/0000-0001-8881-1550; Lin, Shau-Ping/0000-0003-3423-991X; Chang, Chia Chun/0000-0001-7942-6300	National Taiwan University [97similar to99R0066-41]; Council of Agriculture [99AS-1.2.3-ST-aM]	National Taiwan University(National Taiwan University); Council of Agriculture	This work was supported by grants from National Taiwan University (97 similar to 99R0066-41) and Council of Agriculture (99AS-1.2.3-ST-aM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Castillo MD, 2008, CTS-CLIN TRANSL SCI, V1, P27, DOI 10.1111/j.1752-8062.2008.00018.x; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Dar A, 2012, CIRCULATION, V125, P87, DOI 10.1161/CIRCULATIONAHA.111.048264; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Epting CL, 2008, J CELL PHYSIOL, V217, P250, DOI 10.1002/jcp.21500; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Eslaminejad MB, 2006, DEV GROWTH DIFFER, V48, P361, DOI 10.1111/j.1440-169x.2006.00874.x; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Granero-Molto F, 2011, STEM CELLS, V29, P1537, DOI 10.1002/stem.697; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Gronthos S, 1996, J Hematother, V5, P15, DOI 10.1089/scd.1.1996.5.15; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hisanaga E, 2008, ENDOCR J, V55, P535, DOI 10.1507/endocrj.K07E-173; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Hsiao FSH, 2010, CELL PROLIFERAT, V43, P235, DOI 10.1111/j.1365-2184.2010.00674.x; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kitano Y, 2000, EXP HEMATOL, V28, P1460, DOI 10.1016/S0301-472X(00)00551-8; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Lapi Simone, 2008, BMC Res Notes, V1, P53, DOI 10.1186/1756-0500-1-53; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Lian WS, 2011, LIFE SCI, V88, P455, DOI 10.1016/j.lfs.2010.12.020; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Moorefield EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026535; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Nagano M, 2007, BLOOD, V110, P151, DOI 10.1182/blood-2006-10-047092; Nagano M, 2010, STEM CELLS DEV, V19, P1195, DOI 10.1089/scd.2009.0447; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ozbey O, 2010, HISTOL HISTOPATHOL, V25, P1437, DOI 10.14670/HH-25.1437; Patel SA, 2008, ARCH IMMUNOL THER EX, V56, P1, DOI 10.1007/s00005-008-0001-x; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peters R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015689; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Phinney Donald G., 2008, V449, P171, DOI 10.1007/978-1-60327-169-1_12; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Taguchi K, 2005, BIOCHEM BIOPH RES CO, V331, P31, DOI 10.1016/j.bbrc.2005.03.119; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; Toutain CE, 2009, CIRC RES, V104, P245, DOI 10.1161/CIRCRESAHA.108.182410; Tuli R, 2003, STEM CELLS, V21, P681, DOI 10.1634/stemcells.21-6-681; Uccelli A, 2011, LANCET NEUROL, V10, P649, DOI 10.1016/S1474-4422(11)70121-1; Uysal AC, 2009, PLAST RECONSTR SURG, V124, P804, DOI 10.1097/PRS.0b013e3181b17bb4; UZUKA M, 1981, BIOCHIM BIOPHYS ACTA, V673, P387, DOI 10.1016/0304-4165(81)90470-0; Williams JT, 1999, AM SURGEON, V65, P22; Wilson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-229; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zanini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028175; Zeng LP, 2006, STEM CELLS, V24, P2355, DOI 10.1634/stemcells.2005-0551; Zhang YQ, 2012, MOL BIOL REP, V39, P285, DOI 10.1007/s11033-011-0737-y; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	77	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36085	10.1371/journal.pone.0036085	http://dx.doi.org/10.1371/journal.pone.0036085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558340	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000124
J	Lee, CC; Ho, HC; Su, YC; Chiu, BCH; Su, YC; Lee, YD; Chou, P; Chien, SH; Huang, YS				Lee, Ching-Chih; Ho, Hsu-Chueh; Su, Yu-Chieh; Chiu, Brian C-H; Su, Yung-Cheng; Lee, Yi-Da; Chou, Pesus; Chien, Sou-Hsin; Huang, Yung-Sung			Increased Risk of Vascular Events in Emergency Room Patients Discharged Home with Diagnosis of Dizziness or Vertigo: A 3-Year Follow-Up Study	PLOS ONE			English	Article							STROKE INCIDENCE; ISCHEMIC-STROKE; POPULATION; MANIFESTATION; DIZZY	Background: Dizziness and vertigo symptoms are commonly seen in emergency room (ER). However, these patients are often discharged without a definite diagnosis. Conflicting data regarding the vascular event risk among the dizziness or vertigo patients have been reported. This study aims to determine the risk of developing stroke or cardiovascular events in ER patients discharged home with a diagnosis of dizziness or vertigo. Methodology: A total of 25,757 subjects with at least one ER visit in 2004 were identified. Of those, 1,118 patients were discharged home with a diagnosis of vertigo or dizziness. A Cox proportional hazard model was performed to compare the three-year vascular event-free survival rates between the dizziness/vertigo patients and those without dizziness/vertigo after adjusting for confounding and risk factors. Results: We identified 52 (4.7%) vascular events in patients with dizziness/vertigo and 454 (1.8%) vascular events in patients without dizziness/vertigo. ER patients discharged home with a diagnosis of vertigo or dizziness had 2-fold (95% confidence interval [CI], 1.35-2.96; p<0.001) higher risk of stroke or cardiovascular events after adjusting for patient characteristics, comorbidities, urbanization level of residence, individual socio-economic status, and initially taking medications after the onset of dizziness or vertigo during the first year. Conclusions: ER patients discharged home with a diagnosis of dizziness or vertigo were at a increased risk of developing subsequent vascular events than those without dizziness/vertigo after the onset of dizziness or vertigo. Further studies are warranted for developing better diagnostic and follow-up strategies in increased risk patients.	[Lee, Ching-Chih; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih; Ho, Hsu-Chueh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Yi-Da] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Cardiol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Lee, Ching-Chih; Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Su, Yung-Cheng] Buddhist Dalin Tzu Chi Gen Hosp, Dept Emergency Med, Chiayi, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Div Neurol, Dept Internal Med, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Chien, Sou-Hsin] Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Div Plast Surg, Chiayi, Taiwan; [Lee, Ching-Chih; Ho, Hsu-Chueh; Su, Yu-Chieh; Su, Yung-Cheng; Chien, Sou-Hsin] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chiu, Brian C-H] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; University of Chicago	Lee, CC (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan.	enttcd2@hotamil.com; enttcd@hotamil.com	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017	National Health Research Institutes [100363]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health and managed by the National Health Research Institutes (Serial No. 100363). The interpretation and conclusions contained herein do not represent those of the aforementioned institutions.	Bos MJ, 2007, JAMA-J AM MED ASSOC, V298, P2877, DOI 10.1001/jama.298.24.2877; Chase M, 2011, AM J EMERG IN PRESS; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; DALLARA J, 1994, AM J EMERG MED, V12, P421, DOI 10.1016/0735-6757(94)90052-3; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Finnegan JR, 2000, PREV MED, V31, P205, DOI 10.1006/pmed.2000.0702; Karatas M, 2008, NEUROLOGIST, V14, P355, DOI 10.1097/NRL.0b013e31817533a3; Kerber KA, 2006, STROKE, V37, P2484, DOI 10.1161/01.STR.0000240329.48263.0d; Kerber KA, 2010, J EVAL CLIN PRACT, V16, P186, DOI 10.1111/j.1365-2753.2009.01133.x; Kim AS, 2011, ANN EMERG MED, V57, P34, DOI 10.1016/j.annemergmed.2010.06.559; Lee H, 2006, NEUROLOGY, V67, P1178, DOI 10.1212/01.wnl.0000238500.02302.b4; Lee HY, 2004, J NEUROL SCI, V222, P105, DOI 10.1016/j.jns.2004.04.005; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; MADLONKAY DJ, 1985, J FAM PRACTICE, V21, P109; McFadden E, 2009, STROKE, V40, P1070, DOI 10.1161/STROKEAHA.108.533414; Molshatzki N, 2011, MED CARE, V49, P673, DOI 10.1097/MLR.0b013e318222a508; Moon SY, 2006, J KOREAN MED SCI, V21, P539, DOI 10.3346/jkms.2006.21.3.539; National Health Insurance Research Database, 2009, NAT HLTH INS RES DAT; Newman-Toker DE, 2008, MAYO CLIN PROC, V83, P765, DOI 10.4065/83.7.765; Newman-Toker DE, 2006, NAT CLIN PRACT NEURO, V2, P167, DOI 10.1038/ncpneuro0125; NHI, 2008, NHI PROF; Schappert SM, 2006, VITAL HLTH STAT, V13, P1; Schneider AT, 2003, JAMA-J AM MED ASSOC, V289, P343, DOI 10.1001/jama.289.3.343; Seok JI, 2008, J CLIN NEUROL, V4, P107, DOI 10.3988/jcn.2008.4.3.107; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735	26	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35923	10.1371/journal.pone.0035923	http://dx.doi.org/10.1371/journal.pone.0035923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558272	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000086
J	Mandeville, JS; Bourassa, P; Thomas, TJ; Tajmir-Riahi, HA				Mandeville, Jean-Sebastian; Bourassa, Phillipe; Thomas, Thekkumkattil John; Tajmir-Riahi, Heidar-Ali			Biogenic and Synthetic Polyamines Bind Cationic Dendrimers	PLOS ONE			English	Article							POLYAMIDOAMINE DENDRIMERS; GROWTH-INHIBITION; PAMAM DENDRIMERS; TRANSFER-RNA; CELL-GROWTH; IN-VITRO; ANALOGS; CANCER; METABOLISM; EXPRESSION	Biogenic polyamines are essential for cell growth and differentiation, while polyamine analogues exert antitumor activity in multiple experimental model systems, including breast and lung cancer. Dendrimers are widely used for drug delivery in vitro and in vivo. We report the bindings of biogenic polyamines, spermine (spm), and spermidine (spmd), and their synthetic analogues, 3,7,11,15-tetrazaheptadecane. 4HCl (BE-333) and 3,7,11,15,19-pentazahenicosane.5HCl (BE-3333) to dendrimers of different compositions, mPEG-PAMAM (G3), mPEG-PAMAM (G4) and PAMAM (G4). FTIR and UV-visible spectroscopic methods as well as molecular modeling were used to analyze polyamine binding mode, the binding constant and the effects of polyamine complexation on dendrimer stability and conformation. Structural analysis showed that polyamines bound dendrimers through both hydrophobic and hydrophilic contacts with overall binding constants of Kspm-mPEG-G3 = 7.6 x 10(4) M-1, Kspm-mPEG-PAMAM-G4 = 4.6 x 10(4) M-1, Kspm-PAMAM-G4 = 6.6x10(4) M-1, Kspmd-mPEG-G3 = 1.0x10(5) M-1, Kspmd-mPEG-PAMAM-G4 = 5.5x10(4) M-1, Kspmd-PAMAM-G4 = 9.2 x 10(4) M-1, KBE-333-mPEG-G3 = 4.2x10(4) M-1, KBe-333-mPEG-PAMAM-G4 = 3.2 x 10(4) M-1, KBE-333-PAMAM-G4 = 3.6 x 10(4) M-1, KBE-3333-mPEG-G3 = 2.2x10(4) M-1, KBe-3333-mPEG-PAMAM-G4 = 2.4 x 10(4) M-1, KBE-3333-PAMAM-G4 = 2.3 x 10(4) M-1. Biogenic polyamines showed stronger affinity toward dendrimers than those of synthetic polyamines, while weaker interaction was observed as polyamine cationic charges increased. The free binding energies calculated from docking studies were: -3.2 (spermine), -3.5 (spermidine) and -3.03 (BE-3333) kcal/mol, with the following order of binding affinity: spermidine-PAMAM-G-4>spermine-PAMMAM-G4>BE-3333-PAMAM-G4 consistent with spectroscopic data. Our results suggest that dendrimers can act as carrier vehicles for delivering antitumor polyamine analogues to target tissues.	[Mandeville, Jean-Sebastian; Bourassa, Phillipe; Tajmir-Riahi, Heidar-Ali] Univ Quebec Trois Rivieres, Dept Chim Biol, Trois Rivieres, PQ GA9 5H7, Canada; [Thomas, Thekkumkattil John] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA; [Thomas, Thekkumkattil John] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA	University of Quebec; University of Quebec Trois Rivieres; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Mandeville, JS (corresponding author), Univ Quebec Trois Rivieres, Dept Chim Biol, CP 500, Trois Rivieres, PQ GA9 5H7, Canada.	tajmirri@uqtr.ca	Bourassa, Philippe/H-7281-2012	Bourassa, Philippe/0000-0003-2662-2118				Abderrezak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033102; BERGERON RJ, 1994, J MED CHEM, V37, P3464, DOI 10.1021/jm00047a004; BERGERON RJ, 1988, J MED CHEM, V31, P1183, DOI 10.1021/jm00401a019; Casero RA, 2001, J MED CHEM, V44, P1, DOI 10.1021/jm000084m; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Connors K, BINDING CONSTANTS ME; D'Agostino L, 2005, FEBS J, V272, P3777, DOI 10.1111/j.1742-4658.2005.04782.x; DAVIDSON NE, 1993, CANCER RES, V53, P2071; Dubeau S, 2010, BIOMACROMOLECULES, V11, P1507, DOI 10.1021/bm100144v; Esseminea J, 2011, INT J BIOL MACROMOL, V49; Faaland CA, 2000, BIOCHEM CELL BIOL, V78, P415, DOI 10.1139/bcb-78-4-415; Froehlich E, 2011, BIOMACROMOLECULES, V12, P511, DOI 10.1021/bm1013102; Galeazzi S, 2010, BIOMACROMOLECULES, V11, P182, DOI 10.1021/bm901055a; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Ha HC, 1997, P NATL ACAD SCI USA, V94, P11557, DOI 10.1073/pnas.94.21.11557; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hardy JG, 2006, BIOCONJUGATE CHEM, V17, P172, DOI 10.1021/bc050212r; Hawke CJ, 1999, J CHEM SOC PERK T, P1287; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; Hu JJ, 2010, J PHYS CHEM B, V114, P7148, DOI 10.1021/jp1007889; Huang Y, 2004, MOL CANCER RES, V2, P81; Huang Y, 2006, J BIOL CHEM, V281, P19055, DOI 10.1074/jbc.M600910200; Iyer J, 1998, MACROMOLECULES, V31, P8757, DOI 10.1021/ma980654g; JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226; JANSEN JFGA, 1995, J AM CHEM SOC, V117, P4417, DOI 10.1021/ja00120a032; JEVPRASCSPHANT R, 2000, INT J PHARMACEUT, V252, P263; Klajnert B, 2007, NEW DEV MUTATION RES, P217; Klajnert B., 2007, DENDRIMERS MED; Kojima C, 2000, BIOCONJUGATE CHEM, V11, P910, DOI 10.1021/bc0000583; Kono K, 1999, BIOCONJUGATE CHEM, V10, P1115, DOI 10.1021/bc990082k; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Maiti PK, 2004, MACROMOLECULES, V37, P6236, DOI 10.1021/ma035629b; Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; McCloskey DE, 2003, J BIOL CHEM, V278, P13881, DOI 10.1074/jbc.M205689200; N'soukpoe-Kossi CN, 2008, BIOMACROMOLECULES, V9, P2712, DOI 10.1021/bm800412r; N'soukpoe-Kossi CN, 2009, BIOCHEM CELL BIOL, V87, P621, DOI [10.1139/O09-036, 10.1139/o09-036]; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Ouameur AA, 2010, RNA, V16, P1968, DOI 10.1261/rna.1994310; Patri AK, 2002, CURR OPIN CHEM BIOL, V6, P466, DOI 10.1016/S1367-5931(02)00347-2; PEGG AE, 1988, CANCER RES, V48, P759; Popescu MC, 2006, J PHYS CHEM B, V110, P14198, DOI 10.1021/jp061311k; Singh P, 2008, BIOCONJUGATE CHEM, V19, P2239, DOI 10.1021/bc800125u; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Thomas T, 2003, J CELL MOL MED, V7, P113, DOI 10.1111/j.1582-4934.2003.tb00210.x; Thomas T, 2002, ONCOL RES, V13, P123; Tkachenko AG, 2003, BIOCHEMISTRY-MOSCOW+, V68, P850, DOI 10.1023/A:1025790729797; Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007; Twyman LJ, 1999, TETRAHEDRON LETT, V40, P1743, DOI 10.1016/S0040-4039(98)02680-X; Zhuo RX, 1999, J CONTROL RELEASE, V57, P249, DOI 10.1016/S0168-3659(98)00120-5	51	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36087	10.1371/journal.pone.0036087	http://dx.doi.org/10.1371/journal.pone.0036087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558341	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000125
J	Neoh, KB; Yeap, BK; Tsunoda, K; Yoshimura, T; Lee, CY				Neoh, Kok-Boon; Yeap, Beng-Keok; Tsunoda, Kunio; Yoshimura, Tsuyoshi; Lee, Chow-Yang			Do Termites Avoid Carcasses? Behavioral Responses Depend on the Nature of the Carcasses	PLOS ONE			English	Article							FORMOSAN SUBTERRANEAN TERMITE; DEVELOPMENTAL PATHWAYS; DEFENSIVE BEHAVIOR; CASTE COMPOSITIONS; OLEIC-ACID; HONEY-BEE; ISOPTERA; COLONIES; NITROGEN; ANT	Background: Undertaking behavior is a significant adaptation to social life in enclosed nests. Workers are known to remove dead colony members from the nest. Such behavior prevents the spread of pathogens that may be detrimental to a colony. To date, little is known about the ethological aspects of how termites deal with carcasses. Methodology and Principal Findings: In this study, we tested the responses to carcasses of four species from different subterranean termite taxa: Coptotermes formosanus Shiraki and Reticulitermes speratus (Kolbe) (lower termites) and Microcerotermes crassus Snyder and Globitermes sulphureus Haviland (higher termites). We also used different types of carcasses (freshly killed, 1-, 3-, and 7-day-old, and oven-killed carcasses) and mutilated nestmates to investigate whether the termites exhibited any behavioral responses that were specific to carcasses in certain conditions. Some behavioral responses were performed specifically on certain types of carcasses or mutilated termites. C. formosanus and R. speratus exhibited the following behaviors: (1) the frequency and time spent in antennating, grooming, and carcass removal of freshly killed, 1-day-old, and oven-killed carcasses were high, but these behaviors decreased as the carcasses aged; (2) the termites repeatedly crawled under the aging carcass piles; and (3) only newly dead termites were consumed as a food source. In contrast, M. crassus and G. sulphureus workers performed relatively few behavioral acts. Our results cast a new light on the previous notion that termites are necrophobic in nature. Conclusion: We conclude that the behavioral response towards carcasses depends largely on the nature of the carcasses and termite species, and the response is more complex than was previously thought. Such behavioral responses likely are associated with the threat posed to the colony by the carcasses and the feeding habits and nesting ecology of a given species.	[Neoh, Kok-Boon; Yeap, Beng-Keok; Lee, Chow-Yang] Univ Sains Malaysia, Sch Biol Sci, Vector Control Res Unit, Urban Entomol Lab, George Town, Malaysia; [Tsunoda, Kunio; Yoshimura, Tsuyoshi; Lee, Chow-Yang] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan	Universiti Sains Malaysia; Kyoto University	Neoh, KB (corresponding author), Kyoto Univ, Ctr SE Asian Studies, Yoshida Sakyo Ku, Kyoto, Japan.	chowyang@usm.my	Lee, Chow-Yang/C-7129-2009; Neoh, Kok-Boon/A-4070-2011	Lee, Chow-Yang/0000-0001-8279-4104; Neoh, Kok-Boon/0000-0002-8462-6662	Japan Society for the Promotion of Science; Bayer Environmental Science (Singapore); Universiti Sains Malaysia; Kyoto University, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bayer Environmental Science (Singapore); Universiti Sains Malaysia(Universiti Sains Malaysia); Kyoto University, Japan	This research was a part of the experiment conducted with funding aid from the Japan Society for the Promotion of Science - Exchange Program for East Asian Young Researchers (2010) [Fostering Program of Leading Young Scientists toward the Establishment of Humanosphere Science in East Asia at the Research Institute for Sustainable Humanosphere of Kyoto University] which K-BN and B-KY participated in the program. The other portion of the work carried out in Universiti Sains Malaysia was funded by Bayer Environmental Science (Singapore). K-BN was funded by a postdoctoral fellowship from Universiti Sains Malaysia, and C-YL by a visiting professorship, Kyoto University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 1996, JPN J APPL ENTOMOL Z, V40, P265, DOI 10.1303/jjaez.40.265; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bordereau C, 1997, INSECT SOC, V44, P289, DOI 10.1007/s000400050049; Campora Cory E., 2007, Proceedings of the Hawaiian Entomological Society, V39, P127; Choe DH, 2009, P NATL ACAD SCI USA, V106, P8251, DOI 10.1073/pnas.0901270106; Chouvenc T, 2012, INSECT SOC, V59, P119, DOI 10.1007/s00040-011-0197-3; Chouvenc T, 2005, 16 ANN M EUR CHEM RE, pE1; COWLING EB, 1966, CAN J BOTANY, V44, P1539, DOI 10.1139/b66-167; Crosland MWJ, 2004, ETHOL ECOL EVOL, V16, P117; Crosland MWJ, 1997, ANIM BEHAV, V54, P999, DOI 10.1006/anbe.1997.0509; Dawes-Gromadzki T, 2003, J TROP ECOL, V19, P449, DOI 10.1017/S0266467403003481; EISNER T, 1976, BEHAV ECOL SOCIOBIOL, V1, P83, DOI 10.1007/BF00299954; Fei HX, 2005, J AGR URBAN ENTOMOL, V22, P159; GORDON DM, 1983, J CHEM ECOL, V9, P105, DOI 10.1007/BF00987774; HASKINS C P, 1974, Psyche (Cambridge), V81, P258, DOI 10.1155/1974/80395; Howse P, 1965, INSECTES SOC, V12, P335; Hu XP, 2006, NAT C URB ENT, P40; HUNGATE R. E., 1941, ANN ENT SOC AMERICA, V34, P467; Kitade O, 2010, SOCIOBIOLOGY, V55, P379; Korb J, 2003, NATURWISSENSCHAFTEN, V90, P212, DOI 10.1007/s00114-002-0401-4; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; LINDSTROM M, 1990, NATURWISSENSCHAFTEN, V77, P134, DOI 10.1007/BF01134477; Lopez-Riquelme GO, 2006, PHYSIOL ENTOMOL, V31, P353, DOI 10.1111/j.1365-3032.2006.00526.x; Masterman R, 2001, J COMP PHYSIOL A, V187, P441, DOI 10.1007/s003590100216; Moore B. P., 1969, BIOL TERMITES, P233; POTRIKUS CJ, 1981, P NATL ACAD SCI-BIOL, V78, P4601, DOI 10.1073/pnas.78.7.4601; Renucci M, 2011, INSECT SOC, V58, P9, DOI 10.1007/s00040-010-0109-y; Roisin Y, 1999, INSECT SOC, V46, P273, DOI 10.1007/s000400050146; ROLLO CD, 1994, NATURWISSENSCHAFTEN, V81, P409, DOI 10.1007/BF01132695; Roonwal M. L., 1970, P315; Rosengaus RB, 1999, NATURWISSENSCHAFTEN, V86, P544, DOI 10.1007/s001140050672; Rosengaus RB, 1998, BEHAV ECOL SOCIOBIOL, V44, P125, DOI 10.1007/s002650050523; Saran RK, 2007, J ECON ENTOMOL, V100, P495, DOI 10.1603/0022-0493(2007)100[495:TUATEO]2.0.CO;2; Sobotnik J, 2008, J INSECT BEHAV, V21, P521, DOI 10.1007/s10905-008-9147-y; Sobotnik J, 2008, J CHEM ECOL, V34, P478, DOI 10.1007/s10886-008-9450-2; Song DL, 2006, SOCIOBIOLOGY, V47, P27; Stewart AD, 2006, SOCIOBIOLOGY, V48, P727; Su NY, 1999, SOCIOBIOLOGY, V33, P185; Su NY, 2005, J ECON ENTOMOL, V98, P2143, DOI 10.1603/0022-0493-98.6.2143; SU NY, 1982, J ECON ENTOMOL, V75, P188, DOI 10.1093/jee/75.2.188; Tayasu I, 2002, SOIL BIOL BIOCHEM, V34, P297, DOI 10.1016/S0038-0717(01)00181-X; Thorne B.L., 1982, Psyche (Cambridge), V89, P133, DOI 10.1155/1982/86584; Torales GJ, 2004, SOCIOBIOLOGY, V43, P523; Trumbo ST, 1997, ETHOLOGY, V103, P966; Ulyshen MD, 2012, NATURWISSENSCHAFTEN, V99, P89, DOI 10.1007/s00114-011-0871-3; VISSCHER PK, 1983, ANIM BEHAV, V31, P1070, DOI 10.1016/S0003-3472(83)80014-1; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391; Wong N, 2010, SOCIOBIOLOGY, V55, P353; Woodrow RJ, 2008, SOCIOBIOLOGY, V52, P107; Yao M, 2009, EVOL BIOL, V36, P267, DOI 10.1007/s11692-009-9069-4; Yeoh BH, 2007, SOCIOBIOLOGY, V50, P457	51	33	36	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36375	10.1371/journal.pone.0036375	http://dx.doi.org/10.1371/journal.pone.0036375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558452	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000199
J	Nomura, K; Inoue, K; Akimoto, K				Nomura, Kyoko; Inoue, Kazuo; Akimoto, Kimihiko			A Two-Step Screening, Measurement of HbA1c in Association with FPG, May Be Useful in Predicting Diabetes	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; HBA(1C); RISK; A1C; PROGRESSION; HEMOGLOBIN; VALUES	Backgrounds: We compared the usefulness of fasting plasma glucose (FPG), or hemoglobin A1c (HbA1c), or both in predicting type 2 diabetes. Methods: This retrospective cohort study investigated 9,322 Japanese adults (4,786 men and 4,536 women), aged 19-69 yrs, free of diabetes at baseline. Usefulness was assessed by predictive values (PV), sensitivity, specificity, and the area under the receiver operating characteristic curve (AUROC) maximised under the best cut-off point. Results: During the average 6 years of follow-up, 221 men (4.6%) and 92 women (2%) developed diabetes. The best cut-off points for FPG (i.e., 5.67 mmol/l for men and 5.5 mmol/l for women) gave excellent AUROC, and the highest positive PV (13% for men and 9% for women) in predicting diabetes. In high risk subjects with FPG 6.1-6.9 mmol/l, 119 men (26.8%) and 39 women (28.3%) developed diabetes. Under the best cut-off points of FPG 6.39 mmol/l and A1c 5.8, AUROC and positive PV for FPG slightly decreased indicating FPG became less useful and were statistically indistinguishable from those for HbA1c in men. In fact, HbA1c was the most useful in women: HbA1c of 6.0% gave the highest positive likelihood ratio of 2.74 and larger AUROC than did FPG. Although AUROC for HbA1c was acceptable and indistinguishable from that for the combined use, HbA1c had higher specificity and positive LR than did the combined use. Conclusions: This study demonstrated that FPG was the most useful to predict diabetes in the general population. However, in subjects with FPG 6.1-6.9 mmol/l, FPG became less useful and diagnostic performance of FPG was indistinguishable from that of HbA1c in men whereas HbA1c was the most useful in women. Thus, a two-step screening, measurement of HbA1c in association with FPG, may be useful in predicting diabetes.	[Nomura, Kyoko] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Dept Community Med, Tokyo 173, Japan; [Akimoto, Kimihiko] Med Checkup Ctr, Tokyo, Japan	Teikyo University; Teikyo University	Nomura, K (corresponding author), Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan.	kyoko@med.teikyo-u.ac.jp	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 1999, Diabetologia, V42, P647; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu YM, 2010, ACTA DIABETOL, V47, P231, DOI 10.1007/s00592-009-0143-2; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Ko GTC, 1998, DIABETES CARE, V21, P1221, DOI 10.2337/diacare.21.8.1221; Ko GTC, 2000, DIABETES CARE, V23, P1770, DOI 10.2337/diacare.23.12.1770; Malkani S, 2011, AM J MED, V124, P395, DOI 10.1016/j.amjmed.2010.11.025; Mannucci E, 2003, ACTA DIABETOL, V40, P181, DOI 10.1007/s00592-003-0109-8; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; PANZER RJ, 1999, DIAGNOSTIC STRATEGIE, P18; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Sato KK, 2009, DIABETES CARE, V32, P644, DOI 10.2337/dc08-1631; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Takahashi O, 2010, DIABETES CARE, V33, P2016, DOI 10.2337/dc10-0588; Tominaga M, 2005, ANN CLIN BIOCHEM, V42, P41, DOI 10.1258/0004563053026835; Wang WY, 2002, DIABETES CARE, V25, P1365, DOI 10.2337/diacare.25.8.1365; Zhou J, 2009, DIABETES CARE, V32, P1188, DOI 10.2337/dc09-0076	23	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36309	10.1371/journal.pone.0036309	http://dx.doi.org/10.1371/journal.pone.0036309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558430	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000185
J	Studds, CE; DeLuca, WV; Baker, ME; King, RS; Marra, PP				Studds, Colin E.; DeLuca, William V.; Baker, Matthew E.; King, Ryan S.; Marra, Peter P.			Land Cover and Rainfall Interact to Shape Waterbird Community Composition	PLOS ONE			English	Article							CHESAPEAKE BAY; COASTAL URBANIZATION; NITROGEN EXPORT; MARINE; NUTRIENT; ABUNDANCE; CLIMATE; EUTROPHICATION; INDICATORS; INTEGRITY	Human land cover can degrade estuaries directly through habitat loss and fragmentation or indirectly through nutrient inputs that reduce water quality. Strong precipitation events are occurring more frequently, causing greater hydrological connectivity between watersheds and estuaries. Nutrient enrichment and dissolved oxygen depletion that occur following these events are known to limit populations of benthic macroinvertebrates and commercially harvested species, but the consequences for top consumers such as birds remain largely unknown. We used non-metric multidimensional scaling (MDS) and structural equation modeling (SEM) to understand how land cover and annual variation in rainfall interact to shape waterbird community composition in Chesapeake Bay, USA. The MDS ordination indicated that urban subestuaries shifted from a mixed generalist-specialist community in 2002, a year of severe drought, to generalist-dominated community in 2003, of year of high rainfall. The SEM revealed that this change was concurrent with a sixfold increase in nitrate-N concentration in subestuaries. In the drought year of 2002, waterbird community composition depended only on the direct effect of urban development in watersheds. In the wet year of 2003, community composition depended both on this direct effect and on indirect effects associated with high nitrate-N inputs to northern parts of the Bay, particularly in urban subestuaries. Our findings suggest that increased runoff during periods of high rainfall can depress water quality enough to alter the composition of estuarine waterbird communities, and that this effect is compounded in subestuaries dominated by urban development. Estuarine restoration programs often chart progress by monitoring stressors and indicators, but rarely assess multivariate relationships among them. Estuarine management planning could be improved by tracking the structure of relationships among land cover, water quality, and waterbirds. Unraveling these complex relationships may help managers identify and mitigate ecological thresholds that occur with increasing human land cover.	[Studds, Colin E.; Marra, Peter P.] Smithsonian Inst, Natl Zool Pk, Migratory Bird Ctr, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [DeLuca, William V.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Baker, Matthew E.] Univ Maryland, Dept Geog & Environm Syst, Baltimore, MD 21201 USA; [King, Ryan S.] Baylor Univ, Dept Biol, Ctr Reservoir & Aquat Syst, Waco, TX 76798 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Massachusetts System; University of Massachusetts Amherst; University System of Maryland; University of Maryland Baltimore; Baylor University	Studds, CE (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	c.studds@uq.edu.au	Studds, Colin/C-3701-2012; Baker, Matthew/I-2839-2014	Studds, Colin/0000-0001-5715-1692; Marra, Peter/0000-0002-0508-7577; DeLuca, William/0000-0002-5099-2293; Baker, Matthew/0000-0001-5069-0204	United States Environmental Protection Agency's (USEPA) Science to Achieve Results (STAR) Estuarine and Great Lakes (EaGLe) program [R-82868401]; USEPA	United States Environmental Protection Agency's (USEPA) Science to Achieve Results (STAR) Estuarine and Great Lakes (EaGLe) program; USEPA(United States Environmental Protection Agency)	This study was funded by a grant from the United States Environmental Protection Agency's (USEPA) Science to Achieve Results (STAR) Estuarine and Great Lakes (EaGLe) program to the Atlantic Slope Consortium, USEPA Agreement #R-82868401. Although the research described in this article was funded by the USEPA, it was not subjected to the Agency's peer and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021852; [Anonymous], AMOS VERSION 19; Bollen K. A., 1993, TESTING STRUCTURAL E; Boyer EW, 2002, BIOGEOCHEMISTRY, V57, P137, DOI 10.1023/A:1015709302073; Brinker DF, 2007, WATERBIRDS, V30, P93, DOI 10.1675/1524-4695(2007)030[0093:CSITCB]2.0.CO;2; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Bundy MH, 2003, ESTUARIES, V26, P365, DOI 10.1007/BF02695974; Chesapeake Bay Foundation, 2010, 2010 STAT BAY; Chesney E. J., 1989, POPULATION BIOL BAY, P184; CONNELL DW, 1984, CHEM ECOTOXICOLOGY P; DeLuca WV, 2008, BIOL CONSERV, V141, P2669, DOI 10.1016/j.biocon.2008.07.023; DeLuca WV, 2004, WETLANDS, V24, P837, DOI 10.1672/0277-5212(2004)024[0837:IOLUOT]2.0.CO;2; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Erwin RM, 1996, ESTUARIES, V19, P213, DOI 10.2307/1352226; Essington TE, 2010, ECOSYSTEMS, V13, P1035, DOI 10.1007/s10021-010-9372-z; FAITH DP, 1989, BIOL CONSERV, V50, P77, DOI 10.1016/0006-3207(89)90006-2; Fear JM, 2007, ESTUAR COAST, V30, P1027, DOI 10.1007/BF02841393; Haas K, 2007, ECOLOGY, V88, P2915, DOI 10.1890/06-1981.1; Howarth RW, 2006, BIOGEOCHEMISTRY, V79, P163, DOI 10.1007/s10533-006-9010-1; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; Jordan TE, 2003, ESTUARIES, V26, P226, DOI 10.1007/BF02695964; Jung S, 2003, ESTUAR COAST SHELF S, V58, P335, DOI 10.1016/S0272-7714(03)00085-4; Kaushal SS, 2008, ENVIRON SCI TECHNOL, V42, P5872, DOI 10.1021/es800264f; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; King RS, 2004, ENVIRON SCI TECHNOL, V38, P6546, DOI 10.1021/es049059m; King RS, 2005, ECOL APPL, V15, P137, DOI 10.1890/04-0481; King RS, 2007, ESTUAR COAST, V30, P469, DOI 10.1007/BF02819393; Kloskowski J, 2010, NATURWISSENSCHAFTEN, V97, P673, DOI 10.1007/s00114-010-0684-9; Langland M. J., 2004, 20045259 US GEOL SUR; Lawrie RA, 2010, ESTUAR COAST SHELF S, V87, P237, DOI 10.1016/j.ecss.2010.01.020; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lyons JE, 2008, J WILDLIFE MANAGE, V72, P1683, DOI 10.2193/2008-141; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Miller DC, 2002, MAR BIOL, V140, P287, DOI 10.1007/s002270100702; Mitsch W., 2000, WETLANDS, V3rd; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; O'Connell TJ, 2000, ECOL APPL, V10, P1706, DOI 10.2307/2641233; Oksanen J., 2016, R PACKAG; Paerl HW, 2009, ESTUAR COAST, V32, P593, DOI 10.1007/s12237-009-9158-8; Paracuellos M, 2004, WATERBIRDS, V27, P446, DOI 10.1675/1524-4695(2004)027[0446:FATDOA]2.0.CO;2; Preston S. D., 1999, 994054 US GEOL SURV; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Ronicke H, 2008, FUND APPL LIMNOL, V172, P111, DOI 10.1127/1863-9135/2008/0172-0111; Rudstam LG, 2004, ECOL APPL, V14, P149, DOI 10.1890/03-5010; Seo Dong Cheol, 2008, Archives of Agronomy and Soil Science, V54, P249, DOI 10.1080/03650340701679075; Shields CA, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006360; Shipley B., 2000, CAUSE CORRELATIONS B; Somers CM, 2007, WATERBIRDS, V30, P241, DOI 10.1675/1524-4695(2007)30[241:IBDCAH]2.0.CO;2; Thorpe AS, 2011, J APPL ECOL, V48, P275, DOI 10.1111/j.1365-2664.2011.01972.x; Thrush SF, 2008, ECOL APPL, V18, P12, DOI 10.1890/07-0436.1; Traut AH, 2004, LANDSCAPE URBAN PLAN, V69, P69, DOI 10.1016/j.landurbplan.2003.08.009; *USEPA, 2000, MULT LAND CHAR CONS; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Wazniak CE, 2007, ECOL APPL, V17, pS64, DOI 10.1890/05-1554.1	56	11	12	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35969	10.1371/journal.pone.0035969	http://dx.doi.org/10.1371/journal.pone.0035969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558286	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000093
J	Thomas, DC; Ahmed, A; Gilberger, TW; Sharma, P				Thomas, Divya Catherine; Ahmed, Anwar; Gilberger, Tim Wolf; Sharma, Pushkar			Regulation of Plasmodium falciparum Glideosome Associated Protein 45 (PfGAP45) Phosphorylation	PLOS ONE			English	Article							B-LIKE ENZYME; ERYTHROCYTE INVASION; MALARIA PARASITES; CELL INVASION; MYOSIN; KINASE; IDENTIFICATION; MEMBRANE; COMPLEX; TRANSFECTION	The actomyosin motor complex of the glideosome provides the force needed by apicomplexan parasites such as Toxoplasma gondii (Tg) and Plasmodium falciparum (Pf) to invade their host cells and for gliding motility of their motile forms. Glideosome Associated Protein 45 (PfGAP45) is an essential component of the glideosome complex as it facilitates anchoring and effective functioning of the motor. Dissection of events that regulate PfGAP45 may provide insights into how the motor and the glideosome operate. We found that PfGAP45 is phosphorylated in response to Phospholipase C (PLC) and calcium signaling. It is phosphorylated by P. falciparum kinases Protein Kinase B (PfPKB) and Calcium Dependent Protein Kinase 1 (PfCDPK1), which are calcium dependent enzymes, at S89, S103 and S149. The Phospholipase C pathway influenced the phosphorylation of S103 and S149. The phosphorylation of PfGAP45 at these sites is differentially regulated during parasite development. The localization of PfGAP45 and its association may be independent of the phosphorylation of these sites. PfGAP45 regulation in response to calcium fits in well with the previously described role of calcium in host cell invasion by malaria parasite.	[Thomas, Divya Catherine; Ahmed, Anwar; Sharma, Pushkar] Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; [Gilberger, Tim Wolf] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, Hamburg, Germany; [Gilberger, Tim Wolf] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Gilberger, Tim Wolf] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Bernhard Nocht Institut fur Tropenmedizin; McMaster University; McMaster University	Thomas, DC (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India.	pushkar@nii.ac.in	Ahmed, Anwar/ADH-1445-2022; Ahmed, Anwar/AAL-7789-2021	Ahmed, Anwar/0000-0001-8147-714X; Gilberger, Tim-Wolf/0000-0002-7965-8272	Department of Science and Technology, India; Signalling in life cycle stages of malaria parasites (MALSIG); European Union; Bundesministerium fur Bildung und Forschung, Germany [IND 09/024]; National Institutes of Health from National Insitute of Allergies and Infectious Diseases [R01AI075459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075459] Funding Source: NIH RePORTER	Department of Science and Technology, India(Department of Science & Technology (India)); Signalling in life cycle stages of malaria parasites (MALSIG); European Union(European Commission); Bundesministerium fur Bildung und Forschung, Germany(Federal Ministry of Education & Research (BMBF)); National Institutes of Health from National Insitute of Allergies and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PS is a recipient of Swarnajayanti Fellowship Grant from Department of Science and Technology, India and his laboratory is supported by "Signalling in life cycle stages of malaria parasites (MALSIG)'' project funded by European Union under FP7 and an Indo-German collaborative grant by Department of Biotechnology, India and Bundesministerium fur Bildung und Forschung (IND 09/024), Germany. This work was also supported in part by National Institutes of Health Grant R01AI075459 from National Insitute of Allergies and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Beraldo FH, 2005, J PINEAL RES, V39, P224, DOI 10.1111/j.1600-079X.2005.00249.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; Fauquenoy S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.008953, 10.1074/mcp.A111.008953]; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Gilk SD, 2009, EUKARYOT CELL, V8, P190, DOI 10.1128/EC.00201-08; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Hotta CT, 2003, BRAZ J MED BIOL RES, V36, P1583, DOI 10.1590/S0100-879X2003001100016; Jones ML, 2009, MOL BIOCHEM PARASIT, V168, P55, DOI 10.1016/j.molbiopara.2009.06.007; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Mamoun CB, 2001, MOL MICROBIOL, V39, P26, DOI 10.1046/j.1365-2958.2001.02222.x; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Raabe AC, 2011, CELL MICROBIOL, V13, P955, DOI 10.1111/j.1462-5822.2011.01591.x; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vaid A, 2006, J BIOL CHEM, V281, P27126, DOI 10.1074/jbc.M601914200; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Winter D, 2009, ANAL BIOCHEM, V393, P41, DOI 10.1016/j.ab.2009.06.022; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Yeoman JA, 2011, EUKARYOT CELL, V10, P556, DOI 10.1128/EC.00244-10	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35855	10.1371/journal.pone.0035855	http://dx.doi.org/10.1371/journal.pone.0035855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558243	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000067
J	Lioudyno, MI; Broccio, M; Sokolov, Y; Rasool, S; Wu, J; Alkire, MT; Liu, V; Kozak, JA; Dennison, PR; Glabe, CG; Losche, M; Hall, JE				Lioudyno, Maria I.; Broccio, Matteo; Sokolov, Yuri; Rasool, Suhail; Wu, Jessica; Alkire, Michael T.; Liu, Virginia; Kozak, J. Ashot; Dennison, Philip R.; Glabe, Charles G.; Loesche, Mathias; Hall, James E.			Effect of Synthetic A beta Peptide Oligomers and Fluorinated Solvents on Kv1.3 Channel Properties and Membrane Conductance	PLOS ONE			English	Article							ALPHA-7 NICOTINIC ACETYLCHOLINE; SOLUBLE AMYLOID OLIGOMERS; GATED POTASSIUM CHANNELS; ALZHEIMERS-DISEASE; K+ CHANNELS; FIBRILLAR OLIGOMERS; CORTICAL-NEURONS; PRIMARY CULTURES; LIPID-BILAYERS; PROTEIN 1-40	The impact of synthetic amyloid beta (1-42) (A beta(1-42)) oligomers on biophysical properties of voltage-gated potassium channels Kv 1.3 and lipid bilayer membranes (BLMs) was quantified for protocols using hexafluoroisopropanol (HFIP) or sodium hydroxide (NaOH) as solvents prior to initiating the oligomer formation. Regardless of the solvent used A beta(1-42) samples contained oligomers that reacted with the conformation-specific antibodies A11 and OC and had similar size distributions as determined by dynamic light scattering. Patch-clamp recordings of the potassium currents showed that synthetic A beta(1-42) oligomers accelerate the activation and inactivation kinetics of Kv 1.3 current with no significant effect on current amplitude. In contrast to oligomeric samples, freshly prepared, presumably monomeric, A beta(1-42) solutions had no effect on Kv 1.3 channel properties. A beta(1-42) oligomers had no effect on the steady-state current (at -80 mV) recorded from Kv 1.3-expressing cells but increased the conductance of artificial BLMs in a dose-dependent fashion. Formation of amyloid channels, however, was not observed due to conditions of the experiments. To exclude the effects of HFIP (used to dissolve lyophilized A beta(1-42) peptide), and trifluoroacetic acid (TFA) (used during A beta(1-42) synthesis), we determined concentrations of these fluorinated compounds in the stock A beta(1-42) solutions by F-19 NMR. After extensive evaporation, the concentration of HFIP in the 100 x stock A beta(1-42) solutions was,similar to 1.7 mu M. The concentration of residual TFA in the 70 x stock A beta(1-42) solutions was similar to 20 mu M. Even at the stock concentrations neither HFIP nor TFA alone had any effect on potassium currents or BLMs. The A beta(1-42) oligomers prepared with HFIP as solvent, however, were more potent in the electrophysiological tests, suggesting that fluorinated compounds, such as HFIP or structurally-related inhalational anesthetics, may affect A beta(1-42) aggregation and potentially enhance ability of oligomers to modulate voltage-gated ion channels and biological membrane properties.	[Lioudyno, Maria I.; Sokolov, Yuri; Liu, Virginia; Hall, James E.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Broccio, Matteo; Loesche, Mathias] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Rasool, Suhail; Wu, Jessica; Glabe, Charles G.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Alkire, Michael T.; Liu, Virginia] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Irvine, CA USA; [Kozak, J. Ashot] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA; [Dennison, Philip R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Loesche, Mathias] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Loesche, Mathias] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	University of California System; University of California Irvine; Carnegie Mellon University; University of California System; University of California Irvine; University of California System; University of California Irvine; University System of Ohio; Wright State University Dayton; University of California System; University of California Irvine; National Institute of Standards & Technology (NIST) - USA; Carnegie Mellon University	Lioudyno, MI (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	jhall@uci.edu	Lösche, Mathias/J-2986-2013; Hall, James E/K-6306-2012	Lösche, Mathias/0000-0001-6666-916X; 	National Institutes of Health [1P01 AG032131]; Larry L. Hillblom Foundation; NATIONAL INSTITUTE ON AGING [P01AG032131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (1P01 AG032131) and the Larry L. Hillblom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Artym VV, 2002, J GEN PHYSIOL, V120, P29, DOI 10.1085/jgp.20028607; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; Bittner EA, 2011, CAN J ANESTH, V58, P216, DOI 10.1007/s12630-010-9418-x; Bobich JA, 2004, J ALZHEIMERS DIS, V6, P243; BURDICK D, 1992, J BIOL CHEM, V267, P546; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Carnini A, 2007, CURR ALZHEIMER RES, V4, P233; Chen C, 2005, BIOCHEM BIOPH RES CO, V338, P1913, DOI 10.1016/j.bbrc.2005.10.169; Cherubini A, 2010, NEUROSCI LETT, V469, P214, DOI 10.1016/j.neulet.2009.11.077; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Chung S, 2001, NEUROSCI LETT, V300, P67, DOI 10.1016/S0304-3940(01)01516-6; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Colley BS, 2007, NEUROSCIENCE, V144, P531, DOI 10.1016/j.neuroscience.2006.09.055; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Esteban JA, 2004, TRENDS NEUROSCI, V27, P1, DOI 10.1016/j.tins.2003.10.008; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Fadool DA, 1998, J NEUROSCI, V18, P6126; Fodale V, 2010, ANAESTHESIA, V65, P388, DOI 10.1111/j.1365-2044.2010.06244.x; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Good TA, 1996, BIOPHYS J, V70, P296, DOI 10.1016/S0006-3495(96)79570-X; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Han J, 2001, BIOCHEM BIOPH RES CO, V285, P1136, DOI 10.1006/bbrc.2001.5291; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Holmes TC, 1996, J NEUROSCI, V16, P1581; Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3; Jeon YJ, 2008, NEUROREPORT, V19, P1661, DOI 10.1097/WNR.0b013e3283140f10; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Juhasz G, 2010, J ALZHEIMERS DIS, V19, P1055, DOI [10.3233/JAD-2010-1301, 10.3233/JAD-2009-1301]; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kawahara M, 2000, BRAIN RES BULL, V53, P389, DOI 10.1016/S0361-9230(00)00370-1; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Koch RO, 1997, J BIOL CHEM, V272, P27577, DOI 10.1074/jbc.272.44.27577; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; KUES WA, 1992, EUR J NEUROSCI, V4, P1296, DOI 10.1111/j.1460-9568.1992.tb00155.x; Kupper J, 2002, PFLUG ARCH EUR J PHY, V443, P541, DOI 10.1007/s00424-001-0734-4; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levitt M, 1997, ANNU REV BIOCHEM, V66, P549, DOI 10.1146/annurev.biochem.66.1.549; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Lopez-Toledano MA, 2010, J ALZHEIMERS DIS, V20, P395, DOI 10.3233/JAD-2010-1388; MacManus A, 2000, J BIOL CHEM, V275, P4713, DOI 10.1074/jbc.275.7.4713; Mamikonyan G, 2007, J BIOL CHEM, V282, P22376, DOI 10.1074/jbc.M700088200; Mandal PK, 2009, BIOCHEM BIOPH RES CO, V379, P716, DOI 10.1016/j.bbrc.2008.12.092; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; OhnoShosaku T, 1996, NEUROSCI LETT, V207, P195, DOI 10.1016/0304-3940(96)12518-0; Pannaccione A, 2005, J NEUROCHEM, V94, P572, DOI 10.1111/j.1471-4159.2005.03075.x; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Ramsden M, 2002, BRAIN RES, V956, P254, DOI 10.1016/S0006-8993(02)03547-3; Ramsden M, 2001, J NEUROCHEM, V79, P699, DOI 10.1046/j.1471-4159.2001.00618.x; Rodriguez JJ, 2008, PLOS ONE, V3, P1; Rodriguez JJ, 2009, NEUROREPORT, V20, P907, DOI 10.1097/WNR.0b013e32832be77d; Sarsoza F, 2009, ACTA NEUROPATHOL, V118, P505, DOI 10.1007/s00401-009-0530-3; Seidler NW, 2009, PROTEIN PEPTIDE LETT, V16, P182, DOI 10.2174/092986609787316324; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Somodi S, 2004, AM J PHYSIOL-CELL PH, V287, pC1067, DOI 10.1152/ajpcell.00438.2003; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Valincius G, 2008, BIOPHYS J, V95, P4845, DOI 10.1529/biophysj.108.130997; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Xie ZC, 2006, EXP GERONTOL, V41, P346, DOI 10.1016/j.exger.2006.01.014; Ye CP, 2003, NEUROBIOL DIS, V13, P177, DOI 10.1016/S0969-9961(03)00068-8; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	82	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35090	10.1371/journal.pone.0035090	http://dx.doi.org/10.1371/journal.pone.0035090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563377	Green Published, gold			2022-12-25	WOS:000305349100006
J	Zhou, WB; He, ZY; Xue, JL; Wang, MH; Zha, XM; Ling, LJ; Chen, L; Wang, S; Liu, X				Zhou, Wenbin; He, Zhongyuan; Xue, Jialei; Wang, Minghai; Zha, Xiaoming; Ling, Lijun; Chen, Lin; Wang, Shui; Liu, Xiaoan			Molecular Subtype Classification Is a Determinant of Non-Sentinel Lymph Node Metastasis in Breast Cancer Patients with Positive Sentinel Lymph Nodes	PLOS ONE			English	Article							GUIDELINE RECOMMENDATIONS; AXILLARY DISSECTION; ONLINE CALCULATOR; BIOPSY; INVOLVEMENT; PREDICTION; MORBIDITY; MODELS	Background: Previous studies suggested that the molecular subtypes were strongly associated with sentinel lymph node (SLN) status. The purpose of this study was to determine whether molecular subtype classification was associated with non-sentinel lymph nodes (NSLN) metastasis in patients with a positive SLN. Methodology and Principal Findings: Between January 2001 and March 2011, a total of 130 patients with a positive SLN were recruited. All these patients underwent a complete axillary lymph node dissection. The univariate and multivariate analyses of NSLN metastasis were performed. In univariate and multivariate analyses, large tumor size, macrometastasis and high tumor grade were all significant risk factors of NSLN metastasis in patients with a positive SLN. In univariate analysis, luminal B subgroup showed higher rate of NSLN metastasis than other subgroup (P = 0.027). When other variables were adjusted in multivariate analysis, the molecular subtype classification was a determinant of NSLN metastasis. Relative to triple negative subgroup, both luminal A (P = 0.047) and luminal B (P = 0.010) subgroups showed a higher risk of NSLN metastasis. Otherwise, HER2 over-expression subgroup did not have a higher risk than triple negative subgroup (P = 0.183). The area under the curve (AUC) value was 0.8095 for the Cambridge model. When molecular subtype classification was added to the Cambridge model, the AUC value was 0.8475. Conclusions: Except for other factors, molecular subtype classification was a determinant of NSLN metastasis in patients with a positive SLN. The predictive accuracy of mathematical models including molecular subtype should be determined in the future.	[Zhou, Wenbin; He, Zhongyuan; Xue, Jialei; Wang, Minghai; Zha, Xiaoming; Ling, Lijun; Chen, Lin; Wang, Shui; Liu, Xiaoan] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Peoples R China	Nanjing Medical University	Zhou, WB (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Peoples R China.	ws0801@hotmail.com; liuxiaoan@126.com			National Natural Science Foundation of China [81172502]; Science and Education for Health Foundation of Jiangsu Province [RC2007054]; First Affiliated Hospital of NJMU [IRT-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Education for Health Foundation of Jiangsu Province; First Affiliated Hospital of NJMU	This work was supported in part by the National Natural Science Foundation of China (81172502), the Science and Education for Health Foundation of Jiangsu Province (RC2007054), and the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdessalam SF, 2001, AM J SURG, V182, P316, DOI 10.1016/S0002-9610(01)00719-X; Cady B, 1997, J SURG ONCOL, V66, P7, DOI 10.1002/(SICI)1096-9098(199709)66:1<7::AID-JSO3>3.0.CO;2-8; Chen K, 2011, CANC SCI; Cserni G, 2004, JPN J CLIN ONCOL, V34, P519, DOI 10.1093/jjco/hyh090; Degnim AC, 2005, AM J SURG, V190, P543, DOI 10.1016/j.amjsurg.2005.06.008; Gabos Z, 2006, J CLIN ONCOL, V24, P5658, DOI 10.1200/JCO.2006.07.0250; Hack TF, 1999, J CLIN ONCOL, V17, P143, DOI 10.1200/JCO.1999.17.1.143; Hwang RF, 2003, ANN SURG ONCOL, V10, P248, DOI 10.1245/ASO.2003.05.020; Keshtgar MRS, 2002, LANCET ONCOL, V3, P105, DOI 10.1016/S1470-2045(02)00652-6; Kohrt HE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-66; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Moghaddam Y, 2010, BRIT J SURG, V97, P1646, DOI 10.1002/bjs.7181; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; Nos C, 2003, BRIT J SURG, V90, P1354, DOI 10.1002/bjs.4325; Pal A, 2008, BRIT J SURG, V95, P302, DOI 10.1002/bjs.5943; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rahusen FD, 2001, ARCH SURG-CHICAGO, V136, P1059, DOI 10.1001/archsurg.136.9.1059; Reyal F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020297; Reynolds C, 1999, J CLIN ONCOL, V17, P1720, DOI 10.1200/JCO.1999.17.6.1720; Schrenk P, 2005, BRIT J SURG, V92, P707, DOI 10.1002/bjs.4937; Scow JS, 2009, CANCER-AM CANCER SOC, V115, P4064, DOI 10.1002/cncr.24469; Turner RR, 1997, ANN SURG, V226, P271, DOI 10.1097/00000658-199709000-00006; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Weaver DL, 2000, CANCER, V88, P1099, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1099::AID-CNCR22>3.3.CO;2-Z; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yin WJ, 2009, BREAST CANCER RES TR, V115, P325, DOI 10.1007/s10549-008-0096-0; Zhou WB, 2011, CAN J SURG, V54, P300, DOI 10.1503/cjs.006010	30	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35881	10.1371/journal.pone.0035881	http://dx.doi.org/10.1371/journal.pone.0035881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563412	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349100038
J	Chi, A; Liao, ZX; Nguyen, NP; Xu, JH; Welsh, JS; Jang, SY; Howe, C; Komaki, R				Chi, Alexander; Liao, Zhongxing; Nguyen, Nam P.; Xu, Jiahong; Welsh, James S.; Jang, Si Young; Howe, Carol; Komaki, Ritsuko			Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases	PLOS ONE			English	Article							BODY RADIATION-THERAPY; TOXICITY; VOLUME; TUMORS; IMRT	Background: No selection criteria for helical tomotherapy (HT) based stereotactic ablative radiotherapy (SABR) to treat early stage non-small cell lung cancer (NSCLC) or solitary lung metastases has been established. In this study, we investigate the dosimetric selection criteria for HT based SABR delivering 70 Gy in 10 fractions to avoid severe toxicity in the treatment of centrally located lesions when adequate target dose coverage is desired. Materials and Methods: 78 HT-SABR plans for solitary lung lesions were created to prescribe 70 Gy in 10 fractions to the planning target volume (PTV). The PTV was set to have >= 95% PTV receiving 70 Gy in each case. The cases for which dose constraints for >= 1 OAR could not be met without compromising the target dose coverage were compared with cases for which all target and OAR dose constraints were met. Results: There were 23 central lesions for which OAR dose constraints could not be met without compromising PTV dose coverage. Comparing to cases for which optimal HT-based SABR plans were generated, they were associated with larger tumor size (5.72 +/- 1.96 cm vs. 3.74 +/- 1.49 cm, p < 0.0001), higher lung dose, increased number of immediately adjacent OARs (3.45 +/- 1.34 vs. 1.66 +/- 0.81, p < 0.0001), and shorter distance to the closest OARs (GTV: 0.26 +/- 0.22 cm vs. 0.88 +/- 0.54 cm, p < 0.0001; PTV 0.19 +/- 0.18 cm vs. 0.48 +/- 0.36 cm, p = 0.0001). Conclusion: Delivery of 70 Gy in 10 fractions with HT to meet all the given OAR and PTV dose constraints are most likely when the following parameters are met: lung lesions <= 3.78 cm (11.98 cc), <= 2 immediately adjacent OARs which are >= 0.45 cm from the gross lesion and >= 0.21 cm from the PTV.	[Chi, Alexander; Nguyen, Nam P.; Jang, Si Young] W Virginia Univ, Dept Radiat Oncol, Morgantown, WV USA; [Liao, Zhongxing; Komaki, Ritsuko] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Xu, Jiahong] Westat An Employee Owned Res Corp, Rockville, MD USA; [Welsh, James S.] Louisiana State Univ, Dept Radiat Oncol, Shreveport, LA 71105 USA; [Howe, Carol] Univ Arizona, Med Lib, Tucson, AZ USA	West Virginia University; University of Texas System; UTMD Anderson Cancer Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Arizona	Chi, A (corresponding author), W Virginia Univ, Dept Radiat Oncol, Morgantown, WV USA.	achiaz2010@gmail.com		Howe, Carol/0000-0002-7911-4160				Baisden JM, 2007, INT J RADIAT ONCOL, V68, P1229, DOI 10.1016/j.ijrobp.2007.03.024; Cattaneo GM, 2008, RADIOTHER ONCOL, V88, P310, DOI 10.1016/j.radonc.2008.06.006; Chi A, 2011, INT J RADIAT ONCOL, V81, P856, DOI 10.1016/j.ijrobp.2010.11.051; Chi A, 2011, AM J CLIN ONCOL-CANC, V34, P432, DOI 10.1097/COC.0b013e3181df4b3f; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Fenwick JD, 2006, SEMIN RADIAT ONCOL, V16, P199, DOI 10.1016/j.semradonc.2006.04.002; Gutierrez AN, 2011, MED DOSIM, V36, P126, DOI 10.1016/j.meddos.2010.02.003; Kanagaki B, 2007, PHYS MED BIOL, V52, P243, DOI 10.1088/0031-9155/52/1/016; Kirkpatrick JP, 2010, INT J RADIAT ONCOL, V76, pS42, DOI 10.1016/j.ijrobp.2009.04.095; Milano MT, 2009, RADIOTHER ONCOL, V91, P301, DOI 10.1016/j.radonc.2009.03.005; Nagata Y, 2011, INT J RADIAT ONCOL, V79, P660, DOI 10.1016/j.ijrobp.2010.10.004; Onimaru R, 2003, INT J RADIAT ONCOL, V56, P126, DOI 10.1016/S0360-3016(03)00095-6; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Oshiro Y, 2010, STRAHLENTHER ONKOL, V186, P274, DOI 10.1007/s00066-010-2072-y; Peulen H, 2011, RADIOTHER ONCOL, V101, P260, DOI 10.1016/j.radonc.2011.09.012; Ricardi U, 2012, LUNG CANCER, V75, P77, DOI 10.1016/j.lungcan.2011.04.021; Rodrigues G, 2006, RADIOTHER ONCOL, V80, P374, DOI 10.1016/j.radonc.2006.07.005; Sahgal A, 2010, INT J RADIAT ONCOL, V77, P548, DOI 10.1016/j.ijrobp.2009.05.023; Sheng K, 2006, INT J RADIAT ONCOL, V65, P917, DOI 10.1016/j.ijrobp.2006.02.038; Solberg TD, 2012, PRACT RADIAT ONCOL, V2, P2, DOI 10.1016/j.prro.2011.06.014; Song SY, 2009, LUNG CANCER, V66, P89, DOI 10.1016/j.lungcan.2008.12.016; Stauder MC, 2011, RADIOTHER ONCOL, V99, P166, DOI 10.1016/j.radonc.2011.04.002; Sterzing F, 2008, STRAHLENTHER ONKOL, V184, P8, DOI 10.1007/s00066-008-1778-6; Sterzing F, 2010, INT J RADIAT ONCOL, V76, P1266, DOI 10.1016/j.ijrobp.2009.07.1686; Timmerman R, 2006, J CLIN ONCOL, V24, P4833, DOI 10.1200/JCO.2006.07.5937; Timmerman R, 2011, FRONT RADIAT THER ON, V43, P395, DOI 10.1159/000322503; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Tome WA, 2002, MED PHYS, V29, P1590, DOI 10.1118/1.1485060; Xia TY, 2006, INT J RADIAT ONCOL, V66, P117, DOI 10.1016/j.ijrobp.2006.04.013	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35809	10.1371/journal.pone.0035809	http://dx.doi.org/10.1371/journal.pone.0035809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558228	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200081
J	Laukaitis, CM; Mauss, C; Karn, RC				Laukaitis, Christina M.; Mauss, Corina; Karn, Robert C.			Congenic Strain Analysis Reveals Genes That Are Rapidly Evolving Components of a Prezygotic Isolation Mechanism Mediating Incipient Reinforcement	PLOS ONE			English	Article							ANDROGEN-BINDING-PROTEIN; AMINO-ACID SITES; MUS-MUSCULUS; SEXUAL ISOLATION; GENUS MUS; EVOLUTIONARY RELATIONSHIPS; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; STEROID-BINDING; HOUSE MOUSE	Two decades ago, we developed a congenic strain of Mus musculus, called b-congenic, by replacing the androgen-binding protein Abpa27(a) allele in the C3H/HeJ genome with the Abpa27(b) allele from DBA/2J. We and other researchers used this b-congenic strain and its C3H counterpart, the a-congenic strain, to test the hypothesis that, given the choice between signals from two strains with different a27 alleles on the same genetic background, test subjects would prefer the homosubspecific one. It was our purpose in undertaking this study to characterize the segment transferred from DBA to the C3H background in producing the b-congenic strain on which a role for ABPA27 in behavior has been predicated. We determined the size of the chromosome 7 segment transferred from DBA and the genes it contains that might influence preference. We found that the "functional'' DBA segment is about 1% the size of the mouse haploid genome and contains at least 29 genes expressed in salivary glands, however, only three of these encode proteins identified in the mouse salivary proteome. At least two of the three genes Abpa27, Abpbg26 and Abpbg27 encoding the subunits of androgen-binding protein ABP dimers evolved under positive selection and the third one may have also. In the sense that they are subunits of the same two functional entities, the ABP dimers, we propose that their evolutionary histories might not be independent of each other.	[Laukaitis, Christina M.; Mauss, Corina; Karn, Robert C.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85719 USA	University of Arizona	Laukaitis, CM (corresponding author), Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85719 USA.	cmlaukai@email.arizona.edu	Laukaitis, Christina M/AAL-5865-2021; Laukaitis, Christina/AAW-2510-2020; Laukaitis, Christina/ABF-1739-2021	Laukaitis, Christina M/0000-0003-1466-7941; 	University of Arizona SPORE in GI Cancer [P50 CA95060]; Cancer Center Support Grant [CA023074]; NATIONAL CANCER INSTITUTE [P50CA095060, P30CA023074] Funding Source: NIH RePORTER	University of Arizona SPORE in GI Cancer; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ML received salary support from the University of Arizona SPORE in GI Cancer (P50 CA95060). Laboratory space was supported by Cancer Center Support Grant (CA023074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Bimova B, 2005, BIOL J LINN SOC, V84, P349, DOI 10.1111/j.1095-8312.2005.00439.x; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Callebaut I, 2000, ANN NY ACAD SCI, V923, P90; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; DLOUHY SR, 1986, BIOCHEM GENET, V24, P743, DOI 10.1007/BF00499007; DLOUHY SR, 1987, GENETICS, V115, P535; Emes RD, 2004, GENOME RES, V14, P1516, DOI 10.1101/gr.2540304; Hwang JM, 1997, J HERED, V88, P93, DOI 10.1093/oxfordjournals.jhered.a023083; Karn RC, 1998, BIOCHEM GENET, V36, P105, DOI 10.1023/A:1018708404789; Karn RC, 1999, BIOCHEM GENET, V37, P187, DOI 10.1023/A:1018786622052; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; Karn RC, 2002, MOL BIOL EVOL, V19, P462, DOI 10.1093/oxfordjournals.molbev.a004102; KARN RC, 1991, J HERED, V82, P453, DOI 10.1093/oxfordjournals.jhered.a111127; Karn RC, 2008, MOL BIOL EVOL, V25, P2301, DOI 10.1093/molbev/msn182; Karn RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020979; Karn RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012638; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Laukaitis C, 2012, EVOLUTION H IN PRESS; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-40; Laukaitis CM, 2003, MAMM GENOME, V14, P679, DOI 10.1007/s00335-003-2291-y; Laukaitis CM, 1997, EVOLUTION, V51, P2000, DOI [10.2307/2411020, 10.1111/j.1558-5646.1997.tb05121.x]; NAVEIRA H, 1992, GENETICS, V130, P205; Nielsen R, 1998, GENETICS, V148, P929; SHE JX, 1990, BIOL J LINN SOC, V41, P83, DOI 10.1111/j.1095-8312.1990.tb00823.x; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; Talley HM, 2001, EVOLUTION, V55, P631, DOI 10.1554/0014-3820(2001)055[0631:FPFMSI]2.0.CO;2; Treister NS, 2005, J DENT RES, V84, P160, DOI 10.1177/154405910508400210; Tucker PK, 2005, BIOL J LINN SOC, V84, P653, DOI 10.1111/j.1095-8312.2005.00462.x; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35898	10.1371/journal.pone.0035898	http://dx.doi.org/10.1371/journal.pone.0035898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558260	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200091
J	Long, XB; Hu, S; Wang, N; Zhen, HT; Cui, YH; Liu, Z				Long, Xiao-Bo; Hu, Shuang; Wang, Nan; Zhen, Hong-Tao; Cui, Yong-Hua; Liu, Zheng			Clara Cell 10-kDa Protein Gene Transfection Inhibits NF-kappa B Activity in Airway Epithelial Cells	PLOS ONE			English	Article							VIRUS-INDUCED ASTHMA; CHRONIC RHINOSINUSITIS; TRANSCRIPTION FACTOR; ACTIVATION; INTERLEUKIN-8; INFLAMMATION; EXPRESSION; CYTOKINE; UTEROGLOBIN; MECHANISMS	Background: Clara cell 10-kDa protein (CC10) is a multifunctional protein with anti-inflammatory and immunomodulatory effects. Induction of CC10 expression by gene transfection may possess potential therapeutic effect. Nuclear factor kappa B (NF-kappa B) plays a key role in the inflammatory processes of airway diseases. Method/ Results: To investigate potential therapeutic effect of CC10 gene transfection in controlling airway inflammation and the underlying intracellular mechanisms, in this study, we constructed CC10 plasmid and transfected it into bronchial epithelial cell line BEAS-2B cells and CC10 knockout mice. In BEAS-2B cells, CC10's effect on interleukin (IL)-1 beta induced IL-8 expression was explored by means of RT-PCR and ELISA and its effect on NF-kappa B classical signaling pathway was studied by luciferase reporter, western blot, and immunoprecipitation assay. The effect of endogenous CC10 on IL-1 beta evoked IL-8 expression was studied by means of nasal explant culture. In mice, CC10's effect on IL-1 beta induced IL-8 and nuclear p65 expression was examined by immunohistochemistry. First, we found that the CC10 gene transfer could inhibit IL-1 beta induced IL-8 expression in BEAS-2B cells. Furthermore, we found that CC10 repressed IL-1 beta induced NF-kappa B activation by inhibiting the phosphorylation of I kappa B-alpha but not I kappa B kinase-alpha/beta in BEAS-2B cells. Nevertheless, we did not observe a direct interaction between CC10 and p65 subunit in BEAS-2B cells. In nasal explant culture, we found that IL-1 beta induced IL-8 expression was inversely correlated with CC10 levels in human sinonasal mucosa. In vivo study revealed that CC10 gene transfer could attenuate the increase of IL-8 and nuclear p65 staining in nasal epithelial cells in CC10 knockout mice evoked by IL-1 beta administration. Conclusion: These results indicate that CC10 gene transfer may inhibit airway inflammation through suppressing the activation of NF-kappa B, which may provide us a new consideration in the therapy of airway inflammation.	[Long, Xiao-Bo; Hu, Shuang; Wang, Nan; Zhen, Hong-Tao; Cui, Yong-Hua; Liu, Zheng] Huazhong Univ Sci & Technol, Dept Otolaryngol Head & Neck Surg, Tongji Med Coll, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Long, XB (corresponding author), Huazhong Univ Sci & Technol, Dept Otolaryngol Head & Neck Surg, Tongji Med Coll, Tongji Hosp, Wuhan 430074, Peoples R China.	zhengliuent@hotmail.com			program for New Century Excellent Talents in University from State Education Ministry [NCET-07-0326]; National Nature Science Foundation of China (NSFC) [30872847, 81020108018]	program for New Century Excellent Talents in University from State Education Ministry(Program for New Century Excellent Talents in University (NCET)); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the program for New Century Excellent Talents in University from State Education Ministry (NCET-07-0326) and the National Nature Science Foundation of China (NSFC) grant 30872847 and 81020108018 to Dr. Zheng Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Atsuta J, 1997, AM J RESP CELL MOL, V17, P571, DOI 10.1165/ajrcmb.17.5.2685; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Barnes PJ, 2006, LAB INVEST, V86, P867, DOI 10.1038/labinvest.3700456; Benson M, 2007, ALLERGY, V62, P178, DOI 10.1111/j.1398-9995.2006.01264.x; Chen LC, 2001, J IMMUNOL, V167, P3025, DOI 10.4049/jimmunol.167.6.3025; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Holgate Stephen T, 2004, Proc Am Thorac Soc, V1, P93, DOI 10.1513/pats.2306034; Hung CH, 2004, J ALLERGY CLIN IMMUN, V114, P664, DOI 10.1016/j.jaci.2004.05.042; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Liu Z, 2009, ALLERGY, V64, P149, DOI 10.1111/j.1398-9995.2008.01847.x; Lu X, 2009, ALLERGY, V64, P104, DOI 10.1111/j.1398-9995.2008.01829.x; Mills PR, 1999, AM J RESP CRIT CARE, V160, pS38, DOI 10.1164/ajrccm.160.supplement_1.11; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; Mukherjee AB, 1999, CELL MOL LIFE SCI, V55, P771, DOI 10.1007/s000180050331; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; Polito AJ, 1998, J ALLERGY CLIN IMMUN, V102, P714, DOI 10.1016/S0091-6749(98)70008-9; Poynter ME, 2002, AM J PATHOL, V160, P1325, DOI 10.1016/S0002-9440(10)62559-X; Riccio AN, 2002, CLIN EXP ALLERGY, V32, P422, DOI 10.1046/j.1365-2222.2002.01315.x; SCHRODER JM, 1987, J IMMUNOL, V139, P3474; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; SHUTE J, 1994, CLIN EXP ALLERGY, V24, P203, DOI 10.1111/j.1365-2222.1994.tb00220.x; Shute JK, 1997, AM J RESP CRIT CARE, V155, P1877, DOI 10.1164/ajrccm.155.6.9196089; Singh G, 2000, ANN NY ACAD SCI, V923, P43; Suzuki Hideaki, 2002, ALLERGY, V1, P117; Taraska JW, 2010, NEURON, V66, P170, DOI 10.1016/j.neuron.2010.02.002; Teran LM, 1997, AM J RESP CRIT CARE, V155, P1362, DOI 10.1164/ajrccm.155.4.9105080; VANVYVE T, 1995, J ALLERGY CLIN IMMUN, V95, P60, DOI 10.1016/S0091-6749(95)70153-2; Wang H, 2008, AM J RHINOL, V22, P343, DOI 10.2500/ajr.2008.22.3184; Wang H, 2010, AM J RESP CRIT CARE, V181, P908, DOI 10.1164/rccm.200904-0597OC; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302; Zhang ZJ, 1997, SCIENCE, V276, P1408, DOI 10.1126/science.276.5317.1408	38	23	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35960	10.1371/journal.pone.0035960	http://dx.doi.org/10.1371/journal.pone.0035960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558282	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200096
J	Kundumani-Sridharan, V; Quyen, DV; Subramani, J; Singh, NK; Chin, YE; Rao, GN				Kundumani-Sridharan, Venkatesh; Dong Van Quyen; Subramani, Jaganathan; Singh, Nikhlesh K.; Chin, Y. Eugene; Rao, Gadiparthi N.			Novel Interactions between NFATc1 (Nuclear Factor of Activated T Cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) Mediate G Protein-coupled Receptor Agonist, Thrombin-induced Biphasic Expression of Cyclin D1, with First Phase Influencing Cell Migration and Second Phase Directing Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; INDUCED NEOINTIMA FORMATION; TYROSINE KINASE; GENE-EXPRESSION; DEPENDENT KINASES; VASCULAR INJURY; BREAST-CANCER; DNA-SYNTHESIS; GROWTH	Thrombin, a G protein-coupled receptor agonist, induced a biphasic expression of cyclin D1 in primary vascular smooth muscle cells. Although both phases of cyclin D1 expression require binding of the newly identified cooperative complex, NFATc1.STAT-3, to its promoter, the second phase, which is more robust, depends on NFATc1-mediated recruitment of p300 onto the complex and the subsequent acetylation of STAT-3. In addition, STAT-3 is tyrosine-phosphorylated in a biphasic manner, and the late phase requires NFATc1-mediated p300-dependent acetylation. Furthermore, interference with acetylation of STAT-3 by overexpression of acetylation null STAT-3 mutant led to the loss of the late phase of cyclin D1 expression. EMSA analysis and reporter gene assays revealed that NFATc1.STAT-3 complex binding to the cyclin D1 promoter led to an enhanceosome formation and facilitated cyclin D1 expression. In the early phase of its expression, cyclin D1 is localized mostly in the cytoplasm and influenced cell migration. However, during the late and robust phase of its expression, cyclin D1 is translocated to the nucleus and directed cell proliferation. Together, these results demonstrate for the first time that the dual function of cyclin D1 in cell migration and proliferation is temperospatially separated by its biphasic expression, which is mediated by cooperative interactions between NFATc1 and STAT-3.	[Kundumani-Sridharan, Venkatesh; Dong Van Quyen; Subramani, Jaganathan; Singh, Nikhlesh K.; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Chin, Y. Eugene] Brown Univ, Dept Surg, Sch Med, Providence, RI 02903 USA	University of Tennessee System; University of Tennessee Health Science Center; Brown University	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Subramani, Jaganathan/I-5155-2016; Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Singh, Nikhlesh/AAA-4253-2020	Subramani, Jaganathan/0000-0002-5707-8621; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health from NHLBI [HL069908]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069908] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL069908) from NHLBI (to G. N. R.).	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402; Bittman K, 1997, J NEUROSCI, V17, P7037; Boehm M, 2001, CIRCULATION, V103, P2879, DOI 10.1161/01.CIR.103.24.2879; Boehm Manfred, 2003, Prog Cell Cycle Res, V5, P19; Bonneton C, 1999, CELL MOTIL CYTOSKEL, V43, P288, DOI 10.1002/(SICI)1097-0169(1999)43:4<288::AID-CM2>3.3.CO;2-P; Cao HQ, 2006, CIRC RES, V98, P913, DOI 10.1161/01.RES.0000216954.55724.a2; Casimiro MC, 2012, J CLIN INVEST, V122, P833, DOI 10.1172/JCI60256; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Connell-Crowley L, 1998, CURR BIOL, V8, P65, DOI 10.1016/S0960-9822(98)70021-1; Cullen BR, 2005, NAT GENET, V37, P1163, DOI 10.1038/ng1105-1163; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Edelstein LC, 2003, MOL CELL BIOL, V23, P2749, DOI 10.1128/MCB.23.8.2749-2761.2003; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Gansauge S, 1997, CANCER RES, V57, P1634; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Gui T, 2007, THROMB RES, V121, P225, DOI 10.1016/j.thromres.2007.03.026; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Haque NS, 2004, BLOOD, V103, P1296, DOI 10.1182/blood-2002-05-1480; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hou T, 2008, J BIOL CHEM, V283, P30725, DOI 10.1074/jbc.M805941200; Ishihara S, 2011, J IMMUNOL, V187, P3292, DOI 10.4049/jimmunol.1003173; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; Kawamura T, 2004, CIRC RES, V94, P1492, DOI 10.1161/01.RES.0000129701.14494.52; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Kundumani-Sridharan V, 2010, BLOOD, V115, P2105, DOI 10.1182/blood-2009-09-241802; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li L, 2011, CIRC RES, V108, P1180, DOI 10.1161/CIRCRESAHA.110.237875; Li Z, 2008, J BIOL CHEM, V283, P7007, DOI 10.1074/jbc.M706992200; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Li ZP, 2006, CELL CYCLE, V5, P2440, DOI 10.4161/cc.5.21.3428; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Mziaut H, 2008, P NATL ACAD SCI USA, V105, P674, DOI 10.1073/pnas.0710931105; Neeli I, 2004, J BIOL CHEM, V279, P46122, DOI 10.1074/jbc.M406922200; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; OWENS GK, 1995, PHYSIOL REV, V75, P487; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Pham LV, 2005, BLOOD, V106, P3940, DOI 10.1182/blood-2005-03-1167; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Saxena NK, 2007, J BIOL CHEM, V282, P13316, DOI 10.1074/jbc.M609798200; Schaper W, 1996, CIRC RES, V79, P911, DOI 10.1161/01.RES.79.5.911; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Suehiro J, 2010, BLOOD, V115, P2520, DOI 10.1182/blood-2009-07-233478; Suemoto H, 2007, DEV BIOL, V312, P572, DOI 10.1016/j.ydbio.2007.10.001; Sui SG, 2007, J CELL BIOL, V178, P231, DOI 10.1083/jcb.200611081; Sun JZ, 2005, ONCOGENE, V24, P4701, DOI 10.1038/sj.onc.1208391; Tsytsykova AV, 2002, MOL CELL BIOL, V22, P2620, DOI 10.1128/MCB.22.8.2620-2631.2002; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Xue Y, 2012, NAT MED, V18, P100, DOI 10.1038/nm.2575; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zwart W, 2011, EMBO J, V30, P4764, DOI 10.1038/emboj.2011.368; Zwicker J, 1999, ONCOGENE, V18, P19, DOI 10.1038/sj.onc.1202286	88	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22463	22482		10.1074/jbc.M112.362996	http://dx.doi.org/10.1074/jbc.M112.362996			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22566696	Green Published, hybrid			2022-12-25	WOS:000306495000006
J	Andersen, SB; Ferrari, M; Evans, HC; Elliot, SL; Boomsma, JJ; Hughes, DP				Andersen, Sandra B.; Ferrari, Matthew; Evans, Harry C.; Elliot, Simon L.; Boomsma, Jacobus J.; Hughes, David P.			Disease Dynamics in a Specialized Parasite of Ant Societies	PLOS ONE			English	Article							TROPICAL FOREST ECOSYSTEMS; ANISOPLIAE VAR. ACRIDUM; LIFE; FUNGI; FORMICIDAE; EVOLUTION; CADAVERS; GROWTH	Coevolution between ant colonies and their rare specialized parasites are intriguing, because lethal infections of workers may correspond to tolerable chronic diseases of colonies, but the parasite adaptations that allow stable coexistence with ants are virtually unknown. We explore the trade-offs experienced by Ophiocordyceps parasites manipulating ants into dying in nearby graveyards. We used field data from Brazil and Thailand to parameterize and fit a model for the growth rate of graveyards. We show that parasite pressure is much lower than the abundance of ant cadavers suggests and that hyperparasites often castrate Ophiocordyceps. However, once fruiting bodies become sexually mature they appear robust. Such parasite life-history traits are consistent with iteroparity-a reproductive strategy rarely considered in fungi. We discuss how tropical habitats with high biodiversity of hyperparasites and high spore mortality has likely been crucial for the evolution and maintenance of iteroparity in parasites with low dispersal potential.	[Andersen, Sandra B.; Boomsma, Jacobus J.] Univ Copenhagen, Ctr Social Evolut, Dept Biol, Copenhagen, Denmark; [Ferrari, Matthew] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Evans, Harry C.] CAB Int, E UK, Egham, Surrey, England; [Evans, Harry C.; Elliot, Simon L.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Hughes, David P.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade Federal de Vicosa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Andersen, SB (corresponding author), Univ Copenhagen, Ctr Social Evolut, Dept Biol, Copenhagen, Denmark.	SBAndersen@bio.ku.dk; DPHughes@psu.edu	Boomsma, Jacobus J/M-2785-2014; Elliot, Simon Luke/A-5557-2013	Boomsma, Jacobus J/0000-0002-3598-1609; Elliot, Simon Luke/0000-0002-7469-2949; Andersen, Sandra Breum/0000-0002-7030-040X	Ph.D. Scholarship from Science Faculty of the University of Copenhagen; Danish National Research Foundation; Brazilian science foundation (CNPq); Outgoing International Marie Curie Fellowship	Ph.D. Scholarship from Science Faculty of the University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Brazilian science foundation (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Outgoing International Marie Curie Fellowship	SBA was funded by a Ph.D. Scholarship from the Science Faculty of the University of Copenhagen, and JJB and SBA were supported by the Danish National Research Foundation. HCE and SLE were funded by the Brazilian science foundation (CNPq). DPH was funded by an Outgoing International Marie Curie Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; Arthurs S, 2001, J INVERTEBR PATHOL, V78, P59, DOI 10.1006/jipa.2001.5050; Arthurs SP, 2001, ENTOMOL EXP APPL, V100, P69, DOI 10.1023/A:1019265214318; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; BOOMSMA JJ, 2005, INSECT EVOLUTIONARY; CARNEY WP, 1969, AM MIDL NAT, V82, P605, DOI 10.2307/2423801; CHARNOV EL, 1973, AM NAT, V107, P791, DOI 10.1086/282877; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; Evans HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017024; EVANS HC, 1982, ECOL ENTOMOL, V7, P47, DOI 10.1111/j.1365-2311.1982.tb00643.x; EVANS HC, 1974, J APPL ECOL, V11, P37, DOI 10.2307/2402003; EVANS HC, 1984, T BRIT MYCOL SOC, V82, P127, DOI 10.1016/S0007-1536(84)80219-3; Hamilton W.D., 1987, P81; Harper J. L, 1977, POPULATION BIOL PLAN; Hatzipapas P, 2002, MYCOL RES, V106, P1349, DOI 10.1017/S0953756202006792; HOLLDOBLER B, ANTS; Hoover K, 2011, SCIENCE, V333, P1401, DOI 10.1126/science.1209199; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Isaka M, 2005, ACCOUNTS CHEM RES, V38, P813, DOI 10.1021/ar040247r; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Keller S, 2003, BIOCONTROL, V48, P307, DOI 10.1023/A:1023646207455; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Leger RJS, 2008, J INVERTEBR PATHOL, V98, P271, DOI 10.1016/j.jip.2008.01.007; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; LESTON D, 1973, PANS (PEST ARTIC NEWS SUMM), V19, P311; Liu HP, 2003, J INVERTEBR PATHOL, V82, P139, DOI 10.1016/S0022-2011(03)00018-1; MACKAY WP, 1985, OECOLOGIA, V66, P484, DOI 10.1007/BF00379338; Majer Jonathan D., 1993, P115; Marikovsky P. I., 1962, Insectes Sociaux Paris, V9, P173, DOI 10.1007/BF02224263; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; MIRENDA JT, 1981, ANIM BEHAV, V29, P410, DOI 10.1016/S0003-3472(81)80100-5; Moore D, 2008, BR MYCOL SY, V28, P79; Naug D, 2002, J THEOR BIOL, V215, P427, DOI 10.1006/jtbi.2001.2524; Pontoppidan MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004835; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; Poulin R, EVOLUTIONARY ECOLOGY; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Sanjuan T, 2001, REV BIOL TROP, V49, P945; Schmid-Hempel P, EVOLUTIONARY PARASIT; Schmid-Hempel P, PARASITES SOCIAL INS; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; Soanes DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012725; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Vega FE, 2008, J INVERTEBR PATHOL, V98, P277, DOI 10.1016/j.jip.2008.01.008; Wilson K, 2003, J ANIM ECOL, V72, P133, DOI 10.1046/j.1365-2656.2003.00680.x; Yanoviak SP, 2008, AM NAT, V171, P536, DOI 10.1086/528968	47	31	31	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36352	10.1371/journal.pone.0036352	http://dx.doi.org/10.1371/journal.pone.0036352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567151	Green Published, gold			2022-12-25	WOS:000305341500070
J	Buffart, LM; Thong, MSY; Schep, G; Chinapaw, MJM; Brug, J; van de Poll-Franse, LV				Buffart, Laurien M.; Thong, Melissa S. Y.; Schep, Goof; Chinapaw, Mai J. M.; Brug, Johannes; van de Poll-Franse, Lonneke V.			Self-Reported Physical Activity: Its Correlates and Relationship with Health-Related Quality of Life in a Large Cohort of Colorectal Cancer Survivors	PLOS ONE			English	Article							EXERCISE BEHAVIOR; RANDOMIZED-TRIAL; HOSPITAL ANXIETY; COLON-CANCER; FATIGUE; VALIDATION; DEPRESSION; IMPACT; QUESTIONNAIRE; COMPENDIUM	Background: Physical activity (PA) is suggested to be an important non-pharmacologic means to improve health-related outcomes among cancer survivors. We aimed to describe the PA level, its correlates, and association with health-related quality of life (HRQoL) in colorectal cancer (CRC) survivors. Methods: CRC survivors identified from the Eindhoven Cancer Registry treated between 1998 and 2007 were included. Survivors completed validated questionnaires on PA, distress, fatigue, and HRQoL. Moderate-to-vigorous physical activity (MVPA) levels were calculated by summing the time spent on walking, bicycling, gardening and sports (>= 3 MET). Multiple linear regression analyses were conducted to study which socio-demographic and clinical factors were associated with MVPA. Furthermore, we examined associations between MVPA and physical and mental HRQoL, and whether these associations were mediated by fatigue and distress. Results: Cross-sectional data of 1371 survivors (response: 82%) were analysed. Participants were 69.5 (SD 9.7) years old, 56% were male, and survival duration was 3.9 (SD 2.5) years. Participants self-reported on average 95.5 (SD 80.3) min on MVPA per day. Younger age, male sex, being employed, non-smoking, lower BMI, colon cancer (vs. rectal cancer), chemotherapy treatment and having no co-morbidities were associated with higher MVPA (p<0.05). MVPA was positively associated with physical HRQoL (regression coefficient of total association (c) = 0.030; se = 0.004) after adjusting for socio-demographic and clinical factors. Fatigue mediated this association between MVPA and physical HRQoL (44% mediated). The association between MVPA and mental HRQoL was not statistically significant after adjusting for socio-demographic and cancer-related factors (c = 0.005; se = 0.004). Conclusion: In CRC survivors, clinical factors including the absence of co-morbidity, tumour site and chemotherapy treatment were associated with higher MVPA, in addition to several socio-demographic factors. Higher MVPA was associated with higher physical HRQoL but not with mental HRQoL. Fatigue and distress mediated the association between MVPA and HRQoL.	[Buffart, Laurien M.; Brug, Johannes] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Buffart, Laurien M.; Chinapaw, Mai J. M.; Brug, Johannes] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Thong, Melissa S. Y.; van de Poll-Franse, Lonneke V.] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands; [Thong, Melissa S. Y.; van de Poll-Franse, Lonneke V.] Comprehens Canc Ctr S, Eindhoven, Netherlands; [Schep, Goof] Maxima Med Ctr Veldhoven, Dept Sports Med, Veldhoven, Netherlands; [Chinapaw, Mai J. M.] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Tilburg University; Maxima Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Buffart, LM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands.	l.buffart@vumc.nl	van de Poll, Lonneke/AAA-9509-2021; Thong, Melissa/AAC-8052-2021; Buffart, Laurien/ABA-8889-2020; Paw, Mai Chin A/N-1665-2019; Brug, Johannes/A-8242-2018	Buffart, Laurien/0000-0002-8095-436X; Paw, Mai Chin A/0000-0001-6259-2441; Brug, Johannes/0000-0002-1904-7349	Comprehensive Cancer Centre South, Eindhoven, the Netherlands; EMGO Institute for Health and Care Research; Cancer Research Award from Dutch Cancer Society [UVT-2009-4349]	Comprehensive Cancer Centre South, Eindhoven, the Netherlands; EMGO Institute for Health and Care Research; Cancer Research Award from Dutch Cancer Society	The data collection of this study was funded by the Comprehensive Cancer Centre South, Eindhoven, the Netherlands. The contribution of Laurien M. Buffart was supported by a fellowship granted by the EMGO Institute for Health and Care Research. Dr. Lonneke van de Poll-Franse is supported by a Cancer Research Award from the Dutch Cancer Society (#UVT-2009-4349). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Blanchard CM, 2003, PREV MED, V37, P389, DOI 10.1016/S0091-7435(03)00150-6; Centraal Bureau voor de Statistiek, 2011, GEZ LEEFST ZORGG T M; Courneya K S, 1997, J Altern Complement Med, V3, P215, DOI 10.1089/acm.1997.3.215; Courneya KS, 2009, BREAST CANCER RES TR, V114, P179, DOI 10.1007/s10549-008-9987-3; Courneya KS, 2005, ANN BEHAV MED, V29, P147, DOI 10.1207/s15324796abm2902_9; Courneya KS, 2003, EUR J CANCER CARE, V12, P347, DOI 10.1046/j.1365-2354.2003.00437.x; Courneya KS, 2003, MED SCI SPORT EXER, V35, P1846, DOI 10.1249/01.MSS.0000093622.41587.B6; Courneya KS, 1999, ANN BEHAV MED, V21, P171, DOI 10.1007/BF02908298; Courneya KS, 2001, PSYCHO-ONCOL, V10, P444, DOI 10.1002/pon.524; COURNEYA KS, 1999, PSYCHOL HEALTH MED, V4, P181, DOI DOI 10.1080/135485099106315; Craft LL, 2012, CANCER EPIDEM BIOMAR, V21, P3, DOI 10.1158/1055-9965.EPI-11-0634; Cramp F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006145.pub2; Curt G A, 2000, Oncologist, V5, P353, DOI 10.1634/theoncologist.5-5-353; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Demark-Wahnefried W, 2008, AM FAM PHYSICIAN, V77, P1573; Denlinger CS, 2009, J NATL COMPR CANC NE, V7, P883, DOI 10.6004/jnccn.2009.0058; Dimeo FC, 2001, CANCER, V92, P1689, DOI 10.1002/1097-0142(20010915)92:6+<1689::AID-CNCR1498>3.0.CO;2-H; Duijn C, 2002, MAANDSTATISTIEK BEVO, V50, P32; Duijts SFA, 2011, PSYCHO-ONCOLOGY, V20, P115, DOI 10.1002/pon.1728; Grimmett C, 2011, QUAL LIFE RES, V20, P1237, DOI 10.1007/s11136-011-9855-1; Hawkes AL, 2008, SUPPORT CARE CANCER, V16, P1097, DOI 10.1007/s00520-008-0421-5; Hawkes AL, 2011, EUR J CANCER, V47, P267, DOI 10.1016/j.ejca.2010.10.002; Haydon AMM, 2006, GUT, V55, P62, DOI 10.1136/gut.2005.068189; Husson O, 2013, PSYCHO-ONCOLOGY, V22, P490, DOI 10.1002/pon.3042; IKCnet Dutch Cancer Registration, 2012, SURV; Irwin ML, 2008, CANCER J, V14, P435, DOI 10.1097/PPO.0b013e31818daeee; Janssen-Heijnen MLG., 2005, RESULTS 50 YEARS CAN; Jones LW, 2004, ANN BEHAV MED, V28, P105, DOI 10.1207/s15324796abm2802_5; Lynch BM, 2008, J CLIN ONCOL, V26, P4480, DOI 10.1200/JCO.2007.15.7917; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Meyerhardt JA, 2009, ARCH INTERN MED, V169, P2102, DOI 10.1001/archinternmed.2009.412; Michielsen HJ, 2004, EUR J PSYCHOL ASSESS, V20, P39, DOI 10.1027/1015-5759.20.1.39; Michielsen HJ, 2003, J PSYCHOSOM RES, V54, P345, DOI 10.1016/S0022-3999(02)00392-6; Montazeri A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-102; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Sapp AL, 2003, CANCER-AM CANCER SOC, V98, P1749, DOI 10.1002/cncr.11717; Schwartz AL, 1999, QUAL LIFE RES, V8, P529, DOI 10.1023/A:1008978611274; SNAITH P, 1988, BRIT MED J, V297, P1544, DOI 10.1136/bmj.297.6662.1544; Speck RM, 2010, J CANCER SURVIV, V4, P87, DOI 10.1007/s11764-009-0110-5; Speed-Andrews AE, 2012, EUR J CANCER CARE, V21, P187, DOI 10.1111/j.1365-2354.2011.01290.x; Speed-Andrews AE, 2009, CURR SPORT MED REP, V8, P176, DOI 10.1249/JSR.0b013e3181ae98f3; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Thong MSY, 2011, EUR J CANCER, V47, P1798, DOI 10.1016/j.ejca.2011.02.006; Thong MSY, 2011, INT J RADIAT ONCOL, V81, pE49, DOI 10.1016/j.ijrobp.2010.12.030; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Union Internationale Contre le Cancer (UICC), 2002, CLASS MAL TUM; van de Poll-Franse LV, 2011, EUR J CANCER, V47, P2188, DOI 10.1016/j.ejca.2011.04.034; Velthuis MJ, 2010, CLIN ONCOL-UK, V22, P208, DOI 10.1016/j.clon.2009.12.005; Vodermaier A, 2009, JNCI-J NATL CANCER I, V101, P1464, DOI 10.1093/jnci/djp336; Voskuil DW, 2010, ANN ONCOL, V21, P2094, DOI 10.1093/annonc/mdq151; Wolin KY, 2011, RECENT RESULTS CANC, V186, P73, DOI 10.1007/978-3-642-04231-7_4; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	63	71	73	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36164	10.1371/journal.pone.0036164	http://dx.doi.org/10.1371/journal.pone.0036164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959US	22567135	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500054
J	Pence, BD; Lowder, TW; Keylock, KT; Potter, VJV; Cook, MD; McAuley, E; Woods, JA				Pence, Brandt D.; Lowder, Thomas W.; Keylock, K. Todd; Potter, Victoria J. Vieira; Cook, Marc D.; McAuley, Edward; Woods, Jeffrey A.			Relationship between Systemic Inflammation and Delayed-Type Hypersensitivity Response to Candida Antigen in Older Adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; IMMUNE FUNCTION; ANTIBODY-RESPONSE; CELL DIVERSITY; EXERCISE; DISEASE; VACCINATION; MECHANISMS; DECREASES; HUMANS	Research has shown that aging is associated with increased systemic inflammation as well as a reduction in the strength of immune responses. However, little evidence exists linking the decrease in cell-mediated immunity in older adults with other health parameters. We sought to examine the relationship between cell-mediated immunity as measured in vivo by the delayed-type hypersensitivity (DTH) response to candida antigen and demographic and physiological variables in older (6580 y.o.) adults. Candida antigen response was not related to gender or obesity, or to a number of other physiological variables including fitness and body composition. However, positive responders had significantly lower serum C-reactive protein levels (CRP, p<0.05) vs. non-responders. Furthermore, subjects with CRP<4.75 mg.L-1 had greater odds of developing a positive response compared to those with CRP>4.75 mg.L-1. Therefore, positive responses to candida antigen in older adults appears to be related to lower levels of systemic inflammation.	[Pence, Brandt D.; Lowder, Thomas W.; Keylock, K. Todd; Cook, Marc D.; McAuley, Edward; Woods, Jeffrey A.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Pence, Brandt D.; Potter, Victoria J. Vieira; Cook, Marc D.; Woods, Jeffrey A.] Univ Illinois, Integrat Immunol & Behav Program, Urbana, IL USA; [Potter, Victoria J. Vieira; Woods, Jeffrey A.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [McAuley, Edward] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [McAuley, Edward] Univ Illinois, Dept Psychol, Urbana, IL USA; [Woods, Jeffrey A.] Univ Illinois, Dept Pathol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Pence, BD (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA.	woods1@illinois.edu	Lowder, Thomas/GZM-3182-2022	Pence, Brandt/0000-0002-4059-9092; Lowder, Thomas/0000-0001-9301-4599	National Institutes of Health [R01 AG18861]; NATIONAL INSTITUTE ON AGING [R01AG018861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (nih.gov, grant number R01 AG18861) to JAW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; CHRISTOU NV, 1995, ANN SURG, V222, P534; Christou NV, 1995, ANN SURG, V222, P546; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; El Yousfi M, 2005, MECH AGEING DEV, V126, P874, DOI 10.1016/j.mad.2005.03.008; FIETTA A, 1994, GERONTOLOGY, V40, P237; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; Grant RW, 2008, BRAIN BEHAV IMMUN, V22, P923, DOI 10.1016/j.bbi.2008.01.006; Iannitti T, 2011, HUM BIOL, V83, P531, DOI 10.3378/027.083.0407; Keylock KT, 2008, AM J PHYSIOL-REG I, V294, pR179, DOI 10.1152/ajpregu.00177.2007; Keylock KT, 2007, J APPL PHYSIOL, V102, P1090, DOI 10.1152/japplphysiol.00790.2006; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Pawelec G, 2010, J COMP PATHOL, V141, pS39, DOI 10.1016/j.jcpa.2009.09.005; Pence BD, 2011, AM J LIFESTYLE MED, V5, P238, DOI 10.1177/1559827610392317; Phan HM, 2008, AM J GERIATR CARDIOL, V17, P101; Rafi A, 2005, ANN ALLERG ASTHMA IM, V94, P445, DOI 10.1016/S1081-1206(10)61114-3; Simpson RJ, 2011, EXERC SPORT SCI REV, V39, P23, DOI 10.1097/JES.0b013e318201f39d; Smith TP, 2004, J APPL PHYSIOL, V97, P491, DOI 10.1152/japplphysiol.01404.2003; Vieira VJ, 2009, BRAIN BEHAV IMMUN, V23, P485, DOI 10.1016/j.bbi.2009.01.011; WAKSMAN BH, 1979, CELL IMMUNOL, V42, P155, DOI 10.1016/0008-8749(79)90229-6; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Windgassen EB, 2011, POSTGRAD MED, V123, P114, DOI 10.3810/pgm.2011.01.2252; Wolters B, 2003, VACCINE, V21, P3623, DOI 10.1016/S0264-410X(03)00399-2; Woods JA, 1999, MECH AGEING DEV, V109, P1, DOI 10.1016/S0047-6374(99)00014-7; Woods JA, 2003, BRAIN BEHAV IMMUN, V17, P384, DOI 10.1016/S0889-1591(03)00030-8; Woods JA, 2009, J AM GERIATR SOC, V57, P2183, DOI 10.1111/j.1532-5415.2009.02563.x; Ye JP, 2010, AGING-US, V2, P361, DOI 10.18632/aging.100155	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36403	10.1371/journal.pone.0036403	http://dx.doi.org/10.1371/journal.pone.0036403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567155	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500074
J	Potgieter, KR; Davies-Mostert, HT				Potgieter, Katherine R.; Davies-Mostert, Harriet T.			A Simple Visual Estimation of Food Consumption in Carnivores	PLOS ONE			English	Article							AFRICAN WILD DOGS; LYCAON-PICTUS	Belly-size ratings or belly scores are frequently used in carnivore research as a method of rating whether and how much an animal has eaten. This method provides only a rough ordinal measure of fullness and does not quantify the amount of food an animal has consumed. Here we present a method for estimating the amount of meat consumed by individual African wild dogs Lycaon pictus. We fed 0.5 kg pieces of meat to wild dogs being temporarily held in enclosures and measured the corresponding change in belly size using lateral side photographs taken perpendicular to the animal. The ratio of belly depth to body length was positively related to the mass of meat consumed and provided a useful estimate of the consumption. Similar relationships could be calculated to determine amounts consumed by other carnivores, thus providing a useful tool in the study of feeding behaviour.	[Potgieter, Katherine R.; Davies-Mostert, Harriet T.] Endangered Wildlife Trust, Modderfontein, South Africa		Potgieter, KR (corresponding author), Endangered Wildlife Trust, Modderfontein, South Africa.	kathpotgieter@gmail.com		Davies-Mostert, Harriet/0000-0001-7824-4863; Potgieter Forssman, Katherine/0000-0003-1704-984X				Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 2002, AFRICAN WILD DOG BEH; Davies-Mostert Harriet T., 2009, P10, DOI 10.1002/9781444312034.ch2; Fanshawe John H., 1997, P11; FRAME LH, 1979, Z TIERPSYCHOL, V50, P225; Knobel DL, 2002, J WILDLIFE DIS, V38, P352, DOI 10.7589/0090-3558-38.2.352; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; MALCOLM JR, 1979, THESIS HARVARD U; McNutt J. W., 2008, IUCN 2010 IUCN RED L; MILLS M. G. L., 2004, WILD CANIDS STATUS S, P174; Spong G, 2004, BEHAV ECOL SOCIOBIOL, V55, P325, DOI 10.1007/s00265-003-0723-z; Woodroffe R, 1997, STATUS SURVEY CONSER	13	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34543	10.1371/journal.pone.0034543	http://dx.doi.org/10.1371/journal.pone.0034543			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567086	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500004
J	Sendagire, I; Van der Loeff, MS; Kambugu, A; Konde-Lule, J; Cobelens, F				Sendagire, Ibrahim; Van der Loeff, Maarten Schim; Kambugu, Andrew; Konde-Lule, Joseph; Cobelens, Frank			Urban Movement and Alcohol Intake Strongly Predict Defaulting from Tuberculosis Treatment: An Operational Study	PLOS ONE			English	Article							TREATMENT ADHERENCE; CONTROL PROGRAM; RISK-FACTORS; HIV; ETHIOPIA; DISTRICT; FAILURE; KAMPALA; COHORT; ADULTS	Background: High levels of defaulting from treatment challenge tuberculosis control in many African cities. We assessed defaulting from tuberculosis treatment in an African urban setting. Methods: An observational study among adult patients with smear-positive pulmonary tuberculosis receiving treatment at urban primary care clinics in Kampala, Uganda. Defaulting was defined as having missed two consecutive monthly clinic visits while not being reported to have died or continued treatment elsewhere. Defaulting patients were actively followedup and interviewed. We assessed proportions of patients abandoning treatment with and without the information obtained through active follow-up and we examined associated factors through multivariable logistic regression. Results: Between April 2007 and April 2008, 270 adults aged >= 15 years were included; 54 patients (20%) were recorded as treatment defaulters. On active follow-up vital status was established of 28/54 (52%) patients. Of these, 19 (68%) had completely stopped treatment, one (4%) had died and eight (29%) had continued treatment elsewhere. Extrapolating this to all defaulters meant that 14% rather than 20% of all patients had truly abandoned treatment. Daily consumption of alcohol, recorded at the start of treatment, predicted defaulting (adjusted odds ratio [ORadj] 4.4, 95% CI 1.8-13.5), as did change of residence during treatment (ORadj 8.7, 95% CI 1.8-41.5); 32% of patients abandoning treatment had changed residence. Conclusions: A high proportion of tuberculosis patients in primary care clinics in Kampala abandon treatment. Assessing change of residence during scheduled clinic appointments may serve as an early warning signal that the patient may default and needs adherence counseling.	[Sendagire, Ibrahim] Kampala Capital City Author, Directorate Hlth, Kampala, Uganda; [Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Van der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Van der Loeff, Maarten Schim] Publ Hlth Serv Amsterdam, Dept Res, Amsterdam, Netherlands; [Kambugu, Andrew] Makerere Univ, Coll Hlth Sci, Sch Med, Infect Dis Inst, Kampala, Uganda; [Konde-Lule, Joseph] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Cobelens, Frank] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Makerere University; Makerere University	Sendagire, I (corresponding author), Kampala Capital City Author, Directorate Hlth, Kampala, Uganda.	f.cobelens@aighd.org		Cobelens, Frank/0000-0002-4367-1133	Netherlands African Partnership for Clinical Trials and Capacity Building Program (NACCAP)	Netherlands African Partnership for Clinical Trials and Capacity Building Program (NACCAP)	This study was funded by the Netherlands African Partnership for Clinical Trials and Capacity Building Program (NACCAP: http://www.nwo.nl/nwohome.nsf/pages/NWOP_5VWBMM_eng). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XQ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-112; Deribew A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-400; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Dodor Ea, 2008, Ghana Med J, V42, P144; Edginton ME, 2002, INT J TUBERC LUNG D, V6, P1075; Edington ME, 2008, INT J TUBERC LUNG D, V12, P786; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; Hill RC, 2005, INT J TUBERC LUNG D, V9, P1349; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Matsubayashi T, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S9; Meissner PE, 2002, INT J TUBERC LUNG D, V6, P903; Ministry of Health, 2010, HLTH SECT STRAT INV; Obiri-Danso K, 2009, INTERNET J PULMONARY, V11, P1; Okwera A, 2006, INT J TUBERC LUNG D, V10, P39; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; Vijay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010043; Vree M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-134; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2010, GLOB TUB CONTR; World Health Organization, 2009, GLOB TUB CONTR EP ST	24	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35908	10.1371/journal.pone.0035908	http://dx.doi.org/10.1371/journal.pone.0035908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567119	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341500037
J	Cepeda, GD; Blanco-Bercial, L; Bucklin, A; Beron, CM; Vinas, MD				Cepeda, Georgina D.; Blanco-Bercial, Leocadio; Bucklin, Ann; Beron, Corina M.; Vinas, Maria D.			Molecular Systematic of Three Species of Oithona (Copepoda, Cyclopoida) from the Atlantic Ocean: Comparative Analysis Using 28S rDNA	PLOS ONE			English	Article							CALANUS-FINMARCHICUS; SPAWNING AREA; SEA; PHYLOGENY; SIMILIS; 34-DEGREES-S-41-DEGREES-S; ASSEMBLAGES; CRUSTACEA; SEQUENCE; LARVAE	Species of Oithona (Copepoda, Cyclopoida) are highly abundant, ecologically important, and widely distributed throughout the world oceans. Although there are valid and detailed descriptions of the species, routine species identifications remain challenging due to their small size, subtle morphological diagnostic traits, and the description of geographic forms or varieties. This study examined three species of Oithona (O. similis, O. atlantica and O. nana) occurring in the Argentine sector of the South Atlantic Ocean based on DNA sequence variation of a 575 base-pair region of 28S rDNA, with comparative analysis of these species from other North and South Atlantic regions. DNA sequence variation clearly resolved and discriminated the species, and revealed low levels of intraspecific variation among North and South Atlantic populations of each species. The 28S rDNA region was thus shown to provide an accurate and reliable means of identifying the species throughout the sampled domain. Analysis of 28S rDNA variation for additional species collected throughout the global ocean will be useful to accurately characterize biogeographical distributions of the species and to examine phylogenetic relationships among them.	[Cepeda, Georgina D.; Vinas, Maria D.] Inst Nacl Invest & Desarrollo Pesquero INIDEP, Mar Del Plata, Buenos Aires, Argentina; [Cepeda, Georgina D.; Beron, Corina M.] Ctr Estudios Biodiversidad & Biotecnol CEBB CIB F, Mar Del Plata, Buenos Aires, Argentina; [Cepeda, Georgina D.; Beron, Corina M.; Vinas, Maria D.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Cepeda, Georgina D.; Vinas, Maria D.] Univ Nacl Mar del Plata, IIMyC, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn, Mar Del Plata, Buenos Aires, Argentina; [Blanco-Bercial, Leocadio; Bucklin, Ann] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National Fisheries Research & Development Institute (INIDEP); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; University of Connecticut	Cepeda, GD (corresponding author), Inst Nacl Invest & Desarrollo Pesquero INIDEP, Mar Del Plata, Buenos Aires, Argentina.	gcepeda@fiba.org.ar	Blanco-Bercial, Leocadio/G-5441-2013; Blanco-Bercial, Leocadio/N-4061-2019	Blanco-Bercial, Leocadio/0000-0003-0658-7183; Blanco-Bercial, Leocadio/0000-0003-0658-7183; Beron, Corina/0000-0002-0365-3571; Bucklin, Ann/0000-0003-3750-9348	Instituto Nacional de Investigacion y Desarrollo Pesquero, Fundacion para Investigaciones Biologicas Aplicadas; Agencia Nacional de Promocion Cientifica y Tecnologica [15227/03]; Universidad Nacional de Mar del Plata [15/E269]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Department of Marine Sciences at the University of Connecticut; Alfred P. Sloan Foundation	Instituto Nacional de Investigacion y Desarrollo Pesquero, Fundacion para Investigaciones Biologicas Aplicadas; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Mar del Plata(National University of La Plata); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Department of Marine Sciences at the University of Connecticut; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was partially supported by Instituto Nacional de Investigacion y Desarrollo Pesquero, Fundacion para Investigaciones Biologicas Aplicadas; Agencia Nacional de Promocion Cientifica y Tecnologica [Grant No. 15227/03 to M.D.V.]; Universidad Nacional de Mar del Plata [Grant No. 15/E269 to M.D.V.]; and a PhD. fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) to G.C. Additional support was provided by the Department of Marine Sciences at the University of Connecticut, and by the Alfred P. Sloan Foundation (Marine Barcode of Life project, MarBOL). This study is a contribution from the Census of Marine Zooplankton (CMarZ, see www.CMarZ.org), an ocean realm field project of the Census of Marine Life. This is INIDEP contribution N 1736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antacli JC, 2010, J SEA RES, V63, P71, DOI 10.1016/j.seares.2009.09.004; Berasategui AD, 2006, ESTUAR COAST SHELF S, V66, P483, DOI 10.1016/j.ecss.2005.09.014; Bik HM, BMC EVOLUTIONARY BIO, V10, P353; Boltovskoy D, 2011, ENVIRON SCI POLICY, V14, P578, DOI 10.1016/j.envsci.2011.03.007; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Bradford-Grieve Janet M., 1999, P869; Brown L, 2010, EUR J PHYCOL, V45, P375, DOI 10.1080/09670262.2010.495164; Bucklin A., 2000, P533, DOI 10.1016/B978-012327645-2/50012-8; Bucklin A, 2000, ICES J MAR SCI, V57, P1592, DOI 10.1006/jmsc.2000.0957; Castellani C, 2007, J PLANKTON RES, V29, P1051, DOI 10.1093/plankt/fbm079; Claus C., 1866, SCHRIFTEN GESELLSCHA, VSupplement, P1; Claus C, 1863, FREILEBENDEN COPEPOD, DOI [10.5962/bhl.title.58676, DOI 10.5962/BHL.TITLE.58676]; Dana J.D., 1853, CRUSTACEA US EXPLORI; Di Mauro R, 2009, BRAZ J OCEANOGR, V57, P205, DOI 10.1590/S1679-87592009000300004; Dvoretsky VG, 2009, MAR ECOL PROG SER, V385, P165, DOI 10.3354/meps07984; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farran G. P, 1908, 2 REPORT COPEPODA IR, V2, P1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferrari F.D., 1980, SMITHSON CONTR ZOOL, V312, P1, DOI [10.5479/si.00810282.312, DOI 10.5479/SI.00810282.312]; Fish CJ, 1936, BIOL BULL-US, V71, P168, DOI 10.2307/1537414; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fruohtl F., 1920, Sitzungsberichte der Akademie der Wissenschaften in Wien, V129, P463; Gallienne CP, 2001, J PLANKTON RES, V23, P1421, DOI 10.1093/plankt/23.12.1421; Giesbrecht W, 1892, FAUNA FLORA GOLFES N, V19, P1, DOI [10.5962/bhl.title.59541, DOI 10.5962/BHL.TITLE.59541]; Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; Hayward CJ, 2011, AQUACULTURE, V320, P178, DOI 10.1016/j.aquaculture.2010.10.039; Holznagel WE, 2010, MOL PHYLOGENET EVOL, V57, P1017, DOI 10.1016/j.ympev.2010.09.021; Jukes T. H., 1969, MAMMALIAN PROTEIN ME; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Machida RJ, 2002, MAR BIOTECHNOL, V4, P406, DOI 10.1007/s10126-002-0033-x; Marques E., 1966, Revue de Zoologie et de Botanique Africaines, V73, P1; Marrari M, 2004, ICES J MAR SCI, V61, P667, DOI 10.1016/j.icesjms.2004.03.025; Mazzocchi MG, 1995, ATLAS MARINE ZOOPLAN, P23; Mori T, 1964, PELAGIC COPEPODS NEI; Nielsen TG, 2002, MAR ECOL PROG SER, V236, P301, DOI 10.3354/meps236301; Nielsen TG, 1996, MAR ECOL PROG SER, V139, P79, DOI 10.3354/meps139079; NISHIDA S, 1977, Bulletin of Plankton Society of Japan, V24, P119; Nishida S., 1985, B OCEAN RES I U TOKY, V20, P1; Ortman B. D., 2008, THESIS U CONNECTICUT; PAFFENHOFER GA, 1993, J PLANKTON RES, V15, P37, DOI 10.1093/plankt/15.1.37; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramirez F. C., 1966, Physis Buenos Aires, V26, P285; Ramirez F. C., 1971, Revta Mus La Plata (Zool), V11, P73; Razouls C., 2005, DIVERSITE REPARTITIO; Sabatini Marina, 2009, Revista de Investigacion y Desarrollo Pesquero, V19, P5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Selifonova ZP, 2009, INLAND WATER BIOL, V2, P30, DOI 10.1134/S1995082909010052; Shuvalov VS, 1980, COPEPOD CYCLOPOIDS F; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueda H, 2011, J NAT HIST, V45, P2069, DOI DOI 10.1080/00222933.2011.574801; Unal E, 2010, PROG OCEANOGR, V87, P175, DOI 10.1016/j.pocean.2010.09.017; Vinas MD, 2002, MAR FRESHWATER RES, V53, P1031, DOI 10.1071/MF00105; Vinas MD, 2000, ARCH FISH MAR RES, V48, P242; Vinas MD, 1996, ARCH FISH MAR RES, V43, P231; Voznesensky M, 2004, J EXP MAR BIOL ECOL, V311, P37, DOI 10.1016/j.jembe.2004.04.017; White T., 1990, PCR PROTOCOLS GUIDE, P315; Williams JA, 2006, J PLANKTON RES, V28, P1055, DOI 10.1093/plankt/fbl039	62	21	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35861	10.1371/journal.pone.0035861	http://dx.doi.org/10.1371/journal.pone.0035861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558245	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000068
J	Seki, S; Mazur, P				Seki, Shinsuke; Mazur, Peter			Ultra-Rapid Warming Yields High Survival of Mouse Oocytes Cooled to-196 degrees C in Dilutions of a Standard Vitrification Solution	PLOS ONE			English	Article							INTRACELLULAR ICE FORMATION; EMBRYOS; CRYOPRESERVATION; RECRYSTALLIZATION; BLASTOCYSTS; SPERMATOZOA	Intracellular ice is generally lethal. One way to avoid it is to vitrify cells; that is, to convert cell water to a glass rather than to ice. The belief has been that this requires both the cooling rate and the concentration of glass-inducing solutes be very high. But high solute concentrations can themselves be damaging. However, the findings we report here on the vitrification of mouse oocytes are not in accord with the first belief that cooling needs to be extremely rapid. The important requirement is that the warming rate be extremely high. We subjected mouse oocytes in the vitrification solution EAFS 10/10 to vitrification procedures using a broad range of cooling and warming rates. Morphological survivals exceeded 80% when they were warmed at the highest rate (117,000 degrees C/min) even when the prior cooling rate was as low as 880 degrees C/min. Functional survival was >81% and 54% with the highest warming rate after cooling at 69,000 and 880 degrees C/min, respectively. Our findings are also contrary to the second belief. We show that a high percentage of mouse oocytes survive vitrification in media that contain only half the usual concentration of solutes, provided they are warmed extremely rapidly; that is, >100,000 degrees C/min. Again, the cooling rate is of less consequence.	[Seki, Shinsuke; Mazur, Peter] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Fundamental & Appl Cryobiol Grp, Knoxville, TN 37920 USA; [Seki, Shinsuke] Tokyo Univ Marine Sci & Technol, Tokyo, Japan	University of Tennessee System; University of Tennessee Knoxville; Tokyo University of Marine Science & Technology	Seki, S (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Fundamental & Appl Cryobiol Grp, Knoxville, TN 37920 USA.	pmazur@utk.edu			National Institutes of Health [R01-RR018470]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018470] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01-RR018470 to P. Mazur, Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TZ, 1999, CRYOBIOLOGY, V38, P27, DOI 10.1006/cryo.1998.2141; Borini A., 2009, PRESERVATION HUMAN O; FAHY GM, 1987, BIOPHYSICS ORGAN CRY, P265; KARLSSON JOM, 1993, BIOPHYS J, V65, P2524, DOI 10.1016/S0006-3495(93)81319-5; Kleinhans FW, 2010, CRYOBIOLOGY, V61, P231, DOI 10.1016/j.cryobiol.2010.06.011; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P608, DOI 10.1016/S1472-6483(10)61169-8; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; LANDA V, 1990, FOLIA BIOL-PRAGUE, V36, P153; Lane M, 2001, MOL REPROD DEV, V58, P342, DOI 10.1002/1098-2795(200103)58:3&lt;342::AID-MRD13&gt;3.0.CO;2-X; Lee HJ, 2010, REPROD BIOMED ONLINE, V20, P201, DOI 10.1016/j.rbmo.2009.11.012; LEIBO SP, 1993, CRYO-LETT, V14, P133; Macas E, 2011, REPROD BIOMED ONLINE, V22, P376, DOI 10.1016/j.rbmo.2011.01.004; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Matsumoto H, 2001, CRYOBIOLOGY, V42, P139, DOI 10.1006/cryo.2001.2309; Mazur P, 2005, CRYOBIOLOGY, V51, P29, DOI 10.1016/j.cryobiol.2005.04.008; Mazur P, 2008, BIOL REPROD, V78, P2, DOI 10.1095/biolreprod.107.064113; Mazur P, 2007, CRYOBIOLOGY, V55, P158, DOI 10.1016/j.cryobiol.2007.06.007; Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159; Nakagata N, 1997, BIOL REPROD, V57, P1050, DOI 10.1095/biolreprod57.5.1050; Noyes N, 2009, REPROD BIOMED ONLINE, V18, P769, DOI 10.1016/S1472-6483(10)60025-9; Papis K, 1999, CRYO-LETT, V20, P203; Pedro P, 1997, J REPROD DEVELOP, V51, P235; RALL WF, 1987, CRYOBIOLOGY, V24, P387, DOI 10.1016/0011-2240(87)90042-3; Seki S, 2008, BIOL REPROD, V79, P727, DOI 10.1095/biolreprod.108.069401; Seki S, 2008, CRYOBIOLOGY, V56, P171, DOI 10.1016/j.cryobiol.2008.02.001; Seki S, 2009, CRYOBIOLOGY, V59, P75, DOI 10.1016/j.cryobiol.2009.04.012; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Vanderzwalmen P, 2009, REPROD BIOMED ONLINE, V19, P700, DOI 10.1016/j.rbmo.2009.09.011; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411; YAMAUCHI Y, 2005, CRYOBIOLOGY, V51, P400; Yavin S, 2009, HUM REPROD, V24, P797, DOI 10.1093/humrep/den397	31	73	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36058	10.1371/journal.pone.0036058	http://dx.doi.org/10.1371/journal.pone.0036058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558325	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000115
J	Kadirkamanathan, V; Anderson, SR; Billings, SA; Zhang, XL; Holmes, GR; Reyes-Aldasoro, CC; Elks, PM; Renshaw, SA				Kadirkamanathan, Visakan; Anderson, Sean R.; Billings, Stephen A.; Zhang, Xiliang; Holmes, Geoffrey R.; Reyes-Aldasoro, Constantino C.; Elks, Philip M.; Renshaw, Stephen A.			The Neutrophil's Eye-View: Inference and Visualisation of the Chemoattractant Field Driving Cell Chemotaxis In Vivo	PLOS ONE			English	Article							ZEBRAFISH; MODEL; INFLAMMATION; RESOLUTION; GRADIENTS; UNDERSTAND; MIGRATION; MOTILITY; SYSTEM; GUIDE	As we begin to understand the signals that drive chemotaxis in vivo, it is becoming clear that there is a complex interplay of chemotactic factors, which changes over time as the inflammatory response evolves. New animal models such as transgenic lines of zebrafish, which are near transparent and where the neutrophils express a green fluorescent protein, have the potential to greatly increase our understanding of the chemotactic process under conditions of wounding and infection from video microscopy data. Measurement of the chemoattractants over space (and their evolution over time) is a key objective for understanding the signals driving neutrophil chemotaxis. However, it is not possible to measure and visualise the most important contributors to in vivo chemotaxis, and in fact the understanding of the main contributors at any particular time is incomplete. The key insight that we make in this investigation is that the neutrophils themselves are sensing the underlying field that is driving their action and we can use the observations of neutrophil movement to infer the hidden net chemoattractant field by use of a novel computational framework. We apply the methodology to multiple in vivo neutrophil recruitment data sets to demonstrate this new technique and find that the method provides consistent estimates of the chemoattractant field across the majority of experiments. The framework that we derive represents an important new methodology for cell biologists investigating the signalling processes driving cell chemotaxis, which we label the neutrophils eye-view of the chemoattractant field.	[Kadirkamanathan, Visakan; Anderson, Sean R.; Billings, Stephen A.; Zhang, Xiliang; Holmes, Geoffrey R.] Univ Sheffield, Dept Automat Control & Syst Engn, Complex Syst & Signal Proc Grp, Sheffield, S Yorkshire, England; [Reyes-Aldasoro, Constantino C.] Univ Sussex, Sch Engn & Design, Brighton, E Sussex, England; [Elks, Philip M.; Renshaw, Stephen A.] Univ Sheffield, MRC Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Renshaw, Stephen A.] Univ Sheffield, Dept Infect & Immun, Acad Unit Resp Med, Sheffield, S Yorkshire, England	University of Sheffield; University of Sussex; University of Sheffield; University of Sheffield	Kadirkamanathan, V (corresponding author), Univ Sheffield, Dept Automat Control & Syst Engn, Complex Syst & Signal Proc Grp, Sheffield, S Yorkshire, England.	visakan@sheffield.ac.uk	Renshaw, Steve/E-6192-2010; Reyes-Aldasoro, Constantino/S-5093-2019	Renshaw, Steve/0000-0003-1790-1641; Reyes-Aldasoro, Constantino/0000-0002-9466-2018; Holmes, Geoffrey/0000-0002-8861-9638; Kadirkamanathan, Visakan/0000-0002-4243-2501; Anderson, Sean/0000-0002-7452-5681; Elks, Philip/0000-0003-1683-0749	Engineering and Physical Sciences Research Council, UK [EP/H00453X/1]; European Research Council [NSYS 226037]; Medical Research Council, UK [G0700091, G0701932]; Wellcome Trust [WT082909MA]; EPSRC [EP/G042209/1, EP/H00453X/1] Funding Source: UKRI; MRC [G0701932] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H00453X/1, EP/G042209/1] Funding Source: researchfish; Medical Research Council [G0701932] Funding Source: researchfish	Engineering and Physical Sciences Research Council, UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Engineering and Physical Sciences Research Council, UK Grant No: EP/H00453X/1 (http://www.epsrc.ac.uk). European Research Council, Advanced Investigator Award: NSYS 226037 (http://erc.europa.eu/). Medical Research Council, UK, Centre Grant for Stephen A. Renshaw: G0700091, Senior Clinical Fellowship to Stephen A. Renshaw: G0701932 (http://www.mrc.ac.uk). Wellcome Trust, Project Grant supporting Philip M. Elks: WT082909MA (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billings SA, 2007, NEURAL NETWORKS, V20, P1081, DOI 10.1016/j.neunet.2007.09.017; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851; Coca D, 2002, AUTOMATICA, V38, P1851, DOI 10.1016/S0005-1098(02)00099-7; Dewar M, 2009, IEEE T SIGNAL PROCES, V57, P83, DOI 10.1109/TSP.2008.2005091; Dewar MA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-21; Elks PM, 2011, METHODS MOL BIOL, V769, P261, DOI 10.1007/978-1-61779-207-6_18; Elks PM, 2011, BLOOD, V118, P712, DOI 10.1182/blood-2010-12-324186; FIORETTI S, 1989, INT J SYST SCI, V20, P33, DOI 10.1080/00207728908910103; Freestone DR, 2011, NEUROIMAGE, V56, P1043, DOI 10.1016/j.neuroimage.2011.02.027; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Kailath T, 2000, PR H INF SY, pXIX; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Liu GPP, 1999, IEEE T SYST MAN CY C, V29, P34, DOI 10.1109/5326.740668; Martin JS, 2009, BIOCHEM SOC T, V37, P830, DOI 10.1042/BST0370830; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathias JR, 2009, METHODS MOL BIOL, V571, P151, DOI 10.1007/978-1-60761-198-1_10; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Olariu V, 2009, BIOINFORMATICS, V25, P2824, DOI 10.1093/bioinformatics/btp456; Otsu N, 1975, AUTOMATICA, V11, P285; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; PETERKA V, 1981, AUTOMATICA, V17, P41, DOI 10.1016/0005-1098(81)90083-2; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Renshaw SA, 2007, EXP LUNG RES, V33, P549, DOI 10.1080/01902140701756778; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Reyes-Aldasoro CC, 2008, J MICROSC-OXFORD, V229, P162, DOI 10.1111/j.1365-2818.2007.01877.x; Scerri K, 2009, IEEE T SIGNAL PROCES, V57, P482, DOI 10.1109/TSP.2008.2008550; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Wikle CK, 2011, J TIME SER ANAL, V32, P339, DOI 10.1111/j.1467-9892.2011.00729.x; Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018805; Young P, 1999, J APPL STAT, V26, P103, DOI 10.1080/02664769922692; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	42	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35182	10.1371/journal.pone.0035182	http://dx.doi.org/10.1371/journal.pone.0035182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563379	Green Accepted, gold, Green Published			2022-12-25	WOS:000305349100008
J	Somalinga, BR; Day, CE; Wei, SG; Roth, MG; Thomas, PJ				Somalinga, Balajee R.; Day, Cameron E.; Wei, Shuguang; Roth, Michael G.; Thomas, Philip J.			TDP-43 Identified from a Genome Wide RNAi Screen for SOD1 Regulators	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; MOTOR-NEURONS; IN-VITRO; PROTEIN; MUTATIONS; DEGENERATION; GLUTAMATE; COMPLEMENTATION	Amyotrophic Lateral Sclerosis (ALS) is a late-onset, progressive neurodegenerative disease affecting motor neurons in the brain stem and spinal cord leading to loss of voluntary muscular function and ultimately, death due to respiratory failure. A subset of ALS cases are familial and associated with mutations in superoxide dismutase 1 (SOD1) that destabilize the protein and predispose it to aggregation. In spite of the fact that sporadic and familial forms of ALS share many common pathophysiological features, the mechanistic relationship between SOD1-associated and sporadic forms of the disease if any, is not well understood. To better understand any molecular connections, a cell-based protein folding assay was employed to screen a whole genome RNAi library for genes that regulate levels of soluble SOD1. Statistically significant hits that modulate SOD1 levels, when analyzed by pathway analysis revealed a highly ranked network containing TAR DNA binging protein (TDP-43), a major component of aggregates characteristic of sporadic ALS. Biochemical experiments confirmed the action of TDP-43 on SOD1. These results highlight an unexpected relationship between TDP-43 and SOD1 which may have implications in disease pathogenesis.	[Somalinga, Balajee R.; Day, Cameron E.; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Wei, Shuguang; Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Somalinga, BR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	balajee.somalinga@utsouthwestern.edu; philip.thomas@utsouthwestern.edu	Thomas, Philip J/F-7115-2012	Somalinga, Balajee/0000-0002-6930-2790; Roth, Michael/0000-0002-9056-332X	ALS Association; Reata Pharmaceuticals; University of Texas; NATIONAL CANCER INSTITUTE [P30CA142543, P01CA095471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835] Funding Source: NIH RePORTER	ALS Association; Reata Pharmaceuticals; University of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research work was funded through grants from the ALS Association and a Sponsored Research Agreement from Reata Pharmaceuticals. Chris Wigley at Reata Pharmaceuticals gave comments and suggestions during the preparation of the manuscript.; Philip J. Thomas is a founder and Scientific Advisory Board Member of Reata Pharmaceuticals. He holds shares of Reata common stock. Reata has a sponsored research agreement with the University of Texas that supports work in Phillip J. Thomas' laboratory. Reata has licensed the beta galactosidase assay from the University of Texas Board of Reagent (Patent holders) for small molecule discovery. The license does not restrict the use of or distribution of the assay for research purposes. Patents: U.S. Patent Number: 7,635,569 Patent Title: Protein/Solubility Folding Assessed by Structural Complementation. Inventors: Thomas, Philip J.; Hunt, John F.; Wigley, William C., Stidham, Rhesa D. Issued: 12/22/09 U. S. Patent Number: 7,455,978 Patent Title: Protein/Solubility Folding Assessed by Structural Complementation. Inventors: Thomas, Philip J.; Hunt, John F.; Wigley, William C.; Stidham, Rhesa D. Issued: 11/25/08 U.S. Patent Number: 6,727,070 Patent Title: Protein/Solubility Folding Assessed by Structural Complementation. Inventors: Thomas, Philip J.; Hunt, John F.; Wigley, William C.; Stidham, Rhesa D. Issued: 04/27/04 This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Beal MF, 2000, BRAIN, V123, P1291, DOI 10.1093/brain/123.7.1291; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Broom WJ, 2008, AMYOTROPH LATERAL SC, V9, P229, DOI 10.1080/17482960802103107; Broom WJ, 2006, J BIOMOL SCREEN, V11, P729, DOI 10.1177/1087057106290937; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; COURATIER P, 1993, LANCET, V341, P265, DOI 10.1016/0140-6736(93)92615-Z; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kambuj PA, 2003, THESIS U TEXAS ARLIN; Kruman II, 1999, EXP NEUROL, V160, P28, DOI 10.1006/exnr.1999.7190; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lalmansingh AS, 2011, J BIOL CHEM, V286, P10970, DOI 10.1074/jbc.M110.166587; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Robertson J, 2007, NEUROSCI LETT, V420, P128, DOI 10.1016/j.neulet.2007.03.066; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Somalinga BR, 2011, J BIOMOL SCREEN, V16, P974, DOI 10.1177/1087057111418505; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	52	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35818	10.1371/journal.pone.0035818	http://dx.doi.org/10.1371/journal.pone.0035818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563406	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100033
J	Fradin, D; Le Fur, S; Mille, C; Naoui, N; Groves, C; Zelenika, D; McCarthy, MI; Lathrop, M; Bougneres, P				Fradin, Delphine; Le Fur, Sophie; Mille, Clemence; Naoui, Nadia; Groves, Chris; Zelenika, Diana; McCarthy, Mark I.; Lathrop, Mark; Bougneres, Pierre			Association of the CpG Methylation Pattern of the Proximal Insulin Gene Promoter with Type 1 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; HUMAN THYMUS; EXPRESSION; LOCUS; LINKAGE; RISK	The insulin (INS) region is the second most important locus associated with Type 1 Diabetes (T1D). The study of the DNA methylation pattern of the 7 CpGs proximal to the TSS in the INS gene promoter revealed that T1D patients have a lower level of methylation of CpG -19, -135 and -234 (p = 2.10(-16)) and a higher methylation of CpG -180 than controls, while methylation was comparable for CpG -69, -102, -206. The magnitude of the hypomethylation relative to a control population was 8-15% of the corresponding levels in controls and was correlated in CpGs -19 and -135 (r = 0.77) and CpG 135 and -234 (r = 0.65). 70/485 (14%) of T1D patients had a simultaneous decrease in methylation of CpG -19, -135, -234 versus none in 317 controls. CpG methylation did not correlate with glycated hemoglobin or with T1D duration. The methylation of CpG -69, -102, -180, -206, but not CpG -19, -135, -234 was strongly influenced by the cis-genotype at rs689, a SNP known to show a strong association with T1D. We hypothesize that part of this genetic association could in fact be mediated at the statistical and functional level by the underlying changes in neighboring CpG methylation. Our observation of a CpG-specific, locus-specific methylation pattern, although it can provide an epigenetic biomarker of a multifactorial disease, does not indicate whether the reported epigenetic pattern preexists or follows the establishment of T1D. To explore the effect of chronic hyperglycemia on CpG methylation, we studied non obese patients with type 2 diabetes (T2D) who were found to have decreased CpG-19 methylation versus age-matched controls, similar to T1D (p = 2.10(-6)) but increased CpG-234 methylation (p = 5.10(-8)), the opposite of T1D. The causality and natural history of the different epigenetic changes associated with T1D or T2D remain to be determined.	[Fradin, Delphine; Le Fur, Sophie; Mille, Clemence; Naoui, Nadia; Bougneres, Pierre] Univ Paris 11, INSERM, U986, Bicetre Hosp, Paris, France; [Fradin, Delphine; Le Fur, Sophie; Mille, Clemence; Naoui, Nadia; Bougneres, Pierre] Univ Paris 11, Dept Pediat Endocrinol, Bicetre Hosp, Paris, France; [Le Fur, Sophie; Mille, Clemence; Naoui, Nadia; Bougneres, Pierre] Hop St Vincent de Paul, F-75674 Paris, France; [Le Fur, Sophie; Mille, Clemence; Naoui, Nadia; Bougneres, Pierre] ISIS DIAB Cohort, Le Kremlin Bicetre, France; [Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Groves, Chris; McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Fradin, D (corresponding author), Univ Paris 11, INSERM, U986, Bicetre Hosp, Paris, France.	pierre.bougneres@inserm.fr	Fradin, Delphine/K-7181-2015; McCarthy, Mark/M-3763-2015	Fradin, Delphine/0000-0001-6231-2649; McCarthy, Mark/0000-0002-4393-0510	Centre National de Genotypage (Evry); Association pour la Recherche sur le Diabete; Programme Hospitalier de Recherche Clinique	Centre National de Genotypage (Evry); Association pour la Recherche sur le Diabete(Fondation ARC pour la Recherche sur le Cancer); Programme Hospitalier de Recherche Clinique	The authors acknowledge the support of "Alliance Diabete de Type 1 NovoNordisk-INSERM,'' Centre National de Genotypage (Evry), Association pour la Recherche sur le Diabete, and Programme Hospitalier de Recherche Clinique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bougneres P, 2008, J EXP MED, V205, P2953, DOI 10.1084/jem.20082622; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Concannon P, 2005, DIABETES, V54, P2995, DOI 10.2337/diabetes.54.10.2995; COX NJ, 1989, DIABETES, V38, P653, DOI 10.2337/diabetes.38.5.653; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; MEABURN EL, 2010, EPIGENETICS, V5; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Yang BT, 2010, DIABETOLOGIA; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138	26	67	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36278	10.1371/journal.pone.0036278	http://dx.doi.org/10.1371/journal.pone.0036278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567146	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500065
J	Meyers, SC; Liston, A; Meinke, R				Meyers, Stephen C.; Liston, Aaron; Meinke, Robert			An Evaluation of Putative Sympatric Speciation within Limnanthes (Limnanthaceae)	PLOS ONE			English	Article							EVOLUTIONARY BIOLOGY; CHLOROPLAST; POPULATION; CALIFORNIA; GENOME; PALMS	Limnanthes floccosa ssp. floccosa and L. floccosa ssp. grandiflora are two of five subspecies within Limnanthes floccosa endemic to vernal pools in southern Oregon and northern California. Three seasons of monitoring natural populations have quantified that L. floccosa ssp. grandiflora is always found growing sympatrically with L. floccosa ssp. floccosa and that their flowering times overlap considerably. Despite their subspecific rank within the same species crossing experiments have confirmed that their F1 hybrids are sterile. An analysis of twelve microsatellite markers, with unique alleles in each taxon, also shows exceedingly low levels of gene flow between populations of the two subspecies. Due to the lack of previous phylogenetic resolution among L. floccosa subspecies, we used Illumina next generation sequencing to identify single nucleotide polymorphisms from genomic DNA libraries of L. floccosa ssp. floccosa and L. floccosa ssp. grandiflora. These data were used to identify single nucleotide polymorphisms in the chloroplast, mitochondrial, and nuclear genomes. From these variable loci, a total of 2772 bp was obtained using Sanger sequencing of ten individuals representing all subspecies of L. floccosa and an outgroup. The resulting phylogenetic reconstruction was fully resolved. Our results indicate that although L. floccosa ssp. floccosa and L. floccosa ssp. grandiflora are closely related, they are not sister taxa and therefore likely did not diverge as a result of a sympatric speciation event.	[Meyers, Stephen C.; Liston, Aaron; Meinke, Robert] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University	Meyers, SC (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	meyersst@science.oregonstate.edu			Leslie and Vera Gottlieb Research Fund in Plant Evolutionary Biology	Leslie and Vera Gottlieb Research Fund in Plant Evolutionary Biology	This work was funded, in part, by the Leslie and Vera Gottlieb Research Fund in Plant Evolutionary Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARROYO MTK, 1973, EVOLUTION, V27, P679, DOI 10.1111/j.1558-5646.1973.tb00715.x; ARROYO MTK, 1973, BRITTONIA, V25, P177, DOI 10.2307/2805936; Babik W, 2009, MOL ECOL, V18, P3629, DOI 10.1111/j.1365-294X.2009.04306.x; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Coyne JA, 2004, SPECIATION, V37; Darwin C., 1859, ORIGIN SPECIES MEANS; Dobzhansky T., 1937; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; King JL, 1996, HYDROBIOLOGIA, V328, P85, DOI 10.1007/BF00018707; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kishore VK, 2004, THEOR APPL GENET, V108, P450, DOI 10.1007/s00122-003-1447-1; Marshall JL, 2002, TRENDS ECOL EVOL, V17, P558, DOI 10.1016/S0169-5347(02)02636-8; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Mayr E., 1942, SYSTEMATICS ORIGIN S; Meyers SC, 2010, ACTA HORTIC, V859, P309, DOI 10.17660/ActaHortic.2010.859.36; Meyers SC, 2008, SURVEY SEED BULKING; Meyers SC, 2010, SYST BOT, V35, P552, DOI 10.1600/036364410792495854; ORNDUFF R, 1993, JEPSON MANUAL HIGHER, P736; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Peck ME, 1961, MANUAL HIGHER PLANTS, P506; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schliewen UK, 2006, NATURE, V444, pE12, DOI 10.1038/nature05419; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stuessy TF, 2006, NATURE, V443, DOI 10.1038/nature05216; TOY SJ, 1966, ECON BOT, V20, P71, DOI 10.1007/BF02861928; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	35	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36480	10.1371/journal.pone.0036480	http://dx.doi.org/10.1371/journal.pone.0036480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563502	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340700051
J	Wasti, SP; Simkhada, P; Randall, J; Freeman, JV; van Teijlingen, E				Wasti, Sharada P.; Simkhada, Padam; Randall, Julian; Freeman, Jennifer V.; van Teijlingen, Edwin			Factors Influencing Adherence to Antiretroviral Treatment in Nepal: A Mixed-Methods Study	PLOS ONE			English	Article							SELF-REPORTED ADHERENCE; MEDICATION ADHERENCE; THERAPY ADHERENCE; DRUG-RESISTANCE; CLINICAL-TRIALS; SOCIAL SUPPORT; ART ADHERENCE; HIV; BARRIERS; FACILITATORS	Background: Antiretroviral therapy (ART) is a lifesaver for individual patients treated for Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS). Maintaining optimal adherence to antiretroviral drugs is essential for HIV infection management. This study aimed to understand the factors influencing adherence amongst ART-prescribed patients and care providers in Nepal. Methods: A cross-sectional mixed-methods study surveying 330 ART-prescribed patients and 34 in-depth interviews with three different types of stakeholders: patients, care providers, and key people at policy level. Adherence was assessed through survey self-reporting and during the interviews. A multivariate logistic regression model was used to identify factors associated with adherence, supplemented with a thematic analysis of the interview transcripts. Results: A total of 282 (85.5%) respondents reported complete adherence, i.e. no missed doses in the four-weeks prior to interview. Major factors influencing adherence were: non-disclosure of HIV status (OR = 17.99, p = 0.014); alcohol use (OR = 12.89, p =<0.001), being female (OR = 6.91, p = 0.001), being illiterate (OR = 4.58, p = 0.015), side-effects (OR = 6.04, p = 0.025), ART started <= 24 months (OR = 3.18, p = 0.009), travel time to hospital >1 hour (OR = 2.84, p = 0.035). Similarly, lack of knowledge and negative perception towards ART medications also significantly affected non-adherence. Transport costs (for repeat prescription), followed by pills running out, not wanting others to notice, side-effects, and being busy were the most common reasons for non-adherence. The interviews also revealed religious or ritual obstacles, stigma and discrimination, ART-associated costs, transport problems, lack of support, and side-effects as contributing to non-adherence. Conclusion: Improving adherence requires a supportive environment; accessible treatment; clear instructions about regimens; and regimens tailored to individual patients' lifestyles. Healthcare workers should address some of the practical and cultural issues around ART medicine whilst policy-makers should develop appropriate social policy to promote adherence among ART-prescribed patients.	[Wasti, Sharada P.; Simkhada, Padam; Freeman, Jennifer V.] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England; [Randall, Julian] Univ Aberdeen, Sch Business, Aberdeen, Scotland; [van Teijlingen, Edwin] Bournemouth Univ, Bournemouth, Dorset, England	University of Sheffield; University of Aberdeen; Bournemouth University	Wasti, SP (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England.	s.wasti@sheffield.ac.uk	Wasti, Sharada/AAO-7742-2021; van Teijlingen, Edwin R/A-3727-2010	van Teijlingen, Edwin R/0000-0001-5523-8583; Simkhada, Padam/0000-0002-5706-6479; Wasti, Dr. Sharada Prasad/0000-0001-8833-7801				Adam BD, 2003, AIDS CARE, V15, P263, DOI 10.1080/0954012031000068407; Adeneye A K, 2006, World Health Popul, V8, P46; Alakija Kazeem Salami, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P191, DOI 10.1177/1545109710368722; Alker AP, 2004, 15 INT C AIDS BANGK; Amico KR, 2009, AIDS BEHAV, V13, P66, DOI 10.1007/s10461-007-9311-y; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bazeley, 2007, QUALITATIVE DATA ANA; Bonolo PD, 2005, AIDS, V19, pS5; Bowling A., 2014, RES METHODS HLTH INV; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Catz SL, 2000, HEALTH PSYCHOL, V19, P124, DOI 10.1037/0278-6133.19.2.124; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Fletcher CV, 2005, JAIDS-J ACQ IMM DEF, V40, P301, DOI 10.1097/01.qai.0000180078.53321.6a; Fumaz CR, 2008, AIDS CARE, V20, P796, DOI 10.1080/09540120701694022; Furber AS, 2004, BMJ-BRIT MED J, V329, P1281, DOI 10.1136/bmj.329.7477.1281; Hansel A, 2001, J ACQ IMMUN DEF SYND, V26, P191, DOI 10.1097/00126334-200102010-00016; Hardon A., 2006, ACCESS ADHERENCE CHA; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Johnson VR, 2010, PATIENT EDUC COUNS, V79, P14, DOI 10.1016/j.pec.2009.07.002; Keenan KF, 2005, J FAM PLAN REPROD H, V31, P40, DOI 10.1783/0000000052972825; Kleeberger CA, 2001, J ACQ IMMUN DEF SYND, V26, P82, DOI 10.1097/00126334-200101010-00012; Konkle-Parker DJ, 2008, J ASSOC NURSE AIDS C, V19, P98, DOI 10.1016/j.jana.2007.09.005; Kumarasamy N, 2005, AIDS PATIENT CARE ST, V19, P526, DOI 10.1089/apc.2005.19.526; Lewis MP, 2006, AIDS CARE, V18, P140, DOI 10.1080/09540120500161835; Li L, 2010, NURS HEALTH SCI, V12, P212, DOI 10.1111/j.1442-2018.2010.00521.x; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Mbonu NC, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/145891; Mehta S, 1997, AIDS, V11, P1665, DOI 10.1097/00002030-199714000-00002; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mimiaga MJ, 2010, AIDS CARE, V22, P1305, DOI 10.1080/09540121003758515; Murphy DA, 2005, ARCH PEDIAT ADOL MED, V159, P764, DOI 10.1001/archpedi.159.8.764; Murphy DA, 2003, AIDS CARE, V15, P217, DOI 10.1080/0954012031000068362; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Ncama BP, 2008, INT J NURS STUD, V45, P1757, DOI 10.1016/j.ijnurstu.2008.06.006; NCASC, 2009, FACTSH 4 ANT ART SER; Olupot-Olupot P, 2008, AIDS, V22, P1882, DOI 10.1097/QAD.0b013e3283112ba6; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Poudel P, 2000, Gend Dev, V8, P74, DOI 10.1080/741923626; Protopopescu C, 2009, J ANTIMICROB CHEMOTH, V64, P599, DOI 10.1093/jac/dkp232; Rabkin J G, 1998, GMHC Treat Issues, V12, P8; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Remien RH, 2003, AIDS BEHAV, V7, P61, DOI 10.1023/A:1022513507669; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Royal SW, 2009, AIDS CARE, V21, P448, DOI 10.1080/09540120802270250; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Sarna A, 2008, INDIAN J MED RES, V127, P28; Schein E.H., 1985, CLASSICS ORG THEORY, V3, P490; Shah B, 2007, CLIN INFECT DIS, V44, P1235, DOI 10.1086/513429; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Smith-Estelle A, 2003, REPROD HEALTH MATTER, V11, P142, DOI 10.1016/S0968-8080(03)02292-4; Sorensen S, 2002, 14 INT AIDS C BARC I; Stevens W, 2004, BMJ-BRIT MED J, V328, P280, DOI 10.1136/bmj.328.7434.280; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Swartz L, 2002, BMJ-BRIT MED J, V325, P914, DOI 10.1136/bmj.325.7370.914; Thomas D., 2004, INCREASING ACCESS ES; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; van der Wal MHL, 2006, EUR HEART J, V27, P434, DOI 10.1093/eurheartj/ehi603; van Teijlingen Edwin, 2002, Nurs Stand, V16, P33; Wagner G, 2004, JAIDS-J ACQ IMM DEF, V35, P203, DOI 10.1097/00126334-200402010-00016; Wang HH, 2008, AIDS PATIENT CARE ST, V22, P71, DOI 10.1089/apc.2007.0047; Wanyama J, 2007, AIDS, V21, P1486, DOI 10.1097/QAD.0b013e32823ecf7f; Wasti SP, 2012, TROP MED INT HEALTH, V17, P71, DOI 10.1111/j.1365-3156.2011.02888.x; Wasti SP., 2011, HLTH SCI J, V5, P37; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; *WHO, 2003, ADH LONG TERM EV ACT; WHO, INN CAR CHRON COND B; Willard S., 2008, Journal of the International Association of Physicians in AIDS Care, V7, pS17, DOI 10.1177/1545109708315404; World Bank, 2001, UND ACC DEM UT HLTH	75	104	105	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35547	10.1371/journal.pone.0035547	http://dx.doi.org/10.1371/journal.pone.0035547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UN	22563464	Green Published, Green Accepted, gold			2022-12-25	WOS:000305340700013
J	Dura, B; Kovacs, GTA; Giovangrandi, L				Dura, Burak; Kovacs, Gregory T. A.; Giovangrandi, Laurent			Spatiotemporally Controlled Cardiac Conduction Block Using High-Frequency Electrical Stimulation	PLOS ONE			English	Article							ULTRARAPID SUBTHRESHOLD STIMULATION; ALTERNATING-CURRENT; VENTRICULAR REFRACTORINESS; REENTRANT TACHYCARDIA; HL-1 CARDIOMYOCYTES; CURRENTS; CELL; TERMINATION; MODEL; EXCITATION	Background: Methods for the electrical inhibition of cardiac excitation have long been sought to control excitability and conduction, but to date remain largely impractical. High-amplitude alternating current (AC) stimulation has been known to extend cardiac action potentials (APs), and has been recently exploited to terminate reentrant arrhythmias by producing reversible conduction blocks. Yet, low-amplitude currents at similar frequencies have been shown to entrain cardiac tissues by generation of repetitive APs, leading in some cases to ventricular fibrillation and hemodynamic collapse in vivo. Therefore, an inhibition method that does not lead to entrainment - irrespective of the stimulation amplitude (bound to fluctuate in an in vivo setting) - is highly desirable. Methodology/Principal Findings: We investigated the effects of broader amplitude and frequency ranges on the inhibitory effects of extracellular AC stimulation on HL-1 cardiomyocytes cultured on microelectrode arrays, using both sinusoidal and square waveforms. Our results indicate that, at sufficiently high frequencies, cardiac tissue exhibits a binary response to stimulus amplitude with either prolonged APs or no effect, thereby effectively avoiding the risks of entrainment by repetitive firing observed at lower frequencies. We further demonstrate the ability to precisely define reversible local conduction blocks in beating cultures without influencing the propagation activity in non-blocked areas. The conduction blocks were spatiotemporally controlled by electrode geometry and stimuli duration, respectively, and sustainable for long durations (300 s). Conclusion/Significance: Inhibition of cardiac excitation induced by high-frequency AC stimulation exhibits a binary response to amplitude above a threshold frequency, enabling the generation of reversible conduction blocks without the risks of entrainment. This inhibition method could yield novel approaches for arrhythmia modeling in vitro, as well as safer and more efficacious tools for in vivo cardiac mapping and radio-frequency ablation guidance applications.	[Dura, Burak; Kovacs, Gregory T. A.; Giovangrandi, Laurent] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University	Dura, B (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	giovan@stanford.edu			Medtronic, Inc.; Medtronic	Medtronic, Inc.(Medtronic); Medtronic(Medtronic)	The authors have read the journal's policy and have the following conflicts: Stanford University has filed U.S. provisional patent applications related to this work. In addition, this research effort has been funded by Medtronic, Inc. Dr. Giovangrandi benefited from a travel grant from Medtronic. GTAK owns Medtronic stocks. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANTONI H, 1970, PFLUG ARCH EUR J PHY, V314, P274, DOI 10.1007/BF00592287; Antoni H., 1970, PFLUGERS ARCH, V814, P274; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Basser PJ, 2000, ANNU REV BIOMED ENG, V2, P377, DOI 10.1146/annurev.bioeng.2.1.377; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bromm B, 1971, PFLUGERS ARCH, V329, P155; CHORRO FJ, 1994, EUR HEART J, V15, P1681, DOI 10.1093/oxfordjournals.eurheartj.a060452; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dura B, 2012, IEEE T BIO-MED ENG, V59, P1381, DOI 10.1109/TBME.2012.2188136; FISHER JD, 1983, AM J CARDIOL, V51, P1334, DOI 10.1016/0002-9149(83)90308-9; FROMER M, 1992, J AM COLL CARDIOL, V20, P879, DOI 10.1016/0735-1097(92)90188-S; Gilchrist KH, 2001, BIOSENS BIOELECTRON, V16, P557, DOI 10.1016/S0956-5663(01)00169-5; Gonzalez H, 2003, BIOSYSTEMS, V71, P71, DOI 10.1016/S0303-2647(03)00111-4; Gray RA, 1996, PACE 2, V19, P666; Katz B, 1939, J PHYSIOL-LONDON, V96, P202, DOI 10.1113/jphysiol.1939.sp003771; Malkin RA, 2003, MED BIOL ENG COMPUT, V41, P640, DOI 10.1007/BF02349971; Malkin RA, 2001, J CARDIOVASC ELECTR, V12, P1154, DOI 10.1046/j.1540-8167.2001.01154.x; Meunier JM, 1999, J CARDIOVASC ELECTR, V10, P1619, DOI 10.1111/j.1540-8167.1999.tb00226.x; Meunier JM, 2001, J CARDIOVASC ELECTR, V12, P1176, DOI 10.1046/j.1540-8167.2001.01176.x; Nygren A, 1998, CIRC RES, V82, P63; PAYA R, 1991, J ELECTROCARDIOL, V24, P63, DOI 10.1016/0022-0736(91)90082-W; Prevost J, 1899, CR HEBD ACAD SCI, V128, P668; PRYSTOWSKY EN, 1983, CIRCULATION, V68, P707, DOI 10.1161/01.CIR.68.4.707; Sartiani L, 2002, J PHYSIOL-LONDON, V545, P81, DOI 10.1113/jphysiol.2002.021535; Schoen I, 2008, J NEUROPHYSIOL, V100, P346, DOI 10.1152/jn.90287.2008; SHENASA M, 1988, CIRCULATION, V78, P1135, DOI 10.1161/01.CIR.78.5.1135; Swedlow CD, 1987, CIRCULATION, V76, P1101; Tandri H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002445; Thomas SP, 2000, CIRC RES, V87, P467; Vigmond EJ, 2001, J CARDIOVASC ELECTR, V12, P1145, DOI 10.1046/j.1540-8167.2001.01145.x; VINET A, 1994, ANN BIOMED ENG, V22, P568, DOI 10.1007/BF02368285; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Whittington RH, 2006, THESIS STANFORD U ST; Willems S, 2001, J AM COLL CARDIOL, V37, P1645, DOI 10.1016/S0735-1097(01)01206-2; WINDLE JR, 1986, AM J CARDIOL, V57, P381, DOI 10.1016/0002-9149(86)90757-5; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	36	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36217	10.1371/journal.pone.0036217	http://dx.doi.org/10.1371/journal.pone.0036217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558389	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200050
J	Dahia, CL; Mahoney, E; Wylie, C				Dahia, Chitra Lekha; Mahoney, Eric; Wylie, Christopher			Shh Signaling from the Nucleus Pulposus Is Required for the Postnatal Growth and Differentiation of the Mouse Intervertebral Disc	PLOS ONE			English	Article							SONIC HEDGEHOG; LIMB DEVELOPMENT; COLLAGEN GENE; EXPRESSION; INHIBITION; SOX9; DEGENERATION; CHONDROCYTES; INDUCTION; BLOCKADE	Intervertebral discs (IVD) are essential components of the vertebral column. They maintain separation, and provide shock absorbing buffers, between adjacent vertebrae, while also allowing movements between them. Each IVD consists of a central semi-liquid nucleus pulposus (NP) surrounded by a multi-layered fibrocartilagenous annulus fibrosus (AF). Although the IVDs grow and differentiate after birth along with the vertebral column, little is known about the mechanism of this. Understanding the signals that control normal IVD growth and differentiation would also provide potential therapies for degenerative disc disease, which is the major cause of lower back pain and affects a large proportion of the population. In this work, we show that during postnatal growth of the mouse, Sonic hedgehog (Shh) signaling from the NP cells controls many aspects of growth and differentiation of both the NP cells themselves and of the surrounding AF, and that it acts, at least partly, by regulating other signaling pathways in the NP and AF. Recent studies have shown that the NP cells arise from the embryonic notochord, which acts as a major signaling center in the embryo. This work shows that this notochord-derived tissue continues to carry out a major signaling function in the postnatal body and that the IVDs are signaling centers, in addition to their already known functions in the mechanics of vertebral column function.	[Dahia, Chitra Lekha; Mahoney, Eric] Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, Cincinnati, OH 45229 USA; [Wylie, Christopher] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Dahia, CL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, Cincinnati, OH 45229 USA.	Chitra.Dahia@cchmc.org; Christopher.Wylie@cchmc.org			Orthopaedic Research and Education Foundation (OREF) Career Development Grant [11-228]	Orthopaedic Research and Education Foundation (OREF) Career Development Grant	This work was supported by an Orthopaedic Research and Education Foundation (OREF) Career Development Grant to CD (Grant number 11-228; http://www.oref.org/site/PageServer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastida MF, 2009, DEVELOPMENT, V136, P3779, DOI 10.1242/dev.036418; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Dahia CL, 2011, SPINE, V36, P1071, DOI 10.1097/BRS.0b013e3181f7a3ca; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Dahia CL, 2009, SPINE, V34, P456, DOI 10.1097/BRS.0b013e3181913e98; Dassule HR, 2000, DEVELOPMENT, V127, P4775; DEYO RA, 1987, SPINE, V12, P264, DOI 10.1097/00007632-198704000-00013; DiPaola CP, 2005, J ORTHOP RES, V23, P1112, DOI 10.1016/j.orthres.2005.03.008; Dray N, 2010, SCIENCE, V329, P339, DOI 10.1126/science.1188913; Faure E, 2000, CELL TISSUE RES, V300, P89, DOI 10.1007/s004410000183; Faure S, 2002, DEV BIOL, V244, P44, DOI 10.1006/dbio.2002.0579; Frymoyer John W., 1996, P8; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Ireland D, 2009, BIOSCIENCE HORIZONS, V1, P83; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; POONI JS, 1986, SURG RADIOL ANAT, V8, P175, DOI 10.1007/BF02427846; Sanz-Ezquerro JJ, 2000, DEVELOPMENT, V127, P4811; Surace EM, 2006, MOL THER, V13, P573, DOI 10.1016/j.ymthe.2005.10.010; Tew SR, 2008, BIOCHEM J, V414, P231, DOI 10.1042/BJ20080262; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629	31	61	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35944	10.1371/journal.pone.0035944	http://dx.doi.org/10.1371/journal.pone.0035944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558278	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000090
J	Esposito, DL; Aru, F; Lattanzio, R; Morgano, A; Abbondanza, M; Malekzadeh, R; Bishehsari, F; Valanzano, R; Russo, A; Piantelli, M; Moschetta, A; Lotti, LV; Mariani-Costantini, R				Esposito, Diana L.; Aru, Federica; Lattanzio, Rossano; Morgano, Annalisa; Abbondanza, Michela; Malekzadeh, Reza; Bishehsari, Faraz; Valanzano, Rosa; Russo, Antonio; Piantelli, Mauro; Moschetta, Antonio; Lotti, Lavinia Vittoria; Mariani-Costantini, Renato			The Insulin Receptor Substrate 1 (Irs1) in Intestinal Epithelial Differentiation and in Colorectal Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-I; COLON-CARCINOMA-CELLS; IGF-I; NUCLEAR TRANSLOCATION; BETA-CATENIN; STEM-CELL; EXPRESSION; MUTATIONS; CACO-2; ADENOCARCINOMA	Colorectal cancer (CRC) is associated with lifestyle factors that affect insulin/IGF signaling, of which the insulin receptor substrate 1 (IRS1) is a key transducer. We investigated expression, localization and pathologic correlations of IRS1 in cancer-uninvolved colonic epithelium, primary CRCs with paired liver metastases and in vitro polarizing Caco2 and HT29 cells. IRS1 mRNA and protein resulted higher, relative to paired mucosa, in adenomas of familial adenomatous polyposis patients and in CRCs that overexpressed c-MYC, beta-catenin, InsR beta, and IGF1R. Analysis of IRS1 immunostaining in 24 cases of primary CRC with paired colonic epithelium and hepatic metastasis showed that staining intensity was significantly higher in metastases relative to both primary CRC (P<0.01) and colonic epithelium (P<0.01). Primary and metastatic CRCs, compared to colonic epithelium, contained significantly higher numbers of IRS1-positive cells (P = 0.013 and P = 0.014, respectively). Pathologic correlations in 163 primary CRCs revealed that diffuse IRS1 staining was associated with tumors combining differentiated phenotype and aggressive markers (high Ki67, p53, and beta-catenin). In Caco 2 IRS1 and InsR were maximally expressed after polarization, while IGF1R was highest in pre-polarized cells. No nuclear IRS1 was detected, while, with polarization, phosphorylated IRS1 (pIRS1) shifted from the lateral to the apical plasma membrane and was expressed in surface cells only. In HT29, that carry mutations constitutively activating survival signaling, IRS1 and IGF1R decreased with polarization, while pIRS1 localized in nuclear spots throughout the course. Overall, these data provide evidence that IRS1 is modulated according to CRC differentiation, and support a role of IRS1 in CRC progression and liver metastatization.	[Esposito, Diana L.; Aru, Federica; Lattanzio, Rossano; Morgano, Annalisa; Bishehsari, Faraz; Piantelli, Mauro; Mariani-Costantini, Renato] Univ G dAnnunzio, Aging Res Ctr, Unit Gen Pathol, Chieti, Italy; [Esposito, Diana L.; Mariani-Costantini, Renato] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Morgano, Annalisa; Moschetta, Antonio] Consorzio Mario Negri Sud, Dept Translat Pharmacol, Lab Lipid Metab & Canc, Chieti, Italy; [Abbondanza, Michela; Lotti, Lavinia Vittoria] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Malekzadeh, Reza; Bishehsari, Faraz] Univ Tehran, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Valanzano, Rosa] Univ Florence, Dept Clin Physiopathol, Florence, Italy; [Russo, Antonio] Univ Palermo, Dept Surg & Oncol Sci, Palermo, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Consorzio Mario Negri Sud; Sapienza University Rome; Tehran University of Medical Sciences; University of Tehran; University of Florence; University of Palermo	Esposito, DL (corresponding author), Univ G dAnnunzio, Aging Res Ctr, Unit Gen Pathol, Chieti, Italy.	rmc@unich.it	Malekzadeh, Reza/U-1382-2017; Lattanzio, Rossano/K-1927-2018; Moschetta, Antonio/K-6211-2016; Mariani-Costantini, Renato/B-6637-2012; Moschetta, Antonio/AAC-5295-2022	Malekzadeh, Reza/0000-0002-9820-6335; Lattanzio, Rossano/0000-0001-9803-4476; Mariani-Costantini, Renato/0000-0002-4440-1848; Malekzadeh, Reza/0000-0003-1043-3814; Piantelli, Mauro/0000-0003-0154-482X; Moschetta, Antonio/0000-0003-2123-6074; Bishehsari, Faraz/0000-0001-5644-2586	Associazione Italiana per la Ricerca sul Cancro [IG 9168]; Italian Ministry for Scientific Research	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for Scientific Research(Ministry of Education, Universities and Research (MIUR))	Associazione Italiana per la Ricerca sul Cancro (http://www.airc.it/), IG 9168 (2009); Italian Ministry for Scientific Research (http://www.istruzione.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bishehsari F, 2006, ANN ONCOL, V17, pVII91, DOI 10.1093/annonc/mdl959; Bommer GT, 2010, J BIOL CHEM, V285, P1928, DOI 10.1074/jbc.M109.060319; Carraway Coralie A Carothers, 2007, Sci STKE, V2007, pre3, DOI 10.1126/stke.3812007re3; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chang Q, 2002, CANCER RES, V62, P6035; CHANTRET I, 1988, CANCER RES, V48, P1936; Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Chiang JM, 2010, INT J COLORECTAL DIS, V25, P941, DOI 10.1007/s00384-010-0958-x; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Drakas R, 2004, P NATL ACAD SCI USA, V101, P9272, DOI 10.1073/pnas.0403328101; Durai R, 2005, INT J COLORECTAL DIS, V20, P203, DOI 10.1007/s00384-004-0675-4; Ewton DZ, 2002, INT J CANCER, V98, P665, DOI 10.1002/ijc.10229; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; GUO YS, 1992, GASTROENTEROLOGY, V102, P1101; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; Haydon AMM, 2006, GUT, V55, P689, DOI 10.1136/gut.2005.081547; Howarth GS, 2003, J NUTR, V133, P2109, DOI 10.1093/jn/133.7.2109; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Johnson .T, 2007, ALIMENT PHARM THER, V26, P161, DOI 10.1111/j.1365-2036.2007.03371.x; Kawasaki H, 1998, CANCER RES, V58, P5071; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; MACDONALD RS, 1993, J RECEPTOR RES, V13, P1093, DOI 10.3109/10799899309063266; Mahdavinia M, 2008, J CELL PHYSIOL, V216, P543, DOI 10.1002/jcp.21428; Modica S, 2009, GUT, V58, P1250, DOI 10.1136/gut.2008.158386; Ngo TH, 2002, CANCER CAUSE CONTROL, V13, P929, DOI 10.1023/A:1021911517010; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prisco M, 2002, J BIOL CHEM, V277, P32078, DOI 10.1074/jbc.M204658200; Ramocki NM, 2008, ENDOCRINOLOGY, V149, P261, DOI 10.1210/en.2007-0869; Reinmuth N, 2002, LAB INVEST, V82, P1377, DOI 10.1097/01.LAB.0000032411.41603.C2; REMACLEBONNET M, 1992, INT J CANCER, V52, P910, DOI 10.1002/ijc.2910520614; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Serhan MF, 2010, GEN COMP ENDOCR, V167, P228, DOI 10.1016/j.ygcen.2010.03.010; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Simmons JG, 2007, AM J PHYSIOL-GASTR L, V293, pG995, DOI 10.1152/ajpgi.00537.2006; Tu X, 2003, HORM METAB RES, V35, P734; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu A, 2008, ONCOGENE, V27, P397, DOI 10.1038/sj.onc.1210636; Wu A, 2003, J CELL PHYSIOL, V195, P453, DOI 10.1002/jcp.10261; Yang GY, 2008, CANCER SCI, V99, P879, DOI 10.1111/j.1349-7006.2008.00762.x; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yokoyama S, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-8; Yuan ZQ, 2003, ONCOGENE, V22, P6304, DOI 10.1038/sj.onc.1206609; ZARRILLI R, 1994, CELL GROWTH DIFFER, V5, P1085	63	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36190	10.1371/journal.pone.0036190	http://dx.doi.org/10.1371/journal.pone.0036190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558377	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000149
J	Johnson, AR; Lao, S; Wang, TW; Galanko, JA; Zeisel, SH				Johnson, Amy R.; Lao, Sai; Wang, Tongwen; Galanko, Joseph A.; Zeisel, Steven H.			Choline Dehydrogenase Polymorphism rs12676 Is a Functional Variation and Is Associated with Changes in Human Sperm Cell Function	PLOS ONE			English	Article							RAT-LIVER MITOCHONDRIA; MOUSE SPERM; BETAINE; MOTILITY; ZINC; REPRODUCTION; METABOLISM; STRESS; KINASE; HOMOCYSTEINE	Approximately 15% of couples are affected by infertility and up to half of these cases arise from male factor infertility. Unidentified genetic aberrations such as chromosomal deletions, translocations and single nucleotide polymorphisms (SNPs) may be the underlying cause of many cases of idiopathic male infertility. Deletion of the choline dehydrogenase (Chdh) gene in mice results in decreased male fertility due to diminished sperm motility; sperm from Chdh 2/2 males have decreased ATP concentrations likely stemming from abnormal sperm mitochondrial morphology and function in these cells. Several SNPs have been identified in the human CHDH gene that may result in altered CHDH enzymatic activity. rs12676 (G233T), a non-synonymous SNP located in the CHDH coding region, is associated with increased susceptibility to dietary choline deficiency and risk of breast cancer. We now report evidence that this SNP is also associated with altered sperm motility patterns and dysmorphic mitochondrial structure in sperm. Sperm produced by men who are GT or TT for rs12676 have 40% and 73% lower ATP concentrations, respectively, in their sperm. rs12676 is associated with decreased CHDH protein in sperm and hepatocytes. A second SNP located in the coding region of IL17BR, rs1025689, is linked to altered sperm motility characteristics and changes in choline metabolite concentrations in sperm.	[Johnson, Amy R.; Lao, Sai; Wang, Tongwen; Zeisel, Steven H.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA; [Galanko, Joseph A.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Wang, Tongwen; Zeisel, Steven H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Inst Nutr Res, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Johnson, AR (corresponding author), Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA.	steven_zeisel@unc.edu			National Institutes of Health [DK055865, DK056350]; Balchem Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK055865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Balchem Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was funded by The National Institutes of Health grants DK055865 and DK056350 to SHZ. ARJ is the recipient of the Balchem Corporation Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Barratt CDJaC, SPERM CELL PRODUCTIO; BROWN BW, 1994, REPROD NUTR DEV, V34, P89, DOI 10.1051/rnd:19940201; Chern MK, 2000, BIOCHEM PHARMACOL, V60, P1629, DOI 10.1016/S0006-2952(00)00469-X; Cooper TG, 2003, MICROSC RES TECHNIQ, V61, P28, DOI 10.1002/jemt.10314; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; Danshina PV, 2009, BIOL REPROD; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; DERIDDER JJ, 1973, BIOCHIM BIOPHYS ACTA, V291, P557, DOI 10.1016/0005-2736(73)90507-5; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; ELIASSON R, 1971, LIFE SCI, V10, P1317, DOI 10.1016/0024-3205(71)90331-6; FAVIER AE, 1992, BIOL TRACE ELEM RES, V32, P363, DOI 10.1007/BF02784623; Ferlin A, 2007, REPROD BIOMED ONLINE, V14, P734, DOI 10.1016/S1472-6483(10)60677-3; Foresta C, 2002, BIOL REPROD, V67, P967, DOI 10.1095/biolreprod.102.003822; FRASER LR, 1977, J EXP ZOOL, V202, P439, DOI 10.1002/jez.1402020314; GARCIAPEREZ A, 1991, J MEMBRANE BIOL, V119, P1, DOI 10.1007/BF01868535; Garrido N, 2004, ASIAN J ANDROL, V6, P59; GEER BW, 1967, BIOL BULL-US, V133, P548, DOI 10.2307/1539917; Goldberg E, 2009, J ANDROL; HAUBRICH DR, 1981, J NEUROCHEM, V37, P476, DOI 10.1111/j.1471-4159.1981.tb00480.x; Holt WV, 2000, THERIOGENOLOGY, V53, P47, DOI 10.1016/S0093-691X(99)00239-3; HONG CY, 1986, INT J ANDROL, V9, P118, DOI 10.1111/j.1365-2605.1986.tb00874.x; HUACUJA L, 1973, LIFE SCI, V13, P1383, DOI 10.1016/0024-3205(73)90159-8; Huang SB, 2003, BIOCHEM BIOPH RES CO, V309, P344, DOI 10.1016/j.bbrc.2003.08.010; Institute of Medicine National Academy of Sciences USA, 1998, CHOL DIET REF INT FO, P390; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; KOSKINEN E, 1989, J VET MED A, V36, P110, DOI 10.1111/j.1439-0442.1989.tb00710.x; Kvist U, 1980, Acta Physiol Scand Suppl, V486, P1; KVIST U, 1990, INT J ANDROL, V13, P245, DOI 10.1111/j.1365-2605.1990.tb01028.x; LERUDULIER D, 1984, SCIENCE, V224, P1064, DOI 10.1126/science.224.4653.1064; LIN CS, 1986, J PROTEIN CHEM, V5, P193, DOI 10.1007/BF01025488; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Mann PJG, 1937, BIOCHEM J, V31, P869, DOI 10.1042/bj0310869; MCGRADY AV, 1984, ARCH ANDROLOGY, V13, P1; Michel V, 2009, FASEB J, V23, P2749, DOI 10.1096/fj.08-121491; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; NEVO AC, 1970, J THEOR BIOL, V26, P11, DOI 10.1016/S0022-5193(70)80027-3; O'Rand MG, 2009, BIOL REPROD, V80, P279, DOI 10.1095/biolreprod.108.072942; PORTER RK, 1992, J BIOL CHEM, V267, P14637; PORTER RK, 1993, BIOCHIM BIOPHYS ACTA, V1141, P269, DOI 10.1016/0005-2728(93)90052-H; PORTER TJ, 1990, J BIOL CHEM, V265, P414; PRASAD AS, 1995, NUTRITION, V11, P93; SANCHEZPARTIDA LG, 1992, REPROD FERT DEVELOP, V4, P113, DOI 10.1071/RD9920113; SANSTEAD HH, 1967, AM J CLIN NUTR, V20, P422, DOI 10.1093/ajcn/20.5.422; Sikka SC, 1995, J ANDROL, V16, P464; STEEGERSTHEUNISSEN RP, 1995, AM J OBSTET GYNECOL, V172, P1436, DOI 10.1016/0002-9378(95)90474-3; STEVEN FS, 1982, INT J ANDROL, V5, P401, DOI 10.1111/j.1365-2605.1982.tb00270.x; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; SUAREZ SS, 1987, BIOL REPROD, V36, P1191, DOI 10.1095/biolreprod36.5.1191; THAKKAR JK, 1984, BIOL REPROD, V30, P679, DOI 10.1095/biolreprod30.3.679; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; VANPELT AMM, 1991, ENDOCRINOLOGY, V128, P697, DOI 10.1210/endo-128-2-697; Wang Z, 2007, CLIN CANCER RES, V13, P6327, DOI 10.1158/1078-0432.CCR-07-0310; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; Yeung CH, 2000, BIOL REPROD, V63, P612, DOI 10.1095/biolreprod63.2.612; Zeisel SH, 2000, NUTRITION, V16, P669, DOI 10.1016/S0899-9007(00)00349-X; Zeisel SH, 2005, AM J CLIN NUTR, V82, P719, DOI 10.1093/ajcn/82.4.719; Zeisel SH, 2003, J NUTR, V133, P1302	64	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36047	10.1371/journal.pone.0036047	http://dx.doi.org/10.1371/journal.pone.0036047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558321	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000112
J	Kirby, BJ; Jodari, M; Loftus, MS; Gakhar, G; Pratt, ED; Chanel-Vos, C; Gleghorn, JP; Santana, SM; Liu, H; Smith, JP; Navarro, VN; Tagawa, ST; Bander, NH; Nanus, DM; Giannakakou, P				Kirby, Brian J.; Jodari, Mona; Loftus, Matthew S.; Gakhar, Gunjan; Pratt, Erica D.; Chanel-Vos, Chantal; Gleghorn, Jason P.; Santana, Steven M.; Liu, He; Smith, James P.; Navarro, Vicente N.; Tagawa, Scott T.; Bander, Neil H.; Nanus, David M.; Giannakakou, Paraskevi			Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device	PLOS ONE			English	Article							MEMBRANE ANTIGEN-EXPRESSION; DOCETAXEL PLUS PREDNISONE; BREAST-CANCER; CARCINOMA-CELLS; LYMPH-NODE; PHASE-I; RESISTANT; SURVIVAL; MITOXANTRONE; THERAPY	Cancer metastasis accounts for the majority of cancer-related deaths owing to poor response to anticancer therapies. Molecular understanding of metastasis- associated drug resistance remains elusive due to the scarcity of available tumor tissue. Isolation of circulating tumor cells (CTCs) from the peripheral blood of patients has emerged as a valid alternative source of tumor tissue that can be subjected to molecular characterization. However, issues with low purity and sensitivity have impeded adoption to clinical practice. Here we report a novel method to capture and molecularly characterize CTCs isolated from castrate-resistant prostate cancer patients (CRPC) receiving taxane chemotherapy. We have developed a geometrically enhanced differential immunocapture (GEDI) microfluidic device that combines an anti-prostate specific membrane antigen (PSMA) antibody with a 3D geometry that captures CTCs while minimizing nonspecific leukocyte adhesion. Enumeration of GEDI-captured CTCs (defined as intact, nucleated PSMA+/CD45- cells) revealed a median of 54 cells per ml identified in CRPC patients versus 3 in healthy donors. Direct comparison with the commercially available CellSearch (R) revealed a 2-400 fold higher sensitivity achieved with the GEDI device. Confocal microscopy of patient-derived GEDI-captured CTCs identified the TMPRSS2:ERG fusion protein, while sequencing identified specific androgen receptor point mutation (T868A) in blood samples spiked with only 50 PC C4-2 cells. On-chip treatment of patient-derived CTCs with docetaxel and paclitaxel allowed monitoring of drug-target engagement by means of microtubule bundling. CTCs isolated from docetaxel-resistant CRPC patients did not show any evidence of drug activity. These measurements constitute the first functional assays of drug-target engagement in living circulating tumor cells and therefore have the potential to enable longitudinal monitoring of target response and inform the development of new anticancer agents.	[Kirby, Brian J.; Pratt, Erica D.; Gleghorn, Jason P.; Santana, Steven M.; Smith, James P.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Kirby, Brian J.; Pratt, Erica D.; Gleghorn, Jason P.; Santana, Steven M.; Smith, James P.] Cornell Univ, Ithaca, NY USA; [Jodari, Mona; Loftus, Matthew S.; Gakhar, Gunjan; Chanel-Vos, Chantal; Tagawa, Scott T.; Nanus, David M.; Giannakakou, Paraskevi] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY USA; [Jodari, Mona; Loftus, Matthew S.; Gakhar, Gunjan; Chanel-Vos, Chantal; Liu, He; Navarro, Vicente N.; Tagawa, Scott T.; Bander, Neil H.; Nanus, David M.; Giannakakou, Paraskevi] New York Presbyterian Hosp, New York, NY USA; [Liu, He; Navarro, Vicente N.; Bander, Neil H.; Nanus, David M.] Weill Cornell Med Coll, Dept Urol, New York, NY USA	Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Cornell University	Kirby, BJ (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	bk88@cornell.edu; pag2015@med.cornell.edu	Gleghorn, Jason/AAG-3355-2020; Kirby, Brian/D-4139-2012; Pratt, Erica/H-6566-2015	Gleghorn, Jason/0000-0003-1283-2966; Kirby, Brian/0000-0002-7479-9738; Smith, James/0000-0001-7432-126X; Pratt, Erica/0000-0002-5868-6020; Giannakakou, Paraskevi/0000-0001-7378-262X	US National Institutes of Health [R01 CA137020-01, U54 CA143876]; NIH Physical Sciences Oncology Center at Cornell; New York Office of Science, Technology, and Research; Weill Cornell Clinical and Translational Science Center; Creativity Award from the Prostate Cancer Foundation; Genitourinary Oncology Research Fund; NRSA postdoctoral fellowship; National Science Foundation Graduate Research Fellowships; NATIONAL CANCER INSTITUTE [R01CA137020, U54CA143876] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Physical Sciences Oncology Center at Cornell; New York Office of Science, Technology, and Research; Weill Cornell Clinical and Translational Science Center; Creativity Award from the Prostate Cancer Foundation; Genitourinary Oncology Research Fund; NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the US National Institutes of Health (R01 CA137020-01 and U54 CA143876) (PG), the NIH Physical Sciences Oncology Center at Cornell (BK, PG DN), New York Office of Science, Technology, and Research (BK), the Weill Cornell Clinical and Translational Science Center (DN, PG BK) a Creativity Award from the Prostate Cancer Foundation (PG and DN) and support from the Genitourinary Oncology Research Fund (DN). CCV is a recipient of an NRSA postdoctoral fellowship. EP and SS were supported by National Science Foundation Graduate Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar NH, 2012, ADV UROL, V2012, DOI 10.1155/2012/973820; Ananias HJK, 2009, PROSTATE, V69, P1101, DOI 10.1002/pros.20957; Attard G, 2009, J CLIN PATHOL, V62, P373, DOI 10.1136/jcp.2008.061515; Attard G, 2011, CURR OPIN GENET DEV, V21, P50, DOI 10.1016/j.gde.2010.10.010; Bander NH, 2003, SEMIN ONCOL, V30, P667, DOI 10.1016/S0093-7754(03)00358-0; Chang SS, 1999, CANCER RES, V59, P3192; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2010, ANN ONCOL, V21, P1851, DOI 10.1093/annonc/mdq030; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; Danila DC, 2011, CLIN CANCER RES, V17, P3903, DOI 10.1158/1078-0432.CCR-10-2650; Darshan MS, 2011, CANC RES; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; EXTRA JM, 1993, CANCER RES, V53, P1037; Gleghorn JP, 2010, LAB CHIP, V10, P27, DOI 10.1039/b917959c; Gostner JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-45; Gradilone A, 2011, J CELL MOL MED, V15, P1066, DOI 10.1111/j.1582-4934.2011.01285.x; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Haffner MC, 2009, HUM PATHOL, V40, P1754, DOI 10.1016/j.humpath.2009.06.003; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; HOROSZEWICZ JS, 1987, ANTICANCER RES, V7, P927; ISRAELI RS, 1994, CANCER RES, V54, P6306; ISRAELI RS, 1994, CANCER RES, V54, P1807; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Komlodi-Pasztor E, 2011, NAT REV CLIN ONCOL, V8, DOI 10.1038/nrclinonc.2010.228-c2; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; McDaid HM, 2002, CLIN CANCER RES, V8, P2035; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Riethdorf S, 2010, ANN NY ACAD SCI, V1210, P66, DOI 10.1111/j.1749-6632.2010.05779.x; Scher HI, 2011, J CLIN ONCOL, V29, P2191, DOI 10.1200/JCO.2010.32.8815; Scher HI, 2009, LANCET ONCOL, V10, P233, DOI 10.1016/S1470-2045(08)70340-1; Silver DA, 1997, CLIN CANCER RES, V3, P81; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Sweat SD, 1998, UROLOGY, V52, P637, DOI 10.1016/S0090-4295(98)00278-7; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Wicha MS, 2011, J CLIN ONCOL, V29, P1508, DOI 10.1200/JCO.2010.34.0026; Wright GL, 1996, UROLOGY, V48, P326, DOI 10.1016/S0090-4295(96)00184-7; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zieglschmid V, 2005, CRIT REV CL LAB SCI, V42, P155, DOI 10.1080/10408360590913696	54	176	186	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35976	10.1371/journal.pone.0035976	http://dx.doi.org/10.1371/journal.pone.0035976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558290	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000094
J	Schachtele, SJ; Hu, SX; Lokensgard, JR				Schachtele, Scott J.; Hu, Shuxian; Lokensgard, James R.			Modulation of Experimental Herpes Encephalitis-Associated Neurotoxicity through Sulforaphane Treatment	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; SIMPLEX-VIRUS; REACTIVE OXYGEN; MICROGLIAL CELLS; GENE-EXPRESSION; ASTROCYTES; PROTECTS; BRAIN	Reactive oxygen species (ROS) produced by brain-infiltrating macrophages and neutrophils, as well as resident microglia, are pivotal to pathogen clearance during viral brain infection. However, unchecked free radical generation is also responsible for damage to and cytotoxicity of critical host tissue bystander to primary infection. These unwanted effects of excessive ROS are combated by local cellular production of antioxidant enzymes, including heme oxygenase-1 (HO-1) and glutathione peroxidase 1 (Gpx1). In this study, we showed that experimental murine herpes encephalitis triggered robust ROS production, as well as an opposing upregulation of the antioxidants HO-1 and Gpx1. This antioxidant response was insufficient to prevent tissue damage, neurotoxicity, and mortality associated with viral brain infection. Previous studies corroborate our data supporting astrocytes as the major antioxidant producer in brain cell cultures exposed to HSV-1 stimulated microglia. We hypothesized that stimulating opposing antioxidative responses in astrocytes, as well as neurons, would mitigate the effects of ROS-mediated neurotoxicity both in vitro and during viral brain infection in vivo. Here, we demonstrate that the addition of sulforaphane, a potent stimulator of antioxidant responses, enhanced HO-1 and Gpx1 expression in astrocytes through the activation of nuclear factor-E2-related factor 2 (Nrf2). Additionally, sulforaphane treatment was found to be effective in reducing neurotoxicity associated with HSV-stimulated microglial ROS production. Finally, intraperitoneal injections of sulforaphane into mice during active HSV infection reduced neuroinflammation via a decrease in brain-infiltrating leukocytes, macrophage- and neutrophil-produced ROS, and MHCII-positive, activated microglia. These data support a key role for astrocyte-produced antioxidants in modulating oxidative stress and neuronal damage in response to viral infection.	[Schachtele, Scott J.; Hu, Shuxian; Lokensgard, James R.] Univ Minnesota, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Schachtele, SJ (corresponding author), Univ Minnesota, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Box 736 UMHC, Minneapolis, MN 55455 USA.	loken006@umn.edu			National Institute of Mental Health [R01MH-066703]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066703] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by grant R01MH-066703 from the National Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2006, GENE THER, V13, P1645, DOI 10.1038/sj.gt.3302821; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; ARMIEN A, 2009, BRAIN PATHOL; Bergstrom P, 2011, NEUROPHARMACOLOGY, V60, P343, DOI 10.1016/j.neuropharm.2010.09.023; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Chang G, 2010, BIOL PHARM BULL, V33, P1477, DOI 10.1248/bpb.33.1477; Chen G, 2011, J NEUROSCI RES, V89, P515, DOI 10.1002/jnr.22577; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Duffy S, 1998, J NEUROCHEM, V71, P69; FORD AL, 1995, J IMMUNOL, V154, P4309; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Gonenc S, 2000, NEUROSCI LETT, V289, P107, DOI 10.1016/S0304-3940(00)01272-6; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hamo L, 2007, GLIA, V55, P1169, DOI 10.1002/glia.20538; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Hu S, 2010, J NEUROINFLAMM, V8, P123; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Jazwa A, 2011, ANTIOXID REDOX SIGN, V14, P2347, DOI 10.1089/ars.2010.3731; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kavouras JH, 2007, J NEUROVIROL, V13, P416, DOI 10.1080/13550280701460573; Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792; Lima GK, 2010, AM J PATHOL, V177, P2433, DOI 10.2353/ajpath.2010.100121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louboutin JP, 2009, NEUROBIOL DIS, V34, P462, DOI 10.1016/j.nbd.2009.03.003; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Marques CP, 2008, J NEUROVIROL, V14, P229, DOI 10.1080/13550280802093927; Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009; Martin LD, 1997, ENVIRON HEALTH PERSP, V105, P1301, DOI 10.2307/3433551; Milatovic D, 2002, J NEUROVIROL, V8, P295, DOI 10.1080/13550280290100743; Nimura T, 1996, MOL BRAIN RES, V37, P201, DOI 10.1016/0169-328X(95)00315-J; Reddy PV, 2011, NEUROCHEM INT; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Sacktor N, 2004, J NEUROIMMUNOL, V157, P176, DOI 10.1016/j.jneuroim.2004.08.037; Scapagnini G, 2004, ANTIOXID REDOX SIGN, V6, P811, DOI 10.1089/ars.2004.6.811; Schachtele SJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-35; Siebert A, 2009, J NEUROSCI RES, V87, P1659, DOI 10.1002/jnr.21975; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Teng ZP, 2004, NEUROBIOL DIS, V17, P179, DOI 10.1016/j.nbd.2004.07.009; Turchan-Cholewo J, 2009, ANTIOXID REDOX SIGN, V11, P193, DOI [10.1089/ars.2008.2097, 10.1089/ARS.2008.2097]; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wang X, 2012, J NEUROTRAUMA; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	47	43	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36216	10.1371/journal.pone.0036216	http://dx.doi.org/10.1371/journal.pone.0036216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558388	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000159
J	Schwartz, SR; Rees, H; Mehta, S; Venter, WDF; Taha, TE; Black, V				Schwartz, Sheree R.; Rees, Helen; Mehta, Shruti; Venter, Willem Daniel Francois; Taha, Taha E.; Black, Vivian			High Incidence of Unplanned Pregnancy after Antiretroviral Therapy Initiation: Findings from a Prospective Cohort Study in South Africa	PLOS ONE			English	Article							CONTRACEPTIVE USE; HORMONAL CONTRACEPTION; WOMEN; PREVENTION; INTENTIONS; FERTILITY	Background: Increased fertility rates in HIV-infected women receiving antiretroviral therapy (ART) have been attributed to improved immunological function; it is unknown to what extent the rise in pregnancy rates is due to unintended pregnancies. Methods: Non-pregnant women ages 18-35 from four public-sector ART clinics in Johannesburg, South Africa, were enrolled into a prospective cohort and followed from August 2009-March 2011. Fertility intentions, contraception and pregnancy status were measured longitudinally at participants' routine ART clinic visits. Findings: Of the 850 women enrolled, 822 (97%) had at least one follow-up visit and contributed 745.2 person-years (PY) at-risk for incident pregnancy. Overall, 170 pregnancies were detected in 161 women (incidence rate [IR]: 21.6/100 PY [95% confidence interval (CI): 18.5-25.2]). Of the 170 pregnancies, 105 (62%) were unplanned. Unmet need for contraception was 50% higher in women initiating ART in the past year as compared to women on ART> 1 year (prevalence ratio 1.5 [95% CI: 1.1-2.0]); by two years post-ART initiation, nearly one quarter of women had at least one unplanned pregnancy. Cumulative incidence of pregnancy was equally high among recent ART initiators and ART experienced participants: 23.9% [95% CI: 16.4-34.1], 15.9% [12.0-20.8], and 21.0% [16.8-26.1] for women on ART 0-1 yr, >1 yr-2 yrs, and >2 yrs respectively (log-rank, p = 0.54). Eight hormonal contraceptive failures were detected [IR: 4.4 [95% CI: 2.2-8.9], 7/8 among women using injectable methods. Overall 47% (80/170) of pregnancies were not carried to term. Conclusions: Rates of unintended pregnancies among women on ART are high, including women recently initiating ART with lower CD4 counts and higher viral loads. A substantial burden of pregnancy loss was observed. Integration of contraceptive services and counselling into ART care is necessary to reduce maternal and child health risks related to mistimed and unwanted pregnancies. Further research into injectable contraceptive failures on ART is warranted.	[Schwartz, Sheree R.; Rees, Helen; Venter, Willem Daniel Francois; Black, Vivian] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Schwartz, Sheree R.; Mehta, Shruti; Taha, Taha E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Schwartz, SR (corresponding author), Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa.	sschwartz@wrhi.ac.za		Taha, Taha/0000-0001-9814-4894; Venter, Willem/0000-0002-4157-732X; Rees, Helen/0000-0003-1442-6734	United States Centers for Disease Control and Prevention (CDC) public health dissertation [1R36PS001584-01]; Johns Hopkins Bloomberg School of Public Health [1R36PS001584-01]; Johns Hopkins Bloomberg School of Public Health Global Field Experience Fund; PEPFAR (President's Emergency Plan For AIDS Relief); United States Agency for International Development; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [R36PS001584] Funding Source: NIH RePORTER	United States Centers for Disease Control and Prevention (CDC) public health dissertation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Johns Hopkins Bloomberg School of Public Health(Johns Hopkins University); Johns Hopkins Bloomberg School of Public Health Global Field Experience Fund(Johns Hopkins University); PEPFAR (President's Emergency Plan For AIDS Relief); United States Agency for International Development(United States Agency for International Development (USAID)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study received funding from the United States Centers for Disease Control and Prevention (CDC) public health dissertation grant 1R36PS001584-01. SS received support from grant 1R36PS001584-01, the Department of Epidemiology Doctoral Student Fund at the Johns Hopkins Bloomberg School of Public Health, and the Johns Hopkins Bloomberg School of Public Health Global Field Experience Fund. The research was conducted in clinics supported by PEPFAR (President's Emergency Plan For AIDS Relief) and the United States Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cejtin HE, 2006, OBSTET GYNECOL, V108, P1423, DOI 10.1097/01.AOG.0000245442.29969.5c; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Coutsoudis A, 2010, AIDS, V24, P2859, DOI 10.1097/QAD.0b013e32834041b7; Department of Health SA, 2004, NAT ANT TREATM GUID; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; El-Ibiary SY, 2008, EUR J CONTRACEP REPR, V13, P123, DOI 10.1080/13625180701829952; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Kaida A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013868; Kaida A, 2011, AM J PUBLIC HEALTH, V101, P350, DOI 10.2105/AJPH.2009.177469; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Makumbi FE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/519492; Morrison CS, 2007, AIDS, V21, P85, DOI 10.1097/QAD.0b013e3280117c8b; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Ngure K, 2009, AIDS, V23, pS89, DOI 10.1097/01.aids.0000363781.50580.03; Polis CB, 2010, AIDS, V24, P1937, DOI 10.1097/QAD.0b013e32833b3282; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Schwartz SR, 2012, AIDS BEHAV, V16, P69, DOI 10.1007/s10461-011-9981-3; Stringer EM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.031; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Trussell J, 2004, CONTRACEPTIVE TECHNO; UNAIDS, 2010, UNAIDS REP GLOB AIDS; World Health Organization, 2010, PMTCT STRAT VIS 2010; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	29	104	106	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36039	10.1371/journal.pone.0036039	http://dx.doi.org/10.1371/journal.pone.0036039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558319	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000110
J	Sun, Y; Lim, Y; Li, F; Liu, S; Lu, JJ; Haberberger, R; Zhong, JH; Zhou, XF				Sun, Ying; Lim, Yoon; Li, Fang; Liu, Shen; Lu, Jian-Jun; Haberberger, Rainer; Zhong, Jin-Hua; Zhou, Xin-Fu			ProBDNF Collapses Neurite Outgrowth of Primary Neurons by Activating RhoA	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; AXON REGENERATION; NOGO RECEPTOR; PRO-BDNF; SIGNAL-TRANSDUCTION; PERIPHERAL-NERVE; SENSORY NEURONS	Background: Neurons extend their dendrites and axons to build functional neural circuits, which are regulated by both positive and negative signals during development. Brain-derived neurotrophic factor (BDNF) is a positive regulator for neurite outgrowth and neuronal survival but the functions of its precursor (proBDNF) are less characterized. Methodology/Principal Findings: Here we show that proBDNF collapses neurite outgrowth in murine dorsal root ganglion (DRG) neurons and cortical neurons by activating RhoA via the p75 neurotrophin receptor (p75NTR). We demonstrated that the receptor proteins for proBDNF, p75NTR and sortilin, were highly expressed in cultured DRG or cortical neurons. ProBDNF caused a dramatic neurite collapse in a dose-dependent manner and this effect was about 500 fold more potent than myelin-associated glycoprotein. Neutralization of endogenous proBDNF by using antibodies enhanced neurite outgrowth in vitro and in vivo, but this effect was lost in p75NTR(-/-) mice. The neurite outgrowth of cortical neurons from p75NTR deficient (p75NTR(-/-)) mice was insensitive to proBDNF. There was a time-dependent reduction of length and number of filopodia in response to proBDNF which was accompanied with a polarized RhoA activation in growth cones. Moreover, proBDNF treatment of cortical neurons resulted in a time-dependent activation of RhoA but not Cdc42 and the effect was absent in p75NTR(-/-) neurons. Rho kinase (ROCK) and the collapsin response mediator protein-2 (CRMP-2) were also involved in the proBDNF action. Conclusions: proBDNF has an opposing role in neurite outgrowth to that of mature BDNF. Our observations suggest that proBDNF collapses neurites outgrowth and filopodial growth cones by activating RhoA through the p75NTR signaling pathway.	[Sun, Ying; Lim, Yoon; Li, Fang; Liu, Shen] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; [Sun, Ying; Lim, Yoon; Li, Fang; Liu, Shen; Haberberger, Rainer] Flinders Univ S Australia, Ctr Neurosci, Adelaide, SA 5001, Australia; [Haberberger, Rainer] Flinders Univ S Australia, Dept Anat & Histol, Adelaide, SA 5001, Australia; [Lim, Yoon; Liu, Shen; Lu, Jian-Jun; Zhong, Jin-Hua; Zhou, Xin-Fu] Univ S Australia, Sansom Inst, Div Hlth Sci, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	Flinders University South Australia; Flinders University South Australia; Flinders University South Australia; University of South Australia	Sun, Y (corresponding author), Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia.	Xin-Fu.Zhou@unisa.edu.au	zhou, xin-fu/F-4119-2013; zhou, xin-fu/G-6643-2011; Zhou, Xiaofang/C-6169-2013	zhou, xin-fu/0000-0002-8687-0175; Zhou, Xiaofang/0000-0001-6343-1455; Haberberger, Rainer Viktor/0000-0001-8043-3786; Lim, Yoon/0000-0003-1110-1969	National Health and Medical Research Council (NHMRC ) [595937]; Australian Postgraduate Award at Flinders University; Central South University of China	National Health and Medical Research Council (NHMRC ); Australian Postgraduate Award at Flinders University; Central South University of China	This work was supported by National Health and Medical Research Council (NHMRC grants 595937). Ying Sun was supported by an Australian Postgraduate Award at Flinders University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Miao Yang and Fang Li for helpful suggestions. Fang Li was a visiting scholar from Central South University of China.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Bastian I, 2011, HISTOCHEM CELL BIOL, V135, P37, DOI 10.1007/s00418-010-0772-0; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Bentley CA, 2000, J NEUROSCI, V20, P7706; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fan YJ, 2008, EUR J NEUROSCI, V27, P2380, DOI 10.1111/j.1460-9568.2008.06215.x; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; Gallo G, 2000, J NEUROBIOL, V44, P159, DOI 10.1002/1097-4695(200008)44:2<159::AID-NEU6>3.0.CO;2-H; Gehler S, 2004, J NEUROSCI, V24, P4363, DOI 10.1523/JNEUROSCI.0404-04.2004; Grados-Munro EM, 2003, J NEUROSCI RES, V74, P479, DOI 10.1002/jnr.10803; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Lee JK, 2010, J NEUROSCI, V30, P10899, DOI 10.1523/JNEUROSCI.2269-10.2010; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lee JK, 2011, EXP NEUROL; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liu XX, 2009, BIOCHEM BIOPH RES CO, V382, P795, DOI 10.1016/j.bbrc.2009.03.115; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Marler KJM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-30; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; Naska S, 2010, MOL CELL NEUROSCI, V45, P108, DOI 10.1016/j.mcn.2010.05.015; Nguyen N, 2009, NEUROCHEM RES, V34, P942, DOI 10.1007/s11064-008-9848-9; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Song XY, 2009, LIFE SCI, V84, P61, DOI 10.1016/j.lfs.2008.10.013; Song XY, 2004, J NEUROSCI, V24, P542, DOI 10.1523/JNEUROSCI.4281-03.2004; Tang XQ, 2004, J NEUROSCI, V24, P819, DOI 10.1523/JNEUROSCI.1263-03.2004; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tomita K, 2007, GLIA, V55, P1199, DOI 10.1002/glia.20533; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang H, 2006, EUR J NEUROSCI, V24, P2444, DOI 10.1111/j.1460-9568.2006.05138.x; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang YJ, 2010, NEUROTOX RES, V17, P257, DOI 10.1007/s12640-009-9098-x; Wong I, 2010, BRAIN BEHAV IMMUN, V24, P585, DOI 10.1016/j.bbi.2010.01.001; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Woolf CJ, 2002, SCIENCE, V297, P1132, DOI 10.1126/science.1076247; Wu D, 2008, J BIOL CHEM, V283, P416, DOI 10.1074/jbc.M703177200; Wu LLY, 2010, J BIOL CHEM, V285, P5614, DOI 10.1074/jbc.M109.073197; Xu ZQ, 2011, EUR J NEUROSCI, V33, P1376, DOI 10.1111/j.1460-9568.2011.07635.x; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang F, 2009, J CELL BIOL, V185, P727, DOI 10.1083/jcb.200811147; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Zhang G, 2011, J NEUROSCI, V31, P1664, DOI 10.1523/JNEUROSCI.3829-10.2011; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x; Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220	66	80	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35883	10.1371/journal.pone.0035883	http://dx.doi.org/10.1371/journal.pone.0035883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558255	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305336000074
J	Swearingen, MC; Porwollik, S; Desai, PT; McClelland, M; Ahmer, BMM				Swearingen, Matthew C.; Porwollik, Steffen; Desai, Prerak T.; McClelland, Michael; Ahmer, Brian M. M.			Virulence of 32 Salmonella Strains in Mice	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; CAMELS CAMELUS-DROMEDARIUS; REFERENCE COLLECTION; INFECTION; SEROVAR; IDENTIFICATION; COLONIZATION; ABORTUSOVIS; ATTENUATION; PERSISTENCE	Virulence and persistence in the BALB/c mouse gut was tested for 32 strains of Salmonella enterica for which genome sequencing is complete or underway, including 17 serovars within subspecies I (enterica), and two representatives of each of the other five subspecies. Only serovar Paratyphi C strain BAA1715 and serovar Typhimurium strain 14028 were fully virulent in mice. Three divergent atypical Enteritidis strains were not virulent in BALB/c, but two efficiently persisted. Most of the other strains in all six subspecies persisted in the mouse intestinal tract for several weeks in multiple repeat experiments although the frequency and level of persistence varied considerably. Strains with heavily degraded genomes persisted very poorly, if at all. None of the strains tested provided immunity to Typhimurium infection. These data greatly expand on the known significant strain-to-strain variation in mouse virulence and highlight the need for comparative genomic and phenotypic studies.	[Swearingen, Matthew C.; Ahmer, Brian M. M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Porwollik, Steffen; Desai, Prerak T.; McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	University System of Ohio; Ohio State University; University of California System; University of California Irvine	Swearingen, MC (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ahmer.1@osu.edu	Ahmer, Brian M. M./F-2228-2010; Desai, Prerak/ABF-8529-2020	Ahmer, Brian M. M./0000-0002-4267-7322; McClelland, Michael/0000-0003-1788-9347	National Institute of Allergy and Infectious Disease [R01AI075093, R01AI073971, R01AI097116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097116, R01AI073971, R01AI075093] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by award numbers R01AI075093 (MM) and R01AI073971 and R01AI097116 (BMMA) from the National Institute of Allergy and Infectious Disease. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkititrakul Sunpetch, 2005, Southeast Asian J Trop Med Public Health, V36, P1510; ARCHER G. T. L., 1957, JOUR HYG, V55, P513; BARBER C, 1975, ZBL BAKT-INT J MED M, V230, P452; BELTRAN P, 1991, J GEN MICROBIOL, V137, P601, DOI 10.1099/00221287-137-3-601; BESZNYAK I, 1965, ARCH SURG-CHICAGO, V91, P1023; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; COLLINS FM, 1968, J BACTERIOL, V95, P1343, DOI 10.1128/JB.95.4.1343-1349.1968; Crawford RW, 2008, INFECT IMMUN, V76, P5341, DOI 10.1128/IAI.00786-08; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Dima V F, 1989, Arch Roum Pathol Exp Microbiol, V48, P299; Enriquez C, 2001, Rev Environ Health, V16, P117; Estevan M, 2006, VET MICROBIOL, V118, P124, DOI 10.1016/j.vetmic.2006.07.004; FRANKLIN J, 1968, LAB ANIM CARE, V18, P92; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Guibourdenche M, 2009, RES MICROBIOL; HOWARD JG, 1961, NATURE, V191, P87, DOI 10.1038/191087a0; JOSEPH P G, 1984, Southeast Asian Journal of Tropical Medicine and Public Health, V15, P326; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; KULKARNI V. B., 1966, INDIAN J PATHOL BACTERIOL, V9, P272; Lan RT, 2009, INFECT GENET EVOL, V9, P996, DOI 10.1016/j.meegid.2009.04.011; LAVERGNE GM, 1977, LAB ANIM SCI, V27, P806; Lazarus R, 2007, SCAND J INFECT DIS, V39, P257, DOI 10.1080/00365540600818037; LEE JA, 1974, J HYG-CAMBRIDGE, V72, P185, DOI 10.1017/S0022172400023391; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Magnino S, 2009, INT J FOOD MICROBIOL, V134, P163, DOI 10.1016/j.ijfoodmicro.2009.07.001; MARGARD WL, 1963, J BACTERIOL, V85, P1451, DOI 10.1128/JB.85.6.1451-1452.1963; Molla B, 2004, TROP ANIM HEALTH PRO, V36, P451, DOI 10.1023/B:TROP.0000035013.01459.c9; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Monack DM, 2011, CURR OPIN MICROBIOL; MUKKUR TKS, 1991, J MED MICROBIOL, V34, P57, DOI 10.1099/00222615-34-1-57; Nairz M, 2009, CELL MICROBIOL, V11, P1365, DOI 10.1111/j.1462-5822.2009.01337.x; Ogunsanmi A O, 2001, Afr J Med Med Sci, V30, P115; Porta A, 2010, J BACTERIOL, V192, P1999, DOI 10.1128/JB.00990-09; RAY K, 1983, INDIAN J MED RES, V77, P602; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; SHIMI A, 1979, LAB ANIM, V13, P33, DOI 10.1258/002367779781071258; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uzzau S, 2005, INFECT IMMUN, V73, P4302, DOI 10.1128/IAI.73.7.4302-4308.2005; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Warwick C, 2001, J ROY SOC MED, V94, P124, DOI 10.1177/014107680109400306; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; WERNERY U, 1992, BRIT VET J, V148, P445, DOI 10.1016/0007-1935(92)90031-U	45	18	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36043	10.1371/journal.pone.0036043	http://dx.doi.org/10.1371/journal.pone.0036043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558320	Green Published, gold			2022-12-25	WOS:000305336000111
J	Zeng, H; Li, LF; Chen, JX				Zeng, Heng; Li, Lanfang; Chen, Jian-Xiong			Overexpression of Angiopoietin-1 Increases CD133+/c-kit+ Cells and Reduces Myocardial Apoptosis in db/db Mouse Infarcted Hearts	PLOS ONE			English	Article							PROGENITOR CELLS; BONE-MARROW; ISCHEMIA/REPERFUSION INJURY; CD31(+) CELLS; TOPCARE-AMI; ANGIOGENESIS; ACTIVATION; EXPRESSION; APELIN; TISSUE	Hematopoietic progenitor CD133(+)/c-kit(+) cells have been shown to be involved in myocardial healing following myocardial infarction (MI). Previously we demonstrated that angiopoietin-1(Ang-1) is beneficial in the repair of diabetic infarcted hearts. We now investigate whether Ang-1 affects CD133(+)/c-kit(+) cell recruitment to the infarcted myocardium thereby mediating cardiac repair in type II (db/db) diabetic mice. db/db mice were administered either adenovirus Ang-1 (Ad-Ang-1) or Ad-beta-gal systemically immediately after ligation of the left anterior descending coronary artery ( LAD). Overexpression of Ang-1 resulted in a significant increase in CXCR-4/SDF-1 alpha expression and promoted CD133(+)/c-kit(+), CD133(+)/CXCR-4(+) and CD133(+)/SDF-1 alpha(+) cell recruitment into ischemic hearts. Overexpression of Ang-1 led to significant increases in number of CD31(+) and smooth muscle-like cells and VEGF expression in bone marrow ( BM). This was accompanied by significant decreases in cardiac apoptosis and fibrosis and an increase in myocardial capillary density. Ang-1 also upregulated Jagged-1, Notch3 and apelin expression followed by increases in arteriole formation in the infarcted myocardium. Furthermore, overexpression of Ang-1 resulted in a significant improvement of cardiac functional recovery after 14 days of ischemia. Our data strongly suggest that Ang-1 attenuates cardiac apoptosis and promotes cardiac repair by a mechanism involving in promoting CD133(+)/c-kit(+) cells and angiogenesis in diabetic db/db mouse infarcted hearts.	[Zeng, Heng; Li, Lanfang; Chen, Jian-Xiong] Univ Mississippi Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Zeng, H (corresponding author), Univ Mississippi Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	JChen3@umc.edu			United States National Institutes of Health [HL102042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102042] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a grant from the United States National Institutes of Health, HL102042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Chen JX, 2008, ARTERIOSCL THROM VAS, V28, P1606, DOI 10.1161/ATVBAHA.108.169235; Chen JX, 2007, AM J PHYSIOL-HEART C, V292, pH1664, DOI 10.1152/ajpheart.01138.2006; Chen JX, 2008, DIABETES, V57, P3335, DOI 10.2337/db08-0503; Chen JX, 2004, J APPL PHYSIOL, V96, P612, DOI 10.1152/japplphysiol.00728.2003; Dallabrida SM, 2008, FASEB J, V22, P3010, DOI 10.1096/fj.07-100966; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Doi H, 2009, BIOCHEM BIOPH RES CO, V381, P654, DOI 10.1016/j.bbrc.2009.02.116; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Frederick JR, 2010, CIRCULATION, V122, pS107, DOI 10.1161/CIRCULATIONAHA.109.930404; Glass CE, 2010, HEART FAIL REV, V15, P581, DOI 10.1007/s10741-010-9172-8; High FA, 2009, J CLIN INVEST, V119, P1986, DOI 10.1172/JCI38922; Hu CH, 2010, CLIN EXP PHARMACOL P, V37, P551, DOI 10.1111/j.1440-1681.2010.05347.x; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Invernici G, 2008, CYTOTECHNOLOGY, V58, P43, DOI 10.1007/s10616-008-9167-7; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Joussen AM, 2002, AM J PATHOL, V160, P1683, DOI 10.1016/S0002-9440(10)61115-7; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kim SW, 2011, REGEN MED, V6, P335, DOI [10.2217/RME.11.24, 10.2217/rme.11.24]; Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070; Kunduzova O, 2008, FASEB J, V22, P4146, DOI 10.1096/fj.07-104018; Morrow D, 2008, CARDIOVASC RES, V79, P313, DOI 10.1093/cvr/cvn108; Morrow D, 2007, ARTERIOSCL THROM VAS, V27, P1289, DOI 10.1161/ATVBAHA.107.142778; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Quazi R, 2009, CARDIOL REV, V17, P283, DOI 10.1097/CRD.0b013e3181b3fe0d; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Suchting Steven, 2007, Novartis Found Symp, V283, P77; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takahashi K, 2003, MOL THER, V8, P584, DOI 10.1016/S1525-0016(03)00230-2; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tuo QH, 2008, AM J PHYSIOL-HEART C, V294, pH2547, DOI 10.1152/ajpheart.01250.2007; Voo S, 2009, J INTERN MED, V265, P238, DOI 10.1111/j.1365-2796.2008.02011.x; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Zeng XJ, 2009, PEPTIDES, V30, P1144, DOI 10.1016/j.peptides.2009.02.010; Zubair AC, 2010, CYTOTHERAPY, V12, P178, DOI 10.3109/14653240903493409	45	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35905	10.1371/journal.pone.0035905	http://dx.doi.org/10.1371/journal.pone.0035905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558265	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000081
J	Chatani, E; Yagi, H; Naiki, H; Goto, Y				Chatani, Eri; Yagi, Hisashi; Naiki, Hironobu; Goto, Yuji			Polymorphism of beta(2)-Microglobulin Amyloid Fibrils Manifested by Ultrasonication-enhanced Fibril Formation in Trifluoroethanol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORINE-SUBSTITUTED ALCOHOLS; ATOMIC-FORCE MICROSCOPY; SOLID-STATE NMR; NEUTRAL PH; IN-VITRO; TRYPTOPHAN MUTAGENESIS; STRUCTURAL BASIS; DISULFIDE BOND; H/D-EXCHANGE; PROTEIN	The polymorphic property of amyloid structures has been focused on as a molecular basis of the presence and propagation of different phenotypes of amyloid diseases, although little is known about the molecular mechanism for expressing diverse structures from only one protein sequence. Here, we have found that, in combination with an enhancing effect of ultrasonication on nucleation, beta(2)-microglobulin, a protein responsible for dialysis-related amyloidosis, generates distinct fibril conformations in a concentration-dependent manner in the presence of 2,2,2-trifluoroethanol (TFE). Although the newly formed fibrils all exhibited a similar needle-like morphology with an extensive cross-beta core, as suggested by Fourier transform infrared absorption spectra, they differed in thioflavin T intensity, extension kinetics, and tryptophan fluorescence spectra even in the same solvents, representing polymorphic structures. The hydrophobic residues seemed to be more exposed in the fibrils originating at higher concentrations of TFE, as indicated by the increased binding of 1-anilinonaphthalene-8-sulfonic acid, suggesting that the modulation of hydrophobic interactions is critical to the production of polymorphic amyloid structures. Interestingly, the fibrils formed at higher TFE concentrations showed significantly higher stability against guanidium hydrochloride, the perturbation of ionic strength, and, furthermore, pressurization. The cross-beta structure inside the fibrils seems to have been more idealized, resulting in increased stability when nucleation occurred in the presence of the alcohol, indicating that a weaker contribution of hydrophobic interactions is intrinsically more amenable to the formation of a non-defective amyloid structure.	[Chatani, Eri] Kobe Univ, Dept Chem, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Chatani, Eri; Yagi, Hisashi; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Naiki, Hironobu] Univ Fukui, Div Mol Pathol, Dept Pathol Sci, Fac Med Sci, Fukui 9101193, Japan	Kobe University; Osaka University; University of Fukui	Chatani, E (corresponding author), Kobe Univ, Dept Chem, Grad Sch Sci, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	chatani@crystal.kobe-u.ac.jp	Naiki, Hironobu/G-5599-2014		Japanese Ministry of Education, Culture, Sports, Science, and Technology [21370044, 23770188]; Japan Society for the Promotion of Science [22810014]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Japanese Ministry of Education, Culture, Sports, Science, and Technology Scientific Research Grant-in-Aid 21370044 and Young Scientists Grant-in-Aid 23770188 and by Japan Society for the Promotion of Science Research Activity Start-up Grant-in-Aid 22810014.	Andersen CB, 2010, J MOL BIOL, V397, P932, DOI 10.1016/j.jmb.2010.02.012; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hirota N, 1998, J MOL BIOL, V275, P365, DOI 10.1006/jmbi.1997.1468; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Kihara M, 2006, J BIOL CHEM, V281, P31061, DOI 10.1074/jbc.M605358200; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Madine J, 2008, J AM CHEM SOC, V130, P14990, DOI 10.1021/ja802483d; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Narimoto T, 2004, FEBS LETT, V576, P313, DOI 10.1016/j.febslet.2004.09.024; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Ohhashi Y, 2002, J BIOCHEM, V131, P45, DOI 10.1093/oxfordjournals.jbchem.a003076; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Rennella E, 2010, J MOL BIOL, V401, P286, DOI 10.1016/j.jmb.2010.06.016; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Yamaguchi I, 2001, BIOCHEMISTRY-US, V40, P8499, DOI 10.1021/bi0027128; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Yanagi K, 2011, J BIOL CHEM, V286, P23959, DOI 10.1074/jbc.M111.226688	53	36	36	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22827	22837		10.1074/jbc.M111.333310	http://dx.doi.org/10.1074/jbc.M111.333310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22566695	hybrid, Green Published			2022-12-25	WOS:000306495000040
J	Gibbs, KE; Currie, DJ				Gibbs, Katherine E.; Currie, David J.			Protecting Endangered Species: Do the Main Legislative Tools Work?	PLOS ONE			English	Article							CRITICAL HABITAT; ACT; RECOVERY; CONSERVATION; EVOLUTION	It is critical to assess the effectiveness of the tools used to protect endangered species. The main tools enabled under the U. S. Endangered Species Act (ESA) to promote species recovery are funding, recovery plan development and critical habitat designation. Earlier studies sometimes found that statistically significant effects of these tools could be detected, but they have not answered the question of whether the effects were large enough to be biologically meaningful. Here, we ask: how much does the recovery status of ESA-listed species improve with the application of these tools? We used species' staus reports to Congress from 1988 to 2006 to quantify two measures of recovery for 1179 species. We related these to the amount of federal funding, years with a recovery plan, years with critical habitat designation, the amount of peer-reviewed scientific information, and time listed. We found that change in recovery status of listed species was, at best, only very weakly related to any of these tools. Recovery was positively related to the number of years listed, years with a recovery plan, and funding, however, these tools combined explain <13% of the variation in recovery status among species. Earlier studies that reported significant effects of these tools did not focus on effect sizes; however, they are in fact similarly small. One must conclude either that these tools are not very effective in promoting species' recovery, or (as we suspect) that species recovery data are so poor that it is impossible to tell whether the tools are effective or not. It is critically important to assess the effectiveness of tools used to promote species recovery; it is therefore also critically important to obtain population status data that are adequate to that task.	[Gibbs, Katherine E.; Currie, David J.] Univ Ottawa, Ottawa Carleton Inst Biol, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Gibbs, KE (corresponding author), Univ Ottawa, Ottawa Carleton Inst Biol, Ottawa, ON K1N 6N5, Canada.	katiemgibbs@gmail.com		Currie, David J./0000-0002-4906-2363	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by grants from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbitt RJF, 2001, CONSERV BIOL, V15, P1274, DOI 10.1046/j.1523-1739.2001.00430.x; Bean MJ, 2009, ENDANGERED SPECIES A, P369; Boersma PD, 2001, BIOSCIENCE, V51, P643; Ferraro PJ, 2007, J ENVIRON ECON MANAG, V54, P245, DOI 10.1016/j.jeem.2007.01.002; Gosnell H, 2001, NAT RESOUR J, V41, P561; Greenwald DN, 2006, ENDANGERED SPECIES A, P51; Hagen AN, 2006, CONSERV BIOL, V20, P399, DOI 10.1111/j.1523-1739.2006.00320.x; Hoekstra JM, 2002, ECOL APPL, V12, P701, DOI 10.1890/1051-0761(2002)012[0701:ACRFCH]2.0.CO;2; Kerkvliet J, 2007, ECOL ECON, V63, P499, DOI 10.1016/j.ecolecon.2006.12.007; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; McFadden D, 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Miller JK, 2002, BIOSCIENCE, V52, P163, DOI 10.1641/0006-3568(2002)052[0163:TESADA]2.0.CO;2; Mittlbock M, 1999, COMPUT METH PROG BIO, V58, P17, DOI 10.1016/S0169-2607(98)00061-3; *NATURESERVE, 2009, NATURESERVE EXPL ONL; Pullin AS, 2009, BIOL CONSERV, V142, P931, DOI 10.1016/j.biocon.2009.01.010; Rachlinski JJ, 1997, CORNELL LAW REV, V82, P356; SALZMAN J, 1990, HARVARD ENVIRON LAW, V14, P311; Schwartz MW, 2008, ANNU REV ECOL EVOL S, V39, P279, DOI 10.1146/annurev.ecolsys.39.110707.173538; Scott JM, 2005, FRONT ECOL ENVIRON, V3, P383, DOI 10.1890/1540-9295(2005)003[0383:ROISUT]2.0.CO;2; Solomon BD, 1998, ENVIRON MANAGE, V22, P9, DOI 10.1007/s002679900080; Suckling Kieran F., 2006, P75; Taylor MFJ, 2005, BIOSCIENCE, V55, P360, DOI 10.1641/0006-3568(2005)055[0360:TEOTES]2.0.CO;2; TEAR TH, 1995, CONSERV BIOL, V9, P182, DOI 10.1046/j.1523-1739.1995.09010182.x; Thompson Jr. BH, 2006, ENDANGERED SPECIES A, P101; U. S. Department of the Interior, 2003, END SPEC ACT BROK; U. S. Fish and Wildlife Service, 2008, REP C REC THREAT END; U.S. Fish and Wildlife Service, 1990, FED STAT END THREAT; U. S. Fish and Wildlife Service, 2007, CRIT HAB WHAT IS IT; U. S. Fish and Wildlife Service, 1990, REP C REC THREAT END; *US FISH WILDL SER, 2006, THREAT END SPEC SYST; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	31	32	33	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35730	10.1371/journal.pone.0035730	http://dx.doi.org/10.1371/journal.pone.0035730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959US	22567111	gold, Green Published			2022-12-25	WOS:000305341500029
J	Glavan, G; See, RE; Zivin, M				Glavan, Gordana; See, Ronald Eugene; Zivin, Marko			Differential Patterns of Synaptotagmin7 mRNA Expression in Rats with Kainate- and Pilocarpine-Induced Seizures	PLOS ONE			English	Article							STRIATAL DOPAMINE; SUBSTANTIA-NIGRA; GENE-EXPRESSION; NMDA RECEPTORS; EPILEPSY; STIMULATION; GLUTAMATE; NEURONS; BRAIN; VII	Previous studies in rat models of neurodegenerative disorders have shown disregulation of striatal synaptotagmin7 mRNA. Here we explored the expression of synaptotagmin7 mRNA in the brains of rats with seizures triggered by the glutamatergic agonist kainate (10 mg/kg) or by the muscarinic agonist pilocarpine (30 mg/kg) in LiCl (3 mEq/kg) pre-treated (24 h) rats, in a time-course experiment (30 min - 1 day). After kainate-induced seizures, synaptotagmin7 mRNA levels were transiently and uniformly increased throughout the dorsal and ventral striatum (accumbens) at 8 and 12 h, but not at 24 h, followed at 24 h by somewhat variable upregulation within different parts of the cerebral cortex, amigdala and thalamic nuclei, the hippocampus and the lateral septum. By contrast, after LiCl/pilocarpine-induced seizures, there was a more prolonged increase of striatal Synaptotagmin7 mRNA levels (at 8, 12 and 24 h), but only in the ventromedial striatum, while in some other of the aforementioned brain regions there was a decline to below the basal levels. After systemic post-treatment with muscarinic antagonist scopolamine in a dose of 2 mg/kg the seizures were either extinguished or attenuated. In scopolamine post-treated animals with extinguished seizures the striatal synaptotagmin7 mRNA levels (at 12 h after the onset of seizures) were not different from the levels in control animals without seizures, while in rats with attenuated seizures, the upregulation closely resembled kainate seizures-like pattern of striatal upregulation. In the dose of 1 mg/kg, scopolamine did not significantly affect the progression of pilocarpine-induced seizures or pilocarpine seizures-like pattern of striatal upregulation of synaptotagmin7 mRNA. In control experiments, equivalent doses of scopolamine per se did not affect the expression of synaptotagmin7 mRNA. We conclude that here described differential time course and pattern of synaptotagmin7 mRNA expression imply regional differences of pathophysiological brain activation and plasticity in these two models of seizures.	[Glavan, Gordana; Zivin, Marko] Univ Ljubljana, Fac Med, Inst Pathophysiol, Brain Res Lab, Ljubljana, Slovenia; [See, Ronald Eugene] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	University of Ljubljana; Medical University of South Carolina	Glavan, G (corresponding author), Univ Ljubljana, Fac Med, Inst Pathophysiol, Brain Res Lab, Ljubljana, Slovenia.	zivin@mf.uni-lj.si			Ministry of Higher Education, Science and Technology [P3-0171]	Ministry of Higher Education, Science and Technology	This study was supported by a grant from the Ministry of Higher Education, Science and Technology, grant no P3-0171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam AM, 1996, NEUROPHARMACOLOGY, V35, P159, DOI 10.1016/0028-3908(95)00154-9; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BONHAUS DW, 1986, J NEUROSCI, V6, P3024; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; CAVALHEIRO EA, 1986, BRAIN RES, V377, P173, DOI 10.1016/0006-8993(86)91204-7; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; CLIFFORD DB, 1987, NEUROSCIENCE, V23, P953, DOI 10.1016/0306-4522(87)90171-0; Danzer SC, 2010, HIPPOCAMPUS, V20, P113, DOI 10.1002/hipo.20589; DeLapp NW, 1996, LIFE SCI, V59, P565, DOI 10.1016/0024-3205(96)00337-2; Fukuda M, 2006, MOL MECH EXOCYTOSIS, P42; Glavan G, 2005, NEUROSCIENCE, V135, P545, DOI 10.1016/j.neuroscience.2005.05.050; Glavan G, 2009, ANAT REC, V292, P1849, DOI 10.1002/ar.21026; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Keefe KA, 1996, J COMP NEUROL, V367, P165, DOI 10.1002/(SICI)1096-9861(19960401)367:2<165::AID-CNE1>3.0.CO;2-3; Konradi C, 1996, J NEUROSCI, V16, P4231; KUSSKE JA, 1979, EXP NEUROL, V65, P616, DOI 10.1016/0014-4886(79)90048-7; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Lukasiuk K, 2006, PROG BRAIN RES, V158, P223, DOI 10.1016/S0079-6123(06)58011-2; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; Morris TA, 2000, MOL BRAIN RES, V79, P138, DOI 10.1016/S0169-328X(00)00112-1; Pal R, 2007, NEUROSCI LETT, V424, P194, DOI 10.1016/j.neulet.2007.07.033; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Slaght SJ, 2002, EPILEPTIC DISORD, V4, pS9; Smolders I, 1997, J NEUROCHEM, V68, P1942; Smolders I, 1996, J NEUROCHEM, V66, P2373; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Tarazi FI, 1998, SYNAPSE, V30, P227, DOI 10.1002/(SICI)1098-2396(199810)30:2<227::AID-SYN13>3.3.CO;2-F; Tayebati SK, 2004, EXP GERONTOL, V39, P217, DOI 10.1016/j.exger.2003.10.016; TURSKI L, 1986, BRAIN RES, V370, P294, DOI 10.1016/0006-8993(86)90484-1; Wang JQ, 1996, NEUROSCIENCE, V75, P43, DOI 10.1016/0306-4522(96)00277-1; Wirtshafter D, 2004, EUR J PHARMACOL, V488, P85, DOI 10.1016/j.ejphar.2004.02.025; Zagulska-Szymczak S, 2001, NEUROCHEM INT, V38, P485, DOI 10.1016/S0197-0186(00)00101-7; Zivin M, 1996, BRIT J PHARMACOL, V119, P1187, DOI 10.1111/j.1476-5381.1996.tb16021.x	41	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36114	10.1371/journal.pone.0036114	http://dx.doi.org/10.1371/journal.pone.0036114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567130	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500048
J	Kefford, BJ; Hickey, GL; Gasith, A; Ben-David, E; Dunlop, JE; Palmer, CG; Allan, K; Choy, SC; Piscart, C				Kefford, Ben J.; Hickey, Graeme L.; Gasith, Avital; Ben-David, Elad; Dunlop, Jason E.; Palmer, Carolyn G.; Allan, Kaylene; Choy, Satish C.; Piscart, Christophe			Global Scale Variation in the Salinity Sensitivity of Riverine Macroinvertebrates: Eastern Australia, France, Israel and South Africa	PLOS ONE			English	Article							RISK-ASSESSMENT; TOLERANCE; DISTRIBUTIONS; WATER; VICTORIA; SALINIZATION; COMMUNITIES; HATCHLINGS; STREAMS; EGGS	Salinity is a key abiotic property of inland waters; it has a major influence on biotic communities and is affected by many natural and anthropogenic processes. Salinity of inland waters tends to increase with aridity, and biota of inland waters may have evolved greater salt tolerance in more arid regions. Here we compare the sensitivity of stream macroinvertebrate species to salinity from a relatively wet region in France (Lorraine and Brittany) to that in three relatively arid regions eastern Australia (Victoria, Queensland and Tasmania), South Africa (south-east of the Eastern Cape Province) and Israel using the identical experimental method in all locations. The species whose salinity tolerance was tested, were somewhat more salt tolerant in eastern Australia and South Africa than France, with those in Israel being intermediate. However, by far the greatest source of variation in species sensitivity was between taxonomic groups (Order and Class) and not between the regions. We used a Bayesian statistical model to estimate the species sensitivity distributions (SSDs) for salinity in eastern Australia and France adjusting for the assemblages of species in these regions. The assemblage in France was slightly more salinity sensitive than that in eastern Australia. We therefore suggest that regional salinity sensitivity is therefore likely to depend most on the taxonomic composition of respective macroinvertebrate assemblages. On this basis it would be possible to screen rivers globally for risk from salinisation.	[Kefford, Ben J.] Univ Technol Sydney, Sch Environm, Ctr Environm Sustainabil, Broadway, NSW, Australia; [Hickey, Graeme L.] Univ Manchester, NIBHI, Manchester, Lancs, England; [Gasith, Avital; Ben-David, Elad] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Dunlop, Jason E.; Choy, Satish C.] Dept Environm & Resource Management, Brisbane, Qld, Australia; [Palmer, Carolyn G.] Rhodes Univ, Inst Water Res, ZA-6140 Grahamstown, South Africa; [Allan, Kaylene] Univ Tasmania, Dept Zool, Sandy Bay, Tas, Australia; [Piscart, Christophe] Univ Lyon 1, UMR CNRS Ecol Hydrosyst Nat & Anthropises 5023, F-69622 Villeurbanne, France	University of Technology Sydney; University of Manchester; Tel Aviv University; Rhodes University; University of Tasmania; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kefford, BJ (corresponding author), Univ Technol Sydney, Sch Environm, Ctr Environm Sustainabil, Broadway, NSW, Australia.	ben.kefford@rmit.edu.au	Piscart, christophe/AAD-8973-2019	Piscart, christophe/0000-0002-4054-4542; Palmer, Carolyn/0000-0001-7349-1304; Kefford, Ben/0000-0001-6789-4254				Allan K, BIOL EFFECTS SECONDA; Barnett S, 2003, 200326 DWLBC, P37; Bayly IAE, 1973, INLAND WATERS THEIR; Dunlop JE, 2008, ENVIRON POLLUT, V151, P621, DOI 10.1016/j.envpol.2007.03.020; Forbes VE, 2002, HUM ECOL RISK ASSESS, V8, P473, DOI 10.1080/10807030290879781; Gelman A, 1996, BAYESIAN ANAL, V1, P1; Grist EPM, 2006, ENVIRON SCI TECHNOL, V40, P395, DOI 10.1021/es050871e; Hassell KL, 2006, J EXP BIOL, V209, P4024, DOI 10.1242/jeb.02457; Hayashi TI, 2011, ENVIRON SCI POLLUT R, V18, P365, DOI 10.1007/s11356-010-0380-5; Hayashi TI, 2010, HUM ECOL RISK ASSESS, V16, P251, DOI 10.1080/10807031003670279; Hickey GL, 2008, ENVIRON TOXICOL CHEM, V27, P2403, DOI 10.1897/08-079.1; Horrigan N, 2007, MAR FRESHWATER RES, V58, P178, DOI 10.1071/MF05241; Illies J., 1978, LIMNOFAUNA EUROPAEA; Kaushal SS, 2005, P NATL ACAD SCI USA, V102, P13517, DOI 10.1073/pnas.0506414102; Kay WR, 2001, J N AM BENTHOL SOC, V20, P182, DOI 10.2307/1468314; Kefford B, 2007, SALT NUTR SEDIMENT I, P9; Kefford BJ, 2007, MAR FRESHWATER RES, V58, P1019, DOI 10.1071/MF06046; Kefford BJ, 2007, AQUAT ECOL, V41, P335, DOI 10.1007/s10452-006-9066-y; Kefford BJ, 2006, CAN J FISH AQUAT SCI, V63, P1865, DOI 10.1139/F06-080; Kefford BJ, 2011, ENVIRON POLLUT, V159, P302, DOI 10.1016/j.envpol.2010.08.025; Kefford BJ, 2010, ENVIRON TOXICOL CHEM, V29, P2123, DOI 10.1002/etc.256; Kefford BJ, 2006, ENVIRON POLLUT, V141, P409, DOI 10.1016/j.envpol.2005.08.064; Kefford BJ, 2005, HUM ECOL RISK ASSESS, V11, P1025, DOI 10.1080/10807030500257770; Kefford BJ, 2005, MAR FRESHWATER RES, V56, P163, DOI 10.1071/MF04098; Kefford BJ, 2005, ENVIRON POLLUT, V134, P377, DOI 10.1016/j.envpol.2004.09.018; Kefford BJ, 2004, HYDROBIOLOGIA, V517, P179, DOI 10.1023/B:HYDR.0000027346.06304.bc; Kefford BJ, 2004, ENVIRON POLLUT, V129, P355, DOI 10.1016/j.envpol.2003.12.005; Kefford BJ, 2003, MAR FRESHWATER RES, V54, P755, DOI 10.1071/MF02081; McNeil VH, 2007, HYDROL EARTH SYST SC, V11, P1295, DOI 10.5194/hess-11-1295-2007; NIELSEN DL, 2000, ECOLOGICAL EFFECTS D; PECK AJ, 1978, AUST J SOIL RES, V16, P157, DOI 10.1071/SR9780157; Pinder AM, 2005, HYDROBIOLOGIA, V543, P1, DOI 10.1007/s10750-004-5712-3; Piscart C, 2005, HYDROBIOLOGIA, V551, P227, DOI 10.1007/s10750-005-4463-0; Posthuma L., 2001, SPECIES SENSITIVITY; R Development Core Team, 2010, R LANG ENV STAT COMP; Schulz Claus-Juergen, 1998, Limnologica, V28, P367; Statzner B, 2010, FRESHWATER BIOL, V55, P80, DOI 10.1111/j.1365-2427.2009.02369.x; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; WILLIAMS WD, 1991, HYDROBIOLOGIA, V210, P151, DOI 10.1007/BF00014329; WILLIAMS WD, 1987, AMBIO, V16, P180; Wood W.E., 1924, J ROYAL SOC W AUSTR, V10, P35	41	70	70	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35224	10.1371/journal.pone.0035224	http://dx.doi.org/10.1371/journal.pone.0035224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567097	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500015
J	Ritter, DI; Dong, ZQ; Guo, S; Chuang, JH				Ritter, Deborah I.; Dong, Zhiqiang; Guo, Su; Chuang, Jeffrey H.			Transcriptional Enhancers in Protein-Coding Exons of Vertebrate Developmental Genes	PLOS ONE			English	Article							PREDICTIVE CHROMATIN SIGNATURES; REGULATORY ELEMENTS; CONSERVED ELEMENTS; BINDING-SITES; IN-VIVO; C-MYC; SEQUENCE; ZEBRAFISH; IDENTIFICATION; EXPRESSION	Many conserved noncoding sequences function as transcriptional enhancers that regulate gene expression. Here, we report that protein-coding DNA also frequently contains enhancers functioning at the transcriptional level. We tested the enhancer activity of 31 protein-coding exons, which we chose based on strong sequence conservation between zebrafish and human, and occurrence in developmental genes, using a Tol2 transposable GFP reporter assay in zebrafish. For each exon we measured GFP expression in hundreds of embryos in 10 anatomies via a novel system that implements the voice-recognition capabilities of a cellular phone. We find that 24/31 (77%) exons drive GFP expression compared to a minimal promoter control, and 14/24 are anatomy-specific (expression in four anatomies or less). GFP expression driven by these coding enhancers frequently overlaps the anatomies where the host gene is expressed (60%), suggesting self-regulation. Highly conserved coding sequences and highly conserved noncoding sequences do not significantly differ in enhancer activity (coding: 24/31 vs. noncoding: 105/147) or tissue-specificity (coding: 14/24 vs. noncoding: 50/105). Furthermore, coding and noncoding enhancers display similar levels of the enhancer-related histone modification H3K4me1 (coding: 9/24 vs noncoding: 34/81). Meanwhile, coding enhancers are over three times as likely to contain an H3K4me1 mark as other exons of the host gene. Our work suggests that developmental transcriptional enhancers do not discriminate between coding and noncoding DNA and reveals widespread dual functions in protein-coding DNA.	[Ritter, Deborah I.; Chuang, Jeffrey H.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Dong, Zhiqiang; Guo, Su] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Program Biol Sci, San Francisco, CA 94143 USA; [Dong, Zhiqiang; Guo, Su] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Program Human Genet, San Francisco, CA 94143 USA	Boston College; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ritter, DI (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	Su.Guo@ucsf.edu; chuangj@bc.edu		Chuang, Jeffrey/0000-0002-3298-2358	National Institutes of Health [NS042626]; National Science Foundation [EF0850155]; Emerging Frontiers [0850155] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NS042626 (SG) and National Science Foundation EF0850155 (JHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday AW, 2011, DEV BIOL; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Barthel KKB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002184; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Birnbaum RY, 2012, GENOME RES IN PRESS, DOI [10.1101//gr.133546.111, DOI 10.1101//GR.133546.111]; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen HP, 2008, GENOMICS, V92, P292, DOI 10.1016/j.ygeno.2008.07.009; Chen LS, 2011, J BIOL CHEM, V286, P18641, DOI 10.1074/jbc.M111.236471; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Delporte FM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-53; Dong XJ, 2010, NUCLEIC ACIDS RES, V38, P1071, DOI 10.1093/nar/gkp1124; Eagleson GW, 2008, BRAIN RES BULL, V75, P281, DOI 10.1016/j.brainresbull.2007.11.014; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fort A, 2011, BLOOD, V117, P276, DOI 10.1182/blood-2010-07-295410; Fox AK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-186; Friedli M, SYSTEMATIC ENHANCER, DOI [10.1371/journal.pone.0015741, DOI 10.1371/JOURNAL.PONE.0015741]; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Grogan SP, 2008, ARTHRITIS RHEUM-US, V58, P2754, DOI 10.1002/art.23730; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ho PA, 2011, J CLIN ONCOL, V29, P704, DOI 10.1200/JCO.2010.31.9327; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Hufton AL, 2009, GENOME RES, V19, P2036, DOI 10.1101/gr.093237.109; Itzkovitz S, 2007, GENOME RES, V17, P405, DOI 10.1101/gr.5987307; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kikuta Hiroshi, 2009, V546, P69, DOI 10.1007/978-1-60327-977-2_5; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; KIMURA M, 1979, SCI AM, V241, P98, DOI 10.1038/scientificamerican1179-98; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kural D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r133; Lampe X, 2008, NUCLEIC ACIDS RES, V36, P3214, DOI 10.1093/nar/gkn148; Lang G, 2005, IMMUNOLOGY, V114, P25, DOI 10.1111/j.1365-2567.2004.02073.x; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Loots GG, 2008, ADV GENET, V61, P269, DOI 10.1016/S0065-2660(07)00010-7; Macquarrie KL, 2011, TRENDS GENET; Maile T, 2004, SCIENCE, V304, P1010, DOI 10.1126/science.1095001; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; McGrath MF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-254; Muller F, 1999, DEVELOPMENT, V126, P2103; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Navratilova P, 2010, MOL GENET GENOMICS, V283, P171, DOI 10.1007/s00438-009-0503-1; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Oulion S, 2010, MOL BIOL EVOL, V27, P2829, DOI 10.1093/molbev/msq172; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2022, R LANG ENV STAT COMP; REINHARD E, 1994, DEVELOPMENT, V120, P1767; Ritter DI, 2010, MOL BIOL EVOL, V27, P2322, DOI 10.1093/molbev/msq128; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubinstein ND, 2011, MOL BIOL EVOL, V28, P3297, DOI 10.1093/molbev/msr162; Sanges R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r56; Schattner P, 2006, NUCLEIC ACIDS RES, V34, P1700, DOI 10.1093/nar/gkl095; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Suzuki R, 2011, DNA RES, V18, P177, DOI 10.1093/dnares/dsr010; Tang H, 1999, IMMUNITY, V11, P517, DOI 10.1016/S1074-7613(00)80127-2; Tumpel S, 2008, P NATL ACAD SCI USA, V105, P20077, DOI 10.1073/pnas.0806360105; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Winkler C, 2003, DEV GENES EVOL, V213, P541, DOI 10.1007/s00427-003-0360-6; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	90	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35202	10.1371/journal.pone.0035202	http://dx.doi.org/10.1371/journal.pone.0035202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567096	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500014
J	Holiga, S; Moller, HE; Sieger, T; Schroeter, ML; Jech, R; Mueller, K				Holiga, Stefan; Moeller, Harald E.; Sieger, Tomas; Schroeter, Matthias L.; Jech, Robert; Mueller, Karsten			Accounting for Movement Increases Sensitivity in Detecting Brain Activity in Parkinson's Disease	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; FMRI TIME-SERIES; FUNCTIONAL MRI; BASAL GANGLIA; CORTICAL ACTIVATION; INFERENCE; DIAGNOSIS; LEVODOPA; AMPLITUDE; FEATURES	Parkinson's disease (PD) is manifested by motor impairment, which may impede the ability to accurately perform motor tasks during functional magnetic resonance imaging (fMRI). Both temporal and amplitude deviations of movement performance affect the blood oxygenation level-dependent (BOLD) response. We present a general approach for assessing PD patients' movement control employing simultaneously recorded fMRI time series and behavioral data of the patients' kinematics using MR-compatible gloves. Twelve male patients with advanced PD were examined with fMRI at 1.5T during epoch-based visually paced finger tapping. MR-compatible gloves were utilized online to quantify motor outcome in two conditions with or without dopaminergic medication. Modeling of individual-level brain activity included (i) a predictor consisting of a condition-specific, constant-amplitude boxcar function convolved with the canonical hemodynamic response function (HRF) as commonly used in fMRI statistics (standard model), or (ii) a custom-made predictor computed from glove time series convolved with the HRF (kinematic model). Factorial statistics yielded a parametric map for each modeling technique, showing the medication effect on the group level. Patients showed bilateral response to levodopa in putamen and globus pallidus during the motor experiment. Interestingly, kinematic modeling produced significantly higher activation in terms of both the extent and amplitude of activity. Our results appear to account for movement performance in fMRI motor experiments with PD and increase sensitivity in detecting brain response to levodopa. We strongly advocate quantitatively controlling for motor performance to reach more reliable and robust analyses in fMRI with PD patients.	[Holiga, Stefan; Moeller, Harald E.; Schroeter, Matthias L.; Mueller, Karsten] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Sieger, Tomas; Jech, Robert] Charles Univ Prague, Dept Neurol, Prague, Czech Republic; [Sieger, Tomas; Jech, Robert] Charles Univ Prague, Ctr Clin Neurosci, Prague, Czech Republic; [Sieger, Tomas] Czech Tech Univ, Dept Cybernet, CR-16635 Prague, Czech Republic; [Schroeter, Matthias L.] Univ Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Schroeter, Matthias L.] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Schroeter, Matthias L.] FTLD Consortium, Leipzig, Germany	Max Planck Society; Charles University Prague; Charles University Prague; Czech Technical University Prague; Leipzig University; Leipzig University	Holiga, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	holiga@cbs.mpg.de	Jech, Robert/HHY-7342-2022; Möller, Harald/AAB-4679-2019; Moller, Harald E/A-1565-2008; Sieger, Tomas/AAD-9342-2019	Jech, Robert/0000-0002-9732-8947; Möller, Harald/0000-0002-5659-1925; Moller, Harald E/0000-0002-5659-1925; Sieger, Tomas/0000-0003-4960-1934	Czech Science Foundation [309/09/1145]; Czech Ministry of Education [MSM 0021620849]; Czech Technical University in Prague [SGS10/279/OHK3/3T/13]; International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom);  [PRVOUK-P26/LF1/4]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Technical University in Prague; International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom); 	This work was supported by the Czech Science Foundation: grant project 309/09/1145, by the Czech Ministry of Education: research project MSM 0021620849, by the research project PRVOUK-P26/LF1/4 and by the Czech Technical University in Prague: grant project SGS10/279/OHK3/3T/13. Stefan Holiga is supported by a stipend from the International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andrade A, 1999, NEUROIMAGE, V10, P483, DOI 10.1006/nimg.1999.0479; Antonini A, 2009, LANCET NEUROL, V8, P929, DOI 10.1016/S1474-4422(09)70225-X; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brett M., 2002, NEUROIMAGE, V16, P1140, DOI DOI 10.1016/S1053-8119(02)90013-3; Brooks DJ, 2001, J NEURAL TRANSM, V108, P1283, DOI 10.1007/s007020100005; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Casellato C, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-49; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Dagher A, 2007, MOL IMAGING BIOL, V9, P234, DOI 10.1007/s11307-007-0089-0; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; Evans A.C., 1993, NUCL SCI S MED IM C, P1813, DOI DOI 10.1109/NSSMIC.1993.373602; Feigin A, 2001, NEUROLOGY, V57, P2083, DOI 10.1212/WNL.57.11.2083; Foki T, 2010, EXP NEUROL, V225, P416, DOI 10.1016/j.expneurol.2010.07.019; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Helmich RC, 2011, HUM BRAIN MAPP; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holden A, 2006, PARKINSONISM RELAT D, V12, P73, DOI 10.1016/j.parkreldis.2005.11.001; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kraft E, 2009, PARKINSONISM RELAT D, V15, P558, DOI 10.1016/j.parkreldis.2009.02.005; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lewis MM, 2007, NEUROSCIENCE, V147, P224, DOI 10.1016/j.neuroscience.2007.04.006; Little MA, 2010, INT CONF ACOUST SPEE, P4162, DOI 10.1109/ICASSP.2010.5495722; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; Luo WL, 2003, NEUROIMAGE, V19, P1014, DOI 10.1016/S1053-8119(03)00149-6; Lutz K, 2005, NEUROSCI LETT, V373, P61, DOI 10.1016/j.neulet.2004.09.058; MacIntosh BJ, 2004, NEUROIMAGE, V22, P1619, DOI 10.1016/j.neuroimage.2004.03.035; MacIntosh B, 2007, HUM BRAIN MAPP, V28, P835, DOI 10.1002/hbm.20308; Mohamed MA, 2004, AM J ROENTGENOL, V183, P759, DOI 10.2214/ajr.183.3.1830759; Moonen C., 1999, FUNCTIONAL MRI; Moraschi M, 2010, MAGN RESON IMAGING, V28, P1152, DOI 10.1016/j.mri.2010.03.025; Ng B, 2010, HUM BRAIN MAPP, V31, P88, DOI 10.1002/hbm.20847; Parkinson's Disease Foundation (U.S.), 1986, REC DEV PARK DIS; Penny W, 2003, NEUROIMAGE, V19, P727, DOI 10.1016/S1053-8119(03)00071-5; Peters S, 2003, NEUROREPORT, V14, P809, DOI 10.1097/00001756-200305060-00006; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Roweis S, 1999, NEURAL COMPUT, V11, P305, DOI 10.1162/089976699300016674; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Sadato N, 1997, J CEREBR BLOOD F MET, V17, P670; Schaechter JD, 2006, NEUROIMAGE, V31, P1549, DOI 10.1016/j.neuroimage.2006.02.029; Scholz VH, 2000, BRAIN RES, V879, P204, DOI 10.1016/S0006-8993(00)02749-9; Sen S, 2010, NEUROSCIENCE, V166, P712, DOI 10.1016/j.neuroscience.2009.12.036; Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766; Thickbroom GW, 1998, EXP BRAIN RES, V121, P59, DOI 10.1007/s002210050437; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; van Nuenen BFL, 2009, MOVEMENT DISORD, V24, pS703, DOI 10.1002/mds.22635; Van Rootselaar AF, 2007, HUM BRAIN MAPP, V28, P1117, DOI 10.1002/hbm.20336; Waldvogel D, 1999, J CEREBR BLOOD F MET, V19, P1209, DOI 10.1097/00004647-199911000-00004; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	62	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36271	10.1371/journal.pone.0036271	http://dx.doi.org/10.1371/journal.pone.0036271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563486	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340700035
J	Molinas, A; Sicard, G; Jakob, I				Molinas, Adrien; Sicard, Gilles; Jakob, Ingrid			Functional Evidence of Multidrug Resistance Transporters (MDR) in Rodent Olfactory Epithelium	PLOS ONE			English	Article							PRODUCT P-GLYCOPROTEIN; BLOOD-BRAIN-BARRIER; RECEPTOR NEURONS; CYCLIC-NUCLEOTIDES; TUMOR-CELLS; EXPRESSION; LOCALIZATION; PROTEIN; GENE; TISSUES	Background: P-glycoprotein (Pgp) and multidrug resistance-associated protein (MRP1) are membrane transporter proteins which function as efflux pumps at cell membranes and are considered to exert a protective function against the entry of xenobiotics. While evidence for Pgp and MRP transporter activity is reported for olfactory tissue, their possible interaction and participation in the olfactory response has not been investigated. Principal Findings: Functional activity of putative MDR transporters was assessed by means of the fluorometric calcein acetoxymethyl ester (calcein-AM) accumulation assay on acute rat and mouse olfactory tissue slices. Calcein-AM uptake was measured as fluorescence intensity changes in the presence of Pgp or MRP specific inhibitors. Epifluorescence microscopy measured time course analysis in the olfactory epithelium revealed significant inhibitor-dependent calcein uptake in the presence of each of the selected inhibitors. Furthermore, intracellular calcein accumulation in olfactory receptor neurons was also significantly increased in the presence of either one of the Pgp or MRP inhibitors. The presence of Pgp or MRP1 encoding genes in the olfactory mucosa of rat and mouse was confirmed by RT-PCR with appropriate pairs of species-specific primers. Both transporters were expressed in both newborn and adult olfactory mucosa of both species. To assess a possible involvement of MDR transporters in the olfactory response, we examined the electrophysiological response to odorants in the presence of the selected MDR inhibitors by recording electroolfactograms (EOG). In both animal species, MRPs inhibitors induced a marked reduction of the EOG magnitude, while Pgp inhibitors had only a minor or no measurable effect. Conclusions: The findings suggest that both Pgp and MRP transporters are functional in the olfactory mucosa and in olfactory receptor neurons. Pgp and MRPs may be cellular constituents of olfactory receptor neurons and represent potential mechanisms for modulation of the olfactory response.	[Molinas, Adrien; Sicard, Gilles; Jakob, Ingrid] Univ Bourgogne, Equipe Neurophysiol Peripherie Syst Chimiosensori, Ctr Sci Gout & Alimentat, INRA,CNRS UMR 6265, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Molinas, A (corresponding author), Univ Bourgogne, Equipe Neurophysiol Peripherie Syst Chimiosensori, Ctr Sci Gout & Alimentat, INRA,CNRS UMR 6265, Dijon, France.	ingrid.jakob@u-bourgogne.fr			Fondation Edmond Roudnitska (Paris, France)	Fondation Edmond Roudnitska (Paris, France)	AM was supported by a PhD fellowship from the Fondation Edmond Roudnitska (Paris, France). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bakos E, 2007, PFLUG ARCH EUR J PHY, V453, P621, DOI 10.1007/s00424-006-0160-8; BROXTERMAN HJ, 1990, BRIT J CANCER, V62, P85, DOI 10.1038/bjc.1990.234; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Chen S, 2000, J NEUROPHYSIOL, V84, P575, DOI 10.1152/jn.2000.84.1.575; Chen Y, 2000, J CELL BIOL, V148, P863, DOI 10.1083/jcb.148.5.863; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Costa VM, 2009, CHEM RES TOXICOL, V22, P129, DOI 10.1021/tx8002577; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; Dogan AL, 2004, LEUKEMIA RES, V28, P619, DOI 10.1016/j.leukres.2003.10.015; Falcao AS, 2007, NEUROSCIENCE, V144, P878, DOI 10.1016/j.neuroscience.2006.10.026; FELLER N, 1995, BRIT J CANCER, V72, P543, DOI 10.1038/bjc.1995.371; FELLER N, 1995, FEBS LETT, V368, P385, DOI 10.1016/0014-5793(95)00677-2; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; Flens MJ, 1996, AM J PATHOL, V148, P1237; FOXWELL BMJ, 1989, MOL PHARMACOL, V36, P543; Gautam SH, 2007, NEUROSCIENCE, V144, P702, DOI 10.1016/j.neuroscience.2006.10.012; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V208, P345, DOI 10.1006/bbrc.1995.1344; Genter MB, 2010, DRUG METAB DISPOS, V38, P1644, DOI 10.1124/dmd.110.034611; Gollapudi S, 1997, CANCER CHEMOTH PHARM, V40, P150, DOI 10.1007/s002800050640; Graff CL, 2005, PHARM RES-DORDR, V22, P86, DOI 10.1007/s11095-004-9013-3; Hall RA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001672; Hegg CC, 2003, J NEUROSCI, V23, P8291; Heydel JM, 2010, DRUG METAB REV, V42, P74, DOI 10.3109/03602530903208363; Hirrlinger J, 2002, J NEUROCHEM, V82, P716, DOI 10.1046/j.1471-4159.2002.01082.x; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; Jakob I, 1998, AM J PHYSIOL-CELL PH, V274, pC182, DOI 10.1152/ajpcell.1998.274.1.C182; Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kandimalla KK, 2005, PHARM RES-DORDR, V22, P1121, DOI 10.1007/s11095-005-5420-3; Karssen AM, 2004, ANN NY ACAD SCI, V1032, P308, DOI 10.1196/annals.1314.048; Kawai F, 1999, NAT NEUROSCI, V2, P133, DOI 10.1038/5686; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Kudo H, 2010, NEUROSCI LETT, V468, P98, DOI 10.1016/j.neulet.2009.10.073; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Litman T, 2003, J PHARMACOL EXP THER, V307, P846, DOI 10.1124/jpet.103.056960; Manzini I, 2003, J PHYSIOL-LONDON, V546, P375, DOI 10.1113/jphysiol.2002.033175; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; McAleer MA, 1999, J BIOL CHEM, V274, P23541, DOI 10.1074/jbc.274.33.23541; Motulsky H, 2010, INTUITIVE BIOSTATIST, P237; NEF P, 1989, J BIOL CHEM, V264, P6780, DOI 10.1016/S0021-9258(18)83497-4; Rautio J, 2006, DRUG METAB DISPOS, V34, P786, DOI 10.1124/dmd.105.008615; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Reisert J, 2011, J GEN PHYSIOL, V138, P303, DOI 10.1085/jgp.201110645; Rosati A, 2003, DEV GROWTH DIFFER, V45, P377; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; Schiengold M, 2001, MECH AGEING DEV, V122, P255, DOI 10.1016/S0047-6374(00)00223-2; Steinke A, 2008, HISTOCHEM CELL BIOL, V130, P339, DOI 10.1007/s00418-008-0441-8; STROTMANN J, 1991, CELL TISSUE RES, V266, P247, DOI 10.1007/BF00318180; Thiebaud N, 2011, NEUROSCI LETT, V505, P180, DOI 10.1016/j.neulet.2011.10.018; Thiebaud N, 2010, DRUG METAB DISPOS, V38, P1865, DOI 10.1124/dmd.110.035014; THIEBAUT F, 1989, J HISTOCHEM CYTOCHEM, V37, P159, DOI 10.1177/37.2.2463300; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; ThorntonManning JR, 1997, MUTAT RES-FUND MOL M, V380, P43, DOI 10.1016/S0027-5107(97)00126-7; Tsai CE, 2002, BIOL NEONATE, V81, P58, DOI 10.1159/000047185; Volk H, 2005, J HISTOCHEM CYTOCHEM, V53, P517, DOI 10.1369/jhc.4A6451.2005; Volk HA, 2004, NEUROSCIENCE, V123, P751, DOI 10.1016/j.neuroscience.2003.10.012; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Wioland MA, 2000, J HISTOCHEM CYTOCHEM, V48, P1215, DOI 10.1177/002215540004800905; Xie M, 2011, MOL PHARMACOL, V80, P281, DOI 10.1124/mol.111.071134	64	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36167	10.1371/journal.pone.0036167	http://dx.doi.org/10.1371/journal.pone.0036167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563480	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700029
J	Panaampon, J; Ngaosuwankul, N; Suptawiwat, O; Noisumdaeng, P; Sangsiriwut, K; Siridechadilok, B; Lerdsamran, H; Auewarakul, P; Pooruk, P; Puthavathana, P				Panaampon, Jutatip; Ngaosuwankul, Nathamon; Suptawiwat, Ornpreya; Noisumdaeng, Pirom; Sangsiriwut, Kantima; Siridechadilok, Bunpote; Lerdsamran, Hatairat; Auewarakul, Prasert; Pooruk, Phisanu; Puthavathana, Pilaipan			A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors	PLOS ONE			English	Article							N-LINKED GLYCOSYLATION; A-VIRUS; PROVED VIREMIA; INFECTION; VIRULENCE; SYSTEM; NEUTRALIZATION; COLLECTIN; PROTEINS	In this study, the effect of innate serum inhibitors on influenza virus infection was addressed. Seasonal influenza A(H1N1) and A(H3N2), 2009 pandemic A(H1N1) (H1N1pdm) and highly pathogenic avian influenza (HPAI) A(H5N1) viruses were tested with guinea pig sera negative for antibodies against all of these viruses as evaluated by hemagglutination-inhibition and microneutralization assays. In the presence of serum inhibitors, the infection by each virus was inhibited differently as measured by the amount of viral nucleoprotein produced in Madin-Darby canine kidney cells. The serum inhibitors inhibited seasonal influenza A(H3N2) virus the most, while the effect was less in seasonal influenza A(H1N1) and H1N1pdm viruses. The suppression by serum inhibitors could be reduced by heat inactivation or treatment with receptor destroying enzyme. In contrast, all H5N1 strains tested were resistant to serum inhibitors. To determine which structure (hemagglutinin (HA) and/or neuraminidase (NA)) on the virus particles that provided the resistance, reverse genetics (rg) was applied to construct chimeric recombinant viruses from A/Puerto Rico/8/1934(H1N1) (PR8) plasmid vectors. rgPR8-H5 HA and rgPR8-H5 HANA were resistant to serum inhibitors while rgPR8-H5 NA and PR8 A(H1N1) parental viruses were sensitive, suggesting that HA of HPAI H5N1 viruses bestowed viral resistance to serum inhibition. These results suggested that the ability to resist serum inhibition might enable the viremic H5N1 viruses to disseminate to distal end organs. The present study also analyzed for correlation between susceptibility to serum inhibitors and number of glycosylation sites present on the globular heads of HA and NA. H3N2 viruses, the subtype with highest susceptibility to serum inhibitors, harbored the highest number of glycosylation sites on the HA globular head. However, this positive correlation cannot be drawn for the other influenza subtypes.	[Panaampon, Jutatip; Suptawiwat, Ornpreya; Noisumdaeng, Pirom; Lerdsamran, Hatairat; Auewarakul, Prasert; Pooruk, Phisanu; Puthavathana, Pilaipan] Mahidol Univ, Dept Microbiol, Fac Med Siriraj Hosp, Bangkok 10700, Thailand; [Panaampon, Jutatip; Ngaosuwankul, Nathamon; Suptawiwat, Ornpreya; Noisumdaeng, Pirom; Lerdsamran, Hatairat; Auewarakul, Prasert; Puthavathana, Pilaipan] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand; [Ngaosuwankul, Nathamon] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Sangsiriwut, Kantima] Mahidol Univ, Dept Prevent Med, Fac Med Siriraj Hosp, Bangkok 10700, Thailand; [Siridechadilok, Bunpote] Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Panaampon, J (corresponding author), Mahidol Univ, Dept Microbiol, Fac Med Siriraj Hosp, Bangkok 10700, Thailand.	siput@mahidol.ac.th		Auewarakul, Prasert/0000-0002-4745-4291; Kosoltanapiwat, Nathamon/0000-0001-7465-0696	Thailand Research Fund for Senior Research Scholar; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Faculty of Medicine Siriraj Hospital, Mahidol University; Mahidol University	Thailand Research Fund for Senior Research Scholar; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Faculty of Medicine Siriraj Hospital, Mahidol University; Mahidol University	This study was supported by the Thailand Research Fund for Senior Research Scholar, Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative, scholarship for graduate students, Faculty of Medicine Siriraj Hospital, Mahidol University, and Mahidol University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; ANDERS EM, 1994, J GEN VIROL, V75, P615, DOI 10.1099/0022-1317-75-3-615; ANDERS EM, 1990, P NATL ACAD SCI USA, V87, P4485, DOI 10.1073/pnas.87.12.4485; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Blue CE, 2004, VIROLOGY, V319, P176, DOI 10.1016/j.virol.2003.11.029; Cherry Joshua L, 2009, PLoS Curr, V1, pRRN1001; Chutinimitkul S, 2006, EMERG INFECT DIS, V12, P1041, DOI 10.3201/eid1206.060227; COHEN A, 1961, VIROLOGY, V13, P58, DOI 10.1016/0042-6822(61)90032-0; Cwach KT, 2012, INFLUENZA OTHER RESP, V6, P127, DOI 10.1111/j.1750-2659.2011.00283.x; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; Hawkes RA, 1979, DIAGNOSTIC PROCEDURE, P32; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horvath A, 2001, ANTIVIR RES, V52, P43, DOI 10.1016/S0166-3542(01)00158-9; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Kase T, 1999, IMMUNOLOGY, V97, P385; KHAKPOUR M, 1969, BRIT MED J, V4, P208, DOI 10.1136/bmj.4.5677.208; Krizanova O, 1969, Curr Top Microbiol Immunol, V47, P125; Krug RM, 2006, SCIENCE, V311, P1562, DOI 10.1126/science.1125998; Leth-Larsen R, 2003, CLIN IMMUNOL, V108, P29, DOI 10.1016/S1521-6616(03)00042-1; NAFICY K, 1963, NEW ENGL J MED, V269, P964, DOI 10.1056/NEJM196310312691807; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piwpankaew Y, 2010, APMIS, V118, P895, DOI 10.1111/j.1600-0463.2010.02676.x; PRITCHETT TJ, 1989, J BIOL CHEM, V264, P9850; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Reading PC, 2007, ADV EXP MED BIOL, V598, P279; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; Reading PC, 1995, BIOCHEM BIOPH RES CO, V217, P1128, DOI 10.1006/bbrc.1995.2886; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295; Tate MD, 2011, VIROLOGY, V413, P84, DOI 10.1016/j.virol.2011.01.036; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; Tsuruoka H, 1997, Nihon Rinsho, V55, P2714; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; World Health Organization, 2002, WHO MAN AN INFL DIAG	41	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36318	10.1371/journal.pone.0036318	http://dx.doi.org/10.1371/journal.pone.0036318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563489	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700038
J	Chen, YC; Su, YC; Lee, CC; Huang, YS; Hwang, SJ				Chen, Yi-Chun; Su, Yu-Chieh; Lee, Ching-Chih; Huang, Yung-Sung; Hwang, Shang-Jyh			Chronic Kidney Disease Itself Is a Causal Risk Factor for Stroke beyond Traditional Cardiovascular Risk Factors: A Nationwide Cohort Study in Taiwan	PLOS ONE			English	Article							GENERAL JAPANESE POPULATION; GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; ISCHEMIC-STROKE; RENAL-INSUFFICIENCY; NORTHERN-MANHATTAN; PROPENSITY SCORE; YOUNG-ADULTS; CANCER; CKD	Background: Cardiovascular disease (CVD) is a leading cause of mortality and morbidity in patients with chronic kidney disease (CKD). In Taiwan, CVD is dominated by strokes but there is no robust evidence for a causal relationship between CKD and stroke. This study aimed to explore such causal association. Methods: We conducted a nationwide retrospective cohort study based on the Taiwan National Health Insurance Research Database from 2004 to 2007. Each patient identified was individually tracked for a full three years from the index admission to identify those in whom any type of stroke developed. The study cohort consisted of patients hospitalized with a principal diagnosis of CKD and no traditional cardiovascular risk factors at baseline (n = 1393) and an age-matched control cohort of patients hospitalized for appendectomies (n = 1393, a surrogate for the general population). Cox proportional hazard regression and propensity score model were used to compare the three-year stroke-free survival rate of the two cohorts after adjustment for possible confounding factors. Results: There were 256 stroke patients, 156 (11.2%) in the study cohort and 100 (7.2%) in the control cohort. After adjusting for covariates, patients with primary CKD had a 1.94-fold greater risk for stroke (95% CI, 1.45-2.60; p<0.001) based on Cox regression and a 1.68-fold greater risk for stroke (95% CI, 1.25-2.25; p = 0.001) based on propensity score. This was still the case for two cohorts younger than 75 years old and without traditional cardiovascular risk factors. Conclusions: This study of Taiwanese patients indicates that CKD itself is a causal risk factor for stroke beyond the traditional cardiovascular risk factors. Primary CKD patients have higher risk for stroke than the general population and all CKD patients, irrespective of the presence or severity of traditional cardiovascular risk factors, should be made aware of the stroke risk and monitored for stroke prevention.	[Chen, Yi-Chun] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Nephrol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Chen, Yi-Chun; Su, Yu-Chieh; Lee, Ching-Chih; Huang, Yung-Sung] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hwang, Shang-Jyh] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, YC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Nephrol, Chiayi, Taiwan.	df254246@tzuchi.com.tw; solomons1117@yahoo.com.tw	Su, Yu-Chieh/M-7867-2013; Chen, Yi-Chun/GYJ-2065-2022	Su, Yu-Chieh/0000-0002-1771-9017				Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bos MJ, 2007, STROKE, V38, P3127, DOI 10.1161/STROKEAHA.107.489807; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chiu HF, 2011, AM J GASTROENTEROL, V106, P894, DOI 10.1038/ajg.2010.475; Cho AH, 2009, NEUROLOGY, V73, P1645, DOI 10.1212/WNL.0b013e3181c1defa; Collins AJ, 2011, AM J KIDNEY DIS, V57, pA8, DOI 10.1053/j.ajkd.2010.10.007; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS27, DOI 10.1053/j.ajkd.2008.07.055; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Daly C, 2007, NEPHROL DIAL TRANSPL, V22, P19, DOI 10.1093/ndt/gfm445; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; Khatri M, 2007, STROKE, V38, P3121, DOI 10.1161/STROKEAHA.107.493593; Kobayashi S, 2004, AM J KIDNEY DIS, V44, P35, DOI 10.1053/j.ajkd.2004.03.026; Koren-Morag N, 2006, NEUROLOGY, V67, P224, DOI 10.1212/01.wnl.0000229099.62706.a3; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Lee CC, 2011, STROKE, V42, P48, DOI 10.1161/STROKEAHA.110.597070; Lee M, 2011, BMJ-BRIT MED J, V341, pc4249; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liao DP, 1997, STROKE, V28, P1908, DOI 10.1161/01.STR.28.10.1908; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Lin HC, 2007, J AFFECT DISORDERS, V100, P49, DOI 10.1016/j.jad.2006.09.016; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; McFadden E, 2009, STROKE, V40, P1070, DOI 10.1161/STROKEAHA.108.533414; Nakayama M, 2007, NEPHROL DIAL TRANSPL, V22, P1910, DOI 10.1093/ndt/gfm051; Nickolas TL, 2008, STROKE, V39, P2876, DOI 10.1161/STROKEAHA.107.513713; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sheu JJ, 2010, STROKE, V41, P2033, DOI 10.1161/STROKEAHA.110.588558; Sheu JJ, 2010, STROKE, V41, P961, DOI 10.1161/STROKEAHA.109.577742; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Winkelmayer WC, 2005, AM J KIDNEY DIS, V46, P225, DOI 10.1053/j.ajkd.2005.04.029; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882	43	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36332	10.1371/journal.pone.0036332	http://dx.doi.org/10.1371/journal.pone.0036332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558437	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200066
J	Ishii, S; Karlamangla, AS; Bote, M; Irwin, MR; Jacobs, DR; Cho, HJ; Seeman, TE				Ishii, Shinya; Karlamangla, Arun S.; Bote, Marcos; Irwin, Michael R.; Jacobs, David R., Jr.; Cho, Hyong Jin; Seeman, Teresa E.			Gender, Obesity and Repeated Elevation of C-Reactive Protein: Data from the CARDIA Cohort	PLOS ONE			English	Article							ARTERY RISK DEVELOPMENT; PUBLIC-HEALTH PRACTICE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; YOUNG-ADULTS; SOCIOECONOMIC-STATUS; HORMONE-THERAPY; SEX-DIFFERENCES; MARKERS; INFLAMMATION	C-reactive Protein (CRP) measurements above 10 mg/L have been conventionally treated as acute inflammation and excluded from epidemiologic studies of chronic inflammation. However, recent evidence suggest that such CRP elevations can be seen even with chronic inflammation. The authors assessed 3,300 participants in The Coronary Artery Risk Development in Young Adults study, who had two or more CRP measurements between 1992/3 and 2005/6 to a) investigate characteristics associated with repeated CRP elevation above 10 mg/L; b) identify subgroups at high risk of repeated elevation; and c) investigate the effect of different CRP thresholds on the probability of an elevation being one-time rather than repeated. 225 participants (6.8%) had one-time and 103 (3.1%) had repeated CRP elevation above 10 mg/L. Repeated elevation was associated with obesity, female gender, low income, and sex hormone use. The probability of an elevation above 10 mg/L being one-time rather than repeated was lowest (51%) in women with body mass index above 31 kg/m(2), compared to 82% in others. These findings suggest that CRP elevations above 10 mg/L in obese women are likely to be from chronic rather than acute inflammation, and that CRP thresholds above 10 mg/L may be warranted to distinguish acute from chronic inflammation in obese women.	[Ishii, Shinya] Univ Tokyo, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Karlamangla, Arun S.; Seeman, Teresa E.] Univ Calif Los Angeles, Dept Med, Div Geriatr, Los Angeles, CA 90024 USA; [Bote, Marcos] Univ Murcia, Dept Sociol & Social Policy, Murcia, Spain; [Irwin, Michael R.; Cho, Hyong Jin] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA	University of Tokyo; University of California System; University of California Los Angeles; University of Murcia; University of California System; University of California Los Angeles; University of Minnesota System; University of Minnesota Twin Cities	Ishii, S (corresponding author), Univ Tokyo, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan.	sishii76@gmail.com	Cho, Joshua Hyong-Jin/B-9934-2014; Irwin, Michael R./H-4870-2013; Bote, Marcos/AAB-1950-2019	Cho, Joshua Hyong-Jin/0000-0002-8629-8500; Irwin, Michael R./0000-0002-1502-8431; Bote, Marcos/0000-0002-9178-3105; Jacobs, David/0000-0002-7232-0543	National Institute on Aging of National Institutes of Health [P30 AG028748, 5R01 AG26105-3, P30 AG017265]; VA Greater Los Angeles Healthcare System Geriatric Research, Education and Clinical Center; VA Advanced Geriatrics Fellowship; NATIONAL INSTITUTE ON AGING [R01AG026105, P30AG017265, P30AG028748] Funding Source: NIH RePORTER	National Institute on Aging of National Institutes of Health; VA Greater Los Angeles Healthcare System Geriatric Research, Education and Clinical Center(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); VA Advanced Geriatrics Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant P30 AG028748, 5R01 AG26105-3 to A. K. and P30 AG017265 to T. E. S. from the National Institute on Aging of National Institutes of Health, and VA Greater Los Angeles Healthcare System Geriatric Research, Education and Clinical Center; and VA Advanced Geriatrics Fellowship to S. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2006, BRAIN BEHAV IMMUN, V20, P498, DOI 10.1016/j.bbi.2005.10.003; Bazzano LA, 2003, ANN INTERN MED, V138, P891, DOI 10.7326/0003-4819-138-11-200306030-00010; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Calabro P, 2005, J AM COLL CARDIOL, V46, P1112, DOI 10.1016/j.jacc.2005.06.017; Cartier A, 2009, AM J CLIN NUTR, V89, P1307, DOI 10.3945/ajcn.2008.27030; Chenillot O, 2000, CLIN CHEM LAB MED, V38, P1003, DOI 10.1515/CCLM.2000.149; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Cutter G R, 1991, Control Clin Trials, V12, p1S, DOI 10.1016/0197-2456(91)90002-4; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Goldstein D.S., 1995, STRESS CATECHOLAMINE; Greenfield JR, 2004, CIRCULATION, V109, P3022, DOI 10.1161/01.CIR.0000130640.77501.79; Groblewska M, 2008, CLIN CHEM LAB MED, V46, P1423, DOI 10.1515/CCLM.2008.278; Hamer M, 2010, CLIN CHEM, V56, P132, DOI 10.1373/clinchem.2009.130740; Harrell FE, 2001, REGRESSION MODELING; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Hu PF, 2006, ATHEROSCLEROSIS, V185, P347, DOI 10.1016/j.atherosclerosis.2005.06.011; Izenman A. J., 2008, MODERN MULTIVARIATE; Karlamangla AS, 2005, SOC SCI MED, V60, P999, DOI 10.1016/j.socscimed.2004.06.056; Khera A, 2009, J CLIN ENDOCR METAB, V94, P3251, DOI 10.1210/jc.2008-2406; Lakoski SG, 2005, AM HEART J, V150, P907, DOI 10.1016/j.ahj.2004.11.025; Lloyd-Jones DM, 2007, CIRCULATION, V115, P1004, DOI 10.1161/CIRCULATIONAHA.106.648642; Lukanova A, 2004, EUR J ENDOCRINOL, V150, P161, DOI 10.1530/eje.0.1500161; Macintyre S, 1997, J Health Psychol, V2, P315, DOI 10.1177/135910539700200304; Muir KW, 1999, STROKE, V30, P981, DOI 10.1161/01.STR.30.5.981; Myers GL, 2004, CIRCULATION, V110, pE545, DOI 10.1161/01.CIR.0000148980.87579.5E; Nazmi A, 2008, BRAZ J MED BIOL RES, V41, P357, DOI 10.1590/S0100-879X2008000500003; O'Connor MF, 2009, BRAIN BEHAV IMMUN, V23, P887, DOI 10.1016/j.bbi.2009.04.005; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Ray KK, 2005, J AM COLL CARDIOL, V46, P1417, DOI 10.1016/j.jacc.2005.08.024; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; RODGERS JR, 1993, J HUM RESOUR, V28, P25, DOI 10.2307/146087; Ruhl CE, 2004, AM J CLIN NUTR, V80, P576; SIDNEY S, 1991, AM J EPIDEMIOL, V133, P1231, DOI 10.1093/oxfordjournals.aje.a115835; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131	41	62	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36062	10.1371/journal.pone.0036062	http://dx.doi.org/10.1371/journal.pone.0036062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558327	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340200035
J	Ashek, A; Menzies, RI; Mullins, LJ; Bellamy, COC; Harmar, AJ; Kenyon, CJ; Flatman, PW; Mullins, JJ; Bailey, MA				Ashek, Ali; Menzies, Robert I.; Mullins, Linda J.; Bellamy, Christopher O. C.; Harmar, Anthony J.; Kenyon, Christopher J.; Flatman, Peter W.; Mullins, John J.; Bailey, Matthew A.			Activation of Thiazide-Sensitive Co-Transport by Angiotensin II in the cyp1a1-Ren2 Hypertensive Rat	PLOS ONE			English	Article							NA+-CL-COTRANSPORTER; CYP1A1REN-2 TRANSGENIC RATS; TUBULAR SODIUM-REABSORPTION; BLOOD-PRESSURE; DISTAL TUBULE; RENAL HEMODYNAMICS; CONVERTING-ENZYME; COLLECTING DUCT; DIETARY SALT; ALDOSTERONE	Transgenic rats with inducible expression of the mouse Ren2 gene were used to elucidate mechanisms leading to the development of hypertension and renal injury. Ren2 transgene activation was induced by administration of a naturally occurring aryl hydrocarbon, indole-3-carbinol (100 mg/kg/day by gastric gavage). Blood pressure and renal parameters were recorded in both conscious and anesthetized (butabarbital sodium; 120 mg/kg IP) rats at selected time-points during the development of hypertension. Hypertension was evident by the second day of treatment, being preceded by reduced renal sodium excretion due to activation of the thiazide-sensitive sodium-chloride co-transporter. Renal injury was evident after the first day of transgene induction, being initially limited to the pre-glomerular vasculature. Mircoalbuminuria and tubuloinsterstitial injury developed once hypertension was established. Chronic treatment with either hydrochlorothiazide or an AT1 receptor antagonist normalized sodium reabsorption, significantly blunted hypertension and prevented renal injury. Urinary aldosterone excretion was increased similar to 20 fold, but chronic mineralocorticoid receptor antagonism with spironolactone neither restored natriuretic capacity nor prevented hypertension. Spironolactone nevertheless ameliorated vascular damage and prevented albuminuria. This study finds activation of sodium-chloride co-transport to be a key mechanism in angiotensin II-dependent hypertension. Furthermore, renal vascular injury in this setting reflects both barotrauma and pressure-independent pathways associated with direct detrimental effects of angiotensin II and aldosterone.	[Ashek, Ali; Menzies, Robert I.; Mullins, Linda J.; Harmar, Anthony J.; Kenyon, Christopher J.; Mullins, John J.; Bailey, Matthew A.] Univ Edinburgh, Univ British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Flatman, Peter W.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Bellamy, Christopher O. C.] Edinburgh New Royal Infirm, Dept Pathol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Ashek, A (corresponding author), Univ Edinburgh, Univ British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	matthew.bailey@ed.ac.uk	Bailey, Matthew A./AAH-3395-2020	Bailey, Matthew A./0000-0003-4244-5668; Harmar, Anthony/0000-0002-3838-9264; Mullins, Linda/0000-0002-6743-8707	British Heart Foundation; Wellcome Trust; European Commission; University of Edinburgh; British Heart Foundation Centre of Research Excellence (CoRE)	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); University of Edinburgh; British Heart Foundation Centre of Research Excellence (CoRE)	This work was supported by the British Heart Foundation (www.BHF.org.uk); the Wellcome Trust www.wellcome.ac.uk); and the European Commission FP7: Euratrans (www.euratrans.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gillian Brooker for expert technical assistance. Ali Ashek received a University of Edinburgh PhD Studentship; Robert Menzies holds a 4-year PhD studentship from the British Heart Foundation Centre of Research Excellence (CoRE) Award to The University of Edinburgh.	Al-Dujaili EAS, 2009, STEROIDS, V74, P456, DOI 10.1016/j.steroids.2008.12.012; ANDO K, 1990, AM J PHYSIOL, V259, pR1012, DOI 10.1152/ajpregu.1990.259.5.R1012; Ballew JR, 2001, J HYPERTENS, V19, P1601, DOI 10.1097/00004872-200109000-00012; Beutler KT, 2003, HYPERTENSION, V41, P1143, DOI 10.1161/01.HYP.0000066129.12106.E2; Bidani AK, 2004, HYPERTENSION, V44, P595, DOI 10.1161/01.HYP.0000145180.38707.84; Bidani AK, 2009, HYPERTENSION, V54, P393, DOI 10.1161/HYPERTENSIONAHA.109.133777; Brem AS, 2010, AM J PHYSIOL-RENAL, V298, pF1178, DOI 10.1152/ajprenal.00532.2009; Cherney DZI, 2010, DIABETES CARE, V33, P361, DOI 10.2337/dc09-1303; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Crowley SD, 2011, AM J PHYSIOL-RENAL, V301, pF1124, DOI 10.1152/ajprenal.00305.2011; Csiky B, 1997, AM J PHYSIOL-HEART C, V273, pH1275, DOI 10.1152/ajpheart.1997.273.3.H1275; DEGASPARO M, 1987, J PHARMACOL EXP THER, V240, P650; Ellison DH, 2009, HYPERTENSION, V54, P196, DOI 10.1161/HYPERTENSIONAHA.109.129171; Erbanova M, 2009, J HYPERTENS, V27, P575, DOI 10.1097/HJH.0b013e32831cbd5a; Fink GD, 1997, CLIN EXP PHARMACOL P, V24, P91, DOI 10.1111/j.1440-1681.1997.tb01789.x; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; HALL JE, 1986, AM J PHYSIOL, V250, pR960, DOI 10.1152/ajpregu.1986.250.6.R960; Hannemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017992; HARRIS PJ, 1977, PFLUG ARCH EUR J PHY, V367, P295, DOI 10.1007/BF00581370; Hiranyachattada S, 1996, BRIT J PHARMACOL, V119, P617, DOI 10.1111/j.1476-5381.1996.tb15717.x; Hollenberg NK, 2004, KIDNEY INT, V66, P1, DOI 10.1111/j.1523-1755.2004.00701.x; Honetschlagerova Z, 2011, J PHYSIOL-LONDON, V589, P207, DOI 10.1113/jphysiol.2010.199505; Hu LF, 1998, J HYPERTENS, V16, P1285, DOI 10.1097/00004872-199816090-00010; Huskova Z, 2010, J HYPERTENS, V28, P495, DOI 10.1097/HJH.0b013e3283345d69; KANAGY NL, 1990, AM J PHYSIOL, V259, pR102, DOI 10.1152/ajpregu.1990.259.1.R102; Kantachuvesiri S, 2001, J BIOL CHEM, V276, P36727, DOI 10.1074/jbc.M103296200; Lee DH, 2009, AM J PHYSIOL-RENAL, V296, pF810, DOI 10.1152/ajprenal.90606.2008; Leviel F, 2011, J CLIN INVEST, V121, P1668, DOI 10.1172/JCI57722; Liu XJ, 2009, J BIOL CHEM, V284, P15564, DOI 10.1074/jbc.M806584200; Maitland K, 2006, CIRCULATION, V114, P905, DOI 10.1161/CIRCULATIONAHA.106.622316; McDonough AA, 2010, AM J PHYSIOL-REG I, V298, pR851, DOI 10.1152/ajpregu.00002.2010; Mitchell KD, 2005, AM J PHYSIOL-RENAL, V289, pF1210, DOI 10.1152/ajprenal.00461.2004; Mori T, 2004, HYPERTENSION, V43, P752, DOI 10.1161/01.HYP.0000120971.49659.6a; Nishikawa T, 2005, J STEROID BIOCHEM, V96, P309, DOI 10.1016/j.jsbmb.2005.03.005; Ortiz RM, 2007, AM J PHYSIOL-RENAL, V293, pF1584, DOI 10.1152/ajprenal.00124.2007; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Pallone TL, 2003, AM J PHYSIOL-RENAL, V284, pF253, DOI 10.1152/ajprenal.00304.2002; Patterson ME, 2005, AM J PHYSIOL-RENAL, V289, pF754, DOI 10.1152/ajprenal.00419.2004; Peters B, 2008, J HYPERTENS, V26, P102, DOI 10.1097/HJH.0b013e3282f0ab66; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; Polichnowski AJ, 2009, HYPERTENSION, V54, P1269, DOI 10.1161/HYPERTENSIONAHA.109.139287; Prieto MC, 2011, AM J PHYSIOL-RENAL, V300, pF581, DOI 10.1152/ajprenal.00433.2010; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; RAUCH AL, 1988, J HYPERTENS, V6, P537, DOI 10.1097/00004872-198807000-00004; Rocha R, 2000, ENDOCRINOLOGY, V141, P3871, DOI 10.1210/en.141.10.3871; Sandberg MB, 2006, AM J PHYSIOL-RENAL, V291, pF503, DOI 10.1152/ajprenal.00482.2005; Schluter T, 2010, J HYPERTENS, V28, P2267, DOI 10.1097/HJH.0b013e32833d77b4; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Silva GB, 2008, HYPERTENSION, V52, P1091, DOI 10.1161/HYPERTENSIONAHA.108.120212; Talati G, 2010, BIOCHEM BIOPH RES CO, V393, P844, DOI 10.1016/j.bbrc.2010.02.096; Thomsen K, 1997, NEPHRON, V77, P125, DOI 10.1159/000190264; Vallon V, 2009, AM J PHYSIOL-RENAL, V297, pF704, DOI 10.1152/ajprenal.00030.2009; van der Lubbe N, 2011, KIDNEY INT, V79, P66, DOI 10.1038/ki.2010.290; Velazquez H, 1996, AM J PHYSIOL-RENAL, V270, pF211, DOI 10.1152/ajprenal.1996.270.1.F211; Wang T, 1996, AM J PHYSIOL-RENAL, V271, pF143, DOI 10.1152/ajprenal.1996.271.1.F143; Young JH, 2002, J AM SOC NEPHROL, V13, P2776, DOI 10.1097/01.ASN.0000031805.09178.37; Zhao D, 2009, HYPERTENSION, V54, P120, DOI 10.1161/HYPERTENSIONAHA.109.133785	58	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36311	10.1371/journal.pone.0036311	http://dx.doi.org/10.1371/journal.pone.0036311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558431	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000186
J	Campbell, P; McIntyre, P; Quinn, H; Hueston, L; Gilbert, GL; McVernon, J				Campbell, Patricia; McIntyre, Peter; Quinn, Helen; Hueston, Linda; Gilbert, Gwendolyn L.; McVernon, Jodie			Increased Population Prevalence of Low Pertussis Toxin Antibody Levels in Young Children Preceding a Record Pertussis Epidemic in Australia	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; SEROEPIDEMIOLOGY; INFECTION; VACCINE; IMMUNIZATION; DISEASES; SAMPLE; WALES; AGE	Background: Cross-sectional serosurveys using IgG antibody to pertussis toxin (IgG-PT) are increasingly being used to estimate trends in recent infection independent of reporting biases. Methods/Principal Findings: We compared the age-specific seroprevalence of various levels of IgG-PT in cross-sectional surveys using systematic collections of residual sera from Australian diagnostic laboratories in 1997/8, 2002 and 2007 with reference to both changes in the pertussis vaccine schedule and the epidemic cycle, as measured by disease notifications. A progressive decline in high-level (>= 62.5 EU/ml) IgG-PT prevalence from 19% (95% CI 16-22%) in 1997/98 to 12% (95% CI 11-14%) in 2002 and 5% (95% CI 4-6%) in 2007 was consistent with patterns of pertussis notifications in the year prior to each collection. Concomitantly, the overall prevalence of undetectable (< 5 EU/ml) levels increased from 17% (95% CI 14-20%) in 1997/98 to 38% (95% CI 36-40%) in 2007 but among children aged 1-4 years, from 25% (95% CI 17-34%) in 1997/98 to 62% (95% CI 56-68%) in 2007. This change followed withdrawal of the 18-month booster dose in 2003 and preceded record pertussis notifications from 2008 onwards. Conclusions/Significance: Population seroprevalence of high levels of IgG-PT is accepted as a reliable indicator of pertussis disease activity over time within and between countries with varying diagnostic practices, especially in unimmunised age groups. Our novel findings suggest that increased prevalence of undetectable IgG-PT is an indicator of waning immunity useful for population level monitoring following introduction of acellular vaccines and/or schedule changes.	[Campbell, Patricia; McVernon, Jodie] Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Campbell, Patricia; McVernon, Jodie] Univ Melbourne, Melbourne Sch Populat Hlth, Parkville, Vic 3052, Australia; [McIntyre, Peter; Quinn, Helen] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Sydney, NSW, Australia; [Hueston, Linda; Gilbert, Gwendolyn L.] Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol Publ Hlth, Sydney, NSW, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Sydney; University of Sydney	Campbell, P (corresponding author), Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	pca@student.unimelb.edu.au; j.mcvernon@unimelb.edu.au	McIntyre, Peter/GNM-5277-2022; Gilbert, Gwendolyn/B-7733-2013	McIntyre, Peter/0000-0001-5808-7450; Gilbert, Gwendolyn/0000-0001-7490-6727; Campbell, Patricia/0000-0003-4013-9835; McVernon, Jodie/0000-0001-9774-1961	National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS); National Health and Medical Research Council of Australia Career Development Award; Australian Postgraduate Award	National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS); National Health and Medical Research Council of Australia Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	Serosurveys conducted by the Centre for Infectious Diseases and Microbiology - Public Health (CIDM) are funded by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) as a core surveillance activity. GlaxoSmithKline (GSK) provided antigen for the assay, however, all testing and analysis was conducted at CIDM and NCIRS. JMcV is supported by a National Health and Medical Research Council of Australia Career Development Award. PC is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 1997, Commun Dis Intell, V21, P145; Australian Bureau of Statistics, 2011, AUSTR DEM STAT TABL; Australian Government Department of Health, 2004, AUSTR NAT NOT DIS CA; Australian Government Department of Health and Ageing, 2011, NAT NOT DIS SURV SYS; Cagney M, 2006, EPIDEMIOL INFECT, V134, P1208, DOI 10.1017/S095026880600625X; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; Giammanco A, 2003, VACCINE, V21, P1924, DOI 10.1016/S0264-410X(02)00823-X; Giuliano M, 1998, J PEDIATR-US, V132, P983, DOI 10.1016/S0022-3476(98)70395-6; Guiso Nicole, 2011, Vaccine, V29, P1115, DOI 10.1016/j.vaccine.2010.12.010; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; Hallander HO, 2005, VACCINE, V23, P5359, DOI 10.1016/j.vaccine.2005.06.009; Hueston L, 2007, NSW PUBLIC HLTH B, V18, P67; Hull B, 2009, COMMUN DIS INTELL, V33, P170; Kelly H, 2002, VACCINE, V20, P3130, DOI 10.1016/S0264-410X(02)00255-4; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; McIntyre Peter, 2003, N S W Public Health Bull, V14, P69, DOI 10.1071/NB03022; Nardone A, 2004, VACCINE, V22, P1314, DOI 10.1016/j.vaccine.2003.08.039; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Quinn HE, 2010, EPIDEMIOL INFECT, V138, P426, DOI 10.1017/S0950268809990707; Quinn HE, 2007, COMMUN DIS INTELL, V31, P205; Quinn HE, 2011, B WORLD HEALTH ORGAN, V89, P666, DOI 10.2471/BLT.11.086538; RAMSAY MEB, 1993, EPIDEMIOL INFECT, V111, P41, DOI 10.1017/S095026880005665X; Rendi-Wagner P, 2010, VACCINE, V28, P3285, DOI 10.1016/j.vaccine.2010.02.104; RUSHWORTH RL, 1991, MED J AUSTRALIA, V154, P828, DOI 10.5694/j.1326-5377.1991.tb121376.x; Spokes Paula J, 2010, N S W Public Health Bull, V21, P167, DOI 10.1071/NB10031; Storsaeter J, 2003, VACCINE, V21, P3542, DOI 10.1016/S0264-410X(03)00407-9; Torvaldsen S, 2003, PEDIATR INFECT DIS J, V22, P956, DOI 10.1097/01.inf.0000095198.75170.b6; Wang CQ, 2011, PEDIATR INFECT DIS J, V30, P593, DOI 10.1097/INF.0b013e31820eaf88; World Health Organization, 2010, IMM VACC BIOL PERT	33	62	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35874	10.1371/journal.pone.0035874	http://dx.doi.org/10.1371/journal.pone.0035874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558249	Green Published, gold			2022-12-25	WOS:000305336000071
J	LeSauter, J; Lambert, CM; Robotham, MR; Model, Z; Silver, R; Weaver, DR				LeSauter, Joseph; Lambert, Christopher M.; Robotham, Margaret R.; Model, Zina; Silver, Rae; Weaver, David R.			Antibodies for Assessing Circadian Clock Proteins in the Rodent Suprachiasmatic Nucleus	PLOS ONE			English	Article							CASEIN KINASE 1; STRIA TERMINALIS; GENE-EXPRESSION; MPER2 PROTEIN; PER1 PROTEIN; BED NUCLEUS; RHYTHMS; CELLS; SCN; OSCILLATOR	Research on the mechanisms underlying circadian rhythmicity and the response of brain and body clocks to environmental and physiological challenges requires assessing levels of circadian clock proteins. Too often, however, it is difficult to acquire antibodies that specifically and reliably label these proteins. Many of these antibodies also lack appropriate validation. The goal of this project was to generate and characterize antibodies against several circadian clock proteins. We examined mice and hamsters at peak and trough times of clock protein expression in the suprachiasmatic nucleus (SCN). In addition, we confirmed specificity by testing the antibodies on mice with targeted disruption of the relevant genes. Our results identify antibodies against PER1, PER2, BMAL1 and CLOCK that are useful for assessing circadian clock proteins in the SCN by immunocytochemistry.	[LeSauter, Joseph; Robotham, Margaret R.; Model, Zina; Silver, Rae] Columbia Univ, Barnard Coll, Dept Psychol, New York, NY 10027 USA; [Lambert, Christopher M.; Weaver, David R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA; [Silver, Rae] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Silver, Rae] Columbia Univ Hlth Sci, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; University of Massachusetts System; University of Massachusetts Worcester; Columbia University; Columbia University	LeSauter, J (corresponding author), Columbia Univ, Barnard Coll, Dept Psychol, New York, NY 10027 USA.	David.weaver@umassmed.edu		Weaver, David/0000-0001-7941-6719; LeSauter, Joseph/0000-0002-2963-1901; Silver, Rae/0000-0001-8633-739X	NIH [NS37919, MH075045, NS056125]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037919, R01NS056125] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS37919 and MH075045 to R.S. and NS056125 to D.R.W. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Beaule C, 2011, J BIOL RHYTHM, V26, P561, DOI 10.1177/0748730411416329; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bur IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015316; Carr AJF, 2000, PARTIAL CLONING SYRI; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Foley NC, 2011, EUR J NEUROSCI, V33, P1851, DOI 10.1111/j.1460-9568.2011.07682.x; Hastings M H, 1999, J Neurosci, V19, pRC11; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Jilg A, 2005, EUR J NEUROSCI, V22, P2845, DOI 10.1111/j.1460-9568.2005.04485.x; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Lemos DR, 2007, ENDOCRINOLOGY, V148, P5811, DOI 10.1210/en.2007-0610; LeSauter J, 2003, BRAIN RES, V964, P279, DOI 10.1016/S0006-8993(02)04084-2; Loh DH, 2011, J BIOL RHYTHM, V26, P200, DOI 10.1177/0748730411401740; Maywood ES, 2011, J NEUROSCI, V31, P1539, DOI 10.1523/JNEUROSCI.4107-10.2011; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Munoz M, 2005, J BIOL RHYTHM, V20, P3, DOI 10.1177/0748730404272858; Quintero JE, 2003, J NEUROSCI, V23, P8070; Ramanathan C, 2008, NEUROSCIENCE, V156, P48, DOI 10.1016/j.neuroscience.2008.07.020; Ramanathan C, 2006, BRAIN RES, V1073, P348, DOI 10.1016/j.brainres.2005.11.082; Ramanathan C, 2010, NEUROSCIENCE, V170, P758, DOI 10.1016/j.neuroscience.2010.07.053; Ramanathan C, 2008, NEUROSCI LETT, V441, P86, DOI 10.1016/j.neulet.2008.06.019; Ramanathan C, 2010, NEUROSCI LETT, V473, P220, DOI 10.1016/j.neulet.2010.02.051; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Resuehr HES, 2009, MOL CELL ENDOCRINOL, V311, P120, DOI 10.1016/j.mce.2009.07.005; Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770; Schrader JA, 2010, NEUROSCIENCE, V171, P513, DOI 10.1016/j.neuroscience.2010.08.057; Schrader JA, 2011, J BIOL RHYTHM, V26, P363, DOI 10.1177/0748730411409714; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sheynzon P, 2005, CELL TISSUE RES, V321, P211, DOI 10.1007/s00441-005-1150-4; Tamaru T, 2000, J NEUROSCI, V20, P7525; Tavakoli-Nezhad M, 2007, J BIOL RHYTHM, V22, P81, DOI 10.1177/0748730406296717; Verwey M, 2009, EUR J NEUROSCI, V29, P2217, DOI 10.1111/j.1460-9568.2009.06766.x; von Gall C, 2002, NAT NEUROSCI, V5, P234, DOI 10.1038/nn806; von Gall C, 2003, EUR J NEUROSCI, V18, P125, DOI 10.1046/j.1460-9568.2003.02735.x; Walton KM, 2009, J PHARMACOL EXP THER, V330, P430, DOI 10.1124/jpet.109.151415; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wyse CA, 2010, BRAIN RES, V1337, P21, DOI 10.1016/j.brainres.2010.03.113; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yasuo S, 2008, EUR J NEUROSCI, V28, P2443, DOI 10.1111/j.1460-9568.2008.06541.x	46	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35938	10.1371/journal.pone.0035938	http://dx.doi.org/10.1371/journal.pone.0035938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558277	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000089
J	Lin, MT; Huang, KH; Huang, CL; Huang, YJ; Tsai, GCE; Lane, HY				Lin, Ming-Teng; Huang, Kuo-Hao; Huang, Chieh-Liang; Huang, Yu-Jhen; Tsai, Guochuan E.; Lane, Hsien-Yuan			MET and AKT Genetic Influence on Facial Emotion Perception	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; HEPATOCYTE GROWTH-FACTOR; SCHIZOPHRENIA-PATIENTS; AUTISM; ASSOCIATION; RECOGNITION; AMYGDALA; VARIANT; BRAIN; LOCALIZATION	Background: Facial emotion perception is a major social skill, but its molecular signal pathway remains unclear. The MET/AKT cascade affects neurodevelopment in general populations and face recognition in patients with autism. This study explores the possible role of MET/AKT cascade in facial emotion perception. Methods: One hundred and eighty two unrelated healthy volunteers (82 men and 100 women) were recruited. Four single nucleotide polymorphisms (SNP) of MET (rs2237717, rs41735, rs42336, and rs1858830) and AKT rs1130233 were genotyped and tested for their effects on facial emotion perception. Facial emotion perception was assessed by the face task of Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT). Thorough neurocognitive functions were also assessed. Results: Regarding MET rs2237717, individuals with the CT genotype performed better in facial emotion perception than those with TT (p = 0.016 by ANOVA, 0.018 by general linear regression model [GLM] to control for age, gender, and education duration), and showed no difference with those with CC. Carriers with the most common MET CGA haplotype (frequency = 50.5%) performed better than non-carriers of CGA in facial emotion perception (p = 0.018, df = 1, F = 5.69, p = 0.009 by GLM). In MET rs2237717/AKT rs1130233 interaction, the C carrier/G carrier group showed better facial emotion perception than those with the TT/AA genotype (p = 0.035 by ANOVA, 0.015 by GLM), even when neurocognitive functions were controlled (p = 0.046 by GLM). Conclusions: To our knowledge, this is the first study to suggest that genetic factors can affect performance of facial emotion perception. The findings indicate that MET variances and MET/AKT interaction may affect facial emotion perception, implicating that the MET/AKT cascade plays a significant role in facial emotion perception. Further replication studies are needed.	[Lin, Ming-Teng; Huang, Kuo-Hao; Huang, Yu-Jhen; Lane, Hsien-Yuan] China Med Univ, Inst Clin Med Sci, Taichung, Taiwan; [Lin, Ming-Teng] Zhudong Vet Hosp, Dept Psychiat, Hsinchu, Taiwan; [Huang, Kuo-Hao; Huang, Chieh-Liang; Huang, Yu-Jhen; Lane, Hsien-Yuan] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Tsai, Guochuan E.] Harbor UCLA Med Ctr, Dept Psychiat, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Lin, MT (corresponding author), China Med Univ, Inst Clin Med Sci, Taichung, Taiwan.	hylane@gmail.com			National Science Council, Taiwan [NSC-97-2314-B-039-006-MY3, NSC-98-2627-B-039-001]; National Health Research Institutes, Taiwan [NHRI-EX-100-9904NI]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; China Medical University Hospital, Taiwan [DMR-98-093, DMR-98-095]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence; China Medical University Hospital, Taiwan	This work was funded by the National Science Council, Taiwan (NSC-97-2314-B-039-006-MY3, NSC-98-2627-B-039-001), National Health Research Institutes, Taiwan (NHRI-EX-100-9904NI), Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004), and China Medical University Hospital, Taiwan (DMR-98-093 and DMR-98-095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barbour T, 2010, SCHIZOPHR RES, V123, P126, DOI 10.1016/j.schres.2010.07.023; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Battaglia M, 2007, GENES BRAIN BEHAV, V6, P364, DOI 10.1111/j.1601-183X.2006.00265.x; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Burdick KE, 2010, AM J PSYCHIAT, V167, P436, DOI 10.1176/appi.ajp.2009.09050615; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; Chan RCK, 2010, PSYCHIAT RES, V178, P381, DOI 10.1016/j.psychres.2009.03.035; Chen WJ, 1998, AM J PSYCHIAT, V155, P1214, DOI 10.1176/ajp.155.9.1214; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; Cohen J., 1988, STAT POWER ANAL BEHA; Dawson G, 2005, DEV PSYCHOPATHOL, V17, P679, DOI 10.1017/S0954579405050327; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Eack SM, 2010, SCHIZOPHRENIA BULL, V36, P370, DOI 10.1093/schbul/sbn091; Edwards J, 2001, SCHIZOPHR RES, V48, P235, DOI 10.1016/S0920-9964(00)00099-2; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Fakra E, 2009, ARCH GEN PSYCHIAT, V66, P33, DOI 10.1001/archpsyc.66.1.33; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Heuer L, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.48; Hofer A, 2009, EUR PSYCHIAT, V24, P27, DOI 10.1016/j.eurpsy.2008.06.008; HONDA S, 1995, MOL BRAIN RES, V32, P197, DOI 10.1016/0169-328X(95)00075-4; Hossain MA, 2002, J NEUROCHEM, V81, P365, DOI 10.1046/j.1471-4159.2002.00837.x; Ieraci A, 2002, P NATL ACAD SCI USA, V99, P15200, DOI 10.1073/pnas.222362099; Ihnen GH, 1998, PSYCHIAT RES, V80, P275, DOI 10.1016/S0165-1781(98)00079-1; Iidaka T, 2005, J NEUROSCI, V25, P6460, DOI 10.1523/JNEUROSCI.5261-04.2005; Judson MC, 2011, J NEURODEV DISORD, V3, P282, DOI 10.1007/s11689-011-9081-8; Judson MC, 2009, J COMP NEUROL, V513, P511, DOI 10.1002/cne.21969; Karam CS, 2010, TRENDS PHARMACOL SCI, V31, P381, DOI 10.1016/j.tips.2010.05.004; Kee KS, 2009, SCHIZOPHR RES, V107, P61, DOI 10.1016/j.schres.2008.08.016; Kee KS, 2003, SCHIZOPHRENIA BULL, V29, P487, DOI 10.1093/oxfordjournals.schbul.a007021; Kee KS, 2004, SCHIZOPHR RES, V67, P87, DOI 10.1016/S0920-9964(03)00217-2; Kern RS, 2008, AM J PSYCHIAT, V165, P214, DOI 10.1176/appi.ajp.2007.07010043; Kern RS, 2004, SCHIZOPHR RES, V72, P11, DOI 10.1016/j.schres.2004.09.004; Kvajo M, 2010, CURR TOP BEHAV NEURO, V4, P629, DOI 10.1007/7854_2010_41; Lelli-Chiesa G, 2011, PSYCHOL MED, V41, P779, DOI 10.1017/S0033291710001431; Leppanen JM, 2008, SCHIZOPHR RES, V99, P270, DOI 10.1016/j.schres.2007.11.003; Li HJ, 2010, PROG NEURO-PSYCHOPH, V34, P393, DOI 10.1016/j.pnpbp.2010.01.007; Li HJ, 2010, SCHIZOPHRENIA BULL, V36, P1029, DOI 10.1093/schbul/sbn190; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Liu YL, 2006, PSYCHIAT GENET, V16, P39, DOI 10.1097/01.ypg.0000180681.80546.f3; Lo CH, 2010, BIOL PSYCHOL, V83, P79, DOI 10.1016/j.biopsycho.2009.11.002; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Marder SR, 2004, SCHIZOPHR RES, V72, P5, DOI 10.1016/j.schres.2004.09.010; Mayer JD, MAYER SALOVEY CARUSO; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nicodemus KK, 2010, ARCH GEN PSYCHIAT, V67, P991, DOI 10.1001/archgenpsychiatry.2010.117; Pantazopoulos H, 2010, ARCH GEN PSYCHIAT, V67, P155, DOI 10.1001/archgenpsychiatry.2009.196; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Pinkham Amy E, 2007, Cogn Neuropsychiatry, V12, P198; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Rametti G, 2009, EUR ARCH PSY CLIN N, V259, P203, DOI 10.1007/s00406-008-0852-5; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Schwab SG, 2005, BIOL PSYCHIAT, V58, P446, DOI 10.1016/j.biopsych.2005.05.005; Sousa I, 2009, EUR J HUM GENET, V17, P749, DOI 10.1038/ejhg.2008.215; Sun W, 2002, MOL BRAIN RES, V103, P36, DOI 10.1016/S0169-328X(02)00168-7; Tan HY, 2008, J CLIN INVEST, V118, P2200, DOI [10.1172/JCI3472S, 10.1172/JCI34725]; Thanseem I, 2010, NEUROSCI RES, V68, P137, DOI 10.1016/j.neures.2010.06.014; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Whittaker JF, 2001, PSYCHOL MED, V31, P499, DOI 10.1017/S0033291701003701; Wilhelm O, 2010, J PERS SOC PSYCHOL, V99, P530, DOI 10.1037/a0019972; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Xu MQ, 2007, J CLIN PSYCHIAT, V68, P1358, DOI 10.4088/JCP.v68n0906; Zaja RH, 2008, CURR OPIN PSYCHIATR, V21, P441, DOI 10.1097/YCO.0b013e328305e5fd; Zhou X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027428	73	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36143	10.1371/journal.pone.0036143	http://dx.doi.org/10.1371/journal.pone.0036143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558359	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000137
J	Mancini, E; Castiglione, F; Bernaschi, M; de Luca, A; Sloot, PMA				Mancini, Emiliano; Castiglione, Filippo; Bernaschi, Massimo; de Luca, Andrea; Sloot, Peter M. A.			HIV Reservoirs and Immune Surveillance Evasion Cause the Failure of Structured Treatment Interruptions: A Computational Study	PLOS ONE			English	Article							CELLULAR-AUTOMATA APPROACH; ANTIRETROVIRAL THERAPY; VIRAL LOAD; IN-VIVO; INFECTION; DYNAMICS; HAART; MODEL; OPTIMIZATION; SIMULATION	Continuous antiretroviral therapy is currently the most effective way to treat HIV infection. Unstructured interruptions are quite common due to side effects and toxicity, among others, and cannot be prevented. Several attempts to structure these interruptions failed due to an increased morbidity compared to continuous treatment. The cause of this failure is poorly understood and often attributed to drug resistance. Here we show that structured treatment interruptions would fail regardless of the emergence of drug resistance. Our computational model of the HIV infection dynamics in lymphoid tissue inside lymph nodes, demonstrates that HIV reservoirs and evasion from immune surveillance themselves are sufficient to cause the failure of structured interruptions. We validate our model with data from a clinical trial and show that it is possible to optimize the schedule of interruptions to perform as well as the continuous treatment in the absence of drug resistance. Our methodology enables studying the problem of treatment optimization without having impact on human beings. We anticipate that it is feasible to steer new clinical trials using computational models.	[Mancini, Emiliano; Sloot, Peter M. A.] Univ Amsterdam, Amsterdam, Netherlands; [Castiglione, Filippo; Bernaschi, Massimo] CNR, Inst Comp Applicat Mauro Picone, Rome, Italy; [de Luca, Andrea] Catholic Univ, Inst Clin Infect Dis, Rome, Italy; [de Luca, Andrea] Siena Univ Hosp, Infect Dis Unit, Siena, Italy; [Sloot, Peter M. A.] Natl Res Univ ITMO, St Petersburg, Russia; [Sloot, Peter M. A.] Nanyang Technol Univ, Singapore, Singapore	University of Amsterdam; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Siena; University Hospital of Siena; ITMO University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mancini, E (corresponding author), Univ Amsterdam, Amsterdam, Netherlands.	E.Mancini@uva.nl	Sloot, Peter/B-3078-2014; De Luca, Andrea/G-8810-2011; Mancini, Emiliano/ABC-1704-2020; Castiglione, Filippo/B-1366-2010	Sloot, Peter/0000-0002-3848-5395; De Luca, Andrea/0000-0002-9561-9193; Castiglione, Filippo/0000-0002-1442-3552	European Union under the EC [FP6-2004-IST-4, 028069]	European Union under the EC	Partial support from the European Union under the EC contract FP6-2004-IST-4, No. 028069 (ImmunoGrid) http://igrid-ext.cryst.bbk.ac.uk/immunogrid/site/. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; Ananworanich J, 2006, LANCET, V368, P459, DOI 10.1016/S0140-6736(06)69153-8; Aviran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000883; Bernaschi M, 2001, COMPUT BIOL MED, V31, P303, DOI 10.1016/S0010-4825(01)00011-7; Burkhead E, 2009, B MATH BIOL, V71, P25, DOI 10.1007/s11538-008-9351-0; Castiglione F, 2007, BIOINFORMATICS, V23, P3350, DOI 10.1093/bioinformatics/btm408; Castiglione F, 2005, INT J MOD PHYS C, V16, P1869, DOI 10.1142/S0129183105008394; Castiglione F, 2004, AIDS RES HUM RETROV, V20, P1314, DOI 10.1089/aid.2004.20.1314; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; dos Santos RMZ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168102; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; Dybul M, 2003, 10 C RETR OPP INF; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Ferreira J, 2011, COMPUT METH PROG BIO, V104, P50, DOI 10.1016/j.cmpb.2011.07.011; Garcia F, 2003, AIDS, V17, P43, DOI 10.1097/00002030-200301030-00007; Garcia F, 2001, AIDS, V15, pF29, DOI 10.1097/00002030-200106150-00002; Girard MP, 2012, CURR OPIN HIV AIDS, V7, P4, DOI 10.1097/COH.0b013e32834ddc96; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kranzer K, 2011, TROP MED INT HEALTH, V16, P134; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Kwon HD, 2007, APPL MATH COMPUT, V188, P1193, DOI 10.1016/j.amc.2006.10.071; Lafeuillade A, 2001, J ACQ IMMUN DEF SYND, V28, P197, DOI 10.1097/00126334-200110010-00015; Lambert-Niclot S, 2011, J INFECT DIS, V204, P1211, DOI 10.1093/infdis/jir518; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Mei S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-118; Nowak M. A., 2000, VIRUS DYNAMICS MATH; Paci P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-56; Paci P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-172; Palladini A, 2010, CANCER RES, V70, P7755, DOI 10.1158/0008-5472.CAN-10-0701; PANDEY RB, 1990, J STAT PHYS, V61, P235, DOI 10.1007/BF01013962; Papasavvas E, 2000, J INFECT DIS, V182, P766, DOI 10.1086/315748; Pensierosoa S, 2009, P NATL ACAD SCI USA, V106, P7939, DOI 10.1073/pnas.0901702106; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Ruskin HJ, 2002, PHYSICA A, V311, P213, DOI 10.1016/S0378-4371(02)00832-4; Shi V, 2008, J THEOR BIOL, V253, P24, DOI 10.1016/j.jtbi.2007.11.005; Simon V, 2003, NAT REV MICROBIOL, V1, P181, DOI 10.1038/nrmicro772; Sloot P, 2002, LECT NOTES COMPUT SC, V2493, P282; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; University of Washington, 2011, PARTNERS PREP STUDY; Wu Y, 2012, J MATH BIOL, V64, P495, DOI 10.1007/s00285-011-0422-8	43	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36108	10.1371/journal.pone.0036108	http://dx.doi.org/10.1371/journal.pone.0036108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558348	Green Published, gold			2022-12-25	WOS:000305336000129
J	Malinovschi, A; Janson, C; Hogman, M; Rolla, G; Toren, K; Norback, D; Olin, AC				Malinovschi, Andrei; Janson, Christer; Hogman, Marieann; Rolla, Giovanni; Toren, Kjell; Norback, Dan; Olin, Anna-Carin			Bronchial Responsiveness Is Related to Increased Exhaled NO (FENO) in Non-Smokers and Decreased FENO in Smokers	PLOS ONE			English	Article							NITRIC-OXIDE MEASUREMENTS; RESPIRATORY HEALTH SURVEY; AIRWAY RESPONSIVENESS; METHACHOLINE RESPONSIVENESS; BREATH CONDENSATE; MURINE MODEL; GUINEA-PIGS; ASTHMA; ATOPY; HYPERRESPONSIVENESS	Rationale: Both atopy and smoking are known to be associated with increased bronchial responsiveness. Fraction of nitric (NO) in the exhaled air (FENO), a marker of airways inflammation, is decreased by smoking and increased by atopy. NO has also a physiological bronchodilating and bronchoprotective role. Objectives: To investigate how the relation between FENO and bronchial responsiveness is modulated by atopy and smoking habits. Methods: Exhaled NO measurements and methacholine challenge were performed in 468 subjects from the random sample of three European Community Respiratory Health Survey II centers: Turin (Italy), Gothenburg and Uppsala (both Sweden). Atopy status was defined by using specific IgE measurements while smoking status was questionnaire-assessed. Main Results: Increased bronchial responsiveness was associated with increased FENO levels in non-smokers (p = 0.02) and decreased FENO levels in current smokers (p = 0.03). The negative association between bronchial responsiveness and FENO was seen only in the group smoking less <10 cigarettes/day (p = 0.008). Increased bronchial responsiveness was associated with increased FENO in atopic subjects (p = 0.04) while no significant association was found in non-atopic participants. The reported interaction between FENO and smoking and atopy, respectively were maintained after adjusting for possible confounders (p-values<0.05). Conclusions: The present study highlights the interactions of the relationship between FENO and bronchial responsiveness with smoking and atopy, suggesting different mechanisms behind atopy- and smoking-related increases of bronchial responsiveness.	[Malinovschi, Andrei] Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden; [Janson, Christer; Hogman, Marieann; Norback, Dan] Uppsala Univ, Asthma & Allergy Res Ctr, Uppsala, Sweden; [Janson, Christer; Hogman, Marieann] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; [Hogman, Marieann] Uppsala Univ, Ctr Res & Dev, Cty Council Gavleborg, Uppsala, Sweden; [Rolla, Giovanni] Univ Turin, Dept Allergy & Clin Immunol, Turin, Italy; [Rolla, Giovanni] Mauriziano Hosp, Turin, Italy; [Toren, Kjell; Olin, Anna-Carin] Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden; [Norback, Dan] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Sahlgrenska University Hospital; Uppsala University	Malinovschi, A (corresponding author), Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden.	Andrei.Malinovschi@medsci.uu.se	Olin, Anna-Carin/ABH-2627-2021; Rolla, Giovanni/C-9901-2009	Rolla, Giovanni/0000-0001-5997-7172; Norback, Dan/0000-0002-5174-6668	Swedish Heart Lung Foundation; Swedish Medical Research Council; Swedish Association against Asthma and Allergy; Bror Hjerpstedts Foundation; Agnes and Mac Rudbergs Foundation; Italian Ministry of Education, University and Research (MUIR)	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Association against Asthma and Allergy; Bror Hjerpstedts Foundation; Agnes and Mac Rudbergs Foundation; Italian Ministry of Education, University and Research (MUIR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by: Swedish Heart Lung Foundation; Swedish Medical Research Council; Swedish Association against Asthma and Allergy; Bror Hjerpstedts Foundation; Agnes and Mac Rudbergs Foundation; Italian Ministry of Education, University and Research (MUIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; ASSREUY J, 1993, BRIT J PHARMACOL, V108, P833, DOI 10.1111/j.1476-5381.1993.tb12886.x; Balint B, 2001, THORAX, V56, P456, DOI 10.1136/thorax.56.6.456; Borrill Z, 2006, RESP MED, V100, P1392, DOI 10.1016/j.rmed.2005.11.018; BRUSSELLE G, 1995, AM J RESP CELL MOL, V12, P254, DOI 10.1165/ajrcmb.12.3.7873190; BRYANT DH, 1976, CLIN ALLERGY, V6, P373, DOI 10.1111/j.1365-2222.1976.tb01919.x; Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; Chinn S, 1997, EUR RESPIR J, V10, P2495, DOI 10.1183/09031936.97.10112495; Corradi M, 2001, AM J RESP CRIT CARE, V163, P854, DOI 10.1164/ajrccm.163.4.2001108; Deykin A, 2002, AM J RESP CRIT CARE, V165, P1597, DOI 10.1164/rccm.2201081; DJUKANOVIC R, 1992, EUR RESPIR J, V5, P538; Emms JC, 1997, BRIT J PHARMACOL, V122, P779, DOI 10.1038/sj.bjp.0701440; Franklin PJ, 2004, CHEST, V126, P1540, DOI 10.1378/chest.126.5.1540; Franklin PJ, 2003, THORAX, V58, P1048, DOI 10.1136/thorax.58.12.1048; GERRARD JW, 1980, AM REV RESPIR DIS, V122, P577; Hessel EM, 1998, J IMMUNOL, V160, P2998; Horvath I, 1999, CLIN EXP ALLERGY, V29, P1276; Hoyt JC, 2003, EXP LUNG RES, V29, P17, DOI 10.1080/01902140303759; Janson C, 1997, EUR RESPIR J, V10, P1795, DOI 10.1183/09031936.97.10081795; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Jatakanon A, 1998, THORAX, V53, P91, DOI 10.1136/thx.53.2.91; Jones KL, 1998, AM J PHYSIOL-LUNG C, V275, pL1120, DOI 10.1152/ajplung.1998.275.6.L1120; KHARITONOV SA, 1994, LANCET, V343, P133, DOI 10.1016/S0140-6736(94)90931-8; Laan M, 1999, THORAX, V54, P911, DOI 10.1136/thx.54.10.911; Laberge S, 1997, AM J RESP CELL MOL, V17, P193, DOI 10.1165/ajrcmb.17.2.2750; Laprise C, 1999, EUR RESPIR J, V14, P63, DOI 10.1034/j.1399-3003.1999.14a12.x; Ludviksdottir D, 1999, RESP MED, V93, P552, DOI 10.1016/S0954-6111(99)90154-3; Malinovschi A, 2006, EUR RESPIR J, V28, P339, DOI 10.1183/09031936.06.00113705; Malinovschi A, 2009, ALLERGY, V64, P55, DOI 10.1111/j.1398-9995.2008.01835.x; Malinovschi A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-92; Olin AC, 2006, CHEST, V130, P1319, DOI 10.1378/chest.130.5.1319; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Ricciardolo FLM, 1996, LANCET, V348, P374, DOI 10.1016/S0140-6736(96)04450-9; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; Riess A, 1996, AM J RESP CRIT CARE, V154, P1444, DOI 10.1164/ajrccm.154.5.8912762; Rytila P, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-69; Salome CM, 1999, AM J RESP CRIT CARE, V159, P911, DOI 10.1164/ajrccm.159.3.9802108; Schwartz J, 2002, CHEST, V122, P812, DOI 10.1378/chest.122.3.812; Silvestri M, 1999, EUR RESPIR J, V13, P321, DOI 10.1034/j.1399-3003.1999.13b17.x; Smith AD, 2004, AM J RESP CRIT CARE, V169, P473, DOI 10.1164/rccm.200310-1376OC; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Sunyer J, 1997, THORAX, V52, P235, DOI 10.1136/thx.52.3.235; Suresh V, 2007, AM J RESP CELL MOL, V37, P97, DOI 10.1165/rcmb.2006-0419OC; Taylor DR, 2006, THORAX, V61, P817, DOI 10.1136/thx.2005.056093; Taylor DA, 1998, THORAX, V53, P483, DOI 10.1136/thx.53.6.483; Verbanck S, 2004, AM J RESP CRIT CARE, V170, P414, DOI 10.1164/rccm.200401-037OC; Wang H, 2002, EARLY HUM DEV, V67, P79, DOI 10.1016/S0378-3782(01)00257-2; Wang Y, 2005, CLIN EXP ALLERGY, V35, P1104, DOI 10.1111/j.1365-2222.2005.02301.x; Warke TJ, 2002, THORAX, V57, P383, DOI 10.1136/thorax.57.5.383; Yoshihara S, 1998, AM J RESP CRIT CARE, V157, P547, DOI 10.1164/ajrccm.157.2.9704074	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35725	10.1371/journal.pone.0035725	http://dx.doi.org/10.1371/journal.pone.0035725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563393	Green Published, gold			2022-12-25	WOS:000305349100021
J	Zheng, Y; Lilo, S; Mena, P; Bliska, JB				Zheng, Ying; Lilo, Sarit; Mena, Patricio; Bliska, James B.			YopJ-Induced Caspase-1 Activation in Yersinia-Infected Macrophages: Independent of Apoptosis, Linked to Necrosis, Dispensable for Innate Host Defense	PLOS ONE			English	Article							INDUCED CELL-DEATH; NF-KAPPA-B; BACTERIA-FACED MACROPHAGES; CHROMATIN PROTEIN HMGB1; III SECRETION SYSTEM; NLRP3 INFLAMMASOME; DENDRITIC CELLS; PROINFLAMMATORY CYTOKINE; LEGIONELLA-PNEUMOPHILA; NALP3 INFLAMMASOME	Yersinia outer protein J (YopJ) is a type III secretion system (T3SS) effector of pathogenic Yersinia (Yersinia pestis, Yersinia enterocolitica and Yersinia pseudotuberculosis) that is secreted into host cells. YopJ inhibits survival response pathways in macrophages, causing cell death. Allelic variation of YopJ is responsible for differential cytotoxicity in Yersinia strains. YopJ isoforms in Y. enterocolitica O:8 (YopP) and Y. pestis KIM (YopJ(KIM)) strains have high cytotoxic activity. In addition, YopJ(KIM)-induced macrophage death is associated with caspase-1 activation and interleukin-1 beta (IL-1 beta secretion. Here, the mechanism of YopJ(KIM)-induced cell death, caspase-1 activation, and IL-1 beta secretion in primary murine macrophages was examined. Caspase-3/7 activity was low and the caspase-3 substrate poly (ADP-ribose) polymerase (PARP) was not cleaved in Y. pestis KIM5-infected macrophages. In addition, cytotoxicity and IL-1 beta secretion were not reduced in the presence of a caspase-8 inhibitor, or in B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax)/Bcl-2 homologous antagonist/killer (Bak) knockout macrophages, showing that YopJ(KIM)-mediated cell death and caspase-1 activation occur independent of mitochondrial-directed apoptosis. KIM5-infected macrophages released high mobility group protein B1 (HMGB1), a marker of necrosis, and microscopic analysis revealed that necrotic cells contained active caspase-1, indicating that caspase-1 activation is associated with necrosis. Inhibitor studies showed that receptor interacting protein 1 (RIP1) kinase and reactive oxygen species (ROS) were not required for cytotoxicity or IL-beta release in KIM5-infected macrophages. IL-1 beta secretion was reduced in the presence of cathepsin B inhibitors, suggesting that activation of caspase-1 requires cathepsin B activity. Ectopically-expressed YopP caused higher cytotoxicity and secretion of IL-1 beta in Y. pseudotuberculosis-infected macrophages than YopJ(KIM). Wild-type and congenic caspase 1 knockout C57BL/6 mice were equally susceptible to lethal infection with Y. pseudotuberculosis ectopically expressing YopP. These data suggest that YopJ-induced caspase-1 activation in Yersinia-infected macrophages is a downstream consequence of necrotic cell death and is dispensable for innate host resistance to a strain with enhanced cytotoxicity.	[Zheng, Ying] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zheng, Y (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	jbliska@ms.cc.sunysb.edu			Public Health Service [R56-AI043389, P01-AI055621]; Northeast Biodefense Center [U54-AI057158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R56AI043389, P01AI055621] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants R56-AI043389, P01-AI055621 and the Northeast Biodefense Center U54-AI057158-Lipkin awarded to JBB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Brodsky IE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000067; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Das R, 2007, GENES IMMUN, V8, P308, DOI 10.1038/sj.gene.6364389; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dockrell DH, 2001, J INFECTION, V42, P227, DOI 10.1053/jinf.2001.0836; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Fairbairn IP, 2004, BIOCHEM SOC T, V32, P496, DOI 10.1042/BST0320496; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Grobner S, 2007, APOPTOSIS, V12, P1813, DOI 10.1007/s10495-007-0100-x; Grobner S, 2007, INFECT IMMUN, V75, P512, DOI 10.1128/IAI.00756-06; Grobner S, 2006, APOPTOSIS, V11, P1959, DOI 10.1007/s10495-006-0189-3; Haase R, 2003, J IMMUNOL, V171, P4294, DOI 10.4049/jimmunol.171.8.4294; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Lilo S, 2008, INFECT IMMUN; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mittal R, 2010, J BIOL CHEM, V285, P19927, DOI 10.1074/jbc.M110.126581; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; Porcelli SA, 2008, NAT IMMUNOL, V9, P1101, DOI 10.1038/ni1008-1101; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Ruckdeschel K, 2002, J IMMUNOL, V168, P4601, DOI 10.4049/jimmunol.168.9.4601; Ruckdeschel K, 2004, J IMMUNOL, V173, P3320, DOI 10.4049/jimmunol.173.5.3320; Ruckdeschel K, 2001, INFECT IMMUN, V69, P7652, DOI 10.1128/IAI.69.12.7652-7662.2001; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Spinner JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009279; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005938; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhang Y, 2003, INFECT IMMUN, V71, P1513, DOI 10.1128/IAI.71.3.1513-1519.2003; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zheng Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002026; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	85	31	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36019	10.1371/journal.pone.0036019	http://dx.doi.org/10.1371/journal.pone.0036019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563435	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349100061
J	Johansson, AS; Vestling, M; Zetterstrom, P; Lang, L; Leinartaite, L; Karlstrom, M; Danielsson, J; Marklund, SL; Oliveberg, M				Johansson, Ann-Sofi; Vestling, Monika; Zetterstrom, Per; Lang, Lisa; Leinartaite, Lina; Karlstrom, Mikael; Danielsson, Jens; Marklund, Stefan L.; Oliveberg, Mikael			Cytotoxicity of Superoxide Dismutase 1 in Cultured Cells Is Linked to Zn2+ Chelation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; DISULFIDE REDUCTION; MOTOR-NEURONS; CONFORMATIONAL STABILITY; ZINC DEPRIVATION; AMYLOID-BETA; FAMILIAL ALS; METAL-IONS	Neurodegeneration in protein-misfolding disease is generally assigned to toxic function of small, soluble protein aggregates. Largely, these assignments are based on observations of cultured neural cells where the suspect protein material is titrated directly into the growth medium. In the present study, we use this approach to shed light on the cytotoxic action of the metalloenzyme Cu/Zn superoxide dismutase 1 (SOD1), associated with misfolding and aggregation in amyotrophic lateral sclerosis (ALS). The results show, somewhat unexpectedly, that the toxic species of SOD1 in this type of experimental setting is not an aggregate, as typically observed for proteins implicated in other neuro-degenerative diseases, but the folded and fully soluble apo protein. Moreover, we demonstrate that the toxic action of apoSOD1 relies on the protein's ability to chelate Zn2+ ions from the growth medium. The decreased cell viability that accompanies this extraction is presumably based on disturbed Zn2+ homeostasis. Consistently, mutations that cause global unfolding of the apoSOD1 molecule or otherwise reduce its Zn2+ affinity abolish completely the cytotoxic response. So does the addition of surplus Zn2+. Taken together, these observations point at a case where the toxic response of cultured cells might not be related to human pathology but stems from the intrinsic limitations of a simplified cell model. There are several ways proteins can kill cultured neural cells but all of these need not to be relevant for neurodegenerative disease.	[Johansson, Ann-Sofi; Lang, Lisa; Leinartaite, Lina; Karlstrom, Mikael; Danielsson, Jens; Oliveberg, Mikael] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Vestling, Monika] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Zetterstrom, Per; Marklund, Stefan L.] Umea Univ, Dept Med Biosci, Umea, Sweden	Stockholm University; Umea University; Umea University	Johansson, AS (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	mikael@dbb.su.se	Zetterström, Per/AAL-5018-2020; Danielsson, Jens/AAG-6915-2021	Zetterström, Per/0000-0001-8718-3249; Danielsson, Jens/0000-0002-6048-6896	Swedish Research Council; Swedish Brain Foundation; Knut and Alice Wallenberg Foundation; Hallsten Foundation; Kempe Foundation; Ahlen stiftelsen; Stohnes stiftelse; Stiftelsen for gamla tjanarinnor; Palle Ferbs minnesfond; EC [RII3-026145]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Hallsten Foundation; Kempe Foundation; Ahlen stiftelsen; Stohnes stiftelse; Stiftelsen for gamla tjanarinnor; Palle Ferbs minnesfond; EC(European CommissionEuropean Commission Joint Research Centre)	The work was supported by the Swedish Research Council (www.vr.se), the Swedish Brain Foundation (www.hjarnfonden.se), the Knut and Alice Wallenberg Foundation (www.wallenberg.com/kaw), the Hallsten Foundation, and the Kempe Foundation (www.kempe.com). Additionally, grants have been received from Ahlen stiftelsen (www.ahlen-stiftelsen.se), Stohnes stiftelse (http://home.swipnet.se/similar to w-125115), Stiftelsen for gamla tjanarinnor and Palle Ferbs minnesfond. NMR time at CERM was funded by the 6th Framework Program of the EC (Contract #RII3-026145, EU-NMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 1999, NEUROTOXICOLOGY, V20, P571; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2000, BIOCHEMISTRY-US, V39, P9108, DOI 10.1021/bi000067z; BANCI L, 1991, EUR J BIOCHEM, V196, P123, DOI 10.1111/j.1432-1033.1991.tb15794.x; Banci L, 2002, PROTEIN SCI, V11, P2479, DOI 10.1110/ps.0210802; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; BERTINI I, 1994, EUR BIOPHYS J BIOPHY, V23, P167, DOI 10.1007/BF01007608; BIEDLER JL, 1978, CANCER RES, V38, P3751; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colvin RA, 2003, EUR J PHARMACOL, V479, P171, DOI 10.1016/j.ejphar.2003.08.067; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Crow JP, 1997, J NEUROCHEM, V69, P1936; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Ding WQ, 2008, CANCER LETT, V271, P251, DOI 10.1016/j.canlet.2008.06.011; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Ermilova IP, 2005, NEUROSCI LETT, V379, P42, DOI 10.1016/j.neulet.2004.12.045; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Giulian D, 1998, J BIOL CHEM, V273, P29719, DOI 10.1074/jbc.273.45.29719; Hashemi M, 2007, EUR J PHARMACOL, V557, P9, DOI 10.1016/j.ejphar.2006.11.010; Hou X, 2005, BIOCHEMISTRY-US, V44, P11618, DOI 10.1021/bi050700m; Ilinskaya ON, 2002, PROTEIN SCI, V11, P2522, DOI 10.1110/ps.0216702; Jonsson PA, 2008, ANN NEUROL, V63, P671, DOI 10.1002/ana.21356; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Klink TA, 2000, J BIOL CHEM, V275, P17463, DOI 10.1074/jbc.M001132200; Leinartaite L, 2010, J AM CHEM SOC, V132, P13495, DOI 10.1021/ja1057136; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lulloff SJ, 2004, J LAB CLIN MED, V144, P208, DOI 10.1016/j.lab.2004.07.007; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Meerarani P, 2000, AM J CLIN NUTR, V71, P81; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Otsu K, 2004, BIOCHEM J, V377, P241, DOI 10.1042/BJ20030935; Paoletti P, 1997, J NEUROSCI, V17, P5711; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Ravits J, 2007, NEUROLOGY, V68, P1576, DOI 10.1212/01.wnl.0000261045.57095.56; Sandelin E, 2007, J BIOL CHEM, V282, P21230, DOI 10.1074/jbc.M700765200; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shen H, 2008, NUTR RES, V28, P406, DOI 10.1016/j.nutres.2008.02.011; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Smith AP, 2007, AMYOTROPH LATERAL SC, V8, P131, DOI 10.1080/17482960701249241; Sohnle PG, 2000, ANTIMICROB AGENTS CH, V44, P139, DOI 10.1128/AAC.44.1.139-142.2000; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Tummala H, 2005, J BIOL CHEM, V280, P17725, DOI 10.1074/jbc.M501705200; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yui S, 2002, MEDIAT INFLAMM, V11, P165, DOI 10.1080/09622935020138208	71	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36104	10.1371/journal.pone.0036104	http://dx.doi.org/10.1371/journal.pone.0036104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558346	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200116
J	Ezoe, S; Morooka, T; Noda, T; Sabin, ML; Koike, S				Ezoe, Satoshi; Morooka, Takeo; Noda, Tatsuya; Sabin, Miriam Lewis; Koike, Soichi			Population Size Estimation of Men Who Have Sex with Men through the Network Scale-Up Method in Japan	PLOS ONE			English	Article							INTERNET; PEOPLE	Background: Men who have sex with men (MSM) are one of the groups most at risk for HIV infection in Japan. However, size estimates of MSM populations have not been conducted with sufficient frequency and rigor because of the difficulty, high cost and stigma associated with reaching such populations. This study examined an innovative and simple method for estimating the size of the MSM population in Japan. We combined an internet survey with the network scale-up method, a social network method for estimating the size of hard-to-reach populations, for the first time in Japan. Methods and Findings: An internet survey was conducted among 1,500 internet users who registered with a nationwide internet-research agency. The survey participants were asked how many members of particular groups with known population sizes (firepersons, police officers, and military personnel) they knew as acquaintances. The participants were also asked to identify the number of their acquaintances whom they understood to be MSM. Using these survey results with the network scale-up method, the personal network size and MSM population size were estimated. The personal network size was estimated to be 363.5 regardless of the sex of the acquaintances and 174.0 for only male acquaintances. The estimated MSM prevalence among the total male population in Japan was 0.0402% without adjustment, and 2.87% after adjusting for the transmission error of MSM. Conclusions: The estimated personal network size and MSM prevalence seen in this study were comparable to those from previous survey results based on the direct-estimation method. Estimating population sizes through combining an internet survey with the network scale-up method appeared to be an effective method from the perspectives of rapidity, simplicity, and low cost as compared with more-conventional methods.	[Ezoe, Satoshi; Sabin, Miriam Lewis] Joint United Nations Programme HIV AIDS UNAIDS, Evidence Strategy & Results Dept, Geneva, Switzerland; [Ezoe, Satoshi] Juntendo Univ, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Morooka, Takeo] Int Univ Hlth & Welf, Grad Sch, Dept Hlth Serv Management, Tokyo, Japan; [Noda, Tatsuya] Hamamatsu Univ Sch Med, Dept Community Hlth & Prevent Med, Hamamatsu, Shizuoka 4313192, Japan; [Koike, Soichi] Tokyo Univ Hosp, Dept Planning Informat & Management, Tokyo 113, Japan	UNAIDS; Juntendo University; International University of Health & Welfare; Hamamatsu University School of Medicine; University of Tokyo	Ezoe, S (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, Evidence Strategy & Results Dept, Geneva, Switzerland.	ezoes@unaids.org		Noda, Tatsuya/0000-0002-3652-7547; Sabin, Miriam/0000-0002-7758-8338	Health and Labour Sciences Research Grants; Ministry of Health Labour and Welfare, Japan	Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Ministry of Health Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Health and Labour Sciences Research Grants (Research on HIV/AIDS), the Ministry of Health Labour and Welfare (http://www.mhlw.go.jp/english/), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Fire and Disaster Management Agency, 2007, WHIT PAP FIR SERV; Hidaka Y, 2005, REACH ONLINE 2005 ST; Hidaka Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-239; Kadushin C, 2006, J DRUG ISSUES, V36, P417, DOI 10.1177/002204260603600209; Kihara M, 1999, NATL SURVEY HIV STD; Killworth PD, 1998, EVALUATION REV, V22, P289, DOI 10.1177/0193841X9802200205; Killworth PD, 1998, SOC NETWORKS, V20, P23, DOI 10.1016/S0378-8733(96)00305-X; Mahy M, 2010, NETWORK SCALE UP PRO; McCarty C, 2001, HUM ORGAN, V60, P28, DOI 10.17730/humo.60.1.efx5t9gjtgmga73y; McCormick TH, 2010, J AM STAT ASSOC, V105, P59, DOI 10.1198/jasa.2009.ap08518; Ministry of Defense, 2008, DEF JAP ANN WHIT PAP; Ministry of Internal Affairs and Communication, 2009, STAT TEL SERV US; Munakata T, 1993, Nihon Rinsho, V51 Suppl, P479; National Police Agency, 2008, WHIT PAP POL; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; Tsuji R, 2003, SOCIOL THEOR METHOD, V18, P15; UNAIDS, 2010, GETTING ZERO 2011 20; UNAIDS, 2010, REP UNAIDS HIV UNPUB; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS/WHO, 2010, WORK GROUP GLOB HIV; Yasunaga H, 2004, NIPPON KOSHU EISEI Z, V53, P40; Zheng T, 2006, J AM STAT ASSOC, V101, P409, DOI 10.1198/016214505000001168	25	47	48	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31184	10.1371/journal.pone.0031184	http://dx.doi.org/10.1371/journal.pone.0031184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KO	22563366	Green Published, gold			2022-12-25	WOS:000305693600001
J	Guerra, E; Trerotola, M; Aloisi, AL; Tripaldi, R; Vacca, G; La Sorda, R; Lattanzio, R; Piantelli, M; Alberti, S				Guerra, E.; Trerotola, M.; Aloisi, A. L.; Tripaldi, R.; Vacca, G.; La Sorda, R.; Lattanzio, R.; Piantelli, M.; Alberti, S.			The Trop-2 signalling network in cancer growth	ONCOGENE			English	Article						Trop-2; human tumours; cell growth; cell signalling	CELL-ADHESION MOLECULES; HUMAN CARCINOMAS; BREAST-CANCER; MESSENGER-RNA; FREE SURVIVAL; PH DOMAINS; CYCLIN D1; EP-CAM; GENE; TRANSCRIPTION	Our findings show that upregulation of a wild-type Trop-2 has a key controlling role in human cancer growth, and that tumour development is quantitatively driven by Trop-2 expression levels. However, little is known about the regulation of expression of the TROP2 gene. Hence, we investigated the TROP2 transcription control network. TROP2 expression was shown to depend on a highly interconnected web of transcription factors: TP63/TP53L, ERG, GRHL1/Get-1 (grainyhead-like epithelial transactivator), HNF1A/TCF-1 (T-cell factor), SPI1/PU.1, WT (Wilms' tumour) 1, GLIS2, AIRE (autoimmune regulator), FOXM1 (forkhead box M1) and FOXP3, with HNF4A as the major network hub. TROP2 upregulation was shown to subsequently drive the expression and activation of CREB1 (cyclic AMP-responsive-element binding protein), Jun, NF-kappa B, Rb, STAT1 and STAT3 through induction of the cyclin D1 and ERK (extracellular signal regulated kinase)/MEK (MAPK/ERK kinase) pathways. Growth-stimulatory signalling through NF-kappa B, cyclin D1 and ERK was shown to require an intact Trop-2 cytoplasmic tail. Network hubs and interacting partners are co-expressed with Trop-2 in primary human tumours, supporting a role of this signalling network in cancer growth. Oncogene (2013) 32, 1594-1600; doi:10.1038/onc.2012.151; published online 7 May 2012	[Guerra, E.; Trerotola, M.; Aloisi, A. L.; Tripaldi, R.; Vacca, G.; La Sorda, R.; Lattanzio, R.; Piantelli, M.; Alberti, S.] Fdn Univ G DAnnunzio, Dept Oncol & Expt Med, Unit Canc Pathol, Chieti, Italy; [Guerra, E.; Trerotola, M.; Aloisi, A. L.; Tripaldi, R.; Vacca, G.; La Sorda, R.; Lattanzio, R.; Piantelli, M.; Alberti, S.] Fdn Univ G DAnnunzio, CeSI, Chieti, Italy; [Alberti, S.] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Alberti, S (corresponding author), Fdn Univ G DAnnunzio, CeSI, Dept Oncol & Expt Med, Unit Canc Pathol, Via Colle Ara, I-66100 Chieti, Italy.	s.alberti@unich.it	Lattanzio, Rossano/K-1927-2018; Alberti, Saverio/M-4511-2014; Trerotola, Marco/J-9015-2016	Lattanzio, Rossano/0000-0001-9803-4476; Alberti, Saverio/0000-0002-4647-6042; Trerotola, Marco/0000-0003-1855-7002; Piantelli, Mauro/0000-0003-0154-482X; Guerra, Emanuela/0000-0002-7091-8621	Fondazione of the Cassa di Risparmio della Provincia di Chieti; ABO Foundation [CH01D0081]; Fondazione compagnia di San Paolo; Italian Ministry of Health [RicOncol RF-EMR-2006-361866]; Italian Foundation for Cancer Research (FIRC, Italy); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Fondazione of the Cassa di Risparmio della Provincia di Chieti; ABO Foundation; Fondazione compagnia di San Paolo(Compagnia di San Paolo); Italian Ministry of Health(Ministry of Health, Italy); Italian Foundation for Cancer Research (FIRC, Italy)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was supported by the Fondazione of the Cassa di Risparmio della Provincia di Chieti, ABO Foundation (Grant CH01D0081), Fondazione compagnia di San Paolo, and the Italian Ministry of Health (RicOncol RF-EMR-2006-361866). MT was a recipient of a scholarship from the Italian Foundation for Cancer Research (FIRC, Italy).	Alberti S, 1999, PROTEINS, V35, P360; Alberti S, 1998, PROTEINS, V31, P1, DOI 10.1002/(SICI)1097-0134(19980401)31:1<1::AID-PROT1>3.0.CO;2-R; ALBERTI S, 1988, P NATL ACAD SCI USA, V85, P8391, DOI 10.1073/pnas.85.22.8391; ALBERTI S, 1990, NUCLEIC ACIDS RES, V18, P351, DOI 10.1093/nar/18.2.351; ALBERTI S, 1992, HYBRIDOMA, V11, P539, DOI 10.1089/hyb.1992.11.539; Ambrogi F, 2006, CLIN CANCER RES, V12, P781, DOI 10.1158/1078-0432.CCR-05-0763; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aplin AE, 1998, PHARMACOL REV, V50, P197; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bienvenu F, 2005, MOL BIOL CELL, V16, P1850, DOI 10.1091/mbc.e04-08-0654; Biganzoli E, 2011, JPN J CLIN ONCOL, V41, P172, DOI 10.1093/jjco/hyq227; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Calabrese G, 2001, CYTOGENET CELL GENET, V92, P164, DOI 10.1159/000056891; Castellone MD, 2009, CANCER RES, V69, P1867, DOI 10.1158/0008-5472.CAN-08-1982; Cheng C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-225; Chong JM, 2001, J BIOL CHEM, V276, P5804, DOI 10.1074/jbc.M008839200; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; Cubas R, 2009, BBA-REV CANCER, V1796, P309, DOI 10.1016/j.bbcan.2009.08.001; El Sewedy T, 1998, INT J CANCER, V75, P324, DOI 10.1002/(SICI)1097-0215(19980119)75:2<324::AID-IJC24>3.3.CO;2-5; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Guerra E, 2008, CANCER RES, V68, P8113, DOI 10.1158/0008-5472.CAN-07-6135; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Humphries MJ, 1998, TRENDS CELL BIOL, V8, P78, DOI 10.1016/S0962-8924(98)80016-0; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LINNENBACH AJ, 1993, MOL CELL BIOL, V13, P1507, DOI 10.1128/MCB.13.3.1507; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Loeb DM, 2002, INT J HEMATOL, V76, P117, DOI 10.1007/BF02982573; Mangino G, 2002, INT J CANCER, V101, P353, DOI 10.1002/ijc.10616; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036; NAQUET P, 1989, THYMUS, V13, P217; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Peiro G, 2007, AM J CLIN PATHOL, V127, P780, DOI 10.1309/FWHEQX6HB9190LVY; Querzoli P, 2006, CLIN CANCER RES, V12, P6696, DOI 10.1158/1078-0432.CCR-06-0569; Ronneberg JA, 2011, MOL ONCOL, V5, P61, DOI 10.1016/j.molonc.2010.11.004; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Su AI, 2001, CANCER RES, V61, P7388; Terrinoni A, 2001, GENE CHROMOSOME CANC, V31, P209, DOI 10.1002/gcc.1137; Tinari N, 2006, CLIN CANCER RES, V12, P1501, DOI 10.1158/1078-0432.CCR-05-0978; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Trerotola M, 2010, BBA-REV CANCER, V1805, P119, DOI 10.1016/j.bbcan.2009.12.002; Varughese J, 2011, CANCER-AM CANCER SOC, V117, P3163, DOI 10.1002/cncr.25891; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Yuan L, 2009, CIRC RES, V104, P1049, DOI 10.1161/CIRCRESAHA.108.190751; Zanna P, 2007, CANCER-AM CANCER SOC, V110, P452, DOI 10.1002/cncr.22785; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	55	71	80	5	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2013	32	12					1594	1600		10.1038/onc.2012.151	http://dx.doi.org/10.1038/onc.2012.151			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22562244				2022-12-25	WOS:000316456000012
J	Song, JK; Park, MH; Choi, DY; Yoo, HS; Han, SB; Yoon, DY; Hong, JT				Song, Ju Kyoung; Park, Mi Hee; Choi, Dong-Young; Yoo, Hwan Soo; Han, Sang Bae; Yoon, Do Young; Hong, Jin Tae			Deficiency of C-C Chemokine Receptor 5 Suppresses Tumor Development via Inactivation of NF-kappa B and Upregulation of IL-1Ra in Melanoma Model	PLOS ONE			English	Article							HUMAN BREAST-CANCER; CELL GROWTH; IN-VIVO; INTERLEUKIN-1; ANTAGONIST; EXPRESSION; ADENOCARCINOMA; INHIBITION; LYMPHOMA; PROMOTES	To evaluate the relevance of C-C chemokine receptor type 5 (CCR5) expression and tumor development, we compared melanoma growth in CCR5 knockout (CCR5(-/-)) mice and wild type (CCR5(+/+)) mice. CCR5(-/-) mice showed reduced tumor volume, tumor weight, and increased survival rate when compared to CCR5(+/+) mice. We investigated the activation of NF-kappa B since it is an implicated transcription factor in the regulation of genes involving cell growth, apoptosis, and tumor growth. Significant inhibition of DNA binding activity of NF-kappa B, and translocation of p50 and p65 into the nucleus through the inhibition of phosphorylation of I kappa B was found in the melanoma tissues of CCR5(-/-) mice compared to melanoma tissues of CCR5(+/+) mice. NF-kappa B target apoptotic protein expression, such as cleaved caspase-3, cleaved PARP, and Bax, was elevated, whereas the survival protein expression levels, such as Bcl-2, C-IAP1, was decreased in the melanoma tissues of CCR5(-/-) mice. Interestingly, we found that the level of IL-1Ra, a tumor growth suppressive cytokine, was significantly elevated in tumor tissue and spleen of CCR5(-/-) mice compared to the level in CCR5(+/+) mice. Moreover, infiltration of CD8(+) cytotoxic T cell and CD57(+) natural killer cells was significantly increased in melanoma tumor and spleen tissue of CCR5(-/-) mice compared to that of CCR5(+/+) mice. Therefore, these results showed that CCR5 deficiency caused apoptotic cell death of melanoma through inhibition of NF-kappa B and upregulation of IL-1Ra.	[Song, Ju Kyoung; Park, Mi Hee; Choi, Dong-Young; Yoo, Hwan Soo; Han, Sang Bae; Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm & Med Res Ctr, Cheongju, Chungbuk, South Korea; [Yoon, Do Young] Konkuk Univ, Bio Mol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea	Chungbuk National University; Konkuk University	Song, JK (corresponding author), Chungbuk Natl Univ, Coll Pharm & Med Res Ctr, Cheongju, Chungbuk, South Korea.	jinthong@chungbuk.ac.kr			Korea Research Foundation [MRC 9440, R13-2010-002948]	Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the Korea Research Foundation Grant (MRC 9440, R13-2010-002948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Aldinucci D, 2008, INT J CANCER, V122, P769, DOI 10.1002/ijc.23119; Arend WP, 2000, ANN RHEUM DIS, V59, P60, DOI 10.1136/ard.59.suppl_1.i60; Bar D, 2004, FASEB J, V18, P161, DOI 10.1096/fj.03-0483fje; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Borczuk AC, 2008, ONCOGENE, V27, P557, DOI 10.1038/sj.onc.1210662; Chan KK, 2010, J PATHOL, V221, P164, DOI 10.1002/path.2699; Cheng J, 2012, J SURG RES, V174, P166, DOI 10.1016/j.jss.2010.12.014; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; Dabaghmanesh N, 2009, CANCER SCI, V100, P737, DOI 10.1111/j.1349-7006.2009.01083.x; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DINARELLO CA, 1991, BLOOD, V77, P1627; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; Elkabets M, 2009, J IMMUNOL, V182, P4874, DOI 10.4049/jimmunol.0803916; Erreni M, 2009, METHOD ENZYMOL, V460, P105, DOI 10.1016/S0076-6879(09)05205-7; Fukuda M, 2010, INT J ONCOL, V36, P1355, DOI 10.3892/ijo_00000620; Garat C, 2003, CYTOKINE, V23, P31, DOI 10.1016/S1043-4666(03)00182-0; Gerondakis S, 1996, P NATL ACAD SCI USA, V93, P3405, DOI 10.1073/pnas.93.8.3405; Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898; Huang CY, 2009, BIOCHEM PHARMACOL, V77, P794, DOI 10.1016/j.bcp.2008.11.014; Jewett A, 2006, CANCER IMMUNOL IMMUN, V55, P1052, DOI 10.1007/s00262-005-0093-7; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kazmierski W, 2003, BIOORGAN MED CHEM, V11, P2663, DOI 10.1016/S0968-0896(03)00161-5; Kokura S, 2005, CANCER LETT, V218, P171, DOI 10.1016/j.canlet.2004.07.026; Konishi N, 2005, ONCOLOGY-BASEL, V68, P138, DOI 10.1159/000086768; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; La E, 1999, MOL CARCINOGEN, V24, P276, DOI 10.1002/(SICI)1098-2744(199904)24:4<276::AID-MC5>3.0.CO;2-#; La EH, 2001, MOL CARCINOGEN, V30, P218, DOI 10.1002/mc.1031; Lavi G, 2007, J CONTROL RELEASE, V123, P123, DOI 10.1016/j.jconrel.2007.07.015; Lentsch AB, 1997, J CLIN INVEST, V100, P2443, DOI 10.1172/JCI119786; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Ng-Cashin J, 2003, J IMMUNOL, V170, P4201, DOI 10.4049/jimmunol.170.8.4201; Oh JH, 2011, ONCOGENE, V30, P3345, DOI 10.1038/onc.2011.52; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Ricote M, 2004, CANCER-AM CANCER SOC, V100, P1388, DOI 10.1002/cncr.20142; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Seidl H, 2007, HUM PATHOL, V38, P768, DOI 10.1016/j.humpath.2006.11.013; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Smith MF, 1998, J BIOL CHEM, V273, P24272, DOI 10.1074/jbc.273.37.24272; Sutton A, 2007, MOL CANCER RES, V5, P21, DOI 10.1158/1541-7786.MCR-06-0103; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Triozzi PL, 2010, ANTICANCER RES, V30, P345; Valdivia-Silva JE, 2009, CANCER LETT, V283, P176, DOI 10.1016/j.canlet.2009.03.040; VIDALVANACLOCHA F, 1994, CANCER RES, V54, P2667; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Weinreich DM, 2003, CANCER RES, V63, P5957; Wu XS, 2009, CURR PHARM DESIGN, V15, P742, DOI 10.2174/138161209787582165; Zhang XP, 2010, BIOORG MED CHEM LETT, V20, P4627, DOI 10.1016/j.bmcl.2010.06.003	54	134	137	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e33747	10.1371/journal.pone.0033747	http://dx.doi.org/10.1371/journal.pone.0033747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567084	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500002
J	Peterson, AJ; Jensen, PA; Shimell, M; Stefancsik, R; Wijayatonge, R; Herder, R; Raftery, LA; O'Connor, MB				Peterson, Aidan J.; Jensen, Philip A.; Shimell, MaryJane; Stefancsik, Ray; Wijayatonge, Ranjula; Herder, Rachel; Raftery, Laurel A.; O'Connor, Michael B.			R-Smad Competition Controls Activin Receptor Output in Drosophila	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BMP; SIGNALS; PHOSPHORYLATION; PROTEIN; EMBRYO; PROLIFERATION; ACTIVATION; MECHANISMS; COMPLEXES	Animals use TGF-beta superfamily signal transduction pathways during development and tissue maintenance. The superfamily has traditionally been divided into TGF-beta/Activin and BMP branches based on relationships between ligands, receptors, and R-Smads. Several previous reports have shown that, in cell culture systems, "BMP-specific" Smads can be phosphorylated in response to TGF-beta/Activin pathway activation. Using Drosophila cell culture as well as in vivo assays, we find that Baboon, the Drosophila TGF-beta/Activin-specific Type I receptor, can phosphorylate Mad, the BMP-specific R-Smad, in addition to its normal substrate, dSmad2. The Baboon-Mad activation appears direct because it occurs in the absence of canonical BMP Type I receptors. Wing phenotypes generated by Baboon gain-of-function require Mad, and are partially suppressed by over-expression of dSmad2. In the larval wing disc, activated Baboon cell-autonomously causes C-terminal Mad phosphorylation, but only when endogenous dSmad2 protein is depleted. The Baboon-Mad relationship is thus controlled by dSmad2 levels. Elevated P-Mad is seen in several tissues of dSmad2 protein-null mutant larvae, and these levels are normalized in dSmad2; baboon double mutants, indicating that the cross-talk reaction and Smad competition occur with endogenous levels of signaling components in vivo. In addition, we find that high levels of Activin signaling cause substantial turnover in dSmad2 protein, providing a potential cross-pathway signal-switching mechanism. We propose that the dual activity of TGF-beta/Activin receptors is an ancient feature, and we discuss several ways this activity can modulate TGF-beta signaling output.	[Peterson, Aidan J.; Jensen, Philip A.; Shimell, MaryJane; Herder, Rachel; O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Stefancsik, Ray; Wijayatonge, Ranjula; Raftery, Laurel A.] Harvard Univ, Sch Med, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Charlestown, MA USA; [Raftery, Laurel A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Peterson, AJ (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	moconnor@umn.edu	Raftery, Laurel/H-1406-2012; O'Connor, Michael B/C-9977-2014	Raftery, Laurel/0000-0003-4797-4163; O'Connor, Michael B/0000-0002-3067-5506; Stefancsik, Ray/0000-0001-8314-2140	National Institutes of Health [R01 GM95746, R01 GM060501, T32 HD007430-11A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095746, R01GM060501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants to MBO (R01 GM95746) and LAR (R01 GM060501). PAJ was supported in part by a National Institutes of Health Institutional Training Grant (T32 HD007430-11A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Haerry TE, 2010, MECH DEVELOP, V127, P358, DOI 10.1016/j.mod.2010.04.001; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Jornvall H, 2001, J BIOL CHEM, V276, P5140, DOI 10.1074/jbc.M005200200; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Ng J, 2008, DEVELOPMENT, V135, P4025, DOI 10.1242/dev.028209; PADGETT RW, 1993, P NATL ACAD SCI USA, V90, P2905, DOI 10.1073/pnas.90.7.2905; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Ting CY, 2007, NEURON, V56, P793, DOI 10.1016/j.neuron.2007.09.033; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	30	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36548	10.1371/journal.pone.0036548	http://dx.doi.org/10.1371/journal.pone.0036548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563507	gold, Green Submitted, Green Published			2022-12-25	WOS:000305340700056
J	Tan, CW; Chan, YF; Sim, KM; Tan, EL; Poh, CL				Tan, Chee Wah; Chan, Yoke Fun; Sim, Kooi Mow; Tan, Eng Lee; Poh, Chit Laa			Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1	PLOS ONE			English	Article							SIMPLEX-VIRUS INFECTION; LACTOFERRICIN INHIBIT; ADENOVIRAL INFECTION; HEPARAN-SULFATE; BINDING; ENTRY; INTERFERENCE; EPIDEMIC; TARGETS; HIV-1	Enterovirus 71 (EV-71) is the main causative agent of hand, foot and mouth disease (HFMD). In recent years, EV-71 infections were reported to cause high fatalities and severe neurological complications in Asia. Currently, no effective antiviral or vaccine is available to treat or prevent EV-71 infection. In this study, we have discovered a synthetic peptide which could be developed as a potential antiviral for inhibition of EV-71. Ninety five synthetic peptides (15-mers) overlapping the entire EV-71 capsid protein, VP1, were chemically synthesized and tested for antiviral properties against EV-71 in human Rhabdomyosarcoma (RD) cells. One peptide, SP40, was found to significantly reduce cytopathic effects of all representative EV-71 strains from genotypes A, B and C tested, with IC50 values ranging from 6-9.3 mu M in RD cells. The in vitro inhibitory effect of SP40 exhibited a dose dependent concentration corresponding to a decrease in infectious viral particles, total viral RNA and the levels of VP1 protein. The antiviral activity of SP40 peptide was not restricted to a specific cell line as inhibition of EV-71 was observed in RD, HeLa, HT-29 and Vero cells. Besides inhibition of EV-71, it also had antiviral activities against CV-A16 and poliovirus type 1 in cell culture. Mechanism of action studies suggested that the SP40 peptide was not virucidal but was able to block viral attachment to the RD cells. Substitutions of arginine and lysine residues with alanine in the SP40 peptide at positions R3A, R4A, K5A and R13A were found to significantly decrease antiviral activities, implying the importance of positively charged amino acids for the antiviral activities. The data demonstrated the potential and feasibility of SP40 as a broad spectrum antiviral agent against EV-71.	[Tan, Chee Wah; Chan, Yoke Fun] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Sim, Kooi Mow] Univ Tunku Abdul Rahman, Fac Sci, Dept Chem Sci, Kampar, Malaysia; [Tan, Eng Lee] Singapore Polytech, Ctr Biomed & Life Sci, Singapore, Singapore; [Poh, Chit Laa] Sunway Univ, Sch Hlth & Nat Sci, Petaling Jaya, Malaysia	Universiti Malaya; Universiti Tunku Abdul Rahman (UTAR); Singapore Polytechnic; Sunway University	Tan, CW (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	chitlaa.poh@gmail.com	Tan, Chee Wah/K-7450-2012; abubakar, sazaly/B-3957-2010; Chan, Yoke Fun/B-5351-2010	abubakar, sazaly/0000-0002-9267-1420; Chan, Yoke Fun/0000-0001-7089-0510; Poh, Chit-Laa/0000-0001-8475-6291; Tan, Chee Wah/0000-0001-9837-1413	UTAR (Universiti Tunku Abdul Rahman) Research Fund [6200/P04]; University of Malaya Research Grant [RG245/10HTM]; Sunway University Research Grant [INT-SHNS-0111-01]; High Impact Research Grant [UM.C/625/1/HIR/014]	UTAR (Universiti Tunku Abdul Rahman) Research Fund; University of Malaya Research Grant; Sunway University Research Grant; High Impact Research Grant	This work was supported by grants from UTAR (Universiti Tunku Abdul Rahman) Research Fund (6200/P04), University of Malaya Research Grant (RG245/10HTM), Sunway University Research Grant (INT-SHNS-0111-01) awarded to CLP and High Impact Research Grant (UM.C/625/1/HIR/014) awarded to YFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarawongsa R, 2009, ANTIMICROB AGENTS CH, V53, P987, DOI 10.1128/AAC.00793-08; Andersen JH, 2003, ANTIVIR RES, V58, P209, DOI 10.1016/S0166-3542(02)00214-0; Andersen JH, 2001, ANTIVIR RES, V51, P141, DOI 10.1016/S0166-3542(01)00146-2; Bastian A, 2001, REGUL PEPTIDES, V101, P157, DOI 10.1016/S0167-0115(01)00282-8; Belaid A, 2002, J MED VIROL, V66, P229, DOI 10.1002/jmv.2134; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chan YF, 2011, NEUROL ASIA, V16, P1; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; Chen P, 2012, J BIOL CHEM, V287, P6406, DOI 10.1074/jbc.M111.301622; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Gropp R, 1999, HUM GENE THER, V10, P957, DOI 10.1089/10430349950018355; HEINZ BA, 1995, J VIROL, V69, P4189, DOI 10.1128/JVI.69.7.4189-4197.1995; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; Huther A, 2007, AIDS REV, V9, P208; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kim DH, 2008, BMB REP, V41, P640, DOI 10.5483/BMBRep.2008.41.9.640; Li C, 2007, CURR MED CHEM, V14, P847, DOI 10.2174/092986707780363032; Li ZH, 2008, J INFECT DIS, V197, P854, DOI 10.1086/527326; Lin TY, 2002, J INFECT DIS, V186, P1161, DOI 10.1086/343809; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Liu R, 2010, ANTIVIR RES, V86, P172, DOI 10.1016/j.antiviral.2010.02.316; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; MANN DM, 1994, J BIOL CHEM, V269, P23661; Marchetti M, 2004, VIROLOGY, V318, P405, DOI 10.1016/j.virol.2003.09.029; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Patick AK, 1997, 10 INT C ANT RES ANT; Pevear DC, 1999, ANTIMICROB AGENTS CH, V43, P2109, DOI 10.1128/AAC.43.9.2109; Reed L.J., 1983, AM J HYG, V27, P493; Rotbart HA, 1998, ANTIVIR RES, V38, P1, DOI 10.1016/S0166-3542(97)00068-5; Shih SR, 2004, ANTIMICROB AGENTS CH, V48, P3523, DOI 10.1128/AAC.48.9.3523-3529.2004; Shimazaki K, 1998, J DAIRY SCI, V81, P2841, DOI 10.3168/jds.S0022-0302(98)75843-6; Shindarov LM, 1979, J HYG EPID MICROB IM, V23, P12; Sim ACN, 2005, VIROLOGY, V341, P72, DOI 10.1016/j.virol.2005.06.047; Stanway G, 2005, VIRUS TAXONOMY, P757; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Tiwari V, 2011, J BIOL CHEM, V286, P25406, DOI 10.1074/jbc.M110.201103; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Weng TY, 2005, ANTIVIR RES, V67, P31, DOI 10.1016/j.antiviral.2005.03.005; Wu KX, 2010, DRUG DISCOV TODAY, V15, P1041, DOI 10.1016/j.drudis.2010.10.008; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723	46	29	36	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e34589	10.1371/journal.pone.0034589	http://dx.doi.org/10.1371/journal.pone.0034589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563456	Green Published, Green Accepted, gold			2022-12-25	WOS:000305340700005
J	Bailleul, AM; Hall, BK; Horner, JR				Bailleul, Alida M.; Hall, Brian K.; Horner, John R.			First Evidence of Dinosaurian Secondary Cartilage in the Post-Hatching Skull of Hypacrosaurus stebingeri (Dinosauria, Ornithischia)	PLOS ONE			English	Article							MEMBRANE BONES; CHONDROID TISSUE; CHICK-EMBRYO; ONTOGENY; GROWTH; REPAIR; MORPHOGENESIS; TRICERATOPS; VERTEBRATES; HISTOLOGY	Bone and calcified cartilage can be fossilized and preserved for hundreds of millions of years. While primary cartilage is fairly well studied in extant and fossilized organisms, nothing is known about secondary cartilage in fossils. In extant birds, secondary cartilage arises after bone formation during embryonic life at articulations, sutures and muscular attachments in order to accommodate mechanical stress. Considering the phylogenetic inclusion of birds within the Dinosauria, we hypothesized a dinosaurian origin for this "avian" tissue. Therefore, histological thin sectioning was used to investigate secondary chondrogenesis in disarticulated craniofacial elements of several post-hatching specimens of the non-avian dinosaur Hypacrosaurus stebingeri (Ornithischia, Lambeosaurinae). Secondary cartilage was found on three membrane bones directly involved with masticatory function: (1) as nodules on the dorso-caudal face of a surangular; and (2) on the bucco-caudal face of a maxilla; and (3) between teeth as islets in the alveolar processes of a dentary. Secondary chondrogenesis at these sites is consistent with the locations of secondary cartilage in extant birds and with the induction of the cartilage by different mechanical factors -stress generated by the articulation of the quadrate, stress of a ligamentous or muscular insertion, and stress of tooth formation. Thus, our study reveals the first evidence of "avian" secondary cartilage in a non-avian dinosaur. It pushes the origin of this "avian" tissue deep into dinosaurian ancestry, suggesting the creation of the more appropriate term "dinosaurian" secondary cartilage.	[Bailleul, Alida M.; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Bailleul, Alida M.; Horner, John R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Hall, Brian K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Dalhousie University	Bailleul, AM (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	alida.bailleul@msu.montana.edu			NSERC of Canada [A5056]; Australian Research Grants Committee [J044823]	NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Grants Committee	Two of the authors, A. M. B and J.R.H., are indebted to Gerry Ohrstrom for funding. B. K. H. was supported by NSERC of Canada (Grant A5056) and by the Australian Research Grants Committee, grant no. J044823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardack D., 1971, BIOL LAMPREYS, V1, P67; BARRETO C, 1993, SCIENCE, V262, P2020, DOI 10.1126/science.262.5142.2020; Bloom W., 1986, TXB HISTOLOGY; Buxton PG, 2003, DEVELOPMENT, V130, P4729, DOI 10.1242/dev.00610; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; COULY GF, 1993, DEVELOPMENT, V117, P409; de Ricqles A., 1975, ANN PALEONTOL, V61, P51; Enlow D. H., 1990, FACIAL GROWTH; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Goret-Nicaise M, 1986, THESIS UCL BOLOGNA; GORETNICAISE M, 1984, ARCH ANAT MICROSC MO, V73, P291; HALL B. K., 1967, AUST J ZOOL, V15, P685, DOI 10.1071/ZO9670685; HALL B K, 1968, Australian Journal of Zoology, V16, P795, DOI 10.1071/ZO9680795; Hall B.K., 2015, BONES CARTILAGE DEV; HALL BK, 1968, HISTOCHEMISTRY, V16, P206, DOI 10.1007/BF00307849; HALL BK, 1986, J EMBRYOL EXP MORPH, V93, P133; HALL BK, 1985, J EXP ZOOL, V233, P359, DOI 10.1002/jez.1402330304; Hall BK, 2000, WENN GR INT, V76, P101; HALL BK, 1975, ANAT RECORD, V181, P55, DOI 10.1002/ar.1091810105; HALL BK, 1971, CLIN ORTHOP RELAT R, P249; HALL BK, 1971, CLIN ORTHOP RELAT R, P182, DOI 10.1097/00003086-197107000-00015; Hall BK, 1997, ENCY HUMAN BIOL, V2; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Horner JR, 2011, CR PALEVOL, V10, P439, DOI 10.1016/j.crpv.2011.04.006; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner John R., 1994, P312; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; IRWIN CR, 1986, J ANAT, V146, P53; Lamm ET, 2007, MICROSC MICROANAL, V13, P50, DOI 10.1017/S1431927607075368; LENGELE B, 1990, J CRAN GENET DEV BIO, V10, P103; Lengele B, 1996, ANAT EMBRYOL, V193, P505; Lengele B, 1996, ANAT REC, V246, P377, DOI 10.1002/(SICI)1097-0185(199611)246:3<377::AID-AR9>3.0.CO;2-V; MURRAY P. D. F., 1963, AUSTRALIAN JOUR ZOOL, V11, P368, DOI 10.1071/ZO9630368; Murray P. D. F., 1965, Australian Journal of Zoology, V13, P351, DOI 10.1071/ZO9650351; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Scheyer TM, 2007, J ANAT, V211, P737, DOI 10.1111/j.1469-7580.2007.00815.x; TRAN S, 1989, ACTA ANAT, V135, P200; Tumarkin-Deratzian Allison R., 2010, P251; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575	40	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36112	10.1371/journal.pone.0036112	http://dx.doi.org/10.1371/journal.pone.0036112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558351	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200042
J	Knappskog, S; Gansmo, LB; Romundstad, P; Bjornslett, M; Trovik, J; Sommerfelt-Pettersen, J; Lokkevik, E; Tollenaar, RAEM; Seynaeve, C; Devilee, P; Salvesen, HB; Dorum, A; Hveem, K; Vatten, L; Lonning, PE				Knappskog, Stian; Gansmo, Liv B.; Romundstad, Pal; Bjornslett, Merete; Trovik, Jone; Sommerfelt-Pettersen, Jan; Lokkevik, Erik; Tollenaar, Rob A. E. M.; Seynaeve, Caroline; Devilee, Peter; Salvesen, Helga B.; Dorum, Anne; Hveem, Kristian; Vatten, Lars; Lonning, Per E.		Norwegian Breast Canc Grp	MDM2 Promoter SNP344T > A (rs1196333) Status Does Not Affect Cancer Risk	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; ACCELERATES TUMOR-FORMATION; ADVANCED BREAST-CANCER; P53 PROTEIN; SNP309; GENE; POLYMORPHISM; AMPLIFICATION; EXPRESSION; MUTATIONS	The MDM2 proto-oncogene plays a key role in central cellular processes like growth control and apoptosis, and the gene locus is frequently amplified in sarcomas. Two polymorphisms located in the MDM2 promoter P2 have been shown to affect cancer risk. One of these polymorphisms (SNP309T>G; rs2279744) facilitates Sp1 transcription factor binding to the promoter and is associated with increased cancer risk. In contrast, SNP285G>C (rs117039649), located 24 bp upstream of rs2279744, and in complete linkage disequilibrium with the SNP309G allele, reduces Sp1 recruitment and lowers cancer risk. Thus, fine tuning of MDM2 expression has proven to be of significant importance with respect to tumorigenesis. We assessed the potential functional effects of a third MDM2 promoter P2 polymorphism (SNP344T>A; rs1196333) located on the SNP309T allele. While in silico analyses indicated SNP344A to modulate TFAP2A, SPIB and AP1 transcription factor binding, we found no effect of SNP344 status on MDM2 expression levels. Assessing the frequency of SNP344A in healthy Caucasians (n = 2,954) and patients suffering from ovarian (n = 1,927), breast (n = 1,271), endometrial (n = 895) or prostatic cancer (n = 641), we detected no significant difference in the distribution of this polymorphism between any of these cancer forms and healthy controls (6.1% in healthy controls, and 4.9%, 5.0%, 5.4% and 7.2% in the cancer groups, respectively). In conclusion, our findings provide no evidence indicating that SNP344A may affect MDM2 transcription or cancer risk.	[Knappskog, Stian; Gansmo, Liv B.; Lonning, Per E.] Univ Bergen, Inst Med, Sect Oncol, Bergen, Norway; [Knappskog, Stian; Gansmo, Liv B.; Lonning, Per E.] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Romundstad, Pal; Hveem, Kristian; Vatten, Lars] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7034 Trondheim, Norway; [Bjornslett, Merete] Oslo Univ Hosp Radiumhosp, Dept Med Genet, Oslo, Norway; [Bjornslett, Merete; Dorum, Anne] Univ Oslo, Norwegian Radium Hosp, Fac Div, Oslo, Norway; [Trovik, Jone; Salvesen, Helga B.] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Trovik, Jone; Salvesen, Helga B.] Univ Bergen, Inst Clin Med, Bergen, Norway; [Sommerfelt-Pettersen, Jan] Royal Norwegian Navy, Bergen, Norway; [Lokkevik, Erik] Oslo Univ Hosp, Dept Oncol, Div Surg & Canc Med, Oslo, Norway; [Tollenaar, Rob A. E. M.] Leiden Univ Med Ctr, Dept Surg, Leiden, Netherlands; [Seynaeve, Caroline] Erasmus MC Daniel den Hoed Canc Ctr Rotterdam, Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [Devilee, Peter] Leiden Univ Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands; [Dorum, Anne] Oslo Univ Hosp Radiumhosp, Dept Gynecol Oncol, Oslo, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Oslo	Knappskog, S (corresponding author), Univ Bergen, Inst Med, Sect Oncol, Bergen, Norway.	stian.knappskog@med.uib.no	Hveem, Kristian/AFV-4683-2022; Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022; DEVILEE, PETER/ABR-2140-2022; Devilee, Peter/GXV-8005-2022; salvesen, Helga B/C-1187-2017	salvesen, Helga B/0000-0002-4438-8831; Gansmo, Liv B./0000-0002-2914-9103; Dorum, Anne/0000-0002-6274-2398; Lonning, Per Eystein/0000-0002-8890-6303; Knappskog, Stian/0000-0002-4153-1655; Sommerfelt-Pettersen, Jan/0000-0002-3008-5928; Romundstad, Pal Richard/0000-0003-2061-4336	Norwegian Cancer Society; Norwegian Health Region West	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Health Region West	The study was supported by grants from the Norwegian Cancer Society and the Norwegian Health Region West. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bond GL, 2006, J MED GENET, V43, P950, DOI 10.1136/jmg.2006.043539; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chrisanthar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019249; Chrisanthar R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003062; Economopoulos KP, 2010, BREAST CANCER RES TR, V120, P211, DOI 10.1007/s10549-009-0467-1; Geisler S, 2003, CLIN CANCER RES, V9, P5582; Geisler S, 2001, CANCER RES, V61, P2505; Hu ZB, 2007, CANCER EPIDEM BIOMAR, V16, P2717, DOI 10.1158/1055-9965.EPI-07-0634; Knappskog S, 2012, EUR J CANCER, V48, P1988, DOI 10.1016/j.ejca.2011.10.024; Knappskog S, 2011, ONCOTARGET, V2, P251; Knappskog S, 2011, CANCER CELL, V19, P273, DOI 10.1016/j.ccr.2010.12.019; Landers JE, 1997, CANCER RES, V57, P3562; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SHEIKH MS, 1993, CANCER RES, V53, P3226; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0	20	11	12	0	297	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36263	10.1371/journal.pone.0036263	http://dx.doi.org/10.1371/journal.pone.0036263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558411	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200058
J	Phua, DYL; Rifkin-Graboi, A; Saw, SM; Meaney, MJ; Qiu, AQ				Phua, Desiree Yee-Ling; Rifkin-Graboi, Anne; Saw, Seang-Mei; Meaney, Michael J.; Qiu, Anqi			Executive Functions of Six-Year-Old Boys with Normal Birth Weight and Gestational Age	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; COGNITIVE FUNCTION; POSTNATAL-GROWTH; NORMAL RANGE; INFANTS BORN; CHILDREN; PRETERM; TERM; PERFORMANCE; OUTCOMES	Impaired fetal development, reflected by low birth weight or prematurity, predicts an increased risk for psychopathology, especially attention deficit hyperactivity disorder (ADHD). Such effects cut across the normal range of birth weight and gestation. Despite the strength of existing epidemiological data, cognitive pathways that link fetal development to mental health are largely unknown. In this study we examined the relation of birth weight (>2500 g) and gestational age (37-41 weeks) within the normal range with specific executive functions in 195 Singaporean six-year-old boys of Chinese ethnicity. Birth weight adjusted for gestational age was used as indicator of fetal growth while gestational age was indicative of fetal maturity. Linear regression revealed that increased fetal growth within the normal range is associated with an improved ability to learn rules during the intra/extra-dimensional shift task and to retain visual information for short period of time during the delayed matching to sample task. Moreover, faster and consistent reaction times during the stop-signal task were observed among boys born at term, but with higher gestational age. Hence, even among boys born at term with normal birth weight, variations in fetal growth and maturity showed distinct effects on specific executive functions.	[Phua, Desiree Yee-Ling; Rifkin-Graboi, Anne; Meaney, Michael J.; Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Saw, Seang-Mei] Singapore Eye Res Inst, Singapore, Singapore; [Saw, Seang-Mei] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Meaney, Michael J.] McGill Univ, Sackler Program Epigenet & Psychobiol, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Qiu, Anqi] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; Singapore National Eye Center; National University of Singapore; McGill University; National University of Singapore; National University of Singapore	Phua, DYL (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore.	bieqa@nus.edu.sg	Meaney, Michael/N-5931-2019; Phua, Desiree Y/I-1791-2019; Rifkin-Graboi, Anne/AAH-3658-2022; Rifkin-Graboi, Anne/AFM-0959-2022; Qiu, Anqi/H-2267-2011	Phua, Desiree Y/0000-0001-6055-656X; Qiu, Anqi/0000-0002-0215-6338; Rifkin-Graboi, Anne/0000-0002-7641-4678	Agency of Science, Technology and Research (A*STAR) [SICS-09/1/1/001]	Agency of Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This study was supported by the Agency of Science, Technology and Research (A*STAR; ref: SICS-09/1/1/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Boulet SL, 2011, MATERN CHILD HLTH J, V15, P836, DOI 10.1007/s10995-009-0538-2; Breslau N, 1996, J ABNORM CHILD PSYCH, V24, P385, DOI 10.1007/BF01441637; Breslau N, 2004, PEDIATRICS, V114, P1035, DOI 10.1542/peds.2004-0069; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Chyi LJ, 2008, J PEDIATR-US, V153, P25, DOI 10.1016/j.jpeds.2008.01.027; Corbett BA, 2009, PSYCHIAT RES, V166, P210, DOI 10.1016/j.psychres.2008.02.005; Dannemiller JL, 2004, INFANT BEHAV DEV, V27, P204, DOI 10.1016/j.infbeh.2003.09.003; De Blasio MJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE75, DOI 10.1152/ajpendo.00689.2006; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Diamond A, 2006, TRENDS COGN SCI, V10, P212, DOI 10.1016/j.tics.2006.03.003; Dirani M, 2010, INVEST OPHTH VIS SCI, V51, P1348, DOI 10.1167/iovs.09-3587; Fray PJ, 1996, INT J GERIATR PSYCH, V11, P329; Heinonen K, 2008, PEDIATRICS, V121, pE1325, DOI 10.1542/peds.2007-1172; HUGHES C, 1994, NEUROPSYCHOLOGIA, V32, P477, DOI 10.1016/0028-3932(94)90092-2; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Kalff AC, 2005, J INT NEUROPSYCH SOC, V11, P173; Kinney HC, 2006, SEMIN PERINATOL, V30, P81, DOI 10.1053/j.semperi.2006.02.006; Kirkhart MW, 2001, J GEN PSYCHOL, V128, P447, DOI 10.1080/00221300109598921; LAGERSTROM M, 1994, INT J PSYCHOPHYSIOL, V17, P175, DOI 10.1016/0167-8760(94)90033-7; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; Livesey D, 2006, HUM MOVEMENT SCI, V25, P50, DOI 10.1016/j.humov.2005.10.008; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Luciana M, 2002, DEV NEUROPSYCHOL, V22, P595, DOI 10.1207/S15326942DN2203_3; Lundgren EM, 2008, BEST PRACT RES CL EN, V22, P477, DOI 10.1016/j.beem.2008.01.014; Marit M, 2009, J PEDIAT, V155, p[848, e841]; Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136/bmj.323.7308.310; Moe V, 2001, INFANT MENT HEALTH J, V22, P334, DOI 10.1002/imhj.1005; Molfese VJ, 2010, CONTEMP EDUC PSYCHOL, V35, P116, DOI 10.1016/j.cedpsych.2010.03.004; Morse SB, 2009, PEDIATRICS, V123, pE622, DOI 10.1542/peds.2008-1405; Mullis PE, 2008, BEST PRACT RES CL EN, V22, P173, DOI 10.1016/j.beem.2007.07.010; Power C, 2006, J PEDIATR-US, V148, P54, DOI 10.1016/j.jpeds.2005.07.028; Richards M, 2002, INT J EPIDEMIOL, V31, P342, DOI 10.1093/ije/31.2.342; RICKARDS AL, 1993, J DEV BEHAV PEDIATR, V14, P363; Roth S, 1999, EARLY HUM DEV, V55, P39, DOI 10.1016/S0378-3782(99)00002-X; Shenkin SD, 2001, ARCH DIS CHILD, V85, P189, DOI 10.1136/adc.85.3.189; Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989; Silva A, 2006, ANN EPIDEMIOL, V16, P469, DOI 10.1016/j.annepidem.2005.06.056; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; van Batenburg-Eddes T, 2008, EARLY HUM DEV, V84, P659, DOI 10.1016/j.earlhumdev.2008.04.007; van der Sluis S, 2007, INTELLIGENCE, V35, P427, DOI 10.1016/j.intell.2006.09.001; Yang S, 2010, AM J EPIDEMIOL, V171, P399, DOI 10.1093/aje/kwp413	46	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36502	10.1371/journal.pone.0036502	http://dx.doi.org/10.1371/journal.pone.0036502			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UL	22558470	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200083
J	Eswaramoorthy, S; Poulain, S; Hienerwadel, R; Bremond, N; Sylvester, MD; Zhang, YB; Berthomieu, C; Van der Lelie, D; Matin, A				Eswaramoorthy, Subramaniam; Poulain, Sebastien; Hienerwadel, Rainer; Bremond, Nicolas; Sylvester, Matthew D.; Zhang, Yian-Biao; Berthomieu, Catherine; Van der Lelie, Daniel; Matin, A.			Crystal Structure of ChrR-A Quinone Reductase with the Capacity to Reduce Chromate	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA; ENZYME; PROTEIN; IMPROVEMENT; URANIUM; STRESS; SYSTEM	The Escherichia coli ChrR enzyme is an obligatory two-electron quinone reductase that has many applications, such as in chromate bioremediation. Its crystal structure, solved at 2.2 angstrom resolution, shows that it belongs to the flavodoxin superfamily in which flavin mononucleotide (FMN) is firmly anchored to the protein. ChrR crystallized as a tetramer, and size exclusion chromatography showed that this is the oligomeric form that catalyzes chromate reduction. Within the tetramer, the dimers interact by a pair of two hydrogen bond networks, each involving Tyr128 and Glu146 of one dimer and Arg125 and Tyr85 of the other; the latter extends to one of the redox FMN cofactors. Changes in each of these amino acids enhanced chromate reductase activity of the enzyme, showing that this network is centrally involved in chromate reduction.	[Eswaramoorthy, Subramaniam; Zhang, Yian-Biao] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Poulain, Sebastien; Sylvester, Matthew D.; Matin, A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Poulain, Sebastien; Bremond, Nicolas; Berthomieu, Catherine] CEA, DSV IBEB, Lab Interact Prot Met, St Paul Les Durance, France; [Poulain, Sebastien; Hienerwadel, Rainer; Bremond, Nicolas; Berthomieu, Catherine] CNRS, UMR Biol Vegetale & Microbiol Environm, St Paul Les Durance, France; [Poulain, Sebastien; Bremond, Nicolas; Berthomieu, Catherine] Univ Aix Marseille, St Paul Les Durance, France; [Hienerwadel, Rainer] Univ Aix Marseille, Lab Genet & Biophys Plantes, Marseille, France; [Hienerwadel, Rainer] CEA, DSV IBEB, Marseille, France; [Van der Lelie, Daniel] RTI Int, Discovery & Analyt Sci, Res Triangle Pk, NC USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Stanford University; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Aix-Marseille Universite; CEA; Research Triangle Institute	Eswaramoorthy, S (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	a.matin@stanford.edu	Matin, AC/A-1315-2007; Berthomieu, Catherine/AAX-9559-2021	Matin, AC/0000-0003-4468-980X; Berthomieu, Catherine/0000-0001-8784-5396	European Commission [FP7-PEOPLE-2007-4-1-IOF-ENV-219786]; DTRA under DOE prime [BO742081, DEAC02-98CH10886]; Brookhaven National Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); DTRA under DOE prime; Brookhaven National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Marie Curie International Outgoing Fellowship No. FP7-PEOPLE-2007-4-1-IOF-ENV-219786 from the European Commission. SE was supported by an award from DTRA BO742081 under DOE prime contract No. DEAC02-98CH10886 with Brookhaven National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley DF, 2006, J BACTERIOL, V188, P3371, DOI 10.1128/JB.188.9.3371-3381.2006; Ackerley DF, 2004, ENVIRON MICROBIOL, V6, P851, DOI 10.1111/j.1462-2920.2004.00639.x; Ackerley DF, 2004, APPL ENVIRON MICROB, V70, P873, DOI 10.1128/AEM.70.2.873-882.2004; Agarwal R, 2006, ACTA CRYSTALLOGR D, V62, P383, DOI [10.1107/S0907444906001600, 10.1107/S0904777906001600]; Barak Y, 2006, MOL CANCER THER, V5, P97, DOI 10.1158/1535-7163.MCT-05-0365; Barak Y, 2006, APPL ENVIRON MICROB, V72, P7074, DOI 10.1128/AEM.01334-06; Barak Y, 2008, ISME J, V2, P171, DOI 10.1038/ismej.2007.100; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carey J, 2007, PROTEIN SCI, V16, P2301, DOI 10.1110/ps.073018907; Deller S, 2006, BIOCHEMISTRY-US, V45, P7083, DOI 10.1021/bi052478r; Devi MP, 2011, CLEAN-SOIL AIR WATER, V39, P900, DOI 10.1002/clen.201000588; Fredrickson JK, 2008, GEOBIOLOGY, V6, P245, DOI 10.1111/j.1472-4669.2008.00146.x; Gihring TM, 2011, APPL ENVIRON MICROB, V77, P5955, DOI 10.1128/AEM.00220-11; Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200; Gonzalez CF, 2003, ACTA BIOTECHNOL, V23, P233, DOI 10.1002/abio.200390030; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keyhan M, 2004, TARGETS IMPROVEMENT; KUIPERS OP, 1991, NUCLEIC ACIDS RES, V19, P4558, DOI 10.1093/nar/19.16.4558; Lovley DR, ADV MICROB PHYSL, V59, P1; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Park CH, 2000, APPL ENVIRON MICROB, V66, P1788, DOI 10.1128/AEM.66.5.1788-1795.2000; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Puzon GJ, 2002, BIOCHEM BIOPH RES CO, V294, P76, DOI 10.1016/S0006-291X(02)00438-2; Scherr KE, 2010, J BIOTECHNOL, V150, pS47, DOI 10.1016/j.jbiotec.2010.08.129; SHI XL, 1990, FEBS LETT, V276, P189, DOI 10.1016/0014-5793(90)80539-U; Thorne SH, 2009, MOL CANCER THER, V8, P333, DOI 10.1158/1535-7163.MCT-08-0707; Wall JD, 2006, ANNU REV MICROBIOL, V60, P149, DOI 10.1146/annurev.micro.59.030804.121357; Ye J, 2007, FEBS LETT, V581, P3996, DOI 10.1016/j.febslet.2007.07.039	29	44	50	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36017	10.1371/journal.pone.0036017	http://dx.doi.org/10.1371/journal.pone.0036017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558308	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000101
J	Schechter, LM; Valenta, JC; Schneider, DJ; Collmer, A; Sakk, E				Schechter, Lisa M.; Valenta, Joy C.; Schneider, David J.; Collmer, Alan; Sakk, Eric			Functional and Computational Analysis of Amino Acid Patterns Predictive Type III Secretion System Substrates in Pseudomonas syringae	PLOS ONE			English	Article							PV. TOMATO DC3000; EFFECTOR PROTEINS; YERSINIA-ENTEROCOLITICA; MESSENGER-RNA; PROTEOMIC ANALYSIS; VIRULENCE FACTORS; ESCHERICHIA-COLI; EUKARYOTIC CELLS; HRPL REGULON; PLANT-CELLS	Bacterial type III secretion systems (T3SSs) deliver proteins called effectors into eukaryotic cells. Although N-terminal amino acid sequences are required for translocation, the mechanism of substrate recognition by the T3SS is unknown. Almost all actively deployed T3SS substrates in the plant pathogen Pseudomonas syringae pathovar tomato strain DC3000 possess characteristic patterns, including (i) greater than 10% serine within the first 50 amino acids, (ii) an aliphatic residue or proline at position 3 or 4, and (iii) a lack of acidic amino acids within the first 12 residues. Here, the functional significance of the P. syringae T3SS substrate compositional patterns was tested. A mutant AvrPto effector protein lacking all three patterns was secreted into culture and translocated into plant cells, suggesting that the compositional characteristics are not absolutely required for T3SS targeting and that other recognition mechanisms exist. To further analyze the unique properties of T3SS targeting signals, we developed a computational algorithm called TEREE (Type III Effector Relative Entropy Evaluation) that distinguishes DC3000 T3SS substrates from other proteins with a high sensitivity and specificity. Although TEREE did not efficiently identify T3SS substrates in Salmonella enterica, it was effective in another P. syringae strain and Ralstonia solanacearum. Thus, the TEREE algorithm may be a useful tool for identifying new effector genes in plant pathogens. The nature of T3SS targeting signals was additionally investigated by analyzing the N-terminus of FtsX, a putative membrane protein that was classified as a T3SS substrate by TEREE. Although the first 50 amino acids of FtsX were unable to target a reporter protein to the T3SS, an AvrPto protein substituted with the first 12 amino acids of FtsX was translocated into plant cells. These results show that the T3SS targeting signals are highly mutable and that secretion may be directed by multiple features of substrates.	[Schechter, Lisa M.; Valenta, Joy C.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Schneider, David J.] ARS, Plant Microbe Interact Res Unit, Robert W Holley Ctr Agr & Hlth, USDA, Ithaca, NY USA; [Schneider, David J.; Collmer, Alan] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Sakk, Eric] Morgan State Univ, Dept Comp Sci, Baltimore, MD 21239 USA	University of Missouri System; University of Missouri Saint Louis; United States Department of Agriculture (USDA); Cornell University; Morgan State University	Schechter, LM (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	schechterl@umsl.edu	Schneider, David J/H-2236-2012	Schneider, David J/0000-0002-2124-8385	University of Misssouri-St. Louis; National Science Foundation [DBI-0077622]; United States Department of Agriculture-Agriculture Research Service [1907-21000-017-00]	University of Misssouri-St. Louis; National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture-Agriculture Research Service(United States Department of Agriculture (USDA))	This work was supported by start-up research funds from the University of Misssouri-St. Louis, National Science Foundation award DBI-0077622, and United States Department of Agriculture-Agriculture Research Service project 1907-21000-017-00. The funders had no role in study design, data collection and analysis, decison to publish, or preparation of the manuscript.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Amer AAA, 2011, J BACTERIOL, V193, P6683, DOI 10.1128/JB.00210-11; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Anderson DM, 1999, P NATL ACAD SCI USA, V96, P12839, DOI 10.1073/pnas.96.22.12839; Arnold R, 2010, MICROBES INFECT, V12, P346, DOI 10.1016/j.micinf.2010.02.003; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Badea L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-30; Blaylock B, 2008, MOL MICROBIOL, V70, P1210, DOI 10.1111/j.1365-2958.2008.06474.x; Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000; Buchko GW, 2010, MOL BIOSYST, V6, P2448, DOI 10.1039/c0mb00097c; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Cover TM, 1991, ELEMENTS INFORM THEO, Vxxii; Cunnac S, 2009, CURR OPIN MICROBIOL, V12, P53, DOI 10.1016/j.mib.2008.12.003; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Dawson JE, 2009, P NATL ACAD SCI USA, V106, P8543, DOI 10.1073/pnas.0809138106; DEFEYTER R, 1990, GENE, V88, P65, DOI 10.1016/0378-1119(90)90060-5; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Fouts DE, 2003, MOL PLANT MICROBE IN, V16, P43, DOI 10.1094/MPMI.2003.16.1.43; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gazi AD, 2009, CELL MICROBIOL, V11, P719, DOI 10.1111/j.1462-5822.2009.01297.x; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Goss JW, 2004, J BACTERIOL, V186, P6320, DOI 10.1128/JB.186.18.6320-6324.2004; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Ham JH, 1998, P NATL ACAD SCI USA, V95, P10206, DOI 10.1073/pnas.95.17.10206; Higashide W, 2006, J BACTERIOL, V188, P2411, DOI 10.1128/JB.188.7.2411-2420.2006; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; KING EO, 1954, J LAB CLIN MED, V44, P301; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Lan LF, 2006, MOL PLANT MICROBE IN, V19, P976, DOI 10.1094/MPMI-19-0976; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lee VT, 2002, J BACTERIOL, V184, P3740, DOI 10.1128/JB.184.13.3740-3745.2002; Lewis JD, 2009, SEMIN CELL DEV BIOL, V20, P1055, DOI 10.1016/j.semcdb.2009.06.003; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; McDermott JE, 2011, INFECT IMMUN; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Mukaihara T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251; Mukaihara T, 2009, MICROBIOL-SGM, V155, P2235, DOI 10.1099/mic.0.027763-0; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Poueymiro M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/j.mib.2008.11.008; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1189, DOI 10.1046/j.1365-2958.2003.03772.x; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x; Sakk E, 2005, COMPUTATIONAL IDENTI, P191; Sambrook J, 2001, MOL CLONING LAB MANU; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Sorg JA, 2005, J BACTERIOL, V187, P7090, DOI 10.1128/JB.187.20.7090-7102.2005; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Subtil A, 2005, MOL MICROBIOL, V56, P1636, DOI 10.1111/j.1365-2958.2005.04647.x; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Tay DMM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S4; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Vidal JE, 2008, CELL MICROBIOL, V10, P1975, DOI 10.1111/j.1462-5822.2008.01181.x; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; Wehling MD, 2004, J BACTERIOL, V186, P3621, DOI 10.1128/JB.186.11.3621-3630.2004; Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47; Young BM, 2002, J BACTERIOL, V184, P1324, DOI 10.1128/JB.184.5.1324-1334.2002; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x; Zong N, 2008, PLANT SIGNAL BEHAV, V3, P583, DOI 10.4161/psb.3.8.5741	84	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36038	10.1371/journal.pone.0036038	http://dx.doi.org/10.1371/journal.pone.0036038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558318	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000109
J	Wang, XH; Wen, XH; Xia, Y; Hu, M; Zhao, F; Ding, K				Wang, Xiaohui; Wen, Xianghua; Xia, Yu; Hu, Ma; Zhao, Fang; Ding, Kun			Ammonia Oxidizing Bacteria Community Dynamics in a Pilot-Scale Wastewater Treatment Plant	PLOS ONE			English	Article							RESTRICTION FRAGMENT LENGTH; AEROBIC BIOFILM REACTORS; ACTIVATED-SLUDGE; MICROBIAL COMMUNITIES; DIVERSITY; QUANTIFICATION; GROWTH	Background: Chemoautotrophic ammonia oxidizing bacteria (AOB) have the metabolic ability to oxidize ammonia to nitrite aerobically. This metabolic feature has been widely used, in combination with denitrification, to remove nitrogen from wastewater in wastewater treatment plants (WWTPs). However, the relative influence of specific deterministic environmental factors to AOB community dynamics in WWTP is uncertain. The ecological principles underlying AOB community dynamics and nitrification stability and how they are related are also poorly understood. Methodology/Principal Findings: The community dynamics of ammonia oxidizing bacteria (AOB) in a pilot-scale WWTP were monitored over a one-year period by Terminal Restriction Fragment Length Polymorphism (T-RFLP). During the study period, the effluent ammonia concentrations were almost below 2 mg/L, except for the first 60 days, indicting stable nitrification. T-RFLP results showed that, during the test period with stable nitrification, the AOB community structures were not stable, and the average change rate (every 15 days) of AOB community structures was 10%+/- 8%. The correlations between T-RFLP profiles and 10 operational and environmental parameters were tested by Canonical Correlation Analysis (CCA) and Mantel test. The results indicated that the dynamics of AOB community correlated most strongly with Dissolved Oxygen (DO), effluent ammonia, effluent Biochemical Oxygen Demand (BOD) and temperature. Conclusions/Significance: This study suggests that nitrification stability is not necessarily accompanied by a stable AOB community, and provides insight into parameters controlling the AOB community dynamics within bioreactors with stable nitrification.	[Wang, Xiaohui; Wen, Xianghua; Xia, Yu; Hu, Ma; Zhao, Fang; Ding, Kun] Tsinghua Univ, Environm Simulat & Pollut Control State Key Joint, Sch Environm, Beijing 100084, Peoples R China	Tsinghua University	Wang, XH (corresponding author), Tsinghua Univ, Environm Simulat & Pollut Control State Key Joint, Sch Environm, Beijing 100084, Peoples R China.	xhwen@tsinghua.edu.cn	wen, xianghua/A-7551-2015		NSFC [51078207]; Specialized Research Fund for the Doctoral Program of Higher Education [20090002770003]; Tsinghua University [20101081834]	NSFC(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tsinghua University	This study was supported by the NSFC (51078207), Specialized Research Fund for the Doctoral Program of Higher Education (20090002770003), and the Research funding of Tsinghua University (20101081834). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsubasi AT, 2009, ENVIRON SCI TECHNOL, V43, P2950, DOI 10.1021/es8026488; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Dytczak MA, 2008, WATER RES, V42, P2320, DOI 10.1016/j.watres.2007.12.018; Gentile ME, 2007, APPL ENVIRON MICROB, V73, P680, DOI 10.1128/AEM.01519-06; Gilbride KA, 2006, J MICROBIOL METH, V66, P1, DOI 10.1016/j.mimet.2006.02.016; Hallin S, 2005, J APPL MICROBIOL, V99, P629, DOI 10.1111/j.1365-2672.2005.02608.x; Kaplan CW, 2003, J MICROBIOL METH, V54, P121, DOI 10.1016/S0167-7012(03)00003-4; Lim J, 2008, BIOTECHNOL BIOENG, V99, P1374, DOI 10.1002/bit.21715; Limpiyakorn T, 2005, FEMS MICROBIOL ECOL, V54, P205, DOI 10.1016/j.femsec.2005.03.017; Limpiyakorn T, 2007, FEMS MICROBIOL ECOL, V60, P501, DOI 10.1111/j.1574-6941.2007.00307.x; Lydmark P, 2007, ENVIRON MICROBIOL, V9, P2220, DOI 10.1111/j.1462-2920.2007.01336.x; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Miura Y, 2007, WATER RES, V41, P627, DOI 10.1016/j.watres.2006.11.005; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Park HD, 2009, J MICROBIOL BIOTECHN, V19, P346, DOI 10.4014/jmb.0806.399; Park JJ, 2008, WATER SCI TECHNOL, V57, P1889, DOI 10.2166/wst.2008.622; Park JJ, 2008, KOREAN J CHEM ENG, V25, P1448, DOI 10.1007/s11814-008-0238-4; Pholchan MK, 2010, WATER RES, V44, P1341, DOI 10.1016/j.watres.2009.11.005; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Rowan AK, 2003, WATER SCI TECHNOL, V48, P17, DOI 10.2166/wst.2003.0149; Satoh H, 2006, BIOTECHNOL BIOENG, V94, P762, DOI 10.1002/bit.20894; Siripong S, 2007, WATER RES, V41, P1110, DOI 10.1016/j.watres.2006.11.050; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Wang X, 2010, J APPL MICROBIOL, V109, P1218, DOI 10.1111/j.1365-2672.2010.04742.x; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Wang XH, 2010, J ENVIRON SCI-CHINA, V22, P627, DOI 10.1016/S1001-0742(09)60155-8; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Wittebolle L, 2009, J APPL MICROBIOL, V107, P385, DOI 10.1111/j.1365-2672.2009.04222.x; Wittebolle L, 2008, APPL ENVIRON MICROB, V74, P286, DOI 10.1128/AEM.01006-07; Xia S, 2008, ECOL ENG, V32, P256, DOI 10.1016/j.ecoleng.2007.11.013; Xie JP, 2011, APPL ENVIRON MICROB, V77, P991, DOI 10.1128/AEM.01798-10; Zhang B, 2010, BIORESOURCE TECHNOL, V101, P3054, DOI 10.1016/j.biortech.2009.12.048	34	26	30	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36272	10.1371/journal.pone.0036272	http://dx.doi.org/10.1371/journal.pone.0036272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558415	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000176
J	Xiong, YW; Wang, P; Lan, RT; Ye, CY; Wang, H; Ren, J; Jing, HQ; Wang, YT; Zhou, ZM; Bai, XM; Cui, ZG; Luo, X; Zhao, AL; Wang, Y; Zhang, SM; Sun, H; Wang, L; Xu, JG				Xiong, Yanwen; Wang, Ping; Lan, Ruiting; Ye, Changyun; Wang, Hua; Ren, Jun; Jing, Huaiqi; Wang, Yiting; Zhou, Zhemin; Bai, Xuemei; Cui, Zhigang; Luo, Xia; Zhao, Ailan; Wang, Yan; Zhang, Shaomin; Sun, Hui; Wang, Lei; Xu, Jianguo			A Novel Escherichia coli O157:H7 Clone Causing a Major Hemolytic Uremic Syndrome Outbreak in China	PLOS ONE			English	Article							SHIGA-TOXIN; HEMORRHAGIC COLITIS; O157-H7; VIRULENCE; SEQUENCE; STRAINS; O157H7; SECRETION; GENOTYPES; PROFILES	An Escherichia coli O157:H7 outbreak in China in 1999 caused 177 deaths due to hemolytic uremic syndrome. Sixteen outbreak associated isolates were found to belong to a new clone, sequence type 96 (ST96), based on multilocus sequence typing of 15 housekeeping genes. Whole genome sequencing of an outbreak isolate, Xuzhou21, showed that the isolate is phylogenetically closely related to the Japan 1996 outbreak isolate Sakai, both of which share the most recent common ancestor with the US outbreak isolate EDL933. The levels of IL-6 and IL-8 of peripheral blood mononuclear cells induced by Xuzhou21 and Sakai were significantly higher than that induced by EDL933. Xuzhou21 also induced a significantly higher level of IL-8 than Sakai while both induced similar levels of IL-6. The expression level of Shiga toxin 2 in Xuzhou21 induced by mitomycin C was 68.6 times of that under non-inducing conditions, twice of that induced in Sakai (32.7 times) and 15 times higher than that induced in EDL933 (4.5 times). Our study shows that ST96 is a novel clone and provided significant new insights into the evolution of virulence of E. coli O157:H7.	[Xiong, Yanwen; Wang, Ping; Ye, Changyun; Jing, Huaiqi; Wang, Yiting; Bai, Xuemei; Cui, Zhigang; Luo, Xia; Zhao, Ailan; Wang, Yan; Zhang, Shaomin; Sun, Hui; Xu, Jianguo] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Wang, Hua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Ren, Jun] Anhui Prov Ctr Dis Control & Prevent, Hefei, Anhui, Peoples R China; [Zhou, Zhemin; Wang, Lei] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of New South Wales Sydney; Jiangsu Provincial Center for Disease Control & Prevention; Nankai University	Xiong, YW (corresponding author), Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xujianguo@icdc.cn	Zhou, Zhemin/AAX-5539-2020; wang, yiting/GYU-5306-2022; Wang, Lei/C-5176-2009	Zhou, Zhemin/0000-0001-9783-0366; Wang, Lei/0000-0003-4427-0881; Lan, Ruiting/0000-0001-9834-5258	National Key Programs for Infectious Diseases of China [2008ZX10004-001, 2008ZX10004-009, 2009ZX10004-101]; Ministry of Science and Technology, People's Republic of China [2005CB522904]	National Key Programs for Infectious Diseases of China; Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China)	This work was supported by grants (2008ZX10004-001, 2008ZX10004-009 and 2009ZX10004-101) from the National Key Programs for Infectious Diseases of China and the grant (2005CB522904) from the Ministry of Science and Technology, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; CHAPMAN PA, 1994, J MED MICROBIOL, V40, P424, DOI 10.1099/00222615-40-6-424; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Davis BM, 2002, EMBO J, V21, P4240, DOI 10.1093/emboj/cdf427; Eklund M, 2002, J CLIN MICROBIOL, V40, P4585, DOI 10.1128/JCM.40.12.4585-4593.2002; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Eppinger M, 2011, APPL ENVIRON MICROB, V77, P2916, DOI 10.1128/AEM.02554-10; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Feng PCH, 2007, EMERG INFECT DIS, V13, P1701, DOI 10.3201/eid1311.070381; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Grant J, 2008, EMERG INFECT DIS, V14, P1633, DOI 10.3201/eid1410.071341; Guessous F, 2005, INFECT IMMUN, V73, P8306, DOI 10.1128/IAI.73.12.8306-8316.2005; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Kobayashi M, 1999, AM J TROP MED HYG, V61, P625, DOI 10.4269/ajtmh.1999.61.625; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Lacher DW, 2007, J BACTERIOL, V189, P342, DOI 10.1128/JB.01472-06; Laing CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-287; Litalien C, 1999, PEDIATR NEPHROL, V13, P840, DOI 10.1007/s004670050712; LOUISE CB, 1995, J INFECT DIS, V172, P1397, DOI 10.1093/infdis/172.5.1397; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Murata A, 1998, CYTOKINE, V10, P544, DOI 10.1006/cyto.1997.0329; Nakagawa S, 2003, BIOCHEM BIOPH RES CO, V310, P1194, DOI 10.1016/j.bbrc.2003.09.145; Neupane M, 2011, MICROB PATHOGENESIS, V51, P466, DOI 10.1016/j.micpath.2011.07.009; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Proulx F, 1998, PEDIATR INFECT DIS J, V17, P899, DOI 10.1097/00006454-199810000-00010; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Thorpe CM, 1999, INFECT IMMUN, V67, P5985, DOI 10.1128/IAI.67.11.5985-5993.1999; Wang Hua, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P938; Wang P, 2011, J CLIN MICROBIOL, V49, P1594, DOI 10.1128/JCM.02530-10; Xu Jianguo, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P114; Yang Z, 2004, APPL ENVIRON MICROB, V70, P6846, DOI 10.1128/AEM.70.11.6846-6854.2004; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	49	51	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36144	10.1371/journal.pone.0036144	http://dx.doi.org/10.1371/journal.pone.0036144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558360	Green Published, gold			2022-12-25	WOS:000305336000138
J	Yabuki, M; Cummings, WJ; Leppard, JB; Immormino, RM; Wood, CL; Allison, DS; Gray, PW; Tjoelker, LW; Maizels, N				Yabuki, Munehisa; Cummings, W. Jason; Leppard, John B.; Immormino, Robert M.; Wood, Christi L.; Allison, Daniel S.; Gray, Patrick W.; Tjoelker, Larry W.; Maizels, Nancy			Antibody Discovery Ex Vivo Accelerated by the LacO/Lacl Regulatory Network	PLOS ONE			English	Article							GENE CONVERSION; RAD51 PARALOGS; CHICKEN; CELLS; HUMANIZATION; GENERATION; EXPRESSION	Monoclonal antibodies (mAbs) can be potent and highly specific therapeutics, diagnostics and research reagents. Nonetheless, mAb discovery using current in vivo or in vitro approaches can be costly and time-consuming, with no guarantee of success. We have established a platform for rapid discovery and optimization of mAbs ex vivo. This DTLacO platform derives from a chicken B cell line that has been engineered to enable rapid selection and seamless maturation of high affinity mAbs. We have validated the DTLacO platform by generation of high affinity and specific mAbs to five cell surface targets, the receptor tyrosine kinases VEGFR2 and TIE2, the glycoprotein TROP2, the small TNF receptor family member FN14, and the G protein-coupled receptor FZD10. mAb discovery is rapid and humanization is straightforward, establishing the utility of the DTLacO platform for identification of mAbs for therapeutic and other applications.	[Yabuki, Munehisa; Cummings, W. Jason; Immormino, Robert M.; Maizels, Nancy] Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA; [Yabuki, Munehisa; Cummings, W. Jason; Leppard, John B.; Wood, Christi L.; Allison, Daniel S.; Tjoelker, Larry W.] XORI Corp, Seattle, WA USA; [Gray, Patrick W.] Accelerator Corp, Seattle, WA USA; [Maizels, Nancy] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Yabuki, M (corresponding author), Omeros Corp, Seattle, WA 98101 USA.	maizels@u.washington.edu			NIH [R01 GM41712, U54 AI081680]; Fred Hutchinson Cancer Research Center; XORI Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI081680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039799, R01GM041712] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Hutchinson Cancer Research Center; XORI Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH R01 GM41712 (NM), U54 AI081680 (NM), and the Fred Hutchinson Cancer Research Center Molecular Diagnostics Pilot Program (NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by XORI Corporation who, through the employment of MY, WJC, JBL, CLW, DSA and LWT, were involved with providing funds for selection and characterization of some antibodies.	Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495; Bratkovic T, 2010, CELL MOL LIFE SCI, V67, P749, DOI 10.1007/s00018-009-0192-2; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Chiarella P, 2008, BIOTECHNOL LETT, V30, P1303, DOI 10.1007/s10529-008-9706-5; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; Cummings WJ, 2007, PLOS BIOL, V5, P2145, DOI 10.1371/journal.pbio.0050246; Cummings WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004075; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Hammond PW, 2010, MABS-AUSTIN, V2, P157, DOI 10.4161/mabs.2.2.11301; Hatanaka A, 2005, MOL CELL BIOL, V25, P1124, DOI 10.1128/MCB.25.3.1124-1134.2005; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Kajita M, 2010, J BIOSCI BIOENG, V109, P407, DOI 10.1016/j.jbiosc.2009.09.050; Katoh M, 2007, STEM CELL REV, V3, P30, DOI 10.1007/s12015-007-0006-6; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Nishibori N, 2006, MOL IMMUNOL, V43, P634, DOI 10.1016/j.molimm.2005.04.002; Ordinario EC, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-98; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Tsurushita N, 2004, J IMMUNOL METHODS, V295, P9, DOI 10.1016/j.jim.2004.08.018; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; Yabuki M, 2009, J IMMUNOL, V182, P408, DOI 10.4049/jimmunol.182.1.408	33	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36032	10.1371/journal.pone.0036032	http://dx.doi.org/10.1371/journal.pone.0036032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558313	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000104
J	Marquez-Ruiz, J; Cheron, G				Marquez-Ruiz, Javier; Cheron, Guy			Sensory Stimulation-Dependent Plasticity in the Cerebellar Cortex of Alert Mice	PLOS ONE			English	Article							LONG-TERM DEPRESSION; PARALLEL FIBER SYNAPSES; PURKINJE-CELL DENDRITES; SYNAPTIC PLASTICITY; GRANULE CELL; GLUTAMATE SENSITIVITY; SPATIAL-ORGANIZATION; TACTILE STIMULATION; IN-VIVO; RAT	In vitro studies have supported the occurrence of cerebellar long-term depression (LTD), an interaction between the parallel fibers and Purkinje cells (PCs) that requires the combined activation of the parallel and climbing fibers. To demonstrate the existence of LTD in alert animals, we investigated the plasticity of local field potentials (LFPs) evoked by electrical stimulation of the whisker pad. The recorded LFP showed two major negative waves corresponding to trigeminal (broken into the N2 and N3 components) and cortical responses. PC unitary extracellular recording showed that N2 and N3 occurred concurrently with PC evoked simple spikes, followed by an evoked complex spike. Polarity inversion of the N3 component at the PC level and N3 amplitude reduction after electrical stimulation of the parallel fiber volley applied on the surface of the cerebellum 2 ms earlier strongly suggest that N3 was related to the parallel fiber-PC synapse activity. LFP measurements elicited by single whisker pad stimulus were performed before and after trains of electrical stimuli given at a frequency of 8 Hz for 10 min. We demonstrated that during this later situation, the stimulation of the PC by parallel and climbing fibers was reinforced. After 8-Hz stimulation, we observed long-term modifications (lasting at least 30 min) characterized by a specific decrease of the N3 amplitude accompanied by an increase of the N2 and N3 latency peaks. These plastic modifications indicated the existence of cerebellar LTD in alert animals involving both timing and synaptic modulations. These results corroborate the idea that LTD may underlie basic physiological functions related to calcium-dependent synaptic plasticity in the cerebellum.	[Marquez-Ruiz, Javier] Univ Pablo de Olavide, Div Neurociencias, Seville, Spain; [Cheron, Guy] Univ Mons, Lab Electrophysiol, B-7000 Mons, Belgium; [Cheron, Guy] Univ Libre Brussels, Lab Neurophysiol & Movement Biomech CP601, Brussels, Belgium	Universidad Pablo de Olavide; University of Mons; Universite Libre de Bruxelles	Marquez-Ruiz, J (corresponding author), Univ Pablo de Olavide, Div Neurociencias, Seville, Spain.	gcheron@ulb.ac.be	Márquez-Ruiz, Javier/P-3998-2014	Márquez-Ruiz, Javier/0000-0002-8036-8707	Belgian Federal Science Policy Office; European Space Agency [AO-2004,118]; Belgian National Fund for Scientific Research (FNRS); Universite Libre de Bruxelles; Universite de Mons (Belgium); Ministerio de Educacion of the Spanish Government	Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); European Space Agency(European Space AgencyEuropean Commission); Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles; Universite de Mons (Belgium); Ministerio de Educacion of the Spanish Government(Spanish Government)	This work was funded by the Belgian Federal Science Policy Office, the European Space Agency, (AO-2004,118), the Belgian National Fund for Scientific Research (FNRS), and the research funds of the Universite Libre de Bruxelles and the Universite de Mons (Belgium). This work was also supported by the Ministerio de Educacion y Ciencia Programa Nacional de Movilidad de Recursos Humanos del Plan nacional de I-D+I 2008-2011 of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ARMSTRONG DM, 1980, J PHYSIOL-LONDON, V309, P357, DOI 10.1113/jphysiol.1980.sp013513; Bidoret C, 2009, P NATL ACAD SCI USA, V106, P14126, DOI 10.1073/pnas.0904284106; Bosman LWJ, 2010, J PHYSIOL-LONDON, V588, P3757, DOI 10.1113/jphysiol.2010.195180; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; CARVELL GE, 1990, J NEUROSCI, V10, P2638; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chen G, 2009, J NEUROPHYSIOL, V101, P234, DOI 10.1152/jn.90829.2008; Cheron G, 2004, J NEUROSCI, V24, P434, DOI 10.1523/JNEUROSCI.3197-03.2004; Cheron G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007991; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; EBNER TJ, 1983, J NEUROPHYSIOL, V50, P205, DOI 10.1152/jn.1983.50.1.205; ECCLES JC, 1967, EXP BRAIN RES, V3, P58; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; Eccles JC, 1967, CEREBELLUM NEURONAL; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EKEROT CF, 1989, NEUROSCI RES, V6, P264, DOI 10.1016/0168-0102(89)90065-5; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Holtzman T, 2006, J PHYSIOL-LONDON, V574, P491, DOI 10.1113/jphysiol.2006.108282; Isope P, 2002, J NEUROSCI, V22, P9668; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Ito M, 1984, CEREBELLUM NEURAL CO; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Llinas R, 1997, LEARN MEMORY, V3, P445, DOI 10.1101/lm.3.6.445; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Llinas RR, 1982, CEREBELLUM NEW VISTA, P189; Lu H, 2009, J COMP NEUROL, V514, P583, DOI 10.1002/cne.22041; Mapelli J, 2007, J NEUROSCI, V27, P1285, DOI 10.1523/JNEUROSCI.4873-06.2007; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Megevand P, 2009, J NEUROSCI, V29, P5326, DOI 10.1523/JNEUROSCI.5965-08.2009; Mittmann W, 2007, J NEUROSCI, V27, P5559, DOI 10.1523/JNEUROSCI.5117-06.2007; Morissette J, 1996, EXP BRAIN RES, V109, P240; OJAKANGAS CL, 1992, J NEUROPHYSIOL, V68, P2222, DOI 10.1152/jn.1992.68.6.2222; Piochon Claire, 2010, J Neurosci, V30, P15330, DOI 10.1523/JNEUROSCI.4344-10.2010; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Roggeri L, 2008, J NEUROSCI, V28, P6354, DOI 10.1523/JNEUROSCI.5709-07.2008; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Servais L, 2007, P NATL ACAD SCI USA, V104, P9858, DOI 10.1073/pnas.0607037104; Sims RE, 2006, J NEUROSCI, V26, P5153, DOI 10.1523/JNEUROSCI.4121-05.2006; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang X, 2009, NEUROSCIENCE, V162, P713, DOI 10.1016/j.neuroscience.2009.01.071; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1	56	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36184	10.1371/journal.pone.0036184	http://dx.doi.org/10.1371/journal.pone.0036184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563448	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100073
J	Crouzier, L; Dubois, C; Edwards, SL; Lauridsen, LH; Wengel, J; Veedu, RN				Crouzier, Lucile; Dubois, Camille; Edwards, Stacey L.; Lauridsen, Lasse H.; Wengel, Jesper; Veedu, Rakesh N.			Efficient Reverse Transcription Using Locked Nucleic Acid Nucleotides towards the Evolution of Nuclease Resistant RNA Aptamers	PLOS ONE			English	Article							DNA-POLYMERASE; EMERGING CLASS; LNA; LIGANDS; SELEX; THERAPEUTICS; RECOGNITION; DIAGNOSTICS; MOLECULES; DUPLEXES	Background: Modified nucleotides are increasingly being utilized in the de novo selection of aptamers for enhancing their drug-like character and abolishing the need for time consuming trial-and-error based post-selection modifications. Locked nucleic acid (LNA) is one of the most prominent and successful nucleic acid analogues because of its remarkable properties, and widely explored as building blocks in therapeutic oligonucleotides. Evolution of LNA-modified RNA aptamers requires an efficient reverse transcription method for PCR enrichment of the selected RNA aptamer candidates. Establishing this key step is a pre-requisite for performing LNA-modified RNA aptamer selection. Methodology: In this study three different reverse transcriptases were investigated towards the enzymatic recognition of LNA nucleotides. Both incorporation as well as reading capabilities of the LNA nucleotides was investigated to fully understand the limitations of the enzymatic recognition. Conclusions: We found that SuperScript (R) III Reverse Transcriptase is an efficient enzyme for the recognition of LNA nucleotides, making it a prime candidate to be used in de novo selection of LNA containing RNA aptamers	[Crouzier, Lucile; Dubois, Camille; Edwards, Stacey L.; Lauridsen, Lasse H.; Veedu, Rakesh N.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Crouzier, Lucile; Dubois, Camille] Inst Polytech LaSalle Beauvais, Beauvais, France; [Lauridsen, Lasse H.] Scion DTU, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [Wengel, Jesper] Univ So Denmark, Dept Chem & Phys, Nucle Acid Ctr, Odense, Denmark	University of Queensland; UniLaSalle; Technical University of Denmark; University of Southern Denmark	Crouzier, L (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	rakesh@uq.edu.au	Edwards, Stacey/A-4980-2011; wengel, jesper/K-1177-2013	Edwards, Stacey/0000-0001-7428-4139; Wengel, Jesper/0000-0001-9835-1009	University of Queensland Fellowship [2009001762]; University of Queensland Early Career Research Grant [2010002143]; EU [ERC-2010-AdG_20100317]	University of Queensland Fellowship; University of Queensland Early Career Research Grant; EU(European Commission)	The work was supported by the University of Queensland Fellowship (Project ID: 2009001762) and The University of Queensland Early Career Research Grant (ID: 2010002143) to RNV. JW acknowledges the funding from EU (ERC-2010-AdG_20100317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Jayasena SD, 1999, CLIN CHEM, V45, P1628; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Veedu RN, 2007, CHEMBIOCHEM, V8, P490, DOI 10.1002/cbic.200600501; Veedu RN, 2010, BIOORG MED CHEM LETT, V20, P6565, DOI 10.1016/j.bmcl.2010.09.044; Veedu RN, 2010, CHEM BIODIVERS, V7, P536, DOI 10.1002/cbdv.200900343; Veedu RN, 2009, RNA BIOL, V6, P321, DOI 10.4161/rna.6.3.8807; Veedu RN, 2009, ORG BIOMOL CHEM, V7, P1404, DOI 10.1039/b819946a; Veedu RN, 2009, MOL BIOSYST, V5, P787, DOI 10.1039/b905513b; Wengel J, 1999, ACCOUNTS CHEM RES, V32, P301, DOI 10.1021/ar980051p	22	25	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35990	10.1371/journal.pone.0035990	http://dx.doi.org/10.1371/journal.pone.0035990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558297	Green Published, gold			2022-12-25	WOS:000305345200106
J	Dong, C; Wu, Y; Wang, Y; Wang, C; Kang, T; Rychahou, PG; Chi, YI; Evers, BM; Zhou, BP				Dong, C.; Wu, Y.; Wang, Y.; Wang, C.; Kang, T.; Rychahou, P. G.; Chi, Y-I; Evers, B. M.; Zhou, B. P.			Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer	ONCOGENE			English	Article						metastasis; EMT; chromatin modifications; transcription; Snail	EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; HISTONE H3; DNA METHYLATION; GENE-EXPRESSION; G9A; METHYLTRANSFERASES; DOMAIN; INFLAMMATION; SUPERFAMILY	Expression of E-cadherin, a hallmark of epithelial-mesenchymal transition (EMT), is often lost due to promoter DNA methylation in basal-like breast cancer (BLBC), which contributes to the metastatic advantage of this disease; however, the underlying mechanism remains unclear. Here, we identified that Snail interacted with Suv39H1 (suppressor of variegation 3-9 homolog 1), a major methyltransferase responsible for H3K9me3 that intimately links to DNA methylation. We demonstrated that the SNAG domain of Snail and the SET domain of Suv39H1 were required for their mutual interactions. We found that H3K9me3 and DNA methylation on the E-cadherin promoter were higher in BLBC cell lines. We showed that Snail interacted with Suv39H1 and recruited it to the E-cadherin promoter for transcriptional repression. Knockdown of Suv39H1 restored E-cadherin expression by blocking H3K9me3 and DNA methylation and resulted in the inhibition of cell migration, invasion and metastasis of BLBC. Our study not only reveals a critical mechanism underlying the epigenetic regulation of EMT, but also paves a way for the development of new treatment strategies against this disease. Oncogene (2013) 32, 1351-1362; doi:10.1038/onc.2012.169; published online 7 May 2012	[Dong, C.; Wang, Y.; Chi, Y-I; Evers, B. M.; Zhou, B. P.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Dong, C.; Wu, Y.; Wang, Y.; Wang, C.; Rychahou, P. G.; Evers, B. M.; Zhou, B. P.] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40506 USA; [Wu, Y.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40506 USA; [Wang, C.] Univ Kentucky, Coll Med, Dept Biostat, Lexington, KY 40506 USA; [Kang, T.] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Rychahou, P. G.; Evers, B. M.] Univ Kentucky, Coll Med, Dept Surg, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; State Key Lab Oncology South China; University of Kentucky	Zhou, BP (corresponding author), Univ Kentucky, Coll Med, Markey Canc Ctr, Dept Mol & Cellular Biochem, BBSRB Room B336,741 South Limestone, Lexington, KY 40506 USA.	peter.zhou@uky.edu		Rychahou, Piotr/0000-0001-7352-9122	NIH [RO1CA125454]; Susan G Komen Foundation [KG081310]; Mary Kay Ash Foundation; NATIONAL CANCER INSTITUTE [R01CA125454] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); Mary Kay Ash Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Nathan L Vanderford for critical reading and editing of this manuscript. This work was supported by grants from NIH (RO1CA125454), Susan G Komen Foundation (KG081310), and Mary Kay Ash Foundation (to BP Zhou).	Barrallo-Gimeno A, 2009, TRENDS GENET, V25, P248, DOI 10.1016/j.tig.2009.04.001; Bergamaschi A, 2009, MOL ONCOL, V3, P469, DOI 10.1016/j.molonc.2009.07.003; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Forneris F, 2008, TRENDS BIOCHEM SCI, V33, P181, DOI 10.1016/j.tibs.2008.01.003; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Mullins M, 2007, CLIN CHEM, V53, P1273, DOI 10.1373/clinchem.2006.083725; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wang Yifan, 2011, Chin J Cancer, V30, P603, DOI 10.5732/cjc.011.10226; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Wu YD, 2009, J BIOL CHEM, V284, P640, DOI 10.1074/jbc.M806916200; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	65	145	153	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2013	32	11					1351	1362		10.1038/onc.2012.169	http://dx.doi.org/10.1038/onc.2012.169			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22562246	Green Accepted, Green Submitted			2022-12-25	WOS:000316455600002
J	Weiler, M; Pfenning, PN; Thiepold, AL; Blaes, J; Jestaedt, L; Gronych, J; Dittmann, LM; Berger, B; Jugold, M; Kosch, M; Combs, SE; von Deimling, A; Weller, M; Bendszus, M; Platten, M; Wick, W				Weiler, M.; Pfenning, P-N; Thiepold, A-L; Blaes, J.; Jestaedt, L.; Gronych, J.; Dittmann, L. M.; Berger, B.; Jugold, M.; Kosch, M.; Combs, S. E.; von Deimling, A.; Weller, M.; Bendszus, M.; Platten, M.; Wick, W.			Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment	ONCOGENE			English	Article						angiogenesis; glioblastoma; invasion; mammalian target of rapamycin; regulator of G protein signaling	MAMMALIAN TARGET; PHASE-III; CELLS; GLIOBLASTOMA; REGULATOR; PHOSPHORYLATION; RADIOTHERAPY; EXPRESSION; PROTEINS; CCI-779	An essential mode of acquired resistance to radiotherapy (RT) appears to be promotion of tumor cell motility and invasiveness in various cancer types, including glioblastoma, a process resembling 'evasive resistance'. Hence, a logical advancement of RI would be to identify suitable complementary treatment strategies, ideally targeting cell motility. Here we report that the combination of focal RT and mammalian target of rapamycin (mTOR) inhibition using clinically relevant concentrations of temsirolimus (CCI-779) prolongs survival in a syngeneic mouse glioma model through additive cytostatic effects. In vitro, the mTOR inhibitor CCI-779 exerted marked anti-invasive effects, irrespective of the phosphatase and tensin homolog deleted on chromosome 10 status and counteracted the proinvasive effect of sublethal irradiation. Mechanistically, we identified regulator of G-protein signaling 4 (RGS4) as a novel target of mTOR inhibition and a key driver of glioblastoma invasiveness, sensitive to the anti-invasive properties of CCI-779. Notably, suppression of RGS4-dependent glioma cell invasion was signaled through both mTOR complexes, mTORC1 and mTORC2, in a concentration-dependent manner, indicating that high doses of CCI-779 may overcome tumor-cell resistance associated with the sole inhibition of mTORC1. We conclude that combined RT and mTOR inhibition is a promising therapeutic option that warrants further clinical investigation in upfront glioblastoma therapy. Oncogene (2013) 32, 1099-1109; doi:10.103g/onc.2012.137; published online 7 May 2012	[Weiler, M.; Pfenning, P-N; Thiepold, A-L; Blaes, J.; Berger, B.; Wick, W.] German Canc Res Ctr, Clin Cooperat Unit Neurooncol, Heidelberg, Germany; [Weiler, M.; Platten, M.; Wick, W.] Univ Heidelberg Hosp, Dept Neurooncol, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Jestaedt, L.; Bendszus, M.] Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany; [Gronych, J.; Dittmann, L. M.] German Canc Res Ctr, Project Grp, Small Anim Imaging Ctr, Div Mol Genet, Heidelberg, Germany; [Berger, B.] Univ Heidelberg Hosp, Dept Neurol, D-69120 Heidelberg, Germany; [Jugold, M.] German Canc Res Ctr, Project Grp, Small Anim Imaging Ctr, Div Med Phys Radiol, Heidelberg, Germany; [Kosch, M.] Pfizer, Berlin, Germany; [Combs, S. E.] Univ Heidelberg Hosp, Dept Radiat Oncol, D-69120 Heidelberg, Germany; [von Deimling, A.] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [von Deimling, A.] Univ Heidelberg Hosp, Dept Neuropathol, D-69120 Heidelberg, Germany; [Weller, M.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Platten, M.] German Canc Res Ctr, Helmholtz Grp Expt Neuroimmunol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Pfizer; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Zurich; University Zurich Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	Wick, W (corresponding author), Univ Heidelberg Hosp, Dept Neurooncol, Natl Ctr Tumor Dis, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	wolfgang.wick@med.uni-heidelberg.de	Thiepold, Anna-Luisa/AAW-8310-2021; Wick, Wolfgang/AAA-2545-2020; von Deimling, Andreas/F-7774-2013; Platten, Michael/F-2902-2013; Gronych, Jan/G-9954-2013	Wick, Wolfgang/0000-0002-6171-634X; von Deimling, Andreas/0000-0002-5863-540X; Platten, Michael/0000-0002-4746-887X; Combs, Stephanie/0000-0002-6934-2864; Weller, Michael/0000-0002-1748-174X	Brain Tumor Network (BTNplus) [10 01GS0883\]; National Genome Research Network (NGFNplus) by the Federal Ministry of Education and Research (BMBF); Charitable Hertie Foundation	Brain Tumor Network (BTNplus); National Genome Research Network (NGFNplus) by the Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Charitable Hertie Foundation	We thank P Rubmann, A-C Klein and N Sims for excellent technical assistance. We also thank the Microscopy Core Facility of the DKFZ and the Nikon Imaging Center at the University of Heidelberg, Heidelberg, Germany. We are grateful to T Wieland, University of Heidelberg, Mannheim, Germany, for providing the pCR3.0-RGS4 expression vector. This work was supported by the Brain Tumor Network (BTNplus), Subproject 10 01GS0883 (WW) and Subproject 4 (JG, LMD) of the National Genome Research Network (NGFNplus) by the Federal Ministry of Education and Research (BMBF), and the Charitable Hertie Foundation. BB is a fellow in the Postdoc Program of the Medical Faculty of the University of Heidelberg.	Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Doherty L, 2006, NEUROLOGY, V67, P156, DOI 10.1212/01.wnl.0000223844.77636.29; Dudkin L, 2001, CLIN CANCER RES, V7, P1758; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erdely HA, 2004, EUR J NEUROSCI, V19, P3125, DOI 10.1111/j.0953-816X.2004.03364.x; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Geoerger B, 2001, CANCER RES, V61, P1527; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Hu WH, 2009, AM J PHYSIOL-CELL PH, V296, pC1310, DOI 10.1152/ajpcell.00573.2008; Hurst JH, 2009, BIOCHEM PHARMACOL, V78, P1289, DOI 10.1016/j.bcp.2009.06.028; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Levitt P, 2006, BIOL PSYCHIAT, V60, P534, DOI 10.1016/j.biopsych.2006.04.028; Minniti G, 2010, RADIOTHER ONCOL, V97, P377, DOI 10.1016/j.radonc.2010.08.020; Motzer RJ, 2007, J CLIN ONCOL, V25, P3958, DOI 10.1200/JCO.2006.10.5916; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park IH, 2002, J BIOL CHEM, V277, P31423, DOI 10.1074/jbc.M204080200; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pitter KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014545; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Reardon DA, 2010, J NEURO-ONCOL, V96, P219, DOI 10.1007/s11060-009-9950-0; Rieger J, 2008, J NEUROCHEM, V106, P2436, DOI 10.1111/j.1471-4159.2008.05586.x; Ronellenfitsch MW, 2009, BRAIN, V132, P1509, DOI 10.1093/brain/awp093; Sampson JH, 1997, NEUROSURGERY, V41, P1365, DOI 10.1097/00006123-199712000-00024; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tabatabai G, 2006, BRAIN, V129, P2426, DOI 10.1093/brain/awl173; Tatenhorst L, 2004, J NEUROPATH EXP NEUR, V63, P210, DOI 10.1093/jnen/63.3.210; Weiler M, 2006, CELL DEATH DIFFER, V13, P1156, DOI 10.1038/sj.cdd.4401786; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wild-Bode C, 2001, CANCER RES, V61, P2744; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Yang L, 2008, CLIN CANCER RES, V14, P3993, DOI 10.1158/1078-0432.CCR-07-4152	49	27	28	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2013	32	9					1099	1109		10.1038/onc.2012.137	http://dx.doi.org/10.1038/onc.2012.137			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110FU	22562250	Green Accepted			2022-12-25	WOS:000316428800004
J	Connell, C; Tong, HI; Wang, Z; Allmann, E; Lu, YA				Connell, Christina; Tong, Hsin-I; Wang, Zi; Allmann, Erin; Lu, Yuanan			New Approaches for Enhanced Detection of Enteroviruses from Hawaiian Environmental Waters	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; TIME RT-PCR; REVERSE-TRANSCRIPTASE PCR; WATERBORNE ENTERIC VIRUSES; CELL-CULTURE; INFECTIOUS ENTEROVIRUSES; SURFACE WATERS; ASSAY; IDENTIFICATION; AMPLIFICATION	Health risks associated with sewage-contaminated recreational waters are of important public health concern. Reliable water monitoring systems are therefore crucial. Current recreational water quality criteria rely predominantly on the enumeration of bacterial indicators, while potentially dangerous viral pathogens often remain undetected. Human enteric viruses have been proposed as alternative indicators; however, their detection is often hindered by low viral concentrations present in the environment. Reported here are novel and effective laboratory protocols for viral concentration and highly sensitive and optimized RT-PCR for the efficient detection of enteroviruses, an important enteric virus subset, in Hawaiian environmental waters. Eighteen published enterovirus primer pairs were comparatively evaluated for detection sensitivity. The primer set exhibiting the lowest detection limit under optimized conditions, EQ-1/EQ-2, was validated in a field survey of 22 recreational bodies of water located around the island of Oahu, Hawaii. Eleven sites tested positive for enterovirus, indicating fecal contamination at these locations. As an additional means of viral concentration, shellfish were collected from 9 sample sites and subjected to dissection, RNA extraction, and subsequent RT-PCR. Shellfish tissue from 6 of 9 sites tested positive for enterovirus. The techniques implemented here are valuable resources to aid accurate reflection of microbial contamination in Hawaii's environmental waters.	[Connell, Christina] Univ Hawaii Manoa, Dept Publ Hlth Sci, Honolulu, HI 96822 USA; Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Connell, C (corresponding author), Univ Hawaii Manoa, Dept Publ Hlth Sci, Honolulu, HI 96822 USA.	yuanan@hawaii.edu			Centers for Oceans and Human Health (COHH); National Institutes of Environmental Health Sciences [P50ES012740]; National Science Foundation [OCE04-32479, OCE09-11000]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012740] Funding Source: NIH RePORTER	Centers for Oceans and Human Health (COHH); National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from the Centers for Oceans and Human Health (COHH) program, the National Institutes of Environmental Health Sciences (P50ES012740) and the National Science Foundation (OCE04-32479 and OCE09-11000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBASZADEGAN M, 1993, APPL ENVIRON MICROB, V59, P1318, DOI 10.1128/AEM.59.5.1318-1324.1993; Asahina AY, 2009, J VIROL METHODS, V158, P46, DOI 10.1016/j.jviromet.2009.01.013; Bej AK, 2001, APPL ENVIRON MICROB, V57, P1013; Bessaud M, 2008, J VIROL METHODS, V149, P277, DOI 10.1016/j.jviromet.2008.01.027; Boehm AB, 2003, ENVIRON SCI TECHNOL, V37, P673, DOI 10.1021/es025934x; Bosch A., 1998, CURR OPIN BIOTECH, V19, P295; Byappanahalli M, 2004, WATER SCI TECHNOL, V50, P27, DOI 10.2166/wst.2004.0009; Choi S, 2005, APPL ENVIRON MICROB, V71, P7426, DOI 10.1128/AEM.71.11.7426-7433.2005; Chung HM, 1996, APPL ENVIRON MICROB, V62, P3772, DOI 10.1128/AEM.62.10.3772-3778.1996; Dierssen U, 2008, J CLIN VIROL, V42, P58, DOI 10.1016/j.jcv.2007.11.016; Donaldson KA, 2002, WATER RES, V36, P2505, DOI 10.1016/S0043-1354(01)00479-1; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; Formiga-Cruz M, 2003, APPL ENVIRON MICROB, V69, P1556, DOI 10.1128/AEM.69.3.1556-1563.2003; Fuhrman JA, 2005, APPL ENVIRON MICROB, V71, P4523, DOI 10.1128/AEM.71.8.4523-4530.2005; FUJIOKA RS, 1980, APPL ENVIRON MICROB, V39, P1105, DOI 10.1128/AEM.39.6.1105-1110.1980; Gersberg RM, 2006, APPL ENVIRON MICROB, V72, P7438, DOI 10.1128/AEM.01024-06; Gregory JB, 2006, APPL ENVIRON MICROB, V72, P3960, DOI 10.1128/AEM.02291-05; Griffin DW, 2003, CLIN MICROBIOL REV, V16, P129, DOI 10.1128/CMR.16.1.129-143.2003; Hot D, 2003, WATER RES, V37, P4703, DOI 10.1016/S0043-1354(03)00439-1; Hymas WC, 2008, CLIN CHEM, V54, P406, DOI 10.1373/clinchem.2007.095414; Ijzerman MM, 1997, J VIROL METHODS, V63, P145, DOI 10.1016/S0166-0934(96)02123-4; Iturriza-Gomara M, 2006, J MED VIROL, V78, P243, DOI 10.1002/jmv.20533; Jothikumar N, 2010, J VIROL METHODS, V169, P8, DOI 10.1016/j.jviromet.2010.06.005; Karamoko Y, 2005, J VIROL METHODS, V126, P135, DOI 10.1016/j.jviromet.2005.02.003; Lee C, 2004, APPL ENVIRON MICROB, V70, P6695, DOI 10.1128/AEM.70.11.6695-6705.2004; LEES DN, 1994, APPL ENVIRON MICROB, V60, P2999, DOI 10.1128/AEM.60.8.2999-3005.1994; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; PIRAINO FF, 1982, PUBLIC HEALTH REP, V97, P346; PUIG M, 1994, APPL ENVIRON MICROB, V60, P2963, DOI 10.1128/AEM.60.8.2963-2970.1994; Rajtar B, 2008, ANN AGR ENV MED, V15, P199; Reynolds KA, 1998, CAN J MICROBIOL, V44, P598, DOI 10.1139/cjm-44-6-598; Reynolds KA, 1996, APPL ENVIRON MICROB, V62, P1424, DOI 10.1128/AEM.62.4.1424-1427.1996; Schvoerer E, 2001, RES MICROBIOL, V152, P179, DOI 10.1016/S0923-2508(01)01190-1; Schwab KJ, 1996, APPL ENVIRON MICROB, V62, P2086, DOI 10.1128/AEM.62.6.2086-2094.1996; Tan EL, 2006, MOL CELL PROBE, V20, P135, DOI 10.1016/j.mcp.2005.11.003; Tong H, 2011, THESIS U HAWAII MANO; Tong HI, 2011, WATER RES, V45, P5837, DOI 10.1016/j.watres.2011.08.030; Tong HI, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-57; Zhang CM, 2010, J ENVIRON SCI-CHINA, V22, P1261, DOI 10.1016/S1001-0742(09)60248-5; Zoll GJ, 1991, J CLIN VIROL, V30, P160	40	89	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e32442	10.1371/journal.pone.0032442	http://dx.doi.org/10.1371/journal.pone.0032442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567083	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500001
J	Asad, S; Nikamo, P; Gyllenberg, A; Bennet, H; Hansson, O; Wierup, N; Carlsson, A; Forsander, G; Ivarsson, SA; Larsson, H; Lernmark, A; Lindblad, B; Ludvigsson, J; Marcus, C; Ronningen, KS; Nerup, J; Pociot, F; Luthman, H; Fex, M; Kockum, I				Asad, Samina; Nikamo, Pernilla; Gyllenberg, Alexandra; Bennet, Hedvig; Hansson, Ola; Wierup, Nils; Carlsson, Annelie; Forsander, Gun; Ivarsson, Sten-Anders; Larsson, Helena; Lernmark, Ake; Lindblad, Bengt; Ludvigsson, Johnny; Marcus, Claude; Ronningen, Kjersti S.; Nerup, Jan; Pociot, Flemming; Luthman, Holger; Fex, Malin; Kockum, Ingrid		Diabet Incidence Sweden Study Grp	HTR1A a Novel Type 1 Diabetes Susceptibility Gene on Chromosome 5p13-q13	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ASSOCIATION ANALYSIS; RECEPTORS; LINKAGE; RISK; SEROTONIN; MULTIPLEX; FAMILIES; PEPTIDE; REGIONS	Background: We have previously performed a genome-wide linkage study in Scandinavian Type 1 diabetes (T1D) families. In the Swedish families, we detected suggestive linkage (LOD <= 2.2) to the chromosome 5p13-q13 region. The aim of our study was to investigate the linked region in search for possible T1D susceptibility genes. Methodology/Principal Findings: Microsatellites were genotyped in the Scandinavian families to fine-map the previously linked region. Further, SNPs were genotyped in Swedish and Danish families as well as Swedish sporadic cases. In the Swedish families we detected genome-wide significant linkage to the 5-hydroxytryptamine receptor 1A (HTR1A) gene (LOD 3.98, p<9.8x10(-6)). Markers tagging two separate genes; the ring finger protein 180 (RNF180) and HTR1A showed association to T1D in the Swedish and Danish families (p<0.002, p<0.001 respectively). The association was not confirmed in sporadic cases. Conditional analysis indicates that the primary association was to HTR1A. Quantitative PCR show that transcripts of both HTR1A and RNF180 are present in human islets of Langerhans. Moreover, immunohistochemical analysis confirmed the presence of the 5-HTR1A protein in isolated human islets of Langerhans as well as in sections of human pancreas. Conclusions: We have identified and confirmed the association of both HTR1A and RFN180, two genes in high linkage disequilibrium (LD) to T1D in two separate family materials. As both HTR1A and RFN180 were expressed at the mRNA level and HTR1A as protein in human islets of Langerhans, we suggest that HTR1A may affect T1D susceptibility by modulating the initial autoimmune attack or either islet regeneration, insulin release, or both.	[Asad, Samina; Gyllenberg, Alexandra; Kockum, Ingrid] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Nikamo, Pernilla] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Bennet, Hedvig; Ivarsson, Sten-Anders; Larsson, Helena; Lernmark, Ake; Pociot, Flemming; Luthman, Holger; Fex, Malin] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Diabet & Celiac Unit, Malmo, Sweden; [Bennet, Hedvig; Hansson, Ola; Wierup, Nils; Luthman, Holger; Fex, Malin] Lund Univ, Ctr Diabet, Lund, Sweden; [Carlsson, Annelie] Univ Lund Hosp, Dept Pediat, S-22185 Lund, Sweden; [Forsander, Gun; Lindblad, Bengt] Queen Silvia Childrens Hosp, Dept Pediat, Gothenburg, Sweden; [Ludvigsson, Johnny] Linkoping Univ Hosp, Div Pediat, Dept Clin & Expt Med, Diabet Res Ctr, S-58185 Linkoping, Sweden; [Marcus, Claude] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Natl Childhood Obes Ctr, Stockholm, Sweden; [Ronningen, Kjersti S.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pediat Res, N-0027 Oslo, Norway; [Nerup, Jan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pociot, Flemming] Univ Hosp Glostrup, Glostrup Res Inst, Glostrup, Denmark	Karolinska Institutet; Karolinska Institutet; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Queen Silvia Children's Hospital; Linkoping University; Karolinska Institutet; University of Oslo; National Hospital Norway; Steno Diabetes Center; University of Copenhagen	Asad, S (corresponding author), Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden.	ingrid.kockum@ki.se	Ludvigsson, Johnny/AAI-2051-2020; Lernmark, Åke/F-8140-2015; Kockum, Ingrid/O-8781-2018; Hansson, Ola/F-1793-2011; Marcus, Claude/ABE-1177-2020	Ludvigsson, Johnny/0000-0003-1695-5234; Lernmark, Åke/0000-0003-1735-0499; Kockum, Ingrid/0000-0002-0867-4726; Hansson, Ola/0000-0002-7394-7639; Marcus, Claude/0000-0003-0890-2650; Pociot, Flemming/0000-0003-3274-5448; Fex, Malin/0000-0003-0675-7576; Elding Larsson, Helena/0000-0003-3306-1742	Swedish Research Council; Svenska Diabetes Fonden; Barndiabetes Fonden; Magnus Bergvalls Stiftelse; Novo Nordisk Foundation; Krapperup foundation; Ake Wiberg foundation; Swedish Society for Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Svenska Diabetes Fonden; Barndiabetes Fonden; Magnus Bergvalls Stiftelse; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Krapperup foundation; Ake Wiberg foundation; Swedish Society for Medicine	The study has been funded by Swedish Research Council, Svenska Diabetes Fonden, Barndiabetes Fonden, Magnus Bergvalls Stiftelse, the Novo Nordisk Foundation, the Krapperup foundation, the Ake Wiberg foundation and the Swedish Society for Medicine (to MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUNE TM, 1993, J IMMUNOL, V151, P1175; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlsson AKI, 2011, INT J OBESITY, P1; Coulie B, 1998, AM J PHYSIOL-ENDOC M, V274, pE317, DOI 10.1152/ajpendo.1998.274.2.E317; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ekelund E, 2008, ACTA DERM-VENEREOL, V88, P15, DOI 10.2340/00015555-0383; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hedstrom AK, 2009, NEUROLOGY, V73, P696, DOI 10.1212/WNL.0b013e3181b59c40; Holm P, 2004, DIABETES, V53, P1584, DOI 10.2337/diabetes.53.6.1584; Holm P, 2001, AM J HUM GENET, V69, P1301; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Jensen RA, 2007, J DIABETES COMPLICAT, V21, P205, DOI 10.1016/j.jdiacomp.2006.01.004; Kirchgessner AL, 1996, J COMP NEUROL, V364, P439, DOI 10.1002/(SICI)1096-9861(19960115)364:3<439::AID-CNE5>3.0.CO;2-5; Kling A, 2008, ANN RHEUM DIS, V67, P1111, DOI 10.1136/ard.2007.074948; Lesurtel M, 2008, CELL MOL LIFE SCI, V65, P940, DOI 10.1007/s00018-007-7377-3; Li MA, 2006, AM J HUM GENET S, VS79, P416; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mohanan VV, 2006, LIFE SCI, V78, P1603, DOI 10.1016/j.lfs.2005.07.027; Namjou B, 2005, ARTHRITIS RHEUM-US, V52, P3646, DOI 10.1002/art.21413; Namjou B, 2002, ARTHRITIS RHEUM, V46, P2937, DOI 10.1002/art.10588; Oturai A, 1999, ANN NEUROL, V46, P612, DOI 10.1002/1531-8249(199910)46:4<612::AID-ANA9>3.3.CO;2-N; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Stockmeier CA, 1998, J NEUROSCI, V18, P7394; SUNDLER F, 1980, INVEST CELL PATHOL, V3, P87; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Zawalich WS, 2004, ENDOCRINE, V23, P11, DOI 10.1385/ENDO:23:1:11	35	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35439	10.1371/journal.pone.0035439	http://dx.doi.org/10.1371/journal.pone.0035439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563461	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700010
J	Vitaliano, GD; Vitaliano, F; Rios, JD; Renshaw, PF; Teicher, MH				Vitaliano, Gordana D.; Vitaliano, Franco; Rios, Jose D.; Renshaw, Perry F.; Teicher, Martin H.			New Clathrin-Based Nanoplatforms for Magnetic Resonance Imaging	PLOS ONE			English	Article							MRI CONTRAST AGENTS; CENTRAL-NERVOUS-SYSTEM; DRUG-DELIVERY; IN-VITRO; GD-DTPA; VIRAL NANOPARTICLES; RELAXIVITY; ALBUMIN; ENDOCYTOSIS; STRATEGIES	Background: Magnetic Resonance Imaging (MRI) has high spatial resolution, but low sensitivity for visualization of molecular targets in the central nervous system (CNS). Our goal was to develop a new MRI method with the potential for non-invasive molecular brain imaging. We herein introduce new bio-nanotechnology approaches for designing CNS contrast media based on the ubiquitous clathrin cell protein. Methodology/Principal Findings: The first approach utilizes three-legged clathrin triskelia modified to carry 81 gadolinium chelates. The second approach uses clathrin cages self-assembled from triskelia and designed to carry 432 gadolinium chelates. Clathrin triskelia and cages were characterized by size, structure, protein concentration, and chelate and gadolinium contents. Relaxivity was evaluated at 0.47 T. A series of studies were conducted to ascertain whether fluorescent-tagged clathrin nanoplatforms could cross the blood brain barriers (BBB) unaided following intranasal, intravenous, and intraperitoneal routes of administration. Clathrin nanoparticles can be constituted as triskelia (18.5 nm in size), and as cages assembled from them (55 nm). The mean chelate: clathrin heavy chain molar ratio was 27.04+/-4.8: 1 for triskelia, and 4.2+/-1.04: 1 for cages. Triskelia had ionic relaxivity of 16 mM(-1) s(-1), and molecular relaxivity of 1,166 mM(-1) s(-1), while cages had ionic relaxivity of 81 mM(-1) s(-1) and molecular relaxivity of 31,512 mM(-1) s(-1). Thus, cages exhibited 20 times higher ionic relaxivity and 8,000-fold greater molecular relaxivity than gadopentetate dimeglumine. Clathrin nanoplatforms modified with fluorescent tags were able to cross or bypass the BBB without enhancements following intravenous, intraperitoneal and intranasal administration in rats. Conclusions/Significance: Use of clathrin triskelia and cages as carriers of CNS contrast media represents a new approach. This new biocompatible protein-based nanotechnology demonstrated suitable physicochemical properties to warrant further in vivo imaging and drug delivery studies. Significantly, both nanotransporters crossed and/or bypassed the BBB without enhancers. Thus, clathrin nanoplatforms could be an appealing alternative to existing CNS bio-nanotechnologies.	[Vitaliano, Gordana D.; Rios, Jose D.; Teicher, Martin H.] Harvard Univ, McLean Hosp, Sch Med, Lab Dev Psychopharmacol,Brain Imaging Ctr,Dept Ps, Belmont, MA USA; [Vitaliano, Franco] VXM, Boston, MA USA; [Renshaw, Perry F.] Univ Utah, Sch Med, Inst Brain, Salt Lake City, UT USA	Harvard University; McLean Hospital; Utah System of Higher Education; University of Utah	Vitaliano, GD (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Lab Dev Psychopharmacol,Brain Imaging Ctr,Dept Ps, Belmont, MA USA.	gvitaliano@mclean.harvard.edu	Teicher, Martin H/P-3906-2017; Renshaw, Perry/O-1384-2018	Teicher, Martin H/0000-0002-6036-0177; 	National Institute on Drug Abuse [1R03DA025804]; Brain and Behavior Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA025804, K05DA031247] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Brain and Behavior Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported, in part, by research grants from the National Institute on Drug Abuse www.nida.nih.gov (1R03DA025804) and the Brain and Behavior Research Foundation www.bbrfoundation.org to GV, who was a NARSAD Sidney R. Baer, Jr. Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P; Aime S, 2009, ACCOUNTS CHEM RES, V42, P822, DOI 10.1021/ar800192p; Allen M, 2005, MAGN RESON MED, V54, P807, DOI 10.1002/mrm.20614; Ananta JS, 2010, NAT NANOTECHNOL, V5, P815, DOI [10.1038/nnano.2010.203, 10.1038/NNANO.2010.203]; Anderson EA, 2006, NANO LETT, V6, P1160, DOI 10.1021/nl060378g; Artemov D, 2004, CURR PHARM BIOTECHNO, V5, P485, DOI 10.2174/1389201043376553; Baba T, 2001, TRAFFIC, V2, P501, DOI 10.1034/j.1600-0854.2001.20707.x; Basilion JP, 2005, CURR TOP DEV BIOL, V70, P1, DOI 10.1016/S0070-2153(05)70001-6; Bhaskar S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-3; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J; Caravan P, 2006, CHEM SOC REV, V35, P512, DOI 10.1039/b510982p; Caravan P, 2009, ACCOUNTS CHEM RES, V42, P851, DOI 10.1021/ar800220p; Cheng ZL, 2008, LANGMUIR, V24, P8169, DOI 10.1021/la801027q; Cheng ZL, 2010, ANGEW CHEM INT EDIT, V49, P346, DOI 10.1002/anie.200905133; Cooper MS, 2006, NAT PROTOC, V1, P314, DOI 10.1038/nprot.2006.49; CROWTHER RA, 1981, J CELL BIOL, V91, P790, DOI 10.1083/jcb.91.3.790; Datta A, 2008, J AM CHEM SOC, V130, P2546, DOI 10.1021/ja0765363; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Fatouros PP, 2006, RADIOLOGY, V240, P756, DOI 10.1148/radiol.2403051341; Ferguson ML, 2006, BIOCHEMISTRY-US, V45, P5916, DOI 10.1021/bi052568w; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Fries PH, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3456987; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Gasco MR, 2009, PROG BRAIN RES, V180, P181, DOI 10.1016/S0079-6123(08)80010-6; Giesel FL, 2006, INVEST RADIOL, V41, P222, DOI 10.1097/01.rli.0000192421.81037.d5; Gouin S, 2001, BIOCONJUGATE CHEM, V12, P372, DOI 10.1021/bc000109w; GRAGERA RR, 1993, CELL MOL BIOL, V39, P819; Granseth B, 2007, J PHYSIOL-LONDON, V585, P681, DOI 10.1113/jphysiol.2007.139022; Hooker JM, 2007, NANO LETT, V7, P2207, DOI 10.1021/nl070512c; Jaszberenyi Z, 2007, J BIOL INORG CHEM, V12, P406, DOI 10.1007/s00775-006-0197-3; Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441; Kateb B, 2011, NEUROIMAGE, V54, pS106, DOI 10.1016/j.neuroimage.2010.01.105; Kircher MF, 2003, CANCER RES, V63, P8122; KIRCHHAUSEN T, 1986, J ULTRA MOL STRUCT R, V94, P199, DOI 10.1016/0889-1605(86)90067-4; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kobayashi H, 2005, ADV DRUG DELIVER REV, V57, P2271, DOI 10.1016/j.addr.2005.09.016; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; Kotova S, 2010, FEBS LETT, V584, P44, DOI 10.1016/j.febslet.2009.11.039; Kozlowska D, 2009, ADV DRUG DELIVER REV, V61, P1402, DOI 10.1016/j.addr.2009.09.003; Liepold L, 2007, MAGN RESON MED, V58, P871, DOI 10.1002/mrm.21307; MaHam A, 2009, SMALL, V5, P1706, DOI 10.1002/smll.200801602; Manchester M, 2006, ADV DRUG DELIVER REV, V58, P1505, DOI 10.1016/j.addr.2006.09.014; McAteer MA, 2009, PROG BRAIN RES, V180, P73, DOI 10.1016/S0079-6123(08)80004-0; Mirzadeh S, 1990, BIOCONJUGATE CHEM, V1, P59, DOI 10.1021/bc00001a007; Morawski AM, 2004, MAGN RESON MED, V51, P480, DOI 10.1002/mrm.20010; Mulder WJM, 2009, ACCOUNTS CHEM RES, V42, P904, DOI 10.1021/ar800223c; Nagaraja TN, 2006, J NEUROSCI METH, V157, P238, DOI 10.1016/j.jneumeth.2006.05.013; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Nicolle GM, 2002, CHEM-EUR J, V8, P1040, DOI 10.1002/1521-3765(20020301)8:5<1040::AID-CHEM1040>3.0.CO;2-D; Noebauer-Huhmann IM, 2010, INVEST RADIOL, V45, P554, DOI 10.1097/RLI.0b013e3181ebd4e3; OGAN MD, 1987, INVEST RADIOL, V22, P665, DOI 10.1097/00004424-198708000-00008; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; PAAJANEN H, 1990, MAGNET RESON MED, V13, P38, DOI 10.1002/mrm.1910130106; Park JW, 2008, BIOCHEM BIOPH RES CO, V366, P769, DOI 10.1016/j.bbrc.2007.12.045; Partha R, 2009, INT J NANOMED, V4, P261; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; Pierre VC, 2006, INORG CHEM, V45, P8355, DOI 10.1021/ic061262q; PIPPIN CG, 1992, BIOCONJUGATE CHEM, V3, P342, DOI 10.1021/bc00016a014; Port M, 2005, INVEST RADIOL, V40, P565, DOI 10.1097/01.rli.0000175388.98721.9b; Provenzale JM, 2009, AM J NEURORADIOL, V30, P1293, DOI 10.3174/ajnr.A1590; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; SCHUHMANNGIAMPIERI G, 1991, INVEST RADIOL, V26, P969, DOI 10.1097/00004424-199111000-00008; Shvedova AA, 2010, ANNU REV PHARMACOL, V50, P63, DOI 10.1146/annurev.pharmtox.010909.105819; Traub LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000192; Villaraza AJL, 2010, CHEM REV, V110, P2921, DOI 10.1021/cr900232t; Vitaliano F, 2008, US Patent, Patent No. 7393924; Yang Z, 2010, J R SOC INTERFACE, V7, pS411, DOI 10.1098/rsif.2010.0158.focus; YOSHIMURA T, 1991, BIOCHEMISTRY-US, V30, P4528, DOI 10.1021/bi00232a023; ZARRILLI R, 1985, ARCH BIOCHEM BIOPHYS, V241, P22, DOI 10.1016/0003-9861(85)90356-X; Zhu YX, 2001, METHOD ENZYMOL, V329, P379	72	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35821	10.1371/journal.pone.0035821	http://dx.doi.org/10.1371/journal.pone.0035821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563470	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340700019
J	Ahlehoff, O; Skov, L; Gislason, G; Lindhardsen, J; Kristensen, SL; Iversen, L; Lasthein, S; Gniadecki, R; Dam, TN; Torp-Pedersen, C; Hansen, PR				Ahlehoff, Ole; Skov, Lone; Gislason, Gunnar; Lindhardsen, Jesper; Kristensen, Soren Lund; Iversen, Lars; Lasthein, Stine; Gniadecki, Robert; Dam, Tomas Norman; Torp-Pedersen, Christian; Hansen, Peter Riis			Pharmacological Undertreatment of Coronary Risk Factors in Patients with Psoriasis: Observational Study of the Danish Nationwide Registries	PLOS ONE			English	Article							CONSENSUS; QUALITY; DISEASE; CARE	Background: Patients with psoriasis have increased prevalence of coronary risk factors and limited recent results have suggested that these risk factors are undertreated in patients with psoriasis. This may contribute to the increased risk of cardiovascular diseases observed in patients with psoriasis. Objective: To examine the pharmacological treatment of coronary risk factors in patients with severe psoriasis treated with biologic agents in a real-world setting. Methods and Findings: Medical history of patients with severe psoriasis treated with biologic agents in the time period 2007-09 was retrieved from a Danish nationwide registry (DERMBIO). Individual-level linkage of nationwide administrative registries of hospitalizations, concomitant medications, and socioeconomic status was performed to gain insights into the use of pharmacological treatment. A total of 693 patients (mean age 46.1+/-12.7 years, 65.7% male) with severe psoriasis treated with biologic agents were identified. Hypertension, hypercholesterolemia, and diabetes mellitus were identified in 16.6%, 9.2%, and 6.7% of cases, respectively. Patients with severe psoriasis were significantly less likely to receive cardiovascular pharmacotherapy compared to age, sex, and coronary risk factor matched controls. In psoriatic patients with hypertension 27.7% received no antihypertensive pharmacotherapy. Patients with dyslipidemia received cholesterol-lowering medications in 55.8% of cases and patients with diabetes mellitus received angiotensin converting enzyme inhibitors/angiotensin II receptor blockers and cholesterol-lowering medications in 42.1% and 23.7% of cases, respectively. Similar results were found for the subset of patients with >1 coronary risk factor and for high risk patients with established atherosclerotic disease. Conclusion: This nationwide study of patients with severe psoriasis demonstrated substantial undertreatment of coronary risk factors. Increased focus on identifying cardiovascular risk factors and initiation of preventive cardiovascular pharmacotherapy in patients with psoriasis is warranted.	[Ahlehoff, Ole; Gislason, Gunnar; Lindhardsen, Jesper; Kristensen, Soren Lund; Torp-Pedersen, Christian; Hansen, Peter Riis] Copenhagen Univ Hosp Gentofte, Dept Cardiol, Hellerup, Denmark; [Ahlehoff, Ole] Copenhagen Univ Hosp Roskilde, Dept Internal Med, Roskilde, Denmark; [Skov, Lone] Copenhagen Univ Hosp Gentofte, Dept Dermatol, Hellerup, Denmark; [Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus, Denmark; [Lasthein, Stine] Odense Univ Hosp, Dept Dermatol, DK-5000 Odense, Denmark; [Gniadecki, Robert] Copenhagen Univ Hosp Bispebjerg, Dept Dermatol, Copenhagen, Denmark; [Dam, Tomas Norman] Copenhagen Univ Hosp Roskilde, Dept Dermatol, Roskilde, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Ahlehoff, O (corresponding author), Copenhagen Univ Hosp Gentofte, Dept Cardiol, Hellerup, Denmark.	olahha01@geh.regionh.dk	Gniadecki, Robert/A-5696-2010; Kristensen, Søren Lund/J-5267-2019; Gislason, Gunnar/B-7561-2009; Skov, Lone/W-3575-2018; Hansen, Peter Riis/AAR-7659-2020	Gniadecki, Robert/0000-0002-2310-8300; Kristensen, Søren Lund/0000-0002-9759-7397; Gislason, Gunnar/0000-0002-0548-402X; Skov, Lone/0000-0002-4784-9680; Iversen, Lars/0000-0003-1816-4508; Hansen, Peter Riis/0000-0002-9056-535X	Axel Muusfeldts Foundation; DERMBIO, (Dermatologisk Database for Biologisk Behandling af Psoriasis); Danish Psoriasis Association; Abbott; Janssen-Cilag; Merck-Serono; MSD; Pfizer	Axel Muusfeldts Foundation; DERMBIO, (Dermatologisk Database for Biologisk Behandling af Psoriasis); Danish Psoriasis Association; Abbott(Abbott Laboratories); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck-Serono(Merck & Company); MSD; Pfizer(Pfizer)	The study was financially supported by unrestricted grants from the Axel Muusfeldts Foundation, DERMBIO, (Dermatologisk Database for Biologisk Behandling af Psoriasis) and the Danish Psoriasis Association. DERMBIO database maintenance expenditure is covered by unrestricted equal grants from the manufacturers of biologics (Abbott, Janssen-Cilag, Merck-Serono [2007-2009], MSD, Pfizer). The database is administered by an independent steering committee of specialists in dermatology representing the dermatological departments and private practices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlehoff O, 2011, J INTERN MED, V270, P237, DOI 10.1111/j.1365-2796.2011.02368.x; Ahlehoff O, 2011, J INTERN MED, V270, P147, DOI 10.1111/j.1365-2796.2010.02310.x; Ahlehoff O, 2011, EUR HEART J     0825; [Anonymous], 2010, 18 UDV NEDS DDS DCS; Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Balci DD, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2008.02936.x; Basavaraj KH, 2010, INT J DERMATOL, V49, P1351, DOI 10.1111/j.1365-4632.2010.04570.x; De Simone C, 2011, EUR J DERMATOL, V21, P510, DOI 10.1684/ejd.2011.1324; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Friedewald VE, 2008, AM J CARDIOL, V102, P1631, DOI 10.1016/j.amjcard.2008.10.004; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gisondi P, 2010, AM J CARDIOL, V106, P1754, DOI 10.1016/j.amjcard.2010.08.016; Gniadecki R, 2011, BRIT J DERMATOL, V164, P1091, DOI 10.1111/j.1365-2133.2011.10213.x; Kimball AB, 2011, J AM ACAD DERMA 1021; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Kones Richard, 2011, Ther Adv Cardiovasc Dis, V5, P61, DOI 10.1177/1753944710391350; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; MacLean CH, 2000, JAMA-J AM MED ASSOC, V284, P984, DOI 10.1001/jama.284.8.984; Malik S, 2007, DIABETES RES CLIN PR, V77, P126, DOI 10.1016/j.diabres.2006.10.016; Mehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567; Menter A, 2010, J EUR ACAD DERMATOL, V24, P1371, DOI 10.1111/j.1468-3083.2010.03656.x; Parsi KK, 2011, J AM ACAD DERMA 1112; Peters MJ, ANN RHEUM DIS, V69, P325; Wakkee M, 2007, ATHEROSCLEROSIS, V190, P1, DOI 10.1016/j.atherosclerosis.2006.07.011; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Zafrir B, 2006, EUR J INTERN MED, V17, P495, DOI 10.1016/j.ejim.2006.03.005	26	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36342	10.1371/journal.pone.0036342	http://dx.doi.org/10.1371/journal.pone.0036342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558442	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340200069
J	Chen, CC; Tsai, SH; Lu, CC; Hu, ST; Wu, TS; Huang, TT; Said-Sadier, N; Ojcius, DM; Lai, HC				Chen, Chang-Chieh; Tsai, Sheng-Hui; Lu, Chia-Chen; Hu, Shiau-Ting; Wu, Ting-Shu; Huang, Tsung-Teng; Said-Sadier, Najwane; Ojcius, David M.; Lai, Hsin-Chih			Activation of an NLRP3 Inflammasome Restricts Mycobacterium kansasii Infection	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; NONTUBERCULOUS MYCOBACTERIA; TUBERCULOSIS INFECTION; INTERFERON-GAMMA; CLINICAL-MANIFESTATIONS; FRANCISELLA-TULARENSIS; CHLAMYDIAL INFECTION; PROTECTIVE IMMUNITY; RECEPTOR ANTAGONIST; NALP3 INFLAMMASOME	Mycobacterium kansasii has emerged as an important nontuberculous mycobacterium pathogen, whose incidence and prevalence have been increasing in the last decade. M. kansasii can cause pulmonary tuberculosis clinically and radiographically indistinguishable from that caused by Mycobacterium tuberculosis infection. Unlike the widely-studied M. tuberculosis, little is known about the innate immune response against M. kansasii infection. Although inflammasome activation plays an important role in host defense against bacterial infection, its role against atypical mycobacteria remains poorly understood. In this report, the role of inflammasome activity in THP-1 macrophages against M. kansasii infection was studied. Results indicated that viable, but not heat-killed, M. kansasii induced caspase-1-dependent IL-1 beta secretion in macrophages. The underlying mechanism was found to be through activation of an inflammasome containing the NLR (Nod-like receptor) family member NLRP3 and the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD). Further, potassium efflux, lysosomal acidification, ROS production and cathepsin B release played a role in M. kansasii-induced inflammasome activation. Finally, the secreted IL-1 beta derived from caspase-1 activation was shown to restrict intracellular M. kansasii. These findings demonstrate a biological role for the NLRP3 inflammasome in host defense against M. kansasii.	[Chen, Chang-Chieh] Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu, Taiwan; [Tsai, Sheng-Hui; Hu, Shiau-Ting] Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, Taipei, Taiwan; [Hu, Shiau-Ting] Natl Yang Ming Univ, Sch Med, Dept Microbiol & Immunol, Taipei 112, Taiwan; [Wu, Ting-Shu] Chang Gung Mem Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Wu, Ting-Shu] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Ojcius, David M.; Lai, Hsin-Chih] Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Huang, Tsung-Teng] Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Lai, Hsin-Chih] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Tao Yuan, Taiwan; [Said-Sadier, Najwane; Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Said-Sadier, Najwane; Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	Industrial Technology Research Institute - Taiwan; National Yang Ming Chiao Tung University; Fu Jen Catholic University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; University of California System; University of California Merced; University of California System; University of California Merced	Chen, CC (corresponding author), Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu, Taiwan.	hclai@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council, Taiwan, ROC [NSC 99-2321-B-002-022]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grant NSC 99-2321-B-002-022 from the National Science Council, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2011, J IMMUNOL, V187, P4744, DOI 10.4049/jimmunol.1101457; Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Arend SM, 2005, J INFECT DIS, V191, P1301, DOI 10.1086/428950; Arend SM, 2004, CLIN MICROBIOL INFEC, V10, P738, DOI 10.1111/j.1469-0691.2004.00898.x; Atianand MK, 2011, J BIOL CHEM, V286, P39033, DOI 10.1074/jbc.M111.244079; Awomoyi AA, 2005, J ENDOTOXIN RES, V11, P281, DOI 10.1179/096805105X58706; Bartralot R, 2000, J CUTAN PATHOL, V27, P124, DOI 10.1034/j.1600-0560.2000.027003124.x; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Bittner MJ, 1996, CLIN INFECT DIS, V22, P1109, DOI 10.1093/clinids/22.6.1109; Bloch KC, 1998, ANN INTERN MED, V129, P698, DOI 10.7326/0003-4819-129-9-199811010-00004; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; BUCKNER CB, 1991, AM J ROENTGENOL, V156, P255, DOI 10.2214/ajr.156.2.1898796; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Caruso AM, 1999, J IMMUNOL, V162, P5407; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; CHENSUE SW, 1992, AM J PATHOL, V140, P269; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Corbett EL, 1999, AM J RESP CRIT CARE, V160, P15, DOI 10.1164/ajrccm.160.1.9812080; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Evans AJ, 1996, THORAX, V51, P1243, DOI 10.1136/thx.51.12.1243; Evans SA, 1996, THORAX, V51, P1248, DOI 10.1136/thx.51.12.1248; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Field SK, 2006, CHEST, V129, P1653, DOI 10.1378/chest.129.6.1653; Florido M, 2002, IMMUNOLOGY, V106, P590, DOI 10.1046/j.1365-2567.2002.01459.x; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gadkowski LB, 2008, CLIN MICROBIOL REV, V21, P305, DOI 10.1128/CMR.00060-07; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gavrilin MA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00011; Gomez LM, 2006, TISSUE ANTIGENS, V67, P290, DOI 10.1111/j.1399-0039.2006.00566.x; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; HAVELL EA, 1992, J IMMUNOL, V148, P1486; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; KASAHARA K, 1988, AM J PATHOL, V130, P629; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kleinnijenhuis J, 2009, EUR J IMMUNOL, V39, P1914, DOI 10.1002/eji.200839115; Koh WJ, 2006, INT J TUBERC LUNG D, V10, P1001; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kurenuma T, 2009, INFECT IMMUN, V77, P3992, DOI 10.1128/IAI.00015-09; Lee HM, 2012, IMMUNOL CELL BIOL, V90, P601, DOI 10.1038/icb.2011.72; LILLO M, 1990, REV INFECT DIS, V12, P760; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; McIntire CR, 2009, APOPTOSIS, V14, P522, DOI 10.1007/s10495-009-0312-3; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; MULLER I, 1987, INFECT IMMUN, V55, P2037; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Netea MG, 2008, EXPERT OPIN BIOL TH, V8, P1867, DOI [10.1517/14712590802494212, 10.1517/14712590802494212 ]; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5; Paull DE, 2003, TRANSPLANTATION, V76, P270, DOI 10.1097/01.TP.0000072018.06230.A1; Pintado V, 2001, INFECTION, V29, P48, DOI 10.1007/s15010-001-0061-x; Pollock JM, 1997, J INFECT DIS, V175, P1251, DOI 10.1086/593686; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Satoskar AR, 1998, EUR J IMMUNOL, V28, P2066, DOI 10.1002/(SICI)1521-4141(199807)28:07<2066::AID-IMMU2066>3.0.CO;2-X; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; SHAFER RW, 1992, CLIN INFECT DIS, V15, P161, DOI 10.1093/clinids/15.1.161; SHERER R, 1986, ANN INTERN MED, V105, P710, DOI 10.7326/0003-4819-105-5-710; Shitrit D, 2007, EUR J CLIN MICROBIOL, V26, P679, DOI 10.1007/s10096-007-0331-3; Silva RA, 2001, IMMUNOLOGY, V103, P368, DOI 10.1046/j.1365-2567.2001.01237.x; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Taillard C, 2003, J CLIN MICROBIOL, V41, P1240, DOI 10.1128/JCM.41.3.1240-1244.2003; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; TSUKAMURA M, 1988, AM REV RESPIR DIS, V137, P1280, DOI 10.1164/ajrccm/137.6.1280; VALAINIS GT, 1991, J ACQ IMMUN DEF SYND, V4, P516; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Wallace RJ, 1998, AM J RESP CRIT CARE, V158, P1235, DOI 10.1164/ajrccm.158.4.9712098; Walter K, 2010, IMMUNOBIOLOGY, V215, P804, DOI 10.1016/j.imbio.2010.05.015; Wieland CW, 2006, MICROBES INFECT, V8, P2409, DOI 10.1016/j.micinf.2006.05.002; Wieland CW, 2006, AM J RESP CELL MOL, V34, P167, DOI 10.1165/rcmb.2005-0198OC; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; WITZIG RS, 1995, CLIN INFECT DIS, V21, P77, DOI 10.1093/clinids/21.1.77; WOLINSKY E, 1979, AM REV RESPIR DIS, V119, P107; Wu TS, 2009, J ANTIMICROB CHEMOTH, V64, P511, DOI 10.1093/jac/dkp238; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Yang CS, 2009, J IMMUNOL, V182, P3696, DOI 10.4049/jimmunol.0802217; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Yazdi AS, 2010, J INNATE IMMUN, V2, P228, DOI 10.1159/000283688; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	115	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36292	10.1371/journal.pone.0036292	http://dx.doi.org/10.1371/journal.pone.0036292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558425	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200064
J	Lussiana, C; Clemente, SVL; Ghelardi, A; Lonardi, M; Tarquino, IAP; Floridia, M				Lussiana, Cristina; Loa Clemente, Sofia Vanda; Ghelardi, Angelo; Lonardi, Magda; Pulido Tarquino, Ivan Alejandro; Floridia, Marco			Effectiveness of a Prevention of Mother-to-Child HIV Transmission Programme in an Urban Hospital in Angola	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; WOMEN; PREGNANCY; OUTCOMES; INFECTION	Background: Antiretroviral therapy is effective in reducing rates of mother-to child transmission of HIV to low levels in resource-limited contexts but the applicability and efficacy of these programs in the field are scarcely known. In order to explore such issues, we performed a descriptive study on retrospective data from hospital records of HIV-infected pregnant women who accessed in 2007-2010 the Luanda Municipal Hospital service for prevention of mother-to-child transmission (PMTCT). The main outcome measure was infant survival and HIV transmission. Our aim was to evaluate PMTCT programme in a local hospital setting in Africa. Results: Data for 104 pregnancies and 107 infants were analysed. Sixty-eight women (65.4%) had a first visit before or during pregnancy and received combination antiretroviral treatment (ART) in pregnancy. The remaining 36 women (34.6%) presented after delivery and received no ART during pregnancy. Across a median cohort follow-up time of 73 weeks, mortality among women with and without ART in pregnancy was 4.4% and 16.7%, respectively (death hazard ratio: 0.30, 95% CI 0.07-1.20, p = 0.089). The estimated rates of HIV transmission or death in the infants over a median follow up time of 74 weeks were 8.5% with maternal ART during pregnancy and 38.9% without maternal ART during pregnancy. Following adjustment for use of oral zidovudine in the newborn and exposure to maternal milk, no ART in pregnancy remained associated with a 5-fold higher infant risk of HIV transmission or death (adjusted odds ratio: 5.13, 95% CI: 1.31-20.15, p = 0.019). Conclusions: Among the women and infants adhering to the PMTCT programme, HIV transmission and mortality were low. However, many women presented too late for PMTCT, and about 20% of infants did not complete follow up. This suggests the need of targeted interventions that maintain the access of mothers and infants to prevention and care services for HIV.	[Lussiana, Cristina; Pulido Tarquino, Ivan Alejandro] Hosp Divina Providencia, Infect Dis Lab, Luanda, Angola; [Loa Clemente, Sofia Vanda] Hosp Divina Providencia, Clin Direct, Luanda, Angola; [Ghelardi, Angelo] Hosp Divina Providencia, Project Direct, Luanda, Angola; [Lonardi, Magda] Hosp Divina Providencia, Dept Pediat, Luanda, Angola; [Floridia, Marco] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Lussiana, C (corresponding author), Hosp Divina Providencia, Infect Dis Lab, Luanda, Angola.	cristinaelle@hotmail.it	Floridia, Marco/Q-6571-2017; Pulido Tarquino, Ivan Alejandro/GPS-7553-2022	Floridia, Marco/0000-0003-3971-0141; Pulido Tarquino, Ivan Alejandro/0000-0002-1448-8268				Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; Azcoaga-Lorenzo A, 2011, AIDS CARE, V23, P274, DOI 10.1080/09540121.2010.507750; Balogun M, 2010, PAN AFR MED J, V5; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dryden-Peterson S, 2011, J ACQUIR IMMUNE 0722; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Kouanda S, 2010, AIDS CARE, V22, P843, DOI 10.1080/09540120903499204; Koura K G, 2011, Med Trop (Mars), V71, P63; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Marazzi MC, 2010, AIDS, V24, P2819, DOI 10.1097/QAD.0b013e32833ff58c; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mirkuzie AH, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-267; Mockenhaupt FP, 2000, T ROY SOC TROP MED H, V94, P477, DOI 10.1016/S0035-9203(00)90057-9; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2018, RECOMMENDATIONS USE; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Tchendjou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010411; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2021, ANT DRUGS TREAT PREG; Youngleson MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013891	21	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36381	10.1371/journal.pone.0036381	http://dx.doi.org/10.1371/journal.pone.0036381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558455	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200073
J	Blum, ID; Lamont, EW; Rodrigues, T; Abizaid, A				Blum, Ian David; Lamont, Elaine Waddington; Rodrigues, Trevor; Abizaid, Alfonso			Isolating Neural Correlates of the Pacemaker for Food Anticipation	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; ENTRAINABLE CIRCADIAN OSCILLATOR; MIDBRAIN RAPHE NUCLEI; C-FOS EXPRESSION; SUPRACHIASMATIC NUCLEUS; FEEDING SCHEDULES; BRAIN-STEM; NEURONAL ACTIVATION; BEHAVIORAL AROUSAL; STRIA TERMINALIS	Mice fed a single daily meal at intervals within the circadian range exhibit food anticipatory activity. Previous investigations strongly suggest that this behaviour is regulated by a circadian pacemaker entrained to the timing of fasting/refeeding. The neural correlate(s) of this pacemaker, the food entrainable oscillator (FEO), whether found in a neural network or a single locus, remain unknown. This study used a canonical property of circadian pacemakers, the ability to continue oscillating after removal of the entraining stimulus, to isolate activation within the neural correlates of food entrainable oscillator from all other mechanisms driving food anticipatory activity. It was hypothesized that continued anticipatory activation of central nuclei, after restricted feeding and a return to ad libitum feeding, would elucidate a neural representation of the signaling circuits responsible for the timekeeping component of the food entrainable oscillator. Animals were entrained to a temporally constrained meal then placed back on ad libitum feeding for several days until food anticipatory activity was abolished. Activation of nuclei throughout the brain was quantified using stereological analysis of c-FOS expressing cells and compared against both ad libitum fed and food entrained controls. Several hypothalamic and brainstem nuclei remained activated at the previous time of food anticipation, implicating them in the timekeeping mechanism necessary to track previous meal presentation. This study also provides a proof of concept for an experimental paradigm useful to further investigate the anatomical and molecular substrates of the FEO.	[Blum, Ian David; Lamont, Elaine Waddington; Rodrigues, Trevor; Abizaid, Alfonso] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Blum, ID (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	alfonso_abizaid@carleton.ca	Blum, Ian D/B-3768-2012	Abizaid, Alfonso/0000-0001-9303-3511; Blum, Ian David/0000-0001-6999-8364	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This project was funded by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca/) and the Canada Foundation for Innovation (CFI, www.innovation.ca/) awarded to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2005, EUR J NEUROSCI, V21, P1536, DOI 10.1111/j.1460-9568.2005.03964.x; Acosta-Galvan G., 2011, P NATL ACAD SCI; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Angeles-Castellanos M, 2005, AM J PHYSIOL-REG I, V288, pR678, DOI 10.1152/ajpregu.00590.2004; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; BEALER SL, 1986, AM J PHYSIOL, V250, pR18, DOI 10.1152/ajpregu.1986.250.1.R18; BLOCK M, 1976, J COMP PHYSIOL, V109, P235, DOI 10.1007/BF00663606; Blum ID, 2012, NEUROSCI BIOBEHAV R, V36, P254, DOI 10.1016/j.neubiorev.2011.06.003; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P290, DOI 10.1037/h0022308; Boudaba C, 1996, J NEUROSCI, V16, P7151; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; Challet E, 1997, BRAIN RES, V770, P228, DOI 10.1016/S0006-8993(97)00796-8; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; Choi DC, 2006, FRONT NEUROENDOCRIN, V27, P51, DOI 10.1016/j.yfrne.2006.03.105; Choi SJ, 1998, J NEUROSCI, V18, P3843; CLARKE JD, 1986, PHYSIOL BEHAV, V36, P105, DOI 10.1016/0031-9384(86)90082-X; COLEMAN GJ, 1982, PHYSIOL BEHAV, V29, P107, DOI 10.1016/0031-9384(82)90373-0; Cullinan WE, 1996, J COMP NEUROL, V368, P88; Cullinan WE, 2008, BRAIN STRUCT FUNCT, V213, P63, DOI 10.1007/s00429-008-0192-2; Davidson AJ, 2006, AM J PHYSIOL-REG I, V290, pR1524, DOI 10.1152/ajpregu.00073.2006; Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x; Davidson AJ, 1998, J BIOL RHYTHM, V13, P422, DOI 10.1177/074873098129000246; Davidson AJ, 2000, AM J PHYSIOL-REG I, V278, pR1296, DOI 10.1152/ajpregu.2000.278.5.R1296; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Escobar C, 1998, AM J PHYSIOL-REG I, V274, pR1309, DOI 10.1152/ajpregu.1998.274.5.R1309; Escobar C, 2007, EUR J NEUROSCI, V26, P2804, DOI 10.1111/j.1460-9568.2007.05893.x; Escobar C, 2009, EUR J NEUROSCI, V30, P1665, DOI 10.1111/j.1460-9568.2009.06972.x; Faulconbridge LF, 2008, BRAIN RES, V1218, P151, DOI 10.1016/j.brainres.2008.04.068; Glass JD, 2003, J NEUROSCI, V23, P7451; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Guido ME, 1999, J BIOL RHYTHM, V14, P275, DOI 10.1177/074873099129000687; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; Herman JP, 2002, PHARMACOL BIOCHEM BE, V71, P457, DOI 10.1016/S0091-3057(01)00681-5; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; JACOBS BL, 1978, BRAIN RES, V147, P149, DOI 10.1016/0006-8993(78)90779-5; Johnstone LE, 2006, CELL METAB, V4, P313, DOI 10.1016/j.cmet.2006.08.003; Kalsbeek A, 2010, J NEUROENDOCRINOL, V22, P362, DOI 10.1111/j.1365-2826.2010.01956.x; Lamont EW, 2007, NEUROSCIENCE, V144, P402, DOI 10.1016/j.neuroscience.2006.09.027; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Mistlberger RE, 2006, CURR BIOL, V16, pR968, DOI 10.1016/j.cub.2006.10.020; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; MORI T, 1983, PHYSIOL BEHAV, V30, P259, DOI 10.1016/0031-9384(83)90016-1; Moriya T, 2009, EURO J NEUROSCI, V7, P1447; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Poulin AM, 2008, BRAIN RES, V1227, P128, DOI 10.1016/j.brainres.2008.06.039; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Ribeiro AC, 2007, P NATL ACAD SCI USA, V104, P20078, DOI 10.1073/pnas.0710096104; ROSENWASSER AM, 1984, PHYSIOL BEHAV, V32, P25, DOI 10.1016/0031-9384(84)90064-7; Sanchez E, 2008, ENDOCRINOLOGY, V149, P4329, DOI 10.1210/en.2008-0411; Carneiro BTS, 2009, CHRONOBIOL INT, V26, P1273, DOI 10.3109/07420520903404480; Schmidt Tiffany M, 2008, Cellscience, V5, P77; Skibicka KP, 2010, ENDOCR J, V57, pS518; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHAN FK, 1984, PHYSIOL BEHAV, V32, P663, DOI 10.1016/0031-9384(84)90323-8; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Sutton GM, 2010, FASEB J, V24, P862, DOI 10.1096/fj.09-142000; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Takase LF, 2008, BRAIN RES, V1200, P10, DOI 10.1016/j.brainres.2008.01.036; TSURUMI C, 1995, MOL CELL BIOL, V15, P5682; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Varcoe TJ, 2008, BRAIN RES, V1209, P19, DOI 10.1016/j.brainres.2008.02.091; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Verwey M, 2008, NEUROSCI LETT, V440, P54, DOI 10.1016/j.neulet.2008.05.043; Verwey M, 2012, J MOL NEUROSCI, V46, P258, DOI 10.1007/s12031-011-9529-z; Verwey M, 2009, EUR J NEUROSCI, V29, P2217, DOI 10.1111/j.1460-9568.2009.06766.x; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Webb IC, 2010, NEUROSCIENCE, V166, P739, DOI 10.1016/j.neuroscience.2010.01.014; Williams DL, 2009, AM J PHYSIOL-REG I, V297, pR1238, DOI 10.1152/ajpregu.00182.2009; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003; Ziegler DR, 2002, J COMP NEUROL, V448, P217, DOI 10.1002/cne.10257	87	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36117	10.1371/journal.pone.0036117	http://dx.doi.org/10.1371/journal.pone.0036117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558352	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000131
J	Guo, TT; Kong, J; Zhang, L; Zhang, CC; Hu, SM				Guo, Tingting; Kong, Jian; Zhang, Li; Zhang, Chenchen; Hu, Shumin			Fine Tuning of the Lactate and Diacetyl Production through Promoter Engineering in Lactococcus lactis	PLOS ONE			English	Article							ALPHA-ACETOLACTATE SYNTHASE; ELECTRON-TRANSPORT CHAIN; COMPLETE GENOME SEQUENCE; ACID BACTERIA; NADH OXIDASE; HYDROGEN-PEROXIDE; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; RESPIRATION CAPACITY; IN-VIVO	Lactococcus lactis is a well-studied bacterium widely used in dairy fermentation and capable of producing metabolites with organoleptic and nutritional characteristics. For fine tuning of the distribution of glycolytic flux at the pyruvate branch from lactate to diacetyl and balancing the production of the two metabolites under aerobic conditions, a constitutive promoter library was constructed by randomizing the promoter sequence of the H2O-forming NADH oxidase gene in L. lactis. The library consisted of 30 promoters covering a wide range of activities from 7,000 to 380,000 relative fluorescence units using a green fluorescent protein as reporter. Eleven typical promoters of the library were selected for the constitutive expression of the H2O-forming NADH oxidase gene in L. lactis, and the NADH oxidase activity increased from 9.43 to 58.17-fold of the wild-type strain in small steps of activity change under aerobic conditions. Meanwhile, the lactate yield decreased from 21.15 +/- 0.08 mM to 9.94 +/- 0.07 mM, and the corresponding diacetyl production increased from 1.07 +/- 0.03 mM to 4.16 +/- 0.06 mM with the intracellular NADH/NAD(+) ratios varying from 0.711 +/- 0.005 to 0.383 +/- 0.003. The results indicated that the reduced pyruvate to lactate flux was rerouted to the diacetyl with an almost linear flux variation via altered NADH/NAD(+) ratios. Therefore, we provided a novel strategy to precisely control the pyruvate distribution for fine tuning of the lactate and diacetyl production through promoter engineering in L. lactis. Interestingly, the increased H2O-forming NADH oxidase activity led to 76.95% lower H2O2 concentration in the recombinant strain than that of the wild-type strain after 24 h of aerated cultivation. The viable cells were significantly elevated by four orders of magnitude within 28 days of storage at 4 degrees C, suggesting that the increased enzyme activity could eliminate H2O2 accumulation and prolong cell survival.	[Guo, Tingting; Kong, Jian; Zhang, Li; Zhang, Chenchen; Hu, Shumin] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Guo, TT (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	kongjian@sdu.edu.cn			National Natural Science Foundation of China (NSFC) [31070091]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20100131110035]; Hi-tech Research and Development Program of China [2011AA100902]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was financially supported by a grant from the National Natural Science Foundation of China (NSFC, grant no. 31070091, http://www.nsfc.gov.cn/Portal0/default106.htm); a grant from the Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP, grant no. 20100131110035, http://www.cutech.edu.cn/cn/index.htm); and Hi-tech Research and Development Program of China (grant no. 2011AA100902, http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Andersen HW, 2001, EUR J BIOCHEM, V268, P6379, DOI 10.1046/j.0014-2956.2001.02599.x; BASSIT N, 1993, APPL ENVIRON MICROB, V59, P1893, DOI 10.1128/AEM.59.6.1893-1897.1993; Benson KH, 1996, APPL MICROBIOL BIOT, V45, P107, DOI 10.1007/s002530050656; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bruno-Barcena JM, 2004, APPL ENVIRON MICROB, V70, P4702, DOI 10.1128/AEM.70.8.4702-4710.2004; de Felipe FL, 1998, J BACTERIOL, V180, P3804; de Felipe FL, 2001, INT DAIRY J, V11, P37, DOI 10.1016/S0958-6946(01)00031-0; de Vos WM, 2004, TRENDS BIOTECHNOL, V22, P72, DOI 10.1016/j.tibtech.2003.11.011; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gaudu P, 2002, ANTON LEEUW INT J G, V82, P263, DOI 10.1023/A:1020635600343; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Heux S, 2006, METAB ENG, V8, P303, DOI 10.1016/j.ymben.2005.12.003; Hoefnagel MHN, 2002, MICROBIOL-SGM, V148, P1003, DOI 10.1099/00221287-148-4-1003; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hols P, 1999, NAT BIOTECHNOL, V17, P588, DOI 10.1038/9902; Hugenholtz J, 2000, APPL ENVIRON MICROB, V66, P4112, DOI 10.1128/AEM.66.9.4112-4114.2000; Hugenholtz J, 2008, INT DAIRY J, V18, P466, DOI 10.1016/j.idairyj.2007.11.015; Jensen NBS, 2001, APPL ENVIRON MICROB, V67, P2677, DOI 10.1128/AEM.67.6.2677-2682.2001; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Jeppsson M, 2003, YEAST, V20, P1263, DOI 10.1002/yea.1043; Jiang RR, 2004, TETRAHEDRON-ASYMMETR, V15, P2939, DOI 10.1016/j.tetasy.2004.07.057; Kleerebezem M, 2003, CURR OPIN BIOTECH, V14, P232, DOI 10.1016/S0958-1669(03)00033-8; Kleerebezem M, 2002, J BIOTECHNOL, V98, P199, DOI 10.1016/S0168-1656(02)00132-3; Kleerebezem M, 2000, ENZYME MICROB TECH, V26, P840, DOI 10.1016/S0141-0229(00)00180-0; Koebmann BJ, 2002, ANTON LEEUW INT J G, V82, P237, DOI 10.1023/A:1020643918089; Le Loir Y, 1998, J BACTERIOL, V180, P1895, DOI 10.1128/JB.180.7.1895-1903.1998; Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Liu SQ, 2003, INT J FOOD MICROBIOL, V83, P115, DOI 10.1016/S0168-1605(02)00366-5; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Marty-Teysset C, 2000, APPL ENVIRON MICROB, V66, P262, DOI 10.1128/AEM.66.1.262-267.2000; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Mijakovic I, 2005, CURR OPIN BIOTECH, V16, P329, DOI 10.1016/j.copbio.2005.04.003; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Odamaki T, 2011, J DAIRY SCI, V94, P1112, DOI 10.3168/jds.2010-3286; Papagianni M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-16; Pedersen MB, 2008, J BACTERIOL, V190, P4903, DOI 10.1128/JB.00447-08; PLATTEEUW C, 1995, APPL ENVIRON MICROB, V61, P3967, DOI 10.1128/AEM.61.11.3967-3971.1995; Pudlik AM, 2011, J BACTERIOL, V193, P4049, DOI [10.1128/JB.05012-11, 10.1128/JB.01171-10]; Rezaiki L, 2004, MOL MICROBIOL, V53, P1331, DOI 10.1111/j.1365-2958.2004.04217.x; Sambrook J, 1989, MOL CLONING, V2; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Solem C, 2002, APPL ENVIRON MICROB, V68, P2397, DOI 10.1128/AEM.68.5.2397-2403.2002; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Sybesma W, 2003, APPL ENVIRON MICROB, V69, P3069, DOI 10.1128/AEM.69.6.3069-3076.2003; Tachon S, 2010, APPL ENVIRON MICROB, V76, P1311, DOI 10.1128/AEM.02120-09; Tachon S, 2009, MICROBIOL-SGM, V155, P2941, DOI 10.1099/mic.0.029678-0; Vogel RF, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S6; Vos W. M. de, 1994, Genetics and biotechnology of lactic acid bacteria., P52; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wisselink HW, 2004, APPL ENVIRON MICROB, V70, P4286, DOI 10.1128/AEM.70.7.4286-4292.2004	55	41	45	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36296	10.1371/journal.pone.0036296	http://dx.doi.org/10.1371/journal.pone.0036296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558426	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000181
J	Leclercq, V; Seitz, AR				Leclercq, Virginie; Seitz, Aaron R.			Fast-TIPL Occurs for Salient Images without a Memorization Requirement in Men but Not in Women	PLOS ONE			English	Article							ACETYLCHOLINE; PLASTICITY; SPECIFICITY; DOPAMINE	Recent research of task-irrelevant perceptual learning (TIPL) demonstrates that stimuli that are consistently presented at relevant point in times (e.g. with task-targets or rewards) are learned, even in the absence of attention to these stimuli. However, different research paradigms have observed different results for how salient stimuli are learned; with some studies showing no learning, some studies showing positive learning and others showing negative learning effects. In this paper we focused on how the level of processing of stimuli impacts fast-TIPL. We conducted three different experiments in which the level of processing of the information paired with a target was manipulated. Our results indicated that fast-TIPL occurs when participants have to memorize the information presented with the target, but also when they just have to process this information for a secondary task without an explicit memorization of those stimuli. However, fast-TIPL does not occur when participants have to ignore the target-paired information. This observation is consistent with recent models of TIPL that suggest that attentional signals can either enhance or suppress learning depending on whether those stimuli are distracting or not to the subjects' objectives. Our results also revealed a robust gender effect in fast-TIPL, where male subjects consistently show fast-TIPL, whereas the observation of fast-TIPL is inconsistent in female subjects.	[Leclercq, Virginie; Seitz, Aaron R.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Leclercq, V (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	virginie.leclercq@ucr.edu						Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Choi H, 2009, VISION RES, V49, P2586, DOI 10.1016/j.visres.2009.07.004; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; DeSchepper B, 1996, J EXP PSYCHOL LEARN, V22, P27, DOI 10.1037/0278-7393.22.1.27; Dewald AD, 2011, ACTA PSYCHO IN PRESS; Kilgard MP, 2002, P NATL ACAD SCI USA, V99, P3205, DOI 10.1073/pnas.261705198; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimchi R, 2009, ACTA PSYCHOL, V130, P64, DOI 10.1016/j.actpsy.2008.10.002; Leclercq V, 2012, ATTEN PERCE IN PRESS; Leclercq V, 2012, VISION RES, V61, P70, DOI 10.1016/j.visres.2011.07.017; Lin JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000337; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Rokem A, 2010, CURR BIOL, V20, P1723, DOI 10.1016/j.cub.2010.08.027; Schacter DL, 2004, NAT REV NEUROSCI, V5, P853, DOI 10.1038/nrn1534; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Seitz AR, 2009, VISION RES, V49, P2604, DOI 10.1016/j.visres.2009.08.003; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Swallow KM, 2011, ATTEN PERCEPT PSYCHO, V73, P389, DOI 10.3758/s13414-010-0045-y; Swallow KM, 2010, COGNITION, V115, P118, DOI 10.1016/j.cognition.2009.12.003; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; Tully K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-15; Urban NBL, 2010, BIOL PSYCHIAT, V68, P689, DOI 10.1016/j.biopsych.2010.06.005; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Wilson DA, 2004, LEARN MEMORY, V11, P28, DOI 10.1101/lm.66404; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36228	10.1371/journal.pone.0036228	http://dx.doi.org/10.1371/journal.pone.0036228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558395	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000162
J	Mizuochi, C; Fraser, ST; Biasch, K; Horio, Y; Kikushige, Y; Tani, K; Akashi, K; Tavian, M; Sugiyama, D				Mizuochi, Chiyo; Fraser, Stuart T.; Biasch, Katia; Horio, Yuka; Kikushige, Yoshikane; Tani, Kenzaburo; Akashi, Koichi; Tavian, Manuela; Sugiyama, Daisuke			Intra-Aortic Clusters Undergo Endothelial to Hematopoietic Phenotypic Transition during Early Embryogenesis	PLOS ONE			English	Article							STEM-CELLS; DEFINITIVE HEMATOPOIESIS; AORTIC ENDOTHELIUM; MATURATION; THYMOCYTES; SELECTION; LINEAGE; REVEAL; RUNX1; CBFA2	Intra-aortic clusters (IACs) attach to floor of large arteries and are considered to have recently acquired hematopoietic stem cell (HSC)-potential in vertebrate early mid-gestation embryos. The formation and function of IACs is poorly understood. To address this issue, IACs were characterized by immunohistochemistry and flow cytometry in mouse embryos. Immunohistochemical analysis revealed that IACs simultaneously express the surface antigens CD31, CD34 and c-Kit. As embryos developed from 9.5 to 10.5 dpc, IACs up-regulate the hematopoietic markers CD41 and CD45 while down-regulating the endothelial surface antigen VE-cadherin/CD144, suggesting that IACs lose endothelial phenotype after 9.5 dpc. Analysis of the hematopoietic potential of IACs revealed a significant change in macrophage CFC activity from 9.5 to 10.5 dpc. To further characterize IACs, we isolated IACs based on CD45 expression. Correspondingly, the expression of hematopoietic transcription factors in the CD45(neg) fraction of IACs was significantly up-regulated. These results suggest that the transition from endothelial to hematopoietic phenotype of IACs occurs after 9.5 dpc.	[Mizuochi, Chiyo; Horio, Yuka; Sugiyama, Daisuke] Kyushu Univ, Dept Hematopoiet Stem Cells, SSP Stem Cell Unit, Fac Med Sci, Fukuoka 812, Japan; [Fraser, Stuart T.] Univ Sydney, Sch Med Sci, Disciplines Physiol Anat & Histol, Lab Blood Cell Dev, Camperdown, NSW, Australia; [Biasch, Katia; Tavian, Manuela] INSERM, U682, Strasbourg, France; [Kikushige, Yoshikane; Akashi, Koichi] Kyushu Univ, Dept Med & Biosyst Sci, Grad Sch Med Sci, Fukuoka 812, Japan; [Tani, Kenzaburo] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 812, Japan	Kyushu University; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kyushu University; Kyushu University	Mizuochi, C (corresponding author), Kyushu Univ, Dept Hematopoiet Stem Cells, SSP Stem Cell Unit, Fac Med Sci, Fukuoka 812, Japan.	ds-mons@yb3.so-net.ne.jp	Tavian, Manuela/S-3201-2019; Tavian, Manuela/E-4210-2018	Tavian, Manuela/0000-0003-4746-3240; Tavian, Manuela/0000-0003-4746-3240; Biasch, Katia/0000-0002-0834-8330; Fraser, Stuart/0000-0003-3795-9461	Ministry of Education, Science, Sports and Culture; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by the Project for Realization of Regenerative Medicine, Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Science, Sports and Culture (www.mext.go.jp/english); and SAKURA program of the Japan Society for the Promotion of Science (www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Dieterlen-Lievre F, 2006, TRENDS CARDIOVAS MED, V16, P128, DOI 10.1016/j.tcm.2006.02.005; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Fraser ST, 2003, DEV GROWTH DIFFER, V45, P63; Garcia-Porrero JA, 1998, DEV COMP IMMUNOL, V22, P303, DOI 10.1016/S0145-305X(98)00006-8; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Jaffredo T, 2005, INT J DEV BIOL, V49, P269, DOI 10.1387/ijdb.041948tj; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Matsubara A, 2005, J EXP MED, V202, P1483, DOI 10.1084/jem.20051325; McKinney-Freeman SL, 2009, BLOOD, V114, P268, DOI 10.1182/blood-2008-12-193888; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Sasaki T, 2010, DEVELOPMENT, V137, P3941, DOI 10.1242/dev.051359; Sugiyama D, 2006, TRENDS CARDIOVAS MED, V16, P45, DOI 10.1016/j.tcm.2005.11.006; Sugiyama D, 2005, STEM CELLS DEV, V14, P687, DOI 10.1089/scd.2005.14.687; Sugiyama D, 2003, BLOOD, V101, P4733, DOI 10.1182/blood-2002-09-2799; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Tavian M, 2005, EXP HEMATOL, V33, P1062, DOI 10.1016/j.exphem.2005.06.025; Theiler K, 1972, HOUSE MOUSE DEV NORM; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wood HB, 1997, BLOOD, V90, P2300; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	42	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35763	10.1371/journal.pone.0035763	http://dx.doi.org/10.1371/journal.pone.0035763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558218	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000058
J	Moran, NA; Hansen, AK; Powell, JE; Sabree, ZL				Moran, Nancy A.; Hansen, Allison K.; Powell, J. Elijah; Sabree, Zakee L.			Distinctive Gut Microbiota of Honey Bees Assessed Using Deep Sampling from Individual Worker Bees	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; BACTERIAL COMMUNITY; DIVERSITY; ASSEMBLAGES; GENOMES; HINDGUT	Surveys of 16S rDNA sequences from the honey bee, Apis mellifera, have revealed the presence of eight distinctive bacterial phylotypes in intestinal tracts of adult worker bees. Because previous studies have been limited to relatively few sequences from samples pooled from multiple hosts, the extent of variation in this microbiota among individuals within and between colonies and locations has been unclear. We surveyed the gut microbiota of 40 individual workers from two sites, Arizona and Maryland USA, sampling four colonies per site. Universal primers were used to amplify regions of 16S ribosomal RNA genes, and amplicons were sequenced using 454 pyrotag methods, enabling analysis of about 330,000 bacterial reads. Over 99% of these sequences belonged to clusters for which the first blastn hits in GenBank were members of the known bee phylotypes. Four phylotypes, one within Gammaproteobacteria (corresponding to "Candidatus Gilliamella apicola'') one within Betaproteobacteria ("Candidatus Snodgrassella alvi''), and two within Lactobacillus, were present in every bee, though their frequencies varied. The same typical bacterial phylotypes were present in all colonies and at both sites. Community profiles differed significantly among colonies and between sites, mostly due to the presence in some Arizona colonies of two species of Enterobacteriaceae not retrieved previously from bees. Analysis of Sanger sequences of rRNA of the Snodgrassella and Gilliamella phylotypes revealed that single bees contain numerous distinct strains of each phylotype. Strains showed some differentiation between localities, especially for the Snodgrassella phylotype.	[Moran, Nancy A.; Hansen, Allison K.; Powell, J. Elijah; Sabree, Zakee L.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University	Moran, NA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	nancy.moran@yale.edu	Moran, Nancy A/G-1591-2010	Hansen, Allison/0000-0002-3066-5527; Powell, Jenkyn/0000-0002-2758-6174	National Science Foundation [1046153]; Yale University; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	National Science Foundation(National Science Foundation (NSF)); Yale University; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	Financial support was provided by the National Science Foundation Dimensions of Biodiversity award 1046153 to Nancy Moran. Some funding came from Yale University. Sample processing and sequencing was conducted by the U.S. Department of Energy Joint Genome Institute, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Colwell R. K., 2006, ESTIMATES VERSION 8; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Drummond AJ, 2011, GENEIOUS V5 4 WEBSIT; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Hansen AK, 2009, NORTHWEST SCI, V83, P348, DOI 10.3955/046.083.0406; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kunin V, 2010, OPEN J, V1, P1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martinson VG, 2012, APPL ENV MICROBIOL, P78; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mather P. M., 1976, COMPUTATIONAL METHOD; McCune B., 2011, PC ORD MULTIVARIATE; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; MOORE AJ, 1987, ANIM BEHAV, V35, P1159, DOI 10.1016/S0003-3472(87)80172-0; Nalepa CA, 2001, INSECT SOC, V48, P194, DOI 10.1007/PL00001767; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SPSS Inc, 2007, SPSS WIND STAND VERS; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269	43	237	253	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36393	10.1371/journal.pone.0036393	http://dx.doi.org/10.1371/journal.pone.0036393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558460	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000204
J	Raju, G; Srinivas, R; Reddy, VS; Idris, MM; Kamal, A; Nagesh, N				Raju, Gajjela; Srinivas, Ragampeta; Reddy, Vangala Santhosh; Idris, Mohammed M.; Kamal, Ahmed; Nagesh, Narayana			Interaction of Pyrrolobenzodiazepine (PBD) Ligands with Parallel Intermolecular G-Quadruplex Complex Using Spectroscopy and ESI-MS	PLOS ONE			English	Article							MASS-SPECTROMETRY; G-QUARTETS; DNA; BINDING; SEQUENCE; TELOMERASE; PROMOTER; DESIGN; RECOGNITION; DERIVATIVES	Studies on ligand interaction with quadruplex DNA, and their role in stabilizing the complex at concentration prevailing under physiological condition, has attained high interest. Electrospray ionization mass spectrometry (ESI-MS) and spectroscopic studies in solution were used to evaluate the interaction of PBD and TMPyP4 ligands, stoichiometry and selectivity to G-quadruplex DNA. Two synthetic ligands from PBD family, namely pyrene-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrid (PBD1), mixed imine-amide pyrrolobenzodiazepine dimer (PBD2) and 5,10,15,20-tetrakis(N-methyl-4-pyridyl) porphyrin (TMPyP4) were studied. G-rich single-stranded oligonucleotide d(5'GGGGTTGGGG39') designated as d(T(2)G(8)), from the telomeric region of Tetrahymena Glaucoma, was considered for the interaction with ligands. ESI-MS and spectroscopic methods viz., circular dichroism (CD), UV-Visible, and fluorescence were employed to investigate the G-quadruplex structures formed by d(T(2)G(8)) sequence and its interaction with PBD and TMPyP4 ligands. From ESI-MS spectra, it is evident that the majority of quadruplexes exist as d(T(2)G(8))(2) and d(T(2)G(8))(4) forms possessing two to ten cations in the centre, thereby stabilizing the complex. CD band of PBD1 and PBD2 showed hypo and hyperchromicity, on interaction with quadruplex DNA, indicating unfolding and stabilization of quadruplex DNA complex, respectively. UV-Visible and fluorescence experiments suggest that PBD1 bind externally where as PBD2 intercalate moderately and bind externally to G-quadruplex DNA. Further, melting experiments using SYBR Green indicate that PBD1 unfolds and PBD2 stabilizes the G-quadruplex complex. ITC experiments using d(T(2)G(8)) quadruplex with PBD ligands reveal that PBD1 and PBD2 prefer external/loop binding and external/intercalative binding to quadruplex DNA, respectively. From experimental results it is clear that the interaction of PBD2 and TMPyP4 impart higher stability to the quadruplex complex.	[Raju, Gajjela; Srinivas, Ragampeta] Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad 500007, Andhra Pradesh, India; [Reddy, Vangala Santhosh; Kamal, Ahmed] Indian Inst Chem Technol, Div Organ Chem, Hyderabad 500007, Andhra Pradesh, India; [Idris, Mohammed M.; Nagesh, Narayana] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Raju, G (corresponding author), Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad 500007, Andhra Pradesh, India.	nagesh@ccmb.res.in		Nagesh, Narayana/0000-0002-8998-8013; Gajjela, Raju/0000-0002-3715-4762	UGC; CSIR, New Delhi	UGC(University Grants Commission, India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank Dr. J. S. Yadav, Director, IICT, Hyderabad and Dr. Ch Mohan Rao, Director, CCMB for their encouragement and support. G. R. and V.S.R thank UGC and CSIR, New Delhi for the award of Senior Research Fellowships.	Brown A, 2009, INT J MOL SCI, V10, P3457, DOI 10.3390/ijms10083457; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chaires JB, 2001, METHOD ENZYMOL, V340, P3; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; Cipolla L, 2009, ANTI-CANCER AGENT ME, V9, P1, DOI 10.2174/187152009787047743; Clark GR, 2003, J AM CHEM SOC, V125, P4066, DOI 10.1021/ja0297988; Cui XJ, 2011, J MASS SPECTROM, V46, P849, DOI 10.1002/jms.1959; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Dixon IM, 2005, CHEMBIOCHEM, V6, P123, DOI 10.1002/cbic.200400113; El Bakali J, 2009, BIOORG MED CHEM LETT, V19, P3434, DOI 10.1016/j.bmcl.2009.05.025; Fukuda H, 2002, P NATL ACAD SCI USA, V99, P12685, DOI 10.1073/pnas.152456899; Giglio S, 2003, NUCLEIC ACIDS RES, V31, P15; Gonzalez JM, 2005, EXTREMOPHILES, V9, P75, DOI 10.1007/s00792-004-0417-0; Hadjivassileva T, 2005, J ANTIMICROB CHEMOTH, V56, P513, DOI 10.1093/jac/dki256; Han FXG, 1999, J AM CHEM SOC, V121, P3561, DOI 10.1021/ja984153m; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; Hofstadler SA, 2006, NAT REV DRUG DISCOV, V5, P585, DOI 10.1038/nrd2083; Hopton SR, 2011, BIOCHEMISTRY-US, V50, P4720, DOI 10.1021/bi102017e; HURLEY LH, 1989, J MED CHEM, V32, P2027, DOI 10.1021/jm00129a001; Hyun KM, 1997, BBA-GEN SUBJECTS, V1334, P312, DOI 10.1016/S0304-4165(96)00111-0; Kamal A, 2004, BIOORG MED CHEM LETT, V14, P471, DOI 10.1016/j.bmcl.2003.10.050; Kamal A, 2002, J MED CHEM, V45, P4679, DOI 10.1021/jm020124h; Kamal A, 2011, CHEMMEDCHEM, V6, P1665, DOI 10.1002/cmdc.201100207; Kamal A, 2011, EUR J MED CHEM, V46, P3820, DOI 10.1016/j.ejmech.2011.05.050; Kamal A, 2011, BIOORGAN MED CHEM, V19, P2565, DOI 10.1016/j.bmc.2011.03.015; Keating LR, 2004, BIOCHEMISTRY-US, V43, P15891, DOI 10.1021/bi0483209; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Koeppel F, 2001, NUCLEIC ACIDS RES, V29, P1087, DOI 10.1093/nar/29.5.1087; Kraus GA, 1999, TETRAHEDRON LETT, V40, P2039, DOI 10.1016/S0040-4039(99)00087-8; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; LAUGHLAN G, 1994, SCIENCE, V265, P520, DOI 10.1126/science.8036494; Lavie A, 2008, J GEN VIROL, V89, P1672, DOI 10.1099/vir.0.2008/000273-0; Lubitz I, 2007, BIOCHEMISTRY-US, V46, P12925, DOI 10.1021/bi701301u; Nagesh N, 2003, J BIOCHEM BIOPH METH, V57, P65, DOI 10.1016/S0165-022X(03)00081-2; NAGESH N, 1995, J BIOCHEM BIOPH METH, V30, P1, DOI 10.1016/0165-022X(94)00057-K; Nagesh N, 2007, NUCLEOS NUCLEOT NUCL, V26, P303, DOI 10.1080/15257770701257590; Nagesh N, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/146418; Nagesh N, 2010, BIOPHYS J, V98, P2628, DOI 10.1016/j.bpj.2010.02.050; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Qiu B, 2011, J MASS SPECTROM, V46, P587, DOI 10.1002/jms.1928; Rangan A, 2001, J BIOL CHEM, V276, P4640, DOI 10.1074/jbc.M005962200; Reddy BSP, 2000, ANTI-CANCER DRUG DES, V15, P225; Reddy TVK, 2011, INT J SYST EVOL MICR, V61, P76, DOI 10.1099/ijs.0.020446-0; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Rettig M, 2010, ORG BIOMOL CHEM, V8, P3179, DOI 10.1039/c001893g; Rettig M, 2009, BIOCHEMISTRY-US, V48, P12223, DOI 10.1021/bi901655t; Rettig M, 2009, BIOORGAN MED CHEM, V17, P919, DOI 10.1016/j.bmc.2008.11.033; Reyes S, 2011, ORG BIOMOL CHEM, V9, P3041, DOI 10.1039/c0ob00925c; Rezler EM, 2003, ANNU REV PHARMACOL, V43, P359, DOI 10.1146/annurev.pharmtox.43.100901.135733; Rosu F, 2002, RAPID COMMUN MASS SP, V16, P1729, DOI 10.1002/rcm.778; Rosu F, 2010, NUCLEIC ACIDS RES, V38, P5217, DOI 10.1093/nar/gkq208; Rujan IN, 2005, NUCLEIC ACIDS RES, V33, P2022, DOI 10.1093/nar/gki345; SUH D, 1995, BIOORGAN MED CHEM, V3, P723, DOI 10.1016/0968-0896(95)00053-J; Tajmir-Riahi HA, 2005, J IRAN CHEM SOC, V2, P78, DOI 10.1007/BF03247200; Thurston D. E., 1993, MOL ASPECTS ANTICANC, P54; Todd AK, 2007, NUCLEIC ACIDS RES, V35, P5799, DOI 10.1093/nar/gkm609; Tuntiwechapikul W, 2001, J AM CHEM SOC, V123, P5606, DOI 10.1021/ja0156439; Viglasky V, 2010, BIOCHEMISTRY-US, V49, P2110, DOI 10.1021/bi902099u; Wang LH, 2011, ORG BIOMOL CHEM, V9, P2648, DOI 10.1039/c0ob00961j; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Yuan G, 2011, MASS SPECTROM REV, V30, P1121, DOI 10.1002/mas.20315	61	19	20	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35920	10.1371/journal.pone.0035920	http://dx.doi.org/10.1371/journal.pone.0035920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558271	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000085
J	Ye, M; Luo, SM; Xie, JF; Li, YF; Xu, T; Liu, Y; Song, YY; Zhu-Salzman, K; Zeng, RS				Ye, Mao; Luo, Shi Ming; Xie, Jie Fen; Li, Yan Fang; Xu, Tao; Liu, Yang; Song, Yuan Yuan; Zhu-Salzman, Keyan; Zeng, Ren Sen			Silencing COI1 in Rice Increases Susceptibility to Chewing Insects and Impairs Inducible Defense	PLOS ONE			English	Article							NILAPARVATA-LUGENS EGGS; METHYL JASMONATE; NICOTIANA-ATTENUATA; PLANT DEFENSE; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; GENE-EXPRESSION; PHYTOTOXIN CORONATINE; PROTEASE INHIBITORS; MICROARRAY ANALYSIS	The jasmonic acid (JA) pathway plays a key role in plant defense responses against herbivorous insects. CORONATINE INSENSITIVE1 (COI1) is an F-box protein essential for all jasmonate responses. However, the precise defense function of COI1 in monocotyledonous plants, especially in rice (Oryza sativa L.) is largely unknown. We silenced OsCOI1 in rice plants via RNA interference (RNAi) to determine the role of OsCOI1 in rice defense against rice leaf folder (LF) Cnaphalocrocis medinalis, a chewing insect, and brown planthopper (BPH) Nilaparvata lugens, a phloem-feeding insect. In wild-type rice plants (WT), the transcripts of OsCOI1 were strongly and continuously up-regulated by LF infestation and methyl jasmonate (MeJA) treatment, but not by BPH infestation. The abundance of trypsin protease inhibitor (TrypPI), and the enzymatic activities of polyphenol oxidase (PPO) and peroxidase (POD) were enhanced in response to both LF and BPH infestation, but the activity of lipoxygenase (LOX) was only induced by LF. The RNAi lines with repressed expression of OsCOI1 showed reduced resistance against LF, but no change against BPH. Silencing OsCOI1 did not alter LF-induced LOX activity and JA content, but it led to a reduction in the TrypPI content, POD and PPO activity by 62.3%, 48.5% and 27.2%, respectively. In addition, MeJA-induced TrypPI and POD activity were reduced by 57.2% and 48.2% in OsCOI1 RNAi plants. These results suggest that OsCOI1 is an indispensable signaling component, controlling JA-regulated defense against chewing insect (LF) in rice plants, and COI1 is also required for induction of TrypPI, POD and PPO in rice defense response to LF infestation.	[Ye, Mao; Song, Yuan Yuan; Zeng, Ren Sen] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Minist Agr, Guangzhou, Guangdong, Peoples R China; [Ye, Mao; Luo, Shi Ming; Xie, Jie Fen; Xu, Tao; Song, Yuan Yuan; Zeng, Ren Sen] S China Agr Univ, Key Lab Trop Agroenvironm, Minist Agr, Guangzhou, Guangdong, Peoples R China; [Li, Yan Fang] Guangdong Acad Agr Sci China, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China; [Liu, Yang] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhu-Salzman, Keyan] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Ministry of Agriculture & Rural Affairs; South China Agricultural University; Ministry of Agriculture & Rural Affairs; South China Agricultural University; Guangdong Academy of Agricultural Sciences; South China Agricultural University; Texas A&M University System; Texas A&M University College Station	Ye, M (corresponding author), S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Minist Agr, Guangzhou, Guangdong, Peoples R China.	rszeng@scau.edu.cn	Zeng, Ren-sen/AAI-2067-2020; li, yan/GTI-4638-2022	Zeng, Rensen/0000-0002-6435-3054; Song, Yuanyuan/0000-0002-5295-803X	National 973 Project of China [2011CB100400]; National Natural Science Foundation of China [31070388, 31028018, 30870390]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Science and Technology Plan Project [2008A030101008, 2008B021500001]; Ph.D. Programs Foundation of the Ministry of Education of China [20104404110004]	National 973 Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Science and Technology Plan Project; Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This research was financially supported by the National 973 Project of China (2011CB100400), National Natural Science Foundation of China (31070388, 31028018, 30870390), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2010), Guangdong Science and Technology Plan Project (2008A030101008, 2008B021500001) and Ph.D. Programs Foundation of the Ministry of Education of China (20104404110004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2010, J EXP BOT, V61, P4373, DOI 10.1093/jxb/erq240; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BENDER CL, 1989, J BACTERIOL, V171, P807, DOI 10.1128/jb.171.2.807-812.1989; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Bodenhausen N, 2007, MOL PLANT MICROBE IN, V20, P1406, DOI 10.1094/MPMI-20-11-1406; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campa A., 1991, PEROXIDASES CHEM BIO, P25; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Delphia CM, 2007, J CHEM ECOL, V33, P997, DOI 10.1007/s10886-007-9273-6; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; FARMER EE, 1992, PLANT PHYSIOL, V98, P995, DOI 10.1104/pp.98.3.995; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Fidantsef AL, 1999, PHYSIOL MOL PLANT P, V54, P97, DOI 10.1006/pmpp.1998.0192; Gosset V, 2009, J EXP BOT, V60, P1231, DOI 10.1093/jxb/erp015; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Heidel AJ, 2004, PLANT CELL ENVIRON, V27, P1362, DOI 10.1111/j.1365-3040.2004.01228.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu TZ, 2006, PROG BIOCHEM BIOPHYS, V33, P388; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Keinanen M, 2001, J AGR FOOD CHEM, V49, P3553, DOI 10.1021/jf010200+; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kiefer E, 2000, PLANT MOL BIOL REP, V18, P33, DOI 10.1007/BF02825291; Koiwa H, 1997, TRENDS PLANT SCI, V2, P379, DOI 10.1016/S1360-1385(97)90052-2; KRAUS TE, 1994, PLANT CELL PHYSIOL, V35, P45; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; Lou YG, 2005, J CHEM ECOL, V31, P1985, DOI 10.1007/s10886-005-6072-9; Lou YG, 2006, J CHEM ECOL, V32, P2375, DOI 10.1007/s10886-006-9151-7; MACRI F, 1994, BBA-LIPID LIPID MET, V1215, P109, DOI 10.1016/0005-2760(94)90098-1; Mei Chuansheng, 2007, Methods Mol Biol, V354, P161; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; MITCHELL RE, 1982, PHYSIOL PLANT PATHOL, V20, P83, DOI 10.1016/0048-4059(82)90026-1; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Mosblech A, 2011, PLANT J, V65, P949, DOI 10.1111/j.1365-313X.2011.04480.x; Paschold A, 2008, PLANT CELL PHYSIOL, V49, P1165, DOI 10.1093/pcp/pcn091; Paschold A, 2007, PLANT J, V51, P79, DOI 10.1111/j.1365-313X.2007.03119.x; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Rani PU, 2010, ACTA PHYSIOL PLANT, V32, P695, DOI 10.1007/s11738-009-0449-2; Rayapuram C, 2007, PLANT J, V52, P700, DOI 10.1111/j.1365-313X.2007.03267.x; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; Shoji T, 2008, PLANT CELL PHYSIOL, V49, P1003, DOI 10.1093/pcp/pcn077; Song YuanYuan, 2010, Acta Agriculturae Universitatis Jiangxiensis, V32, P1056; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Stenzel I, 2003, PLANT MOL BIOL, V51, P895, DOI 10.1023/A:1023049319723; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; VanDoorn A, 2011, NEW PHYTOL, V190, P640, DOI 10.1111/j.1469-8137.2010.03622.x; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wang Qi-Xiang, 2008, Acta Entomologica Sinica, V51, P1265; Wang Z, 2008, PLANT CELL REP, V27, P125, DOI 10.1007/s00299-007-0410-z; Wang ZL, 2005, MOL PLANT MICROBE IN, V18, P1285, DOI 10.1094/MPMI-18-1285; Ward KA, 1999, PLANT GROWTH REGUL, V27, P49, DOI 10.1023/A:1006188418523; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Xu T, 2003, CHINESE SCI BULL, V48, P1982, DOI 10.1360/03wc0072; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; ZAUBERMAN G, 1991, SCI HORTIC-AMSTERDAM, V47, P89, DOI 10.1016/0304-4238(91)90030-3; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; Zhou GX, 2009, PLANT J, V60, P638, DOI 10.1111/j.1365-313X.2009.03988.x; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	72	74	83	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36214	10.1371/journal.pone.0036214	http://dx.doi.org/10.1371/journal.pone.0036214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558386	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000157
J	Luchetti, F; Canonico, B; Arcangeletti, M; Guescini, M; Cesarini, E; Stocchi, V; Degli Esposti, M; Papa, S				Luchetti, Francesca; Canonico, Barbara; Arcangeletti, Marcella; Guescini, Michele; Cesarini, Erica; Stocchi, Vilberto; Degli Esposti, Mauro; Papa, Stefano			Fas Signalling Promotes Intercellular Communication in T Cells	PLOS ONE			English	Article							MEMBRANE NANOTUBES; SURFACE MOLECULES; IMMUNE CELLS; TROGOCYTOSIS; VESICLES; FRAGMENTS; PROTEINS; CAPTURE; LIGAND; DEATH	Cell-to-cell communication is a fundamental process for development and maintenance of multicellular organisms. Diverse mechanisms for the exchange of molecular information between cells have been documented, such as the exchange of membrane fragments (trogocytosis), formation of tunneling nanotubes (TNTs) and release of microvesicles (MVs). In this study we assign to Fas signalling a pivotal role for intercellular communication in CD4+ T cells. Binding of membrane-bound FasL to Fas expressing target cells triggers a well-characterized pro-apoptotic signalling cascade. However, our results, pairing up flow cytometric studies with confocal microscopy data, highlight a new social dimension for Fas/FasL interactions between CD4+ T cells. Indeed, FasL enhances the formation of cell conjugates (8 fold of increase) in an early time-frame of stimulation (30 min), and this phenomenon appears to be a crucial step to prime intercellular communication. Our findings show that this communication mainly proceeds along a cytosolic material exchange (ratio of exchange >10, calculated as ratio of stimulated cells signal divided by that recorded in control cells) via TNTs and MVs release. In particular, inhibition of TNTs genesis by pharmacological agents (Latruculin A and Nocodazole) markedly reduced this exchange (inhibition percentage: >40% and >50% respectively), suggesting a key role for TNTs in CD4+ T cells communication. Although MVs are present in supernatants from PHA-activated T cells, Fas treatment also leads to a significant increase in the amount of released MVs. In fact, the co-culture performed between MVs and untreated cells highlights a higher presence of MVs in the medium (1.4 fold of increase) and a significant MVs uptake (6 fold of increase) by untreated T lymphocytes. We conclude that Fas signalling induces intercellular communication in CD4+ T cells by different mechanisms that seem to start concomitantly with the main pathway (programmed cell death) promoted by FasL.	[Luchetti, Francesca; Canonico, Barbara; Arcangeletti, Marcella; Cesarini, Erica; Papa, Stefano] Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, Urbino, Italy; [Guescini, Michele; Stocchi, Vilberto] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Degli Esposti, Mauro] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Degli Esposti, Mauro] IIT Genova, Genoa, Italy	University of Urbino; University of Urbino; University of Manchester; Istituto Italiano di Tecnologia - IIT	Luchetti, F (corresponding author), Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, Urbino, Italy.	francesca.luchetti@uniurb.it	sourisseau, marion/M-7542-2014; Guescini, Michele/L-1297-2019	Guescini, Michele/0000-0001-9372-7038; Canonico, Barbara/0000-0003-3383-715X; Degli Esposti, Mauro/0000-0002-0977-119X	University of Urbino	University of Urbino	The research was supported by University of Urbino. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkwright PD, 2010, CELL RES, V20, P72, DOI 10.1038/cr.2009.112; Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Blott EJ, 2001, J CELL SCI, V114, P2405; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Canonico B, 2012, CYTOM PART A, V81A, P5, DOI 10.1002/cyto.a.21151; Canonico B, 2010, CYTOM PART B-CLIN CY, V78B, P267, DOI 10.1002/cyto.b.20510; Daubeuf S, 2006, NAT PROTOC, V1, P2536, DOI 10.1038/nprot.2006.400; Daubeuf S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008716; Daubeuf S, 2009, CYTOM PART A, V75A, P380, DOI 10.1002/cyto.a.20679; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Domhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021283; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Fulcher DA, 1999, IMMUNOL CELL BIOL, V77, P559, DOI 10.1046/j.1440-1711.1999.00870.x; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Herr I, 2000, ONCOGENE, V19, P4255, DOI 10.1038/sj.onc.1203776; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kassahn D, 2009, CELL DEATH DIFFER, V16, P115, DOI 10.1038/cdd.2008.133; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; LeMaoult J, 2007, HUM IMMUNOL, V68, P240, DOI 10.1016/j.humimm.2006.11.001; LORBER MI, 1982, J IMMUNOL, V128, P2798; Luchetti F, 2009, FREE RADICAL BIO MED, V46, P339, DOI 10.1016/j.freeradbiomed.2008.09.017; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Ouasti S, 2007, CELL DEATH DIFFER, V14, P453, DOI 10.1038/sj.cdd.4402043; Poupot M, 2003, J IMMUNOL, V171, P2517, DOI 10.4049/jimmunol.171.5.2517; Puaux AL, 2006, EUR J IMMUNOL, V36, P779, DOI 10.1002/eji.200535407; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Sowinski S, 2011, METHODS, V53, P27, DOI 10.1016/j.ymeth.2010.04.002; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Veranic P, 2008, BIOPHYS J, V95, P4416, DOI 10.1529/biophysj.108.131375; Wang Y, 2011, CELL DEATH DIFFER, V18, P732, DOI 10.1038/cdd.2010.147; Waschbisch A, 2009, J NEUROIMMUNOL, V209, P131, DOI 10.1016/j.jneuroim.2009.02.005; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Zhang J, 2004, CELL MOL IMMUNOL, V1, P186	51	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35766	10.1371/journal.pone.0035766	http://dx.doi.org/10.1371/journal.pone.0035766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558220	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345200076
J	Bessoltane, N; Toffano-Nioche, C; Solignac, M; Mougel, F				Bessoltane, Nadia; Toffano-Nioche, Claire; Solignac, Michel; Mougel, Florence			Fine Scale Analysis of Crossover and Non-Crossover and Detection of Recombination Sequence Motifs in the Honeybee (Apis mellifera)	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; GENE CONVERSION; CROSSING-OVER; LINKAGE MAP; HOT-SPOTS; GENOME; HOTSPOTS; RATES; HETEROGENEITY; ORGANIZATION	Background: Meiotic exchanges are non-uniformly distributed across the genome of most studied organisms. This uneven distribution suggests that recombination is initiated by specific signals and/or regulations. Some of these signals were recently identified in humans and mice. However, it is unclear whether or not sequence signals are also involved in chromosomal recombination of insects. Methodology: We analyzed recombination frequencies in the honeybee, in which genome sequencing provided a large amount of SNPs spread over the entire set of chromosomes. As the genome sequences were obtained from a pool of haploid males, which were the progeny of a single queen, an oocyte method (study of recombination on haploid males that develop from unfertilized eggs and hence are the direct reflect of female gametes haplotypes) was developed to detect recombined pairs of SNP sites. Sequences were further compared between recombinant and non-recombinant fragments to detect recombination-specific motifs. Conclusions: Recombination events between adjacent SNP sites were detected at an average distance of 92 bp and revealed the existence of high rates of recombination events. This study also shows the presence of conversion without crossover (i.e. non-crossover) events, the number of which largely outnumbers that of crossover events. Furthermore the comparison of sequences that have undergone recombination with sequences that have not, led to the discovery of sequence motifs (CGCA, GCCGC, CCGCA), which may correspond to recombination signals.	[Bessoltane, Nadia; Solignac, Michel; Mougel, Florence] CNRS, Lab Evolut Genomes Speciat, Gif Sur Yvette, France; [Bessoltane, Nadia; Toffano-Nioche, Claire; Solignac, Michel; Mougel, Florence] Univ Paris 11, Orsay, France; [Bessoltane, Nadia; Toffano-Nioche, Claire] Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR8621, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bessoltane, N (corresponding author), CNRS, Lab Evolut Genomes Speciat, Gif Sur Yvette, France.	mougel@legs.cnrs-gif.fr						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Anderson LK, 1999, GENETICS, V151, P1569; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Buard J, 2007, TRENDS GENET, V23, P301, DOI 10.1016/j.tig.2007.03.014; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Cirulli ET, 2007, J MOL EVOL, V64, P129, DOI 10.1007/s00239-006-0142-7; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; DARLINGTON C. D., 1932, CYTOLOGIA, V3, P169; Defrance M, 2008, NAT PROTOC, V3, P1589, DOI 10.1038/nprot.2008.98; Drouaud J, 2006, GENOME RES, V16, P106, DOI 10.1101/gr.4319006; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Gadau J, 2000, NATURWISSENSCHAFTEN, V87, P87, DOI 10.1007/s001140050016; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hellenthal G, 2006, CURR OPIN GENET DEV, V16, P565, DOI 10.1016/j.gde.2006.10.001; HILLIKER AJ, 1994, GENETICS, V137, P1019; HUNT GJ, 1995, GENETICS, V139, P1371; Janky R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-37; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kulathinal RJ, 2008, P NATL ACAD SCI USA, V105, P10051, DOI 10.1073/pnas.0801848105; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; LINDEGREN CC, 1953, J GENET, V51, P625, DOI 10.1007/BF02982949; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mather K, 1936, J GENET, V33, P207, DOI 10.1007/BF02982533; Mezard C, 2006, BIOCHEM SOC T, V34, P531, DOI 10.1042/BST0340531; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Qi J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-475; *R DEV COR TEAM, R LANG ENV STAT COMP; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Sirvio A, 2006, J EVOLUTION BIOL, V19, P1475, DOI 10.1111/j.1420-9101.2006.01131.x; Smit A.F.A., REPEATMASKER; Solignac M, 2004, GENETICS, V167, P253, DOI 10.1534/genetics.167.1.253; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Steiner WW, 2009, GENETICS, V182, P459, DOI 10.1534/genetics.109.101253; Steiner WW, 2005, MOL CELL BIOL, V25, P9054, DOI 10.1128/MCB.25.20.9054-9062.2005; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; Szekvolgyi L, 2010, FEBS J, V277, P571, DOI 10.1111/j.1742-4658.2009.07502.x; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; von Salome J, 2007, IMMUNOGENETICS, V59, P261, DOI 10.1007/s00251-007-0196-8; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; Yin JM, 2009, BIOINFORMATICS, V25, pI231, DOI 10.1093/bioinformatics/btp229; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	61	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36229	10.1371/journal.pone.0036229	http://dx.doi.org/10.1371/journal.pone.0036229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567142	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341500061
J	Sun, YY; Yu, WZ; Huang, LZ; Hou, J; Gong, PH; Zheng, Y; Zhao, MW; Zhou, P; Li, XX				Sun, Yaoyao; Yu, Wenzhen; Huang, Lvzhen; Hou, Jing; Gong, Peihua; Zheng, Yi; Zhao, Mingwei; Zhou, Peng; Li, Xiaoxin			Is Asthma Related to Choroidal Neovascularization?	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; VISUAL IMPAIRMENT; MOUSE MODEL; COMPLEMENT; C3; PROGRESSION; PREVALENCE; COMPSTATIN; INHIBITOR	Background: Age-related degeneration(AMD) and asthma are both diseases that are related to the activation of the complement system. The association between AMD and asthma has been debated in previous studies. The authors investigated the relationship between AMD and asthma systemically. Principal Findings: The epidemiological study showed that asthma was related to choroidal neovascularization(CNV) subtype(OR = 1.721, P = 0.023). However, the meta-analysis showed there was no association between AMD and asthma. In an animal model, we found more fluoresce in leakage of CNV lesions by FA analysis and more angiogenesis by histological analysis in rats with asthma. Western blot demonstrated an elevated level of C3 alpha-chain, C3 alpha'-chain and VEGF. After compstatin was intravitreally injected, CNV leakage decreased according to FA analysis, with the level of C3 and VEGF protein decreasing at the same time. Significance: This study first investigated the relationship between AMD and asthma systematically, and it was found that asthma could be a risk factor for the development of AMD. The study may provide a better understanding of the disease, which may advance the potential for screening asthma patients in clinical practice.	[Sun, Yaoyao; Yu, Wenzhen; Huang, Lvzhen; Hou, Jing; Zhao, Mingwei; Zhou, Peng; Li, Xiaoxin] Peking Univ Peoples Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Sun, Yaoyao; Yu, Wenzhen; Huang, Lvzhen; Hou, Jing; Zhao, Mingwei; Zhou, Peng; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Gong, Peihua] Peking Univ Peoples Hosp, Dept Respirat, Beijing, Peoples R China; [Zheng, Yi] Peking Univ, Dept Immunol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Zhou, Peng] Fudan Univ, Dept Ophthalmol Eye & ENT, Hosp Affiliated, Shanghai 200433, Peoples R China	Peking University; Peking University; Peking University; Fudan University	Sun, YY (corresponding author), Peking Univ Peoples Hosp, Dept Ophthalmol, Beijing, Peoples R China.	dr_lixiaoxin@126.com			National Basic Research Program of China (973 Program) [2011CB510200]; National Natural Science Foundation of China [81070740]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Basic Research Program of China (973 Program 2011CB510200, http://www.973.gov. cn/AreaAppl.aspx) and the National Natural Science Foundation of China (Grant No. 81070740, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdugo M, 2008, INVEST OPHTH VIS SCI, V49, P1633, DOI 10.1167/iovs.07-0767; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen SD, 2008, NEUROSCI LETT, V440, P87, DOI 10.1016/j.neulet.2008.03.092; Fattah MA, 2010, INDIAN J PEDIATR, V77, P771, DOI 10.1007/s12098-010-0117-y; Francis PJ, 2009, J MED GENET, V46, P300, DOI 10.1136/jmg.2008.062737; Ida H, 2003, INVEST OPHTH VIS SCI, V44, P5430, DOI 10.1167/iovs.03-0609; Inoue H, 2008, J HUM GENET, V53, P728, DOI 10.1007/s10038-008-0304-0; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kim Cinoo, 2010, Korean J Ophthalmol, V24, P163, DOI 10.3341/kjo.2010.24.3.163; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P840, DOI 10.1001/archopht.126.6.840; Lee YL, 2004, J BIOL CHEM, V279, P12763, DOI 10.1074/jbc.M311160200; Lopez de Victoria A, 2011, CHEM BIOL DRUG DES, V77, P431, DOI 10.1111/j.1747-0285.2011.01111.x; Lyzogubov VV, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204701; Mizutani N, 2009, J IMMUNOL, V183, P4039, DOI 10.4049/jimmunol.0901468; Montezuma Sandra R, 2007, Semin Ophthalmol, V22, P229, DOI 10.1080/08820530701745140; Moorthy S, 2011, AM J OPHTHALMOL, V151, P375, DOI 10.1016/j.ajo.2010.09.001; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Park KH, 2009, INVEST OPHTH VIS SCI, V50, P3386, DOI 10.1167/iovs.08-3231; Rakic J-M, 2006, Bull Soc Belge Ophtalmol, P9; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; Sahu A, 2003, MOL IMMUNOL, V39, P557, DOI 10.1016/S0161-5890(02)00212-2; Scholl HPN, 2007, MOL VIS, V13, P196; Seddon JM, 2004, INT OPHTHALMOL CLIN, V44; Seddon JM, 2009, INVEST OPHTHALMOL, V50, P2050; Shalev V, 2011, OPHTHAL EPIDEMIOL, V18, P83, DOI 10.3109/09286586.2011.560746; Sheets KG, 2010, MOL VIS, V16, P320; VINDING T, 1990, ACTA OPHTHALMOL, V68, P162; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Werner-Klein M, 2008, PULM PHARMACOL THER, V21, P648, DOI 10.1016/j.pupt.2008.03.002; Wysong A, 2009, ARCH OPHTHALMOL-CHIC, V127, P320, DOI 10.1001/archophthalmol.2008.613; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yu KD, 2011, BREAST CANCER RES TR, V126, P365, DOI 10.1007/s10549-010-0937-5; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258	37	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35415	10.1371/journal.pone.0035415	http://dx.doi.org/10.1371/journal.pone.0035415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567103	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500021
J	Thiaville, MM; Stoeck, A; Chen, L; Wu, RC; Magnani, L; Oidtman, J; Shih, IM; Lupien, M; Wang, TL				Thiaville, Michelle M.; Stoeck, Alexander; Chen, Li; Wu, Ren-Chin; Magnani, Luca; Oidtman, Jessica; Shih, Ie-Ming; Lupien, Mathieu; Wang, Tian-Li			Identification of PBX1 Target Genes in Cancer Cells by Global Mapping of PBX1 Binding Sites	PLOS ONE			English	Article							HOMEODOMAIN PROTEINS; OVARIAN-CANCER; HOX; EXPRESSION; MOTIF; DNA; PROLIFERATION; TRANSCRIPTION; HEXAPEPTIDE; CARCINOMAS	PBX1 is a TALE homeodomain transcription factor involved in organogenesis and tumorigenesis. Although it has been shown that ovarian, breast, and melanoma cancer cells depend on PBX1 for cell growth and survival, the molecular mechanism of how PBX1 promotes tumorigenesis remains unclear. Here, we applied an integrated approach by overlapping PBX1 ChIP-chip targets with the PBX1-regulated transcriptome in ovarian cancer cells to identify genes whose transcription was directly regulated by PBX1. We further determined if PBX1 target genes identified in ovarian cancer cells were co-overexpressed with PBX1 in carcinoma tissues. By analyzing TCGA gene expression microarray datasets from ovarian serous carcinomas, we found co-upregulation of PBX1 and a significant number of its direct target genes. Among the PBX1 target genes, a homeodomain protein MEOX1 whose DNA binding motif was enriched in PBX1-immunoprecipicated DNA sequences was selected for functional analysis. We demonstrated that MEOX1 protein interacts with PBX1 protein and inhibition of MEOX1 yields a similar growth inhibitory phenotype as PBX1 suppression. Furthermore, ectopically expressed MEOX1 functionally rescued the PBX1-withdrawn effect, suggesting MEOX1 mediates the cellular growth signal of PBX1. These results demonstrate that MEOX1 is a critical target gene and cofactor of PBX1 in ovarian cancers.	[Thiaville, Michelle M.; Stoeck, Alexander; Chen, Li; Wu, Ren-Chin; Oidtman, Jessica; Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Thiaville, Michelle M.; Stoeck, Alexander; Chen, Li; Wu, Ren-Chin; Oidtman, Jessica; Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Chen, Li] Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Arlington, VA USA; [Magnani, Luca; Lupien, Mathieu] Dartmouth Med Sch, Norris Cotton Canc Ctr, Inst Quantitat Biomed Sci, Lebanon, NH USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Virginia Polytechnic Institute & State University; Dartmouth College; Norris Cotton Cancer Center	Thiaville, MM (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	tlw@jhmi.edu	sdsd, shihieih/ABE-6190-2020; Magnani, Luca/N-1094-2015; Chen, Li/P-5945-2014	Magnani, Luca/0000-0002-7534-0785; Lupien, Mathieu/0000-0003-0929-9478; Wu, Ren-Chin/0000-0003-1439-0874	American Cancer Society [RSG-08-174-01-GMC]; NIH/NCI [R01CA148826, R01CA103937, R01CA129080, U24CA160036]; NATIONAL CANCER INSTITUTE [U24CA160036, R01CA129080, R01CA148826, R01CA103937] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by American Cancer Society grant RSG-08-174-01-GMC and NIH/NCI grants: R01CA148826, R01CA103937, R01CA129080, and U24CA160036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspland SE, 2001, ONCOGENE, V20, P5708, DOI 10.1038/sj.onc.1204592; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Delval S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025247; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; DiRocco G, 1997, EMBO J, V16, P3644, DOI 10.1093/emboj/16.12.3644; Fernandez LC, 2008, CANCER LETT, V266, P144, DOI 10.1016/j.canlet.2008.02.042; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Guazzi S, 1998, J BIOL CHEM, V273, P11092, DOI 10.1074/jbc.273.18.11092; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; Ma JL, 2011, FERTIL STERIL, V95, P2615, DOI 10.1016/j.fertnstert.2011.04.074; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Morgan R, 2007, CANCER RES, V67, P5806, DOI 10.1158/0008-5472.CAN-06-4231; Morgan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-89; Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517; PHELAN ML, 1995, MOL CELL BIOL, V15, P3989; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rodrigo I, 2004, MOL CELL BIOL, V24, P2757, DOI 10.1128/MCB.24.7.2757-2766.2004; Schnabel CA, 2003, DEV BIOL, V254, P262, DOI 10.1016/S0012-1606(02)00038-6; Selleri L, 2001, DEVELOPMENT, V128, P3543; Su AI, 2001, CANCER RES, V61, P7388; Xiao Y, 2011, ONCOGENE, V30, P287, DOI 10.1038/onc.2010.405; Yeasmin S, 2010, GYNECOL ONCOL, V117, P409, DOI 10.1016/j.ygyno.2010.03.004	28	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36054	10.1371/journal.pone.0036054	http://dx.doi.org/10.1371/journal.pone.0036054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567123	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341500041
J	Furmaga, H; Carreno, FR; Frazer, A				Furmaga, Havan; Carreno, Flavia Regina; Frazer, Alan			Vagal Nerve Stimulation Rapidly Activates Brain-Derived Neurotrophic Factor Receptor TrkB in Rat Brain	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; HIPPOCAMPAL-NEURONS; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; FACTOR BDNF; SEROTONIN TRANSPORTER; ANTIDEPRESSANT ACTION; TRUNCATED RECEPTORS; GENE-EXPRESSION	Background: Vagal nerve stimulation (VNS) has been approved for treatment-resistant depression. Many antidepressants increase expression of brain-derived neurotrophic factor (BDNF) in brain or activate, via phosphorylation, its receptor, TrkB. There have been no studies yet of whether VNS would also cause phosphorylation of TrkB. Methods: Western blot analysis was used to evaluate the phosphorylation status of TrkB in the hippocampus of rats administered VNS either acutely or chronically. Acute effects of VNS were compared with those caused by fluoxetine or desipramine (DMI) whereas its chronic effects were compared with those of sertraline or DMI. Results: All treatments, given either acutely or chronically, significantly elevated phosphorylation of tyrosines 705 and 816 on TrkB in the hippocampus. However, only VNS increased the phosphorylation of tyrosine 515, with both acute and chronic administration causing this effect. Pretreatment with K252a, a nonspecific tyrosine kinase inhibitor, blocked the phosphorylation caused by acute VNS at all three tyrosines. Downstream effectors of Y515, namely Akt and ERK, were also phosphorylated after acute treatment with VNS, whereas DMI did not cause this effect. Conclusion: VNS rapidly activates TrkB phosphorylation and this effect persists over time. VNS-induced phosphorylation of tyrosine 515 is distinct from the effect of standard antidepressant drugs.	[Furmaga, Havan; Carreno, Flavia Regina; Frazer, Alan] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Frazer, Alan] S Texas Vet Hlth Care Syst, Audie L Murphy Div, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Furmaga, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	frazer@uthscsa.edu		frazer, alan/0000-0003-1525-9974	National Institute of Mental Health grant [R01 MH082933]; Cyberonics, Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082933] Funding Source: NIH RePORTER	National Institute of Mental Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Cyberonics, Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grant R01 MH082933 (Alan Frazer). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Drs. Furmaga and Carreno have no competing interests to declare. Previously, Dr. Frazer received financial compensation as a consultant for Cyberonics, Inc. and had also obtained grant support from them for a preclinical study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Benmansour S, 2002, J NEUROSCI, V22, P6766; Benmansour S, 1999, J NEUROSCI, V19, P10494; Benmansour S, 2008, EUR J PHARMACOL, V587, P90, DOI 10.1016/j.ejphar.2008.03.048; Berghuis P, 2005, P NATL ACAD SCI USA, V102, P19115, DOI 10.1073/pnas.0509494102; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Biggio F, 2009, INT J NEUROPSYCHOPH, V12, P1209, DOI 10.1017/S1461145709000200; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Bondi CO, 2007, NEUROPSYCHOPHARMACOL; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; Cunningham JT, 2008, NEUROPSYCHOPHARMACOL, V33, P1884, DOI 10.1038/sj.npp.1301570; Dorr AE, 2006, J PHARMACOL EXP THER, V318, P890, DOI 10.1124/jpet.106.104166; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Eide FF, 1996, J NEUROSCI, V16, P3123; Follesa P, 2007, BRAIN RES, V1179, P28, DOI 10.1016/j.brainres.2007.08.045; Frazer A, 2000, J CLIN PSYCHIAT, V61, P25; Furmaga H, 2011, BIOL PSYCHI IN PRESS; George MS, 2005, BIOL PSYCHIAT, V58, P364, DOI 10.1016/j.biopsych.2005.07.028; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; KASE H, 1986, J ANTIBIOT, V39, P1059, DOI 10.7164/antibiotics.39.1059; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; KOIZUMI S, 1988, J NEUROSCI, V8, P715; Krahl SE, 2004, J PSYCHIATR RES, V38, P237, DOI 10.1016/j.jpsychires.2003.11.005; Lee FS, 2002, CYTOKINE GROWTH F R, V13, P11, DOI 10.1016/S1359-6101(01)00024-7; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lewis MA, 2006, MOL PHARMACOL, V69, P1396, DOI 10.1124/mol.105.020255; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; Manta Stella, 2009, J Psychiatry Neurosci, V34, P272; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MIDDLEMAS DS, 1994, J BIOL CHEM, V269, P5458; Nahas Z, 2005, J CLIN PSYCHIAT, V66, P1097, DOI 10.4088/JCP.v66n0902; NIBUYA M, 1995, J NEUROSCI, V15, P7539; NYE SH, 1992, MOL BIOL CELL, V3, P677, DOI 10.1091/mbc.3.6.677; Pereira DB, 2006, J NEUROSCI RES, V83, P832, DOI 10.1002/jnr.20784; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; RANTAMAKI T, 2007, NEUROPSYCHOPHARMACOL; Rantamaki T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020567; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Rush AJ, 2005, BIOL PSYCHIAT, V58, P355, DOI 10.1016/j.biopsych.2005.05.024; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Saarelainen T, 2003, J NEUROSCI, V23, P349; Salio C, 2005, EUR J NEUROSCI, V22, P1951, DOI 10.1111/j.1460-9568.2005.04392.x; Schlaepfer TE, 2008, PSYCHOL MED, V38, P651, DOI 10.1017/S0033291707001924; Shah BH, 2004, TRENDS NEUROSCI, V27, P48, DOI 10.1016/j.tins.2003.11.003; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; TAPLEY P, 1992, ONCOGENE, V7, P371; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Xu HY, 2003, NEUROPSYCHOPHARMACOL, V28, P53, DOI 10.1038/sj.npp.1300009; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Yuen EC, 1999, EXP NEUROL, V159, P297, DOI 10.1006/exnr.1999.7148	66	61	62	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e34844	10.1371/journal.pone.0034844	http://dx.doi.org/10.1371/journal.pone.0034844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563458	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700007
J	Richard, M; Erny, A; Care, B; Traversier, A; Barthelemy, M; Hay, A; Lin, YP; Ferraris, O; Lina, B				Richard, Mathilde; Erny, Alexandra; Care, Bertrand; Traversier, Aurelien; Barthelemy, Mendy; Hay, Alan; Lin, Yi Pu; Ferraris, Olivier; Lina, Bruno			Rescue of a H3N2 Influenza Virus Containing a Deficient Neuraminidase Protein by a Hemagglutinin with a Low Receptor-Binding Affinity	PLOS ONE			English	Article							A VIRUS; POSTREASSORTMENT CHANGES; ACTIVE-SITE; AMINO-ACID; 4-GUANIDINO-NEU5AC2EN; REPLICATION; SPECIFICITY; SENSITIVITY; INHIBITORS; MUTATIONS	Influenza viruses possess at their surface two glycoproteins, the hemagglutinin and the neuraminidase, of which the antagonistic functions have to be well balanced for the virus to grow efficiently. Ferraris et al. isolated in 2003-2004 viruses lacking both a NA gene and protein (H3NA-viruses) (Ferraris O., 2006, Vaccine, 24(44-46): 6656-9). In this study we showed that the hemagglutinins of two of the H3NA-viruses have reduced affinity for SA alpha 2.6Gal receptors, between 49 and 128 times lower than that of the A/Moscow/10/99 (H3N2) virus and no detectable affinity for SA alpha 2.3Gal receptors. We also showed that the low hemagglutinin affinity of the H3NA-viruses compensates for the lack of NA activity and allows the restoration of the growth of an A/Moscow/10/99 virus deficient in neuraminidase. These observations increase our understanding of H3NA-viruses in relation to the balance between the functional activities of the neuraminidase and hemagglutinin.	[Richard, Mathilde; Erny, Alexandra; Traversier, Aurelien; Barthelemy, Mendy; Ferraris, Olivier; Lina, Bruno] Univ Lyon, Fac Med RTH Laennec, EMR UCBL 4610, Lab Virol & Pathol Humaine VirPath, Lyon, France; [Care, Bertrand; Hay, Alan; Lin, Yi Pu] Univ Lyon, CNRS, INRIA, INSA Lyon,LIRIS,UMR5205, F-69621 Lyon, France; Natl Inst Med Res, London NW7 1AA, England	Centre National de la Recherche Scientifique (CNRS); Inria; Institut National des Sciences Appliquees de Lyon - INSA Lyon; MRC National Institute for Medical Research	Richard, M (corresponding author), Univ Lyon, Fac Med RTH Laennec, EMR UCBL 4610, Lab Virol & Pathol Humaine VirPath, Lyon, France.	richard.mathilde@gmail.com	lina, bruno/N-3663-2019; Richard, Mathilde/F-5461-2017; LINA, bruno/M-4572-2014	lina, bruno/0000-0002-8959-2123; Richard, Mathilde/0000-0003-0240-9312; Traversier, Aurelien/0000-0003-1874-3075; Barthelemy, Mendy/0000-0001-6939-7796	Centre National de Recherche Scientifique; Groupement d'Etudes Immunologiques; Ministere de la Recherche; Roche; Sanofi-Pasteur; Novartis; GSK; Biocryst; Merck	Centre National de Recherche Scientifique; Groupement d'Etudes Immunologiques; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Roche(Roche Holding); Sanofi-Pasteur; Novartis(Novartis); GSK(GlaxoSmithKline); Biocryst; Merck(Merck & Company)	This work was supported by the Centre National de Recherche Scientifique, the Groupement d'Etudes Immunologiques. Dr. Richard received a grant from the Ministere de la Recherche. These funding sources had no role in study design, data collection, analysis and interpretation of the results, decision to publish, and preparation of the manuscript.; Dr. Lina has received travel grants from Roche, research grants from Roche, Sanofi-Pasteur and consulting fees from Roche, Novartis, GSK, Biocryst, Merck, Sanofi-Pasteur. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AKAIKE H, 1978, ANN I STAT MATH, V30, P9, DOI 10.1007/BF02480194; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Baz M, 2007, ANTIVIR RES, V74, P159, DOI 10.1016/j.antiviral.2006.10.012; Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Ferraris O, 2006, VACCINE, V24, P6656, DOI 10.1016/j.vaccine.2006.05.050; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; Hughes MT, 2000, J VIROL, V74, P5206, DOI 10.1128/JVI.74.11.5206-5212.2000; Ilyushina NA, 2005, ARCH VIROL, V150, P1327, DOI 10.1007/s00705-005-0490-4; Kaverin NV, 1998, VIROLOGY, V244, P315, DOI 10.1006/viro.1998.9119; Kaverin NV, 2000, VIRUS RES, V66, P123, DOI 10.1016/S0168-1702(99)00131-8; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; Linderman JJ, 1993, RECEPTORS MODELS BIN; Luo C, 1999, J GEN VIROL, V80, P2969, DOI 10.1099/0022-1317-80-11-2969; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Mochalova L, 2010, GLYCOCONJUGATE J, V27, P321, DOI 10.1007/s10719-010-9280-7; Moules V, 2010, VIROLOGY, V404, P215, DOI 10.1016/j.virol.2010.04.030; OHUCHI M, 1995, VIROLOGY, V212, P77, DOI 10.1006/viro.1995.1455; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richard M, 2011, ANTIMICROB AGENTS CH; SAUTER NK, 1992, P NATL ACAD SCI USA, V89, P324, DOI 10.1073/pnas.89.1.324; Yang P, 1997, VIROLOGY, V229, P155, DOI 10.1006/viro.1996.8421	24	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e33880	10.1371/journal.pone.0033880	http://dx.doi.org/10.1371/journal.pone.0033880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563453	gold, Green Submitted, Green Published			2022-12-25	WOS:000305340700002
J	Xu, F; Yan, SX; Li, F; Cai, MQ; Chai, WH; Wu, MM; Fu, CW; Zhao, ZH; Kan, HD; Kang, KF; Xu, JH				Xu, Feng; Yan, Shuxian; Li, Fei; Cai, Minqiang; Chai, Weihan; Wu, Minmin; Fu, Chaowei; Zhao, Zhuohui; Kan, Haidong; Kang, Kefei; Xu, Jinhua			Prevalence of Childhood Atopic Dermatitis: An Urban and Rural Community-Based Study in Shanghai, China	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; ALLERGIC RHINITIS; RISK-FACTORS; ECZEMA; ASTHMA; SYMPTOMS; CHILDREN	Background: Atopic dermatitis (AD) is a common inflammatory and chronically relapsing disorder with increasing prevalence. However, little is known about its prevalence in Shanghai, the top metropolitan of China. This study will estimate and compare the prevalence of AD in urban and rural areas in representative samples of 3 to 6-year-old children in Shanghai. Methodology/Principal Findings: A descriptive cross-sectional study was performed. Pre-school children were obtained by cluster sampling from 8 communities in different districts in Shanghai. The main instrument was the core questionnaire module for AD used in the U. K. Working Party's study. All the data were statistically analyzed by EpiData 3.1 and SPSS16.0. A total of 10436 children completed the study satisfactorily, with a response rate of 95.8%. The prevalence of AD in 3 to 6-year-old children was 8.3% (Male: 8.5%, Female: 8.2%). The prevalence in urban areas of Shanghai was gradiently and significantly higher than that in rural areas. The highest prevalence was in the core urban area (10.2% in Xuhui Tianping) vs. the lowest far from the urban areas (4.6% in Chongming Baozhen). Conclusions/Significance: The prevalence of AD was 8.3% (95%CI: 7.6%-9.1%) in children aged 3 to 6 in Shanghai. The prevalence of AD decreased from the center to the rural areas in Shanghai.	[Xu, Feng; Yan, Shuxian; Li, Fei; Kang, Kefei; Xu, Jinhua] Fudan Univ, Dept Dermatol, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Cai, Minqiang] Xinjing Community Hlth Serv Ctr, Shanghai, Peoples R China; [Chai, Weihan] Jiading Dist Tradit Chinese Med Hosp, Dept Dermatol, Shanghai, Peoples R China; [Wu, Minmin; Fu, Chaowei; Zhao, Zhuohui; Kan, Haidong] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ,Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Xu, F (corresponding author), Fudan Univ, Dept Dermatol, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	xjhhuashan@yahoo.com.cn	Kan, Haidong/AGU-0328-2022; Fu, Chaowei/H-7811-2013	Fu, Chaowei/0000-0003-0966-8552; zhao, zhuohui/0000-0001-8596-0278	Chinese Medical Fund of Shanghai Municipal Health Bureau [2010QL034A]; National Natural Science Foundation of China (NSFC) [30800894]	Chinese Medical Fund of Shanghai Municipal Health Bureau; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by Chinese Medical Fund of Shanghai Municipal Health Bureau (2010QL034A), National Natural Science Foundation of China (NSFC no. 30800894) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braback L, 2004, CLIN EXP ALLERGY, V34, P38, DOI 10.1111/j.1365-2222.2004.01841.x; Dotterud LK, 2004, J EUR ACAD DERMATOL, V18, P131, DOI 10.1111/j.1468-3083.2004.00794.x; Gu H, 2001, BRIT J DERMATOL, V145, P428, DOI 10.1046/j.1365-2133.2001.04379.x; [顾恒 Gu Heng], 2004, [中华皮肤科杂志, Chinese Journa of Dermatology], V37, P29; Guiote-Dominguez MV, 2008, ACTAS DERMO-SIFILOGR, V99, P628, DOI 10.1016/S0001-7310(08)74759-8; Hatakka K, 2009, ACTA PAEDIATR, V98, P817, DOI 10.1111/j.1651-2227.2008.01198.x; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Peters AS, 2010, J ALLERGY CLIN IMMUN, V126, P590, DOI 10.1016/j.jaci.2010.06.020; Saeki H, 2005, BRIT J DERMATOL, V152, P110, DOI 10.1111/J.1365-2133.2004.06271.X; Schram ME, 2010, BRIT J DERMATOL, V162, P964, DOI 10.1111/j.1365-2133.2010.09689.x; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Van De Ven MOM, 2006, EUR J PUBLIC HEALTH, V16, P549, DOI 10.1093/eurpub/ckl022; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x	14	67	90	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36174	10.1371/journal.pone.0036174	http://dx.doi.org/10.1371/journal.pone.0036174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563481	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340700030
J	Angelini, S; My, L; Bouveret, E				Angelini, Sandra; My, Laetitia; Bouveret, Emmanuelle			Disrupting the Acyl Carrier Protein/SpoT Interaction In Vivo: Identification of ACP Residues Involved in the Interaction and Consequence on Growth	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; SPOT-DEPENDENT ACCUMULATION; AMINO-ACID-RESIDUES; ESCHERICHIA-COLI; PHOSPHOLIPID-SYNTHESIS; BINDING; SYNTHASE; SYSTEM; REVEAL; MUTAGENESIS	In bacteria, Acyl Carrier Protein (ACP) is the central cofactor for fatty acid biosynthesis. It carries the acyl chain in elongation and must therefore interact successively with all the enzymes of this pathway. Yet, ACP also interacts with proteins of diverse unrelated function. Among them, the interaction with SpoT has been proposed to be involved in regulating ppGpp levels in the cell in response to fatty acid synthesis inhibition. In order to better understand this mechanism, we screened for ACP mutants unable to interact with SpoT in vivo by bacterial two-hybrid, but still functional for fatty acid synthesis. The position of the selected mutations indicated that the helix II of ACP is responsible for the interaction with SpoT. This suggested a mechanism of recognition similar to one used for the enzymes of fatty acid synthesis. Consistently, the interactions tested by bacterial two-hybrid of ACP with fatty acid synthesis enzymes were also affected by the mutations that prevented the interaction with SpoT. Yet, interestingly, the corresponding mutant strains were viable, and the phenotypes of one mutant suggested a defect in growth regulation.	[Angelini, Sandra; My, Laetitia; Bouveret, Emmanuelle] Aix Marseille Univ, CNRS, Lab Macromol Syst Engn LISM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Angelini, S (corresponding author), Aix Marseille Univ, CNRS, Lab Macromol Syst Engn LISM, Marseille, France.	bouveret@imm.cnrs.fr		Angelini, Sandra/0000-0002-8671-8018; Bouveret, Emmanuelle/0000-0001-5511-6375; MY, Laetitia/0000-0002-7876-1809	Fondation pour la Recherche Medicale; Centre National de la Recherche Scientifique (CNRS); ANR (French National Research Agency) [ANR-09-JCJC-0018]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ANR (French National Research Agency)(French National Research Agency (ANR))	SA was funded by a grant from the Fondation pour la Recherche Medicale (http://www.frm.org). The work was funded by the Centre National de la Recherche Scientifique (CNRS) and by ANR (French National Research Agency) grant LipidStress (ANR-09-JCJC-0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Babu M, 2010, STRUCTURE, V18, P1450, DOI 10.1016/j.str.2010.08.015; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Battesti A, 2009, J BACTERIOL, V191, P616, DOI 10.1128/JB.01195-08; Battesti A, 2008, PROTEOMICS, V8, P4768, DOI 10.1002/pmic.200800270; Borgaro JG, 2011, BIOCHEMISTRY-US, V50, P10678, DOI 10.1021/bi201199x; Bouveret E, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P231; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; De Lay NR, 2006, J BACTERIOL, V188, P287, DOI 10.1128/JB.188.1.287-296.2006; den Blaauwen T, 2001, MOL MICROBIOL, V42, P1179, DOI 10.1046/j.1365-2958.2001.02691.x; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; Gully D, 2006, PROTEOMICS, V6, P282, DOI 10.1002/pmic.200500115; Gully D, 2003, FEBS LETT, V548, P90, DOI 10.1016/S0014-5793(03)00746-4; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; ROCK CO, 1982, J BACTERIOL, V152, P1298; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SEYFZADEH M, 1993, P NATL ACAD SCI USA, V90, P11004, DOI 10.1073/pnas.90.23.11004; Shanklin J, 2000, PROTEIN EXPRES PURIF, V18, P355, DOI 10.1006/prep.2000.1206; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; ULRICH AK, 1983, J BACTERIOL, V154, P221, DOI 10.1128/JB.154.1.221-230.1983; Vinella D, 2005, MOL MICROBIOL, V56, P958, DOI 10.1111/j.1365-2958.2005.04601.x; Volkmann G, 2010, J BIOL CHEM, V285, P8605, DOI 10.1074/jbc.M109.060863; Wahl A, 2011, MOL MICROBIOL, V80, P1260, DOI 10.1111/j.1365-2958.2011.07641.x; Worsham LAS, 2003, BIOCHEMISTRY-US, V42, P167, DOI 10.1021/bi0261950; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200	46	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36111	10.1371/journal.pone.0036111	http://dx.doi.org/10.1371/journal.pone.0036111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558350	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200041
J	Bateman, BT; Shaw, KM; Kuklina, EV; Callaghan, WM; Seely, EW; Hernandez-Diaz, S				Bateman, Brian T.; Shaw, Kate M.; Kuklina, Elena V.; Callaghan, William M.; Seely, Ellen W.; Hernandez-Diaz, Sonia			Hypertension in Women of Reproductive Age in the United States: NHANES 1999-2008	PLOS ONE			English	Article							ANTIHYPERTENSIVE MEDICATION USE; MAJOR CONGENITAL-MALFORMATIONS; EARLY-PREGNANCY; RISK-FACTORS; DISPARITIES; PREVALENCE; TRENDS; US; DISORDERS; AWARENESS	Objective: To examine the epidemiology of hypertension in women of reproductive age. Methods: Using NHANES from 1999-2008, we identified 5,521 women age 20-44 years old. Hypertension status was determined using blood pressure measurements and/or self-reported medication use. Results: The estimated prevalence of hypertension in women of reproductive age was 7.7% (95% confidence interval (CI): 6.9%-8.5%). The prevalence of anti-hypertensive pharmacologic therapy was 4.2% (95% CI 3.5%-4.9%). The prevalence of hypertension was relatively stable across the study period; the age and race adjusted odds of hypertension in 2007-2008 did not differ significantly from 1999-2000 (odds ratio 1.2, CI 0.8 to 1.7, p = 0.45). Significant independent risk factors associated with hypertension included older age, non-Hispanic black race (compared to non-Hispanic whites), diabetes mellitus, chronic kidney disease, and higher body mass index. The most commonly used antihypertensive medications included diuretics, angiotensin-converting enzyme inhibitors (ACE), and beta blockers. Conclusion: Hypertension occurs in about 8% of women of reproductive age. There are remarkable differences in the prevalence of hypertension between racial/ethnic groups. Obesity is a risk factor of particular importance in this population because it affects over 30% of young women in the U. S., is associated with more than 4 fold increased risk of hypertension, and is potentially modifiable.	[Bateman, Brian T.] Harvard Univ, Massachusetts Gen Hosp, Div Obstet Anesthesia, Sch Med,Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Shaw, Kate M.; Kuklina, Elena V.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Callaghan, William M.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Seely, Ellen W.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Hernandez-Diaz, Sonia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Bateman, BT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Div Obstet Anesthesia, Sch Med,Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA.	BBateman@partners.org	Kuklina, Elena/AAF-3532-2020	Kuklina, Elena/0000-0002-9686-6495; Shaw, Kate/0000-0002-1087-2457	National Institutes of Health [GM007592]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL096141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health T32 training grant GM007592 (BTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins, 2001, Obstet Gynecol, V98, P177; Ananth CV, 1995, ACTA OBSTET GYN SCAN, V74, P788, DOI 10.3109/00016349509021198; Ashaye MO, 2003, ETHNIC DIS, V13, P456; Bateman BT, 2006, NEUROLOGY, V67, P424, DOI 10.1212/01.wnl.0000228277.84760.a2; Beilin LJ, 2006, HYPERTENSION, V47, P1035, DOI 10.1161/01.HYP.0000218586.21932.3c; Caton AR, 2009, HYPERTENSION, V54, P63, DOI 10.1161/HYPERTENSIONAHA.109.129098; ChasanTaber L, 1996, CIRCULATION, V94, P483, DOI 10.1161/01.CIR.94.3.483; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P1588, DOI 10.1001/jama.292.13.1588; Davis RL, 2011, PHARMACOEPIDEM DR S, V20, P138, DOI 10.1002/pds.2068; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Frieden Thomas R, 2011, MMWR Suppl, V60, P1; Gilbert WM, 2007, J REPROD MED, V52, P1046; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Halperin RO, 2008, AM J HYPERTENS, V21, P148, DOI 10.1038/ajh.2007.36; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Hsiao Chun-Ju, 2010, Natl Health Stat Report, P1; Jain L, 1997, J Perinatol, V17, P425; Kallen BAJ, 2003, REPROD TOXICOL, V17, P255, DOI 10.1016/S0890-6238(03)00012-1; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25; Lennestal R, 2009, EUR J CLIN PHARMACOL, V65, P615, DOI 10.1007/s00228-009-0620-0; Li DK, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5931; LIM KG, 1987, BRIT MED J, V294, P1057, DOI 10.1136/bmj.294.6579.1057; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Nakhai-Pour HR, 2010, BIRTH DEFECTS RES B, V89, P147, DOI 10.1002/bdrb.20238; Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895; REY E, 1994, AM J OBSTET GYNECOL, V171, P410, DOI 10.1016/0002-9378(94)90276-3; Samadi AR, 1996, OBSTET GYNECOL, V87, P557, DOI 10.1016/0029-7844(95)00480-7; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; SIBAI BM, 1983, OBSTET GYNECOL, V61, P571; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2; WOODS JW, 1988, HYPERTENSION, V11, pS11; Yoder SR, 2009, AM J MED, V122, P890, DOI 10.1016/j.amjmed.2009.03.036	39	75	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36171	10.1371/journal.pone.0036171	http://dx.doi.org/10.1371/journal.pone.0036171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558371	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200047
J	Bertram, S; Heurich, A; Lavender, H; Gierer, S; Danisch, S; Perin, P; Lucas, JM; Nelson, PS; Pohlmann, S; Soilleux, EJ				Bertram, Stephanie; Heurich, Adeline; Lavender, Hayley; Gierer, Stefanie; Danisch, Simon; Perin, Paula; Lucas, Jared M.; Nelson, Peter S.; Poehlmann, Stefan; Soilleux, Elizabeth J.			Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts	PLOS ONE			English	Article							TRYPSIN-LIKE PROTEASE; SPIKE-PROTEIN; VIRUS HEMAGGLUTININ; SERINE-PROTEASE; NEUTRALIZING ANTIBODIES; PROTEOLYTIC ACTIVATION; FUNCTIONAL RECEPTOR; TISSUE DISTRIBUTION; A VIRUS; PATHOGENESIS	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS-coronavirus (TMPRSS2) in cell culture and may play an important role in viral spread and pathogenesis in the infected host. However, it is at present largely unclear to what extent these proteases are expressed in viral target cells in human tissues. Here, we show that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids, the major receptor determinant of human influenza viruses, throughout the human respiratory tract. Similarly, coexpression of ACE2, the SARS-coronavirus receptor, and TMPRSS2 was frequently found in the upper and lower aerodigestive tract, with the exception of the vocal folds, epiglottis and trachea. Finally, activation of influenza virus was conserved between human, avian and porcine TMPRSS2, suggesting that this protease might activate influenza virus in reservoir-, intermediate- and human hosts. In sum, our results show that TMPRSS2 and HAT are expressed by important influenza and SARS-coronavirus target cells and could thus support viral spread in the human host.	[Bertram, Stephanie; Heurich, Adeline; Gierer, Stefanie; Poehlmann, Stefan] German Primate Ctr, Gottingen, Germany; [Lavender, Hayley] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxfabs, Oxford OX3 9DU, England; [Danisch, Simon; Perin, Paula] Hannover Med Sch, Inst Virol, D-3000 Hannover, Germany; [Lucas, Jared M.; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Soilleux, Elizabeth J.] Univ Oxford, John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England	Deutsches Primatenzentrum (DPZ); University of Oxford; Hannover Medical School; Fred Hutchinson Cancer Center; University of Oxford	Bertram, S (corresponding author), German Primate Ctr, Gottingen, Germany.	s.poehlmann@dpz.eu; Elizabeth.Soilleux@ndcls.ox.ac.uk	Pöhlmann, Stefan/H-2395-2011	Pöhlmann, Stefan/0000-0001-6086-9136; Soilleux, Elizabeth Jane/0000-0002-4032-7249; Lavender, Hayley/0000-0001-9996-8107	NIHR Biomedical Research Centre Programme; German Federal Ministry of Education and Research (BMBF) via the project Ecology and Pathogenesis of SARS, an Archetypical Zoonosis [01KIO701, 01KIO703]; National Cancer Institute (NCI) [P01CA085859]; NATIONAL CANCER INSTITUTE [P01CA085859] Funding Source: NIH RePORTER	NIHR Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); German Federal Ministry of Education and Research (BMBF) via the project Ecology and Pathogenesis of SARS, an Archetypical Zoonosis; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	HL is funded by the NIHR Biomedical Research Centre Programme. SB, AH, SG and SP were supported by the German Federal Ministry of Education and Research (BMBF) via the project Ecology and Pathogenesis of SARS, an Archetypical Zoonosis (project codes 01KIO701, 01KIO703). PSN was supported by National Cancer Institute (NCI) grant P01CA085859. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron E, 2005, BIOCHEM BIOPH RES CO, V326, P554, DOI 10.1016/j.bbrc.2004.11.063; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; He YX, 2004, J IMMUNOL, V173, P4050, DOI 10.4049/jimmunol.173.6.4050; Hofmann H, 2004, J VIROL, V78, P6134, DOI 10.1128/JVI.78.12.6134-6142.2004; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Jacquinet E, 2000, FEBS LETT, V468, P93, DOI 10.1016/S0014-5793(00)01196-0; Jacquinet E, 2001, EUR J BIOCHEM, V268, P2687, DOI 10.1046/j.1432-1327.2001.02165.x; Kido H, 2012, BBA-PROTEINS PROTEOM, V1824, P186, DOI 10.1016/j.bbapap.2011.07.001; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lin BY, 1999, CANCER RES, V59, P4180; Lucas J, 2008, J PATHOL, V215, P118, DOI 10.1002/path.2330; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Mossel EC, 2008, VIROLOGY, V372, P127, DOI 10.1016/j.virol.2007.09.045; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Pulford K, 1997, BLOOD, V89, P1394, DOI 10.1182/blood.V89.4.1394; Ren XF, 2006, J GEN VIROL, V87, P1691, DOI 10.1099/vir.0.81749-0; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2011, VIROLOGY, V413, P265, DOI 10.1016/j.virol.2011.02.020; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Skowronski DA, 2005, ANNU REV MED, V56, P357, DOI 10.1146/annurev.med.56.091103.134135; Takahashi M, 2001, HISTOCHEM CELL BIOL, V115, P181; Tedoldl S, 2006, J PATHOL, V209, P454, DOI 10.1002/path.2002; To KF, 2004, J PATHOL, V203, P740, DOI 10.1002/path.1597; Vaarala MH, 2001, INT J CANCER, V94, P705, DOI 10.1002/ijc.1526; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; WALSH JJ, 1961, ARCH INTERN MED, V108, P376, DOI 10.1001/archinte.1961.03620090048006; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com; Yao YX, 2004, J INFECT DIS, V190, P91, DOI 10.1086/421280; Young B, 2006, WHEATERS FUNCTIONAL; ZHIRNOV OP, 1984, VOP VIRUSOL+, P491; ZHIRNOV OP, 1984, J GEN VIROL, V65, P191, DOI 10.1099/0022-1317-65-1-191; Zhirnov OP, 2011, APROTININ SIMILAR PR	54	269	278	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35876	10.1371/journal.pone.0035876	http://dx.doi.org/10.1371/journal.pone.0035876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558251	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200027
J	Feekings, J; Bartolino, V; Madsen, N; Catchpole, T				Feekings, Jordan; Bartolino, Valerio; Madsen, Niels; Catchpole, Tom			Fishery Discards: Factors Affecting Their Variability within a Demersal Trawl Fishery	PLOS ONE			English	Article							NEPHROPS-NORVEGICUS FISHERY; NORTH-SEA; SELECTIVE DEVICES; KATTEGAT; MANAGEMENT; BYCATCH; RATES	Discards represent one of the most important issues within current commercial fishing. It occurs for a range of reasons and is influenced by an even more complex array of factors. We address this issue by examining the data collected within the Danish discard observer program and describe the factors that influence discarding within the Danish Kattegat demersal fleet over the period 1997 to 2008. Generalised additive models were used to assess how discards of the 3 main target species, Norway lobster, cod and plaice, and their subcomponents (under and over minimum landings size) are influenced by important factors and their potential relevance to management. Our results show that discards are influenced by a range of different factors that are different for each species and portion of discards. We argue that knowledge about the factors influential to discarding and their use in relation to potential mitigation measures are essential for future fisheries management strategies.	[Feekings, Jordan; Madsen, Niels] Tech Univ Denmark DTU Aqua, Natl Inst Aquat Resources, Hirtshals, Denmark; [Bartolino, Valerio] Swedish Univ Agr Sci, Dept Aquat Resources, Lysekil, Sweden; [Bartolino, Valerio] Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden; [Catchpole, Tom] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England	Technical University of Denmark; Swedish University of Agricultural Sciences; University of Gothenburg; Centre for Environment Fisheries & Aquaculture Science	Feekings, J (corresponding author), Tech Univ Denmark DTU Aqua, Natl Inst Aquat Resources, Hirtshals, Denmark.	jpfe@aqua.dtu.dk	Feekings, Jordan/AAJ-1245-2021	Feekings, Jordan/0000-0001-9103-7332; Madsen, Niels/0000-0002-4409-1122; Bartolino, Valerio/0000-0002-4506-4329	European Union; Danish Ministry of Food, Agriculture, and Fisheries	European Union(European Commission); Danish Ministry of Food, Agriculture, and Fisheries	This study was conducted as part of the BADMINTON project (Bycatch And Discards: Management INdicators, Trends and location), which was carried out with the financial support of the European Union and Danish Ministry of Food, Agriculture, and Fisheries (http://83.212.243.10/badminton.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2009, ICES J MAR SCI, V66, P763, DOI 10.1093/icesjms/fsp033; Alverson DL, 1996, REV FISH BIOL FISHER, V6, P443, DOI 10.1007/BF00164325; [Anonymous], 2007, POLICY REDUCE UNWANT; Borges L, 2006, ICES J MAR SCI, V63, P1086, DOI 10.1016/j.icesjms.2006.03.017; Catchpole TL, 2011, FISH RES, V107, P94, DOI 10.1016/j.fishres.2010.10.012; Catchpole TL, 2005, MAR POLICY, V29, P421, DOI 10.1016/j.marpol.2004.07.001; Catchpole TL, 2005, FISH RES, V72, P45, DOI 10.1016/j.fishres.2004.10.012; Catchpole TL, 2010, J ENVIRON MANAGE, V91, P717, DOI 10.1016/j.jenvman.2009.09.035; Diamond B, 2011, REV FISH SCI, V19, P231, DOI 10.1080/10641262.2011.585432; Frandsen RP, 2010, ICES J MAR SCI, V67, P1721, DOI 10.1093/icesjms/fsq050; Frandsen RP, 2009, FISH RES, V97, P243, DOI 10.1016/j.fishres.2009.02.010; Frandsen RP, 2010, FISH RES, V101, P156, DOI 10.1016/j.fishres.2009.09.017; Groenewold S, 2000, ICES J MAR SCI, V57, P1395, DOI 10.1006/jmsc.2000.0914; Hastie TJ., 1990, GEN ADDITIVE MODELS; Herrmann B, 2006, FISH RES, V80, P148, DOI 10.1016/j.fishres.2006.04.018; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; ICES, 2004, 2004ACFM13 ICES CM; Johnsen JP, 2011, MAR POLICY, V35, P130, DOI 10.1016/j.marpol.2010.08.011; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; Krag LA, 2008, FISH RES, V91, P175, DOI 10.1016/j.fishres.2007.11.022; Madsen N, 2010, ICES J MAR SCI, V67, P2042, DOI 10.1093/icesjms/fsq153; Madsen N, 2010, FISH RES, V103, P25, DOI 10.1016/j.fishres.2010.01.008; Mark Freeberg J.G.Pope, 1994, GLOBAL ASSESSMENT FI; Murawski S. A., 1996, Journal of Northwest Atlantic Fishery Science, V19, P31; Pascoe S., 1997, FAO FISH TECH PAP, V370, p137p; Poos JJ, 2010, ICES J MAR SCI, V67, P323, DOI 10.1093/icesjms/fsp241; Reeves SA, 1990, 990G53 ICES CM; Rochet MJ, 2005, CAN J FISH AQUAT SCI, V62, P224, DOI 10.1139/F04-185; Rochet MJ, 2002, ICES J MAR SCI, V59, P538, DOI 10.1006/jmsc.2002.1182; STECF, 2011, EV FISH EFF REG REG; Stratoudakis Y, 2001, AQUAT LIVING RESOUR, V14, P283, DOI 10.1016/S0990-7440(01)01135-4; Stratoudakis Y, 1999, ICES J MAR SCI, V56, P592, DOI 10.1006/jmsc.1999.0500; Stratoudakis Y, 1998, CAN J FISH AQUAT SCI, V55, P1632, DOI 10.1139/cjfas-55-7-1632; Ulleweit J, 2010, J APPL ICHTHYOL, V26, P54, DOI 10.1111/j.1439-0426.2010.01449.x; Valentinsson D, 2008, FISH RES, V90, P109, DOI 10.1016/j.fishres.2007.10.011; VANBEEK FA, 1990, NETH J SEA RES, V26, P151, DOI 10.1016/0077-7579(90)90064-N; Vitale F, 2008, FISH RES, V90, P36, DOI 10.1016/j.fishres.2007.09.023; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Welch DJ, 2008, FISH RES, V90, P247, DOI 10.1016/j.fishres.2007.10.023; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; WOODS SN, 2006, GEN ADDITIVE MODELS; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x; Zuur Alain F., 2009, P1; 2009, REFORM COMMON FISHER	45	77	77	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36409	10.1371/journal.pone.0036409	http://dx.doi.org/10.1371/journal.pone.0036409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558463	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305340200077
J	Chen, M; Zou, M; Yang, L; He, SP				Chen, Ming; Zou, Ming; Yang, Lei; He, Shunping			Basal Jawed Vertebrate Phylogenomics Using Transcriptomic Data from Solexa Sequencing	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; CARTILAGINOUS FISHES; DIVERGENCE TIMES; MONTE-CARLO; PROTEIN; ALIGNMENTS; ORIGIN; TREE; ORTHOSELECT; EUKARYOTES	The traditionally accepted relationships among basal jawed vertebrates have been challenged by some molecular phylogenetic analyses based on mitochondrial sequences. Those studies split extant gnathostomes into two monophyletic groups: tetrapods and piscine branch, including Chondrichthyes, Actinopterygii and sarcopterygian fishes. Lungfish and bichir are found in a basal position on the piscine branch. Based on transcriptomes of an armored bichir (Polypterus delhezi) and an African lungfish (Protopterus sp.) we generated, expressed sequences and whole genome sequences available from public databases, we obtained 111 genes to reconstruct the phylogenetic tree of basal jawed vertebrates and estimated their times of divergence. Our phylogenomic study supports the traditional relationship. We found that gnathostomes are divided into Chondrichthyes and the Osteichthyes, both with 100% support values (posterior probabilities and bootstrap values). Chimaeras were found to have a basal position among cartilaginous fishes with a 100% support value. Osteichthyes were divided into Actinopterygii and Sarcopterygii with 100% support value. Lungfish and tetrapods form a monophyletic group with 100% posterior probability. Bichir and two teleost species form a monophyletic group with 100% support value. The previous tree, based on mitochondrial data, was significantly rejected by an approximately unbiased test (AU test, p=0). The time of divergence between lungfish and tetrapods was estimated to be 391.8 Ma and the divergence of bichir from pufferfish and medaka was estimated to be 330.6 Ma. These estimates closely match the fossil record. In conclusion, our phylogenomic study successfully resolved the relationship of basal jawed vertebrates based on transtriptomes, EST and whole genome sequences.	[Chen, Ming; Zou, Ming; He, Shunping] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China; [Chen, Ming; Zou, Ming] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Yang, Lei] St Louis Univ, Lab Integrated Biodivers Conservat & Genom, Dept Biol, St Louis, MO 63103 USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Saint Louis University	Chen, M (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China.	clad@ihb.ac.cn			National Natural Science Foundation of China (NSFC) [30530120]; National Science Foundation USA (NSF) [EF-0431326]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science Foundation USA (NSF)(National Science Foundation (NSF))	Funding support was provided by grants 30530120 from National Natural Science Foundation of China (NSFC) and EF-0431326 (to R. L. Mayden) from National Science Foundation USA (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ADACHI J, 1993, J MOL EVOL, V36, P270, DOI 10.1007/BF00160483; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Archibald JD, 1996, SCIENCE, V272, P1150, DOI 10.1126/science.272.5265.1150; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bernardos S, 2006, ACTA BOT GALLICA, V153, P153, DOI 10.1080/12538078.2006.10515534; Birney E, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P56; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cranston K, 2005, HEREDITY, V94, P461, DOI 10.1038/sj.hdy.6800644; Dimmick WW, 2001, COPEIA, P536, DOI 10.1643/0045-8511(2001)001[0536:SIAFPA]2.0.CO;2; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallstrom BM, 2009, MOL BIOL EVOL, V26, P463, DOI 10.1093/molbev/msn271; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Janvier P., 1996, EARLY VERTEBRATES; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Kullberg M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000775; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; Martin A, 2001, GENETICA, V111, P349, DOI 10.1023/A:1013747532647; MEYER A, 1990, J MOL EVOL, V31, P359, DOI 10.1007/BF02106050; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Noack K, 1996, GENETICS, V144, P1165; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Rasmussen AS, 1999, P NATL ACAD SCI USA, V96, P2177, DOI 10.1073/pnas.96.5.2177; Rasmussen AS, 1999, J MOL EVOL, V48, P118, DOI 10.1007/PL00006439; Roeding F, 2007, MOL PHYLOGENET EVOL, V45, P942, DOI 10.1016/j.ympev.2007.09.002; Romer AS., 1986, VERTEBRATE BODY; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN D E, 1981, Bulletin of the American Museum of Natural History, V167, P159; Sansom IJ, 2005, BIOL LETT-UK, V1, P446, DOI 10.1098/rsbl.2005.0349; Schreiber F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-219; Schreiber F, 2009, NUCLEIC ACIDS RES, V37, pW185, DOI 10.1093/nar/gkp434; Schurko AM, 2010, INSECT MOL BIOL, V19, P165, DOI 10.1111/j.1365-2583.2009.00948.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; THOMAS WK, 1989, J MOL EVOL, V29, P233, DOI 10.1007/BF02100207; Venkatesh B, 2001, P NATL ACAD SCI USA, V98, P11382, DOI 10.1073/pnas.201415598; Wilkinson M, 2000, SYST BIOL, V49, P754, DOI 10.1080/106351500750049815; Zardoya R, 1996, GENETICS, V142, P1249; Zardoya R, 2001, VERTEBRATE PHYLOGENY; Zhu M, 2004, NATURE, V432, P94, DOI 10.1038/nature02843	59	29	29	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36256	10.1371/journal.pone.0036256	http://dx.doi.org/10.1371/journal.pone.0036256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558409	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000173
J	Skouloudaki, K; Walz, G				Skouloudaki, Kassiani; Walz, Gerd			YAP1 Recruits c-Abl to Protect Angiomotin-Like 1 from Nedd4-Mediated Degradation	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; WW DOMAIN; HIPPO PATHWAY; COILED-COIL; ORGAN SIZE; PHOSPHORYLATION; FAMILY; UBIQUITINATION; STABILITY; COMPLEX	Background: Tissue development and organ growth require constant remodeling of cell-cell contacts formed between epithelial cells. The Hippo signaling cascade curtails organ growth by excluding the transcriptional co-activator Yes Associated Protein 1 (YAP1) from the nucleus. Angiomotin family members recruit YAP1 to tight junctions [1], but whether YAP1 plays a specific role outside of the nucleus is currently unknown. Methodology/Principal Findings: The present study demonstrates that the E3 ubiquitin ligase Nedd4.2 targets Angiomotin-like 1 (AMOTL1), a family member that promotes the formation of epithelial tight junctions, for ubiquitin-dependent degradation. Unexpectedly, YAP1 antagonizes the function of Nedd4.2, and protects AMOTL1 against Nedd4.2-mediated degradation. YAP1 recruits c-Abl, a tyrosine kinase that binds and phosphorylates Nedd4.2 on tyrosine residues, thereby modifying its ubiquitin-ligase activity. Conclusions/Significance: Our results uncover a novel function for cytoplasmic YAP1. YAP1 recruits c-Abl to protect AMOTL1 against Nedd4.2-mediated degradation. Thus, YAP1, excluded from the nucleus, contributes to the maintenance of tight junctions.	[Skouloudaki, Kassiani; Walz, Gerd] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Walz, Gerd] Ctr Biol Signaling Studies Bioss, Freiburg, Germany	University of Freiburg	Skouloudaki, K (corresponding author), Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden.	gerd.walz@uniklinik-freiburg.de			Deutsche Forschungsgemeinschaft (DFG) [WA 597, SFB 592]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG WA 597, SFB 592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fu X, P NATL ACAD SCI US, V107, P4579; Gagne V, 2009, CELL MOTIL CYTOSKEL, V66, P754, DOI 10.1002/cm.20405; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Patrie KM, 2005, BBA-MOL CELL RES, V1745, P131, DOI 10.1016/j.bbamcr.2005.05.011; Pires JR, 2001, J MOL BIOL, V314, P1147, DOI 10.1006/jmbi.2000.5199; Raikwar NS, 2010, AM J PHYSIOL-RENAL, V299, pF436, DOI 10.1152/ajprenal.00674.2009; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Schlosser A, 2005, ANAL CHEM, V77, P5243, DOI 10.1021/ac050232m; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; SUDOL M, 1994, ONCOGENE, V9, P2145; Sugihara-Mizuno Y, 2007, GENES CELLS, V12, P473, DOI 10.1111/j.1365-2443.2007.01066.x; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao B, GENES DEV, V25, P51; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156	39	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35735	10.1371/journal.pone.0035735	http://dx.doi.org/10.1371/journal.pone.0035735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558212	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000054
J	Tavel, L; Jaquillard, L; Karsisiotis, AI; Saab, F; Jouvensal, L; Brans, A; Delmas, AF; Schoentgen, F; Cadene, M; Damblon, C				Tavel, Laurette; Jaquillard, Lucie; Karsisiotis, Andreas I.; Saab, Fabienne; Jouvensal, Laurence; Brans, Alain; Delmas, Agnes F.; Schoentgen, Francoise; Cadene, Martine; Damblon, Christian			Ligand Binding Study of Human PEBP1/RKIP: Interaction with Nucleotides and Raf-1 Peptides Evidenced by NMR and Mass Spectrometry	PLOS ONE			English	Article							KINASE INHIBITOR PROTEIN; PROSTATE-CANCER METASTASIS; CRYSTAL-STRUCTURE; BOVINE BRAIN; N-REGION; RKIP; EXPRESSION; SUPPRESSION; ACTIVATION; MECHANISM	Backgroound: Human Phosphatidylethanolamine binding protein 1 (hPEBP1) also known as Raf kinase inhibitory protein RKIP), affects various cellular processes, and is implicated in metastasis formation and Alzheimer's disease. Human PEBP1 has also been shown to inhibit the Raf/MEK/ERK pathway. Numerous reports concern various mammalian PEBP1 binding ligands. However, since PEBP1 proteins from many different species were investigated, drawing general conclusions regarding human PEBP1 binding properties is rather difficult. Moreover, the binding site of Raf-1 on hPEBP1 is still unknown. Methods/Findings: In the present study, we investigated human PEBP1 by NMR to determine the binding site of four different ligands: GTP, FMN, and one Raf-1 peptide in tri-phosphorylated and non-phosphorylated forms. The study was carried out by NMR in near physiological conditions, allowing for the identification of the binding site and the determination of the affinity constants K-D for different ligands. Native mass spectrometry was used as an alternative method for measuring KD values. Conclusions/Significance: Our study demonstrates and/or confirms the binding of hPEBP1 to the four studied ligands. All of them bind to the same region centered on the conserved ligand-binding pocket of hPEBP1. Although the affinities for GTP and FMN decrease as pH, salt concentration and temperature increase from pH 6.5/NaCl 0 mM/20 degrees C to pH 7.5/NaCl 100 mM/30 degrees C, both ligands clearly do bind under conditions similar to what is found in cells regarding pH, salt concentration and temperature. In addition, our work confirms that residues in the vicinity of the pocket rather than those within the pocket seem to be required for interaction with Raf-1.	[Tavel, Laurette; Damblon, Christian] Univ Liege, Dept Chem, Liege, Belgium; [Jaquillard, Lucie; Karsisiotis, Andreas I.; Saab, Fabienne; Jouvensal, Laurence; Delmas, Agnes F.; Cadene, Martine] CNRS, CBM, F-45071 Orleans, France; [Saab, Fabienne] Univ Orleans, ICOA, CNRS FR 2708, UMR 7311, Orleans, France; [Brans, Alain] Univ Liege, CIP, Liege, Belgium; [Schoentgen, Francoise] Univ Paris 06, IMPMC, Paris, France	University of Liege; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CNRS - Institute of Chemistry (INC); University of Liege; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Tavel, L (corresponding author), Univ Liege, Dept Chem, Liege, Belgium.	c.damblon@ulg.ac.be	Karsisiotis, Andreas Ioannis/G-3622-2013	Cadene, Martine/0000-0003-4936-2662; Karsisiotis, Andreas Ioannis/0000-0001-7413-5045; Brans, Alain/0000-0003-4001-2762	ANR (Agence Nationale pour la Recherche) [ANR-08-BLAN- 0033]; La Ligue contre le cancer; Canceropole Grand Ouest [AO2007-2010]; CNRS (Centre National de la Recherche Scientifique); Regions Bretagne, Centre, Pays de la Loire et Poitou-Charentes [AO2007-2010]; Patrimoine de l'ULg; EU-NMR [RII3-026145]	ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); La Ligue contre le cancer(Ligue nationale contre le cancer); Canceropole Grand Ouest; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Regions Bretagne, Centre, Pays de la Loire et Poitou-Charentes(Region Nouvelle-Aquitaine); Patrimoine de l'ULg; EU-NMR	This research was supported by ANR (Agence Nationale pour la Recherche; http://www.agencenationale-recherche.fr/) grant ANR-08-BLAN- 0033 including a post-doctoral fellowship to LT, "La Ligue contre le cancer" (http://www.ligue-cancer.net), "Canceropole Grand Ouest" (AO2007-2010; http://www.canceropole-grandouest.com), CNRS (Centre National de la Recherche Scientifique; http://www.cnrs.fr), "Regions Bretagne, Centre, Pays de la Loire et Poitou-Charentes (AO2007-2010; http://www.bretagne.fr; http://www.regioncentre.fr; http://www.paysdelaloire.fr; http://www.poitou-charentes.fr), "Patrimoine de l'ULg" (http://www.ulg.ac.be) and the EU-NMR program (RII3-026145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmanene C, 2009, MED SCI MONITOR, V15, P178; Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; BUCQUOY S, 1994, EUR J BIOCHEM, V225, P1203, DOI 10.1111/j.1432-1033.1994.1203b.x; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Dadvar P, 2009, CHEMBIOCHEM, V10, P2654, DOI 10.1002/cbic.200900452; Dahl A, 2003, RAPID COMMUN MASS SP, V17, P2195, DOI 10.1002/rcm.1183; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Farmer BT, 1996, J BIOMOL NMR, V7, P59; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Granovsky AE, 2009, MOL CELL BIOL, V29, P1306, DOI 10.1128/MCB.01271-08; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Hahm JR, 2010, BMB REP, V43, P337, DOI 10.5483/BMBRep.2010.43.5.337; Hickox DM, 2002, BIOL REPROD, V67, P917, DOI 10.1095/biolreprod.101.001446; Jaquillard L, J AM SOC MA IN RPESS; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Keller ET, 2004, ANTI-CANCER DRUG, V15, P663, DOI 10.1097/01.cad.0000136877.89057.b9; Klysik J, 2008, CELL SIGNAL, V20, P1, DOI 10.1016/j.cellsig.2007.07.003; Kroslak T, 2001, J BIOL CHEM, V276, P39772, DOI 10.1074/jbc.M106991200; Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012; LIMBACH PA, 1995, J AM SOC MASS SPECTR, V6, P27, DOI 10.1016/1044-0305(94)00086-F; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Maki M, 2002, J NEUROPATH EXP NEUR, V61, P176, DOI 10.1093/jnen/61.2.176; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Moffit JS, 2007, J ANDROL, V28, P883, DOI 10.2164/jandrol.107.002964; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Park S, 2006, FEBS LETT, V580, P6405, DOI 10.1016/j.febslet.2006.10.054; Rath O, 2008, CELL SIGNAL, V20, P935, DOI 10.1016/j.cellsig.2008.01.012; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sagisaka T, 2010, BRAIN RES, V1327, P107, DOI 10.1016/j.brainres.2010.02.071; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schoentgen F, 2010, INT J HIGH THROUGHPU, V2010, P81, DOI [10.2147/IJHTS.S9157, DOI 10.2147/IJHTS.S9157]; Serre L, 1998, STRUCTURE, V6, P1255, DOI 10.1016/S0969-2126(98)00126-9; Shemon AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010479; Shemon AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006028; Simister PC, 2011, FOR IMMUNOPATHOL DIS, V1, P59, DOI [10.1615/ForumImmunDisTher.v2.i1.70, DOI 10.1615/FORUMIMMUNDISTHER.V2.I1.70]; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Yi CY, 2011, BIOMOL NMR ASSIGN, V5, P63, DOI 10.1007/s12104-010-9268-z; Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	46	18	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36187	10.1371/journal.pone.0036187	http://dx.doi.org/10.1371/journal.pone.0036187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558375	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000148
J	Harms, LR; Turner, KM; Eyles, DW; Young, JW; McGrath, JJ; Burne, THJ				Harms, Lauren R.; Turner, Karly M.; Eyles, Darryl W.; Young, Jared W.; McGrath, John J.; Burne, Thomas H. J.			Attentional Processing in C57BL/6J Mice Exposed to Developmental Vitamin D Deficiency	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; REACTION-TIME-TASK; LATENT INHIBITION; ADULT-RAT; SCHIZOPHRENIA; ALTERS; HYPERLOCOMOTION; RISK; NEUROANATOMY; METAANALYSIS	Epidemiological evidence suggests that Developmental Vitamin D (DVD) deficiency is associated with an increased risk of schizophrenia. DVD deficiency in mice is associated with altered behaviour, however there has been no detailed investigation of cognitive behaviours in DVD-deficient mice. The aim of this study was to determine the effect of DVD deficiency on a range of cognitive tasks assessing attentional processing in C57BL/6J mice. DVD deficiency was established by feeding female C57BL/6J mice a vitamin D-deficient diet from four weeks of age. After six weeks on the diet, vitamin D-deficient and control females were mated with vitamin D-normal males and upon birth of the pups, all dams were returned to a diet containing vitamin D. The adult offspring were tested on a range of cognitive behavioural tests, including the five-choice serial reaction task (5C-SRT) and five-choice continuous performance test (5C-CPT), as well as latent inhibition using a fear conditioning paradigm. DVD deficiency was not associated with altered attentional performance on the 5C-SRT. In the 5C-CPT DVD-deficient male mice exhibited an impairment in inhibiting repetitive responses by making more perseverative responses, with no changes in premature or false alarm responding. DVD deficiency did not affect the acquisition or retention of cued fear conditioning, nor did it affect the expression of latent inhibition using a fear conditioning paradigm. DVD-deficient mice exhibited no major impairments in any of the cognitive domains tested. However, impairments in perseverative responding in DVD-deficient mice may indicate that these animals have specific alterations in systems governing compulsive or reward-seeking behaviour.	[Harms, Lauren R.; Turner, Karly M.; Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia; [Young, Jared W.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [McGrath, John J.] Univ Queensland, Discipline Psychiat, St Lucia, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research; University of California System; University of California San Diego; University of Queensland	Harms, LR (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	t.burne@uq.edu.au	Harms, Lauren R/J-8698-2012; Turner, Karly/F-4607-2012; Young, Jared W/G-9601-2012; Burne, Thomas H/C-5656-2009; McGrath, John Joseph/G-5493-2010; Eyles, Darryl W/X-3386-2018	Turner, Karly/0000-0003-3714-5118; Burne, Thomas H/0000-0003-3502-9789; McGrath, John Joseph/0000-0002-4792-6068; Eyles, Darryl W/0000-0002-5023-7095; Harms, Lauren/0000-0003-2268-8654	National Health and Medical Research Council of Australia [511066]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grant no. 511066 from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00158; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Becker A, 2005, BEHAV BRAIN RES, V161, P306, DOI 10.1016/j.bbr.2005.02.015; Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023; Burne THJ, 2006, BEHAV BRAIN RES, V174, P119, DOI 10.1016/j.bbr.2006.07.015; de Abreu DAF, 2010, BEHAV BRAIN RES, V208, P603, DOI 10.1016/j.bbr.2010.01.005; de Bruin NMWJ, 2006, PHYSIOL BEHAV, V89, P692, DOI 10.1016/j.physbeh.2006.08.009; Eagle DM, 2010, NEUROSCI BIOBEHAV R, V34, P50, DOI 10.1016/j.neubiorev.2009.07.003; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D.W., 2009, PSYCHNEURO S1, V34, pS247, DOI [10.1016/B978-0-12-381978-9.10032-0, DOI 10.1016/J.PSYNEUEN.2009.04.015]; Eyles DW, 2010, ACTA PAEDIATR, V99, P645, DOI 10.1111/j.1651-2227.2010.01797.x; FELDON J, 1991, BIOL PSYCHIAT, V29, P635, DOI 10.1016/0006-3223(91)90133-7; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; Fineberg NA, 2011, BRIT J PHARMACOL, V164, P1044, DOI 10.1111/j.1476-5381.2011.01422.x; Green MF, 1996, AM J PSYCHIAT, V153, P321; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; Harms LR, 2008, BEHAV BRAIN RES, V187, P343, DOI 10.1016/j.bbr.2007.09.032; Harms LR, 2012, BEHAV BRAIN RES, V230, P125, DOI 10.1016/j.bbr.2012.02.007; Harms LR, 2011, BEST PRACT RES CL EN, V25, P657, DOI 10.1016/j.beem.2011.05.009; Harvey PD, 1998, AM J PSYCHIAT, V155, P1080, DOI 10.1176/ajp.155.8.1080; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004; Humby T, 1999, EUR J NEUROSCI, V11, P2813, DOI 10.1046/j.1460-9568.1999.00701.x; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Kesby JP, 2006, BIOL PSYCHIAT, V60, P591, DOI 10.1016/j.biopsych.2006.02.033; Kesby James P, 2012, Psychopharmacology (Berl), V220, P455, DOI 10.1007/s00213-011-2492-0; Kesby JP, 2010, PSYCHOPHARMACOLOGY, V208, P159, DOI 10.1007/s00213-009-1717-y; LUBOW RE, 1995, PSYCHOL BULL, V117, P87, DOI 10.1037/0033-2909.117.1.87; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Mongeau R, 2007, BEHAV BRAIN RES, V183, P147, DOI 10.1016/j.bbr.2007.06.002; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; O'Loan J, 2007, PSYCHONEUROENDOCRINO, V32, P227, DOI 10.1016/j.psyneuen.2006.12.006; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; ROBBINS TW, 1979, NEUROPHARMACOLOGY, V18, P931, DOI 10.1016/0028-3908(79)90157-6; SCARONE S, 1992, PSYCHIAT RES-NEUROIM, V45, P115, DOI 10.1016/0925-4927(92)90005-O; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Vidal CN, 2008, PSYCHIAT RES-NEUROIM, V163, P106, DOI 10.1016/j.pscychresns.2007.11.002; Winstanley CA, 2003, PSYCHOPHARMACOLOGY, V167, P304, DOI 10.1007/s00213-003-1398-x; Young JW, 2011, BEHAV BRAIN RES, V222, P183, DOI 10.1016/j.bbr.2011.03.054	43	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35896	10.1371/journal.pone.0035896	http://dx.doi.org/10.1371/journal.pone.0035896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563415	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349100041
J	Robertson, B; Huerta-Ocampo, I; Ericsson, J; Stephenson-Jones, M; Perez-Fernandez, J; Bolam, JP; Diaz-Heijtz, R; Grillner, S				Robertson, Brita; Huerta-Ocampo, Icnelia; Ericsson, Jesper; Stephenson-Jones, Marcus; Perez-Fernandez, Juan; Bolam, J. Paul; Diaz-Heijtz, Rochellys; Grillner, Sten			The Dopamine D2 Receptor Gene in Lamprey, Its Expression in the Striatum and Cellular Effects of D2 Receptor Activation	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; IN-SITU HYBRIDIZATION; BASAL GANGLIA; TYROSINE-HYDROXYLASE; MESSENGER-RNA; LAMPETRA-FLUVIATILIS; NUCLEUS-ACCUMBENS; SLICE PREPARATION; CALCIUM-CHANNELS; RAT-BRAIN	All basal ganglia subnuclei have recently been identified in lampreys, the phylogenetically oldest group of vertebrates. Furthermore, the interconnectivity of these nuclei is similar to mammals and tyrosine hydroxylase-positive (dopaminergic) fibers have been detected within the input layer, the striatum. Striatal processing is critically dependent on the interplay with the dopamine system, and we explore here whether D2 receptors are expressed in the lamprey striatum and their potential role. We have identified a cDNA encoding the dopamine D2 receptor from the lamprey brain and the deduced protein sequence showed close phylogenetic relationship with other vertebrate D2 receptors, and an almost 100% identity within the transmembrane domains containing the amino acids essential for dopamine binding. There was a strong and distinct expression of D2 receptor mRNA in a subpopulation of striatal neurons, and in the same region tyrosine hydroxylase-immunoreactive synaptic terminals were identified at the ultrastructural level. The synaptic incidence of tyrosine hydroxylase-immunoreactive boutons was highest in a region ventrolateral to the compact layer of striatal neurons, a region where most striatal dendrites arborise. Application of a D2 receptor agonist modulates striatal neurons by causing a reduced spike discharge and a diminished post-inhibitory rebound. We conclude that the D2 receptor gene had already evolved in the earliest group of vertebrates, cyclostomes, when they diverged from the main vertebrate line of evolution (560 mya), and that it is expressed in striatum where it exerts similar cellular effects to that in other vertebrates. These results together with our previous published data (Stephenson-Jones et al. 2011, 2012) further emphasize the high degree of conservation of the basal ganglia, also with regard to the indirect loop, and its role as a basic mechanism for action selection in all vertebrates.	[Robertson, Brita; Ericsson, Jesper; Stephenson-Jones, Marcus; Diaz-Heijtz, Rochellys; Grillner, Sten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Huerta-Ocampo, Icnelia; Bolam, J. Paul] Univ Oxford, Dept Pharmacol, MRC Anat Neuropharmacol Unit, Oxford OX1 3QT, England; [Perez-Fernandez, Juan] Univ Vigo, Fac Biol, Dept Funct Biol & Hlth Sci, Neurolam Grp, Vigo 36310, Spain	Karolinska Institutet; University of Oxford; Universidade de Vigo	Robertson, B (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	sten.grillner@ki.se	Perez Fernandez, Juan/A-8561-2019; Pérez-Fernández, Juan/AAR-7467-2021	Perez Fernandez, Juan/0000-0001-7109-951X; Pérez-Fernández, Juan/0000-0001-7109-951X; Bolam, J Paul/0000-0002-5008-8405; Stephenson-Jones, Marcus/0000-0003-4718-4452	EU [001917, 21610]; Swedish research council [VR-M-3026, VR-NT 621-2007-6049]; Karolinska Institutet; FP7 [201716]; Stockholm Brain Institute; Spanish MICINN-FEDER [BFU2009-13369]; MRC [MC_U138164490] Funding Source: UKRI; Medical Research Council [MC_U138164490] Funding Source: researchfish	EU(European Commission); Swedish research council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); FP7; Stockholm Brain Institute; Spanish MICINN-FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by EU FP5 `Neurobotics' 001917 (to Dr. Grillner), EU FP7 'Lampetra' 21610 (to Dr. Grillner), Swedish research council, VR-M-3026, VR-NT 621-2007-6049 (to Dr. Grillner), Karolinska Institutet's Research funds (to Dr. Robertson), FP7 Select-and-Act 201716 (to Dr. Grillner and Dr. Bolam) and Karolinska Institutet Doctoral funds (to Dr. Ericsson), Stockholm Brain Institute (to Dr. Grillner and Dr. Diaz-Heijtz), Spanish MICINN-FEDER BFU2009-13369 (to Dr. Perez-Fernandez). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Barral J, 2010, CELL MOL NEUROBIOL, V30, P743, DOI 10.1007/s10571-010-9499-7; Boehmler W, 2004, DEV DYNAM, V230, P481, DOI 10.1002/dvdy.20075; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; BOUYER JJ, 1984, J COMP NEUROL, V227, P92, DOI 10.1002/cne.902270110; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; Ericsson J, 2007, J NEUROSCI METH, V165, P251, DOI 10.1016/j.jneumeth.2007.05.034; Ericsson J, 2011, J PHYSIOL-LONDON, V589, P2979, DOI 10.1113/jphysiol.2011.209643; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FREUND TF, 1984, NEUROSCIENCE, V13, P1189, DOI 10.1016/0306-4522(84)90294-X; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Grillner S, 1997, SCIENCE, V278, P1087, DOI 10.1126/science.278.5340.1087; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Le Crom Stephane, 2003, Journal of Structural and Functional Genomics, V3, P161, DOI 10.1023/A:1022686622752; LeMoine C, 1996, NEUROSCIENCE, V73, P131, DOI 10.1016/0306-4522(96)00029-2; Lipscombe D, 2002, CIRC RES, V90, P933, DOI 10.1161/01.RES.0000019740.52306.92; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Megias M, 2007, SOC NEUROSCIENCE, P35129; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Moss J, 2008, J NEUROSCI, V28, P11221, DOI 10.1523/JNEUROSCI.2780-08.2008; NEVE KA, 2003, STRUCTURAL ANAL MAMM, P17; O'Connell LA, 2011, J COMP NEUROL, V519, P75, DOI 10.1002/cne.22506; O'Keeffe GC, 2009, CELL CYCLE, V8, P2888, DOI 10.4161/cc.8.18.9512; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pasqualini C, 2009, ENDOCRINOLOGY, V150, P1377, DOI 10.1210/en.2008-0578; Pierre J, 1997, J COMP NEUROL, V380, P119; Pierre-Simons J, 2002, J COMP NEUROL, V447, P163, DOI 10.1002/cne.10225; Pombal MA, 1997, J COMP NEUROL, V386, P71; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Reiner A, 1998, BRAIN RES REV, V28, P235, DOI 10.1016/S0165-0173(98)00016-2; Schnell SA, 1999, J COMP NEUROL, V407, P543, DOI 10.1002/(SICI)1096-9861(19990517)407:4<543::AID-CNE6>3.0.CO;2-O; Stephenson-Jones M, 2012, J COMP NEUROL; Stephenson-Jones M, 2011, CURR BIOL, V21, P1081, DOI 10.1016/j.cub.2011.05.001; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Thompson RH, 2008, EUR J NEUROSCI, V27, P1452, DOI 10.1111/j.1460-9568.2008.06125.x; Vacher C, 2003, J COMP NEUROL, V458, P32, DOI 10.1002/cne.10545; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Vernier P, 1997, AMPHIOXUS D1 BETA RE; Wang D, 2011, J NEUROPHYSIOL, V105, P1212, DOI 10.1152/jn.00324.2009; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; Xhaard H, 2006, J MED CHEM, V49, P1706, DOI 10.1021/jm0511031	58	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35642	10.1371/journal.pone.0035642	http://dx.doi.org/10.1371/journal.pone.0035642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563388	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100017
J	Churyukanov, M; Plaghki, L; Legrain, V; Mouraux, A				Churyukanov, Maxim; Plaghki, Leon; Legrain, Valery; Mouraux, Andre			Thermal Detection Thresholds of A delta- and C-Fibre Afferents Activated by Brief CO2 Laser Pulses Applied onto the Human Hairy Skin	PLOS ONE			English	Article							EVOKED BRAIN POTENTIALS; WARM FIBERS; NOCICEPTIVE AFFERENTS; CEREBRAL POTENTIALS; INCREMENTAL CHANGES; SURFACE-AREAS; PAIN; LASER; RESPONSES; MONKEY	Brief high-power laser pulses applied onto the hairy skin of the distal end of a limb generate a double sensation related to the activation of A delta- and C-fibres, referred to as first and second pain. However, neurophysiological and behavioural responses related to the activation of C-fibres can be studied reliably only if the concomitant activation of A delta- fibres is avoided. Here, using a novel CO2 laser stimulator able to deliver constant-temperature heat pulses through a feedback regulation of laser power by an online measurement of skin temperature at target site, combined with an adaptive staircase algorithm using reaction-time to distinguish between responses triggered by A delta- and C-fibre input, we show that it is possible to estimate robustly and independently the thermal detection thresholds of A delta- fibres (46.9 +/- 1.7 degrees C) and C-fibres (39.8 +/- 1.7 degrees C). Furthermore, we show that both thresholds are dependent on the skin temperature preceding and/or surrounding the test stimulus, indicating that the A delta- and C-fibre afferents triggering the behavioural responses to brief laser pulses behave, at least partially, as detectors of a change in skin temperature rather than as pure level detectors. Most importantly, our results show that the difference in threshold between A delta- and C-fibre afferents activated by brief laser pulses can be exploited to activate C-fibres selectively and reliably, provided that the rise in skin temperature generated by the laser stimulator is well-controlled. Our approach could constitute a tool to explore, in humans, the physiological and pathophysiological mechanisms involved in processing C-and A delta- fibre input, respectively.	[Churyukanov, Maxim; Plaghki, Leon; Mouraux, Andre] Catholic Univ Louvain, Inst Neurosci IONS, B-1200 Brussels, Belgium; [Churyukanov, Maxim] IM Sechenov First Moscow State Med Univ, Dept Nervous Dis, Moscow, Russia; [Churyukanov, Maxim] Inst Gen Pathol & Pathophysiol RAMS, Lab Pathophysiol Pain, Moscow, Russia; [Legrain, Valery] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Universite Catholique Louvain; Sechenov First Moscow State Medical University; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Ghent University	Churyukanov, M (corresponding author), Catholic Univ Louvain, Inst Neurosci IONS, B-1200 Brussels, Belgium.	andre.mouraux@uclouvain.be	Чурюканов, Максим/G-9255-2018; El-Deredy, Wael/H-6521-2015; Mouraux, Andre/F-3724-2012	Чурюканов, Максим/0000-0001-6542-1963; El-Deredy, Wael/0000-0002-9822-1092; Mouraux, Andre/0000-0003-1056-5980	Russian Federation; IASP Early Career Research Grant; Marie Curie European Reintegration Grant (ERG)	Russian Federation(Russian Federation); IASP Early Career Research Grant; Marie Curie European Reintegration Grant (ERG)(European Commission)	MC acknowledges support from the bursary of President of the Russian Federation for an internship abroad. VL is a fellow of the Research Foundation Flanders, Belgium (FWO). AM acknowledges support from the IASP Early Career Research Grant, and from a Marie Curie European Reintegration Grant (ERG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner U, 2005, PAIN, V116, P1, DOI 10.1016/j.pain.2005.04.021; BJERRING P, 1988, J NEUROL NEUROSUR PS, V51, P43, DOI 10.1136/jnnp.51.1.43; Bragard D, 1996, NEUROSCI LETT, V209, P81, DOI 10.1016/0304-3940(96)12604-5; BROMM B, 1983, NEUROSCI LETT, V43, P109, DOI 10.1016/0304-3940(83)90137-4; BROMM B, 1984, HUM NEUROBIOL, V3, P33; BROMM B, 1984, EXP BRAIN RES, V55, P158; CAMPBELL JN, 1983, BRAIN RES, V266, P203, DOI 10.1016/0006-8993(83)90650-9; CARMON A, 1976, EXP BRAIN RES, V25, P103; Cruccu G, 2004, EUR J NEUROL, V11, P153, DOI 10.1111/j.1468-1331.2004.00791.x; DARIANSMITH I, 1979, J NEUROPHYSIOL, V42, P1316, DOI 10.1152/jn.1979.42.5.1316; DARIANSMITH I, 1979, J NEUROPHYSIOL, V42, P1297, DOI 10.1152/jn.1979.42.5.1297; HALLIN RG, 1982, J NEUROL NEUROSUR PS, V45, P313, DOI 10.1136/jnnp.45.4.313; HARDY JD, 1956, J APPL PHYSIOL, V9, P257, DOI 10.1152/jappl.1956.9.2.257; HARDY JD, 1951, SCIENCE, V114, P149, DOI 10.1126/science.114.2954.149; JOHNSON KO, 1979, J NEUROPHYSIOL, V42, P1332, DOI 10.1152/jn.1979.42.5.1332; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Magerl W, 1999, PAIN, V82, P127, DOI 10.1016/S0304-3959(99)00061-5; MEYER RA, 1976, IEEE T BIO-MED ENG, V23, P54, DOI 10.1109/TBME.1976.324616; MEYER RA, 1981, BRAIN RES, V224, P149, DOI 10.1016/0006-8993(81)91124-0; MEYER RA, 1981, SCIENCE, V213, P1527, DOI 10.1126/science.7280675; Mouraux A, 2007, PAIN, V129, P321, DOI 10.1016/j.pain.2006.10.018; Mouraux A, 2004, PAIN, V112, P16, DOI 10.1016/j.pain.2004.05.024; Mouraux A, 2003, CLIN NEUROPHYSIOL, V114, P710, DOI 10.1016/S1388-2457(03)00027-0; Nahra H, 2003, EUR J PAIN, V7, P189, DOI 10.1016/S1090-3801(02)00099-X; OCHOA J, 1969, ACTA NEUROPATHOL, V13, P197, DOI 10.1007/BF00690642; Opsommer E, 2001, CLIN NEUROPHYSIOL, V112, P1868, DOI 10.1016/S1388-2457(01)00622-8; Opsommer E, 1999, NEUROPHYSIOL CLIN, V29, P411, DOI 10.1016/S0987-7053(00)87265-2; Peng YB, 2003, BRAIN RES, V976, P217, DOI 10.1016/S0006-8993(03)02718-5; Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003; Plaghki L., 2002, INT C SERIES, V1232, P181; Plaghki Leon, 2005, Curr Opin Investig Drugs, V6, P58; Plaghki L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010269; Treede RD, 2003, J NEUROL, V250, P1152, DOI 10.1007/s00415-003-0237-7; TREEDE RD, 1995, J PHYSIOL-LONDON, V483, P747, DOI 10.1113/jphysiol.1995.sp020619; Zaitsev AV, 2002, HUMAN PHYSL, V28, P494	35	75	76	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35817	10.1371/journal.pone.0035817	http://dx.doi.org/10.1371/journal.pone.0035817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558230	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200083
J	Zadjali, F; Santana-Farre, R; Vesterlund, M; Carow, B; Mirecki-Garrido, M; Hernandez-Hernandez, I; Flodstrom-Tullberg, M; Parini, P; Rottenberg, M; Norstedt, G; Fernandez-Perez, L; Flores-Morales, A				Zadjali, Fahad; Santana-Farre, Ruyman; Vesterlund, Mattias; Carow, Berit; Mirecki-Garrido, Mercedes; Hernandez-Hernandez, Irene; Flodstrom-Tullberg, Malin; Parini, Paolo; Rottenberg, Martin; Norstedt, Gunnar; Fernandez-Perez, Leandro; Flores-Morales, Amilcar			SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice	FASEB JOURNAL			English	Article						growth hormone; inflammation; suppressor of cytokine signaling	LACKING SUPPRESSOR; LIVER; DEFICIENCY; OBESITY; STEATOHEPATITIS; HYPERLIPIDEMIA; EXPRESSION; PROTEINS	Hepatic steatosis is a prominent feature in patients with growth hormone (GH) deficiency. The ubiquitin ligase SOCS2 attenuates hepatic GH signaling by inhibiting the Janus kinase 2 (JAK2)-signal transducer and activator of transcription 5b (STAT5b) axis. Here, we investigated the role of SOCS2 in the development of diet-induced hepatic steatosis and insulin resistance. SOCS2-knockout (SOCS2(-/-)) mice and wild-type littermates were fed for 4 mo with control or high-fat diet, followed by assessment of insulin sensitivity, hepatic lipid content, and expression of inflammatory cytokines. SOCS2(-/-) mice exhibited increased hepatic TG secretion by 77.6% (P<0.001) as compared with wild-type control mice and were protected from high-fat-diet (HFD)-induced hepatic steatosis, showing 49.3% (P<0.01) reduction in liver TG levels compared to HFD-fed wild-type littermates. In contrast, we found that HFD-triggered attenuation of systemic insulin sensitivity was more marked in SOCS2(-/-) mice. Livers from the HFD-fed SOCS2(-/-) mice showed increased NF-kappa B activity as well as elevated expression of genes for the inflammatory cytokines IFN-gamma and IL-6. An inhibitory role of SOCS2 on Toll-like receptor 4 signaling was demonstrated in macrophages obtained from the SOCS2(-/-) and wild-type mice. This study identified SOCS2 as an important regulator of hepatic homeostasis under conditions of high-fat dietary stress.-Zadjali, F., Santana-Farre, R., Vesterlund, M., Carow, B., Mirecki-Garrido, M., Hernandez-Hernandez, I., Flodstrom-Tullberg, M., Parini, P., Rottenberg, M., Norstedt, G., Fernandez-Perez, L., Flores-Morales, A. SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice. FASEB J. 26, 3282-3291 (2012). www.fasebj.org	[Zadjali, Fahad; Vesterlund, Mattias; Flores-Morales, Amilcar] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Flodstrom-Tullberg, Malin] Karolinska Inst, Dept Med, Stockholm, Sweden; [Zadjali, Fahad; Vesterlund, Mattias; Norstedt, Gunnar] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Parini, Paolo] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Carow, Berit; Rottenberg, Martin] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Zadjali, Fahad] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Biochem, Al Khoud, Oman; [Santana-Farre, Ruyman; Mirecki-Garrido, Mercedes; Fernandez-Perez, Leandro] Univ Las Palmas Gran Canaria, Canary Inst Canc Res ICIC, Fac Hlth Sci, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Hernandez-Hernandez, Irene] Univ Las Palmas Gran Canaria, Immune Signaling Lab, Dept Biochem & Mol Biol, Las Palmas Gran Canaria, Spain; [Hernandez-Hernandez, Irene] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid, Spain	University of Copenhagen; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Sultan Qaboos University; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Flores-Morales, A (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, Blegdamsvej 3B,Bldg 6-1, DK-2200 Copenhagen, Denmark.	amilcar.flores@cpr.ku.dk	Mirecki-Garrido, Mercedes/H-6075-2015; Carow, Berit/AAE-3970-2020; Hernández, Irene/N-7551-2016; Vesterlund, Mattias/AAX-8014-2021; Fernandez-Perez, Leandro/H-1493-2015; ZADJALI, FAHAD/B-5091-2019	Mirecki-Garrido, Mercedes/0000-0003-0488-6307; Hernández, Irene/0000-0001-7174-7599; Fernandez-Perez, Leandro/0000-0001-7802-465X; ZADJALI, FAHAD/0000-0001-5891-4700; Rottenberg, Martin/0000-0003-0514-7434; Flodstrom Tullberg, Malin/0000-0003-2685-2052; Carow, Berit/0000-0002-8760-6253; Norstedt, Gunnar/0000-0002-7759-3241; Vesterlund, Mattias/0000-0001-9471-6592	Novo Nordisk Foundation; The Swedish Research Council [2009-3738]; Danish Research Council; Spanish Ministry of Science and Innovation; European Regional Development Fund-European Social Fund [SAF2006-07824, SAF2009-13296]; Sultan Qaboos University; Karolinska Institutet; University of Las Palmas de Gran Canaria	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); The Swedish Research Council(Swedish Research Council); Danish Research Council(Det Frie Forskningsrad (DFF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund-European Social Fund; Sultan Qaboos University; Karolinska Institutet(Karolinska Institutet); University of Las Palmas de Gran Canaria	The SOCS2<SUP>-/-</SUP> mice were provided by Dr. D. Hilton (Walter and Eliza Hall Institute, Melbourne, VIC, Australia). The authors are indebted to Carlos Mateos-Diaz, M. Mercedes Diaz, and Michael Huhn for their technical assistance. This work was supported by grants from the Novo Nordisk Foundation, The Swedish Research Council (no. 2009-3738), and the Danish Research Council to A.F.-M. and in part by grants to L.F.-P. from the Spanish Ministry of Science and Innovation with funding from the European Regional Development Fund-European Social Fund (SAF2006-07824; SAF2009-13296). F.Z., M.V., and M.M.-G. were supported by fellowships from Sultan Qaboos University, Karolinska Institutet, and the University of Las Palmas de Gran Canaria, respectively.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Elam MB, 2009, OBESITY, V17, P1563, DOI 10.1038/oby.2009.49; Emanuelli B, 2008, BIOCHEM BIOPH RES CO, V377, P447, DOI 10.1016/j.bbrc.2008.09.158; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Hu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007178; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Kodama Y, 2009, GASTROENTEROLOGY, V137, P1467, DOI 10.1053/j.gastro.2009.06.045; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Li XH, 1996, J LIPID RES, V37, P210; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Martinez-Clemente M, 2010, HEPATOLOGY, V51, P817, DOI 10.1002/hep.23463; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Rico-Bautista E, 2005, MOL ENDOCRINOL, V19, P781, DOI 10.1210/me.2004-0040; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Vesterlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025358; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	34	52	53	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3282	3291		10.1096/fj.12-205583	http://dx.doi.org/10.1096/fj.12-205583			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22562833				2022-12-25	WOS:000307162800019
J	Paramanik, V; Thakur, MK				Paramanik, Vijay; Thakur, Mahendra Kumar			Estrogen Receptor beta and Its Domains Interact with Casein Kinase 2, Phosphokinase C, and N-Myristoylation Sites of Mitochondrial and Nuclear Proteins in Mouse Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; HISTONE DEACETYLASE; TYROSINE KINASES; ER-BETA; COACTIVATOR; GENE; COMPLEX; ALPHA; CELLS; PHOSPHORYLATION	The localization of estrogen receptor (ER)beta in mitochondria suggests ER beta-dependent regulation of genes, which is poorly understood. Here, we analyzed the ER beta interacting mitochondrial as well as nuclear proteins in mouse brain using pull-down assay and matrix-assisted laser desorption ionization mass spectroscopy (MALDI-MS). In the case of mitochondria, ER beta interacted with six proteins of 35-152 kDa, its transactivation domain (TAD) interacted with four proteins of 37-172 kDa, and ligand binding domain (LBD) interacted with six proteins of 37-161 kDa. On the other hand, in nuclei, ER beta interacted with seven proteins of 30-203 kDa, TAD with ten proteins of 31-160 kDa, and LBD with fourteen proteins of 42-179 kDa. For further identification, these proteins were cleaved by trypsin into peptides and analyzed by MALDI-MS using mascot search engine, immunoprecipitation, immunoblotting, and far-Western blotting. To find the consensus binding motifs in interacting proteins, their unique tryptic peptides were analyzed by the motif scan software. All the interacting proteins were found to contain casein kinase (CK) 2, phosphokinase (PK)C phosphorylation, and N-myristoylation sites. These were further confirmed by peptide pull-down assays using specific mutations in the interacting sites. Thus, the present findings provide evidence for the interaction of ER beta with specific mitochondrial and nuclear proteins through consensus CK2, PKC phosphorylation, and N-myristoylation sites, and may represent an essential step toward designing selective ER modulators for regulating estrogen-mediated signaling.	[Paramanik, Vijay; Thakur, Mahendra Kumar] Banaras Hindu Univ, Dept Zool, Ctr Adv Study, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Thakur, MK (corresponding author), Banaras Hindu Univ, Dept Zool, Ctr Adv Study, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	mkt_bhu@yahoo.com			Indian Council of Medical Research (ICMR); Department of Biotechnology [DBT/BT/PR3593/Med/14/468/2003]; Government of India; Senior Research Fellowship from ICMR	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Biotechnology; Government of India; Senior Research Fellowship from ICMR	This work was supported by the Indian Council of Medical Research (ICMR) and Department of Biotechnology (DBT/BT/PR3593/Med/14/468/2003), Government of India (to M. K. T.) and a Senior Research Fellowship from ICMR (to V. P.).	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; Gascard P, 2000, CURR OPIN HEMATOL, V7, P123, DOI 10.1097/00062752-200003000-00009; Hadrys T, 1998, DEVELOPMENT, V125, P33; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; Kato S, 2005, CANCER CHEMOTH PHARM, V56, pS4, DOI 10.1007/s00280-005-0102-8; Klein FAC, 2005, J BIOL CHEM, V280, P5682, DOI 10.1074/jbc.M411697200; KUBOTA R, 1995, GENOMICS, V26, P430, DOI 10.1016/0888-7543(95)80239-I; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007489; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; McPartland JM, 2007, GENE, V397, P126, DOI 10.1016/j.gene.2007.04.017; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Okazaki N, 2003, DNA RES, V10, P35, DOI 10.1093/dnares/10.1.35; ONATE SA, 1995, SCIENCE, V270, P1354; Paramanik V, 2011, BIOGERONTOLOGY, V12, P321, DOI 10.1007/s10522-011-9330-y; Paramanik V, 2011, MOL BIOL REP, V38, P4657, DOI 10.1007/s11033-010-0600-6; Paramanik V, 2011, MOL BIOTECHNOL, V47, P26, DOI 10.1007/s12033-010-9308-z; Paramanik V, 2010, CELL MOL NEUROBIOL, V30, P961, DOI 10.1007/s10571-010-9526-8; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Schiller D, 2008, MOL CELL BIOL, V28, P4424, DOI 10.1128/MCB.00007-08; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Selvam R, 2003, MOL CELL BIOCHEM, V243, P1, DOI 10.1023/A:1021641223419; Shao G, 2000, MOL ENDOCRINOL, V14, P1198, DOI 10.1210/me.14.8.1198; Shao WL, 2002, MOL CELL BIOL, V22, P3358, DOI 10.1128/MCB.22.10.3358-3372.2002; Sharma A, 2005, EXP CELL RES, V309, P185, DOI 10.1016/j.yexcr.2005.05.014; Singh K, 2008, BIOGERONTOLOGY, V9, P455, DOI 10.1007/s10522-008-9178-y; Song RXD, 2006, BIOL REPROD, V75, P9, DOI 10.1095/biolreprod.105.050070; Streuli M, 1996, CURR OPIN CELL BIOL, V8, P182, DOI 10.1016/S0955-0674(96)80064-0; Stukenberg PT, 1997, CURR BIOL, V7, P338, DOI 10.1016/S0960-9822(06)00157-6; Takahashi H, 2004, BIOCHEM BIOPH RES CO, V314, P830, DOI 10.1016/j.bbrc.2003.12.163; Thakur MK, 2009, HORM RES, V71, P194, DOI 10.1159/000201107; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	54	9	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22305	22316		10.1074/jbc.M112.351262	http://dx.doi.org/10.1074/jbc.M112.351262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22566700	Green Published, hybrid			2022-12-25	WOS:000306418600068
J	Letouze, E; Sow, A; Petel, F; Rosati, R; Figueiredo, BC; Burnichon, N; Gimenez-Roqueplo, AP; Lalli, E; de Reynies, A				Letouze, Eric; Sow, Aliou; Petel, Fabien; Rosati, Roberto; Figueiredo, Bonald C.; Burnichon, Nelly; Gimenez-Roqueplo, Anne-Paule; Lalli, Enzo; de Reynies, Aurelien			Identity by Descent Mapping of Founder Mutations in Cancer Using High-Resolution Tumor SNP Data	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; LOSS-OF-HETEROZYGOSITY; ADRENOCORTICAL TUMORS; BREAST-CANCER; ARRAYS; BRCA1; INDIVIDUALS; POPULATIONS; EXPRESSION; FREQUENCY	Dense genotype data can be used to detect chromosome fragments inherited from a common ancestor in apparently unrelated individuals. A disease-causing mutation inherited from a common founder may thus be detected by searching for a common haplotype signature in a sample population of patients. We present here FounderTracker, a computational method for the genome-wide detection of founder mutations in cancer using dense tumor SNP profiles. Our method is based on two assumptions. First, the wild-type allele frequently undergoes loss of heterozygosity (LOH) in the tumors of germline mutation carriers. Second, the overlap between the ancestral chromosome fragments inherited from a common founder will define a minimal haplotype conserved in each patient carrying the founder mutation. Our approach thus relies on the detection of haplotypes with significant identity by descent (IBD) sharing within recurrent regions of LOH to highlight genomic loci likely to harbor a founder mutation. We validated this approach by analyzing two real cancer data sets in which we successfully identified founder mutations of well-characterized tumor suppressor genes. We then used simulated data to evaluate the ability of our method to detect IBD tracts as a function of their size and frequency. We show that FounderTracker can detect haplotypes of low prevalence with high power and specificity, significantly outperforming existing methods. FounderTracker is thus a powerful tool for discovering unknown founder mutations that may explain part of the "missing" heritability in cancer. This method is freely available and can be used online at the FounderTracker website.	[Letouze, Eric; Sow, Aliou; Petel, Fabien; de Reynies, Aurelien] Ligue Natl Contre Canc, Programme Cartes Identite Tumeurs, Paris, France; [Rosati, Roberto; Figueiredo, Bonald C.] Inst Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil; [Rosati, Roberto; Figueiredo, Bonald C.] Fac Pequeno Principe, Curitiba, Parana, Brazil; [Burnichon, Nelly; Gimenez-Roqueplo, Anne-Paule] INSERM, UMR970, Paris Cardiovasc Res Ctr, Paris, France; [Burnichon, Nelly; Gimenez-Roqueplo, Anne-Paule] Hop Europe Georges Pompidou, Assistance Publique Hopitaux Paris, Serv Genet, Paris, France; [Burnichon, Nelly; Gimenez-Roqueplo, Anne-Paule] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Lalli, Enzo] Univ Nice, Valbonne, France; [Lalli, Enzo] CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, Valbonne, France	Hospital Pequeno Principe; Hospital Pequeno Principe; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Letouze, E (corresponding author), Ligue Natl Contre Canc, Programme Cartes Identite Tumeurs, Paris, France.	LetouzeE@ligue-cancer.net	Burnichon, Nelly/AAF-6003-2020; Letouzé, Eric/AAP-9924-2020; GIMENEZ-ROQUEPLO, Anne-Paule/T-6752-2018; de Reyniès, Aurélien/Q-8640-2017; Rosati, Roberto/AAF-3708-2020; de Figueiredo, Bonald Cavalcante/AAD-6672-2021; Lalli, Enzo/F-7052-2013	Letouzé, Eric/0000-0002-6369-2839; GIMENEZ-ROQUEPLO, Anne-Paule/0000-0002-4816-670X; de Reyniès, Aurélien/0000-0002-1328-5290; Rosati, Roberto/0000-0002-0475-3654; de Figueiredo, Bonald Cavalcante/0000-0002-1051-2056; Lalli, Enzo/0000-0002-0584-5681	Institut National du Cancer and CNRS (LIA NEOGENEX); CNPq; CAPES; Programme Hospitalier de Recherche Clinique grant COMETE 3 [AOM 06 179]	Institut National du Cancer and CNRS (LIA NEOGENEX); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programme Hospitalier de Recherche Clinique grant COMETE 3	This work is part of the CIT program from the French Ligue Nationale Contre le Cancer (http://cit.ligue-cancer.net/index.php/en). This work was supported by grants from Institut National du Cancer and CNRS (LIA NEOGENEX) to Enzo Lalli; CNPq and CAPES grants to Bonald C. Figueiredo. This work was supported by the Programme Hospitalier de Recherche Clinique grant COMETE 3 (AOM 06 179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Beroukhim R, 2006, PLOS COMPUT BIOL, V2, P323, DOI 10.1371/journal.pcbi.0020041; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning SR, 2008, GENETICS, V178, P2123, DOI 10.1534/genetics.107.084624; Burnichon N, 2011, HUMAN MOL GENETICS; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Chapman NH, 2003, THEOR POPUL BIOL, V64, P141, DOI 10.1016/S0040-5809(03)00071-6; CORNELIS RS, 1995, GENE CHROMOSOME CANC, V13, P203, DOI 10.1002/gcc.2870130310; Dworkin AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001136; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Figueiredo BC, 2006, J MED GENET, V43, P91, DOI 10.1136/jmg.2004.030551; Freeman EA, 2008, J STAT SOFTW, V23, P1; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gimenez-Roqueplo AP, 2008, CLIN EXP PHARMACOL P, V35, P376, DOI 10.1111/j.1440-1681.2008.04881.x; Gusev A, 2011, AM J HUM GENET, V88, P706, DOI 10.1016/j.ajhg.2011.04.023; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Kenny EE, 2009, P NATL ACAD SCI USA, V106, P13886, DOI 10.1073/pnas.0907336106; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; LaFramboise T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001086; Latronico AC, 2001, J CLIN ENDOCR METAB, V86, P4970, DOI 10.1210/jc.86.10.4970; Letouze E, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r76; Moltke I, 2011, GENOME RES, V21, P1168, DOI 10.1101/gr.115360.110; Osorio A, 2002, INT J CANCER, V99, P305, DOI 10.1002/ijc.10337; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pianovski MAD, 2006, PEDIATR BLOOD CANCER, V47, P56, DOI 10.1002/pbc.20624; Pinto Emilia M., 2004, Arq Bras Endocrinol Metab, V48, P647, DOI 10.1590/S0004-27302004000500009; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Probst CM, 2000, HUM BIOL, V72, P597; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosati R, 2008, CANCER GENET CYTOGEN, V186, P19, DOI 10.1016/j.cancergencyto.2008.05.010; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; TONIN P, 1995, AM J HUM GENET, V57, P189; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35897	10.1371/journal.pone.0035897	http://dx.doi.org/10.1371/journal.pone.0035897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567117	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500035
J	Molina-Ortiz, P; Villarejo, A; MacPherson, M; Santos, V; Montes, A; Souchelnytskyi, S; Portillo, F; Cano, A				Molina-Ortiz, Patricia; Villarejo, Ana; MacPherson, Matthew; Santos, Vanesa; Montes, Amalia; Souchelnytskyi, Serhiy; Portillo, Francisco; Cano, Amparo			Characterization of the SNAG and SLUG Domains of Snail2 in the Repression of E-Cadherin and EMT Induction: Modulation by Serine 4 Phosphorylation	PLOS ONE			English	Article							NEURAL CREST DEVELOPMENT; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; GENE-EXPRESSION; PROTEIN; REGULATOR; CANCER; CELLS; MEMBERS; TWIST	Snail1 and Snail2, two highly related members of the Snail superfamily, are direct transcriptional repressors of E-cadherin and EMT inducers. Previous comparative gene profiling analyses have revealed important differences in the gene expression pattern regulated by Snail1 and Snail2, indicating functional differences between both factors. The molecular mechanism of Snail1- mediated repression has been elucidated to some extent, but very little is presently known on the repression mediated by Snail2. In the present work, we report on the characterization of Snail2 repression of E-cadherin and its regulation by phosphorylation. Both the N-terminal SNAG and the central SLUG domains of Snail2 are required for efficient repression of the E-cadherin promoter. The co-repressor NCoR interacts with Snail2 through the SNAG domain, while CtBP1 is recruited through the SLUG domain. Interestingly, the SNAG domain is absolutely required for EMT induction while the SLUG domain plays a negative modulation of Snail2 mediated EMT. Additionally, we identify here novel in vivo phosphorylation sites at serine 4 and serine 88 of Snail2 and demonstrate the functional implication of serine 4 in the regulation of Snail2-mediated repressor activity of E-cadherin and in Snail2 induction of EMT.	[Molina-Ortiz, Patricia; Villarejo, Ana; MacPherson, Matthew; Santos, Vanesa; Montes, Amalia; Portillo, Francisco; Cano, Amparo] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Inst Invest Biomed Alberto Sols CSIC UAM,IdiPAZ, Madrid, Spain; [Souchelnytskyi, Serhiy] Karolinska Inst, Karolinska Biom Ctr, Dept Oncol Pathol, Stockholm, Sweden	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Karolinska Institutet	Molina-Ortiz, P (corresponding author), Univ Liege, GIGA Res Ctr, Lab Funct Genet, Liege, Belgium.	acano@iib.uam.es	Souchelnytskyi, Serhiy/J-9446-2014; Souchelnytskyi, Serhiy/G-6491-2011	Portillo Perez, Francisco/0000-0003-4922-346X; Souchelnytskyi, Serhiy/0000-0001-8243-9276	EU-FP6 (RTN-Epiplast Carcinoma) [MRTN-CT-2004-005428]; Spanish Ministry of Science Innovation [SAF2007-06351, SAF2010-21143, CDS2007-00017]; Fundacion Mutua Madrilena [FMM2009]; EU Marie Curie program; FPI fellowship from Spanish Ministry of Science Innovation; FPU fellowship from Spanish Ministry of Education	EU-FP6 (RTN-Epiplast Carcinoma); Spanish Ministry of Science Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); EU Marie Curie program(European Commission); FPI fellowship from Spanish Ministry of Science Innovation; FPU fellowship from Spanish Ministry of Education(German Research Foundation (DFG))	This work was supported by the EU-FP6 (RTN-Epiplast Carcinoma, MRTN-CT-2004-005428), the Spanish Ministry of Science & Innovation (SAF2007-06351, SAF2010-21143, Consolider Ingenio CDS2007-00017) and Fundacion Mutua Madrilena (FMM2009) to AC. During the realization of this work MMcP was supported by the EU Marie Curie program and PMO was supported by a FPI fellowship from the Spanish Ministry of Science & Innovation. AV is supported by a FPU fellowship from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Aybar MJ, 2003, DEVELOPMENT, V130, P483, DOI 10.1242/dev.00238; Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Bailey CK, 2007, BIOCHEM BIOPH RES CO, V353, P661, DOI 10.1016/j.bbrc.2006.12.097; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hajra KM, 2002, CANCER RES, V62, P1613; Hemavathy K, 2000, MOL CELL BIOL, V20, P5087, DOI 10.1128/MCB.20.14.5087-5095.2000; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Manzanares M, 2001, TRENDS GENET, V17, P178, DOI 10.1016/S0168-9525(01)02232-6; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Mittal MK, 2008, BIOCHEM BIOPH RES CO, V372, P30, DOI 10.1016/j.bbrc.2008.04.187; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nakayama H, 1998, DEV BIOL, V199, P150, DOI 10.1006/dbio.1998.8914; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Qi D, 2008, EMBO J, V27, P898, DOI 10.1038/emboj.2008.26; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Sefton M, 1998, DEVELOPMENT, V125, P3111; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Vernon AE, 2006, DEVELOPMENT, V133, P3359, DOI 10.1242/dev.02504; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	54	39	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36132	10.1371/journal.pone.0036132	http://dx.doi.org/10.1371/journal.pone.0036132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567133	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500051
J	Desrues, L; Lefebvre, T; Lecointre, C; Schouft, MT; Leprince, J; Compere, V; Morin, F; Proust, F; Gandolfo, P; Tonon, MC; Castel, H				Desrues, Laurence; Lefebvre, Thomas; Lecointre, Celine; Schouft, Marie-Therese; Leprince, Jerome; Compere, Vincent; Morin, Fabrice; Proust, Francois; Gandolfo, Pierrick; Tonon, Marie-Christine; Castel, Helene			Down-Regulation of GABA(A) Receptor via Promiscuity with the Vasoactive Peptide Urotensin II Receptor. Potential Involvement in Astrocyte Plasticity	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-ADRENERGIC-RECEPTOR; SUBUNIT MESSENGER-RNAS; A RECEPTOR; ION CHANNELS; ENDOGENOUS LIGAND; ORPHAN RECEPTOR; RAT-BRAIN; CELL; MODULATION	GABA(A) receptor (GABA(A)R) expression level is inversely correlated with the proliferation rate of astrocytes after stroke or during malignancy of astrocytoma, leading to the hypothesis that GABA(A)R expression/activation may work as a cell proliferation repressor. A number of vasoactive peptides exhibit the potential to modulate astrocyte proliferation, and the question whether these mechanisms may imply alteration in GABA(A)R-mediated functions and/or plasma membrane densities is open. The peptide urotensin II (UII) activates a G protein-coupled receptor named UT, and mediates potent vasoconstriction or vasodilation in mammalian vasculature. We have previously demonstrated that UII activates a PLC/PIPs/Ca2+ transduction pathway, via both G(q) and G(i/o) proteins and stimulates astrocyte proliferation in culture. It was also shown that UT/G(q)/IP3 coupling is regulated by the GABA(A)R in rat cultured astrocytes. Here we report that UT and GABA(A)R are co-expressed in cerebellar glial cells from rat brain slices, in human native astrocytes and in glioma cell line, and that UII inhibited the GABAergic activity in rat cultured astrocytes. In CHO cell line co-expressing human UT and combinations of GABA(A)R subunits, UII markedly depressed the GABA current (beta(3)gamma(2)>alpha(2)beta(3)gamma(2)>alpha(2)beta(1)gamma(2)). This effect, characterized by a fast short-term inhibition followed by drastic and irreversible run-down, is not relayed by G proteins. The run-down partially involves Ca2+ and phosphorylation processes, requires dynamin, and results from GABA(A)R internalization. Thus, activation of the vasoactive G protein-coupled receptor UT triggers functional inhibition and endocytosis of GABA(A)R in CHO and human astrocytes, via its receptor C-terminus. This UII-induced disappearance of the repressor activity of GABA(A)R, may play a key role in the initiation of astrocyte proliferation.	[Desrues, Laurence; Lefebvre, Thomas; Lecointre, Celine; Schouft, Marie-Therese; Leprince, Jerome; Compere, Vincent; Morin, Fabrice; Proust, Francois; Gandolfo, Pierrick; Tonon, Marie-Christine; Castel, Helene] Univ Rouen, Inserm U982, Lab Neuronal & Neuroendocrine Commun & Differenti, Mont St Aignan, France; [Desrues, Laurence; Lefebvre, Thomas; Lecointre, Celine; Schouft, Marie-Therese; Leprince, Jerome; Compere, Vincent; Morin, Fabrice; Proust, Francois; Gandolfo, Pierrick; Tonon, Marie-Christine; Castel, Helene] Univ Rouen, Normandy Univ PRES, Inst Res & Biomed Innovat IRIB, Mont St Aignan, France; [Compere, Vincent] Rouen Univ Hosp, Dept Anesthesiol & Crit Care, Rouen, France; [Proust, Francois] Rouen Univ Hosp, Dept Neurosurg, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen	Desrues, L (corresponding author), Univ Rouen, Inserm U982, Lab Neuronal & Neuroendocrine Commun & Differenti, Mont St Aignan, France.	helene.castel@univ-rouen.fr	castel, helene/B-8675-2009; Leprince, Jerome/N-9083-2017	castel, helene/0000-0002-8972-5555; Morin, Fabrice/0000-0001-6785-1967; Leprince, Jerome/0000-0002-7814-9927	Inserm; University of Rouen; Conseil regional de Haute-Normandie	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Rouen; Conseil regional de Haute-Normandie(Region Normandie)	This work was supported by Inserm, University of Rouen and the Conseil regional de Haute-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; Barnes EM, 2001, INT REV NEUROBIOL, V48, P1, DOI 10.1016/S0074-7742(01)48012-3; Behm DJ, 2008, BRIT J PHARMACOL, V155, P374, DOI 10.1038/bjp.2008.266; Bianchi MT, 2001, J NEUROSCI, V21, P1127; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; BOVOLIN P, 1992, P NATL ACAD SCI USA, V89, P9344, DOI 10.1073/pnas.89.19.9344; Brandon NJ, 2002, PHARMACOL THERAPEUT, V94, P113, DOI 10.1016/S0163-7258(02)00175-4; BUREAU M, 1995, J NEUROCHEM, V65, P2006; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Castel H, 2006, J NEUROCHEM, V99, P582, DOI 10.1111/j.1471-4159.2006.04130.x; Chatenet D, 2004, PEPTIDES, V25, P1819, DOI 10.1016/j.peptides.2004.04.019; Clark SD, 2001, BRAIN RES, V923, P120, DOI 10.1016/S0006-8993(01)03208-5; Clozel M, 2004, J PHARMACOL EXP THER, V311, P204, DOI 10.1124/jpet.104.068320; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; D'Hulst C, 2009, DRUG DISCOV TODAY, V14, P866, DOI 10.1016/j.drudis.2009.06.009; Desrues L, 2008, PEPTIDES, V29, P727, DOI 10.1016/j.peptides.2008.01.024; Diallo M, 2008, PEPTIDES, V29, P813, DOI 10.1016/j.peptides.2007.10.023; DominguezPerrot C, 1996, J PHYSIOL-LONDON, V497, P145, DOI 10.1113/jphysiol.1996.sp021756; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; EDDLESTON ALWF, 1993, GASTROENTEROL JPN, V28, P57; Elshourbagy NA, 2002, BRIT J PHARMACOL, V136, P9, DOI 10.1038/sj.bjp.0704671; FRASER DD, 1995, J NEUROSCI, V15, P2720; Fritschy JM, 2006, CEREBELLUM, V5, P275, DOI 10.1080/14734220600962805; Gandolfo P, 1997, EUR J PHARMACOL, V322, P275, DOI 10.1016/S0014-2999(97)00012-5; Gartlon J, 2001, PSYCHOPHARMACOLOGY, V155, P426, DOI 10.1007/s002130100715; Gong H, 2004, J APPL PHYSIOL, V97, P2228, DOI 10.1152/japplphysiol.00540.2004; Green SA, 1996, J BIOL CHEM, V271, P24029, DOI 10.1074/jbc.271.39.24029; Guidolin D, 2010, REGUL PEPTIDES, V162, P26, DOI 10.1016/j.regpep.2010.02.009; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Herring D, 2003, J BIOL CHEM, V278, P24046, DOI 10.1074/jbc.M301420200; Jakubik J, 2002, J PHARMACOL EXP THER, V301, P1033, DOI 10.1124/jpet.301.3.1033; Jarry M, 2010, BIOCHEM J, V428, P113, DOI 10.1042/BJ20090867; Jegou S, 2006, J COMP NEUROL, V495, P21, DOI 10.1002/cne.20845; Johns DG, 2004, N-S ARCH PHARMACOL, V370, P238, DOI 10.1007/s00210-004-0980-z; Kawabata Keita, 1996, Kaku Igaku, V33, P391; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; Labarrere P, 2003, J ENZYM INHIB MED CH, V18, P77, DOI 10.1080/1475636031000093507; Labrakakis C, 1998, EUR J NEUROSCI, V10, P231, DOI 10.1046/j.1460-9568.1998.00036.x; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Lefebvre T, 2009, J NEUROCHEM, V110, P976, DOI 10.1111/j.1471-4159.2009.06197.x; LI HL, 1993, HIPPOCAMPUS, V3, P527, DOI 10.1002/hipo.450030412; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin YZ, 2003, HYPERTENS RES, V26, P839, DOI 10.1291/hypres.26.839; Liu QY, 1999, BIOCHEM BIOPH RES CO, V266, P174, DOI 10.1006/bbrc.1999.1796; Lo EH, 2009, STROKE, V40, pS2, DOI 10.1161/STROKEAHA.108.534404; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LUHMANN HJ, 1995, EPILEPSY RES, V22, P43, DOI 10.1016/0920-1211(95)00032-6; McKhann GM, 1997, J NEUROSCI, V17, P6850; Mori M, 1999, BIOCHEM BIOPH RES CO, V265, P123, DOI 10.1006/bbrc.1999.1640; Moriwaki H, 1998, J NUCL MED, V39, P1348; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; Muller V, 2002, NUCL MED COMMUN, V23, P1191, DOI 10.1097/01.mnm.0000046211.83338.0c; NILSSON M, 1993, NEUROSCIENCE, V54, P605, DOI 10.1016/0306-4522(93)90232-5; Nothacker HP, 1999, NAT CELL BIOL, V1, P383, DOI 10.1038/14081; Nutt DJ, 2010, J PSYCHOPHARMACOL, V24, P1601, DOI 10.1177/0269881109106927; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ohyama M, 1999, ANN NUCL MED, V13, P309, DOI 10.1007/BF03164869; Ono T, 2008, NEUROSCI LETT, V440, P275, DOI 10.1016/j.neulet.2008.05.096; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; Proulx CD, 2005, BIOCHEM J, V385, P115, DOI 10.1042/BJ20040807; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; PUIA G, 1991, MOL PHARMACOL, V39, P691; Qi JG, 2004, HEART VESSELS, V19, P81, DOI 10.1007/s00380-003-0739-3; Rissman RA, 2003, NEUROSCIENCE, V120, P695, DOI 10.1016/S0306-4522(03)00030-7; Sauzeau V, 2001, CIRC RES, V88, P1102, DOI 10.1161/hh1101.092034; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shi LB, 2006, ATHEROSCLEROSIS, V188, P260, DOI 10.1016/j.atherosclerosis.2005.10.044; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Sugo T, 2003, BIOCHEM BIOPH RES CO, V310, P860, DOI 10.1016/j.bbrc.2003.09.102; Taft JR, 2005, INT J NEUROSCI, V115, P1333, DOI 10.1080/00207450590934570; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tateishi N, 2006, BRAIN RES, V1089, P79, DOI 10.1016/j.brainres.2006.02.139; Tretter V, 1997, J NEUROSCI, V17, P2728; VERHEUL HB, 1993, EUR J NEUROSCI, V5, P955, DOI 10.1111/j.1460-9568.1993.tb00946.x; VONBLANKENFELD G, 1991, EUR J NEUROSCI, V3, P310; WAFFORD KA, 1993, MOL PHARMACOL, V43, P240; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Watanabe T, 2001, CIRCULATION, V104, P16, DOI 10.1161/hc2601.092848; YOON KW, 1994, J NEUROPHYSIOL, V71, P2151, DOI 10.1152/jn.1994.71.6.2151; ZERN MA, 1993, GASTROENTEROL JPN, V28, P76; Ziltener P, 2002, J RECEPT SIGNAL TR R, V22, P155, DOI 10.1081/RRS-120014593	92	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36319	10.1371/journal.pone.0036319	http://dx.doi.org/10.1371/journal.pone.0036319			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563490	Green Published, gold			2022-12-25	WOS:000305340700039
J	Fujiwara, M				Fujiwara, Masami			Demographic Diversity and Sustainable Fisheries	PLOS ONE			English	Article							HISTORY; RECRUITMENT; RESILIENCE; STABILITY; PATTERNS; MODELS	Fish species are diverse. For example, some exhibit early maturation while others delay maturation, some adopt semelparous reproductive strategies while others are iteroparous, and some are long-lived and others short-lived. The diversity is likely to have profound effects on fish population dynamics, which in turn has implications for fisheries management. In this study, a simple density-dependent stage-structured population model was used to investigate the effect of life history traits on sustainable yield, population resilience, and the coefficient of variation (CV) of the adult abundance. The study showed that semelparous fish can produce very high sustainable yields, near or above 50% of the carrying capacity, whereas long-lived iteroparous fish can produce very low sustainable yields, which are often much less than 10% of the carrying capacity. The difference is not because of different levels of sustainable fishing mortality rate, but because of difference in the sensitivity of the equilibrium abundance to fishing mortality. On the other hand, the resilience of fish stocks increases from delayed maturation to early maturation strategies but remains almost unchanged from semelparous to long-lived iteroparous. The CV of the adult abundance increases with increased fishing mortality, not because more individuals are recruited into the adult stage (as previous speculated), but because the mean abundance is more sensitive to fishing mortality than its standard deviation. The magnitudes of these effects vary depending on the life history strategies of the fish species involved. It is evident that any past high yield of long-lived iteroparous fish is a transient yield level, and future commercial fisheries should focus more on fish that are short-lived (including semelparous species) with high compensatory capacity.	Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Fujiwara, M (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	fujiwara@tamu.edu	Fujiwara, Masami/C-3115-2012	Fujiwara, Masami/0000-0002-9255-6043	United States National Oceanic and Atmospheric Administration (DOC) [NFFR7500-10-18114]	United States National Oceanic and Atmospheric Administration (DOC)	This work was funded in part by the United States National Oceanic and Atmospheric Administration (DOC Contract-NFFR7500-10-18114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ADAMS PB, 1980, FISH B-NOAA, V78, P1; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; [Anonymous], QUANTITATIVE FISHERI; BALON EK, 1975, J FISH RES BOARD CAN, V32, P821, DOI 10.1139/f75-110; BEDDINGTON JR, 1976, J ANIM ECOL, V45, P791, DOI 10.2307/3581; Beverton R.J.H., 1957, FISH INVEST SER, P19; Brooks EN, 2010, ICES J MAR SCI, V67, P165, DOI 10.1093/icesjms/fsp225; Cadrin SX, 2008, FISH RES, V94, P367, DOI 10.1016/j.fishres.2008.06.004; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; COSTANTINO RF, 1995, NATURE, V375, P227, DOI 10.1038/375227a0; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; DEANGELIS DL, 1980, ECOLOGY, V61, P764, DOI 10.2307/1936746; Fromentin JM, 2001, FISH RES, V53, P133, DOI 10.1016/S0165-7836(00)00299-X; Fujiwara M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00107; Goodwin NB, 2006, CAN J FISH AQUAT SCI, V63, P494, DOI 10.1139/f05-234; Haddon M., 2011, MODELLING QUANTITATI; Hannesson R, 1994, 04299337 FAO DN; HARRISON GW, 1979, AM NAT, V113, P659, DOI 10.1086/283424; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Jennings S., 2001, MARINE FISHERIES ECO; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Myers RA, 1996, FISH B-NOAA, V94, P707; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Quinn T. J., 1999, BIOL RES MANAG SER; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rose KA, 2003, ANNU REV ECOL EVOL S, V34, P127, DOI 10.1146/annurev.ecolsys.34.011802.132423; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shuter BJ, 2005, CAN J FISH AQUAT SCI, V62, P725, DOI 10.1139/F05-067; Stearns S., 1992, EVOLUTION LIFE HIST; USDOC, 2007, 94265 USDOC; Verhulst P.-F., 1838, CORRESP MATH PHYS, V10, P113; Wiedenmann J, 2009, BIOL CONSERV, V142, P2990, DOI 10.1016/j.biocon.2009.07.031; Williams EH, 2003, CAN J FISH AQUAT SCI, V60, P1037, DOI 10.1139/F03-099; Winemiller KO, 2005, CAN J FISH AQUAT SCI, V62, P872, DOI 10.1139/F05-040; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; WINEMILLER KO, 1993, AM NAT, V142, P585, DOI 10.1086/285559; Worden L, 2010, THEOR POPUL BIOL, V78, P239, DOI 10.1016/j.tpb.2010.07.004	38	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e34556	10.1371/journal.pone.0034556	http://dx.doi.org/10.1371/journal.pone.0034556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563455	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340700004
J	Raza, H; John, A				Raza, Haider; John, Annie			Implications of Altered Glutathione Metabolism in Aspirin-Induced Oxidative Stress and Mitochondrial Dysfunction in HepG2 Cells	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYTOCHROME-C; REACTIVE OXYGEN; NITRIC-OXIDE; ELECTRON-TRANSPORT; INDUCED APOPTOSIS; N-ACETYLCYSTEINE; REDOX METABOLISM; PROTEIN-KINASE; CANCER	We have previously reported that acetylsalicylic acid (aspirin, ASA) induces cell cycle arrest, oxidative stress and mitochondrial dysfunction in HepG2 cells. In the present study, we have further elucidated that altered glutathione (GSH)-redox metabolism in HepG2 cells play a critical role in ASA-induced cytotoxicity. Using selected doses and time point for ASA toxicity, we have demonstrated that when GSH synthesis is inhibited in HepG2 cells by buthionine sulfoximine (BSO), prior to ASA treatment, cytotoxicity of the drug is augmented. On the other hand, when GSH-depleted cells were treated with N-acetyl cysteine (NAC), cytotoxicity/apoptosis caused by ASA was attenuated with a significant recovery in oxidative stress, GSH homeostasis, DNA fragmentation and some of the mitochondrial functions. NAC treatment, however, had no significant effects on the drug-induced inhibition of mitochondrial aconitase activity and ATP synthesis in GSH-depleted cells. Our results have confirmed that aspirin increases apoptosis by increased reactive oxygen species production, loss of mitochondrial membrane potential and inhibition of mitochondrial respiratory functions. These effects were further amplified when GSH-depleted cells were treated with ASA. We have also shown that some of the effects of aspirin might be associated with reduced GSH homeostasis, as treatment of cells with NAC attenuated the effects of BSO and aspirin. Our results strongly suggest that GSH dependent redox homeostasis in HepG2 cells is critical in preserving mitochondrial functions and preventing oxidative stress associated complications caused by aspirin treatment.	[Raza, Haider; John, Annie] United Arab Emirates UAE Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates	United Arab Emirates University	Raza, H (corresponding author), United Arab Emirates UAE Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates.	h.raza@uaeu.ac.ae		Raza, Haider/0000-0001-9680-5388	Terry Fox Cancer Research Funds; Faculty of Medicine and Health Sciences Research Committee fund from UAE University	Terry Fox Cancer Research Funds; Faculty of Medicine and Health Sciences Research Committee fund from UAE University	The work was supported by Terry Fox Cancer Research Funds and Faculty of Medicine and Health Sciences Research Committee fund from UAE University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2007, HISTOL HISTOPATHOL, V22, P437, DOI 10.14670/HH-22.437; Al-Belooshi T, 2010, FOOD CHEM TOXICOL, V48, P2624, DOI 10.1016/j.fct.2010.06.031; Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672; Chen G, 2011, ANTIOXID REDOX SIGN, V15, P2911, DOI 10.1089/ars.2011.4170; Dikshit P, 2006, J BIOL CHEM, V281, P29228, DOI 10.1074/jbc.M602629200; Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; Franco R, 2008, J BIOL CHEM, V283, P36071, DOI 10.1074/jbc.M807061200; Fulda S, 2011, ANTIOXID REDOX SIGN, V15, P2937, DOI 10.1089/ars.2011.4078; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; Goel A, 2003, CLIN CANCER RES, V9, P383; Grosser N, 2003, ARTERIOSCL THROM VAS, V23, P1345, DOI 10.1161/01.ATV.0000083296.57581.AE; Hammond CL, 2004, TOXICOL APPL PHARM, V195, P12, DOI 10.1016/j.taap.2003.10.008; Husain SS, 2002, AM J GASTROENTEROL, V97, P542; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Kim KM, 2005, J BIOL CHEM, V280, P41047, DOI 10.1074/jbc.M503713200; Krishna S, 2011, BIOCHEM J, V435, P545, DOI 10.1042/BJ20101996; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Low ICC, 2011, ANTIOXID REDOX SIGN, V15, P2975, DOI 10.1089/ars.2010.3851; Lu Y, 2007, FREE RADICAL BIO MED, V43, P1061, DOI 10.1016/j.freeradbiomed.2007.06.021; Luyendyk JP, 2010, COMPREHENSIVE TOXICOLOGY, VOL 9: HEPATIC TOXICOLOGY, 2ND EDITION, P295; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; Manov I, 2004, BASIC CLIN PHARMACOL, V94, P213, DOI 10.1111/j.1742-7843.2004.pto940504.x; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Pique M, 2000, FEBS LETT, V480, P193, DOI 10.1016/S0014-5793(00)01922-0; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Raza H, 2005, TOXICOL APPL PHARM, V207, P212, DOI 10.1016/j.taap.2005.01.004; Raza H, 2002, BIOCHEM J, V366, P45, DOI 10.1042/BJ20020533; Raza H, 2008, TOXICOL APPL PHARM, V226, P161, DOI 10.1016/j.taap.2007.09.002; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Spear JF, 2007, AM J PHYSIOL-HEART C, V292, pH2459, DOI 10.1152/ajpheart.00459.2006; Sun J, 2010, ARCH BIOCHEM BIOPHYS, V494, P130, DOI 10.1016/j.abb.2009.11.019; Sun Y, 2011, J PHARMACOL EXP THER, V338, P775, DOI 10.1124/jpet.111.183533; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Voehringer DW, 1998, P NATL ACAD SCI USA, V95, P2956, DOI 10.1073/pnas.95.6.2956; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Wu YJ, 2005, J PHARMACOL EXP THER, V312, P424, DOI 10.1124/jpet.104.075119; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200; Zimmermann KC, 2000, NEOPLASIA, V2, P505, DOI 10.1038/sj.neo.7900120; Zweier JL, 2011, ANTIOXID REDOX SIGN, V14, P1769, DOI 10.1089/ars.2011.3904	54	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36325	10.1371/journal.pone.0036325	http://dx.doi.org/10.1371/journal.pone.0036325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558435	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200065
J	Sandau, US; Alderman, Z; Corfas, G; Ojeda, SR; Raber, J				Sandau, Ursula S.; Alderman, Zefora; Corfas, Gabriel; Ojeda, Sergio R.; Raber, Jacob			Astrocyte-Specific Disruption of SynCAM1 Signaling Results in ADHD-Like Behavioral Manifestations	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CELL-ADHESION MOLECULE; FEMALE SEXUAL DEVELOPMENT; IMMUNOGLOBULIN SUPERFAMILY; 3'-UNTRANSLATED REGION; NEUROENDOCRINE BRAIN; PREPULSE INHIBITION; CALCIUM-CHANNELS; CLOCK GENE	SynCAM1 is an adhesion molecule involved in synaptic differentiation and organization. SynCAM1 is also expressed in astroglial cells where it mediates astrocyte-to astrocyte and glial-neuronal adhesive communication. In astrocytes, SynCAM1 is functionally linked to erbB4 receptors, which are involved in the control of both neuronal/glial development and mature neuronal and glial function. Here we report that mice carrying a dominant-negative form of SynCAM1 specifically targeted to astrocytes (termed GFAP-DNSynCAM1 mice) exhibit disrupted diurnal locomotor activity with enhanced and more frequent episodes of activity than control littermates during the day (when the animals are normally sleeping) accompanied by shorter periods of rest. GFAP-DNSynCAM1 mice also display high levels of basal activity in the dark period (the rodent's awake/active time) that are attenuated by the psychostimulant D, L-amphetamine, and reduced anxiety levels in response to both avoidable and unavoidable provoking stimuli. These results indicate that disruption of SynCAM1-dependent astroglial function results in behavioral abnormalities similar to those described in animals model of attention-deficit hyperactive disorder (ADHD), and suggest a hitherto unappreciated contribution of glial cells to the pathophysiology of this disorder.	[Sandau, Ursula S.; Alderman, Zefora; Ojeda, Sergio R.; Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Beaverton, OR USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Beaverton, OR USA; [Corfas, Gabriel] Harvard Univ, Childrens Hosp, Sch Med, FM Kirby Neurobiol Program, Boston, MA 02115 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Harvard University; Boston Children's Hospital; Harvard Medical School	Sandau, US (corresponding author), Legacy Emanuel Hosp, Ctr Hlth, Portland, OR 97227 USA.	ojedas@ohsu.edu; raberj@ohsu.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473	National Institutes of Health [MH-77647, MH-65438, HD25123, RR000163]; NINDS [National Institute of Neurological Disorders and Stroke] [R01 NS35884]; NARSAD [National Alliance for Research on Schizophrenia and Depression] Independent Investigator Award; Development Disability Research Center Grant NIH [P30-HD 18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, K01RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077647, R01MH065438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS [National Institute of Neurological Disorders and Stroke](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NARSAD [National Alliance for Research on Schizophrenia and Depression] Independent Investigator Award; Development Disability Research Center Grant NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health MH-77647 (JR), MH-65438, HD25123, and RR000163 for the operation of the Oregon National Primate Research Center (SRO), NINDS [National Institute of Neurological Disorders and Stroke] R01 NS35884, a NARSAD [National Alliance for Research on Schizophrenia and Depression] Independent Investigator Award, and a Development Disability Research Center Grant NIH P30-HD 18655 (Dr. Corfas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arime Y, 2011, BIOL PHARM BULL, V34, P1373, DOI 10.1248/bpb.34.1373; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; Brunner D, 1999, BEHAV NEUROSCI, V113, P587; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dopheide JA, 2009, PHARMACOTHERAPY, V29, P656, DOI 10.1592/phco.29.6.656; Drolet G, 2002, NEUROPSYCHOPHARMACOL, V27, P400, DOI 10.1016/S0893-133X(02)00303-2; Dziedzic B, 2003, J NEUROSCI, V23, P915; Fan Xueliang, 2012, Curr Top Behav Neurosci, V9, P273, DOI 10.1007/7854_2011_121; Fan XL, 2010, NEUROBIOL DIS, V37, P228, DOI 10.1016/j.nbd.2009.10.009; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fujita E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.23; Fukami T, 2002, GENE, V295, P7, DOI 10.1016/S0378-1119(02)00835-1; Furuse T, 2010, EUR J NEUROSCI, V31, P1281, DOI 10.1111/j.1460-9568.2010.07164.x; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Giaume C, 2009, NEUROSCIENTIST, V15, P351, DOI 10.1177/1073858409336092; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Hoy JL, 2009, MOL CELL NEUROSCI, V42, P466, DOI 10.1016/j.mcn.2009.09.010; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Kissling C, 2008, AM J MED GENET B, V147B, P333, DOI 10.1002/ajmg.b.30602; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lomniczi A, 2006, J NEUROSCI, V26, P51, DOI 10.1523/JNEUROSCI.2939-05.2006; Marpegan L, 2011, J NEUROSCI, V31, P8342, DOI 10.1523/JNEUROSCI.6537-10.2011; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Plappert CF, 2004, BEHAV BRAIN RES, V152, P403, DOI 10.1016/j.bbr.2003.10.025; Prevot V, 2003, J NEUROSCI, V23, P230; Raber J, 1997, J NEUROCHEM, V68, P176; Ralph RJ, 2001, J PHARMACOL EXP THER, V298, P148; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Sandau US, 2011, ENDOCRINOLOGY, V152, P2364, DOI 10.1210/en.2010-1435; Sandau US, 2011, ENDOCRINOLOGY, V152, P2353, DOI 10.1210/en.2010-1434; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Stagi M, 2010, P NATL ACAD SCI USA, V107, P7568, DOI 10.1073/pnas.0911798107; Studer FE, 2006, NEUROSCIENCE, V142, P125, DOI 10.1016/j.neuroscience.2006.06.016; Thapar A, 2005, HUM MOL GENET, V14, pR275, DOI 10.1093/hmg/ddi263; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Xu XH, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-48; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995	56	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36424	10.1371/journal.pone.0036424	http://dx.doi.org/10.1371/journal.pone.0036424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558465	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200079
J	Duan, KM; McCullough, WM; Surette, MG; Ware, T; Song, JZ				Duan, Kangmin; McCullough, William M.; Surette, Michael G.; Ware, Tony; Song, Jiuzhou			Comprehensive Analysis of Gene-Environmental Interactions with Temporal Gene Expression Profiles in Pseudomonas aeruginosa	PLOS ONE			English	Article							REGULATORY NETWORKS; MODULATION; MOTIFS	To explore gene-environment interactions, based on temporal gene expression information, we analyzed gene and treatment information intensively and inferred interaction networks accordingly. The main idea is that gene expression reflects the response of genes to environmental factors, assuming that variations of gene expression occur under different conditions. Then we classified experimental conditions into several subgroups based on the similarity of temporal gene expression profiles. This procedure is useful because it allows us to combine diverse gene expression data as they become available, and, especially, allowing us to lay the regulatory relationships on a concrete biological basis. By estimating the activation points, we can visualize the gene behavior, and obtain a consensus gene activation order, and hence describe conditional regulatory relationships. The estimation of activation points and building of synthetic genetic networks may result in important new insights in the ongoing endeavor to understand the complex network of gene regulation.	[Duan, Kangmin] Univ Manitoba, Dept Med Microbiol, Dept Biol, Winnipeg, MB, Canada; [McCullough, William M.; Surette, Michael G.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Dept Med, Hamilton, ON, Canada; [Ware, Tony] Univ Calgary, Dept Math & Stat, Calgary, AB T2N 1N4, Canada; [Song, Jiuzhou] Univ Maryland, Anim Sci Ctr, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University of Manitoba; McMaster University; University of Calgary; University System of Maryland; University of Maryland College Park	Duan, KM (corresponding author), Univ Manitoba, Dept Med Microbiol, Dept Biol, Winnipeg, MB, Canada.	songj88@umd.edu	Song, Jiuzhou/AAD-6440-2020	Duan, Kangmin/0000-0002-3016-786X	Canadian Cystic Fibrosis Foundation	Canadian Cystic Fibrosis Foundation	This research was supported by a grant from the Canadian Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arda HE, 2010, BRIEF FUNCT GENOMICS, V9, P4, DOI 10.1093/bfgp/elp049; Banerjee N, 2002, CURR OPIN MICROBIOL, V5, P313, DOI 10.1016/S1369-5274(02)00322-3; Bickel DR, 2005, BIOINFORMATICS, V21, P1121, DOI 10.1093/bioinformatics/bti140; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fabry-Asztalos L, 2008, BIOORGAN MED CHEM, V16, P2903, DOI 10.1016/j.bmc.2007.12.055; Hache H, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/617281; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hempel S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-292; Huang MC, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3385468; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Lin K, 2010, METHODS MOL BIOL, V673, P253, DOI 10.1007/978-1-60761-842-3_17; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Logan MR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-336; Malcom JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021541; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Ooi BNS, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-13; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Shen LX, 2008, J MICROBIOL, V46, P441, DOI 10.1007/s12275-008-0054-x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shimamura T, 2010, BIOINFORMATICS, V26, P1064, DOI 10.1093/bioinformatics/btq080; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Summer G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S18; SZALLASI Z, 1999, PAC S BIOC, V4, P5; Takahashi H, 2011, OMICS, V15, P15, DOI 10.1089/omi.2010.0074; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Taylor Ronald C., 2011, International Journal of Computational Biology and Drug Design, V4, P56, DOI 10.1504/IJCBDD.2011.038657; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; Waaijenborg S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-315; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Weaver D C, 1999, Pac Symp Biocomput, P112; Xu R, 2011, INTEGR BIOL-UK, V3, P368, DOI 10.1039/c0ib00087f; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35993	10.1371/journal.pone.0035993	http://dx.doi.org/10.1371/journal.pone.0035993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558298	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000096
J	Erb, M; Hoffmann-Enger, B; Deppe, H; Soeberdt, M; Haefeli, RH; Rummey, C; Feurer, A; Gueven, N				Erb, Michael; Hoffmann-Enger, Barbara; Deppe, Holger; Soeberdt, Michael; Haefeli, Roman H.; Rummey, Christian; Feurer, Achim; Gueven, Nuri			Features of Idebenone and Related Short-Chain Quinones that Rescue ATP Levels under Conditions of Impaired Mitochondrial Complex I	PLOS ONE			English	Article							BRAIN MITOCHONDRIA; LIPID-PEROXIDATION; NAD(P)H-QUINONE OXIDOREDUCTASE-1; COENZYME-Q; INHIBITION; METABOLISM; MECHANISMS; REDUCTION; CHEMISTRY; SUBSTRATE	Short-chain quinones have been investigated as therapeutic molecules due to their ability to modulate cellular redox reactions, mitochondrial electron transfer and oxidative stress, which are pathologically altered in many mitochondrial and neuromuscular disorders. Recently, we and others described that certain short-chain quinones are able to bypass a deficiency in complex I by shuttling electrons directly from the cytoplasm to complex III of the mitochondrial respiratory chain to produce ATP. Although this energy rescue activity is highly interesting for the therapy of disorders associated with complex I dysfunction, no structure-activity-relationship has been reported for short-chain quinones so far. Using a panel of 70 quinones, we observed that the capacity for this cellular energy rescue as well as their effect on lipid peroxidation was influenced more by the physicochemical properties (in particular logD) of the whole molecule than the quinone moiety itself. Thus, the observed correlations allow us to explain the differential biological activities and therapeutic potential of short-chain quinones for the therapy of disorders associated with mitochondrial complex I dysfunction and/or oxidative stress.	[Erb, Michael; Hoffmann-Enger, Barbara; Deppe, Holger; Soeberdt, Michael; Haefeli, Roman H.; Rummey, Christian; Feurer, Achim; Gueven, Nuri] Santhera Pharmaceut, Liestal, Switzerland; [Haefeli, Roman H.] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Erb, M (corresponding author), Santhera Pharmaceut, Liestal, Switzerland.	nuri.gueven@santhera.com	Soeberdt, Michael/AAP-8617-2020	Soeberdt, Michael/0000-0003-2594-9901; Guven, Nuri/0000-0003-3782-767X; Rummey, Christian/0000-0003-4911-911X				Adikesavan AK, 2007, CANCER RES, V67, P7966, DOI 10.1158/0008-5472.CAN-06-4480; Becker C, 2010, EXPERT OPIN DRUG MET, V6, P1437, DOI 10.1517/17425255.2010.530656; Boutin JA, 2005, CHEM-BIOL INTERACT, V151, P213, DOI 10.1016/j.cbi.2005.01.002; Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180; Chan TS, 2002, FREE RADICAL RES, V36, P421, DOI 10.1080/10715760290021270; Colucci MA, 2008, ORG BIOMOL CHEM, V6, P637, DOI 10.1039/b715270a; Courdier-Fruh I, 2006, MUSCLE NERVE, V33, P753, DOI 10.1002/mus.20549; Dragan M, 2006, BRAIN RES, V1078, P9, DOI 10.1016/j.brainres.2006.01.068; Ernster, 1967, METHOD ENZYMOL, V10, P309, DOI [DOI 10.1016/0076-6879(67)10059-1, 10.1016/0076-6879(67)10059-1]; Esposti MD, 1996, ARCH BIOCHEM BIOPHYS, V330, P395, DOI 10.1006/abbi.1996.0267; FATO R, 2008, BIOCHIM BIOPHYS ACTA, V1787, P384; Feurer A, 2012, Patent No. [WO/2012/022468, 2012022468]; Feurer A, 2012, Patent No. [WO/2012/ 022467, 2012022467]; Genova MW, 2003, EXP BIOL MED, V228, P506, DOI 10.1177/15353702-0322805-14; Giorgio V, 2011, BIOCHIM BIOPHYS ACTA, V1817, P363; Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963; Haginoya K, 2009, J NEUROL SCI, V278, P112, DOI 10.1016/j.jns.2008.11.008; Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170; Long DJ, 2000, CHEM-BIOL INTERACT, V129, P99, DOI 10.1016/S0009-2797(00)00200-3; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Mordente A, 1998, CHEM RES TOXICOL, V11, P54, DOI 10.1021/tx970136j; Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Rauchova H, 2008, J BIOENERG BIOMEMBR, V40, P85, DOI 10.1007/s10863-008-9134-1; Rauchova H, 2006, BIOCHEM BIOPH RES CO, V339, P362, DOI 10.1016/j.bbrc.2005.11.035; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; SUGIYAMA Y, 1985, J PHARMACOBIO-DYNAM, V8, P1006; SUNO M, 1984, BIOCHEM BIOPH RES CO, V125, P1046, DOI 10.1016/0006-291X(84)91389-5; SUNO M, 1989, ARCH GERONTOL GERIAT, V8, P291, DOI 10.1016/0167-4943(89)90010-1; TSURUO Y, 1994, JPN J PHARMACOL, V65, P285, DOI 10.1254/jjp.65.285	35	60	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36153	10.1371/journal.pone.0036153	http://dx.doi.org/10.1371/journal.pone.0036153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558363	Green Published, gold			2022-12-25	WOS:000305336000140
J	Krejci, P; Aklian, A; Kaucka, M; Sevcikova, E; Prochazkova, J; Masek, JK; Mikolka, P; Pospisilova, T; Spoustova, T; Weis, M; Paznekas, WA; Wolf, JH; Gutkind, JS; Wilcox, WR; Kozubik, A; Jabs, EW; Bryja, V; Salazar, L; Vesela, I; Balek, L				Krejci, Pavel; Aklian, Anie; Kaucka, Marketa; Sevcikova, Eva; Prochazkova, Jirina; Masek, Jan Kukla; Mikolka, Pavol; Pospisilova, Tereza; Spoustova, Tereza; Weis, MaryAnn; Paznekas, William A.; Wolf, Joshua H.; Gutkind, J. Silvio; Wilcox, William R.; Kozubik, Alois; Jabs, Ethylin Wang; Bryja, Vitezslav; Salazar, Lisa; Vesela, Iva; Balek, Lukas			Receptor Tyrosine Kinases Activate Canonical WNT/beta-Catenin Signaling via MAP Kinase/LRP6 Pathway and Direct beta-Catenin Phosphorylation	PLOS ONE			English	Article							WNT; FGFR3; MUTATIONS; MECHANISM; INSULIN	Receptor tyrosine kinase signaling cooperates with WNT/beta-catenin signaling in regulating many biological processes, but the mechanisms of their interaction remain poorly defined. We describe a potent activation of WNT/beta-catenin by FGFR2, FGFR3, EGFR and TRKA kinases, which is independent of the PI3K/AKT pathway. Instead, this phenotype depends on ERK MAP kinase-mediated phosphorylation of WNT co-receptor LRP6 at Ser1490 and Thr1572 during its Golgi network-based maturation process. This phosphorylation dramatically increases the cellular response to WNT. Moreover, FGFR2, FGFR3, EGFR and TRKA directly phosphorylate beta-catenin at Tyr142, which is known to increase cytoplasmic beta-catenin concentration via release of beta-catenin from membranous cadherin complexes. We conclude that signaling via ERK/LRP6 pathway and direct beta-catenin phosphorylation at Tyr142 represent two mechanisms used by various receptor tyrosine kinase systems to activate canonical WNT signaling.	[Krejci, Pavel; Aklian, Anie; Wilcox, William R.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Krejci, Pavel; Kaucka, Marketa; Sevcikova, Eva; Prochazkova, Jirina; Masek, Jan Kukla; Mikolka, Pavol; Pospisilova, Tereza; Spoustova, Tereza; Kozubik, Alois; Bryja, Vitezslav; Vesela, Iva; Balek, Lukas] Masaryk Univ, Dept Anim Physiol & Immunol, Inst Expt Biol, Brno, Czech Republic; [Krejci, Pavel; Kozubik, Alois; Bryja, Vitezslav] Inst Biophys AS CR, Dept Cytokinet, Brno, Czech Republic; [Weis, MaryAnn] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Paznekas, William A.; Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Wolf, Joshua H.; Gutkind, J. Silvio] NIH, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Wilcox, William R.] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; [Salazar, Lisa] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	Cedars Sinai Medical Center; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine	Krejci, P (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA.	krejcip@sci.muni.cz	Kaucka, Marketa/AAG-2000-2021; Krejčí, Pavel/I-4285-2014; Bryja, Vítězslav/P-4217-2019; Masek, Jan/I-9029-2014; Gutkind, J. Silvio/J-1201-2016; Kozubík, Alois/H-1954-2014; Mikolka, Pavol/X-6080-2018; Mašek, Jan/N-3169-2019; Bryja, Vít?zslav/H-1925-2014; Medalova, Jirina/D-7528-2012	Kaucka, Marketa/0000-0002-8781-9769; Bryja, Vítězslav/0000-0002-9136-5085; Gutkind, J. Silvio/0000-0002-5150-4482; Mikolka, Pavol/0000-0001-8485-4748; Mašek, Jan/0000-0003-2904-3808; Bryja, Vít?zslav/0000-0002-9136-5085; Renzova, Tereza/0000-0003-3928-7195; Vesela, Iva/0000-0001-5751-0130; Krejci, Pavel/0000-0003-0618-9134; Jabs, Ethylin/0000-0001-8983-5466	National Institutes of Health (NIH) [5P01HD022657-21A]; NIH GCRC [M01-RR00425]; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622430]; Grant Agency of the Czech Republic [301/09/0587, 204/09/H058, 204/09/J030, 305/11/0752]; Winnick Family Research Scholars award; EMBO; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Winnick Family Research Scholars award; EMBO(European Molecular Biology Organization (EMBO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by: National Institutes of Health (NIH) 5P01HD022657-21A, NIH GCRC Grant M01-RR00425 (www.nih.gov/); Ministry of Education, Youth and Sports of the Czech Republic (MSM0021622430) (www.msmt.cz/); Grant Agency of the Czech Republic (301/09/0587, 204/09/H058, 204/09/J030, 305/11/0752) (www.gacr.cz); Winnick Family Research Scholars award (WRW) (www.winnickfamilyfoundation.com); and EMBO Installation grant (VB) (www.embo.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Hernandez S, 2009, MODERN PATHOL, V22, P848, DOI 10.1038/modpathol.2009.46; Krejci P, 2010, BONE, V47, P102, DOI 10.1016/j.bone.2010.03.021; Krejci P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003961; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Wilcox WR, 1998, AM J MED GENET, V78, P274, DOI 10.1002/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C; Wolf J, 2008, FEBS LETT, V582, P255, DOI 10.1016/j.febslet.2007.12.013; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	24	110	115	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35826	10.1371/journal.pone.0035826	http://dx.doi.org/10.1371/journal.pone.0035826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558232	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000063
J	Mah, CL; Blake, DB				Mah, Christopher L.; Blake, Daniel B.			Global Diversity and Phylogeny of the Asteroidea (Echinodermata)	PLOS ONE			English	Review							SEA STARS ASTEROIDEA; HIGH-DISPERSAL STARFISH; OF-THORNS STARFISH; PHOTOPERIODIC REGULATION; FEEDING-BEHAVIOR; ASTERIAS-AMURENSIS; LARV-AE; BATHYMETRIC DISTRIBUTION; SEASTARS ECHINODERMATA; MOLECULAR SYSTEMATICS	Members of the Asteroidea (phylum Echinodermata), popularly known as starfish or sea stars, are ecologically important and diverse members of marine ecosystems in all of the world's oceans. We present a comprehensive overview of diversity and phylogeny as they have figured into the evolution of the Asteroidea from Paleozoic to the living fauna. Living post-Paleozoic asteroids, the Neoasteroidea, are morphologically separate from those in the Paleozoic. Early Paleozoic asteroid faunas were diverse and displayed morphology that foreshadowed later living taxa. Preservation presents significant difficulties, but fossil occurrence and current accounts suggests a diverse Paleozoic fauna, which underwent extinction around the Permian-Triassic interval was followed by re-diversification of at least one surviving lineage. Ongoing phylogenetic classification debates include the status of the Paxillosida and the Concentricycloidea. Fossil and molecular evidence has been and continues to be part of the ongoing evolution of asteroid phylogenetic research. The modern lineages of asteroids include the Valvatacea, the Forcipulatacea, the Spinlosida, and the Velatida. We present an overview of diversity in these taxa, as well as brief notes on broader significance, ecology, and functional morphology of each. Although much asteroid taxonomy is stable, many new taxa remain to be discovered with many new species currently awaiting description. The Goniasteridae is currently one of the most diverse families within the Asteroidea. New data from molecular phylogenetics and the advent of global biodiversity databases, such as the World Asteroidea Database (http://www.marinespecies.org/Asteroidea/) present important new springboards for understanding the global biodiversity and evolution of asteroids.	[Mah, Christopher L.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Mah, Christopher L.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Blake, Daniel B.] Univ Illinois, Dept Geol, Urbana, IL USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Louisiana State University System; Louisiana State University; University of Illinois System; University of Illinois Urbana-Champaign	Mah, CL (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	mahch@si.edu		Mah, Christopher/0000-0002-0178-8237	National Science Foundation [1036358]; Division Of Environmental Biology [1036358] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This publication has been supported by National Science Foundation 1036358 Assembling the Echinoderm Tree of Life grant to Louisiana State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTON MS, 1966, J FISH RES BOARD CAN, V23, P1673, DOI 10.1139/f66-158; ANDERSON JM, 1960, BIOL BULL, V119, P371, DOI 10.2307/1539257; [Anonymous], 2005, J SYST PALAEONTOL, V3, P29; Ayers KL, 2005, MAR BIOL, V147, P1045, DOI 10.1007/s00227-005-1632-7; BAKER AN, 1986, NATURE, V321, P862, DOI 10.1038/321862a0; BARKER MF, 1977, J EXP MAR BIOL ECOL, V30, P95, DOI 10.1016/0022-0981(77)90030-2; BARKER MF, 1979, J EXP MAR BIOL ECOL, V41, P195, DOI 10.1016/0022-0981(79)90133-3; BARTELS C, 1998, CAMB PALEOBIOL SER, V3, pR9; BEDDINGFIELD SD, 1993, MAR BIOL, V115, P669, DOI 10.1007/BF00349375; Benavides-Serrato Milena, 2007, Memoirs of Museum Victoria, V64, P71; BIRKELAND C, 1974, ECOL MONOGR, V44, P211, DOI 10.2307/1942312; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Blake D.B., 1988, P309; Blake D.B., 1989, Echinoderm Studies, V3, P179; Blake D.B., 1984, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P74; Blake DB, 2008, J PALEONTOL, V82, P645, DOI 10.1666/07-013.1; Blake DB, 2007, ACTA PALAEONTOL POL, V52, P519; Blake DB, 2006, PALAEONTOL Z, V80, P284, DOI 10.1007/BF02988442; Blake Daniel B., 2002, Palaeontologische Zeitschrift, V76, P357; Blake Daniel B., 2003, Palaeontologische Zeitschrift, V77, P23; Blake DB, 2009, PALAEONTOL Z, V83, P293, DOI 10.1007/s12542-009-0020-x; BLAKE DB, 1979, J PALEONTOL, V53, P1145; BLAKE DB, 1983, B MAR SCI, V33, P703; BLAKE DB, 1994, LETHAIA, V27, P235, DOI 10.1111/j.1502-3931.1994.tb01415.x; BLAKE DB, 1984, ECLOGAE GEOL HELV, V77, P631; BLAKE DB, 1987, J NAT HIST, V21, P481, DOI 10.1080/00222938700771141; Blake DB, 2000, RIV ITAL PALEONTOL S, V106, P141, DOI 10.13130/2039-4942/5395; Blake DB, 1996, PALAEONTOLOGY, V39, P179; BLAKE DB, 1972, SCIENCE, V176, P306, DOI 10.1126/science.176.4032.306; BLAKE DB, 1990, B MAR SCI, V46, P701; Boolootian R.A, 1966, PHYSL ECHINODERMATA; Bos AR, 2008, MAR BIOL, V156, P55, DOI 10.1007/s00227-008-1064-2; Bos AR, 2011, MAR BIOL, V158, P639, DOI 10.1007/s00227-010-1588-0; Bowden DA, 2011, DEEP-SEA RES PT II, V58, P119, DOI 10.1016/j.dsr2.2010.09.006; Breton G., 1986, Bulletin Trimestriel de la Societe Geologique de Normandie et des Amis du Museum du Havre, V72, P91; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Byrne M, 2005, DEV GENES EVOL, V215, P608, DOI 10.1007/s00427-005-0018-7; Byrne M, 2003, BIOL BULL-US, V205, P285, DOI 10.2307/1543292; BYRNE M, 1995, BIOL BULL, V188, P293, DOI 10.2307/1542306; Byrne M, 2007, B MAR SCI, V81, P209; Byrne M, 2006, INTEGR COMP BIOL, V46, P243, DOI 10.1093/icb/icj033; Cerra A, 2004, EVOL DEV, V6, P105, DOI 10.1111/j.1525-142X.2004.04015.x; CHESHER RH, 1969, SCIENCE, V165, P280, DOI 10.1126/science.165.3890.280; CHIA FS, 1994, MICROSCOPIC ANATOMY, V14, P169; Chia Fu Shiang, 1991, P301; Clark A.M., 1984, Bulletin of the British Museum (Natural History) Zoology, V47, P19; Clark A.M., 1989, Echinoderm Studies, V3, P225; Clark A.M., 1992, P1; Clark A.M., 1962, BANZ ANTARCTIC RES B, V9, P68; Clark A. M., 1993, ECHINODERM STUDIES, P187, DOI DOI 10.1201/9781003072553-4; Clark A. M., 1977, STARFISHES RELATED E; Clark Ailsa M., 1996, V5, P183; Clark AM, 2001, ECHINOD ST, V6, P229; Clark AM, 1971, BR MUS NAT HIST PUBL, V690, p[ix, 1]; Clark AM, 1962, ANN MAG NAT HIST, V13, P243; CLARK H E S, 1982, National Museum of New Zealand Records, V2, P35; Clark H. L., 1921, Department of Marine Biology Carnegie Institution Washington, V10, P1; Clark HES, 2001, NIWA BIODIVERSITY ME, V117, P1; Clark HL, 1920, B MUS COMP ZOOL HARV, V51, P25; Coteur G, 2003, ARCH ENVIRON CON TOX, V45, P190, DOI 10.1007/s00244-003-0199-x; Cuenot L, 1966, TRAITE ZOOLOGIE ANAT, P3; Danis B, 2003, MAR ECOL PROG SER, V253, P155, DOI 10.3354/meps253155; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; Dean J, 1999, ZOOL J LINN SOC-LOND, V126, P225, DOI 10.1006/zjls.1998.0159; DEARBORN JH, 1991, MAR ECOL PROG SER, V77, P65, DOI 10.3354/meps077065; Dearborn JH, 1977, ADAPTATIONS ANTARCTI, P293; Djakonov AM, 1968, TABL ANAL FAUNE URSS; Doderlein L., 1936, Siboga Expeditie Leiden, V46c, P295; Doderlein L., 1917, SIBOGA EXPED A, V46, P1, DOI 10.5962/bhl.title.11319; Doderlein L., 1935, SIBOGA EXPED, V46, P71, DOI 10.5962/bhl.title.11319; Doderlein LH, 1920, SIBOGA EXPED, V46b, P193; Doderlein LH, 1924, SIBOGA EXPED, V46, P4969; Downey M. E., 1970, Smithson. Contr. Zool., VNo. 64, P1; Downey ME, 1986, SMITH CONTRIB ZOOL, V435, P1, DOI [10.5479/si.00810282.435, DOI 10.5479/SI.00810282.435]; Duxbury A. C., 2010, INTRO WORLDS OCEANS, V10th; Eernisse DJ, 2010, ZOOTAXA, P22, DOI 10.11646/zootaxa.2329.1.2; EMSON RH, 1994, MAR BIOL, V118, P433, DOI 10.1007/BF00350300; ERICSSON J, 1973, Ophelia, V12, P53; Fell H. B., 1963, Report of the Smithsonian Institution, V1962, P457; FELL HB, 1962, SCIENCE, V136, P633, DOI 10.1126/science.136.3516.633; FELL HB, 1963, PHILOS T ROY SOC B, V246, P381, DOI 10.1098/rstb.1963.0010; Fell HB, 1962, U KANS PALEONTOL CON, V6, P1; Fisher W. K., 1928, Bulletin United States National Museum, V76, P1; Fisher W. K., 1930, Bulletin United States National Museum, V76, P1; Fisher WK, 1911, B US NAT MUS, V76, pxiii+420; FLAMMANG P, 1995, BELG J ZOOL, V125, P125; Flammang P, 1998, J EXP BIOL, V201, P2383; FLAMMANG P, 1994, BIOL BULL, V187, P35, DOI 10.2307/1542163; Flammang Patrick, 1996, Echinoderm Studies, V5, P1; Flowers JM, 2001, MAR BIOL, V139, P475, DOI 10.1007/s002270100595; Foltz DW, 2008, MAR BIOL, V154, P593, DOI 10.1007/s00227-008-0952-9; Foltz DW, 2007, MOL PHYLOGENET EVOL, V43, P627, DOI 10.1016/j.ympev.2006.10.012; Fontanella FM, 2001, ECHINODERM RES, P91; Fujita Toshihiko, 2002, Species Diversity, V7, P317; Fujita Toshihiko, 1994, Bulletin of the National Science Museum Series A (Zoology), V20, P183; Gale Andrew Scott, 2011, Special Papers in Palaeontology, V85, P1; GALE AS, 1987, ZOOL J LINN SOC-LOND, V89, P107, DOI 10.1111/j.1096-3642.1987.tb00652.x; Galkin S.V., 1984, Tsitologiya, V119, P164; Gasparini JL, 2005, BIODIVERS CONSERV, V14, P2883, DOI 10.1007/s10531-004-0222-1; Gaymer CF, 2001, J MAR BIOL ASSOC UK, V81, P827, DOI 10.1017/S0025315401004660; Gemmill JF, 1915, P ZOOL SOC LOND, V1915, P1; Georgiades ET, 2006, CHEMOSPHERE, V65, P1869, DOI 10.1016/j.chemosphere.2006.03.071; Gerard K, 2008, CR BIOL, V331, P137, DOI 10.1016/j.crvi.2007.11.005; Gollub M, 2003, COMP BIOCHEM PHYS B, V134, P89, DOI 10.1016/S1096-4959(02)00190-2; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Grace R.V., 1974, Tane, V20, P162; Grainger E. H., 1966, Bulletin Fisheries Research Board of Canada, VNo. 152, P1; Green E, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P31; Guensburg Thomas, 2003, American Paleontologist, V11, P3; Guensburg TE, 2009, J PALEONTOL, V83, P350, DOI 10.1666/08-090.1; HALPERN JA, 1970, B MAR SCI, V20, P193; HEALY JM, 1988, ZOOL SCR, V17, P297, DOI 10.1111/j.1463-6409.1988.tb00105.x; Herringshaw LG, 2007, ZOOL J LINN SOC-LOND, V150, P743, DOI 10.1111/j.1096-3642.2007.00299.x; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Hotchkiss F.H.C., 1976, Bulletin Br Mus nat Hist (Zool), V30, P263; Howell KL, 2004, MAR BIOL, V144, P977, DOI 10.1007/s00227-003-1248-8; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; Hrincevich AW, 2000, AM ZOOL, V40, P365, DOI 10.1668/0003-1569(2000)040[0365:PAOMLI]2.0.CO;2; Hyman L. H., 1955, INVERTEBRATES; Jackson AC, 2009, MAR ECOL PROG SER, V376, P153, DOI 10.3354/meps07807; Jagt John W.M., 2000, Scripta Geologica, V121, P377; JANGOUX M, 1984, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V6, P279; Jangoux M., 1982, ECHINODERM NUTR, P117, DOI DOI 10.1201/9781003078920-6; Janies D, 2001, CAN J ZOOL, V79, P1232, DOI 10.1139/cjz-79-7-1232; JANIES DA, 1994, ECHINODERMS THROUGH TIME, P319; JANIES DA, 1994, REPRODUCTION AND DEVELOPMENT OF MARINE INVERTEBRATES, P246; Janies Daniel, 1999, P311; Janies DA, 2011, SYST BIOL, V60, P420, DOI 10.1093/sysbio/syr044; Janosik AM, 2011, POLAR BIOL, V34, P575, DOI 10.1007/s00300-010-0916-7; Janosik AM, 2010, INTEGR COMP BIOL, V50, P981, DOI 10.1093/icb/icq119; Joly-Turquin G, 2009, ARCH ENVIRON CON TOX, V56, P209, DOI 10.1007/s00244-008-9176-8; JONES DS, 1988, J PALEONTOL, V62, P126; KESLING R V, 1971, Contributions from the Museum of Paleontology University of Michigan, V23, P181; KESLING R V, 1970, Contributions from the Museum of Paleontology University of Michigan, V23, P73; Kesling R. V., 1967, Contributions from the Museum of Paleontology University of Michigan, V21, P73; KESLING R V, 1969, Contributions from the Museum of Paleontology University of Michigan, V22, P249; Kesling R. V., 1964, Contributions from the Museum of Paleontology University of Michigan, V19, P115; KESLING R V, 1969, Contributions from the Museum of Paleontology University of Michigan, V22, P361; KESLING ROBERT V., 1966, J PALEONTOL, V40, P1157; KESLING RV, 1962, J PALEONTOL, V36, P933; Kitajima A, 2005, DEV BIOL, V280, P48, DOI 10.1016/j.ydbio.2004.12.033; Knott KE, 2000, AM ZOOL, V40, P382, DOI 10.1668/0003-1569(2000)040[0382:CACIAS]2.0.CO;2; Kochzius M, 2009, MAR ECOL PROG SER, V396, P211, DOI 10.3354/meps08281; Koseoglu M, 2001, CRYOBIOLOGY, V43, P248, DOI 10.1006/cryo.2001.2348; LAFAY B, 1995, SYST BIOL, V44, P190, DOI 10.2307/2413706; Lawrence J. M., 1987, FUNCTIONAL BIOL ECHI, DOI 10.1002/iroh.19890740316; Lawrence JM, 2001, CAN J ZOOL, V79, P1251, DOI 10.1139/cjz-79-7-1251; LECLAIR EE, 1993, PALAIOS, V8, P233, DOI 10.2307/3515146; Lehmann W. M., 1957, Abhandlungen der Hessischen Landesamtes fuer Bodenforschung, V21, P1; Lemaitre R, 2009, ANTIZ V 1 07 DATABAS; MacBride EW, 1923, NATURE, V111, P47, DOI 10.1038/111047a0; MacBride EW, 1921, NATURE, V106, P501; MacBridge EW, 1923, NATURE, V111, P323, DOI 10.1038/111323a0; Madsen F. J., 1961, Galathea Report, V4, P177; MADSEN F J, 1987, Steenstrupia, V13, P201; Madsen F. J., 1961, Galathea Report, V4, P33; MADSEN FJ, 1966, NATURE, V209, P1367, DOI 10.1038/2091367a0; Mah C, 2005, ZOOSYSTEMA, V27, P137; Mah C, 2011, WORLD ASTEROIDEA DAT; Mah C, 2012, WORLD ASTEROIDEA DAT; Mah C, 2010, WORLD ASTEROIDEA DAT; Mah C. L., 1998, P273; Mah C, 2007, INVERTEBR SYST, V21, P311, DOI 10.1071/IS06049; Mah C, 2007, ZOOL J LINN SOC-LOND, V150, P177, DOI 10.1111/j.1096-3642.2007.00291.x; Mah C, 2011, ZOOL J LINN SOC-LOND, V162, P646, DOI 10.1111/j.1096-3642.2010.00688.x; Mah C, 2011, ZOOL J LINN SOC-LOND, V161, P769, DOI 10.1111/j.1096-3642.2010.00659.x; Mah C, 2010, ZOOL J LINN SOC-LOND, V160, P266, DOI 10.1111/j.1096-3642.2010.00638.x; Mah CL, 2006, ZOOSYSTEMA, V28, P917; Mah CL, 2006, INVERTEBR BIOL, V125, P136, DOI 10.1111/j.1744-7410.2006.00048.x; Mah CL, 2011, ZOOTAXA, P1; Mah Christopher L., 1999, Zoosystema, V21, P535; Mah CL, 2003, B MAR SCI, V73, P685; Mah CL, 2000, AM ZOOL, V40, P375, DOI 10.1668/0003-1569(2000)040[0375:PPOTFA]2.0.CO;2; Mah CL, 2009, WORLD ASTEROIDEA DAT; Matsubara M, 2005, MOL PHYLOGENET EVOL, V36, P598, DOI 10.1016/j.ympev.2005.03.018; Matsubara M, 2004, ZOOL SCI, V21, P785, DOI 10.2108/zsj.21.785; MAUZEY KP, 1968, ECOLOGY, V49, P603, DOI 10.2307/1935526; MCCLARY DJ, 1989, MAR BIOL, V103, P531, DOI 10.1007/BF00399585; MCCLARY DJ, 1990, J EXP MAR BIOL ECOL, V142, P183, DOI 10.1016/0022-0981(90)90090-Y; McClintock JB, 2011, J GEOL, V119, P457, DOI 10.1086/660890; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; MCCLINTOCK JB, 1988, MAR BIOL, V99, P235, DOI 10.1007/BF00391986; MCCLINTOCK JB, 1985, OECOLOGIA, V66, P291, DOI 10.1007/BF00379867; MCEDWARD LR, 1995, BIOL J LINN SOC, V54, P299, DOI 10.1111/j.1095-8312.1995.tb01040.x; McEdward LR, 2001, CAN J ZOOL, V79, P1125, DOI 10.1139/cjz-79-7-1125; MCEDWARD LR, 1992, BIOL BULL, V182, P177, DOI 10.2307/1542111; MCKNIGHT DG, 1975, J ROY SOC NEW ZEAL, V5, P13, DOI 10.1080/03036758.1975.10419376; Melarange R, 2003, J EXP BIOL, V206, P893, DOI 10.1242/jeb.00197; MENGE BA, 1972, ECOLOGY, V53, P635, DOI 10.2307/1934777; MENGE BA, 1974, ECOLOGY, V55, P84, DOI 10.2307/1934620; MENGE BA, 1975, MAR BIOL, V31, P87, DOI 10.1007/BF00390651; Menge BA, 1999, ECOL MONOGR, V69, P297, DOI 10.1890/0012-9615(1999)069[0297:TDABUR]2.0.CO;2; MENGE JL, 1974, ECOL MONOGR, V44, P189, DOI 10.2307/1942311; Micael J, 2009, OCEANOGR MAR BIOL, V47, P191; Mooi R, 2001, CAN J ZOOL, V79, P1209, DOI 10.1139/cjz-79-7-1209; Mortensen T, 1922, NATURE, V110, P806, DOI 10.1038/110806a0; Mortensen TH, 1923, NATURE, V111, P322, DOI 10.1038/111322b0; Muller A.H., 1963, LEHRBUCH PALAOZOOLOG; NANCE JM, 1979, J EXP MAR BIOL ECOL, V40, P259, DOI 10.1016/0022-0981(79)90055-8; Naughton KM, 2009, INVERTEBR SYST, V23, P348, DOI 10.1071/IS08021; NERAUDEAU D, 1993, GEOBIOS-LYON, V26, P105, DOI 10.1016/S0016-6995(93)80011-F; O'Loughlin P. Mark, 2004, Memoirs of Museum Victoria, V61, P1; OCLAIR CE, 1985, MAR BIOL, V84, P331, DOI 10.1007/BF00392503; Ortiz M, 2003, ARCH HYDROBIOL, V157, P213, DOI 10.1127/0003-9136/2003/0157-0213; Otim O, 2005, GENE EXPR PATTERNS, V5, P381, DOI 10.1016/j.modgep.2004.09.009; PAINE RT, 1969, ECOLOGY, V50, P950, DOI 10.2307/1936888; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; PAINE RT, 1971, ECOLOGY, V52, P1096, DOI 10.2307/1933819; Pawson D. L., 1976, Thalassia Jugosl, V12, P287; PEARSE JS, 1986, INT J INVER REP DEV, V9, P71, DOI 10.1080/01688170.1986.10510181; PEARSE JS, 1986, INT J INVER REP DEV, V9, P289, DOI 10.1080/01688170.1986.10510205; PEARSE JS, 1986, AM ZOOL, V26, P417; PEARSE JS, 1982, MAR BIOL, V67, P121, DOI 10.1007/BF00401277; Pearse JS, 2002, INVERTEBR REPROD DEV, V41, P73, DOI 10.1080/07924259.2002.9652737; PEARSE VB, 1994, ECHINODERMS THROUGH TIME, P121; Perrier E., 1894, EXPEDITIONS SCI TRAV, V3, P1; Perrier E., 1884, NOUVELLES ARCH MUSEU, V6, P127; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; PHILIP GM, 1965, NATURE, V208, P766, DOI 10.1038/208766a0; Pillay D, 2010, MAR ECOL PROG SER, V398, P173, DOI 10.3354/meps08286; Rodenhouse Inria Zintheo, 1946, UNIV WASHINGTON PUBL BIOL, V12, P21; Ross DJ, 2006, ESTUAR COAST SHELF S, V67, P695, DOI 10.1016/j.ecss.2005.11.038; Ross DJ, 2002, MAR ECOL PROG SER, V241, P99, DOI 10.3354/meps241099; Ross DJ, 2004, MAR BIOL, V144, P747, DOI 10.1007/s00227-003-1223-4; Ross DJ, 2003, J EXP MAR BIOL ECOL, V288, P257, DOI 10.1016/S0022-0981(03)00022-4; Rowe F.W.E., 1994, P149; ROWE F W E, 1989, Proceedings of the Linnean Society of New South Wales, V111, P293; ROWE FWE, 1988, PROC R SOC SER B-BIO, V233, P431, DOI 10.1098/rspb.1988.0032; Rowe FWE, 1982, MICRONESICA, V18, P89; Santos R, 2005, J MORPHOL, V263, P259, DOI 10.1002/jmor.10187; Scheibling RE, 2008, B MAR SCI, V82, P221; SCHMID P H, 1981, Marine Ecology, V2, P207, DOI 10.1111/j.1439-0485.1981.tb00095.x; Schondorf F., 1910, Jahrbuecher des Vereins fuer Naturkunde Wiesbaden, V63; SCHUCHERT C, 1914, FOSSILIUM CATALOGUS, V1; Schuchert C., 1915, B US NAT MUS, V88; SHICK JM, 1981, MAR ECOL PROG SER, V5, P165, DOI 10.3354/meps005165; Sladen WP, 1889, REPORT SCI RESULTS V, V30; Sloan N.A., 1980, Oceanography and Marine Biology an Annual Review, V18, P57; SLOAN NA, 1983, OPHELIA, V22, P125, DOI 10.1080/00785326.1983.10426591; Smith A.B., 1988, P17; SMITH A B, 1990, Memoirs of the Queensland Museum, V28, P715; SMITH AB, 1985, GEOL MAG, V122, P351, DOI 10.1017/S0016756800031794; Spencer W.K., 1966, TREATISE INVERTEBRAT, V3, pU4; SPENCER WK, 1951, PHILOS T ROY SOC B, V235, P87, DOI 10.1098/rstb.1951.0001; Spencer WK, 1914, BRIT PALAEOZOIC AST; Stickle WB, 2001, INVERTEBR BIOL, V120, P88, DOI 10.1111/j.1744-7410.2001.tb00029.x; Stohr S., 2007, WORLD OPHIUROIDEA DA; Szathmary PL, 2009, MAR ECOL PROG SER, V374, P43, DOI 10.3354/meps07682; Twitchett RJ, 2005, CR PALEVOL, V4, P531, DOI 10.1016/j.crpv.2005.02.006; Ubaghs G., 1953, TRAITE PALEONTOLOGIE, V3, P774; Valentincic T., 1983, Echinoderm Studies, V1, P111; VANVELDHUIZEN HD, 1981, OECOLOGIA, V48, P214, DOI 10.1007/BF00347967; VENTURA CRR, 1995, B MAR SCI, V56, P268; Viguier C., 1878, Compte Rendu, Vlxxxvi, P681; Villier L, 1999, CR ACAD SCI II A, V328, P353, DOI 10.1016/S1251-8050(99)80129-3; Villier L, 2004, GEOBIOS-LYON, V37, P807, DOI 10.1016/j.geobios.2003.05.010; Villier L, 2009, J PALEONTOL, V83, P389, DOI 10.1666/08-030.1; Villier Loic, 2004, Palaeontologische Zeitschrift, V78, P281; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; Wabnitz Colette, 2003, P1; Wada H, 1996, MOL PHYLOGENET EVOL, V6, P97, DOI 10.1006/mpev.1996.0062; Wares JP, 2001, BIOL BULL-US, V201, P95, DOI 10.2307/1543530; Waters JM, 2004, MOL PHYLOGENET EVOL, V30, P872, DOI 10.1016/j.ympev.2003.08.019; Waters JM, 2003, J BIOGEOGR, V30, P1787, DOI 10.1046/j.0305-0270.2003.00978.x; Waters JM, 2003, MAR BIOL, V142, P185, DOI 10.1007/s00227-002-0915-5; Williams ST, 1997, MOL ECOL, V6, P559, DOI 10.1046/j.1365-294X.1997.00221.x; Williams ST, 2000, MAR BIOL, V136, P137, DOI 10.1007/s002270050016; Williams ST, 1998, EVOLUTION, V52, P87, DOI 10.1111/j.1558-5646.1998.tb05141.x; Wong MC, 2005, J EXP MAR BIOL ECOL, V327, P1, DOI 10.1016/j.jembe.2005.05.018; YAMAGUCHI M, 1975, Biotropica, V7, P12, DOI 10.2307/2989795; Yamaoka M, 1987, KASEKI TOMO PUBLICAT, V31, P5; Yasuda N, 2009, MOL ECOL, V18, P1574, DOI 10.1111/j.1365-294X.2009.04133.x; Zhao YL, 2010, J PALEONTOL, V84, P668, DOI 10.1666/09-159.1; Zulliger Deborah E., 2010, Zootaxa, V2504, P1	275	94	106	9	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35644	10.1371/journal.pone.0035644	http://dx.doi.org/10.1371/journal.pone.0035644			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22563389	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000043
J	Brookshire, G; Casasanto, D				Brookshire, Geoffrey; Casasanto, Daniel			Motivation and Motor Control: Hemispheric Specialization for Approach Motivation Reverses with Handedness	PLOS ONE			English	Article							FRONTAL EEG ASYMMETRY; BEHAVIORAL ACTIVATION; INHIBITION SYSTEMS; BRAIN ACTIVITY; ALPHA; STIMULI; VALENCE; FMRI; BAD	Background: According to decades of research on affective motivation in the human brain, approach motivational states are supported primarily by the left hemisphere and avoidance states by the right hemisphere. The underlying cause of this specialization, however, has remained unknown. Here we conducted a first test of the Sword and Shield Hypothesis (SSH), according to which the hemispheric laterality of affective motivation depends on the laterality of motor control for the dominant hand (i.e., the "sword hand,'' used preferentially to perform approach actions) and the nondominant hand (i.e., the "shield hand,'' used preferentially to perform avoidance actions). Methodology/Principal Findings: To determine whether the laterality of approach motivation varies with handedness, we measured alpha-band power (an inverse index of neural activity) in right- and left-handers during resting-state electroencephalography and analyzed hemispheric alpha-power asymmetries as a function of the participants' trait approach motivational tendencies. Stronger approach motivation was associated with more left-hemisphere activity in right-handers, but with more right-hemisphere activity in left-handers. Conclusions: The hemispheric correlates of approach motivation reversed between right- and left-handers, consistent with the way they typically use their dominant and nondominant hands to perform approach and avoidance actions. In both right- and left-handers, approach motivation was lateralized to the same hemisphere that controls the dominant hand. This covariation between neural systems for action and emotion provides initial support for the SSH.	[Brookshire, Geoffrey; Casasanto, Daniel] New Sch Social Res, Dept Psychol, New York, NY 10011 USA; [Brookshire, Geoffrey; Casasanto, Daniel] Max Planck Inst Psycholinguist, Neurobiol Language Dept, Nijmegen, Netherlands; [Casasanto, Daniel] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	The New School; Max Planck Society; Radboud University Nijmegen	Brookshire, G (corresponding author), New Sch Social Res, Dept Psychol, New York, NY 10011 USA.	casasanto@alum.mit.edu		Brookshire, Geoffrey/0000-0002-3830-2587	Max Planck Gesellschaft; University of California at Berkeley; James S. McDonnell Foundation [220020236]	Max Planck Gesellschaft(Max Planck Society); University of California at Berkeley; James S. McDonnell Foundation	Research was supported by the Max Planck Gesellschaft (http://www.mpg.de), a Haas Fellowship from the University of California at Berkeley (http://berkeley.edu) to G.B., and a James S. McDonnell Foundation Scholar Award (#220020236; http://www.jsmf.org) to D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2008, PSYCHOPHYSIOLOGY, V45, P11, DOI 10.1111/j.1469-8986.2007.00609.x; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Berkman ET, 2010, J COGNITIVE NEUROSCI, V22, P1970, DOI 10.1162/jocn.2009.21317; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Casasanto D, 2012, COGNITIVE SCI, V36, P359, DOI 10.1111/j.1551-6709.2011.01199.x; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Coan JA, 2003, PSYCHOPHYSIOLOGY, V40, P106, DOI 10.1111/1469-8986.00011; COREN S, 1992, AM J PUBLIC HEALTH, V82, P1176, DOI 10.2105/AJPH.82.8.1176-b; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P39, DOI 10.1111/j.1467-9280.1992.tb00254.x; Everhart DE, 1996, PERCEPT MOTOR SKILL, V82, P264, DOI 10.2466/pms.1996.82.1.264; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Harmon-Jones E, 1997, J ABNORM PSYCHOL, V106, P159, DOI 10.1037/0021-843X.106.1.159; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Harris LJ, 2010, LATERALITY, V15, P15, DOI 10.1080/13576500701650430; HELLIGE JB, 1994, J EXP PSYCHOL GEN, V123, P235, DOI 10.1037/0096-3445.123.3.235; Janicak PG, 2010, BRAIN STIMUL, V3, P187, DOI 10.1016/j.brs.2010.07.003; Kinsbourne M., 1978, ASYMMETRICAL FUNCTIO, P3; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Markman AB, 2005, PSYCHOL SCI, V16, P6, DOI 10.1111/j.0956-7976.2005.00772.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Reuter-Lorenz P, 1983, NEUROPSYCHOLOGIA, V22, P687; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; Shackman AJ, 2009, PSYCHOL SCI, V20, P1500, DOI 10.1111/j.1467-9280.2009.02476.x; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	32	43	45	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36036	10.1371/journal.pone.0036036	http://dx.doi.org/10.1371/journal.pone.0036036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WQ	22563436	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100062
J	Caffrey, BE; Williams, TA; Jiang, XW; Toft, C; Hokamp, K; Fares, MA				Caffrey, Brian E.; Williams, Tom A.; Jiang, Xiaowei; Toft, Christina; Hokamp, Karsten; Fares, Mario A.			Proteome-Wide Analysis of Functional Divergence in Bacteria: Exploring a Host of Ecological Adaptations	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; GENOME SEQUENCE; STATISTICAL-METHODS; LIKELIHOOD METHOD; COG DATABASE; EVOLUTION; BUCHNERA; APHIDS; SUBSTITUTION; DIVERSITY	Functional divergence is the process by which new genes and functions originate through the modification of existing ones. Both genetic and environmental factors influence the evolution of new functions, including gene duplication or changes in the ecological requirements of an organism. Novel functions emerge at the expense of ancestral ones and are generally accompanied by changes in the selective forces at constrained protein regions. We present software capable of analyzing whole proteomes, identifying putative amino acid replacements leading to functional change in each protein and performing statistical tests on all tabulated data. We apply this method to 750 complete bacterial proteomes to identify high-level patterns of functional divergence and link these patterns to ecological adaptations. Proteome-wide analyses of functional divergence in bacteria with different ecologies reveal a separation between proteins involved in information processing (Ribosome biogenesis etc.) and those which are dependent on the environment (energy metabolism, defense etc.). We show that the evolution of pathogenic and symbiotic bacteria is constrained by their association with the host, and also identify unusual events of functional divergence even in well-studied bacteria such as Escherichia coli. We present a description of the roles of phylogeny and ecology in functional divergence at the level of entire proteomes in bacteria.	[Caffrey, Brian E.; Williams, Tom A.; Jiang, Xiaowei; Hokamp, Karsten; Fares, Mario A.] Univ Dublin, Dept Genet, Trinity Coll, Dublin, Ireland; [Toft, Christina] Uppsala Univ, Evolutionary Biol Ctr, Dept Mol Evolut, Uppsala, Sweden; [Fares, Mario A.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Integrat Syst Biol Grp, E-46071 Valencia, Spain	Trinity College Dublin; Uppsala University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Caffrey, BE (corresponding author), Univ Dublin, Dept Genet, Trinity Coll, Dublin, Ireland.	faresm@tcd.ie	Toft, Christina/I-1693-2015; Fares, Mario/L-7100-2016; Jiang, Xiaowei/D-1079-2010	Toft, Christina/0000-0003-1714-6703; Fares, Mario/0000-0002-4345-3013; Jiang, Xiaowei/0000-0002-6030-1249; Williams, Tom/0000-0003-1072-0223; Hokamp, Karsten/0000-0001-7464-2370	Spanish Ministerio de Ciencia e Inovacion [BFU2009-12022]; Science Foundation Ireland [10/RFP/GEN2685]	Spanish Ministerio de Ciencia e Inovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This study was supported by a grant from the Spanish Ministerio de Ciencia e Inovacion (BFU2009-12022) and a grant of the Research Frontiers Program (10/RFP/GEN2685) from Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Anderson BE, 1997, CLIN MICROBIOL REV, V10, P203, DOI 10.1128/CMR.10.2.203; Azuma Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-111; Bailey S, 2006, P NATL ACAD SCI USA, V103, P2582, DOI 10.1073/pnas.0511216103; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Baron C, 2010, CURR OPIN MICROBIOL, V13, P100, DOI 10.1016/j.mib.2009.12.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berglund AC, 2005, J MOL EVOL, V60, P499, DOI 10.1007/s00239-004-0223-4; BRENNER DJ, 1991, J CLIN MICROBIOL, V29, P1299, DOI 10.1128/JCM.29.7.1299-1302.1991; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137; Dutheil J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-188; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fares MA, 2002, J MOL EVOL, V55, P509, DOI 10.1007/s00239-002-2346-9; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gil R, 2002, P NATL ACAD SCI USA, V99, P4454, DOI 10.1073/pnas.062067299; Gillespie J. H., 2004, POPULATION GENETICS; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, J COMPUT BIOL, V8, P221, DOI 10.1089/10665270152530827; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kampinga HH, 2004, INT J HYPERTHER, V20, P131, DOI 10.1080/02656730310001627713; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Lake JA, 1999, SCIENCE, V283, P2027, DOI 10.1126/science.283.5410.2027; LASZLO A, 1992, CELL PROLIFERAT, V25, P59, DOI 10.1111/j.1365-2184.1992.tb01482.x; Lepock J, 1997, ADV MOL CEL, P223; Lima T, 2009, NUCLEIC ACIDS RES, V37, pD471, DOI 10.1093/nar/gkn661; Lund PA, 2009, FEMS MICROBIOL REV, V33, P785, DOI 10.1111/j.1574-6976.2009.00178.x; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Makarova KS, 1999, GENOME RES, V9, P608; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nielsen R, 1998, GENETICS, V148, P929; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohno S., 1970, P1; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Pikuta EV, 2007, CRIT REV MICROBIOL, V33, P183, DOI 10.1080/10408410701451948; Pinto G, 2008, P ROY SOC B-BIOL SCI, V275, P2749, DOI 10.1098/rspb.2008.0686; Ren CP, 2005, J BACTERIOL, V187, P1430, DOI 10.1128/JB.187.4.1430-1440.2005; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Sandstrom J, 2000, J INSECT PHYSIOL, V46, P33, DOI 10.1016/S0022-1910(99)00098-0; SCHERER DC, 1993, INFECT IMMUN, V61, P4962, DOI 10.1128/IAI.61.12.4962-4971.1993; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Suzuki Y, 2004, J MOL EVOL, V59, P11, DOI 10.1007/s00239-004-2599-6; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Suzuki Y, 2004, MOL BIOL EVOL, V21, P2352, DOI 10.1093/molbev/msh249; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Toft C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000344; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Williams TA, 2009, TRENDS GENET; Williams TA, 2010, TRENDS GENET, V26, P47, DOI 10.1016/j.tig.2009.11.009; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 2004, MOL BIOL EVOL, V21, P1332, DOI 10.1093/molbev/msh117; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	84	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35659	10.1371/journal.pone.0035659	http://dx.doi.org/10.1371/journal.pone.0035659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563391	Green Published, gold			2022-12-25	WOS:000305349100019
J	Kuhl, HS; N'Guessan, A; Riedel, J; Metzger, S; Deschner, T				Kuehl, Hjalmar S.; N'Guessan, Antoine; Riedel, Julia; Metzger, Sonja; Deschner, Tobias			The Effect of Climate Fluctuation on Chimpanzee Birth Sex Ratio	PLOS ONE			English	Article							TAI-NATIONAL-PARK; EL-NINO; IMPACTS; ECOLOGY; PHENOLOGY; RAINFALL; DENSITY; AFRICA; LINK	Climate and weather conditions, such as the North Atlantic Oscillation, precipitation and temperature influence the birth sex ratio (BSR) of various higher latitude species, including deer, elephant seals or northern human populations. Although, tropical regions show only little variation in temperature, climate and weather conditions can fluctuate with consequences for phenology and food resource availability. Here, we evaluate, whether the BSR of chimpanzees, inhabiting African tropical forests, is affected by climate fluctuations as well. Additionally, we evaluate, if variation in consumption of a key food resource with high nutritional value, Coula edulis nuts, is linked to both climate fluctuations and variation in BSR. We use long-term data from two study groups located in Tai National Park, Cote d'Ivoire to assess the influence of local weather conditions and the global climate driver El Nino Southern Oscillation (ENSO) on offspring sex. Cote d'Ivoire has experienced considerable climate variation over the last decades, with increasing temperature and declining precipitation. For both groups we find very similar time windows around the month of conception, in which offspring sex is well predicted by ENSO, with more males following low ENSO values, corresponding to periods of high rainfall. Furthermore, we find that the time spent cracking and feeding on Coula nuts is strongly influenced by climate conditions. Although, some of our analysis suggest that a higher proportion of males is born after periods with higher nut consumption frequency, we cannot conclude decisively at this point that nut consumption may influence shifts in BSR. All results combined suggest that also chimpanzees may experience climate related shifts in offspring sex ratios as response to climate fluctuation.	[Kuehl, Hjalmar S.; Riedel, Julia; Deschner, Tobias] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [N'Guessan, Antoine] Univ Cocody, Abidjan, Cote Ivoire; [N'Guessan, Antoine] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Metzger, Sonja] Robert Koch Inst, Berlin, Germany	Max Planck Society; Robert Koch Institute	Kuhl, HS (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	kuehl@eva.mpg.de			Max Planck Society; Ivorian authorities; Ministry of the Environment and Forests; Ministry of Research; Tai National Park; Swiss Research Center in Abidjan	Max Planck Society(Max Planck SocietyFoundation CELLEX); Ivorian authorities; Ministry of the Environment and Forests; Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Tai National Park; Swiss Research Center in Abidjan	This work was funded by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ivorian authorities for long-term support, especially the Ministry of the Environment and Forests as well as the Ministry of Research, the directorship of the Tai National Park, and the Swiss Research Center in Abidjan. We thank Christophe Boesch for making all data available for this study and all the numerous field assistants and students who collected the demographic and behavioral data in the Tai Chimpanzee Project over the last three decades. We thank Roger Mundry for statistical advice on data analysis, Fabian Leendertz for very helpful discussions about the manuscript, and Klaus Wolters for providing the MEI dataset.	Anderson DP, 2005, BIOTROPICA, V37, P631, DOI 10.1111/j.1744-7429.2005.00080.x; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Boesch C, 2000, CHIMPANZEES TAI FORE; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Castellan NJ, 1988, NONPARAMETRIC STAT B; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Fisher R.A., 1930, GENETICAL THEORY NAT; Goldenberg SB, 1996, J CLIMATE, V9, P1169, DOI 10.1175/1520-0442(1996)009<1169:PMFTAO>2.0.CO;2; Gomendio M, 2006, SCIENCE, V314, P1445, DOI 10.1126/science.1133064; Gone M, 2007, THESIS U COCODY ABID; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Helle S, 2008, BIOL LETTERS, V4, P60, DOI 10.1098/rsbl.2007.0482; Henzi P, 2003, EVOL ANTHROPOL, V12, P217, DOI 10.1002/evan.10121; Herbinger I, 2001, INT J PRIMATOL, V22, P143, DOI 10.1023/A:1005663212997; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Lee DE, 2009, J MAMMAL, V90, P1, DOI 10.1644/08-MAMM-A-130.1; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Post E, 1999, P NATL ACAD SCI USA, V96, P4467, DOI 10.1073/pnas.96.8.4467; R Core Team, 2022, R LANG ENV STAT COMP; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Riedel J, 2011, AM J PRIMATOL, V73, P305, DOI 10.1002/ajp.20897; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Servat E, 1997, J HYDROL, V191, P1, DOI 10.1016/S0022-1694(96)03068-5; SHINODA M, 1995, INT J CLIMATOL, V15, P639, DOI 10.1002/joc.3370150605; Silk JB, 2008, P ROY SOC B-BIOL SCI, V275, P1761, DOI 10.1098/rspb.2008.0340; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P548, DOI 10.1002/ajhb.20936; [No title captured], DOI 10.1093/ajcn/70.3.504s	37	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35610	10.1371/journal.pone.0035610	http://dx.doi.org/10.1371/journal.pone.0035610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563387	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100016
J	Tezuka, T; Marubashi, W				Tezuka, Takahiro; Marubashi, Wataru			Genes in S and T Subgenomes Are Responsible for Hybrid Lethality in Interspecific Hybrids between Nicotiana tabacum and Nicotiana occidentalis	PLOS ONE			English	Article							Q-CHROMOSOME; SECTION SUAVEOLENTES; DNA MARKERS; CELL-DEATH; TOBACCO; SOLANACEAE; ORIGIN; RESISTANCE; HYBRIDIZATION; CROSSES	Background: Many species of Nicotiana section Suaveolentes produce inviable F-1 hybrids after crossing with Nicotiana tabacum (genome constitution SSTT), a phenomenon that is often called hybrid lethality. Through crosses with monosomic lines of N. tabacum lacking a Q chromosome, we previously determined that hybrid lethality is caused by interaction between gene(s) on the Q chromosome belonging to the S subgenome of N. tabacum and gene(s) in Suaveolentes species. Here, we examined if hybrid seedlings from the cross N. occidentalis (section Suaveolentes) xN. tabacum are inviable despite a lack of the Q chromosome. Methodology/Principal Findings: Hybrid lethality in the cross of N. occidentalis xN. tabacum was characterized by shoots with fading color. This symptom differed from what has been previously observed in lethal crosses between many species in section Suaveolentes and N. tabacum. In crosses of monosomic N. tabacum plants lacking the Q chromosome with N. occidentalis, hybrid lethality was observed in hybrid seedlings either lacking or possessing the Q chromosome. N. occidentalis was then crossed with two progenitors of N. tabacum, N. sylvestris (SS) and N. tomentosiformis (TT), to reveal which subgenome of N. tabacum contains gene(s) responsible for hybrid lethality. Hybrid seedlings from the crosses N. occidentalis xN. tomentosiformis and N. occidentalis xN. sylvestris were inviable. Conclusions/Significance: Although the specific symptoms of hybrid lethality in the cross N. occidentalis xN. tabacum were similar to those appearing in hybrids from the cross N. occidentalis xN. tomentosiformis, genes in both the S and T subgenomes of N. tabacum appear responsible for hybrid lethality in crosses with N. occidentalis.	[Tezuka, Takahiro] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan; [Marubashi, Wataru] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan	Osaka Metropolitan University; Meiji University	Tezuka, T (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan.	tezuka@plant.osakafu-u.ac.jp	Tezuka, Takahiro/AAH-9589-2021	Tezuka, Takahiro/0000-0002-9203-1140	Japan Society for the Promotion of Science, Japan [20880024]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grant-in-Aid for Young Scientists (Start-up) No. 20880024 from the Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bai D, 1995, THEOR APPL GENET, V91, P1184, DOI 10.1007/BF00220927; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; BURK LG, 1966, ECON BOT, V20, P76, DOI 10.1007/BF02861929; CAMERON DR, 1959, TOBACCO SCI, V3, P164; Chase MW, 2003, ANN BOT-LONDON, V92, P107, DOI 10.1093/aob/mcg087; Clarkson JJ, 2010, MOL PHYLOGENET EVOL, V55, P99, DOI 10.1016/j.ympev.2009.10.003; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; Clausen RE, 1944, GENETICS, V29, P447; Dilkes BP, 2008, PLOS BIOL, V6, P2707, DOI 10.1371/journal.pbio.0060308; Figueroa-Castro DM, 2009, SEX PLANT REPROD, V22, P187, DOI 10.1007/s00497-009-0103-6; GOODSPEED TH, 1954, GENUS NICOTIANA; GRAY JC, 1974, NATURE, V252, P226, DOI 10.1038/252226a0; Hancock CN, 2003, PHILOS T R SOC B, V358, P1133, DOI 10.1098/rstb.2003.1284; Hannah MA, 2007, NEW PHYTOL, V176, P537, DOI 10.1111/j.1469-8137.2007.02215.x; Ichitani K, 2011, RICE, V4, P29, DOI 10.1007/s12284-011-9062-2; Iizuka T, 2012, EUPHYTICA IN PRESS, DOI [10.1007/s10681-011-0570-3, DOI 10.1007/S10681-011-0570-3]; Jeuken MJW, 2009, PLANT CELL, V21, P3368, DOI 10.1105/tpc.109.070334; KENTON A, 1993, MOL GEN GENET, V240, P159, DOI 10.1007/BF00277053; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; KUBO T, 1982, TOBACCO SCI, V26, P126; Kuboyama T, 2000, SEX PLANT REPROD, V12, P333, DOI 10.1007/s004970000027; KUBOYAMA T, 1994, SEX PLANT REPROD, V7, P250, DOI 10.1007/BF00232744; Kuboyama T, 2009, RICE, V2, P93, DOI 10.1007/s12284-009-9026-y; Ladiges PY, 2011, J BIOGEOGR, V38, P2066, DOI 10.1111/j.1365-2699.2011.02554.x; Lee CB, 2008, SEX PLANT REPROD, V21, P183, DOI 10.1007/s00497-008-0077-9; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; Li BC, 2006, CROP SCI, V46, P554, DOI 10.2135/cropsci2005.04-0027; Lim KY, 2000, CHROMOSOMA, V109, P245, DOI 10.1007/s004120000074; Marks CE, 2011, AUST SYST BOT, V24, P61, DOI 10.1071/SB11006; Martienssen RA, 2010, NEW PHYTOL, V186, P46, DOI 10.1111/j.1469-8137.2010.03193.x; MERXMUELLER H, 1975, Mitteilungen der Botanischen Staatssammlung Muenchen, V12, P91; Moyle LC, 2009, TRENDS ECOL EVOL, V24, P591, DOI 10.1016/j.tree.2009.05.010; Murad L, 2004, HEREDITY, V92, P352, DOI 10.1038/sj.hdy.6800431; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NIKOVA VM, 1990, PLANT CELL TISS ORG, V23, P71, DOI 10.1007/BF00116092; NIKOVA VM, 1991, PLANT CELL TISS ORG, V27, P289, DOI 10.1007/BF00157593; Olmo HP, 1935, GENETICS, V20, P0286; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; SHEEN SJ, 1972, EVOLUTION, V26, P143, DOI 10.1111/j.1558-5646.1972.tb00181.x; Ternovskii MF, 1972, SOV GENET, V8, p[27, 38]; Tezuka T, 2006, THEOR APPL GENET, V112, P1172, DOI 10.1007/s00122-006-0219-0; Tezuka T, 2004, PLANT CELL PHYSIOL, V45, P1863, DOI 10.1093/pcp/pch204; Tezuka T, 2004, BREEDING SCI, V54, P59, DOI 10.1270/jsbbs.54.59; Tezuka T, 2007, PLANTA, V226, P753, DOI 10.1007/s00425-007-0522-2; Tezuka T, 2010, ANN BOT-LONDON, V106, P267, DOI 10.1093/aob/mcq114; Yamada T, 1999, BREEDING SCI, V49, P203, DOI 10.1270/jsbbs.49.203	48	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36204	10.1371/journal.pone.0036204	http://dx.doi.org/10.1371/journal.pone.0036204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563450	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100075
J	Yacoby, I; Tegler, LT; Pochekailov, S; Zhang, SG; King, PW				Yacoby, Iftach; Tegler, Lotta Tollstoy; Pochekailov, Sergii; Zhang, Shuguang; King, Paul W.			Optimized Expression and Purification for High-Activity Preparations of Algal [FeFe]-Hydrogenase	PLOS ONE			English	Article							ESCHERICHIA-COLI; HYDROGENASES; CLASSIFICATION; MATURATION; DIVERSITY; PROTEINS; ENZYMES; SITE	Background: Recombinant expression and purification of metallo-enzymes, including hydrogenases, at high-yields is challenging due to complex, and enzyme specific, post-translational maturation processes. Low fidelities of maturation result in preparations containing a significant fraction of inactive, apo-protein that are not suitable for biophysical or crystallographic studies. Principal Findings: We describe the construction, overexpression and high-yield purification of a fusion protein consisting of the algal [2Fe2S]-ferredoxin PetF (Fd) and [FeFe]-hydrogenase HydA1. The maturation of Fd-HydA1 was optimized through improvements in culture conditions and media components used for expression. We also demonstrated that fusion of Fd to the N-terminus of HydA1, in comparison to the C-terminus, led to increased expression levels that were 4-fold higher. Together, these improvements led to enhanced HydA1 activity and improved yield after purification. The strong binding-affinity of Fd for DEAE allowed for two-step purification by ion exchange and StrepTactin affinity chromatography. In addition, the incorporation of a TEV protease site in the Fd-HydA1 linker allowed for the proteolytic removal of Fd after DEAE step, and purification of HydA1 alone by StrepTactin. In combination, this process resulted in HydA1 purification yields of 5 mg L-1 of culture from E. coli with specific activities of 1000 U (U = 1 mu mol hydrogen evolved mg(-1) min(-1)). Significance: The [FeFe]-hydrogenases are highly efficient enzymes and their catalytic sites provide model structures for synthetic efforts to develop robust hydrogen activation catalysts. In order to characterize their structure-function properties in greater detail, and to use hydrogenases for biotechnological applications, reliable methods for rapid, high-yield expression and purification are required.	[Yacoby, Iftach; Tegler, Lotta Tollstoy; Pochekailov, Sergii; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [King, Paul W.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Yacoby, I (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel.	iftachy@post.tau.ac.il; shuguang@mit.edu; Paul.King@nrel.gov	Yacoby, Iftach/HDL-7206-2022; King, Paul W./D-9979-2011; Yacoby, Iftach/AAF-4056-2020	King, Paul W./0000-0001-5039-654X; Yacoby, Iftach/0000-0003-0177-0624; Zhang, Shuguang/0000-0002-3856-3752; Tollstoy Tegler, Lotta/0000-0003-0875-9516	MITei; EMBO; Yang Trust Fund; Swedish Chemical Society; Wenner-Gren Foundation; US Department of Energy [DE-AC36-08-GO28308]; National Renewable Energy Laboratory; US Department of Energy Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division	MITei; EMBO(European Molecular Biology Organization (EMBO)); Yang Trust Fund; Swedish Chemical Society; Wenner-Gren Foundation; US Department of Energy(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); US Department of Energy Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division(United States Department of Energy (DOE))	This work was supported by a MITei grant to SZ and IY. IY also gratefully acknowledges support from an EMBO Fellowship and the Yang Trust Fund. LTT gratefully acknowledges fellowship support from the Swedish Chemical Society and the Wenner-Gren Foundation. PWK gratefully acknowledges support from the US Department of Energy under contract DE-AC36-08-GO28308 with the National Renewable Energy Laboratory; and the US Department of Energy Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Brown KA, 2010, J AM CHEM SOC, V132, P9672, DOI 10.1021/ja101031r; Calusinska M, 2010, MICROBIOL-SGM, V156, P1575, DOI 10.1099/mic.0.032771-0; English CM, 2009, DALTON T, P9970, DOI 10.1039/b913426n; Evans DJ, 2003, CHEM SOC REV, V32, P268, DOI 10.1039/b201317g; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Lambertz C, 2011, J BIOL CHEM, V286, P40614, DOI 10.1074/jbc.M111.283648; Lee HS, 2010, TRENDS BIOTECHNOL, V28, P262, DOI 10.1016/j.tibtech.2010.01.007; Madden C, 2012, J AM CHEM SOC, V134, P1577, DOI 10.1021/ja207461t; Magnuson A, 2009, ACCOUNTS CHEM RES, V42, P1899, DOI 10.1021/ar900127h; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; Melis A, 2007, ADV EXP MED BIOL, V616, P108; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Reisner E, 2009, J AM CHEM SOC, V131, P18457, DOI 10.1021/ja907923r; Seibert M, 2008, BIOENERGY, P273; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; Yacoby I, 2011, P NATL ACAD SCI USA, V108, P9396, DOI 10.1073/pnas.1103659108; Zhang LP, 2002, PHILOS T R SOC B, V357, P1499, DOI 10.1098/rstb.2002.1152	34	31	32	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35886	10.1371/journal.pone.0035886	http://dx.doi.org/10.1371/journal.pone.0035886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563413	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349100039
J	Kamper, N; Kessler, J; Temme, S; Wegscheid, C; Winkler, J; Koch, N				Kamper, Nadine; Kessler, Jorg; Temme, Sebastian; Wegscheid, Claudia; Winkler, Johannes; Koch, Norbert			A Novel BAT3 Sequence Generated by Alternative RNA Splicing of Exon 11B Displays Cell Type-Specific Expression and Impacts on Subcellular Localization	PLOS ONE			English	Article							SCYTHE REGULATES APOPTOSIS; B-ASSOCIATED TRANSCRIPT-3; PROTEIN; RECEPTOR; SIGNAL; IDENTIFICATION; MHC	Background: The human lymphocyte antigen (HLA) encoded BAT3/BAG6 recently attracted interest as a regulator of protein targeting and degradation, a function that could be exerted in the cytosol and in the nucleus. The BAT3 gene was described to consist of 25 exons. Diversity of transcripts can be generated by alternative RNA splicing, which may control subcellular distribution of BAT3. Methodology/Principal Findings: By cDNA sequencing we identified a novel alternatively spliced sequence of the BAT3 gene located between exons 11 and 12, which was designated as exon 11B. Using PCR and colony hybridization we identified six cDNA variants, which were produced by RNA splicing of BAT3 exons 5, 11B and 24. In four examined cell types the content of BAT3 splice variants was examined. Most of the cDNA clones from monocyte-derived dendritic cells contain exon 11B, whereas this sequence was almost absent in the B lymphoma Raji. Exon 5 was detected in most and exon 24 in approximately half of the cDNA clones. The subcellular distribution of endogenous BAT3 largely correlates with a cell type specific splicing pattern. In cells transfected with BAT3 variants, full-length and Delta 24 BAT3 displayed nearly exclusive nuclear staining, whereas variants deleted of exon 11B showed substantial cytosolic expression. We show here that BAT3 is mainly expressed in the cytosol of Raji cells, while other cell types displayed both cytosolic and nuclear staining. Export of BAT3 from the nucleus to the cytosol is inhibited by treatment with leptomycin B, indicating that the Crm1 pathway is involved. Nuclear expression of BAT3 containing exon 11B suggests that this sequence plays a role for nuclear retention of the protein. Conclusions/Significance: Cell type-specific subcellular expression of BAT3 suggests distinct functions in the cytosol and in the nucleus. Differential expression of BAT3 variants may reconcile the multiple roles described for BAT3.	[Kamper, Nadine; Kessler, Jorg; Temme, Sebastian; Wegscheid, Claudia; Winkler, Johannes; Koch, Norbert] Univ Bonn, Inst Genet, Div Immunobiol, Bonn, Germany	University of Bonn	Kamper, N (corresponding author), Univ Bonn, Inst Genet, Div Immunobiol, Bonn, Germany.	nadine.kaemper@uni-bonn.de		Winkler, Johannes/0000-0001-7309-8342	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Chu CT, 2007, J NEUROPATH EXP NEUR, V66, P873, DOI 10.1097/nen.0b013e318156a3d7; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Huang YH, 2002, NUCLEIC ACIDS RES, V30, P186, DOI 10.1093/nar/30.1.186; Hui LJ, 2004, ONCOGENE, V23, P3013, DOI 10.1038/sj.onc.1207362; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; JOHNSON JP, 1981, EUR J IMMUNOL, V11, P825, DOI 10.1002/eji.1830111015; Kamper N, 2012, FASEB J, V26, P104, DOI 10.1096/fj.11-189670; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Kohl K, 2007, EUR J CELL BIOL, V86, P719, DOI 10.1016/j.ejcb.2007.06.007; Kumar R, 2004, BIOCHEM BIOPH RES CO, V323, P1293, DOI 10.1016/j.bbrc.2004.09.006; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Lynch KW, 2007, ADV EXP MED BIOL, V623, P161, DOI 10.1007/978-0-387-77374-2_10; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; MILNER CM, 2000, HLA HLTH DIS, P35; Minami R, 2007, BIOCHEM J, V405, P495, DOI 10.1042/BJ20061886; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Vandiedonck C, 2004, P NATL ACAD SCI USA, V101, P15464, DOI 10.1073/pnas.0406756101; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang SC, 2005, ANN NY ACAD SCI, V1059, P11, DOI 10.1196/annals.1339.002; WATANABE M, 1983, TRANSPLANTATION, V36, P712, DOI 10.1097/00007890-198336060-00025; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098; Williams P, 2008, J VIROL, V82, P10946, DOI 10.1128/JVI.01403-08; Winkler J, 2003, THESIS BONN U GERMAN; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786	49	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35972	10.1371/journal.pone.0035972	http://dx.doi.org/10.1371/journal.pone.0035972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558287	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200099
J	Schmidt, NW; Tai, KP; Kamdar, K; Mishra, A; Lai, GH; Zhao, K; Ouellette, AJ; Wong, GCL				Schmidt, Nathan W.; Tai, Kenneth P.; Kamdar, Karishma; Mishra, Abhijit; Lai, Ghee Hwee; Zhao, Kun; Ouellette, Andre J.; Wong, Gerard C. L.			Arginine in alpha-Defensins DIFFERENTIAL EFFECTS ON BACTERICIDAL ACTIVITY CORRESPOND TO GEOMETRY OF MEMBRANE CURVATURE GENERATION AND PEPTIDE-LIPID PHASE BEHAVIOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; NEUTROPHIL DEFENSINS; MOUSE CRYPTDIN-4; LIPID COMPLEXES; F-ACTIN; CURVATURE; PHASE; TRANSLOCATION; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; GUANIDINIUM	The conserved tridisulfide array of the alpha-defensin family imposes a common triple-stranded beta-sheet topology on peptides that may have highly diverse primary structures, resulting in differential outcomes after targeted mutagenesis. In mouse cryptdin-4 (Crp4) and rhesus myeloid alpha-defensin-4 (RMAD4), complete substitutions of Arg with Lys affect bactericidal peptide activity very differently. Lys-for-Arg mutagenesis attenuates Crp4, but RMAD4 activity remains mostly unchanged. Here, we show that the differential biological effect of Lys-for-Arg replacements can be understood by the distinct phase behavior of the experimental peptide-lipid system. In Crp4, small-angle x-ray scattering analyses showed that Arg-to-Lys replacements shifted the induced nanoporous phases to a different range of lipid compositions compared with the Arg-rich native peptide, consistent with the attenuation of bactericidal activity by Lys-for-Arg mutations. In contrast, such phases generated by RMAD4 were largely unchanged. The concordance between small-angle x-ray scattering measurements and biological activity provides evidence that specific types of alpha-defensin-induced membrane curvature-generating tendencies correspond directly to bactericidal activity via membrane destabilization.	[Schmidt, Nathan W.; Mishra, Abhijit; Lai, Ghee Hwee; Zhao, Kun; Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Tai, Kenneth P.; Kamdar, Karishma; Ouellette, Andre J.] Univ So Calif, Keck Sch Med, USC Norris Canc Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90089 USA; [Mishra, Abhijit] Indian Inst Technol, Dept Met Engn & Mat Sci, Ahmadabad 382424, Gujarat, India	University of California System; University of California Los Angeles; University of Southern California; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Gandhinagar	Wong, GCL (corresponding author), Univ Calif Los Angeles, Dept Bioengn, 5121 Engn V, Los Angeles, CA 90095 USA.	gclwong.ucla@gmail.com	zhao, kun/A-1998-2011; Mishra, Abhijit/K-4486-2019; Lai, GH/GRX-9180-2022	Mishra, Abhijit/0000-0003-1057-3550; 	National Institutes of Health [R01 DK044632, R01 AI059346]; USC Norris Cancer Center Support Grant [P30 CA014089, 1UO1 AI082192-01]; National Science Foundation [DMR0846582, DMR1106106, DMR0409769]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; UCLA California NanoSystems Institute; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082192, R01AI059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC Norris Cancer Center Support Grant; National Science Foundation(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); UCLA California NanoSystems Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK044632 and R01 AI059346 and USC Norris Cancer Center Support Grant P30 CA014089 (to A.J.O.) and Grant 1UO1 AI082192-01. This work was also supported by National Science Foundation Grants DMR0846582, DMR1106106, and DMR0409769.; We thank the Aspen Center for Physics for promoting this multidisciplinary collaboration. X-ray research was carried out at the Stanford Synchrotron Radiation Lightsource; at the SLAC National Accelerator Laboratory, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University; at the Advance Light Source, supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231; and at the UCLA California NanoSystems Institute.	ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; ANDERSON DM, 1988, P NATL ACAD SCI USA, V85, P5364, DOI 10.1073/pnas.85.15.5364; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Befus AD, 1999, J IMMUNOL, V163, P947; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; Cunliffe RN, 2003, MOL IMMUNOL, V40, P463, DOI 10.1016/S0161-5890(03)00157-3; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Figueredo S, 2010, METHODS MOL BIOL, V618, P47, DOI 10.1007/978-1-60761-594-1_4; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Harper PE, 2000, EUR PHYS J E, V2, P217, DOI 10.1007/PL00013660; Hristova K, 1996, BIOCHEMISTRY-US, V35, P11888, DOI 10.1021/bi961100d; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Llenado RA, 2009, INFECT IMMUN, V77, P5035, DOI 10.1128/IAI.00695-09; May S, 1997, BIOPHYS J, V73, P2427, DOI 10.1016/S0006-3495(97)78271-7; Mishra A, 2008, ANGEW CHEM INT EDIT, V47, P2986, DOI 10.1002/anie.200704444; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003; Sanders LK, 2007, P NATL ACAD SCI USA, V104, P15994, DOI 10.1073/pnas.0705898104; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Schug KA, 2005, CHEM REV, V105, P67, DOI 10.1021/cr040603j; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shearman GC, 2006, J PHYS-CONDENS MAT, V18, pS1105, DOI 10.1088/0953-8984/18/28/S01; SHYAMSUNDER E, 1988, BIOCHEMISTRY-US, V27, P2332, DOI 10.1021/bi00407a014; Siegel DP, 2004, BIOPHYS J, V87, P366, DOI 10.1529/biophysj.104.040782; SO PTC, 1993, PHYS REV LETT, V70, P3455, DOI 10.1103/PhysRevLett.70.3455; Som A, 2009, J AM CHEM SOC, V131, P15102, DOI 10.1021/ja9067063; Su YC, 2009, BIOCHEMISTRY-US, V48, P4587, DOI 10.1021/bi900080d; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; Vasudevan S, 2008, J BIOL CHEM, V283, P35869, DOI 10.1074/jbc.M806915200; Wong GCL, 2000, SCIENCE, V288, P2035, DOI 10.1126/science.288.5473.2035; Yang LH, 2004, NAT MATER, V3, P615, DOI 10.1038/nmat1195; Yang LH, 2007, J AM CHEM SOC, V129, P12141, DOI 10.1021/ja072310o; Yang LH, 2008, P NATL ACAD SCI USA, V105, P20595, DOI 10.1073/pnas.0806456105; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; [No title captured], DOI DOI 10.1038/NBT0795-658	44	46	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21866	21872		10.1074/jbc.M112.358721	http://dx.doi.org/10.1074/jbc.M112.358721			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22566697	Green Published, hybrid			2022-12-25	WOS:000306418600028
J	Kao, FF; Mahmuda, S; Pinto, R; Triccas, JA; West, NP; Britton, WJ				Kao, Fan F.; Mahmuda, Sultana; Pinto, Rachel; Triccas, James A.; West, Nicholas P.; Britton, Warwick J.			The Secreted Lipoprotein, MPT83, of Mycobacterium tuberculosis Is Recognized during Human Tuberculosis and Stimulates Protective Immunity in Mice	PLOS ONE			English	Article							BACILLE-CALMETTE-GUERIN; DNA VACCINES; ANTIGEN MPB83; BOVINE TUBERCULOSIS; FUSION PROTEIN; PLASMID DNA; SKIN-TEST; T-CELLS; INFECTION; BCG	The long-term control of tuberculosis (TB) will require the development of more effective anti-TB vaccines, as the only licensed vaccine, Mycobacterium bovis bacille Calmette-Guerin (BCG), has limited protective efficacy against infectious pulmonary TB. Subunit vaccines have an improved safety profile over live, attenuated vaccines, such as BCG, and may be used in immuno-compromised individuals. MPT83 (Rv2873) is a secreted mycobacterial lipoprotein expressed on the surface of Mycobacterium tuberculosis. In this study, we examined whether recombinant MPT83 is recognized during human and murine M. tuberculosis infection. We assessed the immunogenicity and protective efficacy of MPT83 as a protein vaccine, with monophosphyl lipid A (MPLA) in dimethyl-dioctadecyl ammonium bromide (DDA) as adjuvant, or as a DNA vaccine in C57BL/6 mice and mapped the T cell epitopes with peptide scanning. We demonstrated that rMPT83 was recognised by strong proliferative and Interferon (IFN)-gamma-secreting T cell responses in peripheral blood mononuclear cells (PBMC) from patients with active TB, but not from healthy, tuberculin skin test-negative control subjects. MPT83 also stimulated strong IFN-gamma T cell responses during experimental murine M. tuberculosis infection. Immunization with either rMPT83 in MPLA/DDA or DNA-MPT83 stimulated antigen-specific T cell responses, and we identified MPT83(127-135) (PTNAAFDKL) as the dominant H-2(b)-restricted CD8(+) T cell epitope within MPT83. Further, immunization of C57BL/6 mice with rMPT83/MPLA/DDA or DNA-MPT83 stimulated significant levels of protection in the lungs and spleens against aerosol challenge with M. tuberculosis. Interestingly, immunization with rMPT83 in MPLA/DDA primed for stronger IFN-gamma T cell responses to the whole protein following challenge, while DNA-MPT83 primed for stronger CD8(+) T cell responses to MPT83(127-135). Therefore MPT83 is a protective T cell antigen commonly recognized during human M. tuberculosis infection and should be considered for inclusion in future TB subunit vaccines.	[Kao, Fan F.; Mahmuda, Sultana; Triccas, James A.; West, Nicholas P.; Britton, Warwick J.] Centenary Inst, Mycobacterial Res Program, Sydney, NSW, Australia; [Pinto, Rachel; Triccas, James A.; Britton, Warwick J.] Univ Sydney, Sydney Med Sch, Discipline Infect Dis & Immunol, Cent Clin Sch, Sydney, NSW 2006, Australia; [Britton, Warwick J.] Univ Sydney, Sydney Med Sch, Discipline Med, Cent Clin Sch, Sydney, NSW 2006, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney	Kao, FF (corresponding author), Centenary Inst, Mycobacterial Res Program, Sydney, NSW, Australia.	wbritton@med.usyd.edu.au	West, Nicholas P/C-3119-2008; Triccas, Jamie/AAD-7629-2020	West, Nicholas P/0000-0003-0955-9890; Triccas, James/0000-0003-3730-2339; Britton, Warwick/0000-0001-6721-9646	National Health and Medical Research Council of Australia [512269]; New South Wales Department of Health; Australian Postgraduate Award; AusAid Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Department of Health; Australian Postgraduate Award(Australian Government); AusAid Scholarship	This work was supported by Project Grant 512269 from the National Health and Medical Research Council of Australia and the New South Wales Department of Health through its research infrastructure grant to the Centenary Institute. F. Kao and S. Mahmuda were recipients of an Australian Postgraduate Award and an AusAid Scholarship respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Cai H, 2005, DNA CELL BIOL, V24, P605, DOI 10.1089/dna.2005.24.605; Cai H, 2005, VACCINE, V23, P3887, DOI 10.1016/j.vaccine.2005.03.025; Chambers MA, 2002, INFECT IMMUN, V70, P2159, DOI 10.1128/IAI.70.4.2159-2165.2002; Chambers MA, 2004, FEMS IMMUNOL MED MIC, V41, P93, DOI 10.1016/j.femsim.2004.01.004; Chambers MA, 2000, CLIN INFECT DIS, V30, pS283, DOI 10.1086/313875; Charlet D, 2005, MOL MICROBIOL, V56, P1302, DOI 10.1111/j.1365-2958.2005.04618.x; Derrick SC, 2004, VACCINE, V23, P780, DOI 10.1016/j.vaccine.2004.07.036; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023360; Feng CG, 2001, INFECT IMMUN, V69, P4174, DOI 10.1128/IAI.69.6.4174-4176.2001; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; GOODGER J, 1994, VET REC, V135, P82, DOI 10.1136/vr.135.4.82; Green LR, 2009, CLIN VACCINE IMMUNOL, V16, P1309, DOI 10.1128/CVI.00028-09; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Harboe M, 1998, INFECT IMMUN, V66, P289, DOI 10.1128/IAI.66.1.289-296.1998; Henriksen- Lacey M, 2011, J CONTROL RELEASE; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Hewinson RG, 1996, SCAND J IMMUNOL, V43, P490, DOI 10.1046/j.1365-3083.1996.d01-78.x; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lesellier S, 2008, VET IMMUNOL IMMUNOP, V122, P35, DOI 10.1016/j.vetimm.2007.11.005; Malen H, 2008, PROTEOMICS, V8, P1859, DOI 10.1002/pmic.200700528; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Morris S, 2000, VACCINE, V18, P2155, DOI 10.1016/S0264-410X(99)00540-X; Mustafa AS, 2011, CLIN VACCINE IMMUNOL, V18, P1752, DOI 10.1128/CVI.05260-11; Nambiar JK, 2010, EUR J IMMUNOL, V40, P153, DOI 10.1002/eji.200939665; Reed S, 2005, MICROBES INFECT, V7, P922, DOI 10.1016/j.micinf.2005.03.011; Romero CD, 2011, INFECT IMMUN; Said-Salim B, 2006, MOL MICROBIOL, V62, P1251, DOI 10.1111/j.1365-2958.2006.05455.x; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Shanahan ER, 2010, VACCINE, V28, P1341, DOI 10.1016/j.vaccine.2009.11.010; Skeiky YAW, 2010, VACCINE, V28, P1084, DOI 10.1016/j.vaccine.2009.10.114; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; Vordermeier HM, 2000, VACCINE, V19, P1246, DOI 10.1016/S0264-410X(00)00238-3; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; Whelan AO, 2010, J CLIN MICROBIOL, V48, P3176, DOI 10.1128/JCM.00420-10; WHO, 2011, WHO GLOBAL TUBERCULO; WIKER HG, 1991, J GEN MICROBIOL, V137, P875, DOI 10.1099/00221287-137-4-875; Wiker HG, 1998, INFECT IMMUN, V66, P1445, DOI 10.1128/IAI.66.4.1445-1452.1998; Xue T, 2004, INFECT IMMUN, V72, P6324, DOI 10.1128/IAI.72.11.6324-6329.2004	49	25	28	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34991	10.1371/journal.pone.0034991	http://dx.doi.org/10.1371/journal.pone.0034991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567094	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500012
J	Broome, HJ; Hebert, MD				Broome, Hanna J.; Hebert, Michael D.			In Vitro RNase and Nucleic Acid Binding Activities Implicate Coilin in U snRNA Processing	PLOS ONE			English	Article							C-TERMINAL DOMAIN; CAJAL BODIES; BODY; SMN; PHOSPHORYLATION; INTERPHASE; PROTEIN; GENES; TRANSCRIPTION; ASSOCIATION	Coilin is known as the marker protein for Cajal bodies (CBs), subnuclear domains important for the biogenesis of small nuclear ribonucleoproteins (snRNPs) which function in pre-mRNA splicing. CBs associate non-randomly with U1 and U2 gene loci, which produce the small nuclear RNA (snRNA) component of the respective snRNP. Despite recognition as the CB marker protein, coilin is primarily nucleoplasmic, and the function of this fraction is not fully characterized. Here we show that coilin binds double stranded DNA and has RNase activity in vitro. U1 and U2 snRNAs undergo a processing event of the primary transcript prior to incorporation in the snRNP. We find that coilin displays RNase activity within the CU region of the U2 snRNA primary transcript in vitro, and that coilin knockdown results in accumulation of the 3' pre-processed U1 and U2 snRNA. These findings present new characteristics of coilin in vitro, and suggest additional functions of the protein in vivo.	[Broome, Hanna J.; Hebert, Michael D.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Broome, HJ (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA.	mhebert@umc.edu			United States National Institutes of Health [R01GM081448]; Mississippi INBRE [P20RR016476]; National Center for Research Resources, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081448] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mississippi INBRE; National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the United States National Institutes of Health (R01GM081448) and supported in part by the Mississippi INBRE (P20RR016476) funded by the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bellini M, 1998, MOL BIOL CELL, V9, P2987, DOI 10.1091/mbc.9.10.2987; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; CARMOFONSECA M, 1993, J CELL BIOL, V120, P841, DOI 10.1083/jcb.120.4.841; Carrero ZI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025743; Cioce M, 2006, J CELL BIOL, V175, P401, DOI 10.1083/jcb.200604099; Cuello P, 1999, EMBO J, V18, P2867, DOI 10.1093/emboj/18.10.2867; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; FREY MR, 1995, P NATL ACAD SCI USA, V92, P5915, DOI 10.1073/pnas.92.13.5915; Frey MR, 1999, CURR BIOL, V9, P126, DOI 10.1016/S0960-9822(99)80066-9; Frey MR, 2001, J CELL BIOL, V154, P499, DOI 10.1083/jcb.200105084; Gilder AS, 2011, MOL BIOL CELL, V22, P1070, DOI 10.1091/mbc.E10-08-0731; Hearst SM, 2009, J CELL SCI, V122, P1872, DOI 10.1242/jcs.044040; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Hebert MD, 2010, ARCH BIOCHEM BIOPHYS, V496, P69, DOI 10.1016/j.abb.2010.02.012; Jacobs EY, 1999, MOL BIOL CELL, V10, P1653, DOI 10.1091/mbc.10.5.1653; Jacobs EY, 2004, MOL CELL BIOL, V24, P846, DOI 10.1128/MCB.24.2.846-855.2004; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Li Y, 2010, TOXICOL SCI, V118, P435, DOI 10.1093/toxsci/kfq282; Licciulli S, 2011, AM J PATHOL, V178, P2397, DOI 10.1016/j.ajpath.2011.01.019; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Mao YS, 2011, TRENDS GENET; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Rajendra TK, 2010, COLD SH Q B, V75, P365, DOI 10.1101/sqb.2010.75.043; Shanbhag R, 2010, FEBS LETT, V584, P4351, DOI 10.1016/j.febslet.2010.09.034; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Smith KP, 2000, MOL BIOL CELL, V11, P2987, DOI 10.1091/mbc.11.9.2987; Strzelecka M, 2010, NUCLEUS IN PRESS; Sun J, 2005, J CELL SCI, V118, P4995, DOI 10.1242/jcs.02613; Takata H, 2012, J CELL SCI, V125, P166, DOI 10.1242/jcs.090837; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Uguen P, 2004, NUCLEIC ACIDS RES, V32, P2987, DOI 10.1093/nar/gkh619; Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004; Walker MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006171; White AE, 2011, J CELL BIOL, V193, P677, DOI 10.1083/jcb.201012077; Whittom AA, 2008, CELL MOL LIFE SCI, V65, P1256, DOI 10.1007/s00018-008-7587-3; Xu HZ, 2005, CHROMOSOMA, V114, P155, DOI 10.1007/s00412-005-0003-y; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858	55	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36300	10.1371/journal.pone.0036300	http://dx.doi.org/10.1371/journal.pone.0036300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558428	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000183
J	Pacheco-Tucuch, FS; Ramirez-Sierra, MJ; Gourbiere, S; Dumonteil, E				Santiago Pacheco-Tucuch, Freddy; Jesus Ramirez-Sierra, Maria; Gourbiere, Sebastien; Dumonteil, Eric			Public Street Lights Increase House Infestation by the Chagas Disease Vector Triatoma dimidiata	PLOS ONE			English	Article							YUCATAN PENINSULA; HEMIPTERA REDUVIIDAE; TRYPANOSOMA-CRUZI; COLORED LIGHT; DISPERSAL; DYNAMICS; TRANSMISSION; PERSPECTIVES; HETEROPTERA; INSECTICIDE	Triatoma dimidiata is one of the primary vectors of Chagas disease. We previously documented the spatio-temporal infestation of houses by this species in the Yucatan peninsula, Mexico, and found that non-domiciliated triatomines were specifically attracted to houses. However, the factors mediating this attraction remained unclear. Artificial light has been known for a long time to attract many insect species, and therefore may contribute to the spread of different vector-borne diseases. Also, based on the collection of different species of triatomines with light traps, several authors have suggested that light might attract triatomines to houses, but the role of artificial light in house infestation has never been clearly demonstrated and quantified. Here we performed a spatial analysis of house infestation pattern by T. dimidiata in relation to the distribution of artificial light sources in three different villages from the Yucatan peninsula, Mexico. In all three villages, infested houses were significantly closer to public street light sources than non-infested houses (18.0 +/- 0.6 vs 22.6 +/- 0.4 m), and street lights rather than domestic lights were associated with house infestation. Accordingly, houses closer to a public street lights were 1.64 times more likely to be infested than houses further away (OR, CI95% 1.23-2.18). Behavioral experiments using a dual-choice chamber further confirmed that adult male and females were attracted to white light during their nocturnal activity. Attraction was also dependent on light color and decreased with increasing wavelength. While public lighting is usually associated with increased development, these data clearly show that it also directly contributes to house infestation by non-domiciliated T. dimidiata.	[Santiago Pacheco-Tucuch, Freddy; Jesus Ramirez-Sierra, Maria; Dumonteil, Eric] Univ Autonoma Yucatan, Parasitol Lab, Ctr Invest Reg Dr Hideyo Noguchi, Merida, Yucatan, Mexico; [Gourbiere, Sebastien] Univ Perpignan, UMR CNRS UPVD Ecol & Evolut Interact 5244, F-66025 Perpignan, France; [Gourbiere, Sebastien] Univ Sussex, Sch Life Sci, Ctr Study Evolut, Brighton, E Sussex, England; [Dumonteil, Eric] Tulane Univ, Dept Trop Med, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA	Universidad Autonoma de Yucatan; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; University of Sussex; Tulane University	Pacheco-Tucuch, FS (corresponding author), Univ Autonoma Yucatan, Parasitol Lab, Ctr Invest Reg Dr Hideyo Noguchi, Merida, Yucatan, Mexico.	oliver@uady.mx	Gourbière, Sébastien/C-4320-2011	Dumonteil, Eric/0000-0001-9376-0209; Gourbiere, Sebastien/0000-0002-6701-4795	UNDP/WorldBank/ WHO International Development Research Center (IDRC) [A90276]; EU [253483]	UNDP/WorldBank/ WHO International Development Research Center (IDRC); EU(European Commission)	This investigation received financial support from the UNDP/WorldBank/ WHO Special Program for Research and Training in Tropical Diseases (TDR)/International Development Research Center (IDRC), Project #A90276, and by EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) grant no. 253483. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbu C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001045; Barbu C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000777; Barbu C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000416; Barghini A, 2010, ENVIRON HEALTH PERSP, V118, P1503, DOI 10.1289/ehp.1002115; BARGUES MD, 2002, T R SOC TROP MED S1, V96, P159, DOI DOI 10.1016/S0035-9203(02)90069-6; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Burkett DA, 2005, FLA ENTOMOL, V88, P383, DOI 10.1653/0015-4040(2005)88[383:LEOCLA]2.0.CO;2; Burkett DA, 1998, J AM MOSQUITO CONTR, V14, P186; CAMPOS F, 1931, REV COL NAC VICENTE, V13, P107; de la Fuente ALC, 2007, ACTA TROP, V101, P115, DOI 10.1016/j.actatropica.2006.12.007; Castro MCM, 2010, MEM I OSWALDO CRUZ, V105, P1061, DOI 10.1590/S0074-02762010000800019; Bargues MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000233; Dorn PL, 2007, INFECT GENET EVOL, V7, P343, DOI 10.1016/j.meegid.2006.10.001; Dorn PL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000393; Dumonteil E, 2004, MEM I OSWALDO CRUZ, V99, P253, DOI 10.1590/S0074-02762004000300002; Dumonteil E, 2002, AM J TROP MED HYG, V67, P176, DOI 10.4269/ajtmh.2002.67.176; Dumonteil E, 2009, J PARASITOL, V95, P469, DOI 10.1645/GE-1712.1; Feliciangeli MD, 2002, TROP MED INT HEALTH, V7, P280, DOI 10.1046/j.1365-3156.2002.00853.x; Gamboa-Leon R, 2011, J PARASITOL, V97, P338, DOI 10.1645/GE-2545.1; Gourbiere S, 2012, HEREDITY, V108, P190, DOI 10.1038/hdy.2011.71; Gourbiere S, 2008, AM J TROP MED HYG, V78, P133, DOI 10.4269/ajtmh.2008.78.133; Guerenstein PG, 2009, ACTA TROP, V110, P148, DOI 10.1016/j.actatropica.2008.09.019; Guzman-Tapia Y, 2007, VECTOR-BORNE ZOONOT, V7, P597, DOI 10.1089/vbz.2007.0133; Herrera-Aguilar M, 2009, INFECT GENET EVOL, V9, P1345, DOI 10.1016/j.meegid.2009.09.009; Kelber A, 2002, NATURE, V419, P922, DOI 10.1038/nature01065; Lazzari CR, 2009, MEM I OSWALDO CRUZ, V104, P65, DOI 10.1590/S0074-02762009000900011; Minoli SA, 2006, ACTA TROP, V97, P324, DOI 10.1016/j.actatropica.2005.12.005; Nakagawa J, 2003, ANN TROP MED PARASIT, V97, P289, DOI 10.1179/000349803235001895; Noireau F, 1999, MEM I OSWALDO CRUZ, V94, P451, DOI 10.1590/S0074-02761999000400004; Nouvellet P, 2011, INFECT GENET EVOL, V11, P1243, DOI 10.1016/j.meegid.2011.04.008; Payet V, 2009, VECTOR-BORNE ZOONOT, V9, P243, DOI 10.1089/vbz.2008.0078; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Dias JC, 2008, REV SOC BRAS MED TRO, V41, P193, DOI 10.1590/S0037-86822008000200012; Polonio R, 2009, VECTOR-BORNE ZOONOT, V9, P19, DOI 10.1089/vbz.2008.0002; Quantum GIS Development Team, 2011, QUANT GIS GEOGR INF; Ramirez-Sierra MJ, 2010, TROP MED INT HEALTH, V15, P77, DOI 10.1111/j.1365-3156.2009.02422.x; Rebollar-Tellez EA, 2009, J VECTOR ECOL, V34, P304, DOI [10.1111/j.1948-7134.2009.00038.x, 10.3376/038.034.0216]; Reisenman CE, 2006, J COMP PHYSIOL A, V192, P39, DOI 10.1007/s00359-005-0045-x; Ruebenbauer A, 2008, CURR BIOL, V18, P1438, DOI 10.1016/j.cub.2008.08.062; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Stavenga DG, 2002, J COMP PHYSIOL A, V188, P337, DOI 10.1007/s00359-002-0307-9; Tamay-Segovia P, 2008, AM J TROP MED HYG, V78, P472, DOI 10.4269/ajtmh.2008.78.472; Vazquez-Prokopec GM, 2006, MED VET ENTOMOL, V20, P273, DOI 10.1111/j.1365-2915.2006.00637.x; Wastavino GR, 2004, MEM I OSWALDO CRUZ, V99, P433, DOI 10.1590/S0074-02762004000400015; WISNIVESKYCOLLI C, 1993, MEM I OSWALDO CRUZ, V88, P27, DOI 10.1590/S0074-02761993000100006; Zeledon R, 2006, MEM I OSWALDO CRUZ, V101, P75, DOI 10.1590/S0074-02762006000100014	46	66	68	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36207	10.1371/journal.pone.0036207	http://dx.doi.org/10.1371/journal.pone.0036207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558384	gold, Green Published			2022-12-25	WOS:000305336000155
J	Ci, XX; Chu, X; Wei, MM; Yang, XF; Cai, QR; Deng, XM				Ci, Xinxin; Chu, Xiao; Wei, Miaomiao; Yang, Xiaofeng; Cai, Qinren; Deng, Xuming			Different Effects of Farrerol on an OVA-Induced Allergic Asthma and LPS-induced Acute Lung Injury	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; MURINE MODEL; INFLAMMATION; MICE; HYPERRESPONSIVENESS; INFILTRATION; INHIBITION; PROTECTS; THERAPY; AIRWAYS	Background: Farrerol, isolated from rhododendron, has been shown to have the anti-bacterial activity, but no details on the anti-inflammatory activity. We further evaluated the effects of this compound in two experimental models of lung diseases. Methodology/Principal Findings: For the asthma model, female BALB/c mice were challenged with ovalbumin (OVA), and then treated daily with farrerol (20 and 40 mg/kg, ip) as a therapeutic treatment from day 22 to day 26 post immunization. To induce acute lung injury, female BALB/c mice were injected intranasally with LPS and treated with farrerol (20 and 40 mg/kg, i.p.) 1 h prior to LPS stimulation. Inflammation in the two different models was determined using ELISA, histology, real-time PCR and western blot. Farrerol significantly regulated the phenotype challenged by OVA, like cell number, Th1 and Th2 cytokines levels in the BALF, the OVA-specific IgE level in the serum, goblet cell hyperplasia in the airway, airway hyperresponsiveness to inhaled methacholine and mRNA expression of chemokines and their receptors. Furthermore, farrerol markedly attenuated the activation of phosphorylation of Akt and nuclear factor-kappa B (NF-kappa B) subunit p65 both in vivo and in vitro. However, farrerol has no effect on the acute lung injury model. Conclusion/Significance: Our finding demonstrates that the distinct anti-inflammatory effect of farrerol in the treatment of asthma acts by inhibiting the PI3K and NF-kappa B pathway.	[Ci, Xinxin; Chu, Xiao; Wei, Miaomiao; Yang, Xiaofeng; Cai, Qinren; Deng, Xuming] Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonoses, Changchun 130023, Jilin, Peoples R China	Jilin University	Ci, XX (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonoses, Changchun 130023, Jilin, Peoples R China.	xumingdeng@jluhp.edu.cn			National Science and Technology Supporting Plan of China [2006BAD31B03- 4]	National Science and Technology Supporting Plan of China	This study was financed by the National Science and Technology Supporting Plan of China (No. 2006BAD31B03- 4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Bao Z, 2007, AM J RESP CRIT CARE, V176, P431, DOI 10.1164/rccm.200609-1292OC; Barnes PJ, 2006, LAB INVEST, V86, P867, DOI 10.1038/labinvest.3700456; Broide DH, 2011, J ALLERGY CLIN IMMUN, V127, P689, DOI 10.1016/j.jaci.2011.01.027; Cao YH, 2002, J CHROMATOGR A, V943, P153, DOI 10.1016/S0021-9673(01)01434-0; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Choi JR, 2009, INT IMMUNOPHARMACOL, V9, P918, DOI 10.1016/j.intimp.2009.03.018; Choi SE, 2011, PHYTOTHER RES; Duan W, 2006, CURR DRUG TARGETS, V7, P691, DOI 10.2174/138945006777435353; Edwan JH, 2004, J IMMUNOL, V172, P5016, DOI 10.4049/jimmunol.172.8.5016; Greenberger PA, 2008, J ALLERGY CLIN IMMUN, V121, pS393, DOI 10.1016/j.jaci.2007.07.039; Ito K, 2001, J BIOL CHEM, V276, P30208, DOI 10.1074/jbc.M103604200; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; KosKudla B, 1997, ULTRASOUND MED BIOL, V23, P1325, DOI 10.1016/S0301-5629(97)00195-6; Li QY, 2011, ACTA PHARMACOL SIN, V32, P433, DOI 10.1038/aps.2011.1; Manson SC, 2009, RESP MED, V103, P975, DOI 10.1016/j.rmed.2009.01.003; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Pantano C, 2008, AM J RESP CRIT CARE, V177, P959, DOI 10.1164/rccm.200707-1096OC; Park SJ, 2008, RESPIROLOGY, V13, P764, DOI 10.1111/j.1440-1843.2008.01369.x; Qiu JZ, 2011, FEMS MICROBIOL LETT, V315, P129, DOI 10.1111/j.1574-6968.2010.02183.x; Rogerio AP, 2008, EUR J PHARMACOL, V580, P262, DOI 10.1016/j.ejphar.2007.10.034; Rogerio AP, 2009, BRIT J PHARMACOL, V158, P1074, DOI 10.1111/j.1476-5381.2009.00177.x; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Roth M, 2006, CURR DRUG TARGETS, V7, P589, DOI 10.2174/138945006776818638; Shields Conor J, 2002, Curr Opin Crit Care, V8, P158, DOI 10.1097/00075198-200204000-00012; Tian JN, 2005, BIOORGAN MED CHEM, V13, P4124, DOI 10.1016/j.bmc.2005.02.065; Tritar-Cherif Fatma, 2002, Tunis Med, V80, P1; Xu YD, 2010, RESP RES, V11, DOI [10.1186/1465-9921-11-166, 10.1186/1465-9921-11-107]; Zhang XM, 2009, INT IMMUNOPHARMACOL, V9, P1525, DOI 10.1016/j.intimp.2009.09.007; Zhou HQ, 2011, INFLAMM RES, V60, P981, DOI 10.1007/s00011-011-0359-9; Zhou LM, 2005, AM J RESP CELL MOL, V33, P195, DOI 10.1165/rcmb.2004-0411OC	35	60	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e34634	10.1371/journal.pone.0034634	http://dx.doi.org/10.1371/journal.pone.0034634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563373	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100003
J	Kim, HS; Ernst, JA; Brown, C; Bostrom, J; Fuh, G; Lee, CWV; Huang, A; Vandlen, RL; Yansura, DG				Kim, Hok Seon; Ernst, James A.; Brown, Cecilia; Bostrom, Jenny; Fuh, Germaine; Lee, Chingwei V.; Huang, Arthur; Vandlen, Richard L.; Yansura, Daniel G.			Translation Levels Control Multi-Spanning Membrane Protein Expression	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; ENDOTHELIAL GROWTH-FACTOR; ESCHERICHIA-COLI; COUPLED RECEPTOR; NUCLEOTIDE-SEQUENCE; HUMAN HOMOLOG; GENE; OVEREXPRESSION; ANTIBODIES; PROMOTERS	Attempts to express eukaryotic multi-spanning membrane proteins at high-levels have been generally unsuccessful. In order to investigate the cause of this limitation and gain insight into the rate limiting processes involved, we have analyzed the effect of translation levels on the expression of several human membrane proteins in Escherichia coli (E. coli). These results demonstrate that excessive translation initiation rates of membrane proteins cause a block in protein synthesis and ultimately prevent the high-level accumulation of these proteins. Moderate translation rates allow coupling of peptide synthesis and membrane targeting, resulting in a significant increase in protein expression and accumulation over time. The current study evaluates four membrane proteins, CD20 (4-transmembrane (TM) helixes), the G-protein coupled receptors (GPCRs, 7-TMs) RA1c and EG-VEGFR1, and Patched 1 (12-TMs), and demonstrates the critical role of translation initiation rates in the targeting, insertion and folding of integral membrane proteins in the E. coli membrane.	[Kim, Hok Seon; Brown, Cecilia; Bostrom, Jenny; Fuh, Germaine; Lee, Chingwei V.; Huang, Arthur; Yansura, Daniel G.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Ernst, James A.; Bostrom, Jenny; Fuh, Germaine; Lee, Chingwei V.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Ernst, James A.; Vandlen, Richard L.; Yansura, Daniel G.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kim, HS (corresponding author), Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA.	ernst.james@gene.com; yansura.dan@gene.com						Battersby S, 2004, J CLIN ENDOCR METAB, V89, P2463, DOI 10.1210/jc.2003-032012; Berinstein NL, 1998, ANN ONCOL, V9, P995, DOI 10.1023/A:1008416911099; Columbus L, 2009, J AM CHEM SOC, V131, P7320, DOI 10.1021/ja808776j; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Ernst JA, 2005, BIOCHEMISTRY-US, V44, P15150, DOI 10.1021/bi0511078; Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hayhurst A, 1999, PROTEIN EXPRES PURIF, V15, P336, DOI 10.1006/prep.1999.1035; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; ISHIDATE K, 1986, J BIOL CHEM, V261, P428; JENSEN PR, 1993, EUR J BIOCHEM, V211, P181, DOI 10.1111/j.1432-1033.1993.tb19885.x; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; KIKUCHI Y, 1981, NUCLEIC ACIDS RES, V9, P5671, DOI 10.1093/nar/9.21.5671; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; MAKINO K, 1986, J MOL BIOL, V190, P37, DOI 10.1016/0022-2836(86)90073-2; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; MIOZZARI GF, 1978, J BACTERIOL, V133, P1457, DOI 10.1128/JB.133.3.1457-1466.1978; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Parker R, 2000, BBA-GENE STRUCT EXPR, V1491, P369, DOI 10.1016/S0167-4781(00)00023-3; Polyak MJ, 2002, BLOOD, V99, P3256, DOI 10.1182/blood.V99.9.3256; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; SCHOLTISSEK S, 1987, NUCLEIC ACIDS RES, V15, P3185, DOI 10.1093/nar/15.7.3185; SHAND RF, 1991, BIOCHEMISTRY-US, V30, P3082, DOI 10.1021/bi00226a015; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; van Dalen A, 2000, EMBO REP, V1, P340, DOI 10.1093/embo-reports/kvd067; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; WALTER P, 1983, J CELL BIOL, V97, P1693, DOI 10.1083/jcb.97.6.1693; Weng JS, 2005, J CELL BIOCHEM, V96, P1034, DOI 10.1002/jcb.20600; Xu LL, 2000, CANCER RES, V60, P6568	39	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35844	10.1371/journal.pone.0035844	http://dx.doi.org/10.1371/journal.pone.0035844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563408	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100034
J	Ryan, SJ; Ehrlich, DE; Jasnow, AM; Daftary, S; Madsen, TE; Rainnie, DG				Ryan, Steven J.; Ehrlich, David E.; Jasnow, Aaron M.; Daftary, Shabrine; Madsen, Teresa E.; Rainnie, Donald G.			Spike-Timing Precision and Neuronal Synchrony Are Enhanced by an Interaction between Synaptic Inhibition and Membrane Oscillations in the Amygdala	PLOS ONE			English	Article							RAT BASOLATERAL AMYGDALA; METABOTROPIC GLUTAMATE RECEPTORS; FEAR-POTENTIATED STARTLE; PARVALBUMIN-IMMUNOREACTIVE INTERNEURONS; DEPENDENT PROTEIN-KINASE; CURRENT I-H; T-TYPE; LATERAL AMYGDALA; CALCIUM-CHANNELS; NEOCORTICAL NEURONS	The basolateral complex of the amygdala (BLA) is a critical component of the neural circuit regulating fear learning. During fear learning and recall, the amygdala and other brain regions, including the hippocampus and prefrontal cortex, exhibit phase-locked oscillations in the high delta/low theta frequency band (similar to 2-6 Hz) that have been shown to contribute to the learning process. Network oscillations are commonly generated by inhibitory synaptic input that coordinates action potentials in groups of neurons. In the rat BLA, principal neurons spontaneously receive synchronized, inhibitory input in the form of compound, rhythmic, inhibitory postsynaptic potentials (IPSPs), likely originating from burst-firing parvalbumin interneurons. Here we investigated the role of compound IPSPs in the rat and rhesus macaque BLA in regulating action potential synchrony and spike-timing precision. Furthermore, because principal neurons exhibit intrinsic oscillatory properties and resonance between 4 and 5 Hz, in the same frequency band observed during fear, we investigated whether compound IPSPs and intrinsic oscillations interact to promote rhythmic activity in the BLA at this frequency. Using whole-cell patch clamp in brain slices, we demonstrate that compound IPSPs, which occur spontaneously and are synchronized across principal neurons in both the rat and primate BLA, significantly improve spike-timing precision in BLA principal neurons for a window of similar to 300 ms following each IPSP. We also show that compound IPSPs coordinate the firing of pairs of BLA principal neurons, and significantly improve spike synchrony for a window of,130 ms. Compound IPSPs enhance a 5 Hz calcium-dependent membrane potential oscillation (MPO) in these neurons, likely contributing to the improvement in spike-timing precision and synchronization of spiking. Activation of the cAMP-PKA signaling cascade enhanced the MPO, and inhibition of this cascade blocked the MPO. We discuss these results in the context of spike-timing dependent plasticity and modulation by neurotransmitters important for fear learning, such as dopamine.	[Ryan, Steven J.; Ehrlich, David E.; Jasnow, Aaron M.; Daftary, Shabrine; Madsen, Teresa E.; Rainnie, Donald G.] Emory Univ, Sch Med, Div Behav Neurosci & Psychiat Disorders, Dept Psychiat & Behav Sci,Yerkes Res Ctr, Atlanta, GA 30322 USA	Emory University	Ryan, SJ (corresponding author), Emory Univ, Sch Med, Div Behav Neurosci & Psychiat Disorders, Dept Psychiat & Behav Sci,Yerkes Res Ctr, Atlanta, GA 30322 USA.	drainni@emory.edu	Rainnie, Donald/L-3853-2016; Madsen, Teresa/J-2645-2013	Rainnie, Donald/0000-0003-0758-0530; Madsen, Teresa/0000-0002-7358-5869; Ryan, Steven/0000-0003-3650-7746; Ehrlich, David/0000-0003-2823-731X	NIH [MH 069852, RR-00165]; Atlanta Clinical and Translational Science Institute (ACTSI); PHS, National Institutes of Health, National Center for Research Resources [UL1 RR025008]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069852] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Atlanta Clinical and Translational Science Institute (ACTSI); PHS, National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NIH Grant MH 069852 to DGR was the primary source of funding for materials and salaries for those involved in the design and execution of all experiments, as well as data analysis and manuscript preparation. NIH Base grant RR-00165 to the Yerkes National Primate Research center also provides some support to this research in the form of facilities. The authors also received some support from the Atlanta Clinical and Translational Science Institute (ACTSI), in turn supported in part by PHS Grant UL1 RR025008 from the Clinical and Translational Science Award program, National Institutes of Health, National Center for Research Resources. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript; the funders' only role in data analysis was ACTSI's consultation on techniques for statistical comparisons of data presented in figures 3 and 4.	Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bauer EP, 2007, J NEUROSCI, V27, P9369, DOI 10.1523/JNEUROSCI.2153-07.2007; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Buzsaki G, 1997, CAN J PHYSIOL PHARM, V75, P508, DOI 10.1139/cjpp-75-5-508; CAMPEAU S, 1992, BEHAV NEUROSCI, V106, P569, DOI 10.1037/0735-7044.106.3.569; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CARLSEN J, 1988, BRAIN RES, V441, P377, DOI 10.1016/0006-8993(88)91418-7; Chhatwal JP, 2009, NEUROPSYCHOPHARMACOL, V34, P509, DOI 10.1038/npp.2008.97; Chung L, 2007, NEUROPEPTIDES, V41, P453, DOI 10.1016/j.npep.2007.08.001; Collins DR, 2001, J NEUROPHYSIOL, V85, P1661, DOI 10.1152/jn.2001.85.4.1661; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Davis M., 2000, AMYGDALA, P213; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; GEAN PW, 1989, BRAIN RES, V480, P160, DOI 10.1016/0006-8993(89)91578-3; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Hammack SE, 2007, J NEUROPHYSIOL, V98, P638, DOI 10.1152/jn.00382.2007; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; HUTCHEON B, 1994, J NEUROPHYSIOL, V71, P583, DOI 10.1152/jn.1994.71.2.583; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P698, DOI 10.1152/jn.1996.76.2.698; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Josselyn SA, 2004, NEUROBIOL LEARN MEM, V82, P159, DOI 10.1016/j.nlm.2004.05.008; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Jutrast MJ, 2010, CURR OPIN NEUROBIOL, V20, P150, DOI 10.1016/j.conb.2010.02.006; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Lamont EW, 1998, BRAIN RES, V795, P128, DOI 10.1016/S0006-8993(98)00281-9; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Li CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026065; Lin CH, 2005, LEARN MEMORY, V12, P130, DOI 10.1101/lm.85304; Lin HC, 2000, J NEUROSCI, V20, P9017; Loretan K, 2004, NEUROPHARMACOLOGY, V47, P631, DOI 10.1016/j.neuropharm.2004.07.015; Madsen TE, 2009, SOC NEUR ANN M CHIC; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mascagni F, 2003, BRAIN RES, V976, P171, DOI 10.1016/S0006-8993(03)02625-8; McDonald AJ, 2005, BRAIN RES, V1035, P32, DOI 10.1016/j.brainres.2004.11.052; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; McDonald AJ, 2002, BRAIN RES, V943, P237, DOI 10.1016/S0006-8993(02)02650-1; McDonald AJ, 2001, NEUROSCIENCE, V102, P413, DOI 10.1016/S0306-4522(00)00481-4; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Mitra S, 2008, OBSERVED BRAIN DYNAM; Molineux ML, 2005, J NEUROSCI, V25, P10863, DOI 10.1523/JNEUROSCI.3436-05.2005; Muller JF, 2005, J NEUROSCI, V25, P7366, DOI 10.1523/JNEUROSCI.0899-05.2005; Muller JF, 2006, J COMP NEUROL, V494, P635, DOI 10.1002/cne.20832; Muly EC, 2007, J COMP NEUROL, V505, P682, DOI 10.1002/cne.21525; Muly EC, 2009, BRAIN STRUCT FUNCT, V213, P375, DOI 10.1007/s00429-009-0214-8; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 1998, J NEUROPHYSIOL, V79, P217, DOI 10.1152/jn.1998.79.1.217; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; Pape HC, 2004, PFLUG ARCH EUR J PHY, V448, P131, DOI 10.1007/s00424-003-1234-5; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Paz R, 2008, LEARN MEMORY, V15, P524, DOI 10.1101/lm.932408; Pelletier JG, 2004, BIOL PSYCHIAT, V55, P559, DOI 10.1016/j.biopsych.2003.08.019; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Popescu AT, 2011, J NEUROPHYSIOL, V105, P687, DOI 10.1152/jn.00732.2010; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; RAINNIE DG, 1991, J NEUROPHYSIOL, V66, P986, DOI 10.1152/jn.1991.66.3.986; RAINNIE DG, 1994, J NEUROSCI, V14, P7208; Rainnie DG, 1999, J NEUROPHYSIOL, V82, P69, DOI 10.1152/jn.1999.82.1.69; RAINNIE DG, 1993, J NEUROPHYSIOL, V69, P1350, DOI 10.1152/jn.1993.69.4.1350; Rainnie DG, 1999, SOC NEUR ANN M MIAM; Rainnie DG, 2009, POST TRAUMATIC STRES; Rainnie DG, 2006, J COMP NEUROL, V498, P142, DOI 10.1002/cne.21049; Ramadan O, 2009, J BIOL CHEM, V284, P5042, DOI 10.1074/jbc.M809132200; Randall FE, 2011, EUR J NEUROSCI, V33, P914, DOI 10.1111/j.1460-9568.2010.07582.x; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Russier M, 2003, J PHYSIOL-LONDON, V549, P21, DOI 10.1113/jphysiol.2002.037069; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schafe GE, 1999, LEARN MEMORY, V6, P97; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sinfield JL, 2006, EUR J NEUROSCI, V24, P3091, DOI 10.1111/j.1460-9568.2006.05202.x; Sohal VS, 2006, J NEUROSCI, V26, P4247, DOI 10.1523/JNEUROSCI.3812-05.2006; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Szinyei C, 2000, J NEUROSCI, V20, P8909; Szucs A, 2009, NEURON, V61, P439, DOI 10.1016/j.neuron.2008.12.032; Vargas G, 2002, J MEMBRANE BIOL, V188, P115, DOI 10.1007/s00232-001-0178-y; Woodruff AR, 2007, J NEUROPHYSIOL, V98, P2956, DOI 10.1152/jn.00739.2007; Woodruff AR, 2007, J NEUROSCI, V27, P553, DOI 10.1523/JNEUROSCI.3686-06.2007; Young CK, 2011, J NEUROPHYSIOL, V106, P497, DOI 10.1152/jn.00358.2011; Zaccolo M, 2003, TRENDS NEUROSCI, V26, P53, DOI 10.1016/S0166-2236(02)00017-6; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106	106	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35320	10.1371/journal.pone.0035320	http://dx.doi.org/10.1371/journal.pone.0035320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563382	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100011
J	Sun, YP; Dong, ZQ; Khodabakhsh, H; Chatterjee, S; Guo, S				Sun, Yaping; Dong, Zhiqiang; Khodabakhsh, Hadie; Chatterjee, Sandip; Guo, Su			Zebrafish Chemical Screening Reveals the Impairment of Dopaminergic Neuronal Survival by Cardiac Glycosides	PLOS ONE			English	Article							PARKINSONS-DISEASE; SMALL MOLECULES; ROTENONE MODEL; IDENTIFICATION; GENES; SYSTEM; DRUGS; NA,K-ATPASE; EXPRESSION; MUTATIONS	Parkinson's disease is a neurodegenerative disorder characterized by the prominent degeneration of dopaminergic (DA) neurons among other cell types. Here we report a first chemical screen of over 5,000 compounds in zebrafish, aimed at identifying small molecule modulators of DA neuron development or survival. We find that Neriifolin, a member of the cardiac glycoside family of compounds, impairs survival but not differentiation of both zebrafish and mammalian DA neurons. Cardiac glycosides are inhibitors of Na+/K+ ATPase activity and widely used for treating heart disorders. Our data suggest that Neriifolin impairs DA neuronal survival by targeting the neuronal enriched Na+/K+ ATPase alpha 3 subunit (ATP1A3). Modulation of ionic homeostasis, knockdown of p53, or treatment with antioxidants protects DA neurons from Neriifolin-induced death. These results reveal a previously unknown effect of cardiac glycosides on DA neuronal survival and suggest that it is mediated through ATP1A3 inhibition, oxidative stress, and p53. They also elucidate potential approaches for counteracting the neurotoxicity of this valuable class of medications.	[Sun, Yaping; Dong, Zhiqiang; Khodabakhsh, Hadie; Chatterjee, Sandip; Guo, Su] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Program Human Genet, San Francisco, CA 94143 USA; [Sun, Yaping; Dong, Zhiqiang; Khodabakhsh, Hadie; Chatterjee, Sandip; Guo, Su] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Program Biol Sci, San Francisco, CA 94143 USA; [Khodabakhsh, Hadie] George Washington Univ, Sch Med, Washington, DC USA; [Chatterjee, Sandip] Scripps Res Inst, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; George Washington University; Scripps Research Institute	Sun, YP (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Program Human Genet, San Francisco, CA 94143 USA.	su.guo@ucsf.edu			NIH [DA023904]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by NIH DA023904. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; Bournival J, 2009, CELL MOL NEUROBIOL, V29, P1169, DOI 10.1007/s10571-009-9411-5; Bretaud S, 2004, NEUROTOXICOL TERATOL, V26, P857, DOI 10.1016/j.ntt.2004.06.014; CARNEY MWP, 1985, CLIN NEUROPHARMACOL, V8, P193, DOI 10.1097/00002826-198506000-00011; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; CHIUEH CC, 1984, PSYCHOPHARMACOL BULL, V20, P548; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Guo S, 2009, EXPERT OPIN DRUG DIS, V4, P715, DOI 10.1517/17460440902988464; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Heo HJ, 2004, J AGR FOOD CHEM, V52, P7514, DOI 10.1021/jf049243r; Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; McCarty, 1998, CATECHOLAMINES BRIDG; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; Meissner WG, 2011, NAT REV DRUG DISCOV, V10, P377, DOI 10.1038/nrd3430; Miyazaki I, 2008, ACTA MED OKAYAMA, V62, P141; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; North TE, 2010, P NATL ACAD SCI USA, V107, P17315, DOI 10.1073/pnas.1008209107; Perier C, 2003, TRENDS NEUROSCI, V26, P345, DOI 10.1016/S0166-2236(03)00144-9; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Rajarao SJR, 2001, GENOME RES, V11, P1211, DOI 10.1101/gr.186001; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Rink E, 2002, BRAIN RES BULL, V57, P385, DOI 10.1016/S0361-9230(01)00696-7; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Smeets W. J. A. J., 1994, PHYLOGENY DEV CATECH; Song YH, 2001, PSYCHOSOMATICS, V42, P369, DOI 10.1176/appi.psy.42.4.369; Speciale SG, 2002, NEUROTOXICOL TERATOL, V24, P607, DOI 10.1016/S0892-0362(02)00222-2; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Thisse C, 2005, ZFIN DIRECT DATA SUB; Yeh JRJ, 2009, NAT CHEM BIOL, V5, P236, DOI 10.1038/nchembio.147; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	54	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35645	10.1371/journal.pone.0035645	http://dx.doi.org/10.1371/journal.pone.0035645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563390	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100018
J	Harris, S; Craze, M; Newton, J; Fisher, M; Shima, DT; Tozer, GM; Kanthou, C				Harris, Sheila; Craze, Madeleine; Newton, Jillian; Fisher, Matthew; Shima, David T.; Tozer, Gillian M.; Kanthou, Chryso			Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SPLICE VARIANT; MESSENGER-RNA; DIFFERENTIAL EXPRESSION; EXTRACELLULAR-MATRIX; POOR-PROGNOSIS; TUMOR-GROWTH; A ISOFORM; VEGF(165)B; BINDING	Splicing of the human vascular endothelial growth factor-A (VEGF-A) gene has been reported to generate angiogenic (VEGFxxx) and anti-angiogenic (VEGFxxxb) isoforms. Corresponding VEGFxxxb isoforms have also been reported in rat and mouse. We examined VEGFxxxb expression in mouse fibrosarcoma cell lines expressing all or individual VEGF isoforms (VEGF120, 164 or 188), grown in vitro and in vivo, and compared results with those from normal mouse and human tissues. Importantly, genetic construction of VEGF164 and VEGF188 expressing fibrosarcomas, in which exon 7 is fused to the conventional exon 8, precludes VEGFxxxb splicing from occurring. Thus, these two fibrosarcoma cell lines provided endogenous negative controls. Using RT-PCR we show that primers designed to simultaneously amplify VEGFxxx and VEGFxxxb isoforms amplified only VEGFxxx variants in both species. Moreover, only VEGFxxx species were generated when mouse podocytes were treated with TGF beta-1, a reported activator of VEGFxxxb splice selection in human podocytes. A VEGF164/120 heteroduplex species was identified as a PCR artefact, specifically in mouse. VEGFxxxb isoform-specific PCR did amplify putative VEGFxxxb species in mouse and human tissues, but unexpectedly also in VEGF188 and VEGF164 fibrosarcoma cells and tumours, where splicing to produce true VEGFxxxb isoforms cannot occur. Moreover, these products were only consistently generated using reverse primers spanning more than 5 bases across the 8b/7 or 8b/5 splice junctions. Primer annealing to VEGFxxx transcripts and amplification of exon 8b primer 'tails' explained the artefactual generation of VEGFxxxb products, since the same products were generated when the PCR reactions were performed with cDNA from VEGF164/VEGF188 'knock-in' vectors used in the generation of single VEGF isoform-expressing transgenic mice from which the fibrosarcoma lines were developed. Collectively, our results highlight important pitfalls in data interpretation associated with detecting VEGFxxxb isoforms using current methods, and demonstrate that anti-angiogenic isoforms are not commonly expressed in mouse or human tissues.	[Harris, Sheila; Craze, Madeleine; Fisher, Matthew; Tozer, Gillian M.; Kanthou, Chryso] Univ Sheffield, Sch Med, Dept Oncol, Canc Res United Kingdom Tumour Microcirculat Grp, Sheffield, S Yorkshire, England; [Newton, Jillian] Sheffield Hallam Univ, Biomed Ctr, Sheffield S1 1WB, S Yorkshire, England; [Shima, David T.] UCL, Inst Ophthalmol, London, England	University of Sheffield; Sheffield Hallam University; University of London; University College London	Harris, S (corresponding author), Univ Sheffield, Sch Med, Dept Oncol, Canc Res United Kingdom Tumour Microcirculat Grp, Sheffield, S Yorkshire, England.	Sheila.harris@sheffield.ac.uk			Cancer Research United Kingdom [C1276/A9993]	Cancer Research United Kingdom(Cancer Research UK)	This work was supported by Cancer Research United Kingdom (Programme Grant Tumour Microcirculation, grant number C1276/A9993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artac RA, 2009, BIOL REPROD, V81, P978, DOI 10.1095/biolreprod.109.078097; Bates DO, 2002, CANCER RES, V62, P4123; Bevan HS, 2008, NEPHRON PHYSIOL, V110, P57, DOI 10.1159/000177614; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Catena R, MOL CANC, V9, P320; Cui TG, 2004, AM J PHYSIOL-RENAL, V286, pF767, DOI 10.1152/ajprenal.00337.2003; Das K, 2007, UROL ONCOL-SEMIN ORI, V25, P317, DOI 10.1016/j.urolonc.2007.01.015; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ebrahem Q, 2010, AM J PATHOL, V176, P496, DOI 10.2353/ajpath.2010.080642; Eckhart L, 1999, J BIOL CHEM, V274, P2613, DOI 10.1074/jbc.274.5.2613; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ergorul C, 2008, MOL VIS, V14, P1517; FERRARA N, 1995, BREAST CANCER RES TR, V36, P127, DOI 10.1007/BF00666035; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; Kawamura H, 2008, CANCER RES, V68, P4683, DOI 10.1158/0008-5472.CAN-07-6577; Konopatskaya O, 2006, MOL VIS, V12, P626; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lee YH, 1999, EUR J CANCER, V35, P1089, DOI 10.1016/S0959-8049(99)00073-8; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Magnussen AL, INVEST OPHTHALMOL VI; Miller-Kasprzak E, 2008, BIOMED PHARMACOTHER, V62, P158, DOI 10.1016/j.biopha.2007.07.015; Mundel P, 1997, EXPT CELL RES; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Perrin RM, 2005, DIABETOLOGIA, V48, P2422, DOI 10.1007/s00125-005-1951-8; Pritchard-Jones RO, 2007, BRIT J CANCER, V97, P223, DOI 10.1038/sj.bjc.6603839; Qiu Y, 2008, FASEB J, V22, P1104, DOI 10.1096/fj.07-9718com; Qiu Y, 2009, BIOCHEM SOC T, V37, P1207, DOI 10.1042/BST0371207; Rennel ES, 2008, BRIT J CANCER, V98, P1250, DOI 10.1038/sj.bjc.6604309; Rennel ES, 2009, BRIT J CANCER, V101, P1183, DOI 10.1038/sj.bjc.6605249; Rennel ES, 2008, EUR J CANCER, V44, P1883, DOI 10.1016/j.ejca.2008.05.027; Rennel ES, 2009, FUTURE ONCOL, V5, P703, DOI 10.2217/FON.09.33; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Schumacher VA, 2007, J AM SOC NEPHROL, V18, P719, DOI 10.1681/ASN.2006020124; Senger DR, 2010, MOL BIOL CELL, V21, P377, DOI 10.1091/mbc.E09-07-0591; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Suarez SC, 2006, CELL MOL LIFE SCI, V63, P2067, DOI 10.1007/s00018-006-6254-9; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tokunaga T, 1998, BRIT J CANCER, V77, P998, DOI 10.1038/bjc.1998.164; Tomisawa M, 1999, EUR J CANCER, V35, P133, DOI 10.1016/S0959-8049(98)00278-0; Tozer GM, 2008, CANCER RES, V68, P2301, DOI 10.1158/0008-5472.CAN-07-2011; Uthoff SMS, 2002, INT J CANCER, V101, P32, DOI 10.1002/ijc.10552; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Wedam SB, 2006, J CLIN ONCOL, V24, P769, DOI 10.1200/JCO.2005.03.4645; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Zhang L, 2002, BIOCHEM BIOPH RES CO, V292, P860, DOI 10.1006/bbrc.2002.6710; Zhao M, 2011, EXP EYE RES, V93, P921, DOI 10.1016/j.exer.2011.10.013	55	41	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35231	10.1371/journal.pone.0035231	http://dx.doi.org/10.1371/journal.pone.0035231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567098	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500016
J	Hneino, M; Francois, A; Buard, V; Tarlet, G; Abderrahmani, R; Blirando, K; Hoodless, PA; Benderitter, M; Milliat, F				Hneino, Mohammad; Francois, Agnes; Buard, Valerie; Tarlet, Georges; Abderrahmani, Rym; Blirando, Karl; Hoodless, Pamela A.; Benderitter, Marc; Milliat, Fabien			The TGF-beta/Smad Repressor TG-Interacting Factor 1 (TGIF1) Plays a Role in Radiation-Induced Intestinal Injury Independently of a Smad Signaling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; UBIQUITIN-DEPENDENT DEGRADATION; TRANSCRIPTIONAL COREPRESSOR TGIF; ENDOTHELIAL-CELLS; RENAL FIBROSIS; OBSTRUCTIVE NEPHROPATHY; IONIZING-RADIATION; DOWN-REGULATION; EXPRESSION; TGF-BETA-1	Despite advances in radiation delivery protocols, exposure of normal tissues during the course of radiation therapy remains a limiting factor of cancer treatment. If the canonical TGF-beta/Smad pathway has been extensively studied and implicated in the development of radiation damage in various organs, the precise modalities of its activation following radiation exposure remain elusive. In the present study, we hypothesized that TGF-beta 1 signaling and target genes expression may depend on radiation-induced modifications in Smad transcriptional co-repressors/inhibitors expressions (TGIF1, SnoN, Ski and Smad7). In endothelial cells (HUVECs) and in a model of experimental radiation enteropathy in mice, radiation exposure increases expression of TGF-beta/Smad pathway and of its target gene PAI-1, together with the overexpression of Smad co-repressor TGIF1. In mice, TGIF1 deficiency is not associated with changes in the expression of radiation-induced TGF-beta pathway-related transcripts following localized small intestinal irradiation. In HUVECs, TGIF1 overexpression or silencing has no influence either on the radiation-induced Smad activation or the Smad3-dependent PAI-1 overexpression. However, TGIF1 genetic deficiency sensitizes mice to radiation-induced intestinal damage after total body or localized small intestinal radiation exposure, demonstrating that TGIF1 plays a role in radiation-induced intestinal injury. In conclusion, the TGF-beta/Smad co-repressor TGIF1 plays a role in radiation-induced normal tissue damage by a Smad-independent mechanism.	[Hneino, Mohammad; Francois, Agnes; Buard, Valerie; Tarlet, Georges; Abderrahmani, Rym; Blirando, Karl; Benderitter, Marc; Milliat, Fabien] Inst Radiol Protect & Nucl Safety IRSN, Lab Radiopathol & Expt, Fontenay Aux Roses, France; [Hoodless, Pamela A.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Hoodless, Pamela A.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	University of British Columbia; British Columbia Cancer Agency	Hneino, M (corresponding author), Inst Radiol Protect & Nucl Safety IRSN, Lab Radiopathol & Expt, Fontenay Aux Roses, France.	fabien.milliat@irsn.fr		TARLET, Georges/0000-0002-4756-5127; Hoodless, Pamela/0000-0003-1371-0725; Milliat, Fabien/0000-0001-8249-9498				Aguilella C, 2003, HUM GENET, V112, P131, DOI 10.1007/s00439-002-0862-8; Andarawewa KL, 2007, INT J RADIAT BIOL, V83, P803, DOI 10.1080/09553000701711063; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; ANSCHER MS, 1990, RADIAT RES, V122, P77, DOI 10.2307/3577586; Anscher MS, 1998, LUNG CANCER-J IASLC, V19, P109, DOI 10.1016/S0169-5002(97)00076-7; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; Bartholin L, 2008, DEV BIOL, V319, P285, DOI 10.1016/j.ydbio.2008.04.027; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Demange C, 2009, MOL CELL, V36, P1073, DOI 10.1016/j.molcel.2009.12.009; Denham JW, 2002, RADIOTHER ONCOL, V63, P129, DOI 10.1016/S0167-8140(02)00060-9; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Ehrhart EJ, 1997, FASEB J, V11, P991, DOI 10.1096/fasebj.11.12.9337152; Flanders KC, 2003, AM J PATHOL, V163, P2247, DOI 10.1016/S0002-9440(10)63582-1; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Fukasawa H, 2006, KIDNEY INT, V69, P1733, DOI 10.1038/sj.ki.5000261; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Hamid R, 2008, BBA-GENE REGUL MECH, V1779, P347, DOI 10.1016/j.bbagrm.2008.04.003; Hamid R, 2009, MOL ONCOL, V3, P451, DOI 10.1016/j.molonc.2009.07.004; Haydont V, 2008, AM J PHYSIOL-CELL PH, V294, pC1332, DOI 10.1152/ajpcell.90626.2007; Huang Y, 2006, KIDNEY INT, V69, P1713, DOI 10.1038/sj.ki.5000260; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jobling ME, 2006, RADIAT RES, V166, P839, DOI 10.1667/RR0695.1; Kraft M, 1996, RADIAT RES, V146, P619, DOI 10.2307/3579377; Kruse JJCM, 2009, RADIAT RES, V171, P188, DOI 10.1667/RR1526.1; Liu ZM, 2011, BIOCHEM J, V438, P349, DOI 10.1042/BJ20101653; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; Mar L, 2006, MOL CELL BIOL, V26, P4302, DOI 10.1128/MCB.02156-05; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Melhuish TA, 2000, J BIOL CHEM, V275, P39762, DOI 10.1074/jbc.C000416200; Milliat F, 2008, AM J PATHOL, V172, P691, DOI 10.2353/ajpath.2008.070930; Milliat F, 2006, AM J PATHOL, V169, P1484, DOI 10.2353/ajpath.2006.060116; Randall K, 1996, INT J RADIAT BIOL, V70, P351, DOI 10.1080/095530096145085; Robbins MEC, 2001, RADIAT RES, V155, P481, DOI 10.1667/0033-7587(2001)155[0481:TROTTI]2.0.CO;2; Scharpfenecker M, 2009, RADIOTHER ONCOL, V92, P484, DOI 10.1016/j.radonc.2009.06.013; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Schultze-Mosgau S, 2004, RADIOTHER ONCOL, V70, P249, DOI 10.1016/j.radonc.2004.01.010; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Tan RY, 2006, J AM SOC NEPHROL, V17, P2781, DOI 10.1681/ASN.2005101055; Wang JR, 1998, AM J PATHOL, V153, P1531, DOI 10.1016/S0002-9440(10)65741-0; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827	48	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35672	10.1371/journal.pone.0035672	http://dx.doi.org/10.1371/journal.pone.0035672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567107	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341500025
J	Liu, DB; Gong, J; Dai, WK; Kang, XC; Huang, Z; Zhang, HM; Liu, W; Liu, L; Ma, JP; Xia, ZL; Chen, YX; Chen, YW; Wang, DP; Ni, PX; Guo, AY; Xiong, XY				Liu, Dongbo; Gong, Jing; Dai, Wenkui; Kang, Xincong; Huang, Zhuo; Zhang, Hong-Mei; Liu, Wei; Liu, Le; Ma, Junping; Xia, Zhilan; Chen, Yuxin; Chen, Yuewen; Wang, Depeng; Ni, Peixiang; Guo, An-Yuan; Xiong, Xingyao			The Genome of Ganderma lucidum Provide Insights into Triterpense Biosynthesis and Wood Degradation	PLOS ONE			English	Article							GANODERMA-LUCIDUM; VEGETATIVE INCOMPATIBILITY; NATURAL-PRODUCTS; GENE; PROTEIN; DATABASE; LIGNIN; TOOL; BIODEGRADATION; IDENTIFICATION	Background: Ganoderma lucidum (Reishi or Ling Zhi) is one of the most famous Traditional Chinese Medicines and has been widely used in the treatment of various human diseases in Asia countries. It is also a fungus with strong wood degradation ability with potential in bioenergy production. However, genes, pathways and mechanisms of these functions are still unknown. Methodology/Principal Findings: The genome of G. lucidum was sequenced and assembled into a 39.9 megabases (Mb) draft genome, which encoded 12,080 protein-coding genes and similar to 83% of them were similar to public sequences. We performed comprehensive annotation for G. lucidum genes and made comparisons with genes in other fungi genomes. Genes in the biosynthesis of the main G. lucidum active ingredients, ganoderic acids (GAs), were characterized. Among the GAs synthases, we identified a fusion gene, the N and C terminal of which are homologous to two different enzymes. Moreover, the fusion gene was only found in basidiomycetes. As a white rot fungus with wood degradation ability, abundant carbohydrate-active enzymes and ligninolytic enzymes were identified in the G. lucidum genome and were compared with other fungi. Conclusions/Significance: The genome sequence and well annotation of G. lucidum will provide new insights in function analyses including its medicinal mechanism. The characterization of genes in the triterpene biosynthesis and wood degradation will facilitate bio-engineering research in the production of its active ingredients and bioenergy.	[Liu, Dongbo; Xiong, Xingyao] Hunan Agr Univ, Key Lab Crop Germplasm Innovat & Utilizat Hunan P, Changsha, Hunan, Peoples R China; [Liu, Dongbo; Kang, Xincong; Xia, Zhilan; Chen, Yuxin; Chen, Yuewen] State Key Lab Subhlth Intervent Technol, Changsha, Hunan, Peoples R China; [Gong, Jing; Zhang, Hong-Mei; Liu, Wei; Guo, An-Yuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China; [Dai, Wenkui; Liu, Le; Ma, Junping; Ni, Peixiang] Beijing Genome Inst BGI Shenzhen, Shenzhen, Guangdong, Peoples R China; [Huang, Zhuo] Hunan Wanyuan Biotech Co Ltd, Changsha, Hunan, Peoples R China; [Gong, Jing; Zhang, Hong-Mei; Liu, Wei; Wang, Depeng] Next Biosci Co Ltd, Wuhan, Hubei, Peoples R China; [Wang, Depeng] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	Hunan Agricultural University; Huazhong University of Science & Technology; Beijing Genomics Institute (BGI); South China University of Technology	Guo, AY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China.	guoay@mail.hust.edu.cn; xiongxy@hunau.net	Guo, An-Yuan/K-3656-2012		National Program on Key Basic Research Project (973 Program) [2012CB723000]; Key Projects in the National Science & Technology Program [2012BAD33B00]; National Natural Science Foundation of China [31171271]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); Key Projects in the National Science & Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding of this project was provided by the programs National Program on Key Basic Research Project (973 Program, 2012CB723000 to DBL), Key Projects in the National Science & Technology Program (2012BAD33B00 to DBL), and National Natural Science Foundation of China (31171271 to AYG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Asgher M, 2008, BIODEGRADATION, V19, P771, DOI 10.1007/s10532-008-9185-3; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Borodovsky Mark, 2003, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0405s01; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chu TT, 2011, BR J NUTR, P1; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Haralampidis K, 2002, ADV BIOCHEM ENG BIOT, V75, P31; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hefner T, 2002, BIOORGAN MED CHEM, V10, P1731, DOI 10.1016/S0968-0896(02)00029-9; JiDing Z, 1989, CHINESE GANODERMA LU; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang XinCong, 2011, Journal of Hunan Agricultural University, V37, P147, DOI 10.3724/SP.J.1238.2011.00147; KERSTEN PJ, 1990, P NATL ACAD SCI USA, V87, P2936, DOI 10.1073/pnas.87.8.2936; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LEE SY, 1990, CHEM PHARM BULL, V38, P1359, DOI 10.1248/cpb.38.1359; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin ZB, 2005, J PHARMACOL SCI, V99, P144, DOI 10.1254/jphs.CRJ05008X; Lin ZB, 2004, ACTA PHARMACOL SIN, V25, P1387; Lin ZB, 2007, MODERN RES GANODERMA; Loubradou G, 2000, RES MICROBIOL, V151, P239, DOI 10.1016/S0923-2508(00)00145-5; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Makela MR, 2006, CURR GENET, V50, P323, DOI 10.1007/s00294-006-0090-1; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; MARZULLO L, 1995, J BIOL CHEM, V270, P3823, DOI 10.1074/jbc.270.8.3823; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Murugesan K, 2009, APPL MICROBIOL BIOT, V82, P341, DOI 10.1007/s00253-008-1819-1; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shang CH, 2008, BIOSCI BIOTECH BIOCH, V72, P1333, DOI 10.1271/bbb.80011; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; Shi LA, 2010, APPL MICROBIOL BIOT, V88, P1243, DOI 10.1007/s00253-010-2871-1; Shiao MS, 2003, CHEM REC, V3, P172, DOI 10.1002/tcr.10058; Sijia Zhao XC, 2011, P 2011 INT M GAN RES; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wang X, 2006, APPL MICROBIOL BIOT, V72, P508, DOI 10.1007/s00253-006-0314-9; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yuen JWM, 2005, NUTR CANCER, V53, P11, DOI 10.1207/s15327914nc5301_2; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106	63	70	78	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36146	10.1371/journal.pone.0036146	http://dx.doi.org/10.1371/journal.pone.0036146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567134	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500052
J	Lima, MJ; Docherty, HM; Chen, YX; Vallier, L; Docherty, K				Lima, Maria Joao; Docherty, Hilary M.; Chen, Yuanxiao; Vallier, Ludovic; Docherty, Kevin			Pancreatic Transcription Factors Containing Protein Transduction Domains Drive Mouse Embryonic Stem Cells towards Endocrine Pancreas	PLOS ONE			English	Article							DUODENAL HOMEOBOX-1; BETA-CELLS; DIFFERENTIATION; PDX-1; EXPRESSION; ENDODERM; MAFA	Protein transduction domains (PTDs), such as the HIV1-TAT peptide, have been previously used to promote the uptake of proteins into a range of cell types, including stem cells. Here we generated pancreatic transcription factors containing PTD sequences and administered these to endoderm enriched mouse embryonic stem (ES) cells under conditions that were designed to mimic the pattern of expression of these factors in the developing pancreas. The ES cells were first cultured as embryoid bodies and treated with Activin A and Bone morphogenetic protein 4 (BMP4) to promote formation of definitive endoderm. Cells were subsequently plated as a monolayer and treated with different combinations of the modified recombinant transcription factors Pdx1 and MafA. The results demonstrate that each transcription factor was efficiently taken up by the cells, where they were localized in the nuclei. RT-qPCR was used to measure the expression levels of pancreatic markers. After the addition of Pdx1 alone for a period of five days, followed by the combination of Pdx1 and TAT-MafA in a second phase, up-regulation of insulin 1, insulin 2, Pdx1, Glut2, Pax4 and Nkx6.1 was observed. As assessed by immunocytochemistry, double positive insulin and Pdx1 cells were detected in the differentiated cultures. Although the pattern of pancreatic markers expression in these cultures was comparable to that of a mouse transformed beta-cell line (MIN6) and human islets, the expression levels of insulin observed in the differentiated ES cell cultures were several orders of magnitude lower. This suggests that, although PTD-TFs may prove useful in studying the role of exogenous TFs in the differentiation of ES cells towards islets and other pancreatic lineages, the amount of insulin generated is well below that required for therapeutically useful cells.	[Lima, Maria Joao; Docherty, Hilary M.; Chen, Yuanxiao; Docherty, Kevin] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen, Scotland; [Vallier, Ludovic] Anne McLaren Lab Regenerat Med, Cambridge, England	University of Aberdeen; University of Cambridge	Lima, MJ (corresponding author), Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen, Scotland.	k.docherty@abdn.ac.uk	vallier, ludovic/C-6368-2011; Lima, Maria Joao/HHR-9895-2022	Lima, Maria Joao/0000-0003-0597-7892; Vallier, Ludovic/0000-0002-3848-2602; Docherty, Kevin/0000-0001-6765-2060	Juvenile Diabetes Research Foundation International (JDRF); Wellcome Trust; Medical Research Council [G0800784B, G0701448, G0800784] Funding Source: researchfish; MRC [G0800784, G0701448] Funding Source: UKRI	Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was provided by the Juvenile Diabetes Research Foundation International (JDRF) and Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Baetge EE, 2008, DIABETES OBES METAB, V10, P186, DOI 10.1111/j.1463-1326.2008.00956.x; Bernardo AS, 2009, STEM CELLS, V27, P341, DOI 10.1634/stemcells.2008-0310; Chen J, 2006, BIOCHEM BIOPH RES CO, V347, P931, DOI 10.1016/j.bbrc.2006.06.173; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Docherty K, 2011, STEM CELL BIOL REGEN, P177; Docherty K, 2007, SEMIN CELL DEV BIOL, V18, P827, DOI 10.1016/j.semcdb.2007.09.009; Dominguez-Bendala J, 2005, DIABETES, V54, P720, DOI 10.2337/diabetes.54.3.720; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Koya V, 2008, DIABETES, V57, P757, DOI 10.2337/db07-1441; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Krosl G, 2005, BIOL BLOOD MARROW TR, V11, P19, DOI 10.1016/j.bbmt.2004.12.054; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lima MJ, MOL CELL ENDOCRINOL; Manceur A, 2007, ANAL BIOCHEM, V364, P51, DOI 10.1016/j.ab.2007.02.015; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Noguchi H, 2003, DIABETES, V52, P1732, DOI 10.2337/diabetes.52.7.1732; Offield MF, 1996, DEVELOPMENT, V122, P983; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353	29	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36481	10.1371/journal.pone.0036481	http://dx.doi.org/10.1371/journal.pone.0036481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563503	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340700052
J	Amyot, J; Semache, M; Ferdaoussi, M; Fontes, G; Poitout, V				Amyot, Julie; Semache, Meriem; Ferdaoussi, Mourad; Fontes, Ghislaine; Poitout, Vincent			Lipopolysaccharides Impair Insulin Gene Expression in Isolated Islets of Langerhans via Toll-Like Receptor-4 and NF-kappa B Signalling	PLOS ONE			English	Article							PANCREATIC-BETA-CELLS; BINDING PROTEIN BETA; DIET-INDUCED OBESITY; HIGH-FAT DIET; GUT MICROBIOTA; TRANSCRIPTION FACTOR; ADIPOSE-TISSUE; PALMITATE INHIBITION; DIABETES-MELLITUS; INNATE IMMUNITY	Background: Type 2 diabetes is characterized by pancreatic beta-cell dysfunction and is associated with low-grade inflammation. Recent observations suggest that the signalling cascade activated by lipopolysaccharides (LPS) binding to Toll-Like Receptor 4 (TLR4) exerts deleterious effects on pancreatic beta-cell function; however, the molecular mechanisms of these effects are incompletely understood. In this study, we tested the hypothesis that LPS alters insulin gene expression via TLR4 and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) in islets. Methodology/Principal Findings: A 24-h exposure of isolated human, rat and mouse islets of Langerhans to LPS dose-dependently reduced insulin gene expression. This was associated in mouse and rat islets with decreased mRNA expression of pancreas-duodenum homebox-1 (PDX-1) and mammalian homologue of avian MafA/l-Maf (MafA). Accordingly, LPS exposure also decreased glucose-induced insulin secretion. LPS repression of insulin, PDX-1 and MafA expression, as well as its inhibition of insulin secretion, were not observed in islets from TLR4-deficient mice. LPS inhibition of beta-cell gene expression in rat islets was prevented by inhibition of the NF-kappa B pathway, but not the p38 mitogen-activated protein kinase (p38 MAPK) pathway. Conclusions/Significance: Our findings demonstrate that LPS inhibit beta-cell gene expression in a TLR4-dependent manner and via NF-kappa B signaling in pancreatic islets, suggesting a novel mechanism by which the gut microbiota might affect pancreatic beta-cell function.	[Amyot, Julie; Semache, Meriem; Ferdaoussi, Mourad; Fontes, Ghislaine; Poitout, Vincent] CRCHUM, Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Amyot, Julie; Semache, Meriem; Poitout, Vincent] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Poitout, Vincent] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Amyot, J (corresponding author), CRCHUM, Montreal Diabet Res Ctr, Montreal, PQ, Canada.	vincent.poitout@umontreal.ca	Ferdaoussi, Mourad/AGN-8892-2022	Ferdaoussi, Mourad/0000-0001-7636-0959; Poitout, Vincent/0000-0002-6555-5053	National Institutes of Health [R01DK58096]; Fonds de la Recherche en Sante du Quebec; Diabete Quebec; Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM); Faculte des Etudes Superieures de l'Universite de Montreal; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Diabete Quebec; Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM); Faculte des Etudes Superieures de l'Universite de Montreal; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (R01DK58096 to VP). VP holds the Canada Research Chair in Diabetes and Pancreatic Beta-cell Function. JA and MS are supported by a training award from the Fonds de la Recherche en Sante du Quebec and received support from Diabete Quebec, the Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM) and the Faculte des Etudes Superieures de l'Universite de Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PD, 2007, J CLIN ENDOCR METAB, V92, P2272, DOI 10.1210/jc.2006-2545; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Cha-Molstad H, 2007, MOL IMMUNOL, V44, P2933, DOI 10.1016/j.molimm.2007.01.015; Chang I, 2003, DIABETES, V52, P1169, DOI 10.2337/diabetes.52.5.1169; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Garay-Malpartida HM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-18; Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hammar EB, 2005, J BIOL CHEM, V280, P30630, DOI 10.1074/jbc.M502493200; He B, 2004, BIOCHEM BIOPH RES CO, V321, P13, DOI 10.1016/j.bbrc.2004.06.101; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hutton MJH, 2010, ISLETS, V2, P104, DOI 10.4161/isl.2.2.11209; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kiely A, 2009, J ENDOCRINOL, V202, P365, DOI 10.1677/JOE-09-0160; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lee SM, 2011, MOL CELL BIOCHEM, V354, P207, DOI 10.1007/s11010-011-0820-7; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; Norlin S, 2005, DIABETES, V54, P125, DOI 10.2337/diabetes.54.1.125; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Poitout V, 2004, INT TXB DIABETES MEL; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rafiq I, 1998, J BIOL CHEM, V273, P23241, DOI 10.1074/jbc.273.36.23241; Rozen S, 2000, Methods Mol Biol, V132, P365; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Seufert J, 1998, J CLIN INVEST, V101, P2528, DOI 10.1172/JCI2401; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	61	91	109	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36200	10.1371/journal.pone.0036200	http://dx.doi.org/10.1371/journal.pone.0036200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558381	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000153
J	Gao, CH; Yang, M; He, ZG				Gao, Chun-hui; Yang, Min; He, Zheng-Guo			Characterization of a Novel ArsR-Like Regulator Encoded by Rv2034 in Mycobacterium tuberculosis	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORS; CRYSTAL-STRUCTURE; HYPOXIC RESPONSE; SMTB REPRESSOR; PROTEIN; FAMILY; SITES; VIRULENCE; SEQUENCE; OPERON	The genome of Mycobacterium tuberculosis, the causative agent of tuberculosis, encodes a large number of putative transcriptional regulators. However, the identity and target genes of only a few of them have been clearly identified to date. In a recent study, the ArsR family regulator Rv2034 was characterized as a novel positive regulator of phoP. In the current study, we characterized the auto-repressive capabilities of Rv2034 and identified several residues in the protein critical for its DNA binding activities. We also provide evidence that Rv2034 forms dimers in vitro. Furthermore, by using DNaseI footprinting assays, a palindromic sequence was identified as its binding site. Notably, we found that the dosR promoter region contains the binding motif for Rv2034, and that Rv2034 positively regulates the expression of the dosR gene. The potential roles of Rv2034 in the regulation of lipid metabolism and hypoxic adaptation are discussed.	[Gao, Chun-hui; Yang, Min; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Peoples R China.	he.zhengguo@hotmail.com	Gao, Chun-Hui/B-3667-2016; Gao, Chun-Hui/B-4111-2008; He, Zheng-Guo/P-3647-2014	Gao, Chun-Hui/0000-0002-1445-7939; Gao, Chun-Hui/0000-0002-1445-7939; Yang, Min/0000-0003-2924-5717	National Natural Science Foundation of China [30930003, 31025002]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program	This work is supported by the National Natural Science Foundation of China (30930003 and 31025002), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z.-G.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunkumar AI, 2009, P NATL ACAD SCI USA, V106, P18177, DOI 10.1073/pnas.0905558106; Barbosa RL, 2007, J BACTERIOL, V189, P6185, DOI 10.1128/JB.00331-07; Campbell DR, 2007, J BIOL CHEM, V282, P32298, DOI 10.1074/jbc.M703451200; Canneva F, 2005, J BACTERIOL, V187, P5837, DOI 10.1128/JB.187.16.5837-5840.2005; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Cavet JS, 2003, J BIOL CHEM, V278, P44560, DOI 10.1074/jbc.M307877200; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Chauhan S, 2009, FEBS J, V276, P3428, DOI 10.1111/j.1742-4658.2009.07066.x; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Gao CH, 2011, BIOCHEM BIOPH RES CO, V411, P726, DOI 10.1016/j.bbrc.2011.07.014; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005; Korch SB, 2009, J BACTERIOL, V191, P1618, DOI 10.1128/JB.01318-08; Lee JH, 2007, J MICROBIOL, V45, P146; Liu M, 2007, INFECT IMMUN, V75, P3282, DOI 10.1128/IAI.00045-07; Liu W, 2007, J MOL BIOL, V369, P474, DOI 10.1016/j.jmb.2007.03.044; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Miller JH., 1972, EXPT MOL GENETICS; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Murphy JN, 2009, J BACTERIOL, V191, P6722, DOI 10.1128/JB.00801-09; O'Rourke KP, 2010, J BACTERIOL, V192, P1433, DOI 10.1128/JB.01161-09; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Summers AO, 2009, CURR OPIN MICROBIOL, V12, P138, DOI 10.1016/j.mib.2009.02.003; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; WILLIAMS SG, 1993, MOL MICROBIOL, V9, P751, DOI 10.1111/j.1365-2958.1993.tb01735.x; World Health Organization, 2010, GLOB TUB CONTR WHO R; WU J, 1991, MOL MICROBIOL, V5, P1331, DOI 10.1111/j.1365-2958.1991.tb00779.x; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Zhao HY, 2010, MICROBIOL-SGM, V156, P385, DOI 10.1099/mic.0.033548-0	41	34	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36255	10.1371/journal.pone.0036255	http://dx.doi.org/10.1371/journal.pone.0036255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558408	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000172
J	Luiz, OC; Gianini, RJ; Goncalves, FT; Francisco, G; Festa-Neto, C; Sanches, JA; Gattas, GJF; Chammas, R; Eluf-Neto, J				Luiz, Olinda C.; Gianini, Reinaldo Jose; Goncalves, Fernanda T.; Francisco, Guilherme; Festa-Neto, Cyro; Sanches, Jose Antonio; Gattas, Gilka J. F.; Chammas, Roger; Eluf-Neto, Jose			Ethnicity and Cutaneous Melanoma in the City of Sao Paulo, Brazil: A Case-Control Study	PLOS ONE			English	Article							RISK-FACTORS; REPAIR GENES; EUROPEAN ANCESTRY; UV INDEX; POLYMORPHISMS; POPULATION; SKIN; PIGMENTATION; EPIDEMIOLOGY; LATITUDE	Background: Over the last century the incidence of cutaneous melanoma has increased worldwide, a trend that has also been observed in Brazil. The identified risk factors for melanoma include the pattern of sun exposure, family history, and certain phenotypic features. In addition, the incidence of melanoma might be influenced by ethnicity. Like many countries, Brazil has high immigration rates and consequently a heterogenous population. However, Brazil is unique among such countries in that the ethnic heterogeneity of its population is primarily attributable to admixture. This study aimed to evaluate the contribution of European ethnicity to the risk of cutaneous melanoma in Brazil. Methodology/Principal Findings: We carried out a hospital-based case-control study in the metropolitan area of Sao Paulo, Brazil. We evaluated 424 hospitalized patients (202 melanoma patients and 222 control patients) regarding phenotypic features, sun exposure, and number of grandparents born in Europe. Through multivariate logistic regression analysis, we found the following variables to be independently associated with melanoma: grandparents born in Europe-Spain (OR = 3.01, 95% CI: 1.03-8.77), Italy (OR = 3.47, 95% CI: 1.41-8.57), a Germanic/Slavic country (OR = 3.06, 95% CI: 1.05-8.93), or >= 2 European countries (OR = 2.82, 95% CI: 1.06-7.47); eye color-light brown (OR = 1.99, 95% CI: 1.14-3.84) and green/blue (OR = 4.62; 95% CI 2.22-9.58); pigmented lesion removal (OR = 3.78; 95% CI: 2.21-6.49); no lifetime sunscreen use (OR = 3.08; 95% CI: 1.03-9.22); and lifetime severe sunburn (OR = 1.81; 95% CI: 1.03-3.19). Conclusions: Our results indicate that European ancestry is a risk factor for cutaneous melanoma. Such risk appears to be related not only to skin type, eye color, and tanning capacity but also to others specific characteristics of European populations introduced in the New World by European immigrants.	[Luiz, Olinda C.; Eluf-Neto, Jose] Univ Sao Paulo, Fac Med, Lab Epidemiol & Imunobiol LIM38, Dept Prevent Med, Sao Paulo, Brazil; [Gianini, Reinaldo Jose] Univ Sao Paulo, Fac Med, Lab Processamento Dados Biomed LIM39, Dept Prevent Med, Sao Paulo, Brazil; [Gianini, Reinaldo Jose] Pontificia Univ Catolica Sao Paulo, Sorocaba, Brazil; [Goncalves, Fernanda T.; Gattas, Gilka J. F.] Univ Sao Paulo, Fac Med, Lab Imunohematol & Hematol Forense LIM40, Dept Med Legal Etica Med Med Social & Trabalho, Sao Paulo, Brazil; [Francisco, Guilherme; Chammas, Roger] Univ Sao Paulo, Fac Med, Lab Oncol Expt LIM24, Dept Radiol, Sao Paulo, Brazil; [Festa-Neto, Cyro; Sanches, Jose Antonio] Univ Sao Paulo, Fac Med, Dept Dermatol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Pontificia Universidade Catolica de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Luiz, OC (corresponding author), Univ Sao Paulo, Fac Med, Lab Epidemiol & Imunobiol LIM38, Dept Prevent Med, Sao Paulo, Brazil.	olinda@usp.br	Eluf-Neto, Jose/B-2522-2009; Gattas, Gilka JF/H-4846-2013; SANCHES, JOSE ANTONIO/B-3250-2011; Gianini, Reinaldo/G-2475-2012; Chammas, Roger/A-8004-2011; Luiz, Olinda do Carmo/C-6075-2012	Eluf-Neto, Jose/0000-0001-7504-2115; SANCHES, JOSE ANTONIO/0000-0002-5709-092X; Chammas, Roger/0000-0003-0342-8726; Luiz, Olinda do Carmo/0000-0002-2596-3626	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [06-52041-9, 5-56069-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (National Counsel of Technological and Scientific Development - Brazil) - CNPq [478239/03-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (National Counsel of Technological and Scientific Development - Brazil) - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (process 06-52041-9, 5-56069-2) www.fapesp.br. 2. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (National Counsel of Technological and Scientific Development - Brazil) - CNPq (process no478239/03-3)- www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acton RT, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-47; Bakos L, 2009, J EUR ACAD DERMATOL, V23, P304, DOI 10.1111/j.1468-3083.2008.03027.x; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Breslow NE, 1980, IARC SCI PUBL, V32; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; CLARK WH, 1969, CANCER RES, V29, P705; Correa MD, 2010, PHOTOCHEM PHOTOBIOL, V86, P438, DOI 10.1111/j.1751-1097.2009.00659.x; Cust AE, 2009, AM J EPIDEMIOL, V170, P1541, DOI 10.1093/aje/kwp307; de Vries E, 2005, EUR J CANCER, V41, P2150, DOI 10.1016/j.ejca.2005.04.042; Eide MJ, 2005, ARCH DERMATOL, V141, P477, DOI 10.1001/archderm.141.4.477; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Goncalves FT, 2011, J DERMATOL SCI, V64, P59, DOI 10.1016/j.jdermsci.2011.06.003; Gruber F, 2008, COLLEGIUM ANTROPOL, V32, P147; Hu S, 2004, ARCH DERMATOL, V140, P819, DOI 10.1001/archderm.140.7.819; IBGE, 2012, BRAS 500 AN POV; Khan SG, 2002, NUCLEIC ACIDS RES, V30, P3624, DOI 10.1093/nar/gkf469; Lascano AR, 2004, MEDICINA-BUENOS AIRE, V64, P504; Li CY, 2006, CANCER EPIDEM BIOMAR, V15, P2526, DOI 10.1158/1055-9965.EPI-06-0672; Loria D, 2001, INT J DERMATOL, V40, P108, DOI 10.1046/j.1365-4362.2001.01132.x; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Mendes GLQ, 2010, J TOXICOL ENV HEAL A, V73, P850, DOI 10.1080/15287391003744757; Millikan RC, 2006, CARCINOGENESIS, V27, P610, DOI 10.1093/carcin/bgi252; Nijsten T, 2005, J EUR ACAD DERMATOL, V19, P332, DOI 10.1111/j.1468-3083.2005.01196.x; Ou-Yang H, 2004, J INVEST DERMATOL, V122, P492, DOI 10.1046/j.0022-202X.2004.22247.x; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Swan MC, 2003, MELANOMA RES, V13, P415, DOI 10.1097/00008390-200308000-00012; Tomescu D, 2001, CARCINOGENESIS, V22, P403, DOI 10.1093/carcin/22.3.403; Trotti A., 2010, AJCC AM JOINT COMMIT	33	11	12	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36348	10.1371/journal.pone.0036348	http://dx.doi.org/10.1371/journal.pone.0036348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558444	Green Published, gold			2022-12-25	WOS:000305336000194
J	Shen, DW; Alain, C				Shen, Dawei; Alain, Claude			Implicit Temporal Expectation Attenuates Auditory Attentional Blink	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; SELECTIVE-ATTENTION; P300; TASK; PROBABILITY; SUPPRESSION; ALLOCATION; INTERVAL; SURPRISE; MASKING	Attentional blink (AB) describes a phenomenon whereby correct identification of a first target impairs the processing of a second target (i.e., probe) nearby in time. Evidence suggests that explicit attention orienting in the time domain can attenuate the AB. Here, we used scalp-recorded, event-related potentials to examine whether auditory AB is also sensitive to implicit temporal attention orienting. Expectations were set up implicitly by varying the probability (i.e., 80% or 20%) that the probe would occur at the +2 or +8 position following target presentation. Participants showed a significant AB, which was reduced with the increased probe probability at the +2 position. The probe probability effect was paralleled by an increase in P3b amplitude elicited by the probe. The results suggest that implicit temporal attention orienting can facilitate short-term consolidation of the probe and attenuate auditory AB.	[Shen, Dawei; Alain, Claude] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Alain, Claude] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto	Shen, DW (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	dshen@rotman-baycrest.on.ca			Canadian Institutes of Health Research [737103912]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research, 737103912 [http://www.cihr-irsc.gc.ca/e/193.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 1994, PERCEPT PSYCHOPHYS, V56, P501, DOI 10.3758/BF03206947; Alain C, 2000, FRONT BIOSCI-LANDMRK, V5, pD202, DOI 10.2741/Alain; ALHO K, 1986, PSYCHOPHYSIOLOGY, V23, P189, DOI 10.1111/j.1469-8986.1986.tb00617.x; Arnell KM, 2006, PERCEPT PSYCHOPHYS, V68, P447, DOI 10.3758/BF03193689; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Dell'Acqua R, 2003, PSYCHOPHYSIOLOGY, V40, P629, DOI 10.1111/1469-8986.00064; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Du F, 2010, EXP BRAIN RES, V205, P115, DOI 10.1007/s00221-010-2345-9; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Ecker UKH, 2010, J EXP PSYCHOL LEARN, V36, P170, DOI 10.1037/a0017891; Geng JJ, 2005, PERCEPT PSYCHOPHYS, V67, P1252, DOI 10.3758/BF03193557; Giesbrecht B, 1998, J EXP PSYCHOL HUMAN, V24, P1454, DOI 10.1037/0096-1523.24.5.1454; Gonsalvez CJ, 2002, PSYCHOPHYSIOLOGY, V39, P388, DOI 10.1017/S0048577201393137; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; JOHNSON R, 1980, PSYCHOPHYSIOLOGY, V17, P167, DOI 10.1111/j.1469-8986.1980.tb00131.x; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Kahneman D., 1973, ATTENTION EFFORT; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KRAMER A, 1986, PSYCHOPHYSIOLOGY, V23, P33, DOI 10.1111/j.1469-8986.1986.tb00590.x; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Los SA, 2005, J EXP PSYCHOL GEN, V134, P52, DOI 10.1037/0096-3445.134.1.52; Martens S, 2005, MEM COGNITION, V33, P234, DOI 10.3758/BF03195312; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; Muller-Gethmann H, 2003, PSYCHOPHYSIOLOGY, V40, P597, DOI 10.1111/1469-8986.00061; Nieuwenstein MR, 2005, J EXP PSYCHOL HUMAN, V31, P1463, DOI 10.1037/0096-1523.31.6.1463; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Picton TW, 2000, CLIN NEUROPHYSIOL, V111, P53, DOI 10.1016/S1388-2457(99)00227-8; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Ptito A, 2008, PSYCHOPHYSIOLOGY, V45, P794, DOI 10.1111/j.1469-8986.2008.00677.x; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rimmele J, 2011, J COGNITIVE NEUROSCI, V23, P1136, DOI 10.1162/jocn.2010.21437; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; RUCHKIN DS, 1987, PSYCHOPHYSIOLOGY, V24, P87, DOI 10.1111/j.1469-8986.1987.tb01867.x; Seiffert AE, 1997, J EXP PSYCHOL HUMAN, V23, P1061, DOI 10.1037/0096-1523.23.4.1061; SHAW ML, 1978, J EXP PSYCHOL HUMAN, V4, P586, DOI 10.1037/0096-1523.4.4.586; SHAW ML, 1977, J EXP PSYCHOL HUMAN, V3, P201, DOI 10.1037/0096-1523.3.2.201; Shen DW, 2006, PERCEPT PSYCHOPHYS, V68, P228, DOI 10.3758/BF03193672; Shen D, 2011, EXP BRAIN RES, V215, P285, DOI 10.1007/s00221-011-2897-3; Shen DW, 2010, PSYCHOPHYSIOLOGY, V47, P184, DOI 10.1111/j.1469-8986.2009.00924.x; Shen DW, 2008, PERCEPT PSYCHOPHYS, V70, P896, DOI 10.3758/PP.70.5.896; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vogel EK, 2002, PSYCHON B REV, V9, P739, DOI 10.3758/BF03196329; Zhang DX, 2008, EXP BRAIN RES, V185, P287, DOI 10.1007/s00221-007-1153-3	47	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36031	10.1371/journal.pone.0036031	http://dx.doi.org/10.1371/journal.pone.0036031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558312	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000103
J	Lopez-Castejon, G; Corbett, D; Goldrick, M; Roberts, IS; Brough, D				Lopez-Castejon, Gloria; Corbett, David; Goldrick, Marie; Roberts, Ian S.; Brough, David			Inhibition of Calpain Blocks the Phagosomal Escape of Listeria monocytogenes	PLOS ONE			English	Article							MACROPHAGES; ACTIN; GENE; CASPASE-1; INFECTION; VIRULENCE; CELLS; INFLAMMASOME; ACTIVATION; MATURATION	Listeria monocytogenes is a Gram-positive facultative intracellular bacterium responsible for the food borne infection listeriosis, affecting principally the immunocompromised, the old, neonates and pregnant women. Following invasion L. monocytogenes escapes the phagosome and replicates in the cytoplasm. Phagosome escape is central to L. monocytogenes virulence and is required for initiating innate host-defence responses such as the secretion of the cytokine interleukin-1. Phagosome escape of L. monocytogenes is reported to depend upon host proteins such as gamma-interferon-inducible lysosomal thiol reductase and the cystic fibrosis transmembrane conductance regulator. The host cytosolic cysteine protease calpain is required in the life cycle of numerous pathogens, and previous research reports an activation of calpain by L. monocytogenes infection. Thus we sought to determine whether host calpain was required for the virulence of L. monocytogenes. Treatment of macrophages with calpain inhibitors blocked escape of L. monocytogenes from the phagosome and consequently its proliferation within the cytosol. This was independent of any direct effect on the production of bacterial virulence factors or of a bactericidal effect. Furthermore, the secretion of interleukin-1 beta, a host cytokine whose secretion induced by L. monocytogenes depends upon phagosome escape, was also blocked by calpain inhibition. These data indicate that L. monocytogenes co-opts host calpain to facilitate its escape from the phagosome, and more generally, that calpain may represent a cellular Achilles heel exploited by pathogens.	[Lopez-Castejon, Gloria; Corbett, David; Goldrick, Marie; Roberts, Ian S.; Brough, David] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Lopez-Castejon, G (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	david.brough@manchester.ac.uk	Lopez-Castejon, Gloria/F-6985-2015	Lopez-Castejon, Gloria/0000-0002-8585-3381; Brough, David/0000-0002-2250-2381	Wellcome Trust; Medical Research Council; MRC [G0601205] Funding Source: UKRI; Medical Research Council [G0601205] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Lopez-Castejon and Brough are supported by the Wellcome Trust. Corbett was supported by a Medical Research Council grant to Roberts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPUCHEARANDA CM, 1995, INFECT IMMUN, V63, P4456, DOI 10.1128/IAI.63.11.4456-4462.1995; Andersen JB, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-86; Baron C, 2010, CURR OPIN MICROBIOL, V13, P100, DOI 10.1016/j.mib.2009.12.003; Bozym RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001135; Capani F, 2001, J HISTOCHEM CYTOCHEM, V49, P1351, DOI 10.1177/002215540104901103; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Dewamitta SR, 2010, INFECT IMMUN, V78, P1884, DOI 10.1128/IAI.01143-09; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goldfine H, 2002, MICROBES INFECT, V4, P1335, DOI 10.1016/S1286-4579(02)00011-4; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; HARTFORD T, 1993, INT J SYST BACTERIOL, V43, P26, DOI 10.1099/00207713-43-1-26; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Perez-Cordon G, 2011, MICROBES INFECT, V13, P103, DOI 10.1016/j.micinf.2010.10.007; Radtke AL, 2011, P NATL ACAD SCI USA, V108, P1633, DOI 10.1073/pnas.1013262108; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Sorimachi H, 2010, EXP ANIM TOKYO, V59, P549, DOI 10.1538/expanim.59.549; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Warren SE, 2008, J IMMUNOL, V180, P7558, DOI 10.4049/jimmunol.180.11.7558; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; WUENSCHER MD, 1991, MOL GEN GENET, V228, P177, DOI 10.1007/BF00282463	40	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35936	10.1371/journal.pone.0035936	http://dx.doi.org/10.1371/journal.pone.0035936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563421	Green Submitted, gold, Green Published			2022-12-25	WOS:000305349100047
J	Pang, Y; Xiao, R; Liu, X; Li, QW				Pang, Yue; Xiao, Rong; Liu, Xin; Li, Qingwei			Identification and Characterization of the Lamprey High-Mobility Group Box 1 Gene	PLOS ONE			English	Article							BUCCAL GLAND SECRETION; VARIABLE LYMPHOCYTE RECEPTORS; LAMPETRA-JAPONICA; CYTOKINE ACTIVITY; DENDRITIC CELLS; CONCANAVALIN-A; HMGB PROTEINS; DNA; ACTIVATION; STIMULATION	High-mobility group box 1 (HMGB1), a highly conserved DNA-binding protein, plays an important role in maintaining nucleosome structures, transcription, and inflammation. We identified a homolog of HMGB1 in the Japanese lamprey (Lampetra japonica). The Lampetra japonica HMGB1 gene (Lj-HMGB1) has over 70% sequence identity with its homologs in jawed vertebrates. Despite the reasonably high sequence identity with other HMGB1 proteins, Lj-HMGB1 did not group together with these proteins in a phylogenetic analysis. We examined Lj-HMGB1 expression in lymphocyte-like cells, and the kidneys, heart, gills, and intestines of lampreys before and after the animals were challenged with lipopolysaccharide (LPS) and concanavalin A (ConA). Lj-HMGB1 was initially expressed at a higher level in the heart, but after treatment with LPS and ConA only the gills demonstrated a significant up-regulation of expression. The recombinant Lj-HMGB1 (rLj-HMGB1) protein bound double-stranded DNA and induced the proliferation of human adenocarcinoma cells to a similar extent as human HMGB1. We further revealed that Lj-HMGB1 was able to induce the production of tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory mediator, in activated human acute monocytic leukemia cells. These results suggest that lampreys use HMGB1 to activate their innate immunity for the purpose of pathogen defense.	[Pang, Yue; Xiao, Rong; Liu, Xin; Li, Qingwei] Liaoning Normal Univ, Inst Marine Genom & Prote, Dalian, Peoples R China; [Pang, Yue] Dalian Univ, Coll Life Sci & Technol, Dalian, Peoples R China	Liaoning Normal University; Dalian University	Pang, Y (corresponding author), Liaoning Normal Univ, Inst Marine Genom & Prote, Dalian, Peoples R China.	liqw@263.net			National Natural Science Foundation of China [31071991]; Science and Technology Project of Dalian [2011J21DW016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Dalian	This work was jointly supported by the National Natural Science Foundation of China (No. 31071991, http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html) and the Science and Technology Project of Dalian (No. 2011J21DW016, http://kjjh.dlinfo.gov.cn/login.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Amemiya CT, 2007, CURR OPIN IMMUNOL, V19, P535, DOI 10.1016/j.coi.2007.08.003; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bajoghli B, 2011, NATURE, V470, P90, DOI 10.1038/nature09655; Bassi R, 2008, J NEURO-ONCOL, V87, P23, DOI 10.1007/s11060-007-9488-y; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Campana L, 2008, CURR OPIN IMMUNOL, V20, P518, DOI 10.1016/j.coi.2008.04.012; Chi SP, 2009, PFLUG ARCH EUR J PHY, V458, P537, DOI 10.1007/s00424-008-0631-1; Chung HW, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-38; Craig DGN, 2011, LIVER INT, V31, P1127, DOI 10.1111/j.1478-3231.2011.02528.x; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; DWYER JM, 1981, CLIN EXP IMMUNOL, V46, P237; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Huang HQ, 2011, J BIOL CHEM, V286, P36739, DOI 10.1074/jbc.M111.245944; Ishii A, 2007, J IMMUNOL, V178, P397, DOI 10.4049/jimmunol.178.1.397; Ito N, 2007, BIOCHEM BIOPH RES CO, V358, P35, DOI 10.1016/j.bbrc.2007.04.065; Kadowaki T, 2009, FISH SHELLFISH IMMUN, V27, P585, DOI 10.1016/j.fsi.2008.12.006; Krauss S, 1999, BBA-BIOENERGETICS, V1412, P129, DOI 10.1016/S0005-2728(99)00058-4; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Liu XJ, 2009, DEV COMP IMMUNOL, V33, P257, DOI 10.1016/j.dci.2008.09.008; Mahoney JA, 2005, CURR OPIN IMMUNOL, V17, P583, DOI 10.1016/j.coi.2005.09.018; Maroso M, 2011, J INTERN MED, V270, P319, DOI 10.1111/j.1365-2796.2011.02431.x; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ronchetti A, 1999, J IMMUNOL, V163, P130; Sharman AC, 1997, GENE, V184, P99, DOI 10.1016/S0378-1119(96)00580-X; Shen XK, 2009, ONCOL REP, V22, P535, DOI 10.3892/or_00000468; Sower SA, 2006, GEN COMP ENDOCR, V148, P22, DOI 10.1016/j.ygcen.2005.11.009; Sparatore B, 2002, BIOCHEM J, V363, P529, DOI 10.1042/0264-6021:3630529; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Sun J, 2008, BIOCHIMIE, V90, P1760, DOI 10.1016/j.biochi.2008.08.002; Sun Nian-Kang, 2005, Chang Gung Med J, V28, P673; Sundberg E, 2009, IMMUNOBIOLOGY, V214, P303, DOI 10.1016/j.imbio.2008.09.006; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Topalova D, 2008, INT J BIOCHEM CELL B, V40, P1536, DOI 10.1016/j.biocel.2007.11.014; Tsutsui S, 2007, IMMUNOGENETICS, V59, P873, DOI 10.1007/s00251-007-0254-2; Vande Walle L, 2011, VIRULENCE, V2, P162, DOI 10.4161/viru.2.2.15480; Xiao R, 2007, BIOCHIMIE, V89, P383, DOI 10.1016/j.biochi.2006.09.002; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Zhao X, 2011, J BIOL CHEM, V286, P23200, DOI 10.1074/jbc.M111.223834	50	22	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35755	10.1371/journal.pone.0035755	http://dx.doi.org/10.1371/journal.pone.0035755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563397	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100025
J	Rouzeau, S; Cordelieres, FP; Buhagiar-Labarchede, G; Hurbain, I; Onclercq-Delic, R; Gemble, S; Magnaghi-Jaulin, L; Jaulin, C; Amor-Gueret, M				Rouzeau, Sebastien; Cordelieres, Fabrice P.; Buhagiar-Labarchede, Geraldine; Hurbain, Ilse; Onclercq-Delic, Rosine; Gemble, Simon; Magnaghi-Jaulin, Laura; Jaulin, Christian; Amor-Gueret, Mounira			Bloom's Syndrome and PICH Helicases Cooperate with Topoisomerase II alpha in Centromere Disjunction before Anaphase	PLOS ONE			English	Article							BLM HELICASE; DNA THREADS; DECATENATION; EPIGENETICS; INSTABILITY; CHECKPOINT; CANCER; CELLS	Centromeres are specialized chromosome domains that control chromosome segregation during mitosis, but little is known about the mechanisms underlying the maintenance of their integrity. Centromeric ultrafine anaphase bridges are physiological DNA structures thought to contain unresolved DNA catenations between the centromeres separating during anaphase. BLM and PICH helicases colocalize at these ultrafine anaphase bridges and promote their resolution. As PICH is detectable at centromeres from prometaphase onwards, we hypothesized that BLM might also be located at centromeres and that the two proteins might cooperate to resolve DNA catenations before the onset of anaphase. Using immunofluorescence analyses, we demonstrated the recruitment of BLM to centromeres from G2 phase to mitosis. With a combination of fluorescence in situ hybridization, electron microscopy, RNA interference, chromosome spreads and chromatin immunoprecipitation, we showed that both BLM-deficient and PICH-deficient prometaphase cells displayed changes in centromere structure. These cells also had a higher frequency of centromeric non disjunction in the absence of cohesin, suggesting the persistence of catenations. Both proteins were required for the correct recruitment to the centromere of active topoisomerase II alpha, an enzyme specialized in the catenation/decatenation process. These observations reveal the existence of a functional relationship between BLM, PICH and topoisomerase II alpha in the centromere decatenation process. They indicate that the higher frequency of centromeric ultrafine anaphase bridges in BLM-deficient cells and in cells treated with topoisomerase IIa inhibitors is probably due not only to unresolved physiological ultrafine anaphase bridges, but also to newly formed ultrafine anaphase bridges. We suggest that BLM and PICH cooperate in rendering centromeric catenates accessible to topoisomerase IIa, thereby facilitating correct centromere disjunction and preventing the formation of supernumerary centromeric ultrafine anaphase bridges.	[Rouzeau, Sebastien; Cordelieres, Fabrice P.; Buhagiar-Labarchede, Geraldine; Onclercq-Delic, Rosine; Gemble, Simon; Amor-Gueret, Mounira] Ctr Univ, Ctr Rech, Inst Curie, Bat Orsay, France; [Rouzeau, Sebastien; Cordelieres, Fabrice P.; Buhagiar-Labarchede, Geraldine; Onclercq-Delic, Rosine; Gemble, Simon; Amor-Gueret, Mounira] CNRS, UMR3348, F-91405 Orsay, France; [Cordelieres, Fabrice P.] Ctr Univ, Ctr Rech Plateforme Imagerie Cellulaire & Tissula, Inst Curie, Bat Orsay, France; [Hurbain, Ilse] Ctr Rech, Inst Curie, Paris, France; [Hurbain, Ilse] CNRS, UMR144, Plateforme Imagerie Cellulaire & Tissulaire IBiSA, Paris, France; [Magnaghi-Jaulin, Laura; Jaulin, Christian] Univ Rennes 1, CNRS, UMR 6290, Inst Genet & Dev, Rennes, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Rouzeau, S (corresponding author), Ctr Univ, Ctr Rech, Inst Curie, Bat Orsay, France.	mounira.amor@curie.fr	Jaulin, Christian/L-9126-2018; Cordelières, Fabrice P/G-3574-2017	Cordelières, Fabrice P/0000-0002-5383-5816	Institut Curie (PIC); Centre National de la Recherche Scientifique (CNRS); Canceropole/Region Ilede-France; Ligue contre le Cancer Grand-Ouest; Association pour la Recherche sur le Cancer [1071]; Agence Nationale de la Recherche (EpiCentr); Ministere delegue de l'Enseignement Superieur et de la Recherche; Ligue Nationale contre le Cancer	Institut Curie (PIC); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Canceropole/Region Ilede-France(Region Ile-de-France); Ligue contre le Cancer Grand-Ouest; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche (EpiCentr)(French National Research Agency (ANR)); Ministere delegue de l'Enseignement Superieur et de la Recherche; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the Institut Curie (PIC), the Centre National de la Recherche Scientifique (CNRS), the Canceropole/Region Ilede-France, the Ligue contre le Cancer Grand-Ouest, the Association pour la Recherche sur le Cancer (1071), the Agence Nationale de la Recherche (EpiCentr) and by fellowships from the Ministere delegue de l'Enseignement Superieur et de la Recherche and from the Ligue Nationale contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababou M, 2002, CELL CYCLE, V1, P262, DOI 10.4161/cc.1.4.136; Agostinho M, 2004, MOL BIOL CELL, V15, P2388, DOI 10.1091/mbc.E03-08-0558; Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Batram C, 2008, J STRUCT BIOL, V164, P293, DOI 10.1016/j.jsb.2008.09.002; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Baxter J, 2011, SCIENCE, V331, P1328, DOI 10.1126/science.1201538; Bennani-Belhaj KL, 2010, MOL CANCER RES, V8, P385, DOI 10.1158/1541-7786.MCR-09-0534; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Chabosseau P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1363; Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Diaz-Martinez LA, 2008, J CELL SCI, V121, P2107, DOI 10.1242/jcs.029132; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Eot-Houllier G, 2008, GENE DEV, V22, P2639, DOI 10.1101/gad.484108; Guo RB, 2007, NUCLEIC ACIDS RES, V35, P6297, DOI 10.1093/nar/gkm536; Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103; Savino TM, 2001, J CELL BIOL, V153, P1097, DOI 10.1083/jcb.153.5.1097; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Wang LHC, 2010, J CELL SCI, V123, P806, DOI 10.1242/jcs.058255; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	31	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e33905	10.1371/journal.pone.0033905	http://dx.doi.org/10.1371/journal.pone.0033905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563370	Green Published, gold			2022-12-25	WOS:000305349100001
J	Donners, MMPC; Wolfs, IMJ; Stoger, LJ; van der Vorst, EPC; Pottgens, CCH; Heymans, S; Schroen, B; Gijbels, MJJ; de Winther, MPJ				Donners, Marjo M. P. C.; Wolfs, Ine M. J.; Stoger, Lauran J.; van der Vorst, Emiel P. C.; Pottgens, Chantal C. H.; Heymans, Stephane; Schroen, Blanche; Gijbels, Marion J. J.; de Winther, Menno P. J.			Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; INFLAMMATORY RESPONSE; LIPID UPTAKE; MICRORNA-155; MACROPHAGES; INHIBITION; ACTIVATION; CYTOKINES; MIR-155	microRNA-155 (miR155) is a central regulator of immune responses that is induced by inflammatory mediators. Although miR155 is considered to be a pro-inflammatory microRNA, in vitro reports show anti-inflammatory effects in lipid-loaded cells. In this study we examined the role of miR155 in atherosclerosis in vivo using bone marrow transplantation from miR155 deficient or wildtype mice to hyperlipidemic mice. Hematopoietic deficiency of miR155 enhanced atherosclerotic plaque development and decreased plaque stability, as evidenced by increased myeloid inflammatory cell recruitment to the plaque. The increased inflammatory state was mirrored by a decrease in circulating CD4(+)CD25(+)FoxP3(+) regulatory T cells, and an increase in granulocytes (CD11b(+)Ly6G(+)) in blood of miR155(-/-) transplanted mice. Moreover, we show for the first time a crucial role of miR155 in monocyte subset differentiation, since hematopoietic deficiency of miR155 increases the 'inflammatory' monocyte subset (CD11b(+)Ly6G(-)Ly6C(hi)) and reduces 'resident' monocytes (CD11b(+)Ly6G(-)Ly6C(low)) in the circulation. Furthermore, cytokine production by resident peritoneal macrophages of miR155(-/-) transplanted hyperlipidemic mice was skewed towards a more pro-inflammatory state since anti-inflammatory IL-10 production was reduced. In conclusion, in this hyperlipidemic mouse model miR155 acts as an anti-inflammatory, atheroprotective microRNA. Additionally, besides a known role in lymphoid cell development, we show a crucial role of miR155 in myeloid lineage differentiation.	[Donners, Marjo M. P. C.; Wolfs, Ine M. J.; Stoger, Lauran J.; van der Vorst, Emiel P. C.; Pottgens, Chantal C. H.; Gijbels, Marion J. J.; de Winther, Menno P. J.] Maastricht Univ, Dept Mol Genet, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Gijbels, Marion J. J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [Heymans, Stephane; Schroen, Blanche] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands; [de Winther, Menno P. J.] Acad Med Ctr Amsterdam, Dept Med Biochem, Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	Donners, MMPC (corresponding author), Maastricht Univ, Dept Mol Genet, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.	Marjo.donners@maastrichtuniversity.nl	Stöger, Lauran/AAE-9667-2021; Stoger, Lauran/AAX-5117-2021; de Winther, Menno/E-8721-2012	Stöger, Lauran/0000-0002-4705-4837; de Winther, Menno/0000-0002-4038-6636; Heymans, Stephane/0000-0001-9477-7803	Netherlands Heart Foundation (Dr. E. Dekker post-doctoral fellow grant) [2007T034]; Dr. E. Dekker Established Investigator grant [2007T067]; NWO-VIDI [917.066.329]; National Health Service (NHS) [2009B025]	Netherlands Heart Foundation (Dr. E. Dekker post-doctoral fellow grant); Dr. E. Dekker Established Investigator grant; NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); National Health Service (NHS)	Dr. Donners and Dr. de Winther and Dr. Schroen are supported by the Netherlands Heart Foundation (Dr. E. Dekker post-doctoral fellow grant 2007T034 to Dr. Donners; Dr. E. Dekker Established Investigator grant 2007T067 and NWO-VIDI grant 917.066.329 to Dr. de Winther; and National Health Service (NHS) 2009B025 research grant to Dr. Schroen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Chen T, 2011, INT J CARDIOL, V147, P446, DOI 10.1016/j.ijcard.2010.10.133; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Goossens P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022327; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schroen B, 2011, CARDIOVASC RES; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228	22	124	129	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35877	10.1371/journal.pone.0035877	http://dx.doi.org/10.1371/journal.pone.0035877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558252	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200090
J	Lee, BH; Hwang, DM; Palaniyar, N; Grinstein, S; Philpott, DJ; Hu, J				Lee, Benjamin H.; Hwang, David M.; Palaniyar, Nades; Grinstein, Sergio; Philpott, Dana J.; Hu, Jim			Activation of P2X(7) Receptor by ATP Plays an Important Role in Regulating Inflammatory Responses during Acute Viral Infection	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; INFLUENZA-VIRUS INFECTION; EXTRACELLULAR ATP; AIRWAY INFLAMMATION; ADENOVIRAL VECTORS; EPITHELIAL-CELLS; GENE-TRANSFER; OXIDIZED ATP; LUNG INJURY; MACROPHAGE	Acute viral infection causes damages to the host due to uncontrolled viral replication but even replication deficient viral vectors can induce systemic inflammatory responses. Indeed, overactive host innate immune responses to viral vectors have led to devastating consequences. Macrophages are important innate immune cells that recognize viruses and induce inflammatory responses at the early stage of infection. However, tissue resident macrophages are not easily activated by the mere presence of virus suggesting that their activation requires additional signals from other cells in the tissue in order to trigger inflammatory responses. Previously, we have shown that the cross-talk between epithelial cells and macrophages generates synergistic inflammatory responses during adenoviral vector infection. Here, we investigated whether ATP is involved in the activation of macrophages to induce inflammatory responses during an acute adenoviral infection. Using a macrophage-epithelial cell co-culture system we demonstrated that ATP signaling through P2X(7) receptor (P2X(7)R) is required for induction of inflammatory mediators. We also showed that ATP-P2X(7)R signaling regulates inflammasome activation as inhibition or deficiency of P2X(7)R as well as caspase-1 significantly reduced IL-1 beta secretion. Furthermore, we found that intranasal administration of replication deficient adenoviral vectors in mice caused a high mortality in wild-type mice with symptoms of acute respiratory distress syndrome but the mice deficient in P2X(7)R or caspase-1 showed increased survival. In addition, wild-type mice treated with apyrase or inhibitors of P2X(7)R or caspase-1 showed higher rates of survival. The improved survival in the P2X(7)R deficient mice correlated with diminished levels of IL-1 beta and IL-6 and reduced neutrophil infiltration in the early phase of infection. These results indicate that ATP, released during viral infection, is an important inflammatory regulator that activates the inflammasome pathway and regulates inflammatory responses.	[Lee, Benjamin H.; Palaniyar, Nades; Grinstein, Sergio; Hu, Jim] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Hwang, David M.] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada; [Lee, Benjamin H.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Hwang, David M.; Palaniyar, Nades; Hu, Jim] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Grinstein, Sergio] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Lee, BH (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jim.hu@utoronto.ca		Hu, Jim/0000-0001-9134-7103; Palaniyar, Nades/0000-0002-2170-8548	Canadian Institute of Health Research; Cystic Fibrosis Canada; National Science and Engineering Research Council	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was partially funded by grants to JH from the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and from Cystic Fibrosis Canada (http://www.cysticfibrosis.ca/en/index.php). BHL received studentships from both the Cystic Fibrosis Canada and the National Science and Engineering Research Council (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Beigi RD, 2003, BRIT J PHARMACOL, V140, P507, DOI 10.1038/sj.bjp.0705470; BEYER EC, 1991, J BIOL CHEM, V266, P7971; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Bours Martijn Jan Leo, 2011, Front Biosci (Schol Ed), V3, P1443; Cao HB, 2004, VIRAL IMMUNOL, V17, P327, DOI 10.1089/0882824041857111; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kuzmin AI, 1997, GENE THER, V4, P309, DOI 10.1038/sj.gt.3300377; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lee BH, 2010, IMMUNOL LETT, V134, P93, DOI 10.1016/j.imlet.2010.09.003; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Pang IK, 2011, TRENDS IMMUNOL, V32, P34, DOI 10.1016/j.it.2010.11.004; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pfeiffer ZA, 2007, FREE RADICAL BIO MED, V42, P1506, DOI 10.1016/j.freeradbiomed.2007.02.010; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Shayakhmetov DM, 2000, J VIROL, V74, P10274, DOI 10.1128/JVI.74.22.10274-10286.2000; Taylor SRJ, 2009, J AM SOC NEPHROL, V20, P1275, DOI 10.1681/ASN.2008060559; TERAMOTO S, 1995, HUM GENE THER, V6, P1045, DOI 10.1089/hum.1995.6.8-1045; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284; Zsengeller Z, 2000, J VIROL, V74, P9655, DOI 10.1128/JVI.74.20.9655-9667.2000	48	74	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35812	10.1371/journal.pone.0035812	http://dx.doi.org/10.1371/journal.pone.0035812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558229	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345200082
J	Pecci, A; Biino, G; Fierro, T; Bozzi, V; Mezzasoma, A; Noris, P; Ramenghi, U; Loffredo, G; Fabris, F; Momi, S; Magrini, U; Pirastu, M; Savoia, A; Balduini, C; Gresele, P				Pecci, Alessandro; Biino, Ginevra; Fierro, Tiziana; Bozzi, Valeria; Mezzasoma, Annamaria; Noris, Patrizia; Ramenghi, Ugo; Loffredo, Giuseppe; Fabris, Fabrizio; Momi, Stefania; Magrini, Umberto; Pirastu, Mario; Savoia, Anna; Balduini, Carlo; Gresele, Paolo		Italian Registry MYH9-Releated Dis	Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; MAY-HEGGLIN; FECHTNER-SYNDROME; INHERITED THROMBOCYTOPENIAS; DIAGNOSTIC ALGORITHM; EPSTEIN-SYNDROME; MYH9 MUTATIONS; CELL MOTILITY; IIA; MACROTHROMBOCYTOPENIA	Background: MYH9-related disease (MYH9-RD) is a rare autosomal dominant genetic syndrome characterized by congenital thrombocytopenia associated with the risk of developing progressive nephropathy, sensorineural deafness, and presenile cataract. During the collection of a large case-series of patients with MYH9-RD we noticed several cases with unexplained elevation of liver enzymes. Our aim was to evaluate if the alteration of liver tests is a feature of the MYH9-RD and to define its clinical significance. Methods and Findings: Data concerning liver tests, prospectively recorded in the Italian Registry for MYH9-RD, were collected and compared with those of three control populations: patients with autoimmune thrombocytopenia, patients with inherited thrombocytopenias other than MYH9-RD, and the participants to a large epidemiologic survey in an Italian geographic isolate. Thirty-eight of 75 evaluable MYH9-RD patients (50.7%) showed an elevation of ALT and/or AST, and 17 of 63 (27.0%) an increase of GGT. The increases ranged from 1.9 +/- 0.7 to 2.7 +/- 1.6 fold the upper normal limit. The prevalence of liver test alterations was significantly higher in MYH9-RD patients than in each of the control populations, with odds ratios ranging from 8.2 (95% CIs 2.2-44.8) to 24.7 (14.8-40.8). Clinical follow-up and more detailed liver studies of a subset of patients, including ultrasound liver scan, liver elastography and liver biopsy in one case, did not show any significant structural damage or evolution towards liver insufficiency. Conclusions: Elevation of liver enzymes is a frequent and previously unrecognized feature of the MYH9-RD syndrome; however, this defect does not appear to have poor prognostic value.	[Pecci, Alessandro; Bozzi, Valeria; Noris, Patrizia; Balduini, Carlo] IRCCS Policlin San Matteo Fdn, Dept Internal Med, Pavia, Italy; [Pecci, Alessandro; Bozzi, Valeria; Noris, Patrizia; Balduini, Carlo] Univ Pavia, I-27100 Pavia, Italy; [Biino, Ginevra] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Fierro, Tiziana; Mezzasoma, Annamaria; Momi, Stefania; Gresele, Paolo] Univ Perugia, Dept Internal Med, Div Internal & Cardiovasc Med, I-06100 Perugia, Italy; [Ramenghi, Ugo] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Loffredo, Giuseppe] Pausilipon Hosp, Dept Oncol, Naples, Italy; [Fabris, Fabrizio] Univ Padua, Dept Med Sci, Padua, Italy; [Magrini, Umberto] Univ Pavia, Dept Pathol, I-27100 Pavia, Italy; [Pirastu, Mario] CNR, Inst Populat Genet, Sassari, Italy; [Savoia, Anna] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Genet Lab, Trieste, Italy	IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Perugia; University of Turin; University of Padua; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); IRCCS Burlo Garofolo	Pecci, A (corresponding author), IRCCS Policlin San Matteo Fdn, Dept Internal Med, Pavia, Italy.	grespa@unipg.it	Savoia, Anna/B-6463-2014; Pecci, Alessandro/E-9288-2012; Savoia, Anna/AIC-4560-2022; Gresele, Paolo/F-6775-2013; Biino, Ginevra/B-5334-2013; gresele, paolo/AAG-8019-2019; Bozzi, Valeria/K-7569-2016	Savoia, Anna/0000-0002-2407-2696; Pecci, Alessandro/0000-0001-9202-7013; Savoia, Anna/0000-0002-2407-2696; Gresele, Paolo/0000-0001-5365-8445; Biino, Ginevra/0000-0002-9936-946X; Bozzi, Valeria/0000-0002-1054-6491; Noris, Patrizia/0000-0002-5035-3707	Fondazione Cassa di Risparmio di Perugia [2010.020.161, 2009.010.0478, 2011.0137.021]	Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This study was supported, in part, by grants from Fondazione Cassa di Risparmio di Perugia (Protocol nr. 2010.020.161, nr. 2009.010.0478 and nr. 2011.0137.021) to PG. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; Balduini CL, 2011, BRIT J HAEMATOL, V154, P161, DOI 10.1111/j.1365-2141.2011.08716.x; Balduini CL, 2003, HAEMATOLOGICA, V88, P582; Bhadriraju K, 2004, EXP CELL RES, V300, P259, DOI 10.1016/j.yexcr.2004.06.033; Biino G, 2011, HAEMATOL-HEMATOL J, V96, P96, DOI 10.3324/haematol.2010.029934; Burt RA, 2008, THROMB RES, V122, P861, DOI 10.1016/j.thromres.2008.06.011; Chan W, 2005, J BIOL CHEM, V280, P23741, DOI 10.1074/jbc.M502767200; D'Apolito M, 2002, GENE, V286, P215, DOI 10.1016/S0378-1119(02)00455-9; GERSHONIBARUCH R, 1988, AM J MED GENET, V31, P357, DOI 10.1002/ajmg.1320310213; Gresele P, 2009, HAEMATOL-HEMATOL J, V94, P663, DOI 10.3324/haematol.2008.002246; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Herrema H, 2006, MOL BIOL CELL, V17, P3291, DOI 10.1091/mbc.E06-01-0067; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Kunishima S, 2003, LAB INVEST, V83, P115, DOI 10.1097/01.LAB.0000050960.48774.17; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Noris P, 2004, HAEMATOLOGICA, V89, P1219; Noris P, 2011, BLOOD, V117, P6673, DOI 10.1182/blood-2011-02-336537; Pecci A, 2002, BRIT J HAEMATOL, V117, P164, DOI 10.1046/j.1365-2141.2002.03385.x; Pecci A, 2008, NEPHROL DIAL TRANSPL, V23, P2690, DOI 10.1093/ndt/gfn277; Pecci A, 2008, HUM MUTAT, V29, P409, DOI 10.1002/humu.20661; ROCCA B, 1993, BRIT J HAEMATOL, V85, P423, DOI 10.1111/j.1365-2141.1993.tb03193.x; Savoia A, 2001, BLOOD, V97, P1330, DOI 10.1182/blood.V97.5.1330; Savoia A, 2010, THROMB HAEMOSTASIS, V103, P826, DOI 10.1160/TH09-08-0593; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Seri M, 2000, NAT GENET, V26, P103; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Subramanian VS, 2010, AM J PHYSIOL-GASTR L, V298, pG267, DOI 10.1152/ajpgi.00435.2009; Toren A, 1999, AM J HUM GENET, V65, P1711, DOI 10.1086/302654; Torok N, 1996, J CELL PHYSIOL, V167, P422; TSUKADA N, 1995, HEPATOLOGY, V21, P1106, DOI 10.1002/hep.1840210433; TSUKADA N, 1994, P NATL ACAD SCI USA, V91, P6919, DOI 10.1073/pnas.91.15.6919; WATANABE S, 1991, LIVER, V11, P185	33	34	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35986	10.1371/journal.pone.0035986	http://dx.doi.org/10.1371/journal.pone.0035986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558294	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200103
J	Kim, DY; Hao, JW; Liu, RL; Turner, G; Shi, FD; Rho, JM				Kim, Do Young; Hao, Junwei; Liu, Ruolan; Turner, Gregory; Shi, Fu-Dong; Rho, Jong M.			Inflammation-Mediated Memory Dysfunction and Effects of a Ketogenic Diet in a Murine Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COGNITIVE DYSFUNCTION; CEREBROSPINAL-FLUID; T-CELLS; EXPRESSION; ATROPHY; RATS; INTERLEUKIN-6; ACCUMULATION; PATHOGENESIS	A prominent clinical symptom in multiple sclerosis (MS), a progressive disorder of the central nervous system (CNS) due to heightened neuro-inflammation, is learning and memory dysfunction. Here, we investigated the effects of a ketogenic diet (KD) on memory impairment and CNS-inflammation in a murine model of experimental autoimmune encephalomyelitis (EAE), using electrophysiological, behavioral, biochemical and in vivo imaging approaches. Behavioral spatial learning deficits were associated with motor disability in EAE mice, and were observed concurrently with brain inflammation. The KD improved motor disability in the EAE model, as well as CA1 hippocampal synaptic plasticity (long-term potentiation) and spatial learning and memory (assessed with the Morris Water Maze). Moreover, hippocampal atrophy and periventricular lesions in EAE mice were reversed in KD-treated EAE mice. Finally, we found that the increased expression of inflammatory cytokines and chemokines, as well as the production of reactive oxygen species (ROS), in our EAE model were both suppressed by the KD. Collectively, our findings indicate that brain inflammation in EAE mice is associated with impaired spatial learning and memory function, and that KD treatment can exert protective effects, likely via attenuation of the robust immune response and increased oxidative stress seen in these animals.	[Kim, Do Young; Hao, Junwei; Liu, Ruolan; Shi, Fu-Dong; Rho, Jong M.] St Josephs Hosp, Barrow Neurol Inst, Med Ctr, Phoenix, AZ 85013 USA; [Hao, Junwei; Shi, Fu-Dong] Tianjin Med Univ Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Turner, Gregory] Barrow Neurol Inst, Keller Ctr Imaging Innovat, Phoenix, AZ 85013 USA; [Rho, Jong M.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Calgary, AB T2N 1N4, Canada; [Rho, Jong M.] Univ Calgary, Dept Clin Neurosci, Alberta Childrens Hosp, Calgary, AB, Canada	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Tianjin Medical University; Barrow Neurological Institute; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary	Kim, DY (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Med Ctr, Phoenix, AZ 85013 USA.	fshi@chw.edu; jong.rho@albertahealthservices.ca		Hao, Junwei/0000-0002-3075-5434	Barrow Neurological Foundation; Arizona Biomedical Research Commission; National Institutes of Health [R01AI083294]; National Natural Science Foundation of China [31170864, 81100887]; Program for New Century Excellent Talents in University of China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083294] Funding Source: NIH RePORTER	Barrow Neurological Foundation; Arizona Biomedical Research Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the Barrow Neurological Foundation (Dr. Rho), the Arizona Biomedical Research Commission (Dr. Kim), the National Institutes of Health (R01AI083294 to Dr. Shi), National Natural Science Foundation of China (31170864 to Dr. Shi and 81100887 to Dr. Hao), and Program for New Century Excellent Talents in University of China (Dr. Hao). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to submit for publication, or preparation of the manuscript.	Amato MP, 2008, NEUROLOGY, V71, P632, DOI 10.1212/01.wnl.0000324621.58447.00; Amato MP, 2006, J NEUROL, V253, P1054, DOI 10.1007/s00415-006-0161-8; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Dastur OK, 1963, NUTR METAB, P59; Fang F, 2010, FASEB J, V24, P1043, DOI 10.1096/fj.09-139634; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farinotti M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004192.pub2; Giuliani F, 2009, BRAIN RES BULL, V80, P302, DOI 10.1016/j.brainresbull.2009.07.009; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Honors MA, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-46; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Kamsler A, 2003, J NEUROSCI, V23, P269; Kang Jing X., 2008, V49, P133, DOI 10.1007/978-1-4020-8831-5_5; Kim DY, 2008, CURR OPIN CLIN NUTR, V11, P113, DOI 10.1097/MCO.0b013e3282f44c06; Kim DY, 2010, J NEUROCHEM, V114, P130, DOI 10.1111/j.1471-4159.2010.06728.x; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kocer B, 2008, NEUROL SCI, V29, P435, DOI 10.1007/s10072-008-1020-4; LEVINE SM, 1992, MED HYPOTHESES, V39, P271, DOI 10.1016/0306-9877(92)90121-R; Liu RL, 2008, EXP NEUROL, V211, P14, DOI 10.1016/j.expneurol.2007.11.004; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Mattsson N, 2007, NEUROSCI LETT, V414, P233, DOI 10.1016/j.neulet.2006.12.044; Mehta LR, 2009, NAT CLIN PRACT NEURO, V5, P82, DOI 10.1038/ncpneuro1009; Miller D, 2005, LANCET NEUROL, V4, P341, DOI 10.1016/S1474-4422(05)70095-8; Mohamed HE, 2010, J CLIN NEUROSCI, V17, P899, DOI 10.1016/j.jocn.2009.11.005; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Papadopoulos D, 2009, BRAIN PATHOL, V19, P238, DOI 10.1111/j.1750-3639.2008.00177.x; Piccio L, 2008, J LEUKOCYTE BIOL, V84, P940, DOI 10.1189/jlb.0208133; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Ruskin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008349; RUULS SR, 1995, J NEUROIMMUNOL, V56, P207, DOI 10.1016/0165-5728(94)00154-G; Shinto L, 2009, PROSTAG LEUKOTR ESS, V80, P131, DOI 10.1016/j.plefa.2008.12.001; Sicotte NL, 2008, BRAIN, V131, P1134, DOI 10.1093/brain/awn030; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tiemann L, 2009, MULT SCLER J, V15, P1164, DOI 10.1177/1352458509106853; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Wada-Isoe K, 2004, ACTA NEUROL SCAND, V110, P124, DOI 10.1111/j.1600-0404.2004.00286.x; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Yadav V, 2010, EXPERT REV CLIN IMMU, V6, P381, DOI [10.1586/eci.10.12, 10.1586/ECI.10.12]; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29; Ziehn MO, 2010, LAB INVEST, V90, P774, DOI 10.1038/labinvest.2010.6; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	48	115	119	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35476	10.1371/journal.pone.0035476	http://dx.doi.org/10.1371/journal.pone.0035476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567104	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341500022
J	Winerdal, M; Winerdal, ME; Kinn, J; Urmaliya, V; Winqvist, O; Aden, U				Winerdal, Max; Winerdal, Malin Elisabeth; Kinn, Johan; Urmaliya, Vijay; Winqvist, Ola; Aden, Ulrika			Long Lasting Local and Systemic Inflammation after Cerebral Hypoxic ischemia in Newborn Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; T-CELLS; EXPERIMENTAL STROKE; BRAIN-DAMAGE; LYMPHOCYTES; EXPRESSION; MICROGLIA; ANTIBODY; INFANTS; INJURY	A Background: Hypoxic ischemia (HI) is an important cause of neonatal brain injury and subsequent inflammation affects neurological outcome. In this study we performed investigations of systemic and local activation states of inflammatory cells from innate and adaptive immunity at different time points after neonatal HI brain injury in mice. Methodology/Principal Findings: We developed a multiplex flow cytometry based method combined with immunohistochemistry to investigate cellular immune responses in the brain 24 h to 7 months after HI brain injury. In addition, functional studies of ex vivo splenocytes after cerebral hypoxic ischemia were performed. Both central and peripheral activation of CD11b(+) and CD11c(+) antigen presenting cells were seen with expression of the costimulatory molecule CD86 and MHC-II, indicating active antigen presentation in the damaged hemisphere and in the spleen. After one week, naive CD45rb(+) T-lymphocytes were demonstrated in the damaged brain hemisphere. In a second phase after three months, pronounced activation of CD45rb(-) T-lymphocytes expressing CD69 and CD25 was seen in the damaged hemisphere. Brain homogenate induced proliferation in splenocytes after HI but not in controls. Conclusions/Significance: Our findings demonstrate activation of both local and systemic immune responses months after hypoxic ischemic neonatal brain injury. The long term immune activation observed is of general importance for future studies of the inflammatory response after brain injury as most previous studies have focused on the first few weeks after damage, while the effects of the late inflammation phase may be missed. Furthermore, the self-reactive component raises the question if there is a correlation with development of autoimmune brain disease later in life.	[Winerdal, Max; Aden, Ulrika] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; [Winerdal, Malin Elisabeth; Kinn, Johan; Winqvist, Ola] Karolinska Inst, Dept Med, Unit Translat Immunol, Stockholm, Sweden; [Urmaliya, Vijay] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Winerdal, M (corresponding author), Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden.	max.winerdal@ki.se		winqvist, Ola/0000-0003-0842-4441	Stockholm County Council and Karolinska Institutet; Swedish Cancer Foundation; Soderberg's Foundation Stockholm, Sweden; John Hedin Cancer Research Foundation, Stockholm, Sweden; Japanese-Swedish Research Foundation, Stockholm, Sweden; Wallenberg Foundation, Stockholm, Sweden, VR [2006-6151]; Linnea and Josef Carlsson's foundation; Brain Foundation; Free Mason Foundation; Jerring Foundation	Stockholm County Council and Karolinska Institutet; Swedish Cancer Foundation; Soderberg's Foundation Stockholm, Sweden; John Hedin Cancer Research Foundation, Stockholm, Sweden; Japanese-Swedish Research Foundation, Stockholm, Sweden; Wallenberg Foundation, Stockholm, Sweden, VR; Linnea and Josef Carlsson's foundation; Brain Foundation; Free Mason Foundation; Jerring Foundation	This work was supported by the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, the Swedish Cancer Foundation, Soderberg's Foundation Stockholm, Sweden, the John Hedin Cancer Research Foundation, Stockholm, Sweden, the Japanese-Swedish Research Foundation, Stockholm, Sweden Wallenberg Foundation, Stockholm, Sweden, VR grant 2006-6151, Linnea and Josef Carlsson's foundation, the Brain Foundation, the Free Mason Foundation, and the Jerring Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aden U, 2002, STROKE, V33, P1405, DOI 10.1161/01.STR.0000014608.78503.DB; ASHMORE LM, 1989, J IMMUNOL METHODS, V118, P209, DOI 10.1016/0022-1759(89)90008-2; BARTEN DM, 1995, J IMMUNOL, V155, P5409; Becker K, 2001, STROKE, V32, P206, DOI 10.1161/01.STR.32.1.206; Bona E, 1999, PEDIATR RES, V45, P500, DOI 10.1203/00006450-199904010-00008; Bornstein NM, 2001, NEUROLOGY, V56, P529, DOI 10.1212/WNL.56.4.529; Brait VH, 2012, J CEREB BLOOD FLOW M; Careaga M, 2010, NEUROTHERAPEUTICS, V7, P283, DOI 10.1016/j.nurt.2010.05.003; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; CLARK WM, 1991, J NEUROSURG, V75, P623, DOI 10.3171/jns.1991.75.4.0623; COSTELLO AMD, 1994, ARCH DIS CHILD-FETAL, V71, pF1, DOI 10.1136/fn.71.1.F1; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Denker SP, 2007, J NEUROCHEM, V100, P893, DOI 10.1111/j.1471-4159.2006.04162.x; Felger JC, 2009, BRAIN BEHAV IMMUN; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Grange C, 2011, J IMMUNOL METHODS, V372, P119, DOI 10.1016/j.jim.2011.07.002; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Hug A, 2011, STROKE, V42, P3580, DOI 10.1161/STROKEAHA.111.620948; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; JENSEN MA, 1992, J NEUROIMMUNOL, V38, P255, DOI 10.1016/0165-5728(92)90018-G; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lin SJ, 2002, CLIN LAB HAEMATOL, V24, P353, DOI 10.1046/j.1365-2257.2002.00462.x; Miller AH, 2010, BRAIN BEHAV IMMUN, V24, P1, DOI 10.1016/j.bbi.2009.09.009; MUNSCHAUER FE, 1993, J CLIN IMMUNOL, V13, P113, DOI 10.1007/BF00919267; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Saliba E, 2001, BIOL NEONATE, V79, P224; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Vogelgesang A, 2011, J NEUROIMMUNOL, V231, P105, DOI 10.1016/j.jneuroim.2010.09.023; Vogelgesang A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008718; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; WANG WZ, 1992, CLIN EXP IMMUNOL, V88, P157; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139	39	67	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36422	10.1371/journal.pone.0036422	http://dx.doi.org/10.1371/journal.pone.0036422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567156	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500075
J	Allen, BL; Leung, LKP				Allen, Benjamin L.; Leung, Luke K. -P.			Assessing Predation Risk to Threatened Fauna from their Prevalence in Predator Scats: Dingoes and Rodents in Arid Australia	PLOS ONE			English	Article							CANIS-LUPUS-DINGO; POPULATION-DYNAMICS; WESTERN-AUSTRALIA; EXTINCTION; PREY; CONSERVATION; PATTERNS; DECLINE; VERTEBRATES; COMPETITION	The prevalence of threatened species in predator scats has often been used to gauge the risks that predators pose to threatened species, with the infrequent occurrence of a given species often considered indicative of negligible predation risks. In this study, data from 4087 dingo (Canis lupus dingo and hybrids) scats were assessed alongside additional information on predator and prey distribution, dingo control effort and predation rates to evaluate whether or not the observed frequency of threatened species in dingo scats warrants more detailed investigation of dingo predation risks to them. Three small rodents (dusky hopping-mice Notomys fuscus; fawn hopping-mice Notomys cervinus; plains mice Pseudomys australis) were the only threatened species detected in <8% of dingo scats from any given site, suggesting that dingoes might not threaten them. However, consideration of dingo control effort revealed that plains mice distribution has largely retracted to the area where dingoes have been most heavily subjected to lethal control. Assessing the hypothetical predation rates of dingoes on dusky hopping-mice revealed that dingo predation alone has the potential to depopulate local hopping-mice populations within a few months. It was concluded that the occurrence of a given prey species in predator scats may be indicative of what the predator ate under the prevailing conditions, but in isolation, such data can have a poor ability to inform predation risk assessments. Some populations of threatened fauna assumed to derive a benefit from the presence of dingoes may instead be susceptible to dingo-induced declines under certain conditions.	[Allen, Benjamin L.; Leung, Luke K. -P.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia	University of Queensland	Allen, BL (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia.	benjamin.allen@dpi.nsw.gov.au	Allen, Benjamin L./H-3066-2019	Allen, Benjamin L./0000-0002-1533-0163; Leung, Luke/0000-0002-8829-4925				Allen B., 2011, Australian Mammalogy, V33, P68, DOI 10.1071/AM10032; Allen BL, 2012, WILDLIFE RES, V39, P35, DOI 10.1071/WR11128; Allen B. L., 2011, GLOVEBOX GUIDE MANAG; Allen B. L., 2012, WOLVES BIOL CONSERVA; Allen Benjamin L., 2011, Ecological Management & Restoration, V12, P26, DOI 10.1111/j.1442-8903.2011.00571.x; Allen Benjamin L., 2010, Australian Mammalogy, V32, P207, DOI 10.1071/AM10012; Allen BL, AUSTR MAMMA IN PRESS, Vxx, pxx; Allen L. R., 2009, TECHNICAL HIGHLIGHTS, P61; Allen LR, RANGELAND J IN PRESS, Vxx, pxx; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Brook LA, 2011, RANGELAND J, V33, P79, DOI 10.1071/RJ10052; Brunner, 2002, HAIR ID INTERACTIVE; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Burnett S, 1995, PROJECT GONDWANA DIS; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; CAUGHLEY G, 1980, AUST WILDLIFE RES, V7, P1, DOI 10.1071/WR9800001; Claridge Andrew W., 2010, Australian Mammalogy, V32, P117, DOI 10.1071/AM09038; Cogger H, 2000, REPTILES AMPHIBIANS; Corbett L. K., 2001, DINGO AUSTR ASIA; CORBETT LK, 1987, OECOLOGIA, V74, P215, DOI 10.1007/BF00379362; Courchamp F, 2000, J ANIM ECOL, V69, P154, DOI 10.1046/j.1365-2656.2000.00383.x; Coutts-Smith A.J., 2007, THREAT POSED PEST AN; Cupples JB, 2011, J MAMMAL, V92, P590, DOI 10.1644/10-MAMM-A-164.1; Davies KF, 2010, BIOL CONSERV, V143, P78, DOI 10.1016/j.biocon.2009.09.006; DEH, 2009, 2010 COMM KANG HARV; Dickman Chris R., 2009, P238, DOI 10.1002/9781444312034.ch11; Fleming P., 2001, MANAGING IMPACTS DIN; Fleming PJS, 2012, AUST MAMMAL, V34, P119, DOI 10.1071/AM11012; Glen AS, 2008, J APPL ECOL, V45, P700, DOI 10.1111/j.1365-2664.2007.01449.x; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; HOLMES JC, 1995, WILDLIFE RES, V22, P11, DOI 10.1071/WR9950011; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; JOHNSON C, 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2003, HOLOCENE, V13, P941, DOI 10.1191/0959683603hl682fa; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Kutsche F, 2003, FIELD GUIDE PLANTS O; Landsberg J., 1997, EFFECTS ARTIFICIAL S; Lee A., 1995, ACTION PLAN AUSTR RO; Letnic M, 2009, ANIM CONSERV, V12, P302, DOI 10.1111/j.1469-1795.2009.00250.x; Letnic M, 2000, BIODIVERS CONSERV, V9, P295, DOI 10.1023/A:1008913826686; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Lundie-Jenkins G., 2005, RECOVERY PLAN BRIDLE; Lunney D, 2001, RANGELAND J, V23, P44, DOI 10.1071/RJ01014; MCILROY JC, 1981, AUST WILDLIFE RES, V8, P369; McKenzie NL, 2007, J BIOGEOGR, V34, P597, DOI 10.1111/j.1365-2699.2006.01639.x; Moseby K., 1998, STUDY DAVENPORT RANG; Moseby KE, 2006, WILDLIFE RES, V33, P223, DOI 10.1071/WR05034; Moseby KE, 2011, BIOL CONSERV, V144, P2863, DOI 10.1016/j.biocon.2011.08.003; Moseby KE, 2009, AUSTRAL ECOL, V34, P156, DOI 10.1111/j.1442-9993.2008.01916.x; Moseby KE, 2011, RECOVERY PL IN PRESS; Newsome AE, 2001, RANGELAND J, V23, P71, DOI 10.1071/RJ01015; Newsome AE, 1975, RODENTS DESERT ENV; Newsome T.M., 2011, ECOLOGY DINGO CANIS; O'Neill Adam, 2008, PERSISTENCE ENDANGER; Paltridge R, 2002, WILDLIFE RES, V29, P389, DOI 10.1071/WR00010; Papenfus, 1992, RANGELAND J, V14, P107, DOI DOI 10.1071/RJ9920107; Pavey CR, 2008, J MAMMAL, V89, P674, DOI 10.1644/07-MAMM-A-168R.1; Saetre P, 2004, MOL BRAIN RES, V126, P198, DOI 10.1016/j.molbrainres.2004.05.003; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; THOMSON PC, 1992, WILDLIFE RES, V19, P585, DOI 10.1071/WR9920585; Triggs B., 2004, TRACKS SCATS OTHER T; Trites AW, 2005, J MAMMAL, V86, P704, DOI 10.1644/1545-1542(2005)086[0704:DAFFSH]2.0.CO;2; Van Dyck S., 2008, MAMMALS AUSTR; Wallach AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006861; West P., 2008, ASSESSING INVASIVE A; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Yelland L., 2012, HOLDING LINE HIST S	72	48	52	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36426	10.1371/journal.pone.0036426	http://dx.doi.org/10.1371/journal.pone.0036426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563498	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000305340700047
J	Morandi, L; de Biase, D; Visani, M; Cesari, V; De Maglio, G; Pizzolitto, S; Pession, A; Tallini, G				Morandi, Luca; de Biase, Dario; Visani, Michela; Cesari, Valentina; De Maglio, Giovanna; Pizzolitto, Stefano; Pession, Annalisa; Tallini, Giovanni			Allele Specific Locked Nucleic Acid Quantitative PCR (ASLNAqPCR): An Accurate and Cost-Effective Assay to Diagnose and Quantify KRAS and BRAF Mutation	PLOS ONE			English	Article							K-RAS MUTATIONS; COLORECTAL-CARCINOMA; LUNG-CANCER; GENE; ADENOCARCINOMAS; ACTIVATION; RESISTANCE; CETUXIMAB	The use of tyrosine kinase inhibitors (TKIs) requires the testing for hot spot mutations of the molecular effectors downstream the membrane-bound tyrosine kinases since their wild type status is expected for response to TKI therapy. We report a novel assay that we have called Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR). The assay uses LNA-modified allele specific primers and LNA-modified beacon probes to increase sensitivity, specificity and to accurately quantify mutations. We designed primers specific for codon 12/13 KRAS mutations and BRAF V600E, and validated the assay with 300 routine samples from a variety of sources, including cytology specimens. All were analyzed by ASLNAqPCR and Sanger sequencing. Discordant cases were pyrosequenced. ASLNAqPCR correctly identified BRAF and KRAS mutations in all discordant cases and all had a mutated/wild type DNA ratio below the analytical sensitivity of the Sanger method. ASLNAqPCR was 100% specific with greater accuracy, positive and negative predictive values compared with Sanger sequencing. The analytical sensitivity of ASLNAqPCR is 0.1%, allowing quantification of mutated DNA in small neoplastic cell clones. ASLNAqPCR can be performed in any laboratory with real-time PCR equipment, is very cost-effective and can easily be adapted to detect hot spot mutations in other oncogenes.	[Morandi, Luca; de Biase, Dario; Visani, Michela; Cesari, Valentina; Tallini, Giovanni] Univ Bologna, AUSL Osped Bellaria, Sez Anat Istol & Citol Patol M Malpighi, Dipartimento Ematol & Sci Oncol L & A Seragnoli, Bologna, Italy; [de Biase, Dario; Visani, Michela; Cesari, Valentina; Pession, Annalisa] Univ Bologna, Dipartimento Patol Sperimentale, I-40126 Bologna, Italy; [De Maglio, Giovanna; Pizzolitto, Stefano] Univ Santa Maria Misericordia, SOC Anat Patol Azienda Osped, Udine, Italy	University of Bologna; University of Bologna; Hospital Santa Maria della Misericordia	Morandi, L (corresponding author), Univ Bologna, AUSL Osped Bellaria, Sez Anat Istol & Citol Patol M Malpighi, Dipartimento Ematol & Sci Oncol L & A Seragnoli, Bologna, Italy.	morandi@ausl.bologna.it; giovanni.tallini@unibo.it	de Biase, Dario/B-9274-2012; Visani, Michela/K-5597-2016; Morandi, Luca/A-3191-2016; Tallini, Giovanni/F-7850-2013	de Biase, Dario/0000-0002-0609-8817; Visani, Michela/0000-0002-9051-2231; Morandi, Luca/0000-0002-3810-9760; Tallini, Giovanni/0000-0003-0113-6682; Pession, Annalisa/0000-0001-9035-9698	Regione Friuli Venezia Giulia [1897, 2008]; ASLNAqPCR; Italian Government MURST [20074zw8la]; Vanini-Cavagnino; Centro Interdipartimentale di Ricerca sul Cancro G. Prodi, University of Bologna, Bologna, Italy	Regione Friuli Venezia Giulia(Regione Friuli Venezia Giulia); ASLNAqPCR; Italian Government MURST; Vanini-Cavagnino; Centro Interdipartimentale di Ricerca sul Cancro G. Prodi, University of Bologna, Bologna, Italy	This study was supported by: a public grant (1897, 2008) given by the Regione Friuli Venezia Giulia to Alphagenics Diaco Biotechnologies S.r.l., Area Science Park, Basovizza-Building Q1, Trieste Italy (to LM). Alphagenics used a very limited amount of this publicly funded grant to support the authors' work by providing free of charge primers and probes for the initial experimental work that lead to the development of ASLNAqPCR; and an Italian Government MURST grant [grant number 20074zw8la] to GT. DdB is supported with Vanini-Cavagnino grants from the Centro Interdipartimentale di Ricerca sul Cancro G. Prodi, University of Bologna, Bologna, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: LM is a consultant for Alphagenics Biotechnologies S.r.l. Two pending patents related to ASLNAqPCR were filed with the European Patent Office and are currently under review: 1) WO2011104695 (A2) 2011-09-01 for KRAS mutation detection; 2) WO2011104694 (A2) 2011-09-01 for BRAF mutation detection. Alphagenics used a very limited amount of this publicly funded grant to support the authors' work by providing free of charge primers and probes. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Arcila M, 2011, J MOL DIAGN, V13, P64, DOI 10.1016/j.jmoldx.2010.11.005; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Farber L, 2011, VIRCHOWS ARCH, V459, P487, DOI 10.1007/s00428-011-1158-y; Goranova TE, 2011, CLIN EXP METASTAS, V28, P427, DOI 10.1007/s10585-011-9381-0; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; HRUBAN RH, 1993, AM J PATHOL, V143, P545; James MR, 2006, CLIN CHEM, V52, P1675, DOI 10.1373/clinchem.2006.070169; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim IJ, 2007, J MOL DIAGN, V9, P55, DOI 10.2353/jmoldx.2007.060072; Kubota K, 2006, APPL ENVIRON MICROB, V72, P5311, DOI 10.1128/AEM.03039-05; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Leboeuf R, 2008, J CLIN ENDOCR METAB, V93, P2194, DOI 10.1210/jc.2007-2825; LIIKANEN E, 2002, OFF J EUR COMMUN L, V131, P17; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchetti A, 2009, NEOPLASIA, V11, P1084, DOI 10.1593/neo.09814; Morandi L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-48; MURRAY A, 1993, Q J MED, V86, P831; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2009, CLIN CANCER RES, V15, P5317, DOI 10.1158/1078-0432.CCR-09-0913; Sun Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003701; Sundstrom M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-660; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Xing M, 2004, J CLIN ENDOCR METAB, V89, P1365, DOI 10.1210/jc.2003-031488; Xing MZ, 2004, J CLIN ENDOCR METAB, V89, P2867, DOI 10.1210/jc.2003-032050; Zhou X, 2011, STAT METHODS DIAGNOS	34	48	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36084	10.1371/journal.pone.0036084	http://dx.doi.org/10.1371/journal.pone.0036084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558339	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200040
J	Peterson, JE; Vittore, CP				Peterson, Joseph E.; Vittore, Christopher P.			Cranial Pathologies in a Specimen of Pachycephalosaurus	PLOS ONE			English	Article							OPEN FRACTURES; NORTH-AMERICA; BONE; ORNITHISCHIA; DINOSAURS; INFECTION; EVOLUTION; INJURIES; BEHAVIOR	Background: A frontoparietal dome of a large pachycephalosaurid collected from the Upper Cretaceous Hell Creek Formation in 2001 is identified as Pachycephalosaurus wyomingensis. The specimen features two large oval depressions on the dorsal surface, accompanied by numerous circular pits on the margin and inner surface of the larger depressions. Methodology/Principal Findings: In order to identify the origin of these structures, computed tomography (CT) data and morphological characteristics of the specimen are analyzed and compared with similar osteological structures in fossil and extant archosaurs caused by taphonomic processes, non-pathologic bone resorption, and traumatic infection/inflammatory origins. The results of these analyses suggest that the structures are pathologic lesions likely resulting from a traumatic injury and followed by secondary infection at the site. Conclusions/Significance: The presence of lesions on a frontoparietal dome, and the exclusivity of their distribution along the dorsal dome surface, offers further insight into frontoparietal dome function and supports previously hypothesized agonistic behavior in pachycephalosaurids.	[Peterson, Joseph E.] Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA; [Vittore, Christopher P.] Rockford Mem Hosp, Dept Radiol, Rockford, IL USA	University of Wisconsin System	Peterson, JE (corresponding author), Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA.	petersoj@uwosh.edu		Vittore, Christopher/0000-0003-4399-3615	Dinosaur Research Institute	Dinosaur Research Institute	This research was funded by the Dinosaur Research Institute (http://www.dinosaurresearch.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker RT, 2006, NEW MEXICO MUSEUM NA, V35, P331; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Blanco G, 1997, J RAPTOR RES, V31, P77; Carpenter Kenneth, 1997, Contributions to Geology University of Wyoming, V32, P19; Chure Daniel J., 2000, Gaia (Lisboa), V15, P227; CIERNY G, 1984, ORTHOPEDICS, V7, P1557, DOI 10.3928/0147-7447-19841001-07; Colbert E.H., 1955, EVOLUTION VERTEBRATE; GALTON P M, 1970, Discovery (New Haven), V6, P23; GALTON PM, 1983, CAN J EARTH SCI, V20, P462, DOI 10.1139/e83-043; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Goodwin MB, 1998, J VERTEBR PALEONTOL, V18, P363, DOI 10.1080/02724634.1998.10011064; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; GUSTILO RB, 1990, J BONE JOINT SURG AM, V72A, P299, DOI 10.2106/00004623-199072020-00023; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Huchzermeyer FW, 2000, VET REC, V147, P515, DOI 10.1136/vr.147.18.515; JOHNSON KR, 2002, GEOLOGICAL SOC AM SP, V361, P503; Kalin J.A., 1936, Z F R MORPHOLOGIE OE, V32, P327; Kemp A., 1995, HORNBILLS BUCEROTIFO; KLEM D, 1990, J FIELD ORNITHOL, V61, P115; Kofron CP, 1999, J ZOOL, V249, P375, DOI 10.1111/j.1469-7998.1999.tb01206.x; Lang J.W., 1989, P102; Lehman TM, 2010, J VERTEBR PALEONTOL, V30, P786, DOI 10.1080/02724631003763532; Longrich NR, 2010, CRETACEOUS RES, V31, P274, DOI 10.1016/j.cretres.2009.12.002; LYMAN RL, 1989, J ARCHAEOL SCI, V16, P293, DOI 10.1016/0305-4403(89)90007-1; Maryanska T., 1990, P564; Maryanska T, 1974, ACTA PALAEONTOLOGICA, V30, P45; Maryanska T, 2004, DINOSAURIA, 2ND EDITION, P464; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Peterson JE, 2011, PALAIOS, V26, P81, DOI 10.2110/palo.2010.p10-080r; Resnick D., 1981, DIAGNOSIS BONE JOINT, V3, P2058; Roberts EM, 2007, J PALEONTOL, V81, P201, DOI 10.1666/0022-3360(2007)81[201:CIBIDB]2.0.CO;2; Rothschild Bruce, 2001, P331; Seeley HG, 1887, BRIT ASS ADV SCI MAN, V57, P698; Sereno Paul C., 2000, P480; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Snively E., 2008, PALAEONTOL ELECTRON, V11, P17; Snively E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021422; Sternberg C. M., 1945, JOUR PALEONTOL, V19, P534; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; SULLIVAN RM, 2006, NEW MEXICO MUSEUM NA, V35, P347; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; Tanke Darren H., 2010, P355; Tanke Darren H., 2007, P319; TAPPEN M, 1994, J ARCHAEOL SCI, V21, P667, DOI 10.1006/jasc.1994.1066; TIEMEIER OTTO W., 1941, AUK, V58, P350; WEBB GJW, 1977, AUST WILDLIFE RES, V4, P311; WHITE EM, 1983, AM ANTIQUITY, V48, P316, DOI 10.2307/280453; Williamson TE, 2002, J VERTEBR PALEONTOL, V22, P779, DOI 10.1671/0272-4634(2002)022[0779:ANGODP]2.0.CO;2; [No title captured]	50	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36227	10.1371/journal.pone.0036227	http://dx.doi.org/10.1371/journal.pone.0036227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558394	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200053
J	Andreozzi, F; Presta, I; Mannino, GC; Scarpelli, D; Di Silvestre, S; Di Pietro, N; Succurro, E; Sciacqua, A; Pandolfi, A; Consoli, A; Hribal, ML; Perticone, F; Sesti, G				Andreozzi, Francesco; Presta, Ivan; Mannino, Gaia Chiara; Scarpelli, Daniela; Di Silvestre, Sara; Di Pietro, Natalia; Succurro, Elena; Sciacqua, Angela; Pandolfi, Assunta; Consoli, Agostino; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio			A Functional Variant of the Dimethylarginine Dimethylaminohydrolase-2 Gene Is Associated with Insulin Sensitivity	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; NITRIC-OXIDE SYNTHESIS; STAGE RENAL-DISEASE; ENDOTHELIAL DYSFUNCTION; ASYMMETRIC DIMETHYLARGININE; ESSENTIAL-HYPERTENSION; GLUCOSE-TOLERANCE; PLASMA-CONCENTRATIONS; SYNTHASE INHIBITOR; RISK-FACTORS	Background: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of endothelial nitric oxide synthase, which was associated with insulin resistance. Dimethylarginine dimethylaminohydrolase (DDAH) is the major determinant of plasma ADMA. Examining data from the DIAGRAM+ (Diabetes Genetics Replication And Meta-analysis), we identified a variant (rs9267551) in the DDAH2 gene nominally associated with type 2 diabetes (P = 3 x 10(-5)). Methodology/Principal Findings: initially, we assessed the functional impact of rs9267551 in human endothelial cells (HUVECs), observing that the G allele had a lower transcriptional activity resulting in reduced expression of DDAH2 and decreased NO production in primary HUVECs naturally carrying it. We then proceeded to investigate whether this variant is associated with insulin sensitivity in vivo. To this end, two cohorts of nondiabetic subjects of European ancestry were studied. In sample 1 (n = 958) insulin sensitivity was determined by the insulin sensitivity index (ISI), while in sample 2 (n = 527) it was measured with a euglycemic-hyperinsulinemic clamp. In sample 1, carriers of the GG genotype had lower ISI than carriers of the C allele (67 +/- 33 vs.79 +/- 44; P=0.003 after adjusting for age, gender, and BMI). ADMA levels were higher in subjects carrying the GG genotype than in carriers of the C allele (0.68 +/- 0.14 vs. 0.57 +/- 0.14 mu mol/l; P=0.04). In sample 2, glucose disposal was lower in GG carriers as compared with C carriers (9.3 +/- 4.1 vs. 11.0 +/- 4.2 mgxKg(-1) free fat massxmin(-1); P=0.009). Conclusions/Significance: A functional polymorphism of the DDAH2 gene may confer increased risk for type 2 diabetes by affecting insulin sensitivity throughout increased ADMA levels.	[Andreozzi, Francesco; Presta, Ivan; Mannino, Gaia Chiara; Scarpelli, Daniela; Succurro, Elena; Sciacqua, Angela; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Di Silvestre, Sara; Di Pietro, Natalia; Pandolfi, Assunta] Univ G DAnnunzio, Dept Biomed Sci, Chieti, Italy; [Consoli, Agostino] Univ G DAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Di Silvestre, Sara; Di Pietro, Natalia; Pandolfi, Assunta; Consoli, Agostino] Univ G dAnnunzio, Aging Res Ctr CeSI, Chieti, Italy	Magna Graecia University of Catanzaro; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Andreozzi, F (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	sesti@unicz.it	Succurro, Elena/K-4138-2016; Mannino, Gaia C/K-1580-2016; Presta, Ivan/AAG-9461-2019; Perticone, Francesco/I-4260-2017; Consoli, Agostino/J-8027-2018; Di Pietro, Natalia/K-1604-2016; pandolfi, assunta/K-4595-2016; Sesti, Giorgio/B-1509-2012; Andreozzi, Francesco/J-4073-2018	Succurro, Elena/0000-0003-2578-692X; Mannino, Gaia C/0000-0002-6341-4572; Presta, Ivan/0000-0003-2668-6381; Consoli, Agostino/0000-0002-1885-451X; Di Pietro, Natalia/0000-0001-9720-2116; pandolfi, assunta/0000-0003-4135-7631; Andreozzi, Francesco/0000-0001-9375-1513; Sesti, Giorgio/0000-0002-1618-7688	Italian Ministry of Instruction, Research and University (MIUR) [2009FATXW3_005]	Italian Ministry of Instruction, Research and University (MIUR)(Ministry of Education, Universities and Research (MIUR))	Grant received by the Italian Ministry of Instruction, Research and University (MIUR) as Research Project of National Interest (PRIN) no2009FATXW3_005 to F.A. (http://prin.miur.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2001, AM J CARDIOL, V88, P1201, DOI 10.1016/S0002-9149(01)02063-X; Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Abhary S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009462; Andreozzi F, 2008, ARTERIOSCL THROM VAS, V28, P1355, DOI 10.1161/ATVBAHA.108.162883; Andreozzi F, 2007, MOL CELL BIOL, V27, P2372, DOI 10.1128/MCB.01340-06; Bai YY, 2009, CLIN SCI, V117, P273, DOI 10.1042/CS20090005; Baron AD, 1999, AM J CARDIOL, V84, p25J; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; Cardellini M, 2005, DIABETES CARE, V28, P2007, DOI 10.2337/diacare.28.8.2007; Ceravolo R, 2003, J AM COLL CARDIOL, V41, P1753, DOI 10.1016/S0735-1097(03)00295-X; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Hribal ML, 2011, DIABETOLOGIA, V54, P795, DOI 10.1007/s00125-010-2038-8; Jones LC, 2003, BIOCHEM BIOPH RES CO, V310, P836, DOI 10.1016/j.bbrc.2003.09.097; Kielstein JT, 1999, J AM SOC NEPHROL, V10, P594; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; LAAKSO M, 1990, J CLIN INVEST, V85, P1844, DOI 10.1172/JCI114644; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lorenzo C, 2010, J CLIN ENDOCR METAB, V95, P5082, DOI 10.1210/jc.2010-1144; Marini MA, 2003, J CLIN ENDOCR METAB, V88, P3368, DOI 10.1210/jc.2002-021716; McLaughlin T, 2006, J CLIN ENDOCR METAB, V91, P1896, DOI 10.1210/jc.2005-1441; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; O'Dwyer MJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5053; OGAWA T, 1987, ARCH BIOCHEM BIOPHYS, V252, P526, DOI 10.1016/0003-9861(87)90060-9; OGAWA T, 1989, J BIOL CHEM, V264, P10205; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Perticone F, 2005, J AM COLL CARDIOL, V46, P518, DOI 10.1016/j.jacc.2005.04.040; Perticone F, 2008, DIABETES, V57, P167, DOI 10.2337/db07-1189; Perticone F, 2010, INT J CARDIOL, V142, P236, DOI 10.1016/j.ijcard.2008.12.131; Pinkney JH, 1997, DIABETES, V46, pS9, DOI 10.2337/diab.46.2.S9; Quyyumi Arshed A., 1998, American Journal of Medicine, V105, p32S, DOI 10.1016/S0002-9343(98)00209-5; Rossi R, 2005, DIABETES CARE, V28, P702, DOI 10.2337/diacare.28.3.702; Sciacqua A, 2003, DIABETES CARE, V26, P1673, DOI 10.2337/diacare.26.6.1673; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Sydow K, 2008, ARTERIOSCL THROM VAS, V28, P692, DOI 10.1161/ATVBAHA.108.162073; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; VALLANCE P, 1992, LANCET, V339, P572; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	45	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36224	10.1371/journal.pone.0036224	http://dx.doi.org/10.1371/journal.pone.0036224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558392	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000161
J	Bhadauria, V; Banniza, S; Vandenberg, A; Selvaraj, G; Wei, YD				Bhadauria, Vijai; Banniza, Sabine; Vandenberg, Albert; Selvaraj, Gopalan; Wei, Yangdou			Peroxisomal Alanine: Glyoxylate Aminotransferase AGT1 Is Indispensable for Appressorium Function of the Rice Blast Pathogen, Magnaporthe oryzae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-DISTRIBUTION; TURGOR GENERATION; MAP KINASE; INFECTION; PROTEIN; GENE; PENETRATION; GRISEA; YEAST	The role of beta-oxidation and the glyoxylate cycle in fungal pathogenesis is well documented. However, an ambiguity still remains over their interaction in peroxisomes to facilitate fungal pathogenicity and virulence. In this report, we characterize a gene encoding an alanine, glyoxylate aminotransferase 1 (AGT1) in Magnaporthe oryzae, the causative agent of rice blast disease, and demonstrate that AGT1 is required for pathogenicity of M. oryzae. Targeted deletion of AGT1 resulted in the failure of penetration via appressoria; therefore, mutants lacking the gene were unable to induce blast symptoms on the hosts rice and barley. This penetration failure may be associated with a disruption in lipid mobilization during conidial germination as turgor generation in the appressorium requires mobilization of lipid reserves from the conidium. Analysis of enhanced green fluorescent protein expression using the transcriptional and translational fusion with the AGT1 promoter and open reading frame, respectively, revealed that AGT1 expressed constitutively in all in vitro grown cell types and during in planta colonization, and localized in peroxisomes. Peroxisomal localization was further confirmed by colocalization with red fluorescent protein fused with the peroxisomal targeting signal 1. Surprisingly, conidia produced by the Delta agt1 mutant were unable to form appressoria on artificial inductive surfaces, even after prolonged incubation. When supplemented with nicotinamide adenine dinucleotide (NAD(+))+pyruvate, appressorium formation was restored on an artificial inductive surface. Taken together, our data indicate that AGT1-dependent pyruvate formation by transferring an amino group of alanine to glyoxylate, an intermediate of the glyoxylate cycle is required for lipid mobilization and utilization. This pyruvate can be converted to non-fermentable carbon sources, which may require reoxidation of NADH generated by the beta-oxidation of fatty acids to NAD(+) in peroxisomes. Therefore, it may provide a means to maintain redox homeostasis in appressoria.	[Bhadauria, Vijai; Wei, Yangdou] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Bhadauria, Vijai; Banniza, Sabine; Vandenberg, Albert] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK S7N 0W0, Canada; [Selvaraj, Gopalan] Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada	University of Saskatchewan; University of Saskatchewan; National Research Council Canada	Bhadauria, V (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	sabine.banniza@usask.ca; yangdou.wei@usask.ca		Vandenberg, Albert/0000-0001-6177-1392	NSERC-CRD; Saskatchewan Pulse Growers	NSERC-CRD(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Pulse Growers	This work was supported by NSERC-CRD and the Saskatchewan Pulse Growers grants to SB, AV and YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Danpure CJ, 1997, BIOESSAYS, V19, P317, DOI 10.1002/bies.950190409; DANPURE CJ, 1994, EUR J CELL BIOL, V64, P295; DANPURE CJ, 1990, J CELL SCI, V97, P669; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Hettema EH, 1999, BBA-MOL CELL RES, V1451, P17, DOI 10.1016/S0167-4889(99)00087-7; HONDRED D, 1985, PLANT PHYSIOL, V79, P95, DOI 10.1104/pp.79.1.95; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; HOWARD RJ, 1994, RICE BLAST DISEASE, P3; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kato A, 1996, PLANT CELL, V8, P1601, DOI 10.1105/tpc.8.9.1601; Khang CH, 2005, FUNGAL GENET BIOL, V42, P483, DOI 10.1016/j.fgb.2005.03.004; KUNAU WH, 1988, BIOCHEM SOC T, V16, P418, DOI 10.1042/bst0160418; KURIHARA T, 1992, EUR J BIOCHEM, V210, P999, DOI 10.1111/j.1432-1033.1992.tb17505.x; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LU SW, 1994, P NATL ACAD SCI USA, V91, P12649, DOI 10.1073/pnas.91.26.12649; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Ou SH, 1985, RICE DIS; Park G, 2004, MOL MICROBIOL, V53, P1695, DOI 10.1111/j.1365-2958.2004.04220.x; PENG YL, 1988, CAN J BOT, V66, P730, DOI 10.1139/b88-107; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; REHFELD DW, 1972, J BIOL CHEM, V247, P4803; Sambrook J, 2001, MOL CLONING LAB MANU; Schlosser T, 2004, YEAST, V21, P63, DOI 10.1002/yea.1058; SCHMALIX W, 1993, J BIOL CHEM, V268, P27428; Smith JJ, 2000, J BIOL CHEM, V275, P20168, DOI 10.1074/jbc.M909285199; Soanes DM, 2005, MOL PLANT PATHOL, V6, P503, DOI [10.1111/j.1364-3703.2005.00298.x, 10.1111/J.1364-3703.2005.00298.X]; Talbot NJ, 2001, ADV BOT RES, V34, P263, DOI 10.1016/S0065-2296(01)34011-9; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Wilkins Thea A., 1996, P21; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116	36	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36266	10.1371/journal.pone.0036266	http://dx.doi.org/10.1371/journal.pone.0036266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558413	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000174
J	Johnson, KR; Longo-Guess, CM; Gagnon, LH				Johnson, Kenneth R.; Longo-Guess, Chantal M.; Gagnon, Leona H.			Mutations of the Mouse ELMO Domain Containing 1 Gene (Elmod1) Link Small GTPase Signaling to Actin Cytoskeleton Dynamics in Hair Cell Stereocilia	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; INNER-EAR; PHOSPHATIDYLINOSITOL PHOSPHATASE; COCHLEAR STEREOCILIA; RHO GTPASES; MYOSIN-XVA; DEAFNESS; MEMBRANE; BUNDLES; DIFFERENTIATION	Stereocilia, the modified microvilli projecting from the apical surfaces of the sensory hair cells of the inner ear, are essential to the mechanoelectrical transduction process underlying hearing and balance. The actin-filled stereocilia on each hair cell are tethered together by fibrous links to form a highly patterned hair bundle. Although many structural components of hair bundles have been identified, little is known about the signaling mechanisms that regulate their development, morphology, and maintenance. Here, we describe two naturally occurring, allelic mutations that result in hearing and balance deficits in mice, named roundabout (rda) and roundabout-2J (rda(2J)). Positional cloning identified both as mutations of the mouse ELMOdomain containing 1 gene (Elmod1), a poorly characterized gene with no previously reported mutant phenotypes. The rda mutation is a 138 kb deletion that includes exons 1-5 of Elmod1, and rda(2J) is an intragenic duplication of exons 3-8 of Elmod1. The deafness associated with these mutations is caused by cochlear hair cell dysfunction, as indicated by conspicuous elongations and fusions of inner hair cell stereocilia and progressive degeneration of outer hair cell stereocilia. Mammalian ELMO-family proteins are known to be involved in complexes that activate small GTPases to regulate the actin cytoskeleton during phagocytosis and cell migration. ELMOD1 and ELMOD2 recently were shown to function as GTPase-activating proteins (GAPs) for the Arf family of small G proteins. Our finding connecting ELMOD1 deficiencies with stereocilia dysmorphologies thus establishes a link between the Ras superfamily of small regulatory GTPases and the actin cytoskeleton dynamics of hair cell stereocilia.	[Johnson, Kenneth R.; Longo-Guess, Chantal M.; Gagnon, Leona H.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Johnson, KR (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	ken.johnson@jax.org			National Institute On Deafness And Other Communication Disorders (NIDCD) [R01DC004301]; National Cancer Institute (NCI) [CA34196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004301] Funding Source: NIH RePORTER	National Institute On Deafness And Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by grant number R01DC004301 from the National Institute On Deafness And Other Communication Disorders (NIDCD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDCD or the National Institutes of Health (NIH). Jackson Laboratory Shared Services are supported by grant number CA34196 from the National Cancer Institute (NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Brzostowski Joseph A., 2009, Communicative & Integrative Biology, V2, P337; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Donaldson JG, 2005, BIOCHEM SOC T, V33, P1276, DOI 10.1042/BST0331276; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Grimsley-Myers CM, 2009, J NEUROSCI, V29, P15859, DOI 10.1523/JNEUROSCI.3998-09.2009; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hertzano R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002309; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Isik N, 2008, DEV CELL, V15, P590, DOI 10.1016/j.devcel.2008.08.006; JOHNSON KR, 1992, GENOMICS, V12, P503, DOI 10.1016/0888-7543(92)90441-T; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kikkawa Y, 2005, HUM MOL GENET, V14, P391, DOI 10.1093/hmg/ddi035; Kitajiri S, 2004, J CELL BIOL, V166, P559, DOI 10.1083/jcb.200402007; Kollmar R, 1999, CURR OPIN NEUROBIOL, V9, P394, DOI 10.1016/S0959-4388(99)80059-2; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Krebs A, 2001, J CELL SCI, V114, P3663; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Lyons BL, 2006, INVEST OPHTH VIS SCI, V47, P1201, DOI 10.1167/iovs.05-1161; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mburu P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011627; Muller U, 2001, TRENDS CELL BIOL, V11, P334, DOI 10.1016/S0962-8924(01)02046-3; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Pataky F, 2004, P NATL ACAD SCI USA, V101, P2601, DOI 10.1073/pnas.0308620100; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Rzadzinska A, 2005, CELL MOTIL CYTOSKEL, V62, P157, DOI 10.1002/cm.20094; SAKAGUCHI H, 2008, CELL MOTIL CYTOSKELE; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Sechi AS, 2000, J CELL SCI, V113, P3685; Seifert RA, 2003, EXP CELL RES, V287, P374, DOI 10.1016/S0014-4827(03)00121-6; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; TAYLOR BA, 1994, GENOMICS, V21, P626, DOI 10.1006/geno.1994.1323; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Ueda S, 2008, J NEUROSCI RES, V86, P3052, DOI 10.1002/jnr.21763; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Yan D, 2006, J MOL BIOL, V357, P755, DOI 10.1016/j.jmb.2006.01.017; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zampini V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001048; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	72	28	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36074	10.1371/journal.pone.0036074	http://dx.doi.org/10.1371/journal.pone.0036074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558334	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000120
J	Lin, LH; Qu, YF; Li, H; Zhou, KY; Ji, X				Lin, Long-Hui; Qu, Yan-Fu; Li, Hong; Zhou, Kai-Ya; Ji, Xiang			Genetic Structure and Demographic History Should Inform Conservation: Chinese Cobras Currently Treated as Homogenous Show Population Divergence	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; NAJA-ATRA; PHYLOGENETIC-RELATIONSHIPS; SPECIES COMPLEX; PHYLOGEOGRAPHY; SOFTWARE; PROGRAM; DIFFERENTIATION; GROWTH; SNAKE	An understanding of population structure and genetic diversity is crucial for wildlife conservation and for determining the integrity of wildlife populations. The vulnerable Chinese cobra (Naja atra) has a distribution from the mouth of the Yangtze River down to northern Vietnam and Laos, within which several large mountain ranges and water bodies may influence population structure. We combined 12 microsatellite loci and 1117 bp of the mitochondrial cytochrome b gene to explore genetic structure and demographic history in this species, using 269 individuals from various localities in Mainland China and Vietnam. High levels of genetic variation were identified for both mtDNA and microsatellites. mtDNA data revealed two main (Vietnam + southern China + southwestern China; eastern + southeastern China) and one minor (comprising only two individuals from the westernmost site) clades. Microsatellite data divided the eastern + southeastern China clade further into two genetic clusters, which include individuals from the eastern and southeastern regions, respectively. The Luoxiao and Nanling Mountains may be important barriers affecting the diversification of lineages. In the haplotype network of cytchrome b, many haplotypes were represented within a "star" cluster and this and other tests suggest recent expansion. However, microsatellite analyses did not yield strong evidence for a recent bottleneck for any population or genetic cluster. The three main clusters identified here should be considered as independent management units for conservation purposes. The release of Chinese cobras into the wild should cease unless their origin can be determined, and this will avoid problems arising from unnatural homogenization.	[Lin, Long-Hui; Qu, Yan-Fu; Li, Hong; Zhou, Kai-Ya; Ji, Xiang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Lin, Long-Hui] Hangzhou Normal Univ, Sch Life Sci, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China	Nanjing Normal University; Hangzhou Normal University	Lin, LH (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	xji@mail.hz.zj.cn			Natural Science Foundation of China [3077038, 31070339]; Zhejiang Provincial Foundation of Natural Science [Z3090461]; Hangzhou Bureau of Science and Technology [20100332T20]; Zhejiang Department of Science and Technology for Innovation Teams [2010R50039-26]; Nanjing Normal University [0319PM0902]; Priority Academic Program Development of Jiangsu Higher Education Institutions [CXLX11_0885]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Foundation of Natural Science(Natural Science Foundation of Zhejiang Province); Hangzhou Bureau of Science and Technology; Zhejiang Department of Science and Technology for Innovation Teams; Nanjing Normal University; Priority Academic Program Development of Jiangsu Higher Education Institutions	The work was supported by grants from the Natural Science Foundation of China (3077038 and 31070339), the Zhejiang Provincial Foundation of Natural Science (Z3090461), Hangzhou Bureau of Science and Technology (20100332T20), Zhejiang Department of Science and Technology for Innovation Teams (2010R50039-26), Innovative Team Project of Nanjing Normal University (0319PM0902) and Priority Academic Program Development of Jiangsu Higher Education Institutions (CXLX11_0885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Angers B, 1998, MOL BIOL EVOL, V15, P143, DOI 10.1093/oxfordjournals.molbev.a025911; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BIRKY CW, 1983, GENETICS, V103, P513; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Butantan-British IBothrops/I Systematics Project, 2002, P111; Cassens I, 2003, MOL ECOL, V12, P1781, DOI 10.1046/j.1365-294X.2003.01876.x; Chen XD, 1988, J TROP OCEANOGR, V7, P39; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Cornuet JM, 1996, GENETICS, V144, P2001; Ding L, 2011, MOL ECOL, V20, P1905, DOI 10.1111/j.1365-294X.2011.05060.x; Epperson BK, 2003, GEOGRAPHICAL GENETIC, V38; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fu JZ, 2005, MOL PHYLOGENET EVOL, V37, P202, DOI 10.1016/j.ympev.2005.03.023; Fu YX, 1997, GENETICS, V147, P915; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goode MG, 2007, BIOINFORMATICS, V23, P1553, DOI 10.1093/bioinformatics/btm128; Goudet J., 2001, FSTAT PROGRAM ESTIMA; HARPENDING HC, 1994, HUM BIOL, V66, P591; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Huang Song, 2003, Acta Zoologica Sinica, V49, P854; Huang S, 2007, MOL PHYLOGENET EVOL, V44, P942, DOI 10.1016/j.ympev.2007.05.019; Huang S, 2009, MOL PHYLOGENET EVOL, V51, P438, DOI 10.1016/j.ympev.2009.02.013; Ineich Ivan, 1996, Bulletin de la Societe Herpetologique de France, V75-76, P7; Ji X, 2005, BIOL J LINN SOC, V85, P27, DOI 10.1111/j.1095-8312.2005.00470.x; Ji Xiang, 2002, Acta Zoologica Sinica, V48, P591; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Lin HC, 2008, CONSERV GENET, V9, P1089, DOI 10.1007/s10592-007-9418-8; Lin LH, 2008, J THERM BIOL, V33, P193, DOI 10.1016/j.jtherbio.2007.12.003; Lin LH, 2011, INT J MOL SCI, V12, P4435, DOI 10.3390/ijms12074435; Lin LH, 2010, MOL PHYLOGENET EVOL, V56, P601, DOI 10.1016/j.ympev.2010.04.032; Lin LH, 2008, ZOOL SCI, V25, P888, DOI 10.2108/zsj.25.888; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Lukoschek V, 2008, MOL ECOL, V17, P3062, DOI 10.1111/j.1365-294X.2008.03815.x; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Minton S.A., 1986, P3; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2004, DOCUMENTATION STRUCT; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sallaberry-Pincheira N, 2011, DIVERS DISTRIB, V17, P152, DOI 10.1111/j.1472-4642.2010.00729.x; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Szaro RC, 2008, INTEGR ZOOL, V3, P75, DOI 10.1111/j.1749-4877.2008.00075.x; SZYNDLAR Z, 1990, Amphibia-Reptilia, V11, P385, DOI 10.1163/156853890X00078; TAJIMA F, 1989, GENETICS, V123, P585; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan QY, 2009, J SNAKE, V21, P183; Tzika AC, 2009, CONSERV GENET, V10, P69, DOI 10.1007/s10592-008-9519-z; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wallach V, 2009, ZOOTAXA, P26, DOI 10.11646/zootaxa.2236.1.2; Wang J, 1980, ACTA GEOGRAPHICA SIN, V35, P299; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; Wuster W, 1997, TOXICON, V35, P319, DOI 10.1016/S0041-0101(96)00152-3; WUSTER W, 1992, HERPETOLOGICA, V48, P69; Wuster W, 2007, MOL PHYLOGENET EVOL, V45, P437, DOI 10.1016/j.ympev.2007.07.021; Zhao EM, 1998, CHINA RED DATA BOOK, P274; Zhao HT, 1999, GEOMORPHOLOGY ENV S	71	17	18	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36334	10.1371/journal.pone.0036334	http://dx.doi.org/10.1371/journal.pone.0036334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558439	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000191
J	Miyazaki, Y; Ikeda, Y; Shiraishi, K; Fujimoto, SN; Aoyama, H; Yoshimura, K; Inui, M; Hoshijima, M; Kasahara, H; Aoki, H; Matsuzaki, M				Miyazaki, Yosuke; Ikeda, Yasuhiro; Shiraishi, Kozo; Fujimoto, Shizuka N.; Aoyama, Hidekazu; Yoshimura, Koichi; Inui, Makoto; Hoshijima, Masahiko; Kasahara, Hideko; Aoki, Hiroki; Matsuzaki, Masunori			Heart Failure-Inducible Gene Therapy Targeting Protein Phosphatase 1 Prevents Progressive Left Ventricular Remodeling	PLOS ONE			English	Article							CALCIUM CYCLING DEFECTS; ADENOASSOCIATED VIRUS; CARDIAC DYSFUNCTION; NATRIURETIC PEPTIDE; INHIBITION; PHOSPHOLAMBAN; EXPRESSION; PHOSPHODIESTERASE; SUPPRESSION; INFARCTION	Background: The targeting of Ca2+ cycling has emerged as a potential therapy for the treatment of severe heart failure. These approaches include gene therapy directed at overexpressing sarcoplasmic reticulum (SR) Ca2+ ATPase, or ablation of phospholamban (PLN) and associated protein phosphatase 1 (PP1) protein complexes. We previously reported that PP1 beta, one of the PP1 catalytic subunits, predominantly suppresses Ca2+ uptake in the SR among the three PP1 isoforms, thereby contributing to Ca2+ downregulation in failing hearts. In the present study, we investigated whether heart-failure-inducible PP1 beta-inhibition by adeno-associated viral-9 (AAV9) vector mediated gene therapy is beneficial for preventing disease progression in genetic cardiomyopathic mice. Methods: We created an adeno-associated virus 9 (AAV9) vector encoding PP1b short-hairpin RNA (shRNA) or negative control (NC) shRNA. A heart failure inducible gene expression system was employed using the B-type natriuretic protein (BNP) promoter conjugated to emerald-green fluorescence protein (EmGFP) and the shRNA sequence. AAV9 vectors (AAV9-BNP- EmGFP-PP1 beta shRNA and AAV9-BNP-EmGFP-NCshRNA) were injected into the tail vein (2x10(11) GC/mouse) of muscle LIM protein deficient mice (MLPKO), followed by serial analysis of echocardiography, hemodynamic measurement, biochemical and histological analysis at 3 months. Results: In the MLPKO mice, BNP promoter activity was shown to be increased by detecting both EmGFP expression and the induced reduction of PP1b by 25% in the myocardium. Inducible PP1 beta shRNA delivery preferentially ameliorated left ventricular diastolic function and mitigated adverse ventricular remodeling. PLN phosphorylation was significantly augmented in the AAV9-BNP-EmGFP-PP1 beta shRNA injected hearts compared with the AAV9-BNP-EmGFP-NCshRNA group. Furthermore, BNP production was reduced, and cardiac interstitial fibrosis was abrogated at 3 months. Conclusion: Heart failure-inducible molecular targeting of PP1b has potential as a novel therapeutic strategy for heart failure.	[Miyazaki, Yosuke; Ikeda, Yasuhiro; Shiraishi, Kozo; Fujimoto, Shizuka N.; Aoyama, Hidekazu; Matsuzaki, Masunori] Yamaguchi Univ, Dept Med & Clin Sci, Div Cardiol, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Yoshimura, Koichi] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan; [Inui, Makoto] Yamaguchi Univ, Grad Sch Med, Dept Pharmacol, Ube, Yamaguchi 755, Japan; [Hoshijima, Masahiko] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kasahara, Hideko] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 830, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; University of California System; University of California San Diego; State University System of Florida; University of Florida; Kurume University	Miyazaki, Y (corresponding author), Yamaguchi Univ, Dept Med & Clin Sci, Div Cardiol, Grad Sch Med, Ube, Yamaguchi 755, Japan.	ysikeda-ymg@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT-Japan) [17590739, 21590932, 19209030, 21390241]; Grants-in-Aid for Scientific Research [22390050, 21390241] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT-Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT-Japan) [grant numbers 17590739 and 21590932 to YI, and 19209030 and 21390241 to MM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Aoyama H, 2011, CARDIOVASC RES, V89, P79, DOI 10.1093/cvr/cvq252; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bish LT, 2008, HUM GENE THER, V19, P1359, DOI 10.1089/hum.2008.123; Chu D, 2003, J THORAC CARDIOV SUR, V126, P671, DOI 10.1016/S0022-5223(03)00082-5; CRUICKSHANK JM, 1993, CARDIOVASC DRUG THER, V7, P655, DOI 10.1007/BF00877818; Dulak J, 2006, CELL BIOCHEM BIOPHYS, V44, P31, DOI 10.1385/CBB:44:1:031; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; Grote-Wessels S, 2008, CARDIOVASC RES, V79, P464, DOI 10.1093/cvr/cvn113; Gwathmey JK, 2010, J MOL CELL CARDIOL; Hajjar RJ, 2008, J CARD FAIL, V14, P355, DOI 10.1016/j.cardfail.2008.02.005; He Q, 2001, HYPERTENSION, V37, P478, DOI 10.1161/01.HYP.37.2.478; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Hoshijima M, 2006, J AM COLL CARDIOL, V48, pA15, DOI 10.1016/j.jacc.2006.06.070; Hoshijima M, 2011, CIRC-HEART FAIL, V4, P89, DOI 10.1161/CIRCHEARTFAILURE.110.957258; Huang BY, 1999, CIRC RES, V85, P848, DOI 10.1161/01.RES.85.9.848; Ikeda Y, HEART FAILURE PATHOP, P27; Ikeda Y, 2008, PHYSIOLOGY, V23, P6, DOI 10.1152/physiol.00033.2007; Iwanaga Y, 2004, J CLIN INVEST, V113, P727, DOI 10.1172/JCI200418716; Jessup M, 2011, CIRCULATION; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Maisel AS, 2003, J AM COLL CARDIOL, V41, P2010, DOI 10.1016/S0735-1097(03)00405-4; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Mays LE, 2011, MOL THER, V19, P16, DOI 10.1038/mt.2010.250; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Nicolaou P, 2009, CIRC RES, V104, P1012, DOI 10.1161/CIRCRESAHA.108.189811; Niwano K, 2008, MOL THER, V16, P1026, DOI 10.1038/mt.2008.61; Njeim Mario T, 2010, Arch Cardiovasc Dis, V103, P477, DOI 10.1016/j.acvd.2010.04.004; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Paul A, HUMAN CARDIAC TISSUE; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Wittkopper K, 2011, CARDIOVASC RES; Wittopper K, 2010, J CLIN INVEST, V120, P617, DOI 10.1172/JCI40545; Wong CY, 2011, AM J MED, V124, P136, DOI 10.1016/j.amjmed.2010.08.017; Yamada M, 2006, FASEB J, V20, P1197, DOI 10.1096/fj.05-5299fje	38	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35875	10.1371/journal.pone.0035875	http://dx.doi.org/10.1371/journal.pone.0035875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558250	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000072
J	Sergeev, M; Godin, AG; Kao, LY; Abuladze, N; Wiseman, PW; Kurtz, I				Sergeev, Mikhail; Godin, Antoine G.; Kao, Liyo; Abuladze, Natalia; Wiseman, Paul W.; Kurtz, Ira			Determination of Membrane Protein Transporter Oligomerization in Native Tissue Using Spatial Fluorescence Intensity Fluctuation Analysis	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; CORRELATION SPECTROSCOPY; PROXIMAL TUBULE; COTRANSPORTER; EXPRESSION; KIDNEY; NBCE1-A; CELLS; RAT; IMMUNOLOCALIZATION	Membrane transporter proteins exist in a complex dynamic equilibrium between various oligomeric states that include monomers, dimers, dimer of dimers and higher order oligomers. Given their sub-optical microscopic resolution size, the oligomerization state of membrane transporters is difficult to quantify without requiring tissue disruption and indirect biochemical methods. Here we present the application of a fluorescence measurement technique which combines fluorescence image moment analysis and spatial intensity distribution analysis (SpIDA) to determine the oligomerization state of membrane proteins in situ. As a model system we analyzed the oligomeric state(s) of the electrogenic sodium bicarbonate cotransporter NBCe1-A in cultured cells and in rat kidney. The approaches that we describe offer for the first time the ability to investigate the oligomeric state of membrane transporter proteins in their native state.	[Sergeev, Mikhail; Godin, Antoine G.; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ, Canada; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Kao, Liyo; Abuladze, Natalia; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kurtz, Ira] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	McGill University; McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Sergeev, M (corresponding author), McGill Univ, Dept Phys, Montreal, PQ, Canada.	ikurtz@mednet.ucla.edu		Godin, Antoine/0000-0003-2417-2563; Sergeev, Mikhail/0000-0001-7047-2378	Canadian Institutes of Health Research (CIHR); National Institutes of Health [DK077162, DK058563]; Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058563, R01DK077162] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	AGG was supported by Fellowships from the Canadian Institutes of Health Research (CIHR) Neurophysics Strategic Training Program Grant. IK is supported in part by National Institutes of Health grants DK077162 and DK058563. PWW is supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the CIHR. PWW also acknowledges equipment funding from the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 1998, AM J PHYSIOL-RENAL, V274, pF628, DOI 10.1152/ajprenal.1998.274.3.F628; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Brandes A, 2007, AM J PHYSIOL-REG I, V293, pR2400, DOI 10.1152/ajpregu.00208.2007; Burnham CE, 1997, J BIOL CHEM, V272, P19111, DOI 10.1074/jbc.272.31.19111; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Cordat E, 2009, BIOCHEM J, V417, P423, DOI 10.1042/BJ20081634; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Godin AG, 2011, P NATL ACAD SCI USA, V108, P7010, DOI 10.1073/pnas.1018658108; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kucik DF, 1999, BIOPHYS J, V76, P314, DOI 10.1016/S0006-3495(99)77198-5; Lee SH, 2005, ACTA OTO-LARYNGOL, V125, P745, DOI 10.1080/00016480510028519; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Maunsbach AB, 2000, J AM SOC NEPHROL, V11, P2179, DOI 10.1681/ASN.V11122179; Meckel T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600002; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; Muller JD, 2004, BIOPHYS J, V86, P3981, DOI 10.1529/biophysj.103.037887; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Saffarian S, 2003, BIOPHYS J, V84, P2030, DOI 10.1016/S0006-3495(03)75011-5; Scherf T, 2001, P NATL ACAD SCI USA, V98, P6629, DOI 10.1073/pnas.111164298; Schmitt BM, 1999, AM J PHYSIOL-RENAL, V276, pF27, DOI 10.1152/ajprenal.1999.276.1.F27; Sergeev M, 2011, BIOPHYSICAL CHEM; Sergeev M, 2006, BIOPHYS J, V91, P3884, DOI 10.1529/biophysj.106.091181; SHOTTON D, 1978, J CELL BIOL, V76, P512, DOI 10.1083/jcb.76.2.512; Starchev K, 1999, J COLLOID INTERF SCI, V213, P479, DOI 10.1006/jcis.1999.6128; Swift JL, 2011, P NATL ACAD SCI USA, V108, P7016, DOI 10.1073/pnas.1018280108; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Unruh JR, 2008, BIOPHYS J, V95, P5385, DOI 10.1529/biophysj.108.130310; Usui T, 2001, J CLIN INVEST, V108, P107, DOI 10.1172/JCI11869; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu QS, 2010, J BIOL CHEM, V285, P37178, DOI 10.1074/jbc.M110.169201; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286	40	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36215	10.1371/journal.pone.0036215	http://dx.doi.org/10.1371/journal.pone.0036215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558387	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000158
J	Tu, WJ; He, J; Chen, H; Shi, XD; Li, Y				Tu, Wen-Jun; He, Jian; Chen, Hui; Shi, Xiao-Dong; Li, Ying			Psychological Effects of False-Positive Results in Expanded Newborn Screening in China	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CYSTIC-FIBROSIS; PEDIATRIC RESIDENTS; CLINICAL-RESEARCH; SWEAT-TEST; PARENTS; COMMUNICATION; TESTS; EXPERIENCE; DISORDERS	Objectives: As more families participate expanded newborn screening for metabolic disorders in China, the overall number of false positives increases. Our goal was to assess the potential impact on parental stress, perceptions of the child's health, and family relationships. Methods: Parents of 49 infants with false-positive screening results for metabolic disorders in the expanded newborn screening panel were compared with parents of 42 children with normal screening results. Parents first completed structured interview using likert scales, closed and open questions. Parents also completed the parenting stress index. Results: A total of 88 mothers and 41 fathers were interviewed. More mothers in the false-positive group reported that their children required extra parental care (21%), compared with 5% of mothers in the normal-screened group (P<0.001). 39% of mothers in the false-positive group reported that they worry about their child's future development, compared with 10% of mothers in the normal-screened group (P<0.001). Fathers in the false-positive group did not differ from fathers in the normal-screened group in reporting worry about their child's extra care requirements, and their child's future development. Children with false-positive results compared with children with normal results were triple as likely to experience hospitalization (27%vs 9%, respectively; P<0.001). Conclusions: The results showing false-positive screening results may affect parental stress and the parent-child relationship. Parental stress and anxiety can be reduced with improved education and communication to parents about false-positive results.	[Tu, Wen-Jun; He, Jian] Chinese Acad Med Sci, Ctr Clin Lab Dev, Beijing 100730, Peoples R China; [Tu, Wen-Jun; He, Jian] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Hui; Shi, Xiao-Dong] China Rehabil Res Ctr, Beijing, Peoples R China; [Li, Ying] Beijing Haidian Maternal & Child Hlth Hosp, Dept Pediat, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Tu, WJ (corresponding author), Chinese Acad Med Sci, Ctr Clin Lab Dev, Beijing 100730, Peoples R China.	twjun8387@163.com	Tu, Wen-Jun/AAC-5696-2019	Tu, Wen-Jun/0000-0002-1703-1802				Abidin RR., 1995, PSYCHOL ASSESSMENT R; Allen EC, 2004, PEDIATRICS, V113, P267, DOI 10.1542/peds.113.2.267; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Beucher J, 2010, J PEDIATR-US, V156, P771, DOI 10.1016/j.jpeds.2009.12.003; Bodegard G, 1983, Acta Paediatr Scand Suppl, V304, P1; Burgess E, 2003, ARCH DIS CHILD-FETAL, V88, P280; Chappuy H, 2006, ARCH DIS CHILD, V91, P112, DOI 10.1136/adc.2005.076141; Fant KE, 2005, PEDIATRICS, V115, P1268, DOI 10.1542/peds.2004-0834; Farrell MH, 2005, PEDIATRICS, V116, P1492, DOI 10.1542/peds.2004-2611; Farrell MH, 2003, J PEDIATR-US, V143, P707, DOI 10.1016/j.jpeds.2003.09.022; Farrell M, 2008, PEDIATRICS, V122, P243, DOI 10.1542/peds.2007-2160; FYRO K, 1987, ACTA PAEDIATR SCAND, V76, P107, DOI 10.1111/j.1651-2227.1987.tb10424.x; Gennaccaro M, 2005, J INHERIT METAB DIS, V28, P819, DOI 10.1007/s10545-005-0135-5; Green JM, 2004, HEALTH TECHNOL ASSES, V8, P1; Green M, 1986, Pediatr Rev, V8, P75, DOI 10.1542/pir.8-3-75; Gurian EA, 2006, PEDIATRICS, V117, P1915, DOI 10.1542/peds.2005-2294; Hewlett J, 2006, J INHERIT METAB DIS, V29, P677, DOI 10.1007/s10545-006-0381-1; Janicke DM, 2001, MED CARE, V39, P990, DOI 10.1097/00005650-200109000-00009; Janicke DM, 2003, J PEDIATR PSYCHOL, V28, P547, DOI 10.1093/jpepsy/jsg045; Khairi MDM, 2011, INT J PEDIATR OTORHI, V75, P513, DOI 10.1016/j.ijporl.2011.01.009; La Pean A, 2005, PEDIATRICS, V116, P1499, DOI 10.1542/peds.2005-0449; Lang CW, 2011, PEDIATRICS, V127, P276, DOI 10.1542/peds.2010-2284; Leslie L K, 1996, Pediatr Rev, V17, P323, DOI 10.1542/pir.17-9-323; Levy HL, 2000, ANNU REV GENOM HUM G, V1, P139, DOI 10.1146/annurev.genom.1.1.139; Lipstein EA, 2009, GENET MED, V11, P716, DOI 10.1097/GIM.0b013e3181b3a61e; Matern D, 2007, J INHERIT METAB DIS, V30, P585, DOI 10.1007/s10545-007-0691-y; Prosser LA, 2008, ARCH PEDIAT ADOL MED, V162, P870, DOI 10.1001/archpediatrics.2008.1; ROTHENBERG MB, 1968, J AMER ACAD CHILD PS, V7, P689, DOI 10.1016/S0002-7138(09)62188-9; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Slaughter JL, 2010, PEDIATRICS, V126, P910, DOI 10.1542/peds.2010-0943; SORENSON JR, 1984, PEDIATRICS, V73, P183; Stenson BJ, 2004, ARCH DIS CHILD-FETAL, V89, pF321, DOI 10.1136/adc.2002.021931; Tarini BA, 2010, PUBLIC HEALTH GENOM, V13, P125, DOI 10.1159/000228724; Tarini BA, 2006, PEDIATRICS, V118, P448, DOI 10.1542/peds.2005-2026; Tluczek A, 2005, PEDIATRICS, V115, P1692, DOI 10.1542/peds.2004-0275; Waisbren SE, 2003, JAMA-J AM MED ASSOC, V290, P2564, DOI 10.1001/jama.290.19.2564	36	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36235	10.1371/journal.pone.0036235	http://dx.doi.org/10.1371/journal.pone.0036235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558398	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000165
J	Nam, JM; Davidson, EH				Nam, Jongmin; Davidson, Eric H.			Barcoded DNA-Tag Reporters for Multiplex Cis-Regulatory Analysis	PLOS ONE			English	Article							SEA-URCHIN EMBRYO; GENE NETWORK; CLONED DNA; EXPRESSION; SPECIFICATION; ENDOMESODERM; FUSION; MICROMERES; NODE; PCR	Cis-regulatory DNA sequences causally mediate patterns of gene expression, but efficient experimental analysis of these control systems has remained challenging. Here we develop a new version of "barcoded'' DNA-tag reporters, "Nanotags'' that permit simultaneous quantitative analysis of up to 130 distinct cis-regulatory modules (CRMs). The activities of these reporters are measured in single experiments by the NanoString RNA counting method and other quantitative procedures. We demonstrate the efficiency of the Nanotag method by simultaneously measuring hourly temporal activities of 126 CRMs from 46 genes in the developing sea urchin embryo, otherwise a virtually impossible task. Nanotags are also used in gene perturbation experiments to reveal cis-regulatory responses of many CRMs at once. Nanotag methodology can be applied to many research areas, ranging from gene regulatory networks to functional and evolutionary genomics.	[Nam, Jongmin; Davidson, Eric H.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Nam, JM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jn322@camden.rutgers.edu; davidson@caltech.edu			American Recovery and Reinvestment Act (ARRA) from the National Human Genome Research Institute, National Institute of Health [RC1 HG005332]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005332] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act (ARRA) from the National Human Genome Research Institute, National Institute of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was supported by American Recovery and Reinvestment Act (ARRA) funds through grant number RC1 HG005332 to (E.H.D.) from the National Human Genome Research Institute, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; De-Leon SBT, 2010, P NATL ACAD SCI USA, V107, P10103, DOI 10.1073/pnas.1004824107; FLYTZANIS CN, 1987, P NATL ACAD SCI USA, V84, P151, DOI 10.1073/pnas.84.1.151; FRANKS RR, 1988, DEVELOPMENT, V102, P287; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Kalendar R., 2009, GENES GENOMES GENOMI, V3, P1; Kenny AP, 2003, DEV BIOL, V261, P412, DOI 10.1016/S0012-1606(03)00331-2; Lee PY, 2007, DEV BIOL, V307, P434, DOI 10.1016/j.ydbio.2007.05.005; LIVANT DL, 1991, DEVELOPMENT, V113, P385; Logan CY, 1999, DEVELOPMENT, V126, P345; Materna SC, 2010, GENE EXPR PATTERNS, V10, P177, DOI 10.1016/j.gep.2010.04.002; Materna SC, 2008, NAT PROTOC, V3, P1876, DOI 10.1038/nprot.2008.187; MCMAHON AP, 1985, DEV BIOL, V108, P420, DOI 10.1016/0012-1606(85)90045-4; Minokawa T, 2005, DEV BIOL, V288, P545, DOI 10.1016/j.ydbio.2005.09.047; Nag A, 2006, RNA, V12, P1534, DOI 10.1261/rna.103206; Nam J, 2007, DEV BIOL, V306, P860, DOI 10.1016/j.ydbio.2007.03.033; Nam JM, 2010, P NATL ACAD SCI USA, V107, P3930, DOI 10.1073/pnas.1000147107; Peter IS, 2011, NATURE, V474, P635, DOI 10.1038/nature10100; Ransick A, 2002, DEV BIOL, V246, P132, DOI 10.1006/dbio.2002.0607; Revilla-i-Domingo R, 2004, DEV BIOL, V274, P438, DOI 10.1016/j.ydbio.2004.07.008; Revilla-I-Domingo R, 2007, P NATL ACAD SCI USA, V104, P12383, DOI 10.1073/pnas.0705324104; Smith J, 2008, DEV BIOL, V313, P863, DOI 10.1016/j.ydbio.2007.10.042; Smith J, 2008, P NATL ACAD SCI USA, V105, P20089, DOI 10.1073/pnas.0806442105; Su YH, 2009, DEV BIOL, V329, P410, DOI 10.1016/j.ydbio.2009.02.029; Wahl ME, 2009, DEV BIOL, V335, P428, DOI 10.1016/j.ydbio.2009.08.005; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895	27	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35934	10.1371/journal.pone.0035934	http://dx.doi.org/10.1371/journal.pone.0035934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563420	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000305349100046
J	Tilghman, MW; May, S; Perez-Santiago, J; Ignacio, CC; Little, SJ; Richman, DD; Smith, DM				Tilghman, Myres W.; May, Susanne; Perez-Santiago, Josue; Ignacio, Caroline C.; Little, Susan J.; Richman, Douglas D.; Smith, Davey M.			A Combined Screening Platform for HIV Treatment Failure and Resistance	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT FAILURE; DRUG-RESISTANCE; INFECTION; VIREMIA	Background: To develop a low cost method to screen for virologic failure of antiretroviral therapy (ART) and HIV-1 drug resistance, we performed a retrospective evaluation of a screening assay using serial dilutions of HIV-1 RNA-spiked blood plasma and samples from patients receiving >6 months of first-line ART. Methods: Serial dilution testing was used to assess sensitivity of a simple PCR-based assay (targeted at >= 1,000 HIV RNA copies/mL). We created blood plasma minipools of five samples, extracted HIV RNA from the pools, PCR amplified the reverse transcriptase (RT) coding region of the HIV-1 pol gene from extracted RNA, sequenced PCR product of positive pools, and used sequences to determine drug resistance. Sensitivity, specificity, and predictive values were determined for different levels of virologic failure based on maximum viral loads of individual samples within a pool. Results: Of 295 samples analyzed, 43 (15%) had virologic failure at >= 50 copies/mL (range 50-10,500 copies/mL, four at >= 1,000 copies/mL). The assay demonstrated 100% sensitivity to detect virus from these four samples, requiring only one round of PCR, and 56% and 89% sensitivity to detect samples with >= 50 and >= 500 copies/mL using two rounds. Amplified PCR products of all positive pools were successfully sequenced and 30% harbored >= 1 major resistance mutation. This method would have cost 10% of the combined costs of individual viral load and resistance testing. Conclusions: We present a novel method that can screen for both virologic failure of first-line ART and drug resistance. The method is much less expensive than current methods, which may offer sustainability in resource-limited settings.	[Tilghman, Myres W.; Ignacio, Caroline C.; Little, Susan J.; Richman, Douglas D.; Smith, Davey M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Richman, Douglas D.; Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [May, Susanne] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Perez-Santiago, Josue] Univ Calif San Diego, Dept Bioinformat & Syst Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego	Tilghman, MW (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mtilghman@ucsd.edu; davey@ucsd.edu	Little, Susan/AAA-6116-2019	Smith, Davey/0000-0003-3603-1733	National Institutes of Health [AI69432, AI043638, MH62512, MH083552, AI077304, AI36214, AI047745, AI74621, AI080353]; James B. Pendleton Charitable Trust; San Diego Veterans Affairs Healthcare System; California HIV Research Program [RN07-SD-702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R21AI080353, UM1AI069432, R56AI047745, U01AI043638, P01AI074621, R21AI047745, R24AI106039, U01AI069432, R01AI047745, R21AI077304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH083552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; San Diego Veterans Affairs Healthcare System; California HIV Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (AI69432, AI043638, MH62512, MH083552, AI077304, AI36214, AI047745, AI74621, AI080353), and by the James B. Pendleton Charitable Trust, the San Diego Veterans Affairs Healthcare System, and the California HIV Research Program RN07-SD-702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Gunthard HF, 1998, J VIROL, V72, P2422; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Martinez V, 2005, AIDS, V19, P1065, DOI 10.1097/01.aids.0000174453.55627.de; May S, 2010, JAIDS-J ACQ IMM DEF, V53, P194, DOI 10.1097/QAI.0b013e3181ba37a7; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Smith DM, 2009, AIDS, V23, P2151, DOI 10.1097/QAD.0b013e3283313ca9; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tilghman MW, 2011, JAIDS-J ACQ IMM DEF, V56, pE70, DOI 10.1097/QAI.0b013e3181ff63d7; van Zyl GU, 2011, CLIN INFECT DIS, V52, P264, DOI 10.1093/cid/ciq084	11	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35401	10.1371/journal.pone.0035401	http://dx.doi.org/10.1371/journal.pone.0035401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563383	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100012
J	Sawaya, MA; Stetz, JB; Clevenger, AP; Gibeau, ML; Kalinowski, ST				Sawaya, Michael A.; Stetz, Jeffrey B.; Clevenger, Anthony P.; Gibeau, Michael L.; Kalinowski, Steven T.			Estimating Grizzly and Black Bear Population Abundance and Trend in Banff National Park Using Noninvasive Genetic Sampling	PLOS ONE			English	Article							CAPTURE-MARK-RECAPTURE; URSUS-AMERICANUS; DNA; DEMOGRAPHY; MANAGEMENT; SURVIVAL; PROGRAM; CONSERVATION; MOUNTAINS; ECOSYSTEM	We evaluated the potential of two noninvasive genetic sampling methods, hair traps and bear rub surveys, to estimate population abundance and trend of grizzly (Ursus arctos) and black bear (U. americanus) populations in Banff National Park, Alberta, Canada. Using Huggins closed population mark-recapture models, we obtained the first precise abundance estimates for grizzly bears ((N) over cap = 73.5, 95% CI = 64-94 in 2006; (N) over cap = 50.4, 95% CI = 49-59 in 2008) and black bears ((N) over cap = 62.6, 95% CI = 51-89 in 2006; (N) over cap = 81.8, 95% CI = 72-102 in 2008) in the Bow Valley. Hair traps had high detection rates for female grizzlies, and male and female black bears, but extremely low detection rates for male grizzlies. Conversely, bear rubs had high detection rates for male and female grizzlies, but low rates for black bears. We estimated realized population growth rates, lambda, for grizzly bear males (lambda = 0.93, 95% CI = 0.74-1.17) and females (lambda = 0.90, 95% CI = 0.67-1.20) using Pradel open population models with three years of bear rub data. Lambda estimates are supported by abundance estimates from combined hair trap/bear rub closed population models and are consistent with a system that is likely driven by high levels of human-caused mortality. Our results suggest that bear rub surveys would provide an efficient and powerful means to inventory and monitor grizzly bear populations in the Central Canadian Rocky Mountains.	[Sawaya, Michael A.; Clevenger, Anthony P.] Montana State Univ, Western Transportat Inst, Bozeman, MT 59717 USA; [Sawaya, Michael A.; Kalinowski, Steven T.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Stetz, Jeffrey B.] Sinopah Wildlife Res Associates, Missoula, MT USA; [Gibeau, Michael L.] Pk Canada, Mt Natl Pk, Lake Louise, AB, Canada	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Sawaya, MA (corresponding author), Montana State Univ, Western Transportat Inst, Bozeman, MT 59717 USA.	sawaya.mike@gmail.com		Clevenger, Anthony P/0000-0003-0380-6272	Parks Canada; Western Transportation Institute-Montana State University (WTI); Woodcock Foundation; Henry P. Kendall Foundation; Wilburforce Foundation; National Fish and Wildlife Foundation; Alberta Conservation Association; Calgary Foundation; Mountain Equipment Cooperative	Parks Canada; Western Transportation Institute-Montana State University (WTI); Woodcock Foundation; Henry P. Kendall Foundation; Wilburforce Foundation; National Fish and Wildlife Foundation; Alberta Conservation Association; Calgary Foundation; Mountain Equipment Cooperative	This project was generously supported by Parks Canada, the Western Transportation Institute-Montana State University (WTI), the Woodcock Foundation, the Henry P. Kendall Foundation, and the Wilburforce Foundation. Other support was provided by the National Fish and Wildlife Foundation, Alberta Conservation Association, Calgary Foundation, and the Mountain Equipment Cooperative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: they received a small amount of funding from a commercial source, the Mountain Equipment Cooperative. Two of the authors have recently become affiliated with a commercial company, Sinopah Wildlife Research Associates. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 37 ALB SUST RES DEV; [Anonymous], 1987, BEARS BIOL MANAG; Benn B, 2002, URSUS, V13, P213; Bertch B., 2009, GRIZZLY BEAR MONITOR; Boulanger J, 2004, CAN J ZOOL, V82, P1267, DOI 10.1139/Z04-100; Boulanger J, 2004, J MAMMAL, V85, P618, DOI 10.1644/BRB-134; Boulanger J, 2002, URSUS, V13, P137; Boulanger J, 2001, CAN J ZOOL, V79, P642, DOI 10.1139/cjz-79-4-642; Boulanger J, 2008, ECOL APPL, V18, P577, DOI 10.1890/06-1941.1; Boulanger J, 2008, J WILDLIFE MANAGE, V72, P589, DOI 10.2193/2006-447; Boulanger J, 2006, URSUS, V17, P149, DOI 10.2192/1537-6176(2006)17[149:AETODM]2.0.CO;2; Brodie JF, 2007, URSUS, V18, P137, DOI 10.2192/1537-6176(2007)18[137:BBPTFD]2.0.CO;2; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Clark JD, 2010, J WILDLIFE MANAGE, V74, P1448, DOI 10.2193/2009-529; Clevenger AP, 2010, ECOL SOC, V15; Clevenger AP, 2000, CONSERV BIOL, V14, P47, DOI 10.1046/j.1523-1739.2000.00099-085.x; Coen G.M., 1983, ALBERTA I PEDOLOGY P, VI; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Dreher BP, 2007, J WILDLIFE MANAGE, V71, P2684, DOI 10.2193/2006-398; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Garshelis DL, 2006, J WILDLIFE MANAGE, V70, P1634, DOI 10.2193/0022-541X(2006)70[1634:DBIALS]2.0.CO;2; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Gibeau ML, 2001, URSUS-SERIES, V12, P121; Harris RB, 2011, URSUS, V22, P24, DOI 10.2192/URSUS-D-10-00028.1; Hayward MW, 2009, BIODIVERS CONSERV, V18, P765, DOI 10.1007/s10531-008-9436-y; Hebblewhite M, 2003, BIOL CONSERV, V112, P415, DOI 10.1016/S0006-3207(02)00341-5; Herrero S, 2001, URSUS-SERIES, V12, P161; Herrero S., 2005, BIOL DEMOGRAPHY ECOL; HOLCROFT AC, 1991, CAN FIELD NAT, V105, P335; HOLROYD G.L., 1983, ECOLOGICAL BIOPHYSIC, VIII; Hristienko H, 2007, URSUS, V18, P72, DOI 10.2192/1537-6176(2007)18[72:GITSCA]2.0.CO;2; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; Kansas JL, 1989, ECOLOGICAL STUDIES B; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kendall WL, 1997, ECOLOGY, V78, P563; KNIGHT RR, 1985, ECOLOGY, V66, P323, DOI 10.2307/1940382; Latham E, 2011, INVESTIGATING EFFECT; Long RA, 2008, NONINVASIVE SURVEY M; Mace RD, 1998, CONSERV BIOL, V12, P1005, DOI 10.1046/j.1523-1739.1998.97031.x; Mattson DJ, 2005, URSUS, V16, P11, DOI 10.2192/1537-6176(2005)016[0011:ABBAFI]2.0.CO;2; McCALL B.S, 2009, THESIS U MONTANA MIS; McGuire TM, 2000, CAN J CIVIL ENG, V27, P523, DOI 10.1139/cjce-27-3-523; McKelvey KS, 2005, MOL ECOL NOTES, V5, P716, DOI 10.1111/j.1471-8286.2005.01038.x; McKelvey KS, 2004, J WILDLIFE MANAGE, V68, P439, DOI 10.2193/0022-541X(2004)068[0439:GEAWPE]2.0.CO;2; McLellan BN, 1989, NATALITY RATE INCREA, V67, P1865; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Obbard ME, 2010, J APPL ECOL, V47, P76, DOI 10.1111/j.1365-2664.2009.01758.x; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Pollock KH, 1990, WILD MONOGR, V107; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; Proctor M, 2010, URSUS, V21, P169, DOI 10.2192/1537-6176-21.2.169; Ruth TK, 2011, J WILDLIFE MANAGE, V75, P1381, DOI 10.1002/jwmg.190; Sawaya MA, 2010, P 2009 INT C EC TRAN; Sawaya MA, 2011, J WILDLIFE MANAGE, V75, P612, DOI 10.1002/jwmg.92; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Stetz JB, 2011, J FISH WILDL MANAG, V2, P216, DOI 10.3996/082011-JFWM-048; Stetz JB, 2010, J WILDLIFE MANAGE, V74, P860, DOI 10.2193/2008-435; van der Putten WH, 2004, BASIC APPL ECOL, V5, P487, DOI 10.1016/j.baae.2004.09.003; Waits JL, 2000, ANIM CONSERV, V3, P191, DOI 10.1017/S1367943000000901; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; White GC, 2008, ENVIRON ECOL STAT, V15, P89, DOI 10.1007/s10651-007-0030-3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Woods JG, 1999, WILDLIFE SOC B, V27, P616; [No title captured]	72	61	62	9	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34777	10.1371/journal.pone.0034777	http://dx.doi.org/10.1371/journal.pone.0034777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567089	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341500007
J	Sobral, D; Schwarz, S; Bergonier, D; Brisabois, A; Fessler, AT; Gilbert, FB; Kadlec, K; Lebeau, B; Loisy-Hamon, F; Treilles, M; Pourcel, C; Vergnaud, G				Sobral, Daniel; Schwarz, Stefan; Bergonier, Dominique; Brisabois, Anne; Fessler, Andrea T.; Gilbert, Florence B.; Kadlec, Kristina; Lebeau, Benoit; Loisy-Hamon, Fabienne; Treilles, Michael; Pourcel, Christine; Vergnaud, Gilles			High Throughput Multiple Locus Variable Number of Tandem Repeat Analysis (MLVA) of Staphylococcus aureus from Human, Animal and Food Sources	PLOS ONE			English	Article							METHICILLIN-RESISTANT; LEGIONELLA-PNEUMOPHILA; GENETIC-VARIATION; STRAINS; BOVINE; DIVERSITY; POULTRY; ST398; MILK; SUSCEPTIBILITY	Staphylococcus aureus is a major human pathogen, a relevant pathogen in veterinary medicine, and a major cause of food poisoning. Epidemiological investigation tools are needed to establish surveillance of S. aureus strains in humans, animals and food. In this study, we investigated 145 S. aureus isolates recovered from various animal species, disease conditions, food products and food poisoning events. Multiple Locus Variable Number of Tandem Repeat (VNTR) analysis (MLVA), known to be highly efficient for the genotyping of human S. aureus isolates, was used and shown to be equally well suited for the typing of animal S. aureus isolates. MLVA was improved by using sixteen VNTR loci amplified in two multiplex PCRs and analyzed by capillary electrophoresis ensuring a high throughput and high discriminatory power. The isolates were assigned to twelve known clonal complexes (CCs) and -a few singletons. Half of the test collection belonged to four CCs (CC9, CC97, CC133, CC398) previously described as mostly associated with animals. The remaining eight CCs (CC1, CC5, CC8, CC15, CC25, CC30, CC45, CC51), representing 46% of the animal isolates, are common in humans. Interestingly, isolates responsible for food poisoning show a CC distribution signature typical of human isolates and strikingly different from animal isolates, suggesting a predominantly human origin.	[Sobral, Daniel; Pourcel, Christine; Vergnaud, Gilles] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Sobral, Daniel; Pourcel, Christine; Vergnaud, Gilles] CNRS, F-91405 Orsay, France; [Sobral, Daniel; Lebeau, Benoit; Loisy-Hamon, Fabienne] CEERAM, La Chapelle Sur Erdre, France; [Schwarz, Stefan; Fessler, Andrea T.; Kadlec, Kristina] Inst Farm Anim Genet, FLI, Neustadt, Germany; [Bergonier, Dominique] INRA, IHAP, UMR1225, F-31931 Toulouse, France; [Bergonier, Dominique] Univ Toulouse, INP, ENVT, IHAP,UMR1225, Toulouse, France; [Brisabois, Anne] ANSES, European Union Community Reference Lab Coagulase, Maisons Alfort, France; [Gilbert, Florence B.] INRA, IASP UR1282, F-37380 Nouzilly, France; [Treilles, Michael] Lab Dept Anal la Manche, St Lo, France; [Vergnaud, Gilles] DGA MRIS, Bagneux, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Friedrich Loeffler Institute; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE	Sobral, D (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France.	gilles.vergnaud@u-psud.fr	Vergnaud, Gilles/P-1304-2015; Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/AAC-1162-2020	Vergnaud, Gilles/0000-0003-0913-194X; Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X	European Defense Agency; German Federal Ministry of Education; Research (BMBF) through the German Aerospace Center (DLR) [01KI1014D]; association Vaincre La Mucoviscidose [RC0630]; French Direction Generale de l'Armement	European Defense Agency; German Federal Ministry of Education(Federal Ministry of Education & Research (BMBF)); Research (BMBF) through the German Aerospace Center (DLR); association Vaincre La Mucoviscidose; French Direction Generale de l'Armement(French National Research Agency (ANR))	Work by GV is part of the European Biodefense Laboratory Network (EBLN) project "Database of B-agents" supported by the European Defense Agency. The contribution of SS, ATF and KK is financially supported by the German Federal Ministry of Education and Research (BMBF) through the German Aerospace Center (DLR), grant number 01KI1014D (MedVet-Staph). This study also benefited from the support of the association Vaincre La Mucoviscidose (Grant No RC0630). The development of tools for the surveillance of bacterial pathogens is supported by the French Direction Generale de l'Armement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Argudin MA, 2011, J MED MICROBIOL, V60, P172, DOI 10.1099/jmm.0.021758-0; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Boundy S, 2012, J CLIN MICROBIOL, V50, P469, DOI 10.1128/JCM.01063-11; Chlebowicz MA, 2010, ANTIMICROB AGENTS CH, V54, P783, DOI 10.1128/AAC.00696-09; Porrero MC, 2012, VET MICROBIOL, V156, P157, DOI 10.1016/j.vetmic.2011.10.015; Cookson BD, 2007, J CLIN MICROBIOL, V45, P1830, DOI 10.1128/JCM.02402-06; Cramton SE, 2000, INFECT IMMUN, V68, P2344, DOI 10.1128/IAI.68.4.2344-2348.2000; de Almeida LM, 2011, J DAIRY RES, V78, P373, DOI 10.1017/S0022029911000379; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fessler AT, 2011, APPL ENVIRON MICROB, V77, P7151, DOI 10.1128/AEM.00561-11; Gilbert FB, 2006, VET MICROBIOL, V117, P297, DOI 10.1016/j.vetmic.2006.04.029; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Hardy KJ, 2006, J CLIN MICROBIOL, V44, P271, DOI 10.1128/JCM.44.1.271-273.2006; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Hata E, 2010, J CLIN MICROBIOL, V48, P2130, DOI 10.1128/JCM.01940-09; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Jorgensen HJ, 2005, APPL ENVIRON MICROB, V71, P8352, DOI 10.1128/AEM.71.12.8352-8361.2005; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Kehrenberg C, 2009, ANTIMICROB AGENTS CH, V53, P779, DOI 10.1128/AAC.01376-08; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Le Loir Yves, 2003, Genet Mol Res, V2, P63; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; Pourcel C, 2009, J CLIN MICROBIOL, V47, P3121, DOI 10.1128/JCM.00267-09; Rabello RF, 2007, J MED MICROBIOL, V56, P1505, DOI 10.1099/jmm.0.47357-0; Rich M, 2005, BRIT J BIOMED SCI, V62, P98, DOI 10.1080/09674845.2005.11732694; Rijnders MIA, 2009, J CLIN MICROBIOL, V47, P4090, DOI 10.1128/JCM.00820-09; Robinson DA, 2004, CLIN MICROBIOL INFEC, V10, P92, DOI 10.1111/j.1469-0691.2004.00768.x; Sabat A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003; Sakwinska O, 2011, APPL ENVIRON MICROB, V77, P5908, DOI 10.1128/AEM.00238-11; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Schwarz S, 2008, J ANTIMICROB CHEMOTH, V61, P282, DOI 10.1093/jac/dkm487; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Sieber S, 2011, MICROB DRUG RESIST, V17, P471, DOI 10.1089/mdr.2010.0188; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Sobral D, 2011, APPL ENVIRON MICROB, V77, P6899, DOI 10.1128/AEM.05556-11; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Vainio A, 2011, EUR J CLIN MICROBIOL, V30, P789, DOI 10.1007/s10096-011-1158-5; van den Berg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026170; Visca P, 2011, MICROBIOL-SGM, V157, P2582, DOI 10.1099/mic.0.047258-0; Vu-Thien H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-24; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Wattinger L, 2012, EUR J CLIN MICROBIOL, V31, P455, DOI 10.1007/s10096-011-1330-y; Witt RT, 2010, EUR J CLIN MICROBIOL, V29, P295, DOI 10.1007/s10096-009-0856-8	54	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e33967	10.1371/journal.pone.0033967	http://dx.doi.org/10.1371/journal.pone.0033967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567085	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341500003
J	Vazquez-Cintron, EJ; Monu, NR; Burns, JC; Blum, R; Chen, G; Lopez, P; Ma, J; Radoja, S; Frey, AB				Vazquez-Cintron, Edwin J.; Monu, Ngozi R.; Burns, Jeremy C.; Blum, Roy; Chen, Gregory; Lopez, Peter; Ma, Jennifer; Radoja, Sasa; Frey, Alan B.			Protocadherin-18 Is a Novel Differentiation Marker and an Inhibitory Signaling Receptor for CD8(+) Effector Memory T Cells	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; LYTIC FUNCTION; ANTIGEN; LYMPHOCYTES; EXPRESSION; ADHESION; ACTIVATION; EXHAUSTION; TOLERANCE; MECHANISM	CD8(+) tumor infiltrating T cells (TIL) lack effector-phase functions due to defective proximal TCR-mediated signaling previously shown to result from inactivation of p56(lck) kinase. We identify a novel interacting partner for p56(lck) in nonlytic TIL, Protocadherin-18 ('pcdh18'), and show that pcdh18 is transcribed upon in vitro or in vivo activation of all CD8+ central memory T cells (CD44(+) CD62L(hi) CD127(+)) coincident with conversion into effector memory cells (CD44(+) CD62L(lo) CD127(+)). Expression of pcdh18 in primary CD8(+) effector cells induces the phenotype of nonlytic TIL: defective proximal TCR signaling, cytokine secretion, and cytolysis, and enhanced AICD. pcdh18 contains a motif (centered at Y842) shared with src kinases (QGQYQP) that is required for the inhibitory phenotype. Thus, pcdh18 is a novel activation marker of CD8+ memory T cells that can function as an inhibitory signaling receptor and restrict the effector phase.	[Vazquez-Cintron, Edwin J.; Burns, Jeremy C.; Chen, Gregory; Frey, Alan B.] NYU, Dept Cell Biol, Langone Sch Med New York, New York, NY 10016 USA; [Monu, Ngozi R.; Blum, Roy; Frey, Alan B.] NYU, Langone Sch Med New York, New York Univ Canc Inst, New York, NY USA; [Lopez, Peter] NYU, Dept Pathol, Langone Sch Med New York, New York, NY 10016 USA; [Ma, Jennifer; Radoja, Sasa] Childrens Natl Med Ctr, Childrens Res Inst, Sheikh Zayed Inst Pediat Surg Innovat, Ctr Canc & Immunol Res, Washington, DC 20010 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Children's National Health System	Vazquez-Cintron, EJ (corresponding author), NYU, Dept Cell Biol, Langone Sch Med New York, 550 1St Ave, New York, NY 10016 USA.	alan.frey@nyumc.org	Lopez, Peter/AAP-7234-2020	Blum, Roy/0000-0002-3987-7198; Lopez, Peter/0000-0002-8587-7148; Burns, Jeremy/0000-0003-3853-0237; frey, alan/0000-0003-4151-561X; Vazquez-Cintron, Edwin/0000-0002-4397-3713	National Institutes of Health [F31 CA136164, F31 CA162875, R01 CA108573, 5P30CA016087-33]; NATIONAL CANCER INSTITUTE [R01CA108573, P30CA016087, F31CA136164, F31CA162875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (grants F31 CA136164 to EJV-C, F31 CA162875 to CB, R01 CA108573 to ABF, and 5P30CA016087-33 in support of the NYUMC Cytometry Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamar E, 2008, DEV BIOL, V318, P335, DOI 10.1016/j.ydbio.2008.03.040; Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blomgran R, 2011, J IMMUNOL, V186, P7110, DOI 10.4049/jimmunol.1100001; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Frey AB, 2006, J LEUKOCYTE BIOL, V79, P652, DOI 10.1189/jlb.1105628; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Homayouni R, 2001, BIOCHEM BIOPH RES CO, V289, P539, DOI 10.1006/bbrc.2001.5998; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Koneru M, 2006, J IMMUNOL, V176, P6103, DOI 10.4049/jimmunol.176.10.6103; Ma JSY, 2007, J IMMUNOL, V178, P7814, DOI 10.4049/jimmunol.178.12.7814; Monu N, 2007, CANCER RES, V67, P11447, DOI 10.1158/0008-5472.CAN-07-1441; Newman DK, 2001, BLOOD, V97, P2351, DOI 10.1182/blood.V97.8.2351; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Radoja S, 2001, J IMMUNOL, V166, P6074, DOI 10.4049/jimmunol.166.10.6074; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Vazquez-Cintron EJ, 2010, J IMMUNOL, V185, P7133, DOI 10.4049/jimmunol.1001157; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	29	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36101	10.1371/journal.pone.0036101	http://dx.doi.org/10.1371/journal.pone.0036101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567129	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341500047
J	van Rikxoort, M; Michaelis, M; Wolschek, M; Muster, T; Egorov, A; Seipelt, J; Doerr, HW; Cinatl, J				van Rikxoort, Marijke; Michaelis, Martin; Wolschek, Markus; Muster, Thomas; Egorov, Andrej; Seipelt, Joachim; Doerr, Hans Wilhelm; Cinatl, Jindrich, Jr.			Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame	PLOS ONE			English	Article							EPITHELIAL-CELLS; IN-VIVO; CANCER-CELLS; TUMOR-CELLS; PROTEIN; APOPTOSIS; MELANOMA; SENSITIVITY; ACTIVATION; RESISTANCE	Oncolytic influenza A viruses with deleted NS1 gene (delNS1) replicate selectively in tumour cells with defective interferon response and/or activated Ras/Raf/MEK/ERK signalling pathway. To develop a delNS1 virus with specific immunostimulatory properties, we used an optimised technology to insert the interleukin-15 (IL-15) coding sequence into the viral NS gene segment (delNS1-IL-15). DelNS1 and delNS1-IL-15 exerted similar oncolytic effects. Both viruses replicated and caused caspase-dependent apoptosis in interferon-defective melanoma cells. Virus replication was required for their oncolytic activity. Cisplatin enhanced the oncolytic activity of delNS1 viruses. The cytotoxic drug increased delNS1 replication and delNS1-induced caspase-dependent apoptosis. Interference with MEK/ERK signalling by RNAi-mediated depletion or the MEK inhibitor U0126 did not affect the oncolytic effects of the delNS1 viruses. In oncolysis sensitive melanoma cells, delNS1-IL-15 (but not delNS1) infection resulted in the production of IL-15 levels ranging from 70 to 1140 pg/mL in the cell culture supernatants. The supernatants of delNS1-IL-15-infected (but not of delNS1-infected) melanoma cells induced primary human natural killer cell-mediated lysis of non-infected tumour cells. In conclusion, we constructed a novel oncolytic influenza virus that combines the oncolytic activity of delNS1 viruses with immunostimulatory properties through production of functional IL-15. Moreover, we showed that the oncolytic activity of delNS1 viruses can be enhanced in combination with cytotoxic anti-cancer drugs.	[van Rikxoort, Marijke; Michaelis, Martin; Doerr, Hans Wilhelm; Cinatl, Jindrich, Jr.] Univ Frankfurt Klinikum, Inst Med Virol, D-6000 Frankfurt, Germany; [Wolschek, Markus; Muster, Thomas; Egorov, Andrej; Seipelt, Joachim] AVIR Green Hills Biotechnol, Vienna, Austria	Goethe University Frankfurt; Goethe University Frankfurt Hospital	van Rikxoort, M (corresponding author), Univ Frankfurt Klinikum, Inst Med Virol, D-6000 Frankfurt, Germany.	Cinatl@em.uni-frankfurt.de		Michaelis, Martin/0000-0002-5710-5888; Seipelt, Joachim/0000-0001-9865-814X	Hilfe fur krebskranke Kinder, Frankfurt/Main e.V.; Frankfurter Stiftung fur krebskranke Kinder der Hilfe fur krebskranke Kinder Frankfurt e.V.; European Commission [512864, 512054]	Hilfe fur krebskranke Kinder, Frankfurt/Main e.V.; Frankfurter Stiftung fur krebskranke Kinder der Hilfe fur krebskranke Kinder Frankfurt e.V.; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the organization "Hilfe fur krebskranke Kinder, Frankfurt/Main e.V." (http://www.hilfe-fuer-krebskranke-kinder.de/), by the foundation "Frankfurter Stiftung fur krebskranke Kinder der Hilfe fur krebskranke Kinder Frankfurt e.V.'' (http://www.kinderkrebsstiftung-frankfurt.de/), and by the European Commission-funded Co-operative Research and SpeciWc Targeted Research Projects; COOP-CT-2004, Contract Nr. 512864 and LSHBCT-2004, Contract Nr. 512054, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann M, 2001, CANCER RES, V61, P8188; Droebner K, 2011, ANTIVIR RES, V92, P195, DOI 10.1016/j.antiviral.2011.08.002; Efferson CL, 2006, J VIROL, V80, P383, DOI 10.1128/JVI.80.1.383-394.2006; Egorov A, 1998, J VIROL, V72, P6437, DOI 10.1128/JVI.72.8.6437-6441.1998; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Goydos JS, 2005, J AM COLL SURGEONS, V200, P362, DOI 10.1016/j.jamcollsurg.2004.10.032; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Hwang TH, 2011, MOL THER, V19, P1913, DOI 10.1038/mt.2011.132; Jackson D, 2010, VIROLOGY, V396, P94, DOI 10.1016/j.virol.2009.10.004; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Kaur B, 2009, CURR GENE THER, V9, P341, DOI 10.2174/156652309789753329; Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07; Lev DC, 2004, J CLIN ONCOL, V22, P2092, DOI 10.1200/JCO.2004.11.070; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Meyer P, 2003, INT J CANCER, V106, P78, DOI 10.1002/ijc.11199; Michaelis M, 2004, MOL PHARMACOL, V65, P520, DOI 10.1124/mol.65.3.520; Michaelis M, 2009, INVEST OPHTH VIS SCI, V50, P5419, DOI 10.1167/iovs.09-3752; Muster T, 2004, INT J CANCER, V110, P15, DOI 10.1002/ijc.20078; Ogbomo H, 2006, BIOCHEM BIOPH RES CO, V339, P375, DOI 10.1016/j.bbrc.2005.11.025; Ogbomo H, 2010, MED MICROBIOL IMMUN, V199, P93, DOI 10.1007/s00430-009-0139-0; Roychowdhury S, 2004, CANCER RES, V64, P8062, DOI 10.1158/0008-5472.CAN-04-1860; Stephenson KB, 2012, CANCER GENE THER, V19, P238, DOI 10.1038/cgt.2011.81; Sturlan S, 2010, CANCER BIOL THER, V10, P592, DOI 10.4161/cbt.10.6.12565; Tamai H, 2011, BLOOD           1024; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang XD, 2010, BIOCHEM BIOPH RES CO, V395, P141, DOI 10.1016/j.bbrc.2010.03.160; Wolschek M, 2011, J VIROL, V85, P2469, DOI 10.1128/JVI.01650-10; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Zhang CF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-181; Zhirnov O, 2003, VIROLOGY, V313, P198, DOI 10.1016/S0042-6822(03)00264-2; Zhirnov OP, 2002, J VIROL, V76, P1617, DOI 10.1128/JVI.76.4.1617-1625.2002; Zito CR, 2012, J CELL BIOCHEM, V113, P725, DOI 10.1002/jcb.23402	36	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36506	10.1371/journal.pone.0036506	http://dx.doi.org/10.1371/journal.pone.0036506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563505	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340700054
J	Cortes-Romero, C; Martinez-Hernandez, A; Mellado-Mojica, E; Lopez, MG; Simpson, J				Cortes-Romero, Celso; Martinez-Hernandez, Aida; Mellado-Mojica, Erika; Lopez, Mercedes G.; Simpson, June			Molecular and Functional Characterization of Novel Fructosyltransferases and Invertases from Agave tequilana	PLOS ONE			English	Article							SUCROSE-FRUCTAN 6-FRUCTOSYLTRANSFERASE; CELL-WALL INVERTASE; X-RAY-DIFFRACTION; PERENNIAL RYEGRASS; EXTRACELLULAR INVERTASE; NEUTRAL INVERTASE; EXPRESSION; GENE; 1-FRUCTOSYLTRANSFERASE; SUBSTRATE	Fructans are the main storage polysaccharides found in Agave species. The synthesis of these complex carbohydrates relies on the activities of specific fructosyltransferase enzymes closely related to the hydrolytic invertases. Analysis of Agave tequilana transcriptome data led to the identification of ESTs encoding putative fructosyltransferases and invertases. Based on sequence alignments and structure/function relationships, two different genes were predicted to encode 1-SST and 6G-FFT type fructosyltransferases, in addition, 4 genes encoding putative cell wall invertases and 4 genes encoding putative vacuolar invertases were also identified. Probable functions for each gene, were assigned based on conserved amino acid sequences and confirmed for 2 fructosyltransferases and one invertase by analyzing the enzymatic activity of recombinant Agave protein s expressed and purified from Pichia pastoris. The genome organization of the fructosyltransferase/invertase genes, for which the corresponding cDNA contained the complete open reading frame, was found to be well conserved since all genes were shown to carry a 9 bp mini-exon and all showed a similar structure of 8 exons/7 introns with the exception of a cell wall invertase gene which has 7 exons and 6 introns. Fructosyltransferase genes were strongly expressed in the storage organs of the plants, especially in vegetative stages of development and to lower levels in photosynthetic tissues, in contrast to the invertase genes where higher levels of expression were observed in leaf tissues and in mature plants.	[Cortes-Romero, Celso; Simpson, June] Cinvestav Irapuato, Dept Plant Genet Engn, Guanajuato, Mexico; [Martinez-Hernandez, Aida] Sihochac, Colegio Postgraduados Campus Campeche, Champoton, Campeche, Mexico; [Mellado-Mojica, Erika; Lopez, Mercedes G.] Cinvestav Irapuato, Dept Biochem & Biotechnol, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Colegio de Postgraduados - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Cortes-Romero, C (corresponding author), Cinvestav Irapuato, Dept Plant Genet Engn, Guanajuato, Mexico.	jsimpson@ira.cinvestav.mx	Simpson, June/I-1057-2012	Simpson, June/0000-0002-1891-4914; Martinez-Hernandez, Aida/0000-0003-1784-670X; Mellado-Mojica, Erika/0000-0002-7845-1085	Fondos Mixtos from Guanajuato State [GTO-04-C02-143]; Fondos Mixtos from Campeche State [CAMP-2006-C01-23821]; CONCYTEG [08-03-K662-076 A05]; CONACyT [203505, 203555]	Fondos Mixtos from Guanajuato State; Fondos Mixtos from Campeche State; CONCYTEG; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support was obtained from Fondos Mixtos from Guanajuato State under grant number GTO-04-C02-143, Fondos Mixtos from Campeche State under grant number CAMP-2006-C01-23821, CONCYTEG under grant number 08-03-K662-076 A05 and doctoral fellowships CONACyT 203505 and 203555 to CCR and EMM respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach D, 2004, FEBS LETT, V567, P214, DOI 10.1016/j.febslet.2004.04.064; Arrizon J, 2010, FOOD CHEM, V122, P123, DOI 10.1016/j.foodchem.2010.02.028; Avila-Fernandez A, 2007, PLANT SCI, V173, P478, DOI 10.1016/j.plantsci.2007.07.009; Bocock PN, 2008, PLANTA, V227, P565, DOI 10.1007/s00425-007-0639-3; Bournay AS, 1996, NUCLEIC ACIDS RES, V24, P2347, DOI 10.1093/nar/24.12.2347; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; De Coninck B, 2005, PLANT CELL ENVIRON, V28, P432, DOI 10.1111/j.1365-3040.2004.01281.x; De Roover J, 2000, PLANTA, V210, P808, DOI 10.1007/s004250050683; FELSENSTEIN J, 1986, ANN STAT, V14, P1304, DOI 10.1214/aos/1176350146; Francki MG, 2006, GENOME, V49, P1081, DOI 10.1139/G06-066; Fujishima M, 2005, NEW PHYTOL, V165, P513, DOI 10.1111/j.1469-8137.2004.01231.x; Curbelo YG, 2009, CUBAN J AGR SCI, V43, P169; Hayes MA, 2010, PLANT PHYSIOL, V153, P211, DOI 10.1104/pp.110.154765; HENDRY GAF, 1993, NEW PHYTOL, V123, P3; Henson CA, 1996, PLANT PHYSIOL, V110, P639, DOI 10.1104/pp.110.2.639; Ji XM, 2005, PLANT MOL BIOL, V59, P945, DOI 10.1007/s11103-005-2415-8; Ji XM, 2005, J MOL EVOL, V60, P615, DOI 10.1007/s00239-004-0242-1; Ji XM, 2007, NEW PHYTOL, V173, P50, DOI 10.1111/j.1469-8137.2006.01896.x; Ji XM, 2010, PLANT CELL ENVIRON, V33, P926, DOI 10.1111/j.1365-3040.2010.02130.x; Kawakami A, 2002, BIOSCI BIOTECH BIOCH, V66, P2297, DOI 10.1271/bbb.66.2297; Lara MEB, 2004, PLANT CELL, V16, P1276, DOI 10.1105/tpc.018929; Lasseur B, 2009, PLANT PHYSIOL, V149, P327, DOI 10.1104/pp.108.125559; Lasseur B, 2006, J EXP BOT, V57, P2719, DOI 10.1093/jxb/erl034; Le Roy K, 2007, PLANT PHYSIOL, V145, P616, DOI 10.1104/pp.107.105049; Le Roy K, 2007, NEW PHYTOL, V176, P317, DOI 10.1111/j.1469-8137.2007.02174.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MG, 2003, J AGR FOOD CHEM, V51, P7835, DOI 10.1021/jf030383v; Mancilla-Margalli NA, 2006, J AGR FOOD CHEM, V54, P7832, DOI 10.1021/jf060354v; PILONSMITS EAH, 1995, PLANT PHYSIOL, V107, P125, DOI 10.1104/pp.107.1.125; Qi XP, 2007, PLANT MOL BIOL, V64, P575, DOI 10.1007/s11103-007-9177-4; Reiffova K, 2006, J CHROMATOGR A, V1110, P214, DOI 10.1016/j.chroma.2006.01.039; Ritsema T, 2004, PLANT MOL BIOL, V54, P853, DOI 10.1007/s11103-004-0276-1; Ritsema T, 2006, PLANT J, V48, P228, DOI 10.1111/j.1365-313X.2006.02862.x; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Sambrook J., 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schroeven L, 2009, J EXP BOT, V60, P3687, DOI 10.1093/jxb/erp208; Seo PJ, 2011, PLANT J, V65, P418, DOI 10.1111/j.1365-313X.2010.04432.x; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; SHIOMI N, 1989, J PLANT PHYSIOL, V134, P151, DOI 10.1016/S0176-1617(89)80048-3; Shiomi N., 2008, Journal of Applied Glycoscience, V55, P25, DOI 10.5458/jag.55.25; Simpson J, 2011, GCB BIOENERGY, V3, P25, DOI 10.1111/j.1757-1707.2010.01079.x; Sturm A, 1999, PLANT PHYSIOL, V121, P1, DOI 10.1104/pp.121.1.1; Taliercio E, 2010, MOL BIOL REP, V37, P3915, DOI 10.1007/s11033-010-0048-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ueno K, 2005, NEW PHYTOL, V165, P813, DOI 10.1111/j.1469-8137.2004.01294.x; Van den Ende W, 2011, PLANT PHYSIOL, V155, P603, DOI 10.1104/pp.110.162222; Van den Ende W, 2009, FEBS J, V276, P5788, DOI 10.1111/j.1742-4658.2009.07316.x; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Verhaest M, 2004, ACTA CRYSTALLOGR D, V60, P553, DOI 10.1107/S0907444903029317; Verhaest M, 2007, NEW PHYTOL, V174, P90, DOI 10.1111/j.1469-8137.2007.01988.x; Vijn I, 1999, PLANT PHYSIOL, V120, P351, DOI 10.1104/pp.120.2.351; Wang N, 1998, PLANT PHYSIOL, V116, P709, DOI 10.1104/pp.116.2.709; Wei JZ, 2001, J PLANT PHYSIOL, V158, P1203, DOI 10.1078/0176-1617-00241; Wingler A, 2004, NEW PHYTOL, V161, P781, DOI 10.1111/j.1469-8137.2004.00996.x; Xiang L, 2011, PLANT SIGNAL BEHAV, V6, P1567, DOI 10.4161/psb.6.10.17036; Yildiz S, 2011, FOOD REV INT, V27, P16, DOI 10.1080/87559129.2010.518295	58	25	26	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35878	10.1371/journal.pone.0035878	http://dx.doi.org/10.1371/journal.pone.0035878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558253	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340200028
J	Duan, ZW; Xie, P; Li, W; Wang, PY				Duan, Zhao-Wen; Xie, Ping; Li, Wei; Wang, Peng-Ye			Are Coiled-Coils of Dimeric Kinesins Unwound during Their Walking on Microtubule?	PLOS ONE			English	Article							NCD MOTOR PROTEIN; CRYSTAL-STRUCTURE; YEAST KAR3; NECK; HEAD; MECHANISM; MOVEMENT; ROTATION; BINDING; DOMAIN	Dimeric kinesin motor proteins such as homodimeric kinesin-1, homodimeric Ncd and heterodimeric Kar3/Vik1are composed of two head domains which are connected together by a rod-shaped, coiled-coil stalk. Despite the extensive and intensive studies on structures, kinetics, dynamics and walking mechanism of the dimers, whether their coiled-coils are unwound or not during their walking on the microtubule is still an unclear issue. Here, we try to clarify this issue by using molecular dynamics simulations. Our simulation results showed that, for Ncd, a large change in potential of mean force is required to unwind the coiled-coil by only several pairs of residues. For both Ncd and kinesin-1, the force required to initiate the coiled-coil unwinding is larger than that required for unfolding of the single alpha-helix that forms the coiled-coil or is larger than that required to unwind the DNA duplex, which is higher than the unbinding force of the kinesin head from the microtubule in strong microtubule-binding states. Based on these results and the comparison of the sequence between the coiled-coil of Kar3/Vik1 and those of Ncd and kinesin-1, it was deduced that the coiled-coil of the Kar3/Vik1 should also be very stable. Thus, we concluded that the coiled-coils of kinesin-1, Ncd and Kar3/Vik1 are almost impossible to unwind during their walking on the microtubule.	[Duan, Zhao-Wen] Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing 100080, Peoples R China; Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Institute of Physics, CAS	Duan, ZW (corresponding author), Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, POB 603, Beijing 100080, Peoples R China.	pxie@aphy.iphy.ac.cn	Duan, Zhaowen/AHE-6206-2022	Wang, Peng-Ye/0000-0002-9765-0610	National Natural Science Foundation of China [10974248, 10834014]; National Basic Research Program of China (973 Program) [2009CB930704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 10974248 and 10834014) and the National Basic Research Program of China (973 Program) (Grant No. 2009CB930704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; Bartels C, 2000, CHEM PHYS LETT, V331, P446, DOI 10.1016/S0009-2614(00)01215-X; Bornschlogl T, 2009, P NATL ACAD SCI USA, V106, P6992, DOI 10.1073/pnas.0812620106; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; Cross RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-107; ENDOW SA, 1994, EMBO J, V13, P2708, DOI 10.1002/j.1460-2075.1994.tb06561.x; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Heuston E, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-19; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Hou RZ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/3/036003; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Ito M, 2006, BIOCHEMISTRY-US, V45, P3315, DOI 10.1021/bi051480f; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kutys ML, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000980; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Miyazono Y, 2010, EMBO J, V29, P93, DOI 10.1038/emboj.2009.319; Paci E, 2000, P NATL ACAD SCI USA, V97, P6521, DOI 10.1073/pnas.100124597; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Scholey JM, 1996, J CELL BIOL, V133, P1, DOI 10.1083/jcb.133.1.1; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Thormahlen M, 1998, J STRUCT BIOL, V122, P30, DOI 10.1006/jsbi.1998.3986; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Tripet B, 2002, J STRUCT BIOL, V137, P220, DOI 10.1006/jsbi.2002.4475; Uemura S, 2002, P NATL ACAD SCI USA, V99, P5977, DOI 10.1073/pnas.092546199; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wade RH, 2000, NAT STRUCT BIOL, V7, P456, DOI 10.1038/75850; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Woehlke G, 2007, CELL, V128, P1033, DOI 10.1016/j.cell.2007.03.003; Xie P, 2008, BBA-BIOENERGETICS, V1777, P1195, DOI 10.1016/j.bbabio.2008.04.040; Xie P, 2007, J MOL BIOL, V366, P976, DOI 10.1016/j.jmb.2006.10.081; Xie P, 2006, BIOPHYS CHEM, V122, P90, DOI 10.1016/j.bpc.2006.02.010; Xie P, 2010, INT J BIOL SCI, V6, P665, DOI 10.7150/ijbs.6.665; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	60	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36071	10.1371/journal.pone.0036071	http://dx.doi.org/10.1371/journal.pone.0036071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558333	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000119
J	Scantlebury, M; Danek-Gontard, M; Bateman, PW; Bennett, NC; Manjerovic, MB; Joubert, KE; Waterman, JM				Scantlebury, Michael; Danek-Gontard, Marine; Bateman, Philip W.; Bennett, Nigel C.; Manjerovic, Mary-Beth; Joubert, Kenneth E.; Waterman, Jane M.			Seasonal Patterns of Body Temperature Daily Rhythms in Group-Living Cape Ground Squirrels Xerus inauris	PLOS ONE			English	Article							COMMON SPINY MICE; NONSHIVERING THERMOGENESIS; AETHOMYS-NAMAQUENSIS; THALLOMYS-PAEDULCUS; HEAT-PRODUCTION; WATER ECONOMY; THERMOREGULATION; RODENTIA; HETEROTHERMY; PHOTOPERIOD	Organisms respond to cyclical environmental conditions by entraining their endogenous biological rhythms. Such physiological responses are expected to be substantial for species inhabiting arid environments which incur large variations in daily and seasonal ambient temperature (T-a). We measured core body temperature (T-b) daily rhythms of Cape ground squirrels Xerus inauris inhabiting an area of Kalahari grassland for six months from the Austral winter through to the summer. Squirrels inhabited two different areas: an exposed flood plain and a nearby wooded, shady area, and occurred in different social group sizes, defined by the number of individuals that shared a sleeping burrow. Of a suite of environmental variables measured, maximal daily T-a provided the greatest explanatory power for mean T-b whereas sunrise had greatest power for T-b acrophase. There were significant changes in mean T-b and T-b acrophase over time with mean T-b increasing and T-b acrophase becoming earlier as the season progressed. Squirrels also emerged from their burrows earlier and returned to them later over the measurement period. Greater increases in T-b, sometimes in excess of 5 degrees C, were noted during the first hour post emergence, after which T-b remained relatively constant. This is consistent with observations that squirrels entered their burrows during the day to 'offload' heat. In addition, greater T-b amplitude values were noted in individuals inhabiting the flood plain compared with the woodland suggesting that squirrels dealt with increased environmental variability by attempting to reduce their T-a-T-b gradient. Finally, there were significant effects of age and group size on T-b with a lower and less variable T-b in younger individuals and those from larger group sizes. These data indicate that Cape ground squirrels have a labile T-b which is sensitive to a number of abiotic and biotic factors and which enables them to be active in a harsh and variable environment.	[Scantlebury, Michael; Bateman, Philip W.; Bennett, Nigel C.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Scantlebury, Michael; Danek-Gontard, Marine] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Manjerovic, Mary-Beth; Waterman, Jane M.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Joubert, Kenneth E.] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Pharmacol Sect, ZA-0002 Pretoria, South Africa; [Waterman, Jane M.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	University of Pretoria; Queens University Belfast; State University System of Florida; University of Central Florida; University of Pretoria; University of Manitoba	Scantlebury, M (corresponding author), Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa.	m.scantlebury@qub.ac.uk	Bateman, Bill/B-7751-2019; Bennett, Nigel/E-4238-2010	Bateman, Bill/0000-0002-3036-5479; Joubert, Kenneth/0000-0003-0656-2090; Bennett, Nigel/0000-0001-9748-2947	National Research Foundation [IBN0130600]; Natural Science and Engineering Research Council of Canada; National Research Foundation-SAR Chair; University of Pretoria PDRF	National Research Foundation; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Foundation-SAR Chair; University of Pretoria PDRF	This research was funded by a National Research Foundation Grant IBN0130600 and a Natural Science and Engineering Research Council of Canada Discovery Grant to JMW, a National Research Foundation-SAR Chair to NCB and a University of Pretoria PDRF to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; Aschoff J., 1982, COMPANION ANIMAL PHY, P173; BENNETT AF, 1984, PHYSIOL ZOOL, V57, P57, DOI 10.1086/physzool.57.1.30155968; Berteaux D, 1996, OIKOS, V76, P330, DOI 10.2307/3546205; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; Canals M, 1998, ACTA THERIOL, V43, P337, DOI 10.4098/AT.arch.98-45; Cowling R.M., 2004, VEGETATION SO AFRICA; Fick LG, 2009, COMP BIOCHEM PHYS A, V152, P334, DOI 10.1016/j.cbpa.2008.11.004; Gilbert C, 2007, AM J PHYSIOL-REG I, V293, pR867, DOI 10.1152/ajpregu.00081.2007; GOLIGHTLY RT, 1978, ECOLOGY, V59, P897, DOI 10.2307/1938542; Gur Hakan, 2010, Hacettepe Journal of Biology and Chemistry, V38, P247; Haim A, 2005, CHRONOBIOL INT, V22, P59, DOI 10.1081/CBI-200038144; Haim A, 1996, J THERM BIOL, V21, P37, DOI 10.1016/0306-4565(96)81275-7; HAIM A, 1987, S AFR J ZOOL, V22, P45; HAIM A, 1990, J EXP ZOOL, V256, P237, DOI 10.1002/jez.1402560302; Haim Abraham, 1994, Polish Ecological Studies, V20, P357; HARRI M, 1988, J THERM BIOL, V13, P169, DOI 10.1016/0306-4565(88)90029-0; HAYES JP, 1992, PHYSIOL ZOOL, V65, P742, DOI 10.1086/physzool.65.4.30158537; HELDMAIER G, 1989, J BIOL RHYTHM, V4, P251, DOI 10.1177/074873048900400211; HERZIGSTRASCHIL B, 1979, FOLIA ZOOL, V28, P119; HERZIGSTRASCHIL B, 1978, Z SAUGETIERKD, V43, P262; Hetem RS, 2010, J COMP PHYSIOL B, V180, P1111, DOI 10.1007/s00360-010-0480-z; Hillegass MA, 2008, BEHAV ECOL, V19, P1006, DOI 10.1093/beheco/arn070; Hudson J.W., 1972, Symposia Zool Soc Lond, VNo. 31, P191; Huey R.B., 1990, Cold Spring Harbor Monograph Series, V19, P37; Jackson CR, 2009, J ZOOL, V278, P299, DOI 10.1111/j.1469-7998.2009.00575.x; Joubert KE, 2011, J S AFR VET ASSOC, V82, P94; Kauffman AS, 2003, PHYSIOL BEHAV, V79, P247, DOI 10.1016/S0031-9384(03)00115-X; Kenagy G. J., 1982, VERTEBRATE CIRCADIAN; Kenagy GJ, 2002, REV CHIL HIST NAT, V75, P567; Kinahan AA, 2007, PHYSIOL BEHAV, V92, P560, DOI 10.1016/j.physbeh.2007.05.001; Kotze J, 2008, PHYSIOL BEHAV, V93, P215, DOI 10.1016/j.physbeh.2007.08.016; Levy O, 2011, PHYSIOL BIOCHEM ZOOL, V84, P175, DOI 10.1086/658171; Long RA, 2005, J MAMMAL, V86, P314, DOI 10.1644/BRG-224.1; Lovegrove BG, 2009, J COMP PHYSIOL B, V179, P451, DOI 10.1007/s00360-008-0329-x; LOVEGROVE BG, 1994, AUST J ZOOL, V42, P65, DOI 10.1071/ZO9940065; LOVEGROVE BG, 1991, J THERM BIOL, V16, P199, DOI 10.1016/0306-4565(91)90026-X; MADISON DM, 1984, BEHAV ECOL SOCIOBIOL, V15, P9, DOI 10.1007/BF00310209; Manjerovic MB, 2010, THESIS U CENTRAL FLO; MINORS DS, 1989, BIOL RHYTHMS CLIN PR, P272; Morgan E, 2004, BIOL RHYTHM RES, V35, P3, DOI 10.1080/09291010412331313205; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Ostrowski S, 2006, J EXP BIOL, V209, P1421, DOI 10.1242/jeb.02151; Ostrowski S, 2003, J EXP BIOL, V206, P1471, DOI 10.1242/jeb.00275; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Pettitt BA, 2008, J ZOOL, V276, P291, DOI 10.1111/j.1469-7998.2008.00491.x; Piccione G, 2002, J THERM BIOL, V27, P333, DOI 10.1016/S0306-4565(01)00076-6; Piccione G, 2009, J THERM BIOL, V34, P171, DOI 10.1016/j.jtherbio.2009.01.004; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Refinetti R, 1999, J THERM BIOL, V24, P477, DOI 10.1016/S0306-4565(99)00077-7; ROOD JP, 1980, J WILDLIFE MANAGE, V44, P500, DOI 10.2307/3807988; ROVERUD RC, 1991, PHYSIOL ZOOL, V64, P1527, DOI 10.1086/physzool.64.6.30158228; Scantlebury M, 2008, J COMP PHYSIOL B, V178, P887, DOI 10.1007/s00360-008-0277-5; Scantlebury M, 2006, FUNCT ECOL, V20, P166, DOI 10.1111/j.1365-2435.2006.01074.x; Scantlebury M, 2003, FUNCT ECOL, V17, P178, DOI 10.1046/j.1365-2435.2003.00717.x; Scantlebury M, 2010, J ZOOL, V281, P132, DOI 10.1111/j.1469-7998.2010.00687.x; Scantlebury M, 2009, COMP BIOCHEM PHYS A, V154, P551, DOI 10.1016/j.cbpa.2009.08.021; Schwimmer H, 2010, CHRONOBIOL INT, V27, P1401, DOI 10.3109/07420528.2010.505355; Shanas U, 2002, COMP BIOCHEM PHYS A, V132, P287, DOI 10.1016/S1095-6433(02)00033-8; Sharpe PB, 1999, J THERM BIOL, V24, P265, DOI 10.1016/S0306-4565(99)00021-2; Signer C, 2011, FUNCT ECOL, V25, P537, DOI 10.1111/j.1365-2435.2010.01806.x; Sothern R., 1972, PHYSIOL TEACH, V1, P1; Spiegel M, 2004, J THERM BIOL, V29, P635, DOI 10.1016/j.jtherbio.2004.08.037; STRASCHIL B, 1975, S AFR J SCI, V71, P215; TURK A, 1988, OECOLOGIA, V76, P544, DOI 10.1007/BF00397867; Unck CE, 2009, ANIM BEHAV, V78, P625, DOI 10.1016/j.anbehav.2009.05.028; VAN ZYL J. H. M., 1965, ZOOL AFRICANA, V1, P55; VANHEERDEN J, 1987, J ARID ENVIRON, V13, P83; Walsberg GE, 2000, BIOSCIENCE, V50, P109, DOI 10.1641/0006-3568(2000)050[0109:SMIHDS]2.3.CO;2; Warnecke L, 2008, NATURWISSENSCHAFTEN, V95, P73, DOI 10.1007/s00114-007-0293-4; Waterman JM, 1996, J MAMMAL, V77, P134, DOI 10.2307/1382715; Waterman JM, 1998, ANIM BEHAV, V56, P459, DOI 10.1006/anbe.1998.0780; WATERMAN JM, 1995, ETHOLOGY, V101, P130, DOI 10.1111/j.1439-0310.1995.tb00352.x; Wilson WA, 2010, J COMP PHYSIOL B, V180, P1099, DOI 10.1007/s00360-010-0472-z; WOLLNIK F, 1995, J COMP PHYSIOL B, V165, P171; Wooden KM, 2004, J EXP BIOL, V207, P41, DOI 10.1242/jeb.00717; Wooden KM, 2002, J EXP BIOL, V205, P2099; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x	79	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36053	10.1371/journal.pone.0036053	http://dx.doi.org/10.1371/journal.pone.0036053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558324	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000114
J	Wu, JQ; Wang, X; Beveridge, NJ; Tooney, PA; Scott, RJ; Carr, VJ; Cairns, MJ				Wu, Jing Qin; Wang, Xi; Beveridge, Natalie J.; Tooney, Paul A.; Scott, Rodney J.; Carr, Vaughan J.; Cairns, Murray J.			Transcriptome Sequencing Revealed Significant Alteration of Cortical Promoter Usage and Splicing in Schizophrenia	PLOS ONE			English	Article							DOUBLECORTIN-LIKE KINASE; DORSOLATERAL PREFRONTAL CORTEX; DIFFERENTIAL GENE-EXPRESSION; MYELINATION-RELATED GENES; SUPERIOR TEMPORAL GYRUS; UP-REGULATION; RNA-SEQ; MICROARRAY ANALYSIS; OLIGODENDROGLIAL ABNORMALITIES; CINGULATE CORTEX	Background: While hybridization based analysis of the cortical transcriptome has provided important insight into the neuropathology of schizophrenia, it represents a restricted view of disease-associated gene activity based on predetermined probes. By contrast, sequencing technology can provide un-biased analysis of transcription at nucleotide resolution. Here we use this approach to investigate schizophrenia-associated cortical gene expression. Methodology/Principal Findings: The data was generated from 76 bp reads of RNA-Seq, aligned to the reference genome and assembled into transcripts for quantification of exons, splice variants and alternative promoters in postmortem superior temporal gyrus (STG/BA22) from 9 male subjects with schizophrenia and 9 matched non-psychiatric controls. Differentially expressed genes were then subjected to further sequence and functional group analysis. The output, amounting to more than 38 Gb of sequence, revealed significant alteration of gene expression including many previously shown to be associated with schizophrenia. Gene ontology enrichment analysis followed by functional map construction identified three functional clusters highly relevant to schizophrenia including neurotransmission related functions, synaptic vesicle trafficking, and neural development. Significantly, more than 2000 genes displayed schizophrenia-associated alternative promoter usage and more than 1000 genes showed differential splicing (FDR<0.05). Both types of transcriptional isoforms were exemplified by reads aligned to the neurodevelopmentally significant doublecortin-like kinase 1 (DCLK1) gene. Conclusions: This study provided the first deep and un-biased analysis of schizophrenia-associated transcriptional diversity within the STG, and revealed variants with important implications for the complex pathophysiology of schizophrenia.	[Wu, Jing Qin; Beveridge, Natalie J.; Tooney, Paul A.; Carr, Vaughan J.; Cairns, Murray J.] Schizophrenia Res Inst, Sydney, NSW, Australia; [Wu, Jing Qin; Wang, Xi; Beveridge, Natalie J.; Tooney, Paul A.; Scott, Rodney J.; Cairns, Murray J.] Univ Newcastle, Sch Biomed Sci & Pharm, Prior Res Ctr Translat Neurosci & Mental Hlth, Fac Hlth, Callaghan, NSW 2308, Australia; [Wu, Jing Qin; Wang, Xi; Beveridge, Natalie J.; Tooney, Paul A.; Scott, Rodney J.; Cairns, Murray J.] Hunter Med Res Inst, New Lambton, NSW, Australia; [Carr, Vaughan J.] Univ New S Wales, Res Unit Schizophrenia Epidemiol, Sch Psychiat, St Vincents Hosp, Darlinghurst, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; St Vincents Hospital Sydney; University of New South Wales Sydney	Wu, JQ (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	murray.cairns@newcastle.edu.au	Scott, Rodney J/B-2827-2013; WANG, XI/G-8328-2013; Wang, Xi/N-9527-2014; TOONEY, PAUL ANTHONY/G-7280-2013; Wu, Jingqin/V-9319-2019	Scott, Rodney J/0000-0001-7724-3404; Wang, Xi/0000-0002-7572-6354; Wu, Jingqin/0000-0002-2052-3875; Cairns, Murray/0000-0003-2490-2538; Beveridge, Natalie/0000-0002-5696-0516; Tooney, Paul/0000-0003-3745-4367	Schizophrenia Research Institute; Neurobehavioral Genetics Unit; NSW Health; M.C. Ainsworth Research Fellowship in Epigenetics; NARSAD Young Investigator Award; Hunter Medical Research Institute; NHMRC [631057]; University of Sydney; National Health and Medical Research Council of Australia; National Institute of Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725, R28AA012725] Funding Source: NIH RePORTER	Schizophrenia Research Institute; Neurobehavioral Genetics Unit; NSW Health; M.C. Ainsworth Research Fellowship in Epigenetics; NARSAD Young Investigator Award(NARSAD); Hunter Medical Research Institute; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by the Schizophrenia Research Institute and the Neurobehavioral Genetics Unit, utilising funding from NSW Health and an M.C. Ainsworth Research Fellowship in Epigenetics (Dr. Cairns); a NARSAD Young Investigator Award; a Hunter Medical Research Institute project grant; an NHMRC project grant 631057 and an NHMRC postdoctoral training fellowship (Dr. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge David Montgomery and the Academic and Research Computing Service (ARCS) at the University of Newcastle, for technical help with the Linux server and installation/maintenance of academic software for sequencing analysis. Tissues were received from the Australian Brain Donor Program's NSW Tissue Resource Centre, supported by The University of Sydney, National Health and Medical Research Council of Australia, Schizophrenia Research Institute, and the National Institute of Alcohol Abuse and Alcoholism.	Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Barakauskas VE, 2010, NEUROPSYCHOPHARMACOL, V35, P1226, DOI 10.1038/npp.2009.228; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bowden NA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-199; Burgess HA, 1999, J NEUROSCI RES, V58, P567, DOI 10.1002/(SICI)1097-4547(19991115)58:4<567::AID-JNR9>3.3.CO;2-K; Burgess HA, 2000, MOL CELL NEUROSCI, V16, P529, DOI 10.1006/mcne.2000.0891; CARPENTER WT, 1994, NEW ENGL J MED, V330, P681, DOI 10.1056/NEJM199403103301006; Chana G, 2009, SCHIZOPHR RES, V113, P273, DOI 10.1016/j.schres.2009.05.015; Chung C, 2003, SYNAPSE, V50, P29, DOI 10.1002/syn.10228; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Deng XD, 2011, AM J MED GENET B, V156B, P850, DOI 10.1002/ajmg.b.31233; Duncan CE, 2008, PSYCHIAT GENET, V18, P226, DOI 10.1097/YPG.0b013e3283053019; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Faludi G, 2011, INT J DEV NEUROSCI, V2011, P4; Ferreira A, 2002, CELL MOL LIFE SCI, V59, P589, DOI 10.1007/s00018-002-8451-5; Gabriel SM, 1997, ARCH GEN PSYCHIAT, V54, P559; Gow A, 1997, J NEUROSCI, V17, P181, DOI 10.1523/JNEUROSCI.17-01-00181.1997; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Haroutunian V, 2007, INT J NEUROPSYCHOPH, V10, P565, DOI 10.1017/S1461145706007310; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Honer WG, 2002, CEREB CORTEX, V12, P349, DOI 10.1093/cercor/12.4.349; Horesh Y, 2011, EUR J NEUROL, V18, P410, DOI 10.1111/j.1468-1331.2010.03166.x; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jacobs EC, 2004, NEUROCHEM RES, V29, P997, DOI 10.1023/B:NERE.0000021244.38279.c4; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Karson CN, 1999, MOL PSYCHIATR, V4, P39, DOI 10.1038/sj.mp.4000459; Katsel P, 2005, SCHIZOPHR RES, V77, P241, DOI 10.1016/j.schres.2005.03.020; Koizumi H, 2007, SEIKAGAKU, V79, P1134; Kontkanen O, 2002, J NEUROCHEM, V83, P1043, DOI 10.1046/j.1471-4159.2002.01213.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; MacDonald ML, 2006, BIPOLAR DISORD, V8, P255, DOI 10.1111/j.1399-5618.2006.00302.x; Marenco S, 2000, DEV PSYCHOPATHOL, V12, P501, DOI 10.1017/S0954579400003138; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McCullumsmith RE, 2007, SCHIZOPHR RES, V90, P15, DOI 10.1016/j.schres.2006.11.017; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Mimmack ML, 2002, P NATL ACAD SCI USA, V99, P4680, DOI 10.1073/pnas.032069099; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Mirnics K, 2006, BIOL PSYCHIAT, V60, P163, DOI 10.1016/j.biopsych.2006.02.003; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Mukaetova-Ladinska EB, 2002, NEUROSCI LETT, V317, P161, DOI 10.1016/S0304-3940(01)02458-2; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rajarethinam RP, 2000, SCHIZOPHR RES, V41, P303, DOI 10.1016/S0920-9964(99)00083-3; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Schachner M, 2000, GLIA, V29, P154, DOI 10.1002/(SICI)1098-1136(20000115)29:2<154::AID-GLIA9>3.0.CO;2-3; Schwab SG, 2000, MOL PSYCHIATR, V5, P638, DOI 10.1038/sj.mp.4000791; Seiler F, 2009, FEBS LETT, V583, P2343, DOI 10.1016/j.febslet.2009.06.025; Sequeira PA, 2012, NEUROBIOL DIS, V45, P23, DOI 10.1016/j.nbd.2011.03.001; Silverman MA, 1999, J BIOL CHEM, V274, P2631, DOI 10.1074/jbc.274.5.2631; Sokolov BP, 2007, INT J NEUROPSYCHOPH, V10, P547, DOI 10.1017/S1461145706007322; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sommer JU, 2010, EUR ARCH PSY CLIN N, V260, pS81, DOI 10.1007/s00406-010-0159-1; Sporkel O, 2002, GLIA, V37, P19, DOI 10.1002/glia.10014; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uriu Y, 2010, J BIOL CHEM, V285, P21750, DOI 10.1074/jbc.M110.101311; Vawter MP, 2002, SCHIZOPHR RES, V58, P11, DOI 10.1016/S0920-9964(01)00377-2; Vawter MP, 2001, BRAIN RES BULL, V55, P641, DOI 10.1016/S0361-9230(01)00522-6; Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Weidenhofer J, 2006, MOL CELL NEUROSCI, V31, P243, DOI 10.1016/j.mcn.2005.09.013; Young CE, 1998, CEREB CORTEX, V8, P261, DOI 10.1093/cercor/8.3.261; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zink M, 2004, SCHIZOPHR RES, V66, P151, DOI 10.1016/S0920-9964(03)00088-4	82	67	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36351	10.1371/journal.pone.0036351	http://dx.doi.org/10.1371/journal.pone.0036351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558445	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000195
J	Garcia, J; Traulsen, A				Garcia, Julian; Traulsen, Arne			The Structure of Mutations and the Evolution of Cooperation	PLOS ONE			English	Article							REPEATED PRISONERS-DILEMMA; FINITE POPULATIONS; PUBLIC-GOODS; GAMES; DYNAMICS; STABILITY; SELECTION; PUNISHMENT; EMERGENCE; STRATEGY	Evolutionary game dynamics in finite populations assumes that all mutations are equally likely, i.e., if there are n strategies a single mutation can result in any strategy with probability 1/n. However, in biological systems it seems natural that not all mutations can arise from a given state. Certain mutations may be far away, or even be unreachable given the current composition of an evolving population. These distances between strategies (or genotypes) define a topology of mutations that so far has been neglected in evolutionary game theory. In this paper we re-evaluate classic results in the evolution of cooperation departing from the assumption of uniform mutations. We examine two cases: the evolution of reciprocal strategies in a repeated prisoner's dilemma, and the evolution of altruistic punishment in a public goods game. In both cases, alternative but reasonable mutation kernels shift known results in the direction of less cooperation. We therefore show that assuming uniform mutations has a substantial impact on the fate of an evolving population. Our results call for a reassessment of the "model-less" approach to mutations in evolutionary dynamics.	[Garcia, Julian; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Res Grp Evolutionary Theory, Plon, Germany	Max Planck Society	Garcia, J (corresponding author), Max Planck Inst Evolutionary Biol, Res Grp Evolutionary Theory, Plon, Germany.	garcia@evolbio.mpg.de	Traulsen, Arne/A-4955-2009	Traulsen, Arne/0000-0002-0669-5267; Garcia, Julian/0000-0001-9639-489X				Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bergin J, 1996, ECONOMETRICA, V64, P943, DOI 10.2307/2171851; Binmore K, 2011, J THEOR BIOL, V278, P63, DOI 10.1016/j.jtbi.2011.02.024; BINMORE KG, 1992, J ECON THEORY, V57, P278, DOI 10.1016/0022-0531(92)90037-I; BOMZE IM, 1995, GAME ECON BEHAV, V11, P146, DOI 10.1006/game.1995.1047; BOYD R, 1987, NATURE, V327, P58, DOI 10.1038/327058a0; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; De Silva H, 2010, J EVOL ECON, V20, P203, DOI 10.1007/s00191-009-0162-8; FARRELL J, 1989, THEOR POPUL BIOL, V36, P161, DOI 10.1016/0040-5809(89)90027-0; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; FUDENBERG D, 1990, AM ECON REV, V80, P274; Fudenberg D, 2006, J ECON THEORY, V131, P251, DOI 10.1016/j.jet.2005.04.006; Fudenberg D, 2006, THEOR POPUL BIOL, V70, P352, DOI 10.1016/j.tpb.2006.07.006; Hauert C, 2002, INT J BIFURCAT CHAOS, V12, P1531, DOI 10.1142/S0218127402005273; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hauert Christoph, 2008, Biology Theory, V3, P114, DOI 10.1162/biot.2008.3.2.114; HOFBAUER J, 1985, J MATH BIOL, V23, P41, DOI 10.1007/BF00276557; Hofbauer J., 1990, APPL MATH LETT, V3, P75, DOI [10.1016/0893-9659(90)90051-C, DOI 10.1016/0893-9659(90)90051-C, DOI 10.1016/0893-9659(90)90051-C)]; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Imhof LA, 2007, J THEOR BIOL, V247, P574, DOI 10.1016/j.jtbi.2007.03.027; Imhof LA, 2010, P ROY SOC B-BIOL SCI, V277, P463, DOI 10.1098/rspb.2009.1171; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; MESZENA G, 2001, SELECTION, V2, P193, DOI [DOI 10.1556/SELECT.2.2001.1-2.14, 10.1556/select.2.2001.1-2.14]; Moran P., 1962, STAT PROCESSES EVOLU; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Page KM, 2002, J THEOR BIOL, V219, P93, DOI 10.1006/yjtbi.3112; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2011, J THEOR BIOL, V274, P30, DOI 10.1016/j.jtbi.2011.01.004; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Traulsen A., 2009, REV NONLINEAR DYN CO, V2, P25, DOI DOI 10.1007/978-3-642-01284-6_12; Traulsen A, 2008, B MATH BIOL, V70, P1410, DOI 10.1007/s11538-008-9305-6; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011901; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Willensdorfer M, 2005, J THEOR BIOL, V237, P355, DOI 10.1016/j.jtbi.2005.04.020; Wu B, 2011, J NEUROSURG, V114, P1288, DOI [10.3171/2010.12.JNS10912, 10.1155/2011/464919]	47	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35287	10.1371/journal.pone.0035287	http://dx.doi.org/10.1371/journal.pone.0035287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563381	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349100010
J	Lin, JT; Chen, PC; Goud, TV; Huang, BR; Lin, TC; Biellmann, JF; Chen, CS				Lin, Jing-Tang; Chen, Po-Chung; Goud, Thirumani Venkatshwar; Huang, Bor-Rong; Lin, Tzu-Chau; Biellmann, Jean-Francois; Chen, Chien-Sheng			A Sulfhydryl-Reactive Ruthenium (II) Complex and Its Conjugation to Protein G as a Universal Reagent for Fluorescent Immunoassays	PLOS ONE			English	Article							RADIOIMMUNOASSAY	To develop a fluorescent ruthenium complex for biosensing, we synthesized a novel sulfhydryl-reactive compound, 4-bromophenanthroline bis-2,2'-dipyridine Ruthenium bis (hexafluorophosphate). The synthesized Ru(II) complex was crosslinked with thiol-modified protein G to form a universal reagent for fluorescent immunoassays. The resulting Ru(II)-protein G conjugates were identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The emission peak wavelength of the Ru(II)-protein G conjugate was 602 nm at the excitation of 452 nm which is similar to the spectra of the Ru(II) complex, indicating that Ru(II)-protein G conjugates still remain the same fluorescence after conjugation. To test the usefulness of the conjugate for biosensing, immunoglobulin G (IgG) binding assay was conducted. The result showed that Ru(II)-protein G conjugates were capable of binding IgG and the more cross-linkers to modify protein G, the higher conjugation efficiency. To demonstrate the feasibility of Ru(II)-protein G conjugates for fluorescent immunoassays, the detection of recombinant histidine-tagged protein using the conjugates and anti-histidine antibody was developed. The results showed that the histidine-tagged protein was successfully detected with dose-response, indicating that Ru(II)-protein G conjugate is a useful universal fluorescent reagent for quantitative immunoassays.	[Lin, Jing-Tang; Chen, Po-Chung; Biellmann, Jean-Francois; Chen, Chien-Sheng] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Goud, Thirumani Venkatshwar] Acad Sinica, Inst Chem, Taipei, Taiwan; [Huang, Bor-Rong; Lin, Tzu-Chau] Natl Cent Univ, Dept Chem, Jhongli, Taiwan	National Central University; Academia Sinica - Taiwan; National Central University	Lin, JT (corresponding author), Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan.	biellman@cc.ncu.edu.tw; cchen103@gmail.com	Chen, Chien-Sheng/ACO-7414-2022		National Central University, Taiwan; Center for Dynamical Biomarkers and Translational Medicine (CDBTM), National Science Council, Taiwan [100-2627-M-008-003-]; Ministry of Education, Taiwan	National Central University, Taiwan; Center for Dynamical Biomarkers and Translational Medicine (CDBTM), National Science Council, Taiwan; Ministry of Education, Taiwan(Ministry of Education, Taiwan)	The authors thank National Central University, Taiwan for the financial support. This work was also supported by Center for Dynamical Biomarkers and Translational Medicine (CDBTM), National Science Council, Taiwan under the grant 100-2627-M-008-003-, and by Ministry of Education, Taiwan under the grant Plan of Developing Top Universities And Research Centers as well as The Aim for the Top University Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTROM B, 1985, J IMMUNOL, V135, P2589; AKERSTROM B, 1986, J BIOL CHEM, V261, P240; BJORCK L, 1984, J IMMUNOL, V133, P969; BLAKE C, 1982, CLIN CHEM, V28, P1469; CASE FH, 1951, J ORG CHEM, V16, P941, DOI 10.1021/jo01146a018; Chen CS, 2005, TALANTA, V67, P205, DOI 10.1016/j.talanta.2005.02.018; Chevalier Francois, 2007, V355, P145; Forster RJ, 2009, ANNU REV ANAL CHEM, V2, P359, DOI 10.1146/annurev-anchem-060908-155305; GILLIS TP, 1978, J CLIN MICROBIOL, V8, P351; Gizeli E, 1996, CURR OPIN BIOTECH, V7, P66, DOI 10.1016/S0958-1669(96)80097-8; GOW SM, 1986, CLIN CHEM, V32, P2191; GUTCHO S, 1977, CLIN CHEM, V23, P1609; Herman L, 2008, J PHYS ORG CHEM, V21, P670, DOI 10.1002/poc.1355; Lee KW, 2003, PHYS CHEM CHEM PHYS, V5, P2706, DOI 10.1039/b302119j; Lin HH, 2011, J MATER CHEM, V21, P3170, DOI 10.1039/c0jm02942d; Liu GD, 2004, ANAL CHEM, V76, P7126, DOI 10.1021/ac049107l; Miao WJ, 2008, CHEM REV, V108, P2506, DOI 10.1021/cr068083a; PACHMANN K, 1976, J IMMUNOL METHODS, V12, P67, DOI 10.1016/0022-1759(76)90097-1; Richter MM, 2004, CHEM REV, V104, P3003, DOI 10.1021/cr020373d; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; SIDKI AM, 1985, THER DRUG MONIT, V7, P101, DOI 10.1097/00007691-198503000-00018; Steinberg TH, 2000, ELECTROPHORESIS, V21, P486, DOI 10.1002/(SICI)1522-2683(20000201)21:3<486::AID-ELPS486>3.0.CO;2-Q; Tokarski C, 2006, ELECTROPHORESIS, V27, P1407, DOI 10.1002/elps.200500426; WIANS FH, 1986, CLIN CHEM, V32, P887; Xiang MH, 2009, J APPL ELECTROCHEM, V39, P921, DOI 10.1007/s10800-008-9742-9; Yousouf SJ, 2007, POLYHEDRON, V26, P318, DOI 10.1016/j.poly.2006.06.004	26	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36086	10.1371/journal.pone.0036086	http://dx.doi.org/10.1371/journal.pone.0036086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563441	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100066
J	van Luijn, MM; de Loosdrecht, AAV; Lampen, MH; van Veelen, PA; Zevenbergen, A; Kester, MGD; de Ru, AH; Ossenkoppele, GJ; van Hall, T; van Ham, SM				van Luijn, Marvin M.; de Loosdrecht, Arjan A. van; Lampen, Margit H.; van Veelen, Peter A.; Zevenbergen, Adri; Kester, Michel G. D.; de Ru, Arnoud H.; Ossenkoppele, Gert J.; van Hall, Thorbald; van Ham, S. Marieke			Promiscuous Binding of Invariant Chain-Derived CLIP Peptide to Distinct HLA-I Molecules Revealed in Leukemic Cells	PLOS ONE			English	Article							MHC CLASS-I; CD4(+) T-LYMPHOCYTES; COMPLEX CLASS-I; CROSS-PRESENTATION; DENDRITIC CELLS; ANTIGEN PRESENTATION; ENDOGENOUS ANTIGEN; ESCAPE VARIANTS; ASSOCIATION; TRANSPORT	Antigen presentation by HLA class I (HLA-I) and HLA class II (HLA-II) complexes is achieved by proteins that are specific for their respective processing pathway. The invariant chain (Ii)-derived peptide CLIP is required for HLA-II-mediated antigen presentation by stabilizing HLA-II molecules before antigen loading through transient and promiscuous binding to different HLA-II peptide grooves. Here, we demonstrate alternative binding of CLIP to surface HLA-I molecules on leukemic cells. In HLA-II-negative AML cells, we found plasma membrane display of the CLIP peptide. Silencing Ii in AML cells resulted in reduced HLA-I cell surface display, which indicated a direct role of CLIP in the HLA-I antigen presentation pathway. In HLA-I-specific peptide eluates from B-LCLs, five Ii-derived peptides were identified, of which two were from the CLIP region. In vitro peptide binding assays strikingly revealed that the eluted CLIP peptide RMATPLLMQALPM efficiently bound to four distinct HLA-I supertypes (-A2, -B7, -A3, -B40). Furthermore, shorter length variants of this CLIP peptide also bound to these four supertypes, although in silico algorithms only predicted binding to HLA-A2 or -B7. Immunization of HLA-A2 transgenic mice with these peptides did not induce CTL responses. Together these data show a remarkable promiscuity of CLIP for binding to a wide variety of HLA-I molecules. The found participation of CLIP in the HLA-I antigen presentation pathway could reflect an aberrant mechanism in leukemic cells, but might also lead to elucidation of novel processing pathways or immune escape mechanisms.	[van Luijn, Marvin M.; de Loosdrecht, Arjan A. van; Zevenbergen, Adri; Ossenkoppele, Gert J.] Vrije Univ Amsterdam, Med Ctr, VU Inst Canc & Immunol, Dept Hematol,Canc Ctr Amesterdam, Amsterdam, Netherlands; [van Luijn, Marvin M.; van Ham, S. Marieke] Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Lampen, Margit H.; van Hall, Thorbald] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [van Veelen, Peter A.; de Ru, Arnoud H.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Kester, Michel G. D.] Leiden Univ, Med Ctr, Dept Hematol, Lab Expt Hematol, Leiden, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Luijn, MM (corresponding author), Vrije Univ Amsterdam, Med Ctr, VU Inst Canc & Immunol, Dept Hematol,Canc Ctr Amesterdam, Amsterdam, Netherlands.	m.luijn@vumc.nl	Lampen, Margit/K-1839-2012; van Hall, Thorbald/Y-5651-2018	Lampen, Margit/0000-0001-5435-1568; van Veelen, Peter/0000-0002-7898-9408; van Hall, Thorbald/0000-0002-9115-558X	Stichting Vanderes [125]; Dutch Cancer Society [UL2007-3879]	Stichting Vanderes; Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported in part by research funding from Stichting Vanderes (grant 125) and the Dutch Cancer Society (grant UL2007-3879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; Armstrong TD, 1997, P NATL ACAD SCI USA, V94, P6886, DOI 10.1073/pnas.94.13.6886; ARUNACHALAM B, 1994, INT IMMUNOL, V6, P439, DOI 10.1093/intimm/6.3.439; Basha G, 2012, NAT IMMUNOL, V13, P237, DOI 10.1038/ni.2225; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; CERUNDOLO V, 1992, EUR J IMMUNOL, V22, P2243, DOI 10.1002/eji.1830220910; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dissanayake SK, 2004, CANCER RES, V64, P1867, DOI 10.1158/0008-5472.CAN-03-2634; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Harris PE, 1996, BLOOD, V87, P5104, DOI 10.1182/blood.V87.12.5104.bloodjournal87125104; Hiemstra HS, 1997, P NATL ACAD SCI USA, V94, P10313, DOI 10.1073/pnas.94.19.10313; Kessler JH, 2003, HUM IMMUNOL, V64, P245, DOI 10.1016/S0198-8859(02)00787-5; Koch J, 2006, CELL MOL LIFE SCI, V63, P653, DOI 10.1007/s00018-005-5462-z; Lampen MH, 2010, J IMMUNOL, V185, P6508, DOI 10.4049/jimmunol.1001774; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Ly LV, 2010, CANCER RES, V70, P8339, DOI 10.1158/0008-5472.CAN-10-2288; Meiring HD, 2002, J SEP SCI, V25, P557, DOI 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; MOLLER P, 1991, INT J CANCER, P155; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Newberg MH, 1996, J IMMUNOL, V156, P2473; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; PIETERS J, 1993, J CELL SCI, V106, P831; Powis SJ, 2006, FEBS LETT, V580, P3112, DOI 10.1016/j.febslet.2006.04.060; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reber AJ, 2002, IMMUNOGENETICS, V54, P74, DOI 10.1007/s00251-002-0446-8; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; Seidel UJE, 2012, CANCER IMMUNOL IMMUN, V61, P119, DOI 10.1007/s00262-011-1160-x; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; Thompson JA, 2006, CANCER RES, V66, P1147, DOI 10.1158/0008-5472.CAN-05-2289; Thompson JA, 2008, CANCER IMMUNOL IMMUN, V57, P389, DOI 10.1007/s00262-007-0381-5; van Hall T, 2006, NAT MED, V12, P417, DOI 10.1038/nm1381; van Luijn MM, 2011, CANCER RES, V71, P2507, DOI 10.1158/0008-5472.CAN-10-3689; van Luijn MM, 2010, CANCER IMMUNOL IMMUN, V59, P1825, DOI 10.1007/s00262-010-0908-z; van Luijn MM, 2010, HAEMATOL-HEMATOL J, V95, P485, DOI 10.3324/haematol.2009.010595; Veenstra H, 1996, CELL IMMUNOL, V171, P68, DOI 10.1006/cimm.1996.0174; Vigna JL, 1996, J IMMUNOL, V157, P4503; Weenink SM, 1997, INT IMMUNOL, V9, P317, DOI 10.1093/intimm/9.2.317; Zwart W, 2010, J CELL SCI, V123, P3817, DOI 10.1242/jcs.068510	47	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e34649	10.1371/journal.pone.0034649	http://dx.doi.org/10.1371/journal.pone.0034649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563374	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100004
J	Xin, H; Cartmell, J; Bailey, JJ; Dziadek, S; Bundle, DR; Cutler, JE				Xin, Hong; Cartmell, Jonathan; Bailey, Justin J.; Dziadek, Sebastian; Bundle, David R.; Cutler, Jim E.			Self-Adjuvanting Glycopeptide Conjugate Vaccine against Disseminated Candidiasis	PLOS ONE			English	Article							IGG3 MONOCLONAL-ANTIBODY; ENHANCE MOUSE RESISTANCE; IMMUNE-RESPONSES; CRYPTOCOCCUS-NEOFORMANS; LINKER METHODOLOGY; PEPTIDE EPITOPES; SIDE-CHAIN; ALBICANS; PROTECTION; INFECTION	Our research on pathogenesis of disseminated candidiasis led to the discovery that antibodies specific for Candida albicans cell surface beta-1, 2-mannotriose [beta-(Man)(3)] protect mice. A 14 mer peptide Fba, which derived from the N-terminal portion of the C. albicans cytosolic/cell surface protein fructose-bisphosphate aldolase, was used as the glycan carrier and resulted in a novel synthetic glycopeptide vaccine beta-(Man)(3)-Fba. By a dendritic cell-based immunization approach, this conjugate induced protective antibody responses against both the glycan and peptide parts of the vaccine. In this report, we modified the beta-(Man)(3)-Fba conjugate by coupling it to tetanus toxoid (TT) in order to improve immunogenicity and allow for use of an adjuvant suitable for human use. By new immunization procedures entirely compatible with human use, the modified beta-(Man)(3)-Fba-TT was administered either alone or as a mixture made with alum or monophosphoryl lipid A (MPL) adjuvants and given to mice by a subcutaneous (s.c.) route. Mice vaccinated with or, surprisingly, without adjuvant responded well by making robust antibody responses. The immunized groups showed a high degree of protection against a lethal challenge with C. albicans as evidenced by increased survival times and reduced kidney fungal burden as compared to control groups that received only adjuvant or DPBS buffer prior to challenge. To confirm that induced antibodies were protective, sera from mice immunized against the beta-(Man)(3)-Fba-TT conjugate transferred protection against disseminated candidiasis to naive mice, whereas C. albicans-absorbed immune sera did not. Similar antibody responses and protection induced by the beta-(Man)(3)-Fba-TT vaccine was observed in inbred BALB/c and outbred Swiss Webster mice. We conclude that addition of TT to the glycopeptide conjugate results in a self-adjuvanting vaccine that promotes robust antibody responses without the need for additional adjuvant, which is novel and represents a major step forward in vaccine design against disseminated candidiasis.	[Xin, Hong; Cutler, Jim E.] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Xin, Hong; Cutler, Jim E.] Childrens Hosp, Res Inst Children, New Orleans, LA USA; [Cartmell, Jonathan; Bailey, Justin J.; Dziadek, Sebastian; Bundle, David R.] Univ Alberta, Dept Chem, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB, Canada	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; University of Alberta	Xin, H (corresponding author), Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA 70112 USA.	hxin@chnola-research.org	Cartmell, Jonathan/GPS-4523-2022		Research Institute for Children (RIC) at Children's Hospital in New Orleans; Alberta Innovates Centre for Carbohydrate Science; Natural Science and Engineering Research Council of Canada	Research Institute for Children (RIC) at Children's Hospital in New Orleans; Alberta Innovates Centre for Carbohydrate Science; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research Institute for Children (RIC) at Children's Hospital in New Orleans supported the authors' research. This work was also supported by the Alberta Innovates Centre for Carbohydrate Science and the Natural Science and Engineering Research Council of Canada. SD now works in Roche Diagnostics GmbH, but all the work he contributed to this study was done when he was supported by the Alberta Innovates Centre for Carbohydrate Science and the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMAN RB, 1990, IMMUNOL CELL BIOL, V68, P179, DOI 10.1038/icb.1990.25; Ashman RB, 1997, FEMS IMMUNOL MED MIC, V19, P183, DOI 10.1111/j.1574-695X.1997.tb01087.x; Bromuro C, 2010, VACCINE, V28, P2615, DOI 10.1016/j.vaccine.2010.01.012; Brown Lorena E., 2005, Current Drug Delivery, V2, P383, DOI 10.2174/156720105774370258; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Casadevall A, 2007, INFECT IMMUN, V75, P5074, DOI 10.1128/IAI.01001-07; Cassone A, 2005, CURR MOL MED, V5, P377, DOI 10.2174/1566524054022549; Cassone A, 2010, MBIO, V1, DOI 10.1128/mBio.00042-10; COOPER LJN, 1991, J IMMUNOL, V146, P2659; Cutler JE, 2005, CURR MOL MED, V5, P383, DOI 10.2174/1566524054022576; Cutler JE, 2007, NAT REV MICROBIOL, V5, P13, DOI 10.1038/nrmicro1537; Cutler JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022030; DeBernardis F, 1997, INFECT IMMUN, V65, P3399, DOI 10.1128/IAI.65.8.3399-3405.1997; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Dziadek S, 2008, CHEM-EUR J, V14, P5908, DOI 10.1002/chem.200800065; Fotin-Mleczek M, 2011, J IMMUNOTHER, V34, P1, DOI 10.1097/CJI.0b013e3181f7dbe8; GERMANN T, 1995, EUR J IMMUNOL, V25, P823, DOI 10.1002/eji.1830250329; Goins TL, 2000, J CLIN MICROBIOL, V38, P2862, DOI 10.1128/JCM.38.8.2862-2869.2000; Han Y, 1997, INFECT IMMUN, V65, P4100, DOI 10.1128/IAI.65.10.4100-4107.1997; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; HAN YM, 1995, INFECT IMMUN, V63, P2714, DOI 10.1128/IAI.63.7.2714-2719.1995; Han YM, 1997, J INFECT DIS, V175, P1169, DOI 10.1086/516455; Han YM, 2001, J IMMUNOL, V167, P1550, DOI 10.4049/jimmunol.167.3.1550; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; HECTOR RF, 1982, INFECT IMMUN, V38, P1020, DOI 10.1128/IAI.38.3.1020-1028.1982; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Hsu FC, 2009, J MICROBIOL IMMUNOL, V42, P378; KANBE T, 1994, INFECT IMMUN, V62, P1662, DOI 10.1128/IAI.62.5.1662-1668.1994; KOBAYASHI H, 1992, ARCH BIOCHEM BIOPHYS, V294, P662, DOI 10.1016/0003-9861(92)90739-J; KOBAYASHI H, 1994, INFECT IMMUN, V62, P615, DOI 10.1128/IAI.62.2.615-622.1994; Krcmery V, 2002, J HOSP INFECT, V50, P243, DOI 10.1053/jhin.2001.1151; Kuroda E, 2000, J IMMUNOL, V164, P2386, DOI 10.4049/jimmunol.164.5.2386; Maitta RW, 2004, INFECT IMMUN, V72, P196, DOI 10.1128/IAI.72.1.196-208.2004; Matthews RC, 2003, ANTIMICROB AGENTS CH, V47, P2208, DOI 10.1128/AAC.47.7.2208-2216.2003; Mochon AB, 2005, MED MYCOL, V43, P97, DOI 10.1080/13693780500035979; Moyle PM, 2008, CURR MED CHEM, V15, P506, DOI 10.2174/092986708783503249; Nitz M, 2002, J BIOL CHEM, V277, P3440, DOI 10.1074/jbc.M109274200; Nussbaum G, 1996, J EXP MED, V183, P1905, DOI 10.1084/jem.183.4.1905; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; PINCUS SH, 1988, J IMMUNOL, V140, P2779; SCHREIBER JR, 1993, J INFECT DIS, V167, P221, DOI 10.1093/infdis/167.1.221; Shibata N, 2003, EUR J BIOCHEM, V270, P2565, DOI 10.1046/j.1432-1033.2003.03622.x; Shibata N, 1996, J BIOL CHEM, V271, P9259, DOI 10.1074/jbc.271.16.9259; Suzuki A, 1997, J BIOL CHEM, V272, P16822, DOI 10.1074/jbc.272.27.16822; UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251, DOI 10.1146/annurev.iy.06.040188.001343; Wu XY, 2007, ORG BIOMOL CHEM, V5, P3477, DOI 10.1039/b709912f; Wu XY, 2005, J ORG CHEM, V70, P7381, DOI 10.1021/jo051065t; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105; Xin H, 2006, INFECT IMMUN, V74, P4310, DOI 10.1128/IAI.00234-06; Xin H, 2011, CLIN VACCINE IMMUNOL, V18, P1656, DOI 10.1128/CVI.05215-11; Yang Q, 2005, VACCINE, V23, P4088, DOI 10.1016/j.vaccine.2004.07.005; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	52	52	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35106	10.1371/journal.pone.0035106	http://dx.doi.org/10.1371/journal.pone.0035106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563378	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100007
J	Tynan, CJ; Clarke, DT; Coles, BC; Rolfe, DJ; Martin-Fernandez, ML; Webb, SED				Tynan, Christopher J.; Clarke, David T.; Coles, Benjamin C.; Rolfe, Daniel J.; Martin-Fernandez, Marisa L.; Webb, Stephen E. D.			Multicolour Single Molecule Imaging in Cells with Near Infra-Red Dyes	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; FLUORESCENCE MICROSCOPY; PROBES; FLUOROPHORES; PROTEINS; BIOLOGY; BRIGHT	Background: The autofluorescence background of biological samples impedes the detection of single molecules when imaging. The most common method of reducing the background is to use evanescent field excitation, which is incompatible with imaging beyond the surface of biological samples. An alternative would be to use probes that can be excited in the near infra-red region of the spectrum, where autofluorescence is low. Such probes could also increase the number of labels that can be imaged in multicolour single molecule microscopes. Despite being widely used in ensemble imaging, there is a currently a shortage of information available for selecting appropriate commercial near infra-red dyes for single molecule work. It is therefore important to characterise available near infra-red dyes relevant to multicolour single molecule imaging. Methodology/Principal Findings: A range of commercially available near infra-red dyes compatible with multi-colour imaging was screened to find the brightest and most photostable candidates. Image series of immobilised samples of the brightest dyes (Alexa 700, IRDye 700DX, Alexa 790 and IRDye 800CW) were analysed to obtain the mean intensity of single dye molecules, their photobleaching rates and long period blinking kinetics. Using the optimum dye pair, we have demonstrated for the first time widefield, multi-colour, near infra-red single molecule imaging using a supercontinuum light source in MCF-7 cells. Conclusions/Significance: We have demonstrated that near infra-red dyes can be used to avoid autofluorescence background in samples where restricting the illumination volume of visible light fails or is inappropriate. We have also shown that supercontinuum sources are suited to single molecule multicolour imaging throughout the 470-1000 nm range. Our measurements of near infra-red dye properties will enable others to select optimal dyes for single molecule imaging.	[Tynan, Christopher J.; Clarke, David T.; Coles, Benjamin C.; Rolfe, Daniel J.; Martin-Fernandez, Marisa L.; Webb, Stephen E. D.] Sci & Technol Facil Council, Rutherford Appleton Lab, Cent Laser Facil, Didcot, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Tynan, CJ (corresponding author), Sci & Technol Facil Council, Rutherford Appleton Lab, Cent Laser Facil, Res Complex Harwell, Didcot, Oxon, England.	stephen.webb@stfc.ac.uk	Webb, Stephen E D/G-5682-2010	Webb, Stephen E D/0000-0002-6304-1702; Bateman, Benji/0000-0003-4580-4662; Rolfe, Daniel/0000-0002-8394-8395; martin-fernandez, marisa/0000-0001-5496-6300; Tynan, Christopher/0000-0002-4553-7018; Clarke, David/0000-0002-8776-1341	Biotechnology and Biological Sciences Research Council [BB/G006911/1]; Science & Technology Facilities Council; BBSRC [BB/G006911/1, BB/G007160/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007160/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Science & Technology Facilities Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was received from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk), grant award BB/G006911/1, and from the Science & Technology Facilities Council (www.stfc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aswathy RG, 2010, ANAL BIOANAL CHEM, V397, P1417, DOI 10.1007/s00216-010-3643-6; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Baddeley D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020645; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; Dalgarno HIC, 2011, J R SOC INTERFACE, V8, P942, DOI 10.1098/rsif.2010.0508; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; de Keijzer Sandra, 2008, V12, P107; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; DeRocco VC, 2010, BIOTECHNIQUES, V49, P807, DOI 10.2144/000113551; Eggeling C, 2006, J PHYS CHEM A, V110, P2979, DOI 10.1021/jp054581w; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Holtzer L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437066; Hou XM, 2012, BIOMED OPT EXPRESS, V3, P340, DOI 10.1364/BOE.3.000340; Kapanidis AN, 2002, J CHEM PHYS, V117, P10953, DOI 10.1063/1.1521158; Kobayashi H, 2007, ACS NANO, V1, P258, DOI 10.1021/nn700062z; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Lee J, 2010, ANGEW CHEM INT EDIT, V49, P9922, DOI 10.1002/anie.201005402; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012270; Lin MZ, 2011, NAT METHODS, V8, P726, DOI 10.1038/nmeth.1678; Marras Salvatore A. E., 2006, V335, P3; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Peng XZ, 2006, PROC SPIE, V6097, DOI 10.1117/12.669173; Peng XX, 2009, ANAL BIOCHEM, V388, P220, DOI 10.1016/j.ab.2009.02.024; Ritter JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011639; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Rurack K, 2011, ANAL CHEM, V83, P1232, DOI 10.1021/ac101329h; Sabanayagam CR, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2136157; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Webb SED, 2012, BIOMED OPT EXPRESS, V3, P400, DOI 10.1364/BOE.3.000400; Yanagida T., 2009, SINGLE MOL DYNAMICS	33	22	25	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36265	10.1371/journal.pone.0036265	http://dx.doi.org/10.1371/journal.pone.0036265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558412	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200120
J	Deshiere, A; Duchemin-Pelletier, E; Spreux, E; Ciais, D; Combes, F; Vandenbrouck, Y; Coute, Y; Mikaelian, I; Giusiano, S; Charpin, C; Cochet, C; Filhol, O				Deshiere, A.; Duchemin-Pelletier, E.; Spreux, E.; Ciais, D.; Combes, F.; Vandenbrouck, Y.; Coute, Y.; Mikaelian, I.; Giusiano, S.; Charpin, C.; Cochet, C.; Filhol, O.			Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction	ONCOGENE			English	Article						EMT; protein kinase CK2; Snail1; epithelial plasticity; breast cancer	BREAST-CANCER CELLS; FACTOR-KAPPA-B; BETA-CATENIN; STEM-CELLS; TUMOR PROGRESSION; CASEIN KINASE-2; ALPHA-CATENIN; MAMMARY-GLAND; PHENOTYPE; PHOSPHORYLATION	Epithelial-to-mesenchymal transition (EMT) is closely linked to conversion of early-stage tumours into invasive malignancies. Many signalling pathways are involved in EMT, but the key regulatory kinases in this important process have not been clearly identified. Protein kinase CK2 is a multi-subunit protein kinase, which, when overexpressed, has been linked to disease progression and poor prognosis in various cancers. Specifically, overexpression of CK2 alpha in human breast cancers is correlated with metastatic risk. In this article, we show that an imbalance of CK2 subunits reflected by a decrease in the CK2 beta regulatory subunit in a subset of breast tumour samples is correlated with induction of EMT-related markers. CK2 beta-depleted epithelial cells displayed EMT-like morphological changes, enhanced migration, and anchorage-independent growth, all of which require Snail1 induction. In epithelial cells, Snail1 stability is negatively regulated by CK2 and GSK3 beta through synergistic hierarchal phosphorylation. This process depends strongly on CK2 beta, thus confirming that CK2 functions upstream of Snail1. In primary breast tumours, CK2 beta underexpression also correlates strongly with expression of EMT markers, emphasizing the link between asymmetric expression of CK2 subunits and EMT in vivo. Our results therefore highlight the importance of CK2 beta in controlling epithelial cell plasticity. They show that CK2 holoenzyme activity is essential to suppress EMT, and that it contributes to maintaining a normal epithelial morphology. This study also suggests that unbalanced expression of CK2 subunits may drive EMT, thereby contributing to tumour progression. Oncogene (2013) 32, 1373-1383; doi:10.1038/onc.2012.165; published online 7 May 2012	[Deshiere, A.; Duchemin-Pelletier, E.; Spreux, E.; Ciais, D.; Cochet, C.; Filhol, O.] INSERM, U1036, Grenoble, France; [Deshiere, A.; Duchemin-Pelletier, E.; Spreux, E.; Ciais, D.; Cochet, C.; Filhol, O.] Univ Grenoble 1, U1036, Grenoble, France; [Deshiere, A.; Duchemin-Pelletier, E.; Spreux, E.; Ciais, D.; Cochet, C.; Filhol, O.] CEA, Dept Sci Vivant, Inst Rech Technol & Sci Vivant, F-38054 Grenoble, France; [Combes, F.; Vandenbrouck, Y.; Coute, Y.] CEA, DSV, iRTSV, Lab Etud Dynam Proteomes, F-38054 Grenoble, France; [Mikaelian, I.] Univ Lyon 1, Ctr Rech Cancerol Lyon, INSERM, CNRS,UMR5286,U1052, F-69365 Lyon, France; [Giusiano, S.; Charpin, C.] Univ Aix Marseille 2, Marseille, France; [Giusiano, S.; Charpin, C.] Univ Aix Marseille 2, INSERM, UMR 624, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Filhol, O (corresponding author), CEA, INSERM, DSV, iRTSV,U1036, 17 Rue Martyrs, F-38054 Grenoble, France.	odile.filhol-cochet@cea.fr	Couté, Yohann/G-2695-2015; VANDENBROUCK, Yves/Q-2675-2017; Filhol-Cochet, Odile/I-3962-2016; Ciais, Delphine/O-9435-2016	Couté, Yohann/0000-0003-3896-6196; VANDENBROUCK, Yves/0000-0002-1292-373X; Combes, Florence/0000-0001-7384-4587; Ciais, Delphine/0000-0002-1649-897X; Filhol, Odile/0000-0003-1964-7958; Cochet, Claude/0000-0002-1772-4270; GIUSIANO, sophie/0000-0003-3490-5556	INSERM; CEA; Ligue Nationale contre le Cancer; UJF; French National Research Agency [PCV-08 CoCCINet]; ARC	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); UJF; French National Research Agency(French National Research Agency (ANR)); ARC(Australian Research Council)	This research was supported by recurrent institutional funding from INSERM, CEA, Ligue Nationale contre le Cancer (accredited team 2010-2012), UJF, and grants from the French National Research Agency (PCV-08 CoCCINet), ARC. We thank L Larue and BP Zhou for promoter reporter constructs, AG de Herreros for Snail1 antibody, M Thery and S Ansieau for critical reading of the manuscript.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Canton DA, 2006, CELL SIGNAL, V18, P267, DOI 10.1016/j.cellsig.2005.07.008; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Charpin C, 2009, INT J CANCER, V124, P2124, DOI 10.1002/ijc.24177; COCHET C, 1983, J BIOL CHEM, V258, P1403; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deshiere A, 2011, MOL CELL BIOCHEM, V316, P107; Deshiere A, 2008, MOL CELL BIOCHEM, V316, P107, DOI 10.1007/s11010-008-9845-y; Filhol O, 2003, MOL CELL BIOL, V23, P975, DOI 10.1128/MCB.23.3.975-987.2003; Filhol O, 2009, CELL MOL LIFE SCI, V66, P1830, DOI 10.1007/s00018-009-9151-1; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Giusiano S, 2011, EUR J CANCER, V47, P792, DOI 10.1016/j.ejca.2010.11.028; Gort EH, 2008, CURR MOL MED, V8, P60; Gyenis L, 2008, MOL CELL BIOCHEM, V316, P5, DOI 10.1007/s11010-008-9830-5; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Huillard E, 2010, MOL CELL BIOL, V30, P2737, DOI 10.1128/MCB.01566-09; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mottet D, 2005, INT J CANCER, V117, P764, DOI 10.1002/ijc.21268; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pluemsampant S, 2008, INT J CANCER, V122, P333, DOI 10.1002/ijc.23094; Poletto G, 2008, BIOCHEMISTRY-US, V47, P8317, DOI 10.1021/bi800216d; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Romieu-Mourez R, 2001, CANCER RES, V61, P3810; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN GENET DEV, V13, P365, DOI 10.1016/S0959-437X(03)00088-1; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Wu H, 2009, J CELL BIOCHEM, V108, P52, DOI 10.1002/jcb.22260; Xu Y, 2010, ONCOGENE, V29, P3124, DOI 10.1038/onc.2010.77; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	54	58	61	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 14	2013	32	11					1373	1383		10.1038/onc.2012.165	http://dx.doi.org/10.1038/onc.2012.165			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22562247				2022-12-25	WOS:000316455600004
J	Junqueira, C; Guerrero, AT; Galvao, B; Andrade, WA; Salgado, APC; Cunha, TM; Ropert, C; Campos, MA; Penido, MLO; Mendonca-Previato, L; Previato, JO; Ritter, G; Cunha, FQ; Gazzinelli, RT				Junqueira, Caroline; Guerrero, Ana Tereza; Galvao-Filho, Bruno; Andrade, Warrison A.; Salgado, Ana Paula C.; Cunha, Thiago M.; Ropert, Catherine; Campos, Marco Antonio; Penido, Marcus L. O.; Mendonca-Previato, Lucia; Previato, Jose Oswaldo; Ritter, Gerd; Cunha, Fernando Q.; Gazzinelli, Ricardo T.			Trypanosoma cruzi Adjuvants Potentiate T Cell-Mediated Immunity Induced by a NY-ESO-1 Based Antitumor Vaccine	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; REDUCING INJECTION PAIN; TOLL-LIKE RECEPTORS; HOST-RESISTANCE; INNATE IMMUNITY; PROINFLAMMATORY CYTOKINES; ADAPTIVE IMMUNITY; INTERFERON-GAMMA; DENDRITIC CELLS; TLR9 AGONISTS	Immunological adjuvants that induce T cell-mediate immunity (TCMI) with the least side effects are needed for the development of human vaccines. Glycoinositolphospholipids (GIPL) and CpGs oligodeoxynucleotides (CpG ODNs) derived from the protozoa parasite Trypanosoma cruzi induce potent pro-inflammatory reaction through activation of Toll-Like Receptor (TLR) 4 and TLR9, respectively. Here, using mouse models, we tested the T. cruzi derived TLR agonists as immunological adjuvants in an antitumor vaccine. For comparison, we used well-established TLR agonists, such as the bacterial derived monophosphoryl lipid A (MPL), lipopeptide (Pam3Cys), and CpG ODN. All tested TLR agonists were comparable to induce antibody responses, whereas significant differences were noticed in their ability to elicit CD4(+) T and CD8(+) T cell responses. In particular, both GIPLs (GTH, and GY) and CpG ODNs (B344, B297 and B128) derived from T. cruzi elicited interferon-gamma (IFN-gamma) production by CD4(+) T cells. On the other hand, the parasite derived CpG ODNs, but not GIPLs, elicited a potent IFN-gamma response by CD8(+) T lymphocytes. The side effects were also evaluated by local pain (hypernociception). The intensity of hypernociception induced by vaccination was alleviated by administration of an analgesic drug without affecting protective immunity. Finally, the level of protective immunity against the NY-ESO-1 expressing melanoma was associated with the magnitude of both CD4+ T and CD8+ T cell responses elicited by a specific immunological adjuvant.	[Junqueira, Caroline; Galvao-Filho, Bruno; Andrade, Warrison A.; Salgado, Ana Paula C.; Ropert, Catherine; Campos, Marco Antonio; Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Lab Imunopatol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Junqueira, Caroline; Galvao-Filho, Bruno; Andrade, Warrison A.; Penido, Marcus L. O.; Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Guerrero, Ana Tereza] Fundacao Oswaldo Cruz, Inst Cerrado Pantanal, Campo Grande, Brazil; [Andrade, Warrison A.; Gazzinelli, Ricardo T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA; [Cunha, Thiago M.; Cunha, Fernando Q.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, Ribeirao Preto, Brazil; [Mendonca-Previato, Lucia; Previato, Jose Oswaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ctr Ciencias Saude, Rio De Janeiro, Brazil; [Ritter, Gerd] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; University of Massachusetts System; University of Massachusetts Worcester; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Junqueira, C (corresponding author), Fundacao Oswaldo Cruz, Lab Imunopatol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	ritoga@cpqrr.fiocruz.br	junqueira, caroline/B-4750-2010; Cunha, Fernando Q/M-3090-2014; Ropert, Catherine/G-2463-2012; Campos, Marco A/C-4000-2013; Junqueira, Caroline/GVR-8109-2022; Campos, Marco Antonio/AAU-6229-2021; Ropert, Catherine/AAL-7302-2021; Andrade, Warrison Athanasio/P-7722-2015; Cunha, Thiago M/B-7729-2012	Campos, Marco A/0000-0003-4683-0176; Campos, Marco Antonio/0000-0003-4683-0176; Ropert, Catherine/0000-0002-3077-714X; Andrade, Warrison Athanasio/0000-0003-2709-6463; Cunha, Thiago M/0000-0003-1084-0065; Cunha, Fernando Queiroz/0000-0003-4755-1670; Junqueira, Caroline/0000-0003-0545-0986; Mendonca Previato, Lucia/0000-0003-3927-3244; Previato, Jose Osvaldo/0000-0002-9233-9954; Gazzinelli, Ricardo/0000-0003-2427-7699	Atlantic Philanthropies/Ludwig Institute for Cancer Research (LICR) - Clinical Discovery Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq) - Instituto Nacional de Ciencia e Tecnologia de Vacinas; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil (FAPEMIG	Atlantic Philanthropies/Ludwig Institute for Cancer Research (LICR) - Clinical Discovery Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq) - Instituto Nacional de Ciencia e Tecnologia de Vacinas; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil (FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from The Atlantic Philanthropies/Ludwig Institute for Cancer Research (LICR) - Clinical Discovery Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq) - Instituto Nacional de Ciencia e Tecnologia de Vacinas; and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2009, IMMUNOTHERAPY-UK, V1, P949, DOI [10.2217/imt.09.70, 10.2217/IMT.09.70]; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Anderson BJ, 2008, PEDIATR ANESTH, V18, P915, DOI 10.1111/j.1460-9592.2008.02764.x; Aoki M, 2009, VACCINE, V27, P6854, DOI 10.1016/j.vaccine.2009.09.018; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bartholomeu DC, 2008, J IMMUNOL, V181, P1333, DOI 10.4049/jimmunol.181.2.1333; Caetano BC, 2011, J IMMUNOL, V187, P1903, DOI 10.4049/jimmunol.1003911; Camargo MM, 1997, J IMMUNOL, V158, P5890; Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Carroll MW, 1997, VACCINE, V15, P387, DOI 10.1016/S0264-410X(96)00195-8; Chen PW, 1996, J IMMUNOL, V156, P224; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Gazzinelli RT, 2004, IMMUNOL REV, V201, P9, DOI 10.1111/j.0105-2896.2004.00174.x; Gnjatic S, 2009, CLIN CANCER RES, V15, P2130, DOI 10.1158/1078-0432.CCR-08-2632; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kis-Toth K, 2011, J IMMUNOL, V187, P1222, DOI 10.4049/jimmunol.1100469; Krieg AM, 2008, ONCOGENE, V27, P161, DOI 10.1038/sj.onc.1210911; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Maraskovsky E, 2004, CLIN CANCER RES, V10, P2879, DOI 10.1158/1078-0432.CCR-03-0245; Melief CJM, 2002, IMMUNOL REV, V188, P177, DOI 10.1034/j.1600-065X.2002.18816.x; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nishikawa H, 2008, BLOOD, V111, P1404, DOI 10.1182/blood-2007-09-113761; Nishikawa H, 2006, J CLIN INVEST, V116, P1946, DOI 10.1172/JCI28045; Oliveira AC, 2004, J IMMUNOL, V173, P5688, DOI 10.4049/jimmunol.173.9.5688; Parada CA, 2003, P NATL ACAD SCI USA, V100, P2923, DOI 10.1073/pnas.252777799; PARKER KC, 1994, J IMMUNOL, V152, P163; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; PREVIATO JO, 1990, J BIOL CHEM, V265, P2518; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Shah V, 2009, CLIN THER, V31, pS104, DOI 10.1016/j.clinthera.2009.08.001; Singh R, 2011, HUM VACCIN, V7; Su L, 2000, J Epidemiol Biostat, V5, P359; Taddio A, 2009, CLIN THER, V31, pS48, DOI 10.1016/j.clinthera.2009.07.024; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; Wang RF, 1998, J IMMUNOL, V161, P3596; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059; Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335; Zarour HM, 2002, CANCER RES, V62, P213; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	59	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36245	10.1371/journal.pone.0036245	http://dx.doi.org/10.1371/journal.pone.0036245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567144	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341500063
J	Ricciardi, M; Malpeli, G; Bifari, F; Bassi, G; Pacelli, L; Kamdje, AHN; Chilosi, M; Krampera, M				Ricciardi, Mario; Malpeli, Giorgio; Bifari, Francesco; Bassi, Giulio; Pacelli, Luciano; Kamdje, Armel Herve Nwabo; Chilosi, Marco; Krampera, Mauro			Comparison of Epithelial Differentiation and Immune Regulatory Properties of Mesenchymal Stromal Cells Derived from Human Lung and Bone Marrow	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; RETINOIC ACID; FIBROBLASTS; APOPTOSIS; PATHOGENESIS; TRANSITIONS; MECHANISMS; EXPRESSION	Mesenchymal stromal cells (MSCs) reside in many organs including lung, as shown by their isolation from fetal lung tissues, bronchial stromal compartment, bronchial-alveolar lavage and transplanted lung tissues. It is still controversial whether lung MSCs can undergo mesenchymal-to-epithelial-transition (MET) and possess immune regulatory properties. To this aim, we isolated, expanded and characterized MSCs from normal adult human lung (lung-hMSCs) and compared with human bone marrow-derived MSCs (BM-hMSCs). Our results show that lung-MSCs reside at the perivascular level and do not significantly differ from BM-hMSCs in terms of immunophenotype, stemness gene profile, mesodermal differentiation potential and modulation of T, B and NK cells. However, lung-hMSCs express higher basal level of the stemness-related marker nestin and show, following in vitro treatment with retinoic acid, higher epithelial cell polarization, which is anyway partial when compared to a control epithelial bronchial cell line. Although these results question the real capability of acquiring epithelial functions by MSCs and the feasibility of MSC-based therapeutic approaches to regenerate damaged lung tissues, the characterization of this lung-hMSC population may be useful to study the involvement of stromal cell compartment in lung diseases in which MET plays a role, such as in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.	[Ricciardi, Mario; Bifari, Francesco; Bassi, Giulio; Pacelli, Luciano; Kamdje, Armel Herve Nwabo; Krampera, Mauro] Univ Verona, Dept Med, Sect Hematol, Stem Cell Res Lab, I-37100 Verona, Italy; [Malpeli, Giorgio; Chilosi, Marco] Univ Verona, Dept Pathol & Diagnost, Sect Pathol Anat, I-37100 Verona, Italy	University of Verona; University of Verona	Ricciardi, M (corresponding author), Univ Verona, Dept Med, Sect Hematol, Stem Cell Res Lab, I-37100 Verona, Italy.	mauro.krampera@univr.it	Bifari, Francesco/M-3430-2014; CHILOSI, MARCO/ABB-8028-2021; KRAMPERA, MAURO/K-5596-2018	Bifari, Francesco/0000-0003-2028-3012; KRAMPERA, Mauro/0000-0002-7280-2040; Ricciardi, Mario/0000-0003-3694-8218; Malpeli, Giorgio/0000-0002-2996-2903	Regione del Veneto; Italian Ministry of University and Scientific Research; Fondazione CARIVERONA	Regione del Veneto(Regione Veneto); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIVERONA(Fondazione Cariverona)	This work was supported by the grant "Ricerca Sanitaria Finalizzata per l'anno 2009'' from "Regione del Veneto" and by the Italian Ministry of University and Scientific Research (PRIN 2007) and Fondazione CARIVERONA, Bando 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Badri L, 2011, AM J RESP CELL MOL, V45, P809, DOI 10.1165/rcmb.2010-0446OC; Baraldo S, 2008, EUR RESPIR J, V31, P486, DOI 10.1183/09031936.00000608; Barcelo B, 2008, EUR RESPIR J, V31, P555, DOI 10.1183/09031936.00010407; Bozyk PD, 2011, STEM CELLS DEV, V20, P1995, DOI 10.1089/scd.2010.0494; Brzoska M, 2005, BIOCHEM BIOPH RES CO, V330, P142, DOI 10.1016/j.bbrc.2005.02.141; Castaldi PJ, 2010, HUM MOL GENET, V19, P526, DOI 10.1093/hmg/ddp519; Chilosi M, 2010, SARCOIDOSIS VASC DIF, V27, P7; Conese M, 2006, J CYST FIBROS, V5, P141, DOI 10.1016/j.jcf.2006.02.001; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dickman ED, 1997, DEVELOPMENT, V124, P3111; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Geiser T, 2003, SWISS MED WKLY, V133, P405; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Hua JL, 2009, TISSUE CELL, V41, P448, DOI 10.1016/j.tice.2009.05.004; Jarvinen L, 2008, J IMMUNOL, V181, P4389, DOI 10.4049/jimmunol.181.6.4389; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kaza AK, 2001, ANN THORAC SURG, V71, P1645, DOI 10.1016/S0003-4975(01)02478-X; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Koshiol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007380; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Krampera M, 2011, LEUKEMIA, V25, P1408, DOI 10.1038/leu.2011.108; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Krampera M, 2006, CURR OPIN PHARMACOL, V6, P435, DOI 10.1016/j.coph.2006.02.008; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Lane MA, 1999, P NATL ACAD SCI USA, V96, P13524, DOI 10.1073/pnas.96.23.13524; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Loi R, 2006, AM J RESP CRIT CARE, V173, P171, DOI 10.1164/rccm.200502-309OC; MacNee William, 2009, Proc Am Thorac Soc, V6, P527, DOI 10.1513/pats.200905-027DS; Maden M, 2004, PHILOS T R SOC B, V359, P799, DOI 10.1098/rstb.2004.1470; Malpel S, 2000, DEVELOPMENT, V127, P3057; Massaro D, 2010, NEW ENGL J MED, V362, P1829, DOI 10.1056/NEJMe1002366; MASUYAMA H, 1995, BIOL NEONATE, V67, P264, DOI 10.1159/000244174; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Mochizuki T, 2006, ARTHRITIS RHEUM-US, V54, P843, DOI 10.1002/art.21651; Muller KC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-32; Noordhoek JA, 2003, EXP LUNG RES, V29, P291, DOI 10.1080/01902140303789; Plateroti M, 1997, J CELL SCI, V110, P1227; PROCKOP DJ, 1997, SCIENCE, V276, P71, DOI [DOI 10.1126/SCIENCE.276.5309.71, 10.1126/science.276.5309.71]; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Tabata C, 2006, AM J PHYSIOL-LUNG C, V290, pL597, DOI 10.1152/ajplung.00282.2005; Tabata C, 2006, AM J RESP CRIT CARE, V174, P1352, DOI 10.1164/rccm.200606-862OC; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Wolbach SB, 1933, J EXP MED, V57, P511, DOI 10.1084/jem.57.3.511; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	57	53	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35639	10.1371/journal.pone.0035639	http://dx.doi.org/10.1371/journal.pone.0035639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567106	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341500024
J	Hagemann, S; Kuck, D; Stresemann, C; Prinz, F; Brueckner, B; Mund, C; Mumberg, D; Sommer, A				Hagemann, Sabine; Kuck, Dirk; Stresemann, Carlo; Prinz, Florian; Brueckner, Bodo; Mund, Cora; Mumberg, Dominik; Sommer, Anette			Antiproliferative Effects of DNA Methyltransferase 3B Depletion Are Not Associated with DNA Demethylation	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; DE-NOVO METHYLATION; COLORECTAL-CANCER; INTESTINAL NEOPLASIA; CELL-SURVIVAL; DNMT3B; GENES; EXPRESSION; HYPERMETHYLATION; LYMPHOMAGENESIS	Silencing of genes by hypermethylation contributes to cancer progression and has been shown to occur with increased frequency at specific genomic loci. However, the precise mechanisms underlying the establishment and maintenance of aberrant methylation marks are still elusive. The de novo DNA methyltransferase 3B (DNMT3B) has been suggested to play an important role in the generation of cancer-specific methylation patterns. Previous studies have shown that a reduction of DNMT3B protein levels induces antiproliferative effects in cancer cells that were attributed to the demethylation and reactivation of tumor suppressor genes. However, methylation changes have not been analyzed in detail yet. Using RNA interference we reduced DNMT3B protein levels in colon cancer cell lines. Our results confirm that depletion of DNMT3B specifically reduced the proliferation rate of DNMT3B-overexpressing colon cancer cell lines. However, genome-scale DNA methylation profiling failed to reveal methylation changes at putative DNMT3B target genes, even in the complete absence of DNMT3B. These results show that DNMT3B is dispensable for the maintenance of aberrant DNA methylation patterns in human colon cancer cells and they have important implications for the development of targeted DNA methyltransferase inhibitors as epigenetic cancer drugs.	[Hagemann, Sabine; Kuck, Dirk; Brueckner, Bodo] German Canc Res Ctr, Div Epigenet, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany; [Kuck, Dirk; Stresemann, Carlo; Prinz, Florian; Mund, Cora; Mumberg, Dominik; Sommer, Anette] Bayer Healthcare Pharmaceut, Global Drug Discovery, Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Bayer AG; Bayer Healthcare Pharmaceuticals	Hagemann, S (corresponding author), German Canc Res Ctr, Div Epigenet, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany.	anette.sommer@bayer.com	Sommer, Anette/T-7674-2019; Stresemann, Carlo/AAF-6643-2020	Sommer, Anette/0000-0002-1576-3110; 				Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Chik F, 2011, CARCINOGENESIS, V32, P224, DOI 10.1093/carcin/bgq221; Choi SH, 2011, NUCLEIC ACIDS RES, V39, P104, DOI 10.1093/nar/gkq774; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Egner U, 2005, CHEMBIOCHEM, V6, P468, DOI 10.1002/cbic.200400158; Esteller M, 2001, CANCER RES, V61, P3225; Geiman TM, 2004, NUCLEIC ACIDS RES, V32, P2716, DOI 10.1093/nar/gkh589; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Hlady RA, 2012, J CLIN INVEST, V122, P163, DOI 10.1172/JCI57292; Ibrahim AEK, 2011, GUT, V60, P499, DOI 10.1136/gut.2010.223602; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kang ES, 2001, BIOCHEM BIOPH RES CO, V289, P862, DOI 10.1006/bbrc.2001.6057; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lin HJ, 2006, MOL CELL BIOL, V26, P2976, DOI 10.1128/MCB.26.8.2976-2983.2006; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Milutinovic S, 2004, J BIOL CHEM, V279, P27915, DOI 10.1074/jbc.M312823200; Milutinovic S, 2003, J BIOL CHEM, V278, P14985, DOI 10.1074/jbc.M213219200; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Rasband W., 2006, IMAGEJ; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shah MY, 2010, CANCER RES, V70, P5840, DOI 10.1158/0008-5472.CAN-10-0847; Shi HD, 2003, CANCER RES, V63, P2164; Simo-Riudalbas L, 2011, GENE CHROMOSOME CANC, V50, P527, DOI 10.1002/gcc.20877; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Team R. D. C, 2011, R LANG ENV STAT COMP; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Unterberger A, 2006, MOL CELL BIOL, V26, P7575, DOI 10.1128/MCB.01887-05; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yaqinuddin A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-13	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36125	10.1371/journal.pone.0036125	http://dx.doi.org/10.1371/journal.pone.0036125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563479	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700028
J	Lin, AHM; Nichols, BL; Quezada-Calvillo, R; Avery, SE; Sim, L; Rose, DR; Naim, HY; Hamaker, BR				Lin, Amy Hui-Mei; Nichols, Buford L.; Quezada-Calvillo, Roberto; Avery, Stephen E.; Sim, Lyann; Rose, David R.; Naim, Hassan Y.; Hamaker, Bruce R.			Unexpected High Digestion Rate of Cooked Starch by the Ct-Maltase-Glucoamylase Small Intestine Mucosal alpha-Glucosidase Subunit	PLOS ONE			English	Article							ENZYME-RESISTANT STARCH; SUCRASE-ISOMALTASE; SUBSITE AFFINITIES; SUBSTRATE BRAKE; FOODS; HYDROLYSIS; DISACCHARIDASES; CLASSIFICATION; CHROMATOGRAPHY; ONTOGENY	For starch digestion to glucose, two luminal alpha-amylases and four gut mucosal alpha-glucosidase subunits are employed. The aim of this research was to investigate, for the first time, direct digestion capability of individual mucosal alpha-glucosidases on cooked (gelatinized) starch. Gelatinized normal maize starch was digested with N- and C-terminal subunits of recombinant mammalian maltase-glucoamylase (MGAM) and sucrase-isomaltase (SI) of varying amounts and digestion periods. Without the aid of alpha-amylase, Ct-MGAM demonstrated an unexpected rapid and high digestion degree near 80%, while other subunits showed 20 to 30% digestion. These findings suggest that Ct-MGAM assists alpha-amylase in digesting starch molecules and potentially may compensate for developmental or pathological amylase deficiencies.	[Lin, Amy Hui-Mei; Hamaker, Bruce R.] Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA; [Nichols, Buford L.; Quezada-Calvillo, Roberto; Avery, Stephen E.] Baylor Coll Med, USDA, ARS, Childrens Nutr Res Ctr,Dept Pediat, Houston, TX 77030 USA; [Sim, Lyann] Univ Toronto, Ontario Canc Inst, Toronto, ON, Canada; [Sim, Lyann] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Naim, Hassan Y.] Univ Vet Med Hannover, Inst Physiol Chem, Hannover, Germany	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Waterloo; University of Veterinary Medicine Hannover, Foundation	Lin, AHM (corresponding author), Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, Smith Hall, W Lafayette, IN 47907 USA.	hamakerb@purdue.edu			internal sources from the Whistler Center for Carbohydrate Research at Purdue University (West Lafayette, IN, U.S.A.); USDA, Agricultural Research Service, under Cooperative Agreement [58-6250-1-003]	internal sources from the Whistler Center for Carbohydrate Research at Purdue University (West Lafayette, IN, U.S.A.); USDA, Agricultural Research Service, under Cooperative Agreement(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by internal sources from the Whistler Center for Carbohydrate Research at Purdue University (West Lafayette, IN, U.S.A.) and, for one collaborator (BLN), USDA, Agricultural Research Service, under Cooperative Agreement no. 58-6250-1-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerberg A, 1998, J CEREAL SCI, V28, P71, DOI 10.1006/jcrs.1997.0173; Akerberg AKE, 1998, J NUTR, V128, P651; Ao Z, 2007, FEBS LETT, V581, P2381, DOI 10.1016/j.febslet.2007.04.035; Chung HJ, 2006, J CEREAL SCI, V43, P353, DOI 10.1016/j.jcs.2005.12.001; DAHLQVIST A, 1969, BIOCHEM J, V111, P139, DOI 10.1042/bj1110139; DAHLQVIST A, 1963, J CLIN INVEST, V42, P556, DOI 10.1172/JCI104744; DAHLQVIST A, 1962, J CLIN INVEST, V41, P463, DOI 10.1172/JCI104499; EERLINGEN RC, 1993, CEREAL CHEM, V70, P339; EERLINGEN RC, 1993, CEREAL CHEM, V70, P345; ENGLYST H, 1982, ANALYST, V107, P307, DOI 10.1039/an9820700307; Englyst HN, 1996, FOOD CHEM, V57, P15, DOI 10.1016/0308-8146(96)00056-8; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; Faraj A, 2004, FOOD RES INT, V37, P517, DOI 10.1016/j.foodres.2003.09.015; French D., 1984, STARCH CHEM TECHNOLO, V2, P183, DOI DOI 10.1016/B978-0-12-746270-7.50013-6; Goni I, 1996, FOOD CHEM, V56, P445, DOI 10.1016/0308-8146(95)00222-7; Gunther S, 1996, ARCH BIOCHEM BIOPHYS, V327, P295, DOI 10.1006/abbi.1996.0125; Gunther S, 1998, ARCH BIOCHEM BIOPHYS, V354, P111, DOI 10.1006/abbi.1998.0684; HENNING SJ, 1985, ANNU REV PHYSIOL, V47, P231; HENNING SJ, 1979, ENVIRON HEALTH PERSP, V33, P9, DOI 10.2307/3429067; HEYMANN H, 1995, BIOL CHEM H-S, V376, P249; HEYMANN H, 1994, BIOL CHEM H-S, V375, P451, DOI 10.1515/bchm3.1994.375.7.451; HIROMI K, 1973, BIOCHIM BIOPHYS ACTA, V302, P362, DOI 10.1016/0005-2744(73)90164-2; Hizukuri S., 1996, CARBOHYDRATES FOOD, P347; LARNER J, 1955, J BIOL CHEM, V215, P723; Layer P, 1999, J CLIN GASTROENTEROL, V28, P3, DOI 10.1097/00004836-199901000-00002; LEBENTHAL E, 1980, PEDIATRICS, V66, P556; Lin AHM, 2010, FASEB J, V24; MCCLEAN P, 1993, ARCH DIS CHILD-FETAL, V68, P62, DOI 10.1136/adc.68.1_Spec_No.62; McCleary BV, 2002, J AOAC INT, V85, P1103; MCMICHAEL HB, 1971, P NUTR SOC, V30, P248, DOI 10.1079/PNS19710048; Megazyme, 2008, RES STARCH ASS PROC; MUIR JG, 1992, AM J CLIN NUTR, V56, P123, DOI 10.1093/ajcn/56.1.123; Nichols BL, 1998, J BIOL CHEM, V273, P3076, DOI 10.1074/jbc.273.5.3076; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Nichols BL, 2009, J NUTR, V139, P684, DOI 10.3945/jn.108.098434; Quezada-Calvillo R, 2008, J NUTR, V138, P685, DOI 10.1093/jn/138.4.685; Quezada-Calvillo R, 2007, J NUTR, V137, P1725, DOI 10.1093/jn/137.7.1725; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; Segrest J P, 1971, Biochem Biophys Res Commun, V44, P390; Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x; SAURACALIXTO F, 1993, J FOOD SCI, V58, P642, DOI 10.1111/j.1365-2621.1993.tb04346.x; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SEMENZA G, 1991, INDIAN J BIOCHEM BIO, V28, P331; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; SORENSEN SH, 1982, EUR J BIOCHEM, V126, P559, DOI 10.1111/j.1432-1033.1982.tb06817.x; TRINDER P., 1969, Journal of Clinical Pathology, V22, P158, DOI 10.1136/jcp.22.2.158; UGOLEV AM, 1965, PHYSIOL REV, V45, P555, DOI 10.1152/physrev.1965.45.3.555; UGOLEV AM, 1973, BIOCHIM BIOPHYS ACTA, V300, P105, DOI 10.1016/0304-4157(73)90001-4; VANBEERS EH, 1995, CRIT REV BIOCHEM MOL, V30, P197, DOI 10.3109/10409239509085143	49	38	38	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35473	10.1371/journal.pone.0035473	http://dx.doi.org/10.1371/journal.pone.0035473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563462	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340700011
J	Lang, MF; Yang, S; Zhao, CN; Sun, GQ; Murai, K; Wu, XW; Wang, JH; Gao, HL; Brown, CE; Liu, XX; Zhou, JH; Peng, L; Rossi, JJ; Shi, YH				Lang, Ming-Fei; Yang, Su; Zhao, Chunnian; Sun, Guoqiang; Murai, Kiyohito; Wu, Xiwei; Wang, Jinhui; Gao, Hanlin; Brown, Christine E.; Liu, Xiaoxuan; Zhou, Jiehua; Peng, Ling; Rossi, John J.; Shi, Yanhong			Genome-Wide Profiling Identified a Set of miRNAs that Are Differentially Expressed in Glioblastoma Stem Cells and Normal Neural Stem Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR TLX; HEPATOCELLULAR-CARCINOMA; REGULATORY LOOP; MICRORNAS; PROLIFERATION; CANCER; GLIOMA; GROWTH; NEUROGENESIS; PATTERNS	A major challenge in cancer research field is to define molecular features that distinguish cancer stem cells from normal stem cells. In this study, we compared microRNA (miRNA) expression profiles in human glioblastoma stem cells and normal neural stem cells using combined microarray and deep sequencing analyses. These studies allowed us to identify a set of 10 miRNAs that are considerably up-regulated or down-regulated in glioblastoma stem cells. Among them, 5 miRNAs were further confirmed to have altered expression in three independent lines of glioblastoma stem cells by real-time RT-PCR analysis. Moreover, two of the miRNAs with increased expression in glioblastoma stem cells also exhibited elevated expression in glioblastoma patient tissues examined, while two miRNAs with decreased expression in glioblastoma stem cells displayed reduced expression in tumor tissues. Furthermore, we identified two oncogenes, NRAS and PIM3, as downstream targets of miR-124, one of the down-regulated miRNAs; and a tumor suppressor, CSMD1, as a downstream target of miR-10a and miR-10b, two of the up-regulated miRNAs. In summary, this study led to the identification of a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. Characterizing the role of these miRNAs in glioblastoma stem cells may lead to the development of miRNA-based therapies that specifically target tumor stem cells, but spare normal stem cells.	[Lang, Ming-Fei; Yang, Su; Zhao, Chunnian; Sun, Guoqiang; Murai, Kiyohito; Shi, Yanhong] Beckman Res Inst City Hope, Dept Neurosci, Ctr Gene Express & Drug Discovery, Ctr Canc, Duarte, CA 91010 USA; [Yang, Su; Rossi, John J.; Shi, Yanhong] Beckman Res Inst City Hope, Irell & Manella Grad Sch Biol Sci, Duarte, CA USA; [Wu, Xiwei] Beckman Res Inst City Hope, Dept Mol Med, Duarte, CA USA; [Wang, Jinhui; Gao, Hanlin] Beckman Res Inst City Hope, DNA Sequencing Solexa Core, Duarte, CA USA; [Brown, Christine E.] Beckman Res Inst City Hope, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA; [Liu, Xiaoxuan; Peng, Ling] Aix Marseille Univ, CNRS UMR 7325, Ctr Interdisciplinaire Nanosci Marseille, Marseille, France; [Zhou, Jiehua; Rossi, John J.] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; City of Hope; Beckman Research Institute of City of Hope	Lang, MF (corresponding author), Beckman Res Inst City Hope, Dept Neurosci, Ctr Gene Express & Drug Discovery, Ctr Canc, Duarte, CA 91010 USA.	yshi@coh.org	PENG, Ling/A-6366-2019; zhou, Jiehua/B-4045-2010	PENG, Ling/0000-0003-3990-5248; Brown, Christine/0000-0003-4915-8207; Shi, Yanhong/0000-0002-3938-5839	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS) [R01 NS059546, RC1 NS068370]; California Institute for Regenerative medicine [TR2-01832]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068370, R01NS059546] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS) R01 NS059546, RC1 NS068370 (http://www.ninds.nih.gov/) and California Institute for Regenerative medicine TR2-01832 (http://www.cirm.ca.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asadi-Moghaddam K, 2010, EXPERT REV ANTICANC, V10, P1753, DOI [10.1586/era.10.168, 10.1586/ERA.10.168]; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Cheng L, 2010, BIOCHEM PHARMACOL, V80, P654, DOI 10.1016/j.bcp.2010.04.035; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Clayton PE, 2011, NAT REV ENDOCRINOL, V7, P11, DOI 10.1038/nrendo.2010.171; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Godlewski J, 2010, CELL DEATH DIFFER, V17, P221, DOI 10.1038/cdd.2009.71; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hunt S, 2011, FEBS LETT, V585, P187, DOI 10.1016/j.febslet.2010.11.038; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kamal M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/s10549-009-0500-4; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kiessling MK, 2011, BLOOD, V117, P2433, DOI 10.1182/blood-2010-09-305128; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Roth P, 2011, J NEUROCHEM, V118, P449, DOI 10.1111/j.1471-4159.2011.07307.x; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Verissimo CS, 2011, ENDOCR-RELAT CANCER, V18, pR213, DOI 10.1530/ERC-11-0251; Wu Y, 2010, ONCOGENE, V29, P2228, DOI 10.1038/onc.2009.504; Xia H, 2012, J BIOL CHEM; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhou JH, 2006, CHEM COMMUN, P2362, DOI 10.1039/b601381c; Zhou JH, 2011, MOL THER, V19, P2228, DOI 10.1038/mt.2011.207	46	84	90	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36248	10.1371/journal.pone.0036248	http://dx.doi.org/10.1371/journal.pone.0036248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558405	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200056
J	Leon, A; Elgueda, D; Silva, MA; Hamame, CM; Delano, PH				Leon, Alex; Elgueda, Diego; Silva, Maria A.; Hamame, Carlos M.; Delano, Paul H.			Auditory Cortex Basal Activity Modulates Cochlear Responses in Chinchillas	PLOS ONE			English	Article							INFERIOR COLLICULUS; CORTICOFUGAL MODULATION; ELECTRICAL-STIMULATION; CONTRALATERAL SUPPRESSION; ACETYLCHOLINE-RECEPTOR; OLIVOCOCHLEAR NEURONS; NERVE ACTIVITY; GUINEA-PIG; INACTIVATION; PROJECTIONS	Background: The auditory efferent system has unique neuroanatomical pathways that connect the cerebral cortex with sensory receptor cells. Pyramidal neurons located in layers V and VI of the primary auditory cortex constitute descending projections to the thalamus, inferior colliculus, and even directly to the superior olivary complex and to the cochlear nucleus. Efferent pathways are connected to the cochlear receptor by the olivocochlear system, which innervates outer hair cells and auditory nerve fibers. The functional role of the cortico-olivocochlear efferent system remains debated. We hypothesized that auditory cortex basal activity modulates cochlear and auditory-nerve afferent responses through the efferent system. Methodology/Principal Findings: Cochlear microphonics (CM), auditory-nerve compound action potentials (CAP) and auditory cortex evoked potentials (ACEP) were recorded in twenty anesthetized chinchillas, before, during and after auditory cortex deactivation by two methods: lidocaine microinjections or cortical cooling with cryoloops. Auditory cortex deactivation induced a transient reduction in ACEP amplitudes in fifteen animals (deactivation experiments) and a permanent reduction in five chinchillas (lesion experiments). We found significant changes in the amplitude of CM in both types of experiments, being the most common effect a CM decrease found in fifteen animals. Concomitantly to CM amplitude changes, we found CAP increases in seven chinchillas and CAP reductions in thirteen animals. Although ACEP amplitudes were completely recovered after ninety minutes in deactivation experiments, only partial recovery was observed in the magnitudes of cochlear responses. Conclusions/Significance: These results show that blocking ongoing auditory cortex activity modulates CM and CAP responses, demonstrating that cortico-olivocochlear circuits regulate auditory nerve and cochlear responses through a basal efferent tone. The diversity of the obtained effects suggests that there are at least two functional pathways from the auditory cortex to the cochlea.	[Leon, Alex; Elgueda, Diego; Silva, Maria A.; Hamame, Carlos M.; Delano, Paul H.] Univ Chile, Fac Med, Lab Neurobiol Audic, Programa Fisiol & Biofis,ICBM, Santiago 7, Chile; [Elgueda, Diego] Univ Maryland, Inst Syst Res & Neurosci, College Pk, MD 20742 USA; [Elgueda, Diego] Univ Maryland, Cognit Sci Program, College Pk, MD 20742 USA; [Hamame, Carlos M.] CNRS, INSERM, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team,U1028,UMR5292, Lyon, France; [Delano, Paul H.] Univ Chile, Serv Otorrinolaringol, Hosp Clin, Santiago, Chile	Universidad de Chile; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universidad de Chile	Leon, A (corresponding author), Univ Chile, Fac Med, Lab Neurobiol Audic, Programa Fisiol & Biofis,ICBM, Santiago 7, Chile.	pdelano@med.uchile.cl	Delano, Paul/I-1030-2013; Elgueda, Diego/P-7239-2019	Delano, Paul/0000-0003-2588-4757; Elgueda, Diego/0000-0003-3542-9483	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11080033]; Sociedad Chilena de Otorrinolaringologia (SOCHIORL) [2008]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Sociedad Chilena de Otorrinolaringologia (SOCHIORL)	Supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 11080033 and Sociedad Chilena de Otorrinolaringologia (SOCHIORL) 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes FM, 2011, J NEUROSCI, V31, P17306, DOI 10.1523/JNEUROSCI.1915-11.2011; Bajo VM, 2005, J COMP NEUROL, V486, P101, DOI 10.1002/cne.20542; Coomber B, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00053; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; daCosta DL, 1997, EXP BRAIN RES, V116, P259, DOI 10.1007/PL00005754; Darrow KN, 2006, NAT NEUROSCI, V9, P1474, DOI 10.1038/nn1807; De Boer J, 2007, HEARING RES, V233, P117, DOI 10.1016/j.heares.2007.08.002; De Venecia RK, 2005, J COMP NEUROL, V487, P345, DOI 10.1002/cne.20550; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Doucet JR, 2002, BRAIN RES, V925, P28, DOI 10.1016/S0006-8993(01)03248-6; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Elgueda D, 2011, JARO-J ASSOC RES OTO, V12, P317, DOI 10.1007/s10162-011-0260-9; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; EYBALIN M, 1993, PHYSIOL REV, V73, P309, DOI 10.1152/physrev.1993.73.2.309; FELICIANO M, 1995, J NEUROCHEM, V65, P1348; Fenoy AJ, 2006, BRAIN RES, V1118, P75, DOI 10.1016/j.brainres.2006.08.013; FEX J, 1959, Acta Otolaryngol, V50, P540, DOI 10.3109/00016485909129230; FROEHLICH P, 1990, BRAIN RES, V508, P286, DOI 10.1016/0006-8993(90)90408-4; GALAMBOS R, 1956, J NEUROPHYSIOL, V19, P424, DOI 10.1152/jn.1956.19.5.424; GIFFORD ML, 1987, HEARING RES, V29, P179, DOI 10.1016/0378-5955(87)90166-3; Groff JA, 2003, J NEUROPHYSIOL, V90, P3178, DOI 10.1152/jn.00537.2003; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Harel N, 1997, HEARING RES, V110, P25, DOI 10.1016/S0378-5955(97)00061-0; Harel N, 2000, NEUROIMAGE, V11, P302, DOI 10.1006/nimg.1999.0537; Harrison RV, 1996, HEARING RES, V100, P157, DOI 10.1016/0378-5955(96)00120-7; Hatzopoulos S, 2002, HEARING RES, V170, P12, DOI 10.1016/S0378-5955(02)00448-3; Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626, DOI 10.1152/jn.2000.83.5.2626; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; HUNT CC, 1951, J PHYSIOL-LONDON, V113, P283, DOI 10.1113/jphysiol.1951.sp004572; Khalfa S, 2001, NEUROSCIENCE, V104, P347, DOI 10.1016/S0306-4522(01)00072-0; KUFFLER SW, 1951, J NEUROPHYSIOL, V14, P29, DOI 10.1152/jn.1951.14.1.29; Le Prell CG, 2005, JARO-J ASSOC RES OTO, V6, P48, DOI 10.1007/s10162-004-5009-2; Le Prell CG, 2003, JARO-J ASSOC RES OTO, V4, P276, DOI 10.1007/s10162-002-3018-6; Liu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013021; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Luebke AE, 2002, J NEUROSCI, V22, P4241, DOI 10.1523/JNEUROSCI.22-10-04241.2002; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; Maison SF, 2000, J NEUROSCI, V20, P4701, DOI 10.1523/JNEUROSCI.20-12-04701.2000; Malmierca MS, 2011, AUDITORY CORTEX, P189, DOI 10.1007/978-1-4419-0074-6_9; Mulders WHA, 2000, HEARING RES, V149, P11, DOI 10.1016/S0378-5955(00)00157-X; Mulders WHAM, 2005, EXP BRAIN RES, V160, P235, DOI 10.1007/s00221-004-2003-1; Mulders WHAM, 2002, HEARING RES, V167, P206, DOI 10.1016/S0378-5955(02)00395-7; Nakamoto KT, 2010, J NEUROPHYSIOL, V103, P2050, DOI 10.1152/jn.00451.2009; Perrot X, 2006, CEREB CORTEX, V16, P941, DOI 10.1093/cercor/bhj035; Riga M, 2007, OTOL NEUROTOL, V28, P185, DOI 10.1097/MAO.0b013e31802e2a14; Robles L, 2008, EFFERENT SYSTEM SENS, P413; Ruel J, 2001, EUR J NEUROSCI, V14, P977, DOI 10.1046/j.0953-816x.2001.01721.x; Ryugo D.K., 2010, INTRO EFFERENT SYSTE, P1; Schofield B.R., 2010, CENTRAL DESCENDING A, P261; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Tehovnik EJ, 1997, J NEUROSCI METH, V74, P17, DOI 10.1016/S0165-0270(97)02229-2; THOMPSON AM, 1993, J COMP NEUROL, V335, P402, DOI 10.1002/cne.903350309; VELLUTI R, 1989, HEARING RES, V39, P203, DOI 10.1016/0378-5955(89)90091-9; WARR WB, 1979, BRAIN RES, V173, P152, DOI 10.1016/0006-8993(79)91104-1; Winer JA, 2005, HEARING RES, V207, P1, DOI 10.1016/j.heares.2005.06.007; Xiao ZJ, 2005, P NATL ACAD SCI USA, V102, P19162, DOI 10.1073/pnas.0509761102; Xiao ZJ, 2002, P NATL ACAD SCI USA, V99, P15743, DOI 10.1073/pnas.242606699; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z; Zhang W, 2006, BRAIN RES, V1081, P138, DOI 10.1016/j.brainres.2006.01.049; Zheng XY, 2000, HEARING RES, V143, P14, DOI 10.1016/S0378-5955(99)00217-8	63	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36203	10.1371/journal.pone.0036203	http://dx.doi.org/10.1371/journal.pone.0036203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558383	gold, Green Submitted, Green Published			2022-12-25	WOS:000305340200049
J	Renga, B; Francisci, D; D'Amore, C; Schiaroli, E; Mencarelli, A; Cipriani, S; Baldelli, F; Fiorucci, S				Renga, Barbara; Francisci, Daniela; D'Amore, Claudio; Schiaroli, Elisabetta; Mencarelli, Andrea; Cipriani, Sabrina; Baldelli, Franco; Fiorucci, Stefano			The HIV Matrix Protein p17 Subverts Nuclear Receptors Expression and Induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes	PLOS ONE			English	Article							DENDRITIC CELLS; DOWN-REGULATION; ACTIVATION; MACROPHAGES; INDUCTION; CD4(+); CD36; INFLAMMATION; PATHOGENESIS; METABOLISM	Background: Long-term remission of HIV-1 disease can be readily achieved by combinations of highly effective antiretroviral therapy (HAART). However, a residual persistent immune activation caused by circulating non infectious particles or viral proteins is observed under HAART and might contribute to an higher risk of non-AIDS pathologies and death in HIV infected persons. A sustained immune activation supports lipid dysmetabolism and increased risk for development of accelerated atehrosclerosis and ischemic complication in virologically suppressed HIV-infected persons receiving HAART. Aim: While several HIV proteins have been identified and characterized for their ability to maintain immune activation, the role of HIV-p17, a matrix protein involved in the viral replication, is still undefined. Results: Here, we report that exposure of macrophages to recombinant human p17 induces the expression of proinflammatory and proatherogenic genes (MCP-1, ICAM-1, CD40, CD86 and CD36) while downregulating the expression of nuclear receptors (FXR and PPAR gamma) that counter-regulate the proinflammatory response and modulate lipid metabolism in these cells. Exposure of macrophage cell lines to p17 activates a signaling pathway mediated by Rack-1/Jak-1/STAT-1 and causes a promoter-dependent regulation of STAT-1 target genes. These effects are abrogated by sera obtained from HIV-infected persons vaccinated with a p17 peptide. Ligands for FXR and PPAR gamma counteract the effects of p17. Conclusions: The results of this study show that HIV p17 highjacks a Rack-1/Jak-1/STAT-1 pathway in macrophages, and that the activation of this pathway leads to a simultaneous dysregulation of immune and metabolic functions. The binding of STAT-1 to specific responsive elements in the promoter of PPAR gamma and FXR and MCP-1 shifts macrophages toward a pro-atherogenetic phenotype characterized by high levels of expression of the scavenger receptor CD36. The present work identifies p17 as a novel target in HIV therapy and grounds the development of anti-p17 small molecules or vaccines.	[Renga, Barbara; D'Amore, Claudio; Mencarelli, Andrea; Cipriani, Sabrina; Fiorucci, Stefano] Univ Perugia, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy; [Francisci, Daniela; Schiaroli, Elisabetta; Baldelli, Franco] Univ Perugia, Dipartimento Med Clin & Sci Biochim, I-06100 Perugia, Italy	University of Perugia; University of Perugia	Renga, B (corresponding author), Univ Perugia, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy.	fiorucci@unipg.it	schiaroli, elisabetta/N-9098-2015; Fiorucci, Stefano/I-1251-2012	schiaroli, elisabetta/0000-0002-3216-4144; D'Amore, Claudio/0000-0001-9217-9404	Medestea, Turin, Italy	Medestea, Turin, Italy	This study was in part supported by Medestea, Turin, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bovolenta C, 1999, BLOOD, V94, P4202, DOI 10.1182/blood.V94.12.4202.424k22_4202_4209; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Calza L, 2009, JAIDS-J ACQ IMM DEF, V50, P430, DOI 10.1097/QAI.0b013e31819a292c; Chinetti-Gbaguidi G, 2009, BBA-MOL CELL BIOL L, V1791, P486, DOI 10.1016/j.bbalip.2009.01.009; CHOUDHURY AM, 1992, MICROBIOL IMMUNOL, V36, P833, DOI 10.1111/j.1348-0421.1992.tb02085.x; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; De Francesco MA, 2011, J BIOL CHEM, V286, P19541, DOI 10.1074/jbc.M110.191270; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Esser MT, 2001, J VIROL, V75, P1152, DOI 10.1128/JVI.75.3.1152-1164.2001; Fang C, 2004, BIOCHEM PHARMACOL, V67, P1389, DOI 10.1016/j.bcp.2003.12.012; Fantuzzi L, 2000, J LEUKOCYTE BIOL, V68, P391; Fiorentini S, 2006, NEW MICROBIOL, V29, P1; Fiorentini S, 2004, BIOPOLYMERS, V76, P334, DOI 10.1002/bip.20130; Fiorentini S, 2008, P NATL ACAD SCI USA, V105, P3867, DOI 10.1073/pnas.0800370105; Fiorentini S, 2010, PHARMACOL THERAPEUT, V128, P433, DOI 10.1016/j.pharmthera.2010.08.005; Fiorucci S, 2010, CURR MOL MED, V10, P579; Fiorucci S, 2010, PROG LIPID RES, V49, P171, DOI 10.1016/j.plipres.2009.11.001; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Giagulli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017831; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Harvey EJ, 2007, ARTERIOSCL THROM VAS, V27, P806, DOI 10.1161/01.ATV.0000258867.79411.96; Herbein G., 2002, Current Molecular Medicine (Hilversum), V2, P723, DOI 10.2174/1566524023361844; Ho W Z, 1994, Immunol Ser, V60, P569; Hogan JC, 2001, BIOCHEM BIOPH RES CO, V287, P484, DOI 10.1006/bbrc.2001.5606; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Huang JW, 2006, BIOCHEM BIOPH RES CO, V350, P227, DOI 10.1016/j.bbrc.2006.09.035; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Magnani M, 2003, J LEUKOCYTE BIOL, V74, P764, DOI 10.1189/jlb.0403156; Marini E, 2008, CELL MICROBIOL, V10, P655, DOI 10.1111/j.1462-5822.2007.01073.x; Meroni L, 2005, JAIDS-J ACQ IMM DEF, V38, P310; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Muthumani K, 2005, INT IMMUNOL, V17, P103, DOI 10.1093/intimm/dxh190; MYERS CL, 1992, AM J PHYSIOL, V263, pC767, DOI 10.1152/ajpcell.1992.263.4.C767; Nicholson AC, 2001, ANN NY ACAD SCI, V947, P224; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Ren ZG, 2002, LAB INVEST, V82, P245, DOI 10.1038/labinvest.3780418; Renga B, 2011, BBA-GENE REGUL MECH, V1809, P157, DOI 10.1016/j.bbagrm.2011.01.008; Renga Barbara, 2009, Biochim Biophys Acta, V1792, P564, DOI 10.1016/j.bbadis.2009.04.004; Sekhar RV, 2010, EXPERT OPIN PHARMACO, V11, P1845, DOI 10.1517/14656566.2010.487484; Suttles J, 2009, SEMIN IMMUNOL, V21, P257, DOI 10.1016/j.smim.2009.05.011; Usacheva A, 2003, J IMMUNOL, V171, P2989, DOI 10.4049/jimmunol.171.6.2989; Varga T, 2008, EUR J CLIN INVEST, V38, P695, DOI 10.1111/j.1365-2362.2008.02022.x; Wahl SM, 2003, J LEUKOCYTE BIOL, V74, P726, DOI 10.1189/jlb.0503220; Yang B, 2009, MICROVASC RES, V77, P212, DOI 10.1016/j.mvr.2008.11.003; Yang YB, 2010, J MED VIROL, V82, P735, DOI 10.1002/jmv.21720; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	55	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35924	10.1371/journal.pone.0035924	http://dx.doi.org/10.1371/journal.pone.0035924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558273	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200031
J	Brocato, R; Josleyn, M; Ballantyne, J; Vial, P; Hooper, JW				Brocato, Rebecca; Josleyn, Matthew; Ballantyne, John; Vial, Pablo; Hooper, Jay W.			DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS)	PLOS ONE			English	Article							ARGENTINE HEMORRHAGIC-FEVER; TO-PERSON TRANSMISSION; ANDES VIRUS; INCUBATION PERIOD; NEUTRALIZING ANTIBODIES; PROTECTS HAMSTERS; IMMUNE PLASMA; INFECTION; IGY; IMMUNOGLOBULINS	Andes virus (ANDV) is the predominant cause of hantavirus pulmonary syndrome (HPS) in South America and the only hantavirus known to be transmitted person-to-person. There are no vaccines, prophylactics, or therapeutics to prevent or treat this highly pathogenic disease (case-fatality 35-40%). Infection of Syrian hamsters with ANDV results in a disease that closely mimics human HPS in incubation time, symptoms of respiratory distress, and disease pathology. Here, we evaluated the feasibility of two postexposure prophylaxis strategies in the ANDV/hamster lethal disease model. First, we evaluated a natural product, human polyclonal antibody, obtained as fresh frozen plasma (FFP) from a HPS survivor. Second, we used DNA vaccine technology to manufacture a polyclonal immunoglobulin-based product that could be purified from the eggs of vaccinated ducks (Anas platyrhynchos). The natural "despeciation" of the duck IgY (i.e., Fc removed) results in an immunoglobulin predicted to be minimally reactogenic in humans. Administration of >= 5,000 neutralizing antibody units (NAU)/kg of FFP-protected hamsters from lethal disease when given up to 8 days after intranasal ANDV challenge. IgY/IgYDFc antibodies purified from the eggs of DNA-vaccinated ducks effectively neutralized ANDV in vitro as measured by plaque reduction neutralization tests (PRNT). Administration of 12,000 NAU/kg of duck egg-derived IgY/IgYDFc protected hamsters when administered up to 8 days after intranasal challenge and 5 days after intramuscular challenge. These experiments demonstrate that convalescent FFP shows promise as a postexposure HPS prophylactic. Moreover, these data demonstrate the feasibility of using DNA vaccine technology coupled with the duck/egg system to manufacture a product that could supplement or replace FFP. The DNA vaccine-duck/egg system can be scaled as needed and obviates the necessity of using limited blood products obtained from a small number of HPS survivors. This is the first report demonstrating the in vivo efficacy of any antiviral product produced using DNA vaccine-duck/egg system.	[Brocato, Rebecca; Josleyn, Matthew; Hooper, Jay W.] USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Ballantyne, John] Aldevron LLC, Fargo, ND USA; [Vial, Pablo] Clin Alemana Univ Desarrollo, Sch Med, Inst Sci, Santiago, Chile	Universidad del Desarrollo	Brocato, R (corresponding author), USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.	jay.w.hooper@us.army.mil	Hooper, Jay/K-2362-2017; Brocato, Rebecca L/H-1236-2019	Hooper, Jay/0000-0002-4475-0415; Brocato, Rebecca L/0000-0003-4377-0710	Military Infectious Disease Research Program (MIDRP), Program Area T; Chemical Biological Medical Systems (CBMS); National Institutes of Health [U01AI045452]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI045452] Funding Source: NIH RePORTER	Military Infectious Disease Research Program (MIDRP), Program Area T; Chemical Biological Medical Systems (CBMS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Military Infectious Disease Research Program (MIDRP), Program Area T; by Chemical Biological Medical Systems (CBMS) and by National Institutes of Health U01AI045452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzid K, 2006, VACCINE, V24, P4615, DOI 10.1016/j.vaccine.2005.08.085; BAUR X, 1995, ALLERGY, V50, P604, DOI 10.1111/j.1398-9995.1995.tb01208.x; Campen MJ, 2006, VIROLOGY, V356, P45, DOI 10.1016/j.virol.2006.07.044; Casadevall A, 2002, NAT BIOTECHNOL, V20, P114, DOI 10.1038/nbt0202-114; Chiou VYN, 2008, CLIN TOXICOL, V46, P539, DOI 10.1080/15563650701771973; de Almeida CMC, 2008, TOXICON, V52, P293, DOI 10.1016/j.toxicon.2008.05.022; Cova L, 2005, J CLIN VIROL, V34, pS70, DOI 10.1016/S1386-6532(05)80013-7; Custer DM, 2003, J VIROL, V77, P9894, DOI 10.1128/JVI.77.18.9894-9905.2003; ENRIA DA, 1984, LANCET, V2, P255, DOI 10.1016/S0140-6736(84)90299-X; FDA, 2010, APPR PROD IMM GLOB; Figueiredo LTM, 2009, EMERG INFECT DIS, V15, P561, DOI 10.3201/eid1504.080289; GREY HM, 1967, J IMMUNOL, V98, P820; Hammerbeck CD, 2010, NEW GENERATION VACCI, P905; Health CMo, 2011, EP REP HANT CHIL; Hooper JW, 2008, J VIROL, V82, P1332, DOI 10.1128/JVI.01822-07; Hooper JW, 2001, J VIROL, V75, P8469, DOI 10.1128/JVI.75.18.8469-8477.2001; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Hooper JW, 1999, VIROLOGY, V255, P269, DOI 10.1006/viro.1998.9586; Humphrey BD, 2004, DEV COMP IMMUNOL, V28, P665, DOI 10.1016/j.dci.2003.11.003; Ibrahim ESM, 2008, VACCINE, V26, P2073, DOI 10.1016/j.vaccine.2008.02.046; Lundquist AL, 2007, LIVER TRANSPLANT, V13, P647, DOI 10.1002/lt.21098; Lundqvist ML, 2006, DEV COMP IMMUNOL, V30, P93, DOI 10.1016/j.dci.2005.06.019; MAIZTEGUI JI, 1979, LANCET, V2, P1216; Martinez VP, 2010, EMERG INFECT DIS, V16, P1853, DOI 10.3201/eid1612.091170; Martinez VP, 2005, EMERG INFECT DIS, V11, P1848, DOI 10.3201/eid1112.050501; Meenatchisundaram S, 2008, TOXICON, V52, P221, DOI 10.1016/j.toxicon.2008.04.179; Nguyen HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010152; Padula PJ, 1998, VIROLOGY, V241, P323, DOI 10.1006/viro.1997.8976; Padula PJ, 2000, J CLIN MICROBIOL, V38, P3029, DOI 10.1128/JCM.38.8.3029-3035.2000; QUARRE JP, 1995, J ALLERGY CLIN IMMUN, V95, P922, DOI 10.1016/S0091-6749(95)70144-3; Rollier C, 2000, VACCINE, V18, P3091, DOI 10.1016/S0264-410X(00)00130-4; Rollier C, 2000, J VIROL, V74, P4908, DOI 10.1128/JVI.74.10.4908-4911.2000; Safronetz D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002426; Safronetz D, 2009, J VIROL, V83, P7285, DOI 10.1128/JVI.00373-09; Smith JJ, 2004, PEDIATR INFECT DIS J, V23, P974, DOI 10.1097/01.inf.0000142011.98248.15; Vial PA, 2006, EMERG INFECT DIS, V12, P1271, DOI 10.3201/eid1708.051127; Wahl-Jensen V, 2007, J VIROL, V81, P7449, DOI 10.1128/JVI.00238-07; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Young JC, 2000, AM J TROP MED HYG, V62, P714, DOI 10.4269/ajtmh.2000.62.714	39	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35996	10.1371/journal.pone.0035996	http://dx.doi.org/10.1371/journal.pone.0035996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558299	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000097
J	Novais, SC; De Coen, W; Amorim, MJB				Novais, Sara C.; De Coen, Wim; Amorim, Monica J. B.			Gene Expression Responses Linked to Reproduction Effect Concentrations (EC10,20,50,90) of Dimethoate, Atrazine and Carbendazim, in Enchytraeus albidus	PLOS ONE			English	Article							FUNCTIONAL GENOMICS; EXPOSURE; BIOTRANSFORMATION; MICROARRAY; BIOMARKERS; MECHANISM; HORMONE; CELLS; RATS; TOOL	Background: Molecular mechanisms of response to pesticides are scarce and information on such responses from soil invertebrates is almost inexistent. Enchytraeus albidus (Oligochaeta) is a standard soil ecotoxicology model species for which effects of many pesticides are known on survival, reproduction and avoidance behaviour. With the recent microarray development additional information can be retrieved on the molecular effects. Methodology/Principal Findings: Experiments were performed to investigate the transcription responses of E. albidus when exposed to three pesticides - dimethoate (insecticide), atrazine (herbicide) and carbendazim (fungicide) - in a range of concentrations that inhibited reproduction by 10%, 20%, 50% and 90% (EC10, EC20, EC50 and EC90, respectively). The goal of this study was to further identify key biological processes affected by each compound and if dose-related. All three pesticides significantly affected biological processes like translation, regulation of the cell cycle or general response to stress. Intracellular signalling and microtubule-based movement were affected by dimethoate and carbendazim whereas atrazine affected lipid and steroid metabolism (also by dimethoate) or carbohydrate metabolism (also by carbendazim). Response to DNA damage/DNA repair was exclusively affected by carbendazim. Conclusions: Changes in gene expression were significantly altered after 2 days of exposure in a dose-related manner. The mechanisms of response were comparable with the ones for mammals, suggesting across species conserved modes of action. The present results indicate the potential of using gene expression in risk assessment and the advantage as early markers.	[Novais, Sara C.; Amorim, Monica J. B.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Novais, Sara C.; Amorim, Monica J. B.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [De Coen, Wim] Univ Antwerp, Dept Biol EBT, B-2020 Antwerp, Belgium	Universidade de Aveiro; Universidade de Aveiro; University of Antwerp	Novais, SC (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	sara.novais@ua.pt	Novais, Sara C/A-9032-2012; Amorim, Mónica J.B./G-8590-2011	Novais, Sara C/0000-0003-1306-3396; Amorim, Mónica J.B./0000-0001-8137-3295	FEDER-Fundo Europeu de Desenvolvimento Regional; National funding through FCT-Fundacao para a Ciencia e Tecnologia [FCOMP-01-0124-FEDER-008944, PTDC/BIA-BEC/103716/2008]; Sara Novais [SFRH/BD/36253/2007]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BEC/103716/2008] Funding Source: FCT	FEDER-Fundo Europeu de Desenvolvimento Regional; National funding through FCT-Fundacao para a Ciencia e Tecnologia; Sara Novais; Fundação para a Ciência e a Tecnologia	This study was sponsored by the funding FEDER-Fundo Europeu de Desenvolvimento Regional through COMPETE-Programa Operacional Factores de Competitividade, and by National funding through FCT-Fundacao para a Ciencia e Tecnologia, within the research project NANOkA FCOMP-01-0124-FEDER-008944 (Refa. FCT PTDC/BIA-BEC/103716/2008) and through a PhD grant to Sara Novais (SFRH/BD/36253/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amorim MJB, 2008, ENVIRON INT, V34, P363, DOI 10.1016/j.envint.2007.08.010; Amorim MJB, 2011, ENVIRON TOXICOL CHEM, V30, P1395, DOI 10.1002/etc.512; Astiz M, 2009, LIPIDS, V44, P703, DOI 10.1007/s11745-009-3323-5; Bisson M, 2002, TOXICOL APPL PHARM, V180, P110, DOI 10.1006/taap.2002.9377; Brattsand G, 2000, BRIT J CANCER, V83, P311, DOI 10.1054/bjoc.2000.1264; Brodkin MA, 2007, ENVIRON TOXICOL CHEM, V26, P80, DOI 10.1897/05-469.1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DAVIDSE LC, 1986, ANNU REV PHYTOPATHOL, V24, P43, DOI 10.1146/annurev.py.24.090186.000355; DAVIDSE LC, 1977, J CELL BIOL, V72, P174, DOI 10.1083/jcb.72.1.174; DEBRABANDER M, 1976, JNCI-J NATL CANCER I, V56, P357, DOI 10.1093/jnci/56.2.357; Dell'Omo G, 1999, ENVIRON TOXICOL CHEM, V18, P237, DOI [10.1897/1551-5028(1999)018&lt;0237:SPITCS&gt;2.3.CO;2, 10.1002/etc.5620180220]; Didden W, 2001, ECOTOX ENVIRON SAFE, V50, P25, DOI 10.1006/eesa.2001.2075; Domingues I, 2007, CHEMOSPHERE, V69, P145, DOI 10.1016/j.chemosphere.2007.04.013; Frasco MF, 2002, FISH PHYSIOL BIOCHEM, V26, P149, DOI 10.1023/A:1025457831923; Gomes SIL, 2012, COMP BIOCHEM PHYS C, V155, P219, DOI 10.1016/j.cbpc.2011.08.008; Hecker M, 2005, TOXICOL SCI, V86, P273, DOI 10.1093/toxsci/kfi203; Henle F. G. J, 1837, ARCH ANAT PHYSL MED, V1837, P74; IPCS, 1989, ENV HLTH CRIT DIM EN; ISO, 2004, SOIL QUAL EFF POLL E; Janer G, 2007, ECOTOXICOLOGY, V16, P145, DOI 10.1007/s10646-006-0110-4; Kobeticova K, 2009, ENVIRON POLLUT, V157, P704, DOI 10.1016/j.envpol.2008.09.032; Kumar A, 2010, ECOTOX ENVIRON SAFE, V73, P1503, DOI 10.1016/j.ecoenv.2010.07.016; Kumar AS, 2004, ONCOGENE, V23, P3454, DOI 10.1038/sj.onc.1207473; Laws SC, 2003, TOXICOL SCI, V76, P190, DOI 10.1093/toxsci/kfg223; Loureiro S, 2009, ENVIRON POLLUT, V157, P625, DOI 10.1016/j.envpol.2008.08.010; McMullin TS, 2004, TOXICOL SCI, V79, P278, DOI 10.1093/toxsci/kfh127; Nota B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-236; Novais SC, 2012, ECOTOXICOLOGY, V21, P213, DOI 10.1007/s10646-011-0780-4; Novais SC, 2010, CHEMOSPHERE, V79, P233, DOI 10.1016/j.chemosphere.2010.01.011; Novais SC, 2012, PLOS ONE IN PRESS; Novais SC, 2011, 21 ANN M SETAC EUR M; Novais SC, 2012, ENV TOXICOL CH UNPUB; OECD, 2004, GUID TEST CHEM; Owen J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-266; Reichert K, 2005, CHEMOSPHERE, V61, P229, DOI 10.1016/j.chemosphere.2005.01.077; Rombke J, 2002, CHEMOSPHERE, V46, P1117, DOI 10.1016/S0045-6535(01)00113-8; Sanchez BC, 2011, J APPL TOXICOL, V31, P108, DOI 10.1002/jat.1553; SHERMAN H, 1975, TOXICOL APPL PHARM, V32, P305, DOI 10.1016/0041-008X(75)90221-5; Stout EP, 2010, P NATL ACAD SCI USA, V107, P11859, DOI 10.1073/pnas.1006074107; Svendsen C, 2008, ENVIRON SCI TECHNOL, V42, P4208, DOI 10.1021/es702745d; Swain S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-32; Takahashi M, 2002, CANCER RES, V62, P6598; Tchounwou PB, 2001, MOL CELL BIOCHEM, V222, P49, DOI 10.1023/A:1017903005541; Thornton BJ, 2010, CHEMOSPHERE, V81, P235, DOI 10.1016/j.chemosphere.2010.06.032; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Walsh LP, 2000, J ENDOCRINOL, V167, P253, DOI 10.1677/joe.0.1670253; Wu SB, 2011, OXIDATIVE STRESS VER; Yamada T, 2005, TOXICOL APPL PHARM, V205, P11, DOI 10.1016/j.taap.2004.09.002; Zaya RM, 2011, AQUAT TOXICOL, V104, P254, DOI 10.1016/j.aquatox.2011.04.022; Zhang Y, 2008, BMB REP, V41, P765, DOI 10.5483/BMBRep.2008.41.11.765	52	18	18	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36068	10.1371/journal.pone.0036068	http://dx.doi.org/10.1371/journal.pone.0036068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558331	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000118
J	Suzuki, S; Fukasawa, H; Misaki, T; Togawa, A; Ohashi, N; Kitagawa, K; Kotake, Y; Liu, N; Niida, H; Nakayama, K; Nakayama, KI; Yamamoto, T; Kitagawa, M				Suzuki, Sayuri; Fukasawa, Hirotaka; Misaki, Taro; Togawa, Akashi; Ohashi, Naro; Kitagawa, Kyoko; Kotake, Yojiro; Liu, Ning; Niida, Hiroyuki; Nakayama, Keiko; Nakayama, Keiichi I.; Yamamoto, Tatsuo; Kitagawa, Masatoshi			The Amelioration of Renal Damage in Skp2-Deficient Mice Canceled by p27 (Kip1) Deficiency in Skp2(-/-) p27(-/-) Mice	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; MESENCHYMAL TRANSITION; UBIQUITIN LIGASE; C-MYC; DEGRADATION; P27(KIP1); SKP2; PROTEIN; SCFSKP2; PROLIFERATION	SCF-Skp2 E3 ubiquitin ligase (Skp2 hereafter) targets several cell cycle regulatory proteins for degradation via the ubiquitin-dependent pathway. However, the target-specific physiological functions of Skp2 have not been fully elucidated in kidney diseases. We previously reported an increase in Skp2 in progressive nephropathy and amelioration of unilateral ureteral obstruction (UUO) renal injury associated with renal accumulation of p27 in Skp2(-/-) mice. However, it remains unclear whether the amelioration of renal injury in Skp2(-/-) mice is solely caused by p27 accumulation, since Skp2 targets several other proteins. Using Skp2(-/-) p27(-/-) mice, we investigated whether Skp2 specifically targets p27 in the progressive nephropathy mediated by UUO. In contrast to the marked suppression of UUO renal injury in Skp2(-/-) mice, progression of tubular dilatation associated with tubular epithelial cell proliferation and tubulointerstitial fibrosis with increased expression of collagen and alpha-smooth muscle actin were observed in the obstructed kidneys in Skp2(-/-) p27(-/-) mice. No significant increases in other Skp2 target proteins including p57, p130, TOB1, cyclin A and cyclin D1 were noted in the UUO kidney in Skp2(-/-) mice, while p21, c-Myc, b-Myb and cyclin E were slightly increased. Contrary to the ameliorated UUO renal injure by Skp2-deficiency, the amelioration was canceled by the additional p27-deficiency in Skp2(-/-) p27(-/-) mice. These findings suggest a pathogenic role of the reduction in p27 targeted by Skp2 in the progression of nephropathy in UUO mice.	[Suzuki, Sayuri; Kitagawa, Kyoko; Kotake, Yojiro; Liu, Ning; Niida, Hiroyuki; Kitagawa, Masatoshi] Hamamatsu Univ Sch Med, Dept Mol Biol, Hamamatsu, Shizuoka 4313192, Japan; [Fukasawa, Hirotaka; Misaki, Taro; Togawa, Akashi; Ohashi, Naro; Yamamoto, Tatsuo] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan; [Nakayama, Keiko] Tohoku Univ, Div Dev Genet, Ctr Translat & Adv Anim Res Human Dis, Grad Sch Med, Sendai, Miyagi 980, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan; [Yamamoto, Tatsuo] Numazu City Hosp, Dept Med 2, Numazu, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Tohoku University; Kyushu University	Suzuki, S (corresponding author), Hamamatsu Univ Sch Med, Dept Mol Biol, Hamamatsu, Shizuoka 4313192, Japan.	kitamasa@hama-med.ac.jp	Misaki, Taro/HHY-7358-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan [22790310, 19057005, 21590062]; Grants-in-Aid for Scientific Research [24659130, 24700975] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant number: Grant-in-Aid for Young Scientists (B) 22790310 (S. Suzuki) and Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan 19057005 (M. Kitagawa) and 21590062 (K. Kitagawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gerth JH, 2002, KIDNEY INT, V61, P68, DOI 10.1046/j.1523-1755.2002.00111.x; GOBE GC, 1987, LAB INVEST, V56, P273; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hiramatsu Y, 2006, CANCER RES, V66, P8477, DOI 10.1158/0008-5472.CAN-06-1603; Hughes J, 1999, AM J PHYSIOL, V277, P948; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; KAMB A, 1995, TRENDS GENET, V11, P136, DOI 10.1016/S0168-9525(00)89027-7; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morrissey JJ, 1996, KIDNEY INT, V50, pS84; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Ophascharoensuk V, 1998, NAT MED, V4, P575, DOI 10.1038/nm0598-575; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Shankland SJ, 1997, KIDNEY INT, V51, P1088, DOI 10.1038/ki.1997.151; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sicari BM, 2012, ENDOCRINOLOGY, V153, P861, DOI 10.1210/en.2011-1590; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Suzuki S, 2007, AM J PATHOL, V171, P473, DOI 10.2353/ajpath.2007.070279; Suzuki S, 2011, GENES CELLS, V16, P1110, DOI 10.1111/j.1365-2443.2011.01553.x; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; WALTON G, 1992, J UROLOGY, V148, P510, DOI 10.1016/S0022-5347(17)36641-7; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	37	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36249	10.1371/journal.pone.0036249	http://dx.doi.org/10.1371/journal.pone.0036249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558406	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000170
J	Torres, M; Cartier, L; Matamala, JM; Hernandez, N; Woehlbier, U; Hetz, C				Torres, Mauricio; Cartier, Luis; Manuel Matamala, Jose; Hernandez, Nancy; Woehlbier, Ute; Hetz, Claudio			Altered Prion Protein Expression Pattern in CSF as a Biomarker for Creutzfeldt-Jakob Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; DIAGNOSTIC-CRITERIA; CLINICAL-DIAGNOSIS; 14-3-3-PROTEIN; CJD	Creutzfeldt-Jakob disease (CJD) is the most frequent human Prion-related disorder (PrD). The detection of 14-3-3 protein in the cerebrospinal fluid (CSF) is used as a molecular diagnostic criterion for patients clinically compatible with CJD. However, there is a pressing need for the identification of new reliable disease biomarkers. The pathological mechanisms leading to accumulation of 14-3-3 protein in CSF are not fully understood, however neuronal loss followed by cell lysis is assumed to cause the increase in 14-3-3 levels, which also occurs in conditions such as brain ischemia. Here we investigated the relation between the levels of 14-3-3 protein, Lactate dehydrogenase (LDH) activity and expression of the prion protein (PrP) in CSF of sporadic and familial CJD cases. Unexpectedly, we found normal levels of LDH activity in CJD cases with moderate levels of 14-3-3 protein. Increased LDH activity was only observed in a percentage of the CSF samples that also exhibited high 14-3-3 levels. Analysis of the PrP expression pattern in CSF revealed a reduction in PrP levels in all CJD cases, as well as marked changes in its glycosylation pattern. PrP present in CSF of CJD cases was sensitive to proteases. The alterations in PrP expression observed in CJD cases were not detected in other pathologies affecting the nervous system, including cases of dementia and tropical spastic paraparesis/HTLV-1 associated myelopathy (HAM/TSP). Time course analysis in several CJD patients revealed that 14-3-3 levels in CSF are dynamic and show a high degree of variability during the end stage of the disease. Post-mortem analysis of brain tissue also indicated that 14-3-3 protein is upregulated in neuronal cells, suggesting that its expression is modulated during the course of the disease. These results suggest that a combined analysis of 14-3-3 and PrP expression pattern in CSF is a reliable biomarker to confirm the clinical diagnosis of CJD patients and follow disease progression.	[Torres, Mauricio; Manuel Matamala, Jose; Hernandez, Nancy; Woehlbier, Ute; Hetz, Claudio] Univ Chile, Fac Med, Neurosci Biomed Inst, Santiago 7, Chile; [Torres, Mauricio; Manuel Matamala, Jose; Hernandez, Nancy; Woehlbier, Ute; Hetz, Claudio] Univ Chile, Ctr Mol Studies Cell, Inst Biomed Sci, Santiago, Chile; [Cartier, Luis; Manuel Matamala, Jose] Univ Chile, Fac Med, Dept Neurol Sci, Santiago 7, Chile; [Hetz, Claudio] Neurounion Biomed Fdn, Santiago, Chile; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Universidad de Chile; Universidad de Chile; Universidad de Chile; Harvard University; Harvard T.H. Chan School of Public Health	Torres, M (corresponding author), Univ Chile, Fac Med, Neurosci Biomed Inst, Santiago 7, Chile.	lcartier@med.uchile.cl; chetz@med.uchile.cl	Hetz, Claudio/I-1900-2013; Hetz, Claudio/ABD-7514-2021	Hetz, Claudio/0000-0001-7724-1767; Woehlbier, Ute/0000-0003-3114-9708; Matamala, Jose Manuel/0000-0001-9062-5642; Hernandez Villegas, Nancy C./0000-0002-3982-7553; Torres-Gutierrez, Mauricio Andres/0000-0002-5081-9044	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1100176, 3110067]; Programa Fondo de Investigacion Avanzado en Areas Prioritarias (FONDAP) [15010006]; Millennium Institute [P09-015-F]; Alzheimer's Association; The Michael J Fox Foundation for Parkinson Research; ALS Therapy Alliance; North American spinal society; International Center for Genetic Engineering and Biotechnology, Italy; Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile (CONICYT)	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa Fondo de Investigacion Avanzado en Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Millennium Institute(Takeda Pharmaceutical Company Ltd); Alzheimer's Association(Alzheimer's Association); The Michael J Fox Foundation for Parkinson Research; ALS Therapy Alliance; North American spinal society; International Center for Genetic Engineering and Biotechnology, Italy; Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported primarily by the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT grant no. 1100176); Programa Fondo de Investigacion Avanzado en Areas Prioritarias (FONDAP grant no. 15010006); Millennium Institute no. P09-015-F (to CH) and Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT grant no. 3110067 to UW). In addition the authors thank support by Alzheimer's Association, The Michael J Fox Foundation for Parkinson Research, ALS Therapy Alliance, North American spinal society and International Center for Genetic Engineering and Biotechnology, Italy (to CH); and Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile (CONICYT Doctoral fellowship to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Beaudry P, 1999, DEMENT GERIATR COGN, V10, P40, DOI 10.1159/000017095; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Bieschke J, 2000, P NATL ACAD SCI USA, V97, P5468, DOI 10.1073/pnas.97.10.5468; BROWN P, 1992, J NEUROL SCI, V112, P65, DOI 10.1016/0022-510X(92)90133-6; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Burkhard PR, 2001, NEUROLOGY, V56, P1528, DOI 10.1212/WNL.56.11.1528; Castellani RJ, 2004, NEUROLOGY, V63, P436, DOI 10.1212/01.WNL.0000135153.96325.3B; Chapman T, 2000, NEUROLOGY, V55, P1396, DOI 10.1212/WNL.55.9.1396; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; De Castro-Costa CM, 2006, AIDS RES HUM RETROV, V22, P931, DOI 10.1089/aid.2006.22.931; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; GALVEZ S, 1987, REV MED CHILE, V115, P1148; Geschwind MD, 2003, ARCH NEUROL-CHICAGO, V60, P813, DOI 10.1001/archneur.60.6.813; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Huang N, 2003, NEUROLOGY, V61, P354, DOI 10.1212/01.WNL.0000078890.89473.ED; JONES DHA, 1995, J MOL BIOL, V245, P375, DOI 10.1006/jmbi.1994.0031; Kretzschmar HA, 1996, ARCH NEUROL-CHICAGO, V53, P913, DOI 10.1001/archneur.1996.00550090125018; Lemstra AW, 2000, NEUROLOGY, V55, P514, DOI 10.1212/WNL.55.4.514; MARTIN H, 1994, J NEUROCHEM, V63, P2259; Meyne F, 2009, J ALZHEIMERS DIS, V17, P863, DOI 10.3233/JAD-2009-1110; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Russelakis-Carneiro M, 2004, AM J PATHOL, V165, P1839, DOI 10.1016/S0002-9440(10)63439-6; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, TRENDS BIOCH SCI, V36, P151; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TAGLIAVINI F, 1992, BIOCHEM BIOPH RES CO, V184, P1398, DOI 10.1016/S0006-291X(05)80038-5; Torres M, PLOS ONE, V5; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Watt NT, 2005, BIOCHEM SOC T, V33, P1123, DOI 10.1042/BST20051123; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; Wiltfang J, 1999, J NEUROCHEM, V73, P2485, DOI 10.1046/j.1471-4159.1999.0732485.x; Wong BS, 2001, J PATHOL, V194, P9, DOI 10.1002/path.872; Zerr I, 2002, APMIS, V110, P88, DOI 10.1034/j.1600-0463.2002.100111.x; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109	47	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36159	10.1371/journal.pone.0036159	http://dx.doi.org/10.1371/journal.pone.0036159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558368	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000143
J	Xiong, XJ; Frank, DN; Robertson, CE; Hung, SS; Markle, J; Canty, AJ; Mccoy, KD; Macpherson, AJ; Poussier, P; Danska, JS; Parkinson, J				Xiong, Xuejian; Frank, Daniel N.; Robertson, Charles E.; Hung, Stacy S.; Markle, Janet; Canty, Angelo J.; McCoy, Kathy D.; Macpherson, Andrew J.; Poussier, Philippe; Danska, Jayne S.; Parkinson, John			Generation and Analysis of a Mouse Intestinal Metatranscriptome through Illumina Based RNA-Sequencing	PLOS ONE			English	Article							ESCHERICHIA-COLI; FUNCTIONAL-ANALYSIS; COG DATABASE; PROTEIN; COMMUNITY; REVEALS; CONSERVATION; MICROBIOTA; EXPRESSION; PHYLOGENY	With the advent of high through-put sequencing (HTS), the emerging science of metagenomics is transforming our understanding of the relationships of microbial communities with their environments. While metagenomics aims to catalogue the genes present in a sample through assessing which genes are actively expressed, metatranscriptomics can provide a mechanistic understanding of community inter-relationships. To achieve these goals, several challenges need to be addressed from sample preparation to sequence processing, statistical analysis and functional annotation. Here we use an inbred non-obese diabetic (NOD) mouse model in which germ-free animals were colonized with a defined mixture of eight commensal bacteria, to explore methods of RNA extraction and to develop a pipeline for the generation and analysis of metatranscriptomic data. Applying the Illumina HTS platform, we sequenced 12 NOD cecal samples prepared using multiple RNA-extraction protocols. The absence of a complete set of reference genomes necessitated a peptide-based search strategy. Up to 16% of sequence reads could be matched to a known bacterial gene. Phylogenetic analysis of the mapped ORFs revealed a distribution consistent with ribosomal RNA, the majority from Bacteroides or Clostridium species. To place these HTS data within a systems context, we mapped the relative abundance of corresponding Escherichia coli homologs onto metabolic and protein-protein interaction networks. These maps identified bacterial processes with components that were well-represented in the datasets. In summary this study highlights the potential of exploiting the economy of HTS platforms for metatranscriptomics.	[Xiong, Xuejian; Hung, Stacy S.; Parkinson, John] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Frank, Daniel N.] Univ Colorado, Div Infect Dis, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Hung, Stacy S.; Parkinson, John] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Markle, Janet; Poussier, Philippe; Danska, Jayne S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Markle, Janet; Danska, Jayne S.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; [Canty, Angelo J.] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Dept Klin Forsch, Bern, Switzerland; [Poussier, Philippe] Univ Toronto, Sunnybrook Hlth Sci Ctr, Res Inst, Toronto, ON, Canada; [Danska, Jayne S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Parkinson, John] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Bern; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	Xiong, XJ (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jparkin@sickkids.ca	Parkinson, John/A-4424-2008; McCoy, Kathy/ABD-5814-2021; Markle, Janet/X-1975-2019	Parkinson, John/0000-0001-9815-1189; Markle, Janet/0000-0003-2189-4368; ROBERTSON, CHARLES/0000-0002-4136-4121	Canadian Institute of Health Research operating grant [82940]; Genome Canada; Ontario Genomics Institute -"Genome-Environment Interactions in type 1 diabetes''; Juvenile Diabetes Research Foundation [17-2011-520]; National Institutes of Health [R21HG005964]; Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award; Hospital for Sick Children Research Training Centre; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER	Canadian Institute of Health Research operating grant(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Ontario Genomics Institute -"Genome-Environment Interactions in type 1 diabetes''; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children Research Training Centre; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to acknowledge support from the following sources: Canadian Institute of Health Research operating grant - CTP-82940 (to JP, SSH and XX); Genome Canada and the Ontario Genomics Institute -"Genome-Environment Interactions in type 1 diabetes'' (to JSD, AJC and PP); Juvenile Diabetes Research Foundation - #17-2011-520 (to JSD, AJC, DNF, JP and PP); National Institutes of Health Grant R21HG005964 (to DNF and CER); Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award (to JM); and the Hospital for Sick Children Research Training Centre (to SSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Bennett WE, 2009, J IMMUNOL METHODS, V349, P56, DOI 10.1016/j.jim.2009.07.013; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Booijink CCGM, 2010, APPL ENVIRON MICROB, V76, P5533, DOI 10.1128/AEM.00502-10; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Green ML, 2006, NUCLEIC ACIDS RES, V34, P3687, DOI 10.1093/nar/gkl438; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hung SS, 2010, BIOINFORMATICS, V26, P1690, DOI 10.1093/bioinformatics/btq266; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nam YD, 2009, INT J FOOD MICROBIOL, V130, P140, DOI 10.1016/j.ijfoodmicro.2009.01.007; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Peregrin-Alvarez JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000523; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Peregrin-Alvarez JM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r238; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Poretslcy RS, 2009, J VIS EXP; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Radax R, 2012, ENV MICROBIOL; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Stewart FJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r26; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Valles SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031828; van Dongen S, GRAPH CLUSTERING FLO; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weckx S, 2011, APPL ENVIRON MICROB, V77, P618, DOI 10.1128/AEM.02028-10; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607; Yooseph S, 2007, PLOS BIOL, V5, pe16, DOI DOI 10.1371/journal.pbio.0050016; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	66	45	48	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36009	10.1371/journal.pone.0036009	http://dx.doi.org/10.1371/journal.pone.0036009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558305	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000100
J	Xu, CY; Schooler, SS; Van Klinken, RD				Xu, Cheng-Yuan; Schooler, Shon S.; Van Klinken, Rieks D.			Differential Influence of Clonal Integration on Morphological and Growth Responses to Light in Two Invasive Herbs	PLOS ONE			English	Article							ALTERNANTHERA-PHILOXEROIDES; PHYSIOLOGICAL INTEGRATION; COMPETITIVE ABILITY; ALLIGATOR WEED; PHENOTYPIC PLASTICITY; RAMETS; PLANTS; AVAILABILITY; DISTURBANCE; ALLOCATION	Background and aims: In contrast to seeds, high sensitivity of vegetative fragments to unfavourable environments may limit the expansion of clonal invasive plants. However, clonal integration promotes the establishment of propagules in less suitable habitats and may facilitate the expansion of clonal invaders into intact native communities. Here, we examine the influence of clonal integration on the morphology and growth of ramets in two invasive plants, Alternanthera philoxeroides and Phyla canescens, under varying light conditions. Methods: In a greenhouse experiment, branches, connected ramets and severed ramets of the same mother plant were exposed under full sun and 85% shade and their morphological and growth responses were assessed. Key results: The influence of clonal integration on the light reaction norm (connectionxlight interaction) of daughter ramets was species-specific. For A. philoxeroides, clonal integration evened out the light response (total biomass, leaf mass per area, and stem number, diameter and length) displayed in severed ramets, but these connectionxlight interactions were largely absent for P. canescens. Nevertheless, for both species, clonal integration overwhelmed light effect in promoting the growth of juvenile ramets during early development. Also, vertical growth, as an apparent shade acclimation response, was more prevalent in severed ramets than in connected ramets. Finally, unrooted branches displayed smaller organ size and slower growth than connected ramets, but the pattern of light reaction was similar, suggesting mother plants invest in daughter ramets prior to their own branches. Conclusions: Clonal integration modifies light reaction norms of morphological and growth traits in a species-specific manner for A. philoxeroides and P. canescens, but it improves the establishment of juvenile ramets of both species in light-limiting environments by promoting their growth during early development. This factor may be partially responsible for their ability to successfully colonize native plant communities.	[Xu, Cheng-Yuan; Schooler, Shon S.; Van Klinken, Rieks D.] CSIRO Ecosyst Sci, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Xu, CY (corresponding author), CSIRO Ecosyst Sci, Dutton Pk, Brisbane, Qld, Australia.	chengyuan.xu@csiro.au	van Klinken, Rieks D/B-1772-2009; Xu, Cheng-Yuan/C-2096-2008; Schooler, Shon/AAE-9369-2019	van Klinken, Rieks D/0000-0002-7578-8977; Xu, Chengyuan/0000-0002-0970-9994	South East Queensland Water Ltd; Land and Water Australia through the Defeating the Weed Menace Program	South East Queensland Water Ltd; Land and Water Australia through the Defeating the Weed Menace Program	This work was supported by South East Queensland Water Ltd (http://www.seqwater.com.au/public/home), and Land and Water Australia through the Defeating the Weed Menace Program (http://lwa.gov.au/programs/defeating-weed-menace). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT P, 1991, ECOLOGY, V72, P69, DOI 10.2307/1938903; ALPERT P, 1990, AM J BOT, V77, P1648, DOI 10.2307/2444496; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 1996, J ECOL, V84, P395, DOI 10.2307/2261201; Alpert P, 1997, EFFECTS CLONAL INTEG, P99; Alpert P, DIVISION LABOUR CLON; Alpert P, 1995, ABSTR BOT, V19, P11; Amsberry L, 2000, ECOL APPL, V10, P1110, DOI 10.1890/1051-0761(2000)010[1110:CIATEO]2.0.CO;2; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BOYD CE, 1987, J AQUAT PLANT MANAGE, V25, P1; Brewer JS, 1996, OIKOS, V77, P107, DOI 10.2307/3545590; Brezina S, 2006, FLORA, V201, P461, DOI 10.1016/j.flora.2005.10.003; Burgin S, 2008, WEED BIOL MANAG, V8, P284, DOI 10.1111/j.1445-6664.2008.00306.x; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; DONG M, 1993, NEW PHYTOL, V124, P291, DOI 10.1111/j.1469-8137.1993.tb03819.x; DONG M, 1995, OECOLOGIA, V101, P282, DOI 10.1007/BF00328813; EARL J, 2003, DISTRIBUTION IMPACTS; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; Herben T, 2004, EVOL ECOL, V18, P493, DOI 10.1007/s10682-004-5141-9; Holm L., 1997, NATURAL HIST DISTRIB; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Julien M., 1995, BIOL AUSTR WEEDS VOL, P1; Julien MH, 2012, AUSTR J BOT IN PRESS; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Liu FH, 2007, FLORA, V202, P106, DOI 10.1016/j.flora.2006.05.004; Liu J, 2008, PHOTOSYNTHETICA, V46, P299, DOI 10.1007/s11099-008-0054-4; LONGSTRETH DJ, 1984, BOT GAZ, V145, P105, DOI 10.1086/337432; LUCY M, 1995, LIPPIA PHYLA CANESCE; Macdonald MJ, 2008, ECOLOGY PHYLA CANESC; Matlaga DP, 2009, AM J BOT, V96, P431, DOI 10.3732/ajb.0800164; Maurer DA, 2002, OECOLOGIA, V131, P279, DOI 10.1007/s00442-002-0886-8; McCosker RO, 1994, LIPPIA PHYLA NODIFLO; Mooney H.A., 2000, INVASIVE SPECIES CHA; OBORNY B, 1994, J ECOL, V82, P341, DOI 10.2307/2261302; Otfinowski R, 2008, PLANT ECOL, V199, P235, DOI 10.1007/s11258-008-9428-8; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Peltzer DA, 2002, AM J BOT, V89, P494, DOI 10.3732/ajb.89.3.494; Pennings SC, 2000, ECOLOGY, V81, P709; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pysek P, CLONALITY PLANT INVA; Reardon-Smith K. M, 2011, DISTURBANCE RESILIEN; Roiloa SR, 2006, PHYSIOL PLANTARUM, V128, P662, DOI 10.1111/j.1399-3054.2006.00790.x; Roiloa SR, 2006, FUNCT PLANT BIOL, V33, P961, DOI 10.1071/FP06018; Roiloa SR, 2010, BIOL INVASIONS, V12, P1815, DOI 10.1007/s10530-009-9592-3; Saitoh T, 2006, ANN BOT-LONDON, V98, P657, DOI 10.1093/aob/mcl147; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; SHUMWAY SW, 1995, ANN BOT-LONDON, V76, P225, DOI 10.1006/anbo.1995.1091; SPENCER N R, 1976, Aquatic Botany, V2, P177, DOI 10.1016/0304-3770(76)90019-X; Tessier JT, 2007, AM J BOT, V94, P25, DOI 10.3732/ajb.94.1.25; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Wang N, 2008, ANN BOT-LONDON, V101, P671, DOI 10.1093/aob/mcn005; Wilson JRU, 2007, ENVIRON EXP BOT, V60, P20, DOI 10.1016/j.envexpbot.2006.06.003; Xu CY, 2010, J ECOL, V98, P833, DOI 10.1111/j.1365-2745.2010.01668.x; Zhang XQ, 2006, FLORA, V201, P547, DOI 10.1016/j.flora.2005.12.002	57	23	23	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35873	10.1371/journal.pone.0035873	http://dx.doi.org/10.1371/journal.pone.0035873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558248	Green Published, gold			2022-12-25	WOS:000305336000070
J	Yang, CJ; Chalasani, G; Ng, YH; Robbins, PD				Yang, Chenjie; Chalasani, Geetha; Ng, Yue-Harn; Robbins, Paul D.			Exosomes Released from Mycoplasma Infected Tumor Cells Activate Inhibitory B Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MALIGNANT-TRANSFORMATION; CYTOKINE SECRETION; MEMBRANE-VESICLES; DENDRITIC CELLS; MACROPHAGES; FERMENTANS; EXPRESSION; RESPONSES; IMMUNOSUPPRESSION	Mycoplasmas cause numerous human diseases and are common opportunistic pathogens in cancer patients and immunocompromised individuals. Mycoplasma infection elicits various host immune responses. Here we demonstrate that mycoplasma-infected tumor cells release exosomes (myco+ exosomes) that specifically activate splenic B cells and induce splenocytes cytokine production. Induction of cytokines, including the proinflammatory IFN-gamma and the anti-inflammatory IL-10, was largely dependent on the presence of B cells. B cells were the major IL-10 producers. In splenocytes from B cell deficient mu MT mice, induction of IFN-gamma+ T cells by myco+ exosomes was greatly increased compared with wild type splenocytes. In addition, anti-CD3-stimulated T cell proliferation was greatly inhibited in the presence of myco+ exosome-treated B cells. Also, anti-CD3-stimulated T cell signaling was impaired by myco+ exosome treatment. Proteomic analysis identified mycoplasma proteins in exosomes that potentially contribute to the effects. Our results demonstrate that mycoplasma-infected tumor cells release exosomes carrying mycoplasma components that preferentially activate B cells, which in turn, are able to inhibit T cell activity. These results suggest that mycoplasmas infecting tumor cells can exploit the exosome pathway to disseminate their own components and modulate the activity of immune cells, in particular, activate B cells with inhibitory activity.	[Yang, Chenjie; Robbins, Paul D.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15260 USA; [Chalasani, Geetha; Ng, Yue-Harn] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA USA; [Chalasani, Geetha; Ng, Yue-Harn] Univ Pittsburgh, Sch Med, Dept Immunol, Renal Electrolyte Div, Pittsburgh, PA USA; [Chalasani, Geetha; Ng, Yue-Harn] Univ Pittsburgh, Sch Med, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yang, CJ (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15260 USA.	probb@pitt.edu			Department of Defense [17-03-1-0488, 17-03-0412]; National Institutes of Health [U01 NS058451, P30 AG024827, R21 AG033907]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033907, P30AG024827] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Department of Defense grants 17-03-1-0488 and 17-03-0412 and U01 NS058451, P30 AG024827 and R21 AG033907 grants from the National Institutes of Health to P.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; BENNETT RH, 1977, AM J VET RES, V38, P1731; BERGQUIST LM, 1974, INFECT IMMUN, V9, P410, DOI 10.1128/IAI.9.2.410-415.1974; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; BLANCHARD A, 1994, ANNU REV MICROBIOL, V48, P687, DOI 10.1146/annurev.mi.48.100194.003351; Brenner C, 1997, INFECT IMMUN, V65, P4322, DOI 10.1128/IAI.65.10.4322-4329.1997; Burdin N, 1997, METHODS, V11, P98, DOI 10.1006/meth.1996.0393; CASSELL GH, 1981, NEW ENGL J MED, V304, P80, DOI 10.1056/NEJM198101083040204; Chan PJ, 1996, GYNECOL ONCOL, V63, P258, DOI 10.1006/gyno.1996.0316; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; COLE BC, 1990, INFECT IMMUN, V58, P228, DOI 10.1128/IAI.58.1.228-236.1990; Denzer K, 2000, J CELL SCI, V113, P3365; Feng SH, 1999, MOL CELL BIOL, V19, P7995; Flanagan BF, 1998, NAT MED, V4, P133, DOI 10.1038/nm0298-133a; Garcia J, 1998, J BIOL CHEM, V273, P34391, DOI 10.1074/jbc.273.51.34391; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; HERBELIN A, 1994, INFECT IMMUN, V62, P4690, DOI 10.1128/IAI.62.10.4690-4694.1994; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kim SH, 2005, J IMMUNOL, V174, P6440, DOI 10.4049/jimmunol.174.10.6440; KOSTYAL DA, 1994, INFECT IMMUN, V62, P3793, DOI 10.1128/IAI.62.9.3793-3800.1994; KOSTYAL DA, 1995, INFECT IMMUN, V63, P3858, DOI 10.1128/IAI.63.10.3858-3863.1995; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; MACPHERSON I, 1966, NATURE, V210, P1343, DOI 10.1038/2101343a0; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; PATON GR, 1965, NATURE, V207, P43, DOI 10.1038/207043a0; PIETSCH K, 1994, MICROBIOL-UK, V140, P2043, DOI 10.1099/13500872-140-8-2043; Quah BJC, 2007, J LEUKOCYTE BIOL, V82, P1070, DOI 10.1189/jlb.0507277; Rawadi G, 1996, J IMMUNOL, V156, P670; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rieger A, 2008, NAT REV IMMUNOL, V8, P486, DOI 10.1038/nri2315-c1; ROTTEM S, 1993, TRENDS BIOTECHNOL, V11, P143, DOI 10.1016/0167-7799(93)90089-R; SCHMIDHAUSER C, 1990, J CELL SCI, V95, P499; SUGIMURA K, 1992, MICROBIOL IMMUNOL, V36, P667, DOI 10.1111/j.1348-0421.1992.tb02069.x; Tarshis M, 2004, CURR MICROBIOL, V49, P136, DOI 10.1007/s00284-004-4298-3; Taylor DD, 2003, CLIN CANCER RES, V9, P5113; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhang BX, 1997, P SOC EXP BIOL MED, V214, P359; Zhang SM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-116; ZuritaSalinas CS, 1996, FEMS IMMUNOL MED MIC, V15, P123, DOI 10.1111/j.1574-695X.1996.tb00062.x	50	51	55	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36138	10.1371/journal.pone.0036138	http://dx.doi.org/10.1371/journal.pone.0036138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558358	Green Published, gold, Green Accepted			2022-12-25	WOS:000305336000136
J	Yang, XF; Yang, Y; Lian, YT; Wang, ZH; Li, XW; Cheng, LX; Liu, JP; Wang, YF; Gao, X; Liao, YH; Wang, M; Zeng, QT; Liu, K				Yang, Xiao-Fang; Yang, Yong; Lian, Yi-Tian; Wang, Zhao-Hui; Li, Xiao-Wei; Cheng, Long-Xian; Liu, Jin-Ping; Wang, Yan-Fu; Gao, Xiang; Liao, Yu-Hua; Wang, Min; Zeng, Qiu-Tang; Liu, Kun			The Antibody Targeting the E314 Peptide of Human Kv1.3 Pore Region Serves as a Novel, Potent and Specific Channel Blocker	PLOS ONE			English	Article							GATED POTASSIUM CHANNEL; MEMORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; QT-INTERVAL PROLONGATION; MULTIPLE-SCLEROSIS; K+ CHANNELS; ION CHANNELS; THERAPEUTIC TARGET; TOXIN; EXPRESSION	Selective blockade of Kv1.3 channels in effector memory T (T-EM) cells was validated to ameliorate autoimmune or autoimmune-associated diseases. We generated the antibody directed against one peptide of human Kv1.3 (hKv1.3) extracellular loop as a novel and possible Kv1.3 blocker. One peptide of hKv1.3 extracellular loop E3 containing 14 amino acids (E314) was chosen as an antigenic determinant to generate the E314 antibody. The E314 antibody specifically recognized 63.8KD protein stably expressed in hKv1.3-HEK 293 cell lines, whereas it did not recognize or cross-react to human Kv1.1(hKv1.1), Kv1.2(hKv1.2), Kv1.4(hKv1.4), Kv1.5(hKv1.5), KCa3.1(hKCa3.1), HERG, hKCNQ1/hKCNE1, Nav1.5 and Cav1.2 proteins stably expressed in HEK 293 cell lines or in human atrial or ventricular myocytes by Western blotting analysis and immunostaining detection. By the technique of whole-cell patch clamp, the E314 antibody was shown to have a directly inhibitory effect on hKv1.3 currents expressed in HEK 293 or Jurkat T cells and the inhibition showed a concentration-dependence. However, it exerted no significant difference on hKv1.1, hKv1.2, hKv1.4, hKv1.5, hKCa3.1, HERG, hKCNQ1/hKCNE1, L-type Ca2+ or voltage-gated Na+ currents. The present study demonstrates that the antibody targeting the E314 peptide of hKv1.3 pore region could be a novel, potent and specific hKv1.3 blocker without affecting a variety of closely related K(v)1 channels, KCa3.1 channels and functional cardiac ion channels underlying central nervous systerm (CNS) disorders or drug-acquired arrhythmias, which is required as a safe clinic-promising channel blocker.	[Yang, Xiao-Fang; Yang, Yong; Lian, Yi-Tian; Cheng, Long-Xian; Liao, Yu-Hua; Wang, Min; Zeng, Qiu-Tang; Liu, Kun] Huazhong Univ Sci & Technol, Dept Cardiol, Union Hosp, Wuhan 430074, Peoples R China; [Wang, Zhao-Hui] Huazhong Univ Sci & Technol, Dept Geriatr, Union Hosp, Wuhan 430074, Peoples R China; [Li, Xiao-Wei] Tianjin Chest Hosp, Dept Cardiol, Tianjin, Peoples R China; [Liu, Jin-Ping] Huazhong Univ Sci & Technol, Dept Cardiovasc Surg, Union Hosp, Wuhan 430074, Peoples R China; [Gao, Xiang] Huazhong Univ Sci & Technol, Dept Geriatr, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, XF (corresponding author), Huazhong Univ Sci & Technol, Dept Cardiol, Union Hosp, Wuhan 430074, Peoples R China.	zengqiutang@163.com; liukun@mail.hust.edu.cn			National Natural Science Foundation of China [30700747/C08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No, 30700747/C08) http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BELMONTE MA, 1986, J RHEUMATOL, V13, P477; Bodendiek SB, 2009, EUR J MED CHEM, V44, P1838, DOI 10.1016/j.ejmech.2008.10.033; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Cahalan MD, 1997, CURR OPIN BIOTECH, V8, P749, DOI 10.1016/S0958-1669(97)80130-9; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chandy KG, 2001, TOXICON, V39, P1269, DOI 10.1016/S0041-0101(01)00120-9; Chiang AY, 2010, J PHARMACOL TOXICOL, V62, P143, DOI 10.1016/j.vascn.2010.05.013; Cotton J, 1997, EUR J BIOCHEM, V244, P192, DOI 10.1111/j.1432-1033.1997.00192.x; Darpo B, 2006, J CLIN PHARMACOL, V46, P498, DOI 10.1177/0091270006286436; Decher N, 2004, J BIOL CHEM, V279, P394, DOI 10.1074/jbc.M307411200; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Donner BC, 2011, BASIC RES CARDIOL, V106, P75, DOI 10.1007/s00395-010-0128-x; Dorner Thomas, 2002, Autoimmun Rev, V1, P119, DOI 10.1016/S1568-9972(02)00029-0; Drici MD, 2000, THERAPIE, V55, P185; Ehling Petra, 2010, Exp Transl Stroke Med, V2, P14, DOI 10.1186/2040-7378-2-14; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Fasth AER, 2004, SCAND J IMMUNOL, V60, P199, DOI 10.1111/j.0300-9475.2004.01464.x; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; GARDINER PVG, 1990, BRIT MED J, V300, P125, DOI 10.1136/bmj.300.6717.125; Goodin DS, 2008, NEUROLOGY, V71, P766, DOI 10.1212/01.wnl.0000320512.21919.d2; Haegele KF, 2007, J NEUROIMMUNOL, V183, P168, DOI 10.1016/j.jneuroim.2006.09.008; Hanson DC, 1999, BRIT J PHARMACOL, V126, P1707, DOI 10.1038/sj.bjp.0702480; Harvey AJ, 2006, J MED CHEM, V49, P1433, DOI 10.1021/jm050839v; Jin L, 2007, J CHEM INF MODEL, V47, P1967, DOI 10.1021/ci700178w; Roman AJ, 2012, REV ESP CARDIOL, V65, P292, DOI [10.1016/j.recesp.2011.05.014, 10.1016/j.rec.2011.05.018]; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Krakauer M, 2006, J NEUROIMMUNOL, V181, P157, DOI 10.1016/j.jneuroim.2006.09.006; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Li EC, 2010, PHARMACOTHERAPY, V30, P684, DOI 10.1592/phco.30.7.684; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Markovic-Plese S, 2001, J CLIN INVEST, V108, P1185, DOI 10.1172/JCI12516; Matsushita Y, 2009, AM J PHYSIOL-CELL PH, V296, pC1079, DOI 10.1152/ajpcell.00668.2008; Otten MH, 2011, J RHEUMATOL, V38, P2258, DOI 10.3899/jrheum.110145; Panyi G, 2006, CURR PHARM DESIGN, V12, P2199, DOI 10.2174/138161206777585120; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Peter M, 2001, J MEMBRANE BIOL, V179, P13, DOI 10.1007/s002320010033; Poulopoulou C, 2008, ARTHRITIS RHEUM, V58, P1445, DOI 10.1002/art.23446; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Schonland SO, 2003, P NATL ACAD SCI USA, V100, P13471, DOI 10.1073/pnas.2233561100; Shah RR, 2005, DRUG SAFETY, V28, P115, DOI 10.2165/00002018-200528020-00003; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Smolen JS, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3094, 10.1186/1478-6354-13-S1-S2]; Srairi-Abid N, 2008, FEBS J, V275, P4641, DOI 10.1111/j.1742-4658.2008.06607.x; Toldi G, 2010, IMMUNOL LETT, V133, P35, DOI 10.1016/j.imlet.2010.06.009; Uyttenhove C, 2007, ANN NY ACAD SCI, V1110, P330, DOI 10.1196/annals.1423.035; Varga Z, 2010, IMMUNOL LETT, V130, P19, DOI 10.1016/j.imlet.2009.12.015; Vasheghani-Farahani A, 2011, J NEUROL SCI, V309, P75, DOI 10.1016/j.jns.2011.07.018; Vennekamp J, 2004, MOL PHARMACOL, V65, P1364, DOI 10.1124/mol.65.6.1364; Viglietta V, 2002, J CLIN INVEST, V109, P895, DOI 10.1172/JCI14114; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Yamashita K, 2004, BLOOD, V103, P3986, DOI 10.1182/blood-2003-09-3286; Zhou BY, 1998, J GEN PHYSIOL, V111, P555, DOI 10.1085/jgp.111.4.555	70	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36379	10.1371/journal.pone.0036379	http://dx.doi.org/10.1371/journal.pone.0036379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558454	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000201
J	Belisle, JM; Levin, LA; Costantino, S				Belisle, Jonathan M.; Levin, Leonard A.; Costantino, Santiago			High-Content Neurite Development Study Using Optically Patterned Substrates	PLOS ONE			English	Article							GROWTH CONE GUIDANCE; MOLECULAR-MECHANISMS; CORTICAL-NEURONS; AXON GUIDANCE; GRADIENTS; LAMININ; OUTGROWTH; BEHAVIOR; CELLS	The study of neurite guidance in vitro relies on the ability to reproduce the distribution of attractive and repulsive guidance molecules normally expressed in vivo. The identification of subtle variations in the neurite response to changes in the spatial distribution of extracellular molecules can be achieved by monitoring the behavior of cells on protein gradients. To do this, automated high-content screening assays are needed to quantify the morphological changes resulting from growth on gradients of guidance molecules. Here, we present the use of laser-assisted protein adsorption by photobleaching (LAPAP) to allow the fabrication of large-scale substrate-bound laminin-1 gradients to study neurite extension. We produced thousands of gradients of different slopes and analyzed the variations in neurite attraction of neuron-like cells (RGC-5). An image analysis algorithm processed bright field microscopy images, detecting each cell and quantifying the soma centroid and the initiation, terminal and turning angles of the longest neurite.	[Belisle, Jonathan M.; Levin, Leonard A.; Costantino, Santiago] Univ Montreal, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada; [Belisle, Jonathan M.; Costantino, Santiago] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada; [Levin, Leonard A.; Costantino, Santiago] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Belisle, JM (corresponding author), Univ Montreal, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada.	santiago.costantino@umontreal.ca	Costantino, Santiago/ABD-5472-2020	Costantino, Santiago/0000-0002-2454-2635	National Science and Engineering Research Council (NSERC); Fonds de Recherche du Quebec Nature et Technologie and Fonds de Recherche du Quebec Sante; Canadian Institutes of Health Research and Canada Research Chairs	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec Nature et Technologie and Fonds de Recherche du Quebec Sante; Canadian Institutes of Health Research and Canada Research Chairs(Canadian Institutes of Health Research (CIHR))	Support is acknowledged for SC from the National Science and Engineering Research Council (NSERC), Fonds de Recherche du Quebec Nature et Technologie and Fonds de Recherche du Quebec Sante. For LAL from Canadian Institutes of Health Research and Canada Research Chairs. For JMB from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075; Aletti G, 2008, IET SYST BIOL, V2, P150, DOI 10.1049/iet-syb:20070059; Belisle JM, 2009, LAB CHIP, V9, P3580, DOI 10.1039/b911967a; Belisle JM, 2008, LAB CHIP, V8, P2164, DOI 10.1039/b813897d; Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4; COHEN J, 1991, J CELL SCI, P1; Costantino S, 2008, J NEUROSCI METH, V171, P165, DOI 10.1016/j.jneumeth.2008.02.009; Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dragunow M, 2008, NAT REV NEUROSCI, V9, P779, DOI 10.1038/nrn2492; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Erskine L, 2007, DEV BIOL, V308, P1, DOI 10.1016/j.ydbio.2007.05.013; Gonzalez R.C., 2010, DIGITAL IMAGE PROCES, V2nd; Goodhill GJ, 1998, NEURAL COMPUT, V10, P521, DOI 10.1162/089976698300017638; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Halfter W, 1996, J NEUROSCI, V16, P4389; Hu M, 2007, BRAIN RES, V1151, P227, DOI 10.1016/j.brainres.2007.03.051; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Keenan TM, 2006, J NEUROSCI METH, V151, P232, DOI 10.1016/j.jneumeth.2005.07.010; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Lang S, 2008, ANAL BIOANAL CHEM, V390, P809, DOI 10.1007/s00216-007-1363-3; Lieven CJ, 2007, EXP EYE RES, V85, P678, DOI 10.1016/j.exer.2007.08.001; MCKENNA MP, 1988, DEV BIOL, V130, P232, DOI 10.1016/0012-1606(88)90429-0; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Paulus JD, 2006, DEV DYNAM, V235, P213, DOI 10.1002/dvdy.20604; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Randlett O, 2011, NEURON, V70, P266, DOI 10.1016/j.neuron.2011.03.013; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Vallotton P, 2007, CYTOM PART A, V71A, P889, DOI 10.1002/cyto.a.20462; Wang CJ, 2008, LAB CHIP, V8, P227, DOI 10.1039/b713945d; Wang DD, 2010, J BIOMOL SCREEN, V15, P1165, DOI 10.1177/1087057110382894; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yao L, 2009, J BIOMED MATER RES, V92, P484; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	40	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35911	10.1371/journal.pone.0035911	http://dx.doi.org/10.1371/journal.pone.0035911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563416	Green Submitted, Green Published, gold			2022-12-25	WOS:000305349100042
J	Riccombeni, A; Vidanes, G; Proux-Wera, E; Wolfe, KH; Butler, G				Riccombeni, Alessandro; Vidanes, Genevieve; Proux-Wera, Estelle; Wolfe, Kenneth H.; Butler, Geraldine			Sequence and Analysis of the Genome of the Pathogenic Yeast Candida orthopsilosis	PLOS ONE			English	Article							HORIZONTAL-GENE-TRANSFER; BLOOD-STREAM INFECTIONS; POPULATION-BASED SURVEILLANCE; ANTIFUNGAL SUSCEPTIBILITY; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; PHYLOGENETIC ANALYSIS; BIOFILM PRODUCTION; HYPOXIC RESPONSE; AZOLE RESISTANCE	Candida orthopsilosis is closely related to the fungal pathogen Candida parapsilosis. However, whereas C. parapsilosis is a major cause of disease in immunosuppressed individuals and in premature neonates, C. orthopsilosis is more rarely associated with infection. We sequenced the C. orthopsilosis genome to facilitate the identification of genes associated with virulence. Here, we report the de novo assembly and annotation of the genome of a Type 2 isolate of C. orthopsilosis. The sequence was obtained by combining data from next generation sequencing (454 Life Sciences and Illumina) with paired-end Sanger reads from a fosmid library. The final assembly contains 12.6 Mb on 8 chromosomes. The genome was annotated using an automated pipeline based on comparative analysis of genomes of Candida species, together with manual identification of introns. We identified 5700 protein-coding genes in C. orthopsilosis, of which 5570 have an ortholog in C. parapsilosis. The time of divergence between C. orthopsilosis and C. parapsilosis is estimated to be twice as great as that between Candida albicans and Candida dubliniensis. There has been an expansion of the Hyr/Iff family of cell wall genes and the JEN family of monocarboxylic transporters in C. parapsilosis relative to C. orthopsilosis. We identified one gene from a Maltose/Galactoside O-acetyltransferase family that originated by horizontal gene transfer from a bacterium to the common ancestor of C. orthopsilosis and C. parapsilosis. We report that TFB3, a component of the general transcription factor TFIIH, undergoes alternative splicing by intron retention in multiple Candida species. We also show that an intein in the vacuolar ATPase gene VMA1 is present in C. orthopsilosis but not C. parapsilosis, and has a patchy distribution in Candida species. Our results suggest that the difference in virulence between C. parapsilosis and C. orthopsilosis may be associated with expansion of gene families.	[Riccombeni, Alessandro; Vidanes, Genevieve; Butler, Geraldine] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Proux-Wera, Estelle; Wolfe, Kenneth H.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland	University College Dublin; Trinity College Dublin	Riccombeni, A (corresponding author), Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland.	gbutler@ucd.ie	Proux-Wéra, Estelle/G-4786-2015; Proux-Wéra, Estelle/AAC-8874-2019	Proux-Wéra, Estelle/0000-0003-3752-1806; Proux-Wéra, Estelle/0000-0003-3752-1806; Wolfe, Kenneth/0000-0003-4992-4979; Butler, Geraldine/0000-0002-1770-5301	Science Foundation Ireland [08/N1B1865, 07/IN.1.B911]; Irish Research Council for Science, Engineering and Technology	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR)	This work was supported by Science Foundation Ireland (08/N1B1865 and 07/IN.1.B911) and by a studentship to AR from the Irish Research Council for Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Almirante B, 2006, J CLIN MICROBIOL, V44, P1681, DOI 10.1128/JCM.44.5.1681-1685.2006; Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Barchiesi F, 2000, ANTIMICROB AGENTS CH, V44, P1578, DOI 10.1128/AAC.44.6.1578-1584.2000; Bates S, 2007, INFECT IMMUN, V75, P2922, DOI 10.1128/IAI.00102-07; Borghi E, 2011, EUR J CLIN MICROBIOL, V30, P1437, DOI 10.1007/s10096-011-1242-x; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Calabrese D, 2000, MICROBIOL-UK, V146, P2743, DOI 10.1099/00221287-146-11-2743; Canton E, 2011, ANTIMICROB AGENTS CH, V55, P5590, DOI 10.1128/AAC.00466-11; Canton E, 2010, ANTIMICROB AGENTS CH, V54, P2194, DOI 10.1128/AAC.01538-09; Chen YC, 2010, DIAGN MICR INFEC DIS, V68, P284, DOI 10.1016/j.diagmicrobio.2010.07.004; Clark TA, 2004, J CLIN MICROBIOL, V42, P4468, DOI 10.1128/JCM.42.10.4468-4472.2004; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; d'Enfert C, 2005, NUCLEIC ACIDS RES, V33, pD353, DOI 10.1093/nar/gki124; de Toro M, 2011, CLIN MICROBIOL INFEC, V17, P418, DOI 10.1111/j.1469-0691.2010.03302.x; Ding C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028151; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dunkel N, 2008, MOL MICROBIOL, V69, P827, DOI 10.1111/j.1365-2958.2008.06309.x; Dunkel N, 2008, EUKARYOT CELL, V7, P1180, DOI 10.1128/EC.00103-08; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Feaver WJ, 1997, J BIOL CHEM, V272, P19319, DOI 10.1074/jbc.272.31.19319; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fitzgerald D., 2010, P INT C DIGITAL AUDI, V13, P1; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Gacser A, 2007, FUNGAL GENET BIOL, V44, P1336, DOI 10.1016/j.fgb.2007.02.002; Garcia-Effron G, 2008, ANTIMICROB AGENTS CH, V52, P2305, DOI 10.1128/AAC.00262-08; Gaur M, 2005, J MOL MICROB BIOTECH, V9, P3, DOI 10.1159/000088141; Gaur M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-579; GIMBLE FS, 1992, NATURE, V357, P301, DOI 10.1038/357301a0; Gogarten JP, 2002, ANNU REV MICROBIOL, V56, P263, DOI 10.1146/annurev.micro.56.012302.160741; Gomez-Lopez A, 2008, ANTIMICROB AGENTS CH, V52, P1506, DOI 10.1128/AAC.01595-07; Gordon JL, 2011, P NATL ACAD SCI USA, V108, P20024, DOI 10.1073/pnas.1112808108; Gordon JL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002190; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guida A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-628; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; Hernendez-Castro R, 2010, EUR J PEDIATR, V169, P783, DOI 10.1007/s00431-009-1109-7; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Holesova Z, 2011, MICROBIOL-SGM, V157, P2152, DOI 10.1099/mic.0.048215-0; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Huang YC, 1998, SCAND J INFECT DIS, V30, P137, DOI 10.1080/003655498750003519; Iida Soji, 2005, Nihon Ishinkin Gakkai Zasshi, V46, P133, DOI 10.3314/jjmm.46.133; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Jona G, 2002, J BIOL CHEM, V277, P39409, DOI 10.1074/jbc.M202733200; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Kosa P, 2006, NUCLEIC ACIDS RES, V34, P2472, DOI 10.1093/nar/gkl327; Koufopanou V, 2005, MOL BIOL EVOL, V22, P1535, DOI 10.1093/molbev/msi149; Koufopanou V, 2002, MOL BIOL EVOL, V19, P239, DOI 10.1093/oxfordjournals.molbev.a004077; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Lasker BA, 2006, J CLIN MICROBIOL, V44, P750, DOI 10.1128/JCM.44.3.750-759.2006; Lattif AA, 2010, INT J MED MICROBIOL, V300, P265, DOI 10.1016/j.ijmm.2009.09.001; LEHMANN PF, 1992, J CLIN MICROBIOL, V30, P3249, DOI 10.1128/JCM.30.12.3249-3254.1992; LIN DM, 1995, J CLIN MICROBIOL, V33, P1815, DOI 10.1128/JCM.33.7.1815-1821.1995; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P374, DOI 10.1128/JCM.01790-07; Lodi T, 2007, FEMS YEAST RES, V7, P646, DOI 10.1111/j.1567-1364.2007.00245.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lupetti A, 2002, J CLIN MICROBIOL, V40, P2363, DOI 10.1128/JCM.40.7.2363-2369.2002; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marr KA, 2001, ANTIMICROB AGENTS CH, V45, P52, DOI 10.1128/AAC.45.1.52-59.2001; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; Melo AS, 2011, MED MYCOL, V49, P253, DOI 10.3109/13693786.2010.530032; Miranda-Zapico I, 2011, J ANTIMICROB CHEMOTH, V66, P2315, DOI 10.1093/jac/dkr298; Mirhendi H, 2010, J MED MICROBIOL, V59, P414, DOI 10.1099/jmm.0.017293-0; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Mitrovich QM, 2010, SCIENCE, V330, P838, DOI 10.1126/science.1194554; Moran GP, 2007, MOL MICROBIOL, V66, P915, DOI 10.1111/j.1365-2958.2007.05965.x; Morschhauser J, 2010, FUNGAL GENET BIOL, V47, P94, DOI 10.1016/j.fgb.2009.08.002; Nguyen NH, 2006, MYCOL RES, V110, P1232, DOI 10.1016/j.mycres.2006.07.002; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Orsi CF, 2010, MED MYCOL, V48, P1024, DOI 10.3109/13693786.2010.489233; Perez A, 2006, FEMS YEAST RES, V6, P1074, DOI 10.1111/j.1567-1364.2006.00131.x; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016; Pfaller MA, 2010, DIAGN MICR INFEC DIS, V68, P278, DOI 10.1016/j.diagmicrobio.2010.06.015; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Silva ATPE, 2009, FEMS YEAST RES, V9, P626, DOI 10.1111/j.1567-1364.2009.00508.x; Posey KL, 2004, NUCLEIC ACIDS RES, V32, P3947, DOI 10.1093/nar/gkh734; Poulter RTM, 2007, FUNGAL GENET BIOL, V44, P153, DOI 10.1016/j.fgb.2006.07.012; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Reiss E, 2008, INFECT GENET EVOL, V8, P103, DOI 10.1016/j.meegid.2007.10.007; Roderick SL, 2005, CR BIOL, V328, P568, DOI 10.1016/j.crvi.2005.03.005; Rossignol T, 2007, ANTIMICROB AGENTS CH, V51, P2304, DOI [10.1128/AAC.01438.06, 10.1128/AAC.01438-06]; Rossignol T, 2009, EUKARYOT CELL, V8, P550, DOI 10.1128/EC.00350-08; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sabino R, 2010, J CLIN MICROBIOL, V48, P1677, DOI 10.1128/JCM.02151-09; Sai SX, 2011, EUKARYOT CELL, V10, P578, DOI 10.1128/EC.00276-10; San Miguel LG, 2004, DIAGN MICR INFEC DIS, V49, P189, DOI 10.1016/j.diagmicrobio.2004.03.017; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Sasse C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025623; Sellam A, 2009, EUKARYOT CELL, V8, P1174, DOI 10.1128/EC.00074-09; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silva AP, 2011, ANTIMICROB AGENTS CH, V55, P3546, DOI 10.1128/AAC.01127-10; Silva AP, 2009, J CLIN MICROBIOL, V47, P2392, DOI 10.1128/JCM.02379-08; Silva RM, 2007, EMBO J, V26, P4555, DOI 10.1038/sj.emboj.7601876; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Song JW, 2005, MED MYCOL, V43, P657, DOI 10.1080/13693780500294915; Stokes C, 2007, FUNGAL GENET BIOL, V44, P920, DOI 10.1016/j.fgb.2006.11.014; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Tavanti A, 2007, J CLIN MICROBIOL, V45, P1455, DOI 10.1128/JCM.00243-07; Tay ST, 2009, J MED MICROBIOL, V58, P185, DOI 10.1099/jmm.0.004242-0; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Theodoro RC, 2011, FUNGAL GENET BIOL, V48, P80, DOI 10.1016/j.fgb.2010.07.010; van Asbeck EC, 2009, MYCOSES, V52, P493, DOI 10.1111/j.1439-0507.2008.01649.x; Vieira N, 2010, MOL MICROBIOL, V75, P1337, DOI 10.1111/j.1365-2958.2009.07003.x; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zancope-Oliveira RM, 2000, EUR J CLIN MICROBIOL, V19, P514, DOI 10.1007/s100960000307; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256; Zordan RE, 2006, P NATL ACAD SCI USA, V103, P12807, DOI 10.1073/pnas.0605138103	126	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35750	10.1371/journal.pone.0035750	http://dx.doi.org/10.1371/journal.pone.0035750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563396	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100024
J	Tidten-Luksch, N; Grimaldi, R; Torrie, LS; Frearson, JA; Hunter, WN; Brenk, R				Tidten-Luksch, Naomi; Grimaldi, Raffaella; Torrie, Leah S.; Frearson, Julie A.; Hunter, William N.; Brenk, Ruth			IspE Inhibitors Identified by a Combination of In Silico and In Vitro High-Throughput Screening	PLOS ONE			English	Article							NON-MEVALONATE PATHWAY; SMALL-MOLECULE INHIBITORS; ISOPRENOID BIOSYNTHESIS; CRYSTAL-STRUCTURE; PROTEIN FLEXIBILITY; ESCHERICHIA-COLI; KINASE ISPE; DOCKING; LIGAND; GENES	CDP-ME kinase (IspE) contributes to the non-mevalonate or deoxy-xylulose phosphate (DOXP) pathway for isoprenoid precursor biosynthesis found in many species of bacteria and apicomplexan parasites. IspE has been shown to be essential by genetic methods and since it is absent from humans it constitutes a promising target for antimicrobial drug development. Using in silico screening directed against the substrate binding site and in vitro high-throughput screening directed against both, the substrate and co-factor binding sites, non-substrate-like IspE inhibitors have been discovered and structure-activity relationships were derived. The best inhibitors in each series have high ligand efficiencies and favourable physico-chemical properties rendering them promising starting points for drug discovery. Putative binding modes of the ligands were suggested which are consistent with established structure-activity relationships. The applied screening methods were complementary in discovering hit compounds, and a comparison of both approaches highlights their strengths and weaknesses. It is noteworthy that compounds identified by virtual screening methods provided the controls for the biochemical screens.	[Tidten-Luksch, Naomi; Grimaldi, Raffaella; Torrie, Leah S.; Frearson, Julie A.; Hunter, William N.; Brenk, Ruth] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland	University of Dundee	Tidten-Luksch, N (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland.	w.n.hunter@dundee.ac.uk; r.brenk@dundee.ac.uk	Hunter, William/AAE-3947-2019	Brenk, Ruth/0000-0002-6204-5488	Wellcome Trust [WT082596, WT083481]; German Academic Exchange Service (DAAD)	Wellcome Trust(Wellcome TrustEuropean Commission); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Wellcome Trust (grants WT082596 and WT083481) and a fellowship from the German Academic Exchange Service (DAAD) to NTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; B-Rao C, 2009, DRUG DISCOV TODAY, V14, P394, DOI 10.1016/j.drudis.2009.01.003; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; Brenk R, 2005, J BIOMOL SCREEN, V10, P667, DOI 10.1177/1087057105281047; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Campbell TL, 2002, J BACTERIOL, V184, P5609, DOI 10.1128/JB.184.20.5609-5618.2002; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Crane CM, 2008, CHEMMEDCHEM, V3, P91, DOI 10.1002/cmdc.200700208; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; Edwards BS, 2005, MOL PHARMACOL, V68, P1301, DOI 10.1124/mol.105.014068; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Englert L, 2010, CHEMMEDCHEM, V5, P930, DOI 10.1002/cmdc.201000084; Erickson JA, 2004, J MED CHEM, V47, P45, DOI 10.1021/jm030209y; Evensen E, 2003, J MED CHEM, V46, P5125, DOI 10.1021/jm025618t; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Freiberg C, 2001, J MOL MICROB BIOTECH, V3, P483; Friedman R, 2009, CHEMMEDCHEM, V4, P1317, DOI 10.1002/cmdc.200900078; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gerber PR, 1998, J COMPUT AID MOL DES, V12, P37, DOI 10.1023/A:1007902804814; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Hajduk PJ, 2006, J MED CHEM, V49, P6972, DOI 10.1021/jm060511h; Hawkins G.D., 2003, AMSOL VERSION 7 0; Hirsch AKH, 2008, ORG BIOMOL CHEM, V6, P2719, DOI 10.1039/b804375b; Hirsch AKH, 2007, CHEMMEDCHEM, V2, P806, DOI 10.1002/cmdc.200700014; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Jenkins JL, 2003, PROTEINS, V50, P81, DOI 10.1002/prot.10270; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m; Liao JJL, 2007, J MED CHEM, V50, P409, DOI 10.1021/jm0608107; Lisurek M, 2010, MOL DIVERS, V14, P401, DOI 10.1007/s11030-009-9187-z; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Miallau L, 2003, P NATL ACAD SCI USA, V100, P9173, DOI 10.1073/pnas.1533425100; Mpamhanga CP, 2009, J MED CHEM, V52, P4454, DOI 10.1021/jm900414x; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; Muthas D, 2008, J MOL GRAPH MODEL, V26, P1237, DOI 10.1016/j.jmgm.2007.11.005; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nilakantan R, 2003, DRUG DISCOV TODAY, V8, P668, DOI 10.1016/S1359-6446(03)02793-4; Paiva AM, 2001, BBA-PROTEIN STRUCT M, V1545, P67, DOI 10.1016/S0167-4838(00)00262-4; Pierce AC, 2002, PROTEINS, V49, P567, DOI 10.1002/prot.10259; Polgar T, 2005, J MED CHEM, V48, P7946, DOI 10.1021/jm050504d; Rarey M, 1998, J COMPUT AID MOL DES, V12, P471, DOI 10.1023/A:1008068904628; Rohdich F, 2005, BIOCHEM SOC T, V33, P785, DOI 10.1042/BST0330785; Rohdich F, 2001, CURR OPIN CHEM BIOL, V5, P535, DOI 10.1016/S1367-5931(00)00240-4; Rohmer M., 1999, COMPREH NATL PROD CH, V2, P45; Ruda GF, 2010, BIOORGAN MED CHEM, V18, P5056, DOI 10.1016/j.bmc.2010.05.077; Sgraja T, 2008, FEBS J, V275, P2779, DOI 10.1111/j.1742-4658.2008.06418.x; Shan S, 2011, FASEB J, V25, P1577, DOI 10.1096/fj.10-175786; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; Singh U, 2006, J BIOMOL SCREEN, V11, P1035, DOI 10.1177/1087057106292798; Tang M, 2011, BIOORGAN MED CHEM, V19, P5886, DOI 10.1016/j.bmc.2011.08.012; Teotico DG, 2009, P NATL ACAD SCI USA, V106, P7455, DOI 10.1073/pnas.0813029106; Wada T, 2003, J BIOL CHEM, V278, P30022, DOI 10.1074/jbc.M304339200; Walters WP, 2003, NAT REV DRUG DISCOV, V2, P259, DOI 10.1038/nrd1063; Wierenga KJ, 2008, J BIOMOL SCREEN, V13, P415, DOI 10.1177/1087057108318331; Zalacain M, 2003, J MOL MICROB BIOTECH, V6, P109, DOI 10.1159/000076741	66	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35792	10.1371/journal.pone.0035792	http://dx.doi.org/10.1371/journal.pone.0035792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22563402	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200078
J	Lee, CG; Park, GY; Han, YK; Lee, JH; Chun, SH; Park, HY; Lim, KH; Kim, EG; Choi, YJ; Yang, K; Lee, CW				Lee, C. G.; Park, G-Y; Han, Y. K.; Lee, J. H.; Chun, S. H.; Park, H-Y; Lim, K-H; Kim, E-G; Choi, Y-J; Yang, K.; Lee, C-W			Roles of 14-3-3 eta in mitotic progression and its potential use as a therapeutic target for cancers	ONCOGENE			English	Article						14-3-3; mitosis; cell death; aneuploid; caspase	CELL-DEATH; SPINDLE DAMAGE; CHECKPOINT; APOPTOSIS; PROTEINS; 14-3-3-PROTEINS; CATASTROPHE; CHROMOSOME; 14-3-3-SIGMA; CYTOKINESIS	14-3-3 proteins are involved in several cellular processes, including the G1/S and G2/M cell cycle transitions. However, their roles during mitosis are not well understood. Here, we showed that depletion of 14-3-3 eta, a 14-3-3 protein isoform, enhanced mitotic cell death, resulting in sensitization to microtubule inhibitors and inhibition of aneuploidy formation. The enhanced mitotic cell death by depletion of 14-3-3 eta appeared to be both caspase-dependent and independent. Furthermore, enhanced mitotic cell death and a reduction in aneuploidy following 14-3-3 eta depletion were independent of the mitotic checkpoint, which is thought to be the primary signaling event in the regulation of the cell death induced by microtubule inhibitors. When 14-3-3 eta depletion was combined with microtubule inhibitors in HCT116 and U87MG cells, it sensitized both cancer cell lines to microtubule inhibitors. These results collectively suggest that 14-3-3 eta may be required for mitotic progression and may be considered as a novel anti-cancer strategy in combination with microtubule inhibitors. Oncogene (2013) 32, 1560-1569; doi:10.1038/onc.2012.170; published online 7 May 2012	[Lee, C. G.; Park, G-Y; Han, Y. K.; Lee, J. H.; Chun, S. H.; Choi, Y-J; Yang, K.] Dongnam Inst Radiol & Med Sci, Res Ctr, Pusan 619953, South Korea; [Lee, C. G.; Park, H-Y; Lim, K-H; Kim, E-G; Lee, C-W] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea; [Lee, C. G.; Lee, C-W] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Ctr Mol Med, Suwon 440746, South Korea; [Lee, C-W] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Suwon 440746, South Korea	Korea Institute of Radiological & Medical Sciences; Sungkyunkwan University (SKKU); Samsung; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Lee, CW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea.	cglee@dirams.re.kr; cwlee1234@skku.edu		Lee, Chang-Woo/0000-0002-0943-1646	National Research Foundation; Korea government (MEST) [2011-0030833, 2010-0007555]; National R and D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [0920290]; National R and D Program through the Dong-nam Institute of Radiological and Medical Sciences (DIRAMS); Ministry of Education, Science and Technology [50593-2011, 50594-2011, 50597-2012]	National Research Foundation; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); National R and D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea; National R and D Program through the Dong-nam Institute of Radiological and Medical Sciences (DIRAMS); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank Ye Won Lee, Dr Jung Ki Kim, Min Young Kim and Min Su Ju for administrative support. This study was supported by National Research Foundation grant funded by the Korea government (MEST) (2011-0030833 and 2010-0007555), a grant from National R and D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (0920290) and National R and D Program through the Dong-nam Institute of Radiological and Medical Sciences (DIRAMS) funded by the Ministry of Education, Science and Technology (50593-2011, 50594-2011 and 50597-2012).	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Di Leonardo A, 1997, CANCER RES, V57, P1013; Didier C, 2008, ONCOGENE, V27, P3811, DOI 10.1038/sj.onc.1211041; Ha GH, 2009, CELL DEATH DIFFER, V16, P483, DOI 10.1038/cdd.2008.182; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Liu Y, 2007, MOL ENDOCRINOL, V21, P3050, DOI 10.1210/me.2007-0323; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; MURRAY AW, 1995, CURR OPIN GENET DEV, V5, P5, DOI 10.1016/S0959-437X(95)90046-2; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Shin HJ, 2003, CANCER CELL, V4, P483, DOI 10.1016/S1535-6108(03)00302-7; Stevens JB, 2007, CANCER RES, V67, P7686, DOI 10.1158/0008-5472.CAN-07-0472; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yang XL, 2009, J NEUROL SCI, V276, P54, DOI 10.1016/j.jns.2008.08.040	35	10	11	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 21	2013	32	12					1560	1569		10.1038/onc.2012.170	http://dx.doi.org/10.1038/onc.2012.170			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22562251				2022-12-25	WOS:000316456000009
J	Chen, PL; Chen, CF; Chen, Y; Guo, XE; Huang, CK; Shew, JY; Reddick, RL; Wallace, DC; Lee, WH				Chen, P-L; Chen, C-F; Chen, Y.; Guo, X. E.; Huang, C-K; Shew, J-Y; Reddick, R. L.; Wallace, D. C.; Lee, W-H			Mitochondrial genome instability resulting from SUV3 haploinsufficiency leads to tumorigenesis and shortened lifespan	ONCOGENE			English	Article						mitochondrial dysfunction; Suv3; animal model; tumorigenesis	TUMOR-SUPPRESSOR; DNA MUTATIONS; OXIDATIVE STRESS; RNA HELICASE; INACTIVATION; METABOLISM; TRANSCRIPTS; MAINTENANCE; STABILITY; INTEGRITY	Mitochondrial dysfunction has been a hallmark of cancer. However, whether it has a causative role awaits to be elucidated. Here, using an animal model derived from inactivation of SUV3, a mitochondrial helicase, we demonstrated that mSuv3+/- mice harbored increased mitochondrial DNA (mtDNA) mutations and decreased mtDNA copy numbers, leading to tumor development in various sites and shortened lifespan. These phenotypes were transmitted maternally, indicating the etiological role of the mitochondria. Importantly, reduced SUV3 expression was observed in human breast tumor specimens compared with corresponding normal tissues in two independent cohorts. These results demonstrated for the first time that maintaining mtDNA integrity by SUV3 helicase is critical for cancer suppression. Oncogene (2013) 32, 1193-1201; doi:10.1038/onc.2012.120; published online 7 May 2012	[Chen, P-L; Chen, C-F; Guo, X. E.; Wallace, D. C.; Lee, W-H] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Chen, Y.] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92697 USA; [Huang, C-K; Shew, J-Y; Lee, W-H] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Reddick, R. L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Wallace, D. C.] Univ Calif Irvine, Sch Med, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Academia Sinica - Taiwan; University of Texas System; University of Texas Health San Antonio; University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, 124 Sprague Hall, Irvine, CA 92697 USA.	plchen@uci.edu; whlee@uci.edu	Chen, Phang-Lang/J-5031-2013	Chen, Chi-Fen/0000-0002-6391-821X	NIH [AG027877, NS21328, AG13154]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328, R01NS041850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027877, R01AG024373, R01AG013154] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dennis Wang for his critical reading, Dr Tom Doetschman for providing 129/Sv mouse genomic library, Andrea Nikitin, Suna Cai and Weiwei Fan for their excellent assistance. This study was supported by grant NIH AG027877 to WHL and PLC, and NS21328 and AG13154 to DCW. Based on the UCI's policy, it is declared that WHL serves as a member of Board of Directors of GeneTex, Inc. This arrangement has been reviewed and approved by the UCI COI committee.	Alberici P, 2006, ONCOGENE, V25, P1841, DOI 10.1038/sj.onc.1209226; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; de Grey ADNJ, 2002, EUR J BIOCHEM, V269, P2003, DOI 10.1046/j.1432-1033.2002.02868.x; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Golden TR, 2001, MECH AGEING DEV, V122, P1577, DOI 10.1016/S0047-6374(01)00288-3; GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780; Guo XE, 2011, J BIOL CHEM, V286, P38783, DOI 10.1074/jbc.M111.257956; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lin XQ, 2007, MOL CELL BIOL, V27, P4905, DOI 10.1128/MCB.02396-06; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Pereira M, 2007, MECH AGEING DEV, V128, P609, DOI 10.1016/j.mad.2007.09.001; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; RILEY DJ, 1994, ANNU REV CELL BIOL, V10, P1, DOI 10.1146/annurev.cb.10.110194.000245; Rodriguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629; Rowley PT, 2005, ANNU REV MED, V56, P539, DOI 10.1146/annurev.med.56.061704.135235; Shu ZY, 2004, BIOCHEMISTRY-US, V43, P4781, DOI 10.1021/bi0356449; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEPIEN PP, 1992, P NATL ACAD SCI USA, V89, P6813, DOI 10.1073/pnas.89.15.6813; STEPIEN PP, 1995, CURR GENET, V27, P234, DOI 10.1007/BF00326154; Ting NSY, 2004, DNA REPAIR, V3, P935, DOI 10.1016/j.dnarep.2004.03.026; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yui R, 2003, GENES GENET SYST, V78, P245; Zanssen S, 2005, PLOS MED, V2, P1082, DOI 10.1371/journal.pmed.0020401; Zheng L, 2002, ADV CANCER RES, V85, P13, DOI 10.1016/S0065-230X(02)85002-3	51	28	29	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2013	32	9					1193	1201		10.1038/onc.2012.120	http://dx.doi.org/10.1038/onc.2012.120			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110FU	22562243	Green Accepted, Green Submitted			2022-12-25	WOS:000316428800013
J	Javaheri, B; Sunters, A; Zaman, G; Suswillo, RFL; Saxon, LK; Lanyon, LE; Price, JS				Javaheri, Behzad; Sunters, Andrew; Zaman, Gul; Suswillo, Rosemary F. L.; Saxon, Leanne K.; Lanyon, Lance E.; Price, Joanna S.			Lrp5 Is Not Required for the Proliferative Response of Osteoblasts to Strain but Regulates Proliferation and Apoptosis in a Cell Autonomous Manner	PLOS ONE			English	Article							HIGH-BONE-MASS; ESTROGEN-RECEPTOR-ALPHA; OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; MARROW STROMAL CELLS; BETA-CATENIN LEVELS; AGE-RELATED-CHANGES; MECHANICAL STRAIN; IN-VITRO; TRANSGENIC MICE; WNT CORECEPTOR	Although Lrp5 is known to be an important contributor to the mechanisms regulating bone mass, its precise role remains unclear. The aim of this study was to establish whether mutations in Lrp5 are associated with differences in the growth and/or apoptosis of osteoblast-like cells and their proliferative response to mechanical strain in vitro. Primary osteoblast-like cells were derived from cortical bone of adult mice lacking functional Lrp5 (Lrp5(-/-)), those heterozygous for the human G171V High Bone Mass (HBM) mutation (LRP5(G171V)) and their WT littermates (WTLrp5, WTHBM). Osteoblast proliferation over time was significantly higher in cultures of cells from LRP5(G171V) mice compared to their WTHBM littermates, and lower in Lrp5(-/-) cells. Cells from female LRP5(G171V) mice grew more rapidly than those from males, whereas cells from female Lrp5(-/-) mice grew more slowly than those from males. Apoptosis induced by serum withdrawal was significantly higher in cultures from Lrp5(-/-) mice than in those from WTHBM or LRP5(G171V) mice. Exposure to a single short period of dynamic mechanical strain was associated with a significant increase in cell number but this response was unaffected by genotype which also did not change the 'threshold' at which cells responded to strain. In conclusion, the data presented here suggest that Lrp5 loss and gain of function mutations result in cell-autonomous alterations in osteoblast proliferation and apoptosis but do not alter the proliferative response of osteoblasts to mechanical strain in vitro.	[Javaheri, Behzad] UMKC Sch Dent, Dept Oral Biol, Kansas City, MO USA; [Sunters, Andrew; Zaman, Gul; Suswillo, Rosemary F. L.; Saxon, Leanne K.; Lanyon, Lance E.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England; [Price, Joanna S.] Bristol Vet Sch, Bristol, Avon, England	University of Missouri System; University of Missouri Kansas City; University of London; University of London Royal Veterinary College; University of Bristol	Javaheri, B (corresponding author), UMKC Sch Dent, Dept Oral Biol, Kansas City, MO USA.	javaherib@umkc.edu	Javaheri, Behzad/AAF-1784-2019; Javaheri, Behzad/L-5997-2018	Javaheri, Behzad/0000-0001-7941-3104; Javaheri, Behzad/0000-0001-7941-3104	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter MP, 2004, BONE, V35, P162, DOI 10.1016/j.bone.2004.02.018; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Battmann A, 1997, EXP CLIN ENDOCR DIAB, V105, P98, DOI 10.1055/s-0029-1211734; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bergman RJ, 1996, J BONE MINER RES, V11, P568; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brighton CT, 1996, J BONE JOINT SURG AM, V78A, P1337, DOI 10.2106/00004623-199609000-00007; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Cheng MZ, 1999, J BONE MINER RES, V14, P1742, DOI 10.1359/jbmr.1999.14.10.1742; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Cullen DM, 2004, J BONE MINER RES, V19, pS396; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; FEDARKO NS, 1995, J BONE MINER RES, V10, P1705; FEDARKO NS, 1992, J CELL PHYSIOL, V151, P215, DOI 10.1002/jcp.1041510202; Fermor B, 1998, BONE, V22, P637, DOI 10.1016/S8756-3282(98)00047-7; FRONTALI M, 1985, AM J MED GENET, V22, P35, DOI 10.1002/ajmg.1320220104; GILADI M, 1991, AM J SPORT MED, V19, P647, DOI 10.1177/036354659101900617; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; JIANG DZ, 1992, EXP HEMATOL, V20, P1216; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2; Kassem M, 1997, OSTEOPOROSIS INT, V7, P514, DOI 10.1007/BF02652556; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; KOSHIHARA Y, 1991, J GERONTOL, V46, pB201, DOI 10.1093/geronj/46.5.B201; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109; RAWLINSON SCF, 1991, J BONE MINER RES, V6, P1345; Rawlinson SCF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008358; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Shen LX, 2009, J CELL BIOCHEM, V106, P337, DOI 10.1002/jcb.22010; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Weyts FAA, 2003, CALCIFIED TISSUE INT, V72, P505, DOI 10.1007/s00223-002-2027-0; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yudoh K, 2001, J BONE MINER RES, V16, P1453, DOI 10.1359/jbmr.2001.16.8.1453; Zaman G, 1997, J BONE MINER RES, V12, P769, DOI 10.1359/jbmr.1997.12.5.769; Zha LB, 2008, J GENET GENOMICS, V35, P525, DOI 10.1016/S1673-8527(08)60072-7; Zhuang HM, 1996, BIOCHEM BIOPH RES CO, V229, P449, DOI 10.1006/bbrc.1996.1824	53	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35726	10.1371/journal.pone.0035726	http://dx.doi.org/10.1371/journal.pone.0035726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567110	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341500028
J	Talos, DM; Sun, HY; Zhou, XP; Fitzgerald, EC; Jackson, MC; Klein, PM; Lan, VJ; Joseph, A; Jensen, FE				Talos, Delia M.; Sun, Hongyu; Zhou, Xiangping; Fitzgerald, Erin C.; Jackson, Michele C.; Klein, Peter M.; Lan, Victor J.; Joseph, Annelise; Jensen, Frances E.			The Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) Pathway	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; LONG-TERM POTENTIATION; TEMPORAL-LOBE EPILEPSY; RECEPTOR SUBUNIT EXPRESSION; INDUCED NEONATAL SEIZURES; MESSENGER-RNA EXPRESSION; HIPPOCAMPAL CA1 NEURONS; CEREBRAL WHITE-MATTER; FRAGILE-X-SYNDROME; MOUSE MODEL	Early life seizures can result in chronic epilepsy, cognitive deficits and behavioral changes such as autism, and conversely epilepsy is common in autistic children. We hypothesized that during early brain development, seizures could alter regulators of synaptic development and underlie the interaction between epilepsy and autism. The mammalian Target of Rapamycin (mTOR) modulates protein translation and is dysregulated in Tuberous Sclerosis Complex, a disorder characterized by epilepsy and autism. We used a rodent model of acute hypoxia-induced neonatal seizures that results in long term increases in neuronal excitability, seizure susceptibility, and spontaneous seizures, to determine how seizures alter mTOR Complex 1 (mTORC1) signaling. We hypothesized that seizures occurring at a developmental stage coinciding with a critical period of synaptogenesis will activate mTORC1, contributing to epileptic networks and autistic-like behavior in later life. Here we show that in the rat, baseline mTORC1 activation peaks during the first three postnatal weeks, and induction of seizures at postnatal day 10 results in further transient activation of its downstream targets phospho-4E-BP1 (Thr37/46), phospho-p70S6K (Thr389) and phospho-S6 (Ser235/236), as well as rapid induction of activity-dependent upstream signaling molecules, including BDNF, phospho-Akt (Thr308) and phospho-ERK (Thr202/Tyr204). Furthermore, treatment with the mTORC1 inhibitor rapamycin immediately before and after seizures reversed early increases in glutamatergic neurotransmission and seizure susceptibility and attenuated later life epilepsy and autistic-like behavior. Together, these findings suggest that in the developing brain the mTORC1 signaling pathway is involved in epileptogenesis and altered social behavior, and that it may be a target for development of novel therapies that eliminate the progressive effects of neonatal seizures.	[Talos, Delia M.; Sun, Hongyu; Zhou, Xiangping; Fitzgerald, Erin C.; Jackson, Michele C.; Klein, Peter M.; Lan, Victor J.; Joseph, Annelise; Jensen, Frances E.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Talos, Delia M.; Sun, Hongyu; Zhou, Xiangping; Jensen, Frances E.] Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; [Jensen, Frances E.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Talos, DM (corresponding author), NYU, Med Ctr, Dept Neurol, New York, NY 10016 USA.	frances.jensen@childrens.harvard.edu	Sun, Hongyu/O-2853-2013	Sun, Hongyu/0000-0002-6816-842X; Klein, Peter/0000-0002-3232-3387	United States National Institutes of Health [RO1 NS 31718, DP1 OD003347]; Mental Retardation Developmental Disorders Research Center [P30 HD18655]; Tuberous Sclerosis Alliance; Ruth L. Kirschstein National Research Service Award [T32HD007466]; Canadian Institutes of Health Research [MFE-115462]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS031718, R01NS031718] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003347] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mental Retardation Developmental Disorders Research Center; Tuberous Sclerosis Alliance; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by United States National Institutes of Health (NIH, www.nih.gov) Grants RO1 NS 31718 (to F.E.J.) and DP1 OD003347 (from the Office of the Director) (to F.E.J.), Mental Retardation Developmental Disorders Research Center Grant P30 HD18655 (National Institute of Child Health and Human Development, www.nichd.nih.gov) (to F.E.J.), Tuberous Sclerosis Alliance (www.tsalliance.org) (to D. M. T.), Ruth L. Kirschstein National Research Service Award (NRSA, grants.nih.gov/training/nrsa.htm) T32HD007466 (to X.Z.), and Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) MFE-115462 (to H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Bolton PF, 2002, BRAIN, V125, P1247, DOI 10.1093/brain/awf124; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brooks-Kayal A, 2010, BRAIN DEV-JPN, V32, P731, DOI 10.1016/j.braindev.2010.04.010; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Carter MD, 2011, AUTISM RES, V4, P57, DOI 10.1002/aur.180; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P156, DOI 10.1016/j.nbd.2011.07.018; Connor SA, 2011, LEARN MEMORY, V18, P207, DOI 10.1101/lm.2043811; Ehninger D, 2009, J INTELL DISABIL RES, V53, P838, DOI 10.1111/j.1365-2788.2009.01208.x; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huang CH, 2010, BRAIN RES, V1326, P143, DOI 10.1016/j.brainres.2010.02.033; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; JENSEN FE, 1991, ANN NEUROL, V29, P629, DOI 10.1002/ana.410290610; JENSEN FE, 1995, EPILEPSIA, V36, P966, DOI 10.1111/j.1528-1157.1995.tb00954.x; Jensen FE, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2010.02904.x; Kanamori K, 2011, BRAIN RES, V1371, P180, DOI 10.1016/j.brainres.2010.11.064; Karouni M, 2010, EUR J CLIN PHARMACOL, V66, P1151, DOI 10.1007/s00228-010-0861-y; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kobau Rosemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Koh S, 2004, EPILEPSIA, V45, P569, DOI 10.1111/j.0013-9580.2004.69103.x; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Mikati MA, 2005, DEV BRAIN RES, V157, P98, DOI 10.1016/j.devbrainres.2005.03.007; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; O'Reilly T, 2010, TRANSL ONCOL, V3, P65, DOI 10.1593/tlo.09277; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Ran I, 2009, J NEUROSCI, V29, P5605, DOI 10.1523/JNEUROSCI.5355-08.2009; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Ronen GM, 2007, NEUROLOGY, V69, P1816, DOI 10.1212/01.wnl.0000279335.85797.2c; Rosner M, 2010, AMINO ACIDS, V38, P223, DOI 10.1007/s00726-008-0230-7; Ruegg S, 2007, EPILEPSY RES, V77, P85, DOI 10.1016/j.eplepsyres.2007.09.009; Schneider A, 2008, NEOPLASIA, V10, P1295, DOI 10.1593/neo.08586; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shaw FZ, 2007, J NEUROPHYSIOL, V97, P238, DOI 10.1152/jn.00340.2006; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Talos DM, 2006, J COMP NEUROL, V497, P61, DOI 10.1002/cne.20978; Talos DM, 2006, J COMP NEUROL, V497, P42, DOI 10.1002/cne.20972; Tandon P, 1999, NEUROSCIENCE, V91, P293, DOI 10.1016/S0306-4522(98)00609-5; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; Trifilieff P, 2007, NEUROBIOL LEARN MEM, V88, P424, DOI 10.1016/j.nlm.2007.05.004; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Tuchman R, 2011, CURR NEUROL NEUROSCI, V11, P428, DOI 10.1007/s11910-011-0195-x; Tuchman R, 2010, BRAIN DEV-JPN, V32, P709, DOI 10.1016/j.braindev.2010.04.008; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wiebe S, 2007, EPILEPSY CURR, V7, P145; Winterkorn EB, 2007, NEUROLOGY, V68, P62, DOI 10.1212/01.wnl.0000250330.44291.54; Wirrell EC, 2011, EPILEPSY RES, V95, P110, DOI 10.1016/j.eplepsyres.2011.03.009; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang B, 2012, EPILEPSIA, V53, P506, DOI 10.1111/j.1528-1167.2011.03384.x; Zhou CW, 2011, J NEUROSCI, V31, P18211, DOI 10.1523/JNEUROSCI.4838-11.2011; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	92	136	141	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35885	10.1371/journal.pone.0035885	http://dx.doi.org/10.1371/journal.pone.0035885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567115	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341500033
J	Dhananjaneyulu, V; Sagar, PVN; Kumar, G; Viswanathan, GA				Dhananjaneyulu, Venkata; Sagar, Vidya Nanda P.; Kumar, Gopalakrishnan; Viswanathan, Ganesh A.			Noise Propagation in Two-Step Series MAPK Cascade	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; STOCHASTIC GENE-EXPRESSION; STEADY-STATE ASSUMPTION; DYNAMICS; TIME; AMPLIFICATION; FLUCTUATIONS; BISTABILITY; VARIABILITY; SENSITIVITY	Series MAPK enzymatic cascades, ubiquitously found in signaling networks, act as signal amplifiers and play a key role in processing information during signal transduction in cells. In activated cascades, cell-to-cell variability or noise is bound to occur and thereby strongly affects the cellular response. Commonly used linearization method (LM) applied to Langevin type stochastic model of the MAPK cascade fails to accurately predict intrinsic noise propagation in the cascade. We prove this by using extensive stochastic simulations for various ranges of biochemical parameters. This failure is due to the fact that the LM ignores the nonlinear effects on the noise. However, LM provides a good estimate of the extrinsic noise propagation. We show that the correct estimate of intrinsic noise propagation in signaling networks that contain at least one enzymatic step can be obtained only through stochastic simulations. Noise propagation in the cascade depends on the underlying biochemical parameters which are often unavailable. Based on a combination of global sensitivity analysis (GSA) and stochastic simulations, we developed a systematic methodology to characterize noise propagation in the cascade. GSA predicts that noise propagation in MAPK cascade is sensitive to the total number of upstream enzyme molecules and the total number of molecules of the two substrates involved in the cascade. We argue that the general systematic approach proposed and demonstrated on MAPK cascade must accompany noise propagation studies in biological networks.	[Dhananjaneyulu, Venkata; Sagar, Vidya Nanda P.; Kumar, Gopalakrishnan; Viswanathan, Ganesh A.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Dhananjaneyulu, V (corresponding author), Vignan Univ, Sch Chem Engn, Vadlamudi Guntur, Andhra Pradesh, India.	ganesh@che.iitb.ac.in		Viswanathan, Ganesh A/0000-0001-6424-0765	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This research was supported by a grant from Department of Science and Technology, Government of India. The funders had no role to study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Alon U., 2007, MATH COMPUTATIONAL B, V10; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Ciliberto A, 2007, PLOS COMPUT BIOL, V3, P463, DOI 10.1371/journal.pcbi.0030045; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; English JM, 2002, TRENDS PHARMACOL SCI, V23, P40, DOI 10.1016/S0165-6147(00)01865-4; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gardiner C. W., 1990, HDB STOCHASTIC METHO; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Grima R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3625958; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P1749, DOI 10.1080/03610928008827996; JACHIMOWSKI CJ, 1964, BIOCHEMISTRY-US, V3, P1732, DOI 10.1021/bi00899a025; Jia J.F., 2007, IEEE 1 INT C BIOINF, V1, P442; JimenezAquino JI, 1997, PHYSICA A, V237, P113, DOI 10.1016/S0378-4371(96)00412-8; JimenezAquino JI, 1996, PHYSICA A, V229, P444, DOI 10.1016/0378-4371(96)00030-1; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Lan Y, 2006, J CHEM PHYS, V125; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ruf F, 2007, BIOPHYS J, V93, P4474, DOI 10.1529/biophysj.107.115170; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; SEGEL LA, 1988, B MATH BIOL, V50, P579, DOI 10.1007/BF02460092; SEYDEL R, 1987, CHEM ENG SCI, V42, P1281, DOI 10.1016/0009-2509(87)85001-7; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Tanase-Nicola S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068102; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Van Kampen NG, 1992, STOCHASTIC PROCESSES; van Oudenaarden A, 1999, NAT CELL BIOL, V1, P493, DOI 10.1038/70281; Viswanathan G, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046002; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20	59	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35958	10.1371/journal.pone.0035958	http://dx.doi.org/10.1371/journal.pone.0035958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563473	Green Published, gold			2022-12-25	WOS:000305340700022
J	Zvi, A; Rotem, S; Cohen, O; Shafferman, A				Zvi, Anat; Rotem, Shahar; Cohen, Ofer; Shafferman, Avigdor			Clusters versus Affinity-Based Approaches in F. tularensis Whole Genome Search of CTL Epitopes	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; TULAREMIA VACCINES; PREDICTION; IDENTIFICATION; MECHANISMS; RESPONSES; PEPTIDES; MOUSE; MICE	Deciphering the cellular immunome of a bacterial pathogen is challenging due to the enormous number of putative peptidic determinants. State-of-the-art prediction methods developed in recent years enable to significantly reduce the number of peptides to be screened, yet the number of remaining candidates for experimental evaluation is still in the range of ten-thousands, even for a limited coverage of MHC alleles. We have recently established a resource-efficient approach for down selection of candidates and enrichment of true positives, based on selection of predicted MHC binders located in high density "hotspots" of putative epitopes. This cluster-based approach was applied to an unbiased, whole genome search of Francisella tularensis CTL epitopes and was shown to yield a 17-25 fold higher level of responders as compared to randomly selected predicted epitopes tested in Kb/Db C57BL/6 mice. In the present study, we further evaluate the cluster-based approach (down to a lower density range) and compare this approach to the classical affinity-based approach by testing putative CTL epitopes with predicted IC50 values of <10 nM. We demonstrate that while the percent of responders achieved by both approaches is similar, the profile of responders is different, and the predicted binding affinity of most responders in the cluster-based approach is relatively low (geometric mean of 170 nM), rendering the two approaches complimentary. The cluster-based approach is further validated in BALB/c F. tularensis immunized mice belonging to another allelic restriction (Kd/Dd) group. To date, the cluster-based approach yielded over 200 novel F. tularensis peptides eliciting a cellular response, all were verified as MHC class I binders, thereby substantially increasing the F. tularensis dataset of known CTL epitopes. The generality and power of the high density cluster-based approach suggest that it can be a valuable tool for identification of novel CTLs in proteomes of other bacterial pathogens.	[Zvi, Anat; Rotem, Shahar; Cohen, Ofer; Shafferman, Avigdor] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel		Zvi, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	avigdors@iibr.gov.il			Prime Minister office/IIBR research funds	Prime Minister office/IIBR research funds	The study was funded by the Prime Minister office/IIBR research funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry EM, 2009, HUM VACCINES, V5, P832, DOI 10.4161/hv.10297; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Conlan JW, 2011, FUTURE MICROBIOL, V6, P391, DOI [10.2217/FMB.11.22, 10.2217/fmb.11.22]; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; Conlan W, 2010, NOVEL LIVE VACCINE C, P213; Gregory SH, 2009, VACCINE, V27, P5299, DOI 10.1016/j.vaccine.2009.06.101; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Hepburn MJ, 2008, EXPERT REV ANTI-INFE, V6, P231, DOI 10.1586/14787210.6.2.231; Kovjazin R, 2011, MOL IMMUNOL, V48, P1009, DOI 10.1016/j.molimm.2011.01.006; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lund O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026494; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Lundegaard C, 2012, EXPERT REV VACCINES, V11, P43, DOI [10.1586/erv.11.160, 10.1586/ERV.11.160]; Lundegaard C, 2011, J IMMUNOL METHODS, V374, P26, DOI 10.1016/j.jim.2010.10.011; Mann BJ, 2009, EXPERT REV VACCINES, V8, P877, DOI [10.1586/erv.09.51, 10.1586/ERV.09.51]; McMurry JA, 2007, CURR MOL MED, V7, P351, DOI 10.2174/156652407780831584; McMurry JA, 2007, VACCINE, V25, P3179, DOI 10.1016/j.vaccine.2007.01.039; McMurry Julie A, 2007, Med Health R I, V90, P311; Moise L, 2008, HUM VACCINES, V4, P219, DOI 10.4161/hv.4.3.5394; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; SETTE A, 1994, J IMMUNOL, V153, P5586; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zvi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020050	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36440	10.1371/journal.pone.0036440	http://dx.doi.org/10.1371/journal.pone.0036440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563500	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340700049
J	Torres, J; Prieto, J; Durupt, FC; Broad, S; Watt, FM				Torres, Josema; Prieto, Javier; Durupt, Fabrice C.; Broad, Simon; Watt, Fiona M.			Efficient Differentiation of Embryonic Stem Cells into Mesodermal Precursors by BMP, Retinoic Acid and Notch Signalling	PLOS ONE			English	Article							MESENCHYMAL STEM; FATE DECISIONS; MOUSE; INDUCTION; GENERATION; NEURONS	The ability to direct differentiation of mouse embryonic stem (ES) cells into specific lineages not only provides new insights into the pathways that regulate lineage selection but also has translational applications, for example in drug discovery. We set out to develop a method of differentiating ES cells into mesodermal cells at high efficiency without first having to induce embryoid body formation. ES cells were plated on a feeder layer of PA6 cells, which have membrane-associated stromal-derived inducing activity (SDIA), the molecular basis of which is currently unknown. Stimulation of ES/PA6 co-cultures with Bone Morphogenetic Protein 4 (BMP4) both favoured self-renewal of ES cells and induced differentiation into a Desmin and Nestin double positive cell population. Combined stimulation with BMP4 and all-trans Retinoic Acid (RA) inhibited self-renewal and resulted in 90% of cells expressing Desmin and Nestin. Quantitative reverse transcription-polymerase chain reaction (qPCR) analysis confirmed that the cells were of mesodermal origin and expressed markers of mesenchymal and smooth muscle cells. BMP4 activation of a MAD-homolog (Smad)-dependent reporter in undifferentiated ES cells was attenuated by co-stimulation with RA and co-culture with PA6 cells. The Notch ligand Jag1 was expressed in PA6 cells and inhibition of Notch signalling blocked the differentiation inducing activity of PA6 cells. Our data suggest that mesodermal differentiation is regulated by the level of Smad activity as a result of inputs from BMP4, RA and the Notch pathway.	[Torres, Josema; Prieto, Javier; Durupt, Fabrice C.] Univ Valencia, Dept Biol Celular, Burjassot, Comunidad Valen, Spain; [Torres, Josema; Broad, Simon; Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England	University of Valencia; University of Cambridge	Torres, J (corresponding author), Univ Valencia, Dept Biol Celular, Burjassot, Comunidad Valen, Spain.	Josema.torres@uv.es; Fiona.watt@cancer.org.uk	Watt, Fiona/AHB-0226-2022; Torres, Josema/F-7070-2013	Watt, Fiona/0000-0001-9151-5154; Torres, Josema/0000-0001-6906-7164; Prieto, Javier/0000-0001-9317-3688	Spanish Ministerio de Sanidad y Consumo (Ministry of Health and Consumer Affairs); Fondo de Investigacion Sanitaria (Health Research Fund); EU; Wellcome Trust; Medical Research Council (MRC); Ramon y Cajal investigator award from Spanish Ministerio de Ciencia y Tecnologia (Spanish Ministry for Science and Technology)	Spanish Ministerio de Sanidad y Consumo (Ministry of Health and Consumer Affairs); Fondo de Investigacion Sanitaria (Health Research Fund); EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ramon y Cajal investigator award from Spanish Ministerio de Ciencia y Tecnologia (Spanish Ministry for Science and Technology)	This work was supported by grants from Spanish Ministerio de Sanidad y Consumo (Ministry of Health and Consumer Affairs), Fondo de Investigacion Sanitaria (Health Research Fund) (http://www.isciii.es/) to JT and grants from the EU (http://cordis.europa.eu/fp7/sis/), Wellcome Trust (http://www.wellcome.ac.uk/) and Medical Research Council (MRC) (http://www.mrc.ac.uk/index.htm) to FMW. JT is the recipient of a Ramon y Cajal investigator award from the former Spanish Ministerio de Ciencia y Tecnologia (Spanish Ministry for Science and Technology) (http://www.micinn.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Chiba S, 2008, STEM CELLS, V26, P2810, DOI 10.1634/stemcells.2008-0085; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Gritti A, 1999, J NEUROSCI, V19, P3287; Herpin A, 2007, FEBS J, V274, P2977, DOI 10.1111/j.1742-4658.2007.05840.x; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ishii S, 2010, J NEUROSCI RES, V88, P722, DOI 10.1002/jnr.22250; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; KODAMA HA, 1986, J CELL PHYSIOL, V129, P20, DOI 10.1002/jcp.1041290104; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakayama N, 2000, BLOOD, V95, P2275, DOI 10.1182/blood.V95.7.2275.007k30_2275_2283; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Schneider MD, 2003, CYTOKINE GROWTH F R, V14, P1, DOI 10.1016/S1359-6101(02)00053-9; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Shimizu N, 2008, INT J HEMATOL, V87, P239, DOI 10.1007/s12185-008-0048-9; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Vazin T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006606; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Yamazoe H, 2005, BIOMATERIALS, V26, P5746, DOI 10.1016/j.biomaterials.2005.02.021; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshida S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028856; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	46	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36405	10.1371/journal.pone.0036405	http://dx.doi.org/10.1371/journal.pone.0036405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558462	gold, Green Submitted, Green Published			2022-12-25	WOS:000305340200076
J	Farkas, IJ; Szanto-Varnagy, A; Korcsmaros, T				Farkas, Illes J.; Szanto-Varnagy, Adam; Korcsmaros, Tamas			Linking Proteins to Signaling Pathways for Experiment Design and Evaluation	PLOS ONE			English	Article							COMPREHENSIVE RESOURCE; GENE; WEB; NETWORKS; DATABASE; CANCER	Biomedical experimental work often focuses on altering the functions of selected proteins. These changes can hit signaling pathways, and can therefore unexpectedly and non-specifically affect cellular processes. We propose PathwayLinker, an online tool that can provide a first estimate of the possible signaling effects of such changes, e.g., drug or microRNA treatments. PathwayLinker minimizes the users' efforts by integrating protein-protein interaction and signaling pathway data from several sources with statistical significance tests and clear visualization. We demonstrate through three case studies that the developed tool can point out unexpected signaling bias in normal laboratory experiments and identify likely novel signaling proteins among the interactors of known drug targets. In our first case study we show that knockdown of the Caenorhabditis elegans gene cdc-25.1 (meant to avoid progeny) may globally affect the signaling system and unexpectedly bias experiments. In the second case study we evaluate the loss-of-function phenotypes of a less known C. elegans gene to predict its function. In the third case study we analyze GJA1, an anti-cancer drug target protein in human, and predict for this protein novel signaling pathway memberships, which may be sources of side effects. Compared to similar services, a major advantage of PathwayLinker is that it drastically reduces the necessary amount of manual literature searches and can be used without a computational background. PathwayLinker is available at http://PathwayLinker.org. Detailed documentation and source code are available at the website.	[Farkas, Illes J.] Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary; [Szanto-Varnagy, Adam] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Korcsmaros, Tamas] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary	Hungarian Academy of Sciences; Eotvos Lorand University; Eotvos Lorand University	Farkas, IJ (corresponding author), Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary.	fij@elte.hu	Korcsmaros, Tamas/C-3526-2015; Farkas, Illes/C-1504-2008	Korcsmaros, Tamas/0000-0003-1717-996X; Farkas, Illes/0000-0001-5341-5582	European Research Council [FP6-518230, TAMOP 4.2.1./B-09/1/KMR-2010-0003]; Hungarian Scientific Research Fund [K75334]; Hungarian Research and Technology Office [5LET-08-2-2009-0041]	European Research Council(European Research Council (ERC)European Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Research and Technology Office	Funding was provided by the European Research Council (http://erc.europa.eu) Grants FP6-518230 and TAMOP 4.2.1./B-09/1/KMR-2010-0003; Hungarian Scientific Research Fund (http://www.otka.hu/?set_lang=991) Grant K75334; and Hungarian Research and Technology Office (http://www.nkth.gov.hu/english) Grant 5LET-08-2-2009-0041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Ashcroft NR, 1999, DEV BIOL, V206, P15, DOI 10.1006/dbio.1998.9135; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Boutet Emmanuel, 2007, V406, P89; Brohee S, 2008, NUCLEIC ACIDS RES, V36, pW444, DOI 10.1093/nar/gkn336; Cary MP, 2005, FEBS LETT, V579, P1815, DOI 10.1016/j.febslet.2005.02.005; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-219; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Korcsmaros T, 2010, BIOINFORMATICS, V26, P2042, DOI 10.1093/bioinformatics/btq310; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Li J, 2007, ONCOGENE, V26, P2860, DOI 10.1038/sj.onc.1210086; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Owen RP, 2008, HUM MUTAT, V29, P456, DOI 10.1002/humu.20731; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Wishart DS, 2008, PHARMACOGENOMICS, V9, P1155, DOI 10.2217/14622416.9.8.1155; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461	27	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36202	10.1371/journal.pone.0036202	http://dx.doi.org/10.1371/journal.pone.0036202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558382	gold, Green Published			2022-12-25	WOS:000305336000154
J	Szyszka, P; Stierle, JS; Biergans, S; Galizia, CG				Szyszka, Paul; Stierle, Jacob S.; Biergans, Stephanie; Galizia, C. Giovanni			The Speed of Smell: Odor-Object Segregation within Milliseconds	PLOS ONE			English	Article							DYNAMIC PROPERTIES; APIS-MELLIFERA; DROSOPHILA; MIXTURES; HONEYBEES; DISCRIMINATION; SIMILARITY; COMPONENTS; PHEROMONE; STIMULUS	Segregating objects from background, and determining which of many concurrent stimuli belong to the same object, remains one of the most challenging unsolved problems both in neuroscience and in technical applications. While this phenomenon has been investigated in depth in vision and audition it has hardly been investigated in olfaction. We found that for honeybees a 6-ms temporal difference in stimulus coherence is sufficient for odor-object segregation, showing that the temporal resolution of the olfactory system is much faster than previously thought.	[Szyszka, Paul; Stierle, Jacob S.; Biergans, Stephanie; Galizia, C. Giovanni] Univ Constance, Dept Biol, Constance, Germany	University of Konstanz	Szyszka, P (corresponding author), Univ Constance, Dept Biol, Constance, Germany.	paul.szyszka@uni-konstanz.de	Galizia, C Giovanni/A-1771-2009; Biergans, Stephanie/H-4595-2019; Szyszka, Paul/ABC-7508-2020	Galizia, C Giovanni/0000-0001-8292-6031; Biergans, Stephanie/0000-0002-0120-1301; Szyszka, Paul/0000-0003-2043-6656	Bundesministerium fur Bildung und Forschung [01GQ0931]; Deutsche Forschungsgemeinschaft	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Bundesministerium fur Bildung und Forschung (01GQ0931 to PS and CGG) and Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Andersson MN, 2011, J CHEM ECOL, V37, P899, DOI 10.1007/s10886-011-9995-3; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Blake Randolph, 2005, Behav Cogn Neurosci Rev, V4, P21, DOI 10.1177/1534582305276839; BREGMAN AS, 1978, CAN J PSYCHOL, V32, P19, DOI 10.1037/h0081664; Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Chandra S, 1998, J EXP BIOL, V201, P3113; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Deisig N, 2003, LEARN MEMORY, V10, P199, DOI 10.1101/lm.55803; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; Eschbach C, 2011, CHEM SENSES, V36, P613, DOI 10.1093/chemse/bjr016; French AS, 2011, J NEUROSCI, V31, P861, DOI 10.1523/JNEUROSCI.5243-10.2011; HOPFIELD JF, 1989, BEHAV NEUROSCI, V103, P329, DOI 10.1037/0735-7044.103.2.329; HOPFIELD JJ, 1991, P NATL ACAD SCI USA, V88, P6462, DOI 10.1073/pnas.88.15.6462; Jinks A, 2001, PHYSIOL BEHAV, V72, P51, DOI 10.1016/S0031-9384(00)00407-8; Justus KA, 2005, J NEUROPHYSIOL, V93, P2233, DOI 10.1152/jn.00888.2004; Justus KA, 2002, PHYSIOL ENTOMOL, V27, P58, DOI 10.1046/j.1365-3032.2002.00269.x; Lachnit H, 2004, ADV STUD BEHAV, V34, P241, DOI 10.1016/S0065-3454(04)34006-4; Linster C, 1999, PHYSIOL BEHAV, V66, P701, DOI 10.1016/S0031-9384(99)00007-4; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Riffell JA, 2008, J CHEM ECOL, V34, P837, DOI 10.1007/s10886-008-9490-7; Schuckel J, 2008, J COMP PHYSIOL A, V194, P483, DOI 10.1007/s00359-008-0322-6; Schuckel J, 2009, J NEUROPHYSIOL, V102, P214, DOI 10.1152/jn.00162.2009; Sekuler AB, 2001, PSYCHOL SCI, V12, P437, DOI 10.1111/1467-9280.00382; Smith BH, 1998, PHYSIOL BEHAV, V65, P397, DOI 10.1016/S0031-9384(98)00142-5; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stevenson RJ, 2007, PERCEPTION, V36, P1821, DOI 10.1068/p5563; Szyszka P, 2011, J NEUROSCI, V31, P7229, DOI 10.1523/JNEUROSCI.6668-10.2011; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Vetter RS, 2006, CHEM SENSES, V31, P359, DOI 10.1093/chemse/bjj040; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524	35	52	53	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36096	10.1371/journal.pone.0036096	http://dx.doi.org/10.1371/journal.pone.0036096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558344	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000128
J	Moffat, CS; Ingle, RA; Wathugala, DL; Saunders, NJ; Knight, H; Knight, MR				Moffat, Caroline S.; Ingle, Robert A.; Wathugala, Deepthi L.; Saunders, Nigel J.; Knight, Heather; Knight, Marc R.			ERF5 and ERF6 Play Redundant Roles as Positive Regulators of JA/Et-Mediated Defense against Botrytis cinerea in Arabidopsis	PLOS ONE			English	Article							DNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; SALICYLIC-ACID; DISEASE RESISTANCE; RESPONSE PATHWAYS; GCC-BOX; ETHYLENE; JASMONATE; GENE; EXPRESSION	The ethylene response factor (ERF) family in Arabidopsis thaliana comprises 122 members in 12 groups, yet the biological functions of the majority remain unknown. Of the group IX ERFs, the IXc subgroup has been studied the most, and includes ERF1, ERF14 and ORA59, which play roles in plant innate immunity. Here we investigate the biological functions of two members of the less studied IXb subgroup: ERF5 and ERF6. In order to identify potential targets of these transcription factors, microarray analyses were performed on plants constitutively expressing either ERF5 or ERF6. Expression of defense genes, JA/Et-responsive genes and genes containing the GCC box promoter motif were significantly upregulated in both ERF5 and ERF6 transgenic plants, suggesting that ERF5 and ERF6 may act as positive regulators of JA-mediated defense and potentially overlap in their function. Since defense against necrotrophic pathogens is generally mediated through JA/Et-signalling, resistance against the fungal necrotroph Botrytis cinerea was examined. Constitutive expression of ERF5 or ERF6 resulted in significantly increased resistance. Although no significant difference in susceptibility to B. cinerea was observed in either erf5 or erf6 mutants, the erf5 erf6 double mutant showed a significant increase in susceptibility, which was likely due to compromised JA-mediated gene expression, since JA-induced gene expression was reduced in the double mutant. Taken together these data suggest that ERF5 and ERF6 play positive but redundant roles in defense against B. cinerea. Since mutual antagonism between JA/Et and salicylic acid (SA) signalling is well known, the UV-C inducibility of an SA-inducible gene, PR-1, was examined. Reduced inducibilty in both ERF5 and ERF6 constitutive overexepressors was consistent with suppression of SA-mediated signalling, as was an increased susceptibility to avirulent Pseudomonas syringae. These data suggest that ERF5 and ERF6 may also play a role in the antagonistic crosstalk between the JA/Et and SA signalling pathways.	[Moffat, Caroline S.; Wathugala, Deepthi L.; Knight, Heather; Knight, Marc R.] Univ Durham, Durham Ctr Crop Improvement Technol, Sch Biol & Biomed Sci, Durham, England; [Moffat, Caroline S.] Curtin Univ Technol, Australian Ctr Necrotroph Fungal Pathogens, Dept Environm & Agr, Perth, WA, Australia; [Ingle, Robert A.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa; [Wathugala, Deepthi L.] Univ Ruhuna, Dept Crop Sci, Kamburupitiya, Sri Lanka; [Saunders, Nigel J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Durham University; Curtin University; University of Cape Town; University Ruhuna; University of Oxford	Moffat, CS (corresponding author), Univ Durham, Durham Ctr Crop Improvement Technol, Sch Biol & Biomed Sci, Durham, England.	m.r.knight@durham.ac.uk	Moffat, Caroline S/I-1058-2014; Saunders, Nigel J/W-6745-2019; Lakmini, Deepthi/AAJ-1967-2020; Ingle, Robert A/C-5599-2008	Moffat, Caroline S/0000-0002-6360-1933; Ingle, Robert A/0000-0002-8362-3777; Knight, Marc/0000-0002-4830-8608; Saunders, Nigel/0000-0002-0160-4573; Knight, Heather/0000-0003-2047-6084	Biotechnology and Biological Sciences Research Council (BBSRC) UK [BBS/S/B/2003/12908, BBS/S/K/2003/10126]; Durham University; National Research Foundation, South Africa	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Durham University; National Research Foundation, South Africa(National Research Foundation - South Africa)	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) UK (studentship BBS/S/B/2003/12908 and BBS/S/K/2003/10126) (http://www.bbsrc.ac.uk/PA/grants/AwardDetails.aspx?FundingReference=BBS%2fS%2fB%2f2003%2f12908; http://www.bbsrc.ac.uk/PA/grants/AwardDetails.aspx?FundingReference =BBS%2fS%2fK%2f2003%2f10126). The authors also thank Durham University's Project Sri Lanka for funding DLW and the National Research Foundation, South Africa for funding RAI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Camehl I, 2010, NEW PHYTOL, V185, P1062, DOI 10.1111/j.1469-8137.2009.03149.x; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Gu YQ, 2000, PLANT CELL, V12, P771, DOI 10.1105/tpc.12.5.771; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Knight H, 2009, PLANT J, V58, P97, DOI 10.1111/j.1365-313X.2008.03763.x; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Laluk KaM T, 2010, NECROTROPH ATTACKS P, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Mulema JM, 2011, MOL BIOL REPORTS; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamoto H, 2009, J EXP BOT, V60, P1991, DOI 10.1093/jxb/erp060; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Onate-Sanchez L, 2007, PLANT PHYSIOL, V143, P400, DOI 10.1104/pp.106.086637; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Saal LH, 2002, GENOME BIOL, V3; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Son GH, 2012, MOL PLANT MICROBE IN, V25, P48, DOI 10.1094/MPMI-06-11-0165; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; van Wees SCM, 2003, PLANT PHYSIOL, V132, P606, DOI 10.1104/pp.103.022186; Verhage A, 2010, PLANT PHYSIOL, V154, P536, DOI 10.1104/pp.110.161570; Wehner N, 2011, PLANT J, V68, P560, DOI 10.1111/j.1365-313X.2011.04704.x; Wilson K, 1996, PLANT CELL, V8, P659, DOI 10.1105/tpc.8.4.659; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zarei A, 2011, PLANT MOL BIOL, V75, P321, DOI 10.1007/s11103-010-9728-y	49	161	178	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35995	10.1371/journal.pone.0035995	http://dx.doi.org/10.1371/journal.pone.0035995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563431	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305349100057
J	Truax, AD; Thakkar, M; Greer, SF				Truax, Agnieszka D.; Thakkar, Meghna; Greer, Susanna F.			Dysregulated Recruitment of the Histone Methyltransferase EZH2 to the Class II Transactivator (CIITA) Promoter IV in Breast Cancer Cells	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CREB BINDING-PROTEIN; T-CELLS; MHC2TA TRANSCRIPTION; ANTIGEN EXPRESSION; UVEAL MELANOMA; ATPASE SUG1; IFN-GAMMA; TUMOR; GENES	One mechanism frequently utilized by tumor cells to escape immune system recognition and elimination is suppression of cell surface expression of Major Histocompatibility Class II (MHC II) molecules. Expression of MHC II is regulated primarily at the level of transcription by the Class II Transactivator, CIITA, and decreased CIITA expression is observed in multiple tumor types. We investigate here contributions of epigenetic modifications to transcriptional silencing of CIITA in variants of the human breast cancer cell line MDA MB 435. Significant increases in histone H3 lysine 27 trimethylation upon IFN-gamma stimulation correlate with reductions in transcription factor recruitment to the interferon-gamma inducible CIITA promoter, CIITApIV, and with significantly increased CIITApIV occupancy by the histone methyltransferase enhancer of zeste homolog 2 (EZH2). Most compelling is evidence that decreased expression of EZH2 in MDA MB 435 variants results in significant increases in CIITA and HLA-DRA mRNA expression, even in the absence of interferon-gamma stimulation, as well as increased cell surface expression of MHC II. Together, these data add mechanistic insight to prior observations of increased EZH2 expression and decreased CIITA expression in multiple tumor types.	[Truax, Agnieszka D.; Thakkar, Meghna; Greer, Susanna F.] Georgia State Univ, Dept Biol, Div Cellular & Mol Biol & Physiol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Truax, AD (corresponding author), Georgia State Univ, Dept Biol, Div Cellular & Mol Biol & Physiol, Atlanta, GA 30302 USA.	sgreer@gsu.edu			American Cancer Society [RSG-09-067-01-L1B]	American Cancer Society(American Cancer Society)	This work was funded by the American Cancer Society, RSG-09-067-01-L1B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; BROCKER EB, 1984, J INVEST DERMATOL, V82, P244, DOI 10.1111/1523-1747.ep12260181; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chan HM, 2001, J CELL SCI, V114, P2363; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Concha A, 1991, Semin Cancer Biol, V2, P47; Croce M, 2003, ONCOGENE, V22, P7848, DOI 10.1038/sj.onc.1207054; DADMARZ R, 1995, CANCER IMMUNOL IMMUN, V40, P1; DEWAARDSIEBINGA I, 1995, HUM IMMUNOL, V44, P111, DOI 10.1016/0198-8859(95)00083-G; Drozina G, 2005, CURR TOP MICROBIOL, V290, P147; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fontes JD, 1999, MOL CELL BIOL, V19, P941; FUJIWARA H, 1984, J IMMUNOL, V133, P1671; Garrido F, 1991, Semin Cancer Biol, V2, P3; GORELIK E, 1993, CLIN EXP METASTAS, V11, P439, DOI 10.1007/BF00054935; GREENBERG PD, 1981, J EXP MED, V154, P952, DOI 10.1084/jem.154.3.952; HOCK H, 1991, J EXP MED, V174, P1291, DOI 10.1084/jem.174.6.1291; Holen I, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2769; Holling TM, 2007, J IMMUNOL, V179, P5317, DOI 10.4049/jimmunol.179.8.5317; Holling TM, 2006, BIOCHEM PHARMACOL, V72, P1570, DOI 10.1016/j.bcp.2006.06.034; Humphreys J S, 2000, Aust J Rural Health, V8, P120; KAUFMAN JF, 1984, CELL, V36, P1, DOI 10.1016/0092-8674(84)90068-0; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Landmann S, 2001, J EXP MED, V194, P379, DOI 10.1084/jem.194.4.379; Langlade-Demoyen P, 2003, EUR J IMMUNOL, V33, P720, DOI 10.1002/eji.200323287; LAURITZSEN GF, 1994, P NATL ACAD SCI USA, V91, P5700, DOI 10.1073/pnas.91.12.5700; Lennon AM, 1997, IMMUNOGENETICS, V45, P266, DOI 10.1007/s002510050202; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; MAIORANA A, 1995, CLIN EXP METASTAS, V13, P43, DOI 10.1007/BF00144017; Mehta NT, 2011, EPIGENETICS, V6; Morris AC, 2002, MOL CELL BIOL, V22, P4781, DOI 10.1128/MCB.22.13.4781-4791.2002; Morris AC, 2000, J IMMUNOL, V164, P4143, DOI 10.4049/jimmunol.164.8.4143; Muhlethaler-Mottet A, 2004, J BIOL CHEM, V279, P40529, DOI 10.1074/jbc.M406585200; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; Pai RK, 2002, J IMMUNOL, V169, P1326, DOI 10.4049/jimmunol.169.3.1326; Piskurich JF, 2006, MOL IMMUNOL, V43, P519, DOI 10.1016/j.molimm.2005.05.005; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; PRICE JE, 1990, CANCER-AM CANCER SOC, V66, P1313, DOI 10.1002/1097-0142(19900915)66:14+<1313::AID-CNCR2820661403>3.0.CO;2-4; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Reijm EA, BREAST CANC RES TREA; RUIZCABELLO F, 1991, IMMUNOL LETT, V29, P181, DOI 10.1016/0165-2478(91)90168-A; Rybtsova N, 2007, NUCLEIC ACIDS RES, V35, P3431, DOI 10.1093/nar/gkm214; Satoh A, 2004, ONCOGENE, V23, P8876, DOI 10.1038/sj.onc.1208144; Shi B, 2006, INT J BIOCHEM CELL B, V38, P544, DOI 10.1016/j.biocel.2005.07.012; Sotiriadou R, 2001, BRIT J CANCER, V85, P1527, DOI 10.1054/bjoc.2001.2089; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Truax AD, 2012, METHODS MOL BIOL, V809, P175, DOI 10.1007/978-1-61779-376-9_12; Truax AD, 2010, J MOL BIOL, V395, P254, DOI 10.1016/j.jmb.2009.10.035; van den Elsen PJ, 2001, J REPROD IMMUNOL, V52, P129, DOI 10.1016/S0165-0378(01)00115-2; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Walter W, 2000, BRIT J CANCER, V83, P1192, DOI 10.1054/bjoc.2000.1415; Warabi M, 2000, PATHOL RES PRACT, V196, P807, DOI 10.1016/S0344-0338(00)80080-1; Wong AW, 2002, J IMMUNOL, V169, P3112, DOI 10.4049/jimmunol.169.6.3112; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Xiao Y, 2011, INT J BIOCH CELL BIO; Yan X, 2006, INT J BIOCHEM CELL B, V38, P2102, DOI 10.1016/j.biocel.2006.06.002; ZHANG RD, 1991, INVAS METAST, V11, P204; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	72	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36013	10.1371/journal.pone.0036013	http://dx.doi.org/10.1371/journal.pone.0036013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563434	Green Published, Green Submitted, gold			2022-12-25	WOS:000305349100060
J	Lu, ZM; Zhou, J; Wang, XH; Guan, ZP; Bai, H; Liu, ZJ; Su, N; Pan, KF; Ji, JF; Deng, DJ				Lu, Zhe-Ming; Zhou, Jing; Wang, Xiuhong; Guan, Zhenpo; Bai, Hua; Liu, Zhao-Jun; Su, Na; Pan, Kaifeng; Ji, Jiafu; Deng, Dajun			Nucleosomes Correlate with In Vivo Progression Pattern of De Novo Methylation of p16 CpG Islands in Human Gastric Carcinogenesis	PLOS ONE			English	Article							ABERRANT DNA METHYLATION; CHROMATIN ACCESSIBILITY; HUMAN CANCERS; HUMAN TISSUES; GENE; P16(INK4A); INHIBITION; OCCUPANCY; DYSPLASIA; POSITIONS	Background: The exact relationship between nucleosome positioning and methylation of CpG islands in human pathogenesis is unknown. Methodology/Principal Findings: In the present study, we characterized the nucleosome position within the p16 CpG island and established a seeding methylation-specific PCR (sMSP) assay based on bisulfite modification to enrich the p16 alleles containing methylated-CpG at the methylation "seeding'' sites within its intron-1 in gastric carcinogenesis. The sMSP-positive rate in primary gastric carcinoma (GC) samples (36/40) was significantly higher than that observed in gastritis (19/45) or normal samples (7/13) (P < 0.01). Extensive clone sequencing of these sMSP products showed that the density of methylated-CpGs in p16 CpG islands increased gradually along with the severity of pathological changes in gastric tissues. In gastritis lesions the methylation was frequently observed in the region corresponding to the exon-1 coding-nucleosome and the 5'UTR-nucleosome; the methylation was further extended to the region corresponding to the promoter-nucleosome in GC samples. Only few methylated-CpG sites were randomly detected within p16 CpG islands in normal tissues. The significantly inversed relationship between the p16 exon-1 methylation and its transcription was observed in GC samples. An exact p16 promoter-specific 83 bp-MSP assay confirms the result of sMSP (33/55 vs. 1/6, P < 0.01). In addition, p16 methylation in chronic gastritis lesions significantly correlated with H. pylori infection; however, such correlation was not observed in GC specimens. Conclusions/Significance: It was determined that de novo methylation was initiated in the coding region of p16 exon-1 in gastritis, then progressed to its 5'UTR, and ultimately to the proximal promoter in GCs. Nucleosomes may function as the basic extension/progression unit of de novo methylation of p16 CpG islands in vivo.	[Lu, Zhe-Ming; Zhou, Jing; Wang, Xiuhong; Guan, Zhenpo; Bai, Hua; Liu, Zhao-Jun; Su, Na; Deng, Dajun] Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst, Minist Educ,Div Canc Etiol, Beijing 100871, Peoples R China; [Pan, Kaifeng] Peking Univ, Canc Hosp & Inst, Dept Epidemiol, Beijing 100871, Peoples R China; [Ji, Jiafu] Peking Univ, Canc Hosp & Inst, Dept Surg, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Lu, ZM (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst, Minist Educ,Div Canc Etiol, Beijing 100871, Peoples R China.	zheminglu@163.com; dengdajun@bjmu.edu.cn	Deng, Dajun/D-4605-2009; liu, zhao/GXV-6141-2022	Deng, Dajun/0000-0001-5161-5943; JI, JIAFU/0000-0001-6878-5543	National Natural Science Foundation of China [90919015, 81071630, 30921140311]; National Basic Research Program of China [2010CB529303, 2011CB504201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China [Grant #90919015, 81071630, and 30921140311]; and National Basic Research Program of China [Grant #2010CB529303 and 2011CB504201]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2003, MUTAT RES-GEN TOX EN, V535, P73, DOI 10.1016/S1383-5718(02)00288-7; Bai H, 2008, CHINESE J CANCER RES, V20, P237, DOI 10.1007/s11670-008-0237-3; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cao J, 2009, CLIN CANCER RES, V15, P5178, DOI 10.1158/1078-0432.CCR-09-0580; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cruickshank M, 2008, BIOCHEM BIOPH RES CO, V367, P349, DOI 10.1016/j.bbrc.2007.12.121; Deng DJ, 2010, CHINESE J CANCER RES, V22, P245, DOI 10.1007/s11670-010-0245-y; Deng DJ, 2010, ADV GENET, V71, P125, DOI [10.1016/S0065-2660(10)71005-1, 10.1016/B978-0-12-380864-6.00005-5]; Deng DJ, 2000, WORLD J GASTROENTERO, V6, P613; Deng DJ, 2000, J AGR FOOD CHEM, V48, P2495, DOI 10.1021/jf990967q; Dong CX, 2009, INT J CANCER, V124, P434, DOI 10.1002/ijc.23891; Eads C, 2002, METHOD MOL BIOL, V200, P53; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Egger G, 2007, CANCER RES, V67, P346, DOI 10.1158/0008-5472.CAN-06-2845; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Francis J, 2006, MOL ENDOCRINOL, V20, P3133, DOI 10.1210/me.2006-0126; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; HERMAN JG, 1995, CANCER RES, V55, P4525; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hinshelwood RA, 2009, HUM MOL GENET, V18, P3098, DOI 10.1093/hmg/ddp251; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Li QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013732; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Liu ZQ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-81; Luo DY, 2006, LAB INVEST, V86, P591, DOI 10.1038/labinvest.3700415; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Perri F, 2007, AM J GASTROENTEROL, V102, P1361, DOI 10.1111/j.1572-0241.2007.01284.x; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sun Y, 2004, CLIN CANCER RES, V10, P5087, DOI 10.1158/1078-0432.CCR-03-0622; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; WANG KH, 1983, ACTA BIOL EXP SINICA, V16, P257; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Yan PS, 2003, CANCER RES, V63, P6178; Yang P, 2012, CANCER EPIDEM BIOMAR, V21, P182, DOI 10.1158/1055-9965.EPI-11-0784; Yao JY, 2010, J BIOL CHEM, V285, P18828, DOI 10.1074/jbc.M109.077974; Zhou J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-67	39	13	18	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35928	10.1371/journal.pone.0035928	http://dx.doi.org/10.1371/journal.pone.0035928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558275	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200094
J	Zhang, SF; Wei, JN; Kang, L				Zhang, Sufang; Wei, Jianing; Kang, Le			Transcriptional Analysis of Arabidopsis thaliana Response to Lima Bean Volatiles	PLOS ONE			English	Article							PLANT DEFENSE; TALKING TREES; COMMUNICATION; ETHYLENE; JASMONATE; EXPRESSION; GROWTH; GENES; RESISTANCE; CHEMISTRY	Background: Exposure of plants to herbivore-induced plant volatiles (HIPVs) alters their resistance to herbivores. However, the whole-genome transcriptional responses of treated plants remain unknown, and the signal pathways that produce HIPVs are also unclear. Methodology/Principal Findings: Time course patterns of the gene expression of Arabidopsis thaliana exposed to Lima bean volatiles were examined using Affymetrix ATH1 genome arrays. Results showed that A. thaliana received and responded to leafminer-induced volatiles from Lima beans through up-regulation of genes related to the ethylene (ET) and jasmonic acid pathways. Time course analysis revealed strong and partly qualitative differences in the responses between exposure at 24 and that at 48 h. Further experiments using either A. thaliana ET mutant ein2-1 or A. thaliana jasmonic acid mutant coi1-2 indicated that both pathways are involved in the volatile response process but that the ET pathway is indispensable for detecting volatiles. Moreover, transcriptional comparisons showed that plant responses to larval feeding do not merely magnify the volatile response process. Finally, (Z)-3-hexen-ol, ocimene, (3E)-4,8-dimethyl-1,3,7-nonatriene, and (3E, 7E)-4,8,12-trimethyl-1,3,7,11-tridecatetraene triggered responses in A. thaliana similar to those induced by the entire suite of Lima bean volatiles after 24 and 48 h. Conclusions/Significance: This study shows that the transcriptional responses of plants to HIPVs become stronger as treatment time increases and that ET signals are critical during this process.	[Zhang, Sufang; Wei, Jianing; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Zhang, Sufang] Chinese Acad Forestry, Key Lab Forest Protect, Res Inst Forest Ecol Environm & Protect, State Forestry Adm, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Zhang, SF (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	lkang@ioz.ac.cn	Kang, Le/ABD-1116-2022; Wei, Jianing/L-7575-2019	Kang, Le/0000-0003-4262-2329; Wei, Jianing/0000-0002-8517-2164	National Basic Research Program of China (973 Program) [2012CB114105]; National Nature Science Foundation of China [30921063]; Chinese Academy of Sciences [KSCX2-EW-N-5, KSCX2-YW-N-045]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The research was supported by the the National Basic Research Program of China (973 Program) (No. 2012CB114105), and National Nature Science Foundation of China (30921063), the Chinese Academy of Sciences (Project No. KSCX2-EW-N-5 and KSCX2-YW-N-045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2000, BIOCHEM BIOPH RES CO, V277, P305, DOI 10.1006/bbrc.2000.3672; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Blande JD, 2010, ECOL LETT, V13, P1172, DOI 10.1111/j.1461-0248.2010.01510.x; BRUIN J, 1992, EXPERIENTIA, V48, P525, DOI 10.1007/BF01928181; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dicke M, 2001, BIOCHEM SYST ECOL, V29, P979, DOI 10.1016/S0305-1978(01)00044-8; Donaldson JR, 2006, NEW PHYTOL, V169, P561, DOI 10.1111/j.1469-8137.2005.01613.x; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dotterl S, 2006, J CHROMATOGR A, V1113, P231, DOI 10.1016/j.chroma.2006.02.011; Dudareva N, 1996, PLANT CELL, V8, P1137, DOI 10.1105/tpc.8.7.1137; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; FOWLER SV, 1985, AM NAT, V126, P181, DOI 10.1086/284408; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Glinwood R, 2004, ECOL ENTOMOL, V29, P188, DOI 10.1111/j.0307-6946.2004.00582.x; Godard KA, 2008, PHYTOCHEMISTRY, V69, P1838, DOI 10.1016/j.phytochem.2008.02.011; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2006, ECOL LETT, V9, P813, DOI 10.1111/j.1461-0248.2006.00932.x; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Himanen SJ, 2010, NEW PHYTOL, V186, P722, DOI 10.1111/j.1469-8137.2010.03220.x; Holopainen JK, 2004, TRENDS PLANT SCI, V9, P529, DOI 10.1016/j.tplants.2004.09.006; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; RHOADES DF, 1983, ACS SYM SER, V208, P55; ROMAN G, 1995, GENETICS, V139, P1393; Ruther J, 2005, J CHEM ECOL, V31, P2217, DOI 10.1007/s10886-005-6413-8; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Walker L, 1998, CURR OPIN PLANT BIOL, V1, P434, DOI 10.1016/S1369-5266(98)80269-0; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Zhang SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011064	47	11	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35867	10.1371/journal.pone.0035867	http://dx.doi.org/10.1371/journal.pone.0035867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558246	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200089
J	Gastaldi, S; Sassi, F; Accornero, P; Torti, D; Galimi, F; Migliardi, G; Molyneux, G; Perera, T; Comoglio, PM; Boccaccio, C; Smalley, MJ; Bertotti, A; Trusolino, L				Gastaldi, S.; Sassi, F.; Accornero, P.; Torti, D.; Galimi, F.; Migliardi, G.; Molyneux, G.; Perera, T.; Comoglio, P. M.; Boccaccio, C.; Smalley, M. J.; Bertotti, A.; Trusolino, L.			Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer	ONCOGENE			English	Article						Met tyrosine kinase receptor; mammary stem cells; mammary morphogenesis; basal-like breast cancer; cell-fate determination; mammary tumorigenesis	GLAND DEVELOPMENT; C-MET; DUCTAL MORPHOGENESIS; MOLECULAR PORTRAITS; TYROSINE KINASE; FACTOR RECEPTOR; EGF RECEPTOR; LUNG-CANCER; STEM-CELLS; EXPRESSION	Basal-like breast cancer is an aggressive subtype of mammary carcinoma. Despite expressing basal markers, typical of mammary stem cells, this tumor has been proposed to originate from luminal progenitors, which are downstream of stem cells along the mammary epithelial hierarchy. This suggests that committed luminal progenitors may reacquire basal, stem-like characteristics, but the mechanisms that regulate this transition remain unclear. Using mouse models, we found that luminal progenitors express high levels of the Met receptor for hepatocyte growth factor (HGF), as compared with the other mammary epithelial sub-populations. Constitutive activation of Met led luminal progenitors to attain stem cell properties, including enhanced clonogenic activity in vitro and de novo ability to reconstitute mammary glands in repopulation assays in vivo. Moreover, in response to Met signaling, luminal progenitors gave rise to hyperplastic ductal morphogenesis and preferentially underwent basal lineage commitment at the expense of luminal cell-fate specification. Opposite and symmetric results were produced by systemic pharmacological inhibition of Met. Hence, Met signaling targets luminal progenitors for expansion, impairs their differentiation toward the mature luminal phenotype and enables their commitment toward the basal lineage. These results emphasize a critical role for Met in promoting deregulated proliferation and basal plasticity of normal luminal progenitors in the mammary gland, a complex of events that may be required for sustaining the functional and phenotypic properties of basal-like breast tumors. Oncogene (2013) 32, 1428-1440; doi:10.1038/onc.2012.154; published online 7 May 2012	[Gastaldi, S.; Sassi, F.; Torti, D.; Galimi, F.; Migliardi, G.; Bertotti, A.; Trusolino, L.] Inst Canc Res & Treatment IRCC, Mol Pharmacol Lab, I-10060 Candiolo, Italy; [Gastaldi, S.; Sassi, F.; Torti, D.; Migliardi, G.; Comoglio, P. M.; Boccaccio, C.; Bertotti, A.; Trusolino, L.] Univ Turin, Sch Med, Dept Oncol Sci, Candiolo, Italy; [Accornero, P.] Univ Torino, Sch Vet Med, Dept Vet Morphophysiol, Grugliasco, Italy; [Molyneux, G.; Smalley, M. J.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Perera, T.] Janssen Res & Dev, Beerse, Belgium; [Comoglio, P. M.] Inst Canc Res & Treatment IRCC, Div Mol Clin Oncol, I-10060 Candiolo, Italy; [Boccaccio, C.] Inst Canc Res & Treatment IRCC, Lab Canc Stem Cell Biol, I-10060 Candiolo, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Turin; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Johnson & Johnson; Janssen Pharmaceuticals; IRCCS Fondazione del Piemonte per l'Oncologia; IRCCS Fondazione del Piemonte per l'Oncologia	Trusolino, L (corresponding author), Inst Canc Res & Treatment IRCC, Mol Pharmacol Lab, Str Prov 142,Km 3-95, I-10060 Candiolo, Italy.	SmalleyMJ@cardiff.ac.uk; livio.trusolino@ircc.it	sassi, francesco/AAB-6844-2020; Smalley, Matthew J/M-7000-2015; Migliardi, Giorgia/AAB-6619-2020; Boccaccio, Carla/AHE-7875-2022	sassi, francesco/0000-0002-4741-0408; Smalley, Matthew J/0000-0001-9540-1146; Boccaccio, Carla/0000-0003-2620-9083; GALIMI, Francesco/0000-0002-5939-6922; Migliardi, Giorgia/0000-0001-5770-8120; Comoglio, Paolo/0000-0002-7056-5328; Trusolino, Livio/0000-0002-6379-3365; Bertotti, Andrea/0000-0001-8196-7608	Janssen pharmaceutical companies; AIRC, Associazione Italiana per la Ricerca sul Cancro (IG project) [10116]; MIUR-FIRB, Fondo per gli Investimenti della Ricerca di Base - Futuro in Ricerca; FPRC, Fondazione Piemontese per la Ricerca sul Cancro; Breakthrough Breast Cancer; United Kingdom National Health Service	Janssen pharmaceutical companies; AIRC, Associazione Italiana per la Ricerca sul Cancro (IG project)(Fondazione AIRC per la ricerca sul cancro); MIUR-FIRB, Fondo per gli Investimenti della Ricerca di Base - Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)); FPRC, Fondazione Piemontese per la Ricerca sul Cancro; Breakthrough Breast Cancer; United Kingdom National Health Service	T Perera is an employee of Janssen pharmaceutical companies of Johnson & Johnson. PM Comoglio receives research grants from Janssen pharmaceutical companies. The other authors declare no potential conflicts of interest.; We thank Erica Lantelme for help with FACS sorting; Noemi Cavalera, Claudio Isella, Howard Kendrick, Simonetta Leto, Barbara Lupo, Paolo Luraghi, Fiona-Ann Magnay, Barbara Martinoglio, Enzo Medico, Roberta Porporato and Eugenia Zanella for help with experiments, discussion and sharing reagents; Fabrizio Maina, Laura Tarditi and Tuti Werdiningsih for animal husbandry; Raffaella Albano, Stefania Giove and Laura Palmas for technical assistance; Antonella Cignetto, Daniela Gramaglia and Francesca Natale for secretarial assistance. This work was supported by AIRC, Associazione Italiana per la Ricerca sul Cancro (IG project 10116 to LT); MIUR-FIRB, Fondo per gli Investimenti della Ricerca di Base - Futuro in Ricerca (AB); FPRC, Fondazione Piemontese per la Ricerca sul Cancro (LT); Breakthrough Breast Cancer and United Kingdom National Health Service funding to the National Institute for Health Research Biomedical Research Centre (MJS).	Andrechek ER, 2005, ONCOGENE, V24, P932, DOI 10.1038/sj.onc.1208230; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bozec A, 2007, BRIT J CANCER, V97, P65, DOI 10.1038/sj.bjc.6603791; Brisken C, 2000, GENE DEV, V14, P650; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Chaffer CL, 2010, CELL STEM CELL, V7, P271, DOI 10.1016/j.stem.2010.08.008; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Garcia S, 2007, HUM PATHOL, V38, P830, DOI 10.1016/j.humpath.2006.11.015; Gastaldi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2617; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Jackson-Fisher AJ, 2004, P NATL ACAD SCI USA, V101, P17138, DOI 10.1073/pnas.0407057101; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mackay A, 2011, JNCI-J NATL CANCER I, V103, P662, DOI 10.1093/jnci/djr071; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; NIRANJAN B, 1995, DEVELOPMENT, V121, P2897; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ponzo MG, 2010, CELL CYCLE, V9, P1043, DOI 10.4161/cc.9.6.11033; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Regan JL, 2012, ONCOGENE, V31, P869, DOI 10.1038/onc.2011.289; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; Schroeder JA, 1997, J MAMMARY GLAND BIOL, V2, P119, DOI 10.1023/A:1026347629876; Sebastian J, 1998, CELL GROWTH DIFFER, V9, P777; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimoyama T, 2006, LUNG CANCER, V53, P13, DOI 10.1016/j.lungcan.2006.03.014; Simian M, 2001, DEVELOPMENT, V128, P3117; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Torti D, 2012, INT J CANCER, V130, P1357, DOI 10.1002/ijc.26137; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wiesen JF, 1999, DEVELOPMENT, V126, P335; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215	60	44	45	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2013	32	11					1428	1440		10.1038/onc.2012.154	http://dx.doi.org/10.1038/onc.2012.154			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22562252	Green Submitted			2022-12-25	WOS:000316455600009
J	Lefebvre, KA; Frame, ER; Gulland, F; Hansen, JD; Kendrick, PS; Beyer, RP; Bammler, TK; Farin, FM; Hiolski, EM; Smith, DR; Marcinek, DJ				Lefebvre, Kathi A.; Frame, Elizabeth R.; Gulland, Frances; Hansen, John D.; Kendrick, Preston S.; Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.; Hiolski, Emma M.; Smith, Donald R.; Marcinek, David J.			A Novel Antibody-Based Biomarker for Chronic Algal Toxin Exposure and Sub-Acute Neurotoxicity	PLOS ONE			English	Article							CALIFORNIA SEA LIONS; DOMOIC ACID TOXICITY; ZALOPHUS-CALIFORNIANUS; CLINICAL SIGNS; SPECIFICITY; MORTALITY; INNATE; BRAIN; CELLS; SELF	The neurotoxic amino acid, domoic acid (DA), is naturally produced by marine phytoplankton and presents a significant threat to the health of marine mammals, seabirds and humans via transfer of the toxin through the foodweb. In humans, acute exposure causes a neurotoxic illness known as amnesic shellfish poisoning characterized by seizures, memory loss, coma and death. Regular monitoring for high DA levels in edible shellfish tissues has been effective in protecting human consumers from acute DA exposure. However, chronic low-level DA exposure remains a concern, particularly in coastal and tribal communities that subsistence harvest shellfish known to contain low levels of the toxin. Domoic acid exposure via consumption of planktivorous fish also has a profound health impact on California sea lions (Zalophus californianus) affecting hundreds of animals yearly. Due to increasing algal toxin exposure threats globally, there is a critical need for reliable diagnostic tests for assessing chronic DA exposure in humans and wildlife. Here we report the discovery of a novel DA-specific antibody response that is a signature of chronic low-level exposure identified initially in a zebrafish exposure model and confirmed in naturally exposed wild sea lions. Additionally, we found that chronic exposure in zebrafish caused increased neurologic sensitivity to DA, revealing that repetitive exposure to DA well below the threshold for acute behavioral toxicity has underlying neurotoxic consequences. The discovery that chronic exposure to low levels of a small, water-soluble single amino acid triggers a detectable antibody response is surprising and has profound implications for the development of diagnostic tests for exposure to other pervasive environmental toxins.	[Lefebvre, Kathi A.; Frame, Elizabeth R.; Kendrick, Preston S.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Gulland, Frances] Marine Mammal Ctr, Sausalito, CA USA; [Hansen, John D.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Hiolski, Emma M.; Smith, Donald R.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Marcinek, David J.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Marcinek, David J.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lefebvre, KA (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA.	Kathi.Lefebvre@noaa.gov		Marcinek, David/0000-0001-5187-2149	NOAA-ECOHAB program; UW NIEHS [P30ES07033]; NIH [AG036606]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021930, P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036606] Funding Source: NIH RePORTER	NOAA-ECOHAB program(National Oceanic Atmospheric Admin (NOAA) - USA); UW NIEHS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this research was provided by the NOAA-ECOHAB program. This work was also supported in part by the UW NIEHS sponsored Center for Ecogenetics & Environmental Health (P30ES07033) and NIH AG036606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA K, 1984, J IMMUNOL, V133, P3286; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bates S.S., 1998, PHYSL ECOLOGY HARMFU, P267; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Colvocoresses JA, CHARACTERIZATION HUM; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goldstein T, 2008, P ROY SOC B-BIOL SCI, V275, P267, DOI 10.1098/rspb.2007.1221; Grattan LM, 2009, 5 S HARMF ALG US C P; Gulland FMD, 2002, VET REC, V150, P475; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HENKART PA, 1977, J EXP MED, V146, P1068, DOI 10.1084/jem.146.4.1068; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JANEWAY CA, 1978, J EXP MED, V147, P1065, DOI 10.1084/jem.147.4.1065; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Lefebvre KA, 1999, NAT TOXINS, V7, P85, DOI 10.1002/(SICI)1522-7189(199905/06)7:3<85::AID-NT39>3.0.CO;2-Q; Lefebvre KA, 2010, TOXICON, V56, P218, DOI 10.1016/j.toxicon.2009.05.034; Lefebvre KA, 2009, TOXICOL SCI, V107, P65, DOI 10.1093/toxsci/kfn207; MARTIN S, 1995, EUR J IMMUNOL, V25, P2788, DOI 10.1002/eji.1830251012; McGeer PL, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00077; Montie EW, 2010, DIS AQUAT ORGAN, V91, P243, DOI 10.3354/dao02259; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; PERL TM, 1990, NEW ENGL J MED, V322, P1775, DOI 10.1056/NEJM199006213222504; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Silvagni PA, 2005, VET PATHOL, V42, P184, DOI 10.1354/vp.42-2-184; Skuljec J, 2011, CELL IMMUNOL, V270, P164, DOI 10.1016/j.cellimm.2011.05.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; TODD ECD, 1993, J FOOD PROTECT, V56, P69, DOI 10.4315/0362-028X-56.1.69; TRUELOVE J, 1994, B ENVIRON CONTAM TOX, V52, P479; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Wekell JC, 2004, J SHELLFISH RES, V23, P927; Wekell John C., 1994, Natural Toxins, V2, P197, DOI 10.1002/nt.2620020408; YOSHIDA T, 1970, J IMMUNOL, V105, P306	32	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36213	10.1371/journal.pone.0036213	http://dx.doi.org/10.1371/journal.pone.0036213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567140	Green Published, gold			2022-12-25	WOS:000305341500059
J	Ma, Z; Zhang, H; Yi, L; Fan, HJ; Lu, CP				Ma, Zhe; Zhang, Hui; Yi, Li; Fan, Hongjie; Lu, Chengping			Microarray Analysis of the Effect of Streptococcus equi subsp zooepidemicus M-Like Protein in Infecting Porcine Pulmonary Alveolar Macrophage	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; GENE-EXPRESSION DATA; IMMUNE-RESPONSES; PHAGOCYTOSIS; ACTIVATION; PATHWAY; CELLS; MENINGITIS; SECRETION	Streptococcus equi subsp. zooepidemicus (S. zooepidemicus), which belongs to Lancefield group C streptococci, is an important pathogen of domesticated species, causing septicemia, meningitis and mammitis. M-like protein (SzP) is an important virulence factor of S. zooepidemicus and contributes to bacterial infection and antiphagocytosis. To increase our knowledge of the mechanism of SzP in infection, we profiled the response of porcine pulmonary alveolar macrophage (PAM) to infection with S. zooepidemicus ATCC35246 wild strain (WD) and SzP-knockout strain (KO) using the Roche NimbleGen Porcine Genome Expression Array. We found SzP contributed to differential expression of 446 genes, with upregulation of 134 genes and downregulation of 312 genes. Gene Ontology category and KEGG pathway were analyzed for relationships among differentially expressed genes. These genes were represented in a variety of functional categories, including genes involved in immune response, regulation of chemokine production, signal transduction and regulation of apoptosis. The reliability of the data obtained from the microarray was verified by performing quantitative real-time PCR on 12 representative genes. The data will contribute to understanding of SzP mediated mechanisms of S. zooepidemicus pathogenesis.	[Ma, Zhe; Zhang, Hui; Yi, Li; Fan, Hongjie; Lu, Chengping] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Ma, Z (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	fhj@njau.edu.cn			Program for New Century Excellent Talents (NCET) at the University of China [NCET-08-0794]; National Transgenic Major Program [2009ZX08009-154B]; Key Technology Program, Jiangsu [R65286D, BE2009388]; Fundamental Research Funds for the Central Universities [KYT 201003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Program for New Century Excellent Talents (NCET) at the University of China(Program for New Century Excellent Talents in University (NCET)); National Transgenic Major Program; Key Technology Program, Jiangsu; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the Program for New Century Excellent Talents (NCET) at the University of China (NCET-08-0794), the National Transgenic Major Program (2009ZX08009-154B), the Key Technology Program (R65286D), Jiangsu (BE2009388), the Fundamental Research Funds for the Central Universities (KYT 201003), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Barichello T, 2009, NEUROSCI LETT, V467, P217, DOI 10.1016/j.neulet.2009.10.039; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BISNO AL, 1979, INFECT IMMUN, V26, P1172, DOI 10.1128/IAI.26.3.1172-1176.1979; CAMPO RE, 1995, J INFECT DIS, V171, P601, DOI 10.1093/infdis/171.3.601; Chae P, 2002, INFECT IMMUN, V70, P3164, DOI 10.1128/IAI.70.6.3164-3169.2002; Dey R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005188; Ernst JD, 2000, CELL MICROBIOL, V2, P379, DOI 10.1046/j.1462-5822.2000.00075.x; Eyre DW, 2010, EUR J CLIN MICROBIOL; Fan HJ, 2009, VACCINE, V27, P56, DOI 10.1016/j.vaccine.2008.10.037; Feng ZG., 1977, ANIM HUSBANDRY VET M, V2, P7; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Heras AL, 2002, J CLIN MICROBIOL, V40, P1106, DOI 10.1128/JCM.40.3.1106-1108.2002; Hess DJ, 2009, J SURG RES, V155, P217, DOI 10.1016/j.jss.2008.07.022; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Ichinose S, 2006, INT J ONCOL, V29, P349; Jovanovic M, 2008, J MED MICROBIOL, V57, P373, DOI 10.1099/jmm.0.47487-0; Liu ML, 2011, VET MICROBIOL, V150, P126, DOI 10.1016/j.vetmic.2010.12.014; Liu PeiHong, 2001, Chinese Journal of Veterinary Science, V21, P42; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032099; Marodi L, 2000, INFECT IMMUN, V68, P2167, DOI 10.1128/IAI.68.4.2167-2170.2000; MOORE BO, 1969, J AM VET MED ASSOC, V155, P416; Mostefaoui Y, 2004, CELL MICROBIOL, V6, P1085, DOI 10.1111/j.1462-5822.2004.00420.x; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soedarmanto I, 1996, J CLIN MICROBIOL, V34, P2201, DOI 10.1128/JCM.34.9.2201-2204.1996; Timoney JF, 2004, VET RES, V35, P397, DOI 10.1051/vetres:2004025; TIMONEY JF, 1995, INFECT IMMUN, V63, P1440, DOI 10.1128/IAI.63.4.1440-1445.1995; Timoney JF, 1997, INFECT IMMUN, V65, P3600, DOI 10.1128/IAI.65.9.3600-3605.1997; Ural O, 2003, SCAND J INFECT DIS, V35, P206, DOI 10.1080/00365540310000076; Vallejo JG, 2000, J IMMUNOL, V165, P419, DOI 10.4049/jimmunol.165.1.419; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Xu H, 2007, BIOCHEM BIOPH RES CO, V353, P812, DOI 10.1016/j.bbrc.2006.12.108; YOON IJ, 1992, J VET DIAGN INVEST, V4, P139, DOI 10.1177/104063879200400204; You YO, 2004, J ETHNOPHARMACOL, V92, P331, DOI 10.1016/j.jep.2004.03.023; Zheng H, 2011, VET MICROBIOL	41	4	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36452	10.1371/journal.pone.0036452	http://dx.doi.org/10.1371/journal.pone.0036452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567158	gold, Green Published			2022-12-25	WOS:000305341500077
J	Mitra, R; Sapolsky, RM				Mitra, Rupshi; Sapolsky, Robert M.			Short-Term Enrichment Makes Male Rats More Attractive, More Defensive and Alters Hypothalamic Neurons	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; FACTOR MESSENGER-RNA; FREELY MOVING RATS; ELEVATED PLUS-MAZE; ENVIRONMENTAL ENRICHMENT; SYNAPTIC-TRANSMISSION; NEURAL PLASTICITY; SEXUAL SELECTION; RECEPTOR-BINDING; CHRONIC STRESS	Innate behaviors are shaped by contingencies built during evolutionary history. On the other hand, environmental stimuli play a significant role in shaping behavior. In particular, a short period of environmental enrichment can enhance cognitive behavior, modify effects of stress on learned behaviors and induce brain plasticity. It is unclear if modulation by environment can extend to innate behaviors which are preserved by intense selection pressure. In the present report we investigate this issue by studying effects of relatively short (14-days) environmental enrichment on two prominent innate behaviors in rats, avoidance of predator odors and ability of males to attract mates. We show that enrichment has strong effects on both the innate behaviors: a) enriched males were more avoidant of a predator odor than non-enriched controls, and had a greater rise in corticosterone levels in response to the odor; and b) had higher testosterone levels and were more attractive to females. Additionally, we demonstrate decrease in dendritic length of neurons of ventrolateral nucleus of hypothalamus, important for reproductive mate-choice and increase in the same in dorsomedial nucleus, important for defensive behavior. Thus, behavioral and hormonal observations provide evidence that a short period of environmental manipulation can alter innate behaviors, providing a good example of gene-environment interaction.	[Mitra, Rupshi] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Mitra, Rupshi] Nanyang Technol Univ, Div Psychol, Singapore, Singapore; [Sapolsky, Robert M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University	Mitra, R (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	rupshi@gmail.com	Mitra, Rupshi/B-5055-2008	Mitra, Rupshi/0000-0003-1440-8931	National Institutes of Health, USA [RO1 AGO 20633]	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, USA, (RO1 AGO 20633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able DJ, 1996, P NATL ACAD SCI USA, V93, P2229, DOI 10.1073/pnas.93.5.2229; Adamec RE, 2006, NEUROSCI BIOBEHAV R, V30, P356, DOI 10.1016/j.neubiorev.2005.04.004; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; Bakker J, 1996, PHYSIOL BEHAV, V60, P489, DOI 10.1016/S0031-9384(96)80023-0; Barreca S, 2003, BRAIN INJURY, V17, P1065, DOI 10.1080/0269905031000110535; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Blanchard RJ, 1998, PHYSIOL BEHAV, V65, P201, DOI 10.1016/S0031-9384(98)00012-2; BLANCHARD RJ, 1989, J COMP PSYCHOL, V103, P70, DOI 10.1037/0735-7036.103.1.70; BROWN TJ, 1994, MOL CELL NEUROSCI, V5, P549, DOI 10.1006/mcne.1994.1067; Buchhold B, 2007, RESTOR NEUROL NEUROS, V25, P467; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; COOPER RM, 1958, CAN J PSYCHOLOGY, V12, P159, DOI 10.1037/h0083747; Correll CM, 2005, BIOL PSYCHIAT, V58, P382, DOI 10.1016/j.biopsych.2005.04.009; DENENBERG VH, 1968, J COMP PHYSIOL PSYCH, V66, P533, DOI 10.1037/h0026345; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Dielenberg RA, 1999, J COMP PSYCHOL, V113, P376, DOI 10.1037/0735-7036.113.4.376; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Duffy SN, 2001, LEARN MEMORY, V8, P26, DOI 10.1101/lm.36301; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; FERNANDEZTERUEL A, 1992, NEUROSCI LETT, V137, P185, DOI 10.1016/0304-3940(92)90400-2; Friske JE, 2005, PHYSIOL BEHAV, V85, P187, DOI 10.1016/j.physbeh.2005.03.022; Gelfo F, 2009, NEUROBIOL LEARN MEM, V91, P353, DOI 10.1016/j.nlm.2009.01.010; Gortz N, 2008, BEHAV BRAIN RES, V191, P43, DOI 10.1016/j.bbr.2008.03.006; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAMMER RP, 1992, PHARMACOL BIOCHEM BE, V42, P25, DOI 10.1016/0091-3057(92)90440-Q; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Imanaka A, 2008, BEHAV BRAIN RES, V186, P91, DOI 10.1016/j.bbr.2007.07.039; Irvine GI, 2006, HIPPOCAMPUS, V16, P149, DOI 10.1002/hipo.20142; Irvine GI, 2005, NEUROSCI LETT, V391, P32, DOI 10.1016/j.neulet.2005.08.031; Iwata E, 2007, PHYSIOL BEHAV, V91, P318, DOI 10.1016/j.physbeh.2007.03.013; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kolber BJ, 2008, P NATL ACAD SCI USA, V105, P12004, DOI 10.1073/pnas.0803216105; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; LEVINE S, 1957, SCIENCE, V126, P405, DOI 10.1126/science.126.3270.405; Lores-Arnaiz S, 2006, BEHAV BRAIN RES, V169, P294, DOI 10.1016/j.bbr.2006.01.016; Magalhaes A, 2004, ANN NY ACAD SCI, V1025, P619, DOI 10.1196/annals.1316.077; MCEWEN BS, 1991, J STEROID BIOCHEM, V39, P223, DOI 10.1016/0960-0760(91)90067-F; Mitra R, EXPERT OPIN BIOL THE, V10, P1289; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Mitra R, 2009, BEHAV BRAIN RES, V205, P535, DOI 10.1016/j.bbr.2009.08.014; Mitra R, 2009, STRESS, V12, P305, DOI 10.1080/10253890802379955; Mong JA, 1999, J NEUROBIOL, V40, P602, DOI 10.1002/(SICI)1097-4695(19990915)40:4<602::AID-NEU14>3.0.CO;2-O; Moriceau S, 2006, J NEUROSCI, V26, P6737, DOI 10.1523/JNEUROSCI.0499-06.2006; Moriceau S, 2009, J NEUROSCI, V29, P15745, DOI 10.1523/JNEUROSCI.4106-09.2009; Papes F, CELL, V141, P692; Pinaud R, 2001, MOL BRAIN RES, V91, P50, DOI 10.1016/S0169-328X(01)00121-8; Ponmanickam P, GEN COMP ENDOCRINOL, V167, P35; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rema V, 2006, NEUROSCIENCE, V140, P659, DOI 10.1016/j.neuroscience.2006.02.043; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Ribeiro-Barbosa ER, 2005, NEUROSCI BIOBEHAV R, V29, P1255, DOI 10.1016/j.neubiorev.2005.04.006; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Sa SI, 2005, NEUROSCIENCE, V133, P919, DOI 10.1016/j.neuroscience.2005.02.033; Saucier DM, 2007, BRAIN RES, V1170, P31, DOI 10.1016/j.brainres.2007.07.020; Savioz A, 2009, BRAIN RES BULL, V80, P309, DOI 10.1016/j.brainresbull.2009.06.006; Segovia G, 2009, J NEURAL TRANSM, V116, P1007, DOI 10.1007/s00702-009-0214-0; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; Sztainberg Y, 2010, MOL PSYCHIATR, V15, P905, DOI 10.1038/mp.2009.151; TAYLOR GT, 1983, J ENDOCRINOL, V96, P43, DOI 10.1677/joe.0.0960043; TAYLOR GT, 1982, PHYSIOL BEHAV, V28, P953, DOI 10.1016/0031-9384(82)90159-7; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; Vyas A, 2002, J NEUROSCI, V22, P6810; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zewail-Foote M, 2009, PHYSIOL BEHAV, V96, P98, DOI 10.1016/j.physbeh.2008.09.007; Zhao LR, 2000, NEUROSCIENCE, V97, P177, DOI 10.1016/S0306-4522(00)00023-3; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	79	29	29	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36092	10.1371/journal.pone.0036092	http://dx.doi.org/10.1371/journal.pone.0036092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567125	Green Published, gold			2022-12-25	WOS:000305341500043
J	Rodriguez, KA; Edrey, YH; Osmulski, P; Gaczynska, M; Buffenstein, R				Rodriguez, Karl A.; Edrey, Yael H.; Osmulski, Pawel; Gaczynska, Maria; Buffenstein, Rochelle			Altered Composition of Liver Proteasome Assemblies Contributes to Enhanced Proteasome Activity in the Exceptionally Long-Lived Naked Mole-Rat	PLOS ONE			English	Article							SISTER-CHROMATID SEPARATION; NF-KAPPA-B; OXIDATIVE-STRESS; 20S PROTEASOME; LIVING RODENT; PROTEIN-DEGRADATION; IMMUNOPROTEASOME; LONGEVITY; MECHANISMS; RESISTANCE	The longest-lived rodent, the naked mole-rat (Bathyergidae; Heterocephalus glaber), maintains robust health for at least 75% of its 32 year lifespan, suggesting that the decline in genomic integrity or protein homeostasis routinely observed during aging, is either attenuated or delayed in this extraordinarily long-lived species. The ubiquitin proteasome system (UPS) plays an integral role in protein homeostasis by degrading oxidatively-damaged and misfolded proteins. In this study, we examined proteasome activity in naked mole-rats and mice in whole liver lysates as well as three subcellular fractions to probe the mechanisms behind the apparently enhanced effectiveness of UPS. We found that when compared with mouse samples, naked mole-rats had significantly higher chymotrypsin-like (ChT-L) activity and a two-fold increase in trypsin-like (T-L) in both whole lysates as well as cytosolic fractions. Native gel electrophoresis of the whole tissue lysates showed that the 20S proteasome was more active in the longer-lived species and that 26S proteasome was both more active and more populous. Western blot analyses revealed that both 19S subunits and immunoproteasome catalytic subunits are present in greater amounts in the naked mole-rat suggesting that the observed higher specific activity may be due to the greater proportion of immunoproteasomes in livers of healthy young adults. It thus appears that proteasomes in this species are primed for the efficient removal of stress-damaged proteins. Further characterization of the naked mole-rat proteasome and its regulation could lead to important insights on how the cells in these animals handle increased stress and protein damage to maintain a longer health in their tissues and ultimately a longer life.	[Rodriguez, Karl A.; Edrey, Yael H.; Osmulski, Pawel; Gaczynska, Maria; Buffenstein, Rochelle] Univ Texas San Antonio, Hlth Sci Ctr, Sam & Ann Barshop Inst Aging & Longev Studies, San Antonio, TX USA; [Rodriguez, Karl A.; Edrey, Yael H.; Buffenstein, Rochelle] Univ Texas San Antonio, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA; [Osmulski, Pawel; Gaczynska, Maria] Univ Texas San Antonio, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX USA; [Buffenstein, Rochelle] Univ Texas San Antonio, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio	Rodriguez, KA (corresponding author), Univ Texas San Antonio, Hlth Sci Ctr, Sam & Ann Barshop Inst Aging & Longev Studies, San Antonio, TX USA.	Buffenstein@uthscsa.edu	Rodriguez, Karl A/F-2689-2012; Osmulski, Pawel/C-7751-2019	Osmulski, Pawel/0000-0002-5359-9200	Institutional Postdoctoral Fellow Training Grant [T32 AG021890-08]; Ellison Medical Foundation [AGSS-178006]; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [T32AG021890, R01AG022891, R21AG043912] Funding Source: NIH RePORTER	Institutional Postdoctoral Fellow Training Grant; Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	T32 AG021890-08 (NIA) Institutional Postdoctoral Fellow Training Grant (KR), AGSS-178006 (RB is PI) Ellison Medical Foundation (Genomic Stability in the Naked Mole-Rat: A Role for Cancer Resistance and Extended Longevity) (http://www.ellisonfoundation.org/), and Glenn Foundation for Medical Research (RB is PI). (Comparative biological mechanisms of aging, insights from the longest lived rodent, the naked mole-rat) (http://glennfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Bajorek M, 2004, CELL MOL LIFE SCI, V61, P1579, DOI 10.1007/s00018-004-4131-y; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Cusimano A, 2010, CELL CYCLE, V9, P1399, DOI 10.4161/cc.9.7.11254; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Dasuri K, 2009, FREE RADICAL RES, V43, P28, DOI 10.1080/10715760802534812; Dasuri K, 2010, FREE RADICAL BIO MED, V49, P1290, DOI 10.1016/j.freeradbiomed.2010.07.014; de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149; Edrey YH, 2011, ILAR J, V52, P41, DOI 10.1093/ilar.52.1.41; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Ferrington DA, 2008, J NEUROCHEM, V106, P158, DOI 10.1111/j.1471-4159.2008.05345.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Gaczynska M, 2005, METHOD ENZYMOL, V398, P425, DOI 10.1016/S0076-6879(05)98035-X; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; HENDIL KB, 1993, ENZYME PROTEIN, V47, P232, DOI 10.1159/000468682; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Ikeno Y, 2005, J GERONTOL A-BIOL, V60, P1510, DOI 10.1093/gerona/60.12.1510; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kaeberlein M, 2011, AGING CELL, V10, P185, DOI 10.1111/j.1474-9726.2010.00665.x; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Kruger E, 2004, REV PHYSIOL BIOCH P, V148, P81, DOI 10.1007/s10254-003-0010-4; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lattanzi L, 2011, IMMUNOBIOLOGY, V216, P537, DOI 10.1016/j.imbio.2010.10.003; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Li J, 2011, FASEB J, V25, P883, DOI 10.1096/fj.10-160895; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Noda C, 2000, BIOCHEM BIOPH RES CO, V277, P348, DOI 10.1006/bbrc.2000.3676; PACIFICI RE, 1993, J BIOL CHEM, V268, P15405; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Rodgers KJ, 2003, INT J BIOCHEM CELL B, V35, P716, DOI 10.1016/S1357-2725(02)00391-6; Rodriguez KA, 2010, MECH AGEING DEV, V131, P144, DOI 10.1016/j.mad.2010.01.002; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Vasuri F, 2010, BIOCHEM BIOPH RES CO, V397, P301, DOI 10.1016/j.bbrc.2010.05.104; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Wang JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001048; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x; Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729; Zwickl P, 2002, ADV PROTEIN CHEM, V59, P187	65	77	83	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35890	10.1371/journal.pone.0035890	http://dx.doi.org/10.1371/journal.pone.0035890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567116	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341500034
J	Wegiel, J; Frackowiak, J; Mazur-Kolecka, B; Schanen, NC; Cook, EH; Sigman, M; Brown, WT; Kuchna, I; Wegiel, J; Nowicki, K; Imaki, H; Ma, SY; Chauhan, A; Chauhan, V; Miller, DL; Mehta, PD; Flory, M; Cohen, IL; London, E; Reisberg, B; de Leon, MJ; Wisniewski, T				Wegiel, Jerzy; Frackowiak, Janusz; Mazur-Kolecka, Bozena; Schanen, N. Carolyn; Cook, Edwin H., Jr.; Sigman, Marian; Brown, W. Ted; Kuchna, Izabela; Wegiel, Jarek; Nowicki, Krzysztof; Imaki, Humi; Ma, Shuang Yong; Chauhan, Abha; Chauhan, Ved; Miller, David L.; Mehta, Pankaj D.; Flory, Michael; Cohen, Ira L.; London, Eric; Reisberg, Barry; de Leon, Mony J.; Wisniewski, Thomas			Abnormal Intracellular Accumulation and Extracellular A beta Deposition in Idiopathic and Dup15q11.2-q13 Autism Spectrum Disorders	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SMOOTH-MUSCLE-CELLS; ALZHEIMERS-DISEASE; DIFFUSE PLAQUES; MONOCLONAL-ANTIBODIES; LIPID-PEROXIDATION; OXIDATIVE STRESS; BRAIN-INJURY; PATHOGENESIS; APP	Background: It has been shown that amyloid beta (A beta), a product of proteolytic cleavage of the amyloid beta precursor protein (APP), accumulates in neuronal cytoplasm in non-affected individuals in a cell type-specific amount. Methodology/Principal Findings: In the present study, we found that the percentage of amyloid-positive neurons increases in subjects diagnosed with idiopathic autism and subjects diagnosed with duplication 15q11.2-q13 (dup15) and autism spectrum disorder (ASD). In spite of interindividual differences within each examined group, levels of intraneuronal A beta load were significantly greater in the dup(15) autism group than in either the control or the idiopathic autism group in 11 of 12 examined regions (p<0.0001 for all comparisons; Kruskall-Wallis test). In eight regions, intraneuronal A beta load differed significantly between idiopathic autism and control groups (p<0.0001). The intraneuronal A beta was mainly N-terminally truncated. Increased intraneuronal accumulation of A beta(17-40/42) in children and adults suggests a life-long enhancement of APP processing with alpha-secretase in autistic subjects. A beta accumulation in neuronal endosomes, autophagic vacuoles, Lamp1-positive lysosomes and lipofuscin, as revealed by confocal microscopy, indicates that products of enhanced alpha-secretase processing accumulate in organelles involved in proteolysis and storage of metabolic remnants. Diffuse plaques containing A beta(1-40/42) detected in three subjects with ASD, 39 to 52 years of age, suggest that there is an age-associated risk of alterations of APP processing with an intraneuronal accumulation of a short form of A beta and an extracellular deposition of full-length A beta in nonfibrillar plaques. Conclusions/Significance: The higher prevalence of excessive A beta accumulation in neurons in individuals with early onset of intractable seizures, and with a high risk of sudden unexpected death in epilepsy in autistic subjects with dup(15) compared to subjects with idiopathic ASD, supports the concept of mechanistic and functional links between autism, epilepsy and alterations of APP processing leading to neuronal and astrocytic A beta accumulation and diffuse plaque formation.	[Wegiel, Jerzy; Frackowiak, Janusz; Mazur-Kolecka, Bozena; Kuchna, Izabela; Wegiel, Jarek; Nowicki, Krzysztof; Imaki, Humi; Ma, Shuang Yong; Mehta, Pankaj D.; Wisniewski, Thomas] NYS Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA; [Schanen, N. Carolyn] DuPont Hosp Children, Wilmington, DE USA; [Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Sigman, Marian] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Brown, W. Ted] NYS Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY USA; [Chauhan, Abha; Chauhan, Ved] NYS Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY USA; [Miller, David L.] NYS Inst Basic Res Dev Disabil, Dept Mol Biol, Staten Isl, NY USA; [Flory, Michael; Cohen, Ira L.; London, Eric] NYS Inst Basic Res Dev Disabil, Dept Psychol, Staten Isl, NY USA; [Reisberg, Barry; de Leon, Mony J.; Wisniewski, Thomas] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA; [Reisberg, Barry; de Leon, Mony J.; Wisniewski, Thomas] NYU, Sch Med, Dept Pathol, New York, NY USA; [Reisberg, Barry; de Leon, Mony J.; Wisniewski, Thomas] NYU, Sch Med, Dept Psychiat, New York, NY USA	Nemours Alfred I. duPont Hospital for Children; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; New York University; New York University; New York University	Wegiel, J (corresponding author), NYS Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA.	Jerzy.Wegiel@opwdd.ny.gov	Wisniewski, Thomas/Q-6525-2019; de Leon, Mony/AAP-7890-2021; Brown, William/GXN-2777-2022	Wisniewski, Thomas/0000-0002-3379-8966; Reisberg, Barry/0000-0002-9104-7423; Cook, Edwin/0000-0002-5848-5114; de Leon, Mony/0000-0003-2245-4380	New York State Office for People with Developmental Disabilities; U.S. Department of Defense [AS073234]; Autism Speaks (Princeton, NJ); National Institutes of Health, National Institute of Child Health and Human Development [R01 HD43960]; NIH [U19 HD35470]; PHS [R24-MH 068855]; National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD; Brain Bank and Tissue Bank for Developmental Disabilities and Aging of the New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043960, U19HD035470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051, R01AG012101, R01AG022374] Funding Source: NIH RePORTER	New York State Office for People with Developmental Disabilities; U.S. Department of Defense(United States Department of Defense); Autism Speaks (Princeton, NJ); National Institutes of Health, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD; Brain Bank and Tissue Bank for Developmental Disabilities and Aging of the New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by funds from the New York State Office for People with Developmental Disabilities, a grant from the U.S. Department of Defense Autism Spectrum Disorders Research Program (AS073234, Program Project; Jerzy Wegiel, TW, AC), a grant from Autism Speaks (Princeton, NJ; Jerzy Wegiel), and grant R01 HD43960 (Jerzy Wegiel) from the National Institutes of Health, National Institute of Child Health and Human Development. Clinical and molecular investigations of the subjects with chromosome 15 duplication were supported by the Collaborative Programs for Excellence in Autism Research (NIH U19 HD35470; NCS) and Nemours Biomedical Research, duPont Hospital for Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; The authors thank Maureen Marlow for editorial corrections, Elaine Marchi for help in laboratory work coordination, and Jadwiga Wegiel, Cathy Wang and En Wu Zhang for histology and immunocytochemistry. Tissue and clinical records acquisition was coordinated by the Autism Tissue Program, Autism Speaks (Princeton, NJ; Directors: Jane Pickett, Ph.D. and Daniel Lightfoot, Ph.D.). Carolyn Komich Hare provided results of post-mortem application of ADI-R. The tissue was obtained from the Harvard Brain Tissue Resource Center, Belmont, MA, supported in part by PHS grant number R24-MH 068855; the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD; and the Brain Bank and Tissue Bank for Developmental Disabilities and Aging of the New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY. We are deeply indebted to the Dup15q Alliance for supporting this project and to the families of the tissue donors who have made this study possible.	Akyol O, 2002, PROG NEURO-PSYCHOPH, V26, P995, DOI 10.1016/S0278-5846(02)00220-8; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bailey AR, 2008, INT J CLIN EXP MED, V1, P338; BANCHER C, 1989, NEUROBIOL AGING, V10, P125, DOI 10.1016/0197-4580(89)90021-3; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; BRODY H, 1960, J GERONTOL, V15, P258, DOI 10.1093/geronj/15.3.258; BRUNK UT, 1992, MUTAT RES, V275, P395, DOI 10.1016/0921-8734(92)90042-N; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Chauhan V, 2010, AUTISM: OXIDATIVE STRESS, INFLAMMATION, AND IMMUNE ABNORMALITIES, P177; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Frackowiak J, 2003, J NEUROPATH EXP NEUR, V62, P685, DOI 10.1093/jnen/62.6.685; Frackowiak J, 2004, BRAIN RES, V1002, P67, DOI 10.1016/j.brainres.2003.12.015; Funato H, 1998, AM J PATHOL, V152, P983; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GORDON PB, 1992, BIOCHEM J, V283, P361, DOI 10.1042/bj2830361; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; GOWING E, 1994, J BIOL CHEM, V269, P10987; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Herken H, 2001, MOL PSYCHIATR, V6, P66, DOI 10.1038/sj.mp.4000789; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; IQBAL K, 1993, J HISTOTECHNOL, V16, P335, DOI 10.1179/his.1993.16.4.335; IVERSEN LL, 1995, BIOCHEM J, V311, P1; JELLINGER K, 1988, ACTA NEUROPATHOL, V76, P142, DOI 10.1007/BF00688098; Kent L, 1999, DEV MED CHILD NEUROL, V41, P153, DOI 10.1017/S001216229900033X; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; KITAMOTO T, 1987, LAB INVEST, V57, P230; Lalowski M, 1996, J BIOL CHEM, V271, P33623, DOI 10.1074/jbc.271.52.33623; Lopez-Hurtado E., 2008, AM J BIOCH BIOTECHNO, V4, P130, DOI DOI 10.3844/AJBBSP.2008.130.145; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MANN DMA, 1989, NEUROPATH APPL NEURO, V15, P317, DOI 10.1111/j.1365-2990.1989.tb01232.x; Mann SM, 2004, HUM GENET, V115, P104, DOI 10.1007/s00439-004-1127-5; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller DL, 2011, J ALZHEIMERS DIS, V23, P293, DOI 10.3233/JAD-2010-101341; Miller DL, 2003, BIOCHEMISTRY-US, V42, P11682, DOI 10.1021/bi030100s; Mochizuki A, 2000, LANCET, V355, P42, DOI 10.1016/S0140-6736(99)04937-5; Moechars D, 1996, EMBO J, V15, P1265, DOI 10.1002/j.1460-2075.1996.tb00468.x; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; NODA T, 1992, J CELL BIOL, V119, P85, DOI 10.1083/jcb.119.1.85; OHM TG, 1995, NEUROSCIENCE, V64, P209, DOI 10.1016/0306-4522(95)90397-P; Pigino G, 2003, J NEUROSCI, V23, P4499; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; PROBST A, 1991, ACTA NEUROPATHOL, V83, P21, DOI 10.1007/BF00294426; Ray B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020405; Rineer S, 1998, AM J MED GENET, V81, P428, DOI 10.1002/(SICI)1096-8628(19980907)81:5<428::AID-AJMG12>3.0.CO;2-E; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Sheikh AM, 2010, NEUROSCIENCE, V165, P363, DOI 10.1016/j.neuroscience.2009.10.035; SIEGEL S, 1988, NONPARAMETRIC STAT, P206; Simon EW, 2000, AM J MED GENET, V96, P432, DOI 10.1002/1096-8628(20000612)96:3<432::AID-AJMG39>3.0.CO;2-T; SOHAL RS, 1989, ADV EXP MED BIOL, V266, P17; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; Sokol DK, 2006, J CHILD NEUROL, V21, P444, DOI 10.1177/08830738060210062201; Tagliavini F, 1989, Prog Clin Biol Res, V317, P1001; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Thal DR, 1999, CLIN NEUROPATHOL, V18, P226; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Wang NJ, 2004, AM J HUM GENET, V75, P267, DOI 10.1086/422854; Wegiel J., 1999, NEUROSCIENCE NEWS, V2, P34; Wegiel J, 2012, J NEUROPATH IN PRESS; Wegiel J, 2007, ACTA NEUROPATHOL, V113, P389, DOI 10.1007/s00401-006-0191-4; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Wei WL, 2002, BRAIN, V125, P2036, DOI 10.1093/brain/awf205; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Westmark CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026549; Westmark CJ, 2010, INT J CLIN EXP PATHO, V3, P56; Westmark CJ, 2008, INT J CLIN EXP PATHO, V1, P157; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Wisniewski HM, 1996, NEUROPATH APPL NEURO, V22, P3, DOI 10.1046/j.1365-2990.1996.1698016.x; Wisniewski HM, 1998, J NEUROPATH EXP NEUR, V57, P674, DOI 10.1097/00005072-199807000-00004; Yamaguchi H, 1998, ACTA NEUROPATHOL, V95, P217, DOI 10.1007/s004010050790; Yanik M, 2004, EUR ARCH PSY CLIN N, V254, P43, DOI 10.1007/s00406-004-0453-x	90	37	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35414	10.1371/journal.pone.0035414	http://dx.doi.org/10.1371/journal.pone.0035414			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567102	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341500020
J	Hu, G; Xu, XH; Wang, YL; Lu, G; Feeley, KJ; Yu, MJ				Hu, Guang; Xu, Xuehong; Wang, Yuling; Lu, Gao; Feeley, Kenneth J.; Yu, Mingjian			Regeneration of Different Plant Functional Types in a Masson Pine Forest Following Pine Wilt Disease	PLOS ONE			English	Article							SHADE TOLERANCE; STAND STRUCTURE; WESTERN JAPAN; DISTURBANCE; TRAITS; VEGETATION; SEEDLINGS; NEMATODE; FIRE; ECOSYSTEMS	Pine wilt disease is a severe threat to the native pine forests in East Asia. Understanding the natural regeneration of the forests disturbed by pine wilt disease is thus critical for the conservation of biodiversity in this realm. We studied the dynamics of composition and structure within different plant functional types (PFTs) in Masson pine forests affected by pine wilt disease (PWD). Based on plant traits, all species were assigned to four PFTs: evergreen woody species (PFT1), deciduous woody species (PFT2), herbs (PFT3), and ferns (PFT4). We analyzed the changes in these PFTs during the initial disturbance period and during post-disturbance regeneration. The species richness, abundance and basal area, as well as life-stage structure of the PFTs changed differently after pine wilt disease. The direction of plant community regeneration depended on the differential response of the PFTs. PFT1, which has a higher tolerance to disturbances, became dominant during the post-disturbance regeneration, and a young evergreen-broad-leaved forest developed quickly after PWD. Results also indicated that the impacts of PWD were dampened by the feedbacks between PFTs and the microclimate, in which PFT4 played an important ecological role. In conclusion, we propose management at the functional type level instead of at the population level as a promising approach in ecological restoration and biodiversity conservation.	[Hu, Guang; Yu, Mingjian] Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Xuehong] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Wang, Yuling] State Forestry Adm, Gen Stn Forest Pest Management, Shenyang, Peoples R China; [Lu, Gao] Xiangshan Forest Pest Control & Quarantine Stn, Xianshan, Peoples R China; [Feeley, Kenneth J.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	Zhejiang University; Chinese Academy of Sciences; Institute of Botany, CAS; State University System of Florida; Florida International University	Hu, G (corresponding author), Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fishmj202@hotmail.com	Hu, Guang/AAF-1689-2020; Feeley, Kenneth James/A-7631-2009	Feeley, Kenneth James/0000-0002-3618-1144; Hu, Guang/0000-0002-4390-6166	National Key Basic Research Project of China [2000046803]; Science and Technology Project of Zhejiang Province [2007C22084]	National Key Basic Research Project of China(National Basic Research Program of China); Science and Technology Project of Zhejiang Province	The funders "National Key Basic Research Project of China (No. 2000046803)" and "Science and Technology Project of Zhejiang Province (2007C22084)" supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman DMJS, 2005, AUST J BOT, V53, P379, DOI 10.1071/BT05022; Chineses National Forestry Bureau, 2011, ANN CHIN NAT FOR BUR, P2011; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Department of Forestry of Zhejiang Province, 2002, NAT RES ZHEJ FOR; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Drever CR, 2006, FOREST ECOL MANAG, V231, P27, DOI 10.1016/j.foreco.2006.04.039; Drobyshev I, 2008, FOREST ECOL MANAG, V256, P1723, DOI 10.1016/j.foreco.2008.05.017; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Editorial Committee of Flora of Zhejiang, 1993, FLOR ZHEJ; ENDA N, 1997, FOREST PESTS, V46, P182; Eviner VT, 2004, ECOLOGY, V85, P2215, DOI 10.1890/03-0405; Ewers BE, 2008, PLANT ECOL, V194, P67, DOI 10.1007/s11258-007-9275-z; Fujihara M, 1996, J VEG SCI, V7, P729, DOI 10.2307/3236384; Fujihara M, 2002, FOREST ECOL MANAG, V170, P55, DOI 10.1016/S0378-1127(01)00779-4; Fujihara M., 1995, NAT HIST RES, V3, P161; Fujihara M, 1997, NATURAL HIST RES, V4, P113; Futai K, 2003, MASS DIEBACK PINE TR; GREENBERG CH, 1995, AM MIDL NAT, V133, P149, DOI 10.2307/2426356; Ke G, 1999, ACTA OECOL, V20, P579, DOI 10.1016/S1146-609X(99)00103-4; Khan A, 1991, PAKISTAN J NEMATOL, V9, P57; Kleyer M, 1999, J VEG SCI, V10, P697, DOI 10.2307/3237084; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; Korner K, 2008, ECOL MODEL, V210, P287, DOI 10.1016/j.ecolmodel.2007.08.002; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lindenmayer DB, 1997, CONSERV BIOL, V11, P1053, DOI 10.1046/j.1523-1739.1997.96150.x; Mamiya U, 1986, FOREST PEST, V35, P145; McIntyre S, 1999, J VEG SCI, V10, P604, DOI 10.1111/j.1654-1103.1999.tb00103.x; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Moghaddas EEY, 2007, FOREST ECOL MANAG, V250, P156, DOI 10.1016/j.foreco.2007.05.011; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nakagoshi N., 1987, ROLE FIRE ECOLOGICAL, P91; Navarro T, 2006, J ARID ENVIRON, V64, P298, DOI 10.1016/j.jaridenv.2005.05.005; NOBLE IR, 1980, VEGETATIO, V43, P5, DOI 10.1007/BF00121013; Noble IR, 1996, J VEG SCI, V7, P337; Olsen MF, 1989, ASPECTS ECOLOGY PHYS; Pausas JG, 1999, J VEG SCI, V10, P717, DOI 10.2307/3237086; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Rusch GM, 2003, J VEG SCI, V14, P307, DOI 10.1658/1100-9233(2003)014[0307:PFTIRT]2.0.CO;2; Sakamoto K., 1995, J JAP SOC REVEGET TE, V21, P18; Shi J, 2007, J INTEGR PLANT BIOL, V49, P1763, DOI 10.1111/j.1744-7909.2007.00613.x; Shibuya M, 2004, ECOL RES, V19, P301, DOI 10.1111/j.1440-1703.2004.00639.x; Shimizu Y, 2005, ECOL RES, V20, P708, DOI 10.1007/s11284-005-0087-0; TAODA H, 1988, Hikobia, V10, P119; Toyohara G, 1998, APPL VEG SCI, V1, P259, DOI 10.2307/1478956; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Walters MB, 1996, ECOLOGY, V77, P841, DOI 10.2307/2265505; Xue L, 2008, ECOL RES, V23, P689, DOI 10.1007/s11284-007-0427-3; Yu MJ, 2011, BIOL INVASIONS, V13, P1283, DOI 10.1007/s10530-010-9889-2; Zhang QF, 1999, CAN J FOREST RES, V29, P106, DOI 10.1139/cjfr-29-1-106	49	9	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36432	10.1371/journal.pone.0036432	http://dx.doi.org/10.1371/journal.pone.0036432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563499	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340700048
J	Nganou-Makamdop, K; van Gemert, GJ; Arens, T; Hermsen, CC; Sauerwein, RW				Nganou-Makamdop, Krystelle; van Gemert, Geert-Jan; Arens, Theo; Hermsen, Cornelus C.; Sauerwein, Robert W.			Long Term Protection after Immunization with P. berghei Sporozoites Correlates with Sustained IFN gamma Responses of Hepatic CD8+Memory T Cells	PLOS ONE			English	Article							ATTENUATED PLASMODIUM-BERGHEI; MALARIA LIVER STAGE; BLOOD-STAGE; PROTRACTED PROTECTION; VACCINE; IMMUNITY; PARASITE; MICE; INOCULATION	Protection against P. berghei malaria can successfully be induced in mice by immunization with both radiation attenuated sporozoites (RAS) arresting early during liver stage development, or sporozoites combined with chloroquine chemoprophylaxis (CPS), resulting in complete intra-hepatic parasite development before killing of blood-stages by chloroquine takes place. We assessed the longevity of protective cellular immune responses by RAS and CPS P. berghei immunization of C57BL/6j mice. Strong effector and memory (T-EM) CD8+ T cell responses were induced predominantly in the liver of both RAS and CPS immunized mice while CD4+ T cells with memory phenotype remained at base line levels. Compared to unprotected naive mice, we found high sporozoite-specific IFN gamma ex vivo responses that associated with induced levels of in vivo CD8+ TEM cells in the liver but not spleen. Long term evaluation over a period of 9 months showed a decline of malaria-specific IFN gamma responses in RAS and CPS mice that significantly correlated with loss of protection (r(2) = 0.60, p<0.0001). The reducing IFN gamma response by hepatic memory CD8+ T cells could be boosted by re-exposure to wildtype sporozoites. Our data show that sustainable protection against malaria associates with distinct intra-hepatic immune responses characterized by strong IFN gamma producing CD8+ memory T cells.	[Nganou-Makamdop, Krystelle; van Gemert, Geert-Jan; Arens, Theo; Hermsen, Cornelus C.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Nganou-Makamdop, K (corresponding author), Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	r.sauerwein@mmb.umcn.nl	Hermsen, C.C./L-4368-2015; Sauerwein, Robert/C-8519-2013		NWO-Mozaiek (The Netherlands Organisation for Scientific Research) [017.005.011]	NWO-Mozaiek (The Netherlands Organisation for Scientific Research)	Financial support for this study was provided by NWO-Mozaiek (The Netherlands Organisation for Scientific Research) grant No. 017.005.011 (K. Nganou-Makamdop recipient). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annoura T, 2012, VACCINE, V30, P2662, DOI 10.1016/j.vaccine.2012.02.010; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Belnoue E, 2008, J IMMUNOL, V181, P8552, DOI 10.4049/jimmunol.181.12.8552; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Bousema JT, 2006, AM J TROP MED HYG, V74, P425; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Friesen J, 2011, VACCINE, V29, P7002, DOI 10.1016/j.vaccine.2011.07.034; Guebre-Xabier M, 1999, EUR J IMMUNOL, V29, P3978, DOI 10.1002/(SICI)1521-4141(199912)29:12&lt;3978::AID-IMMU3978&gt;3.0.CO;2-0; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Jobe O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005075; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; McCarthy JS, 2010, HUM VACCINES, V6, P114, DOI 10.4161/hv.6.1.10394; ORJIH AU, 1985, CLIN EXP IMMUNOL, V61, P67; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SCHELLER LF, 1995, J PARASITOL, V81, P58, DOI 10.2307/3284006; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; Sedegah M, 2007, PARASITE IMMUNOL, V29, P559, DOI 10.1111/j.1365-3024.2007.00976.x; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Tuteja R, 2007, FEBS J, V274, P4670, DOI 10.1111/j.1742-4658.2007.05997.x; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515	25	54	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36508	10.1371/journal.pone.0036508	http://dx.doi.org/10.1371/journal.pone.0036508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563506	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340700055
J	Bee, C; Abdiche, YN; Stone, DM; Collier, S; Lindquist, KC; Pinkerton, AC; Pons, J; Rajpal, A				Bee, Christine; Abdiche, Yasmina N.; Stone, Donna M.; Collier, Sierra; Lindquist, Kevin C.; Pinkerton, Alanna C.; Pons, Jaume; Rajpal, Arvind			Exploring the Dynamic Range of the Kinetic Exclusion Assay in Characterizing Antigen-Antibody Interactions	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; BINDING-PROPERTIES; CHELATE COMPLEXES; AFFINITY; ASSOCIATION; TECHNOLOGY; BIACORE; PROTEIN; FAMILY	Therapeutic antibodies are often engineered or selected to have high on-target binding affinities that can be challenging to determine precisely by most biophysical methods. Here, we explore the dynamic range of the kinetic exclusion assay (KinExA) by exploiting the interactions of an anti-DKK antibody with a panel of DKK antigens as a model system. By tailoring the KinExA to each studied antigen, we obtained apparent equilibrium dissociation constants (K-D values) spanning six orders of magnitude, from approximately 100 fM to 100 nM. Using a previously calibrated antibody concentration and working in a suitable concentration range, we show that a single experiment can yield accurate and precise values for both the apparent K-D and the apparent active concentration of the antigen, thereby increasing the information content of an assay and decreasing sample consumption. Orthogonal measurements obtained on Biacore and Octet label-free biosensor platforms further validated our KinExA-derived affinity and active concentration determinations. We obtained excellent agreement in the apparent affinities obtained across platforms and within the KinExA method irrespective of the assay orientation employed or the purity of the recombinant or native antigens.	[Bee, Christine; Abdiche, Yasmina N.; Stone, Donna M.; Collier, Sierra; Lindquist, Kevin C.; Pinkerton, Alanna C.; Pons, Jaume; Rajpal, Arvind] Pfizer Inc, Rinat, San Francisco, CA 94080 USA	Pfizer	Bee, C (corresponding author), Pfizer Inc, Rinat, San Francisco, CA 94080 USA.	Yasmina.Abdiche@pfizer.com		Lindquist, Kevin/0000-0001-6059-7425				Blake DA, 1996, J BIOL CHEM, V271, P27677, DOI 10.1074/jbc.271.44.27677; Blake RC, 1999, ANAL BIOCHEM, V272, P123, DOI 10.1006/abio.1999.4176; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; Fleury D, 2008, PROTEIN EXPRES PURIF, V60, P74, DOI 10.1016/j.pep.2008.03.023; Glass TR, 2004, ANAL CHIM ACTA, V517, P161, DOI 10.1016/j.aca.2004.04.038; Katsamba PS, 2006, ANAL BIOCHEM, V352, P208, DOI 10.1016/j.ab.2006.01.034; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Khosraviani M, 2000, BIOCONJUGATE CHEM, V11, P267, DOI 10.1021/bc9901548; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nakamura REI, 2010, GROWTH FACTORS, V28, P232, DOI 10.3109/08977191003738832; Navratilova I, 2005, ANAL BIOCHEM, V344, P295, DOI 10.1016/j.ab.2005.05.025; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Owyang AM, 2011, MABS-AUSTIN, V3, P49, DOI 10.4161/mabs.3.1.13989; Rathanaswami P, 2005, BIOCHEM BIOPH RES CO, V334, P1004, DOI 10.1016/j.bbrc.2005.07.002; Rathanaswami P, 2011, ANAL BIOCHEM, V414, P7, DOI 10.1016/j.ab.2011.02.034; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Sigmundsson K, 2002, BIOCHEMISTRY-US, V41, P8263, DOI 10.1021/bi020099h; Xie L, 2005, J IMMUNOL METHODS, V304, P1, DOI 10.1016/j.jim.2005.04.009	22	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36261	10.1371/journal.pone.0036261	http://dx.doi.org/10.1371/journal.pone.0036261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558410	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340200057
J	Namdar, M; Gebhard, C; Studiger, R; Shi, Y; Mocharla, P; Schmied, C; Brugada, P; Luscher, TF; Camici, GG				Namdar, Mehdi; Gebhard, Catherine; Studiger, Rafael; Shi, Yi; Mocharla, Pavani; Schmied, Christian; Brugada, Pedro; Luescher, Thomas F.; Camici, Giovanni G.			Globotriaosylsphingosine Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease	PLOS ONE			English	Article							DEPENDENT CONTRACTIONS; ENZYME REPLACEMENT; ADHESION MOLECULE-1; OXIDATIVE STRESS; KNOCKOUT MOUSE; MICE; ATHEROSCLEROSIS; EXPRESSION; GLOBOTRIAOSYLCERAMIDE; HYPERTENSION	Background: Fabry disease (FD) is caused by a deficiency of the lysosomal enzyme alpha-galactosidase A (GLA) resulting in the accumulation of globotriaosylsphingosine (Gb3) in a variety of tissues. While GLA deficiency was always considered as the fulcrum of the disease, recent attention shifted towards studying the mechanisms through which Gb3 accumulation in vascular cells leads to endothelial dysfunction and eventually multiorgan failure. In addition to the well-described macrovascular disease, FD is also characterized by abnormalities of microvascular function, which have been demonstrated by measurements of myocardial blood flow and coronary flow reserve. To date, the relative importance of Gb3 accumulation versus GLA deficiency in causing endothelial dysfunction is not fully understood; furthermore, its differential effects on cardiac micro-and macrovascular endothelial cells are not known. Methods and Results: In order to assess the effects of Gb3 accumulation versus GLA deficiency, human macro-and microvascular cardiac endothelial cells (ECs) were incubated with Gb3 or silenced by siRNA to GLA. Gb3 loading caused deregulation of several key endothelial pathways such as eNOS, iNOS, COX-1 and COX-2, while GLA silencing showed no effects. Cardiac microvascular ECs showed a greater susceptibility to Gb3 loading as compared to macrovascular ECs. Conclusions: Deregulation of key endothelial pathways as observed in FD vasculopathy is likely caused by intracellular Gb3 accumulation rather than deficiency of GLA. Human microvascular ECs, as opposed to macrovascular ECs, seem to be affected earlier and more severely by Gb3 accumulation and this notion may prove fundamental for future progresses in early diagnosis and management of FD patients.	[Namdar, Mehdi; Brugada, Pedro] Heart Rhythm Management Ctr UZB, Brussels, Belgium; [Namdar, Mehdi; Gebhard, Catherine; Schmied, Christian; Luescher, Thomas F.] Univ Zurich Hosp, Clin Cardiol, CH-8091 Zurich, Switzerland; [Gebhard, Catherine; Studiger, Rafael; Shi, Yi; Mocharla, Pavani; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Studiger, Rafael; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Namdar, M (corresponding author), Heart Rhythm Management Ctr UZB, Brussels, Belgium.	giovannic@access.uzh.ch	Shi, Yi/GXG-2318-2022; Gebhard, Catherine/AAT-7060-2020; Camici, Giovanni/H-1631-2018	Gebhard, Catherine/0000-0001-7240-5822; Camici, Giovanni/0000-0002-0523-0695; Shi, Yi/0000-0003-3005-9655; Namdar, Mehdi/0000-0002-5779-7431	Genzyme; Swiss National Science Foundation [310030_130500]	Genzyme(Sanofi-AventisGenzyme Corporation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by a research grant from Genzyme and by the Swiss National Science Foundation (grant no. 310030_130500 to GGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Altarescu G, 2001, STROKE, V32, P1559, DOI 10.1161/01.STR.32.7.1559; Andersohn F, 2006, CIRCULATION, V113, P1950, DOI 10.1161/CIRCULATIONAHA.105.602425; Askari H, 2007, VIRCHOWS ARCH, V451, P823, DOI 10.1007/s00428-007-0468-6; Barbey F, 2006, ARTERIOSCL THROM VAS, V26, P839, DOI 10.1161/01.ATV.0000209649.60409.38; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; Bulut D, 2003, J HYPERTENS, V21, P1663, DOI 10.1097/00004872-200309000-00015; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Crutchfield KE, 1998, NEUROLOGY, V50, P1746, DOI 10.1212/WNL.50.6.1746; DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.3.CO;2-K; Demuth K, 2002, ACTA PAEDIATR, V91, P57, DOI 10.1080/080352502762457941; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Eitzman DT, 2003, J AM SOC NEPHROL, V14, P298, DOI 10.1097/01.ASN.0000043901.45141.D4; Elliott PM, 2006, HEART, V92, P357, DOI 10.1136/hrt.2004.054015; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Gebhard C, 2010, BASIC RES CARDIOL, V105, P349, DOI 10.1007/s00395-009-0060-0; GREWAL RP, 1994, J NEUROL, V241, P153; Hartford M, 2007, J INTERN MED, V262, P526, DOI 10.1111/j.1365-2796.2007.01862.x; Kalliokoski RJ, 2005, J INHERIT METAB DIS, V28, P563, DOI 10.1007/s10545-005-0563-2; Kanda A, 2000, VIRCHOWS ARCH, V436, P36, DOI 10.1007/PL00008196; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Merat S, 2000, J GERONTOL A-BIOL, V55, pB85; Mitsias P, 1996, ANN NEUROL, V40, P8, DOI 10.1002/ana.410400105; Moore DF, 2001, CIRCULATION, V104, P1506, DOI 10.1161/hc3801.096352; Park JL, 2008, CLIN EXP PHARMACOL P, V35, P1156, DOI 10.1111/j.1440-1681.2008.04984.x; Park JL, 2009, AM J PHYSIOL-HEART C, V296, pH1133, DOI 10.1152/ajpheart.00929.2008; Ries M, 2007, J CLIN PHARMACOL, V47, P1222, DOI 10.1177/0091270007305299; Rombach SM, 2010, MOL GENET METAB, V99, P99, DOI 10.1016/j.ymgme.2009.10.004; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Shu LM, 2009, J AM SOC NEPHROL, V20, P1975, DOI 10.1681/ASN.2008111190; Szerafin T, 2006, CIRC RES, V99, pE12, DOI 10.1161/01.RES.0000241051.83067.62; Tang EHC, 2007, BRIT J PHARMACOL, V151, P15, DOI 10.1038/sj.bjp.0707190; Tang EHC, 2005, J CARDIOVASC PHARM, V46, P761, DOI 10.1097/01.fjc.0000187174.67661.67; Thomaidis T, 2009, KIDNEY INT, V75, P399, DOI 10.1038/ki.2008.576; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321; Yang D, 2002, BRIT J PHARMACOL, V136, P104, DOI 10.1038/sj.bjp.0704669; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5	38	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36373	10.1371/journal.pone.0036373	http://dx.doi.org/10.1371/journal.pone.0036373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558451	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000305340200072
J	Janel-Bintz, R; Wagner, J; Haracska, L; Mah-Becherel, MCM; Bichara, M; Fuchs, RP; Cordonnier, AM				Janel-Bintz, Regine; Wagner, Jerome; Haracska, Lajos; Mah-Becherel, Marcia Chia Miao; Bichara, Marc; Fuchs, Robert P.; Cordonnier, Agnes M.			Evidence for a Rad18-Independent Frameshift Mutagenesis Pathway in Human Cell-Free Extracts	PLOS ONE			English	Article							DNA-POLYMERASE-ETA; FREE REPLICATIVE BYPASS; TRANSLESION SYNTHESIS; POL-ETA; LESION BYPASS; SACCHAROMYCES-CEREVISIAE; PCNA MONOUBIQUITINATION; DAMAGE TOLERANCE; NUCLEAR ANTIGEN; YEAST	Bypass of replication blocks by specialized DNA polymerases is crucial for cell survival but may promote mutagenesis and genome instability. To gain insight into mutagenic sub-pathways that coexist in mammalian cells, we examined N-2-acetylaminofluorene (AAF)-induced frameshift mutagenesis by means of SV40-based shuttle vectors containing a single adduct. We found that in mammalian cells, as previously observed in E. coli, modification of the third guanine of two target sequences, 5'-GGG-3' (3G) and 5'-GGCGCC-3' (NarI site), induces -1 and -2 frameshift mutations, respectively. Using an in vitro assay for translesion synthesis, we investigated the biochemical control of these events. We showed that Pol eta, but neither Pol iota nor Pol zeta, plays a major role in the frameshift bypass of the AAF adduct located in the 3G sequence. By complementing PCNA-depleted extracts with either a wild-type or a non-ubiquitinatable form of PCNA, we found that this Pol eta-mediated pathway requires Rad18 and ubiquitination of PCNA. In contrast, when the AAF adduct is located within the NarI site, TLS is only partially dependent upon Pol eta and Rad18, unravelling the existence of alternative pathways that concurrently bypass this lesion.	[Janel-Bintz, Regine; Wagner, Jerome; Mah-Becherel, Marcia Chia Miao; Bichara, Marc; Cordonnier, Agnes M.] Univ Strasbourg, Biotechnol & Signalisat Cellulaire UMR7242, Ecole Super Biotechnol Strasbourg, Illkirch Graffenstaden, France; [Haracska, Lajos] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; [Fuchs, Robert P.] UPR3081 Genome Instabil & Carcinogenesis, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Hungarian Academy of Sciences; Hungarian Biological Research Center; UDICE-French Research Universities; Aix-Marseille Universite	Janel-Bintz, R (corresponding author), Univ Strasbourg, Biotechnol & Signalisat Cellulaire UMR7242, Ecole Super Biotechnol Strasbourg, Illkirch Graffenstaden, France.	agnes.cordonnier@unistra.fr	Wagner, Jerome/C-3746-2009; Cordonnier, Agnes M/I-5083-2016	Wagner, Jerome/0000-0002-7478-1925; Cordonnier, Agnes M/0000-0002-4216-3524	l'Institut National du Cancer [PLBIO]; la Ligue Regionale contre le Cancer; EU IPA Cross-border Cooperation Programme [HUSRB/1002/214/126]	l'Institut National du Cancer [PLBIO]; la Ligue Regionale contre le Cancer; EU IPA Cross-border Cooperation Programme	This work was supported by l'Institut National du Cancer [PLBIO2010], la Ligue Regionale contre le Cancer and by the grant EU IPA Cross-border Cooperation Programme (HUSRB/1002/214/126) (LH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baynton K, 1998, MOL CELL BIOL, V18, P960, DOI 10.1128/MCB.18.2.960; Baynton K, 1999, MOL MICROBIOL, V34, P124, DOI 10.1046/j.1365-2958.1999.01583.x; BELGUISEVALLADIER P, 1995, J MOL BIOL, V249, P903, DOI 10.1006/jmbi.1995.0347; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Bresson A, 2002, EMBO J, V21, P3881, DOI 10.1093/emboj/cdf363; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Cordonnier AM, 1999, MOL CELL BIOL, V19, P2206; FUCHS RPP, 1981, NATURE, V294, P657, DOI 10.1038/294657a0; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gohler T, 2011, J CELL BIOL, V192, P219, DOI 10.1083/jcb.201008076; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; HUSCHTSCHA LI, 1983, J CELL SCI, V63, P77; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Krijger PHL, 2011, DNA REPAIR, V10, P1051, DOI 10.1016/j.dnarep.2011.08.005; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Napolitano RL, 1997, CHEM RES TOXICOL, V10, P667, DOI 10.1021/tx970018w; Nikolaishvili-Feinberg N, 2008, BIOCHEMISTRY-US, V47, P4141, DOI 10.1021/bi702329h; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Sabbioneda S, 2008, MOL BIOL CELL, V19, P5193, DOI 10.1091/mbc.E08-07-0724; Schmutz V, 2007, DNA REPAIR, V6, P1726, DOI 10.1016/j.dnarep.2007.06.003; Schmutz V, 2010, NUCLEIC ACIDS RES, V38, P6456, DOI 10.1093/nar/gkq403; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; STARY A, 1992, J GEN VIROL, V73, P1679, DOI 10.1099/0022-1317-73-7-1679; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; THOMAS DC, 1995, J BIOL CHEM, V270, P21226, DOI 10.1074/jbc.270.36.21226; VEAUTE X, 1993, SCIENCE, V261, P598, DOI 10.1126/science.8342022; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Yuan FH, 2000, J BIOL CHEM, V275, P8233, DOI 10.1074/jbc.275.11.8233; Zheleva DI, 2000, BIOCHEMISTRY-US, V39, P7388, DOI 10.1021/bi992498r	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36004	10.1371/journal.pone.0036004	http://dx.doi.org/10.1371/journal.pone.0036004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558303	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000098
J	Zhang, WH; Kramer, EM; Davis, CC				Zhang, Wenheng; Kramer, Elena M.; Davis, Charles C.			Similar Genetic Mechanisms Underlie the Parallel Evolution of Floral Phenotypes	PLOS ONE			English	Article							CYCLOIDEA-LIKE GENES; CYC-LIKE GENES; SYMMETRY GENES; MOLECULAR EVOLUTION; EXPRESSION PATTERNS; FLOWER SYMMETRY; TCP DOMAIN; ZYGOMORPHY; PHYLOGENY; DIVERSIFICATION	The repeated origin of similar phenotypes is invaluable for studying the underlying genetics of adaptive traits; molecular evidence, however, is lacking for most examples of such similarity. The floral morphology of neotropical Malpighiaceae is distinctive and highly conserved, especially with regard to symmetry, and is thought to result from specialization on oil-bee pollinators. We recently demonstrated that CYCLOIDEA2-like genes (CYC2A and CYC2B) are associated with the development of the stereotypical floral zygomorphy that is critical to this plant-pollinator mutualism. Here, we build on this developmental framework to characterize floral symmetry in three clades of Malpighiaceae that have independently lost their oil bee association and experienced parallel shifts in their floral morphology, especially in regard to symmetry. We show that in each case these species exhibit a loss of CYC2B function, and a strikingly similar shift in the expression of CYC2A that is coincident with their shift in floral symmetry. These results indicate that similar floral phenotypes in this large angiosperm clade have evolved via parallel genetic changes from an otherwise highly conserved developmental program.	[Zhang, Wenheng; Kramer, Elena M.; Davis, Charles C.] Harvard Univ Herbaria, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Zhang, WH (corresponding author), Harvard Univ Herbaria, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cdavis@oeb.harvard.edu	Zhang, Wenheng/B-1715-2013		National Science Foundation [DEB-0544039]; AToL [EF 04-31242]	National Science Foundation(National Science Foundation (NSF)); AToL	This work was funded by National Science Foundation Grants DEB-0544039 and AToL EF 04-31242 (to C.C.D.) www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ANDERSON W R, 1990, Memoirs of the New York Botanical Garden, V64, P210; ANDERSON WR, 1979, BIOTROPICA, V11, P219, DOI 10.2307/2388042; Anderson WR, 2002, DIOECY MALPIGHIACEAE; Araujo VA, 2006, NEOTROP ENTOMOL, V35, P30, DOI 10.1590/S1519-566X2006000100005; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; Busch A, 2007, P NATL ACAD SCI USA, V104, P16714, DOI 10.1073/pnas.0705338104; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; Citerne H, 2010, ADV BOT RES, V54, P85, DOI 10.1016/S0065-2296(10)54003-5; Citerne HL, 2006, P NATL ACAD SCI USA, V103, P12017, DOI 10.1073/pnas.0600986103; Citerne HL, 2003, PLANT PHYSIOL, V131, P1042, DOI 10.1104/pp.102.016311; Citerne HL, 2000, ANN BOT-LONDON, V86, P167, DOI 10.1006/anbo.2000.1178; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Cubas P, 2001, CURR BIOL, V11, P1050, DOI 10.1016/S0960-9822(01)00295-0; Davis CC, 2004, INT J PLANT SCI, V165, pS107, DOI 10.1086/383337; Davis CC, 2002, P NATL ACAD SCI USA, V99, P6833, DOI 10.1073/pnas.102175899; Davis CC, 2002, AM J BOT, V89, P699, DOI 10.3732/ajb.89.4.699; Davis CC, 2010, AM J BOT, V97, P2031, DOI 10.3732/ajb.1000146; Donoghue MJ, 1998, TRENDS PLANT SCI, V3, P311, DOI 10.1016/S1360-1385(98)01278-3; Du ZY, 2008, J SYST EVOL, V46, P23, DOI 10.3724/SP.J.1002.2008.07059; Eichler A, 1878, MALPIGHIACEEN BLUT 2; Endress PK, 2001, CURR OPIN PLANT BIOL, V4, P86, DOI 10.1016/S1369-5266(00)00140-0; Feng XZ, 2006, P NATL ACAD SCI USA, V103, P4970, DOI 10.1073/pnas.0600681103; Fukuda T, 2003, J MOL EVOL, V57, P588, DOI 10.1007/s00239-003-2498-2; Gao Q, 2008, DEV GENES EVOL, V218, P341, DOI 10.1007/s00427-008-0227-y; Gubitz T, 2003, MOL BIOL EVOL, V20, P1537, DOI 10.1093/molbev/msg166; Hileman LC, 2003, P NATL ACAD SCI USA, V100, P12814, DOI 10.1073/pnas.1835725100; Hileman LC, 2003, MOL BIOL EVOL, V20, P591, DOI 10.1093/molbev/msg063; Howarth DG, 2005, INT J PLANT SCI, V166, P357, DOI 10.1086/428634; Howarth DG, 2006, P NATL ACAD SCI USA, V103, P9101, DOI 10.1073/pnas.0602827103; Howarth DG, 2011, ANN BOT-LONDON, V107, P1521, DOI 10.1093/aob/mcr049; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; Maddison, 2019, MESQUITE MODULAR SYS; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Michener C.D., 2000, BEES WORLD, V1st; Neal PR, 1998, ANNU REV ECOL SYST, V29, P345, DOI 10.1146/annurev.ecolsys.29.1.345; Oakley RV, 2007, PLANT PHYSIOL, V145, P961, DOI 10.1104/pp.107.107086; Pang HB, 2010, J SYST EVOL, V48, P309, DOI 10.1111/j.1759-6831.2010.00091.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Preston JC, 2011, P NATL ACAD SCI USA, V108, P2343, DOI 10.1073/pnas.1011361108; Preston JC, 2009, NEW PHYTOL, V182, P751, DOI 10.1111/j.1469-8137.2009.02794.x; Preston JC, 2009, TRENDS PLANT SCI, V14, P147, DOI 10.1016/j.tplants.2008.12.005; Ree RH, 2004, MOL BIOL EVOL, V21, P321, DOI 10.1093/molbev/msh022; Reeves PA, 2003, MOL BIOL EVOL, V20, P1997, DOI 10.1093/molbev/msg211; Sargent RD, 2004, P ROY SOC B-BIOL SCI, V271, P603, DOI 10.1098/rspb.2003.2644; Sigrist MR, 2004, ANN BOT-LONDON, V94, P33, DOI 10.1093/aob/mch108; Smith JF, 2004, MOL PHYLOGENET EVOL, V31, P765, DOI 10.1016/j.ympev.2003.09.012; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Song CF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-244; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stebbins GL, 1974, FLOWERING PLANT EVOL; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; VOGEL S, 1990, Memoirs of the New York Botanical Garden, V55, P130; Vogel S., 1974, TROPISCHE SUBTROPISC, V7, P283, DOI DOI 10.1002/FEDR.19770880110; Wang Z, 2008, P NATL ACAD SCI USA, V105, P10414, DOI 10.1073/pnas.0803291105; Westerkamp C, 2007, ANN BOT-LONDON, V100, P361, DOI 10.1093/aob/mcm123; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1; Zhang WH, 2010, P NATL ACAD SCI USA, V107, P6388, DOI 10.1073/pnas.0910155107; Zhou XR, 2008, NEW PHYTOL, V178, P532, DOI 10.1111/j.1469-8137.2008.02384.x	62	22	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36033	10.1371/journal.pone.0036033	http://dx.doi.org/10.1371/journal.pone.0036033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558314	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336000105
J	Barbieri, M; Di Filippo, C; Esposito, A; Marfella, R; Rizzo, MR; D'Amico, M; Ferraraccio, F; Di Ronza, C; Duan, SZ; Mortensen, RM; Rossi, F; Paolisso, G				Barbieri, Michelangela; Di Filippo, Clara; Esposito, Antonietta; Marfella, Raffaele; Rizzo, Maria Rosaria; D'Amico, Michele; Ferraraccio, Franca; Di Ronza, Cristina; Duan, Sheng Zhong; Mortensen, Richard M.; Rossi, Francesco; Paolisso, Giuseppe			Effects of PPARs Agonists on Cardiac Metabolism in Littermate and Cardiomyocyte-Specific PPAR-gamma - Knockout (CM-PGKO) Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; RENIN-ANGIOTENSIN SYSTEM; MYOCARDIAL-INFARCTION; QUANTITATIVE-ANALYSIS; LIPID-ACCUMULATION; HEART; HYPERTROPHY; EXPRESSION; ROSIGLITAZONE; PIOGLITAZONE	Understanding the molecular regulatory mechanisms controlling for myocardial lipid metabolism is of critical importance for the development of new therapeutic strategies for heart diseases. The role of PPAR gamma and thiazolidinediones in regulation of myocardial lipid metabolism is controversial. The aim of our study was to assess the role of PPAR gamma on myocardial lipid metabolism and function and differentiate local/from systemic actions of PPARs agonists using cardiomyocyte-specific PPAR gamma -knockout (CM-PGKO) mice. To this aim, the effect of PPAR gamma, PPAR gamma/PPAR alpha and PPAR alpha agonists on cardiac function, intra-myocyte lipid accumulation and myocardial expression profile of genes and proteins, affecting lipid oxidation, uptake, synthesis, and storage (CD36, CPT1MIIA, AOX, FAS, SREBP1-c and ADPR) was evaluated in cardiomyocyte-specific PPAR gamma -knockout (CM-PGKO) and littermate control mice undergoing standard and high fat diet (HFD). At baseline, protein levels and mRNA expression of genes involved in lipid uptake, oxidation, synthesis, and accumulation of CM-PGKO mice were not significantly different from those of their littermate controls. At baseline, no difference in myocardial lipid content was found between CM-PGKO and littermate controls. In standard condition, pioglitazone and rosiglitazone do not affect myocardial metabolism while, fenofibrate treatment significantly increased CD36 and CPT1MIIA gene expression. In both CM-PGKO and control mice submitted to HFD, six weeks of treatment with rosiglitazone, fenofibrate and pioglitazone lowered myocardial lipid accumulation shifting myocardial substrate utilization towards greater contribution of glucose. In conclusion, at baseline, PPAR gamma does not play a crucial role in regulating cardiac metabolism in mice, probably due to its low myocardial expression. PPARs agonists, indirectly protect myocardium from lipotoxic damage likely reducing fatty acids delivery to the heart through the actions on adipose tissue. Nevertheless a direct non- PPAR gamma mediated mechanism of PPAR gamma agonist could not be ruled out.	[Barbieri, Michelangela; Esposito, Antonietta; Marfella, Raffaele; Rizzo, Maria Rosaria; Paolisso, Giuseppe] Univ Naples 2, Dept Geriatr Med & Metab Dis, Naples, Italy; [Di Filippo, Clara; D'Amico, Michele; Di Ronza, Cristina; Rossi, Francesco] Univ Naples 2, Sect Pharmacol L Donatelli, Dept Expt Med, Naples, Italy; [Ferraraccio, Franca] Univ Naples 2, Dept Prevent Med, Naples, Italy; [Duan, Sheng Zhong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Metab Endocrinol & Diabet Div, Ann Arbor, MI USA; [Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Pharmacol, Metab Endocrinol & Diabet Div, Ann Arbor, MI 48109 USA; [Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Internal Med, Metab Endocrinol & Diabet Div, Ann Arbor, MI USA	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Barbieri, M (corresponding author), Univ Naples 2, Dept Geriatr Med & Metab Dis, Naples, Italy.	giuseppe.paolisso@unina2.it	Rizzo, Maria Rosaria/AHH-3649-2022; paolisso, giuseppe/AAP-8516-2020; Barbieri, Michelangela/K-2192-2016; Marfella, Raffaele/AAH-2595-2019; Rizzo, Maria/HGD-6576-2022; rizzo, maria rosaria R/J-1968-2016	Rizzo, Maria Rosaria/0000-0002-1023-4260; paolisso, giuseppe/0000-0002-2137-455X; Barbieri, Michelangela/0000-0002-9223-5792; Marfella, Raffaele/0000-0003-3960-9270; rizzo, maria rosaria R/0000-0002-1023-4260; d'amico, michele/0000-0002-6899-0595; duan, sheng zhong/0000-0001-5399-7252	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK020572] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Baranowski M, 2008, ARCH BIOCHEM BIOPHYS, V477, P86, DOI 10.1016/j.abb.2008.05.015; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Birnbaum Y, 2011, BASIC RES CARDIOL, V106, P431, DOI 10.1007/s00395-011-0162-3; Borradaile NA, 2005, CURR HYPERTENS REP, V7, P412, DOI 10.1007/s11906-005-0035-y; Chaggar PS, 2009, DIABETES VASC DIS RE, V6, P146, DOI 10.1177/1479164109338772; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Ding GL, 2007, CARDIOVASC RES, V76, P269, DOI 10.1016/j.cardiores.2007.06.027; Ding GL, 2007, J MOL CELL CARDIOL, V43, P73, DOI 10.1016/j.yjmcc.2007.04.014; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Erdmann E, 2010, J DIABETES, V2, P212, DOI 10.1111/j.1753-0407.2010.00082.x; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; Fang XP, 2010, AM J PHYSIOL-ENDOC M, V299, pE721, DOI 10.1152/ajpendo.00086.2010; Frantz S, 2004, BRIT J PHARMACOL, V141, P9, DOI 10.1038/sj.bjp.0705585; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Gurnell M, 2003, CLIN ENDOCRINOL, V59, P267, DOI 10.1046/j.1365-2265.2003.01767.x; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Luo JW, 2011, AM J TRANSL RES, V3, P61; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Marfella R, 2009, J LIPID RES, V50, P2314, DOI 10.1194/jlr.P900032-JLR200; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Mehrabi MR, 2003, EUR J HEART FAIL, V5, P733, DOI 10.1016/S1388-9842(03)00148-X; Mughal RS, 2009, CLIN EXP PHARMACOL P, V36, P478, DOI 10.1111/j.1440-1681.2008.05088.x; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Patel D, 2011, JACC-CARDIOVASC INTE, V4, P353, DOI 10.1016/j.jcin.2010.10.016; Ren LQ, 2010, CELL BIOCHEM FUNCT, V28, P58, DOI 10.1002/cbf.1621; Ren YS, 2009, VASC PHARMACOL, V51, P169, DOI 10.1016/j.vph.2009.06.004; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vikramadithyan RK, 2005, J PHARMACOL EXP THER, V313, P586, DOI 10.1124/jpet.104.080259; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Yamamoto K, 2001, CIRCULATION, V104, P1670, DOI 10.1161/hc4001.097186; Yue TL, 2001, CIRCULATION, V104, P2588, DOI 10.1161/hc4601.099403; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zhu PL, 2000, CIRCULATION, V101, P1165, DOI 10.1161/01.CIR.101.10.1165	40	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35999	10.1371/journal.pone.0035999	http://dx.doi.org/10.1371/journal.pone.0035999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563432	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349100058
J	Dong, YW; Wang, HS; Han, GD; Ke, CH; Zhan, X; Nakano, T; Williams, GA				Dong, Yun-wei; Wang, Hai-shan; Han, Guo-Dong; Ke, Cai-huan; Zhan, Xin; Nakano, Tomoyuki; Williams, Gray A.			The Impact of Yangtze River Discharge, Ocean Currents and Historical Events on the Biogeographic Pattern of Cellana toreuma along the China Coast	PLOS ONE			English	Article							ROCKY INTERTIDAL INVERTEBRATES; POPULATION GENETIC-STRUCTURE; LATITUDINAL GRADIENT; MARINE GASTROPODS; LARVAL DISPERSAL; NEW-ZEALAND; DNA; PHYLOGEOGRAPHY; LIMPETS; PACIFIC	Aim: Genetic data were used to measure the phylogeographic distribution of the limpet, Cellana toreuma along the China coast in order to acsertain impacts of historic events, ocean currents and especially freshwater discharge from the Yangtze River on the connectivity of intertidal species with limited larval dispersal capability. Methodology/Principal Findings: Genetic variation in 15 populations of C. toreuma (n = 418), ranging from the Yellow Sea (YS), East China Sea (ECS) and South China Sea (SCS), were determined from partial mitochondrial cytochrome c oxidase subunit I gene. Genetic diversity and divergence based on haplotype frequencies were analyzed using CONTRIB, and AMOVA was used to examine genetic population structure. Historic demographic expansions were evaluated from both neutrality tests and mismatch distribution tests. Among the 30 haplotypes identified, a dominant haplotype No. 1 (H1) existed in all the populations, and a relatively abundant private haplotype (H2) in YS. Pairwise F-ST values between YS and the other two groups were relatively high and the percentage of variation among groups was 10.9%. Conclusions: The high nucleotide and gene diversity in the YS, with large pairwise genetic distances and relatively high percentages of variation among groups, suggests that this group was relatively isolated from ECS and SCS. This is likely driven by historic events, ocean currents, and demographic expansion. We propose that freshwater discharge from the Yangtze River, which may act as physical barrier limiting the southward dispersal of larvae from northern populations, is especially important in determining the separation of the YS group from the rest of the Chinese populations of C. toreuma.	[Dong, Yun-wei; Wang, Hai-shan; Han, Guo-Dong; Ke, Cai-huan; Zhan, Xin] Xiamen Univ, State Key Lab Marine Environm Sci, Coll Oceanog & Earth Sci, Xiamen, Peoples R China; [Dong, Yun-wei] Xiamen Univ, Marine Biodivers & Global Change Lab, Xiamen, Peoples R China; [Nakano, Tomoyuki] Kyoto Univ, Field Sci Educ & Res Ctr, Seto Marine Biol Lab, Wakayama, Japan; [Williams, Gray A.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Williams, Gray A.] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China	Xiamen University; Xiamen University; Kyoto University; University of Hong Kong; University of Hong Kong	Dong, YW (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Coll Oceanog & Earth Sci, Xiamen, Peoples R China.	dongyw@xmu.edu.cn	Ke, CH/G-4635-2010; Dong, Yunwei/C-4617-2011; HUANG, Shuiying/C-3117-2014; zhan, xin/G-2472-2011	Dong, Yunwei/0000-0003-4550-2322; zhan, xin/0000-0001-5873-3141	Natural Science Foundation for National Natural Science Foundation of China [41076083]; Distinguished Young Scholars of Fujian Province, China [2011J06017]; Fundamental Research Funds for the Central Universities [201012028]	Natural Science Foundation for National Natural Science Foundation of China; Distinguished Young Scholars of Fujian Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Natural Science Foundation for National Natural Science Foundation of China (41076083), Distinguished Young Scholars of Fujian Province, China (2011J06017) and the Fundamental Research Funds for the Central Universities (201012028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; BEARDSLEY RC, 1985, CONT SHELF RES, V4, P57, DOI 10.1016/0278-4343(85)90022-6; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; BOUCHET P, 2006, EXPLORATION MARINE B, P32; Branch G.M., 1981, Oceanography and Marine Biology an Annual Review, V19, P235; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; CARLTON JT, 1995, MAR BIOL, V121, P721, DOI 10.1007/BF00349308; Chan BKK, 2008, B MAR SCI, V83, P315; Cheang CC, 2010, MOL ECOL, V19, P2933, DOI 10.1111/j.1365-294X.2010.04685.x; COE WR, 1953, ECOLOGY, V34, P225, DOI 10.2307/1930330; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; Connell J.H., 1972, Annual Rev Ecol Syst, V3, P169, DOI 10.1146/annurev.es.03.110172.001125; CONNELL JH, 1985, J EXP MAR BIOL ECOL, V93, P11, DOI 10.1016/0022-0981(85)90146-7; Connolly SR, 1998, AM NAT, V151, P311, DOI 10.1086/286121; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.1890/0012-9658(2001)082[1799:ALGIRO]2.0.CO;2; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Craw D, 2007, GEOMORPHOLOGY, V84, P98, DOI 10.1016/j.geomorph.2006.07.008; Espinosa F, 2006, J ZOOL SYST EVOL RES, V44, P8, DOI 10.1111/j.1439-0469.2005.00348.x; Espinosa F, 2011, MAR ECOL-EVOL PERSP, V32, P1, DOI 10.1111/j.1439-0485.2010.00410.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang Juanjuan, 2011, Water Resources and Power, V29, P9; FENG S.Z., 1999, INTRO MARINE SCI; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaine MC, 2010, P ROY SOC B-BIOL SCI, V277, P2829, DOI 10.1098/rspb.2010.0412; Fu YX, 1996, GENETICS, V143, P557; GAINES S, 1985, OECOLOGIA, V67, P267, DOI 10.1007/BF00384297; Goldstien SJ, 2006, MOL ECOL, V15, P3259, DOI 10.1111/j.1365-294X.2006.02977.x; Goldstien SJ, 2009, MAR ECOL PROG SER, V388, P111, DOI 10.3354/meps08046; Goldstien SJ, 2006, MOL PHYLOGENET EVOL, V38, P261, DOI 10.1016/j.ympev.2005.09.002; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hidas EZ, 2007, MAR FRESHWATER RES, V58, P835, DOI 10.1071/MF06235; Hu ZM, 2011, MOL ECOL, V20, P3894, DOI 10.1111/j.1365-294X.2011.05220.x; Huang ZG., 2008, MARINE SPECIES THEIR; JIANG C.B., 2006, PERODICAL OCEAN U CH, V36, P147; Kyle CJ, 2000, MAR BIOL, V137, P835, DOI 10.1007/s002270000412; Li YL, 2009, AFR J BIOTECHNOL, V8, P1193; [林军 Lin Jun], 2011, [水产学报, Journal of Fisheries of China], V35, P74; [刘兴泉 LIU XingQuan], 2008, [海洋与湖沼, Oceanologia et Limnologia Sinica], V39, P312; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Nakano T, 2004, J MOLLUS STUD, V70, P31, DOI 10.1093/mollus/70.1.31; Nakano T, 2007, J MOLLUS STUD, V73, P79, DOI 10.1093/mollus/eym001; Nakano T, 2010, ZOOL SCI, V27, P811, DOI 10.2108/zsj.27.811; Ohgaki S, 2005, ARGONAUTA NEWSLET KA, V11, P27; Palmer MA, 1996, TRENDS ECOL EVOL, V11, P322, DOI 10.1016/0169-5347(96)10038-0; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Reid DG, 1996, PHILOS T R SOC B, V351, P877, DOI 10.1098/rstb.1996.0082; Ribeiro PA, 2010, J BIOGEOGR, V37, P1782, DOI 10.1111/j.1365-2699.2010.02330.x; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sa-Pinto A, 2005, J EXP MAR BIOL ECOL, V325, P95, DOI 10.1016/j.jembe.2005.04.025; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Sagarin RD, 2002, J BIOGEOGR, V29, P985, DOI 10.1046/j.1365-2699.2002.00705.x; SCHELTEM.RS, 1968, NATURE, V217, P1159, DOI 10.1038/2171159a0; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; Shanks AL, 2003, ECOL APPL, V13, pS159; Shih HT, 2008, ZOOL STUD, V47, P114; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOLUTION; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsang LM, 2008, MAR ECOL PROG SER, V364, P107, DOI 10.3354/meps07476; WANG PX, 1994, CATENA, V23, P341; Wang YongQing, 2001, Chinese Journal of Zoology, V36, P27; Wang Z.Z., 2000, J ZHEJIANG OCEAN U, V19, P316; Wu Z-Y, 2010, B MAR SCI, V12, P1; York KL, 2008, MOL ECOL, V17, P1948, DOI 10.1111/j.1365-294X.2008.03735.x	76	30	31	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36178	10.1371/journal.pone.0036178	http://dx.doi.org/10.1371/journal.pone.0036178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563446	Green Published, gold			2022-12-25	WOS:000305349100071
J	Scholz-Starke, J; Cesca, F; Schiavo, G; Benfenati, F; Baldelli, P				Scholz-Starke, Joachim; Cesca, Fabrizia; Schiavo, Giampietro; Benfenati, Fabio; Baldelli, Pietro			Kidins220/ARMS Is a Novel Modulator of Short-Term Synaptic Plasticity in Hippocampal GABAergic Neurons	PLOS ONE			English	Article							PAIRED-PULSE DEPRESSION; MEMBRANE-SPANNING PROTEIN; AMPA RECEPTORS; RELEASE; NEUROTROPHIN; STABILITY; TRANSMISSION; INVOLVEMENT; ACTIVATION; SUBSTRATE	Kidins220 (Kinase D interacting substrate of 220 kDa)/ARMS (Ankyrin Repeat-rich Membrane Spanning) is a scaffold protein highly expressed in the nervous system. Previous work on neurons with altered Kidins220/ARMS expression suggested that this protein plays multiple roles in synaptic function. In this study, we analyzed the effects of Kidins220/ARMS ablation on basal synaptic transmission and on a variety of short-term plasticity paradigms in both excitatory and inhibitory synapses using a recently described Kidins220 full knockout mouse. Hippocampal neuronal cultures prepared from embryonic Kidins220(-/-) (KO) and wild type (WT) littermates were used for whole-cell patch-clamp recordings of spontaneous and evoked synaptic activity. Whereas glutamatergic AMPA receptor-mediated responses were not significantly affected in KO neurons, specific differences were detected in evoked GABAergic transmission. The recovery from synaptic depression of inhibitory post-synaptic currents in WT cells showed biphasic kinetics, both in response to paired-pulse and long-lasting train stimulation, while in KO cells the respective slow components were strongly reduced. We demonstrate that the slow recovery from synaptic depression in WT cells is caused by a transient reduction of the vesicle release probability, which is absent in KO neurons. These results suggest that Kidins220/ARMS is not essential for basal synaptic transmission and various forms of short-term plasticity, but instead plays a novel role in the mechanisms regulating the recovery of synaptic strength in GABAergic synapses.	[Scholz-Starke, Joachim; Cesca, Fabrizia; Benfenati, Fabio; Baldelli, Pietro] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Schiavo, Giampietro] Canc Res UK London Res Inst, Mol Neuropathobiol Lab, London, England; [Benfenati, Fabio; Baldelli, Pietro] Univ Genoa, Dept Expt Med, Genoa, Italy; [Benfenati, Fabio; Baldelli, Pietro] Natl Inst Neurosci, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Cancer Research UK; University of Genoa	Scholz-Starke, J (corresponding author), CNR, Inst Biophys, Genoa, Italy.	joachim.scholzstarke@iit.it	Baldelli, Pietro/AAA-6298-2020; Baldelli, Pietro/AAH-2493-2021; Scholz-Starke, Joachim/A-2944-2014	Baldelli, Pietro/0000-0001-9599-3436; Cesca, Fabrizia/0000-0003-2190-6314; Scholz-Starke, Joachim/0000-0002-7376-6635; Schiavo, Giampietro/0000-0002-4319-8745	Compagnia di San Paolo, Torino; Italian Ministry of Health; Italian Ministry of Education, University and Research; Cancer Research UK; Telethon, Italy [GGP05134, GGP09134, GGP09066]	Compagnia di San Paolo, Torino(Compagnia di San Paolo); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Cancer Research UK(Cancer Research UK); Telethon, Italy(Fondazione Telethon)	Work in the authors' laboratories was supported by research grants from the Compagnia di San Paolo, Torino (to PB and FB), the Italian Ministry of Health (to PB), the Italian Ministry of Education, University and Research (to FB), and Cancer Research UK (GS). The support of Telethon, Italy (grants GGP05134 and GGP09134 to FB and grant GGP09066 to PB) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bracale A, 2007, MOL BIOL CELL, V18, P142, DOI 10.1091/mbc.E06-05-0453; Arevalo JC, 2010, MOL CELL NEUROSCI, V45, P92, DOI 10.1016/j.mcn.2010.06.002; Cesca F, 2012, CELL DEATH DIFFER, V19, P194, DOI 10.1038/cdd.2011.141; Cesca F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.108; Chang MS, 2004, J NEUROSCI RES, V78, P186, DOI 10.1002/jnr.20262; Chiappalone M, 2009, CEREB CORTEX, V19, P1422, DOI 10.1093/cercor/bhn182; Cortes RY, 2007, DEV NEUROBIOL, V67, P1687, DOI 10.1002/dneu.20542; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Kirischuk S, 2002, J PHYSIOL-LONDON, V543, P99, DOI 10.1113/jphysiol.2002.021576; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Lopez-Menendez C, 2009, J CELL SCI, V122, P3554, DOI 10.1242/jcs.056473; Luthi A, 2001, J NEUROSCI, V21, P9101, DOI 10.1523/JNEUROSCI.21-23-09101.2001; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Park HJ, 2010, MOL CELLS, V30, P143, DOI 10.1007/s10059-010-0099-7; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Sutachan JJ, 2010, J NEUROSCI RES, V88, P3447, DOI 10.1002/jnr.22513; WILCOX KS, 1994, J NEUROSCI, V14, P1775, DOI 10.1523/JNEUROSCI.14-03-01775.1994; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Wu SH, 2010, J BIOL CHEM, V285, P40472, DOI 10.1074/jbc.M110.171371; Wu SH, 2009, DEV NEUROBIOL, V69, P547, DOI 10.1002/dneu.20723; Xu JY, 2009, EXP NEUROL, V216, P243, DOI 10.1016/j.expneurol.2008.11.013; Yang YM, 2010, NEURON, V67, P100, DOI 10.1016/j.neuron.2010.06.003; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35785	10.1371/journal.pone.0035785	http://dx.doi.org/10.1371/journal.pone.0035785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563401	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349100029
J	Ma, YL; Wang, WY; Zhang, J; Lu, YL; Wu, WY; Yan, H; Wang, YP				Ma, Yanling; Wang, Wenyi; Zhang, Jie; Lu, Youli; Wu, Wenyu; Yan, Hong; Wang, Yiping			Hyperlipidemia and Atherosclerotic Lesion Development in Ldlr-Deficient Mice on a Long-Term High-Fat Diet	PLOS ONE			English	Article							PLASMA-CHOLESTEROL LEVELS; RECEPTOR KNOCKOUT MICE; REDUCES ATHEROSCLEROSIS; INNOMINATE-ARTERY; APOLIPOPROTEIN-E; ATHEROGENESIS; AGONIST; EXPRESSION; CHOLATE; INSULIN	Background: Mice deficient in the LDL receptor (Ldlr(-/-) mice) have been widely used as a model to mimic human atherosclerosis. However, the time-course of atherosclerotic lesion development and distribution of lesions at specific time-points are yet to be established. The current study sought to determine the progression and distribution of lesions in Ldlr(-/-) mice. Methodology/Principal Findings: Ldlr-deficient mice fed regular chow or a high-fat (HF) diet for 0.5 to 12 months were analyzed for atherosclerotic lesions with en face and cross-sectional imaging. Mice displayed significant individual differences in lesion development when fed a chow diet, whereas those on a HF diet developed lesions in a time-dependent and site-selective manner. Specifically, mice subjected to the HF diet showed slight atherosclerotic lesions distributed exclusively in the aortic roots or innominate artery before 3 months. Lesions extended to the thoracic aorta at 6 months and abdominal aorta at 9 months. Cross-sectional analysis revealed the presence of advanced lesions in the aortic sinus after 3 months in the group on the HF diet and in the innominate artery at 6 to 9 months. The HF diet additionally resulted in increased total cholesterol, LDL, glucose, and HBA1c levels, along with the complication of obesity. Conclusions/Significance: Ldlr-deficient mice on the HF diet tend to develop site-selective and size-specific atherosclerotic lesions over time. The current study should provide information on diet induction or drug intervention times and facilitate estimation of the appropriate locations of atherosclerotic lesions in Ldlr(-/-) mice.	[Ma, Yanling; Wang, Wenyi; Zhang, Jie; Wu, Wenyu; Yan, Hong; Wang, Yiping] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Lu, Youli] Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Ma, YL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	ypwang@mail.shcnc.ac.cn	MA, YAN/HHN-2912-2022	Ma, Yanling/0000-0003-0829-3285; Yan, Hong/0000-0001-6665-4419	Shanghai Committee of Science and Technology, China [11ZR1444800]; National Basic Research Program of China [2009CB930300]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the grant from the Shanghai Committee of Science and Technology, China (No. 11ZR1444800), and National Basic Research Program of China (No. 2009CB930300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela GS, 2010, J CLIN LIPIDOL, V4, P156, DOI 10.1016/j.jacl.2010.03.003; Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Chira EC, 2007, ATHEROSCLEROSIS, V195, P100, DOI 10.1016/j.atherosclerosis.2006.12.012; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Game BA, 2007, ATHEROSCLEROSIS, V192, P85, DOI 10.1016/j.atherosclerosis.2006.06.025; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Graham TL, 2005, ATHEROSCLEROSIS, V181, P29, DOI 10.1016/j.atherosclerosis.2004.12.028; Hartvigsen K, 2007, ARTERIOSCL THROM VAS, V27, P878, DOI 10.1161/01.ATV.0000258790.35810.02; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; Merat S, 1999, ARTERIOSCL THROM VAS, V19, P1223, DOI 10.1161/01.ATV.19.5.1223; Moore RE, 2003, ARTERIOSCL THROM VAS, V23, P1914, DOI 10.1161/01.ATV.0000092328.66882.F5; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Peng D, 2009, ATHEROSCLEROSIS, V203, P59, DOI 10.1016/j.atherosclerosis.2008.05.058; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Schreyer SA, 2003, ATHEROSCLEROSIS, V171, P49, DOI 10.1016/j.atherosclerosis.2003.07.010; Sehayek E, 2001, J LIPID RES, V42, P1250; Sharabi Y, 2000, PATHOBIOLOGY, V68, P270, DOI 10.1159/000055937; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Vedre A, 2009, ATHEROSCLEROSIS, V203, P89, DOI 10.1016/j.atherosclerosis.2008.06.027; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; Wang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023425; Wu L, 2006, J LIPID RES, V47, P2215, DOI 10.1194/jlr.M600146-JLR200; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	35	65	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35835	10.1371/journal.pone.0035835	http://dx.doi.org/10.1371/journal.pone.0035835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558236	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200085
J	Bryant, B				Bryant, Barbara			Chromatin Computation	PLOS ONE			English	Article							HISTONE MODIFICATIONS; DNA METHYLATION; MOLECULAR COMPUTATION; REGULATORY NETWORKS; ESCHERICHIA-COLI; EPIGENETIC CODE; GENE-EXPRESSION; GENOME; EPIGENOMICS	In living cells, DNA is packaged along with protein and RNA into chromatin. Chemical modifications to nucleotides and histone proteins are added, removed and recognized by multi-functional molecular complexes. Here I define a new computational model, in which chromatin modifications are information units that can be written onto a one-dimensional string of nucleosomes, analogous to the symbols written onto cells of a Turing machine tape, and chromatin-modifying complexes are modeled as read-write rules that operate on a finite set of adjacent nucleosomes. I illustrate the use of this "chromatin computer" to solve an instance of the Hamiltonian path problem. I prove that chromatin computers are computationally universal - and therefore more powerful than the logic circuits often used to model transcription factor control of gene expression. Features of biological chromatin provide a rich instruction set for efficient computation of nontrivial algorithms in biological time scales. Modeling chromatin as a computer shifts how we think about chromatin function, suggests new approaches to medical intervention, and lays the groundwork for the engineering of a new class of biological computing machines.	Constellat Pharmaceut, Bioinformat Dept, Cambridge, MA USA		Bryant, B (corresponding author), Constellat Pharmaceut, Bioinformat Dept, Cambridge, MA USA.	barbara.bryant@constellationpharma.com		Bryant, Barbara/0000-0003-2707-1186				ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Barbuti R, 2007, LECT NOTES COMPUT SC, V4860, P54; Beaver, 1995, UNIVERSAL MOL COMPUT, P29; Benayoun BA, 2009, TRENDS CELL BIOL, V19, P189, DOI 10.1016/j.tcb.2009.02.003; Borggrefe T, 2001, J BIOL CHEM, V276, P47150, DOI 10.1074/jbc.M109581200; Braich RS, 2002, SCIENCE, V296, P499, DOI 10.1126/science.1069528; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deng WL, 2010, CURR OPIN GENET DEV, V20, P548, DOI 10.1016/j.gde.2010.06.007; Eiben AE, 2002, INFORM PROCESS LETT, V82, P1, DOI 10.1016/S0020-0190(02)00204-1; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Feeney AJ, 2011, CURR OPIN IMMUNOL, V23, P171, DOI 10.1016/j.coi.2010.12.008; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hartmann L, 2011, SCI ANN COMPUT SCI, V21, P73; Haynes KA, 2011, J BIOL CHEM; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hopcroft J. E., 1979, INTRO AUTOMATA THEOR; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivega I, 2011, CURR OPIN GENET DEV; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Madhani HD, 2008, SCIENCE, V322, P43, DOI 10.1126/science.322.5898.43b; Mario Coppo FD, 2010, QUANTITATIVE ASPECTS, P82; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; Perez-Lluch S, 2011, NUCLEIC ACIDS RES, V39, P4628, DOI 10.1093/nar/gkq1322; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Ptashne M, 2010, NATURE, V464, P487, DOI 10.1038/464487c; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Razin SV, 2011, NUCLEIC ACIDS RES, V39, P9085, DOI 10.1093/nar/gkr683; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Regev A, 2004, THEOR COMPUT SCI, V325, P141, DOI 10.1016/j.tcs.2004.03.061; Regev A, 2001, Pac Symp Biocomput, P459; Regev A, 2002, NATURE, V419, P343, DOI 10.1038/419343a; Rooss D., 1996, POWER BIOCOMPUTERS; Rothemund P. W. K, 1995, DNA BASED COMPUTERS, P75; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sakamoto K, 2000, SCIENCE, V288, P1223, DOI 10.1126/science.288.5469.1223; Smith W. D, 1995, DNA BASED COMPUTERS, P121; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takinoue M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041921; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Turing A.M, 1948, TECH REP; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weiss R., 2003, Natural Computing, V2, P47, DOI 10.1023/A:1023307812034; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	56	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35703	10.1371/journal.pone.0035703	http://dx.doi.org/10.1371/journal.pone.0035703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567109	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341500027
J	Pausch, H; Wang, XL; Jung, S; Krogmeier, D; Edel, C; Emmerling, R; Gotz, KU; Fries, R				Pausch, Hubert; Wang, Xiaolong; Jung, Simone; Krogmeier, Dieter; Edel, Christian; Emmerling, Reiner; Goetz, Kay-Uwe; Fries, Ruedi			Identification of QTL for UV-Protective Eye Area Pigmentation in Cattle by Progeny Phenotyping and Genome-Wide Association Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DAIRY-CATTLE; MELANOCYTE DEVELOPMENT; SKIN PIGMENTATION; HEREFORD CATTLE; MILK-PRODUCTION; COMPLEX TRAITS; HUMAN HEIGHT; COMMON SNPS; BOS-TAURUS	Pigmentation patterns allow for the differentiation of cattle breeds. A dominantly inherited white head is characteristic for animals of the Fleckvieh (FV) breed. However, a minority of the FV animals exhibits peculiar pigmentation surrounding the eyes (ambilateral circumocular pigmentation, ACOP). In areas where animals are exposed to increased solar ultraviolet radiation, ACOP is associated with a reduced susceptibility to bovine ocular squamous cell carcinoma (BOSCC, eye cancer). Eye cancer is the most prevalent malignant tumour affecting cattle. Selection for animals with ACOP rapidly reduces the incidence of BOSCC. To identify quantitative trait loci (QTL) underlying ACOP, we performed a genome-wide association study using 658,385 single nucleotide polymorphisms (SNPs). The study population consisted of 3579 bulls of the FV breed with a total of 320,186 progeny with phenotypes for ACOP. The proportion of progeny with ACOP was used as a quantitative trait with high heritability (h(2) = 0.79). A variance component based approach to account for population stratification uncovered twelve QTL regions on seven chromosomes. The identified QTL point to MCM6, PAX3, ERBB3, KITLG, LEF1, DKK2, KIT, CRIM1, ATRN, GSDMC, MITF and NBEAL2 as underlying genes for eye area pigmentation in cattle. The twelve QTL regions explain 44.96% of the phenotypic variance of the proportion of daughters with ACOP. The chromosomes harbouring significantly associated SNPs account for 54.13% of the phenotypic variance, while another 19.51% of the phenotypic variance is attributable to chromosomes without identified QTL. Thus, the missing heritability amounts to 7% only. Our results support a polygenic inheritance pattern of ACOP in cattle and provide the basis for efficient genomic selection of animals that are less susceptible to serious eye diseases.	[Pausch, Hubert; Wang, Xiaolong; Jung, Simone; Fries, Ruedi] Tech Univ Munich, Lehrstuhl Tierzucht, Freising Weihenstephan, Germany; [Krogmeier, Dieter; Edel, Christian; Emmerling, Reiner; Goetz, Kay-Uwe] Bayer Landesanstalt Landwirtschaft, Inst Tierzucht, Poing, Germany	Technical University of Munich	Pausch, H (corresponding author), Tech Univ Munich, Lehrstuhl Tierzucht, Freising Weihenstephan, Germany.	hubert.pausch@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Gotz, Kay-Uwe/0000-0001-5495-7738; Fries, Ruedi/0000-0002-4657-1787	German Federal Ministry of Education and Research (BMBF) within the AgroClustEr [0315527B]; FUGATO-plus GenoTrack [0315134A, 0315134D]	German Federal Ministry of Education and Research (BMBF) within the AgroClustEr(Federal Ministry of Education & Research (BMBF)); FUGATO-plus GenoTrack	This research was funded by the German Federal Ministry of Education and Research (BMBF, http://www.bmbf.de) within the AgroClustEr "Synbreed Synergistic plant and animal breeding (http://www.synbreed.tum.de)'' (grant number 0315527B) and as part of the project FUGATO-plus GenoTrack (grant numbers 0315134A and 0315134D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; ANDERSON DE, 1991, J HERED, V82, P21, DOI 10.1093/jhered/82.1.21; ANDERSON DE, 1963, ANN NY ACAD SCI, V108, P948, DOI 10.1111/j.1749-6632.1963.tb13432.x; ANDERSON DE, 1957, J ANIM SCI, V16, P1007, DOI 10.2527/jas1957.1641007x; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; BARLOW R, 1980, AUST J AGR RES, V31, P417, DOI 10.1071/AR9800417; Baxter LL, 2009, WIRES SYST BIOL MED, V1, P359, DOI 10.1002/wsbm.20; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Buac K, 2009, PIGM CELL MELANOMA R, V22, P773, DOI 10.1111/j.1755-148X.2009.00616.x; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chamberlain AJ, 2007, GENETICS, V177, P1117, DOI 10.1534/genetics.107.077784; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Cieslak M, 2011, BIOL REV, V86, P885, DOI 10.1111/j.1469-185X.2011.00177.x; CLARK P, 1981, ANN HUM BIOL, V8, P529, DOI 10.1080/03014468100005371; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; David Clifford PM, 2006, R NEWS, P6; DENOTTER W, 1995, AM J VET RES, V56, P1440; Druet T, 2010, J DAIRY SCI, V93, P5443, DOI 10.3168/jds.2010-3255; Faigle W, 2000, PROTOPLASMA, V210, P117, DOI 10.1007/BF01276851; FINCH VA, 1977, ECOLOGY, V58, P1384, DOI 10.2307/1935090; FRISANCHO AR, 1981, AM J PHYS ANTHROPOL, V55, P203, DOI 10.1002/ajpa.1330550207; Furumura M, 1998, P NATL ACAD SCI USA, V95, P7374, DOI 10.1073/pnas.95.13.7374; Gage PJ, 2008, DEV BIOL, V317, P310, DOI 10.1016/j.ydbio.2008.02.030; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; GUILBERT HR, 1948, J ANIM SCI, V7, P426; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; HEENEY JL, 1985, CAN J COMP MED, V49, P21; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Klein RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-58; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lovicu FJ, 2000, MECH DEVELOP, V94, P261, DOI 10.1016/S0925-4773(00)00292-6; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; McRae AF, 2008, GENOME RES, V18, P911, DOI 10.1101/gr.074872.107; Newton R, 1996, LANCET, V347, P1450, DOI 10.1016/S0140-6736(96)91685-2; NISHIMURA H, 1977, AUST J EXP AGR, V17, P709, DOI 10.1071/EA9770709; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Picardo M, 2011, J INVEST DERMATOL, V131, P1182, DOI 10.1038/jid.2011.67; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; RUSSELL WC, 1976, J ANIM SCI, V43, P1156, DOI 10.2527/jas1976.4361156x; Sahana G, 2011, J DAIRY SCI, V94, P479, DOI 10.3168/jds.2010-3381; Song YS, 2010, GENETICS, V186, P1467, DOI 10.1534/genetics.110.119008; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; VOGT DW, 1963, J ANIM SCI, V22, P762, DOI 10.2527/jas1963.223762x; WARD JK, 1979, J ANIM SCI, V49, P361, DOI 10.2527/jas1979.492361x; Watabe E, 2001, JPN J CANCER RES, V92, P140, DOI 10.1111/j.1349-7006.2001.tb01076.x; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	65	39	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36346	10.1371/journal.pone.0036346	http://dx.doi.org/10.1371/journal.pone.0036346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567150	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341500069
J	Xie, YC; Chen, SB; Murphy, T				Xie, Yicheng; Chen, Shangbin; Murphy, Timothy			Dendritic Spines and Pre-Synaptic Boutons Are Stable Despite Local Deep Hypothermic Challenge and Re-Warming In Vivo	PLOS ONE			English	Article							THERAPEUTIC HYPOTHERMIA; PROLONGED HYPOTHERMIA; CIRCULATORY ARREST; BLOOD-FLOW; PLASTICITY; TEMPERATURE; ANEURYSMS; TURNOVER; MODERATE; ONSET	Background and Purpose: Deep hypothermia to 20 degrees C is used clinically for major pediatric and adult surgical procedures. In particular, it is used in the "standstill operation" where blood flow is stopped for up to 30 min. Patients recovering from these procedures can exhibit neurological deficits. Such deficits could arise from changes to dendritic spines and plasticity-induced changes in network function as a result of cooling and/or re-warming. In the brain, each dendritic spine represents a single excitatory synapse and their number can be reflective of injury or plasticity-induced changes in network function. This research sought to determine whether deep hypothermia and re-warming have detrimental effects on synaptic stability and network function. Methods: In vivo 2-photon (2-P) imaging in green/yellow fluorescent protein (GFP/YFP)-expressing transgenic mice was performed to determine whether 4 hours of deep hypothermia and 2 hours of re-warming can have relatively covert effects on dendritic spine and presynaptic bouton stability. At the same time, electroencephalographic (EEG) activity was recorded to evaluate network function during deep hypothermia and re-warming. Results: We report that deep hypothermia and subsequent re-warming did not change the stability of dendritic spines or presynaptic boutons in mouse somatosensory cortex measured over 8 hours. As expected, deep hypothermia attenuated ongoing EEG activity over 0.1-80 Hz frequencies. The effects on EEG activity were fully reversible following re-warming. Conclusion: These results are consistent with deep hypothermia being a safe treatment which could be applied clinically to those undergoing major elective surgical procedures.	[Xie, Yicheng; Chen, Shangbin; Murphy, Timothy] Univ British Columbia, Dept Psychiat, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1W5, Canada; [Xie, Yicheng; Chen, Shangbin; Murphy, Timothy] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Xie, YC (corresponding author), Univ British Columbia, Dept Psychiat, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1W5, Canada.	thmurphy@mail.ubc.ca	Murphy, Timothy H/I-4982-2014; Murphy, Timothy/AAW-1975-2021	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490	Heart and Stroke Foundation of British Columbia; Yukon; Canadian Institutes of Health Research (CIHR) [MOP-111009]; University of British Columbia	Heart and Stroke Foundation of British Columbia; Yukon; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of British Columbia	This work was supported by a grant in aid from the Heart and Stroke Foundation of British Columbia and the Yukon and a Canadian Institutes of Health Research (CIHR) operating grant MOP-111009 to TM and a Four Year Fellowship from the University of British Columbia to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; BAKER CJ, 1991, SURG NEUROL, V36, P175, DOI 10.1016/0090-3019(91)90109-M; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Clark DL, 2007, J CEREBR BLOOD F MET, V27, P115, DOI 10.1038/sj.jcbfm.9600327; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DELEON S, 1990, ANN THORAC SURG, V50, P714, DOI 10.1016/0003-4975(90)90668-V; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Engelman RM, 1996, J THORAC CARDIOV SUR, V112, P1622, DOI 10.1016/S0022-5223(96)70021-1; Enomoto S, 1996, ANESTHESIOLOGY, V84, P1392, DOI 10.1097/00000542-199606000-00016; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gao TM, 1998, NEUROSCIENCE, V87, P371, DOI 10.1016/S0306-4522(98)00150-X; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guyton RA, 1996, J THORAC CARDIOV SUR, V112, P1632; Kim JH, 2011, RECENT PATENTS INFLA, V5, P155, DOI 10.2174/187221311795399219; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kurth CD, 1999, J THORAC CARDIOV SUR, V118, P1068, DOI 10.1016/S0022-5223(99)70103-0; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; Mack WJ, 2007, NEUROSURGERY, V60, P815, DOI 10.1227/01.NEU.0000255452.20602.C9; MacLellan CL, 2009, J NEUROTRAUM, V26, P313, DOI 10.1089/neu.2008.0580; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Mostany R, 2010, J NEUROSCI, V30, P14116, DOI 10.1523/JNEUROSCI.3908-10.2010; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; POPOV VI, 1992, NEUROSCIENCE, V48, P53, DOI 10.1016/0306-4522(92)90337-2; POPOV VI, 1992, NEUROSCIENCE, V48, P45, DOI 10.1016/0306-4522(92)90336-Z; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; SILVERBERG GD, 1981, J NEUROSURG, V55, P337, DOI 10.3171/jns.1981.55.3.0337; STEEN PA, 1979, STROKE, V10, P522, DOI 10.1161/01.STR.10.5.522; Steiner T, 2001, STROKE, V32, P2833, DOI 10.1161/hs1201.99511; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tran S, 2012, J CEREBR BLOOD F MET, V32, P437, DOI 10.1038/jcbfm.2011.178; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36305	10.1371/journal.pone.0036305	http://dx.doi.org/10.1371/journal.pone.0036305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563488	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340700037
J	Chung, STL; Li, RW; Levi, DM				Chung, Susana T. L.; Li, Roger W.; Levi, Dennis M.			Learning to Identify Near-Acuity Letters, either with or without Flankers, Results in Improved Letter Size and Spacing Limits in Adults with Amblyopia	PLOS ONE			English	Article							CONTRAST-DEFINED LETTERS; STRABISMIC AMBLYOPIA; CONTOUR INTEGRATION; LETTER-RECOGNITION; VISUAL-ACUITY; READING SPEED; PSYCHOPHYSICS; SENSITIVITY; VISION; DISCRIMINATION	Amblyopia is a developmental abnormality that results in deficits for a wide range of visual tasks, most notably, the reduced ability to see fine details, the loss in contrast sensitivity especially for small objects and the difficulty in seeing objects in clutter (crowding). The primary goal of this study was to evaluate whether crowding can be ameliorated in adults with amblyopia through perceptual learning using a flanked letter identification task that was designed to reduce crowding, and if so, whether the improvements transfer to untrained visual functions: visual acuity, contrast sensitivity and the size of visual span (the amount of information obtained in one fixation). To evaluate whether the improvements following this training task were specific to training with flankers, we also trained another group of adult observers with amblyopia using a single letter identification task that was designed to improve letter contrast sensitivity, not crowding. Following 10,000 trials of training, both groups of observers showed improvements in the respective training task. The improvements generalized to improved visual acuity, letter contrast sensitivity, size of the visual span, and reduced crowding. The magnitude of the improvement for each of these measurements was similar in the two training groups. Perceptual learning regimens aimed at reducing crowding or improving letter contrast sensitivity are both effective in improving visual acuity, contrast sensitivity for near-acuity objects and reducing the crowding effect, and could be useful as a clinical treatment for amblyopia.	[Chung, Susana T. L.; Li, Roger W.; Levi, Dennis M.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Chung, Susana T. L.; Li, Roger W.; Levi, Dennis M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chung, STL (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	s.chung@berkeley.edu	Levi, Dennis/J-7836-2019	Levi, Dennis/0000-0002-5350-8639; Chung, Susana/0000-0003-2729-1808; Li, Roger/0000-0002-1666-0543	National Institutes of Health [R01-EY012810, R01-EY01728]; NATIONAL EYE INSTITUTE [R01EY001728, R01EY012810] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by research grants R01-EY012810 and R01-EY01728 from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Astle AT, 2011, INVEST OPHTH VIS SCI, V52, P7195, DOI 10.1167/iovs.11-7584; Beckmann P. J., 1998, THESIS U MINNESOTA; Bonneh YS, 2004, VISION RES, V44, P3099, DOI 10.1016/j.visres.2004.07.031; BRADLEY A, 1981, INVEST OPHTH VIS SCI, V21, P467; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chung STL, 2005, VISION RES, V45, P1399, DOI 10.1016/j.visres.2004.11.021; Chung STL, 2004, VISION RES, V44, P695, DOI 10.1016/j.visres.2003.09.028; Chung STL, 2008, VISION RES, V48, P2739, DOI 10.1016/j.visres.2008.09.009; Chung STL, 2007, VISION RES, V47, P3150, DOI 10.1016/j.visres.2007.08.017; Chung STL, 2006, VISION RES, V46, P3853, DOI 10.1016/j.visres.2006.06.014; CIUFREDA KJ, 1987, OPHTHAL PHYSL OPT, V7, P461, DOI 10.1111/j.1475-1313.1987.tb00779.x; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Fahle M, 1996, INVEST OPHTH VIS SCI, V37, P869; FLOM MC, 1963, J OPT SOC AM, V53, P1026, DOI 10.1364/JOSA.53.001026; Hariharan S, 2005, VISION RES, V45, P617, DOI 10.1016/j.visres.2004.09.035; HESS RF, 1977, VISION RES, V17, P1049, DOI 10.1016/0042-6989(77)90009-8; Hess RF, 1997, VISION RES, V37, P3145, DOI 10.1016/S0042-6989(96)00281-7; Hess RF, 2001, VISION RES, V41, P2285, DOI 10.1016/S0042-6989(01)00099-2; Huang CB, 2008, P NATL ACAD SCI USA, V105, P4068, DOI 10.1073/pnas.0800824105; Hussain Z, 2012, J NEUROSCI, V32, P474, DOI 10.1523/JNEUROSCI.3845-11.2012; Kozma P, 2003, VISUAL NEUROSCI, V20, P577, DOI 10.1017/S0952523803205113; LEGGE GE, 1989, VISION RES, V29, P989, DOI 10.1016/0042-6989(89)90114-4; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Legge GE, 2007, J VIS, V7, P91; Levi DM, 2007, J VISION, V7, DOI 10.1167/7.2.21; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2007, VISION RES, V47, P512, DOI 10.1016/j.visres.2006.10.014; Levi DM, 2011, J VISION, V11, DOI 10.1167/11.1.10; Levi DM, 2009, VISION RES, V49, P2535, DOI 10.1016/j.visres.2009.02.010; Levi DM, 2009, PHILOS T R SOC B, V364, P399, DOI 10.1098/rstb.2008.0203; LEVI DM, 1977, INVEST OPHTH VIS SCI, V16, P90; LEVI DM, 1982, NATURE, V298, P268, DOI 10.1038/298268a0; Levi DM, 2002, VISION RES, V42, P1379, DOI 10.1016/S0042-6989(02)00061-5; LEVI DM, 1985, VISION RES, V25, P979, DOI 10.1016/0042-6989(85)90208-1; LEVI DM, 1983, VISION RES, V23, P1005, DOI 10.1016/0042-6989(83)90011-1; Li RW, 2005, INVEST OPHTH VIS SCI, V46, P3161, DOI 10.1167/iovs.05-0286; Li RW, 2004, NAT NEUROSCI, V7, P178, DOI 10.1038/nn1183; Liu XY, 2011, INVEST OPHTH VIS SCI, V52, P1531, DOI 10.1167/iovs.10-6355; Loudon SE, 2006, INVEST OPHTH VIS SCI, V47, P4393, DOI 10.1167/iovs.05-1428; Lu ZL, 2004, J VISION, V4, P44, DOI 10.1167/4.1.5; Mansouri B, 2005, VISION RES, V45, P2449, DOI 10.1016/j.visres.2005.02.018; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Pediat Eye Dis Investigator Grp, 2003, ARCH OPHTHALMOL-CHIC, V121, P603; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Polat U, 2009, VISION RES, V49, P2599, DOI 10.1016/j.visres.2009.07.008; RENTSCHLER I, 1985, EXP BRAIN RES, V60, P270; Scheiman MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P437; Selenow A., 1991, AMBLYOPIA BASIC CLIN; STUART JA, 1962, AM J OPHTHALMOL, V53, P471, DOI 10.1016/0002-9394(62)94878-X; Sun GJ, 2010, J VISION, V10, DOI 10.1167/10.5.16; Webber AL, 2008, OPTOMETRY VISION SCI, V85, P1074, DOI 10.1097/OPX.0b013e31818b9911; Wong EH, 2001, VISION RES, V41, P2951, DOI 10.1016/S0042-6989(01)00189-4; WOOD ICJ, 1983, OPHTHAL PHYSL OPT, V3, P337, DOI 10.1111/j.1475-1313.1983.tb00622.x; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Yu DY, 2010, VISION RES, V50, P36, DOI 10.1016/j.visres.2009.10.005; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010; Zhou YF, 2006, VISION RES, V46, P739, DOI 10.1016/j.visres.2005.07.031	59	32	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35829	10.1371/journal.pone.0035829	http://dx.doi.org/10.1371/journal.pone.0035829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558234	Green Published, gold			2022-12-25	WOS:000305340200024
J	Jelsbak, L; Thomsen, LE; Wallrodt, I; Jensen, PR; Olsen, JE				Jelsbak, Lotte; Thomsen, Line Elnif; Wallrodt, Inke; Jensen, Peter Ruhdal; Olsen, John Elmerdahl			Polyamines Are Required for Virulence in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; BACTERIAL SIGNAL MOLECULE; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; GENE-EXPRESSION; ENVIRONMENTAL-REGULATION; INTRACELLULAR SURVIVAL; EFFECTOR PROTEINS	Sensing and responding to environmental cues is a fundamental characteristic of bacterial physiology and virulence. Here we identify polyamines as novel environmental signals essential for virulence of Salmonella enterica serovar Typhimurium, a major intracellular pathogen and a model organism for studying typhoid fever. Central to its virulence are two major virulence loci Salmonella Pathogenicity Island 1 and 2 (SPI1 and SPI2). SPI1 promotes invasion of epithelial cells, whereas SPI2 enables S. Typhimurium to survive and proliferate within specialized compartments inside host cells. In this study, we show that an S. Typhimurium polyamine mutant is defective for invasion, intracellular survival, killing of the nematode Caenorhabditis elegans and systemic infection of the mouse model of typhoid fever. Virulence of the mutant could be restored by genetic complementation, and invasion and intracellular survival could, as well, be complemented by the addition of exogenous putrescine and spermidine to the bacterial cultures prior to infection. Interestingly, intracellular survival of the polyamine mutant was significantly enhanced above the wild type level by the addition of exogenous putrescine and spermidine to the bacterial cultures prior to infection, indicating that these polyamines function as an environmental signal that primes S. Typhimurium for intracellular survival. Accordingly, experiments addressed at elucidating the roles of these polyamines in infection revealed that expression of genes from both of the major virulence loci SPI1 and SPI2 responded to exogenous polyamines and was reduced in the polyamine mutant. Together our data demonstrate that putrescine and spermidine play a critical role in controlling virulence in S. Typhimurium most likely through stimulation of expression of essential virulence loci. Moreover, our data implicate these polyamines as key signals in S. Typhimurium virulence.	[Jelsbak, Lotte; Thomsen, Line Elnif; Wallrodt, Inke; Olsen, John Elmerdahl] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Jensen, Peter Ruhdal] Tech Univ Denmark, Dept Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Jelsbak, L (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg, Denmark.	loj@life.ku.dk	Olsen, John Elmerdahl/N-9271-2019; jensen, Peter Ruhdal/AAC-4891-2019	Jensen, Peter Ruhdal/0000-0003-2080-2070; Thomsen, Line Elnif/0000-0001-5460-9178; Jelsbak, Lotte/0000-0002-6642-7424; Olsen, John Elmerdahl/0000-0001-6225-6587	Danish Research Council for Technology and Production [274-07-0328]	Danish Research Council for Technology and Production	This study was supported by the Danish Research Council for Technology and Production through grant no. 274-07-0328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Carlson PE, 2009, J BACTERIOL, V191, P6855, DOI 10.1128/JB.00995-09; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Durand JMB, 2003, MOL MICROBIOL, V47, P519, DOI 10.1046/j.1365-2958.2003.03314.x; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; ENOMOTO M, 1974, VIROLOGY, V60, P503, DOI 10.1016/0042-6822(74)90344-4; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; GROISMAN EA, 1993, EMBO J, V12, P3779, DOI 10.1002/j.1460-2075.1993.tb06056.x; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Guy RL, 2000, MOL MICROBIOL, V37, P1417, DOI 10.1046/j.1365-2958.2000.02092.x; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Igarashi K., 2009, INT J BIOCH CELL BIO; Jelsbak L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012752; Jelsbak L, 2010, INT J MED MICROBIOL, V300, P229, DOI 10.1016/j.ijmm.2009.07.003; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; Knodler L.A., 2010, P NATL ACAD SCI US; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lober S, 2006, INT J MED MICROBIOL, V296, P435, DOI 10.1016/j.ijmm.2006.05.001; Mastroeni P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001840; McGinnis MW, 2009, FEMS MICROBIOL LETT, V299, P166, DOI 10.1111/j.1574-6968.2009.01744.x; Nasrallah GK, 2011, J BACTERIOL, V193, P4346, DOI 10.1128/JB.01506-10; Ochman H, 1996, INFECT IMMUN, V64, P5410, DOI 10.1128/IAI.64.12.5410-5412.1996; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Osborne SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021648; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pizarro-Cerda J, 2004, MOL MICROBIOL, V52, P1827, DOI 10.1111/j.1365-2958.2004.04122.x; Russo BC, 2011, INFECT IMMUN, V79, P3665, DOI 10.1128/IAI.00135-11; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; SCHNABEL H, 1990, SCIENCE, V250, P686, DOI 10.1126/science.250.4981.686; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; Terui Y, 2009, J BACTERIOL, V191, P5348, DOI 10.1128/JB.00387-09; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Thomsen LE, 2006, APPL ENVIRON MICROB, V72, P1700, DOI 10.1128/AEM.72.2.1700-1701.2006; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Viala JPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022397; WALLIS TS, 1995, INFECT IMMUN, V63, P2755, DOI 10.1128/IAI.63.7.2755-2761.1995; Watson KG, 2010, CELL MICROBIOL, V12, P1389, DOI 10.1111/j.1462-5822.2010.01511.x; WATSON PR, 1995, INFECT IMMUN, V63, P2743, DOI 10.1128/IAI.63.7.2743-2754.1995; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Zhou L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001291	68	81	82	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36149	10.1371/journal.pone.0036149	http://dx.doi.org/10.1371/journal.pone.0036149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558361	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200043
J	Ma, Q; Fan, JB; Zhou, Z; Zhou, BR; Meng, SR; Hu, JY; Chen, J; Liang, Y				Ma, Qian; Fan, Jun-Bao; Zhou, Zheng; Zhou, Bing-Rui; Meng, Sheng-Rong; Hu, Ji-Ying; Chen, Jie; Liang, Yi			The Contrasting Effect of Macromolecular Crowding on Amyloid Fibril Formation	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; PROTEIN AGGREGATION; TAU-PROTEIN; PRION; MUTATIONS; STABILITY; LYSOZYME; RESIDUES; FRAGMENT; DISEASE	Background: Amyloid fibrils associated with neurodegenerative diseases can be considered biologically relevant failures of cellular quality control mechanisms. It is known that in vivo human Tau protein, human prion protein, and human copper, zinc superoxide dismutase (SOD1) have the tendency to form fibril deposits in a variety of tissues and they are associated with different neurodegenerative diseases, while rabbit prion protein and hen egg white lysozyme do not readily form fibrils and are unlikely to cause neurodegenerative diseases. In this study, we have investigated the contrasting effect of macromolecular crowding on fibril formation of different proteins. Methodology/Principal Findings: As revealed by assays based on thioflavin T binding and turbidity, human Tau fragments, when phosphorylated by glycogen synthase kinase-3 beta, do not form filaments in the absence of a crowding agent but do form fibrils in the presence of a crowding agent, and the presence of a strong crowding agent dramatically promotes amyloid fibril formation of human prion protein and its two pathogenic mutants E196K and D178N. Such an enhancing effect of macromolecular crowding on fibril formation is also observed for a pathological human SOD1 mutant A4V. On the other hand, rabbit prion protein and hen lysozyme do not form amyloid fibrils when a crowding agent at 300 g/l is used but do form fibrils in the absence of a crowding agent. Furthermore, aggregation of these two proteins is remarkably inhibited by Ficoll 70 and dextran 70 at 200 g/l. Conclusions/Significance: We suggest that proteins associated with neurodegenerative diseases are more likely to form amyloid fibrils under crowded conditions than in dilute solutions. By contrast, some of the proteins that are not neurodegenerative disease-associated are unlikely to misfold in crowded physiological environments. A possible explanation for the contrasting effect of macromolecular crowding on these two sets of proteins (amyloidogenic proteins and non-amyloidogenic proteins) has been proposed.	[Ma, Qian; Fan, Jun-Bao; Zhou, Zheng; Zhou, Bing-Rui; Meng, Sheng-Rong; Hu, Ji-Ying; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Ma, Q (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Zhou, Zheng/AAK-2669-2021; Liang, Yi/V-1396-2017; Fan, Jun-bao/E-7155-2012; Zhou, Bing-Rui/D-4766-2009	Zhou, Zheng/0000-0002-3124-6041; Liang, Yi/0000-0002-7349-8300; Fan, Junbao/0000-0002-1709-3659; Zhou, Bing-Rui/0000-0002-5375-7977	National Key Basic Research Foundation of China [2012CB911003]; National Natural Science Foundation of China [30970599, 31170744]; Fundamental Research Funds for the Central Universities of China [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant no. 2012CB911003, to YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, grant nos. 30970599 and 31170744, to YL), and Fundamental Research Funds for the Central Universities of China (http://www.moe.edu.cn/, grant no. 1104006, to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Arnaudov LN, 2005, BIOPHYS J, V88, P515, DOI 10.1529/biophysj.104.048819; Barghorn Stefan, 2004, V299, P35; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Christiansen A, 2010, BIOCHEMISTRY-US, V49, P6519, DOI 10.1021/bi100578x; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Ip P, 2011, J MOL BIOL, V409, P839, DOI 10.1016/j.jmb.2011.04.027; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; Johansen D, 2011, BIOPHYS J, V100, P1120, DOI 10.1016/j.bpj.2011.01.020; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; Makarava N, 2007, J BIOL CHEM, V282, P36704, DOI 10.1074/jbc.M704926200; MANDELKOW E, 1995, NEUROBIOL AGING, V16, P347, DOI 10.1016/0197-4580(95)00026-B; Meiering EM, 2008, PLOS BIOL, V6, P1383, DOI 10.1371/journal.pbio.0060193; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Nisbet RM, 2010, J VIROL, V84, P6678, DOI 10.1128/JVI.02709-09; PEOCH, 2000, HUM MUTAT, V15, P482; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Spitzer J, 2011, MICROBIOL MOL BIOL R, V75, P491, DOI 10.1128/MMBR.00010-11; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Sun Y, 2008, J MOL BIOL, V376, P1155, DOI 10.1016/j.jmb.2007.12.053; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; van der Kamp MW, 2009, PROTEIN ENG DES SEL, V22, P461, DOI 10.1093/protein/gzp039; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025020; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	48	63	65	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36288	10.1371/journal.pone.0036288	http://dx.doi.org/10.1371/journal.pone.0036288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558423	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200063
J	Belanger, CL				Belanger, Christina L.			Individual to Community-Level Faunal Responses to Environmental Change from a Marine Fossil Record of Early Miocene Global Warming	PLOS ONE			English	Article							OXYGEN MINIMUM ZONE; CLIMATE-CHANGE; REGIME SHIFTS; BENTHIC FORAMINIFERA; POPULATION-DYNAMICS; BODY-SIZE; TEMPERATURE; EUTROPHICATION; GROWTH; EVOLUTIONARY	Modern climate change has a strong potential to shift earth systems and biological communities into novel states that have no present-day analog, leaving ecologists with no observational basis to predict the likely biotic effects. Fossil records contain long time-series of past environmental changes outside the range of modern observation, which are vital for predicting future ecological responses, and are capable of (a) providing detailed information on rates of ecological change, (b) illuminating the environmental drivers of those changes, and (c) recording the effects of environmental change on individual physiological rates. Outcrops of Early Miocene Newport Member of the Astoria Formation (Oregon) provide one such time series. This record of benthic foraminiferal and molluscan community change from continental shelf depths spans a past interval environmental change (similar to 20.3-16.7 mya) during which the region warmed 2.1-4.5 degrees C, surface productivity and benthic organic carbon flux increased, and benthic oxygenation decreased, perhaps driven by intensified upwelling as on the modern Oregon coast. The Newport Member record shows that (a) ecological responses to natural environmental change can be abrupt, (b) productivity can be the primary driver of faunal change during global warming, (c) molluscs had a threshold response to productivity change while foraminifera changed gradually, and (d) changes in bivalve body size and growth rates parallel changes in taxonomic composition at the community level, indicating that, either directly or indirectly through some other biological parameter, the physiological tolerances of species do influence community change. Ecological studies in modern and fossil records that consider multiple ecological levels, environmental parameters, and taxonomic groups can provide critical information for predicting future ecological change and evaluating species vulnerability.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Belanger, CL (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	belanger@uchicago.edu		Belanger, Christina/0000-0002-1582-7647	National Science Foundation [0910026]; Cushman Foundation; Conchologists of America Research Award; Sigma Xi Grants-in-Aid of Research; Frank H. and Eva B. Buck Foundation	National Science Foundation(National Science Foundation (NSF)); Cushman Foundation; Conchologists of America Research Award; Sigma Xi Grants-in-Aid of Research; Frank H. and Eva B. Buck Foundation	This material is based upon work supported by the National Science Foundation under Grant No. 0910026, the William V. Sliter award from the Cushman Foundation, Conchologists of America Research Award, and Sigma Xi Grants-in-Aid of Research. CLB was also supported by the National Science Foundation Graduate Research Fellowship and the Frank H. and Eva B. Buck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT WO, 1970, PALAEOGEOGR PALAEOCL, V8, P287, DOI 10.1016/0031-0182(70)90103-3; Allmon WD, 2001, PALAEOGEOGR PALAEOCL, V166, P9, DOI 10.1016/S0031-0182(00)00199-1; Alve E, 2010, J SEA RES, V63, P36, DOI 10.1016/j.seares.2009.09.003; AMANO K, 1994, PALAEOGEOGR PALAEOCL, V108, P369, DOI 10.1016/0031-0182(94)90243-7; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; [Anonymous], 2010, R LANG ENV STAT COMP; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Belanger CL, 2011, PALAIOS, V26, P767, DOI 10.2110/palo.2011.p11-032r; Belanger CL, 2011, MAR MICROPALEONTOL, V80, P101, DOI 10.1016/j.marmicro.2011.06.004; BORGESE TA, 1987, COMP BIOCHEM PHYS B, V86, P155, DOI 10.1016/0305-0491(87)90191-X; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Case TJ, 2005, OIKOS, V108, P28, DOI 10.1111/j.0030-1299.2005.13148.x; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; CLARKE A, 1993, PALEOBIOLOGY, V19, P499, DOI 10.1017/S0094837300014111; Collie JS, 2004, PROG OCEANOGR, V60, P281, DOI 10.1016/j.pocean.2004.02.013; CUMMINS H, 1986, PALAEONTOLOGY, V29, P495; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DEBENAY JP, 1994, J MOLLUS STUD, V60, P113, DOI 10.1093/mollus/60.2.113; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dietl GP, 2011, TRENDS ECOL EVOL, V26, P30, DOI 10.1016/j.tree.2010.09.010; Dumas S, 2006, GEOLOGY, V34, P1073, DOI 10.1130/G22930A.1; ERSKIAN MG, 1987, J FORAMIN RES, V17, P240, DOI 10.2113/gsjfr.17.3.240; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FURSICH FT, 1990, LETHAIA, V23, P143, DOI 10.1111/j.1502-3931.1990.tb01355.x; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Gilbert D, 2010, BIOGEOSCIENCES, V7, P2283, DOI 10.5194/bg-7-2283-2010; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Goewert AE, 2008, GEO-MAR LETT, V28, P327, DOI 10.1007/s00367-008-0113-7; Goldstein ST, 2011, MAR ECOL PROG SER, V437, P1, DOI 10.3354/meps09296; Grall J, 2002, GLOBAL CHANGE BIOL, V8, P813, DOI 10.1046/j.1365-2486.2002.00519.x; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Grunert P, 2010, GEOL CARPATH, V61, P129, DOI 10.2478/v10096-010-0006-3; Hall C.A., 2002, GEOL SOC AM SPEC PAP, V357, P1, DOI DOI 10.1130/0-8137-2357-4.1); Hallam A., 1965, Palaeontology, V8, P132; HALLAM A, 1967, PALAEONTOLOGY, V10, P25; HALLOCK P, 1985, PALEOBIOLOGY, V11, P195, DOI 10.1017/S0094837300011507; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; Hunt G, 2008, PALEOBIOLOGY, V34, P360, DOI 10.1666/07073.1; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; JONES DS, 1989, MAR BIOL, V102, P225, DOI 10.1007/BF00428284; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kender S, 2009, GEOLOGY, V37, P699, DOI 10.1130/G30070A.1; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; Kidwell SM, 2002, GEOBIOS MEMOIRE SPEC; Kidwell SM, 2010, PALEOBIOLOGY, V36, P615, DOI 10.1666/09004.1; Kirby MX, 2005, ESTUAR COAST SHELF S, V62, P679, DOI 10.1016/j.ecss.2004.10.004; Knowlton N, 2004, PROG OCEANOGR, V60, P387, DOI 10.1016/j.pocean.2004.02.011; Kosnik MA, 2006, PALAIOS, V21, P588, DOI 10.2110/palo.2006.p06-012r; Kowalewski Michal, 2003, Journal of Taphonomy, V1, P43; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; LEVINTON JS, 1970, LETHAIA, V3, P69, DOI 10.1111/j.1502-3931.1970.tb01264.x; LI Q, 1994, AUST J EARTH SCI, V41, P593, DOI 10.1080/08120099408728169; Lillebo AI, 1999, ACTA OECOL, V20, P289, DOI 10.1016/S1146-609X(99)00137-X; Marincovich LJ, 1992, US GEOLOGICAL SURVEY, V199, P163; Martel P, 2003, ENVIRON POLLUT, V124, P471, DOI 10.1016/S0269-7491(03)00011-3; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McNamara K.J., 2001, P180, DOI 10.1002/9780470999295.ch38; Metcalfe B, 2011, PALAEOGEOGR PALAEOCL, V308, P171, DOI 10.1016/j.palaeo.2010.09.011; Miles EL, 2009, ANNU REV ENV RESOUR, V34, P17, DOI 10.1146/annurev.environ.33.041707.110117; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Moore E. J., 1963, Professional Papers US Geological Survey, V419, P1; MOORE M, 1993, TRENDS ECOL EVOL, V8, P178, DOI 10.1016/0169-5347(93)90144-E; Murray J. W., 1991, ECOLOGY PALEOECOLOGY; MURRAY JW, 1983, J FORAMIN RES, V13, P1, DOI 10.2113/gsjfr.13.1.1; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Murray JW, 2001, MAR MICROPALEONTOL, V41, P1, DOI 10.1016/S0377-8398(00)00057-8; Niem W.A., 1992, GEOLOGY N AM G, P314; NRC, 2005, GEOL REC EC DYN UND; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Oksanen J., 2016, R PACKAG; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Petersen JK, 2008, ECOL APPL, V18, P497, DOI 10.1890/07-0752.1; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; SAVRDA CE, 1987, NATURE, V327, P54, DOI 10.1038/327054a0; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Shepherd AS, 2007, MAR MICROPALEONTOL, V65, P54, DOI 10.1016/j.marmicro.2007.06.001; Smith JR, 2006, ECOLOGY, V87, P1153, DOI 10.1890/0012-9658(2006)87[1153:DDIMBC]2.0.CO;2; Snavely P. D., 1964, Ore Bin, V26, P133; Thomas CD, 2005, RECENT EVOLUTIONARY, P75; Tomasovych A, 2011, PALEOBIOLOGY, V37, P332, DOI 10.1666/09506.1; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Urbanek Adam, 1993, Historical Biology, V7, P29; Valentine J. W., 1961, Bulletin Department Geology University California, V34, P309; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Willis KJ, 2010, TRENDS ECOL EVOL, V25, P583, DOI 10.1016/j.tree.2010.07.006; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zeineddine M, 2009, EVOLUTION, V63, P1498, DOI 10.1111/j.1558-5646.2009.00630.x	99	5	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36290	10.1371/journal.pone.0036290	http://dx.doi.org/10.1371/journal.pone.0036290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558424	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000180
J	Du, J; Zhou, NN; Liu, HX; Jiang, F; Wang, YB; Hu, CY; Qi, H; Zhong, CY; Wang, XR; Li, Z				Du, Juan; Zhou, Nannan; Liu, Hongxia; Jiang, Fei; Wang, Yubang; Hu, Chunyan; Qi, Hong; Zhong, Caiyun; Wang, Xinru; Li, Zhong			Arsenic Induces Functional Re-Expression of Estrogen Receptor alpha by Demethylation of DNA in Estrogen Receptor-Negative Human Breast Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; GENE-EXPRESSION; TRIOXIDE; METHYLATION; INHIBITION; ACTIVATION; RESISTANCE; METHYLTRANSFERASE; MECHANISMS	Estrogen receptor a (ER alpha) is a marker predictive for response of breast cancers to endocrine therapy. About 30% of breast cancers, however, are hormone-independent because of lack of ER alpha expression. New strategies are needed for re-expression of ER alpha and sensitization of ER-negative breast cancer cells to selective ER modulators. The present report shows that arsenic trioxide induces reactivated ER alpha, providing a target for therapy with ER antagonists. Exposure of ER-negative breast cancer cells to arsenic trioxide leads to re-expression of ER alpha mRNA and functional ER alpha protein in in vitro and in vivo. Luciferase reporter gene assays and 3-(4,5-dimethylthiazol-2-yl)- 5-(3-carboxymethoxyphenyl)- 2-(4-sulfophenyl)- 2H-tetrazolium (MTS) assays show that, upon exposure to arsenic trioxide, formerly unresponsive, ER-negative MDA-MB-231 breast cancer cells become responsive to ER antagonists, 4-hydroxytamoxifen and ICI 182,780. Furthermore, methylation-specific PCR and bisulfite-sequencing PCR assays show that arsenic trioxide induces partial demethylation of the ER alpha promoter. A methyl donor, S-adenosylmethionine (SAM), reduces the degree of arsenic trioxide-induced re-expression of ER alpha and demethylation. Moreover, Western blot and ChIP assays show that arsenic trioxide represses expression of DNMT1 and DNMT3a along with partial dissociation of DNMT1 from the ER alpha promoter. Thus, arsenic trioxide exhibits a previously undefined function which induces re-expression ER alpha in ER-negative breast cancer cells through demethylation of the ER alpha promoter. These findings could provide important information regarding the application of therapeutic agents targeting epigenetic changes in breast cancers and potential implication of arsenic trioxide as a new drug for the treatment of ER-negative human breast cancer.	[Du, Juan; Zhou, Nannan; Jiang, Fei; Wang, Yubang; Qi, Hong; Zhong, Caiyun; Wang, Xinru; Li, Zhong] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Peoples R China; [Wang, Xinru; Li, Zhong] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Peoples R China; [Liu, Hongxia; Hu, Chunyan; Zhong, Caiyun; Li, Zhong] Nanjing Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Nanjing, Peoples R China; [Wang, Yubang] Safety Assessment & Res Ctr Drugs, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Du, J (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Peoples R China.	uiuclz@126.com	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	National Natural Science Foundation of China [30972507, 30901186]; National High Technology Research and Development Program of China (863 Program) [2010AA023001]; Qing Lan Project; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA023001] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Qing Lan Project(Jiangsu Polytech Institute); Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grant from the National Natural Science Foundation of China (30972507, 30901186), the National High Technology Research and Development Program of China (863 Program) (2010AA023001), Qing Lan Project (to ZL) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHTHOLD A, 1994, EUR J BIOCHEM, V224, P431, DOI 10.1111/j.1432-1033.1994.00431.x; Billam M, 2009, CANC BIOL THER, P8; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Cai X, 2000, LEUKEMIA, V14, P262, DOI 10.1038/sj.leu.2401650; Chen GQ, 1997, BLOOD, V89, P3345; Chow SKY, 2004, J ENDOCRINOL, V182, P325, DOI 10.1677/joe.0.1820325; COMPERE SJ, 1981, CELL, V25, P233, DOI 10.1016/0092-8674(81)90248-8; CROOKS PA, 1984, J PHARM PHARMACOL, V36, P85, DOI 10.1111/j.2042-7158.1984.tb02999.x; Cui X, 2006, HUM PATHOL, V37, P298, DOI 10.1016/j.humpath.2005.10.013; Davison K, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.33610; Fishman J, 1995, ANN NY ACAD SCI, V768, P91, DOI 10.1111/j.1749-6632.1995.tb12113.x; Giacinti L, 2006, ONCOLOGIST, V11, P1, DOI 10.1634/theoncologist.11-1-1; Gonzalez-Fraile MI, 2002, BRIT J HAEMATOL, V117, P890, DOI 10.1046/j.1365-2141.2002.03502.x; Hu Y, 1998, MUTAT RES-DNA REPAIR, V408, P203, DOI 10.1016/S0921-8777(98)00035-4; JOHNSTON SRD, 1992, ANN ONCOL, V3, P503, DOI 10.1093/oxfordjournals.annonc.a058251; Kito M, 2003, CANCER SCI, V94, P1010, DOI 10.1111/j.1349-7006.2003.tb01393.x; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Lapidus RG, 1998, CANCER RES, V58, P2515; Lapidus RG, 1998, J MAMMARY GLAND BIOL, V3, P85, DOI 10.1023/A:1018778403001; Li Jin-Qing, 2004, Ai Zheng, V23, P626; Li Q, 2009, MOL PHARMACOL, V76, P1072, DOI 10.1124/mol.109.056291; Liu HQ, 2010, J NUTR BIOCHEM, V21, P390, DOI 10.1016/j.jnutbio.2009.01.016; Mass MJ, 1997, MUTAT RES-REV MUTAT, V386, P263, DOI 10.1016/S1383-5742(97)00008-2; MCGUIRE WL, 1978, SEMIN ONCOL, V5, P428; OTTAVIANO YL, 1994, CANCER RES, V54, P2552; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; PRICE JE, 1990, CANCER RES, V50, P717; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; ROODI N, 1995, JNCI-J NATL CANCER I, V87, P446, DOI 10.1093/jnci/87.6.446; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Stoica A, 2000, ENDOCRINOLOGY, V141, P3595, DOI 10.1210/en.141.10.3595; Takeyoshi M, 2002, TOXICOL LETT, V126, P91, DOI 10.1016/S0378-4274(01)00446-5; Tong Hongyan, 2002, Zhonghua Xue Ye Xue Za Zhi, V23, P638; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; WAALKES MP, 1988, CHEM-BIOL INTERACT, V66, P189, DOI 10.1016/0009-2797(88)90071-3; Wang Ming-Ming, 2008, Ai Zheng, V27, P1150; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Yang L, 2009, CHIN J CANCER, V28, P209; Yang XW, 2001, CANCER RES, V61, P7025; Yang XW, 2000, CANCER RES, V60, P6890; Zhang P, 2000, Zhonghua Xue Ye Xue Za Zhi, V21, P67; Zhang WJ, 2011, ONCOL REP, V26, P621, DOI 10.3892/or.2011.1352	43	49	50	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35957	10.1371/journal.pone.0035957	http://dx.doi.org/10.1371/journal.pone.0035957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558281	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000091
J	Lanza, AM; Blazeck, JJ; Crook, NC; Alper, HS				Lanza, Amanda M.; Blazeck, John J.; Crook, Nathan C.; Alper, Hal S.			Linking Yeast Gcn5p Catalytic Function and Gene Regulation Using a Quantitative, Graded Dominant Mutant Approach	PLOS ONE			English	Article							PROBE LEVEL DATA; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLATION; GENOME-WIDE; NEGATIVE MUTATIONS; IN-VIVO; PROMOTER; TRANSCRIPTION; EXPLORATION; EXPRESSION	Establishing causative links between protein functional domains and global gene regulation is critical for advancements in genetics, biotechnology, disease treatment, and systems biology. This task is challenging for multifunctional proteins when relying on traditional approaches such as gene deletions since they remove all domains simultaneously. Here, we describe a novel approach to extract quantitative, causative links by modulating the expression of a dominant mutant allele to create a function-specific competitive inhibition. Using the yeast histone acetyltransferase Gcn5p as a case study, we demonstrate the utility of this approach and (1) find evidence that Gcn5p is more involved in cell-wide gene repression, instead of the accepted gene activation associated with HATs, (2) identify previously unknown gene targets and interactions for Gcn5p-based acetylation, (3) quantify the strength of some Gcn5p-DNA associations, (4) demonstrate that this approach can be used to correctly identify canonical chromatin modifications, (5) establish the role of acetyltransferase activity on synthetic lethal interactions, and (6) identify new functional classes of genes regulated by Gcn5p acetyltransferase activity-all six of these major conclusions were unattainable by using standard gene knockout studies alone. We recommend that a graded dominant mutant approach be utilized in conjunction with a traditional knockout to study multifunctional proteins and generate higher-resolution data that more accurately probes protein domain function and influence.	[Lanza, Amanda M.; Blazeck, John J.; Crook, Nathan C.; Alper, Hal S.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Alper, Hal S.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lanza, AM (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	halper@che.utexas.edu		Crook, Nathan/0000-0001-6165-1972				Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Botet J, 2007, EUKARYOT CELL, V6, P2102, DOI 10.1128/EC.00266-07; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Byun HM, 2008, CANCER LETT, V266, P238, DOI 10.1016/j.canlet.2008.02.069; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GREENBERG ML, 1986, MOL CELL BIOL, V6, P1820, DOI 10.1128/MCB.6.5.1820; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Gustavsson M, 2008, RNA, V14, P666, DOI 10.1261/rna.966208; HAGUENAUERTSAPIS R, 1984, MOL CELL BIOL, V4, P2668, DOI 10.1128/MCB.4.12.2668; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Hirst M, 2009, INT J BIOCHEM CELL B, V41, P136, DOI 10.1016/j.biocel.2008.09.011; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Imoberdorf RM, 2006, MOL CELL BIOL, V26, P1610, DOI 10.1128/MCB.26.5.1610-1616.2006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jansen G, 2002, METHOD ENZYMOL, V344, P82; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Lanza AM, 2012, CURR OPIN BIOTECH, DOI [10.1016/j.cop-bio.2011.12.026, DOI 10.1016/J.COP-BIO.2011.12.026]; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; O'Connor TR, 2007, BIOINFORMATICS, V23, P1828, DOI 10.1093/bioinformatics/btm236; Peng WM, 2008, GENETICS, V179, P277, DOI 10.1534/genetics.107.085068; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sigalotti L, 2007, J CELL PHYSIOL, V212, P330, DOI 10.1002/jcp.21066; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tornoe J, 2002, GENE, V297, P21, DOI 10.1016/S0378-1119(02)00878-8; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; WILSON AK, 1990, MOL GEN GENET, V222, P377, DOI 10.1007/BF00633843; Xue-Franzen Y, 2010, BMC GENOMICS, V11; Yan Z, 2009, GENETICS, V182, P623, DOI 10.1534/genetics.109.103036	56	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36193	10.1371/journal.pone.0036193	http://dx.doi.org/10.1371/journal.pone.0036193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558379	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000151
J	Wortham, M; Jin, GL; Sun, JL; Bigner, DD; He, YP; Yan, H				Wortham, Matthew; Jin, Genglin; Sun, Julia Lailai; Bigner, Darell D.; He, Yiping; Yan, Hai			Aberrant Otx2 Expression Enhances Migration and Induces Ectopic Proliferation of Hindbrain Neuronal Progenitor Cells	PLOS ONE			English	Article							CEREBELLAR-VERMIS-DEFECT; TRANSGENIC MICE; STEM-CELLS; MEDULLOBLASTOMA; DIFFERENTIATION; RAT	Dysregulation of Otx2 is a hallmark of the pediatric brain tumor medulloblastoma, yet its functional significance in the establishment of these tumors is unknown. Here we have sought to determine the functional consequences of Otx2 overexpression in the mouse hindbrain to characterize its potential role in medulloblastoma tumorigenesis and identify the cell types responsive to this lineage-specific oncogene. Expression of Otx2 broadly in the mouse hindbrain resulted in the accumulation of proliferative clusters of cells in the cerebellar white matter and dorsal brainstem of postnatal mice. We found that brainstem ectopia were derived from neuronal progenitors of the rhombic lip and that cerebellar ectopia were derived from granule neuron precursors (GNPs) that had migrated inwards from the external granule layer (EGL). These hyperplasias exhibited various characteristics of medulloblastoma precursor cells identified in animal models of Shh or Wnt group tumors, including aberrant localization and altered spatiotemporal control of proliferation. However, ectopia induced by Otx2 differentiated and dispersed as the animals reached adulthood, indicating that factors restricting proliferative lifespan were a limiting factor to full transformation of these cells. These studies implicate a role for Otx2 in altering the dynamics of neuronal progenitor cell proliferation.	[Wortham, Matthew] Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC USA	Duke University; Duke University	Wortham, M (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA.	hai.yan@dm.duke.edu			NIH [R01CA118822]; Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA118822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01CA118822 (http://www.nih.gov) and the Pediatric Brain Tumor Foundation (www.pbtfus.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Altman J, 1997, DEV CEREBELLAR SYSTE; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Bunt J, 2011, INT J CANC IN PRESS; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Choi Y, 2005, J NEUROSCI, V25, P10437, DOI 10.1523/JNEUROSCI.1559-05.2005; Fossat N, 2006, EMBO REP, V7, P824, DOI 10.1038/sj.embor.7400751; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Kuramoto T, 2004, MOL BRAIN RES, V122, P103, DOI 10.1016/j.molbrainres.2003.12.003; KUWAMURA M, 1994, DEV BRAIN RES, V83, P294, DOI 10.1016/0165-3806(94)00167-7; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Louis P, WHO CLASSIFICATIONS; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Omodei D, 2008, DEVELOPMENT, V135, P3459, DOI 10.1242/dev.027003; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Puelles E, 2006, J NEUROSCI, V26, P5955, DOI 10.1523/JNEUROSCI.1097-06.2006; Shakhova O, 2006, CANCER RES, V66, P5190, DOI 10.1158/0008-5472.CAN-05-3545; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	29	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36211	10.1371/journal.pone.0036211	http://dx.doi.org/10.1371/journal.pone.0036211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558385	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000156
J	Lautenbach, S; Seppelt, R; Liebscher, J; Dormann, CF				Lautenbach, Sven; Seppelt, Ralf; Liebscher, Juliane; Dormann, Carsten F.			Spatial and Temporal Trends of Global Pollination Benefit	PLOS ONE			English	Article							LAND-USE INTENSITY; ECOSYSTEM SERVICES; LANDSCAPE STRUCTURE; CROP POLLINATION; NATIVE BEES; BIODIVERSITY; HABITAT; CONSERVATION; DIVERSITY; DECLINES	Pollination is a well-studied and at the same time a threatened ecosystem service. A significant part of global crop production depends on or profits from pollination by animals. Using detailed information on global crop yields of 60 pollination dependent or profiting crops, we provide a map of global pollination benefits on a 5' by 5' latitude-longitude grid. The current spatial pattern of pollination benefits is only partly correlated with climate variables and the distribution of cropland. The resulting map of pollination benefits identifies hot spots of pollination benefits at sufficient detail to guide political decisions on where to protect pollination services by investing in structural diversity of land use. Additionally, we investigated the vulnerability of the national economies with respect to potential decline of pollination services as the portion of the (agricultural) economy depending on pollination benefits. While the general dependency of the agricultural economy on pollination seems to be stable from 1993 until 2009, we see increases in producer prices for pollination dependent crops, which we interpret as an early warning signal for a conflict between pollination service and other land uses at the global scale. Our spatially explicit analysis of global pollination benefit points to hot spots for the generation of pollination benefits and can serve as a base for further planning of land use, protection sites and agricultural policies for maintaining pollination services.	[Lautenbach, Sven; Seppelt, Ralf; Liebscher, Juliane; Dormann, Carsten F.] UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany; [Lautenbach, Sven] Univ Bonn, Dept Urban Planning & Real Estate Management, Inst Geodesy & Geoinformat IGG, Bonn, Germany; [Liebscher, Juliane] Tech Univ Dresden, Dept Geog, Dresden, Germany; [Dormann, Carsten F.] Univ Freiburg, D-79106 Freiburg, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bonn; Technische Universitat Dresden; University of Freiburg	Lautenbach, S (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany.	sven.lautenbach@ufz.de	Lautenbach, Sven/C-1235-2010; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Seppelt, Ralf/E-6056-2010	Lautenbach, Sven/0000-0003-1825-9996; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Seppelt, Ralf/0000-0002-2723-7150; Dormann, Carsten/0000-0002-9835-1794	German Ministry of Research and Technology [01LG0801A, 01LL0901A]; Helmholtz-University-Group 'Biotic Ecosystem Services [VH-NG-247]; Helmholtz Programme 'Terrestrial Environmental Research'	German Ministry of Research and Technology; Helmholtz-University-Group 'Biotic Ecosystem Services; Helmholtz Programme 'Terrestrial Environmental Research'	The work was funded by grants 01LG0801Aand 01LL0901A (German Ministry of Research and Technology), the Helmholtz-University-Group 'Biotic Ecosystem Services' (VH-NG-247) and the Helmholtz Programme 'Terrestrial Environmental Research'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; [Anonymous], 2010, EC EC BIOD MAINSTR E; Asquith NM, 2008, ECOL ECON, V65, P675, DOI 10.1016/j.ecolecon.2007.12.014; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Chapagain AK, 2007, ECOL ECON, V64, P109, DOI 10.1016/j.ecolecon.2007.02.022; Chiang AY, 2007, TECHNOMETRICS, V49, P360; Committee on the Status of Pollinators in North America, 2006, STAT POLL N AM; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; de Jong M, 2009, J EXP BOT, V60, P1523, DOI 10.1093/jxb/erp094; De la Rua P, 2009, APIDOLOGIE, V40, P263, DOI 10.1051/apido/2009027; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Dormann C. F., 2009, OPEN ECOL J, V2, P7, DOI DOI 10.2174/1874213000902010007; Dormann CF, 2008, ECOL LETT, V11, P235, DOI 10.1111/j.1461-0248.2007.01142.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Erb KH, 2007, J LAND USE SCI, V2, P191, DOI 10.1080/17474230701622981; FAO, 2011, STAT DAT; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; Fisher B, 2008, ECOL APPL, V18, P2050, DOI 10.1890/07-1537.1; Franke G, NUTZPFLANZEN TROPEN, V3, P18; Freitas BM, 2009, APIDOLOGIE, V40, P332, DOI 10.1051/apido/2009012; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Greenleaf SS, 2006, BIOL CONSERV, V133, P81, DOI 10.1016/j.biocon.2006.05.025; Gruber B, 2011, APIDOLOGIE, V42, P564, DOI 10.1007/s13592-011-0059-z; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Heston Alan, 2011, PENN WORLD TABLE VER; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2011, RASTER GEOGRAPHIC AN; Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kevan PG, 1997, J APPL ECOL, V34, P1122, DOI 10.2307/2405226; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2003, J APPL ECOL, V40, P837, DOI 10.1046/j.1365-2664.2003.00847.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Lautenbach S, 2011, ECOL INDIC, V11, P676, DOI 10.1016/j.ecolind.2010.09.007; Legendre P., 2003, NUMERICAL ECOLOGY, VSecond; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; MEA, 2005, ECOSYSTEMS HUMAN WEL; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Ne'eman G, 2010, BIOL REV, V85, P435, DOI 10.1111/j.1469-185X.2009.00108.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pinillos V, 2008, BIOTECH HISTOCHEM, V83, P15, DOI 10.1080/10520290801987204; Polasky S, 2005, ECOL APPL, V15, P1387, DOI 10.1890/03-5423; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Potts SG, 2006, BIOL CONSERV, V129, P519, DOI 10.1016/j.biocon.2005.11.019; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Priess JA, 2007, ECOL APPL, V17, P407, DOI 10.1890/05-1795; R Core Team, 2016, R FDN STAT COMP; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; Schweiger O, 2010, BIOL REV, V85, P777, DOI 10.1111/j.1469-185X.2010.00125.x; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2003, BIODIVERS CONSERV, V12, P1953, DOI 10.1023/A:1024199513365; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; SUMNER D. A., 2006, AGR RESOURCE EC UPDA, V9, P9; Thomson DM, 2006, OIKOS, V114, P407, DOI 10.1111/j.2006.0030-1299.14604.x; Vaissieere BE, 2011, PROTOCOLL DETECT ASE; Westerkamp C, 2000, CROP SCI, V40, P1209, DOI 10.2135/cropsci2000.4051209x; Williams PH, 2007, BIOL CONSERV, V138, P493, DOI 10.1016/j.biocon.2007.06.001; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Winfree R, 2011, ECOL ECON, V71, P80, DOI 10.1016/j.ecolecon.2011.08.001; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; World bank, 2011, INFL GDP DEFL; World bank, 2011, DAT CAT; Wossink A, 2007, ECOL ECON, V64, P297, DOI 10.1016/j.ecolecon.2007.07.003	84	211	221	9	213	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35954	10.1371/journal.pone.0035954	http://dx.doi.org/10.1371/journal.pone.0035954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563427	gold, Green Published, Green Submitted			2022-12-25	WOS:000305349100053
J	Monteiro, CA; Serrao, EA; Pearson, GA				Monteiro, Carla A.; Serrao, Ester A.; Pearson, Gareth A.			Prezygotic Barriers to Hybridization in Marine Broadcast Spawners: Reproductive Timing and Mating System Variation	PLOS ONE			English	Article							SUCCESSFUL EXTERNAL FERTILIZATION; FUCUS-VESICULOSUS; GAMETE RELEASE; FUCOID ALGAE; SELF-FERTILIZATION; INTERTIDAL ALGA; NATURAL-POPULATIONS; GENETIC DIVERSITY; LOW TIDE; PHAEOPHYCEAE	Sympatric assemblages of congeners with incomplete reproductive barriers offer the opportunity to study the roles that ecological and non-ecological factors play in reproductive isolation. While interspecific asynchrony in gamete release and gametic incompatibility are known prezygotic barriers to hybridization, the role of mating system variation has been emphasized in plants. Reproductive isolation between the sibling brown algal species Fucus spiralis, Fucus guiryi (selfing hermaphrodite) and Fucus vesiculosus (dioecious) was studied because they form hybrids in parapatry in the rocky intertidal zone, maintain species integrity over a broad geographic range, and have contrasting mating systems. We compared reproductive synchrony (spawning overlap) between the three species at several temporal scales (yearly/seasonal, semilunar/tidal, and hourly during single tides). Interspecific patterns of egg release were coincident at seasonal (single peak in spring to early summer) to semilunar timescales. Synthesis of available data indicated that spawning is controlled by semidiurnal tidal and daily light-dark cues, and not directly by semilunar cycles. Importantly, interspecific shifts in timing detected at the hourly scale during single tides were consistent with a partial ecological prezygotic hybridization barrier. The species displayed patterns of gamete release consistent with a power law distribution, indicating a high degree of reproductive synchrony, while the hypothesis of weaker selective constraints for synchrony in selfing versus outcrossing species was supported by observed spawning in hermaphrodites over a broader range of tidal phase than in outcrossers. Synchronous gamete release is critical to the success of external fertilization, while high-energy intertidal environments may offer only limited windows of reproductive opportunity. Within these windows, however, subtle variations in reproductive timing have evolved with the potential to form ecological barriers to hybridization.	[Monteiro, Carla A.; Serrao, Ester A.; Pearson, Gareth A.] Univ Algarve, CCMAR CIMAR, Faro, Portugal	Universidade do Algarve	Monteiro, CA (corresponding author), Univ Algarve, CCMAR CIMAR, Faro, Portugal.	gpearson@ualg.pt	Serrao, Ester A/C-6686-2012; Monteiro, Carla/M-6078-2013; Pearson, Gareth/J-3911-2013	Serrao, Ester A/0000-0003-1316-658X; Monteiro, Carla/0000-0002-8410-2092; Pearson, Gareth/0000-0002-0768-464X	Portuguese Science Foundation; FEDER (ERDF, European Regional Development Fund); FCT; ESF (European Social Fund)	Portuguese Science Foundation(Portuguese Foundation for Science and Technology); FEDER (ERDF, European Regional Development Fund); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ESF (European Social Fund)(European Social Fund (ESF))	This work was supported by projects from the Portuguese Science Foundation (http://www.fct.pt) co-sponsored by FEDER (ERDF, European Regional Development Fund), and an FCT and ESF (European Social Fund) PhD fellowship to CAM. The European Union Network of Excellence MARBEF-Marine Biodiversity and Ecosystem Function and the NSF (USA) CORONA network provided opportunities for interesting insights and discussions on the topic of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt ML, 2002, MAR ECOL PROG SER, V226, P273, DOI 10.3354/meps226273; Billard E, 2005, EUR J PHYCOL, V40, P397, DOI 10.1080/09670260500334354; Billard E, 2005, J PHYCOL, V41, P900, DOI 10.1111/j.0022-3646.2005.04221.x; Billard E, 2010, MAR ECOL PROG SER, V405, P163, DOI 10.3354/meps08517; BRAWLEY SH, 1992, MAR BIOL, V113, P145, DOI 10.1007/BF00367648; Brawley SH, 1999, AM ZOOL, V39, P218; Canovas FG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-371; Clifton KE, 1997, SCIENCE, V275, P1116, DOI 10.1126/science.275.5303.1116; Coleman MA, 2005, MAR ECOL PROG SER, V300, P63, DOI 10.3354/meps300063; Coleman MA, 2005, J PHYCOL, V41, P753, DOI 10.1111/j.0022-3646.2005.04136.x; Coyne JA, 2004, SPECIATION, V37; DENNY M, 1992, BIOL BULL, V183, P220, DOI 10.2307/1542209; DENNY MW, 1989, AM NAT, V134, P859, DOI 10.1086/285018; Dudgeon S, 2001, ECOLOGY, V82, P991, DOI 10.1890/0012-9658(2001)082[0991:SDRADO]2.0.CO;2; Dudgeon S, 2001, FUNCT ECOL, V15, P595, DOI 10.1046/j.0269-8463.2001.00559.x; Engel CR, 2005, MOL ECOL, V14, P2033, DOI 10.1111/j.1365-294X.2005.02558.x; Forgarty ND, 2012, PLOS ONE, V7; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; Johnson LE, 1998, OECOLOGIA, V117, P517, DOI 10.1007/s004420050688; Knowlton N, 1997, MAR BIOL, V127, P705, DOI 10.1007/s002270050061; Ladah L, 2003, MAR ECOL PROG SER, V262, P173, DOI 10.3354/meps262173; Ladah LB, 2008, MAR BIOL, V155, P583, DOI 10.1007/s00227-008-1054-4; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Luning K, 1990, SEAWEEDS THEIR ENV B; Marshall DJ, 2004, MAR ECOL PROG SER, V266, P135, DOI 10.3354/meps266135; Marshall DJ, 2002, MAR ECOL PROG SER, V236, P113, DOI 10.3354/meps236113; Martin NH, 2007, EVOLUTION, V61, P68, DOI 10.1111/j.1558-5646.2007.00006.x; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; MEAD KS, 1995, BIOL BULL-US, V188, P46, DOI 10.2307/1542066; Moalic Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-33; MULLER DG, 1977, Z PFLANZENPHYSIOL, V84, P85; ORTON JH, 1956, J MAR BIOL ASSOC UK, V35, P149, DOI 10.1017/S0025315400009036; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Pearson GA, 1996, MAR ECOL PROG SER, V143, P211, DOI 10.3354/meps143211; Pearson GA, 1998, ECOLOGY, V79, P1725; Pearson GA, 1998, PLANT PHYSIOL, V118, P305, DOI 10.1104/pp.118.1.305; Pearson GA, 2006, INTEGR COMP BIOL, V46, P587, DOI 10.1093/icb/icl030; Perrin C, 2007, EUR J PHYCOL, V42, P219, DOI 10.1080/09670260701336554; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rundle HD, 2001, EVOLUTION, V55, P198; Schmidt PS, 2008, ECOLOGY, V89, pS91, DOI 10.1890/07-1162.1; Serrao EA, 1996, P NATL ACAD SCI USA, V93, P5286, DOI 10.1073/pnas.93.11.5286; Serrao EA, 1999, J PHYCOL, V35, P382, DOI 10.1046/j.1529-8817.1999.3520382.x; Serrao EA, 2009, ECOL STU AN, P149; SERRAO EA, 1996, THESIS U MAINE; SERRAO EA, 1997, PHYCOLOGIA S, V36, P101; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Takebayashi N, 2001, AM J BOT, V88, P1143, DOI 10.2307/3558325; Tomaiuolo M, 2007, EVOLUTION, V61, P2584, DOI 10.1111/j.1558-5646.2007.00218.x; Yamahira K, 2004, FUNCT ECOL, V18, P4, DOI 10.1046/j.0269-8463.2004.00795.x; Zardi GI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019402	52	20	20	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35978	10.1371/journal.pone.0035978	http://dx.doi.org/10.1371/journal.pone.0035978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563429	gold, Green Published			2022-12-25	WOS:000305349100055
J	Shiryaev, SA; Thomsen, ER; Cieplak, P; Chudin, E; Cheltsov, AV; Chee, MS; Kozlov, IA; Strongin, AY				Shiryaev, Sergey A.; Thomsen, Elliot R.; Cieplak, Piotr; Chudin, Eugene; Cheltsov, Anton V.; Chee, Mark S.; Kozlov, Igor A.; Strongin, Alex Y.			New Details of HCV NS3/4A Proteinase Functionality Revealed by a High-Throughput Cleavage Assay	PLOS ONE			English	Article							HEPATITIS-C VIRUS; IN-VITRO SELECTION; SUBSTRATE-SPECIFICITY; SERINE PROTEINASE; PROTEASE; NS4A; ACTIVATION; DOMAIN; IDENTIFICATION; DETERMINANTS	Background: The hepatitis C virus (HCV) genome encodes a long polyprotein, which is processed by host cell and viral proteases to the individual structural and non-structural (NS) proteins. HCV NS3/4A serine proteinase (NS3/4A) is a non-covalent heterodimer of the N-terminal, similar to 180-residue portion of the 631-residue NS3 protein with the NS4A co-factor. NS3/4A cleaves the polyprotein sequence at four specific regions. NS3/4A is essential for viral replication and has been considered an attractive drug target. Methodology/Principal Findings: Using a novel multiplex cleavage assay and over 2,660 peptide sequences derived from the polyprotein and from introducing mutations into the known NS3/4A cleavage sites, we obtained the first detailed fingerprint of NS3/4A cleavage preferences. Our data identified structural requirements illuminating the importance of both the short-range (P1-P1') and long-range (P6-P5) interactions in defining the NS3/4A substrate cleavage specificity. A newly observed feature of NS3/4A was a high frequency of either Asp or Glu at both P5 and P6 positions in a subset of the most efficient NS3/4A substrates. In turn, aberrations of this negatively charged sequence such as an insertion of a positively charged or hydrophobic residue between the negatively charged residues resulted in inefficient substrates. Because NS5B misincorporates bases at a high rate, HCV constantly mutates as it replicates. Our analysis revealed that mutations do not interfere with polyprotein processing in over 5,000 HCV isolates indicating a pivotal role of NS3/4A proteolysis in the virus life cycle. Conclusions/Significance: Our multiplex assay technology in light of the growing appreciation of the role of proteolytic processes in human health and disease will likely have widespread applications in the proteolysis research field and provide new therapeutic opportunities.	[Shiryaev, Sergey A.; Cieplak, Piotr; Cheltsov, Anton V.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA 92037 USA; [Thomsen, Elliot R.; Chudin, Eugene; Chee, Mark S.; Kozlov, Igor A.] Prognosys Biosci Inc, R&D Dept, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Shiryaev, SA (corresponding author), Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	NIH [R43GM085884, R01GM98835, R01CA83017, R01CA157328]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the NIH grants R43GM085884 (IAK), R01GM98835 (PC), and R01CA83017 and R01CA157328 (AYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett F, 2010, BIOORG MED CHEM LETT, V20, P2617, DOI 10.1016/j.bmcl.2010.02.063; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Case D.A., 2022, AMBER 2020; Chayama K, 2011, J GASTROEN HEPATOL, V26, P83, DOI 10.1111/j.1440-1746.2010.06550.x; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Fan XF, 2009, HEPATOLOGY, V50, P1765, DOI 10.1002/hep.23290; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Hellen CUT, 1999, J VIRAL HEPATITIS, V6, P79, DOI 10.1046/j.1365-2893.1999.00150.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Koch JO, 1997, VIROLOGY, V237, P78, DOI 10.1006/viro.1997.8760; Kurz M, 2001, CHEMBIOCHEM, V2, P666, DOI 10.1002/1439-7633(20010903)2:9<666::AID-CBIC666>3.0.CO;2-#; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Martin MM, 2011, BIOL CHEM, V392, P927, DOI 10.1515/BC.2011.076; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schregel V, 2009, P NATL ACAD SCI USA, V106, P5342, DOI 10.1073/pnas.0810950106; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Steinkuhler C, 1996, J VIROL, V70, P6694; Stempniak M, 1997, J VIROL, V71, P2881, DOI 10.1128/JVI.71.4.2881-2886.1997; Suzuki R, 1999, INTERVIROLOGY, V42, P145, DOI 10.1159/000024973; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Urbani A, 1997, J BIOL CHEM, V272, P9204; Wang WY, 2004, J VIROL, V78, P700, DOI 10.1128/JVI.78.2.700-709.2004; Zhang RM, 1997, J VIROL, V71, P6208, DOI 10.1128/JVI.71.8.6208-6213.1997; Zhu HM, 2011, PROTEINS, V79, P2428, DOI 10.1002/prot.23064	48	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35759	10.1371/journal.pone.0035759	http://dx.doi.org/10.1371/journal.pone.0035759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22768327	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000057
J	Li, Z; Zhao, ZJ; Zhu, XQ; Ren, QS; Nie, FF; Gao, JM; Gao, XJ; Yang, TB; Zhou, WL; Shen, JL; Wang, Y; Lu, FL; Chen, XG; Hide, G; Ayala, FJ; Lun, ZR				Li, Zhi; Zhao, Zhi-Jun; Zhu, Xing-Quan; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Shen, Ji-Long; Wang, Yong; Lu, Fang-Li; Chen, Xiao-Guang; Hide, Geoff; Ayala, Francisco J.; Lun, Zhao-Rong			Differences in iNOS and Arginase Expression and Activity in the Macrophages of Rats Are Responsible for the Resistance against T. gondii Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATED MURINE MACROPHAGES; L-ARGININE METABOLISM; TOXOPLASMA-GONDII; PERITONEAL-MACROPHAGES; POLYAMINE LEVELS; RH STRAIN; CELLS; MECHANISMS; IMMUNITY	Toxoplasma gondii infects humans and warm blooded animals causing devastating disease worldwide. It has long been a mystery as to why the peritoneal macrophages of rats are naturally resistant to T. gondii infection while those of mice are not. Here, we report that high expression levels and activity of inducible nitric oxide synthase (iNOS) and low levels of arginase-1 (Arg 1) activity in the peritoneal macrophages of rats are responsible for their resistance against T. gondii infection, due to high nitric oxide and low polyamines within these cells. The opposite situation was observed in the peritoneal macrophages of mice. This discovery of the opposing functions of iNOS and Arg 1 in rodent peritoneal macrophages may lead to a better understanding of the resistance mechanisms of mammals, particularly humans and livestock, against T. gondii and other intracellular pathogens.	[Li, Zhi; Zhao, Zhi-Jun; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Lu, Fang-Li; Lun, Zhao-Rong] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Zhi; Zhao, Zhi-Jun; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Lu, Fang-Li; Lun, Zhao-Rong] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Xing-Quan; Lun, Zhao-Rong] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China; [Shen, Ji-Long] Anhui Med Univ, Dept Pathogen Biol, Hefei, Anhui, Peoples R China; [Wang, Yong] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Chen, Xiao-Guang] So Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Hide, Geoff; Lun, Zhao-Rong] Univ Salford, Sch Environm & Life Sci, Ctr Parasitol & Dis, Salford M5 4WT, Lancs, England; [Ayala, Francisco J.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Zhao, Zhi-Jun] Ningxia Med Univ, Affiliated Hosp, Yinchuan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Anhui Medical University; Nanjing Medical University; Southern Medical University - China; University of Salford; University of California System; University of California Irvine; Ningxia Medical University	Li, Z (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsslzr@mail.sysu.edu.cn		Hide, Geoff/0000-0002-3608-0175	National Basic Research Program of China (973 Program) [2010CB530000]; National Special Research Programs for Non-Profit Trades (Agriculture) [200803017]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Special Research Programs for Non-Profit Trades (Agriculture)	The work was supported by National Basic Research Program of China (973 Program) (No. 2010CB530000) and the National Special Research Programs for Non-Profit Trades (Agriculture) (No. 200803017), http://www.973.gov.cn/English/Index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallahi OMS, 2001, CELL MOL LIFE SCI, V58, P1350, DOI 10.1007/PL00000947; ADAMS LB, 1990, J IMMUNOL, V144, P2725; Blachier F, 1997, NITRIC OXIDE-BIOL CH, V1, P268, DOI 10.1006/niox.1997.0127; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cavailles P, 2006, P NATL ACAD SCI USA, V103, P744, DOI 10.1073/pnas.0506643103; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; CHINCHILLA M, 1982, J PARASITOL, V68, P952, DOI 10.2307/3281014; CHINCHILLA M, 1978, INFECT IMMUN, V19, P999, DOI 10.1128/IAI.19.3.999-1012.1978; COOK HT, 1994, AM J PHYSIOL-RENAL, V267, pF646, DOI 10.1152/ajprenal.1994.267.4.F646; Cook T, 2007, MICROBIOL-SGM, V153, P1123, DOI 10.1099/mic.0.2006/001768-0; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Da Gama LM, 2004, MICROBES INFECT, V6, P1287, DOI 10.1016/j.micinf.2004.07.008; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; De Champs C, 1998, PARASITE, V5, P215, DOI 10.1051/parasite/1998053215; DING AH, 1988, J IMMUNOL, V141, P2407; Dubey JP, 1998, VET PARASITOL, V77, P1, DOI 10.1016/S0304-4017(97)00227-6; Dubey JP, 1999, J PARASITOL, V85, P657, DOI 10.2307/3285739; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gobert AP, 2002, J IMMUNOL, V168, P6002, DOI 10.4049/jimmunol.168.12.6002; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Hayashi S, 1996, J IMMUNOL, V156, P1476; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; JAMES SL, 1995, MICROBIOL REV, V59, P533, DOI 10.1128/MMBR.59.4.533-547.1995; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kempf MC, 1999, MED MICROBIOL IMMUN, V187, P137, DOI 10.1007/s004300050085; Kmonickova E, 2007, NITRIC OXIDE-BIOL CH, V17, P160, DOI 10.1016/j.niox.2007.06.006; KRAHENBUHL JL, 1975, EXP PARASITOL, V37, P83, DOI 10.1016/0014-4894(75)90055-7; LANGERMANS JAM, 1992, J IMMUNOL, V148, P568; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403; MCCABE RE, 1986, INFECT IMMUN, V52, P151, DOI 10.1128/IAI.52.1.151-155.1986; Mullner N, 2002, INT J BIOCHEM CELL B, V34, P1080, DOI 10.1016/S1357-2725(02)00028-6; Munder M, 1998, J IMMUNOL, V160, P5347; Nishikawa Y, 2003, INT J PARASITOL, V33, P1525, DOI 10.1016/S0020-7519(03)00204-2; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Seabra SH, 2004, J PARASITOL, V90, P455, DOI 10.1645/GE-179R; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Sergent W, 2005, INFECT IMMUN, V73, P6990, DOI 10.1128/IAI.73.10.6990-6997.2005; Stempin CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/683485; von Bargen K, 2011, INFECT IMMUN, V79, P2098, DOI 10.1128/IAI.00983-10; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Zenner L, 1998, EXP PARASITOL, V90, P86, DOI 10.1006/expr.1998.4301	49	79	87	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35834	10.1371/journal.pone.0035834	http://dx.doi.org/10.1371/journal.pone.0035834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558235	Green Accepted, Green Published, gold			2022-12-25	WOS:000305345200084
J	Li, ZR; Carlow, CKS				Li, Zhiru; Carlow, Clotilde K. S.			Characterization of Transcription Factors That Regulate the Type IV Secretion System and Riboflavin Biosynthesis in Wolbachia of Brugia malayi	PLOS ONE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM; MACROFILARICIDAL ACTIVITY; INTRACELLULAR BACTERIA; LEGIONELLA-PNEUMOPHILA; ENDOSYMBIOTIC BACTERIA; DOXYCYCLINE TREATMENT; GENE CLUSTERS; EXPRESSION; PROTEIN; ENDOBACTERIA	The human filarial parasite Brugia malayi harbors an endosymbiotic bacterium Wolbachia (wBm) that is required for parasite survival. Consequently, targeting wBm is a promising approach for anti-filarial drug development. The Type IV secretion system (T4SS) plays an important role in bacteria-host interactions and is under stringent regulation by transcription factors. In wBm, most T4SS genes are contained in two operons. We show the wBm is active since the essential assembly factor virB8-1, is transcribed in adult worms and larval stages, and VirB8-1 is present in parasite lysates. We also identify two transcription factors (wBmxR1 and wBmxR2) that bind to the promoter region of several genes of the T4SS. Gel shift assays show binding of wBmxR1 to regions upstream of the virB9-2 and wBmxR2 genes, whereas wBmxR2 binds to virB4-2 and wBmxR1 promoter regions. Interestingly, both transcription factors bind to the promoter of the ribA gene that precedes virB8-1, the first gene in operon 1 of the wBm T4SS. RT-PCR reveals ribA and virB8-1 genes are co-transcribed as one operon, indicating the ribA gene and T4SS operon 1 are co-regulated by both wBmxR1 and wBmxR2. RibA encodes a bi-functional enzyme that catalyzes two essential steps in riboflavin (Vitamin B2) biosynthesis. Importantly, the riboflavin pathway is absent in B. malayi. We demonstrate the pathway is functional in wBm, and observe vitamin B2 supplementation partially rescues filarial parasites treated with doxycycline, indicating Wolbachia may supply the essential vitamin to its worm host. This is the first characterization of a transcription factor(s) from wBm and first report of co-regulation of genes of the T4SS and riboflavin biosynthesis pathway. In addition, our results demonstrate a requirement of vitamin B2 for worm health and fertility, and imply a nutritional role of the symbiont for the filarial parasite host.	[Li, Zhiru; Carlow, Clotilde K. S.] New England Biolabs Inc, Div Parasitol, Ipswich, MA USA	New England Biolabs	Carlow, CKS (corresponding author), New England Biolabs Inc, Div Parasitol, Ipswich, MA USA.	carlow@neb.com		Hide, Geoff/0000-0002-3608-0175	New England Biolabs	New England Biolabs	This work was funded by New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10; Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Bennett GM, 2012, FLY, V6; Bennuru S, 2011, P NATL ACAD SCI USA, V108, P9649, DOI 10.1073/pnas.1011481108; Bermingham J, 2009, APPL ENVIRON MICROB, V75, P7294, DOI 10.1128/AEM.01472-09; Cheng ZH, 2008, J BACTERIOL, V190, P2096, DOI 10.1128/JB.01813-07; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Debrah AY, 2007, TROP MED INT HEALTH, V12, P1433, DOI 10.1111/j.1365-3156.2007.01949.x; Debrah AY, 2006, PLOS PATHOG, V2, P829, DOI 10.1371/journal.ppat.0020092; Debrah Alexander Yaw, 2006, Filaria J, V5, P1, DOI 10.1186/1475-2883-5-1; Debrah Alexander Yaw, 2011, J Parasitol Res, V2011, P201617, DOI 10.1155/2011/201617; Felix C, 2008, RES MICROBIOL, V159, P481, DOI 10.1016/j.resmic.2008.05.007; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hilleringmann M, 2006, MICROBIOL-SGM, V152, P2919, DOI 10.1099/mic.0.28984-0; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoerauf A, 2009, PARASITOL RES, V104, P437, DOI 10.1007/s00436-008-1217-8; Hoerauf A, 2008, PARASITOL RES, V103, P279, DOI 10.1007/s00436-008-0964-x; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOZEK WJ, 1977, J PARASITOL, V63, P992, DOI 10.2307/3279832; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Li ZR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001411; Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x; Mand S, 2009, AM J TROP MED HYG, V81, P702, DOI 10.4269/ajtmh.2009.09-0155; Martinez-Nunez C, 2010, J BACTERIOL, V192, P5603, DOI 10.1128/JB.00567-10; Masui S, 2000, J BACTERIOL, V182, P6529, DOI 10.1128/JB.182.22.6529-6531.2000; Mathews SA, 1999, FEBS LETT, V458, P354, DOI 10.1016/S0014-5793(99)01182-5; McGarry HF, 2004, MOL BIOCHEM PARASIT, V135, P57, DOI 10.1016/j.molbiopara.2004.01.006; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; Miller MA, 1972, EXPT MOL GENETICS; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Narita S, 2007, APPL ENVIRON MICROB, V73, P4332, DOI 10.1128/AEM.00145-07; Ohashi N, 2002, INFECT IMMUN, V70, P2128, DOI 10.1128/IAI.70.4.2128-2138.2002; Paschos A, 2011, INFECT IMMUN, V79, P1033, DOI 10.1128/IAI.00993-10; Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118; Rances E, 2008, J BACTERIOL, V190, P5020, DOI 10.1128/JB.00377-08; Rao RU, 2002, EXP PARASITOL, V101, P77, DOI 10.1016/S0014-4894(02)00019-X; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Rikihisa Y, 2009, ANN NY ACAD SCI, V1166, P106, DOI 10.1111/j.1749-6632.2009.04527.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sunish IP, 2011, TROP BIOMED, V28, P569; Taylor MJ, 2005, LANCET, V365, P2116, DOI 10.1016/S0140-6736(05)66591-9; Taylor MJ, 1999, EXP PARASITOL, V91, P356, DOI 10.1006/expr.1998.4383; Wang XQ, 2007, J BACTERIOL, V189, P4880, DOI 10.1128/JB.00318-07; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544; Zusman T, 2007, MOL MICROBIOL, V63, P1508, DOI 10.1111/j.1365-2958.2007.05604.x	62	79	87	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51597	10.1371/journal.pone.0051597	http://dx.doi.org/10.1371/journal.pone.0051597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	22558235	Green Submitted, gold, Green Published			2022-12-25	WOS:000312201900107
J	Han, YL; Li, YL; Jia, LX; Cheng, JZ; Qi, YF; Zhang, HJ; Du, J				Han, Ya-lei; Li, Yu-lin; Jia, Li-xin; Cheng, Ji-zhong; Qi, Yong-fen; Zhang, Hong-jia; Du, Jie			Reciprocal Interaction between Macrophages and T cells Stimulates IFN-gamma and MCP-1 Production in Ang II-induced Cardiac Inflammation and Fibrosis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; ANGIOTENSIN-II; INTERFERON-GAMMA; FIBROBLAST PRECURSORS; CYTOKINE PROFILES; MYOCARDITIS; HYPERTENSION; EXPRESSION; SYSTEM	Background: The inflammatory response plays a critical role in hypertension-induced cardiac remodeling. We aimed to study how interaction among inflammatory cells causes inflammatory responses in the process of hypertensive cardiac fibrosis. Methodology/Principal Findings: Infusion of angiotensin II (Ang II, 1500 ng/kg/min) in mice rapidly induced the expression of interferon gamma (IFN-gamma) and leukocytes infiltration into the heart. To determine the role of IFN-gamma on cardiac inflammation and remodeling, both wild-type (WT) and IFN-gamma-knockout (KO) mice were infused Ang II for 7 days, and were found an equal blood pressure increase. However, knockout of IFN-gamma prevented Ang II-induced: 1) infiltration of macrophages and T cells into cardiac tissue; 2) expression of tumor necrosis factor a and monocyte chemoattractant protein 1 (MCP-1), and 3) cardiac fibrosis, including the expression of alpha-smooth muscle actin and collagen I (all p<0.05). Cultured T cells or macrophages alone expressed very low level of IFN-gamma, however, co-culture of T cells and macrophages increased IFN-gamma expression by 19.860.95 folds ( vs. WT macrophage, p<0.001) and 20.9 +/- 2.09 folds (vs. WT T cells, p<0.001). In vitro co-culture studies using T cells and macrophages from WT or IFN-gamma KO mice demonstrated that T cells were primary source for IFN-gamma production. Co-culture of WT macrophages with WT T cells, but not with IFN-gamma-knockout T cells, increased IFN-gamma production (p<0.01). Moreover, IFN-gamma produced by T cells amplified MCP-1 expression in macrophages and stimulated macrophage migration. Conclusions/Significance: Reciprocal interaction between macrophages and T cells in heart stimulates IFN-gamma expression, leading to increased MCP-1 expression in macrophages, which results a forward-feed recruitment of macrophages, thus contributing to Ang II-induced cardiac inflammation and fibrosis.	[Han, Ya-lei; Li, Yu-lin; Jia, Li-xin; Cheng, Ji-zhong; Qi, Yong-fen; Zhang, Hong-jia; Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China; [Qi, Yong-fen; Zhang, Hong-jia; Du, Jie] Inst Heart Lung & Blood Vessel Dis, Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China	Capital Medical University	Han, YL (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China.	jdu@bcm.edu	Li, yulin/AGZ-5611-2022	Han, Ying/0000-0001-8591-7894; Zhu, Guo-Qing/0000-0002-3132-9592	Chinese Ministry of Science and Technology [2012CB517802, 2012CB945104]; National Science Foundation of China [30888004, 31090363]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the Chinese Ministry of Science and Technology (2012CB517802 and 2012CB945104) and from the National Science Foundation of China (30888004 and 31090363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva M, 2005, P NATL ACAD SCI USA, V102, P180, DOI 10.1073/pnas.0408241102; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Brands MW, 2010, HYPERTENSION, V56, P879, DOI 10.1161/HYPERTENSIONAHA.110.158071; Cheng JZ, 2007, ARTERIOSCL THROM VAS, V27, P1744, DOI 10.1161/ATVBAHA.107.147371; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Coelho PS, 2002, J LEUKOCYTE BIOL, V71, P837; Fairweather D, 2004, AM J PATHOL, V165, P1883, DOI 10.1016/S0002-9440(10)63241-5; Fairweather D, 2003, J IMMUNOL, V170, P4731, DOI 10.4049/jimmunol.170.9.4731; Fauvel JP, 2003, HYPERTENSION, V42, P1112, DOI 10.1161/01.HYP.0000102862.93418.EE; Finckenberg P, 2003, AM J PATHOL, V163, P355, DOI 10.1016/S0002-9440(10)63659-0; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Hilgers KF, 2000, KIDNEY INT, V58, P2408, DOI 10.1046/j.1523-1755.2000.00424.x; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kawai C, 1999, CIRCULATION, V99, P1091, DOI 10.1161/01.CIR.99.8.1091; Lin AA, 2009, J VIROL, V83, P8604, DOI 10.1128/JVI.02477-08; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Mazzolai L, 2004, HYPERTENSION, V44, P277, DOI 10.1161/01.HYP.0000140269.55873.7b; Muller DN, 2000, HYPERTENSION, V35, P193, DOI 10.1161/01.HYP.35.1.193; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Ponomarev ED, 2004, J IMMUNOL, V173, P1587, DOI 10.4049/jimmunol.173.3.1587; Pore D, 2012, J BIOL CHEM IN PRESS; Puddu P, 1997, J IMMUNOL, V159, P3490; Qi GM, 2011, CARDIOVASC TOXICOL, V11, P157, DOI 10.1007/s12012-011-9109-z; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Rogers L, 2008, CARDIOVASC RES, V78, P167, DOI 10.1093/cvr/cvn005; Shao J, 2003, HYPERTENSION, V42, P31, DOI 10.1161/01.HYP.0000075082.06183.4E; Sturgis LC, 2009, AM J PHYSIOL-REG I, V297, pR1742, DOI 10.1152/ajpregu.90995.2008; Takahashi M, 2008, AM J PHYSIOL-HEART C, V294, pH2879, DOI 10.1152/ajpheart.91406.2007; Tang PCY, 2005, FASEB J, V19, P1528, DOI 10.1096/fj.05-3671fje; Valentincic NV, 2011, MOL VIS, V17, P2003; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	43	83	87	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35506	10.1371/journal.pone.0035506	http://dx.doi.org/10.1371/journal.pone.0035506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567105	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341500023
J	Yang, SY; Keshavmurthy, S; Obura, D; Sheppard, CRC; Visram, S; Chen, CA				Yang, Sung-Yin; Keshavmurthy, Shashank; Obura, David; Sheppard, Charles R. C.; Visram, Shakil; Chen, Chaolun Allen			Diversity and Distribution of Symbiodinium Associated with Seven Common Coral Species in the Chagos Archipelago, Central Indian Ocean	PLOS ONE			English	Article							SYMBIOTIC ALGAE; CLIMATE-CHANGE; SCLERACTINIAN CORALS; MOLECULAR DIVERSITY; REEF CORALS; ZOOXANTHELLAE; HOST; PATTERNS; IDENTIFICATION; COMMUNITIES	The Chagos Archipelago designated as a no-take marine protected area in 2010, lying about 500 km south of the Maldives in the Indian Ocean, has a high conservation priority, particularly because of its fast recovery from the ocean-wide massive coral mortality following the 1998 coral bleaching event. The aims of this study were to examine Symbiodinium diversity and distribution associated with scleractinian corals in five atolls of the Chagos Archipelago, spread over 10,000 km(-2). Symbiodinium clade diversity in 262 samples of seven common coral species, Acropora muricata, Isopora palifera, Pocillopora damicornis, P. verrucosa, P. eydouxi, Seriatopora hystrix, and Stylophora pistillata were determined using PCR-SSCP of the ribosomal internal transcribed spacer 1 (ITS1), PCR-DDGE of ITS2, and phylogenetic analyses. The results indicated that Symbiodinium in clade C were the dominant symbiont group in the seven coral species. Our analysis revealed types of Symbiodinium clade C specific to coral species. Types C1 and C3 (with C3z and C3i variants) were dominant in Acroporidae and C1 and C1c were the dominant types in Pocilloporidae. We also found 2 novel ITS2 types in S. hystrix and 1 novel ITS2 type of Symbiodinium in A. muricata. Some colonies of A. muricata and I. palifera were also associated with Symbiodinium A1. These results suggest that corals in the Chagos Archipelago host different assemblages of Symbiodinium types then their conspecifics from other locations in the Indian Ocean; and that future research will show whether these patterns in Symbiodinium genotypes may be due to local adaptation to specific conditions in the Chagos.	[Yang, Sung-Yin; Keshavmurthy, Shashank; Visram, Shakil; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Obura, David; Visram, Shakil] CORDIO, Mombasa, Kenya; [Obura, David; Sheppard, Charles R. C.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Chen, Chaolun Allen] Natl Taiwan Univ, Taipei 10764, Taiwan	Academia Sinica - Taiwan; University of Warwick; National Taiwan University	Yang, SY (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.	cac@gate.sinica.edu.tw	Yu, Hongjie/GZK-5351-2022; Chen, Yu/Y-3292-2019; Xiao, Yonghong/AFS-9054-2022; Keshavmurthy, Shashank/C-3672-2013; Matz, Mikhail/K-4392-2017	Keshavmurthy, Shashank/0000-0002-2235-9132; sheppard, charles/0000-0002-2579-5124; Yang, Sung-Yin/0000-0001-7431-406X; Wang, Dao Wen/0000-0002-9774-3980; Matz, Mikhail/0000-0001-5453-9819; Obura, David/0000-0003-2256-6649; Rao, Xiaoquan/0000-0001-7316-4530	Academia Sinica Thematic Grants; CORDIO; Chagos Conservation Trust; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship	Academia Sinica Thematic Grants; CORDIO; Chagos Conservation Trust; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship(Academia Sinica - Taiwan)	This study was partly funded by Academia Sinica Thematic Grants (2005-2010), CORDIO and Chagos Conservation Trust. SK was supported by National Science Council postdoctoral fellowship (2008-2010) and Academia Sinica postdoctoral fellowship (2010-2012), SV by Academia Sinica postdoctoral fellowship (2007-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Baker AC, 2004, CORAL HEALTH AND DISEASE, P177; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brown BE, 1997, ADV MAR BIOL, V31, P221, DOI 10.1016/S0065-2881(08)60224-2; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; Chen CA, 2000, MAR BIOTECHNOL, V2, P146; Chen CA, 2005, CORAL REEFS, V24, P11, DOI 10.1007/s00338-004-0389-7; Chen CA, 2003, ZOOL STUD, V42, P540; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Goulet TL, 2003, MAR BIOL, V142, P233, DOI 10.1007/s00227-002-0936-0; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Koldewey HJ, 2010, MAR POLLUT BULL, V60, P1906, DOI 10.1016/j.marpolbul.2010.10.002; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, BIOL INVASIONS, V11, P995, DOI 10.1007/s10530-008-9311-5; Lien YT, 2007, CORAL REEFS, V26, P35, DOI 10.1007/s00338-006-0185-7; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; Magalon H, 2007, CORAL REEFS, V26, P551, DOI 10.1007/s00338-007-0215-0; Mangi S, 2010, WORKSH HELD 7 JAN 20; McPhaden MJ, 2009, B AM METEOROL SOC, V90, P459, DOI 10.1175/2008BAMS2608.1; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Pochon X, 2004, MAR BIOL, V146, P17, DOI 10.1007/s00227-004-1427-2; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Sheppard C, 2005, J NAT HIST, V39, P103, DOI 10.1080/00222930310001657900; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard C, 2006, CONSERV BIOL SER, P264; Sheppard Charles R.C., 2000, P3; Sheppard CRC, 1999, AMBIO, V28, P472; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Sheppard CRC, 2012, MAR FRESHWATER RES, DOI [10.1002/aqc.1248, DOI 10.1002/AQC.1248]; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen Madeleine J. H., 2009, V205, P83; Van Woesik Robert, 2009, Galaxea - Tokyo, V11, P53; Visram S, 2006, J MAR BIOL ASSOC UK, V86, P1281, DOI 10.1017/S0025315406014299; Visram S, 2006, CORAL REEFS, V25, P172, DOI 10.1007/s00338-005-0079-0; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x	67	115	121	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35836	10.1371/journal.pone.0035836	http://dx.doi.org/10.1371/journal.pone.0035836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567113	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500031
J	Santos, ARC; Corredor, RG; Obeso, BA; Trakhtenberg, EF; Wang, Y; Ponmattam, J; Dvoriantchikova, G; Ivanov, D; Shestopalov, VI; Goldberg, JL; Fini, ME; Bajenaru, ML				Santos, Andrea Rachelle C.; Corredor, Raul G.; Obeso, Betty Albo; Trakhtenberg, Ephraim F.; Wang, Ying; Ponmattam, Jamie; Dvoriantchikova, Galina; Ivanov, Dmitry; Shestopalov, Valery I.; Goldberg, Jeffrey L.; Fini, Mary Elizabeth; Bajenaru, Michaela Livia			beta 1 Integrin-Focal Adhesion Kinase (FAK) Signaling Modulates Retinal Ganglion Cell (RGC) Survival	PLOS ONE			English	Article							NEURITE OUTGROWTH; EXTRACELLULAR-MATRIX; AXONAL REGENERATION; LINKED KINASE; UP-REGULATION; BRAIN-INJURY; OPTIC-NERVE; IN-VITRO; ISCHEMIA; PATHWAY	Extracellular matrix (ECM) integrity in the central nervous system (CNS) is essential for neuronal homeostasis. Signals from the ECM are transmitted to neurons through integrins, a family of cell surface receptors that mediate cell attachment to ECM. We have previously established a causal link between the activation of the matrix metalloproteinase-9 (MMP-9), degradation of laminin in the ECM of retinal ganglion cells (RGCs), and RGC death in a mouse model of retinal ischemia-reperfusion injury (RIRI). Here we investigated the role of laminin-integrin signaling in RGC survival in vitro, and after ischemia in vivo. In purified primary rat RGCs, stimulation of the beta 1 integrin receptor with laminin, or agonist antibodies enhanced RGC survival in correlation with activation of beta 1 integrin's major downstream regulator, focal adhesion kinase (FAK). Furthermore, beta 1 integrin binding and FAK activation were required for RGCs' survival response to laminin. Finally, in vivo after RIRI, we observed an up-regulation of MMP-9, proteolytic degradation of laminin, decreased RGC expression of beta 1 integrin, FAK and Akt dephosphorylation, and reduced expression of the pro-survival molecule bcl-xL in the period preceding RGC apoptosis. RGC death was prevented, in the context of laminin degradation, by maintaining beta 1 integrin activation with agonist antibodies. Thus, disruption of homeostatic RGC-laminin interaction and signaling leads to cell death after retinal ischemia, and maintaining integrin activation may be a therapeutic approach to neuroprotection.	[Santos, Andrea Rachelle C.; Corredor, Raul G.; Obeso, Betty Albo; Trakhtenberg, Ephraim F.; Wang, Ying; Ponmattam, Jamie; Dvoriantchikova, Galina; Ivanov, Dmitry; Shestopalov, Valery I.; Goldberg, Jeffrey L.; Fini, Mary Elizabeth; Bajenaru, Michaela Livia] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Trakhtenberg, Ephraim F.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Neurosci Program, Miami, FL 33136 USA; [Fini, Mary Elizabeth] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; University of Southern California	Bajenaru, ML (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	lbajenaru@med.miami.edu	Santos, Ana M./AAB-6302-2019; López-Sánchez, Noelia/F-5533-2010; Frade, Jose M/E-7913-2013; Martín-Oliva, David/L-8472-2014; de la Villa, Pedro/G-2322-2016; Shestopalov, Valery/AAE-9838-2020; Cuadros, Miguel A/L-3954-2014	Santos, Ana M./0000-0002-9540-2226; Frade, Jose M/0000-0001-7067-2505; Martín-Oliva, David/0000-0002-8095-5442; de la Villa, Pedro/0000-0001-9856-6616; Cuadros, Miguel A/0000-0003-4259-1649; Goldberg, Jeffrey/0000-0002-1390-7360; Shestopalov, Valery/0000-0002-1568-6637; Lopez-Sanchez, Noelia/0000-0003-3095-3438; Ivanov, Dmitry/0000-0002-5573-4402	American Heart Association (AHA) [09SDG2280555, 0735014B, 11PRE7310069]; National Institutes of Health (NIH) [EY12651]; NIH [EY020913, NS061348, R21EY020613, EY017991, T32 NS007492, 5 P30-EY014801-08]; Glaucoma Foundation (TGF); Research to Prevent Blindness (RPB)	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Foundation (TGF); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	The authors acknowledge support from American Heart Association (http://www.heart.org/HEARTORG/) Scientist Development Grant (AHA SDG) 09SDG2280555 to M.L.B.; National Institutes of Health (http://www.nih.gov/) (NIH) grant EY12651, Walter G. Ross Distinguished Chair in Ophthalmic Research to M.E.F.; NIH grant EY020913, NS061348, and Walter G. Ross Distinguished Chair in Ophthalmic Research to J.L.G; NIH grant R21EY020613, American Heart Association (AHA) 0735014B to D.I.; NIH grant EY017991, The Glaucoma Foundation (http://www.glaucomafoundation.org/) (TGF) grant, Research to Prevent Blindness (https://www.rpbusa.org/rpb/)(RPB) Career Development Award to V.I.S.; NIH grant T32 NS007492, American Heart Association (AHA) 11PRE7310069 to E.F.T. Bascom Palmer is also supported by NIH core center grant 5 P30-EY014801-08, and an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AE, 1998, PHARMACOL REV, V50, P197; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asahi M, 2001, NEUROREPORT, V12, P3003, DOI 10.1097/00001756-200109170-00050; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Bozzi M, 2009, MATRIX BIOL, V28, P179, DOI 10.1016/j.matbio.2009.03.003; BREM RB, 1994, INVEST OPHTH VIS SCI, V35, P3466; Brocco MA, 1999, DEV BRAIN RES, V118, P23, DOI 10.1016/S0165-3806(99)00120-0; BUCHI ER, 1991, OPHTHALMOLOGICA, V203, P138; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Clegg DO, 2003, FRONT BIOSCI-LANDMRK, V8, pD723, DOI 10.2741/1020; COHEN S, 1987, IN VITRO CELL DEV B, V23, P239; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; DECURTIS I, 1993, DEVELOPMENT, V118, P377; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; DRAZBA J, 1990, DEV BIOL, V138, P82, DOI 10.1016/0012-1606(90)90178-L; Dreixler JC, 2009, EXP EYE RES, V88, P512, DOI 10.1016/j.exer.2008.11.013; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gardiner NJ, 2005, MOL CELL NEUROSCI, V28, P229, DOI 10.1016/j.mcn.2004.08.017; Gary DS, 2003, J NEUROCHEM, V84, P878, DOI 10.1046/j.1471-4159.2003.01579.x; Gary DS, 2001, J NEUROCHEM, V76, P1485, DOI 10.1046/j.1471-4159.2001.00173.x; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Grimpe B, 2002, J NEUROSCI, V22, P3144, DOI 10.1523/JNEUROSCI.22-08-03144.2002; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Halfter W, 2000, DEV BIOL, V220, P111, DOI 10.1006/dbio.2000.9649; Hu Y, 2010, INVEST OPHTH VIS SCI, V51, P1747, DOI 10.1167/iovs.09-4450; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Ivins JK, 2004, J NEUROSCI, V24, P1212, DOI 10.1523/JNEUROSCI.4689-03.2004; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; Ju WK, 2003, EXP EYE RES, V77, P137, DOI 10.1016/S0014-4835(03)00128-3; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kaneda K, 1999, BRAIN RES, V815, P11, DOI 10.1016/S0006-8993(98)01074-9; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Kunzevitzky NJ, 2010, INVEST OPHTH VIS SCI, V51, P3800, DOI 10.1167/iovs.09-4540; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P967; Lemons ML, 2006, EXP NEUROL, V202, P324, DOI 10.1016/j.expneurol.2006.06.008; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Libby R T, 2000, Results Probl Cell Differ, V31, P115; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Limb GA, 2002, AM J PATHOL, V160, P1847, DOI 10.1016/S0002-9440(10)61131-5; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Manabe S, 2005, INVEST OPHTH VIS SCI, V46, P4747, DOI 10.1167/iovs.05-0128; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Molina A, 2005, J AM SOC NEPHROL, V16, P374, DOI 10.1681/ASN.2004070528; Morissette N, 1995, J NEUROSCI, V15, P8067; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; NEUGEBAUER KM, 1991, NATURE, V350, P68, DOI 10.1038/350068a0; Otsuka K, 1997, J Nihon Univ Sch Dent, V39, P182; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Plantman S, 2005, NEUROREPORT, V16, P709, DOI 10.1097/00001756-200505120-00011; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; SARTHY PV, 1990, J CELL BIOL, V110, P2099, DOI 10.1083/jcb.110.6.2099; Savitz SI, 2006, BRAIN RES, V1118, P168, DOI 10.1016/j.brainres.2006.05.060; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Tagami Y, 2009, JPN J OPHTHALMOL, V53, P257, DOI 10.1007/s10384-009-0657-8; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Tonges L, 2011, J NEUROCHEM, V117, P892, DOI 10.1111/j.1471-4159.2011.07257.x; Vachon P. H., 2011, J SIGNAL TRANSDUCT, V2011; WEAVER CD, 1995, J NEUROSCI, V15, P5275; Yu WM, 2005, J NEUROSCI, V25, P4463, DOI 10.1523/JNEUROSCI.5032-04.2005; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhang C, 2005, EXP EYE RES, V81, P700, DOI 10.1016/j.exer.2005.04.008; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhang Y, 2005, INVEST OPHTH VIS SCI, V46, P2133, DOI 10.1167/iovs.04-1235; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	89	53	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48332	10.1371/journal.pone.0048332	http://dx.doi.org/10.1371/journal.pone.0048332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	22558402	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500108
J	Tian, DL; Peiffer, M; Shoemaker, E; Tooker, J; Haubruge, E; Francis, F; Luthe, DS; Felton, GW				Tian, Donglan; Peiffer, Michelle; Shoemaker, Erica; Tooker, John; Haubruge, Eric; Francis, Frederic; Luthe, Dawn S.; Felton, Gary W.			Salivary Glucose Oxidase from Caterpillars Mediates the Induction of Rapid and Delayed-Induced Defenses in the Tomato Plant	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; TRANSCRIPTIONAL RESPONSES; HELICOVERPA-ARMIGERA; GLANDULAR TRICHOMES; GENE-EXPRESSION; HOST-PLANT; CROSS-TALK; ARMS-RACE; JASMONATE; HERBIVORY	Caterpillars produce oral secretions that may serve as cues to elicit plant defenses, but in other cases these secretions have been shown to suppress plant defenses. Ongoing work in our laboratory has focused on the salivary secretions of the tomato fruitworm, Helicoverpa zea. In previous studies we have shown that saliva and its principal component glucose oxidase acts as an effector by suppressing defenses in tobacco. In this current study, we report that saliva elicits a burst of jasmonic acid (JA) and the induction of late responding defense genes such as proteinase inhibitor 2 (Pin2). Transcripts encoding early response genes associated with the JA pathway were not affected by saliva. We also observed a delayed response to saliva with increased densities of Type VI glandular trichomes in newly emerged leaves. Proteomic analysis of saliva revealed glucose oxidase (GOX) was the most abundant protein identified and we confirmed that it plays a primary role in the induction of defenses in tomato. These results suggest that the recognition of GOX in tomato may represent a case for effector-triggered immunity. Examination of saliva from other caterpillar species indicates that saliva from the noctuids Spodoptera exigua and Heliothis virescens also induced Pin2 transcripts.	[Tian, Donglan; Peiffer, Michelle; Shoemaker, Erica; Tooker, John; Luthe, Dawn S.; Felton, Gary W.] Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA; [Haubruge, Eric; Francis, Frederic] Univ Liege, Gembloux Agrobio Tech, Liege, Belgium; [Luthe, Dawn S.] Penn State Univ, Dept Crop & Soil Sci, Ctr Chem Ecol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tian, DL (corresponding author), Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA.	gwf10@psu.edu	Felton, Gary W./E-8575-2013; Tooker, John/P-6421-2014; Han, Xingguo/K-7552-2016	Tooker, John/0000-0002-9303-6699; Haubruge, Eric/0000-0002-8138-0476; Han, Xingguo/0000-0002-1836-975X	United States Department of Agriculture and Food Research Initiative program [2010-65105-20639, 2011-67013-30352]	United States Department of Agriculture and Food Research Initiative program	Support by the United States Department of Agriculture and Food Research Initiative program (2010-65105-20639 and 2011-67013-30352) awarded to GWF and DSL made this research possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Alborn HT, 2003, J CHEM ECOL, V29, P1357, DOI 10.1023/A:1024209302628; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Bassel GW, 2004, PLANT PHYSIOL, V136, P2782, DOI 10.1104/pp.103.034876; Bede JC, 2006, PLANT MOL BIOL, V60, P519, DOI 10.1007/s11103-005-4923-y; Bjorkman C, 2008, NEW PHYTOL, V179, P176, DOI 10.1111/j.1469-8137.2008.02442.x; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bonaventure G, 2011, TRENDS PLANT SCI, V16, P294, DOI 10.1016/j.tplants.2011.01.006; Boughton AJ, 2005, J CHEM ECOL, V31, P2211, DOI 10.1007/s10886-005-6228-7; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Campos ML, 2009, J EXP BOT, V60, P4346, DOI 10.1093/jxb/erp270; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung SH, 2011, J CHEM ECOL, V37, P378, DOI 10.1007/s10886-011-9937-0; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; Dalin P, 2003, OECOLOGIA, V134, P112, DOI 10.1007/s00442-002-1093-3; Delphia CM, 2006, PLANT SIGNAL BEHAV, V1, P243, DOI 10.4161/psb.1.5.3279; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; Diez-Diaz M, 2004, PHYTOCHEMISTRY, V65, P1919, DOI 10.1016/j.phytochem.2004.06.007; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; DOARES SH, 1995, PLANT PHYSIOL, V108, P1741, DOI 10.1104/pp.108.4.1741; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Eichenseer H, 2002, J INSECT PHYSIOL, V48, P311, DOI 10.1016/S0022-1910(01)00178-0; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Farmer EE, 2007, NATURE, V448, P659, DOI 10.1038/448659a; Felton Gary W., 2008, P369, DOI 10.1007/978-1-4020-8182-8_18; Felton GW, 2005, P NATL ACAD SCI USA, V102, P18771, DOI 10.1073/pnas.0509895102; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Felton GW, 1999, CURR BIOL, V9, P317, DOI 10.1016/S0960-9822(99)80140-7; FELTON GW, 1993, J CHEM ECOL, V19, P1553, DOI 10.1007/BF00984896; FELTON GW, 1992, J CHEM ECOL, V18, P571, DOI 10.1007/BF00987820; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Gurr GM, 2002, ENTOMOL EXP APPL, V103, P35, DOI 10.1023/A:1019819722203; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Howe G-A, 1996, PLANT CELL; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; Jia YL, 1999, PLANT MOL BIOL, V40, P455, DOI 10.1023/A:1006213324555; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Lawrence SD, 2007, J CHEM ECOL, V33, P1041, DOI 10.1007/s10886-007-9285-2; Leitner M, 2005, NEW PHYTOL, V167, P597, DOI 10.1111/j.1469-8137.2005.01426.x; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; LIGHTNER J, 1993, MOL GEN GENET, V241, P595, DOI 10.1007/BF00279902; Lin L, 2008, J CHEM ECOL, V34, P353, DOI 10.1007/s10886-008-9439-x; Liu F, 2004, J CHEM ECOL, V30, P2439, DOI 10.1007/s10886-004-7944-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Mori N, 2001, J INSECT PHYSIOL, V47, P749, DOI 10.1016/S0022-1910(00)00171-2; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Narvaez-Vasquez J, 2005, P NATL ACAD SCI USA, V102, P12974, DOI 10.1073/pnas.0505248102; Narvaez-Vasquez J, 2004, PLANTA, V218, P360, DOI 10.1007/s00425-003-1115-3; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Orozco-Cardenas ML, 2002, PLANT PHYSIOL, V130, P487, DOI 10.1104/pp.008375; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; Pearce G, 2003, J BIOL CHEM, V278, P30044, DOI 10.1074/jbc.M304159200; Peiffer M, 2005, ARCH INSECT BIOCHEM, V58, P106, DOI 10.1002/arch.20034; Peiffer M, 2009, J CHEM ECOL, V35, P326, DOI 10.1007/s10886-009-9604-x; Qu N, 2004, PLANT PHYSIOL, V135, P539, DOI 10.1104/pp.103.037036; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Rose USR, 2005, PLANTA, V222, P327, DOI 10.1007/s00425-005-1528-2; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sagi M, 2004, PLANT CELL, V16, P616, DOI 10.1105/tpc.019398; Schmelz EA, 2006, P NATL ACAD SCI USA, V103, P8894, DOI 10.1073/pnas.0602328103; Schmelz EA, 2003, P NATL ACAD SCI USA, V100, P10552, DOI 10.1073/pnas.1633615100; Schmidt DD, 2005, PLANT PHYSIOL, V138, P1763, DOI 10.1104/pp.105.061192; Simmons AT, 2004, AUST J ENTOMOL, V43, P196, DOI 10.1111/j.1440-6055.2004.00414.x; TAYLOR BH, 1993, PLANT MOL BIOL, V23, P1005, DOI 10.1007/BF00021815; Thaler J-S, 2001, ECOLOGICAL ENTOMOLOG; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Thaler JS, 2002, OECOLOGIA, V131, P227, DOI 10.1007/s00442-002-0885-9; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thipyapong P, 2007, MOLECULES, V12, P1569, DOI 10.3390/12081569; Tooker JF, 2005, J CHEM ECOL, V31, P2753, DOI 10.1007/s10886-005-8553-2; Traw MB, 2002, OECOLOGIA, V131, P526, DOI 10.1007/s00442-002-0924-6; Vandenabeele S, 2003, P NATL ACAD SCI USA, V100, P16113, DOI 10.1073/pnas.2136610100; Vellosillo T, 2010, PLANT PHYSIOL, V154, P444, DOI 10.1104/pp.110.161273; Victoriano E, 2002, ARTHROPOD STRUCT DEV, V31, P15, DOI 10.1016/S1467-8039(02)00013-0; VINCENT R, 1983, ANAL BIOCHEM, V135, P355, DOI 10.1016/0003-2697(83)90696-6; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Weech MH, 2008, J EXP BOT, V59, P2437, DOI 10.1093/jxb/ern108; Yoshinaga N, 2007, J CHEM ECOL, V33, P1376, DOI 10.1007/s10886-007-9321-2	93	96	107	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36168	10.1371/journal.pone.0036168	http://dx.doi.org/10.1371/journal.pone.0036168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558369	gold, Green Published			2022-12-25	WOS:000305340200046
J	Yang, SG; Cao, B; Liang, LR; Li, XL; Xiao, YH; Cao, ZX; Jia, HY; Yu, HJ; Xu, Z; Gu, L; Yang, YD; Chen, Y; Du, WB; Yan, XX; Liang, ZA; Zhang, W; Zhang, CL; Chen, W; Guo, CP; Jiang, XL; Yang, M; Deng, GM; Yu, KJ; Hu, K; Zou, Q; Li, LJ; Wang, C				Yang, Shi-gui; Cao, Bin; Liang, Li-rong; Li, Xiao-li; Xiao, Yong-hong; Cao, Zhi-xin; Jia, Hong-yu; Yu, Hong-jie; Xu, Zhen; Gu, Li; Yang, Yi-da; Chen, Yu; Du, Wei-bo; Yan, Xi-xin; Liang, Zong-an; Zhang, Wei; Zhang, Chang-le; Chen, Wei; Guo, Cai-ping; Jiang, Xun-liang; Yang, Ming; Deng, Guang-ming; Yu, Kai-jiang; Hu, Ke; Zou, Qi; Li, Lan-juan; Wang, Chen		Natl Influenza Pandemic H1N1 2009	Antiviral Therapy and Outcomes of Patients with Pneumonia Caused by Influenza A Pandemic (H1N1) Virus	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; RISK-FACTORS; HOSPITALIZATION; OSELTAMIVIR; A(H1N1)	Background: There is limited data on the clinical outcome of patients with pandemic H1N1 (pH1N1) pneumonia who received oseltamivir treatment, especially when the treatment was administered more than 48 hours after symptom onset. Methods: During the pandemic in 2009, a cohort of pH1N1 influenza pneumonia was built in China, and their clinical information was collected systematically, and analyzed with Cox models. Results: 920 adults and 541 children with pneumonia who didn't receive corticosteroids were analyzed. In-hospital mortality was higher in adults who did not receive antiviral therapy (18.2%) than those with who received oseltamivir <= 2days (2.9%), between 2-5 days (4.6%) and >5 days after illness onset (4.9%), p<0.01. A similar trend was observed in pediatric patients. Cox regression showed that at 60 days after symptoms onset, 11 patients (10.8%) who did not receive antivirals died versus 4 (1.8%), 18 (3.3%), and 23 (3.7%) patients whose oseltamivir treatment was started <= 2days, between 2-5days, and >5 days, respectively. For males patients, aged >= 14 years and baseline PaO2/FiO(2)<200, oseltamivir administration reduced the mortality risk by 92.1%, 88% and 83.5%, respectively. Higher doses of oseltamivir (>3.8 mg/kg/d) did not improve clinical outcome (mortality, higher dose 2.5% vs standard dose 2.8%, p>0.05). Conclusions: Antiviral therapy might reduce mortality of patients with pH1N1 pneumonia, even when initiated more than 48 hours after onset of illness. Greater protective effects might be in males, patients aged 14-60 years, and patients with PaO2/FiO(2)<200.	[Yang, Shi-gui; Xiao, Yong-hong; Jia, Hong-yu; Yang, Yi-da; Chen, Yu; Du, Wei-bo; Li, Lan-juan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Cao, Bin; Liang, Li-rong; Li, Xiao-li; Cao, Zhi-xin; Gu, Li; Wang, Chen] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Beijing Key Lab Resp & Pulm Circulat, Beijing, Peoples R China; [Yu, Hong-jie; Xu, Zhen] Chinese Ctr Dis Control & Prevent, Dis Control & Emergency Response Off, Beijing, Peoples R China; [Yan, Xi-xin] Hebei Med Univ, Dept Resp Med, Hosp 2, Shijiazhuang, Peoples R China; [Liang, Zong-an] Sichuan Univ, W China Hosp, Chengdu 610064, Peoples R China; [Zhang, Wei] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China; [Zhang, Chang-le] Wenzhou 2 Peoples Hosp, Wenzhou, Peoples R China; [Chen, Wei] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China; [Guo, Cai-ping] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China; [Jiang, Xun-liang] Childrens Hosp Hunan Prov, Changsha, Hunan, Peoples R China; [Yang, Ming] Beijing Childrens Hosp, Beijing, Peoples R China; [Deng, Guang-ming] Shaoyang Cent Hosp, Shaoyang, Peoples R China; [Yu, Kai-jiang] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China; [Hu, Ke] Wuhan Univ, Remin Hosp, Wuhan 430072, Peoples R China; [Zou, Qi] Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China	Zhejiang University; Capital Medical University; Chinese Center for Disease Control & Prevention; Hebei Medical University; Sichuan University; Nanchang University; China Medical University; Capital Medical University; Capital Medical University; Harbin Medical University; Wuhan University; Fujian Medical University	Yang, SG (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; cyh-birm@263.net	Yu, Hongjie/GZK-5351-2022; Chen, Yu/Y-3292-2019; Xiao, Yonghong/AFS-9054-2022; Keshavmurthy, Shashank/C-3672-2013; Matz, Mikhail/K-4392-2017	Keshavmurthy, Shashank/0000-0002-2235-9132; sheppard, charles/0000-0002-2579-5124; Yang, Sung-Yin/0000-0001-7431-406X; Wang, Dao Wen/0000-0002-9774-3980; Matz, Mikhail/0000-0001-5453-9819; Obura, David/0000-0003-2256-6649; Rao, Xiaoquan/0000-0001-7316-4530	Ministry of Health of People's Republic of China; World Health Organization on clinical study for the influenza A pandemic A; Beijing Science Technology [Z09000700090903]; Major State Basic Research Development Program [2009CB522107]; Mega-projects of Science Research for the 11th Five-Year Plan of China [2009ZX10004-901, 2009ZX10004-210]; National Natural Science Foundation of China [81001271]	Ministry of Health of People's Republic of China; World Health Organization on clinical study for the influenza A pandemic A; Beijing Science Technology; Major State Basic Research Development Program(National Basic Research Program of China); Mega-projects of Science Research for the 11th Five-Year Plan of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the Ministry of Health of People's Republic of China and the World Health Organization on clinical study for the influenza A pandemic A (H1N1) 2009, grants from the Beijing Science & Technology (Z09000700090903), and Major State Basic Research Development Program (2009CB522107), Mega-projects of Science Research for the 11th Five-Year Plan of China (2009ZX10004-901, 2009ZX10004-210), and the National Natural Science Foundation of China (81001271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PAND INFL H1N1 2009; [Anonymous], 2010, H1N1 2009 UPD 94; Bai L, 2011, CHEST, V139, P1156, DOI 10.1378/chest.10-1036; *CDCP, 2009, CDC EST 2009 H1N1 IN; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P431; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; KLIMOV AI, 1995, J INFECT DIS, V172, P1352, DOI 10.1093/infdis/172.5.1352; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Lee N, 2008, CLIN INFECT DIS, V46, P1323, DOI 10.1086/533477; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Weinstock DM, 2003, NEW ENGL J MED, V348, P867, DOI 10.1056/NEJM200302273480923; WHO, CDC PROT REALT RTPCR; WHO, 2009, WHO GUID PHARM MAN P; Writing Committee of the WHO Consultation on Pandemic (H1N1), 2009, NEW ENGL J MED, V362, P1708	30	115	121	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29652	10.1371/journal.pone.0029652	http://dx.doi.org/10.1371/journal.pone.0029652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22567113	gold, Green Submitted, Green Published			2022-12-25	WOS:000301568100014
J	Santos, AM; Lopez-Sanchez, N; Martin-Oliva, D; de la Villa, P; Cuadros, MA; Frade, JM				Santos, Ana M.; Lopez-Sanchez, Noelia; Martin-Oliva, David; de la Villa, Pedro; Cuadros, Miguel A.; Frade, Jose M.			Sortilin Participates in Light-dependent Photoreceptor Degeneration in Vivo	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CELL-DEATH; NEUROTROPHIC FACTOR; NEURONAL APOPTOSIS; RECEPTOR SORTILIN; INHIBITORY FACTOR; PRONGF; P75; EXPRESSION; P75(NTR)	Both proNGF and the neurotrophin receptor p75 (p75(NTR)) are known to regulate photoreceptor cell death caused by exposure of albino mice to intense illumination. ProNGF-induced apoptosis requires the participation of sortilin as a necessary p75(NTR) co-receptor, suggesting that sortilin may participate in the photoreceptor degeneration triggered by intense lighting. We report here that light-exposed albino mice showed sortilin, p75(NTR), and proNGF expression in the outer nuclear layer, the retinal layer where photoreceptor cell bodies are located. In addition, cone progenitor-derived 661W cells subjected to intense illumination expressed sortilin and p75(NTR) and released proNGF into the culture medium. Pharmacological blockade of sortilin with either neurotensin or the "pro'' domain of proNGF (pro-peptide) favored the survival of 661W cells subjected to intense light. In vivo, the pro-peptide attenuated retinal cell death in light-exposed albino mice. We propose that an auto/paracrine proapoptotic mechanism based on the interaction of proNGF with the receptor complex p75(NTR)/sortilin participates in intense light-dependent photoreceptor cell death. We therefore propose sortilin as a putative target for intervention in hereditary retinal dystrophies.	[Santos, Ana M.; Martin-Oliva, David; Cuadros, Miguel A.] Univ Granada, Dept Cell Biol, Granada, Spain; [Lopez-Sanchez, Noelia; Frade, Jose M.] IC CSIC, Inst Cajal, Madrid, Spain; [de la Villa, Pedro] Univ Alcala De Henares, Dept Physiol, Sch Med, Madrid, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad de Alcala	Santos, AM (corresponding author), Univ Granada, Dept Cell Biol, Granada, Spain.	frade@cajal.csic.es	Santos, Ana M./AAB-6302-2019; López-Sánchez, Noelia/F-5533-2010; Frade, Jose M/E-7913-2013; Martín-Oliva, David/L-8472-2014; de la Villa, Pedro/G-2322-2016; Shestopalov, Valery/AAE-9838-2020; Cuadros, Miguel A/L-3954-2014	Santos, Ana M./0000-0002-9540-2226; Frade, Jose M/0000-0001-7067-2505; Martín-Oliva, David/0000-0002-8095-5442; de la Villa, Pedro/0000-0001-9856-6616; Cuadros, Miguel A/0000-0003-4259-1649; Goldberg, Jeffrey/0000-0002-1390-7360; Shestopalov, Valery/0000-0002-1568-6637; Lopez-Sanchez, Noelia/0000-0003-3095-3438; Ivanov, Dmitry/0000-0002-5573-4402	Ministerio de Ciencia e Innovacion [BFU2009-07671, BFU2007-61659]; Fundacion Lucha contra la Ceguera [FUNDALUCE-2008]; Junta de Andalucia [P07-CVI-03008]; University of Granada (GREIB)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Lucha contra la Ceguera; Junta de Andalucia(Junta de Andalucia); University of Granada (GREIB)	This study was supported by grants from the "Ministerio de Ciencia e Innovacion'' (BFU2009-07671) and from "Fundacion Lucha contra la Ceguera'' (FUNDALUCE-2008) to JMF, as well as from "Ministerio de Ciencia e Innovacion'' (BFU2007-61659), from "Junta de Andalucia'' (P07-CVI-03008), and from "University of Granada'' (2011 GREIB incentive) to MAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi R, 2008, EUR J NEUROSCI, V27, P2103, DOI 10.1111/j.1460-9568.2008.06152.x; Al-Shawi R, 2007, ANN NY ACAD SCI, V1119, P208, DOI 10.1196/annals.1404.024; ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; Andersen OS, 2010, J BIOL CHEM, V285, P12210, DOI 10.1074/jbc.M109.062364; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Chen LW, 2008, CNS NEUROL DISORD-DR, V7, P512, DOI 10.2174/187152708787122923; Dalke C, 2005, EXP EYE RES, V81, P503, DOI 10.1016/j.exer.2005.06.004; deKozak Y, 1997, OCUL IMMUNOL INFLAMM, V5, P85, DOI 10.3109/09273949709085056; Dicou E, 2004, J NEUROSCI RES, V78, P92, DOI 10.1002/jnr.20231; Dimaras H, 2006, MOL CARCINOGEN, V45, P333, DOI 10.1002/mc.20179; Dobrowsky RT, 2000, J NEUROSCI RES, V61, P237, DOI 10.1002/1097-4547(20000801)61:3<237::AID-JNR1>3.0.CO;2-M; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Frade JM, 1996, NATURE, V383, P166; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kanan Y, 2010, ADV EXP MED BIOL, V664, P3, DOI 10.1007/978-1-4419-1399-9_1; KORSCHING S, 1987, METHOD ENZYMOL, V147, P167; Larsen JV, 2010, MOL CELL BIOL, V30, P4175, DOI 10.1128/MCB.00274-10; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Nakamura K, 2007, CELL DEATH DIFFER, V14, P1552, DOI 10.1038/sj.cdd.4402173; NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Provenzano MJ, 2008, LARYNGOSCOPE, V118, P87, DOI 10.1097/MLG.0b013e31814b8d9f; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rogue RS, 1999, BRAIN RES, V836, P110, DOI 10.1016/S0006-8993(99)01625-X; Rohrer B, 2003, EXP EYE RES, V76, P125, DOI 10.1016/S0014-4835(02)00258-0; Santos AM, 2010, J COMP NEUROL, V518, P477, DOI 10.1002/cne.22227; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Sheedlo HJ, 2002, MOL BRAIN RES, V103, P71, DOI 10.1016/S0169-328X(02)00185-7; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; Srinivasan B, 2004, J BIOL CHEM, V279, P41839, DOI 10.1074/jbc.M402872200; Srinivasan B, 2007, MOL CELL NEUROSCI, V36, P449, DOI 10.1016/j.mcn.2007.08.005; Stoica G, 2008, BRAIN RES, V1208, P204, DOI 10.1016/j.brainres.2008.02.085; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tauris J, 2011, EUR J NEUROSCI, V33, P622, DOI 10.1111/j.1460-9568.2010.07556.x; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Wei Y, 2007, NEUROSCI LETT, V429, P169, DOI 10.1016/j.neulet.2007.10.012; Xu FF, 2009, NEUROSCI LETT, V454, P81, DOI 10.1016/j.neulet.2009.02.036; YAMATO S, 1984, STAIN TECHNOL, V59, P113, DOI 10.3109/10520298409113840; Yang LP, 2007, MOL VIS, V13, P2048; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Yu DY, 2006, INVEST OPHTH VIS SCI, V47, P1109, DOI 10.1167/iovs.05-1118	59	53	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36243	10.1371/journal.pone.0036243	http://dx.doi.org/10.1371/journal.pone.0036243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558402	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000169
J	Shiryaev, SA; Cheltsov, AV; Strongin, AY				Shiryaev, Sergey A.; Cheltsov, Anton V.; Strongin, Alex Y.			Probing of Exosites Leads to Novel Inhibitor Scaffolds of HCV NS3/4A Proteinase	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; WEST-NILE-VIRUS; SERINE-PROTEASE INHIBITORS; NS4A COFACTOR PEPTIDE; IN-VITRO RESISTANCE; MACROCYCLIC INHIBITORS; POLYMERASE INHIBITORS; ANTIVIRAL THERAPY; DRUG-RESISTANCE; DENGUE-VIRUS	Background: Hepatitis C is a treatment-resistant disease affecting millions of people worldwide. The hepatitis C virus (HCV) genome is a single-stranded RNA molecule. After infection of the host cell, viral RNA is translated into a polyprotein that is cleaved by host and viral proteinases into functional, structural and non-structural, viral proteins. Cleavage of the polyprotein involves the viral NS3/4A proteinase, a proven drug target. HCV mutates as it replicates and, as a result, multiple emerging quasispecies become rapidly resistant to anti-virals, including NS3/4A inhibitors. Methodology/Principal Findings: To circumvent drug resistance and complement the existing anti-virals, NS3/4A inhibitors, which are additional and distinct from the FDA-approved telaprevir and boceprevir alpha-ketoamide inhibitors, are required. To test potential new avenues for inhibitor development, we have probed several distinct exosites of NS3/4A which are either outside of or partially overlapping with the active site groove of the proteinase. For this purpose, we employed virtual ligand screening using the 275,000 compound library of the Developmental Therapeutics Program (NCI/NIH) and the X-ray crystal structure of NS3/4A as a ligand source and a target, respectively. As a result, we identified several novel, previously uncharacterized, nanomolar range inhibitory scaffolds, which suppressed of the NS3/4A activity in vitro and replication of a sub-genomic HCV RNA replicon with a luciferase reporter in human hepatocarcinoma cells. The binding sites of these novel inhibitors do not significantly overlap with those of alpha-ketoamides. As a result, the most common resistant mutations, including V36M, R155K, A156T, D168A and V170A, did not considerably diminish the inhibitory potency of certain novel inhibitor scaffolds we identified. Conclusions/Significance: Overall, the further optimization of both the in silico strategy and software platform we developed and lead compounds we identified may lead to advances in novel anti-virals.	[Shiryaev, Sergey A.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA; [Cheltsov, Anton V.] Q MOL LLC, R&D Dept, San Diego, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Shiryaev, SA (corresponding author), Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA.	anton@q-mol.com; strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [R01CA83017, R01CA157328]; NIAID [HHSN272201000009C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health grants R01CA83017 and R01CA157328 to Alex Y. Strongin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Marintha Heil (Southern Research Institute, Birmingham, AL) for performing tests in human hepatocarcinoma cell line Huh7 ET (luc-ubi-neo/ET) that exhibits a sub-genomic HCV RNA replicon with a firefly luciferase reporter (NIAID Contract No. HHSN272201000009C). The authors are also grateful to Drs. Nicholas Cosford and Robert Ardecky (Sanford-Burnham Medical Research Institute, La Jolla, CA) for their expert support in performing our study.	Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bennett F, 2010, BIOORG MED CHEM LETT, V20, P2617, DOI 10.1016/j.bmcl.2010.02.063; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Chen X, 2002, J CHEM INF COMP SCI, V42, P1407, DOI 10.1021/ci025531g; Chevaliez S., 2006, HEPATITIS C VIRUSES, V1, P5; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; Delang L, 2011, ANTIMICROB AGENTS CH, V55, P4103, DOI 10.1128/AAC.00294-11; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fan XF, 2009, HEPATOLOGY, V50, P1765, DOI 10.1002/hep.23290; Flores MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1441, DOI 10.1016/j.bbapap.2009.06.004; Fonseca-Coronado S, 2012, J CLIN MICROBIOL, V50, P281, DOI 10.1128/JCM.05842-11; Fusco DN, 2012, ANNU REV MED, V63, P373, DOI 10.1146/annurev-med-042010-085715; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; Hiraga N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/hep.24460; Jesudian Arun B, 2012, Gastroenterol Hepatol (N Y), V8, P91; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kieffer TL, 2010, J ANTIMICROB CHEMOTH, V65, P202, DOI 10.1093/jac/dkp388; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; Kwong AD, 1999, ANTIVIR RES, V41, P65; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lin C, 2005, J BIOL CHEM, V280, P36784, DOI 10.1074/jbc.M506462200; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Liverton NJ, 2010, ANTIMICROB AGENTS CH, V54, P305, DOI 10.1128/AAC.00677-09; Llinas-Brunet M, 2004, J MED CHEM, V47, P1605, DOI 10.1021/jm0342414; Ma C, 2011, ACS COMB SCI, V13, P223, DOI 10.1021/co100033m; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Manns MP, 2007, NAT REV DRUG DISCOV, V6, P991, DOI 10.1038/nrd2411; Margeridon-Thermet S, 2010, VIRUSES-BASEL, V2, P2696, DOI 10.3390/v2122696; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Nicholls A, 2010, J MED CHEM, V53, P3862, DOI 10.1021/jm900818s; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Ortqvist P, 2010, ANTIVIR THER, V15, P841, DOI 10.3851/IMP1655; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Raboisson P, 2008, BIOORG MED CHEM LETT, V18, P4853, DOI 10.1016/j.bmcl.2008.07.088; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schaefer EAK, 2012, GASTROENTEROLOGY, V142, P1340, DOI 10.1053/j.gastro.2012.02.015; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Shiryaev SA, 2007, PROTEIN EXPRES PURIF, V52, P334, DOI 10.1016/j.pep.2006.11.009; Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136; Shiryaev SA, 2011, ASSAY DRUG DEV TECHN, V9, P69, DOI 10.1089/adt.2010.0309; Sidique S, 2009, BIOORG MED CHEM LETT, V19, P5773, DOI 10.1016/j.bmcl.2009.07.150; Stempniak M, 1997, J VIROL, V71, P2881, DOI 10.1128/JVI.71.4.2881-2886.1997; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Urbani A, 1999, BIOCHEMISTRY-US, V38, P5206, DOI 10.1021/bi982773u; Venkatraman S, 2009, BIOORG MED CHEM LETT, V19, P180, DOI 10.1016/j.bmcl.2008.10.124; Vermehren J, 2012, J VIRAL HEPATITIS, V19, P120, DOI 10.1111/j.1365-2893.2011.01449.x; Vermehren J, 2011, EUR J MED RES, V16, P303, DOI 10.1186/2047-783X-16-7-303; Vicenti I, 2012, J ANTIMICROB CHEMOTH, V67, P984, DOI 10.1093/jac/dkr581; Welsch C, 2012, GUT, V61, P36, DOI 10.1136/gutjnl-2012-302144; Wolynes PG, 1997, P NATL ACAD SCI USA, V94, P6170, DOI 10.1073/pnas.94.12.6170; Zhou Y, 2008, ANTIMICROB AGENTS CH, V52, P110, DOI 10.1128/AAC.00863-07; Zhu HM, 2011, PROTEINS, V79, P2428, DOI 10.1002/prot.23064	75	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40029	10.1371/journal.pone.0040029	http://dx.doi.org/10.1371/journal.pone.0040029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768327	Green Submitted, gold, Green Published			2022-12-25	WOS:000305966500040
J	Wang, XM; Zhu, CF; Bao, WG; Zhao, K; Niu, JQ; Yu, XF; Zhang, WY				Wang, Xiaomei; Zhu, Chunfeng; Bao, Wanguo; Zhao, Ke; Niu, Junqi; Yu, Xiao-Fang; Zhang, Wenyan			Characterization of Full-Length Enterovirus 71 Strains from Severe and Mild Disease Patients in Northeastern China	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FOOT; HAND; TAIWAN; RECOMBINATION; INFECTION; EVOLUTION; OUTBREAK	Human enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) has been a leading cause of childhood infection in China since 2008. Epidemic and molecular characteristics of HFMD have been examined in many areas of China, including the central and southern regions. However, clinical and genetic characterization of EV71 in the northeastern region of China is scarce. In this study, a series of analyses were performed on seven full-length EV71 sequences from HFMD patients who had either severe or mild disease. We have determined that these seven circulating EV71 viruses from Changchun, China are actually complex recombinant viruses involving multiple type A human enterovirus (HEV). Classified as EV71 subtype C4 (EV71 C4), these Changchun EV71 viruses contain genetic recombination events between the CA4, CA5, EV71B4 and EV71C1 strains. Most of the structural protein region (P1) of these viruses resembled that of the prototype EV71 C1 strains. The non-structural protein domains (P2 and P3) showed a high degree of similarity with CA4, CA5 and EV71 B4 in different regions. The 5'UTR had unclassified recombination, while partial 3D region of these viruses showed a high degree of similarity to CA16. Phylogenetic analysis of full-length or partial sequences of isolates from severe or mild disease patients in Changchun always formed a single cluster in various phylogenetic analyses of different genomic regions, suggesting that all seven strains originated from one single common ancestor. There was no correlation between viral genomic sequence and virulence. Thus, we found that circulating recombinant forms of EV71 are prevalent among HFMD patients in Northeastern China. The existence of a unique cluster of EV71 related viruses in Northeast China has important implications for vaccine development that would address the increasing prevalence of HFMD.	[Wang, Xiaomei; Zhu, Chunfeng; Zhao, Ke; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wang, Xiaomei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XM (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	junqiniu@yahoo.com.cn; xfyu@jhsph.edu; zhangwenyan@jlu.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	Specialized Research Fund for the Doctoral Program of Higher Education; Jilin University [200903258]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University); Key Laboratory of Molecular Virology, Jilin Province, China; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by funding from the Specialized Research Fund for the Doctoral Program of Higher Education and Jilin University (No200903258) to Wenyan Zhang, and a grant from the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi XD, 2011, CENT EUR J MED, V6, P220, DOI 10.2478/s11536-010-0075-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	22	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32405	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	23110176	Green Submitted, Green Published, gold			2022-12-25	WOS:000304523400005
J	Wang, XX; Huang, M; Wang, YZ				Wang, Xinxia; Huang, Ming; Wang, Yizhen			The Effect of Insulin, TNF alpha and DHA on the Proliferation, Differentiation and Lipolysis of Preadipocytes Isolated from Large Yellow Croaker (Pseudosciaena Crocea R.)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TROUT ONCORHYNCHUS-MYKISS; FATTY-ACID SYNTHASE; INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED RECEPTORS ALPHA; SIGNAL-RELATED KINASE; LPL GENE-EXPRESSION; RAINBOW-TROUT; LIPOPROTEIN-LIPASE	Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNF alpha and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNF alpha and DHA inhibited cell proliferation and differentiation. While TNF alpha stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor alpha, gamma (PPAR alpha, PPAR gamma) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNF alpha and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.	[Wang, Xinxia; Huang, Ming; Wang, Yizhen] Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	NSFC (National Natural Science Foundation of China) [30901104]; China Postdoctoral Science Foundation [2009046138]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NSFC (National Natural Science Foundation of China, grant # 30901104), and the China Postdoctoral Science Foundation (grant # 2009046138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Albalat A, 2005, COMP BIOCHEM PHYS A, V142, P347, DOI 10.1016/j.cbpa.2005.08.006; Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Albalat A, 2005, J ENDOCRINOL, V184, P527, DOI 10.1677/joe.1.05940; Albalat A, 2006, GEN COMP ENDOCR, V146, P226, DOI 10.1016/j.ygcen.2005.11.011; [Anonymous], 2011, CHIN FISH STAT YB; Awad AB, 2000, J NUTR BIOCHEM, V11, P153, DOI 10.1016/S0955-2863(99)00087-X; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Bouraoui L, 2010, AM J PHYSIOL-REG I, V299, pR33, DOI 10.1152/ajpregu.00457.2009; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Claycombe KJ, 1998, AM J PHYSIOL-REG I, V274, pR1253, DOI 10.1152/ajpregu.1998.274.5.R1253; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; Garcia-Castillo J, 2004, CELL MOL LIFE SCI, V61, P1331, DOI 10.1007/s00018-004-4068-1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HARMON JS, 1992, GEN COMP ENDOCR, V87, P214, DOI 10.1016/0016-6480(92)90025-F; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Khan S, 2002, J LIPID RES, V43, P979; Kim HK, 2006, J NUTR, V136, P409, DOI 10.1093/jn/136.2.409; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Oku H, 2006, COMP BIOCHEM PHYS B, V144, P326, DOI 10.1016/j.cbpb.2006.03.008; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SMITH RA, 1986, J BIOL CHEM, V261, P4871; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Suryawan A, 1997, J ANIM SCI, V75, P105; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao ZY, 2008, J FOOD LIPIDS, V15, P534, DOI 10.1111/j.1745-4522.2008.00138.x; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	87	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48069	10.1371/journal.pone.0048069	http://dx.doi.org/10.1371/journal.pone.0048069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110176	Green Submitted, gold, Green Published			2022-12-25	WOS:000310262500033
J	Wang, XG; Comita, LS; Hao, ZQ; Davies, SJ; Ye, J; Lin, F; Yuan, ZQ				Wang, Xugao; Comita, Liza S.; Hao, Zhanqing; Davies, Stuart J.; Ye, Ji; Lin, Fei; Yuan, Zuoqiang			Local-Scale Drivers of Tree Survival in a Temperate Forest	PLOS ONE			English	Article							TROPICAL TREE; DENSITY-DEPENDENCE; HABITAT ASSOCIATIONS; SHADE TOLERANCE; SPATIAL DISTRIBUTIONS; SIZE DISTRIBUTIONS; SOIL INTERACTIONS; INDIVIDUAL TREES; LONG-TERM; GROWTH	Tree survival plays a central role in forest ecosystems. Although many factors such as tree size, abiotic and biotic neighborhoods have been proposed as being important in explaining patterns of tree survival, their contributions are still subject to debate. We used generalized linear mixed models to examine the relative importance of tree size, local abiotic conditions and the density and identity of neighbors on tree survival in an old-growth temperate forest in northeastern China at three levels (community, guild and species). Tree size and both abiotic and biotic neighborhood variables influenced tree survival under current forest conditions, but their relative importance varied dramatically within and among the community, guild and species levels. Of the variables tested, tree size was typically the most important predictor of tree survival, followed by biotic and then abiotic variables. The effect of tree size on survival varied from strongly positive for small trees (1-20 cm dbh) and medium trees (20-40 cm dbh), to slightly negative for large trees (>40 cm dbh). Among the biotic factors, we found strong evidence for negative density and frequency dependence in this temperate forest, as indicated by negative effects of both total basal area of neighbors and the frequency of conspecific neighbors. Among the abiotic factors tested, soil nutrients tended to be more important in affecting tree survival than topographic variables. Abiotic factors generally influenced survival for species with relatively high abundance, for individuals in smaller size classes and for shade-tolerant species. Our study demonstrates that the relative importance of variables driving patterns of tree survival differs greatly among size classes, species guilds and abundance classes in temperate forest, which can further understanding of forest dynamics and offer important insights into forest management.	[Wang, Xugao; Hao, Zhanqing; Ye, Ji; Lin, Fei; Yuan, Zuoqiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China; [Comita, Liza S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Davies, Stuart J.] Harvard Univ, Ctr Trop Forest Sci, Boston, MA 02115 USA; [Davies, Stuart J.] Smithsonian Trop Res Inst, Boston, MA USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wang, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	Chinese Academy of Sciences [KSCX2-EW-Z-5, KZCX2-YW-QN402]; National Natural Science Foundation of China [40971286, 31011120470, 31061160188]; Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-5 and KZCX2-YW-QN402) and the National Natural Science Foundation of China (40971286, 31011120470 and 31061160188). XW acknowledges the support of a fellowship from the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the HSBC Climate Partnership. LSC acknowledges the support of a fellowship from the National Center for Ecological Analysis and Synthesis, a center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2009, LME4 LINEAR MIXED EF; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castagneri D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009111; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; FILIP GM, 1982, PLANT DIS, V66, P240, DOI 10.1094/PD-66-240; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A, DATA ANAL USING REGR; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrell FE, 2001, REGRESSION MODELING; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HIBBS DE, 1983, ECOLOGY, V64, P1394, DOI 10.2307/1937493; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Development Core Team, 2009, R FDN STAT COMP; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Slik JW, 2001, OECOLOGIA, V141, P114; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang LiWei, 2011, Biodiversity Science, V19, P260, DOI 10.3724/SP.J.1003.2011.11279; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zhang J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008086; Zhao DH, 2006, ECOL MODEL, V196, P90, DOI 10.1016/j.ecolmodel.2006.02.002; Zuur Alain F., 2009, P1	83	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29469	10.1371/journal.pone.0029469	http://dx.doi.org/10.1371/journal.pone.0029469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	23110176	gold, Green Submitted, Green Published			2022-12-25	WOS:000302733900002
J	Wang, XM; Yang, R; Feng, SF; Hou, XQ; Zhang, YQ; Li, Y; Ren, Y				Wang, Xumei; Yang, Rui; Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Li, Yan; Ren, Yi			Genetic Variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), Two Medicinally and Endemic Species in China Using ISSR Markers	PLOS ONE			English	Article							CHLOROPLAST DNA; DIVERSITY; SEQUENCE; EVOLUTION; RHUBARB; DIFFERENTIATION; POPULATIONS; RADIATION; PLATEAU; NUMBER	Aims: Both Rheum palmatum and R. tanguticum are important but endangered medicinal plants endemic to China. In this study, we aimed to (i) investigate the level and pattern of genetic variability within/among populations of those species; (ii) evaluate genetic differentiation between both species and its relationships and ascertain whether both species are consistent with their current taxonomical treatment as separate species; and (iii) discuss the implications for the effective conservation of two species. Methods: Total 574 individuals from 30 populations of R. palmatum and R. tanguticum were collected, covering the entire distribution range of two species in China. The genetic variation within and among 30 populations was evaluated using inter-simple sequence repeat (ISSR) markers. Important Findings: Twelve selected ISSR primers generated a total of 175 fragments, 173 (98.86%) of which were polymorphic. The Nei's gene diversity (H) and Shannon's index (I) of both species were high at species level (H = 0.3107, I = 0.4677 for R. palmatum; H = 0.2848, I = 0.4333 for R. tanguticum). But for both species, the genetic diversity was low at population level, and average within-population diversity of R. palmatum was H = 0.1438, I = 0.2151, and that of R. tanguticum was H = 0.1415, I = 0.2126. The hierarchical AMOVA revealed high levels of among-population genetic differentiation in both species, in line with the gene differentiation coefficient and the limited among-population gene flow (R. palmatum: Phi(st) = 0.592, G(st) = 0.537, N-m = 0.432; R. tanguticum: Phi(st) = 0.567, G(st) = 0.497, N-m = 0.507). By contrast, only 6.52% of the total genetic variance was partitioned between R. palmatum and R. tanguticum. Bayesian analysis, UPGMA cluster analysis, and PCoA analysis all demonstrated the similar results. A significant isolation-by-distance pattern was revealed in R. palmatum (r = 0.547, P = 0.010), but not in R. tanguticum (r = 0.241, P = 0.100). Based on these results, effective conservation strategies were proposed for these two species. The small molecular variance between R. palmatum and R. tanguticum revealed that they had a common ancestor, and we considered that these two species might not be good species.	[Wang, Xumei; Yang, Rui; Li, Yan] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	National Nature Science Foundation of China [81001602]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Nature Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel SH, 2004, GENET RESOUR CROP EV, V51, P269, DOI 10.1023/B:GRES.0000024012.59828.6b; [Anonymous], 1984, GARTENFLORA, V23, P305; Bao BJ., 2003, FLORA CHINA, V5, P341; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Chen Da-Xia, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2309; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chennaoui-Kourda H, 2007, BIOCHEM SYST ECOL, V35, P682, DOI 10.1016/j.bse.2007.05.005; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P22; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freeland J. R., 2011, MOL ECOLOGY; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hogbin PM, 1999, CONSERV BIOL, V13, P514, DOI 10.1046/j.1523-1739.1999.98182.x; Hu YP, 2010, BIOCHEM SYST ECOL, V38, P264, DOI 10.1016/j.bse.2010.01.006; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Knuth P, 1906, HDB FLOWER POLLINATI, V3; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li JM, 2007, PLANT SCI, V172, P1048, DOI 10.1016/j.plantsci.2007.02.009; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Lu Jian-ying, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P66; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Miller MP, 1997, TOOLS POPULATION GEN; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2003, EUPHYTICA, V129, P15, DOI 10.1023/A:1021567821141; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang A. T., 2009, THESIS LANZHOU U; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wang XM, 2010, J MED PLANTS RES, V4, P904; Wright S, 1931, GENETICS, V16, P0097; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Xia T, 2005, BIOCHEM GENET, V43, P87, DOI 10.1007/s10528-005-1502-5; Xiao Su-ping, 2007, Zhongguo Zhong Yao Za Zhi, V32, P195; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yeh F.C., 1997, POPGENE VERSION 1 31	55	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51667	10.1371/journal.pone.0051667	http://dx.doi.org/10.1371/journal.pone.0051667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23110176	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300022
J	Wang, XH; Fiorini, Z; Smith, C; Zhang, YN; Li, J; Watkins, LR; Yin, H				Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Zhang, Yingning; Li, Jing; Watkins, Linda R.; Yin, Hang			Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYCLIN A(2); ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; EXPRESSION; BRAIN; ACTIVATION; RESISTANCE; STABILITY; APOPTOSIS	The lateral transmembrane protein-protein interactions (PPI) have been regarded as "undruggable" despite their importance in many essential biological processes. The homo-trimerization of transmembrane domain 5 (TMD-5) of latent membrane protein 1 (LMP-1) is critical for the constitutive oncogenic activation of the Epstein-Barr virus (EBV). Herein we repurpose the antimicrobial agent pentamidine as a regulator of LMP-1 TMD-5 lateral interactions. The results of ToxR assay, tryptophan fluorescence assay, courmarin fluorescence dequenching assay, and Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) consistently show pentamidine disrupts LMP-1 TMD-5 lateral interactions. Furthermore, pentamidine inhibits LMP-1 signaling, inducing cellular apoptosis and suppressing cell proliferation in the EBV infected B cells. In contrast, EBV negative cells are less susceptible to pentamidine. This study provides a novel non-peptide small molecule agent for regulating LMP-1 TMD-5 lateral interactions.	[Li, Jing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	lijing6515@pumch.cn; hubert.yin@colorado.edu	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	National Institutes of Health [R21CA138373, DA024044]; Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research [SKF-08-101]; Stand Up to Cancer Innovative Research Award [SU2C]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research; Stand Up to Cancer Innovative Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Institutes of Health (R21CA138373, DA024044), Cancer League of Colorado for financial supports of this work. H.Y. is also grateful for the 2009 Elion Award from the American Association of Cancer Research, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-08-101) and a Stand Up to Cancer (SU2C) Innovative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Grigoriev MY, 2002, CELL CYCLE, V1, P337, DOI 10.4161/cc.1.5.152; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Joce C, 2011, JOVE-J VIS EXP, DOI 10.3791/2721; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun BH, 2000, WORLD J GASTROENTERO, V6, P356; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XH, 2008, J PHYS CHEM B, V112, P8346, DOI 10.1021/jp712026m; Wang X, 2007, PROTEIN EXPRES PURIF, V56, P27, DOI 10.1016/j.pep.2007.05.011; Wang XH, 2012, BBA-BIOMEMBRANES, V1818, P2282, DOI 10.1016/j.bbamem.2012.05.013; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878	38	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47703	10.1371/journal.pone.0047703	http://dx.doi.org/10.1371/journal.pone.0047703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23110176	gold, Green Published, Green Submitted			2022-12-25	WOS:000310050200040
